https://pharmadispatch.com/privacy-policy 2019-10-13T13:13:38+11:00 https://pharmadispatch.com/terms-of-service 2018-02-06T04:57:19+11:00 https://pharmadispatch.com/cookies 2014-06-17T00:38:51+10:00 https://pharmadispatch.com/news 2024-06-07T03:15:54+10:00 https://pharmadispatch.com/about 2026-01-10T00:04:48+11:00 https://pharmadispatch.com/about/privacy-statement 2019-06-29T09:00:47+10:00 https://pharmadispatch.com/subscribe 2023-06-16T13:55:17+10:00 https://pharmadispatch.com/jobs 2014-09-24T07:02:46+10:00 https://pharmadispatch.com/events 2014-09-24T07:03:04+10:00 https://pharmadispatch.com/ads 2014-11-06T08:44:17+11:00 https://pharmadispatch.com/ads/300x250 2026-03-17T16:18:26+11:00 https://pharmadispatch.com/ads/home-banner 2024-11-13T04:56:08+11:00 https://pharmadispatch.com/contact 2020-12-27T11:36:35+11:00 https://pharmadispatch.com/plan 2016-10-29T01:06:58+11:00 https://pharmadispatch.com/videos 2020-05-06T08:14:10+10:00 https://pharmadispatch.com/conference-terms-and-condtions 2018-02-06T04:48:56+11:00 https://pharmadispatch.com/api 2023-06-16T13:53:43+10:00 https://pharmadispatch.com/ 2014-11-25T06:31:05+11:00 https://pharmadispatch.com/plan/product/1/premium-digital-access 2026-03-07T13:48:59+11:00 https://pharmadispatch.com/plan/product/3/premium-digital-access-group 2024-05-08T01:51:13+10:00 https://pharmadispatch.com/plan/product/4/conference 2022-08-04T01:57:38+10:00 https://pharmadispatch.com/news/a-decade-of-readiness-as-avita-medical-expands-burn-response-capability 2026-04-09T11:15:01+10:00 https://pharmadispatch.com/news/moderna-names-carolyn-tucek-szabo-to-lead-australia-and-new-zealand-operations 2026-04-09T10:45:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-announces-a-shift-in-treatment-for-blood-cancer 2026-04-09T10:28:01+10:00 https://pharmadispatch.com/news/it-is-imperative-to-very-carefully-read-what-minister-said-and-then-hear-it 2026-04-09T02:00:01+10:00 https://pharmadispatch.com/news/stuart-dignam-joins-mtpconnect-board-as-it-embarks-its-second-decade 2026-04-08T14:41:01+10:00 https://pharmadispatch.com/news/a-frontline-of-everyday-healthcare-and-its-critical-role-in-addressing-stigma 2026-04-08T14:29:01+10:00 https://pharmadispatch.com/news/orthocell-shrugs-off-us-tariff-threat-as-australian-biotechs-play-down-impact 2026-04-08T10:56:01+10:00 https://pharmadispatch.com/news/immutep-reassesses-and-resets-lead-cancer-program-following-trial-setback 2026-04-08T10:33:01+10:00 https://pharmadispatch.com/news/a-flexible-option-for-rett-syndrome-sare-with-broader-access-to-neuren-therapy 2026-04-08T10:26:01+10:00 https://pharmadispatch.com/news/australian-companies-downplay-us-tariff-risk-as-csl-and-mayne-signal-limited-impact 2026-04-08T02:01:01+10:00 https://pharmadispatch.com/news/i-use-the-monitoring-technology-intermittently-when-i-can-afford-it 2026-04-08T02:00:01+10:00 https://pharmadispatch.com/news/sanofis-liz-selby-we-dont-lack-ideas-but-we-do-lack-alignment 2026-04-08T02:00:01+10:00 https://pharmadispatch.com/news/australian-nuclear-medicine-reports-strong-revenue-growth-and-advances-pipeline 2026-04-07T14:21:01+10:00 https://pharmadispatch.com/news/biosimilar-uptake-remains-low-in-australia-despite-rising-biologic-expenditure 2026-04-07T02:00:01+10:00 https://pharmadispatch.com/news/it-was-a-least-a-signal-possibly-a-statement-of-intent-and-even-a-revelation 2026-04-07T02:00:01+10:00 https://pharmadispatch.com/news/families-issue-urgent-call-for-access-to-life-changing-eczema-treatment 2026-04-07T02:00:01+10:00 https://pharmadispatch.com/news/the-rationale-for-a-higher-us-pharmaceutical-tariff-looks-very-familiar-from-here 2026-04-07T02:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-builds-new-communications-team-with-media-appointment 2026-04-06T16:42:01+10:00 https://pharmadispatch.com/news/vitura-health-names-justin-james-as-ceo-to-drive-next-phase-of-growth 2026-04-06T13:43:01+10:00 https://pharmadispatch.com/news/clinuvel-spotlights-vitiligo-progress-and-long-term-safety-data-at-major-dermatology-gathering 2026-04-06T13:25:01+10:00 https://pharmadispatch.com/news/algorae-pharmaceuticals-secures-fresh-capital-to-accelerate-ai-driven-drug-strategy 2026-04-06T13:21:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-2-april 2026-04-02T14:09:01+11:00 https://pharmadispatch.com/news/us-confirmed-trade-concerns-with-australia-and-new-zealand-on-pharmaceuticals-and-ip 2026-04-02T02:00:01+11:00 https://pharmadispatch.com/news/a-call-to-value-life-through-faster-and-fairer-access-to-medicines-in-new-zealand 2026-04-02T02:00:01+11:00 https://pharmadispatch.com/news/law-change-clears-path-for-nationwide-rollout-of-rsv-protection-for-australian-infants 2026-04-02T02:00:01+11:00 https://pharmadispatch.com/news/pets-at-the-heart-of-healing-as-new-campaign-invites-australians-to-share-their-stories 2026-04-02T02:00:01+11:00 https://pharmadispatch.com/news/new-partnership-expands-access-to-menopause-therapy-for-australian-women 2026-04-02T02:00:01+11:00 https://pharmadispatch.com/news/adalta-reports-positive-tumour-responses-in-advanced-mesothelioma-trial 2026-04-01T14:42:01+11:00 https://pharmadispatch.com/news/clearing-the-path-for-neurons-as-new-data-strengthens-case-for-nuz-001 2026-04-01T14:36:01+11:00 https://pharmadispatch.com/news/engineered-immune-cells-show-striking-durability-against-hard-to-treat-cancers 2026-04-01T14:30:01+11:00 https://pharmadispatch.com/news/biogen-to-acquire-apellis-in-significant-bet-on-rare-disease-growth 2026-04-01T03:56:01+11:00 https://pharmadispatch.com/news/locally-developed-therapy-reaches-australian-patients-through-pbs-listing 2026-04-01T02:00:01+11:00 https://pharmadispatch.com/news/patients-australia-survey-reveals-some-targets-to-address-barriers-to-biosimilar-uptake 2026-03-31T18:54:01+11:00 https://pharmadispatch.com/news/gbma-appoints-new-ceo-to-lead-next-phase-of-affordable-medicines-in-australia 2026-03-31T18:41:01+11:00 https://pharmadispatch.com/news/pbs-expands-treatment-options-for-rare-diseases-with-april-listings 2026-03-31T18:36:01+11:00 https://pharmadispatch.com/news/a-process-getting-underway-must-focus-on-making-the-system-netter-not-just-cheaper 2026-03-31T04:13:01+11:00 https://pharmadispatch.com/news/a-silent-crisis-in-plain-sight-as-arthritis-burden-grows-while-research-funding-falls-behind 2026-03-31T02:00:01+11:00 https://pharmadispatch.com/news/a-new-opportunity-for-biosimilars-as-sector-leaders-gather-in-canberra 2026-03-31T02:00:01+11:00 https://pharmadispatch.com/news/those-who-recognise-and-respond-to-the-reality-will-be-better-positioned-to-shape-reforms 2026-03-31T02:00:01+11:00 https://pharmadispatch.com/news/medical-research-powering-australias-health-and-economic-future 2026-03-31T02:00:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-updates-investors-on-key-meeting-with-us-regulator 2026-03-30T12:22:01+11:00 https://pharmadispatch.com/news/aroa-biosurgery-reports-promising-trial-milestone-for-advanced-wound-treatment 2026-03-30T12:17:01+11:00 https://pharmadispatch.com/news/genetic-signatures-reshapes-its-business-to-cut-costs-and-drive-growth 2026-03-30T12:12:01+11:00 https://pharmadispatch.com/news/cynata-reaches-crucial-milestone-as-phase-2-trial-moves-toward-results 2026-03-30T12:09:01+11:00 https://pharmadispatch.com/news/ai-meets-oncology-as-algorae-advances-drug-discovery-collaboration 2026-03-30T12:02:01+11:00 https://pharmadispatch.com/news/the-minister-was-subtle-but-the-message-could-hardly-be-clearer 2026-03-30T09:52:01+11:00 https://pharmadispatch.com/news/breathing-easy-in-an-ageing-asia-pacific-means-fixing-a-neglected-health-crisis 2026-03-30T02:00:01+11:00 https://pharmadispatch.com/news/government-expands-access-to-cancer-therapy-but-holds-short-on-pan-tumour-listing 2026-03-30T02:00:01+11:00 https://pharmadispatch.com/news/new-treatment-milestone-offers-fresh-hope-for-australians-living-with-cidp 2026-03-30T02:00:01+11:00 https://pharmadispatch.com/news/open-letter-calls-for-ministerial-action-on-access-to-continuous-glucose-monitoring-devices 2026-03-30T02:00:01+11:00 https://pharmadispatch.com/news/a-new-chapter-for-juvenile-arthritis-foundation-australia-as-it-continues-search-for-new-leaders 2026-03-27T15:58:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-reviewpodcast-27-march 2026-03-27T11:29:01+11:00 https://pharmadispatch.com/news/this-is-the-not-so-quiet-demand-and-doctrine-of-rationed-health-care 2026-03-27T02:00:01+11:00 https://pharmadispatch.com/news/the-unseen-price-of-survival-for-women-facing-early-breast-cancer-in-australia 2026-03-27T02:00:01+11:00 https://pharmadispatch.com/news/if-these-can-be-presented-as-positives-then-we-really-have-become-accustomed-to-terrible 2026-03-26T15:25:01+11:00 https://pharmadispatch.com/news/liberty-expands-into-asia-pacific-life-sciences-insurance-with-new-tailored-offering 2026-03-25T17:43:01+11:00 https://pharmadispatch.com/news/budget-delivers-progress-but-hundreds-of-thousands-still-waiting-for-access 2026-03-25T16:53:01+11:00 https://pharmadispatch.com/news/to-what-extent-does-the-system-see-itself-as-bound-by-external-review 2026-03-25T15:04:01+11:00 https://pharmadispatch.com/news/pbac-agenda-reflects-increasing-number-of-companies-seeking-revised-recommendations 2026-03-25T14:37:01+11:00 https://pharmadispatch.com/news/community-pharmacies-set-to-expand-patient-care-following-labor-re-election-in-south-australia 2026-03-25T13:28:01+11:00 https://pharmadispatch.com/news/clarity-advances-us-manufacturing-strategy-with-major-copper-64-supply-agreement 2026-03-25T10:50:01+11:00 https://pharmadispatch.com/news/as-horizon-europe-winds-down-its-successor-program-remains-a-work-in-progress 2026-03-25T10:20:01+11:00 https://pharmadispatch.com/news/faster-fda-pathway-approves-new-higher-dose-weight-loss-therapy-in-just-54-days 2026-03-25T03:00:01+11:00 https://pharmadispatch.com/news/even-small-changes-can-still-become-foundations-for-the-next-but-understand-how-decisions-are-ma 2026-03-25T02:00:01+11:00 https://pharmadispatch.com/news/australia-moves-closer-to-europe-as-health-and-research-ties-deepen-under-landmark-agreement 2026-03-25T02:00:01+11:00 https://pharmadispatch.com/news/auditor-general-proposes-possible-reviews-of-new-centre-for-disease-control 2026-03-24T15:45:01+11:00 https://pharmadispatch.com/news/radiopharm-reports-strong-interim-results-for-brain-metastases-imaging-agent 2026-03-24T15:30:01+11:00 https://pharmadispatch.com/news/cyclopharm-expands-us-footprint-with-major-multi-site-agreement-in-leading-academic-health-syste 2026-03-24T15:29:01+11:00 https://pharmadispatch.com/news/first-patient-treated-in-australian-trial-targeting-core-als-disease-mechanism 2026-03-24T15:28:01+11:00 https://pharmadispatch.com/news/pfizer-updates-on-promising-step-towards-a-lyme-disease-vaccine-candidate 2026-03-24T04:16:01+11:00 https://pharmadispatch.com/news/a-new-chapter-for-national-pharmacies-as-experienced-executive-steps-into-customer-leadership 2026-03-24T01:00:01+11:00 https://pharmadispatch.com/news/australian-biotech-surges-in-response-to-trial-suggesting-a-new-hope-in-the-fight-against-pancre 2026-03-24T01:00:01+11:00 https://pharmadispatch.com/news/balancing-price-speed-and-access-how-companies-manage-the-pathway-to-market-access 2026-03-23T02:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-calls-for-tough-action-over-deeply-concerning-pbs-fraud 2026-03-23T02:00:01+11:00 https://pharmadispatch.com/news/pharmac-seeks-public-input-to-improve-understanding-of-complex-cases-program 2026-03-23T02:00:01+11:00 https://pharmadispatch.com/news/the-importance-of-humility-and-understanding-the-other-side-of-the-equation 2026-03-22T02:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-20-march 2026-03-20T12:55:01+11:00 https://pharmadispatch.com/news/australias-peculiar-obsession-with-hta-is-costing-jobs-and-lives 2026-03-20T02:00:01+11:00 https://pharmadispatch.com/news/gilead-fellowships-mark-fifteen-years-of-advancing-australian-patient-care-research 2026-03-20T02:00:01+11:00 https://pharmadispatch.com/news/novo-noridisk-launches-program-aimed-at-turning-the-tide-on-medical-waste 2026-03-20T02:00:01+11:00 https://pharmadispatch.com/news/integrated-alliance-aims-to-fast-track-theranostics-trials-in-australia 2026-03-20T01:00:01+11:00 https://pharmadispatch.com/news/sanofi-opens-new-headquarters-with-a-focus-on-community-and-innovation 2026-03-19T14:04:01+11:00 https://pharmadispatch.com/news/owen-smith-on-the-missing-strategy-at-the-heart-of-australias-life-sciences-sector 2026-03-19T01:00:01+11:00 https://pharmadispatch.com/news/robyn-ward-calls-for-action-on-research-infrastructure-investment 2026-03-19T01:00:01+11:00 https://pharmadispatch.com/news/australia-stakes-a-claim-in-global-gene-therapy-manufacturing-through-new-vvmf-and-oxb-partnersh 2026-03-18T18:47:01+11:00 https://pharmadispatch.com/news/unified-voice-emerges-as-australias-medicinal-cannabis-leaders-join-forces 2026-03-18T15:11:01+11:00 https://pharmadispatch.com/news/the-moral-stakes-of-the-discussion-became-clear-and-then-hta-regains-control 2026-03-18T03:00:01+11:00 https://pharmadispatch.com/news/renewed-calls-for-major-investment-in-life-sciences-to-secure-nations-innovation-future 2026-03-18T02:00:01+11:00 https://pharmadispatch.com/news/advisory-committees-might-live-to-regret-their-increasing-role-as-policy-advisors 2026-03-18T02:00:01+11:00 https://pharmadispatch.com/news/oncosil-secures-full-subscription-entitlement-offer-to-advance-cancer-treatment-program 2026-03-17T15:36:01+11:00 https://pharmadispatch.com/news/firebrick-pharma-recruits-global-dealmaker-to-accelerate-nasodine-expansion 2026-03-17T15:34:01+11:00 https://pharmadispatch.com/news/regulators-clear-path-for-pivotal-trial-of-pyc-vision-therapy-for-rare-blinding-disease 2026-03-17T15:33:01+11:00 https://pharmadispatch.com/news/implantable-sensor-approved-in-australia-could-transform-how-hydrocephalus-is-monitored 2026-03-17T15:32:01+11:00 https://pharmadispatch.com/news/excellence-in-education-drives-a-stronger-pharmaceutical-industry 2026-03-17T02:00:01+11:00 https://pharmadispatch.com/news/royal-visit-highlights-new-collaborations-targeting-obesity-and-liver-disease 2026-03-16T13:22:01+11:00 https://pharmadispatch.com/news/australian-pharmaceutical-partnership-aims-to-expand-access-to-innovative-hypertension-therapy 2026-03-16T13:18:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-australians-still-misunderstand-multiple-sclerosis-despite-advances-in-treatm 2026-03-16T12:49:01+11:00 https://pharmadispatch.com/news/the-current-debate-over-pharmacy-prescribing-is-missing-a-key-fact 2026-03-16T10:07:01+11:00 https://pharmadispatch.com/news/it-is-profoundly-wrong-for-any-system-to-exclude-compassion-while-outsourcing-it-to-others 2026-03-16T00:00:01+11:00 https://pharmadispatch.com/news/scientists-identify-highly-specific-targets-that-could-transform-multiple-myeloma-treatment 2026-03-15T16:05:01+11:00 https://pharmadispatch.com/news/csl-seqirus-adjuvanted-flu-vaccine-approval-extended-to-australians-aged-50-and-over 2026-03-15T15:56:01+11:00 https://pharmadispatch.com/news/gsk-claims-pharma-cup-as-kosi-challenge-surpasses-fundraising-record 2026-03-15T13:28:01+11:00 https://pharmadispatch.com/news/new-program-aims-to-make-womens-health-care-more-affordable-and-accessible 2026-03-13T11:53:01+11:00 https://pharmadispatch.com/news/australians-turn-to-local-pharmacies-as-frontline-of-everyday-healthcare 2026-03-13T11:44:01+11:00 https://pharmadispatch.com/news/sandoz-and-camp-quality-unite-to-strengthen-support-for-australian-families-facing-childhood-can 2026-03-13T04:00:01+11:00 https://pharmadispatch.com/news/the-leadership-challenge-behind-australias-medicine-access-gap 2026-03-13T02:01:01+11:00 https://pharmadispatch.com/news/australia-has-spent-four-decades-having-the-wrong-conversation-about-medicines-access 2026-03-13T02:00:01+11:00 https://pharmadispatch.com/news/an-absolute-medical-miracle-mps-highlight-progress-and-challenges-at-cystic-fibrosis-event 2026-03-13T02:00:01+11:00 https://pharmadispatch.com/news/australias-top-community-pharmacists-honoured-at-national-awards 2026-03-13T02:00:01+11:00 https://pharmadispatch.com/news/a-new-prostate-cancer-technology-moves-closer-to-global-trials-after-strong-early-results 2026-03-12T15:17:01+11:00 https://pharmadispatch.com/news/cell-therapy-company-mesoblast-names-executive-to-guide-clinical-development-and-medical-affairs 2026-03-12T15:16:01+11:00 https://pharmadispatch.com/news/patrys-moves-toward-first-human-trial-for-injectable-delirium-therapy 2026-03-12T15:15:01+11:00 https://pharmadispatch.com/news/imugene-launches-20-million-capital-raise-to-fund-expansion-of-azer-cel-trials 2026-03-12T15:14:01+11:00 https://pharmadispatch.com/news/australia-at-a-crossroads-as-the-nuclear-medicine-revolution-gathers-pace 2026-03-12T02:00:01+11:00 https://pharmadispatch.com/news/new-zealand-confirms-earlier-access-to-breakthrough-cystic-fibrosis-medicines 2026-03-12T02:00:01+11:00 https://pharmadispatch.com/news/fundraising-racing-towards-total-target-as-teams-and-participants-prepare-to-climb 2026-03-11T19:05:01+11:00 https://pharmadispatch.com/news/heidi-and-medadvisor-join-forces-to-bring-ai-powered-clinical-tools-to-australian-pharmacies 2026-03-11T14:29:01+11:00 https://pharmadispatch.com/news/there-is-an-ideology-behind-our-funding-systems-and-its-the-greatest-barrier-to-change 2026-03-11T02:00:01+11:00 https://pharmadispatch.com/news/new-patient-led-tool-launched-in-canberra-to-transform-pain-communication 2026-03-10T15:15:01+11:00 https://pharmadispatch.com/news/new-leader-appointed-to-drive-landmark-sydney-biomedical-hub-toward-global-health-breakthroughs 2026-03-10T14:10:01+11:00 https://pharmadispatch.com/news/new-digital-partnership-expands-access-to-vital-clinical-guidance-for-australian-healthcare-prof 2026-03-10T12:34:01+11:00 https://pharmadispatch.com/news/self-injection-option-offers-new-flexibility-for-australians-living-with-myasthenia-gravis 2026-03-10T11:30:01+11:00 https://pharmadispatch.com/news/csl-expands-us-manufacturing-with-15bn-investment-to-boost-plasma-therapy-production 2026-03-10T11:19:01+11:00 https://pharmadispatch.com/news/labors-foi-backdown-is-a-welcome-victory-for-transparency-and-accountability 2026-03-10T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-steps-in-to-block-eye-injection-funding-change-after-patient-warnings 2026-03-10T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-says-new-agreement-has-improved-access-to-treatment-for-new-zealanders 2026-03-10T03:00:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-expands-antiviral-program-through-burnet-institute-collaboration 2026-03-09T16:26:01+11:00 https://pharmadispatch.com/news/new-cancer-research-highlights-potential-of-narmafotinib-to-koost-kras-inhibitor-therapies 2026-03-09T16:19:01+11:00 https://pharmadispatch.com/news/lateral-pharma-secures-key-us-patent-for-novel-neuropathic-pain-therapy 2026-03-09T10:11:01+11:00 https://pharmadispatch.com/news/nanosonics-achieves-key-fda-clearance-as-coris-endoscope-coverage-expands 2026-03-09T09:42:01+11:00 https://pharmadispatch.com/news/bpdinsightsai-has-arrived-as-a-new-way-to-access-knowledge 2026-03-09T01:00:01+11:00 https://pharmadispatch.com/news/how-to-use-bpdinsightsai-to-learn-and-to-train-the-platform 2026-03-09T01:00:01+11:00 https://pharmadispatch.com/news/life-sciences-leaders-gather-in-sydney-to-advance-womens-leadership-on-international-womens-day 2026-03-05T15:20:01+11:00 https://pharmadispatch.com/news/pharma-teams-power-kosi-challenge-toward-500000-fundraising-milestone 2026-03-05T10:55:01+11:00 https://pharmadispatch.com/news/wesfarmers-health-expands-medicine-access-with-major-new-cairns-fulfilment-centre 2026-03-05T10:26:01+11:00 https://pharmadispatch.com/news/pfizer-and-abbvie-recognised-among-australias-best-workplaces-for-women 2026-03-05T10:12:01+11:00 https://pharmadispatch.com/news/csl-seqirus-to-supply-canada-with-pandemic-influenza-vaccines-from-new-melbourne-facility 2026-03-05T09:46:01+11:00 https://pharmadispatch.com/news/the-myth-of-affordability-australias-medicines-debate-is-really-about-choice 2026-03-05T09:09:01+11:00 https://pharmadispatch.com/news/setting-the-standard-for-safe-and-accountable-virtual-healthcare-in-australia 2026-03-04T18:38:01+11:00 https://pharmadispatch.com/news/a-system-built-for-a-past-is-struggling-to-meets-the-challenge-of-today-let-alone-the-future 2026-03-04T13:20:01+11:00 https://pharmadispatch.com/news/firebrick-pharma-targets-breakout-year-in-2026-as-nasodine-expansion-accelerates 2026-03-04T12:08:01+11:00 https://pharmadispatch.com/news/adalta-strengthens-clinical-push-for-breakthrough-solid-cancer-therapy 2026-03-04T11:47:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-deepens-us-biodefence-ties-to-advance-marburg-treatment 2026-03-04T11:36:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-secures-strong-backing-as-retail-offer-adds-47-million-to-capital-raise 2026-03-04T11:31:01+11:00 https://pharmadispatch.com/news/alterity-strengthens-clinical-leadership-with-appointment-of-neurologist-daniel-claassen 2026-03-04T11:25:01+11:00 https://pharmadispatch.com/news/australian-medtech-innovators-move-closer-to-procurement-through-national-capability-program 2026-03-04T11:19:01+11:00 https://pharmadispatch.com/news/new-report-says-faster-and-fairer-access-to-medicines-within-reach-for-new-zealand 2026-03-03T16:22:01+11:00 https://pharmadispatch.com/news/fda-approved-new-cancer-therapy-and-ensures-patient-access-in-just-44-days 2026-03-03T14:37:01+11:00 https://pharmadispatch.com/news/pharma-teams-surge-past-220000-in-2026-rare-cancers-australia-kosi-challenge 2026-03-03T12:17:01+11:00 https://pharmadispatch.com/news/genetic-breakthrough-brings-new-hope-for-australians-living-with-multiple-sclerosis 2026-03-03T11:58:01+11:00 https://pharmadispatch.com/news/slade-pharmacy-expands-partnership-with-st-john-of-god-health-care-across-eleven-hospitals 2026-03-02T17:16:01+11:00 https://pharmadispatch.com/news/criminals-and-migrants-have-formal-rights-of-appeal-but-not-australian-patients-why 2026-03-02T13:50:01+11:00 https://pharmadispatch.com/news/new-hope-for-australians-with-aggressive-lymphoma-as-roche-therapy-secures-pbs-listing 2026-03-02T12:30:01+11:00 https://pharmadispatch.com/news/healthsave-reaches-100-store-milestone-as-pharmacy-network-accelerates-national-growth 2026-03-02T12:19:01+11:00 https://pharmadispatch.com/news/australia-counts-the-massive-cost-of-obesity-as-new-report-warns-of-a-growing-economic-crisis 2026-03-02T11:52:01+11:00 https://pharmadispatch.com/news/when-work-can-get-in-the-way-of-care-for-endometriosis 2026-03-01T15:20:01+11:00 https://pharmadispatch.com/news/pbs-listings-gives-new-hope-for-people-living-with-rare-autoimmune-disease 2026-03-01T15:14:01+11:00 https://pharmadispatch.com/news/the-nine-year-wait-should-raise-some-important-but-uncomfortable-questions 2026-03-01T10:19:01+11:00 https://pharmadispatch.com/news/pbs-listing-expands-access-to-immunotherapy-for-australians-with-advanced-cancer 2026-03-01T10:05:01+11:00 https://pharmadispatch.com/news/a-claim-and-a-report-that-continue-to-be-consistently-misrepresented 2026-02-28T10:06:01+11:00 https://pharmadispatch.com/news/landmark-trial-pits-next-generation-glp-1-pills-head-to-head-in-type-2-diabetes 2026-02-27T12:07:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-27-february 2026-02-27T11:59:01+11:00 https://pharmadispatch.com/news/senate-committee-backs-reform-to-enable-nurse-prescribing-under-the-pbs 2026-02-27T09:42:01+11:00 https://pharmadispatch.com/news/eu-backs-australian-led-consortium-with-up-to-250m-to-advance-next-generation-influenza-vaccines 2026-02-26T18:33:01+11:00 https://pharmadispatch.com/news/united-front-forms-across-asia-pacific-to-change-the-future-of-pulmonary-arterial-hypertension 2026-02-26T11:32:01+11:00 https://pharmadispatch.com/news/there-are-in-effect-two-pharmaceutical-benefits-schemes-operating-in-australia-today 2026-02-26T09:44:01+11:00 https://pharmadispatch.com/news/reading-the-room-on-reform-might-mean-following-the-budget-message 2026-02-25T18:22:01+11:00 https://pharmadispatch.com/news/weight-loss-medicines-approved-in-new-zealand-and-recommended-for-funding-but-pathway-remains-un 2026-02-25T11:55:01+11:00 https://pharmadispatch.com/news/neurizon-advances-als-drug-program-as-funding-trials-and-global-partnerships-gain-momentum 2026-02-25T11:25:01+11:00 https://pharmadispatch.com/news/acrux-returns-to-profit-as-product-launches-and-strategic-reset-drive-revenue-growth 2026-02-25T11:16:01+11:00 https://pharmadispatch.com/news/immutep-strengthens-focus-on-late-stage-immunotherapy-trial-as-pipeline-momentum-builds 2026-02-25T11:03:01+11:00 https://pharmadispatch.com/news/blood-test-discovery-may-help-predict-head-and-neck-cancer-relapse-risk 2026-02-25T10:55:01+11:00 https://pharmadispatch.com/news/ebos-builds-momentum-as-glp-1-therapy-wave-reshapes-the-healthcare-market 2026-02-25T10:22:01+11:00 https://pharmadispatch.com/news/grnenthal-partners-with-clinect-to-bring-non-opioid-pain-patch-to-australia 2026-02-24T19:09:01+11:00 https://pharmadispatch.com/news/patients-the-priority-as-takeda-australia-reflects-on-purpose-during-patient-week-2026 2026-02-24T19:02:01+11:00 https://pharmadispatch.com/news/omico-precision-oncology-model-delivering-as-it-seeks-new-funding-to-secure-future 2026-02-24T16:36:01+11:00 https://pharmadispatch.com/news/this-kind-of-project-doesnt-ask-for-permission-it-just-creates-pressure-for-change 2026-02-24T16:11:01+11:00 https://pharmadispatch.com/news/formosa-and-arrotex-forge-strategic-partnership-to-expand-access-to-innovative-eye-treatment 2026-02-24T05:28:01+11:00 https://pharmadispatch.com/news/australia-can-demand-tariff-relief-but-unfinished-fta-promises-weaken-its-case 2026-02-23T13:38:01+11:00 https://pharmadispatch.com/news/research-australia-calls-for-investment-to-drive-productivity-agenda 2026-02-23T12:35:01+11:00 https://pharmadispatch.com/news/mtpconnect-launches-new-funding-push-to-fast-track-breakthroughs-in-heart-disease-and-diabetes 2026-02-23T11:21:01+11:00 https://pharmadispatch.com/news/pharmx-and-sigma-announce-alliance-aiming-to-strengthen-pharmacy-supply-chains-across-anz 2026-02-23T11:04:01+11:00 https://pharmadispatch.com/news/argent-biopharma-reaches-milestone-as-major-cannepil-shipment-lands-in-ireland 2026-02-23T10:50:01+11:00 https://pharmadispatch.com/news/mayne-pharma-enters-a-new-phase-as-leadership-transition-coincides-with-resilient-first-half-per 2026-02-23T10:36:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-kosi-challenge-builds-momentum-ahead-of-march-climb 2026-02-22T13:15:01+11:00 https://pharmadispatch.com/news/tariff-ruling-unlikely-to-reverse-industry-shift-toward-us-investment-and-global-pricing-shift 2026-02-22T12:45:01+11:00 https://pharmadispatch.com/news/the-two-sides-of-decision-making-compassion-and-calculation-in-funding-outcomes 2026-02-22T10:58:01+11:00 https://pharmadispatch.com/news/australian-biotech-leader-highlights-the-car-t-access-challenge-for-local-industry 2026-02-21T12:35:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-20-february 2026-02-20T12:16:01+11:00 https://pharmadispatch.com/news/phrma-launches-new-campaign-against-the-backdrop-of-a-more-assertive-us 2026-02-19T15:46:01+11:00 https://pharmadispatch.com/news/why-does-anyone-accept-a-review-outcome-that-simply-affirms-a-settled-order 2026-02-19T11:46:01+11:00 https://pharmadispatch.com/news/wesfarmers-health-emerges-as-growth-engine-after-delivering-strong-first-half 2026-02-19T10:44:01+11:00 https://pharmadispatch.com/news/telix-files-for-european-approval-of-brain-cancer-imaging-candidate-tlx101-px 2026-02-18T14:59:01+11:00 https://pharmadispatch.com/news/idt-signals-turnaround-as-revenue-rises-and-losses-narrow-under-strategic-reset 2026-02-18T14:52:01+11:00 https://pharmadispatch.com/news/nyrada-advances-lead-candidate-into-mid-stage-trial-as-mmomentum-builds-across-programs 2026-02-18T14:45:01+11:00 https://pharmadispatch.com/news/ausbiotechproto-axiom-alliance-aims-to-fast-track-australias-next-wave-of-biotech-innovators 2026-02-18T14:22:01+11:00 https://pharmadispatch.com/news/novo-nordisk-backs-community-led-initiative-that-aims-to-transform-life-for-logans-children 2026-02-18T14:14:01+11:00 https://pharmadispatch.com/news/csl-and-lilly-strike-strategic-deal-to-advance-promising-anti-inflammatory-therapy 2026-02-18T11:51:01+11:00 https://pharmadispatch.com/news/targeted-blood-cancer-treatments-proposed-for-funding-in-new-zealand 2026-02-18T11:46:01+11:00 https://pharmadispatch.com/news/percheron-targets-next-wave-of-immunotherapy-with-novel-vista-checkpoint-candidate 2026-02-18T09:09:01+11:00 https://pharmadispatch.com/news/urgent-action-needed-as-antibiotic-resistance-threatens-australias-health-future 2026-02-17T17:15:01+11:00 https://pharmadispatch.com/news/taylor-confirms-anne-ruston-to-retain-health-and-disability-portfolio-in-opposition-reshuffle 2026-02-17T16:00:01+11:00 https://pharmadispatch.com/news/calls-grow-for-national-response-to-australias-worsening-medicine-shortages 2026-02-17T14:06:01+11:00 https://pharmadispatch.com/news/in-this-system-one-group-of-patients-is-more-or-less-deserving-than-another-and-its-wrong 2026-02-17T11:25:01+11:00 https://pharmadispatch.com/news/phrma-targets-the-pbs-urges-priority-watch-list-inclusion-over-policy-failings 2026-02-17T11:02:01+11:00 https://pharmadispatch.com/news/minister-confirms-pbs-listing-for-new-cystic-fibrosis-therapy-and-funded-access-to-other-medicin 2026-02-16T15:41:01+11:00 https://pharmadispatch.com/news/director-pay-rises-across-asx-healthcare-sector-but-gender-balance-remains-uneven 2026-02-16T14:13:01+11:00 https://pharmadispatch.com/news/life-sciences-sector-unites-to-advance-womens-leadership-at-landmark-2026-events 2026-02-16T13:50:01+11:00 https://pharmadispatch.com/news/new-imaging-agent-shows-stronger-detection-of-recurrent-prostate-cancer-in-head-to-head-trial 2026-02-16T11:30:01+11:00 https://pharmadispatch.com/news/medibank-funding-expansion-signals-momentum-for-emyrias-mental-health-model 2026-02-16T11:12:01+11:00 https://pharmadispatch.com/news/imf-pours-cold-water-on-fears-of-us-pharmaceutical-tariffs-as-pressures-shift-to-care-spending 2026-02-16T10:44:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-names-experienced-biotech-leader-as-chair-in-board-and-executive-refresh 2026-02-16T10:13:01+11:00 https://pharmadispatch.com/news/its-the-first-time-in-over-30-years-that-a-new-way-of-administering-adrenaline-has-been-approved 2026-02-16T09:18:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-sets-sights-on-2026-kosi-challenge-with-renewed-fundraising-momentum 2026-02-15T13:11:01+11:00 https://pharmadispatch.com/news/pbs-spending-is-driven-less-by-explicit-fiscal-choices-and-more-by-the-flow-of-recommendations 2026-02-15T09:28:01+11:00 https://pharmadispatch.com/news/sussan-leys-sometimes-contentious-but-unquesionably-consequential-health-legacy 2026-02-15T09:11:01+11:00 https://pharmadispatch.com/news/australian-medtech-secures-funds-to-advance-real-time-breast-cancer-surgery-technology 2026-02-13T16:08:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-13-february 2026-02-13T15:37:01+11:00 https://pharmadispatch.com/news/pbac-to-reconsider-broader-vaccine-funding-after-late-addition-to-march-agenda 2026-02-13T04:00:01+11:00 https://pharmadispatch.com/news/ten-years-of-process-improvements-is-almost-the-point-says-anne-ruston 2026-02-13T02:07:01+11:00 https://pharmadispatch.com/news/senate-scrutiny-of-pbs-rules-after-canberra-family-highlights-lack-of-biologic-access 2026-02-12T17:39:01+11:00 https://pharmadispatch.com/news/there-is-no-negotiation-yet-so-be-careful-not-to-give-the-impression-of-conceding-anything 2026-02-11T15:31:01+11:00 https://pharmadispatch.com/news/arrotex-and-pfizer-forge-strategic-pharmacy-partnership-for-enbrel-in-australia 2026-02-11T15:09:01+11:00 https://pharmadispatch.com/news/amplia-expands-us-footprint-as-amplicity-pancreatic-cancer-trial-gains-momentum 2026-02-11T14:58:01+11:00 https://pharmadispatch.com/news/canine-osteoarthritis-study-offers-compelling-translational-evidence-for-pps 2026-02-11T14:46:01+11:00 https://pharmadispatch.com/news/csl-presses-ahead-with-transformation-as-earnings-slip-and-leadership-changes 2026-02-11T14:06:01+11:00 https://pharmadispatch.com/news/this-might-be-the-real-once-in-a-generation-opportunity-achieve-reform 2026-02-11T13:36:01+11:00 https://pharmadispatch.com/news/csl-signals-leadership-transition-as-paul-mckenzie-retires-and-gordon-naylor-steps-in-as-interim 2026-02-10T16:14:01+11:00 https://pharmadispatch.com/news/tiny-fragments-of-rna-a-giant-opportunity-for-autoimmune-disease-treatment 2026-02-10T15:34:01+11:00 https://pharmadispatch.com/news/bcec-partners-with-life-sciences-queensland-to-launch-bursary-for-next-gen-bio-innovation-leader 2026-02-10T15:29:01+11:00 https://pharmadispatch.com/news/memphasys-fast-tracks-australian-market-entry-with-early-tga-approval-for-felix-system 2026-02-10T15:27:01+11:00 https://pharmadispatch.com/news/algorae-expands-commercial-footprint-with-new-licensing-deal 2026-02-10T15:26:01+11:00 https://pharmadispatch.com/news/immutep-reaches-midpoint-in-global-phase-3-lung-cancer-trial 2026-02-10T15:24:01+11:00 https://pharmadispatch.com/news/molecule2market-appoints-inaugural-ceo-to-lead-next-phase-of-growth 2026-02-10T15:22:01+11:00 https://pharmadispatch.com/news/can-we-keep-avoiding-the-simplest-of-all-question-in-a-new-global-order 2026-02-10T14:15:01+11:00 https://pharmadispatch.com/news/a-simple-increase-in-published-list-prices-could-have-unintended-consequences 2026-02-10T13:24:01+11:00 https://pharmadispatch.com/news/mfn-is-the-name-but-the-real-consequences-will-be-delivered-through-globe-and-guard 2026-02-10T10:00:01+11:00 https://pharmadispatch.com/news/positive-action-grants-invest-200000-in-community-driven-hiv-initiatives-across-australia 2026-02-09T16:22:01+11:00 https://pharmadispatch.com/news/meeting-of-the-minds-and-the-impact-of-not-being-able-to-unknow-information 2026-02-09T13:59:01+11:00 https://pharmadispatch.com/news/womens-health-reforms-deliver-savings-and-expanded-access-one-year-on 2026-02-09T12:01:01+11:00 https://pharmadispatch.com/news/a-new-option-for-kiwis-with-lilly-confirming-mounjaro-launch-in-new-zealand 2026-02-09T11:46:01+11:00 https://pharmadispatch.com/news/the-race-for-the-pharma-cup-heats-up-as-teams-chase-the-summit 2026-02-08T14:37:01+11:00 https://pharmadispatch.com/news/the-leaders-will-be-thinking-about-this-situation-like-a-game-of-chess 2026-02-07T16:17:01+11:00 https://pharmadispatch.com/news/trumprx-launches-based-on-global-pricing-promise-in-an-insurance-dominated-reality 2026-02-07T13:09:01+11:00 https://pharmadispatch.com/news/queensland-launches-largest-free-flu-vaccination-program-in-australia 2026-02-06T14:19:01+11:00 https://pharmadispatch.com/news/why-australian-men-are-turning-to-their-pharmacies-for-healthcare 2026-02-06T14:19:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-6-february 2026-02-06T14:16:01+11:00 https://pharmadispatch.com/news/ai-in-healthcare-and-why-doing-nothing-might-be-the-biggest-risk 2026-02-05T16:03:01+11:00 https://pharmadispatch.com/news/an-effective-example-of-making-the-case-for-reform-in-a-status-quo-biased-system 2026-02-05T14:28:01+11:00 https://pharmadispatch.com/news/pharmac-consults-on-expanding-access-to-takeda-blood-cancer-therapy 2026-02-05T13:11:01+11:00 https://pharmadispatch.com/news/gbma-moves-to-reclaim-the-reform-agenda-with-a-focus-on-pricing-and-supply 2026-02-05T02:00:01+11:00 https://pharmadispatch.com/news/nuclear-medicine-sector-argues-for-dedicated-scheme-to-unlock-cancer-therapies 2026-02-04T15:04:01+11:00 https://pharmadispatch.com/news/pfizers-once-monthly-weight-loss-injection-delivers-strong-mid-stage-results 2026-02-04T14:02:01+11:00 https://pharmadispatch.com/news/gbma-summit-focuses-on-access-affordability-and-security-in-an-uncertain-world 2026-02-04T13:28:01+11:00 https://pharmadispatch.com/news/medicines-australia-calls-for-budget-action-to-restore-access-to-innovative-medicines 2026-02-03T17:18:01+11:00 https://pharmadispatch.com/news/survey-exposes-deep-gaps-in-support-for-australians-living-with-rare-cancers 2026-02-03T15:09:01+11:00 https://pharmadispatch.com/news/juvenile-arthritis-foundation-australia-seeks-new-ceo-as-angela-mckay-steps-down 2026-02-03T14:28:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-unite-to-accelerate-advanced-therapies 2026-02-03T14:25:01+11:00 https://pharmadispatch.com/news/if-youre-going-to-pay-for-reforms-are-these-the-changes-you-want-pay-for 2026-02-03T09:41:01+11:00 https://pharmadispatch.com/news/arthritis-australia-appoints-louise-hardy-as-ceo-at-pivotal-moment-for-national-advocacy 2026-02-02T17:46:01+11:00 https://pharmadispatch.com/news/ausbiotech-urges-adoption-national-life-sciences-strategy-as-global-competition-intensifies 2026-02-02T15:05:01+11:00 https://pharmadispatch.com/news/cyclopharm-delivers-record-revenue-as-us-emerges-as-growth-engine 2026-02-02T14:05:01+11:00 https://pharmadispatch.com/news/sandoz-adds-to-vision-care-options-with-the-listing-of-biosimilar-aflibercept 2026-02-02T11:47:01+11:00 https://pharmadispatch.com/news/pycs-capital-raise-marks-one-of-the-largest-biotech-fundraisings-in-australian-market-history 2026-02-02T10:21:01+11:00 https://pharmadispatch.com/news/genetic-signatures-appoints-seasoned-life-sciences-executive-as-ceo 2026-02-02T09:42:01+11:00 https://pharmadispatch.com/news/ema-decision-clears-regulatory-path-for-argenicas-lead-stroke-drug-in-europe 2026-02-02T09:35:01+11:00 https://pharmadispatch.com/news/recce-pharmaceuticals-deepens-us-partnership-to-advance-burn-wound-treatment 2026-02-02T09:30:01+11:00 https://pharmadispatch.com/news/another-potential-turning-point-for-immunotherapy-access-in-australia 2026-02-01T15:54:01+11:00 https://pharmadispatch.com/news/an-announcement-that-cost-more-than-the-listing-because-it-would-have-actually-cost-something 2026-02-01T15:39:01+11:00 https://pharmadispatch.com/news/better-access-australias-plan-to-make-care-fair-affordable-and-accountable 2026-02-01T11:51:01+11:00 https://pharmadispatch.com/news/pfizer-calls-for-budget-shift-citing-missed-medicines-and-the-impact-of-lost-productivity 2026-02-01T11:16:01+11:00 https://pharmadispatch.com/news/vertex-announces-pbs-listing-of-new-once-daily-treatment-for-cystic-fibrosis 2026-02-01T11:04:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-episode-2-series-5 2026-01-30T17:31:01+11:00 https://pharmadispatch.com/news/new-long-term-data-suggest-sustained-benefit-of-eisai-therapy-in-early-alzheimers-disease 2026-01-30T13:57:01+11:00 https://pharmadispatch.com/news/amgen-announces-leadership-transition-for-australia-and-new-zealand 2026-01-30T13:57:01+11:00 https://pharmadispatch.com/news/international-hta-collaboration-continues-as-global-pricing-pressures-evolve 2026-01-29T18:23:01+11:00 https://pharmadispatch.com/news/how-an-australian-campaign-is-tackling-the-silent-epidemic-of-heart-and-kidney-disease 2026-01-29T18:11:01+11:00 https://pharmadispatch.com/news/arcs-warns-workforce-gaps-threaten-returns-on-clinical-trials-reform 2026-01-29T15:33:01+11:00 https://pharmadispatch.com/news/astrazeneca-appoints-new-country-president-as-ben-mcdonald-transitions-to-global-role 2026-01-29T13:09:01+11:00 https://pharmadispatch.com/news/why-do-some-appear-so-uncomfortable-with-this-group-of-people-getting-help 2026-01-29T12:29:01+11:00 https://pharmadispatch.com/news/new-digital-health-reforms-to-give-australians-a-more-complete-medicines-history 2026-01-28T13:18:01+11:00 https://pharmadispatch.com/news/peer-reviewed-validation-strengthens-paradigms-osteoarthritis-program 2026-01-28T12:59:01+11:00 https://pharmadispatch.com/news/obesity-medicines-the-limits-of-the-pbs-and-the-test-of-policy-imagination 2026-01-28T11:56:01+11:00 https://pharmadispatch.com/news/patrys-completes-reliis-acquisition-expands-clinical-pipeline-and-strengthens-board 2026-01-28T10:51:01+11:00 https://pharmadispatch.com/news/trump-administration-launches-third-round-of-price-negotiations-including-the-first-renegotiatio 2026-01-28T10:24:01+11:00 https://pharmadispatch.com/news/uk-life-sciences-report-highlights-pressures-familiar-to-australian-industry 2026-01-27T14:38:01+11:00 https://pharmadispatch.com/news/americans-pay-a-much-lower-share-of-health-costs-than-we-do-in-australia 2026-01-27T13:21:01+11:00 https://pharmadispatch.com/news/australias-health-information-ecosystem-is-very-full-but-do-the-best-voices-dominate 2026-01-27T12:13:01+11:00 https://pharmadispatch.com/news/strong-us-debut-for-novo-nordisk-pill-signals-potential-shift-in-global-weight-loss-market 2026-01-26T11:18:01+11:00 https://pharmadispatch.com/news/leading-pharmacists-honoured-in-2026-australia-day-awards 2026-01-26T11:11:01+11:00 https://pharmadispatch.com/news/this-regulatory-restriction-is-too-harmful-to-be-described-as-simply-outdated 2026-01-25T10:57:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-episode-1-series-5 2026-01-23T13:36:01+11:00 https://pharmadispatch.com/news/ausbiotech-announces-new-advisory-groups-to-support-the-life-sciences-sector 2026-01-22T16:41:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics-brings-new-hope-to-women-with-her2-positive-breast-cancer-in-thailand 2026-01-22T16:33:01+11:00 https://pharmadispatch.com/news/new-funding-deal-brings-next-generation-cystic-fibrosis-treatments-closer-for-new-zealanders 2026-01-22T12:29:01+11:00 https://pharmadispatch.com/news/for-almost-all-of-the-last-40-years-governments-have-aimed-to-make-medicines-less-affordable 2026-01-22T10:22:01+11:00 https://pharmadispatch.com/news/argenx-deepens-australian-research-footprint-with-monash-partnership 2026-01-21T18:37:01+11:00 https://pharmadispatch.com/news/new-data-reinforce-promise-of-cancer-vaccine-with-australia-playing-a-key-role 2026-01-21T17:40:01+11:00 https://pharmadispatch.com/news/the-opportunity-for-advocacy-to-shift-from-marginal-reform-to-structural-sustainability 2026-01-21T12:28:01+11:00 https://pharmadispatch.com/news/telix-delivers-on-2025-revenue-targets-as-gozellix-fuels-next-phase-of-growth 2026-01-21T10:54:01+11:00 https://pharmadispatch.com/news/noxopharm-completes-heracles-trial-with-positive-safety-outcome-for-sof-skn 2026-01-21T10:49:01+11:00 https://pharmadispatch.com/news/equipping-life-sciences-leaders-to-manage-foreign-interference-risks 2026-01-21T10:36:01+11:00 https://pharmadispatch.com/news/industry-says-opportunity-cost-isnt-the-whole-story-in-nices-threshold-debate 2026-01-20T14:17:01+11:00 https://pharmadispatch.com/news/new-zealands-pharmac-plots-a-cautious-path-on-weight-loss-therapies 2026-01-20T12:31:01+11:00 https://pharmadispatch.com/news/the-pbs-paradox-a-rising-medicine-spend-but-a-shrinking-investment-capacity 2026-01-20T12:13:01+11:00 https://pharmadispatch.com/news/sanofi-starts-new-chapter-with-the-opening-of-barangaroo-headquarters 2026-01-19T14:04:01+11:00 https://pharmadispatch.com/news/zelira-secures-transformative-funding-to-advance-hope-1-autism-program 2026-01-19T13:14:01+11:00 https://pharmadispatch.com/news/immuron-delivers-continued-sales-growth-across-key-global-markets 2026-01-19T13:07:01+11:00 https://pharmadispatch.com/news/a-universal-program-that-creates-an-unequal-burden-for-the-average-family 2026-01-19T11:19:01+11:00 https://pharmadispatch.com/news/australians-pay-more-out-of-pocket-for-medicines-than-many-comparable-countries 2026-01-19T10:46:01+11:00 https://pharmadispatch.com/news/prescription-medicines-at-the-centre-of-trumps-great-healthcare-plan 2026-01-18T15:17:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-again-recognised-as-a-top-employer-across-australia-and-new-zealand 2026-01-18T15:05:01+11:00 https://pharmadispatch.com/news/the-quiet-and-steady-privatisation-of-this-critical-public-health-program 2026-01-18T10:19:01+11:00 https://pharmadispatch.com/news/abbvie-to-consolidate-sydney-operations-with-move-to-cbd-headquarters 2026-01-15T16:29:01+11:00 https://pharmadispatch.com/news/anne-harris-steps-down-after-defining-leadership-during-covid-and-lasting-impact-on-medicines-au 2026-01-14T17:45:01+11:00 https://pharmadispatch.com/news/ausbiotech-joins-trade-diversification-network-to-boost-global-life-sciences-partnerships 2026-01-13T16:59:01+11:00 https://pharmadispatch.com/news/a-good-to-reread-this-document-even-its-redactions-reveal-that-change-might-be-coming 2026-01-13T15:26:01+11:00 https://pharmadispatch.com/news/johnson-johnson-the-latest-to-sign-most-favored-nation-agreement-with-trump-administration 2026-01-11T19:13:01+11:00 https://pharmadispatch.com/news/reading-between-the-reform-lines-what-the-2005-cabinet-papers-can-teach-us-today 2026-01-11T17:58:01+11:00 https://pharmadispatch.com/news/new-treatment-listed-on-pbs-offering-twice-yearly-dosing-for-australians-with-relapsing-ms 2026-01-09T12:42:01+11:00 https://pharmadispatch.com/news/the-value-of-looking-back-and-the-importance-of-seeing-the-smoke-signals-on-reform 2026-01-08T12:32:01+11:00 https://pharmadispatch.com/news/vaxxas-appoints-former-global-vaccines-leader-to-head-global-commercialisation-push 2026-01-08T11:44:01+11:00 https://pharmadispatch.com/news/reform-was-justified-because-a-committee-prioritising-clinical-considerationswas-culturally-prob 2026-01-04T12:07:01+11:00 https://pharmadispatch.com/news/adalta-and-shcell-launch-cancer-collaboration-to-progress-breakthrough-car-t-therapy 2026-01-02T13:11:01+11:00 https://pharmadispatch.com/news/cabinet-documents-from-the-year-that-led-to-transformational-changes 2026-01-01T12:32:01+11:00 https://pharmadispatch.com/news/is-australia-included-in-new-us-international-reference-pricing-rules 2025-12-22T05:58:01+11:00 https://pharmadispatch.com/news/parsimony-has-become-an-enduring-test-of-the-institutions-legitimacy 2025-12-20T12:33:01+11:00 https://pharmadispatch.com/news/pbac-delivers-a-broad-range-of-outcomes-in-november-including-landmark-for-obesity 2025-12-20T12:24:01+11:00 https://pharmadispatch.com/news/takedas-next-generation-psoriasis-theraph-delivers-landmark-phase-3-results 2025-12-19T11:32:01+11:00 https://pharmadispatch.com/news/a-fit-for-purpose-hta-system-will-be-accompanied-by-a-fit-for-system-cost-recovery-framework 2025-12-19T05:11:01+11:00 https://pharmadispatch.com/news/cleo-diagnostics-raises-funds-to-accelerate-us-launch-and-advance-ovarian-cancer-screening 2025-12-18T15:45:01+11:00 https://pharmadispatch.com/news/actinogen-crosses-key-milestone-as-pivotal-alzheimers-trial-fully-enrols 2025-12-18T15:43:01+11:00 https://pharmadispatch.com/news/pharmac-scraps-plan-to-remove-low-ranked-medicines-from-options-for-funding-list 2025-12-18T14:16:01+11:00 https://pharmadispatch.com/news/pbac-reflects-on-a-year-shaped-by-major-reviews-and-rising-workload 2025-12-18T13:22:01+11:00 https://pharmadispatch.com/news/priceline-moves-to-stabilise-banner-group-as-pressures-force-administrators 2025-12-17T17:42:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-gearing-up-for-2026-kosi-challenge-with-pharma-cup-up-for-grabs-again 2025-12-17T15:40:01+11:00 https://pharmadispatch.com/news/ferronova-secures-funding-to-advance-nanoparticle-technology-for-cancer-surgery 2025-12-17T13:11:01+11:00 https://pharmadispatch.com/news/antimalarial-candidate-under-wehi-msd-partnership-offers-fresh-hope-against-resistance 2025-12-17T12:56:01+11:00 https://pharmadispatch.com/news/oncosil-completes-first-production-run-at-new-sydney-manufacturing-facility 2025-12-17T10:45:01+11:00 https://pharmadispatch.com/news/budget-update-repeats-the-fiscal-illusion-that-has-become-pbs-spending 2025-12-17T09:57:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-key-partnership-with-texas-biomed 2025-12-17T09:06:01+11:00 https://pharmadispatch.com/news/novartis-names-new-country-president-following-leadership-transition 2025-12-16T16:02:01+11:00 https://pharmadispatch.com/news/mayne-pharma-opens-expanded-manufacturing-facility-after-termination-of-takeover 2025-12-16T15:56:01+11:00 https://pharmadispatch.com/news/budget-update-includes-impact-of-listings-but-generally-not-much-else 2025-12-16T12:25:01+11:00 https://pharmadispatch.com/news/the-uk-confirms-the-direct-impact-of-the-transatlantic-shift-in-medicine-pricing 2025-12-16T11:08:01+11:00 https://pharmadispatch.com/news/the-industry-is-probably-right-to-resist-it-just-need-to-prepare-for-the-response 2025-12-16T02:00:01+11:00 https://pharmadispatch.com/news/cynata-completes-patient-enrolment-in-phase-2-trial-for-agvhd-therapy 2025-12-15T11:23:01+11:00 https://pharmadispatch.com/news/prescient-secures-european-approval-to-launch-ptx-100-trial-for-rare-lymphoma 2025-12-15T11:18:01+11:00 https://pharmadispatch.com/news/orthocell-lodges-european-and-uk-regulatory-application-for-remplir 2025-12-15T11:12:01+11:00 https://pharmadispatch.com/news/neuren-wins-second-fda-approval-for-trofinetide-with-launch-of-formulation 2025-12-15T11:09:01+11:00 https://pharmadispatch.com/news/dimerix-completes-adult-recruitment-in-phase-3-trial-for-fsgs-treatment-dmx-200 2025-12-15T11:04:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-reports-high-success-rate-in-phase-2b-imaging-trial 2025-12-15T10:08:01+11:00 https://pharmadispatch.com/news/gbma-to-host-inaugural-summit-aimed-at-addressing-medicine-shortages 2025-12-15T02:00:01+11:00 https://pharmadispatch.com/news/lilly-announces-phase-3-results-for-triple-agonist-in-obesity-and-knee-osteoarthritis 2025-12-15T02:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-opens-applications-for-2026-medtech-procurement-program 2025-12-14T14:06:01+11:00 https://pharmadispatch.com/news/the-lesson-to-learn-from-the-guild-ia-that-you-cannot-defeat-what-you-do-not-know 2025-12-14T14:00:01+11:00 https://pharmadispatch.com/news/amplia-reports-new-rumour-response-for-narmafotinib-in-pancreatic-cancer 2025-12-14T10:23:01+11:00 https://pharmadispatch.com/news/algorae-unveils-major-breakthrough-in-ai-driven-drug-combination-discovery 2025-12-14T10:17:01+11:00 https://pharmadispatch.com/news/new-analysis-finds-mesoblasts-remestemcel-l-outperforms-ruxolitinib-in-severe-gvhd 2025-12-14T10:10:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-12-december 2025-12-12T10:48:01+11:00 https://pharmadispatch.com/news/medicines-australia-gains-a-new-voice-with-vertex-joining-the-association 2025-12-11T16:28:01+11:00 https://pharmadispatch.com/news/bms-marks-70-years-in-australia-with-renewed-commitment-to-innovation-and-access 2025-12-11T16:12:01+11:00 https://pharmadispatch.com/news/opportunity-cost-is-a-moral-and-ethical-question-when-it-involves-travel-tickets-or-treating-sic 2025-12-11T10:45:01+11:00 https://pharmadispatch.com/news/pfizers-high-stakes-sprint-to-build-momentum-in-century-defining-market 2025-12-11T02:10:01+11:00 https://pharmadispatch.com/news/mayne-pharma-rejects-cosettes-attempt-to-terminate-scheme-deal 2025-12-10T10:35:01+11:00 https://pharmadispatch.com/news/tga-clears-the-way-for-ltr-pharmas-phase-2-study-of-spontan 2025-12-10T10:28:01+11:00 https://pharmadispatch.com/news/oncosil-announces-first-uk-patient-treated-with-its-pancreatic-cancer-treatment 2025-12-10T10:24:01+11:00 https://pharmadispatch.com/news/health-department-clarifies-pbac-plan-after-confusion-over-paediatric-access-to-biologics 2025-12-10T03:00:01+11:00 https://pharmadispatch.com/news/if-this-was-the-plan-why-wasnt-it-included-in-the-response-to-questions-last-week 2025-12-10T02:00:01+11:00 https://pharmadispatch.com/news/immutep-strikes-major-licensing-deal-with-dr-reddys-to-commercialise-novel-cancer-immunotherapy 2025-12-09T15:06:01+11:00 https://pharmadispatch.com/news/australian-regulators-approve-longevity-molecule-nmn-for-use-in-therapeutic-goods 2025-12-09T08:37:01+11:00 https://pharmadispatch.com/news/australian-breakthrough-uncovers-genetic-trigger-for-severe-macular-degeneration 2025-12-09T08:36:01+11:00 https://pharmadispatch.com/news/csls-hemophilia-therapy-shows-durable-five-year-benefits-in-landmark-trial-results 2025-12-09T02:00:01+11:00 https://pharmadispatch.com/news/australia-at-a-turning-point-on-access-to-medical-technology-new-report-warns 2025-12-09T02:00:01+11:00 https://pharmadispatch.com/news/arrotex-launches-australias-first-generic-fluticasone-nasal-spray 2025-12-08T16:20:01+11:00 https://pharmadispatch.com/news/australias-imperfect-processes-for-for-sovereign-vaccine-manufacturing-anao-finds 2025-12-08T15:54:01+11:00 https://pharmadispatch.com/news/telix-doses-first-patient-in-expanded-phase-3-prostate-cancer-trial 2025-12-08T15:03:01+11:00 https://pharmadispatch.com/news/chimeric-secures-key-orphan-drug-designation-paving-the-way-for-accelerated-development 2025-12-08T15:00:01+11:00 https://pharmadispatch.com/news/imugene-secures-fda-support-for-azer-cel-registrational-pathway 2025-12-08T15:00:01+11:00 https://pharmadispatch.com/news/psa-ushers-in-new-leadership-team-as-organisation-enters-growth-phase 2025-12-08T12:14:01+11:00 https://pharmadispatch.com/news/new-digital-insights-reveal-what-australians-really-want-from-health-conversations 2025-12-08T02:00:01+11:00 https://pharmadispatch.com/news/daiichi-sankyo-ceo-sets-ambitious-global-oncology-vision-as-company-enters-new-era-of-innovation 2025-12-08T02:00:01+11:00 https://pharmadispatch.com/news/pfizer-unveils-phase-3-results-showing-hympavzi-significantly-reduces-bleeding-in-haemophilia 2025-12-07T10:31:01+11:00 https://pharmadispatch.com/news/algorae-pharmaceuticals-achieves-milestone-with-validation-of-ai-drug-combination-platform 2025-12-07T10:14:01+11:00 https://pharmadispatch.com/news/pbacs-intracycle-agenda-dominated-by-internal-submissions-as-msd-pushes-for-multi-cancer-funding 2025-12-07T09:25:01+11:00 https://pharmadispatch.com/news/either-deliberately-misleading-or-did-not-have-the-correct-information 2025-12-05T18:28:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-5-december 2025-12-05T13:33:01+11:00 https://pharmadispatch.com/news/evinco-therapeutics-launches-to-pioneer-immune-based-treatments-for-alzheimers-disease 2025-12-04T15:25:01+11:00 https://pharmadispatch.com/news/new-report-warns-of-sharp-rise-in-multiple-sclerosis-as-merck-urges-greater-investment 2025-12-04T12:31:01+11:00 https://pharmadispatch.com/news/health-department-defends-its-handling-of-mfn-risk-amid-senate-scrutiny 2025-12-04T12:20:01+11:00 https://pharmadispatch.com/news/government-funds-a-first-of-its-kind-twice-yearly-injectable-for-multiple-sclerosis 2025-12-04T10:57:01+11:00 https://pharmadispatch.com/news/saying-the-quiet-part-out-loud-in-what-one-exchange-reveals-about-the-truth-of-the-pbs 2025-12-04T10:03:01+11:00 https://pharmadispatch.com/news/ltr-pharma-advances-spontan-program-with-ethics-approval-for-phase-2-clinical-trial 2025-12-03T15:57:01+11:00 https://pharmadispatch.com/news/ai-driven-health-performance-platform-launches-in-australia 2025-12-03T15:47:01+11:00 https://pharmadispatch.com/news/tight-budget-settings-raise-the-stakes-for-hta-reform-and-pbs-price-negotiations 2025-12-03T10:49:01+11:00 https://pharmadispatch.com/news/new-reports-highlights-challenges-facing-australias-rare-disease-patients 2025-12-03T10:35:01+11:00 https://pharmadispatch.com/news/medtech-pipeline-accelerates-as-report-showcases-translation-success-of-mtpconnect-backed-innova 2025-12-03T10:26:01+11:00 https://pharmadispatch.com/news/ceo-pay-rebounds-across-asx-health-and-biotech-as-boards-balance-pressure-and-retention 2025-12-03T10:23:01+11:00 https://pharmadispatch.com/news/melbourne-scientists-discover-how-electrical-pulses-could-transform-tissue-and-organ-regeneratio 2025-12-03T09:18:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-boost-as-directors-and-major-shareholders-exercise-options 2025-12-03T09:13:01+11:00 https://pharmadispatch.com/news/bcal-launches-national-registry-to-track-real-world-impact-of-breastestplus 2025-12-03T09:10:01+11:00 https://pharmadispatch.com/news/noxopharm-advances-autoimmune-candidate-as-first-multiple-dose-cohort-clears-safety-review 2025-12-03T09:04:01+11:00 https://pharmadispatch.com/news/cost-of-multiple-sclerosis-in-australia-surges-past-3-billion-as-prevalence-accelerates 2025-12-03T02:00:01+11:00 https://pharmadispatch.com/news/australia-can-just-increase-prices-in-response-to-pressure-as-it-did-three-years-ago-for-950-med 2025-12-02T13:30:01+11:00 https://pharmadispatch.com/news/reforming-australias-opioid-dependence-treatment-program-from-red-tape-to-person-centred-care 2025-12-02T13:17:01+11:00 https://pharmadispatch.com/news/novo-nordisk-raises-over-106000-for-type-1-diabetes-research 2025-12-02T12:31:01+11:00 https://pharmadispatch.com/news/seqirus-ipens-world-class-cell-based-vaccine-and-antivenom-manufacturing-facility 2025-12-02T12:24:01+11:00 https://pharmadispatch.com/news/clinuvel-advances-second-therapy-toward-market-with-planned-2026-european-filing 2025-12-02T12:22:01+11:00 https://pharmadispatch.com/news/burnt-out-australians-rush-to-health-appointments-as-year-end-pressure-peaks 2025-12-02T11:15:01+11:00 https://pharmadispatch.com/news/first-patient-successfully-dosed-in-trp-8803-trial-to-treat-binge-eating-disorder 2025-12-02T10:01:01+11:00 https://pharmadispatch.com/news/immutep-unveils-strong-phase-2-data-ahead-of-san-antonio-breast-cancer-symposium 2025-12-02T09:55:01+11:00 https://pharmadispatch.com/news/new-national-push-to-close-australias-cardiovascular-data-gap 2025-12-02T09:01:01+11:00 https://pharmadispatch.com/news/us-and-uk-strike-landmark-pharmaceutical-pricing-deal-lifting-prices 2025-12-02T02:05:01+11:00 https://pharmadispatch.com/news/cartherics-appoints-dr-ian-nisbet-as-ceo-as-the-company-accelerates-toward-clinical-trials 2025-12-01T18:09:01+11:00 https://pharmadispatch.com/news/novo-nordisk-appoints-michael-azrak-as-new-oceania-general-manager 2025-12-01T17:03:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-brings-immunotherapy-option-to-australians-with-rare-head-and-neck-cancer 2025-12-01T16:54:01+11:00 https://pharmadispatch.com/news/dbg-health-appoints-matt-zeller-to-lead-arrotex-pharmaceuticals-into-its-next-phase-of-growth 2025-12-01T16:23:01+11:00 https://pharmadispatch.com/news/australian-company-reports-high-response-rate-in-trial-of-off-the-shelf-car-t-therapy 2025-12-01T15:27:01+11:00 https://pharmadispatch.com/news/melbourne-showcases-its-health-and-biomedical-strength-as-leaders-gather-for-national-precincts- 2025-12-01T13:33:01+11:00 https://pharmadispatch.com/news/pharmac-to-expand-emergency-medicine-access-for-rural-and-remote-communities 2025-12-01T12:35:01+11:00 https://pharmadispatch.com/news/tetratherix-joint-venture-secures-alcon-partnership-to-accelerate-ophthalmic-biomaterials 2025-12-01T12:19:01+11:00 https://pharmadispatch.com/news/msd-to-bring-vaccine-distribution-back-in-house-after-40-year-partnership 2025-12-01T02:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-offers-fresh-hope-for-australians-living-with-debilitating-skin-condition 2025-12-01T01:19:01+11:00 https://pharmadispatch.com/news/five-australians-honoured-for-leadership-and-community-advocacy-in-evolving-hiv-response 2025-12-01T01:00:01+11:00 https://pharmadispatch.com/news/budget-discipline-tightens-as-agencies-directed-to-target-lowest-priority-work 2025-11-30T14:27:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-30-november 2025-11-30T13:17:01+11:00 https://pharmadispatch.com/news/chimeric-signals-board-refresh-and-shareholder-support-as-lead-trial-advances 2025-11-30T10:33:01+11:00 https://pharmadispatch.com/news/pharmac-announces-90-day-dispensed-quantities-hiv-medicines 2025-11-27T13:16:01+11:00 https://pharmadispatch.com/news/landmark-report-warns-australias-hospital-pharmacy-system-is-at-an-inflection-point 2025-11-27T10:24:01+11:00 https://pharmadispatch.com/news/australia-releases-first-national-estimate-of-women-living-with-metastatic-breast-cancer 2025-11-27T10:05:01+11:00 https://pharmadispatch.com/news/imugene-and-jw-therapeutics-join-forces-on-first-in-class-combination-for-solid-tumours 2025-11-27T09:32:01+11:00 https://pharmadispatch.com/news/algorae-pharmaceuticals-secures-new-supply-of-chemotherapy-for-australia-through-dr-reddys-partn 2025-11-27T09:24:01+11:00 https://pharmadispatch.com/news/an-interview-that-reminds-us-of-the-missing-discussion-in-australia 2025-11-27T02:00:01+11:00 https://pharmadispatch.com/news/neurizon-therapeutics-entering-a-promising-new-horizon-as-als-program-advances 2025-11-26T15:12:01+11:00 https://pharmadispatch.com/news/slade-pharmacy-marks-anniversary-with-record-research-contributions-at-conferences 2025-11-26T11:17:01+11:00 https://pharmadispatch.com/news/us-secures-significant-price-reductions-on-15-medicines-in-second-round-of-medicare-negotiations 2025-11-26T10:59:01+11:00 https://pharmadispatch.com/news/the-us-and-uk-edging-close-to-an-agreement-on-pharmaceutical-pricing 2025-11-26T10:37:01+11:00 https://pharmadispatch.com/news/us-medicare-sets-reimbursement-price-for-promarkerd-paving-way-for-major-commercial-rollout 2025-11-26T10:25:01+11:00 https://pharmadispatch.com/news/recce-reports-strong-preclinical-efficacy-for-inhaled-r327-in-hospital-acquired-pneumonia-model 2025-11-26T10:12:01+11:00 https://pharmadispatch.com/news/race-oncology-secures-human-ethics-approval-for-lung-cancer-trial-of-rc220 2025-11-26T09:57:01+11:00 https://pharmadispatch.com/news/syntara-advances-next-generation-anti-fibrotic-cream-into-phase-1b-trial 2025-11-26T09:31:01+11:00 https://pharmadispatch.com/news/adalta-chair-says-the-company-is-on-the-cusp-of-transformational-growth 2025-11-26T09:04:01+11:00 https://pharmadispatch.com/news/australian-melanoma-oncologist-awarded-inaugural-marie-krogh-prize-for-young-women-in-science 2025-11-26T03:00:01+11:00 https://pharmadispatch.com/news/new-national-scorecard-reveals-australia-is-still-ignoring-its-deadliest-and-most-costly-cancer 2025-11-26T03:00:01+11:00 https://pharmadispatch.com/news/australia-has-all-the-ingredients-but-has-to-decide-what-kind-of-health-system-it-wants 2025-11-26T03:00:01+11:00 https://pharmadispatch.com/news/new-asthma-guidelines-warn-against-blue-puffer-only-treatment-as-deaths-remain-stubbornly-high 2025-11-26T03:00:01+11:00 https://pharmadispatch.com/news/national-report-calls-for-screening-as-25000-australians-live-with-early-disease-without-knowing 2025-11-26T02:00:01+11:00 https://pharmadispatch.com/news/new-report-shows-precision-approach-extends-lives-but-many-still-missing-out 2025-11-25T18:13:01+11:00 https://pharmadispatch.com/news/ausbiotech-appoints-anthea-stephenson-to-lead-national-industry-growth-program 2025-11-25T17:13:01+11:00 https://pharmadispatch.com/news/argenica-validates-optimal-dose-of-arg-007-in-independent-preclinical-stroke-study 2025-11-25T09:38:01+11:00 https://pharmadispatch.com/news/nsw-premier-opens-australias-first-large-scale-health-translation-hub-at-unsw 2025-11-24T13:04:01+11:00 https://pharmadispatch.com/news/cynata-completes-final-patient-visits-in-pivotal-phase-3-osteoarthritis-trial 2025-11-24T09:58:01+11:00 https://pharmadispatch.com/news/new-paper-recommends-a-balanced-and-measure-approach-to-adopting-ai-in-clinical-practice 2025-11-24T09:47:01+11:00 https://pharmadispatch.com/news/sanofi-becomes-first-tenant-of-entri-marking-major-step-for-queenslands-translational-research-a 2025-11-24T09:04:01+11:00 https://pharmadispatch.com/news/moderna-names-csiro-scientist-dr-anne-klein-as-2025-australian-fellow 2025-11-24T08:57:01+11:00 https://pharmadispatch.com/news/new-trojan-horse-treatment-offers-hope-for-australians-facing-relapsed-multiple-myeloma 2025-11-24T03:00:01+11:00 https://pharmadispatch.com/news/new-national-report-warns-of-deepening-ovarian-cancer-burden-and-calls-for-urgent-action 2025-11-24T03:00:01+11:00 https://pharmadispatch.com/news/a-scrapped-websits-almost-100-million-and-the-politics-of-what-really-matters 2025-11-23T14:52:01+11:00 https://pharmadispatch.com/news/mesoblast-to-launch-pivotal-adult-trial-for-cell-therapy-in-severe-steroid-refractory-gvhd 2025-11-22T09:53:01+11:00 https://pharmadispatch.com/news/syntara-launches-phase-2-trial-aiming-to-teduce-transfusion-burden-in-myelodysplastic-syndromes 2025-11-22T09:44:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-chairman-reflects-on-two-decades-of-progress-as-company-enters-new-era 2025-11-22T09:35:01+11:00 https://pharmadispatch.com/news/treasurer-blocks-us-takeover-of-mayne-pharma-on-national-interest-grounds 2025-11-22T09:23:01+11:00 https://pharmadispatch.com/news/if-the-system-properly-applied-results-in-harm-then-surely-surely-we-have-a-huge-problem 2025-11-20T19:00:01+11:00 https://pharmadispatch.com/news/silence-in-response-to-unethical-processes-and-outcomes-is-itself-unethical 2025-11-20T16:57:01+11:00 https://pharmadispatch.com/news/new-analysis-shows-telixs-tlx250-cdx-could-change-management-of-renal-masses 2025-11-20T14:35:01+11:00 https://pharmadispatch.com/news/amplia-secures-positive-fda-feedback-clearing-path-toward-late-2026-registration-trial 2025-11-20T10:25:01+11:00 https://pharmadispatch.com/news/aft-pharmaceuticals-posts-record-first-half-revenue-as-international-strategy-accelerates 2025-11-20T10:18:01+11:00 https://pharmadispatch.com/news/ronak-patel-appointed-to-lead-alcons-commercial-management-for-vision-care 2025-11-20T05:03:01+11:00 https://pharmadispatch.com/news/what-if-the-system-put-people-first-imagining-the-institution-we-dont-have 2025-11-20T01:00:01+11:00 https://pharmadispatch.com/news/vertex-ssecures-tga-approval-for-next-generation-cystic-fibrosis-therapy 2025-11-19T18:44:01+11:00 https://pharmadispatch.com/news/march-pbac-agenda-confirms-a-diverse-range-of-therapies-up-for-consideration 2025-11-19T14:29:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-appoints-experienced-industry-executive-to-its-board 2025-11-19T13:14:01+11:00 https://pharmadispatch.com/news/oncosil-charts-a-new-growth-phase-as-chairman-outlines-progress-and-opportunities 2025-11-19T11:37:01+11:00 https://pharmadispatch.com/news/csl-unveils-us-expansion-cementing-its-position-as-a-global-biopharma-leader 2025-11-19T10:52:01+11:00 https://pharmadispatch.com/news/cleo-diagnostics-appoints-us-oncologist-as-first-key-opinion-leader 2025-11-19T10:33:01+11:00 https://pharmadispatch.com/news/idt-australia-resets-strategy-as-advanced-therapies-drive-new-phase-of-growth 2025-11-19T10:20:01+11:00 https://pharmadispatch.com/news/dimerix-phase-3-kidney-trial-clears-seventh-safety-review 2025-11-19T10:12:01+11:00 https://pharmadispatch.com/news/prescient-secures-eu-orphan-status-for-ptx-100-for-cutaneous-t-cell-lymphomas 2025-11-19T09:58:01+11:00 https://pharmadispatch.com/news/bcal-advances-early-cancer-detection-portfolio-as-australian-launch-looms 2025-11-19T09:18:01+11:00 https://pharmadispatch.com/news/is-this-disconnect-so-entrenched-we-can-no-longer-recognise-the-presence-of-a-problem 2025-11-19T01:00:01+11:00 https://pharmadispatch.com/news/minister-managing-the-double-whammy-of-participant-and-plan-growth 2025-11-19T01:00:01+11:00 https://pharmadispatch.com/news/tryp-advances-world-first-psilocin-trial-for-binge-eating-disorder-as-second-patient-enrolled 2025-11-18T13:16:01+11:00 https://pharmadispatch.com/news/nyrada-advances-toward-phase-2a-trial-of-cardioprotective-candidate 2025-11-18T13:05:01+11:00 https://pharmadispatch.com/news/we-know-theyre-planning-something-on-these-issues-because-they-told-us 2025-11-18T01:00:01+11:00 https://pharmadispatch.com/news/the-need-to-honour-a-strong-history-while-ensuring-the-future-is-guided-by-the-good-guys 2025-11-17T13:56:01+11:00 https://pharmadispatch.com/news/bms-australia-team-cycles-across-japan-raising-nearly-20000-for-bowel-cancer-australia 2025-11-17T13:35:01+11:00 https://pharmadispatch.com/news/syntara-secures-positive-european-opinion-for-orphan-designation-of-amsulostat-in-myelofibrosis 2025-11-17T10:31:01+11:00 https://pharmadispatch.com/news/mesoblast-appoints-new-chief-financial-officer-as-it-evolves-into-fully-integrated-commercial-or 2025-11-17T10:16:01+11:00 https://pharmadispatch.com/news/argent-biopharma-secures-significant-financing-facility-to-support-strategic-expansion 2025-11-17T10:06:01+11:00 https://pharmadispatch.com/news/race-oncology-launches-new-clinical-programs-in-aml-and-lung-cancer 2025-11-17T09:36:01+11:00 https://pharmadispatch.com/news/noxopharm-begins-daily-dosing-in-second-phase-of-heracles-trial 2025-11-17T09:04:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-reaches-enrollment-milestone-in-phase-2b-trial-for-rad101 2025-11-17T08:59:01+11:00 https://pharmadispatch.com/news/new-national-incubator-aims-to-supercharge-australian-vaccine-innovation 2025-11-17T02:00:01+11:00 https://pharmadispatch.com/news/time-to-save-the-government-from-itself-and-its-own-bad-habits-on-this-program 2025-11-17T02:00:01+11:00 https://pharmadispatch.com/news/msd-to-acquire-cidara-therapeutics-adding-long-acting-influenza-antiviral-cd388-to-its-pipeline 2025-11-15T10:30:01+11:00 https://pharmadispatch.com/news/biotron-reports-promising-advances-in-hepatitis-b-program-as-lead-candidate-shows-strong-antivir 2025-11-15T09:52:01+11:00 https://pharmadispatch.com/news/recce-pharmaceuticals-pays-tribute-to-founder-and-scientific-pioneer-dr-graham-melrose 2025-11-15T09:44:01+11:00 https://pharmadispatch.com/news/pyc-reports-sustained-vision-gains-in-rp11-clinical-trial 2025-11-15T09:28:01+11:00 https://pharmadispatch.com/news/sanofi-building-an-ai-literate-organisation-through-expectations-over-experiments 2025-11-14T01:00:01+11:00 https://pharmadispatch.com/news/prospection-says-data-access-and-leadership-are-critical-to-unlock-ais-potential-in-healthcare 2025-11-14T01:00:01+11:00 https://pharmadispatch.com/news/the-four-h-words-that-can-help-drive-the-adoption-of-ai-in-health 2025-11-14T01:00:01+11:00 https://pharmadispatch.com/news/arrotex-launches-new-pbs-listed-combination-therapy-as-gap-emerges-in-hypertension-treatments 2025-11-14T01:00:01+11:00 https://pharmadispatch.com/news/immutep-posts-encouraging-phase-2-results-as-efti-spurs-robust-anti-tumour-activity 2025-11-13T15:37:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-appoints-peter-coleman-as-new-chair-as-part-of-board-renewal 2025-11-13T15:25:01+11:00 https://pharmadispatch.com/news/new-gene-discoveries-improve-diagnosis-of-inherited-heart-disease 2025-11-13T14:24:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-reports-strong-early-results-from-chm-cdh17-phase-12-trial 2025-11-13T11:51:01+11:00 https://pharmadispatch.com/news/australia-joins-global-who-task-force-to-tackle-antimicrobial-resistance 2025-11-13T11:10:01+11:00 https://pharmadispatch.com/news/new-post-market-review-workplan-focuses-on-real-world-data-and-patient-outcomes 2025-11-13T10:59:01+11:00 https://pharmadispatch.com/news/government-adds-new-first-line-treatment-to-the-pbs-for-deadly-blood-cancer 2025-11-13T10:49:01+11:00 https://pharmadispatch.com/news/rage-biotech-raises-29-million-and-appoints-new-leadership-to-advance-precision-rna-therapeutics 2025-11-13T09:42:01+11:00 https://pharmadispatch.com/news/nanosonics-names-new-north-american-president-ahead-of-coris-launch 2025-11-13T09:38:01+11:00 https://pharmadispatch.com/news/australians-open-to-ai-in-healthcare-but-prefer-doctors-to-be-in-control 2025-11-13T01:00:01+11:00 https://pharmadispatch.com/news/every-government-agency-to-get-a 2025-11-12T17:26:01+11:00 https://pharmadispatch.com/news/new-zealand-accelerates-medicines-reform-with-major-regulatory-changes 2025-11-12T12:25:01+11:00 https://pharmadispatch.com/news/fda-moves-to-lift-long-standing-hormone-therapy-warnings-in-major-shift-for-womens-health 2025-11-12T12:18:01+11:00 https://pharmadispatch.com/news/optometry-australia-and-alcon-launch-scholarship-fund-to-support-first-nations-eye-health-leader 2025-11-12T12:11:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-advances-phase-1-trial-of-177lu-rad204-in-pd-l1-positive-cancers 2025-11-12T11:42:01+11:00 https://pharmadispatch.com/news/arovella-appoints-former-csl-chief-scientific-officer-dr-andrew-nash-to-its-board 2025-11-12T11:33:01+11:00 https://pharmadispatch.com/news/dorsavi-secures-breakthrough-neuromorphic-technology-to-power-next-generation-wearables-and-robo 2025-11-12T11:16:01+11:00 https://pharmadispatch.com/news/microba-renews-board-with-new-appointment-as-long-serving-directors-retire 2025-11-12T11:10:01+11:00 https://pharmadispatch.com/news/pathkeyai-and-armstrong-clinical-partner-to-strengthen-early-phase-trial-success-through-ai 2025-11-12T10:40:01+11:00 https://pharmadispatch.com/news/monash-engineers-develop-first-tailored-heart-pump-for-under-treated-heart-failure-patients 2025-11-11T15:51:01+11:00 https://pharmadispatch.com/news/neuroscientific-advances-stemsmart-therapy-with-fourth-patient-treated-in-crohns-disease-program 2025-11-11T15:50:01+11:00 https://pharmadispatch.com/news/noxopharm-and-unsw-collaborate-on-gene-based-approach-to-reducing-implant-inflammation 2025-11-11T15:49:01+11:00 https://pharmadispatch.com/news/csl-welcomes-msac-support-for-gene-therapy-but-questions-strict-cost-neutrality-framework 2025-11-11T15:14:01+11:00 https://pharmadispatch.com/news/professor-robyn-ward-ai-wont-replace-us-but-it-will-redefine-how-we-work 2025-11-11T14:25:01+11:00 https://pharmadispatch.com/news/hta-review-implementation-group-is-is-recommending-a-defining-role-for-ai 2025-11-11T13:59:01+11:00 https://pharmadispatch.com/news/ai-must-be-trusted-transparent-and-integrated-in-the-future-of-health-technology-assessment 2025-11-11T12:44:01+11:00 https://pharmadispatch.com/news/pfizer-clinches-metsera-reshaping-the-balance-in-the-global-obesity-drug-race 2025-11-11T04:16:01+11:00 https://pharmadispatch.com/news/vaxxas-appoints-global-vaccine-leader-to-board-as-needle-free-vaccine-patch-moves-toward-market 2025-11-10T17:43:01+11:00 https://pharmadispatch.com/news/monash-leads-world-first-trial-of-cholesterol-lowering-gene-editing-therapy 2025-11-10T07:20:01+11:00 https://pharmadispatch.com/news/australia-excluded-from-us-generous-benchmarking-model-that-pegs-prices-to-group-of-eight 2025-11-10T01:00:01+11:00 https://pharmadispatch.com/news/proteomics-international-secures-wa-government-grant-to-advance-world-first-blood-test-for-endom 2025-11-09T10:26:01+11:00 https://pharmadispatch.com/news/avita-medical-narrows-losses-and-secures-eu-approval-as-reimbursement-challenges-ease 2025-11-09T10:21:01+11:00 https://pharmadispatch.com/news/from-potential-to-practice-ai-health-summit-to-focus-on-adoption-implementation-and-governance 2025-11-09T09:18:01+11:00 https://pharmadispatch.com/news/experts-call-for-national-action-to-lift-maternal-and-adult-immunisation-as-whooping-cough-epide 2025-11-09T01:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-you-cant-fragment-care-youre-not-receiving 2025-11-08T10:15:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-7-november 2025-11-07T14:45:01+11:00 https://pharmadispatch.com/news/trump-announces-mfn-deal-with-lilly-and-novo-nordisk-and-end-to-global-freeloading 2025-11-07T04:31:01+11:00 https://pharmadispatch.com/news/sanofi-employees-contribute-over-400-volunteer-hours-to-community-and-environmental-causes 2025-11-06T17:18:01+11:00 https://pharmadispatch.com/news/neuren-posts-record-royalties-as-daybue-sales-surpass-us100-million-in-third-quarter 2025-11-06T10:50:01+11:00 https://pharmadispatch.com/news/us-ambassador-warns-uk-risks-losing-pharma-investment-unless-it-pays-more-for-medicines 2025-11-06T10:23:01+11:00 https://pharmadispatch.com/news/pfizer-to-continue-legal-fight-as-court-rejects-bid-to-block-novo-nordisks-metsera-takeover-bid 2025-11-06T09:55:01+11:00 https://pharmadispatch.com/news/what-next-for-pbs-rebate-system-amid-constitutional-breaches-disputed-claims-and-global-pressure 2025-11-06T09:06:01+11:00 https://pharmadispatch.com/news/linda-burney-to-chair-new-first-nations-pharmacy-network 2025-11-05T16:09:01+11:00 https://pharmadispatch.com/news/pharmacy-leaders-tour-npsas-brisbane-medicine-distribution-centre 2025-11-05T15:34:01+11:00 https://pharmadispatch.com/news/bionsw-opens-expressions-of-interest-for-november-bioinvest-catalyst-event 2025-11-05T14:44:01+11:00 https://pharmadispatch.com/news/rhythm-biosciences-appoints-gavin-fox-smith-as-chair 2025-11-05T13:39:01+11:00 https://pharmadispatch.com/news/medibank-expands-primary-care-footprint-with-major-acquisition-of-better-medical 2025-11-05T11:54:01+11:00 https://pharmadispatch.com/news/ndis-growth-begins-to-slow-but-spending-still-tops-46-billion 2025-11-05T11:36:01+11:00 https://pharmadispatch.com/news/mesoblast-to-meet-with-us-fda-over-potential-non-opioid-treatment-for-chronic-back-pain 2025-11-05T10:52:01+11:00 https://pharmadispatch.com/news/hong-kong-positions-itself-as-a-global-bridge-for-biotech-and-life-sciences-innovation 2025-11-05T10:30:01+11:00 https://pharmadispatch.com/news/nanosonics-announces-20-million-share-buy-back-as-confidence-in-growth-outlook-strengthens 2025-11-05T09:59:01+11:00 https://pharmadispatch.com/news/imagion-biosystems-reports-positive-results-from-wayne-state-collaboration-as-phase-2-breast-can 2025-11-05T09:54:01+11:00 https://pharmadispatch.com/news/noxopharm-advances-autoimmune-drug-trial-as-heracles-enters-second-phase 2025-11-05T09:25:01+11:00 https://pharmadispatch.com/news/orthocell-expands-canadian-presence-with-full-national-coverage-for-nerve-repair-device 2025-11-05T09:20:01+11:00 https://pharmadispatch.com/news/radium-capital-surpasses-1-billion-milestone-in-innovation-funding 2025-11-05T08:45:01+11:00 https://pharmadispatch.com/news/sandoz-launches-pbs-listed-adhd-medicine-to-help-ease-national-supply-shortages 2025-11-04T16:27:01+11:00 https://pharmadispatch.com/news/national-vaccine-and-infectious-disease-incubator-to-launch-in-november 2025-11-04T16:13:01+11:00 https://pharmadispatch.com/news/trent-twomey-appointed-president-of-the-world-pharmacy-council 2025-11-04T14:13:01+11:00 https://pharmadispatch.com/news/rebates-are-bad-enough-without-invoices-based-on-unconstitutional-pbs-benefit-claims 2025-11-04T13:47:01+11:00 https://pharmadispatch.com/news/pfizer-escalates-legal-fight-with-novo-nordisk-over-obesity-biotech-takeover 2025-11-04T09:59:01+11:00 https://pharmadispatch.com/news/dr-andre-bates-on-pharmas-real-ai-challenge-if-the-technology-is-ready-why-isnt-the-culture 2025-11-04T09:48:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-that-companies-repaid-over-16m-in-pbs-benefits-every-day 2025-11-04T02:00:01+11:00 https://pharmadispatch.com/news/if-they-keep-ignoring-patient-input-or-worse-inventing-their-own-stop-asking-for-it 2025-11-04T02:00:01+11:00 https://pharmadispatch.com/news/invex-reports-promising-new-data-on-exenatide-in-alzheimers-disease-model 2025-11-03T14:34:01+11:00 https://pharmadispatch.com/news/new-clinical-trial-offers-hope-for-australians-living-with-vitiligo 2025-11-03T12:50:01+11:00 https://pharmadispatch.com/news/eight-finalists-announced-for-inaugural-marie-krogh-young-women-in-science-prize 2025-11-03T12:41:01+11:00 https://pharmadispatch.com/news/resmed-delivers-strong-start-to-year-with-double-digit-profit-growth-and-margin-expansion 2025-11-03T11:47:01+11:00 https://pharmadispatch.com/news/pharmac-marks-milestone-in-change-program-with-completion-of-first-90-day-plan 2025-11-03T10:43:01+11:00 https://pharmadispatch.com/news/orthocell-expands-asian-presence-with-first-remplir-surgical-case-in-hong-kong 2025-11-03T09:41:01+11:00 https://pharmadispatch.com/news/fda-approves-anteris-technologies-global-pivotal-trial-for-duravr-heart-valve 2025-11-03T09:30:01+11:00 https://pharmadispatch.com/news/actinogen-medical-presents-alzheimers-and-depression-program-at-bio-europe-2025 2025-11-03T09:15:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-expands-frontline-options-for-australians-with-advanced-hodgkin-lymphoma 2025-11-03T02:58:01+11:00 https://pharmadispatch.com/news/expanded-pbsaccess-fortherapy-to-includefirst-line-epilepsy-treatment 2025-11-03T02:00:01+11:00 https://pharmadispatch.com/news/global-biosimilars-week-2025-launches-with-focus-on-advancing-health-equity-through-access-and-i 2025-11-03T02:00:01+11:00 https://pharmadispatch.com/news/msac-rejects-calls-to-expand-access-to-continuous-glucose-monitoring-devices 2025-11-01T10:04:01+11:00 https://pharmadispatch.com/news/pfizer-escalates-planned-takeover-of-metsera-after-novo-nordisk-enters-the-fray 2025-11-01T09:17:01+11:00 https://pharmadispatch.com/news/new-dual-immunotherapy-option-for-advanced-liver-cancer-listed-on-the-pbs 2025-11-01T08:33:01+11:00 https://pharmadispatch.com/news/a-new-treatment-for-rare-liver-disease-now-listed-on-the-pbs 2025-10-31T17:19:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-31-october 2025-10-31T12:43:01+11:00 https://pharmadispatch.com/news/aroa-biosurgery-appoints-paul-shearer-to-board-as-john-pinion-retires 2025-10-31T11:09:01+11:00 https://pharmadispatch.com/news/immuron-provides-update-on-us-clinical-trials-for-travelan-and-imm-529 2025-10-31T09:50:01+11:00 https://pharmadispatch.com/news/firebrick-pharma-launches-new-nasodine-throat-spray-for-international-markets 2025-10-31T09:45:01+11:00 https://pharmadispatch.com/news/amplia-therapeutics-begins-trading-on-us-otcqb-venture-market 2025-10-31T09:40:01+11:00 https://pharmadispatch.com/news/dhl-supply-chain-opens-new-zealands-most-advanced-life-sciences-and-healthcare-logistics-facilit 2025-10-31T08:56:01+11:00 https://pharmadispatch.com/news/the-continued-false-framing-aims-to-make-us-feel-guilty-for-wanting-more-on-health 2025-10-31T03:00:01+11:00 https://pharmadispatch.com/news/new-report-warns-of-rising-copd-crisis-as-deaths-outnumber-other-major-conditions 2025-10-31T02:00:01+11:00 https://pharmadispatch.com/news/patients-and-providers-unite-to-shape-national-telehealth-standards 2025-10-30T18:26:01+11:00 https://pharmadispatch.com/news/viral-vector-manufacturing-facility-partners-with-oxb-to-advance-gene-therapy-capability-in-aust 2025-10-30T15:47:01+11:00 https://pharmadispatch.com/news/honouring-a-mothers-memory-az-executives-ride-for-metastatic-breast-cancer-patients 2025-10-30T14:22:01+11:00 https://pharmadispatch.com/news/wintermute-biomedical-appoints-professor-john-skerritt-to-its-board 2025-10-30T09:38:01+11:00 https://pharmadispatch.com/news/fda-moves-to-streamline-biosimilar-development-and-accelerate-approvals 2025-10-30T09:28:01+11:00 https://pharmadispatch.com/news/90-million-investment-marks-30-years-of-the-viertel-foundations-impact-on-medical-research 2025-10-30T09:15:01+11:00 https://pharmadispatch.com/news/csl-seqirus-partners-to-localise-advanced-influenza-vaccine-manufacturing-in-saudi-arabia 2025-10-30T08:52:01+11:00 https://pharmadispatch.com/news/process-as-power-how-our-institutions-defend-policy-decisions-by-making-them-untouchable-truths 2025-10-30T02:00:01+11:00 https://pharmadispatch.com/news/sl-centenary-fellowships-awarded-to-australian-scientists-pioneering-lifelong-immunity-and-ai-de 2025-10-29T17:35:01+11:00 https://pharmadispatch.com/news/medicines-australia-welcomes-new-directors-and-reaffirms-commitment-to-innovation-and-access 2025-10-29T14:50:01+11:00 https://pharmadispatch.com/news/arovella-advances-ala-101-program-with-cro-appointment-and-phase-1-trial-preparations 2025-10-29T13:14:01+11:00 https://pharmadispatch.com/news/duravr-delivers-strong-one-year-results-for-patients-with-small-aortic-annuli 2025-10-29T10:38:01+11:00 https://pharmadispatch.com/news/more-australian-women-to-access-free-gp-led-care-as-evoca-clinics-shift-to-bulk-billing 2025-10-29T10:25:01+11:00 https://pharmadispatch.com/news/advisoty-committee-backs-avitas-burns-treatment-paving-the-way-for-expanded-access-in-australia 2025-10-29T10:17:01+11:00 https://pharmadispatch.com/news/rising-obesity-and-youth-vaping-undercut-health-gains-national-index-reveals 2025-10-29T09:50:01+11:00 https://pharmadispatch.com/news/uniseed-names-alastair-hick-as-new-ceo-to-lead-next-phase-of-growth 2025-10-29T09:30:01+11:00 https://pharmadispatch.com/news/australian-based-world-first-rna-trial-offers-new-hope-for-lupus-patients 2025-10-29T09:24:01+11:00 https://pharmadispatch.com/news/australians-with-chronic-disease-call-for-stronger-investment-in-pbs 2025-10-29T03:00:01+11:00 https://pharmadispatch.com/news/australia-launches-first-clinical-and-commercial-scale-viral-vector-manufacturing-facility 2025-10-28T17:46:01+11:00 https://pharmadispatch.com/news/myrio-therapeutics-partners-with-leading-us-research-institutions-to-advance-t-cell-immunotherap 2025-10-28T17:18:01+11:00 https://pharmadispatch.com/news/mtpconnect-signs-cooperation-agreement-with-saudi-ministry-of-health-to-boost-life-sciences-coll 2025-10-28T17:15:01+11:00 https://pharmadispatch.com/news/obviohealth-partners-with-vaxxas-to-advance-needle-free-vaccination-through-digital-clinical-tri 2025-10-28T17:09:01+11:00 https://pharmadispatch.com/news/abbvie-appoints-david-manifold-to-lead-immunology-anz-and-new-zealand-operations 2025-10-28T15:13:01+11:00 https://pharmadispatch.com/news/australians-want-better-access-to-medical-technology-and-a-clearer-pathway-to-get-there 2025-10-28T12:08:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-backs-expanded-prescribing-rights-for-optometrists 2025-10-28T11:39:01+11:00 https://pharmadispatch.com/news/australians-with-chronic-kidney-disease-to-benefit-from-new-subsidised-treatment 2025-10-28T11:27:01+11:00 https://pharmadispatch.com/news/at-least-mfn-is-exposing-the-institutional-mythologies-that-pollute-proper-debate 2025-10-28T09:14:01+11:00 https://pharmadispatch.com/news/pyc-reports-strong-clinical-momentum-and-cash-position-ahead-of-key-readouts 2025-10-27T15:24:01+11:00 https://pharmadispatch.com/news/government-backs-new-national-push-to-close-bone-health-testing-gap-for-women 2025-10-27T14:50:01+11:00 https://pharmadispatch.com/news/leadership-change-at-polynovo-as-long-time-chair-steps-down 2025-10-27T12:47:01+11:00 https://pharmadispatch.com/news/cann-group-announces-major-debt-restructure-and-capital-raise-to-strengthen-balance-sheet 2025-10-27T11:48:01+11:00 https://pharmadispatch.com/news/fda-awards-the-first-ever-national-priority-vouchers-to-nine-sponsors 2025-10-27T10:33:01+11:00 https://pharmadispatch.com/news/cancer-australia-looks-to-accelerate-the-delivery-of-national-plan 2025-10-27T10:18:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-the-additon-of-another-contraception-option-to-the-pbs 2025-10-27T08:22:01+11:00 https://pharmadispatch.com/news/medicines-australia-hardens-stance-as-us-pressure-sharpens-spotlight-on-pbs-pricing 2025-10-26T09:19:01+11:00 https://pharmadispatch.com/news/immuron-launches-proibs-in-australia-to-support-people-living-with-ibs 2025-10-24T12:33:01+11:00 https://pharmadispatch.com/news/queensland-to-host-ausbiotech-international-conference-and-sector-leadership-strengthened-with-d 2025-10-24T12:23:01+11:00 https://pharmadispatch.com/news/david-henderson-to-lead-takedas-specialty-franchise-in-oceania 2025-10-24T12:16:01+11:00 https://pharmadispatch.com/news/new-zealand-identified-as-a-major-outlier-in-oecd-medicines-investment 2025-10-24T00:00:01+11:00 https://pharmadispatch.com/news/a-perspective-that-more-accurately-belongs-in-a-time-capsule-from-the-1990s 2025-10-23T19:00:01+11:00 https://pharmadispatch.com/news/global-focus-intensifies-as-ausbiotech-strengthens-trade-partnerships-and-international-engageme 2025-10-23T18:58:01+11:00 https://pharmadispatch.com/news/queensland-resources-sector-backs-prevention-first-health-push-to-boost-workforce-productivity 2025-10-23T18:50:01+11:00 https://pharmadispatch.com/news/omico-appoints-richard-vines-as-new-chair-as-it-strengthens-national-precision-oncology-agenda 2025-10-23T16:16:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-fda-response-date-for-galidesivir-approval-pathway 2025-10-23T11:46:01+11:00 https://pharmadispatch.com/news/4dmedical-secures-stanford-as-first-commercial-site-and-expands-astrazeneca-partnership-in-brazi 2025-10-23T11:45:01+11:00 https://pharmadispatch.com/news/noxopharm-granted-first-us-patent-for-sofra-immune-modulation-platform 2025-10-23T11:45:01+11:00 https://pharmadispatch.com/news/impedimed-accelerates-growth-strategy-on-strong-results-and-expanding-market-reach 2025-10-23T11:44:01+11:00 https://pharmadispatch.com/news/clarity-pharmaceuticals-copper-theranostics-platform-delivers-superior-prostate-cancer-imaging-r 2025-10-23T11:43:01+11:00 https://pharmadispatch.com/news/starpharma-receives-upfront-payment-from-genentech-launching-oncology-collaboration 2025-10-23T11:42:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-launches-global-repeat-dose-trial-for-potential-first-in-class-adoa-treatment 2025-10-23T11:41:01+11:00 https://pharmadispatch.com/news/ausbiotech-invest-kicks-off-australias-biggest-week-in-biotech-innovation 2025-10-23T11:40:01+11:00 https://pharmadispatch.com/news/telix-doses-first-patient-in-solace-trial-for-metastatic-bone-pain 2025-10-23T11:39:01+11:00 https://pharmadispatch.com/news/michael-azrak-to-depart-moderna-after-four-years-of-leadership 2025-10-23T10:10:01+11:00 https://pharmadispatch.com/news/gilead-appoints-arthur-miritis-as-new-executive-director-and-general-manager 2025-10-23T09:45:01+11:00 https://pharmadispatch.com/news/sanofi-treatment-for-ultra-rare-asmd-to-be-made-available-through-lsdp 2025-10-22T12:08:01+11:00 https://pharmadispatch.com/news/sigma-reports-strong-growth-and-upgraded-synergies-in-first-full-year-post-merger 2025-10-22T10:56:01+11:00 https://pharmadispatch.com/news/the-mirage-of-us-pharmaceutical-pricing-and-how-it-could-obscure-the-impact-of-the-mostfavoredna 2025-10-22T03:00:01+11:00 https://pharmadispatch.com/news/idt-australia-sharpens-strategy-with-cost-savings-and-radiopharmaceutical-focus 2025-10-21T18:36:01+11:00 https://pharmadispatch.com/news/foi-reforms-setback-transparency-decades-and-will-impact-public-health-decision-making 2025-10-21T10:36:01+11:00 https://pharmadispatch.com/news/astellas-xtandi-achieves-landmark-survival-milestone-in-prostate-cancer 2025-10-21T10:11:01+11:00 https://pharmadispatch.com/news/services-australia-reports-record-number-of-processed-pbs-precriptions 2025-10-21T09:17:01+11:00 https://pharmadispatch.com/news/endometriosis-diagnoses-in-australian-gp-clinics-nearly-double-over-a-decade 2025-10-21T08:51:01+11:00 https://pharmadispatch.com/news/patient-centric-partnerships-will-unlock-brighter-and-more-equitable-outcomes-for-all 2025-10-21T03:00:01+11:00 https://pharmadispatch.com/news/vaccine-confidence-slips-as-australians-grow-more-concerned-about-access-to-healthcare 2025-10-20T11:15:01+11:00 https://pharmadispatch.com/news/nzs-pharmac-proposes-new-rules-to-manage-options-for-investment-list 2025-10-20T11:01:01+11:00 https://pharmadispatch.com/news/monash-scientists-crack-genetic-code-behind-rna-splicing-opening-door-to-to-new-therapies 2025-10-20T10:53:01+11:00 https://pharmadispatch.com/news/radiopharm-secures-funding-to-accelerate-radiopharmaceutical-pipeline-as-data-show-strong-moment 2025-10-20T10:52:01+11:00 https://pharmadispatch.com/news/neuren-secures-fda-fast-track-designation-for-nnz-2591-in-phelan-mcdermid-syndrome 2025-10-20T10:50:01+11:00 https://pharmadispatch.com/news/biogen-earns-fourth-great-place-to-work-sertification-strengthening-culture-of-inclusion 2025-10-20T10:43:01+11:00 https://pharmadispatch.com/news/algorae-partners-with-cadila-pharmaceuticals-to-launch-therapies-in-australia-and-new-zealand 2025-10-20T09:35:01+11:00 https://pharmadispatch.com/news/orthocell-expands-stake-in-marine-biomedical-secures-global-rights-to-regenerative-bone-technolo 2025-10-20T09:34:01+11:00 https://pharmadispatch.com/news/immutep-unveils-dual-breakthroughs-at-esmo-2025-strengthening-case-for-efti-across-multiple-tumo 2025-10-20T09:13:01+11:00 https://pharmadispatch.com/news/pharmac-targets-red-tape-to-streamline-access-to-some-medicines-and-health-consumables 2025-10-20T08:53:01+11:00 https://pharmadispatch.com/news/australia-records-worst-flu-season-on-record-as-vaccination-rates-stagnate 2025-10-20T07:11:01+11:00 https://pharmadispatch.com/news/merck-expands-commitment-to-first-nations-stem-leadership-with-new-scholarships-and-partnerships 2025-10-19T19:55:01+11:00 https://pharmadispatch.com/news/orthocell-boosts-balance-sheet-with-capital-raise-to-drive-nerve-repair-product-growth 2025-10-19T09:24:01+11:00 https://pharmadispatch.com/news/amplia-targets-us-market-expansion-as-fak-inhibitor-shows-promise-in-pancreatic-cancer 2025-10-19T09:08:01+11:00 https://pharmadispatch.com/news/new-combination-therapy-sets-landmark-survival-benchmark-in-bladder-cancer-treatment 2025-10-19T08:48:01+11:00 https://pharmadispatch.com/news/advancell-unveils-promising-first-clinical-results-for-212pb-advc001-in-prostate-cancer 2025-10-19T08:28:01+11:00 https://pharmadispatch.com/news/trump-announces-third-mfn-deal-with-a-focus-on-fertility-drug-costs-and-expanding-ivf-access 2025-10-18T13:17:01+11:00 https://pharmadispatch.com/news/an-exceptional-outcome-that-must-not-become-an-exception 2025-10-18T12:37:01+11:00 https://pharmadispatch.com/news/bms-says-september-outcome-could-set-a-new-policy-benchmark-for-access 2025-10-18T12:06:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-becomes-first-global-employer-to-achieve-dual-region-menopause-friendly-acc 2025-10-18T10:07:01+11:00 https://pharmadispatch.com/news/landmark-trial-confirms-survival-benefit-of-lilly-therapy-in-high-risk-early-breast-cancer 2025-10-18T09:56:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-17-october 2025-10-17T15:28:01+11:00 https://pharmadispatch.com/news/new-partnership-aims-to-to-strengthen-local-cell-and-gene-manufacturing-capability 2025-10-16T14:47:01+11:00 https://pharmadispatch.com/news/vertex-announces-new-zealand-registration-of-next-generation-cystic-fibrosis-treatment 2025-10-16T14:35:01+11:00 https://pharmadispatch.com/news/lillys-oral-glp-1-therapy-delivers-strong-results-in-late-stage-diabetes-trials 2025-10-16T14:08:01+11:00 https://pharmadispatch.com/news/ndis-participant-numbers-and-spending-continue-growth-trajectory-in-latest-quarterly-data 2025-10-15T14:52:01+11:00 https://pharmadispatch.com/news/key-pharmaceuticals-builds-on-40-year-legacy-to-support-frontline-health 2025-10-15T14:30:01+11:00 https://pharmadispatch.com/news/chimeric-and-viral-vector-manufacturing-facility-sign-advanced-manufacturing-agreement 2025-10-15T14:16:01+11:00 https://pharmadispatch.com/news/biotron-limited-to-acquire-sedarex-and-raise-25-million-to-accelerate-anaesthetic-program 2025-10-15T14:09:01+11:00 https://pharmadispatch.com/news/intranasal-insulin-delivers-new-hope-for-delirium-treatment 2025-10-15T09:37:01+11:00 https://pharmadispatch.com/news/medibank-backs-expansion-of-emyrias-trauma-and-depression-programs-to-queensland 2025-10-15T09:34:01+11:00 https://pharmadispatch.com/news/vicki-robinson-joins-proteomics-international-board-as-independent-non-executive-director 2025-10-15T09:29:01+11:00 https://pharmadispatch.com/news/telix-pharmaceuticals-lifts-revenue-guidance-after-strong-third-quarter-performance 2025-10-15T07:48:01+11:00 https://pharmadispatch.com/news/victorian-government-ministers-to-headline-australias-biggest-biotech-week 2025-10-15T04:21:01+11:00 https://pharmadispatch.com/news/cancer-survival-continues-to-rise-but-demand-on-australias-chemotherapy-system-grows 2025-10-14T13:44:01+11:00 https://pharmadispatch.com/news/what-seems-positive-from-afar-can-look-very-different-to-those-who-live-it 2025-10-14T11:28:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-unites-with-the-ama-to-urge-change-on-medicinal-cannabis-regulation 2025-10-14T05:09:01+11:00 https://pharmadispatch.com/news/australian-first-for-argenx-with-autoimmune-research-partnership-with-unisa 2025-10-13T14:52:01+11:00 https://pharmadispatch.com/news/former-ma-chair-to-chair-the-australian-maker-of-the-green-whistle 2025-10-13T13:55:01+11:00 https://pharmadispatch.com/news/of-course-it-will-never-change-if-you-never-make-the-case-for-change 2025-10-13T12:08:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-readies-pyc-002-for-clinic-after-positive-pre-clinical-data 2025-10-13T10:48:01+11:00 https://pharmadispatch.com/news/medical-developments-international-signals-a-turn-to-growth-as-penthrox-momentum-builds 2025-10-13T08:20:01+11:00 https://pharmadispatch.com/news/artrya-clears-key-us-milestone-for-coronary-device-targets-fda-filing-by-year-end 2025-10-13T07:58:01+11:00 https://pharmadispatch.com/news/adherium-launches-early-exercise-incentive-offer-to-reward-optionholders 2025-10-13T07:49:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-12-october 2025-10-12T12:40:01+11:00 https://pharmadispatch.com/news/valuing-life-summit-brings-medicines-access-under-the-spotlight-in-wellington 2025-10-12T12:11:01+11:00 https://pharmadispatch.com/news/we-cant-really-moan-about-another-country-doing-what-we-have-been-doing-for-decades 2025-10-12T11:24:01+11:00 https://pharmadispatch.com/news/astrazeneca-joins-pfizer-in-signing-mfn-pricing-agreement-with-trump-administration 2025-10-12T10:56:01+11:00 https://pharmadispatch.com/news/this-exchange-on-the-hta-review-was-about-as-underwhelming-as-it-sounds 2025-10-09T22:32:01+11:00 https://pharmadispatch.com/news/ausbiotech-unveils-international-conference-program-for-australias-biggest-week-in-biotech 2025-10-09T16:12:01+11:00 https://pharmadispatch.com/news/life-sciences-industry-calls-for-stronger-national-strategy-to-support-trials-and-innovation 2025-10-09T12:04:01+11:00 https://pharmadispatch.com/news/officials-outline-ongoing-measures-to-address-adhd-medicine-shortages 2025-10-09T10:14:01+11:00 https://pharmadispatch.com/news/pharmaceutical-spending-to-rise-by-around-10-billion-but-still-lose-ground-to-other-programs 2025-10-09T02:00:01+11:00 https://pharmadispatch.com/news/australian-company-reports-positive-outcome-from-collaboration 2025-10-08T17:51:01+11:00 https://pharmadispatch.com/news/cureator-opens-33-million-funding-round-with-csl-and-abbvie-partnership 2025-10-08T10:38:01+11:00 https://pharmadispatch.com/news/new-report-highlights-widening-gap-in-access-to-modern-medicines-between-australia-and-nz 2025-10-08T02:00:01+11:00 https://pharmadispatch.com/news/racgp-warns-of-mounting-pressure-on-gps-as-costs-and-complexity-rise 2025-10-07T15:32:01+11:00 https://pharmadispatch.com/news/ausbiotechs-annual-report-highlights-a-defining-year-for-australias-life-sciences-sector 2025-10-07T15:03:01+11:00 https://pharmadispatch.com/news/astrazeneca-becomes-the-latest-to-say-it-could-halt-uk-investment-over-appalling-pricing-regime 2025-10-07T14:48:01+11:00 https://pharmadispatch.com/news/mtpconnect-and-wholesale-investor-unite-to-accelerate-investment-in-life-sciences-sector 2025-10-07T14:34:01+11:00 https://pharmadispatch.com/news/percheron-therapeutics-reports-positive-final-data-from-early-phase-trial-of-hmbd-002 2025-10-07T12:15:01+11:00 https://pharmadispatch.com/news/fda-clears-clinical-hold-on-neurizons-nuz-001-paving-way-for-healey-als-trial 2025-10-07T10:44:01+11:00 https://pharmadispatch.com/news/neuroscientific-gains-tga-approval-for-first-patients-in-crohns-disease-program 2025-10-07T10:20:01+11:00 https://pharmadispatch.com/news/patients-policy-and-productivity-a-call-for-faster-access-to-innovation 2025-10-07T01:00:01+11:00 https://pharmadispatch.com/news/the-theology-of-syntax-and-how-hta-exercises-power-through-language 2025-10-06T18:00:01+11:00 https://pharmadispatch.com/news/no-need-to-look-very-far-for-examples-of-governance-that-could-bring-fairness-to-hta 2025-10-06T18:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-136-million-investment-to-strengthen-clinical-trials 2025-10-05T10:45:01+11:00 https://pharmadispatch.com/news/oncosil-medical-expands-european-reach-with-first-treatment-in-portugal 2025-10-05T10:34:01+11:00 https://pharmadispatch.com/news/4dmedical-raises-226-million-through-near-total-exercise-of-options 2025-10-05T10:28:01+11:00 https://pharmadispatch.com/news/mesoblast-secures-key-us-reimbursement-milestone-for-ryoncil 2025-10-05T10:22:01+11:00 https://pharmadispatch.com/news/artrya-share-purchase-plan-closes-early-after-strong-investor-demand 2025-10-05T10:08:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-3-october 2025-10-03T13:40:01+10:00 https://pharmadispatch.com/news/the-challenge-is-for-our-gatekeepers-can-they-see-beyond-the-gate 2025-10-03T02:00:01+10:00 https://pharmadispatch.com/news/trump-administration-links-mfn-and-lower-prices-to-faster-fda-approvals 2025-10-03T02:00:01+10:00 https://pharmadispatch.com/news/vertex-appoints-elisha-whitfield-as-senior-country-manager-for-australia-and-new-zealand 2025-10-02T17:33:01+10:00 https://pharmadispatch.com/news/race-oncology-uncovers-novel-anticancer-mechanism-for-bisantrene 2025-10-02T15:50:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-boost-for-clinical-trial-reform-after-years-of-delay 2025-10-02T12:17:01+10:00 https://pharmadispatch.com/news/pharmac-moves-to-ease-access-to-hiv-medicines-in-new-zealand 2025-10-02T11:05:01+10:00 https://pharmadispatch.com/news/if-the-uk-has-blinked-on-pharmaceutical-pricing-australia-might-have-to-pay-attention 2025-10-02T03:00:01+10:00 https://pharmadispatch.com/news/rising-influenza-deaths-spark-call-for-nurse-led-vaccination-clinics 2025-10-01T12:19:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-accelerates-her2-cancer-trial-after-positive-safety-review 2025-10-01T11:37:01+10:00 https://pharmadispatch.com/news/dorsavi-achieves-breakthrough-in-robotic-reflex-intelligence 2025-10-01T11:33:01+10:00 https://pharmadispatch.com/news/new-zealand-resets-medical-device-procurement-after-years-of-paralysis 2025-10-01T11:27:01+10:00 https://pharmadispatch.com/news/inoviq-publishes-breakthrough-data-on-next-generation-cancer-therapy 2025-10-01T11:20:01+10:00 https://pharmadispatch.com/news/cancer-vaccine-collaboration-lands-on-the-gold-coast 2025-10-01T10:25:01+10:00 https://pharmadispatch.com/news/trump-signs-executive-order-to-harness-ai-in-the-fight-against-paediatric-cancer 2025-10-01T10:13:01+10:00 https://pharmadispatch.com/news/is-a-new-listing-another-test-for-pbs-biosimilar-policy 2025-10-01T03:00:01+10:00 https://pharmadispatch.com/news/strengthening-medical-affairs-with-a-new-competency-framework 2025-10-01T02:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-launch-new-advisory-group-to-accelerate-advanced-therapies 2025-10-01T02:00:01+10:00 https://pharmadispatch.com/news/new-pricing-dynamics-emerge-for-australian-in-response-to-mfn 2025-10-01T00:00:01+10:00 https://pharmadispatch.com/news/reforming-the-institutional-framework-is-the-only-pathway-to-fairness 2025-09-30T17:00:01+10:00 https://pharmadispatch.com/news/melbourne-clinic-pioneers-integration-of-altered-state-therapies-in-mental-health-care 2025-09-30T11:53:01+10:00 https://pharmadispatch.com/news/the-symptoms-have-been-identified-but-the-widely-held-belief-about-the-cause-is-a-miss 2025-09-30T02:00:01+10:00 https://pharmadispatch.com/news/uk-companies-are-granted-more-time-to-decide-on-pricing-agreement 2025-09-29T15:28:01+10:00 https://pharmadispatch.com/news/anatara-strengthens-board-with-the-appointment-of-dirk-van-dissel 2025-09-29T13:50:01+10:00 https://pharmadispatch.com/news/clinuvel-advances-next-generation-peptide-drug-formulations 2025-09-29T13:43:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-targets-major-market-with-ath434-in-multiple-system-atrophy 2025-09-29T13:30:01+10:00 https://pharmadispatch.com/news/lower-than-expected-uptake-of-new-therapies-impacts-pbs-spend 2025-09-29T13:11:01+10:00 https://pharmadispatch.com/news/chimeric-reports-encouraging-early-data-from-chm-cdh17-trial 2025-09-29T10:50:01+10:00 https://pharmadispatch.com/news/pfizer-says-no-to-recommendation-for-dermatitis-therapy 2025-09-28T18:00:01+10:00 https://pharmadispatch.com/news/is-the-institution-able-to-change-in-response-to-something-it-may-not-be-capable-of-recognising 2025-09-28T15:00:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-pbs-listings-for-1-october 2025-09-28T11:01:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-launches-new-education-hub-with-focus-on-gynaecological-cancers 2025-09-27T09:32:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-26-september 2025-09-26T12:00:01+10:00 https://pharmadispatch.com/news/juvenile-arthritis-foundation-australia-named-small-charity-of-the-year 2025-09-26T09:59:01+10:00 https://pharmadispatch.com/news/waiting-for-any-impact-why-the-albanese-government-will-hold-fire-on-mfn 2025-09-26T03:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-pushes-for-patient-voices-to-lead-policy-reform 2025-09-26T03:00:01+10:00 https://pharmadispatch.com/news/tga-consulting-on-the-ongoing-need-for-paper-product-information-inserts 2025-09-25T13:03:01+10:00 https://pharmadispatch.com/news/gene-therapy-shows-early-promise-in-slowing-huntingtons-disease 2025-09-25T11:55:01+10:00 https://pharmadispatch.com/news/federal-minister-to-address-ausbiotech-international-conference-as-sector-marks-critical-junctur 2025-09-25T11:04:01+10:00 https://pharmadispatch.com/news/recce-pharmaceuticals-begins-patient-dosing-in-pivotal-diabetic-foot-infection-trial 2025-09-25T10:30:01+10:00 https://pharmadispatch.com/news/australians-missing-out-on-faster-care-by-underusing-community-pharmacists 2025-09-25T04:49:01+10:00 https://pharmadispatch.com/news/real-world-evidence-shows-lumos-diagnostics-febridx-cuts-antibiotic-use-and-delivers-system-savi 2025-09-24T16:00:01+10:00 https://pharmadispatch.com/news/tga-approves-eisai-biogen-therapy-for-alzheimers-disease 2025-09-24T15:09:01+10:00 https://pharmadispatch.com/news/painaustralia-backs-tga-reassurance-on-paracetamol-safety-in-pregnancy 2025-09-24T13:25:01+10:00 https://pharmadispatch.com/news/wehi-researchers-unlock-the-immune-systems-instruction-manual 2025-09-24T10:31:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-funding-roche-medicines-under-multi-product-agreement 2025-09-24T10:11:01+10:00 https://pharmadispatch.com/news/inoviqs-car-nk-exosomes-show-potent-tumour-killing-effect-in-breast-cancer-study 2025-09-24T10:00:01+10:00 https://pharmadispatch.com/news/bupa-launches-free-pharmacogenomics-program-to-support-safer-more-effective-medicine-use 2025-09-24T09:42:01+10:00 https://pharmadispatch.com/news/atomos-expands-debt-facility-to-support-strategic-growth 2025-09-24T09:33:01+10:00 https://pharmadispatch.com/news/race-oncology-secures-ind-approval-in-korea-for-rc220 2025-09-24T09:27:01+10:00 https://pharmadispatch.com/news/arovella-showcases-inkt-cell-therapy-platform-at-asx-smidcaps-conference 2025-09-24T09:21:01+10:00 https://pharmadispatch.com/news/familiar-name-appointed-to-lead-the-national-blood-authority 2025-09-24T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-and-government-jointly-assessing-the-impact-of-mfn 2025-09-24T03:00:01+10:00 https://pharmadispatch.com/news/where-did-that-come-from-and-why-are-they-saying-this-out-loud 2025-09-23T16:03:01+10:00 https://pharmadispatch.com/news/clinicians-urge-reform-of-pbs-restrictions-for-pulmonary-arterial-hypertension 2025-09-23T13:31:01+10:00 https://pharmadispatch.com/news/percheron-strengthens-leadership-team-ahead-of-next-trial-for-hmbd-002 2025-09-23T13:02:01+10:00 https://pharmadispatch.com/news/tga-reports-progress-on-gmp-clearance-backlog-strategy 2025-09-23T12:54:01+10:00 https://pharmadispatch.com/news/australias-first-mrna-facility-promises-jobs-growth-and-health-security 2025-09-23T03:00:01+10:00 https://pharmadispatch.com/news/157-million-in-cureator-funding-boosts-australian-startups-tackling-dementia 2025-09-22T10:07:01+10:00 https://pharmadispatch.com/news/starpharma-strikes-landmark-cancer-therapy-deal-with-genentech 2025-09-22T10:04:01+10:00 https://pharmadispatch.com/news/ltr-pharma-expands-into-sustainable-omega-3-with-strategic-stake-in-levomega 2025-09-22T10:01:01+10:00 https://pharmadispatch.com/news/doctors-urge-australians-to-check-their-pulse-as-af-awareness-week-begins 2025-09-22T09:13:01+10:00 https://pharmadispatch.com/news/medicines-australia-opens-ballot-for-board-elections 2025-09-22T05:11:01+10:00 https://pharmadispatch.com/news/new-roadmap-launched-to-support-australians-living-with-aggressive-lymphomas 2025-09-22T03:00:01+10:00 https://pharmadispatch.com/news/national-talks-aim-to-address-rare-cancer-trial-inequities 2025-09-22T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-australia-makes-the-bold-leap-to-sydeys-barangaroo 2025-09-22T03:00:01+10:00 https://pharmadispatch.com/news/women-often-left-to-manage-migraines-without-support-study-finds 2025-09-22T03:00:01+10:00 https://pharmadispatch.com/news/australia-must-choose-its-path-abbvies-pierre-claude-fumoleau-on-access-and-innovation-in-health 2025-09-22T02:00:01+10:00 https://pharmadispatch.com/news/clinuvels-scenesse-demonstrates-promising-results-in-vitiligo-patients 2025-09-21T11:26:01+10:00 https://pharmadispatch.com/news/australian-blood-test-offers-breakthrough-in-detecting-deadly-esophageal-cancer 2025-09-21T11:19:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-fda-backing-for-next-steps-on-marburg-antiviral 2025-09-21T11:11:01+10:00 https://pharmadispatch.com/news/proteomics-international-secures-key-laboratory-certification-in-boost-for-precision-diagnostics 2025-09-21T10:36:01+10:00 https://pharmadispatch.com/news/mark-butler-acknowledges-his-concerns-over-potential-impact-of-us-pharmaceutical-pricing-reforms 2025-09-19T01:00:01+10:00 https://pharmadispatch.com/news/if-the-minister-it-too-embarrassed-to-respond-it-might-be-the-right-response 2025-09-19T01:00:01+10:00 https://pharmadispatch.com/news/csl-appoints-new-global-head-of-search-to-accelerate-innovation-through-strategic-partnerships 2025-09-18T18:13:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-of-australia-acquires-member-benefits-australia 2025-09-18T16:18:01+10:00 https://pharmadispatch.com/news/sanofi-promotes-a-national-dialogue-on-health-literacy-and-trust 2025-09-18T11:58:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-reports-breakthrough-survival-data-for-galidesivir-in-marburg-and-ebola-s 2025-09-17T17:50:01+10:00 https://pharmadispatch.com/news/australian-dementia-network-registry-looking-to-drive-innovation-in-care 2025-09-17T11:18:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-funding-new-adhd-medicine-to-tackle-supply-shortages 2025-09-17T11:05:01+10:00 https://pharmadispatch.com/news/new-data-reveals-deep-inequities-as-sanofi-rolls-out-trust-building-initiative 2025-09-17T02:00:01+10:00 https://pharmadispatch.com/news/ipsen-appoints-dagmar-tschoep-as-general-manager-for-australia-and-new-zealand 2025-09-16T17:42:01+10:00 https://pharmadispatch.com/news/merck-welcomes-new-director-of-market-access-government-affairs-and-communications 2025-09-16T17:37:01+10:00 https://pharmadispatch.com/news/new-mental-health-service-takes-aim-at-the-silent-struggle-of-undiagnosed-adhd 2025-09-16T11:20:01+10:00 https://pharmadispatch.com/news/adelaide-to-host-dhls-next-generation-transport-and-warehousing-facility 2025-09-16T11:16:01+10:00 https://pharmadispatch.com/news/csl-partners-with-varmx-on-first-in-class-coagulation-treatment 2025-09-16T11:09:01+10:00 https://pharmadispatch.com/news/if-this-makes-you-uncomfortable-it-should-because-it-is-the-only-correct-response 2025-09-16T10:32:01+10:00 https://pharmadispatch.com/news/lilly-australia-announces-leadership-transition-as-tori-brown-moves-to-global-role 2025-09-16T03:00:01+10:00 https://pharmadispatch.com/news/decision-making-at-its-nadir-exposing-the-cruelty-of-incoherence 2025-09-16T03:00:01+10:00 https://pharmadispatch.com/news/use-of-psychotics-twice-as-high-in-aged-care-residents-with-dementia 2025-09-15T15:40:01+10:00 https://pharmadispatch.com/news/australian-discovery-advances-to-global-phase-3-breast-cancer-trial-with-pfizer 2025-09-15T15:16:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-delivers-promising-phase-2-data-in-multiple-system-atrophy 2025-09-15T11:46:01+10:00 https://pharmadispatch.com/news/actinogen-secures-fda-agreement-to-advance-xanamem-for-alzheimers-disease 2025-09-15T11:01:01+10:00 https://pharmadispatch.com/news/cleo-diagnostics-gains-positive-fda-feedback-guiding-us-approval-for-ovarian-cancer-test 2025-09-15T10:55:01+10:00 https://pharmadispatch.com/news/adheriums-smartinhaler-shows-breakthrough-results-in-real-world-respiratory-study 2025-09-15T10:42:01+10:00 https://pharmadispatch.com/news/avita-medical-receives-ce-mark-for-recell-go-enabling-commercialisation-across-europe 2025-09-15T10:06:01+10:00 https://pharmadispatch.com/news/is-this-the-sign-that-australias-hta-system-become-too-complex-for-its-own-good 2025-09-15T01:00:01+10:00 https://pharmadispatch.com/news/albania-appoints-ai-generated-minister-to-oversee-public-procurement 2025-09-15T01:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-calls-for-flexibility-on-fixed-17-week-evaluation-timeframe 2025-09-14T12:03:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-12-september 2025-09-12T12:19:01+10:00 https://pharmadispatch.com/news/surely-this-is-what-the-collapse-of-moral-authority-looks-like 2025-09-11T15:32:01+10:00 https://pharmadispatch.com/news/artificial-intelligence-can-only-accelerate-health-technology-assessments 2025-09-11T11:34:01+10:00 https://pharmadispatch.com/news/australian-biotechs-shine-at-asia-pacific-cell-and-gene-therapy-awards 2025-09-11T10:54:01+10:00 https://pharmadispatch.com/news/trump-administrationannounces-new-disclosure-rules-for-medicine-advertising 2025-09-10T18:20:01+10:00 https://pharmadispatch.com/news/chemist-warehouse-partners-with-doordash-to-deliver-health-and-beauty-on-demand 2025-09-10T18:16:01+10:00 https://pharmadispatch.com/news/cancer-leaders-unite-to-tackle-equity-and-innovation-at-2025-pcpa-summit 2025-09-10T17:58:01+10:00 https://pharmadispatch.com/news/roche-links-health-to-sustainability-in-new-report 2025-09-10T03:00:01+10:00 https://pharmadispatch.com/news/pathkeys-ai-shows-promise-in-predicting-clinical-trial-success 2025-09-09T15:52:01+10:00 https://pharmadispatch.com/news/final-trailblazers-episode-highlights-lessons-from-the-pandemic-and-the-future-of-health-policy 2025-09-09T12:42:01+10:00 https://pharmadispatch.com/news/ip-australia-flags-streamlined-patent-opposition-process-in-pharmaceutical-sector 2025-09-08T14:41:01+10:00 https://pharmadispatch.com/news/fda-unveils-landmark-pathway-in-latest-push-to-accelerate-rare-disease-drug-approvals 2025-09-08T12:59:01+10:00 https://pharmadispatch.com/news/mayne-pharma-responds-to-reports-on-the-future-of-adelaide-manufacturing-site 2025-09-08T12:43:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-raises-20-million-in-strategic-placement 2025-09-08T10:07:01+10:00 https://pharmadispatch.com/news/orthocell-says-remplir-study-delivers-compelling-success-rate 2025-09-08T09:27:01+10:00 https://pharmadispatch.com/news/promarkereso-blood-test-detects-early-stages-of-esophageal-adenocarcinoma-with-high-accuracy 2025-09-08T09:03:01+10:00 https://pharmadispatch.com/news/comley-letter-outlines-health-departments-regulatory-reform-agenda 2025-09-08T00:00:01+10:00 https://pharmadispatch.com/news/why-put-an-explicit-target-on-ai-accelerating-regulatory-reviews-but-not-hta 2025-09-08T00:00:01+10:00 https://pharmadispatch.com/news/world-leading-virologist-recognised-for-pioneering-ai-based-infectious-disease-detection-technol 2025-09-08T00:00:01+10:00 https://pharmadispatch.com/news/without-a-major-shift-in-direction-this-new-review-will-deliver-very-little-change 2025-09-08T00:00:01+10:00 https://pharmadispatch.com/news/real-world-data-shows-significant-reduction-in-hospital-stay-using-avita-medicals-recell 2025-09-07T12:32:01+10:00 https://pharmadispatch.com/news/botanix-announces-regulatory-approval-of-ecclock-in-south-korea 2025-09-07T12:27:01+10:00 https://pharmadispatch.com/news/clinuvel-charts-a-profitable-pathway-amid-sector-volatility 2025-09-07T11:55:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-5-september 2025-09-05T11:15:01+10:00 https://pharmadispatch.com/news/novartis-anz-appoints-marco-muscardo-as-ad-interim-country-president 2025-09-04T17:22:01+10:00 https://pharmadispatch.com/news/australian-industry-looks-to-the-uk-as-likely-lessons-for-us-most-favored-nation 2025-09-04T16:57:01+10:00 https://pharmadispatch.com/news/the-review-is-being-squeezed-dry-like-juice-from-a-lemon-and-patients-might-only-get-the-rind 2025-09-04T11:58:01+10:00 https://pharmadispatch.com/news/the-latest-hta-review-report-is-museum-piece-on-policymaking-and-reform 2025-09-03T20:56:01+10:00 https://pharmadispatch.com/news/stakeholders-could-be-mistaken-for-thinking-the-process-is-the-point 2025-09-03T20:25:01+10:00 https://pharmadispatch.com/news/regulate-the-regulators-why-ndis-audit-fees-are-failing-providers-and-participants 2025-09-03T15:11:01+10:00 https://pharmadispatch.com/news/blair-comley-says-ai-and-digital-the-future-of-australian-healthcare 2025-09-03T11:34:01+10:00 https://pharmadispatch.com/news/novartis-announces-leadership-transition-in-australia-and-new-zealand 2025-09-02T20:08:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-genomics-and-healthcare-australia-lags-the-uks-ambition 2025-09-02T14:42:01+10:00 https://pharmadispatch.com/news/merck-recognised-during-womens-health-week 2025-09-02T12:29:01+10:00 https://pharmadispatch.com/news/inspiring-the-next-generation-girls-in-stem-step-into-the-future-of-health 2025-09-02T12:24:01+10:00 https://pharmadispatch.com/news/political-leaders-clash-and-converge-on-medicines-access-and-hta-reform 2025-09-02T12:16:01+10:00 https://pharmadispatch.com/news/csls-rd-struggles-at-home-are-a-warning-australia-cannot-ignore 2025-09-02T02:00:01+10:00 https://pharmadispatch.com/news/judge-the-outcome-by-its-impact-not-by-the-promises-made-this-week 2025-09-02T02:00:01+10:00 https://pharmadispatch.com/news/pharmac-secures-ongoing-supply-of-pfizers-covid-19-vaccine 2025-09-01T13:12:01+10:00 https://pharmadispatch.com/news/arthritis-australia-marks-75-years-with-call-to-end-old-age-myths 2025-09-01T10:52:01+10:00 https://pharmadispatch.com/news/landmark-vaccination-program-protected-140000-australian-babies-this-winter 2025-09-01T10:36:01+10:00 https://pharmadispatch.com/news/new-pbs-listing-brings-relief-for-children-with-severe-asthma 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/australia-expands-childhood-protection-with-new-20-valent-pneumococcal-vaccine 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-draft-national-health-and-medical-research-strategy 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/patients-say-governments-rare-cancer-inquiry-response-falls-short-of-needed-action 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/pbac-to-have-another-attempt-at-broad-immunotherapy-listing 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/new-report-finds-rare-cancer-patients-face-inequities-long-before-diagnosis 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/private-health-insurance-rebate-saves-more-than-it-costs-but-its-value-is-slipping-away 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/pbs-expansion-delivers-earlier-access-to-vertex-cystic-fibrosis-therapy 2025-09-01T00:00:01+10:00 https://pharmadispatch.com/news/immuron-confirms-record-sales-and-major-clinical-milestones 2025-08-31T15:15:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-reports-clinical-progress-and-expanded-pipeline 2025-08-31T15:14:01+10:00 https://pharmadispatch.com/news/oncosil-secures-regulatory-wins-and-expands-global-footprint-in-2025 2025-08-31T15:13:01+10:00 https://pharmadispatch.com/news/prescient-secures-investor-support-to-advance-ptx-100-in-cancer-trials 2025-08-31T15:13:01+10:00 https://pharmadispatch.com/news/neurotech-advances-nti164-with-strong-clinical-data-and-new-leadership 2025-08-31T15:12:01+10:00 https://pharmadispatch.com/news/adherium-pushes-ahead-with-us-expansion-and-stronger-commercial-focus 2025-08-31T15:11:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-29-august 2025-08-29T13:18:01+10:00 https://pharmadispatch.com/news/ndis-quarterly-report-presents-a-positive-picture-but-questions-remain 2025-08-29T02:00:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-delivers-growth-as-priceline-drives-consumer-momentum 2025-08-29T02:00:01+10:00 https://pharmadispatch.com/news/government-pressed-on-diabetes-inquiry-response-as-obesity-costs-hit-12-billion-a-year 2025-08-29T02:00:01+10:00 https://pharmadispatch.com/news/you-can-ignore-reality-but-you-cant-ignore-the-consequences-of-ignoring-reality 2025-08-29T02:00:01+10:00 https://pharmadispatch.com/news/australians-fear-the-loss-of-independence-as-vision-health-concerns-rise 2025-08-29T02:00:01+10:00 https://pharmadispatch.com/news/coalition-turns-debate-on-cheaper-medicines-bill-to-hta-reform-delays 2025-08-27T16:48:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-showcases-more-accessible-healthcare-for-women 2025-08-27T12:10:01+10:00 https://pharmadispatch.com/news/sandoz-pushes-for-biosimilar-reform-while-building-a-great-workplace 2025-08-27T11:19:01+10:00 https://pharmadispatch.com/news/cartherics-secures-chinese-patent-to-boost-immune-cell-function-in-solid-tumours 2025-08-27T11:13:01+10:00 https://pharmadispatch.com/news/neuroscientifics-stemsmart-msc-therapy-shows-promise-in-kidney-transplantation 2025-08-27T10:33:01+10:00 https://pharmadispatch.com/news/starpharma-advances-dendrimer-platform-with-clinical-commercial-and-strategic-progress 2025-08-27T10:21:01+10:00 https://pharmadispatch.com/news/biome-achieves-breakthrough-year-with-first-profit-and-rapid-global-expansion 2025-08-27T10:07:01+10:00 https://pharmadispatch.com/news/neuren-doubles-profit-as-daybue-royalties-and-pipeline-progress-drive-growth 2025-08-27T09:54:01+10:00 https://pharmadispatch.com/news/sigma-healthcare-delivers-strong-first-year-results-after-chemist-warehouse-merger 2025-08-27T09:02:01+10:00 https://pharmadispatch.com/news/mark-butler-asking-questions-about-trumps-most-favored-nation-pricing-push 2025-08-27T02:00:01+10:00 https://pharmadispatch.com/news/bristol-myers-squibb-launches-cancer-resources-for-first-nations-australians 2025-08-27T02:00:01+10:00 https://pharmadispatch.com/news/government-and-coalition-combine-to-defeat-moderna-agreement-motion 2025-08-26T16:30:01+10:00 https://pharmadispatch.com/news/gbma-appoints-teva-regional-director-stephen-jenkins-to-its-board-of-directors 2025-08-26T15:23:01+10:00 https://pharmadispatch.com/news/australians-rapidly-increasing-their-embrace-of-ai-including-for-healthcare 2025-08-26T11:17:01+10:00 https://pharmadispatch.com/news/patients-cant-wait-swift-action-and-access-are-the-only-possible-moves-from-here 2025-08-26T02:00:01+10:00 https://pharmadispatch.com/news/vaxxas-secures-90-million-in-funding-to-commercialise-needle-free-vaccination-delivery-technolog 2025-08-25T17:19:01+10:00 https://pharmadispatch.com/news/bayer-partners-with-arrotex-to-strengthen-access-to-oral-contraceptives 2025-08-25T16:45:01+10:00 https://pharmadispatch.com/news/the-next-negotiation-was-always-going-to-be-complicated-the-new-reality-will-makes-it-more-so 2025-08-25T11:54:01+10:00 https://pharmadispatch.com/news/uk-industry-cites-us-pricing-ambitions-in-collapse-of-new-agreement-negotiation 2025-08-25T10:57:01+10:00 https://pharmadispatch.com/news/botanix-appoints-dr-patricia-walker-as-a-non-executive-director 2025-08-25T10:43:01+10:00 https://pharmadispatch.com/news/first-site-initiated-for-neurens-phelan-mcdermid-syndrome-phase-3-trial 2025-08-25T10:31:01+10:00 https://pharmadispatch.com/news/argent-biopharma-announces-results-of-independent-in-vivo-study 2025-08-25T10:06:01+10:00 https://pharmadispatch.com/news/pbac-delivers-recommendations-dominated-by-price-cuts-and-risk-shares 2025-08-25T02:00:01+10:00 https://pharmadispatch.com/news/an-outcome-that-might-haunt-the-systems-decision-making-like-banquos-ghost 2025-08-25T02:00:01+10:00 https://pharmadispatch.com/news/disappointment-as-committee-stalls-again-on-broad-listing-for-cancer-immunotherapies 2025-08-25T02:00:01+10:00 https://pharmadispatch.com/news/world-first-clinical-trial-reveals-unprecedented-insights-into-brain-cancer-treatment 2025-08-24T12:39:01+10:00 https://pharmadispatch.com/news/girls-to-graduates-program-event-in-partnership-with-astrazeneca 2025-08-24T12:31:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-22-august 2025-08-22T12:07:01+10:00 https://pharmadispatch.com/news/if-companies-accept-conditional-recommendations-they-will-keep-imposing-them 2025-08-22T02:00:01+10:00 https://pharmadispatch.com/news/applications-now-open-for-ausbiotech-invest-and-the-early-stage-innovation-forum 2025-08-21T18:26:01+10:00 https://pharmadispatch.com/news/seymour-welcomes-medsafe-year-on-year-improvement 2025-08-21T13:33:01+10:00 https://pharmadispatch.com/news/draft-nice-guidance-proposes-major-shake-up-of-uk-diabetes-treatment 2025-08-21T02:00:01+10:00 https://pharmadispatch.com/news/we-dont-need-new-laws-for-conditional-outcomes-because-they-are-already-embedded-in-the-system 2025-08-21T02:00:01+10:00 https://pharmadispatch.com/news/the-pbacs-conditionality-and-provisional-revolution-from-2013-to-2024 2025-08-21T02:00:01+10:00 https://pharmadispatch.com/news/ltr-pharma-says-new-study-confirms-faster-onset-of-intranasal-treatment 2025-08-20T13:28:01+10:00 https://pharmadispatch.com/news/neurizons-nuz-001-ole-study-demonstrates-long-term-safety-and-efficacy-signals 2025-08-20T13:22:01+10:00 https://pharmadispatch.com/news/us-fda-grants-orphan-drug-designation-to-invions-inv043 2025-08-20T13:16:01+10:00 https://pharmadispatch.com/news/ai-added-to-the-work-of-hta-review-implementation-advisory-group 2025-08-20T03:00:01+10:00 https://pharmadispatch.com/news/csl-launches-strategic-initiative-with-planned-spinout-of-seqirus 2025-08-20T03:00:01+10:00 https://pharmadispatch.com/news/former-queensland-premier-appointed-to-chair-brandon-biocatalyst 2025-08-19T17:06:01+10:00 https://pharmadispatch.com/news/should-keep-these-processes-separate-until-the-minister-has-determined-the-outcome 2025-08-18T18:00:01+10:00 https://pharmadispatch.com/news/lilly-launches-new-initiative-with-monash-university-to-improve-gaps-in-obesity-management 2025-08-18T18:00:01+10:00 https://pharmadispatch.com/news/new-zealand-might-be-leading-australia-on-ai-in-medicines-evaluation-and-assessment 2025-08-18T18:00:01+10:00 https://pharmadispatch.com/news/novartis-unveils-new-solution-to-simplify-hcp-access-to-private-prescriptions 2025-08-18T15:15:01+10:00 https://pharmadispatch.com/news/from-caution-to-complexity-pbacs-decade-long-changing-language-on-pricing-and-access 2025-08-18T03:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-launches-global-first-marie-krogh-young-women-in-science-prize-in-australia 2025-08-18T03:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-menarini-in-australia-and-new-zealand 2025-08-18T02:00:01+10:00 https://pharmadispatch.com/news/beigene-launches-its-new-name-and-brand-identity-in-australia-and-new-zealand 2025-08-18T02:00:01+10:00 https://pharmadispatch.com/news/lilly-announcement-confirms-the-complexity-of-aligning-prices 2025-08-18T02:00:01+10:00 https://pharmadispatch.com/news/emvision-awarded-non-diluting-grant-for-emu-regional-benefits-study 2025-08-17T16:02:01+10:00 https://pharmadispatch.com/news/fda-review-timeline-extended-for-neurizons-nuz-001-ind-clinical-hold 2025-08-17T15:53:01+10:00 https://pharmadispatch.com/news/new-crispr-technique-could-rewrite-future-of-genetic-disease-treatment 2025-08-17T13:26:01+10:00 https://pharmadispatch.com/news/bionsw-catalyst-dinner-strengthens-connections-and-investment-in-nsw-life-sciences 2025-08-17T13:20:01+10:00 https://pharmadispatch.com/news/healthengine-launches-an-ai-receptionist-supporting-gp-clinics-and-patients 2025-08-17T13:02:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-15-august 2025-08-15T12:20:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-pbac-outcomes-its-all-in-the-language-about-pricing 2025-08-15T03:00:01+10:00 https://pharmadispatch.com/news/nobody-can-possibly-sustain-an-argument-this-is-not-a-price-negotiation 2025-08-15T03:00:01+10:00 https://pharmadispatch.com/news/interim-report-calls-for-prevention-focus-to-boost-the-nations-productivity 2025-08-14T16:19:01+10:00 https://pharmadispatch.com/news/just-because-the-system-involves-humans-does-not-make-it-human 2025-08-14T02:32:01+10:00 https://pharmadispatch.com/news/australian-company-mirugen-secures-backing-to-process-cell-technology 2025-08-13T16:47:01+10:00 https://pharmadispatch.com/news/accesscrs-awards-celebrate-partnerships-between-lived-experience-and-science 2025-08-13T16:04:01+10:00 https://pharmadispatch.com/news/firebrick-says-nasodine-covid-19-patent-accepted-in-europe 2025-08-13T11:41:01+10:00 https://pharmadispatch.com/news/orthocell-advances-us-rollout-of-nerve-repair-product-remplir 2025-08-13T11:16:01+10:00 https://pharmadispatch.com/news/avita-medical-successfully-completes-australian-equity-raise 2025-08-13T10:55:01+10:00 https://pharmadispatch.com/news/experienced-innovation-leader-joins-ausbiotech-as-its-head-of-investment 2025-08-13T05:00:01+10:00 https://pharmadispatch.com/news/government-review-and-action-timelines-are-in-dog-years-compared-to-ai 2025-08-13T02:00:01+10:00 https://pharmadispatch.com/news/australia-is-not-alone-in-tripping-over-reform-of-medical-device-funding-frameworks 2025-08-12T12:01:01+10:00 https://pharmadispatch.com/news/if-the-cost-of-this-process-is-truly-rising-at-this-rate-then-the-process-must-be-the-problem 2025-08-12T02:00:01+10:00 https://pharmadispatch.com/news/biogen-announces-leadership-transition-for-australia-and-new-zealand 2025-08-12T02:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-plan-to-update-access-and-supply-of-covid-19-treatments 2025-08-12T02:00:01+10:00 https://pharmadispatch.com/news/syntara-receives-fda-guidance-for-amsulostat-in-myelofibrosis-treatment 2025-08-11T10:18:01+10:00 https://pharmadispatch.com/news/noxopharm-advances-heracles-trial-for-novel-autoimmune-disease-drug 2025-08-11T10:05:01+10:00 https://pharmadispatch.com/news/could-the-realities-of-ai-quickly-date-or-even-swamp-the-hta-review-outcomes 2025-08-11T02:00:01+10:00 https://pharmadispatch.com/news/we-asked-chatgpt-to-produce-a-podcast-script-about-the-pros-and-cons-of-the-hta-review 2025-08-10T16:43:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-accelerates-clinical-progress-of-pyc-003-in-pkd-trial 2025-08-10T16:08:01+10:00 https://pharmadispatch.com/news/neuren-expands-nnz-2591-pipeline-to-include-syngap1-related-disorder 2025-08-10T16:04:01+10:00 https://pharmadispatch.com/news/ai-has-to-be-seen-as-an-opportunity-to-get-medicines-to-patients-faster 2025-08-10T02:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-8-august 2025-08-08T11:04:01+10:00 https://pharmadispatch.com/news/historic-research-grant-program-aims-to-halve-breast-cancer-deaths 2025-08-08T04:54:01+10:00 https://pharmadispatch.com/news/the-imperative-is-to-fully-understand-the-implications-of-any-change 2025-08-08T04:45:01+10:00 https://pharmadispatch.com/news/mark-butler-says-he-is-very-much-on-the-page-of-ensuring-faster-access-to-medicines 2025-08-08T02:00:01+10:00 https://pharmadispatch.com/news/pfizer-ceo-albert-bourla-says-mfn-and-discussions-are-extremely-productive 2025-08-07T03:00:01+10:00 https://pharmadispatch.com/news/merck-welcomes-new-expert-guidance-on-endocrine-testing-for-children 2025-08-06T17:31:01+10:00 https://pharmadispatch.com/news/cartherics-unveils-state-of-the-art-cleanroom-facility-for-cell-therapy-manufacturing 2025-08-06T17:29:01+10:00 https://pharmadispatch.com/news/medicines-nz-says-new-poll-underscores-the-need-for-urgent-action-on-medicines-access 2025-08-06T13:40:01+10:00 https://pharmadispatch.com/news/gilead-announces-recipients-of-inaugural-glows-grants-for-indigenous-led-hiv-and-hepatitis-proje 2025-08-06T03:00:01+10:00 https://pharmadispatch.com/news/he-will-be-deeply-missed-by-all-who-had-the-pleasure-of-getting-to-know-him 2025-08-06T03:00:01+10:00 https://pharmadispatch.com/news/arrotex-pharmaceuticals-welcomes-strategic-investment-into-dbg-health 2025-08-05T15:09:01+10:00 https://pharmadispatch.com/news/we-do-what-we-say-we-will-do-lead-by-example-and-find-a-way 2025-08-05T14:52:01+10:00 https://pharmadispatch.com/news/novo-nordisk-says-that-without-action-australia-faces-a-sobering-reality-on-life-expectancy 2025-08-05T02:00:01+10:00 https://pharmadispatch.com/news/a-rigged-system-in-which-delays-are-the-intent-not-the-consequence 2025-08-05T02:00:01+10:00 https://pharmadispatch.com/news/tga-halts-the-promotion-of-vitamin-d-for-bone-strength 2025-08-04T16:45:01+10:00 https://pharmadispatch.com/news/compumedics-continues-expansion-into-global-pharmaceutical-clinical-trial-market 2025-08-04T14:38:01+10:00 https://pharmadispatch.com/news/race-oncology-announces-the-publication-of-bisantrene-clinical-trial 2025-08-04T14:30:01+10:00 https://pharmadispatch.com/news/chimeric-therapeutics-provides-update-on-chm-cdh17-car-t-clinical-trial 2025-08-04T13:10:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-australians-want-more-investment-in-the-pbs 2025-08-04T02:00:01+10:00 https://pharmadispatch.com/news/latest-pharmac-decision-shows-up-australias-one-failure-on-critical-vaccine 2025-08-04T02:00:01+10:00 https://pharmadispatch.com/news/major-radiopharmaceutical-patent-case-exits-australias-federal-court 2025-08-04T02:00:01+10:00 https://pharmadispatch.com/news/regeneron-ceo-says-other-countries-need-to-pay-more-and-mfn-will-not-be-easy 2025-08-04T02:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-4-episode-22 2025-08-03T15:16:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-1-august 2025-08-01T11:53:01+10:00 https://pharmadispatch.com/news/trump-administration-takes-another-step-in-most-favored-nation-push 2025-08-01T05:07:01+10:00 https://pharmadispatch.com/news/study-reveals-growing-benefit-of-lilly-therapy-for-early-symptomatic-alzheimers-disease 2025-08-01T03:00:01+10:00 https://pharmadispatch.com/news/novartis-backs-the-launch-of-a-new-cardiovascular-disease-program 2025-08-01T03:00:01+10:00 https://pharmadispatch.com/news/first-in-new-wave-of-biosimilars-receive-pbs-listings 2025-08-01T03:00:01+10:00 https://pharmadispatch.com/news/arrotex-pharmaceuticals-expands-haematology-oncology-portfolio-through-antengene-partnership 2025-08-01T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-celebrate-catalyst-outcomes-and-further-strengthen-industry-c 2025-08-01T03:00:01+10:00 https://pharmadispatch.com/news/sandoz-biosimilars-of-major-osteoporosis-therapy-available-via-the-pbs 2025-08-01T03:00:01+10:00 https://pharmadispatch.com/news/abbvie-therapy-now-available-on-the-pbs-for-treatment-of-advanced-parkinsons 2025-08-01T03:00:01+10:00 https://pharmadispatch.com/news/government-admits-general-safety-net-is-significantly-higher-than-comparable-countries 2025-07-31T03:00:01+10:00 https://pharmadispatch.com/news/companies-face-higher-rebate-payments-as-a-result-of-co-pay-reduction 2025-07-31T03:00:01+10:00 https://pharmadispatch.com/news/substantial-us-program-aims-to-address-gaps-in-hepatitis-c-diagnosis-and-cure 2025-07-31T03:00:01+10:00 https://pharmadispatch.com/news/a-not-so-long-list-of-new-medicines-for-the-november-pbac 2025-07-31T03:00:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-secures-ethics-approval-for-pancreatic-cancer-trial 2025-07-30T09:44:01+10:00 https://pharmadispatch.com/news/world-first-study-uses-dna-to-investigate-who-develops-ms-and-why 2025-07-30T03:00:01+10:00 https://pharmadispatch.com/news/a-lot-going-on-behind-the-scene-but-the-industry-so-far-favouring-public-silence 2025-07-30T03:00:01+10:00 https://pharmadispatch.com/news/the-problem-with-the-ministers-statement-is-that-its-entirely-accurate 2025-07-30T03:00:01+10:00 https://pharmadispatch.com/news/no-data-means-no-prospect-of-access-to-trials-or-funded-medicines 2025-07-30T03:00:01+10:00 https://pharmadispatch.com/news/government-moves-on-general-co-pay-as-safety-gets-further-out-of-reach 2025-07-29T03:00:01+10:00 https://pharmadispatch.com/news/for-these-families-genomics-is-not-a-luxuryits-the-only-viable-path 2025-07-29T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-quantities-the-wider-societal-benefit-of-treatments-for-chronic-conditions 2025-07-28T15:44:01+10:00 https://pharmadispatch.com/news/australian-cell-therapy-company-appoints-experienced-executive-as-ceo 2025-07-28T15:06:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-reports-positive-topline-data-from-phase-2-trial-of-ath434 2025-07-28T14:50:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-receives-ind-approval-to-initiate-phase-1-study 2025-07-28T12:31:01+10:00 https://pharmadispatch.com/news/clarity-successfully-completes-203-million-institutional-placement 2025-07-28T10:09:01+10:00 https://pharmadispatch.com/news/us-and-eu-secure-new-trade-agreement-but-more-to-come-on-pharmaceuticals 2025-07-28T09:13:01+10:00 https://pharmadispatch.com/news/ok-for-north-korea-to-have-a-say-on-our-health-system-but-not-the-us 2025-07-28T03:00:01+10:00 https://pharmadispatch.com/news/leading-stakeholders-call-for-urgency-on-national-genomics-framework 2025-07-28T03:00:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-wants-action-as-new-analysis-reveals-many-still-missing-cures 2025-07-28T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-27-july 2025-07-27T17:26:01+10:00 https://pharmadispatch.com/news/fda-invites-submissions-to-new-rapid-review-priority-program 2025-07-25T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-marks-12-month-anniversary-of-funding-boost 2025-07-25T03:00:01+10:00 https://pharmadispatch.com/news/accesscr-announces-finalists-in-consumer-partnerships-in-research-awards 2025-07-24T15:42:01+10:00 https://pharmadispatch.com/news/australian-life-sciences-venture-capital-firm-brandon-capital-announces-fund-six-final-close 2025-07-24T14:16:01+10:00 https://pharmadispatch.com/news/is-australia-on-the-list-of-nine-countries-to-be-targeted-over-pricing 2025-07-24T12:38:01+10:00 https://pharmadispatch.com/news/latest-trade-agreement-reveals-us-focus-on-resolving-longstanding-issues 2025-07-24T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-to-acquire-vicebio-gaining-rights-to-queensland-discovered-technology 2025-07-23T16:43:01+10:00 https://pharmadispatch.com/news/senate-committee-appointments-reveal-a-significant-shake-up 2025-07-23T14:23:01+10:00 https://pharmadispatch.com/news/oncosil-medical-completes-recruitment-in-tripp-ffx-clinical-trial 2025-07-23T11:10:01+10:00 https://pharmadispatch.com/news/nyrada-advances-xolatryp-towards-phase-2a-trial-in-cardioprotection 2025-07-23T11:01:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-announces-25-million-placement-and-launches-share-purchase-plan 2025-07-23T10:49:01+10:00 https://pharmadispatch.com/news/percheron-therapeutics-announces-publication-of-new-preclinical-hmbd-002-data 2025-07-23T10:36:01+10:00 https://pharmadispatch.com/news/us-leads-the-way-on-cell-and-gene-therapy-with-new-rapid-access-program 2025-07-23T03:00:01+10:00 https://pharmadispatch.com/news/neuraxpharm-continues-international-expansion-with-launch-of-australian-affiliate 2025-07-23T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-minister-asks-for-more-in-new-letter-of-expectations 2025-07-23T03:00:01+10:00 https://pharmadispatch.com/news/viatris-certified-as-a-great-place-to-work-in-australia-and-new-zealand 2025-07-23T03:00:01+10:00 https://pharmadispatch.com/news/sarepta-backs-down-on-fda-demand-to-halt-distribution-of-gene-therapy 2025-07-22T11:42:01+10:00 https://pharmadispatch.com/news/mark-butler-acknowledges-dubious-relationship-between-the-pbs-and-us-tariffs 2025-07-22T03:00:01+10:00 https://pharmadispatch.com/news/some-of-pharmacs-fiercest-critics-appointed-to-guide-its-reset-program 2025-07-22T03:00:01+10:00 https://pharmadispatch.com/news/the-edelman-global-trust-and-health-report-reveals-half-of-young-australians-regret-a-health-dec 2025-07-22T03:00:01+10:00 https://pharmadispatch.com/news/tga-approves-biogen-therapy-for-rare-neurogenerative-disease 2025-07-21T16:13:01+10:00 https://pharmadispatch.com/news/osteopore-secures-clearance-for-jawbone-trial-at-princess-alexandra-hospital 2025-07-21T14:28:01+10:00 https://pharmadispatch.com/news/atomo-diagnostics-announces-successful-placement-from-share-purchase-plan-shortfall 2025-07-21T13:30:01+10:00 https://pharmadispatch.com/news/companies-have-all-the-power-in-this-process-if-they-choose-to-use-it 2025-07-21T03:00:01+10:00 https://pharmadispatch.com/news/another-day-and-another-example-of-our-systems-shortcomings 2025-07-21T03:00:01+10:00 https://pharmadispatch.com/news/ustr-trump-says-countries-will-avoid-tariffs-if-manufacturing-returns-to-the-us 2025-07-21T02:00:01+10:00 https://pharmadispatch.com/news/mesoblast-updates-investors-on-the-succcesful-us-launch-of-cell-therapy 2025-07-20T12:59:01+10:00 https://pharmadispatch.com/news/company-refuses-fda-request-to-halt-distribution-of-gene-therapy 2025-07-20T10:41:01+10:00 https://pharmadispatch.com/news/australian-researcher-awarded-gilead-sciences-global-grant-to-explore-novel-approach-in-breast-c 2025-07-18T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-17-july 2025-07-17T17:59:01+10:00 https://pharmadispatch.com/news/another-day-another-confusing-response-to-the-threat-of-us-tariffs 2025-07-17T09:55:01+10:00 https://pharmadispatch.com/news/ustr-launches-new-investigation-with-minimal-ambition-on-pharmaceuticals 2025-07-17T03:00:01+10:00 https://pharmadispatch.com/news/ndis-keeps-growing-but-signs-emerge-that-reforms-are-starting-to-work 2025-07-17T03:00:01+10:00 https://pharmadispatch.com/news/new-zealand-starting-to-benefit-after-lifting-advertising-prohibition 2025-07-17T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-restates-support-for-health-technology-assessment-reform 2025-07-16T16:24:01+10:00 https://pharmadispatch.com/news/brandon-biocatalyst-welcomes-the-inclusion-of-its-cureator-in-new-program 2025-07-16T14:07:01+10:00 https://pharmadispatch.com/news/cancer-australia-launches-research-program-targeting-early-onset-cancers 2025-07-16T11:21:01+10:00 https://pharmadispatch.com/news/imugene-completes-significant-placement-and-launches-share-purchase-plan 2025-07-16T11:01:01+10:00 https://pharmadispatch.com/news/lumos-diagnostics-signs-febridx-us-distribution-agreement-with-phase-scientific 2025-07-16T10:31:01+10:00 https://pharmadispatch.com/news/noxopharm-confirms-first-patient-dosed-in-sof-skn-heracles-trial 2025-07-16T09:45:01+10:00 https://pharmadispatch.com/news/final-days-to-help-build-australias-longest-running-life-sciences-benchmark-survey 2025-07-15T18:29:01+10:00 https://pharmadispatch.com/news/new-collaboration-between-viral-vector-manufacturing-facilityand-cell-therapies 2025-07-15T15:43:01+10:00 https://pharmadispatch.com/news/the-need-to-correct-a-profound-misconception-of-ethical-decision-making 2025-07-15T09:48:01+10:00 https://pharmadispatch.com/news/hta-reform-is-fine-but-why-is-the-underpinning-framework-immutable 2025-07-15T03:00:01+10:00 https://pharmadispatch.com/news/patient-voice-initiative-announced-the-appointment-of-new-president 2025-07-15T03:00:01+10:00 https://pharmadispatch.com/news/olympians-join-medical-experts-urging-parents-and-young-adults-on-meningococcal-vaccine 2025-07-15T03:00:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-announces-additional-confirmed-partial-response-in-accent-trial 2025-07-14T12:53:01+10:00 https://pharmadispatch.com/news/imugene-reports-two-additional-complete-responses-in-azer-cel-car-t-phase-1b-trial 2025-07-14T12:38:01+10:00 https://pharmadispatch.com/news/australia-is-in-no-position-to-lecture-the-us-about-affordable-access-to-medicines 2025-07-14T03:00:01+10:00 https://pharmadispatch.com/news/biotintelect-amongst-groups-funded-to-foster-research-commercialisation 2025-07-13T14:49:01+10:00 https://pharmadispatch.com/news/new-zealand-moves-again-to-make-it-easier-to-access-medicines 2025-07-11T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-10-july 2025-07-10T18:22:01+10:00 https://pharmadispatch.com/news/the-debate-is-frustrating-but-it-is-an-opportunity-to-amplify-acknowledged-concerns 2025-07-10T12:40:01+10:00 https://pharmadispatch.com/news/medibank-to-subsidise-pharmacogenetic-testing-for-members 2025-07-10T12:38:01+10:00 https://pharmadispatch.com/news/is-this-the-missing-link-in-pharma-engagement-strategies 2025-07-09T17:53:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-medicinal-cannabis-crackdown 2025-07-09T17:41:01+10:00 https://pharmadispatch.com/news/might-australia-be-just-a-little-hypocritical-on-pharmaceutical-tariffs 2025-07-09T16:56:01+10:00 https://pharmadispatch.com/news/this-debate-over-us-tariffs-might-be-the-dumbest-in-pbs-history 2025-07-09T16:03:01+10:00 https://pharmadispatch.com/news/island-expands-portfolio-with-the-acquisition-of-antiviral 2025-07-09T10:38:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-27-new-members-in-first-half-of-2025 2025-07-09T03:00:01+10:00 https://pharmadispatch.com/news/health-spending-under-increasing-pressure-as-department-looks-to-offsets 2025-07-09T03:00:01+10:00 https://pharmadispatch.com/news/consortium-established-to-co-design-new-telehealth-standards 2025-07-08T11:26:01+10:00 https://pharmadispatch.com/news/medadvisor-restates-focus-on-us-following-completion-of-anz-business-sale 2025-07-08T03:00:01+10:00 https://pharmadispatch.com/news/south-australia-expanded-flu-vax-availability-in-response-to-record-outbreak 2025-07-08T03:00:01+10:00 https://pharmadispatch.com/news/more-companies-are-exercising-their-rights-and-they-are-perfectly-entitled 2025-07-07T14:41:01+10:00 https://pharmadispatch.com/news/neurotechs-rett-syndrome-trial-results-published-in-scientific-journal 2025-07-07T10:10:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-to-progress-polycystic-kidney-disease-trial 2025-07-07T09:35:01+10:00 https://pharmadispatch.com/news/uks-ten-year-plan-backs-faster-access-but-industry-laments-lack-of-investment 2025-07-07T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-minister-prepares-to-deliver-letter-of-expectations 2025-07-07T03:00:01+10:00 https://pharmadispatch.com/news/it-signals-the-need-to-renegotiate-the-expiring-statutory-pricing-framework 2025-07-06T10:41:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast 2025-07-04T14:04:01+10:00 https://pharmadispatch.com/news/medicines-australia-backs-focus-on-listings-and-productivity-in-government-brief 2025-07-03T17:18:01+10:00 https://pharmadispatch.com/news/ausbiotech-seeking-a-head-of-investment-to-drive-sector-growth 2025-07-03T15:34:01+10:00 https://pharmadispatch.com/news/whats-the-point-of-pretending-that-australia-doesnt-free-ride-on-us-innovation 2025-07-03T13:19:01+10:00 https://pharmadispatch.com/news/framework-pushes-genomics-funding-to-a-review-that-is-mostly-silent-on-it 2025-07-03T10:56:01+10:00 https://pharmadispatch.com/news/medadvisor-announces-agreement-confirming-the-sale-of-australian-business 2025-07-03T03:00:01+10:00 https://pharmadispatch.com/news/draft-national-health-genomics-policy-framework-out-for-consultation 2025-07-03T03:00:01+10:00 https://pharmadispatch.com/news/gbma-announces-planned-departure-of-long-standing-ceo 2025-07-02T15:58:01+10:00 https://pharmadispatch.com/news/neurizon-announces-global-agreement-with-elanco-for-the-commercialisation-of-nuz-001 2025-07-02T11:10:01+10:00 https://pharmadispatch.com/news/prescient-therapeutics-opens-share-purchase-plan 2025-07-02T10:53:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-announces-additional-confirmed-partial-response-recorded-in-accent-trial 2025-07-02T10:48:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-announces-the-appointment-of-new-chair 2025-07-02T10:42:01+10:00 https://pharmadispatch.com/news/new-treatment-option-for-australians-with-early-breast-cancer-at-high-risk-of-recurrence 2025-07-02T03:00:01+10:00 https://pharmadispatch.com/news/expanded-listing-for-bristol-myers-squibbs-pd-1-to-include-bladder-cancer 2025-07-02T03:00:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-launches-pilot-pharmacy-format-instantscripts-pharmacy-health-hub 2025-07-02T03:00:01+10:00 https://pharmadispatch.com/news/the-industry-backs-productivity-focus-for-albanese-governments-second-term 2025-07-02T03:00:01+10:00 https://pharmadispatch.com/news/new-zealands-medsafe-and-pharmacy-directed-to-explore-ai-use-to-expedite-assessments 2025-07-02T03:00:01+10:00 https://pharmadispatch.com/news/moderna-announces-positive-phase-3-result-of-influenza-vaccines 2025-07-01T03:54:01+10:00 https://pharmadispatch.com/news/1-july-research-lagging-for-sarcoma-despite-accounting-for-one-third-of-adolescent-cancer-deaths 2025-07-01T02:00:01+10:00 https://pharmadispatch.com/news/takeda-therapy-now-available-through-the-pbs-for-serious-viral-infection 2025-07-01T02:00:01+10:00 https://pharmadispatch.com/news/the-real-question-is-why-expectations-were-so-high-in-the-first-place 2025-07-01T02:00:01+10:00 https://pharmadispatch.com/news/national-pharmacies-appoints-experienced-industry-leader-as-new-ceo 2025-07-01T02:00:01+10:00 https://pharmadispatch.com/news/tetratherix-lists-on-the-asx-following-successful-ipo 2025-06-30T14:14:01+10:00 https://pharmadispatch.com/news/ltr-pharma-achieves-key-fda-milestone-through-extractables-study 2025-06-30T10:48:01+10:00 https://pharmadispatch.com/news/arovella-therapeutics-announces-the-retirement-of-non-executive-chair 2025-06-30T10:26:01+10:00 https://pharmadispatch.com/news/incoming-brief-advises-minister-to-dampen-expectations-on-hta-review 2025-06-29T23:00:01+10:00 https://pharmadispatch.com/news/the-focus-on-system-and-patient-productivity-is-an-open-door-opportunity 2025-06-29T23:00:01+10:00 https://pharmadispatch.com/news/incoming-brief-recommends-doing-more-and-reviewing-less 2025-06-28T12:44:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-27-june 2025-06-27T15:48:01+10:00 https://pharmadispatch.com/news/percheron-licenses-phase-2-ready-immuno-oncology-candidate-from-hummingbird 2025-06-27T11:29:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-to-present-progress-in-phelan-mcdermid-syndrome-at-global-congress 2025-06-27T11:18:01+10:00 https://pharmadispatch.com/news/atmo-biosciences-receives-us-fda-clearance-for-ingestible-gas-sensing-capsule 2025-06-27T11:08:01+10:00 https://pharmadispatch.com/news/medadvisor-progressing-strategic-review-including-potential-sale-of-australian-operation 2025-06-27T03:00:01+10:00 https://pharmadispatch.com/news/hospital-pharmacists-call-for-cancer-care-reform-on-rare-cancers-awareness-day 2025-06-27T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-retains-position-on-critical-cabinet-committee 2025-06-26T15:43:01+10:00 https://pharmadispatch.com/news/new-zealand-to-streamline-access-to-adhd-treatments 2025-06-26T03:00:01+10:00 https://pharmadispatch.com/news/cleo-strengthens-fda-submission-following-access-to-globally-recognised-biobank 2025-06-25T14:24:01+10:00 https://pharmadispatch.com/news/leukaemia-foundation-calls-for-urgent-action-to-address-diagnosis-and-treatment-gaps 2025-06-25T12:25:01+10:00 https://pharmadispatch.com/news/qbiotics-candidate-produces-strong-efficacy-result-in-soft-tissue-sarcoma-trial 2025-06-25T11:10:01+10:00 https://pharmadispatch.com/news/noxopharm-says-clinical-trial-recruitment-progressing-rapidly 2025-06-25T10:43:01+10:00 https://pharmadispatch.com/news/us-phrma-puts-australia-in-the-group-of-innovation-free-riders 2025-06-25T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-leads-global-engagement-to-strengthen-australias-life-sciences-sector 2025-06-25T03:00:01+10:00 https://pharmadispatch.com/news/nt-doctors-want-action-as-whooping-cough-cases-soar 2025-06-25T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-clarifies-meaning-of-quick-pbs-listings-statement 2025-06-25T03:00:01+10:00 https://pharmadispatch.com/news/fivephusion-announces-successful-completion-of-phase-1-component-of-paediatric-brain-cancer-tria 2025-06-24T15:29:01+10:00 https://pharmadispatch.com/news/amgen-backs-women-in-cancer-research-as-survey-reveals-workforce-risks 2025-06-24T03:00:01+10:00 https://pharmadispatch.com/news/millions-of-australians-unaware-of-the-simple-test-that-can-expose-australias-most-notorious-sil 2025-06-24T03:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-awareness-day-to-focus-on-the-lived-experience-of-patients 2025-06-24T03:00:01+10:00 https://pharmadispatch.com/news/vertex-announces-new-expanded-australian-reimbursement-for-cf-therapy 2025-06-24T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast 2025-06-23T15:37:01+10:00 https://pharmadispatch.com/news/naccho-announces-2025-aboriginal-and-torres-strait-islander-pharmacist-scholarship-recipients 2025-06-23T13:21:01+10:00 https://pharmadispatch.com/news/proteomics-announces-release-of-new-promarkerd-test-for-predicting-diabetic-kidney-disease 2025-06-23T12:50:01+10:00 https://pharmadispatch.com/news/immutep-announces-positive-update-from-phase-1-study-of-imp761 2025-06-23T12:09:01+10:00 https://pharmadispatch.com/news/tryptamine-therapeutics-secures-human-ethics-approval-for-binge-eating-disorder-trial 2025-06-23T11:55:01+10:00 https://pharmadispatch.com/news/outcomes-published-from-meeting-the-pbac-was-directed-to-hold 2025-06-22T11:22:01+10:00 https://pharmadispatch.com/news/tga-licensed-compounders-call-for-review-to-ensure-sustainability 2025-06-20T15:32:01+10:00 https://pharmadispatch.com/news/awards-recognise-and-celebrate-the-lived-experience-in-health-research 2025-06-20T14:32:01+10:00 https://pharmadispatch.com/news/glp-1-pill-study-marks-potential-new-chapter-in-treating-diabetes-and-weight-loss 2025-06-20T12:11:01+10:00 https://pharmadispatch.com/news/an-ideological-darkness-underpins-our-systems-decision-making 2025-06-20T11:10:01+10:00 https://pharmadispatch.com/news/wa-budget-includes-significant-investments-in-health-and-medical-research 2025-06-20T02:56:01+10:00 https://pharmadispatch.com/news/gilead-confirms-australian-submission-for-major-hiv-innovation-following-us-approval 2025-06-20T02:54:01+10:00 https://pharmadispatch.com/news/advocate-and-founder-of-rare-cancers-australia-steps-down-as-chair 2025-06-20T02:47:01+10:00 https://pharmadispatch.com/news/even-if-most-favored-nation-impacts-pricing-in-the-us-its-impact-on-total-health-spending-will-b 2025-06-19T11:56:01+10:00 https://pharmadispatch.com/news/amplia-announces-second-confirmed-complete-response-in-accent-trial 2025-06-19T10:52:01+10:00 https://pharmadispatch.com/news/government-expands-access-to-melatonin-and-psilocybin 2025-06-18T15:50:01+10:00 https://pharmadispatch.com/news/imugene-announces-us-patent-allowance-for-oncarlytics 2025-06-18T12:04:01+10:00 https://pharmadispatch.com/news/pilot-study-confirms-adjunct-nb-uvb-needed-to-activate-repigmentation-in-vitiligo 2025-06-18T11:57:01+10:00 https://pharmadispatch.com/news/one-csl-innovation-that-allows-for-a-direct-and-timely-comparison 2025-06-18T11:17:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-role-of-credit-cards-and-borrowing-in-healthcare-access 2025-06-18T10:21:01+10:00 https://pharmadispatch.com/news/montu-pushes-for-national-standards-at-productivity-commission-inquiry 2025-06-17T18:01:01+10:00 https://pharmadispatch.com/news/canadian-appointed-to-lead-new-zealands-pharmac 2025-06-17T17:36:01+10:00 https://pharmadispatch.com/news/us-fda-approves-csls-treatment-for-hereditary-angioedema 2025-06-17T17:30:01+10:00 https://pharmadispatch.com/news/australias-system-is-more-uniform-than-the-us-but-not-uniformly-better 2025-06-17T12:51:01+10:00 https://pharmadispatch.com/news/australian-company-secures-us-food-drug-administration-fda-approves-investigational-new-drug-ind 2025-06-16T16:49:01+10:00 https://pharmadispatch.com/news/these-systems-are-and-always-have-been-more-similar-than-most-realise 2025-06-16T11:40:01+10:00 https://pharmadispatch.com/news/confirmation-the-uk-has-agreed-to-review-medicine-prices-in-response-to-us-demand 2025-06-16T11:20:01+10:00 https://pharmadispatch.com/news/amplia-says-pathological-complete-response-in-patient-from-accent-trial 2025-06-16T10:41:01+10:00 https://pharmadispatch.com/news/this-could-be-the-canary-in-the-coal-mine-but-a-lot-of-canaries-have-already-died 2025-06-15T13:47:01+10:00 https://pharmadispatch.com/news/there-is-a-very-real-impact-on-australian-patients-and-clinicians 2025-06-15T13:23:01+10:00 https://pharmadispatch.com/news/why-not-construct-an-off-ramp-based-on-what-you-were-going-to-do-anyway 2025-06-15T10:45:01+10:00 https://pharmadispatch.com/news/go-healthy-with-taiwan-invites-submissions-from-australian-health-innovators 2025-06-13T11:01:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-expands-partnership-with-incyte-to-include-two-additional-therapies-1 2025-06-13T04:48:01+10:00 https://pharmadispatch.com/news/new-immunisation-strategy-highlights-covid-impact-priority-patients-and-new-technologies 2025-06-12T17:20:01+10:00 https://pharmadispatch.com/news/medicines-australia-establishes-radiopharmaceuticals-working-group 2025-06-12T16:02:01+10:00 https://pharmadispatch.com/news/msd-australia-and-new-zealand-certified-a-great-place-to-work 2025-06-12T15:39:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-expands-partnership-with-incyte-to-include-two-additional-therapies 2025-06-12T11:16:01+10:00 https://pharmadispatch.com/news/novo-nordisk-partners-with-heart-of-australia-to-expand-clinical-trial-access 2025-06-12T10:03:01+10:00 https://pharmadispatch.com/news/mark-butler-starts-the-process-of-ndis-pricing-reform 2025-06-11T15:18:01+10:00 https://pharmadispatch.com/news/pfizer-chief-sets-out-the-potential-implications-of-most-favored-naton-pricing 2025-06-11T12:46:01+10:00 https://pharmadispatch.com/news/what-will-the-hta-review-implementation-advisory-group-iag-do-if-the-pbac-rejects-the-process 2025-06-11T11:49:01+10:00 https://pharmadispatch.com/news/advocacy-group-pleading-with-the-nsw-government-to-establish-men-b-vaccine-program 2025-06-10T12:21:01+10:00 https://pharmadispatch.com/news/new-study-reveals-superior-efficacy-of-cell-based-flu-vaccine 2025-06-10T10:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-says-delayed-listings-would-not-be-a-surprising-response 2025-06-10T02:00:01+10:00 https://pharmadispatch.com/news/companies-confirm-renewed-push-for-streamlined-immunotherapy-listing-process 2025-06-09T10:26:01+10:00 https://pharmadispatch.com/news/you-certainly-couldnt-accuse-this-system-of-haste-and-this-might-need-ministerial-intervention 2025-06-09T10:22:01+10:00 https://pharmadispatch.com/news/early-intervention-on-chronic-kidney-disease-would-deliver-economic-boost 2025-06-08T15:17:01+10:00 https://pharmadispatch.com/news/australian-dementia-network-monash-university-and-lilly-sign-research-collaboration 2025-06-06T12:48:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-6-june 2025-06-06T00:12:01+10:00 https://pharmadispatch.com/news/health-department-amends-published-blood-review-information 2025-06-05T15:07:01+10:00 https://pharmadispatch.com/news/my-experience-was-awful-i-really-had-to-fight-to-be-taken-seriously-and-advocate-for-myself 2025-06-05T14:37:01+10:00 https://pharmadispatch.com/news/uk-moves-to-pricing-changes-as-australian-based-companies-baulk-at-listings 2025-06-05T12:08:01+10:00 https://pharmadispatch.com/news/clarity-announces-positive-top-line-results-from-disco-trial 2025-06-05T10:49:01+10:00 https://pharmadispatch.com/news/clinical-trial-success-kicks-off-5m-fund-raising-round-for-was-lixa 2025-06-05T09:51:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-acquires-pharmacy-4-less-group 2025-06-04T17:35:01+10:00 https://pharmadispatch.com/news/cannabis-council-australia-appoints-ceo-to-lead-next-phase-of-industry-reform 2025-06-04T17:24:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-austrade-launch-partnership-to-accelerate-global-expansion-of-life-sciences-indus 2025-06-04T17:15:01+10:00 https://pharmadispatch.com/news/jordan-steele-john-reappointed-to-represent-greens-in-health-portfolio 2025-06-04T10:11:01+10:00 https://pharmadispatch.com/news/arrotex-launches-newly-developed-treatment-for-australians-with-common-skin-conditions-on-the-pb 2025-06-03T17:08:01+10:00 https://pharmadispatch.com/news/bms-australia-celebrates-silver-tier-employer-status-at-australian-lgbtq-inclusion-awards 2025-06-03T16:45:01+10:00 https://pharmadispatch.com/news/sandoz-calls-for-reforms-to-unlock-biosimilar-savings 2025-06-03T15:57:01+10:00 https://pharmadispatch.com/news/tga-approves-lilly-glp-1-for-obstructive-sleep-apnoea 2025-06-03T15:24:01+10:00 https://pharmadispatch.com/news/the-needed-realignment-of-belief-certainty-and-scepticism-in-our-decision-making 2025-06-03T10:55:01+10:00 https://pharmadispatch.com/news/health-department-admits-review-of-blood-arrangements-is-considering-defunding-products 2025-06-03T02:31:01+10:00 https://pharmadispatch.com/news/new-data-uncovers-our-most-painful-moments-as-access-to-treatment-expands 2025-06-02T17:10:01+10:00 https://pharmadispatch.com/news/australian-innovation-could-revolutionise-the-early-detection-of-ovarian-cancer 2025-06-02T14:24:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-shadow-ministry-and-encourages-bipartisan-support-for-life-sciences-sector 2025-06-02T13:12:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-reports-preclinical-lu177-b7h3-mab-data 2025-06-02T10:43:01+10:00 https://pharmadispatch.com/news/neurotech-announces-positive-human-pk-study-results-for-nti164 2025-06-02T10:23:01+10:00 https://pharmadispatch.com/news/cardiex-receives-tga-approval-for-conneqt-pulse-arterial-health-monitor 2025-06-02T10:16:01+10:00 https://pharmadispatch.com/news/pharmac-minister-sworn-in-as-new-zealands-deputy-prime-minister 2025-06-01T12:52:01+10:00 https://pharmadispatch.com/news/an-opportunity-for-reflection-on-the-need-to-humanise-pbs-decision-making 2025-06-01T11:06:01+10:00 https://pharmadispatch.com/news/ipsens-julien-dagher-promoted-to-european-leadership-role 2025-06-01T10:31:01+10:00 https://pharmadispatch.com/news/daiichi-sankyo-secures-certification-as-great-place-to-work 2025-06-01T10:09:01+10:00 https://pharmadispatch.com/news/dimerix-says-first-action3-trial-site-activated-in-japan-and-first-milestone-payment-triggered 2025-05-30T10:22:01+10:00 https://pharmadispatch.com/news/arrotex-pharmaceuticals-appointed-exclusive-partner-for-juniper-biologics 2025-05-29T19:08:01+10:00 https://pharmadispatch.com/news/tga-approves-new-therapy-for-children-with-growth-hormone-deficiency 2025-05-29T19:00:01+10:00 https://pharmadispatch.com/news/abbvie-australia-appoints-dr-carly-levetan-associate-medical-director 2025-05-29T16:29:01+10:00 https://pharmadispatch.com/news/for-patients-its-about-understanding-their-experience-and-accessing-the-touch-points 2025-05-29T10:49:01+10:00 https://pharmadispatch.com/news/pricelien-pharmacy-launches-annual-event-with-national-menopause-project 2025-05-28T17:05:01+10:00 https://pharmadispatch.com/news/anne-ruston-welcomes-her-reappointment-to-health-and-the-addition-of-ndis 2025-05-28T15:58:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-says-healthscope-collapse-provides-stark-warning 2025-05-28T15:42:01+10:00 https://pharmadispatch.com/news/an-across-the-board-pbs-levy-would-be-a-tax-on-the-listing-and-pricing-process 2025-05-28T13:12:01+10:00 https://pharmadispatch.com/news/cartherics-to-present-at-the-2025-bio-international-convention 2025-05-28T10:56:01+10:00 https://pharmadispatch.com/news/sussan-ley-confirms-the-reappointment-of-anne-ruston-to-health 2025-05-28T01:52:01+10:00 https://pharmadispatch.com/news/how-can-you-not-be-sceptical-about-a-rigged-one-sided-process 2025-05-27T11:47:01+10:00 https://pharmadispatch.com/news/roche-advances-the-development-of-innovative-antibiotic 2025-05-27T04:29:01+10:00 https://pharmadispatch.com/news/australian-led-enzamet-prostate-cancer-trials-to-present-data-at-asco-2025 2025-05-27T04:07:01+10:00 https://pharmadispatch.com/news/leadership-transition-for-medical-affairs-professional-association 2025-05-26T15:12:01+10:00 https://pharmadispatch.com/news/nsw-government-to-improve-access-to-adhd-diagnosis-and-treatment 2025-05-26T14:39:01+10:00 https://pharmadispatch.com/news/immuteps-efti-combination-meets-primary-endpoint-in-phase-2-soft-tissue-sarcoma 2025-05-26T12:14:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-change-to-ensure-care-continuity-for-more-cancer-patients 2025-05-26T11:27:01+10:00 https://pharmadispatch.com/news/is-now-the-time-to-be-discussing-these-things-and-resisting-speical-pricing-arrangements 2025-05-26T10:03:01+10:00 https://pharmadispatch.com/news/life-science-leaders-on-australias-strengths-and-the-opportunity-to-do-more 2025-05-25T12:43:01+10:00 https://pharmadispatch.com/news/ustr-invites-stakeholder-input-on-the-impact-of-price-suppressing-policies 2025-05-25T11:39:01+10:00 https://pharmadispatch.com/news/health-department-shifts-its-position-on-uncertified-claims-to-semantics 2025-05-25T03:00:01+10:00 https://pharmadispatch.com/news/merck-joins-forces-with-omico-to-improve-access-to-cancer-trials-in-australia 2025-05-22T14:16:01+10:00 https://pharmadispatch.com/news/new-zealand-announces-12-month-prescription-duration-in-2025-budget 2025-05-22T13:57:01+10:00 https://pharmadispatch.com/news/i-think-we-have-to-step-up-and-help-him-to-understand-that-hes-got-to-deliver-on-it 2025-05-22T12:20:01+10:00 https://pharmadispatch.com/news/tga-approves-first-of-a-kind-medicine-for-early-symptomatic-alzheimers-disease 2025-05-21T12:32:01+10:00 https://pharmadispatch.com/news/examples-are-important-as-evidence-of-the-problem-but-be-prepared-to-defend-them 2025-05-21T10:53:01+10:00 https://pharmadispatch.com/news/trump-administration-invites-companies-to-align-us-pricing-under-mfn-plan 2025-05-21T10:20:01+10:00 https://pharmadispatch.com/news/ndis-minister-restates-the-importance-of-nothing-about-us-without-us 2025-05-20T18:19:01+10:00 https://pharmadispatch.com/news/industry-alarm-over-the-sudden-pursuit-of-surprise-uncertified-claims 2025-05-20T16:38:01+10:00 https://pharmadispatch.com/news/medicines-australias-sharpened-post-election-language-on-reform 2025-05-20T16:26:01+10:00 https://pharmadispatch.com/news/report-highlights-international-confidence-in-australian-clinical-trials 2025-05-19T16:36:01+10:00 https://pharmadispatch.com/news/experts-urge-vigilance-with-rsv-ahead-of-winter-saying-its-as-serious-in-older-adults-as-it-is-i 2025-05-19T16:26:01+10:00 https://pharmadispatch.com/news/fda-clears-the-first-blood-test-used-for-diagnosing-alzheimers-disease 2025-05-19T15:00:01+10:00 https://pharmadispatch.com/news/team-lilly-australia-taking-the-time-to-prioritise-wellbeing 2025-05-18T03:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-the-magnitude-of-the-challenge-facing-mark-butler 2025-05-18T03:00:01+10:00 https://pharmadispatch.com/news/we-need-to-be-honest-about-the-fact-our-governments-ruthlessly-dictate-the-terms-of-care 2025-05-17T13:14:01+10:00 https://pharmadispatch.com/news/applications-now-open-for-moderna-mrna-focused-research-program 2025-05-15T17:04:01+10:00 https://pharmadispatch.com/news/portfolio-change-has-real-implications-for-stakeholders-with-a-revised-approach-required 2025-05-15T13:58:01+10:00 https://pharmadispatch.com/news/novo-nordisk-oceania-announces-departure-of-cem-ozenc-to-lead-new-global-team 2025-05-15T13:53:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-16-may 2025-05-15T13:05:01+10:00 https://pharmadispatch.com/news/uk-health-secretary-identifies-weight-loss-therapies-as-one-solution-to-broader-issue 2025-05-15T11:28:01+10:00 https://pharmadispatch.com/news/csl-behring-wins-major-international-pharmaceutical-engineering-award 2025-05-14T15:10:01+10:00 https://pharmadispatch.com/news/lumos-advances-febridx-sales-with-imedical-purchase-order 2025-05-14T11:23:01+10:00 https://pharmadispatch.com/news/mark-butler-tasked-with-delivering-pbs-level-reduction-in-ndis-spending 2025-05-14T03:00:01+10:00 https://pharmadispatch.com/news/us-bio-joins-phrma-in-challenging-trump-over-most-favored-nation-order 2025-05-14T03:00:01+10:00 https://pharmadispatch.com/news/new-liberal-leader-sussan-ley-was-responsible-for-major-pbs-reforms 2025-05-13T16:56:01+10:00 https://pharmadispatch.com/news/new-administrative-order-confirms-the-total-move-of-ndis-to-health 2025-05-13T15:24:01+10:00 https://pharmadispatch.com/news/trumps-language-on-pricing-matches-australias-reflect-response-to-pbs-criticism 2025-05-13T05:16:01+10:00 https://pharmadispatch.com/news/health-stakeholders-welcome-the-reappointment-of-mark-butler 2025-05-12T17:28:01+10:00 https://pharmadispatch.com/news/pharma-stocks-rise-in-response-to-trumps-mfn-executive-order 2025-05-12T16:29:01+10:00 https://pharmadispatch.com/news/lilly-touts-weight-management-results-in-new-head-to-head-study 2025-05-12T16:07:01+10:00 https://pharmadispatch.com/news/experienced-industry-executive-appointed-chair-of-tryptamine-therapeutics 2025-05-12T13:34:01+10:00 https://pharmadispatch.com/news/monash-scientists-secure-mrff-funding-to-find-new-medicines-for-dementia-by-lighting-up-human-br 2025-05-12T11:09:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-accelerates-177lu-rad204-phase-1-dose-escalation-trial 2025-05-12T11:03:01+10:00 https://pharmadispatch.com/news/an-already-busy-fixed-ministerial-bandwidth-just-got-much-busier 2025-05-12T01:24:01+10:00 https://pharmadispatch.com/news/australia-has-been-managing-the-risk-of-international-reference-pricing-for-most-of-this-century 2025-05-11T22:00:01+10:00 https://pharmadispatch.com/news/australian-nursing-leader-makes-the-finalist-list-of-global-award 2025-05-11T22:00:01+10:00 https://pharmadispatch.com/news/pharmac-funds-and-widens-access-to-melanoma-medicines 2025-05-11T14:00:01+10:00 https://pharmadispatch.com/news/non-descript-vagueness-on-pharmaceuticals-in-us-uk-bilateral-trade-agreement 2025-05-11T11:43:01+10:00 https://pharmadispatch.com/news/mark-butler-reappointed-to-lead-health-portfolio-1 2025-05-11T11:00:01+10:00 https://pharmadispatch.com/news/who-are-legislated-conditional-listings-designed-to-limit-the-industry-or-the-minister 2025-05-11T09:27:01+10:00 https://pharmadispatch.com/news/vertex-welcomes-expanded-tga-approval-for-cystic-fibrosis-therapy 2025-05-09T17:52:01+10:00 https://pharmadispatch.com/news/sanofis-consumer-health-business-opella-becomes-a-standalone-company 2025-05-09T17:49:01+10:00 https://pharmadispatch.com/news/new-partnership-promotes-buy-local-for-homegrown-innovation 2025-05-08T15:28:01+10:00 https://pharmadispatch.com/news/new-zealand-to-change-laws-to-promote-medical-conferences 2025-05-08T15:18:01+10:00 https://pharmadispatch.com/news/australia-is-about-to-get-a-new-industry-minister 2025-05-08T15:06:01+10:00 https://pharmadispatch.com/news/internal-promotions-for-new-generation-of-leaders-at-astellas 2025-05-07T16:14:01+10:00 https://pharmadispatch.com/news/new-study-reveals-the-far-reaching-impact-of-ovarian-cancer 2025-05-07T15:52:01+10:00 https://pharmadispatch.com/news/who-cares-about-the-pbs-when-just-the-threat-of-tariffs-secured-a-quarter-of-a-trillion-in-inves 2025-05-07T14:24:01+10:00 https://pharmadispatch.com/news/percheron-therapeutics-launches-bonus-loyalty-option-offer 2025-05-07T11:20:01+10:00 https://pharmadispatch.com/news/oncosil-medical-reports-positive-analysis-of-pancreatic-cancer-trial 2025-05-07T11:07:01+10:00 https://pharmadispatch.com/news/europe-warned-to-adopt-positive-changes-in-response-us-investment-rush 2025-05-07T11:01:01+10:00 https://pharmadispatch.com/news/clinuvel-recruits-200-patients-for-phase-3-vitiligo-trial-of-scenesse 2025-05-07T09:54:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-calls-for-standardisation-of-access-to-asthma-treatment 2025-05-06T13:50:01+10:00 https://pharmadispatch.com/news/trump-administration-to-streamline-pharma-manufacturing-and-increase-global-inspections 2025-05-06T11:40:01+10:00 https://pharmadispatch.com/news/sigma-delivers-growth-following-the-completion-of-chemist-warehouse-merger 2025-05-06T11:11:01+10:00 https://pharmadispatch.com/news/greg-hunt-to-chair-new-telehealth-sector-working-group 2025-05-06T03:00:01+10:00 https://pharmadispatch.com/news/australias-premier-medtech-investment-event-unites-investors-and-innovators-to-boost-sector-grow 2025-05-05T15:21:01+10:00 https://pharmadispatch.com/news/mark-butler-straight-back-to-work-as-focus-turns-to-issues-and-policy-commitments 2025-05-05T15:00:01+10:00 https://pharmadispatch.com/news/neurotech-says-nti164-shows-positive-tolerability-in-key-preclinical-toxicology-studies 2025-05-05T12:39:01+10:00 https://pharmadispatch.com/news/positive-trial-result-for-immuteps-efti-in-combination-with-msds-anti-pd-1-therapy 2025-05-05T11:54:01+10:00 https://pharmadispatch.com/news/arovella-options-advances-baylor-college-of-technology-to-enhance-inkt-cell-platform 2025-05-05T11:33:01+10:00 https://pharmadispatch.com/news/fda-grants-fast-track-designation-for-alteritys-ath434-to-treat-multiple-aystem-atrophy 2025-05-05T11:01:01+10:00 https://pharmadispatch.com/news/new-immune-therapy-treatment-option-for-women-diagnosed-with-advanced-endometrial-cancer 2025-05-04T17:21:01+10:00 https://pharmadispatch.com/news/stakeholders-should-hope-for-continuity-in-the-health-portfolio 2025-05-04T15:00:01+10:00 https://pharmadispatch.com/news/ucb-welcomes-the-pbs-listing-of-dual-acting-anti-seizure-medication 2025-05-04T09:22:01+10:00 https://pharmadispatch.com/news/pharma-pharmacy-and-biotech-congratulate-government-for-re-election 2025-05-04T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-2-may 2025-05-02T12:02:01+10:00 https://pharmadispatch.com/news/major-parties-share-commitment-to-the-hta-review-process-and-no-pre-election-funding 2025-05-01T18:56:01+10:00 https://pharmadispatch.com/news/dimerix-secures-exclusive-one-of-the-largest-licensing-deals-in-australian-biotechnology 2025-05-01T11:45:01+10:00 https://pharmadispatch.com/news/new-report-shows-us-government-more-interested-in-cheese-names-than-the-pbs 2025-05-01T09:34:01+10:00 https://pharmadispatch.com/news/merck-healthcare-leader-joins-brain-cancer-australia-charity-board 2025-04-30T16:25:01+10:00 https://pharmadispatch.com/news/icon-partners-with-nuffield-health-for-three-new-cancer-centres 2025-04-30T15:35:01+10:00 https://pharmadispatch.com/news/pbs-listing-for-lundbecks-long-acting-injectable-for-schizophrenia 2025-04-30T15:00:01+10:00 https://pharmadispatch.com/news/pbs-listing-for-tevas-treatment-for-motor-neurone-disease 2025-04-30T14:36:01+10:00 https://pharmadispatch.com/news/government-funds-new-targeted-medicine-for-aggressive-lung-cancer 2025-04-30T09:27:01+10:00 https://pharmadispatch.com/news/these-system-shifting-therapies-come-along-every-few-years-but-this-is-a-little-different 2025-04-29T15:00:01+10:00 https://pharmadispatch.com/news/game-changer-clinical-trial-launches-for-australias-second-deadliest-cancer 2025-04-29T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-commissioned-survey-reveals-rising-gp-concerns-over-medical-misinformation 2025-04-29T03:00:01+10:00 https://pharmadispatch.com/news/cultural-review-delivers-a-scathing-assessment-of-new-zealands-pharmac 2025-04-29T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-confirms-significant-interest-in-accessing-weight-loss-therapies 2025-04-28T15:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-appoints-new-communications-director 2025-04-28T15:00:01+10:00 https://pharmadispatch.com/news/recce-pharmaceuticals-enters-research-and-development-agreement-with-us-defence 2025-04-28T11:41:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-doses-first-patient-in-us-phase-2b-imaging-study-of-brain-metastasis 2025-04-28T11:16:01+10:00 https://pharmadispatch.com/news/dimerix-says-fda-confirms-proteinuria-as-acceptable-endpoint-for-dmx-200 2025-04-28T09:58:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-the-pbs-listing-of-abbvies-blood-cancer-therapy 2025-04-28T03:00:01+10:00 https://pharmadispatch.com/news/government-funding-for-new-nasal-spray-ends-three-decade-drought 2025-04-27T14:00:01+10:00 https://pharmadispatch.com/news/repurposed-diabetes-drug-could-deliver-gains-for-people-living-with-major-joint-pain 2025-04-27T14:00:01+10:00 https://pharmadispatch.com/news/march-pbac-delivers-outcomes-for-high-profile-pre-funded-cancer-therapy 2025-04-27T14:00:01+10:00 https://pharmadispatch.com/news/tga-approved-new-indication-for-gsks-rsv-vaccine 2025-04-24T04:43:01+10:00 https://pharmadispatch.com/news/you-need-to-understand-that-health-technology-assessment-is-not-an-enabler 2025-04-24T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-weeks-in-review-24-april 2025-04-23T18:05:01+10:00 https://pharmadispatch.com/news/roche-announces-historice-investment-to-build-us-manufacturing-base 2025-04-23T04:40:01+10:00 https://pharmadispatch.com/news/us-trade-agenda-looks-mostly-disinterested-in-pharmaceuticals 2025-04-23T03:00:01+10:00 https://pharmadispatch.com/news/reflecting-the-experience-of-people-living-with-cancer-pfizers-new-campaign-part-of-the-story-se 2025-04-23T03:00:01+10:00 https://pharmadispatch.com/news/mesoblast-says-ryoncil-payer-coverage-extended-to-over-100-million-americans 2025-04-22T12:54:01+10:00 https://pharmadispatch.com/news/anatara-provides-update-following-completion-of-analysis-of-phase-2-garp-ibs-clinical-trial 2025-04-22T12:52:01+10:00 https://pharmadispatch.com/news/recce-phase-2-trial-receives-additional-approval-for-treating-diabetic-patients-with-topical-gel 2025-04-22T12:50:01+10:00 https://pharmadispatch.com/news/race-says-patient-enrolment-opened-at-second-site-for-rc220-solid-tumour-trial 2025-04-22T12:49:01+10:00 https://pharmadispatch.com/news/neurizon-announces-the-appointment-of-new-chief-financial-officer 2025-04-22T11:10:01+10:00 https://pharmadispatch.com/news/lilly-records-another-win-in-weight-loss-in-trial-of-oral-glp-1-agonist 2025-04-22T03:00:01+10:00 https://pharmadispatch.com/news/australia-increasingly-isolated-after-europe-approves-alzheimers-therapy 2025-04-22T03:00:01+10:00 https://pharmadispatch.com/news/fda-removes-industry-representatives-from-its-advisory-committees 2025-04-22T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-three-monthly-quantities-for-popular-asthma-inhalers 2025-04-22T03:00:01+10:00 https://pharmadispatch.com/news/arguing-over-the-proverbial-lifejacket-whilst-patients-are-in-the-water-drowning-shame 2025-04-22T02:00:01+10:00 https://pharmadispatch.com/news/a-mixed-bag-for-the-industry-in-trump-executive-order-on-medicine-pricing 2025-04-17T03:00:01+10:00 https://pharmadispatch.com/news/telix-says-ipax-linz-study-shows-promising-efficacy-for-glioma-therapy-candidate 2025-04-16T13:14:01+10:00 https://pharmadispatch.com/news/prescients-ptx-100-receives-us-fda-fast-track-designation 2025-04-16T13:01:01+10:00 https://pharmadispatch.com/news/australian-research-finds-turning-off-protein-may-help-prevent-liver-cancer 2025-04-16T10:32:01+10:00 https://pharmadispatch.com/news/uq-tests-vaccine-response-in-cepi-backed-150-day-moonshot-challenge 2025-04-16T09:47:01+10:00 https://pharmadispatch.com/news/cartherics-announces-board-changes-including-a-new-chair 2025-04-16T09:32:01+10:00 https://pharmadispatch.com/news/investors-comfortable-as-trump-administration-says-pharma-tariffs-coming 2025-04-16T03:00:01+10:00 https://pharmadispatch.com/news/astellas-pharma-australia-appoints-new-head-of-medical-affairs 2025-04-16T03:00:01+10:00 https://pharmadispatch.com/news/ucb-welcomes-new-tga-registration-for-monoclonal-antibody 2025-04-16T03:00:01+10:00 https://pharmadispatch.com/news/challenging-headlines-are-the-natural-consequence-of-disrupting-a-very-stale-debate 2025-04-15T15:14:01+10:00 https://pharmadispatch.com/news/viiv-healthcare-australia-announces-recipients-of-2024-positive-action-community-grants 2025-04-15T03:00:01+10:00 https://pharmadispatch.com/news/us-fda-announces-plan-to-phase-out-animal-testing-in-drug-development 2025-04-15T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-appoints-new-senior-policy-executive 2025-04-15T03:00:01+10:00 https://pharmadispatch.com/news/this-could-be-a-path-forward-a-move-to-delay-or-both-and-weve-seen-it-before 2025-04-14T13:35:01+10:00 https://pharmadispatch.com/news/api-launches-new-b2b-e-commerce-platform-to-support-its-mroe-than-4000-customers 2025-04-14T01:00:01+10:00 https://pharmadispatch.com/news/sorry-minister-but-theres-no-world-in-which-you-kept-this-election-commitment-to-newborns 2025-04-14T01:00:01+10:00 https://pharmadispatch.com/news/pharmac-to-fund-novo-nordisks-long-acting-insulin-therapy 2025-04-14T01:00:01+10:00 https://pharmadispatch.com/news/the-review-implementation-process-is-the-next-step-in-a-negotiation 2025-04-14T01:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-11-april 2025-04-11T13:06:01+10:00 https://pharmadispatch.com/news/opthea-updates-investors-confirming-significant-staff-reduction 2025-04-10T17:54:01+10:00 https://pharmadispatch.com/news/from-a-patient-point-of-view-the-point-is-that-we-can-provide-more-solutions-to-more-health-chal 2025-04-10T15:30:01+10:00 https://pharmadispatch.com/news/pharmac-to-fund-wider-access-to-medicines-following-bundle-agreement-with-abbvie 2025-04-10T13:17:01+10:00 https://pharmadispatch.com/news/icon-cancer-centre-and-omico-partner-to-expand-access-to-precision-oncology-1 2025-04-10T05:18:01+10:00 https://pharmadispatch.com/news/president-announces-90-day-pause-on-higher-tariffs-but-pharma-fate-remains-unclear 2025-04-10T04:49:01+10:00 https://pharmadispatch.com/news/us-report-acknowledges-china-is-now-the-leader-in-global-biotechnology 2025-04-10T03:00:01+10:00 https://pharmadispatch.com/news/osteopore-secures-european-approval-for-custom-orthopaedic-and-cranial-implants 2025-04-09T13:21:01+10:00 https://pharmadispatch.com/news/wehi-says-study-puts-first-long-covid-treatment-on-horizon 2025-04-09T09:49:01+10:00 https://pharmadispatch.com/news/most-of-what-will-confront-the-minister-after-the-election-will-be-business-as-usual 2025-04-09T03:00:01+10:00 https://pharmadispatch.com/news/leading-australian-health-companies-provide-updates-on-us-tariff-announcement 2025-04-09T03:00:01+10:00 https://pharmadispatch.com/news/uk-responds-to-global-insecurity-by-investing-in-new-health-data-service-and-accelerating-trials 2025-04-09T03:00:01+10:00 https://pharmadispatch.com/news/atomo-announces-national-scale-up-of-publicly-funded-hiv-self-test-vending-machines 2025-04-08T16:40:01+10:00 https://pharmadispatch.com/news/universal-hepatitis-b-testing-needed-to-stop-rise-in-liver-cancer-deaths 2025-04-08T16:37:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-announces-the-completion-of-placement 2025-04-08T16:34:01+10:00 https://pharmadispatch.com/news/baker-says-advanced-omics-technology-will-supercharge-cardiovascular-research 2025-04-08T16:32:01+10:00 https://pharmadispatch.com/news/late-post-budget-pbs-listings-confirmed-in-pre-election-budget-outlook 2025-04-08T03:00:01+10:00 https://pharmadispatch.com/news/first-face-to-face-meeting-to-work-on-hta-review-implementation-work-plan 2025-04-08T03:00:01+10:00 https://pharmadispatch.com/news/can-i-just-say-that-i-have-been-horrified-through-this-whole-process-that-around-that-hasnt-been 2025-04-07T18:32:01+10:00 https://pharmadispatch.com/news/theres-nothing-wrong-with-incrementalism-we-just-need-to-be-honest-about-it 2025-04-07T03:00:01+10:00 https://pharmadispatch.com/news/new-zealand-plans-to-legislate-rule-of-two-to-accelerate-regulatory-approvals 2025-04-07T03:00:01+10:00 https://pharmadispatch.com/news/next-stop-is-a-review-of-existing-trade-agreements-including-australia 2025-04-06T14:27:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-4-april 2025-04-04T13:30:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-companies-issue-cautious-responses-to-us-tariff-announcement 2025-04-04T03:00:01+11:00 https://pharmadispatch.com/news/pharmx-launches-new-supplier-portal-to-accelerate-supplier-to-pharmacy-trade-integration 2025-04-03T16:25:01+11:00 https://pharmadispatch.com/news/not-even-medicines-australia-believes-the-country-is-capable-of-a-mature-discussion-about-the-pb 2025-04-03T10:42:01+11:00 https://pharmadispatch.com/news/immunisation-coalition-says-vaccinate-now-as-flu-cases-surge 2025-04-03T03:00:01+11:00 https://pharmadispatch.com/news/wesfarmers-health-opens-new-pharmacy-fulfiment-centre-in-brisbane 2025-04-02T17:24:01+11:00 https://pharmadispatch.com/news/anticipated-therapies-and-not-so-anticipated-dominate-july-pbac-agenda 2025-04-02T15:52:01+11:00 https://pharmadispatch.com/news/last-weeks-budget-a-missed-opportunity-for-fairer-policies-to-support-not-for-profits 2025-04-02T03:00:01+11:00 https://pharmadispatch.com/news/diabetes-australia-calls-for-election-focus-on-wider-access-to-technologies 2025-04-01T16:22:01+11:00 https://pharmadispatch.com/news/the-grand-us-conspiracy-against-the-pbs-amounts-to-nothing 2025-04-01T10:46:01+11:00 https://pharmadispatch.com/news/first-targeted-treatment-on-the-pbs-for-rare-unpredictable-and-debilitating-autoimmune-disease 2025-04-01T03:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-forms-aboriginal-and-torres-strait-islander-health-advisory-council 2025-04-01T03:00:01+11:00 https://pharmadispatch.com/news/ipsen-welcomes-tga-registration-of-treatment-for-patients-with-primary-biliary-cholangiti 2025-04-01T03:00:01+11:00 https://pharmadispatch.com/news/gsk-brings-melbourne-discovered-treatment-to-australian-patients 2025-04-01T03:00:01+11:00 https://pharmadispatch.com/news/opthea-announces-decision-to-discontinue-wet-amd-clinical-trials 2025-03-31T16:03:01+11:00 https://pharmadispatch.com/news/bionsw-launches-bioinvest-catalyst-events-to-support-life-sciences-investment-in-nsw 2025-03-31T09:22:01+11:00 https://pharmadispatch.com/news/broader-pbs-listing-recognises-cardioprotective-benefits-of-sglt-2-inhibitor-therapy 2025-03-31T03:00:01+11:00 https://pharmadispatch.com/news/new-government-report-reveals-the-emerging-impact-of-major-reform 2025-03-31T03:00:01+11:00 https://pharmadispatch.com/news/election-writs-trigger-timeline-for-the-release-of-remaining-budgeted-decisions 2025-03-31T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-28-march 2025-03-28T12:18:01+11:00 https://pharmadispatch.com/news/work-of-the-hta-review-implementation-group-to-continue-during-caretaker-period 2025-03-28T03:00:01+11:00 https://pharmadispatch.com/news/health-department-launches-review-of-blood-products-supply 2025-03-27T16:04:01+11:00 https://pharmadispatch.com/news/mesoblast-says-its-fda-approved-mesenchymal-stromal-cell-therapy-available-for-sale-in-the-us 2025-03-27T15:09:01+11:00 https://pharmadispatch.com/news/neuren-initiates-development-of-nnz-2591-to-treat-hie-in-newborns 2025-03-27T15:08:01+11:00 https://pharmadispatch.com/news/amplia-therapeutics-reports-updated-data-from-pancreatic-cancer-trial 2025-03-27T15:07:01+11:00 https://pharmadispatch.com/news/debate-has-provided-the-most-effective-platform-to-focus-attention-on-pbs-problems 2025-03-27T11:04:01+11:00 https://pharmadispatch.com/news/medicines-australia-launches-edition-20-of-its-code-of-conduct 2025-03-27T03:00:01+11:00 https://pharmadispatch.com/news/a-mature-response-that-deals-with-the-childish-political-dog-whistles 2025-03-26T19:00:01+11:00 https://pharmadispatch.com/news/daiichi-sankyo-people-and-culture-head-recognised-as-healthcare-businesswomens-association-lumin 2025-03-26T10:19:01+11:00 https://pharmadispatch.com/news/when-it-comes-to-the-pbs-and-budgets-the-best-guide-to-the-future-is-the-past 2025-03-26T09:37:01+11:00 https://pharmadispatch.com/news/budget-reveals-wholesaling-arrangements-as-a-future-focus 2025-03-25T19:26:01+11:00 https://pharmadispatch.com/news/surely-we-can-all-do-better-than-the-nonsense-of-the-past-few-weeks 2025-03-25T19:16:01+11:00 https://pharmadispatch.com/news/former-speaker-of-the-house-appointed-as-official-patron-of-rare-cancers-australia 2025-03-25T13:27:01+11:00 https://pharmadispatch.com/news/another-day-and-another-example-to-add-to-the-motherload-of-bad-ideas 2025-03-25T09:57:01+11:00 https://pharmadispatch.com/news/australia-eye-therapy-company-now-focused-on-survival-after-clinical-trial-result 2025-03-25T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-patients-are-waiting-too-long-and-as-the-health-minister-of-course-i-am-sorry-for-th 2025-03-24T11:44:01+11:00 https://pharmadispatch.com/news/what-happens-to-the-conspiracy-when-the-industrys-criticisms-look-remarkably-similar-to-the-mini 2025-03-24T09:11:01+11:00 https://pharmadispatch.com/news/nanotechnology-could-improve-odds-in-treating-aggressive-breast-cancers 2025-03-24T03:00:01+11:00 https://pharmadispatch.com/news/half-a-million-australians-missing-out-on-cheaper-medicines-due-to-outdated-systems-1 2025-03-24T03:00:01+11:00 https://pharmadispatch.com/news/when-the-facts-dont-support-you-accusatory-generalities-and-moral-outrage-are-the-only-option 2025-03-22T09:56:01+11:00 https://pharmadispatch.com/news/medicines-australia-announces-appointment-of-new-board-chair 2025-03-20T18:38:01+11:00 https://pharmadispatch.com/news/the-week-in-review-dispatched-podcast-21-march 2025-03-20T17:48:01+11:00 https://pharmadispatch.com/news/new-nz-approval-clears-the-way-for-expanded-access-to-cystic-fibrosis-therapy 2025-03-20T12:57:01+11:00 https://pharmadispatch.com/news/the-minister-and-the-us-based-industry-have-a-lot-in-common-including-their-criticisms-of-the-pb 2025-03-20T10:25:01+11:00 https://pharmadispatch.com/news/sigma-releases-final-pre-merger-full-year-result-confirming-impact-of-cw-supply-contract 2025-03-20T09:32:01+11:00 https://pharmadispatch.com/news/stakeholder-backing-for-another-pbs-co-pay-reduction 2025-03-20T04:59:01+11:00 https://pharmadispatch.com/news/if-our-own-government-wont-do-anything-why-not-welcome-intervention-from-another 2025-03-20T04:00:01+11:00 https://pharmadispatch.com/news/us-price-negotiation-power-reveals-a-very-different-approach-to-patient-input 2025-03-20T03:00:01+11:00 https://pharmadispatch.com/news/brisbane-based-drugmaker-qbiotics-celebrates-25-years-since-its-creation 2025-03-19T13:15:01+11:00 https://pharmadispatch.com/news/imugenes-azer-cel-granted-fda-fast-track-designation-in-blood-cancer 2025-03-19T13:01:01+11:00 https://pharmadispatch.com/news/island-raises-272-million-through-exercise-of-listed-options 2025-03-19T12:49:01+11:00 https://pharmadispatch.com/news/all-manufacturers-decide-to-participate-in-the-second-cycle-of-us-price-negotiation 2025-03-19T04:48:01+11:00 https://pharmadispatch.com/news/recognition-for-outstanding-results-in-medicines-australias-continuing-education-program 2025-03-19T03:00:01+11:00 https://pharmadispatch.com/news/caretaker-convention-creates-pbs-uncertainty-at-the-very-least 2025-03-19T03:00:01+11:00 https://pharmadispatch.com/news/governor-general-supports-earlier-diagnosis-and-greater-awareness 2025-03-18T05:10:01+11:00 https://pharmadispatch.com/news/uk-industry-in-shock-over-significant-increase-in-payment-rate 2025-03-18T04:00:01+11:00 https://pharmadispatch.com/news/regional-clinic-boosts-heart-meds-uptake-with-focused-initiative 2025-03-18T03:00:01+11:00 https://pharmadispatch.com/news/nyrada-commences-recruitment-for-phase-one-clinical-trial 2025-03-17T10:48:01+11:00 https://pharmadispatch.com/news/neurizon-therapeutics-updates-investors-on-initiatives-to-lift-clinical-hold 2025-03-17T10:38:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-says-new-data-confirms-positive-tumour-uptake 2025-03-17T10:30:01+11:00 https://pharmadispatch.com/news/race-secures-ethics-approval-for-rc220-phase-1-solid-tumour-trial 2025-03-17T09:53:01+11:00 https://pharmadispatch.com/news/in-2025-the-us-is-more-likely-to-adopt-pbs-pricing-policies-than-oppose-them 2025-03-17T03:00:01+11:00 https://pharmadispatch.com/news/tthe-tga-registers-a-new-treatment-for-patients-with-the-most-commonly-diagnosed-type-of-early-b 2025-03-17T03:00:01+11:00 https://pharmadispatch.com/news/doctor-group-changes-position-on-weight-loss-therapies-and-the-pbs 2025-03-17T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-and-alexion-secure-back-to-back-pharma-cup-victory 2025-03-17T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-confirms-acting-chief-as-board-launches-global-search-for-new-leader 2025-03-17T03:00:01+11:00 https://pharmadispatch.com/news/gedeon-richter-partners-with-patient-group-for-endometriosis-art-awards-ceremony 2025-03-16T12:21:01+11:00 https://pharmadispatch.com/news/womens-health-listings-sparks-debate-over-the-timing-of-a-ministerial-nudge 2025-03-16T09:51:01+11:00 https://pharmadispatch.com/news/wehi-researchers-solve-decades-long-mystery-on-parkinsons-disease-1 2025-03-14T05:00:01+11:00 https://pharmadispatch.com/news/astellas-cancer-therapy-approved-for-new-indication-in-earlier-prostate-cancer 2025-03-14T03:00:01+11:00 https://pharmadispatch.com/news/kosi-climbers-about-to-embark-on-day-one-of-the-2025-challenge 2025-03-14T03:00:01+11:00 https://pharmadispatch.com/news/world-first-study-identifies-goldilocks-number-of-genes-to-include-in-pre-natal-screening 2025-03-13T11:35:01+11:00 https://pharmadispatch.com/news/australia-is-not-alone-in-using-rebate-payments-but-there-is-one-key-difference 2025-03-13T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-confirms-the-location-of-clinical-trial 2025-03-13T03:00:01+11:00 https://pharmadispatch.com/news/medicines-funded-by-pharmac-tops-50-since-last-years-budget-boost 2025-03-13T03:00:01+11:00 https://pharmadispatch.com/news/new-technology-hits-australia-for-type-1-diabetes-patients 2025-03-12T03:00:01+11:00 https://pharmadispatch.com/news/what-i-love-about-this-event-is-that-it-brings-together-a-community-of-people-who-otherwise-feel 2025-03-11T14:22:01+11:00 https://pharmadispatch.com/news/the-terrible-events-of-2023-were-born-of-a-decade-old-policy-failure 2025-03-11T13:07:01+11:00 https://pharmadispatch.com/news/the-key-for-industry-is-good-ideas-that-will-make-the-system-better 2025-03-11T03:00:01+11:00 https://pharmadispatch.com/news/new-report-delivers-scathing-patient-assessment-of-pharmacs-culture 2025-03-11T03:00:01+11:00 https://pharmadispatch.com/news/total-continues-to-grow-as-astrazeneca-and-alexion-maintain-lead 2025-03-10T14:43:01+11:00 https://pharmadispatch.com/news/anatara-lifesciences-updates-on-garp-irritable-bowel-syndrome-trial 2025-03-10T11:49:01+11:00 https://pharmadispatch.com/news/kidney-health-australia-urges-those-at-risk-to-get-checked 2025-03-10T11:38:01+11:00 https://pharmadispatch.com/news/is-anybody-really-interested-in-bold-once-in-a-generation-reform 2025-03-10T03:00:01+11:00 https://pharmadispatch.com/news/discouraging-treatment-because-of-carbon-emissions-should-be-based-on-facts 2025-03-10T03:00:01+11:00 https://pharmadispatch.com/news/sanofis-people-and-pipeline-attract-new-head-of-medical-vaccines-mike-lee 2025-03-10T03:00:01+11:00 https://pharmadispatch.com/news/public-summary-document-shows-slow-progress-on-weight-loss-therapy 2025-03-08T10:13:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-7-march 2025-03-07T15:33:01+11:00 https://pharmadispatch.com/news/women-twice-as-likely-as-men-to-skip-a-prescription-because-of-cost 2025-03-07T03:00:01+11:00 https://pharmadispatch.com/news/kosi-challenge-fundraising-total-racing-towards-400000-as-pharma-cup-teams-add-to-totals 2025-03-07T03:00:01+11:00 https://pharmadispatch.com/news/omico-welcomes-new-government-investment-in-precision-medical-trial 2025-03-07T03:00:01+11:00 https://pharmadispatch.com/news/six-pharma-companies-recognised-amongst-australias-best-workplaces-for-women 2025-03-07T02:46:01+11:00 https://pharmadispatch.com/news/version-20-of-medicines-australia-code-takes-pr-back-to-the-future 2025-03-07T02:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-gather-for-international-womens-day 2025-03-06T15:32:01+11:00 https://pharmadispatch.com/news/organon-marks-international-womens-day-with-a-partnership-supporting-career-platform-for-women 2025-03-06T15:07:01+11:00 https://pharmadispatch.com/news/government-partners-with-baxter-to-increase-local-production-of-iv-fluids 2025-03-06T03:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-regulatory-enforcement-and-funding-to-secure-nuclear-medicine-potential 2025-03-06T03:00:01+11:00 https://pharmadispatch.com/news/organons-bilal-somra-on-the-welcome-and-overdue-commitment-to-womens-health 2025-03-06T02:00:01+11:00 https://pharmadispatch.com/news/sanofi-consumer-health-business-secures-sustainability-certification 2025-03-05T15:34:01+11:00 https://pharmadispatch.com/news/sepsis-survivors-at-high-risk-after-hospital-discharge-new-figures-reveal 2025-03-05T13:48:01+11:00 https://pharmadispatch.com/news/the-george-institute-welcomes-a-new-board-chair 2025-03-05T13:31:01+11:00 https://pharmadispatch.com/news/atmo-biosciences-announces-publication-of-pivotal-clinical-study-results-supporting-initial-indi 2025-03-05T12:57:01+11:00 https://pharmadispatch.com/news/new-data-supports-effective-delivery-of-dna-based-vaccines-using-patch 2025-03-05T09:41:01+11:00 https://pharmadispatch.com/news/getting-back-to-the-original-question-is-personalised-gene-therapy-ready-for-prime-time 2025-03-05T05:00:01+11:00 https://pharmadispatch.com/news/researchers-disappointed-over-non-approval-of-alzheimers-treatment 2025-03-05T03:00:01+11:00 https://pharmadispatch.com/news/ministers-diary-reveals-no-meetings-on-deferral-controversy-and-this-might-be-why 2025-03-05T03:00:01+11:00 https://pharmadispatch.com/news/pharma-cup-total-raises-towards-200000-with-ten-days-to-go 2025-03-04T17:41:01+11:00 https://pharmadispatch.com/news/astellas-welcomes-tga-approval-of-cancer-combination-as-first-line-treatment 2025-03-04T03:00:01+11:00 https://pharmadispatch.com/news/is-personalised-gene-therapy-ready-for-prime-time 2025-03-04T03:00:01+11:00 https://pharmadispatch.com/news/csl-seqirus-secures-australia-nz-rights-to-commercialise-cholesterol-lowering-therapy 2025-03-04T03:00:01+11:00 https://pharmadispatch.com/news/biogen-and-eisai-working-on-next-steps-after-tga-confirms-non-approval-of-alzheimers-therapy 2025-03-04T03:00:01+11:00 https://pharmadispatch.com/news/sandoz-backs-australian-medicinal-cannabis-company-in-ten-year-agreement 2025-03-03T10:30:01+11:00 https://pharmadispatch.com/news/australian-startup-launches-the-worlds-first-commercial-biological-computer 2025-03-03T09:44:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-expanded-pbs-listing-for-severe-psoriatic-arthritis 2025-03-03T03:00:01+11:00 https://pharmadispatch.com/news/tga-approves-first-biological-therapy-for-serious-respiratory-condition 2025-03-03T03:00:01+11:00 https://pharmadispatch.com/news/the-door-is-finally-ajar-to-initiate-some-much-needed-ceo-led-reforms-at-our-drug-buying-agency 2025-03-03T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-2-march 2025-03-02T16:40:01+11:00 https://pharmadispatch.com/news/first-oral-contraceptive-listed-on-the-pbs-in-over-30-years 2025-03-02T09:58:01+11:00 https://pharmadispatch.com/news/take-the-right-learning-from-a-situation-that-was-mostly-about-ministerial-intervention 2025-02-28T04:00:01+11:00 https://pharmadispatch.com/news/argenx-secures-tga-approval-of-precision-therapy-for-rare-disease 2025-02-28T03:00:01+11:00 https://pharmadispatch.com/news/the-cell-and-gene-catalyst-mobilises-71-leaders-to-accelerate-industry-growth 2025-02-28T03:00:01+11:00 https://pharmadispatch.com/news/health-department-appoints-consultant-to-support-hta-review-implementation-group 2025-02-28T03:00:01+11:00 https://pharmadispatch.com/news/companies-building-their-kosi-challenge-totals-with-two-weeks-to-go 2025-02-28T03:00:01+11:00 https://pharmadispatch.com/news/us-biotech-industry-welcomes-proposed-change-to-price-negotiation-power 2025-02-27T03:00:01+11:00 https://pharmadispatch.com/news/hta-go-slow-on-newborn-screening-leaves-parents-waiting-and-waiting 2025-02-27T03:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-welcomes-future-funding-for-game-changing-cancer-service 2025-02-27T03:00:01+11:00 https://pharmadispatch.com/news/companies-to-blame-for-not-highlighting-quality-of-life-benefits 2025-02-26T12:13:01+11:00 https://pharmadispatch.com/news/us-fda-accepts-application-for-telixs-zircaix-and-grants-priority-review 2025-02-26T11:18:01+11:00 https://pharmadispatch.com/news/arovella-says-with-placement-it-is-now-fully-funded-to-complete-phase-1-clinical-trial 2025-02-26T11:02:01+11:00 https://pharmadispatch.com/news/mtpconnect-refreshes-board-with-new-appointment-and-retirement 2025-02-26T10:16:01+11:00 https://pharmadispatch.com/news/us-fda-approves-elate-ocular-phase-3-clinical-trial-protocol 2025-02-26T10:04:01+11:00 https://pharmadispatch.com/news/health-department-to-front-senate-estimates-for-final-pre-election-hearing 2025-02-26T03:00:01+11:00 https://pharmadispatch.com/news/the-george-institute-welcomes-new-international-push-to-raise-the-bar-in-migraine 2025-02-26T03:00:01+11:00 https://pharmadispatch.com/news/new-whitepaper-reveals-strategies-to-manage-salary-trends-revealed-in-report 2025-02-25T15:58:01+11:00 https://pharmadispatch.com/news/election-could-be-the-the-circuit-breaker-opportunity-to-recharge-reform 2025-02-25T12:48:01+11:00 https://pharmadispatch.com/news/novartis-joins-legal-action-against-unapproved-copy-of-radioligand-therapy 2025-02-25T03:00:01+11:00 https://pharmadispatch.com/news/orthocell-submits-for-remplir-regulatory-approval-in-thailand 2025-02-24T13:00:01+11:00 https://pharmadispatch.com/news/adpha-welcomes-commitment-to-expand-access-to-bulk-billing-incentive 2025-02-24T12:49:01+11:00 https://pharmadispatch.com/news/new-zealand-medtech-start-up-avasa-hits-milestone-in-development-of-worlds-first-arterial-couple 2025-02-24T10:40:01+11:00 https://pharmadispatch.com/news/neuren-receives-rare-paediatric-disease-designation-from-the-us-fda 2025-02-24T10:33:01+11:00 https://pharmadispatch.com/news/ovarian-cancer-australia-says-new-report-highlights-the-need-for-action 2025-02-24T03:00:01+11:00 https://pharmadispatch.com/news/high-profile-australians-expose-the-painful-reality-of-shingles-in-awareness-week 2025-02-24T03:00:01+11:00 https://pharmadispatch.com/news/msd-australia-receives-certification-as-a-family-friendly-workplace 2025-02-24T03:00:01+11:00 https://pharmadispatch.com/news/fix-the-language-accept-the-political-discomfort-it-will-cause-or-forget-about-meaningful-change 2025-02-24T03:00:01+11:00 https://pharmadispatch.com/news/abbvie-appoints-former-bayer-executive-to-lead-market-access-in-australia-and-nz 2025-02-24T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-21-february 2025-02-21T14:43:01+11:00 https://pharmadispatch.com/news/significant-gift-new-academy-for-health-leadership-at-university-of-melbourne 2025-02-21T03:00:01+11:00 https://pharmadispatch.com/news/first-and-only-treatment-for-chronic-hypoparathyroidism-approved-in-australia 2025-02-21T03:00:01+11:00 https://pharmadispatch.com/news/psa-members-endorse-acquisition-of-the-australasian-college-of-pharmacy 2025-02-21T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-maintains-its-lead-as-other-teams-start-to-build 2025-02-21T03:00:01+11:00 https://pharmadispatch.com/news/its-a-good-idea-that-will-need-to-overcome-a-institutional-mindset-to-progress 2025-02-19T18:00:01+11:00 https://pharmadispatch.com/news/pharmaceuticals-the-latest-trump-target-for-tariffs 2025-02-19T18:00:01+11:00 https://pharmadispatch.com/news/idt-delivers-strong-first-half-performance-following-strategic-pivot 2025-02-19T15:59:01+11:00 https://pharmadispatch.com/news/montu-announces-two-new-appointments-to-leadership-team 2025-02-19T15:09:01+11:00 https://pharmadispatch.com/news/gbma-promotes-prescribing-shake-up-to-widen-access-and-deliver-savings 2025-02-19T14:40:01+11:00 https://pharmadispatch.com/news/fda-grants-fast-track-designation-for-neurens-nnz-2591-in-pitt-hopkins-syndrome 2025-02-19T13:47:01+11:00 https://pharmadispatch.com/news/syntaras-topical-anti-fibrotic-drug-leads-to-significant-normalisation-of-skin-in-established-sc 2025-02-18T19:42:01+11:00 https://pharmadispatch.com/news/trump-suspends-law-that-fundamentally-changed-the-industrys-approach-to-public-affairs 2025-02-18T19:19:01+11:00 https://pharmadispatch.com/news/pharmx-technologies-partners-with-toniq-to-expand-pharmacy-solutions-in-new-zealand 2025-02-18T19:13:01+11:00 https://pharmadispatch.com/news/pfizer-teams-up-with-heart-of-australia-to-expand-access-to-gp-education 2025-02-18T18:52:01+11:00 https://pharmadispatch.com/news/hmri-partners-with-novartis-to-supercharge-heart-health-impact 2025-02-17T23:00:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-to-raise-up-to-146-million 2025-02-17T15:53:01+11:00 https://pharmadispatch.com/news/australia-isnt-ready-for-the-next-cardiac-epidemic-warns-landmark-heart-valve-disease-report 2025-02-17T15:19:01+11:00 https://pharmadispatch.com/news/australian-company-axelia-oncology-announces-supply-agreement-for-pbs-listed-cancer-medicines 2025-02-17T15:08:01+11:00 https://pharmadispatch.com/news/pharmacy-renews-cost-of-living-campaign-with-60-day-quantities-still-flatlining 2025-02-17T13:38:01+11:00 https://pharmadispatch.com/news/the-confusing-public-debate-might-be-more-of-a-risk-to-public-confidence-in-genetic-testing 2025-02-16T21:00:01+11:00 https://pharmadispatch.com/news/industry-silence-revealing-as-new-presidential-order-targets-medicines-use 2025-02-16T21:00:01+11:00 https://pharmadispatch.com/news/we-rarely-have-feedback-and-more-often-than-not-the-process-doesnt-necessarily-result-in-better- 2025-02-16T21:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-soars-to-the-lead-in-kosi-challenge-pharma-cup 2025-02-16T19:33:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-14-february 2025-02-14T13:29:01+11:00 https://pharmadispatch.com/news/merck-team-gathers-in-sydney-aiming-to-spark-discovery-and-elevate-humanity 2025-02-14T05:02:01+11:00 https://pharmadispatch.com/news/the-institution-defends-itself-by-effectively-arguing-that-deaths-are-a-necessary-consequence 2025-02-14T04:00:01+11:00 https://pharmadispatch.com/news/research-grants-on-patient-informed-decision-making-but-patients-need-not-apply 2025-02-14T03:02:01+11:00 https://pharmadispatch.com/news/australian-whooping-cough-cases-still-rising-after-record-year 2025-02-13T05:00:01+11:00 https://pharmadispatch.com/news/uk-private-health-insurer-to-cover-weight-loss-therapies 2025-02-12T12:17:01+11:00 https://pharmadispatch.com/news/immunoglobulin-sales-drives-a-strong-first-half-for-csl-but-lower-immunisation-rates-hit-seqirus 2025-02-12T05:59:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics-announces-thai-approval-of-breast-cancer-therapy 2025-02-12T03:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-says-election-it-the-chance-to-end-the-cancer-lottery 2025-02-12T03:00:01+11:00 https://pharmadispatch.com/news/sigma-and-chemist-warehouse-complete-merger-to-create-pbs-giant 2025-02-12T03:00:01+11:00 https://pharmadispatch.com/news/merck-adds-experienced-industry-executive-to-leadership-team 2025-02-11T15:26:01+11:00 https://pharmadispatch.com/news/sandoz-summit-promotes-reform-to-boost-the-use-of-biosimilars 2025-02-11T14:44:01+11:00 https://pharmadispatch.com/news/advancell-enters-strategic-collaboration-with-lilly-to-advance-novel-targeted-alpha-therapies 2025-02-11T14:42:01+11:00 https://pharmadispatch.com/news/immunoglobulin-sales-drives-a-strong-first-half-for-csl-but-lower-immunisation-rates-hit-seqirus 2025-02-11T10:43:01+11:00 https://pharmadispatch.com/news/proponents-of-meaningful-hta-reform-might-consider-pharmacy-prescribing-as-a-case-study 2025-02-11T03:00:01+11:00 https://pharmadispatch.com/news/new-omico-podcast-aims-to-help-people-navigate-precision-oncology-and-genomic-innovation 2025-02-11T03:00:01+11:00 https://pharmadispatch.com/news/national-womens-health-initiatives-a-significant-step-forward-in-improving-access-to-care 2025-02-10T17:09:01+11:00 https://pharmadispatch.com/news/unfortunately-there-remain-significant-gaps-in-knowledge-among-healthcare-professionals-when-it- 2025-02-10T03:00:01+11:00 https://pharmadispatch.com/news/sigma-upgrades-guidance-as-it-prepares-for-chemist-warehouse-merger 2025-02-10T03:00:01+11:00 https://pharmadispatch.com/news/historical-change-on-pharmacy-prescribing-could-be-a-sign-of-more-to-come 2025-02-10T03:00:01+11:00 https://pharmadispatch.com/news/victorian-official-appointed-to-hta-review-implementation-advisory-group 2025-02-10T02:00:01+11:00 https://pharmadispatch.com/news/community-welcomes-new-womens-health-initiative 2025-02-09T10:37:01+11:00 https://pharmadispatch.com/news/gsk-out-to-an-early-lead-in-rare-cancers-australia-kosi-challenge-pharma-cup 2025-02-07T03:02:01+11:00 https://pharmadispatch.com/news/in-an-optimal-equitable-system-access-to-evidence-based-cost-effective-genomics-guided-medicines 2025-02-07T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-7-february 2025-02-06T17:43:01+11:00 https://pharmadispatch.com/news/advancell-successfully-completes-an-oversubscribed-series-c-financing 2025-02-06T05:17:01+11:00 https://pharmadispatch.com/news/one-believes-things-because-one-has-been-conditioned-to-believe-them 2025-02-06T03:07:01+11:00 https://pharmadispatch.com/news/rfk-jr-on-the-cusp-of-securing-his-nomination-to-lead-us-health-department 2025-02-06T03:00:01+11:00 https://pharmadispatch.com/news/omico-calls-for-major-government-industry-support-of-fundamental-change-in-cancer-treatment 2025-02-05T03:00:01+11:00 https://pharmadispatch.com/news/the-mindset-is-that-equitable-access-can-only-be-achieved-by-denying-everyone-on-the-same-basis 2025-02-05T03:00:01+11:00 https://pharmadispatch.com/news/baxter-kidney-care-is-now-vantive-as-a-standalone-organ-therapy-company 2025-02-05T03:00:01+11:00 https://pharmadispatch.com/news/how-is-it-fair-that-patients-have-no-rights-in-this-system-of-health-technology-assessment 2025-02-04T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-tables-proposal-to-fund-a-new-oral-contraceptive 2025-02-04T03:00:01+11:00 https://pharmadispatch.com/news/for-many-people-living-with-cancer-the-journey-is-complex-and-fraught-with-difficulties 2025-02-04T03:00:01+11:00 https://pharmadispatch.com/news/patients-have-waited-and-in-the-health-ministers-own-words-died-wairing-for-this-potemkin-villag 2025-02-03T03:00:01+11:00 https://pharmadispatch.com/news/payment-model-took-four-submissions-and-almost-two-years-to-negotiate 2025-02-03T03:00:01+11:00 https://pharmadispatch.com/news/pbac-delivers-recommendations-for-mental-health-and-paediatric-immune-conditions 2025-02-03T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-confirms-new-listing-for-rare-form-of-lung-cancer 2025-02-03T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review 2025-01-31T12:01:01+11:00 https://pharmadispatch.com/news/teams-lining-up-again-for-the-rare-cancers-australia-kosi-challenge 2025-01-31T03:00:01+11:00 https://pharmadispatch.com/news/trump-backs-price-negotiation-power-as-health-nominee-faces-contentious-hearing 2025-01-31T03:00:01+11:00 https://pharmadispatch.com/news/sigma-chemist-warehouse-merger-set-to-proceed-following-shareholder-backing 2025-01-31T03:00:01+11:00 https://pharmadispatch.com/news/presidential-nominee-denies-calling-for-seizure-of-pharmaceutical-patents 2025-01-30T03:00:01+11:00 https://pharmadispatch.com/news/gps-call-on-nsw-government-to-fund-free-meningococcal-b-vaccine 2025-01-30T03:00:01+11:00 https://pharmadispatch.com/news/new-zealands-pharmac-reconsiders-proposed-move-to-single-oestradiol-patch-brand 2025-01-30T03:00:01+11:00 https://pharmadispatch.com/news/qbiotics-strengthens-medical-leadership-with-two-senior-appointments 2025-01-28T17:13:01+11:00 https://pharmadispatch.com/news/chemist-warehouse-reports-strong-sales-and-earnings-growth-with-merger-to-progress 2025-01-28T14:29:01+11:00 https://pharmadispatch.com/news/medicines-australia-is-trapped-arguing-for-changes-that-wont-make-a-positive-difference-1 2025-01-28T12:34:01+11:00 https://pharmadispatch.com/news/medicines-australia-wants-progress-on-immediate-impact-recommendations 2025-01-28T12:13:01+11:00 https://pharmadispatch.com/news/idt-updates-investors-expecting-a-significant-spike-in-revenue 2025-01-28T11:42:01+11:00 https://pharmadispatch.com/news/is-the-government-willing-to-consider-elevating-patient-rights-at-the-expense-of-its-economic-in 2025-01-28T03:52:01+11:00 https://pharmadispatch.com/news/tga-approves-csls-locally-discovered-and-developed-biologic 2025-01-28T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-congratulates-recipients-of-australia-day-honours 2025-01-28T03:00:01+11:00 https://pharmadispatch.com/news/tga-approves-apellis-therapy-for-a-form-of-age-related-macular-degeneration 2025-01-28T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-24-january 2025-01-24T12:44:01+11:00 https://pharmadispatch.com/news/cabinet-documents-reveal-decades-old-focus-on-faster-pbs-listings 2025-01-24T03:00:01+11:00 https://pharmadispatch.com/news/no-probity-advisor-but-what-about-a-form-of-confidentiality-deed 2025-01-24T03:00:01+11:00 https://pharmadispatch.com/news/cepi-backing-for-vaxxas-to-advance-needle-free-thermostable-mrna-vaccines 2025-01-23T11:51:01+11:00 https://pharmadispatch.com/news/could-preventive-treatments-support-ongoing-fight-against-covid 2025-01-23T04:58:01+11:00 https://pharmadispatch.com/news/pharmac-encourages-input-on-on-cancer-and-adhd-medicines-funding-proposal 2025-01-22T15:04:01+11:00 https://pharmadispatch.com/news/immutep-completes-patient-enrolment-for-eftisarc-neo-phase-2-trial 2025-01-22T11:21:01+11:00 https://pharmadispatch.com/news/emyria-announces-key-leadership-changes 2025-01-22T10:43:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-says-all-subjects-now-enrolled-in-key-arm-protect-clinical-trial 2025-01-22T10:16:01+11:00 https://pharmadispatch.com/news/ltr-pharma-signs-national-pharmacy-distribution-agreement-with-symbion 2025-01-22T10:01:01+11:00 https://pharmadispatch.com/news/fighting-the-technical-endorses-the-framework-that-makes-patients-servile-to-the-states-economic 2025-01-21T08:29:01+11:00 https://pharmadispatch.com/news/biocina-and-novacina-merger-aims-to-bolster-the-global-cdmo-industry 2025-01-21T04:39:01+11:00 https://pharmadispatch.com/news/australian-company-vaxxas-named-stage-winner-of-us-prize-to-advance-vaccine-patches 2025-01-20T14:26:01+11:00 https://pharmadispatch.com/news/us-issues-list-of-next-15-medicines-to-face-price-negotiation-power 2025-01-20T13:47:01+11:00 https://pharmadispatch.com/news/takeda-named-global-top-employer-for-eighth-consecutive-year 2025-01-20T12:19:01+11:00 https://pharmadispatch.com/news/stoking-good-antibodies-key-to-reducing-serious-bee-venom-allergic-reactions 2025-01-20T09:54:01+11:00 https://pharmadispatch.com/news/this-is-a-world-leading-approach-to-reduce-the-impact-of-rsv-on-babies 2025-01-20T05:32:01+11:00 https://pharmadispatch.com/news/new-leadership-for-boehringer-ingelheim-as-the-company-recognised-as-top-employer 2025-01-20T03:00:01+11:00 https://pharmadispatch.com/news/christopher-luxon-replaces-health-minister-in-push-for-faster-progress-on-change 2025-01-20T03:00:01+11:00 https://pharmadispatch.com/news/make-the-institution-and-its-nobility-work-for-patients-not-the-government 2025-01-16T02:18:01+11:00 https://pharmadispatch.com/news/could-this-systems-nobility-recognise-a-new-idea-even-if-they-saw-it 2025-01-15T21:04:01+11:00 https://pharmadispatch.com/news/do-patients-do-not-live-their-condition-in-aggregated-economic-models 2025-01-14T22:25:01+11:00 https://pharmadispatch.com/news/delays-were-the-intended-outcome-not-an-unintended-consequence 2025-01-13T19:48:01+11:00 https://pharmadispatch.com/news/attitudes-may-have-evolved-but-the-framework-they-created-remains-virtually-unchanged 2025-01-13T00:30:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheims-auckland-office-leads-sustainability-in-nz-pharma-sector 2025-01-10T21:35:01+11:00 https://pharmadispatch.com/news/companies-welcome-november-pbac-outcomes 2024-12-23T02:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-this-draws-a-line-through-everything 2024-12-22T14:47:01+11:00 https://pharmadispatch.com/news/found-irregularities-and-anomalies-in-the-instruments-of-delegation-from-the-minister 2024-12-20T03:00:01+11:00 https://pharmadispatch.com/news/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-vers 2024-12-19T19:33:01+11:00 https://pharmadispatch.com/news/wholesalers-secure-agreement-with-government-to-secure-the-national-pbs-medicine-supply-chain 2024-12-19T19:19:01+11:00 https://pharmadispatch.com/news/when-the-government-funds-a-health-technology-the-community-makes-certain-assumptions 2024-12-19T03:00:01+11:00 https://pharmadispatch.com/news/if-this-decision-to-undermine-the-tga-reflects-a-policy-decision-be-transparent-about-it 2024-12-18T18:10:01+11:00 https://pharmadispatch.com/news/race-oncology-appoints-opthea-founder-to-its-board 2024-12-18T11:26:01+11:00 https://pharmadispatch.com/news/new-listings-and-higher-prescription-volumes-driving-pbs-spend 2024-12-18T10:57:01+11:00 https://pharmadispatch.com/news/if-you-have-ovarian-cancer-genomic-testing-may-open-up-new-treatment-option 2024-12-18T10:29:01+11:00 https://pharmadispatch.com/news/cartherics-secures-g-rex-grant-to-support-its-in-house-manufacturing-program 2024-12-18T10:07:01+11:00 https://pharmadispatch.com/news/australias-first-mrna-vaccine-candidate-could-address-covid-immune-imprinting 2024-12-18T09:35:01+11:00 https://pharmadispatch.com/news/government-making-it-easier-for-itself-on-payments-but-patients-missing-out 2024-12-18T03:00:01+11:00 https://pharmadispatch.com/news/hta-implementation-group-waiting-for-ministerial-direction-on-priorities 2024-12-18T03:00:01+11:00 https://pharmadispatch.com/news/australians-with-our-most-misunderstood-arthritis-receive-resources-in-time-for-holidays 2024-12-17T17:10:01+11:00 https://pharmadispatch.com/news/i-really-live-with-a-12-month-timeframeand-i-am-always-waiting 2024-12-17T16:34:01+11:00 https://pharmadispatch.com/news/auditor-general-finds-that-the-administration-of-the-is-partly-effective 2024-12-17T09:42:01+11:00 https://pharmadispatch.com/news/call-for-action-as-pneumococcal-outbreak-hits-20-year-high 2024-12-17T03:00:01+11:00 https://pharmadispatch.com/news/australian-medtech-manufacturing-alliance-strengthens-with-new-steering-group-members 2024-12-16T18:06:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-bionsw-deepen-collaboration-with-new-mou 2024-12-16T17:00:01+11:00 https://pharmadispatch.com/news/pyc-nominates-fourth-clinical-drug-candidate-in-phelan-mcdermid-program 2024-12-16T11:07:01+11:00 https://pharmadispatch.com/news/immutep-and-monash-announce-first-publication-detailing-how-human-lag-3-binds-to-mhc-class-ii 2024-12-16T09:09:01+11:00 https://pharmadispatch.com/news/they-intended-to-launch-a-product-on-the-market-when-that-was-not-their-intention 2024-12-16T03:00:01+11:00 https://pharmadispatch.com/news/the-demand-has-been-higher-than-expected-and-weve-worked-hard-to-make-sure-that-it-remains-affor 2024-12-16T03:00:01+11:00 https://pharmadispatch.com/news/auditor-general-set-to-table-long-awaited-pbs-performance-audit 2024-12-15T10:33:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-13-december 2024-12-13T14:06:01+11:00 https://pharmadispatch.com/news/report-shows-that-weight-is-now-the-leading-risk-factor-for-australias-disease-burden 2024-12-13T03:00:01+11:00 https://pharmadispatch.com/news/racgp-calls-for-free-meningococcal-b-vaccination-program-for-western-australia 2024-12-12T17:51:01+11:00 https://pharmadispatch.com/news/medicines-australia-launches-pbs-explainer-videos 2024-12-12T17:37:01+11:00 https://pharmadispatch.com/news/this-process-has-involved-a-lot-of-work-for-everyone-and-delivered-almost-nothing 2024-12-12T15:38:01+11:00 https://pharmadispatch.com/news/immutep-reports-promising-new-data-in-head-and-neck-cancer-at-esmo-immuno-oncology-2024 2024-12-12T09:43:01+11:00 https://pharmadispatch.com/news/what-could-the-hta-review-change-for-patients-who-waited-for-this-cancer-therapy 2024-12-12T03:00:01+11:00 https://pharmadispatch.com/news/health-groups-call-for-dying-patients-to-receive-free-pain-relief-amid-critical-medicines-shorta 2024-12-12T03:00:01+11:00 https://pharmadispatch.com/news/qimr-berghofer-says-cell-therapy-saving-lives-of-immunocompromised-patients 2024-12-11T17:46:01+11:00 https://pharmadispatch.com/news/leafio-opens-sydney-distribution-facility-to-deliver-same-day-medical-cannabis-to-metro-pharmaci 2024-12-11T15:25:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-biomelbourne-network-welcome-victorias-economic-growth-statement 2024-12-11T15:05:01+11:00 https://pharmadispatch.com/news/dhl-constructs-largest-automated-life-sciences-warehouse-footprint-in-the-southern-hemisphere 2024-12-11T10:19:01+11:00 https://pharmadispatch.com/news/welcome-and-encourage-these-workaround-because-they-expose-the-failing-institution 2024-12-11T03:00:01+11:00 https://pharmadispatch.com/news/fivephusion-secures-resectassist-platform-technology-for-the-localised-delivery-of-cancer-drugs 2024-12-11T03:00:01+11:00 https://pharmadispatch.com/news/budget-update-will-reveal-spending-and-revenue-changes-including-for-the-pbs 2024-12-10T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-seeks-feedback-to-fund-medicines-for-liver-and-ovarian-cancer 2024-12-10T03:00:01+11:00 https://pharmadispatch.com/news/potential-australian-developed-treatment-for-mnd-shows-positive-early-trial-results 2024-12-09T18:43:01+11:00 https://pharmadispatch.com/news/tga-approves-ucb-therapy-for-the-treatment-of-dravet-syndrome 2024-12-09T15:45:01+11:00 https://pharmadispatch.com/news/medtronic-leader-to-chair-medical-device-industry-association 2024-12-09T14:43:01+11:00 https://pharmadispatch.com/news/cyclopharm-says-furst-us-clinical-paper-highlights-technegas-clinical-effectiveness 2024-12-09T11:09:01+11:00 https://pharmadispatch.com/news/recce-receives-approval-from-indonesias-regulator-for-registrational-phase-3-clinical-trial 2024-12-09T11:00:01+11:00 https://pharmadispatch.com/news/btc-announced-new-partnership-agreement-with-corcym 2024-12-09T10:53:01+11:00 https://pharmadispatch.com/news/paradigm-completes-16-million-capital-raise-to-support-global-phase-3-clinical-trial 2024-12-09T10:44:01+11:00 https://pharmadispatch.com/news/industry-executives-travel-to-florida-to-meet-with-incoming-trump-administration 2024-12-09T03:00:01+11:00 https://pharmadispatch.com/news/if-this-is-the-mindset-at-what-point-does-the-question-become-why-fund-anything 2024-12-09T03:00:01+11:00 https://pharmadispatch.com/news/this-pbs-listing-is-a-major-shift-in-diabetes-management-in-australia 2024-12-08T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-invests-more-of-recent-funding-boost-with-astrazeneca-agreement 2024-12-08T00:00:01+11:00 https://pharmadispatch.com/news/novartis-partners-with-advara-heartcare-and-terrywhite-chemmart-to-launch-heart-health-collectiv 2024-12-06T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-australia-launches-innovate-reconciliation-action-plan-to-advance-equitable-access-to-hea 2024-12-06T03:00:01+11:00 https://pharmadispatch.com/news/former-csl-ceo-paul-perreault-appointed-strategic-adviser-to-microbio 2024-12-05T11:23:01+11:00 https://pharmadispatch.com/news/more-evidence-backs-use-of-weight-loss-therapies 2024-12-05T10:25:01+11:00 https://pharmadispatch.com/news/chatgpt-could-have-produced-a-more-human-response-than-these-committees 2024-12-05T03:00:01+11:00 https://pharmadispatch.com/news/anatara-provides-irritable-bowel-syndrome-clinical-trial-update 2024-12-04T17:29:01+11:00 https://pharmadispatch.com/news/digital-health-company-adherium-secures-rd-loan-facility 2024-12-04T17:01:01+11:00 https://pharmadispatch.com/news/australians-rank-access-to-affordable-healthcare-as-second-most-important-priority-after-cost-of 2024-12-04T15:40:01+11:00 https://pharmadispatch.com/news/london-agency-bolsters-public-affairs-team-with-crossbench-experience 2024-12-04T14:34:01+11:00 https://pharmadispatch.com/news/acrux-says-us-fda-approves-its-nitroglycerin-ointment-for-moderate-to-severe-pain 2024-12-04T11:49:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-completes-last-patient-pisit-in-ath434-201-trial-in-multiple-system-atroph 2024-12-04T11:40:01+11:00 https://pharmadispatch.com/news/greens-announce-plan-to-make-contraception-more-widely-accessible 2024-12-04T11:20:01+11:00 https://pharmadispatch.com/news/moderna-opens-first-commercial-scale-mrna-manufacturing-facility-in-southern-hemisphere 2024-12-04T09:56:01+11:00 https://pharmadispatch.com/news/apparently-these-advisory-committees-know-thats-best-for-patients 2024-12-04T03:00:01+11:00 https://pharmadispatch.com/news/advisory-committees-less-than-enthusiastic-about-faster-patient-access-to-innovation 2024-12-04T03:00:01+11:00 https://pharmadispatch.com/news/pbac-supported-prioritising-submissions-in-its-response-to-hta-review 2024-12-04T03:00:01+11:00 https://pharmadispatch.com/news/half-of-australians-live-with-chronic-conditions-with-over-a-third-forced-to-leave-their-jobs-as 2024-12-04T03:00:01+11:00 https://pharmadispatch.com/news/we-are-very-unhappy-that-we-were-not-consulted-as-it-is-an-expectation 2024-12-03T03:38:01+11:00 https://pharmadispatch.com/news/albanese-government-launches-review-of-australias-research-and-development 2024-12-02T16:50:01+11:00 https://pharmadispatch.com/news/brisbane-health-tech-unveils-advanced-manufacturing-facility 2024-12-02T16:22:01+11:00 https://pharmadispatch.com/news/pharmac-minister-celebrates-increase-in-access-to-medicines-following-budget-boost 2024-12-02T16:13:01+11:00 https://pharmadispatch.com/news/orthocell-says-it-has-achieved-all-endpoints-in-pivotal-of-nerve-repair-product 2024-12-02T11:42:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-experienced-industry-executive-to-its-board 2024-12-02T11:33:01+11:00 https://pharmadispatch.com/news/4dmedical-signs-contract-to-expand-in-western-australia 2024-12-02T11:25:01+11:00 https://pharmadispatch.com/news/nsw-government-backs-down-on-health-tax-in-new-agreement-with-health-funds 2024-12-02T10:26:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-australian-adults-living-with-adults-with-von-hippel-lindau-disease 2024-12-02T03:03:01+11:00 https://pharmadispatch.com/news/pbs-listing-of-bayers-endometriosis-treatment-breaks-30-year-drought 2024-12-02T03:00:01+11:00 https://pharmadispatch.com/news/people-can-debate-whether-their-responses-constitute-misleading-the-senate 2024-12-02T03:00:01+11:00 https://pharmadispatch.com/news/publication-of-ministerial-advice-raises-questions-about-the-evidence-given-at-senate-estimates 2024-11-29T15:32:01+11:00 https://pharmadispatch.com/news/we-know-what-will-be-considered-in-march-but-not-what-has-been-pushed-to-may 2024-11-29T03:00:01+11:00 https://pharmadispatch.com/news/new-data-reveals-how-healthcare-professionals-can-support-communities-to-prepare-for-covid-19 2024-11-29T03:00:01+11:00 https://pharmadispatch.com/news/stakeholders-come-together-for-consensus-statement-in-support-of-bridging-fund 2024-11-29T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-29-november 2024-11-28T17:34:01+11:00 https://pharmadispatch.com/news/no-clarity-on-the-five-deferred-submissions-to-be-considered-at-march-pbac-meeting 2024-11-27T18:00:01+11:00 https://pharmadispatch.com/news/outgoing-president-proposes-dramatic-expansion-in-funded-access-to-weight-loss-therapies 2024-11-27T13:53:01+11:00 https://pharmadispatch.com/news/whooping-cough-cases-surge-across-australia-as-vaccination-rates-fall 2024-11-27T13:30:01+11:00 https://pharmadispatch.com/news/australian-backed-triple-combination-hypertension-treatment-proceeding-to-regulatory-submission 2024-11-27T13:06:01+11:00 https://pharmadispatch.com/news/vaxxas-expands-global-ip-portfolio-for-exclusive-manufacture-and-sale-of-needle-free-vaccination 2024-11-27T12:51:01+11:00 https://pharmadispatch.com/news/medical-cannabis-company-montu-appoints-experienced-industry-executive-to-key-policy-and-advocac 2024-11-27T12:40:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-says-isla-101-shows-anti-dengue-activity-in-phase-2a-study-readout 2024-11-27T12:03:01+11:00 https://pharmadispatch.com/news/senate-committee-to-question-pbac-chair-on-submission-deferrals 2024-11-27T03:00:01+11:00 https://pharmadispatch.com/news/study-finds-popular-diabetes-and-obesity-drugs-also-protect-kidneys 2024-11-27T03:00:01+11:00 https://pharmadispatch.com/news/organon-makes-the-move-from-macquarie-park-to-sydneys-cbd 2024-11-26T16:21:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-lack-of-research-on-climate-change-and-health-impacts 2024-11-26T10:42:01+11:00 https://pharmadispatch.com/news/the-comments-were-not-as-clear-but-they-clearly-frame-the-implementation-as-a-negotiation 2024-11-26T03:00:01+11:00 https://pharmadispatch.com/news/ge-healthcare-and-peter-maccallum-cancer-centre-partner-to-advance-cancer-research 2024-11-26T03:00:01+11:00 https://pharmadispatch.com/news/new-research-shows-confidence-robbing-condition-impacts-one-in-three-men-aged-over-40 2024-11-26T03:00:01+11:00 https://pharmadispatch.com/news/five-inspiring-australians-recognised-for-their-advocacy-support-and-care-for-people-living-with 2024-11-25T03:00:01+11:00 https://pharmadispatch.com/news/the-journey-of-a-word-from-high-level-principle-to-specific-policy-proposals 2024-11-25T03:00:01+11:00 https://pharmadispatch.com/news/stakeholders-deserve-clarity-on-the-strategic-objective-before-this-process-gets-underway 2024-11-25T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-22-november 2024-11-22T13:20:01+11:00 https://pharmadispatch.com/news/omicos-professor-david-thomas-receives-nsw-premiers-award-for-outstanding-cancer-researcher 2024-11-22T04:33:01+11:00 https://pharmadispatch.com/news/medicines-australia-says-it-has-been-and-is-still-advocating-against-secrecy-provisions 2024-11-22T03:00:01+11:00 https://pharmadispatch.com/news/another-example-of-why-the-language-used-by-government-really-matters 2024-11-22T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-welcomes-new-qualification-for-the-profession 2024-11-21T02:27:01+11:00 https://pharmadispatch.com/news/amgen-welcomes-expanded-listing-of-biologic-osteoporosis-therapy 2024-11-21T01:00:01+11:00 https://pharmadispatch.com/news/nobody-better-qualified-to-make-a-difference-as-long-as-they-are-allowed-to 2024-11-21T01:00:01+11:00 https://pharmadispatch.com/news/will-its-members-accept-the-same-operating-framework-that-dominated-the-reviews-reference-group 2024-11-20T11:30:01+11:00 https://pharmadispatch.com/news/telix-announces-agreement-to-add-fap-targeting-candidates-to-theranostic-pipeline 2024-11-20T03:13:01+11:00 https://pharmadispatch.com/news/gbma-says-australia-can-benefit-from-a-biosimilar-medicines-funding-windfall 2024-11-20T03:00:01+11:00 https://pharmadispatch.com/news/ramsay-health-care-and-bupa-join-forces-to-develop-our-next-generation-of-nurses 2024-11-19T13:46:01+11:00 https://pharmadispatch.com/news/moderna-appoints-new-director-of-regional-research-centre-for-respiratory-medicines-and-tropical 2024-11-19T13:28:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-mtpconnect-bring-together-life-sciences-sector-for-national-summit 2024-11-19T03:00:01+11:00 https://pharmadispatch.com/news/bms-australia-to-host-a-summit-focused-on-patients-and-the-parliament 2024-11-19T03:00:01+11:00 https://pharmadispatch.com/news/pbac-member-and-former-industry-executive-appointed-to-board-of-local-biotech 2024-11-18T15:26:01+11:00 https://pharmadispatch.com/news/tga-approves-modernas-updated-jn1-covid-19-vaccine 2024-11-18T12:06:01+11:00 https://pharmadispatch.com/news/radiopharma-says-targeted-therapy-demonstrates-potential-for-pancreatic-cancer-patients 2024-11-18T11:46:01+11:00 https://pharmadispatch.com/news/clinuvel-announces-plan-to-prioritises-three-strategic-programs 2024-11-18T11:31:01+11:00 https://pharmadispatch.com/news/the-records-and-decisions-in-one-year-that-reverberate-to-this-day 2024-11-18T03:00:01+11:00 https://pharmadispatch.com/news/industry-gets-nervous-after-trump-appoints-rfk-jr-to-lead-us-health-and-human-services 2024-11-18T03:00:01+11:00 https://pharmadispatch.com/news/australian-companys-candidate-reduces-aggregation-of-key-als-disease-target 2024-11-17T16:33:01+11:00 https://pharmadispatch.com/news/a-response-based-on-short-term-considerations-only-undermines-long-term-objectives 2024-11-15T03:00:01+11:00 https://pharmadispatch.com/news/amplia-enters-into-preclinical-collaboration-with-korean-drug-screening-company 2024-11-14T16:48:01+11:00 https://pharmadispatch.com/news/botanix-expands-us-payer-coverage-for-sofdra-with-ascent-health-agreement 2024-11-14T16:46:01+11:00 https://pharmadispatch.com/news/immutep-says-efti-insight-003-lung-cancer-trial-reveals-positive-survival-data 2024-11-14T15:23:01+11:00 https://pharmadispatch.com/news/a-procurement-mindset-must-not-impede-equitable-access-to-medicines-that-offer-significant-benef 2024-11-14T12:29:01+11:00 https://pharmadispatch.com/news/ma-proposes-ceo-for-hta-review-implementation-group-and-wants-continuity 2024-11-14T03:00:01+11:00 https://pharmadispatch.com/news/any-approach-to-government-relations-based-on-the-montessori-method-is-doomed-to-fail 2024-11-14T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-announces-the-inaugural-depaz-oration 2024-11-14T03:00:01+11:00 https://pharmadispatch.com/news/data-shows-invasive-pneumococcal-disease-at-highest-level-in-15-years 2024-11-13T04:00:01+11:00 https://pharmadispatch.com/news/arthritis-experts-launch-the-atlas-arthritis-elearning-program-for-health-professionals 2024-11-13T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-to-fund-new-heart-medicine-for-18000-new-zealanders 2024-11-12T16:18:01+11:00 https://pharmadispatch.com/news/if-you-read-it-actually-its-a-cap-on-the-number-of-applications-that-can-be-considered-into-the- 2024-11-12T05:09:01+11:00 https://pharmadispatch.com/news/the-pharmacy-guild-welcomes-free-rsv-vaccine-decision 2024-11-12T05:01:01+11:00 https://pharmadispatch.com/news/sandoz-celebrates-the-5th-annual-global-biosimilars-awareness-week 2024-11-12T04:53:01+11:00 https://pharmadispatch.com/news/medical-device-sector-pushes-for-the-adoption-of-health-department-standards-charter 2024-11-12T03:00:01+11:00 https://pharmadispatch.com/news/moderna-announces-the-awardees-for-its-2024-australia-fellowship-program 2024-11-11T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-the-creation-of-hybrid-national-program-for-rsv-vaccine 2024-11-11T03:00:01+11:00 https://pharmadispatch.com/news/patients-win-when-health-ministers-do-what-they-are-elected-to-do 2024-11-11T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-makes-cancer-therapy-the-26th-funded-since-budget-boost 2024-11-11T03:00:01+11:00 https://pharmadispatch.com/news/lundbeck-announces-its-new-leadership-for-australia 2024-11-08T03:00:01+11:00 https://pharmadispatch.com/news/accc-will-not-oppose-sigma-chemist-warehouse-merger-subject-to-undertaking 2024-11-08T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-mtpconnect-launch-joint-discussion-paper-on-life-science-growth-issues 2024-11-08T03:00:01+11:00 https://pharmadispatch.com/news/global-biosimilars-week-to-highlight-the-health-and-financial-benefits-of-biosimilar-medicines 2024-11-08T03:00:01+11:00 https://pharmadispatch.com/news/officials-gauged-evaluator-capacity-after-the-minister-endorsed-their-plan 2024-11-07T16:57:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-life-sciences-western-australia-fign-first-ever-mou 2024-11-07T06:09:01+11:00 https://pharmadispatch.com/news/the-solution-simply-gives-some-certainty-to-submissions-that-had-none 2024-11-07T04:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-set-to-launch-the-2025-kosi-challenge 2024-11-07T03:00:01+11:00 https://pharmadispatch.com/news/the-fight-is-not-over-until-this-is-all-resolved-but-seeing-the-system-start-to-move-is-a-great- 2024-11-07T03:00:01+11:00 https://pharmadispatch.com/news/pbac-instructed-to-meet-for-another-full-meeting-in-may 2024-11-06T11:30:01+11:00 https://pharmadispatch.com/news/doctors-in-australia-lead-phase-3-theranostics-study-targeting-advanced-prostate-cancer 2024-11-06T10:53:01+11:00 https://pharmadispatch.com/news/scope-of-practice-final-report-triggers-debate-over-recommendations-for-reform 2024-11-06T03:00:01+11:00 https://pharmadispatch.com/news/the-relationship-between-hardened-language-and-outcome 2024-11-06T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-minister-welcomes-accelerated-medsafe-approval-assessments 2024-11-05T15:16:01+11:00 https://pharmadispatch.com/news/immugene-says-bile-tract-cancer-patient-maintains-complete-response-in-mast-study 2024-11-05T11:39:01+11:00 https://pharmadispatch.com/news/we-are-doing-something-that-most-people-think-is-impossible 2024-11-05T03:00:01+11:00 https://pharmadispatch.com/news/if-this-is-allowed-to-happen-the-broader-discussion-is-inevitable 2024-11-05T03:00:01+11:00 https://pharmadispatch.com/news/we-are-proud-to-have-been-certified-as-a-great-place-to-work-in-2024 2024-11-05T03:00:01+11:00 https://pharmadispatch.com/news/sometimes-the-industrys-duty-is-to-save-governments-from-stupid-decisions 2024-11-04T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-opens-new-renewable-energy-project-in-macquaries-park 2024-11-04T03:00:01+11:00 https://pharmadispatch.com/news/patients-welcome-breakthrough-in-access-to-migraine-medications 2024-11-04T03:00:01+11:00 https://pharmadispatch.com/news/its-a-tricky-move-pretending-to-honour-the-election-commitment-to-medicines-access 2024-11-04T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-1-november 2024-11-01T10:26:01+11:00 https://pharmadispatch.com/news/liz-selby-goes-from-acting-to-permanent-head-of-sanofis-local-pharmaceutical-business 2024-11-01T03:00:01+11:00 https://pharmadispatch.com/news/arrotex-partners-with-juniper-to-deliver-new-rare-blood-cancer-treatment 2024-11-01T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-proposes-expanding-access-to-amgens-osteoporosis-biologic 2024-11-01T03:00:01+11:00 https://pharmadispatch.com/news/annual-report-reveals-rebates-topped-5-billion-for-the-first-time 2024-10-31T14:00:01+11:00 https://pharmadispatch.com/news/this-circular-and-semantic-argument-ends-with-one-conclusion-a-submission-cap 2024-10-31T03:00:01+11:00 https://pharmadispatch.com/news/this-would-be-the-most-significant-change-in-pbs-decision-making-in-over-30-years 2024-10-31T03:00:01+11:00 https://pharmadispatch.com/news/it-has-been-both-challenging-and-rewarding-to-lead-medicines-australia 2024-10-30T19:44:01+11:00 https://pharmadispatch.com/news/more-stakeholder-responses-to-covid-19-pandemic-response-inquiry 2024-10-30T16:35:01+11:00 https://pharmadispatch.com/news/amplia-announces-capital-raise-to-support-the-completion-of-phase-2a-accent-trial 2024-10-30T11:35:01+11:00 https://pharmadispatch.com/news/priceline-pharmacy-launches-a-refreshed-brand-strategy 2024-10-30T03:00:01+11:00 https://pharmadispatch.com/news/vaccine-procurement-and-rollout-was-slow-but-did-reduce-the-number-of-deaths 2024-10-30T03:00:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-leader-promoted-to-global-role 2024-10-30T03:00:01+11:00 https://pharmadispatch.com/news/at-least-this-means-the-industry-will-never-again-take-lectures-on-these-issues 2024-10-29T12:43:01+11:00 https://pharmadispatch.com/news/decisions-taken-during-the-caretaker-period-are-governed-by-a-formal-convention 2024-10-29T03:00:01+11:00 https://pharmadispatch.com/news/community-pharmacy-leads-nation-wide-transformation-of-womens-health-services 2024-10-29T03:00:01+11:00 https://pharmadispatch.com/news/nz-working-to-catch-up-as-bew-report-reveals-the-magnitude-of-the-challenge 2024-10-29T03:00:01+11:00 https://pharmadispatch.com/news/when-the-government-says-prioritises-it-actually-means-deprioritising 2024-10-28T11:07:01+11:00 https://pharmadispatch.com/news/health-department-officials-would-delighted-with-this-response 2024-10-28T03:01:01+11:00 https://pharmadispatch.com/news/ma-says-health-department-agree-to-consult-should-this-situation-occur-again 2024-10-28T03:00:01+11:00 https://pharmadispatch.com/news/australian-patients-association-announces-the-appointment-of-new-ceo 2024-10-27T19:11:01+11:00 https://pharmadispatch.com/news/rheumagen-strengthens-leadership-with-appointment-of-top-industry-veterans 2024-10-27T14:08:01+11:00 https://pharmadispatch.com/news/an-odd-claim-given-what-it-anticipated-in-the-annual-cost-recovery-statement 2024-10-27T12:34:01+11:00 https://pharmadispatch.com/news/the-claim-the-pbac-has-the-power-to-set-its-meeting-agendas-is-utterly-false 2024-10-25T03:00:01+11:00 https://pharmadispatch.com/news/investigations-into-lung-cancer-and-into-recognised-with-csl-centenary-fellowships 2024-10-25T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-25-october 2024-10-24T18:40:01+11:00 https://pharmadispatch.com/news/the-health-departments-strategy-is-based-on-the-hope-that-sponsors-do-not-submit 2024-10-24T03:00:01+11:00 https://pharmadispatch.com/news/health-department-attempts-to-defer-two-thirds-of-submissions-to-march-meetin 2024-10-24T03:00:01+11:00 https://pharmadispatch.com/news/release-of-white-paper-from-nzs-valuing-life-medicines-access-summit 2024-10-24T03:00:01+11:00 https://pharmadispatch.com/news/this-has-happened-before-there-was-consultation-and-it-was-managed-without-harming-patients 2024-10-23T13:48:01+11:00 https://pharmadispatch.com/news/companies-should-reject-the-letters-and-proceed-with-their-submissions 2024-10-23T10:10:01+11:00 https://pharmadispatch.com/news/our-job-as-advocates-is-to-interpret-what-patients-mean-by-hope-not-to-ignore-it 2024-10-23T03:00:01+11:00 https://pharmadispatch.com/news/daiichi-sankyo-continues-australian-growth-trajectory 2024-10-23T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-special-edition-1 2024-10-22T16:04:01+11:00 https://pharmadispatch.com/news/how-many-people-will-die-because-of-this-institutional-indifference 2024-10-22T03:00:01+11:00 https://pharmadispatch.com/news/patients-groups-slam-pbacs-failure-on-streamlining-cancer-medicines-access 2024-10-22T03:00:01+11:00 https://pharmadispatch.com/news/australias-winter-report-card-the-impact-of-respiratory-illnesses-on-the-elderly-this-year 2024-10-22T01:00:01+11:00 https://pharmadispatch.com/news/alcon-supports-future-optometrists-through-new-educational-grant 2024-10-21T15:16:01+11:00 https://pharmadispatch.com/news/us-fda-grants-rare-paediatric-designation-to-pycs-drug-development-program 2024-10-21T09:50:01+11:00 https://pharmadispatch.com/news/only-those-not-confronting-a-life-ending-diagnosis-can-view-hope-as-intangible-and-false 2024-10-21T03:00:01+11:00 https://pharmadispatch.com/news/disappointment-in-response-to-status-quo-recommendation-on-new-process 2024-10-21T03:00:01+11:00 https://pharmadispatch.com/news/cancer-and-cushing-syndrome-therapies-secure-positive-recommendations 2024-10-21T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-18-october 2024-10-18T13:42:01+11:00 https://pharmadispatch.com/news/new-research-uncovers-australian-women-are-often-reluctant-to-openly-talk-about-menopause 2024-10-18T03:00:01+11:00 https://pharmadispatch.com/news/the-danger-of-this-outlier-is-reflected-in-the-disconnect-with-another-policy-process 2024-10-18T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-seeking-bids-from-suppliers-for-covid-19-vaccines 2024-10-17T11:19:01+11:00 https://pharmadispatch.com/news/auditor-general-launches-audit-of-the-procurement-of-onshore-vaccine-manufacturing-facilities 2024-10-17T10:53:01+11:00 https://pharmadispatch.com/news/this-has-happened-before-and-the-response-should-be-the-same-no 2024-10-17T03:00:01+11:00 https://pharmadispatch.com/news/vitalis-and-servita-partner-to-lead-healthcare-digital-transformation-in-queensland 2024-10-17T03:00:01+11:00 https://pharmadispatch.com/news/commercial-eyes-signs-new-service-agreement-with-opyl 2024-10-17T03:00:01+11:00 https://pharmadispatch.com/news/trailblazers-speaks-with-leading-primary-care-leader-and-researcher 2024-10-17T03:00:01+11:00 https://pharmadispatch.com/news/biogen-awarded-great-place-to-work-certification-for-2024 2024-10-17T03:00:01+11:00 https://pharmadispatch.com/news/disappointment-for-eisai-as-tga-goes-public-early-on-alzheimers-therapy 2024-10-16T17:56:01+11:00 https://pharmadispatch.com/news/nyrada-says-it-has-completed-safety-studies-ahead-of-phase-1-clinical-trial 2024-10-16T14:03:01+11:00 https://pharmadispatch.com/news/funding-unapproved-copies-would-fundamentally-change-our-system-for-the-worst 2024-10-16T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-calling-on-experts-to-become-mentors-for-industry-growth-program 2024-10-15T20:14:01+11:00 https://pharmadispatch.com/news/mark-butler-needs-to-understand-the-implications-of-accepting-this-recommendation 2024-10-15T15:48:01+11:00 https://pharmadispatch.com/news/what-matters-is-whats-rational-for-the-industry-is-not-rational-for-the-government 2024-10-15T03:00:01+11:00 https://pharmadispatch.com/news/on-comparators-maybe-demand-the-return-of-a-policy-already-paid-for 2024-10-15T03:00:01+11:00 https://pharmadispatch.com/news/government-invests-more-in-preparation-for-new-avian-flu-strain 2024-10-14T15:05:01+11:00 https://pharmadispatch.com/news/the-industry-faces-significant-uncertainty-with-barely-three-weeks-until-the-us-election 2024-10-14T03:00:01+11:00 https://pharmadispatch.com/news/tga-signs-memorandum-of-understanding-with-south-africas-regulator 2024-10-14T03:00:01+11:00 https://pharmadispatch.com/news/dementia-set-to-become-australias-leading-cause-of-death 2024-10-13T17:41:01+11:00 https://pharmadispatch.com/news/pharmac-announces-expanded-access-to-three-cancer-medicines 2024-10-11T03:00:01+11:00 https://pharmadispatch.com/news/novartis-led-partnership-says-heart-health-shouldnt-be-dependent-on-where-you-live 2024-10-11T03:00:01+11:00 https://pharmadispatch.com/news/bondi-junction-response-must-include-increased-funding-and-support-for-severe-mental-illness 2024-10-11T00:00:01+11:00 https://pharmadispatch.com/news/new-report-unveils-hidden-cost-of-alzheimers-disease-with-cases-to-double-by-2050 2024-10-10T10:26:01+11:00 https://pharmadispatch.com/news/amplia-therapeutics-ceo-shares-prime-ministers-prize-for-innovation 2024-10-10T03:00:01+11:00 https://pharmadispatch.com/news/healthy-bones-australia-calls-for-greater-government-commitment-to-bone-health 2024-10-09T12:52:01+11:00 https://pharmadispatch.com/news/tga-approves-new-indication-for-telixs-illuccix-to-include-patient-selection-for-psma-targeted-t 2024-10-09T10:13:01+11:00 https://pharmadispatch.com/news/medibank-expands-four-day-work-week-trial-to-500-employees 2024-10-09T09:53:01+11:00 https://pharmadispatch.com/news/anyone-wanting-to-know-how-this-might-work-look-to-new-zealand 2024-10-09T03:00:01+11:00 https://pharmadispatch.com/news/wesfarmers-health-releases-inaugural-wesfarmers-health-releases-australia-most-comprehensive-rea 2024-10-09T03:00:01+11:00 https://pharmadispatch.com/news/peak-bodies-align-in-consensus-statement-on-juvenile-arthritis 2024-10-09T03:00:01+11:00 https://pharmadispatch.com/news/the-consistent-failure-to-speak-out-is-degrading-this-critical-public-health-program 2024-10-08T03:00:01+11:00 https://pharmadispatch.com/news/new-report-reveals-significant-potential-return-from-investment-in-adult-vaccination 2024-10-08T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-confirms-norgines-creation-of-dfmo-access-program 2024-10-07T13:53:01+11:00 https://pharmadispatch.com/news/uq-spider-venom-heart-drug-moves-into-clinical-trials 2024-10-07T11:57:01+11:00 https://pharmadispatch.com/news/chimeric-says-cancer-patient-achieves-complete-response-in-chm-core-nk-trial 2024-10-07T11:34:01+11:00 https://pharmadispatch.com/news/csl-welcomes-new-treatment-for-high-risk-cardiovascular-disease-to-the-pbs 2024-10-07T03:00:01+11:00 https://pharmadispatch.com/news/cyclopharm-sigs-agreement-makes-major-progress-with-us-veterans-and-defence-administrations 2024-10-06T10:10:01+11:00 https://pharmadispatch.com/news/new-drug-could-be-answer-to-an-overlooked-yet-devastating-type-of-dementia 2024-10-06T09:58:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-new-funding-to-support-key-inflection-points-and-pipeline-build 2024-10-06T09:44:01+11:00 https://pharmadispatch.com/news/otsuka-celebrates-its-tenth-anniversary-in-australia 2024-10-04T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-4-october 2024-10-03T16:39:01+10:00 https://pharmadispatch.com/news/womens-health-collaboration-calls-for-mbs-reform-to-improve-access-to-contraceptive-choice 2024-10-03T16:17:01+10:00 https://pharmadispatch.com/news/rare-disease-company-sobi-appoints-new-general-manager-for-australia-and-new-zealand 2024-10-03T14:43:01+10:00 https://pharmadispatch.com/news/the-significant-driver-of-growth-is-the-dramatic-shift-to-free-pbs-prescriptions 2024-10-03T10:18:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-next-steps-on-the-hta-review-its-under-consideration 2024-10-03T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-launches-the-rollout-of-medicines-funded-under-budget-boost 2024-10-02T13:42:01+10:00 https://pharmadispatch.com/news/new-partnership-aims-to-build-a-unified-approach-to-delivery-of-australian-cancer-plan 2024-10-02T13:32:01+10:00 https://pharmadispatch.com/news/medicines-australia-strikes-cautious-tone-on-hta-review-implementation-group 2024-10-02T03:12:01+10:00 https://pharmadispatch.com/news/abbvie-heads-the-list-of-australias-best-workplaces-in-pharma-and-biotech 2024-10-02T03:00:01+10:00 https://pharmadispatch.com/news/sigma-offers-court-enforceable-undertaking-in-response-to-accc-concerns 2024-10-02T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-renews-commitment-to-all-patients-during-fourth-annual-patient-week 2024-10-02T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-vaxxas-receives-significant-investment-from-endpoints-capital 2024-10-01T17:55:01+10:00 https://pharmadispatch.com/news/cartherics-raises-over-15-million-in-private-financing-round 2024-10-01T17:49:01+10:00 https://pharmadispatch.com/news/nyradas-says-lead-drug-candidate-demonstrates-significant-cardioprotection 2024-10-01T17:42:01+10:00 https://pharmadispatch.com/news/omico-welcomes-multi-year-collaboration-with-tessellate-bio-and-cmri-on-alt-cancers 2024-10-01T17:02:01+10:00 https://pharmadispatch.com/news/ucb-confirms-expanded-listing-for-for-severe-psoriatic-arthritis-and-axial-spondyloarthritis 2024-10-01T03:00:01+10:00 https://pharmadispatch.com/news/government-funds-new-dosage-of-eylea-for-common-eye-diseases 2024-10-01T03:00:01+10:00 https://pharmadispatch.com/news/government-funds-jjs-new-combination-blood-cancer-treatment 2024-10-01T03:00:01+10:00 https://pharmadispatch.com/news/organon-welcomes-pbs-listing-of-first-citrate-free-adalimumab-biosimilar 2024-10-01T03:00:01+10:00 https://pharmadispatch.com/news/pfizers-velsipity-pbs-listed-for-people-with-moderately-to-severely-active-ulcerative-colitis 2024-10-01T03:00:01+10:00 https://pharmadispatch.com/news/trent-twomey-secures-second-term-as-pharmacy-guild-national-president 2024-09-30T17:50:01+10:00 https://pharmadispatch.com/news/percheron-therapeutics-updates-of-avicursen-primate-toxicology-study 2024-09-30T17:07:01+10:00 https://pharmadispatch.com/news/mesoblast-option-to-issue-up-to-us50-million-convertible-notes-for-product-launch 2024-09-30T16:27:01+10:00 https://pharmadispatch.com/news/polynovo-announces-the-retirement-of-long-term-non-executive-director 2024-09-30T16:17:01+10:00 https://pharmadispatch.com/news/artrya-submits-application-for-salix-to-the-us-fda 2024-09-30T10:28:01+10:00 https://pharmadispatch.com/news/budget-outcome-confirms-pharmaceutical-spending-topped-20-billion-for-the-first-time 2024-09-30T09:30:01+10:00 https://pharmadispatch.com/news/good-to-be-inside-the-tent-but-first-make-sure-its-safe-to-enter 2024-09-30T03:00:01+10:00 https://pharmadispatch.com/news/csl-welcomes-scientific-community-to-australia-for-global-influenza-conference 2024-09-30T03:00:01+10:00 https://pharmadispatch.com/news/real-life-lady-garden-implores-women-to-put-their-health-first 2024-09-30T03:00:01+10:00 https://pharmadispatch.com/news/bellberry-wins-championing-health-in-telstra-business-awards 2024-09-30T03:00:01+10:00 https://pharmadispatch.com/news/magentus-partners-with-amgen-australia-to-deliver-ai-powered-dermatology-tool 2024-09-27T04:53:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-27-september 2024-09-27T03:00:01+10:00 https://pharmadispatch.com/news/giving-back-is-part-of-our-dna-at-vertex-and-something-we-are-all-very-passionate-about 2024-09-27T03:00:01+10:00 https://pharmadispatch.com/news/gilead-continues-support-for-health-equity-through-2024-community-grants-program 2024-09-27T03:00:01+10:00 https://pharmadispatch.com/news/members-should-demand-more-power-and-directors-should-embrace-it 2024-09-26T03:00:01+10:00 https://pharmadispatch.com/news/organon-medical-director-says-its-time-to-take-a-stand-against-online-misinformation 2024-09-26T03:00:01+10:00 https://pharmadispatch.com/news/painaustralia-new-chief-executive-to-succeed-giulia-jones 2024-09-26T03:00:01+10:00 https://pharmadispatch.com/news/gilead-tops-patient-group-reputation-survey 2024-09-25T04:58:01+10:00 https://pharmadispatch.com/news/an-opportunity-to-act-quickly-to-implement-a-netflix-style-subscription-model-for-antibiotics 2024-09-25T03:00:01+10:00 https://pharmadispatch.com/news/as-a-director-it-is-akin-to-one-company-negotiating-the-listing-of-a-competitors-product 2024-09-25T03:00:01+10:00 https://pharmadispatch.com/news/directors-need-to-protect-themselves-and-medicines-australia-needs-to-protects-it-directors 2024-09-24T03:00:01+10:00 https://pharmadispatch.com/news/auditor-general-extends-time-for-pbs-performance-audit 2024-09-24T03:00:01+10:00 https://pharmadispatch.com/news/telix-to-acquire-north-american-manufacturing-and-distribution-platform 2024-09-24T03:00:01+10:00 https://pharmadispatch.com/news/minister-confirms-expanded-funded-access-to-gsks-shingles-vaccine 2024-09-23T04:44:01+10:00 https://pharmadispatch.com/news/logical-to-gather-more-information-because-of-the-legal-liability-for-decisions 2024-09-23T03:00:01+10:00 https://pharmadispatch.com/news/parliament-backs-government-move-to-clarify-pricing-legislation 2024-09-23T03:00:01+10:00 https://pharmadispatch.com/news/the-hta-review-red-flag-number-five-of-five 2024-09-20T03:00:01+10:00 https://pharmadispatch.com/news/a-way-forward-is-an-opportunity-to-avoid-the-pitfalls-of-previous-processes 2024-09-20T03:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-20-september 2024-09-19T20:10:01+10:00 https://pharmadispatch.com/news/clear-political-leadership-delivers-greeen-shoots-in-new-zealand 2024-09-18T20:40:01+10:00 https://pharmadispatch.com/news/ausbiotech-pays-tribute-to-a-leading-figure-in-the-creation-of-australias-biotech-sector 2024-09-18T18:14:01+10:00 https://pharmadispatch.com/news/pharmac-continues-to-invest-its-post-budget-funding-boost 2024-09-18T17:51:01+10:00 https://pharmadispatch.com/news/the-hta-review-report-red-flag-number-four-of-five 2024-09-18T10:24:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-announces-plan-to-build-new-fulfilment-centre-in-cairns 2024-09-17T18:07:01+10:00 https://pharmadispatch.com/news/medicines-australia-unveils-next-phase-of-stronger-pbs-campaign 2024-09-17T17:46:01+10:00 https://pharmadispatch.com/news/the-hta-review-report-red-flag-number-three-of-five 2024-09-17T10:28:01+10:00 https://pharmadispatch.com/news/immutep-says-it-candidate-in-combination-with-keytruda-delivered-positive-efficacy-and-safety-pr 2024-09-16T22:34:01+10:00 https://pharmadispatch.com/news/medicines-australia-responds-to-questions-on-the-hta-review 2024-09-16T22:27:01+10:00 https://pharmadispatch.com/news/the-hta-review-report-red-flag-number-two-of-five 2024-09-16T10:07:01+10:00 https://pharmadispatch.com/news/australian-company-kazia-executes-licensing-agreement-with-qimr-berghofer 2024-09-16T03:06:01+10:00 https://pharmadispatch.com/news/a-statement-with-intent-that-limits-expectations-and-frames-policy-discussions 2024-09-16T03:00:01+10:00 https://pharmadispatch.com/news/the-hta-review-report-and-red-flag-number-one-of-five 2024-09-16T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-plan-to-deploy-more-of-its-recent-funding-boost 2024-09-16T03:00:01+10:00 https://pharmadispatch.com/news/in-236-pages-this-one-section-captures-the-primary-barrier-to-real-reform 2024-09-13T03:00:01+10:00 https://pharmadispatch.com/news/it-is-never-too-late-for-a-considered-response-caution 2024-09-13T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-13-september 2024-09-12T18:24:01+10:00 https://pharmadispatch.com/news/hta-review-will-achieve-savings-but-it-wont-achieve-better-access-for-all 2024-09-12T05:05:01+10:00 https://pharmadispatch.com/news/pharmaprograms-announces-extension-of-long-standing-partnership-with-nostradata 2024-09-12T03:00:01+10:00 https://pharmadispatch.com/news/telixs-phase-3-zircon-trial-for-kidney-cancer-imaging-published-in-the-lancet-oncology 2024-09-11T16:19:01+10:00 https://pharmadispatch.com/news/brandon-biocatalysts-cureator-incubator-boosts-preclinical-and-health-security-innovations-with- 2024-09-11T15:35:01+10:00 https://pharmadispatch.com/news/this-single-proposal-could-be-the-single-biggest-destruction-of-therapeutic-value 2024-09-11T15:00:01+10:00 https://pharmadispatch.com/news/tga-extends-approval-for-eli-lillys-diabetes-therapy-to-include-weight-management 2024-09-11T12:58:01+10:00 https://pharmadispatch.com/news/this-enthusiastic-response-is-acceptance-of-changes-to-deliver-billions-in-new-savings 2024-09-11T09:56:01+10:00 https://pharmadispatch.com/news/this-report-prioritises-therapies-that-deliver-government-savings-over-those-that-benefit-patien 2024-09-11T03:08:01+10:00 https://pharmadispatch.com/news/new-report-reveals-australia-is-blind-to-the-leading-cause-of-vision-loss 2024-09-11T03:00:01+10:00 https://pharmadispatch.com/news/first-ever-study-of-family-linked-cancer-reveals-skyrocketing-financial-and-emotional-toll 2024-09-11T03:00:01+10:00 https://pharmadispatch.com/news/full-credit-for-the-honesty-but-this-is-pharmac-and-not-even-in-disguise 2024-09-10T20:24:01+10:00 https://pharmadispatch.com/news/dimerix-announces-that-first-patient-enters-dmx-200-open-label-extension 2024-09-10T10:38:01+10:00 https://pharmadispatch.com/news/be-clear-eye-about-whatever-trade-off-the-institution-demands-you-accept 2024-09-10T03:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-and-australian-genomics-to-host-policy-roundtable 2024-09-10T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-first-cancer-medicine-decision-after-funding-boost 2024-09-09T14:39:01+10:00 https://pharmadispatch.com/news/biotron-updates-on-bit225-012-phase-2-covid-19-clinical-trial 2024-09-09T11:06:01+10:00 https://pharmadispatch.com/news/new-us-government-report-upends-the-claims-of-intellectual-property-critics 2024-09-09T03:00:01+10:00 https://pharmadispatch.com/news/ena-respiratory-secures-extension-of-us-funding-for-novel-prophylactic-antiviral 2024-09-08T10:27:01+10:00 https://pharmadispatch.com/news/moderna-australia-celebrates-regional-research-centres-first-12-months 2024-09-08T09:48:01+10:00 https://pharmadispatch.com/news/over-20-groups-join-arthritis-australias-call-for-urgent-action-on-arthritis-and-musculoskeletal 2024-09-08T09:30:01+10:00 https://pharmadispatch.com/news/patients-welcome-wider-access-to-shingles-vaccine-for-immunocompromised-patients 2024-09-06T03:00:01+10:00 https://pharmadispatch.com/news/csl-announces-sale-of-wuhan-plasma-collection-and-fractionation-operations 2024-09-05T18:33:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-6-september 2024-09-05T18:20:01+10:00 https://pharmadispatch.com/news/pfizer-backed-initiative-boosts-aboriginal-and-torres-strait-islander-pharmacy-leadership 2024-09-05T16:16:01+10:00 https://pharmadispatch.com/news/an-increasingly-busy-agenda-risks-squeezing-out-other-issues 2024-09-05T10:35:01+10:00 https://pharmadispatch.com/news/groups-collaborate-on-the-development-of-new-opioid-safety-toolkit 2024-09-05T04:56:01+10:00 https://pharmadispatch.com/news/government-still-working-towards-first-formal-agreement-with-wholesalers 2024-09-05T03:00:01+10:00 https://pharmadispatch.com/news/australian-patients-part-of-global-push-for-personalised-care-solution 2024-09-05T03:00:01+10:00 https://pharmadispatch.com/news/the-decision-making-process-is-generally-complicated-contested-and-slow 2024-09-04T03:00:01+10:00 https://pharmadispatch.com/news/merck-introduces-greener-solutions-for-cold-chain-shipments-in-australia 2024-09-03T15:34:01+10:00 https://pharmadispatch.com/news/the-annual-publication-of-budget-rules-provides-a-historically-unique-insight 2024-09-03T14:18:01+10:00 https://pharmadispatch.com/news/lowering-co-pay-11-times-more-effective-for-cost-of-living-relief-than-increased-quantities 2024-09-03T11:49:01+10:00 https://pharmadispatch.com/news/senate-inquiry-recommends-the-government-explore-a-broader-vaccine-compensation-scheme 2024-09-03T03:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-launches-industry-backed-accelerator-investment-program 2024-09-02T16:25:01+10:00 https://pharmadispatch.com/news/race-oncology-announces-the-detail-of-first-phase-of-board-renewal 2024-09-02T14:25:01+10:00 https://pharmadispatch.com/news/emyria-announces-interim-clinical-trial-results-for-ptsd-program 2024-09-02T14:15:01+10:00 https://pharmadispatch.com/news/wehi-says-cutting-edge-immunotherapy-could-hold-promise-for-incurable-brain-cancer 2024-09-02T09:22:01+10:00 https://pharmadispatch.com/news/tasmania-to-override-federal-law-with-ban-on-otc-vape-sales 2024-09-02T03:05:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-broader-reimbursement-of-ipsen-cancer-therapy 2024-09-02T03:00:01+10:00 https://pharmadispatch.com/news/minister-welcomes-third-tranche-of-60-day-medicines-as-patient-group-urges-caution 2024-09-02T03:00:01+10:00 https://pharmadispatch.com/news/trailblazers-marks-prostate-cancer-awareness-month-this-september 2024-09-01T14:46:01+10:00 https://pharmadispatch.com/news/initial-guidance-on-parameters-that-need-to-be-considered-for-future-broad-pbs-listing-proposals 2024-09-01T13:08:01+10:00 https://pharmadispatch.com/news/ausbiotech-has-announced-the-appointment-of-two-senior-executives 2024-08-30T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-to-fund-continuous-glucose-monitors-from-1-october 2024-08-29T17:27:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-30-august 2024-08-29T17:11:01+10:00 https://pharmadispatch.com/news/we-will-continue-to-advocate-for-earlier-faster-fairer-access-to-medicines-for-the-benefit-of-al 2024-08-29T03:11:01+10:00 https://pharmadispatch.com/news/i-dont-pretend-this-is-going-to-be-an-overnight-thing-really-this-generational-review-to-build-a 2024-08-29T03:00:01+10:00 https://pharmadispatch.com/news/organon-confirms-new-leadership-for-australia-and-new-zealand 2024-08-29T03:00:01+10:00 https://pharmadispatch.com/news/chimeric-says-first-patient-dosed-in-trial-of-cdh17-directed-car-t-cell-therapy 2024-08-28T15:58:01+10:00 https://pharmadispatch.com/news/monash-researchers-developing-finger-prick-test-to-screen-for-early-alzheimers 2024-08-28T10:08:01+10:00 https://pharmadispatch.com/news/hospital-pharmacy-is-no-longer-contained-by-the-four-walls-of-our-hospitals 2024-08-28T09:49:01+10:00 https://pharmadispatch.com/news/medicines-australia-election-process-well-an-truly-underway 2024-08-28T03:00:01+10:00 https://pharmadispatch.com/news/sandoz-welcomes-regulatory-approval-for-the-first-denosumab-biosimilar-in-australia 2024-08-27T17:37:01+10:00 https://pharmadispatch.com/news/the-commonwealth-saving-the-states-from-their-terrible-decisions-again 2024-08-27T17:04:01+10:00 https://pharmadispatch.com/news/more-formal-scrutiny-is-the-obvious-consequence-of-a-broader-role 2024-08-27T03:00:01+10:00 https://pharmadispatch.com/news/pharmaust-says-reports-positive-interim-study-results-from-study-in-als 2024-08-26T13:56:01+10:00 https://pharmadispatch.com/news/nzs-health-minister-says-funding-boost-is-supporting-higher-immunisation-rates 2024-08-26T12:44:01+10:00 https://pharmadispatch.com/news/chp-celebrates-50-years-of-growth-and-contributing-to-better-health-outcomes 2024-08-26T12:26:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-increases-ownership-in-jointly-owned-venture-firm 2024-08-26T12:12:01+10:00 https://pharmadispatch.com/news/archies-embrace-funds-australian-research-into-rare-genetic-disorder 2024-08-26T11:23:01+10:00 https://pharmadispatch.com/news/the-government-can-demonstrate-that-its-support-for-womens-health-is-more-than-talk 2024-08-26T03:00:01+10:00 https://pharmadispatch.com/news/this-is-in-stark-contrast-to-other-parts-of-the-world-where-new-rsv-immunisations-have-been-read 2024-08-26T03:00:01+10:00 https://pharmadispatch.com/news/july-outcomes-disappoint-but-committee-appears-to-relent-on-risk-share-arrangement 2024-08-26T03:00:01+10:00 https://pharmadispatch.com/news/abbvie-australia-makes-the-list-of-best-places-to-work-for-11th-year 2024-08-23T05:13:01+10:00 https://pharmadispatch.com/news/a-post-covid-transition-period-for-the-company-as-it-returns-to-business-as-usual 2024-08-23T03:00:01+10:00 https://pharmadispatch.com/news/government-moves-quickly-to-clarify-pricing-legislation-following-federal-court-victory 2024-08-23T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-22-august 2024-08-22T18:53:01+10:00 https://pharmadispatch.com/news/biogen-marks-the-tenth-anniversary-of-als-ice-bucket-challenge 2024-08-22T16:17:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-proposes-funding-heart-failure-medicine 2024-08-22T03:00:01+10:00 https://pharmadispatch.com/news/tga-approves-the-first-targeted-radioligand-therapy-for-advanced-prostate-cancer 2024-08-22T03:00:01+10:00 https://pharmadispatch.com/news/we-hope-to-be-able-to-make-a-difference-and-pave-the-way-for-some-of-australias-future-health-le 2024-08-22T03:00:01+10:00 https://pharmadispatch.com/news/arthritis-australia-calls-for-improved-access-to-care-to-reduct-the-risk-of-surgeries 2024-08-22T03:00:01+10:00 https://pharmadispatch.com/news/bioxynedelivers-australias-first-pharmaceutical-cannabis-gummies 2024-08-21T10:52:01+10:00 https://pharmadispatch.com/news/queensland-researchers-identify-potential-new-treatment-pathway-for-bladder-cancer 2024-08-21T10:22:01+10:00 https://pharmadispatch.com/news/omico-launches-national-educational-cancer-and-genomics-initiative 2024-08-21T03:16:01+10:00 https://pharmadispatch.com/news/msd-announces-its-new-leadership-for-australia-and-new-zealand 2024-08-21T03:00:01+10:00 https://pharmadispatch.com/news/if-these-are-the-solutions-the-minister-might-question-the-extent-of-the-problem 2024-08-20T11:50:01+10:00 https://pharmadispatch.com/news/without-action-the-recommendations-will-just-remain-as-words-on-a-page 2024-08-20T11:18:01+10:00 https://pharmadispatch.com/news/a-meaningless-measure-that-distracts-from-the-already-identified-cause-of-delays 2024-08-20T03:00:01+10:00 https://pharmadispatch.com/news/weve-had-the-conversationsnow-is-the-time-for-decisive-action 2024-08-20T03:00:01+10:00 https://pharmadispatch.com/news/trailblazers-speaks-with-professor-fran-boyle-about-out-from-the-shadows 2024-08-19T17:11:01+10:00 https://pharmadispatch.com/news/australias-child-vaccination-rates-are-world-leading-our-adult-rates-are-not 2024-08-19T12:34:01+10:00 https://pharmadispatch.com/news/noxopharm-targets-clinical-trial-for-first-in-class-investigative-therapy 2024-08-19T10:59:01+10:00 https://pharmadispatch.com/news/rare-cancer-advocate-and-survivor-recognised-with-national-accolade 2024-08-19T09:55:01+10:00 https://pharmadispatch.com/news/a-cautious-response-will-protect-your-position-for-the-inevitable-negotiation 2024-08-19T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-welcomes-fda-approval-of-needle-free-anaphylaxis-treatment 2024-08-19T03:00:01+10:00 https://pharmadispatch.com/news/one-audit-on-the-pbs-might-be-followed-by-another-on-procurement-and-capability 2024-08-19T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-dispatched-podcast-16-august 2024-08-16T11:10:01+10:00 https://pharmadispatch.com/news/first-ten-medicines-subject-to-pricing-power-to-take-reductions-of-up-to-79-per-cent 2024-08-16T05:04:01+10:00 https://pharmadispatch.com/news/achieving-consensus-around-platform-approaches-is-both-urgent-and-important 2024-08-16T03:00:01+10:00 https://pharmadispatch.com/news/modernas-carolyn-tucek-szabo-on-the-opportunities-and-efficiencies-of-a-platform-approach 2024-08-16T03:00:01+10:00 https://pharmadispatch.com/news/iriss-positive-impact-on-australias-biotech-ecosystem-will-be-felt-for-decades-to-come 2024-08-16T03:00:01+10:00 https://pharmadispatch.com/news/new-lilly-backed-report-calls-for-broad-action-in-the-fight-against-obesity 2024-08-15T03:00:01+10:00 https://pharmadispatch.com/news/we-are-heartbroken-and-devastated-by-the-passing-of-our-well-loved-and-respected-colleague 2024-08-15T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-selected-as-partner-organisation-for-industry-growth-program 2024-08-14T12:00:01+10:00 https://pharmadispatch.com/news/the-surprises-are-already-coming-and-more-is-likely-to-follow 2024-08-14T03:00:01+10:00 https://pharmadispatch.com/news/the-future-price-impact-could-come-down-to-the-timing-and-order-of-the-listings 2024-08-14T03:00:01+10:00 https://pharmadispatch.com/news/moderna-welcomes-the-governments-national-science-statement 2024-08-14T03:00:01+10:00 https://pharmadispatch.com/news/csl-reports-strong-profit-growth-for-full-year-2024 2024-08-13T17:01:01+10:00 https://pharmadispatch.com/news/report-suggest-a-delay-in-accc-decision-on-sigma-cw-merger 2024-08-13T03:00:01+10:00 https://pharmadispatch.com/news/cell-therapy-company-chimeric-announces-collaboration-with-cell-therapies 2024-08-13T03:00:01+10:00 https://pharmadispatch.com/news/gsk-announces-new-leadership-for-australian-operation 2024-08-12T03:00:01+10:00 https://pharmadispatch.com/news/we-think-the-life-sciences-sector-should-be-central-to-our-national-growth 2024-08-12T03:00:01+10:00 https://pharmadispatch.com/news/our-mission-is-to-transform-the-lives-of-people-impacted-by-rare-diseases 2024-08-12T03:00:01+10:00 https://pharmadispatch.com/news/mixed-news-for-neuren-but-royalties-and-milestones-continue-growing 2024-08-11T13:29:01+10:00 https://pharmadispatch.com/news/the-industry-has-leverage-just-dont-be-tricked-into-giving-it-away-again 2024-08-11T11:34:01+10:00 https://pharmadispatch.com/news/patients-in-england-gain-funded-access-to-gene-editing-therapy 2024-08-09T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-8-august 2024-08-08T17:13:01+10:00 https://pharmadispatch.com/news/researchers-develop-ground-breaking-immunotherapy-for-aggressive-brain-cancer 2024-08-08T17:00:01+10:00 https://pharmadispatch.com/news/some-groups-are-willing-to-resist-the-confidentiality-madness 2024-08-08T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-islands-progresses-trial-of-dengue-fever-candidate 2024-08-08T03:00:01+10:00 https://pharmadispatch.com/news/hta-review-report-could-be-released-ahead-of-the-governments-full-response 2024-08-08T03:00:01+10:00 https://pharmadispatch.com/news/people-are-living-longer-but-they-do-so-from-the-shadows-rarely-visible-and-barely-heard 2024-08-08T03:00:01+10:00 https://pharmadispatch.com/news/abbvie-joins-other-organisations-in-the-franklin-women-wikipedia-edit-a-thon 2024-08-07T03:00:01+10:00 https://pharmadispatch.com/news/amgen-australia-announces-partnerships-aimed-at-improving-aboriginal-and-torres-strait-islander- 2024-08-07T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-upgrades-melbourne-plant-making-it-one-of-the-most-advanced-facilities-in-australia 2024-08-07T03:00:01+10:00 https://pharmadispatch.com/news/csl-seqirus-and-st-john-ambulance-launch-potentially-life-saving-partnership 2024-08-06T03:38:01+10:00 https://pharmadispatch.com/news/ausbiotech-announces-the-appointment-of-deputy-chief-executive 2024-08-06T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-funding-additional-treatments-for-bowel-cancer 2024-08-05T16:22:01+10:00 https://pharmadispatch.com/news/the-process-does-not-cause-delays-it-promotes-them 2024-08-05T10:58:01+10:00 https://pharmadispatch.com/news/an-admission-on-the-process-that-should-lead-to-the-most-obvious-solution 2024-08-05T03:00:01+10:00 https://pharmadispatch.com/news/it-took-16-months-but-this-pricing-quirk-has-been-resolved 2024-08-05T03:00:01+10:00 https://pharmadispatch.com/news/psa-launches-its-updated-vision-documents-with-expanded-focus-areas 2024-08-05T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-2-august 2024-08-02T11:18:01+10:00 https://pharmadispatch.com/news/novo-nordisk-says-glp-1-now-available-on-private-prescription-for-weight-loss 2024-08-02T04:59:01+10:00 https://pharmadispatch.com/news/ipsen-and-patients-welcome-new-pbs-listing-for-thyroid-cancer 2024-08-02T03:00:01+10:00 https://pharmadispatch.com/news/pan-tumour-precision-medicine-funded-for-brain-lung-and-soft-tissue-cancers-with-genetic-fault 2024-08-02T03:00:01+10:00 https://pharmadispatch.com/news/the-governments-response-to-this-royal-commission-complicates-hta-reform 2024-08-02T03:00:01+10:00 https://pharmadispatch.com/news/peter-malinauskas-congratulates-bellberry-on-20-year-anniversary 2024-08-01T17:31:01+10:00 https://pharmadispatch.com/news/government-funds-first-immunotherapy-subcutaneous-injection-via-the-pbs 2024-08-01T03:05:01+10:00 https://pharmadispatch.com/news/companies-welcome-updated-pbs-prescribing-criteria-for-sglt-2-inhibitor-therapy 2024-08-01T03:00:01+10:00 https://pharmadispatch.com/news/first-immunotherapy-based-neoadjuvant-treatment-for-resectable-non-small-cell-lung-cancer-is-now 2024-08-01T03:00:01+10:00 https://pharmadispatch.com/news/breakthrough-pbs-listing-for-emergency-treatment-of-life-threatening-seizures 2024-08-01T03:00:01+10:00 https://pharmadispatch.com/news/november-pbac-to-consider-major-new-listings-and-significant-biosimilar 2024-08-01T03:00:01+10:00 https://pharmadispatch.com/news/pharmaceutical-manufacturer-tops-revenue-guidance-in-latest-update 2024-07-31T03:00:01+10:00 https://pharmadispatch.com/news/uncertain-timeline-on-hta-review-outcome-pbac-to-consider-report-in-coming-months 2024-07-30T10:35:01+10:00 https://pharmadispatch.com/news/race-oncology-says-phase-2-trial-of-bisantrene-meets-predetermined-efficacy-criteria 2024-07-30T09:25:01+10:00 https://pharmadispatch.com/news/nothing-but-sorrow-for-the-price-people-are-willing-to-pay-to-be-part-of-this-institution 2024-07-30T03:00:01+10:00 https://pharmadispatch.com/news/youll-never-guess-how-many-people-signed-hta-review-non-disclosure-agreements 2024-07-30T03:00:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-targets-nasdaq-listing-by-end-of-2024 2024-07-29T10:47:01+10:00 https://pharmadispatch.com/news/progress-towards-our-mission-of-providing-a-treatment-for-all-people-living-with-cf 2024-07-29T10:13:01+10:00 https://pharmadispatch.com/news/the-one-upside-is-the-opportunity-to-prepare-for-likely-response 2024-07-29T03:00:01+10:00 https://pharmadispatch.com/news/start-planning-for-a-change-that-would-further-entrench-decision-making-power 2024-07-29T03:00:01+10:00 https://pharmadispatch.com/news/monash-welcomes-funding-for-new-national-centre-for-mrna-medicines 2024-07-29T03:00:01+10:00 https://pharmadispatch.com/news/bms-says-it-is-increasingly-confident-of-managing-the-impact-of-us-price-negotiation 2024-07-29T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-26-july 2024-07-26T11:31:01+10:00 https://pharmadispatch.com/news/we-approached-stakeholders-that-were-highly-engaged-with-the-hta-review-process 2024-07-26T03:00:01+10:00 https://pharmadispatch.com/news/it-is-a-mistake-to-preach-transparency-but-not-practice-it 2024-07-26T03:00:01+10:00 https://pharmadispatch.com/news/cartherics-announces-new-licensing-agreement-for-innovative-cardiac-cell-therapy 2024-07-25T19:00:01+10:00 https://pharmadispatch.com/news/new-large-study-shows-vaccination-halves-the-risk-of-patients-suffering-long-covid 2024-07-25T03:00:01+10:00 https://pharmadispatch.com/news/these-layered-levels-of-privilege-are-not-making-decision-making-or-the-system-better 2024-07-25T03:00:01+10:00 https://pharmadispatch.com/news/telix-completes-significant-raise-that-could-be-used-for-acquistions 2024-07-25T03:00:01+10:00 https://pharmadispatch.com/news/centre-for-sex-and-gender-equity-in-health-and-medicine-confirms-leadership 2024-07-23T18:39:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-special-edition 2024-07-23T16:47:01+10:00 https://pharmadispatch.com/news/chimeric-therapeutics-says-first-patient-dosed-in-cell-therapy-trial 2024-07-23T05:25:01+10:00 https://pharmadispatch.com/news/we-were-promised-an-independent-review-and-this-is-what-we-got 2024-07-23T03:00:01+10:00 https://pharmadispatch.com/news/uk-moves-quickly-to-establish-rsv-vaccination-program-ahead-of-winter 2024-07-23T03:00:01+10:00 https://pharmadispatch.com/news/hcf-research-foundation-hosts-roundtable-to-advance-short-stay-joint-replacements 2024-07-22T19:08:01+10:00 https://pharmadispatch.com/news/viatris-sylvain-vigneault-on-the-importance-of-touch-points-with-the-community 2024-07-22T15:37:01+10:00 https://pharmadispatch.com/news/australian-icon-ita-buttrose-champions-new-rsv-awareness-campaign 2024-07-22T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-to-host-roundtable-aiming-to-drive-hta-reform 2024-07-22T03:00:01+10:00 https://pharmadispatch.com/news/it-is-the-institution-that-needs-reforming-not-the-process-of-technical-inputs 2024-07-21T09:45:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-19-july 2024-07-19T11:43:01+10:00 https://pharmadispatch.com/news/no-agreement-required-to-deliver-early-patient-access-to-neuroblastoma-treatment 2024-07-19T03:00:01+10:00 https://pharmadispatch.com/news/the-combination-of-political-will-and-trust-paving-the-way-forward-on-access 2024-07-19T03:00:01+10:00 https://pharmadispatch.com/news/pink-hope-ceo-discussed-her-own-experience-and-journey-with-trailblazers 2024-07-18T16:05:01+10:00 https://pharmadispatch.com/news/how-can-it-be-fair-that-patients-are-denied-access-to-proven-treatments-while-the-government-fun 2024-07-18T03:00:01+10:00 https://pharmadispatch.com/news/queensland-based-de-motu-cordis-progresses-development-inhaled-anaphylaxis-treatment 2024-07-18T03:00:01+10:00 https://pharmadispatch.com/news/burnet-senior-research-officer-awarded-moderna-global-fellowship-2023 2024-07-18T03:00:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-reports-positive-interim-data-from-multiple-system-atrophy-trial 2024-07-18T03:00:01+10:00 https://pharmadispatch.com/news/gilead-welcomes-car-t-outcome-and-anticipates-price-negotiation 2024-07-18T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-minister-david-seymour-sets-our-the-governments-reform-agenda 2024-07-17T03:00:01+10:00 https://pharmadispatch.com/news/moderna-welcomes-federal-governments-new-rna-blueprint 2024-07-17T03:00:01+10:00 https://pharmadispatch.com/news/recently-established-company-joins-the-generic-and-biosimilar-medicines-association 2024-07-16T10:18:01+10:00 https://pharmadispatch.com/news/it-is-worth-knowing-the-criteria-used-to-justify-the-creation-of-the-dfmo-bridging-fund 2024-07-16T03:00:01+10:00 https://pharmadispatch.com/news/bio-innovation-hub-opens-opportunities-for-new-disease-treatments 2024-07-16T03:00:01+10:00 https://pharmadispatch.com/news/diabetes-australia-wants-expanded-access-to-cgm-and-insulin-pumps 2024-07-15T10:02:01+10:00 https://pharmadispatch.com/news/merck-expands-its-fertility-benefit-to-employees-in-new-zealand 2024-07-15T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-third-funding-proposal-in-response-to-recent-post-budget-boost 2024-07-15T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-reports-positive-results-from-combination-trial-of-cancer-therapy 2024-07-14T13:10:01+10:00 https://pharmadispatch.com/news/a-strategic-acquisition-that-was-almost-six-years-in-the-making-says-icon-groups-david-slade 2024-07-14T10:57:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-12-july 2024-07-12T12:38:01+10:00 https://pharmadispatch.com/news/medicines-australia-says-recent-events-demonstrate-the-need-for-change 2024-07-12T05:07:01+10:00 https://pharmadispatch.com/news/gilead-welcomes-first-regional-car-t-treatment-centre-in-far-north-queensland 2024-07-12T03:00:01+10:00 https://pharmadispatch.com/news/orthocell-receives-regulatory-approval-to-commence-sales-of-striate-in-canada 2024-07-11T17:12:01+10:00 https://pharmadispatch.com/news/zelira-says-it-advances-hope-autism-drug-program-with-us-fda-meeting 2024-07-11T17:10:01+10:00 https://pharmadispatch.com/news/telix-welcomes-cms-proposal-to-improve-payment-for-specialised-diagnostic-radiopharmaceuticals 2024-07-11T17:09:01+10:00 https://pharmadispatch.com/news/clinician-concern-over-ongoing-shortages-of-end-of-life-medicines 2024-07-11T11:18:01+10:00 https://pharmadispatch.com/news/the-governments-good-conscience-should-extent-to-other-patients-waiting-for-access 2024-07-11T03:23:01+10:00 https://pharmadispatch.com/news/icon-group-expands-into-the-uk-with-acquisition-of-specialist-pharmaceutical-and-healthcare-comp 2024-07-11T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-investing-more-of-its-recent-funding-boost 2024-07-11T03:00:01+10:00 https://pharmadispatch.com/news/patients-and-families-welcomes-governments-funding-for-neuroblastoma-treatment 2024-07-11T03:00:01+10:00 https://pharmadispatch.com/news/the-new-medicines-manufacturing-innovation-centre-opens-at-monash 2024-07-10T18:32:01+10:00 https://pharmadispatch.com/news/the-simple-option-for-a-bridging-fund-that-can-fit-in-the-existing-legal-framework 2024-07-10T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-announces-the-appointment-of-its-new-board-chair 2024-07-10T03:00:01+10:00 https://pharmadispatch.com/news/the-one-upside-of-this-statement-that-should-trigger-the-industry-to-change-the-language 2024-07-10T03:00:01+10:00 https://pharmadispatch.com/news/if-this-does-signal-a-new-way-of-communicating-the-industry-does-have-tools-to-deploy 2024-07-09T03:00:01+10:00 https://pharmadispatch.com/news/british-industry-welcomes-new-government-and-its-innovation-and-adoption-strategy 2024-07-09T03:00:01+10:00 https://pharmadispatch.com/news/florey-biotech-spin-out-secures-seed-investment-from-curiebio 2024-07-08T19:24:01+10:00 https://pharmadispatch.com/news/committee-backs-jj-car-t-but-redirects-price-negotiation-with-four-year-proposal 2024-07-08T03:07:01+10:00 https://pharmadispatch.com/news/where-does-the-system-end-if-statements-like-this-become-a-feature-of-our-decision-making 2024-07-08T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-launches-first-consultation-for-medicines-after-funding-boost 2024-07-08T03:00:01+10:00 https://pharmadispatch.com/news/committee-recommends-major-overhaul-of-diabetes-management-and-access 2024-07-05T03:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-strong-growth-in-valuations-of-local-life-science-companies 2024-07-05T03:00:01+10:00 https://pharmadispatch.com/news/mercks-record-support-for-australian-ms-community 2024-07-05T03:00:01+10:00 https://pharmadispatch.com/news/csls-gene-therapy-becomes-the-first-funded-via-the-uks-innovative-medicines-fund 2024-07-05T02:00:01+10:00 https://pharmadispatch.com/news/new-zealand-pharmacies-to-administer-more-childhood-vaccinations 2024-07-04T03:50:01+10:00 https://pharmadispatch.com/news/patients-gather-in-canberra-to-call-for-access-ahead-of-next-weeks-pbac-meeting 2024-07-04T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-wants-changes-made-to-draft-immunisation-strategy 2024-07-03T03:16:01+10:00 https://pharmadispatch.com/news/flagship-biennial-report-reveals-the-wider-health-impact-of-the-covid-19-pandemic 2024-07-03T03:00:01+10:00 https://pharmadispatch.com/news/professional-standards-and-insurance-risks-key-to-pharmacy-concerns 2024-07-03T03:00:01+10:00 https://pharmadispatch.com/news/clinician-questions-pharmacs-decision-to-fund-old-cancer-medicines-over-newer-options 2024-07-03T03:00:01+10:00 https://pharmadispatch.com/news/pharma-companies-named-excellence-awardees-in-australian-hr-awards 2024-07-02T03:00:01+10:00 https://pharmadispatch.com/news/assistant-health-minister-steps-in-to-make-july-pbs-listings 2024-07-02T03:00:01+10:00 https://pharmadispatch.com/news/patients-welcome-ending-the-postcode-lottery-for-access-for-severely-immunocompromised-patients 2024-07-02T03:00:01+10:00 https://pharmadispatch.com/news/apparently-efficiencies-for-the-industry-mean-higher-cost-recovery-fees 2024-07-01T13:12:01+10:00 https://pharmadispatch.com/news/msd-regains-australian-rights-to-supply-and-distribute-its-pneumococcal-vaccine 2024-07-01T03:00:01+10:00 https://pharmadispatch.com/news/sanofis-meningococcal-vaccine-now-funded-for-adolescents 2024-07-01T03:00:01+10:00 https://pharmadispatch.com/news/first-ceo-for-the-sydney-based-viral-vector-manufacturing-facility 2024-07-01T03:00:01+10:00 https://pharmadispatch.com/news/health-products-portal-depreciation-drives-the-above-inflation-fee-increase 2024-07-01T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-28-june 2024-06-28T12:29:01+10:00 https://pharmadispatch.com/news/parliament-backs-changes-included-in-the-new-community-pharmacy-agreement 2024-06-28T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-reports-topline-results-from-clinical-trial-involving-msds-keytruda 2024-06-28T03:00:01+10:00 https://pharmadispatch.com/news/trailblazers-speakers-with-a-leader-about-their-current-public-campaign 2024-06-27T16:35:01+10:00 https://pharmadispatch.com/news/phrma-says-new-analysis-shows-how-new-pricing-power-will-raise-costs-for-millions 2024-06-27T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-groups-lament-parliamentary-support-for-more-accessible-vapes 2024-06-27T03:00:01+10:00 https://pharmadispatch.com/news/the-makers-will-be-delighted-these-products-will-be-more-accessible 2024-06-27T02:00:01+10:00 https://pharmadispatch.com/news/that-the-pbac-cannot-lawfully-condition-its-recommendations-is-a-statement-of-uncontested-fact 2024-06-26T03:00:01+10:00 https://pharmadispatch.com/news/no-time-to-waste-no-more-lives-to-lose-says-genomics-pioneer 2024-06-26T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-says-no-longer-any-need-to-accept-vaping-amendment 2024-06-25T18:51:01+10:00 https://pharmadispatch.com/news/the-department-has-no-intention-to-disclose-protected-information 2024-06-25T03:51:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-the-struggle-for-patients-living-with-eczema 2024-06-25T03:00:01+10:00 https://pharmadispatch.com/news/work-underway-after-nz-government-confirms-funding-commitment-for-new-medicines 2024-06-25T03:00:01+10:00 https://pharmadispatch.com/news/a-welcome-commitment-that-shows-the-challenge-of-catch-up-on-access 2024-06-25T03:00:01+10:00 https://pharmadispatch.com/news/senates-expectation-that-community-pharmacies-become-vape-retailers-and-vape-garbage-collectors- 2024-06-24T17:43:01+10:00 https://pharmadispatch.com/news/imugene-doses-the-first-patient-in-pioneering-phase-1-oncarlytics-trial 2024-06-24T13:17:01+10:00 https://pharmadispatch.com/news/abbvie-announces-new-leadership-for-its-new-zealand-business 2024-06-24T03:00:01+10:00 https://pharmadispatch.com/news/report-suggests-significant-funding-boost-for-pharmac 2024-06-24T03:00:01+10:00 https://pharmadispatch.com/news/joint-submission-recommends-adjustments-to-minimum-stockholding-requirement 2024-06-24T03:00:01+10:00 https://pharmadispatch.com/news/a-legally-questionable-outcome-but-one-that-reveals-the-truth-of-this-process 2024-06-23T11:16:01+10:00 https://pharmadispatch.com/news/oncology-leadership-transitions-for-msd-australia-and-zealand 2024-06-23T10:38:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-21-june 2024-06-21T12:31:01+10:00 https://pharmadispatch.com/news/msd-managing-director-departing-to-leading-the-companys-japan-oncology-business 2024-06-21T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-was-excluded-because-it-was-the-only-way-to-make-a-credible-commitment 2024-06-20T12:46:01+10:00 https://pharmadispatch.com/news/mixed-messaging-drives-confusion-over-cancer-medicines-commitment 2024-06-20T12:30:01+10:00 https://pharmadispatch.com/news/cancer-funding-commitment-did-not-make-it-through-the-budget-processs 2024-06-20T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-urges-caution-on-interpreting-medicine-shortages 2024-06-19T12:44:01+10:00 https://pharmadispatch.com/news/biotron-says-bit225-011-meets-objectives-in-phase-2-hiv-efficacy-trial 2024-06-19T10:22:01+10:00 https://pharmadispatch.com/news/the-pharmacy-guild-is-unique-but-the-past-year-provides-valuable-lessons-for-all-wanting-change 2024-06-19T03:00:01+10:00 https://pharmadispatch.com/news/families-welcome-nsw-budget-investment-to-help-children-with-juvenile-arthritis 2024-06-19T03:00:01+10:00 https://pharmadispatch.com/news/patients-in-new-zealand-welcome-wider-access-to-breast-cancer-therapies 2024-06-18T16:07:01+10:00 https://pharmadispatch.com/news/mark-butler-launches-new-australian-company-targeting-hard-to-treat-cancers 2024-06-18T15:17:01+10:00 https://pharmadispatch.com/news/the-report-likely-to-deliver-enduring-change-will-be-tabled-in-october 2024-06-18T04:49:01+10:00 https://pharmadispatch.com/news/the-pharmacy-guild-has-negotiated-an-incredible-agreement 2024-06-17T18:26:01+10:00 https://pharmadispatch.com/news/access-the-focus-as-uk-based-industry-welcomes-pre-election-manifestos 2024-06-17T14:07:01+10:00 https://pharmadispatch.com/news/lundbeck-scores-again-and-achieves-certification-as-a-great-place-to-work 2024-06-17T05:01:01+10:00 https://pharmadispatch.com/news/it-might-sounds-like-a-lot-but-are-we-these-office-holders-paid-enough 2024-06-17T03:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-the-economic-contribution-of-clinical-trials 2024-06-16T10:10:01+10:00 https://pharmadispatch.com/news/tga-extends-the-use-of-bayer-contraceptive-to-eight-years 2024-06-16T09:52:01+10:00 https://pharmadispatch.com/news/research-australia-challenges-draft-immunisation-strategy-over-major-omissions 2024-06-14T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-13-june 2024-06-13T17:08:01+10:00 https://pharmadispatch.com/news/competition-regulator-outlines-preliminary-competition-concerns-on-cw-sigma-merger 2024-06-13T12:35:01+10:00 https://pharmadispatch.com/news/department-organon-managing-director-moving-to-astellas-australia 2024-06-12T16:47:01+10:00 https://pharmadispatch.com/news/opthea-taps-investors-to-raise-almost-230-million-to-fund-late-stage-trials 2024-06-12T10:33:01+10:00 https://pharmadispatch.com/news/cartherics-secures-an-australian-patent-for-its-cancer-cell-therapy 2024-06-12T10:01:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-health-technology-assessment-i-agree-with-mark-butler 2024-06-12T03:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-makes-senior-public-affairs-and-communications-appointments 2024-06-12T03:00:01+10:00 https://pharmadispatch.com/news/moderna-announces-positive-phase-3-data-for-combination-vaccine-against-influenza-and-covid-19 2024-06-11T10:42:01+10:00 https://pharmadispatch.com/news/a-potential-healthcare-revolution-growing-outside-the-institutional-funding-framework 2024-06-11T03:00:01+10:00 https://pharmadispatch.com/news/former-tga-head-recognised-in-the-2024-kings-birthday-honours 2024-06-11T03:00:01+10:00 https://pharmadispatch.com/news/leadership-transition-coming-for-organon-australia-and-nz 2024-06-10T18:07:01+10:00 https://pharmadispatch.com/news/we-want-to-make-a-fundamental-shift-in-the-health-system-for-people-living-with-cancer 2024-06-10T10:59:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-7-june 2024-06-07T13:20:01+10:00 https://pharmadispatch.com/news/icon-group-and-5d-clinics-enter-a-joint-venture-to-expand-access-to-cancer-cyberknife 2024-06-07T03:00:01+10:00 https://pharmadispatch.com/news/jj-appoints-new-anz-managing-director-as-part-of-global-talent-development-plan 2024-06-06T16:09:01+10:00 https://pharmadispatch.com/news/hta-review-report-was-professionally-edited-before-it-was-presented-to-mark-butler 2024-06-06T15:33:01+10:00 https://pharmadispatch.com/news/officials-confirm-the-sluggish-uptake-of-higher-dispensed-quantities 2024-06-06T10:32:01+10:00 https://pharmadispatch.com/news/genomic-profiling-prospect-achieves-a-significant-patient-milestone 2024-06-06T03:00:01+10:00 https://pharmadispatch.com/news/new-national-strategy-demotes-international-and-region-as-a-priority 2024-06-06T03:00:01+10:00 https://pharmadispatch.com/news/senior-health-officials-defend-vaccine-funding-process-in-response-to-state-action 2024-06-06T03:00:01+10:00 https://pharmadispatch.com/news/secretary-says-its-not-unusual-for-a-deputy-secretary-to-accept-a-demotion 2024-06-05T16:45:01+10:00 https://pharmadispatch.com/news/cyclopharms-technegas-receives-pass-through-status-from-us-agency 2024-06-05T13:16:01+10:00 https://pharmadispatch.com/news/chimeric-announces-progress-in-phase-1b-blood-cancer-cell-therapy-trial 2024-06-05T09:54:01+10:00 https://pharmadispatch.com/news/new-zealands-government-scrambles-to-manage-patient-anger 2024-06-05T03:00:01+10:00 https://pharmadispatch.com/news/brandon-capital-launches-sixth-life-sciences-investment-fund-with-strong-investor-support 2024-06-05T03:00:01+10:00 https://pharmadispatch.com/news/this-is-exactly-why-we-all-need-to-be-looking-to-nz-and-learning 2024-06-05T03:00:01+10:00 https://pharmadispatch.com/news/new-australian-product-partnership-between-sandoz-and-mayne-pharma 2024-06-04T18:21:01+10:00 https://pharmadispatch.com/news/would-have-been-so-much-easier-if-this-had-been-done-12-months-ago 2024-06-04T03:00:01+10:00 https://pharmadispatch.com/news/recognition-for-nz-advocate-as-campaign-demands-cancer-medicines-funding 2024-06-04T03:00:01+10:00 https://pharmadispatch.com/news/not-the-end-but-the-first-act-in-a-sequencethat-will-have-a-broader-impact 2024-06-03T11:36:01+10:00 https://pharmadispatch.com/news/albanese-government-and-pharmacy-guild-sign-new-five-year-agreement 2024-06-03T11:20:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-says-new-data-leads-to-isla-101-phase-2-study-changes 2024-06-03T11:10:01+10:00 https://pharmadispatch.com/news/immutep-announces-major-capital-raise-and-late-stage-collaboration-with-msd 2024-06-03T10:16:01+10:00 https://pharmadispatch.com/news/fda-approves-avita-medicals-recell-go-system 2024-06-03T10:07:01+10:00 https://pharmadispatch.com/news/medicines-new-zealand-says-budget-delivers-broken-hearts-and-a-third-world-position 2024-06-03T03:00:01+10:00 https://pharmadispatch.com/news/vertex-welcomes-wider-pbs-listing-for-cystic-fibrosis-therapy-kalydeco 2024-06-02T12:04:01+10:00 https://pharmadispatch.com/news/patients-secure-an-additional-two-weeks-but-still-question-the-process 2024-06-02T11:38:01+10:00 https://pharmadispatch.com/news/states-immunising-infants-against-rsv-reporting-lower-hospitalisations 2024-06-02T10:29:01+10:00 https://pharmadispatch.com/news/csl-seqirus-announces-us-government-award-in-response-to-avian-influenza 2024-06-02T10:21:01+10:00 https://pharmadispatch.com/news/the-week-in-review-31-may 2024-05-31T12:44:01+10:00 https://pharmadispatch.com/news/the-94-words-that-created-a-national-institution-and-helped-buil 2024-05-31T01:00:01+10:00 https://pharmadispatch.com/news/we-regret-that-it-hasnt-been-possible-in-this-budget 2024-05-31T01:00:01+10:00 https://pharmadispatch.com/news/the-government-developed-this-critical-public-health-strategy-by 2024-05-31T01:00:01+10:00 https://pharmadispatch.com/news/one-year-on-and-people-are-still-dying-waiting-for-funded-access 2024-05-30T03:00:01+10:00 https://pharmadispatch.com/news/once-again-how-many-times-will-this-happen-before-someone-takes- 2024-05-30T03:00:01+10:00 https://pharmadispatch.com/news/study-reveals-decline-in-long-term-prescription-opioid-use-after 2024-05-30T03:00:01+10:00 https://pharmadispatch.com/news/no-responses-on-two-week-consultation-process-as-opposition-call 2024-05-29T17:06:01+10:00 https://pharmadispatch.com/news/percheron-therapeutics-completes-recruitment-in-phase-2b-study-o 2024-05-29T14:09:01+10:00 https://pharmadispatch.com/news/australian-company-noxopharm-joins-global-alliance-for-mrna-medi 2024-05-29T09:30:01+10:00 https://pharmadispatch.com/news/stakeholders-given-two-weeks-to-respond-to-draft-immunisation-st 2024-05-29T04:37:01+10:00 https://pharmadispatch.com/news/is-the-leadership-driving-reform-and-is-the-industry-ready-for-a 2024-05-29T03:00:01+10:00 https://pharmadispatch.com/news/positive-late-stage-trial-result-for-az-daiichi-sankyo-antibody- 2024-05-29T03:00:01+10:00 https://pharmadispatch.com/news/diabetes-medicine-found-to-reduce-risk-of-kidney-disease-and-dea 2024-05-28T17:25:01+10:00 https://pharmadispatch.com/news/you-can-almost-say-theres-reform-with-a-small-r-and-theres-refor 2024-05-28T03:00:01+10:00 https://pharmadispatch.com/news/biosimilar-sector-leaders-call-for-comprehensive-reform-to-promo 2024-05-28T03:00:01+10:00 https://pharmadispatch.com/news/neuren-says-trial-shows-significant-improvements-in-pitt-hopkins 2024-05-27T13:59:01+10:00 https://pharmadispatch.com/news/dimerix-announces-middle-east-license-agreement-for-dmx-200 2024-05-27T09:14:01+10:00 https://pharmadispatch.com/news/organon-promotes-australia-and-nz-founders-to-asia-pacific-roles 2024-05-27T03:00:01+10:00 https://pharmadispatch.com/news/when-youre-looking-at-the-choices-you-have-to-make-what-choice-d 2024-05-27T02:00:01+10:00 https://pharmadispatch.com/news/baxter-launches-second-reconciliation-action-plan-to-mark-nation 2024-05-26T13:21:01+10:00 https://pharmadispatch.com/news/trailblazers-talks-with-medicines-australia-ceo-liz-de-somer 2024-05-26T13:07:01+10:00 https://pharmadispatch.com/news/adherium-will-provide-its-hailie-smartinhaler-for-an-astrazeneca 2024-05-26T10:47:01+10:00 https://pharmadispatch.com/news/racgp-urges-rsv-immunisation-rollout-in-victoria-as-reported-cas 2024-05-26T10:32:01+10:00 https://pharmadispatch.com/news/stem-cell-medicine-advancements-to-be-showcased-at-renews-scient 2024-05-26T10:26:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-24-may 2024-05-24T12:29:01+10:00 https://pharmadispatch.com/news/there-will-be-increasingly-divergent-outcomes-until-we-stop-this 2024-05-24T03:03:01+10:00 https://pharmadispatch.com/news/an-attack-on-any-element-of-that-supply-chain-is-an-attack-on-al 2024-05-24T03:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-says-australias-clinical-trials-sector-more-valuable 2024-05-24T03:00:01+10:00 https://pharmadispatch.com/news/australian-cell-therapy-company-launches-mid-stage-clinical-tria 2024-05-23T05:04:01+10:00 https://pharmadispatch.com/news/mark-butler-moves-to-ban-unapproved-compounded-weight-loss-medic 2024-05-23T03:00:01+10:00 https://pharmadispatch.com/news/we-have-an-ambitious-reform-agenda-and-are-preparing-for-every-s 2024-05-22T16:17:01+10:00 https://pharmadispatch.com/news/astrazeneca-announces-ambition-to-launch-20-new-drugs-and-almost 2024-05-22T04:46:01+10:00 https://pharmadispatch.com/news/australian-clinical-trials-celebrated-on-international-clinical- 2024-05-22T04:34:01+10:00 https://pharmadispatch.com/news/blood-cancer-taskforce-unveils-new-optimal-care-pathways-for-blo 2024-05-22T04:27:01+10:00 https://pharmadispatch.com/news/emerging-australian-biotech-appoints-former-health-minister-to-i 2024-05-21T05:18:01+10:00 https://pharmadispatch.com/news/naccho-announces-recipients-of-sanofi-supported-pharmacy-scholar 2024-05-21T05:10:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-welcomes-recommendations-of-senate-inquir 2024-05-21T05:00:01+10:00 https://pharmadispatch.com/news/just-to-be-clear-the-comment-was-completely-tongue-in-cheek 2024-05-20T06:00:01+10:00 https://pharmadispatch.com/news/can-we-just-have-an-honest-conversation-about-budget-and-reform- 2024-05-20T05:11:01+10:00 https://pharmadispatch.com/news/astrazeneca-welcomes-action-on-co-pays-but-calls-for-more-on-acc 2024-05-20T03:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-welcomes-action-on-co-pays-but-calls-for-more-on-acc 2024-05-20T03:00:01+10:00 https://pharmadispatch.com/news/health-department-makes-a-major-change-inside-critical-divison 2024-05-17T03:00:01+10:00 https://pharmadispatch.com/news/baxter-launches-the-mission-and-logo-of-new-kidney-care-company 2024-05-16T19:45:01+10:00 https://pharmadispatch.com/news/nz-prime-minister-says-we-are-recognising-that-we-have-a-problem 2024-05-16T05:14:01+10:00 https://pharmadispatch.com/news/generic-and-biosimilar-sector-welcomes-the-governments-cost-of-l 2024-05-16T03:00:01+10:00 https://pharmadispatch.com/news/budget-provides-minimal-support-for-projects-to-build-aps-capabi 2024-05-16T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-establishes-place-in-history-by-ruling-out-new-pbs-s 2024-05-16T03:00:01+10:00 https://pharmadispatch.com/news/the-2024-25-budget-review 2024-05-15T03:41:01+10:00 https://pharmadispatch.com/news/the-budget-should-leave-people-in-no-doubt-that-more-announcemen 2024-05-15T03:00:01+10:00 https://pharmadispatch.com/news/stakeholder-response-to-the-albanese-governments-2024-25-budget 2024-05-15T03:00:01+10:00 https://pharmadispatch.com/news/budget-maintains-single-non-financial-performance-indicator-for- 2024-05-15T03:00:01+10:00 https://pharmadispatch.com/news/patients-secure-cost-of-living-win-with-all-indications-there-is 2024-05-14T19:25:01+10:00 https://pharmadispatch.com/news/tga-seeks-views-on-proposed-medical-device-reform-changes 2024-05-14T13:36:01+10:00 https://pharmadispatch.com/news/race-shares-the-resulsts-of-preclinical-studies-combining-bisant 2024-05-14T12:00:01+10:00 https://pharmadispatch.com/news/pre-budget-announcements-keep-coming-for-health-minister-mark-bu 2024-05-14T03:00:01+10:00 https://pharmadispatch.com/news/genesiscare-appoints-experienced-healthcare-executive-to-chair-i 2024-05-14T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-melbourne-based-cell-therapies-as-preferred-m 2024-05-14T03:00:01+10:00 https://pharmadispatch.com/news/some-of-the-signs-might-be-worrying-but-not-for-the-obvious-reas 2024-05-14T03:00:01+10:00 https://pharmadispatch.com/news/the-industrys-own-experience-reveals-the-importance-of-caution-i 2024-05-13T03:00:01+10:00 https://pharmadispatch.com/news/us-lawmakers-moving-to-ban-industry-partnerships-with-some-major 2024-05-13T03:00:01+10:00 https://pharmadispatch.com/news/budget-week-preview-podcast-12-may 2024-05-12T16:05:01+10:00 https://pharmadispatch.com/news/mark-butler-highlights-listing-of-medicines-for-serious-heart-co 2024-05-10T03:31:01+10:00 https://pharmadispatch.com/news/neuren-repors-growing-us-sales-of-australian-developed-product-f 2024-05-10T03:11:01+10:00 https://pharmadispatch.com/news/liz-selby-named-sanofis-new-acting-country-lead-and-head-of-phar 2024-05-10T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-highlights-listing-of-medicines-for-serious-heart-co 2024-05-10T03:00:01+10:00 https://pharmadispatch.com/news/novartis-monash-university-and-monash-health-partner-vision-for- 2024-05-09T03:00:01+10:00 https://pharmadispatch.com/news/new-research-paper-highlight-potential-but-current-failings-of-d 2024-05-08T18:33:01+10:00 https://pharmadispatch.com/news/parliamentary-inquiry-recommends-reforming-access-arrangements-f 2024-05-08T11:38:01+10:00 https://pharmadispatch.com/news/bristol-myers-squibb-announces-new-country-medical-director-for- 2024-05-08T11:22:01+10:00 https://pharmadispatch.com/news/island-announces-reallocation-of-us-grant-funding-to-support-new 2024-05-08T11:15:01+10:00 https://pharmadispatch.com/news/launch-of-new-queensland-based-research-and-manufacturing-hub-ta 2024-05-08T11:13:01+10:00 https://pharmadispatch.com/news/tga-approves-ucbs-pbac-recommended-interleukin-inhibitor 2024-05-08T03:00:01+10:00 https://pharmadispatch.com/news/home-affairs-minister-reveals-the-facts-on-the-independence-of-a 2024-05-08T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-policy-leader-appointed-to-lead-biomelbourne-network 2024-05-08T03:00:01+10:00 https://pharmadispatch.com/news/momentum-clinical-research-recruiting-for-australian-based-clini 2024-05-07T15:26:01+10:00 https://pharmadispatch.com/news/tga-seeks-nominations-for-statutory-advisory-committees 2024-05-07T15:01:01+10:00 https://pharmadispatch.com/news/no-timeline-from-the-minister-on-hta-review-report-and-response 2024-05-07T03:00:01+10:00 https://pharmadispatch.com/news/the-pbac-chair-appointment-took-effect-when-it-did-because-it-ha 2024-05-07T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-groups-call-for-extension-of-the-new-commonwealth-prac- 2024-05-07T03:00:01+10:00 https://pharmadispatch.com/news/amgen-and-arrotex-announce-new-osteoporosis-focused-partnership 2024-05-07T03:00:01+10:00 https://pharmadispatch.com/news/the-truth-is-more-that-they-are-the-heroes-of-every-walk-of-life 2024-05-06T03:00:01+10:00 https://pharmadispatch.com/news/hta-reviews-final-report-now-sits-with-health-minister-mark-butl 2024-05-06T03:00:01+10:00 https://pharmadispatch.com/news/the-secrecy-of-the-process-was-wrong-but-the-report-is-now-the-m 2024-05-06T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-3-may 2024-05-03T12:16:01+10:00 https://pharmadispatch.com/news/new-data-shows-significant-increase-in-the-number-of-pharmacies- 2024-05-03T03:00:01+10:00 https://pharmadispatch.com/news/csl-seqirus-secures-local-rights-to-new-adrenaline-nasal-spray 2024-05-03T03:00:01+10:00 https://pharmadispatch.com/news/industry-applauds-funding-commitment-for-national-one-stop-shop- 2024-05-03T03:00:01+10:00 https://pharmadispatch.com/news/please-do-not-redefine-government-supported-access-as-including- 2024-05-03T03:00:01+10:00 https://pharmadispatch.com/news/another-reform-process-fails-how-many-times-does-this-need-to-ha 2024-05-02T03:00:01+10:00 https://pharmadispatch.com/news/new-coalition-established-to-advocate-for-action-on-radiation-th 2024-05-02T03:00:01+10:00 https://pharmadispatch.com/news/illumina-partners-with-the-garvan-on-major-new-genome-project 2024-05-02T03:00:01+10:00 https://pharmadispatch.com/news/the-term-independent-is-used-to-absolve-decision-makers-of-respo 2024-05-01T03:00:01+10:00 https://pharmadispatch.com/news/the-journey-for-people-living-with-severe-psoriasis-can-be-long- 2024-05-01T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-pbs-listing-of-therapy-for-rare-heart-condition 2024-05-01T03:00:01+10:00 https://pharmadispatch.com/news/first-in-class-targeted-therapy-for-obstructive-hypertrophic-car 2024-05-01T03:00:01+10:00 https://pharmadispatch.com/news/summits-day-one-provided-critical-lessons-for-both-sides-of-the- 2024-04-30T03:00:01+10:00 https://pharmadispatch.com/news/important-for-me-to-share-the-full-picture-as-we-must-never-allo 2024-04-30T03:00:01+10:00 https://pharmadispatch.com/news/nz-government-commits-new-funding-to-address-pharmacs-fiscal-cli 2024-04-29T16:19:01+10:00 https://pharmadispatch.com/news/nz-government-appoints-former-deputy-pm-new-chair-of-pharmac 2024-04-29T03:00:01+10:00 https://pharmadispatch.com/news/the-listing-will-benefit-thousands-of-australian-women-says-mark 2024-04-29T03:00:01+10:00 https://pharmadispatch.com/news/an-important-first-step-to-achieving-reimbursed-access-for-eligi 2024-04-28T16:11:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-26-april 2024-04-28T16:11:01+10:00 https://pharmadispatch.com/news/new-research-shows-adult-vaccination-programs-deliver-major-retu 2024-04-26T03:00:01+10:00 https://pharmadispatch.com/news/proproductivity-commission-research-provides-irrefutable-evidenc 2024-04-26T03:00:01+10:00 https://pharmadispatch.com/news/lets-make-decisions-based-on-credible-information-and-not-guessw 2024-04-24T10:37:01+10:00 https://pharmadispatch.com/news/tour-de-cure-backs-further-development-of-noxopharms-preclinical 2024-04-24T05:22:01+10:00 https://pharmadispatch.com/news/novartis-nominates-ex-bms-chief-executive-as-its-new-chair 2024-04-24T05:04:01+10:00 https://pharmadispatch.com/news/but-for-medicines-we-spend-a-lot-less-than-other-countries-and-s 2024-04-24T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-appoints-experienced-sanofi-leader-as-its-new-chief-e 2024-04-23T13:55:01+10:00 https://pharmadispatch.com/news/should-principles-such-as-equity-and-opportunity-cost-be-applied 2024-04-23T03:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-welcomes-new-appointments-to-its-board 2024-04-23T03:00:01+10:00 https://pharmadispatch.com/news/bms-and-australian-venture-capital-firm-back-immunotherapy-compa 2024-04-23T03:00:01+10:00 https://pharmadispatch.com/news/nz-patients-campaigning-against-pharmacs-decision-to-force-a-swi 2024-04-23T03:00:01+10:00 https://pharmadispatch.com/news/tour-de-cure-backs-further-development-of-noxopharms-preclinical 2024-04-22T13:38:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-nhmrc-funding-for-six-telehealth-research- 2024-04-22T12:27:01+10:00 https://pharmadispatch.com/news/dont-be-alarmed-by-a-flat-or-declining-forecast-because-it-will- 2024-04-22T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-groups-welcome-expansion-of-flu-vaccine-program 2024-04-22T03:00:01+10:00 https://pharmadispatch.com/news/community-organisations-receive-grants-via-global-gileads-all4li 2024-04-22T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-19-april 2024-04-19T12:04:01+10:00 https://pharmadispatch.com/news/new-novartis-backed-report-identifies-nuclear-medicine-opportuni 2024-04-19T03:00:01+10:00 https://pharmadispatch.com/news/scope-of-practice-review-recommends-formation-of-new-committee 2024-04-19T03:00:01+10:00 https://pharmadispatch.com/news/the-hta-review-reference-committee-should-ask-themselves-one-que 2024-04-18T11:08:01+10:00 https://pharmadispatch.com/news/if-coercion-and-retribution-are-bad-for-supermarket-customers-th 2024-04-18T03:00:01+10:00 https://pharmadispatch.com/news/abbvie-announces-the-appointment-of-new-australia-nz-human-resou 2024-04-18T03:00:01+10:00 https://pharmadispatch.com/news/under-karens-leadership-our-local-business-has-thrived-both-comm 2024-04-18T03:00:01+10:00 https://pharmadispatch.com/news/retail-leaders-surprise-at-the-size-of-revenue-revealed-by-chemi 2024-04-17T03:00:01+10:00 https://pharmadispatch.com/news/longstanding-health-sector-leader-and-advocate-steps-down-after- 2024-04-17T03:00:01+10:00 https://pharmadispatch.com/news/as-we-celebrate-our-60th-anniversary-in-australia-i-am-extremely 2024-04-17T03:00:01+10:00 https://pharmadispatch.com/news/ex-ausbiotech-appointed-to-lead-peak-body-for-manufacturing-tech 2024-04-16T03:00:01+10:00 https://pharmadispatch.com/news/plan-recommends-greater-transparency-and-accountability-of-healt 2024-04-16T03:00:01+10:00 https://pharmadispatch.com/news/hta-review-extended-by-three-weeks-following-reference-committee 2024-04-16T03:00:01+10:00 https://pharmadispatch.com/news/gilead-celebrates-25-years-in-australia-and-nz-with-official-off 2024-04-16T03:00:01+10:00 https://pharmadispatch.com/news/seaport-therapeutics-receives-100-million-in-funding-to-maximise 2024-04-15T12:39:01+10:00 https://pharmadispatch.com/news/who-more-than-these-children-deserve-direct-action-from-their-he 2024-04-15T03:00:01+10:00 https://pharmadispatch.com/news/david-seymour-confirms-that-pseudoephedrine-will-ne-back-on-phar 2024-04-15T03:00:01+10:00 https://pharmadispatch.com/news/gsk-agrees-bundle-with-pharmac-that-funds-and-expanded-access-to 2024-04-15T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-12-april 2024-04-12T11:22:01+10:00 https://pharmadispatch.com/news/european-parliament-backs-trade-off-change-in-clinical-data-prot 2024-04-12T03:00:01+10:00 https://pharmadispatch.com/news/three-quarters-at-higher-risk-of-serious-illness-from-covid-19-d 2024-04-12T03:00:01+10:00 https://pharmadispatch.com/news/companies-were-given-just-three-months-to-implement-major-system 2024-04-12T03:00:01+10:00 https://pharmadispatch.com/news/budeven-if-the-budget-does-not-include-specific-measures-it-does 2024-04-11T03:00:01+10:00 https://pharmadispatch.com/news/association-dared-to-say-what-everyone-else-was-thinking-and-reg 2024-04-11T03:00:01+10:00 https://pharmadispatch.com/news/nz-migraine-advocates-say-not-enough-effective-safe-treatments-a 2024-04-11T03:00:01+10:00 https://pharmadispatch.com/news/monash-partners-comprehensive-cancer-consortium-awards-precision 2024-04-10T12:02:01+10:00 https://pharmadispatch.com/news/of-all-the-processes-currently-underway-this-is-the-one-most-lik 2024-04-10T03:00:01+10:00 https://pharmadispatch.com/news/patients-pushing-for-positive-outcome-on-msds-therapy-for-rare-d 2024-04-10T03:00:01+10:00 https://pharmadispatch.com/news/medical-software-companies-deliver-a-scathing-assessment-of-pbs- 2024-04-10T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-says-179-listings-with-additional-funding-in-22-mont 2024-04-09T03:00:01+10:00 https://pharmadispatch.com/news/diabetes-drug-improves-cardiovascular-outcomes-across-a-range-of 2024-04-08T12:30:01+10:00 https://pharmadispatch.com/news/chimeric-secures-us-patent-for-its-chm-0201-cell-therapy-platfor 2024-04-08T11:26:01+10:00 https://pharmadispatch.com/news/australian-company-starpharma-partners-with-uk-investment-firm-t 2024-04-08T10:48:01+10:00 https://pharmadispatch.com/news/submission-highlights-the-success-of-first-population-level-vacc 2024-04-08T03:00:01+10:00 https://pharmadispatch.com/news/why-not-use-the-existing-rhta-process-thats-consistent-with-exis 2024-04-08T03:00:01+10:00 https://pharmadispatch.com/news/regulator-seizes-unapproved-compounded-semaglutide-in-sydney-rai 2024-04-08T03:00:01+10:00 https://pharmadispatch.com/news/biotron-provides-update-on-preliminary-analyses-of-data-from-bit 2024-04-05T10:58:01+11:00 https://pharmadispatch.com/news/astellas-pharma-welcomes-approval-of-first-of-its-kind-non-hormo 2024-04-05T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-5-april 2024-04-05T03:00:01+11:00 https://pharmadispatch.com/news/nz-health-minister-launches-national-flu-vaccine-campaign 2024-04-04T11:20:01+11:00 https://pharmadispatch.com/news/it-is-not-an-act-of-the-person-who-delegated-the-power-to-the-de 2024-04-04T03:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-some-much-anticipated-therapies-at-its-july-mee 2024-04-04T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-launches-review-of-its-code-of-conduct 2024-04-04T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-welcomes-new-lung-cancer-listin-for-immune-checkpoint-inh 2024-04-04T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-invites-submissions-on-sessions-and-speakers-for-nati 2024-04-03T10:33:01+11:00 https://pharmadispatch.com/news/investors-welcome-mesoblast-update-and-pathway-for-resubmission- 2024-04-03T09:54:01+11:00 https://pharmadispatch.com/news/firebrick-pharma-says-nasodine-phase-2-covid-19-trial-results-pu 2024-04-03T09:52:01+11:00 https://pharmadispatch.com/news/cartherics-enters-new-collaborative-research-agreement-with-tica 2024-04-03T09:47:01+11:00 https://pharmadispatch.com/news/if-they-choose-to-ignore-the-minister-what-chance-does-anyone-el 2024-04-03T03:00:01+11:00 https://pharmadispatch.com/news/fees-to-rise-as-new-impact-statement-confirms-review-and-updated 2024-04-03T03:00:01+11:00 https://pharmadispatch.com/news/at-risk-australians-now-have-access-to-a-funded-cell-based-flu-v 2024-04-03T03:00:01+11:00 https://pharmadispatch.com/news/research-grant-to-advance-locally-developed-potential-ovarian-ca 2024-04-03T03:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-the-listing-of-first-in-class-cholesterol-lowe 2024-04-02T05:22:01+11:00 https://pharmadispatch.com/news/bi-lilly-alliance-mark-kidney-disease-pbs-listing-for-sglt-2-inh 2024-04-02T03:00:01+11:00 https://pharmadispatch.com/news/patients-are-still-dying-waiting-for-access-almost-one-year-on-f 2024-04-02T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-proposes-funding-cgm-as-companies-wait-for-australian-te 2024-04-02T03:00:01+11:00 https://pharmadispatch.com/news/gilead-announces-recipients-of-inaugural-260k-community-grants-p 2024-03-28T03:00:01+11:00 https://pharmadispatch.com/news/cancer-groups-call-for-a-new-approach-to-reviewing-and-funding-c 2024-03-28T03:00:01+11:00 https://pharmadispatch.com/news/auditor-general-extends-time-to-contribute-to-pbs-performance-au 2024-03-28T03:00:01+11:00 https://pharmadispatch.com/news/reform-bill-redefines-political-donation-and-could-exclude-the-i 2024-03-27T03:00:01+11:00 https://pharmadispatch.com/news/nz-government-delivers-funding-boost-for-patients-travelling-to- 2024-03-27T03:00:01+11:00 https://pharmadispatch.com/news/clarity-pharmaceuticals-launches-121-million-fully-underwritten- 2024-03-26T11:38:01+11:00 https://pharmadispatch.com/news/more-states-announces-rsv-programs-as-families-call-for-national 2024-03-26T03:00:01+11:00 https://pharmadispatch.com/news/new-study-reveals-impact-of-restrictions-imposed-on-pbs-listed-o 2024-03-26T03:00:01+11:00 https://pharmadispatch.com/news/painaustralia-ceo-goes-red-for-the-19-million-women-living-with- 2024-03-26T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-releases-2023-impact-report-revealing-progress-on-environ 2024-03-26T03:00:01+11:00 https://pharmadispatch.com/news/cochlear-announces-the-resignation-of-non-executive-director-yas 2024-03-25T16:21:01+11:00 https://pharmadispatch.com/news/orthocell-successfully-completes-all-nerve-repair-surgeries-in-r 2024-03-25T16:13:01+11:00 https://pharmadispatch.com/news/once-again-history-is-the-guide-in-that-these-appointments-are-r 2024-03-25T03:00:01+11:00 https://pharmadispatch.com/news/if-the-governemnt-expands-their-power-they-need-to-be-made-more- 2024-03-25T03:00:01+11:00 https://pharmadispatch.com/news/new-zealand-moves-closer-to-funding-cgm-as-australia-waits-for-t 2024-03-25T03:00:01+11:00 https://pharmadispatch.com/news/focus-on-making-high-quality-intellectual-cases-in-support-of-sp 2024-03-22T03:00:01+11:00 https://pharmadispatch.com/news/new-mind-the-treatment-gap-campaign-to-focus-attention-on-drug-r 2024-03-22T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-22-march 2024-03-21T15:15:01+11:00 https://pharmadispatch.com/news/chemist-warehouse-reveals-rapid-growth-in-sigma-full-year-result 2024-03-21T11:39:01+11:00 https://pharmadispatch.com/news/australian-patients-now-one-step-closer-to-accessing-csls-one-ti 2024-03-21T03:00:01+11:00 https://pharmadispatch.com/news/applications-open-for-modernas-2024-australia-fellowship-program 2024-03-21T03:00:01+11:00 https://pharmadispatch.com/news/gbma-announces-changes-to-its-board-at-a-pivotal-time-in-austral 2024-03-21T03:00:01+11:00 https://pharmadispatch.com/news/look-at-these-appointments-and-ideas-like-the-pieces-of-a-puzzle 2024-03-21T03:00:01+11:00 https://pharmadispatch.com/news/these-must-be-the-two-worst-appointments-imaginable-for-patients 2024-03-20T16:46:01+11:00 https://pharmadispatch.com/news/ltr-pharma-says-first-patient-first-dose-in-the-spontan-pivotal- 2024-03-20T15:09:01+11:00 https://pharmadispatch.com/news/rhythm-biosciences-establishes-internationally-renowned-clinical 2024-03-20T14:51:01+11:00 https://pharmadispatch.com/news/developing-and-proactovely-proposing-credible-alternatives-that- 2024-03-20T03:00:01+11:00 https://pharmadispatch.com/news/australian-study-finds-families-gain-the-most-with-treatment-of- 2024-03-20T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-roundtable-to-highlight-push-for-australian-interim- 2024-03-20T03:00:01+11:00 https://pharmadispatch.com/news/giulia-jones-ceo-hair-dye-for-the-19-million-australian-women-li 2024-03-20T03:00:01+11:00 https://pharmadispatch.com/news/minister-to-launch-first-major-program-targeting-early-diagnosis 2024-03-20T03:00:01+11:00 https://pharmadispatch.com/news/stakeholders-force-pharmac-backdown-on-move-to-scrap-childhood-c 2024-03-19T03:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-australia-announces-recipients-of-2023-positive- 2024-03-19T03:00:01+11:00 https://pharmadispatch.com/news/im-a-big-believer-that-we-as-public-servants-need-to-engage-hone 2024-03-19T03:00:01+11:00 https://pharmadispatch.com/news/a-misguided-response-that-is-disconnected-from-its-own-history-a 2024-03-18T03:00:01+11:00 https://pharmadispatch.com/news/where-are-the-stewards-to-maintain-and-protect-this-critical-pub 2024-03-18T03:00:01+11:00 https://pharmadispatch.com/news/the-fast-finishing-astrazeneca-secures-pharma-cup-for-2024-kosi- 2024-03-18T03:00:01+11:00 https://pharmadispatch.com/news/merck-expands-fertility-benefit-for-its-employees-in-australia 2024-03-15T03:00:01+11:00 https://pharmadispatch.com/news/psa-says-it-will-continue-to-advocate-for-an-expanded-scope-of-p 2024-03-15T03:00:01+11:00 https://pharmadispatch.com/news/what-do-people-think-the-minister-means-by-finalising-separate-a 2024-03-15T03:00:01+11:00 https://pharmadispatch.com/news/week-in-review-podcast-15-march 2024-03-14T18:15:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-secures-an-additional-3bn-in-new-agreement 2024-03-14T10:38:01+11:00 https://pharmadispatch.com/news/the-predictable-sequencing-of-this-process-is-gradually-being-re 2024-03-14T03:00:01+11:00 https://pharmadispatch.com/news/we-want-to-give-back-to-the-charity-that-gave-so-much-to-us-in-o 2024-03-14T03:00:01+11:00 https://pharmadispatch.com/news/new-zealand-to-fund-pharmacists-to-administer-childhood-vaccinat 2024-03-14T03:00:01+11:00 https://pharmadispatch.com/news/when-the-minister-delegates-decision-making-they-delegate-decisi 2024-03-13T03:00:01+11:00 https://pharmadispatch.com/news/competition-regulator-launches-a-review-of-chemist-warehouse-sig 2024-03-13T03:00:01+11:00 https://pharmadispatch.com/news/pharmacies-prepare-to-gather-in-queensland-for-the-annual-app-co 2024-03-13T03:00:01+11:00 https://pharmadispatch.com/news/former-roche-executive-appointed-to-lead-not-for-profit-omico 2024-03-13T03:00:01+11:00 https://pharmadispatch.com/news/dimerix-raises-20-million-to-continue-and-expand-late-stage-clin 2024-03-12T12:43:01+11:00 https://pharmadispatch.com/news/msd-maintains-pharma-cup-lead-with-companies-adding-75000-in-fou 2024-03-12T03:00:01+11:00 https://pharmadispatch.com/news/mesoblast-says-us-fda-feedback-indicates-support-for-accelerated 2024-03-11T15:45:01+11:00 https://pharmadispatch.com/news/imricor-says-paris-based-cv-institute-grants-ethics-approval-for 2024-03-11T15:34:01+11:00 https://pharmadispatch.com/news/dimerixs-dmx-200-successfully-passes-interim-analysis-in-action3 2024-03-11T11:37:01+11:00 https://pharmadispatch.com/news/industry-hits-back-at-president-biden-following-criticism-in-sta 2024-03-11T03:00:01+11:00 https://pharmadispatch.com/news/tga-tightens-interpretation-of-advertising-regulations-to-elimin 2024-03-11T03:00:01+11:00 https://pharmadispatch.com/news/the-process-looked-like-a-teddy-bear-but-a-closer-look-has-revea 2024-03-11T03:00:01+11:00 https://pharmadispatch.com/news/stakeholders-can-now-see-what-the-industry-really-thinks-about-h 2024-03-08T03:00:01+11:00 https://pharmadispatch.com/news/organons-nirelle-tolstoshev-says-its-a-day-to-demonstrate-intent 2024-03-08T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcasr-8-march 2024-03-08T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-to-host-annual-women-in-life- 2024-03-08T03:00:01+11:00 https://pharmadispatch.com/news/three-times-in-fives-years-industry-gave-up-prices-so-why-would- 2024-03-07T03:00:01+11:00 https://pharmadispatch.com/news/health-department-rejects-state-and-territory-requests-for-early 2024-03-07T03:00:01+11:00 https://pharmadispatch.com/news/msd-surges-to-the-lead-with-just-over-one-week-until-this-years- 2024-03-07T03:00:01+11:00 https://pharmadispatch.com/news/adalta-announces-positive-results-from-phase-1-extension-study-o 2024-03-06T13:14:01+11:00 https://pharmadispatch.com/news/nyrada-successfully-raises-1755-million-to-support-the-developme 2024-03-06T11:34:01+11:00 https://pharmadispatch.com/news/clarity-pharmaceuticals-says-sar-bispsma-detects-pc-lesions-in-t 2024-03-06T10:50:01+11:00 https://pharmadispatch.com/news/western-australia-acts-quickly-to-fund-access-to-sanofis-rsv-vac 2024-03-06T03:00:01+11:00 https://pharmadispatch.com/news/pre-budget-period-set-to-intensify-as-pharmacy-agreement-moves-o 2024-03-06T03:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-calls-for-rapid-funding-of-paediatric-bra 2024-03-06T03:00:01+11:00 https://pharmadispatch.com/news/nsw-government-lauds-the-impact-of-pharmacy-scope-of-practice-tr 2024-03-05T11:09:01+11:00 https://pharmadispatch.com/news/ama-says-uptake-of-60-day-prescriptions-was-never-going-to-happe 2024-03-05T03:00:01+11:00 https://pharmadispatch.com/news/research-based-industry-welcomes-decision-not-to-extend-covid-19 2024-03-05T03:00:01+11:00 https://pharmadispatch.com/news/no-confidentiality-undertakings-yet-but-the-minister-has-given-t 2024-03-05T03:00:01+11:00 https://pharmadispatch.com/news/emvision-medical-devices-secures-strategic-investment-from-us-ba 2024-03-04T14:33:01+11:00 https://pharmadispatch.com/news/data-management-company-enlitic-appoints-experienced-executive-t 2024-03-04T13:17:01+11:00 https://pharmadispatch.com/news/csl-confirms-the-sale-of-historic-parkville-site-after-more-than 2024-03-04T03:00:01+11:00 https://pharmadispatch.com/news/roche-welcomes-registration-of-the-first-subcutaneous-pd-l1-canc 2024-03-04T03:00:01+11:00 https://pharmadispatch.com/news/government-to-launch-new-awareness-campaign-in-response-to-low-6 2024-03-04T03:00:01+11:00 https://pharmadispatch.com/news/expanded-funding-of-spinraza-for-treatment-of-pre-symptomatic-sm 2024-03-04T03:00:01+11:00 https://pharmadispatch.com/news/immunisation-against-respiratory-illnesses-become-the-focus 2024-03-04T03:00:01+11:00 https://pharmadispatch.com/news/significant-change-is-coming-if-these-recent-appointments-are-an 2024-03-04T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-lauds-the-expanded-pbs-listing-of-astrazeneca-therap 2024-03-04T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-1-march 2024-03-01T10:57:01+11:00 https://pharmadispatch.com/news/agreements-that-started-with-limits-have-become-vehicles-for-gov 2024-03-01T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-says-it-cannot-support-new-basis-for-cost-recovery-fe 2024-03-01T03:00:01+11:00 https://pharmadispatch.com/news/todd-stephenson-joins-minister-david-seymour-in-first-visit-to-p 2024-03-01T03:00:01+11:00 https://pharmadispatch.com/news/fundraising-totals-build-with-just-two-weeks-until-this-years-ko 2024-03-01T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-minister-announces-new-parallel-assessment-for-medicines 2024-02-29T03:00:01+11:00 https://pharmadispatch.com/news/novartis-commissioned-report-calls-for-change-in-cvd-management 2024-02-29T03:00:01+11:00 https://pharmadispatch.com/news/ma-backtracks-and-delivers-a-scathing-response-to-hta-review-opt 2024-02-29T03:00:01+11:00 https://pharmadispatch.com/news/neuren-pharmaceuticals-reports-fourth-quarter-royalties-from-day 2024-02-28T11:28:01+11:00 https://pharmadispatch.com/news/nyrada-says-preclinical-brain-injury-study-shows-statistically-s 2024-02-28T10:02:01+11:00 https://pharmadispatch.com/news/health-department-launches-a-rapid-internal-review-of-national-i 2024-02-28T03:00:01+11:00 https://pharmadispatch.com/news/the-backdrop-of-reviews-and-process-clearly-suggests-that-someth 2024-02-28T03:00:01+11:00 https://pharmadispatch.com/news/new-arthritis-australia-report-reveals-the-future-impact-on-the- 2024-02-28T03:00:01+11:00 https://pharmadispatch.com/news/health-department-partners-with-google-cloud-to-consolidate-data 2024-02-28T03:00:01+11:00 https://pharmadispatch.com/news/a-nz-cancer-doctor-gives-their-view-of-why-reform-of-pharmac-mat 2024-02-27T03:00:01+11:00 https://pharmadispatch.com/news/novartis-asthma-therapy-dramatically-reduces-the-risk-of-allergi 2024-02-27T03:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-the-gap-between-men-and-women-living-with-pai 2024-02-27T03:00:01+11:00 https://pharmadispatch.com/news/investors-back-avita-medical-after-it-reported-full-year-results 2024-02-26T13:32:01+11:00 https://pharmadispatch.com/news/consultation-is-closed-the-industry-must-now-decide-what-side-of 2024-02-26T03:00:01+11:00 https://pharmadispatch.com/news/before-i-was-diagnosed-i-didnt-know-much-about-shingles-and-the- 2024-02-26T03:00:01+11:00 https://pharmadispatch.com/news/daiichi-sankyo-welcomes-more-senior-executives-to-australia 2024-02-26T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-23-february 2024-02-23T10:49:01+11:00 https://pharmadispatch.com/news/sanofi-launches-new-accessibility-action-plan-with-a-focus-on-re 2024-02-23T03:00:01+11:00 https://pharmadispatch.com/news/msac-doubles-down-and-defers-outcomes-despite-ministers-criticis 2024-02-23T03:00:01+11:00 https://pharmadispatch.com/news/gsk-topping-the-pharma-cup-leaderboard-with-three-weeks-to-go 2024-02-23T03:00:01+11:00 https://pharmadispatch.com/news/gedeon-richter-welcomes-tga-approval-of-endometriosis-treatment 2024-02-23T03:00:01+11:00 https://pharmadispatch.com/news/its-in-the-name-a-stakeholder-with-an-interest-has-a-stake-not-a 2024-02-22T03:00:01+11:00 https://pharmadispatch.com/news/tga-approves-new-indication-for-bi-lilly-alliance-sglt-2-inhibit 2024-02-22T03:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-says-ttra-program-delivering-at-its-halfway-mark 2024-02-22T03:00:01+11:00 https://pharmadispatch.com/news/previous-public-statements-about-hta-policies-and-outcomes-are-c 2024-02-21T03:00:01+11:00 https://pharmadispatch.com/news/new-zealand-moves-to-widen-access-to-popular-cold-and-flu-medici 2024-02-21T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-21-february 2024-02-20T17:25:01+11:00 https://pharmadispatch.com/news/not-the-first-time-the-pbac-has-been-given-more-power-to-streaml 2024-02-20T03:00:01+11:00 https://pharmadispatch.com/news/officials-were-planning-joint-negotiations-while-senate-consider 2024-02-20T03:00:01+11:00 https://pharmadispatch.com/news/csl-seqirus-welcomes-extended-approval-for-iron-treatment 2024-02-20T03:00:01+11:00 https://pharmadispatch.com/news/a-remarkable-coincidence-or-an-extraordinary-attempt-to-conceal- 2024-02-20T03:00:01+11:00 https://pharmadispatch.com/news/certa-therapeutics-ft011-granted-us-fda-fast-track-for-systemic- 2024-02-19T17:43:01+11:00 https://pharmadispatch.com/news/ltr-pharma-says-patient-recruitment-commences-for-pivotal-clinic 2024-02-19T13:58:01+11:00 https://pharmadispatch.com/news/if-this-is-the-real-view-then-the-onus-is-on-the-association-to- 2024-02-19T05:13:01+11:00 https://pharmadispatch.com/news/medicines-australia-moderates-celebratory-tone-in-new-member-bri 2024-02-19T05:00:01+11:00 https://pharmadispatch.com/news/the-reference-committee-agreed-the-content-of-the-options-paper- 2024-02-19T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-16-february 2024-02-16T11:07:01+11:00 https://pharmadispatch.com/news/officials-confirm-the-appointment-of-australias-chief-health-eco 2024-02-16T03:00:01+11:00 https://pharmadispatch.com/news/ongoing-debate-over-the-industrys-response-to-hta-review-options 2024-02-16T03:00:01+11:00 https://pharmadispatch.com/news/gsk-negotiates-deal-with-new-zealands-pharmac-for-four-medicines 2024-02-16T03:00:01+11:00 https://pharmadispatch.com/news/senior-officials-defend-appointment-of-former-tga-head-to-ma-boa 2024-02-15T13:18:01+11:00 https://pharmadispatch.com/news/patients-welcome-funding-but-challenge-pharmac-over-eligibility- 2024-02-15T05:21:01+11:00 https://pharmadispatch.com/news/conflicting-messages-and-compare-and-contrast-these-processes 2024-02-15T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-launches-new-blood-cancer-trial-of-lead-candi 2024-02-15T03:00:01+11:00 https://pharmadispatch.com/news/pcpa-invites-medical-oncologists-and-cancer-nurses-to-participat 2024-02-15T03:00:01+11:00 https://pharmadispatch.com/news/with-just-nine-days-to-go-people-need-all-the-available-informat 2024-02-14T05:18:01+11:00 https://pharmadispatch.com/news/can-we-all-just-agree-that-anything-like-pharmac-would-be-unacce 2024-02-14T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-silent-on-key-questions-as-early-enthusiasm- 2024-02-14T03:00:01+11:00 https://pharmadispatch.com/news/csl-reports-strong-first-half-growth-with-immunoglobulins-the-hi 2024-02-13T16:27:01+11:00 https://pharmadispatch.com/news/the-industry-race-is-on-as-hundreds-prepare-for-kosi-challenge 2024-02-13T03:00:01+11:00 https://pharmadispatch.com/news/options-paper-proposes-limits-on-process-for-the-most-important- 2024-02-13T03:00:01+11:00 https://pharmadispatch.com/news/disappointment-as-csls-leading-heart-candidate-misses-in-clinica 2024-02-13T03:00:01+11:00 https://pharmadispatch.com/news/bupa-ventures-to-invest-20m-to-accelerate-healthcare-innovations 2024-02-12T17:19:01+11:00 https://pharmadispatch.com/news/hundreds-of-people-access-national-pharmacies-store-in-first-wee 2024-02-12T17:09:01+11:00 https://pharmadispatch.com/news/cyclopharm-announces-the-appointment-of-new-chief-financial-offi 2024-02-12T17:00:01+11:00 https://pharmadispatch.com/news/focus-on-the-governments-proposals-because-theyre-most-likely-to 2024-02-12T03:00:01+11:00 https://pharmadispatch.com/news/franklin-women-and-organon-partner-to-launch-members-connect-ser 2024-02-12T03:00:01+11:00 https://pharmadispatch.com/news/research-australia-launches-abbvie-backed-mentorship-program 2024-02-12T03:00:01+11:00 https://pharmadispatch.com/news/sandoz-secures-australian-rights-to-two-biosimilar-brands 2024-02-12T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-9-february 2024-02-09T13:01:01+11:00 https://pharmadispatch.com/news/that-is-why-vaccines-matter-andare-one-of-the-most-critical-publ 2024-02-09T03:00:01+11:00 https://pharmadispatch.com/news/tga-extends-approval-for-vertexs-cystic-fibrosis-therapy-ahead-o 2024-02-08T16:35:01+11:00 https://pharmadispatch.com/news/abbvie-announces-the-appointment-of-new-nz-country-head 2024-02-08T16:22:01+11:00 https://pharmadispatch.com/news/the-proposed-centralisation-of-power-in-a-single-committee-needs 2024-02-08T03:00:01+11:00 https://pharmadispatch.com/news/report-recommends-mandatory-reporting-of-arrangements-with-no-ev 2024-02-08T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-signs-mou-with-indonesian-partner-to-progress 2024-02-08T03:00:01+11:00 https://pharmadispatch.com/news/medibank-offering-members-50-to-put-towards-dental-out-of-pocket 2024-02-07T19:07:01+11:00 https://pharmadispatch.com/news/us-fda-approves-edwards-evoque-system-for-major-heart-valve-dise 2024-02-07T16:11:01+11:00 https://pharmadispatch.com/news/private-health-insurers-say-price-gouging-doctors-should-be-name 2024-02-07T15:03:01+11:00 https://pharmadispatch.com/news/what-matters-now-is-avoiding-delusion-and-not-repeating-previous 2024-02-07T03:00:01+11:00 https://pharmadispatch.com/news/industry-calls-for-sustainable-funding-sought-for-clinical-trial 2024-02-07T03:00:01+11:00 https://pharmadispatch.com/news/government-invests-in-development-of-world-first-tissue-engineer 2024-02-07T03:00:01+11:00 https://pharmadispatch.com/news/turnaround-for-uk-labour-with-plan-to-reverse-the-industrys-decl 2024-02-06T03:00:01+11:00 https://pharmadispatch.com/news/a-broader-assessment-of-value-would-increase-the-cost-and-reduce 2024-02-06T03:00:01+11:00 https://pharmadispatch.com/news/psa-uses-its-pre-budget-submission-to-call-for-more-service-base 2024-02-05T12:28:01+11:00 https://pharmadispatch.com/news/mark-butler-these-listings-will-have-a-profound-impact-on-people 2024-02-05T12:11:01+11:00 https://pharmadispatch.com/news/radiopharm-updates-on-models-of-pan-cancer-antibody-dunp19 2024-02-05T11:42:01+11:00 https://pharmadispatch.com/news/fivephusion-says-deflexifol-clinical-data-at-asco-gastrointestin 2024-02-05T11:30:01+11:00 https://pharmadispatch.com/news/bioxyne-secures-australias-first-gmp-license-for-psilocybin-and- 2024-02-05T11:20:01+11:00 https://pharmadispatch.com/news/ideas-dont-appear-out-of-nowhere-and-companies-will-be-pressured 2024-02-05T04:00:01+11:00 https://pharmadispatch.com/news/companies-notified-of-planned-price-reductions-under-new-us-gove 2024-02-05T03:00:01+11:00 https://pharmadispatch.com/news/nzs-cancer-society-wants-new-condition-imposed-on-pharmac-decisi 2024-02-05T03:00:01+11:00 https://pharmadispatch.com/news/this-is-what-accelerated-access-actually-looks-like-when-a-minis 2024-02-05T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-2-february 2024-02-02T10:21:01+11:00 https://pharmadispatch.com/news/the-industry-will-need-to-construct-a-new-capability-to-manage-t 2024-02-02T03:00:01+11:00 https://pharmadispatch.com/news/stakeholder-concern-over-timing-of-chemotherapy-review-update 2024-02-02T03:00:01+11:00 https://pharmadispatch.com/news/thank-you-to-everyone-who-works-in-the-health-sector-and-the-pat 2024-02-02T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-ma-announce-cell-gene-catalyst-working-group-memb 2024-02-02T03:00:01+11:00 https://pharmadispatch.com/news/lilly-says-no-based-on-current-policy-the-new-proposals-would-ma 2024-02-01T03:00:01+11:00 https://pharmadispatch.com/news/if-it-is-necessary-for-me-to-formally-dissent-in-the-final-repor 2024-02-01T03:00:01+11:00 https://pharmadispatch.com/news/csl-seqirus-confirms-availability-of-cell-based-flu-vaccine-for- 2024-02-01T03:00:01+11:00 https://pharmadispatch.com/news/a-new-formulation-of-biogens-ms-therapy-eases-the-way-for-patien 2024-02-01T03:00:01+11:00 https://pharmadispatch.com/news/just-further-evidence-of-how-ideas-linger-waiting-for-the-right- 2024-01-31T03:00:01+11:00 https://pharmadispatch.com/news/commercial-eyes-joins-global-network-after-acquisition-by-produc 2024-01-31T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-minister-says-kiwis-need-access-like-its-a-first-world-c 2024-01-31T03:00:01+11:00 https://pharmadispatch.com/news/just-further-evidence-of-how-ideas-linger-waiting-for-the-right- 2024-01-31T03:00:01+11:00 https://pharmadispatch.com/news/this-is-not-a-messaging-campaign-and-it-needs-to-be-taken-seriou 2024-01-30T03:00:01+11:00 https://pharmadispatch.com/news/medicinal-cannabis-sales-skyrocket-to-165m-in-2023-a-60-surge-re 2024-01-30T03:00:01+11:00 https://pharmadispatch.com/news/shadow-minister-challenges-butler-over-vaccine-rollout 2024-01-30T03:00:01+11:00 https://pharmadispatch.com/news/hta-review-options-paper-proposes-feedback-loop-for-patients 2024-01-29T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-says-the-devil-is-in-the-detail-of-hta-revie 2024-01-29T03:00:01+11:00 https://pharmadispatch.com/news/committee-defers-an-outcome-on-immunotherapies-but-says-it-would 2024-01-29T03:00:01+11:00 https://pharmadispatch.com/news/a-radical-reworking-of-decision-making-in-the-governments-favour 2024-01-28T15:00:01+11:00 https://pharmadispatch.com/news/when-it-comes-to-the-options-paper-what-matters-is-the-detail-no 2024-01-25T03:00:01+11:00 https://pharmadispatch.com/news/novartis-venture-fund-backs-australian-companys-development-of-a 2024-01-25T03:00:01+11:00 https://pharmadispatch.com/news/scope-of-practice-review-issues-paper-suggests-the-reform-of-pay 2024-01-24T12:10:01+11:00 https://pharmadispatch.com/news/the-need-for-genuine-transparency-in-a-system-that-markets-outco 2024-01-24T03:00:01+11:00 https://pharmadispatch.com/news/actual-growth-could-around-one-quarter-of-the-top-line-number 2024-01-24T03:00:01+11:00 https://pharmadispatch.com/news/are-healthcare-professionals-wanting-a-return-to-in-person-medic 2024-01-24T03:00:01+11:00 https://pharmadispatch.com/news/in-such-an-important-year-it-is-worth-understanding-who-will-be- 2024-01-23T03:00:01+11:00 https://pharmadispatch.com/news/tga-revokes-permission-and-bans-advertising-of-nicotine-vaping-p 2024-01-23T03:00:01+11:00 https://pharmadispatch.com/news/still-time-for-stakeholders-to-submit-to-anaos-pbs-performance-a 2024-01-23T03:00:01+11:00 https://pharmadispatch.com/news/remember-when-the-government-spent-almost-20-years-compensating- 2024-01-22T03:00:01+11:00 https://pharmadispatch.com/news/the-other-reason-60-day-prescriptions-must-have-been-irresistibl 2024-01-22T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-to-progress-peanut-allergy-candidate-to-late- 2024-01-22T03:00:01+11:00 https://pharmadispatch.com/news/its-one-of-the-first-reimbursements-and-listings-anywhere-in-the 2024-01-22T03:00:01+11:00 https://pharmadispatch.com/news/gilead-partners-to-launch-grant-to-champion-health-solutions-for 2024-01-19T05:34:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-wins-recognition-as-top-employer-for-2024 2024-01-18T21:53:01+11:00 https://pharmadispatch.com/news/why-the-failure-of-a-hard-won-process-reveals-so-much-about-an-i 2024-01-16T22:35:01+11:00 https://pharmadispatch.com/news/the-individual-numbers-are-meaningless-but-they-still-tell-a-sto 2024-01-14T23:00:01+11:00 https://pharmadispatch.com/news/cabinet-documents-reveal-health-departments-increasing-urgency-o 2024-01-14T20:00:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-announces-new-general-manager-for-australia 2024-01-08T01:42:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics-signs-agreement-for-distribution-and-co 2024-01-08T01:34:01+11:00 https://pharmadispatch.com/news/documents-reveal-central-agency-assault-on-the-industrys-entitle 2024-01-08T01:00:01+11:00 https://pharmadispatch.com/news/novavax-looking-to-2024-with-monovalent-covid-vaccine-and-potent 2023-12-20T03:00:01+11:00 https://pharmadispatch.com/news/a-valuable-therapeutic-option-for-patients-with-this-complex-rap 2023-12-20T03:00:01+11:00 https://pharmadispatch.com/news/envision-sciences-appoints-ex-mayne-pharma-chief-as-new-chief-ex 2023-12-20T03:00:01+11:00 https://pharmadispatch.com/news/the-industry-needs-to-find-a-framework-for-in-principled-disagre 2023-12-19T03:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-more-people-do-not-believe-in-the-adoption-of 2023-12-19T03:00:01+11:00 https://pharmadispatch.com/news/the-end-of-year-review-podcast-19-december 2023-12-18T17:36:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-progressing-to-high-dose-patient-cohort-in-rp11 2023-12-18T11:18:01+11:00 https://pharmadispatch.com/news/neuren-pharmaceuticals-announces-top-line-results-of-phase-2-nnz 2023-12-18T10:04:01+11:00 https://pharmadispatch.com/news/no-recommendation-for-novo-nordisks-much-anticipated-weight-loss 2023-12-18T03:00:01+11:00 https://pharmadispatch.com/news/general-patients-paying-less-as-under-co-payment-prescriptions-c 2023-12-18T03:00:01+11:00 https://pharmadispatch.com/news/tga-warns-against-the-use-of-unapproved-semaglutide-copies 2023-12-18T03:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-gsk-graduate-researcher-program-in-new-podcast 2023-12-18T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-announces-the-appointment-of-rosanne-hyland-as-acting 2023-12-18T03:00:01+11:00 https://pharmadispatch.com/news/accc-chair-gina-cass-gottlieb-calls-for-reform-of-australias-mer 2023-12-15T03:00:01+11:00 https://pharmadispatch.com/news/data-we-have-been-collecting-for-the-past-three-years-is-now-pre 2023-12-15T03:00:01+11:00 https://pharmadispatch.com/news/the-key-findings-of-australian-patients-association-health-engin 2023-12-15T03:00:01+11:00 https://pharmadispatch.com/news/share-price-jumps-as-investors-welcome-sigma-chemist-warehouse-m 2023-12-14T03:00:01+11:00 https://pharmadispatch.com/news/budget-update-confirms-creation-of-genomics-australia-delayed-to 2023-12-14T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-welcomes-budget-update-revealing-investment- 2023-12-14T03:00:01+11:00 https://pharmadispatch.com/news/fda-grants-fast-track-designation-for-engeneics-pancreatic-cance 2023-12-13T15:55:01+11:00 https://pharmadispatch.com/news/science-technology-australia-slams-budget-raid-on-support-for-co 2023-12-13T14:52:01+11:00 https://pharmadispatch.com/news/syntara-commences-dosing-in-phase-2-myelofibrosis-trial-of-its-p 2023-12-13T11:12:01+11:00 https://pharmadispatch.com/news/update-reveals-significant-spending-on-new-listings-since-the-ma 2023-12-13T10:35:01+11:00 https://pharmadispatch.com/news/medibank-releases-its-top-private-health-insurance-claims-for-20 2023-12-13T10:29:01+11:00 https://pharmadispatch.com/news/will-the-government-have-a-policy-response-to-the-retail-corpora 2023-12-13T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-agrees-to-bundle-deal-for-two-cancer-medicines-funded-vi 2023-12-13T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-calls-for-scrutiny-of-sigma-chemist-warehouse-mer 2023-12-13T03:00:01+11:00 https://pharmadispatch.com/news/albanese-government-will-release-its-mid-year-budget-update-toda 2023-12-13T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-partners-with-mediport-to-launch-cold-chain-distribution- 2023-12-13T03:00:01+11:00 https://pharmadispatch.com/news/organon-says-new-report-demonstrates-the-need-for-fertility-awar 2023-12-13T03:00:01+11:00 https://pharmadispatch.com/news/nib-welcomes-the-ndis-review-report-as-a-blueprint-for-the-futur 2023-12-12T08:11:01+11:00 https://pharmadispatch.com/news/sigma-chemist-warehouse-merger-to-create-a-new-pharmacy-sector-g 2023-12-12T03:00:01+11:00 https://pharmadispatch.com/news/a-new-dynamic-and-complication-for-an-already-difficult-negotiat 2023-12-12T03:00:01+11:00 https://pharmadispatch.com/news/ex-tga-head-john-skerritt-joins-ausbiotech-board-after-appointme 2023-12-12T03:00:01+11:00 https://pharmadispatch.com/news/group-call-for-action-from-the-government-on-shortages-of-medici 2023-12-12T03:00:01+11:00 https://pharmadispatch.com/news/prescient-announces-the-results-of-ptx-100-phase-1b-study-in-t-c 2023-12-11T10:19:01+11:00 https://pharmadispatch.com/news/pfizer-ceo-slams-university-presidents-one-of-the-most-despicabl 2023-12-11T03:00:01+11:00 https://pharmadispatch.com/news/senate-launches-an-inquiry-into-lobbyist-access-to-parliament-ho 2023-12-11T03:00:01+11:00 https://pharmadispatch.com/news/new-xbb-15-covid-19-vaccines-available-in-community-pharmacies-t 2023-12-11T03:00:01+11:00 https://pharmadispatch.com/news/biontech-and-victorian-government-announce-new-mrna-manufacturin 2023-12-11T03:00:01+11:00 https://pharmadispatch.com/news/juvenile-arthritis-is-one-of-the-most-under-recognised-misunders 2023-12-11T03:00:01+11:00 https://pharmadispatch.com/news/hcf-announces-national-partnership-with-the-rfds-to-improve-rura 2023-12-10T18:13:01+11:00 https://pharmadispatch.com/news/nib-welcomes-the-ndis-review-report-as-a-blueprint-for-the-futur 2023-12-10T18:04:01+11:00 https://pharmadispatch.com/news/the-week-in-review-8-december 2023-12-08T11:49:01+11:00 https://pharmadispatch.com/news/reform-in-nz-is-easier-because-it-has-far-fewer-institutional-ba 2023-12-08T03:00:01+11:00 https://pharmadispatch.com/news/ndis-to-get-its-own-advisory-committee-but-can-it-do-the-same-jo 2023-12-08T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-urges-caution-and-regulatory-scrutiny-of-sigma-ac 2023-12-08T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-gets-attention-at-the-opening-of-new-zealands-new-parlia 2023-12-07T03:00:01+11:00 https://pharmadispatch.com/news/sector-facing-shake-with-sigma-and-chemist-warehouse-moving-towa 2023-12-07T03:00:01+11:00 https://pharmadispatch.com/news/a-five-page-engagement-strategy-that-does-not-mention-patients-o 2023-12-07T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-says-new-data-confirms-the-need-for-scope-of-prac 2023-12-06T12:56:01+11:00 https://pharmadispatch.com/news/epworth-healthcare-celebrates-20th-anniversary-of-robotic-surger 2023-12-06T11:05:01+11:00 https://pharmadispatch.com/news/dhl-deploys-new-zealands-first-locus-robotics-warehouse-automati 2023-12-06T10:55:01+11:00 https://pharmadispatch.com/news/bupa-says-new-dental-offering-aims-to-assist-on-cost-of-living-p 2023-12-06T10:34:01+11:00 https://pharmadispatch.com/news/telix-says-the-first-patient-dosed-in-european-early-access-prog 2023-12-06T10:18:01+11:00 https://pharmadispatch.com/news/neuren-pharmaceuticals-completes-enrolment-in-pitt-hopkins-syndr 2023-12-06T10:07:01+11:00 https://pharmadispatch.com/news/the-auditor-general-has-its-own-legal-framework-with-broad-and-s 2023-12-06T03:00:01+11:00 https://pharmadispatch.com/news/previous-processes-reveal-the-likely-focus-of-this-performance-a 2023-12-06T03:00:01+11:00 https://pharmadispatch.com/news/the-uks-industry-based-genomics-projects-releases-the-data-of-50 2023-12-06T03:00:01+11:00 https://pharmadispatch.com/news/gmhba-announces-new-clinical-director-to-lead-health-and-branch- 2023-12-05T19:15:01+11:00 https://pharmadispatch.com/news/former-medicines-nz-chair-says-time-for-talk-on-pharmac-change-i 2023-12-05T03:00:01+11:00 https://pharmadispatch.com/news/ex-tga-head-john-skerritt-appointed-to-medicines-australia-board 2023-12-05T03:00:01+11:00 https://pharmadispatch.com/news/fda-confirms-approach-to-sofdra-nda-resubmission-and-materials-r 2023-12-04T13:31:01+11:00 https://pharmadispatch.com/news/national-pharmacies-opens-its-first-24-7-pharmacy-under-south-au 2023-12-04T13:23:01+11:00 https://pharmadispatch.com/news/pharmaust-completes-phase-1-mend-study-and-files-for-us-orphan-d 2023-12-04T12:43:01+11:00 https://pharmadispatch.com/news/oncosil-medical-onboards-first-patient-in-the-pancosil-clinical- 2023-12-04T12:36:01+11:00 https://pharmadispatch.com/news/korean-regulator-approves-amplia-therapeutics-pancreatic-cancer- 2023-12-04T12:20:01+11:00 https://pharmadispatch.com/news/members-health-welcomes-federal-governments-stricter-vaping-laws 2023-12-04T10:00:01+11:00 https://pharmadispatch.com/news/medibank-and-healthscope-annnounce-a-strengthened-partnership 2023-12-04T09:46:01+11:00 https://pharmadispatch.com/news/how-does-this-indicate-progress-on-an-action-plan-to-enhance-org 2023-12-04T03:00:01+11:00 https://pharmadispatch.com/news/company-submissions-request-faster-access-for-cancer-immunothera 2023-12-04T03:00:01+11:00 https://pharmadispatch.com/news/is-the-system-about-to-be-seriously-tested-will-it-deliver-what- 2023-12-04T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-welcomes-expanded-pbs-listing-for-its-immunotherapy 2023-12-04T03:00:01+11:00 https://pharmadispatch.com/news/new-zealands-new-government-accepts-resignation-of-pharmac-chair 2023-12-01T11:15:01+11:00 https://pharmadispatch.com/news/the-week-in-review-1-december 2023-12-01T11:13:01+11:00 https://pharmadispatch.com/news/gilead-announces-research-fellows-and-partners-on-community-cham 2023-12-01T03:00:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-expanded-pbs-listing-for-jak-inhibitor 2023-12-01T03:00:01+11:00 https://pharmadispatch.com/news/a-minimalist-but-entirely-predictable-response-the-opportunities 2023-12-01T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-the-federal-governments-nrf-investment-manda 2023-12-01T03:00:01+11:00 https://pharmadispatch.com/news/japans-regulator-approves-csls-self-amplifying-mrna-covid-19-vac 2023-11-30T04:00:01+11:00 https://pharmadispatch.com/news/asthma-deaths-on-the-rise-again-but-could-be-avoided 2023-11-30T03:00:01+11:00 https://pharmadispatch.com/news/industry-leaders-sign-pledge-against-anti-semitism-others-invite 2023-11-30T03:00:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-australia-launches-its-innovate-reconciliat 2023-11-30T03:00:01+11:00 https://pharmadispatch.com/news/microba-completes-stage-one-screening-for-its-autoimmune-disease 2023-11-29T14:17:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-provides-additional-information-on-vitro-d 2023-11-29T14:02:01+11:00 https://pharmadispatch.com/news/4dmedical-and-philips-sign-memorandum-of-understanding 2023-11-29T13:45:01+11:00 https://pharmadispatch.com/news/claritys-theranostic-prostate-cancer-trial-progresses-at-the-hig 2023-11-29T13:33:01+11:00 https://pharmadispatch.com/news/health-technology-firm-named-among-fastest-growing-australian-st 2023-11-29T13:02:01+11:00 https://pharmadispatch.com/news/medibank-releases-annual-research-report-marking-ten-years-of-su 2023-11-29T12:35:01+11:00 https://pharmadispatch.com/news/american-express-expands-partnership-with-hicaps-to-deliver-inst 2023-11-29T12:26:01+11:00 https://pharmadispatch.com/news/biocurate-announces-the-appointment-of-new-chief-executive-offic 2023-11-29T11:27:01+11:00 https://pharmadispatch.com/news/opioid-and-psychotropic-dispensings-on-the-decline-among-austral 2023-11-29T03:00:01+11:00 https://pharmadispatch.com/news/new-minister-gives-a-less-than-ringing-endorsement-of-pharmacs-l 2023-11-29T03:00:01+11:00 https://pharmadispatch.com/news/the-value-of-knowing-and-the-value-of-community-are-overlooked 2023-11-29T03:00:01+11:00 https://pharmadispatch.com/news/audit-expected-to-closely-scrutinise-the-use-of-list-and-confide 2023-11-29T03:00:01+11:00 https://pharmadispatch.com/news/expanded-audit-adds-complexity-to-an-already-complex-period-of-c 2023-11-28T05:46:01+11:00 https://pharmadispatch.com/news/expanded-audit-adds-complexity-to-an-already-complex-period-of-c 2023-11-28T03:00:01+11:00 https://pharmadispatch.com/news/medical-science-a-priority-area-for-new-industry-growth-program 2023-11-28T03:00:01+11:00 https://pharmadispatch.com/news/federal-government-backs-the-development-of-treatment-for-childh 2023-11-27T17:51:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-doses-first-cohort-in-isla-101-study 2023-11-27T17:20:01+11:00 https://pharmadispatch.com/news/bupa-apac-completes-move-to-100-per-cent-renewable-electricity 2023-11-27T17:08:01+11:00 https://pharmadispatch.com/news/pharmac-has-a-minister-but-what-are-the-limits-on-their-power-to 2023-11-27T03:00:01+11:00 https://pharmadispatch.com/news/anao-expands-audit-to-include-cost-pricing-and-the-listing-proce 2023-11-27T03:00:01+11:00 https://pharmadispatch.com/news/insulet-looks-to-fill-subsidy-gap-for-its-insulin-management-sys 2023-11-27T03:00:01+11:00 https://pharmadispatch.com/news/nzs-new-government-and-what-it-means-for-medicines-access 2023-11-24T09:50:01+11:00 https://pharmadispatch.com/news/new-survey-shows-significant-gaps-in-australians-understanding-o 2023-11-24T03:00:01+11:00 https://pharmadispatch.com/news/nz-has-a-new-government-with-details-of-policy-agreement-to-be-a 2023-11-24T03:00:01+11:00 https://pharmadispatch.com/news/industry-joint-venture-says-using-cell-and-gene-therapies-should 2023-11-24T03:00:01+11:00 https://pharmadispatch.com/news/mtaa-welcomes-release-of-federal-governments-cybersecurity-strat 2023-11-23T15:37:01+11:00 https://pharmadispatch.com/news/nothing-reaffirms-a-governments-commitment-to-a-policy-like-a-de 2023-11-23T03:00:01+11:00 https://pharmadispatch.com/news/a-breakdown-of-the-march-2024-pbac-agenda 2023-11-23T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-announces-the-appointment-of-new-chief-execut 2023-11-23T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-24-november 2023-11-23T03:00:01+11:00 https://pharmadispatch.com/news/record-phi-membership-record-claims-and-the-risk-of-higher-premi 2023-11-22T20:28:01+11:00 https://pharmadispatch.com/news/uk-industry-secures-higher-annual-growth-in-medicines-spend-unde 2023-11-22T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-renews-calls-for-a-further-reduction-in-pbs-patie 2023-11-22T03:00:01+11:00 https://pharmadispatch.com/news/new-reports-recommends-major-reforms-to-encourage-response-to-an 2023-11-22T03:00:01+11:00 https://pharmadispatch.com/news/daiichi-sankyo-ceo-on-the-companys-logical-expansion-into-austra 2023-11-21T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-the-first-healthcare-organisation-to-back-australian-base 2023-11-21T03:00:01+11:00 https://pharmadispatch.com/news/federal-government-accepts-technical-advice-on-the-use-of-new-mo 2023-11-21T03:00:01+11:00 https://pharmadispatch.com/news/hbf-announces-the-launch-of-six-hbf-physio-clinics-across-wa 2023-11-20T16:50:01+11:00 https://pharmadispatch.com/news/bupa-provides-fresh-support-for-six-sustainable-start-ups 2023-11-20T11:09:01+11:00 https://pharmadispatch.com/news/orthocell-announces-final-positive-results-of-cell-therapy-in-te 2023-11-20T10:51:01+11:00 https://pharmadispatch.com/news/south-australia-joins-queensland-in-expanding-pharmacy-scope-of- 2023-11-20T10:26:01+11:00 https://pharmadispatch.com/news/history-says-these-therapies-will-trigger-response-beyond-a-fund 2023-11-20T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-extends-transitional-arrangement-for-non-pbs-private 2023-11-20T03:00:01+11:00 https://pharmadispatch.com/news/uk-eases-competition-laws-to-promote-the-funding-of-combination- 2023-11-19T10:07:01+11:00 https://pharmadispatch.com/news/mark-butler-confirms-wider-pbs-listing-for-prostate-cancer-thera 2023-11-17T03:00:01+11:00 https://pharmadispatch.com/news/new-index-has-found-that-most-australians-are-living-with-everyd 2023-11-17T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-ceo-uses-apec-address-to-call-for-action-to-end-all-forms 2023-11-17T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-17-november 2023-11-16T17:29:01+11:00 https://pharmadispatch.com/news/dhl-supply-chain-and-fresenius-kabi-form-australian-3pl-partners 2023-11-16T05:15:01+11:00 https://pharmadispatch.com/news/new-data-shows-surge-in-diabetes-testing-drop-in-cancer-detectio 2023-11-16T03:00:01+11:00 https://pharmadispatch.com/news/dhl-supply-chain-and-fresenius-kabi-form-australian-3pl-partners 2023-11-16T03:00:01+11:00 https://pharmadispatch.com/news/abbvie-partners-with-research-australia-to-create-the-future-hea 2023-11-16T03:00:01+11:00 https://pharmadispatch.com/news/hcf-recognised-in-customer-service-institute-of-australia-awards 2023-11-15T14:20:01+11:00 https://pharmadispatch.com/news/new-report-confirms-medibank-continues-to-be-a-top-100-australia 2023-11-15T13:44:01+11:00 https://pharmadispatch.com/news/monash-harnesses-new-frontier-in-technology-to-propel-promising- 2023-11-15T13:32:01+11:00 https://pharmadispatch.com/news/sandoz-welcomes-its-inclusion-in-list-of-best-places-to-work-for 2023-11-15T03:00:01+11:00 https://pharmadispatch.com/news/biogen-launches-its-first-reconciliation-action-plan 2023-11-15T03:00:01+11:00 https://pharmadispatch.com/news/slow-and-steady-start-for-60-day-scripts-as-pharmacy-guild-calls 2023-11-15T03:00:01+11:00 https://pharmadispatch.com/news/killer-disease-thousands-dont-realise-theyre-battling-costing-us 2023-11-14T03:00:01+11:00 https://pharmadispatch.com/news/ma-says-it-has-written-to-mark-butler-to-reinforce-agreement-com 2023-11-14T03:00:01+11:00 https://pharmadispatch.com/news/gbma-joins-global-campaign-to-boost-the-use-of-biosimilars 2023-11-14T03:00:01+11:00 https://pharmadispatch.com/news/parliament-debates-motion-calling-for-fast-action-on-funding-wei 2023-11-14T03:00:01+11:00 https://pharmadispatch.com/news/new-survey-finds-that-one-in-four-nurses-are-considering-leaving 2023-11-13T12:12:01+11:00 https://pharmadispatch.com/news/neuren-pharmaceuticals-completes-phelan-mcdermid-syndrome-phase- 2023-11-13T12:06:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-says-fourth-candidate-has-potential-in-polycyst 2023-11-13T10:52:01+11:00 https://pharmadispatch.com/news/hbf-named-australias-most-trusted-private-health-insurer 2023-11-13T09:30:01+11:00 https://pharmadispatch.com/news/i-was-able-to-jump-ship-and-become-a-medical-refugee-in-australi 2023-11-13T03:00:01+11:00 https://pharmadispatch.com/news/the-government-will-want-to-combine-all-of-these-pbs-processes-i 2023-11-13T03:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-has-announced-a-significant-expansion-in-manufactur 2023-11-13T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-10-november 2023-11-10T13:57:01+11:00 https://pharmadispatch.com/news/biopharmaceutical-companies-makes-the-list-of-australias-best-wo 2023-11-10T03:00:01+11:00 https://pharmadispatch.com/news/moderna-highlights-its-digital-and-ai-strategy-at-digital-invest 2023-11-10T03:00:01+11:00 https://pharmadispatch.com/news/novartis-moves-quickly-with-the-appointment-of-new-leader-for-au 2023-11-10T03:00:01+11:00 https://pharmadispatch.com/news/viatris-announces-the-appointment-of-new-business-development-he 2023-11-10T03:00:01+11:00 https://pharmadispatch.com/news/persistently-high-inflation-means-higher-pbs-patient-co-payments 2023-11-09T03:00:01+11:00 https://pharmadispatch.com/news/the-launch-of-medchem-australia-aims-to-boost-local-drug-discove 2023-11-09T03:00:01+11:00 https://pharmadispatch.com/news/australia-and-new-zealand-running-diabetes-tenders-at-the-same-t 2023-11-09T03:00:01+11:00 https://pharmadispatch.com/news/england-moves-ahead-on-repurposing-as-australia-continues-consul 2023-11-08T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-opens-new-slade-health-compounding-facility-in-south 2023-11-08T03:00:01+11:00 https://pharmadispatch.com/news/industry-leaders-reject-calls-for-permanent-adoption-of-ip-waive 2023-11-08T03:00:01+11:00 https://pharmadispatch.com/news/governments-covid-19-inquiry-invites-stakeholders-to-make-submis 2023-11-07T03:00:01+11:00 https://pharmadispatch.com/news/bupa-announces-hip-pocket-and-tooth-pain-relief-for-members 2023-11-06T18:29:01+11:00 https://pharmadispatch.com/news/stlukes-recognised-with-canstar-outstanding-value-award 2023-11-06T12:35:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-secures-fda-agreement-on-clinical-trial-pathway 2023-11-06T12:15:01+11:00 https://pharmadispatch.com/news/immutep-announces-the-completion-of-key-stage-of-aipac-003-trial 2023-11-06T11:53:01+11:00 https://pharmadispatch.com/news/dimerix-receives-first-payment-from-uk-based-partner-for-dmx-200 2023-11-06T11:14:01+11:00 https://pharmadispatch.com/news/guild-welcomes-nurses-submission-on-workforce-review 2023-11-06T10:25:01+11:00 https://pharmadispatch.com/news/the-dangerous-disconnect-between-the-marketing-of-a-process-and- 2023-11-06T03:00:01+11:00 https://pharmadispatch.com/news/new-report-finds-investors-want-global-policy-collaboration-on-a 2023-11-06T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-country-medical-lead-wins-election-to-the-ausbiotech-boar 2023-11-06T03:00:01+11:00 https://pharmadispatch.com/news/another-boost-for-australian-company-as-royalties-start-arriving 2023-11-06T03:00:01+11:00 https://pharmadispatch.com/news/companies-and-clinician-welcome-funded-access-to-new-breast-canc 2023-11-06T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-3-november 2023-11-03T11:24:01+11:00 https://pharmadispatch.com/news/new-report-launched-calling-for-action-on-ibd-ahead-of-national- 2023-11-03T03:00:01+11:00 https://pharmadispatch.com/news/new-leadership-coming-for-novartis-as-local-head-secures-global- 2023-11-03T03:00:01+11:00 https://pharmadispatch.com/news/researchers-work-on-kiss-of-death-protein-gets-industry-accolade 2023-11-03T03:00:01+11:00 https://pharmadispatch.com/news/new-zealands-new-government-taking-shape-and-clock-starts-tickin 2023-11-02T15:10:01+11:00 https://pharmadispatch.com/news/these-confidentiality-undertakings-have-officially-reached-peak- 2023-11-02T03:00:01+11:00 https://pharmadispatch.com/news/what-other-outcomes-does-the-government-want-from-this-negotiati 2023-11-02T03:00:01+11:00 https://pharmadispatch.com/news/new-report-quantifies-the-importance-of-rd-tax-incentive-on-aust 2023-11-02T03:00:01+11:00 https://pharmadispatch.com/news/new-research-grants-will-help-reduce-infectious-diseases-and-hea 2023-11-02T03:00:01+11:00 https://pharmadispatch.com/news/ministers-newborn-screening-process-quickly-hits-msac-hurdle 2023-11-01T03:00:01+11:00 https://pharmadispatch.com/news/merck-welcomes-new-pbs-listing-for-adults-with-severe-growth-hor 2023-11-01T03:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-women-struggle-to-find-timely-relief-for-migr 2023-11-01T03:00:01+11:00 https://pharmadispatch.com/news/new-national-notifiable-diseases-surveillance-system-nndss-data- 2023-11-01T03:00:01+11:00 https://pharmadispatch.com/news/moderna-and-cepi-announce-new-partnership-in-support-of-100-days 2023-11-01T03:00:01+11:00 https://pharmadispatch.com/news/lumi-health-to-offer-affordable-genetic-screening-for-would-be-p 2023-11-01T03:00:01+11:00 https://pharmadispatch.com/news/opthea-appoints-ex-novartis-australia-head-and-ma-board-member-a 2023-10-31T15:18:01+11:00 https://pharmadispatch.com/news/the-new-pharmacy-agreement-was-originally-intended-to-start-on-1 2023-10-31T03:00:01+11:00 https://pharmadispatch.com/news/moderna-announces-inaugural-recipients-of-australia-fellowship-p 2023-10-31T03:00:01+11:00 https://pharmadispatch.com/news/the-pbac-does-not-make-decisions-and-more-hta-process-is-never-t 2023-10-31T03:00:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-unveils-updated-company-brand-that-brings-l 2023-10-31T03:00:01+11:00 https://pharmadispatch.com/news/ausbioinvest-2023-marks-beginning-of-australias-biggest-week-in- 2023-10-30T13:32:01+11:00 https://pharmadispatch.com/news/amplar-home-health-to-continue-delivering-in-home-care-to-south- 2023-10-30T10:14:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-november-expanded-listing-for-migraine-the 2023-10-30T03:00:01+11:00 https://pharmadispatch.com/news/government-funding-breaks-the-treatment-drought-for-hard-to-trea 2023-10-30T03:00:01+11:00 https://pharmadispatch.com/news/surely-that-makes-response-very-easy-for-the-new-health-minister 2023-10-30T03:00:01+11:00 https://pharmadispatch.com/news/viatris-reaches-new-milestone-with-the-addition-of-australian-ma 2023-10-30T03:00:01+11:00 https://pharmadispatch.com/news/belgian-princess-joins-announcement-for-ucb-genome-research-inve 2023-10-30T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-announces-plan-to-separate-its-consumer-healthcare-busine 2023-10-28T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-27-october 2023-10-27T10:35:01+11:00 https://pharmadispatch.com/news/pharmac-chief-fronts-board-as-patients-renew-calls-for-their-res 2023-10-27T03:00:01+11:00 https://pharmadispatch.com/news/we-should-be-engaging-more-with-stakeholders-when-we-provide-adv 2023-10-27T03:00:01+11:00 https://pharmadispatch.com/news/the-albanese-governments-budget-rules-require-cost-offsets-for-a 2023-10-27T03:00:01+11:00 https://pharmadispatch.com/news/these-are-adjustments-and-are-notional-entries-required-for-pres 2023-10-27T03:00:01+11:00 https://pharmadispatch.com/news/projected-us-australia-biotechnology-trade-could-inject-us10-bil 2023-10-26T15:32:01+11:00 https://pharmadispatch.com/news/england-announces-funded-access-to-cancer-therapy-to-coincide-wi 2023-10-26T03:00:01+11:00 https://pharmadispatch.com/news/companies-should-seek-reassurance-on-the-protection-of-confident 2023-10-26T03:00:01+11:00 https://pharmadispatch.com/news/new-report-reveals-enduring-impact-of-pandemic-on-health-spendin 2023-10-25T10:11:01+11:00 https://pharmadispatch.com/news/patient-voice-drives-improvements-for-australian-hospitals-and-h 2023-10-25T09:56:01+11:00 https://pharmadispatch.com/news/companies-says-workplace-flexibility-is-the-priority-over-shorte 2023-10-25T03:00:01+11:00 https://pharmadispatch.com/news/new-health-officials-prepare-to-front-senate-estimates-for-the-f 2023-10-25T03:00:01+11:00 https://pharmadispatch.com/news/roche-confirms-the-appointment-of-new-general-manager-for-austra 2023-10-25T03:00:01+11:00 https://pharmadispatch.com/news/ovarian-cancer-australia-announces-leadership-change-with-appoin 2023-10-23T18:56:01+11:00 https://pharmadispatch.com/news/adalta-reports-favourable-patient-tolerability-after-third-dose- 2023-10-23T14:34:01+11:00 https://pharmadispatch.com/news/national-pharmacies-appoints-new-general-manager-of-member-and-c 2023-10-23T12:14:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-of-australia-announces-the-appointment-of-new-exe 2023-10-23T12:00:01+11:00 https://pharmadispatch.com/news/bupa-says-hi-tech-heart-failure-service-is-helping-to-reduce-hos 2023-10-23T11:11:01+11:00 https://pharmadispatch.com/news/chimeric-announces-positive-preliminary-data-for-cltx-car-t-in-b 2023-10-23T11:00:01+11:00 https://pharmadispatch.com/news/mark-butler-hails-wider-access-to-sma-gene-therapy-but-babies-in 2023-10-23T10:21:01+11:00 https://pharmadispatch.com/news/positive-efficacy-result-for-immuteps-efti-in-combination-with-m 2023-10-23T09:36:01+11:00 https://pharmadispatch.com/news/medibank-announces-the-launch-of-four-day-work-week-trial 2023-10-23T09:05:01+11:00 https://pharmadispatch.com/news/slade-pharmacy-wins-contract-to-provide-pharmacy-services-for-un 2023-10-23T03:00:01+11:00 https://pharmadispatch.com/news/history-provides-the-best-possible-lessons-because-it-constantly 2023-10-23T03:00:01+11:00 https://pharmadispatch.com/news/more-recognition-for-neuren-pharmaceuticals-with-growth-company- 2023-10-23T03:00:01+11:00 https://pharmadispatch.com/news/doctors-argue-for-strict-limits-on-the-expansion-of-pharmacy-sco 2023-10-23T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-20-october 2023-10-20T11:31:01+11:00 https://pharmadispatch.com/news/global-rd-heads-sign-joint-letter-expressing-alarm-over-new-pric 2023-10-20T03:00:01+11:00 https://pharmadispatch.com/news/olympian-and-new-report-encourage-action-on-osteoporosis-risk-fa 2023-10-20T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-leadership-expected-to-resign-or-risk-being-removed-by-t 2023-10-20T03:00:01+11:00 https://pharmadispatch.com/news/will-rebates-become-the-single-biggest-component-of-the-pbs-budg 2023-10-19T03:00:01+11:00 https://pharmadispatch.com/news/services-australia-confirms-jump-in-pbs-prescriptions-processed- 2023-10-19T03:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-bayer-as-ashraf-al-ouf-secures-promotion-to-a 2023-10-18T16:00:01+11:00 https://pharmadispatch.com/news/shortage-in-regional-nuclear-medicine-workforce-attracts-new-fin 2023-10-18T15:56:01+11:00 https://pharmadispatch.com/news/world-first-hearing-innovation-aims-to-reduce-social-isolation-a 2023-10-18T12:34:01+11:00 https://pharmadispatch.com/news/clinuvel-announces-the-starts-global-phase-3-vitiligo-clinical-t 2023-10-18T11:51:01+11:00 https://pharmadispatch.com/news/rafda-green-light-for-trivehexin-diagnostic-phase-1-pancreatic-c 2023-10-18T11:03:01+11:00 https://pharmadispatch.com/news/nib-partners-with-osara-health-to-provide-tailored-cancer-coachi 2023-10-18T10:35:01+11:00 https://pharmadispatch.com/news/rebates-rapidly-approach-5-billion-as-pbs-growth-hits-double-dig 2023-10-18T09:23:01+11:00 https://pharmadispatch.com/news/senate-rejects-push-for-reform-of-lobbyist-engagement-in-parliam 2023-10-18T03:00:01+11:00 https://pharmadispatch.com/news/imminent-annual-report-will-reveal-the-real-situation-with-pbs-s 2023-10-18T03:00:01+11:00 https://pharmadispatch.com/news/biogen-lends-a-hand-at-the-fipfa-powerchair-football-world-cup 2023-10-18T03:00:01+11:00 https://pharmadispatch.com/news/cartherics-appoints-new-chief-scientific-officer 2023-10-17T10:18:01+11:00 https://pharmadispatch.com/news/mark-butler-says-we-need-to-be-agile-on-genomics-but-that-it-can 2023-10-17T09:28:01+11:00 https://pharmadispatch.com/news/bms-presents-the-patient-and-parliament-summit-with-the-focus-on 2023-10-17T03:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-to-use-canforum-to-urge-action-on-genomic 2023-10-17T03:00:01+11:00 https://pharmadispatch.com/news/journalist-and-advocate-to-speak-at-2024-bpd-annual-conference 2023-10-17T03:00:01+11:00 https://pharmadispatch.com/news/nation-first-stem-cell-trial-offers-hope-to-young-australians 2023-10-16T12:08:01+11:00 https://pharmadispatch.com/news/questions-for-pharmac-as-new-zealands-new-government-starts-to-t 2023-10-16T03:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-updates-forecast-as-diabetes-and-weight-loss-sales- 2023-10-16T03:00:01+11:00 https://pharmadispatch.com/news/genuinely-held-belief-in-change-but-would-silence-have-been-more 2023-10-16T03:00:01+11:00 https://pharmadispatch.com/news/pbac-delivers-recommendations-at-its-september-intracycle-meetin 2023-10-16T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-13-october 2023-10-13T12:59:01+11:00 https://pharmadispatch.com/news/former-director-slams-pharmac-over-toxic-culture-and-leadership- 2023-10-13T03:00:01+11:00 https://pharmadispatch.com/news/hta-review-reference-committee-chair-talks-about-the-process-its 2023-10-13T03:00:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics-signs-license-agreement-with-canariabio 2023-10-13T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-launches-the-co-lab-collaboration-and-innovation-hub 2023-10-11T20:00:01+11:00 https://pharmadispatch.com/news/there-has-been-a-managed-access-program-in-place-since-2011 2023-10-11T20:00:01+11:00 https://pharmadispatch.com/news/new-report-reveals-the-neglected-burden-and-ongoing-economic-cos 2023-10-11T20:00:01+11:00 https://pharmadispatch.com/news/tga-approves-pfizer-and-biontech-xbb15-adapted-covid-19-vaccine 2023-10-11T13:18:01+11:00 https://pharmadispatch.com/news/tga-approves-modernas-updated-single-strain-covid-19-vaccine 2023-10-11T03:00:01+11:00 https://pharmadispatch.com/news/next-years-budget-process-underway-as-pbs-enters-highly-complex- 2023-10-11T03:00:01+11:00 https://pharmadispatch.com/news/advocating-for-medicines-is-not-trivial-or-nauseating-as-one-pha 2023-10-11T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatch-podcast-we-respond-to-your-questions-on-the-hta-rev 2023-10-10T17:01:01+11:00 https://pharmadispatch.com/news/bms-acquires-new-cancer-therapy-with-acquisition-of-mirati-thera 2023-10-10T03:00:01+11:00 https://pharmadispatch.com/news/political-involvement-in-decision-making-is-accountability-not-i 2023-10-10T03:00:01+11:00 https://pharmadispatch.com/news/private-hospitals-welcome-ama-support-for-minimum-guaranteed-pay 2023-10-09T20:28:01+11:00 https://pharmadispatch.com/news/hcf-dominates-canstar-2023awards-including-coveted-outstanding-v 2023-10-09T20:17:01+11:00 https://pharmadispatch.com/news/more-calls-for-sarah-fitt-to-go-as-pm-joins-criticism-of-pharmac 2023-10-09T16:19:01+11:00 https://pharmadispatch.com/news/pharmaust-says-data-from-canine-oncology-study-supports-progress 2023-10-09T13:03:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-receives-approval-for-study-of-pdl1-nano 2023-10-09T12:59:01+11:00 https://pharmadispatch.com/news/appointment-of-mr-iain-ross-as-non-executive-director 2023-10-09T11:32:01+11:00 https://pharmadispatch.com/news/why-it-matters-that-this-review-is-neither-comprehensive-nor-the 2023-10-09T03:00:01+11:00 https://pharmadispatch.com/news/call-for-pharmac-chief-executive-to-resign-after-emails-reveal-a 2023-10-09T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-says-5-million-people-will-have-funded-access-to-new 2023-10-09T03:00:01+11:00 https://pharmadispatch.com/news/new-griffith-university-site-for-translational-hub-brings-global 2023-10-09T03:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-opens-applications-for-positive-action-community 2023-10-09T03:00:01+11:00 https://pharmadispatch.com/news/another-day-on-the-election-campaign-and-another-bad-day-for-pha 2023-10-06T05:30:01+11:00 https://pharmadispatch.com/news/moderna-to-progress-combination-vaccine-candidate-to-late-stage- 2023-10-06T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-dimerix-enters-agreement-to-commercialise-dmx 2023-10-06T03:00:01+11:00 https://pharmadispatch.com/news/director-appointed-to-ausbiotech-ma-cell-and-gene-catalyst 2023-10-05T17:55:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-6-october 2023-10-05T17:41:01+11:00 https://pharmadispatch.com/news/health-department-confirms-the-appointment-of-probity-adviser-fo 2023-10-05T02:00:01+11:00 https://pharmadispatch.com/news/kidney-health-australia-launches-this-years-red-socks-run 2023-10-04T19:47:01+11:00 https://pharmadispatch.com/news/pharmac-the-focus-of-my-life-matters-election-campaign-debate 2023-10-04T19:07:01+11:00 https://pharmadispatch.com/news/investors-boost-noxopharm-after-us-fda-grants-orphan-drug-design 2023-10-04T10:20:01+11:00 https://pharmadispatch.com/news/medibank-announces-significant-changes-to-its-leadership-team 2023-10-04T10:16:01+11:00 https://pharmadispatch.com/news/csl-announces-seven-new-global-research-acceleration-initiative- 2023-10-04T10:13:01+11:00 https://pharmadispatch.com/news/pfizer-launches-its-third-annual-week-long-event-focused-on-its- 2023-10-04T03:00:01+11:00 https://pharmadispatch.com/news/usbs-igg1-antibody-now-listed-on-the-pbs-for-adults-with-severe- 2023-10-04T03:00:01+11:00 https://pharmadispatch.com/news/a-name-change-and-significant-sale-as-pharmaxis-becomes-syntara 2023-10-04T03:00:01+11:00 https://pharmadispatch.com/news/the-government-not-letting-these-medicines-off-the-pbs-as-the-tr 2023-10-04T03:00:01+11:00 https://pharmadispatch.com/news/a-day-on-the-campaign-trail-the-magenta-bus-the-party-leader-and 2023-10-03T03:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-bms-once-daily-oral-therapy-for-severe-chronic-p 2023-10-03T03:00:01+11:00 https://pharmadispatch.com/news/new-analysis-reveals-potential-economy-wide-impact-of-weight-los 2023-10-03T03:00:01+11:00 https://pharmadispatch.com/news/cyclopharm-announces-us-approval-for-nuclear-medicine-imaging-ag 2023-10-02T11:27:01+11:00 https://pharmadispatch.com/news/bionomics-announces-positive-topline-results-from-clinical-trial 2023-10-02T11:11:01+11:00 https://pharmadispatch.com/news/edit-delete-the-week-in-podcast-review-1-october 2023-10-02T10:43:01+11:00 https://pharmadispatch.com/news/lung-foundation-australia-launches-campaign-targeting-significan 2023-09-28T21:13:01+10:00 https://pharmadispatch.com/news/the-department-does-not-expect-to-accept-proposals-for-the-inclu 2023-09-28T21:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-new-zealands-access-challenge-two-weeks-ou 2023-09-28T21:00:01+10:00 https://pharmadispatch.com/news/tuh-health-fund-clinches-top-honour-in-roy-morgan-customer-satis 2023-09-28T13:59:01+10:00 https://pharmadispatch.com/news/neo-health-joins-gbma-under-new-affiliate-membership-tier 2023-09-28T03:00:01+10:00 https://pharmadispatch.com/news/queensland-pharmacy-scope-extension-triggers-fight-with-doctors 2023-09-28T03:00:01+10:00 https://pharmadispatch.com/news/we-think-about-the-cost-of-action-but-we-really-need-to-think-ab 2023-09-28T03:00:01+10:00 https://pharmadispatch.com/news/teachers-health-wins-roy-morgan-customer-satsfaction-award 2023-09-27T15:33:01+10:00 https://pharmadispatch.com/news/bupa-tops-up-cashback-to-395-million 2023-09-27T09:15:01+10:00 https://pharmadispatch.com/news/remarkable-intervention-suggests-a-more-assertive-stance-on-othe 2023-09-27T03:00:01+10:00 https://pharmadispatch.com/news/labours-pharmac-funding-promises-dismissed-as-a-lolly-scramble 2023-09-27T03:00:01+10:00 https://pharmadispatch.com/news/this-pain-awareness-month-leading-clinician-calls-for-greater-aw 2023-09-27T03:00:01+10:00 https://pharmadispatch.com/news/queensland-moves-ahead-on-scope-of-practice-by-expanding-prescri 2023-09-26T03:43:01+10:00 https://pharmadispatch.com/news/janssen-tops-reputation-survey-of-mental-health-patient-organisa 2023-09-26T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-further-expands-access-to-funded-covid-19-antivirals 2023-09-26T03:00:01+10:00 https://pharmadispatch.com/news/medibank-has-launched-two-major-reports-including-its-annul-sust 2023-09-25T18:20:01+10:00 https://pharmadispatch.com/news/polynovo-updates-investors-with-significant-revenue-growth 2023-09-25T14:23:01+10:00 https://pharmadispatch.com/news/hbf-reports-revenue-growth-with-expanding-membership-outside-wa 2023-09-25T12:15:01+10:00 https://pharmadispatch.com/news/us-fda-grants-conditional-approval-to-the-brand-name-of-dimerixs 2023-09-25T10:22:01+10:00 https://pharmadispatch.com/news/budget-outcome-confirms-double-digit-growth-for-pharmaceutical-s 2023-09-25T03:00:01+10:00 https://pharmadispatch.com/news/these-major-processes-related-to-public-health-programs-can-not- 2023-09-25T03:00:01+10:00 https://pharmadispatch.com/news/hospital-pharmacy-launches-new-professional-recognition-program 2023-09-25T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-22-september 2023-09-22T12:11:01+10:00 https://pharmadispatch.com/news/national-and-labour-commit-to-addressing-pharmacs-fiscal-cliff 2023-09-22T03:00:01+10:00 https://pharmadispatch.com/news/moderna-launches-welcome-to-the-mrnage-brand-campaign 2023-09-22T03:00:01+10:00 https://pharmadispatch.com/news/this-farcical-inquiry-effectively-puts-major-pandemic-decisions- 2023-09-22T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-announces-the-departure-of-ceo 2023-09-21T10:37:01+10:00 https://pharmadispatch.com/news/joint-congressional-attempt-to-mitigate-the-impact-of-new-price- 2023-09-21T03:00:01+10:00 https://pharmadispatch.com/news/australias-health-department-released-information-on-internation 2023-09-21T03:00:01+10:00 https://pharmadispatch.com/news/nsw-launches-special-commission-of-inquiry-into-healthcare-fundi 2023-09-20T18:26:01+10:00 https://pharmadispatch.com/news/medibanks-amplar-home-health-accredited-for-another-three-years 2023-09-20T09:38:01+10:00 https://pharmadispatch.com/news/hcf-has-announced-the-national-roll-out-of-a-qr-based-digital-me 2023-09-20T09:22:01+10:00 https://pharmadispatch.com/news/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries 2023-09-20T09:15:01+10:00 https://pharmadispatch.com/news/ausbiotech-lauds-australian-developed-drug-after-us-fda-approval 2023-09-20T03:00:01+10:00 https://pharmadispatch.com/news/everything-in-the-policy-soup-is-connected-and-everything-happen 2023-09-20T03:00:01+10:00 https://pharmadispatch.com/news/moderna-announces-the-appointment-of-medical-director-for-austra 2023-09-19T16:54:01+10:00 https://pharmadispatch.com/news/moderna-marks-half-way-point-in-construction-of-mrna-manufacturi 2023-09-19T03:00:01+10:00 https://pharmadispatch.com/news/a-one-off-annual-impact-when-it-comes-to-spending-growth-is-unli 2023-09-19T03:00:01+10:00 https://pharmadispatch.com/news/clinicians-urged-to-access-training-on-voluntary-assisted-dying 2023-09-19T03:00:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-announces-clinicalddata-presentation-for 2023-09-18T20:18:01+10:00 https://pharmadispatch.com/news/nib-joins-dylan-alcotts-shift-20-to-change-how-disability-is-rep 2023-09-18T17:55:01+10:00 https://pharmadispatch.com/news/adherium-announces-new-partnership-with-leading-us-allergy-and-a 2023-09-18T09:38:01+10:00 https://pharmadispatch.com/news/survey-reveals-2-in-3-young-people-needed-mental-health-support- 2023-09-18T09:32:01+10:00 https://pharmadispatch.com/news/final-budget-outcome-will-confirm-the-extent-of-pbs-growth 2023-09-18T03:00:01+10:00 https://pharmadispatch.com/news/johnson-johnson-gives-its-famous-name-to-pharmaceuticals-divisio 2023-09-18T03:00:01+10:00 https://pharmadispatch.com/news/three-more-pbac-members-appointed-to-new-two-year-terms 2023-09-18T03:00:01+10:00 https://pharmadispatch.com/news/survey-reveals-low-awareness-of-cv-risks-and-triggers-call-for-a 2023-09-18T03:00:01+10:00 https://pharmadispatch.com/news/patients-win-reprieve-with-novo-nordisk-listing-a-new-form-of-in 2023-09-17T13:42:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-15-september 2023-09-15T12:00:01+10:00 https://pharmadispatch.com/news/states-and-territories-still-potential-barriers-in-updated-newbo 2023-09-15T03:00:01+10:00 https://pharmadispatch.com/news/scope-of-practice-review-to-open-a-new-front-in-battle-between-p 2023-09-15T03:00:01+10:00 https://pharmadispatch.com/news/csl-seqirus-secures-expanded-approval-for-nine-valent-hpv-vaccin 2023-09-15T03:00:01+10:00 https://pharmadispatch.com/news/icon-group-and-sunsuria-healthcare-partner-to-elevate-cancer-car 2023-09-15T03:00:01+10:00 https://pharmadispatch.com/news/government-introduces-legislation-aimed-at-fight-tobacco-and-nic 2023-09-14T08:06:01+10:00 https://pharmadispatch.com/news/new-zealand-cancer-groups-issue-urgent-call-to-arms-for-politica 2023-09-14T03:00:01+10:00 https://pharmadispatch.com/news/new-paig-co-chair-looks-to-the-future-and-making-the-learnings-m 2023-09-14T03:00:01+10:00 https://pharmadispatch.com/news/early-diagnosis-a-step-closer-for-those-at-risk-of-oesophageal-c 2023-09-13T17:13:01+10:00 https://pharmadispatch.com/news/viatris-says-down-scheduling-of-combination-therapy-can-provide- 2023-09-13T14:07:01+10:00 https://pharmadispatch.com/news/adapt-ideations-announces-the-appointment-of-chief-operating-off 2023-09-13T13:04:01+10:00 https://pharmadispatch.com/news/investors-boost-starpharma-in-response-to-interim-data-from-clin 2023-09-13T12:16:01+10:00 https://pharmadispatch.com/news/world-first-skin-cancer-treatment-for-transplant-patients-seeks- 2023-09-13T11:57:01+10:00 https://pharmadispatch.com/news/terrywhite-chemmart-and-sanofi-partner-on-safe-and-responsible-m 2023-09-13T04:00:01+10:00 https://pharmadispatch.com/news/ndis-prepares-for-sustainability-framework-as-report-shows-20000 2023-09-13T03:00:01+10:00 https://pharmadispatch.com/news/the-growth-might-eventually-slow-but-its-hard-to-imagine-a-wider 2023-09-13T03:00:01+10:00 https://pharmadispatch.com/news/no-more-lectures-from-politicians-about-the-industrys-relationsh 2023-09-13T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-argues-for-reform-in-submission-to-diabetes-parli 2023-09-12T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-announces-the-appointment-of-new-senior-poli 2023-09-12T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-secures-approval-to-expand-the-diseases-inclu 2023-09-12T03:00:01+10:00 https://pharmadispatch.com/news/some-coalition-parliamentarians-not-giving-up-on-pbs-controversi 2023-09-12T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-that-mental-health-has-become-the-pandemic-ha 2023-09-12T03:00:01+10:00 https://pharmadispatch.com/news/bupa-launches-healthy-cities-program-with-a-commitment-to-enviro 2023-09-11T18:43:01+10:00 https://pharmadispatch.com/news/but-for-the-few-insiders-the-hta-review-is-a-bin-fire-when-it-co 2023-09-11T03:00:01+10:00 https://pharmadispatch.com/news/shadow-health-minister-calls-for-action-on-access-to-diabetes-me 2023-09-11T03:00:01+10:00 https://pharmadispatch.com/news/a-department-acting-based-on-what-they-throught-the-law-should-s 2023-09-11T03:00:01+10:00 https://pharmadispatch.com/news/hcf-says-flex-my-extras-reinvents-private-health-cover-for-young 2023-09-10T15:08:01+10:00 https://pharmadispatch.com/news/moderna-updates-with-positive-data-of-vaccine-targeting-emerging 2023-09-08T03:00:01+10:00 https://pharmadispatch.com/news/nz-medical-oncologists-call-for-immediate-action-on-cancer-medic 2023-09-08T03:00:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-joins-global-orphan-drug-association 2023-09-08T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-7-september 2023-09-08T03:00:01+10:00 https://pharmadispatch.com/news/pink-hope-to-premiere-documentary-highlighting-the-plight-of-pat 2023-09-07T03:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-warns-against-throwing-the-baby-out-with-the-bathwate 2023-09-07T03:00:01+10:00 https://pharmadispatch.com/news/health-department-launches-much-anticipated-diabetes-tender 2023-09-07T03:00:01+10:00 https://pharmadispatch.com/news/health-department-says-minister-blocked-msac-consideration-of-ex 2023-09-06T03:00:01+10:00 https://pharmadispatch.com/news/merck-launches-new-resource-aimed-at-addressing-low-birth-rates 2023-09-06T03:00:01+10:00 https://pharmadispatch.com/news/competition-regulator-green-lights-amgen-acquisition-of-horizon- 2023-09-06T03:00:01+10:00 https://pharmadispatch.com/news/anger-the-tone-as-pharmacist-workers-rally-outside-and-inside-pa 2023-09-05T03:00:01+10:00 https://pharmadispatch.com/news/we-know-the-minister-has-been-authorised-to-negotiate-the-8cpa-b 2023-09-05T03:00:01+10:00 https://pharmadispatch.com/news/minister-announces-expansion-of-australias-first-endometriosis-a 2023-09-04T17:46:01+10:00 https://pharmadispatch.com/news/pharmac-widens-access-to-roche-haemophilia-and-multiple-sclerosi 2023-09-04T10:42:01+10:00 https://pharmadispatch.com/news/genetic-signatures-submits-to-fda-for-clearance-of-gi-parasite-d 2023-09-04T09:21:01+10:00 https://pharmadispatch.com/news/modernas-craig-rayner-says-its-now-very-hard-to-go-past-australi 2023-09-04T03:00:01+10:00 https://pharmadispatch.com/news/another-two-year-term-for-industry-nominated-pbac-member 2023-09-04T03:00:01+10:00 https://pharmadispatch.com/news/the-lack-of-unity-makes-it-all-too-easy-for-the-government-at-ti 2023-09-04T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-additional-covid-19-vaccines-dose-for-seni 2023-09-04T03:00:01+10:00 https://pharmadispatch.com/news/pharmacs-policy-framework-needs-to-be-updated-says-todd-stephens 2023-09-04T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-1-september 2023-09-01T11:36:01+10:00 https://pharmadispatch.com/news/bms-welcomes-the-listing-of-new-blood-cancer-therapy 2023-09-01T03:00:01+10:00 https://pharmadispatch.com/news/mayne-pharma-looking-to-growth-after-reporting-significant-loss 2023-09-01T03:00:01+10:00 https://pharmadispatch.com/news/another-fragment-on-hta-collaboration-reveals-ongoing-joint-proj 2023-09-01T03:00:01+10:00 https://pharmadispatch.com/news/csl-seqirus-high-potassium-therapy-listed-on-the-pbs-from-today 2023-09-01T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-briefs-members-on-new-strengthening-campaign 2023-08-31T03:00:01+10:00 https://pharmadispatch.com/news/biden-administration-publishes-list-of-the-first-10-medicines-su 2023-08-31T03:00:01+10:00 https://pharmadispatch.com/news/one-day-before-first-tranche-of-changes-but-pharmacy-is-still-fi 2023-08-31T03:00:01+10:00 https://pharmadispatch.com/news/are-there-lessons-for-australia-in-the-failings-of-britains-inno 2023-08-31T03:00:01+10:00 https://pharmadispatch.com/news/community-health-and-well-being-hub-opens-its-doors-in-the-heart 2023-08-30T18:30:01+10:00 https://pharmadispatch.com/news/government-launches-ten-year-roadmap-to-tackle-eating-disorders 2023-08-30T15:52:01+10:00 https://pharmadispatch.com/news/nz-cancer-patient-says-being-told-to-relocate-to-australia-a-har 2023-08-30T03:00:01+10:00 https://pharmadispatch.com/news/is-the-government-really-the-one-paying-double-for-vial-optimisa 2023-08-30T03:00:01+10:00 https://pharmadispatch.com/news/stateofficial-laments-the-reduction-in-revenue-from-the-pbs 2023-08-30T03:00:01+10:00 https://pharmadispatch.com/news/viatris-wins-recognition-at-national-pharmacies-supplier-of-the- 2023-08-30T03:00:01+10:00 https://pharmadispatch.com/news/changing-the-long-tradition-of-costs-eclipsing-benefits-in-healt 2023-08-29T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-neuren-pharmaceuticals-reports-jump-in-first- 2023-08-29T03:00:01+10:00 https://pharmadispatch.com/news/britain-launches-a-new-weight-loss-program-targeting-younger-peo 2023-08-29T03:00:01+10:00 https://pharmadispatch.com/news/chemotherapy-review 2023-08-29T03:00:01+10:00 https://pharmadispatch.com/news/pharmaust-announces-the-appointment-of-new-chief-executive-offic 2023-08-28T10:57:01+10:00 https://pharmadispatch.com/news/new-action-plan-aims-to-boost-sovereign-manufacturing-capability 2023-08-28T10:00:01+10:00 https://pharmadispatch.com/news/do-health-and-the-pbs-come-of-age-as-the-intergenerational-repor 2023-08-28T03:00:01+10:00 https://pharmadispatch.com/news/patient-organisations-declare-medicines-crisis-in-new-zealand 2023-08-28T03:00:01+10:00 https://pharmadispatch.com/news/az-launches-its-own-challenge-of-the-us-price-negotiation-power 2023-08-28T03:00:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-acquires-commercialisation-rights-to-ne 2023-08-28T03:00:01+10:00 https://pharmadispatch.com/news/does-cost-minimisation-actually-mean-cost-ministration-with-a-re 2023-08-28T03:00:01+10:00 https://pharmadispatch.com/news/igr-reinforces-the-isolation-of-health-spending-as-a-cost-to-be- 2023-08-25T03:12:01+10:00 https://pharmadispatch.com/news/australian-company-in-significant-capital-raise-to-progress-eye- 2023-08-25T03:00:01+10:00 https://pharmadispatch.com/news/telix-says-result-reflects-its-transition-to-a-sustainable-comme 2023-08-25T03:00:01+10:00 https://pharmadispatch.com/news/vaxxas-awarded-wellcome-grant-for-needle-free-typhoid-vaccine-pa 2023-08-25T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-25-august 2023-08-24T17:10:01+10:00 https://pharmadispatch.com/news/sadly-some-cancer-patients-may-not-have-this-time 2023-08-24T03:00:01+10:00 https://pharmadispatch.com/news/lilly-goes-for-private-launch-of-first-in-class-diabetes-therapy 2023-08-24T03:00:01+10:00 https://pharmadispatch.com/news/patient-disappointment-over-pharmac-pocketing-savings-rather-tha 2023-08-24T03:00:01+10:00 https://pharmadispatch.com/news/ebos-says-cso-stop-up-will-largely-offset-the-earnings-impact-of 2023-08-24T03:00:01+10:00 https://pharmadispatch.com/news/professor-gives-the-berlin-wall-argument-in-defence-of-pharmac-1 2023-08-23T05:12:01+10:00 https://pharmadispatch.com/news/ausbiotech-invites-nominations-for-its-vacant-board-position 2023-08-23T03:00:01+10:00 https://pharmadispatch.com/news/will-the-sixth-intergenerational-report-be-as-critical-for-the-p 2023-08-22T09:28:01+10:00 https://pharmadispatch.com/news/nz-nationals-commit-to-funding-medicines-for-13-cancer-types 2023-08-22T03:00:01+10:00 https://pharmadispatch.com/news/bupa-says-renewed-partnership-with-healthscope-helping-modernise 2023-08-21T15:38:01+10:00 https://pharmadispatch.com/news/the-prime-minister-opens-csls-new-global-hq-and-rd-centre 2023-08-21T13:39:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-says-dosing-complete-in-first-patient-cohort-fo 2023-08-21T11:36:01+10:00 https://pharmadispatch.com/news/cleo-diagnostics-to-commercialise-australian-developed-ovarian-c 2023-08-21T11:07:01+10:00 https://pharmadispatch.com/news/new-collaboration-aims-to-push-back-against-viruses-with-pandemi 2023-08-21T10:51:01+10:00 https://pharmadispatch.com/news/albanese-government-consulting-on-australias-rna-potential 2023-08-21T10:39:01+10:00 https://pharmadispatch.com/news/nib-delivers-another-year-of-growth-and-continues-ndis-expansion 2023-08-21T09:52:01+10:00 https://pharmadispatch.com/news/report-finds-covid-and-mental-health-drivers-of-growth-in-high-c 2023-08-21T09:33:01+10:00 https://pharmadispatch.com/news/bms-and-abbvie-listed-as-part-of-great-place-to-works-best-workp 2023-08-21T03:00:01+10:00 https://pharmadispatch.com/news/capability-review-delivers-negative-assessment-of-health-departm 2023-08-21T03:00:01+10:00 https://pharmadispatch.com/news/pbac-outcomes-a-win-for-cf-patients-and-az-cancer-therapies 2023-08-21T03:00:01+10:00 https://pharmadispatch.com/news/in-some-respects-the-health-and-aged-care-consumer-is-missing-fr 2023-08-20T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-18-august 2023-08-18T10:40:01+10:00 https://pharmadispatch.com/news/pharmacy-demonstration-set-against-bleak-outlook-as-aged-care-se 2023-08-18T03:00:01+10:00 https://pharmadispatch.com/news/diabetes-tender-will-proceed-after-delay-in-response-to-stakehol 2023-08-18T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-announces-the-first-senior-appointments-to-translational- 2023-08-18T03:00:01+10:00 https://pharmadispatch.com/news/gilead-launches-its-2023-all4liver-grant-program 2023-08-18T03:00:01+10:00 https://pharmadispatch.com/news/suzanne-greenwood-to-step-down-as-pharmacy-guild-executive-direc 2023-08-17T15:33:01+10:00 https://pharmadispatch.com/news/imugene-licenses-allogeneic-car-t-with-potential-registration-st 2023-08-17T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-takes-control-of-covid-19-vaccine-procurement-and-invite 2023-08-17T03:00:01+10:00 https://pharmadispatch.com/news/another-international-hta-collaboration-that-could-be-a-sign-of- 2023-08-17T03:00:01+10:00 https://pharmadispatch.com/news/richard-vines-to-step-down-as-chief-executive-of-rare-cancers-au 2023-08-17T03:00:01+10:00 https://pharmadispatch.com/news/change-in-leadership-for-medicinal-cannabis-company-little-green 2023-08-16T10:37:01+10:00 https://pharmadispatch.com/news/biotron-completes-clinical-phase-of-bit225-covid-19-clinical-tri 2023-08-16T10:10:01+10:00 https://pharmadispatch.com/news/medical-groups-call-for-action-to-address-growing-hospital-waiti 2023-08-16T09:58:01+10:00 https://pharmadispatch.com/news/the-payment-to-wholesalers-might-be-justified-but-why-the-secrec 2023-08-16T04:00:01+10:00 https://pharmadispatch.com/news/a-really-embarrassing-attempt-to-cover-up-the-mistakes-they-have 2023-08-16T03:00:01+10:00 https://pharmadispatch.com/news/cureator-delivers-funding-boost-to-commercially-focused-biomedte 2023-08-16T03:00:01+10:00 https://pharmadispatch.com/news/csl-reports-strong-profit-growth-with-record-plasma-collections 2023-08-15T10:10:01+10:00 https://pharmadispatch.com/news/a-major-day-for-moderna-as-the-company-builds-its-australian-pre 2023-08-15T09:49:01+10:00 https://pharmadispatch.com/news/mark-butler-highlights-additional-funding-record-since-july-last 2023-08-15T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-advisory-committee-recommended-high-priority-therapies-f 2023-08-15T03:00:01+10:00 https://pharmadispatch.com/news/cso-wholesalers-secure-10m-to-compensate-for-business-impacts-of 2023-08-15T03:00:01+10:00 https://pharmadispatch.com/news/medibank-in-partnership-to-study-the-impact-of-exercise-and-supp 2023-08-14T15:57:01+10:00 https://pharmadispatch.com/news/hcf-to-return-another-40-million-in-covid-19-savings-to-members 2023-08-14T14:50:01+10:00 https://pharmadispatch.com/news/ama-calls-for-government-regulation-in-first-position-statement- 2023-08-14T12:09:01+10:00 https://pharmadispatch.com/news/health-department-contradicts-minister-on-medicine-charges-for-a 2023-08-14T03:00:01+10:00 https://pharmadispatch.com/news/new-report-urges-nz-government-to-take-back-medicine-funding-dec 2023-08-14T03:00:01+10:00 https://pharmadispatch.com/news/servatus-strengthens-board-with-appointment-of-biopharmaceutical 2023-08-14T03:00:01+10:00 https://pharmadispatch.com/news/echo-therapeutics-founder-talks-impact-and-new-office-opening 2023-08-13T15:59:01+10:00 https://pharmadispatch.com/news/government-launches-parliamentary-inquiry-into-trade-agreements 2023-08-11T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-tops-patient-group-survey-ahead-of-janssen-and-astrazenec 2023-08-11T03:00:01+10:00 https://pharmadispatch.com/news/government-secures-crossbench-support-to-oppose-disallowance-wit 2023-08-11T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-11-august 2023-08-11T03:00:01+10:00 https://pharmadispatch.com/news/coalition-delays-senate-vote-on-disallowing-dispensing-change 2023-08-10T11:13:01+10:00 https://pharmadispatch.com/news/a-unique-political-problem-that-is-entirely-of-the-governments-m 2023-08-10T03:00:01+10:00 https://pharmadispatch.com/news/amgen-australia-launches-its-first-reconciliation-action-plan 2023-08-10T03:00:01+10:00 https://pharmadispatch.com/news/senate-to-vote-on-disallowance-of-dispensing-change-today 2023-08-10T03:00:01+10:00 https://pharmadispatch.com/news/the-minister-should-not-be-threatening-to-revert-to-making-the-o 2023-08-10T03:00:01+10:00 https://pharmadispatch.com/news/coalition-will-move-to-disallow-increased-in-dispensed-quantitie 2023-08-09T14:47:01+10:00 https://pharmadispatch.com/news/australian-vaccine-breakthrough-offers-hope-against-ebv-associat 2023-08-09T12:01:01+10:00 https://pharmadispatch.com/news/the-worrying-reference-to-past-findings-and-recommendations-of-r 2023-08-09T03:00:01+10:00 https://pharmadispatch.com/news/survey-confirms-pharmacies-already-cutting-jobs-and-services 2023-08-09T03:00:01+10:00 https://pharmadispatch.com/news/industry-frustration-as-counterparts-enjoy-greater-access-to-ins 2023-08-09T03:00:01+10:00 https://pharmadispatch.com/news/wholesalers-secured-relief-from-cso-obligations-ahead-of-quantit 2023-08-09T03:00:01+10:00 https://pharmadispatch.com/news/the-train-has-left-the-station-for-the-next-round-of-changes 2023-08-08T03:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-negotiation-but-says-it-makes-a-mockery-of-the-go 2023-08-08T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-releases-innovate-reconciliation-action-plan 2023-08-08T03:00:01+10:00 https://pharmadispatch.com/news/government-told-rushed-implementation-timeline-risks-shortages 2023-08-08T03:00:01+10:00 https://pharmadispatch.com/news/new-chief-information-officer-for-bupa-asia-pacific 2023-08-07T16:31:01+10:00 https://pharmadispatch.com/news/medibank-releases-its-we-are-lonely-index-revealing-impact-on-yo 2023-08-07T13:21:01+10:00 https://pharmadispatch.com/news/firebrick-pharma-says-nasal-spray-achieved-endpoint-in-covid-19- 2023-08-07T11:51:01+10:00 https://pharmadispatch.com/news/minister-confirms-plan-to-bring-forward-the-negotiation-of-the-8 2023-08-07T09:37:01+10:00 https://pharmadispatch.com/news/after-hearing-the-stories-of-heartbroken-queensland-families-i-h 2023-08-07T03:00:01+10:00 https://pharmadispatch.com/news/novartis-supports-connection-between-cardiovascular-patient-orga 2023-08-07T03:00:01+10:00 https://pharmadispatch.com/news/robodebt-may-not-be-the-only-case-of-officials-sidestepping-lega 2023-08-07T03:00:01+10:00 https://pharmadispatch.com/news/the-starting-point-might-be-the-key-hurdle-to-starting-8cpa-nego 2023-08-07T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-says-increases-quantities-puts-aged-care-at-risk 2023-08-07T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-4-august 2023-08-04T11:53:01+10:00 https://pharmadispatch.com/news/this-secrecy-means-one-privileged-group-us-telling-the-rest-of-u 2023-08-04T03:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-report-reveals-increasing-us-investment-in-australian 2023-08-04T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-says-it-wants-more-transparency-in-hta-revie 2023-08-04T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-new-supply-agreement-for-vaccines 2023-08-04T03:00:01+10:00 https://pharmadispatch.com/news/new-documents-reveal-that-absurd-position-triggered-refusal-to-m 2023-08-03T03:00:01+10:00 https://pharmadispatch.com/news/formed-deputy-pm-this-is-going-to-sound-the-death-knell-chemists 2023-08-03T03:00:01+10:00 https://pharmadispatch.com/news/apparently-were-all-too-dim-to-understand-the-difference-between 2023-08-03T03:00:01+10:00 https://pharmadispatch.com/news/new-research-reveals-23-billion-cost-of-missed-health-checks 2023-08-02T14:18:01+10:00 https://pharmadispatch.com/news/immutep-receives-positive-scientific-advice-from-the-european-me 2023-08-02T14:09:01+10:00 https://pharmadispatch.com/news/international-collaboration-informally-launched-two-years-before 2023-08-02T03:00:01+10:00 https://pharmadispatch.com/news/federal-government-recruiting-for-a-chief-health-economist 2023-08-02T03:00:01+10:00 https://pharmadispatch.com/news/federal-government-reviewing-legislated-confidentiality-protecti 2023-08-02T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-to-expand-access-criteria-for-its-three-funded-covid-19- 2023-08-02T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-marks-the-beginning-of-its-wellness-months-with-the-relea 2023-08-02T03:00:01+10:00 https://pharmadispatch.com/news/auditor-general-now-accepting-submissions-for-pbs-performance-au 2023-08-01T03:00:01+10:00 https://pharmadispatch.com/news/medadvisor-updates-investors-confirming-significant-growth-in-re 2023-08-01T03:00:01+10:00 https://pharmadispatch.com/news/lung-health-scorecard-marks-world-lung-cancer-day 2023-08-01T03:00:01+10:00 https://pharmadispatch.com/news/abbvies-oral-dmard-listed-on-the-pbs-for-arthritis-of-the-spine- 2023-08-01T03:00:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-sarcoma-therapy-listed-on-the-pbs-from- 2023-08-01T03:00:01+10:00 https://pharmadispatch.com/news/former-coalition-mp-joins-alexion-to-head-government-affairs-and 2023-08-01T03:00:01+10:00 https://pharmadispatch.com/news/dementia-grants-to-support-next-generation-of-researchers-1 2023-07-31T10:48:01+10:00 https://pharmadispatch.com/news/gmhba-offers-connected-health-services-under-the-one-roof 2023-07-31T10:31:01+10:00 https://pharmadispatch.com/news/bayer-moves-to-accelerate-and-improve-diagnosis-with-new-radiolo 2023-07-31T05:17:01+10:00 https://pharmadispatch.com/news/guild-pushes-for-disallowance-as-minister-indicates-new-agreemen 2023-07-31T03:00:01+10:00 https://pharmadispatch.com/news/the-process-of-disallowance-of-a-legislative-instrument 2023-07-31T03:00:01+10:00 https://pharmadispatch.com/news/early-negotiation-sounds-good-but-experience-shows-guarantees-ar 2023-07-31T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-28-july 2023-07-28T13:01:01+10:00 https://pharmadispatch.com/news/meaningful-engagement-and-listening-a-key-focus-of-pfizer-sessio 2023-07-28T03:00:01+10:00 https://pharmadispatch.com/news/one-of-australias-most-senior-economic-advisers-says-economics-i 2023-07-28T03:00:01+10:00 https://pharmadispatch.com/news/bruce-goodwin-one-prospect-trials-as-a-platform-for-change 2023-07-28T03:00:01+10:00 https://pharmadispatch.com/news/coalition-call-for-inquiry-extension-in-senate-committee-report 2023-07-27T12:09:01+10:00 https://pharmadispatch.com/news/neuren-receives-us100-million-initial-payment-for-expanded-daybu 2023-07-27T11:49:01+10:00 https://pharmadispatch.com/news/senateshj-expands-capabilities-through-the-acquisition-of-forge- 2023-07-27T10:19:01+10:00 https://pharmadispatch.com/news/nib-appoints-two-new-independent-non-executive-directors 2023-07-27T10:10:01+10:00 https://pharmadispatch.com/news/tga-approval-for-gileads-antibody-drug-conjugate-for-breast-canc 2023-07-27T03:00:01+10:00 https://pharmadispatch.com/news/national-genomics-initiative-gives-23000-people-their-best-chanc 2023-07-27T03:00:01+10:00 https://pharmadispatch.com/news/november-pbac-to-consider-much-anticipated-weight-loss-and-cance 2023-07-27T03:00:01+10:00 https://pharmadispatch.com/news/bupa-says-virtual-medical-support-helps-ease-pressure-on-the-hea 2023-07-26T14:32:01+10:00 https://pharmadispatch.com/news/haemalogix-and-peter-maccallum-cancer-centre-announce-car-t-clin 2023-07-26T13:34:01+10:00 https://pharmadispatch.com/news/private-health-insurer-says-new-app-makes-the-claims-process-fas 2023-07-26T13:13:01+10:00 https://pharmadispatch.com/news/virtual-psychology-providing-relief-from-the-rising-mental-healt 2023-07-26T11:54:01+10:00 https://pharmadispatch.com/news/previous-audit-provides-insight-on-the-recently-launched-process 2023-07-26T03:00:01+10:00 https://pharmadispatch.com/news/the-last-audit-shows-why-more-process-will-never-lead-to-faster- 2023-07-26T03:00:01+10:00 https://pharmadispatch.com/news/stuart-knight-announces-planned-retirement-from-roche-after-30-y 2023-07-26T03:00:01+10:00 https://pharmadispatch.com/news/organon-announces-the-creation-of-strategy-and-business-excellen 2023-07-26T03:00:01+10:00 https://pharmadispatch.com/news/gbma-welcomes-globally-recognised-organisation-as-its-newest-mem 2023-07-25T03:00:01+10:00 https://pharmadispatch.com/news/auditor-general-launches-performance-audit-of-pbs-administration 2023-07-25T03:00:01+10:00 https://pharmadispatch.com/news/unlike-advisory-committees-the-anao-is-actually-and-legally-inde 2023-07-25T03:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-backing-homegrown-australian-innovation 2023-07-24T17:28:01+10:00 https://pharmadispatch.com/news/federation-asset-management-confirms-sale-of-george-clinical 2023-07-24T14:50:01+10:00 https://pharmadispatch.com/news/painaustralia-ceo-announces-head-shave-to-raise-funds-for-young- 2023-07-24T03:00:01+10:00 https://pharmadispatch.com/news/apa-celebrates-at-annual-awards-night-as-ceo-announces-retiremen 2023-07-24T03:00:01+10:00 https://pharmadispatch.com/news/uk-industry-slams-radical-changes-to-clawback-rates-for-branded- 2023-07-24T03:00:01+10:00 https://pharmadispatch.com/news/future-of-qum-remains-in-review-limbo-seven-months-after-nps-shu 2023-07-24T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-21-july 2023-07-21T11:47:01+10:00 https://pharmadispatch.com/news/ausbiotech-blueprint-says-aligned-market-access-critical-to-buil 2023-07-21T03:00:01+10:00 https://pharmadispatch.com/news/viatris-australia-partners-with-national-pharmacies-to-expand-re 2023-07-21T03:00:01+10:00 https://pharmadispatch.com/news/repeated-claims-about-safety-that-often-do-not-reflect-the-reali 2023-07-21T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-brings-its-unique-operating-model-to-the-collaboration 2023-07-21T03:00:01+10:00 https://pharmadispatch.com/news/viiv-healthcare-hosts-workshops-ahead-of-major-global-hiv-confer 2023-07-21T03:00:01+10:00 https://pharmadispatch.com/news/immunisation-coalition-urging-people-with-flu-like-symptoms-to-g 2023-07-20T04:00:01+10:00 https://pharmadispatch.com/news/novartis-and-wesfarmers-launch-nationwide-heart-health-check-scr 2023-07-20T03:00:01+10:00 https://pharmadispatch.com/news/proposed-law-tells-families-to-do-it-our-way-or-lose-any-protect 2023-07-20T03:00:01+10:00 https://pharmadispatch.com/news/stlukeshealth-supports-tasmanians-oral-health-with-new-dental-pr 2023-07-19T18:17:01+10:00 https://pharmadispatch.com/news/australian-company-collaborates-on-us-launch-of-prostate-cancer- 2023-07-19T13:58:01+10:00 https://pharmadispatch.com/news/opal-biosciences-awarded-investment-attraction-fund-grant-by-wa- 2023-07-19T09:54:01+10:00 https://pharmadispatch.com/news/biocurate-in-new-partnership-with-the-european-healthtech-ventur 2023-07-19T09:45:01+10:00 https://pharmadispatch.com/news/first-patient-dosed-in-study-of-telixs-tlx250-with-mercks-pepose 2023-07-19T09:34:01+10:00 https://pharmadispatch.com/news/positive-trial-welcomed-but-early-diagnosis-is-considered-essent 2023-07-19T03:00:01+10:00 https://pharmadispatch.com/news/anao-to-assess-effectiveness-of-health-departments-procurement-o 2023-07-19T03:00:01+10:00 https://pharmadispatch.com/news/baxter-to-build-new-compounding-facility-with-grant-from-wa-gove 2023-07-19T03:00:01+10:00 https://pharmadispatch.com/news/collaboration-is-currently-exploring-the-similarities-and-differ 2023-07-19T03:00:01+10:00 https://pharmadispatch.com/news/industry-rejects-proposed-use-of-health-products-portal-to-manag 2023-07-18T03:00:01+10:00 https://pharmadispatch.com/news/ama-says-tightening-of-tobacco-and-vaping-laws-a-win-for-public- 2023-07-17T15:20:01+10:00 https://pharmadispatch.com/news/abbvies-shruti-chaturvedi-on-the-changing-landscape-for-clinical 2023-07-17T15:03:01+10:00 https://pharmadispatch.com/news/queensland-government-to-combat-flu-outbreak-with-free-vaccine-p 2023-07-17T14:50:01+10:00 https://pharmadispatch.com/news/first-official-day-on-the-job-for-new-health-department-secretar 2023-07-17T03:00:01+10:00 https://pharmadispatch.com/news/its-official-pharmac-and-an-eighth-agency-join-open-and-transpar 2023-07-17T03:00:01+10:00 https://pharmadispatch.com/news/updated-agreement-assumes-partners-will-share-confidential-infor 2023-07-17T03:00:01+10:00 https://pharmadispatch.com/news/neuren-pharmaceuticals-announces-global-expansion-of-agreement-w 2023-07-17T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-14-july 2023-07-14T13:38:01+10:00 https://pharmadispatch.com/news/abbvie-unveils-2023-2024-reflect-reconciliation-action-plan 2023-07-14T03:00:01+10:00 https://pharmadispatch.com/news/there-is-less-information-on-the-international-hta-collaboration 2023-07-14T03:00:01+10:00 https://pharmadispatch.com/news/tga-in-new-partnerships-with-regulators-in-the-pacific-and-south 2023-07-14T03:00:01+10:00 https://pharmadispatch.com/news/wentworth-capital-backs-new-500-million-biomed-and-innovation-ca 2023-07-14T03:00:01+10:00 https://pharmadispatch.com/news/az-wants-more-strategic-and-connected-approach-to-policy-to-prom 2023-07-13T03:00:01+10:00 https://pharmadispatch.com/news/confidential-information-released-47-times-in-six-months-but-wha 2023-07-13T03:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-reports-positive-analysis-of-data-from-phase-2-pxs-550 2023-07-13T03:00:01+10:00 https://pharmadispatch.com/news/msac-support-funding-pharmacists-in-first-nations-primary-health 2023-07-13T03:00:01+10:00 https://pharmadispatch.com/news/victoria-invites-expressions-of-interest-for-industry-rd-infrast 2023-07-12T14:27:01+10:00 https://pharmadispatch.com/news/dylan-alcott-announced-as-nib-brand-ambassador 2023-07-12T09:00:01+10:00 https://pharmadispatch.com/news/hcf-research-foundation-announces-six-recipients-of-translationa 2023-07-12T08:54:01+10:00 https://pharmadispatch.com/news/new-lung-cancer-indication-for-sanofis-immune-checkpoint-inhibit 2023-07-12T03:00:01+10:00 https://pharmadispatch.com/news/albanese-government-to-make-ms-2-step-more-accessible-from-augus 2023-07-12T03:00:01+10:00 https://pharmadispatch.com/news/have-companies-started-counting-their-savings-from-the-health-pr 2023-07-12T03:00:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-invites-bids-for-diabetes-products 2023-07-11T12:54:01+10:00 https://pharmadispatch.com/news/270-pbs-listed-brands-receive-some-form-of-relief-from-stockhold 2023-07-11T03:00:01+10:00 https://pharmadispatch.com/news/updated-anao-work-program-retains-planned-audit-of-pbs-administr 2023-07-11T03:00:01+10:00 https://pharmadispatch.com/news/medical-receptionists-bear-the-brunt-of-patient-aggression 2023-07-10T18:04:01+10:00 https://pharmadispatch.com/news/two-decades-of-targeted-prostate-cancer-treatment-at-brisbane-ho 2023-07-10T14:40:01+10:00 https://pharmadispatch.com/news/new-canberra-hospial-opening-marks-a-new-era-in-mental-health-tr 2023-07-10T13:19:01+10:00 https://pharmadispatch.com/news/adalta-releases-new-data-on-phase-1-trial-of-ad-214-in-idiopathi 2023-07-10T10:05:01+10:00 https://pharmadispatch.com/news/fda-fast-track-designation-for-australian-companys-cancer-candid 2023-07-10T09:54:01+10:00 https://pharmadispatch.com/news/agreement-prohibits-partner-agencies-from-sharing-information-on 2023-07-10T03:00:01+10:00 https://pharmadispatch.com/news/companies-should-think-about-the-hta-collaboration-as-the-vancou 2023-07-10T03:00:01+10:00 https://pharmadispatch.com/news/these-groups-meet-regularly-to-review-progress-and-discuss-ongoi 2023-07-10T03:00:01+10:00 https://pharmadispatch.com/news/msd-australia-secures-double-certification-for-sydney-headquarte 2023-07-07T03:00:01+10:00 https://pharmadispatch.com/news/industry-associations-still-in-the-dark-on-pharmac-and-hta-colla 2023-07-07T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-7-july 2023-07-07T03:00:01+10:00 https://pharmadispatch.com/news/moderna-submits-rsv-vaccine-to-global-regulatory-agencies 2023-07-07T03:00:01+10:00 https://pharmadispatch.com/news/hbf-completes-acquisition-of-queensland-country-health-fund 2023-07-06T05:44:01+10:00 https://pharmadispatch.com/news/moderna-announces-the-appointment-of-legal-and-compliance-direct 2023-07-06T05:15:01+10:00 https://pharmadispatch.com/news/emerging-two-year-bottleneck-for-pbac-appointments 2023-07-06T03:00:01+10:00 https://pharmadispatch.com/news/nib-thrive-buys-digital-ndis-marketplace-platform-kynd 2023-07-06T03:00:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-secretly-joins-international-hta-collaborat 2023-07-06T03:00:01+10:00 https://pharmadispatch.com/news/industry-can-demonstrate-its-commitment-to-patients-by-blocking- 2023-07-06T03:00:01+10:00 https://pharmadispatch.com/news/us-patients-get-a-better-sense-of-what-happens-in-government-pri 2023-07-05T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-reveal-gaps-in-community-perceptions-of-covid-19-risk 2023-07-05T03:00:01+10:00 https://pharmadispatch.com/news/lower-prices-always-sounds-good-but-there-will-be-negative-conse 2023-07-05T03:00:01+10:00 https://pharmadispatch.com/news/takedas-cockpi-t-program-invites-applications-for-funding 2023-07-05T03:00:01+10:00 https://pharmadispatch.com/news/nutromics-to-progress-wearable-diagnostic-platform-with-latest-c 2023-07-04T07:10:01+10:00 https://pharmadispatch.com/news/patients-and-company-welcome-new-form-of-key-cancer-therapy 2023-07-04T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-set-for-annual-board-election-as-australian- 2023-07-04T03:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-announces-the-significant-expansion-of-reforestation 2023-07-04T03:00:01+10:00 https://pharmadispatch.com/news/medibank-executives-join-vinnies-ceo-sleepout-in-melbourne 2023-07-03T12:25:01+10:00 https://pharmadispatch.com/news/most-australians-experiencing-dry-or-irritated-eyes-in-colder-mo 2023-07-03T12:08:01+10:00 https://pharmadispatch.com/news/ready-to-use-hexavalent-vaccine-added-to-the-national-immunisati 2023-07-03T03:00:01+10:00 https://pharmadispatch.com/news/a-new-head-of-medical-for-biogen-australia-and-new-zealand 2023-07-03T03:00:01+10:00 https://pharmadispatch.com/news/how-many-times-does-this-need-to-happen-before-something-is-done 2023-07-03T03:00:01+10:00 https://pharmadispatch.com/news/new-pbs-listing-for-people-living-with-rare-autoimmune-blood-dis 2023-07-02T13:53:01+10:00 https://pharmadispatch.com/news/our-goal-has-to-be-equitable-access-for-all-patients-globally 2023-07-02T10:49:01+10:00 https://pharmadispatch.com/news/cynata-therapeutics-announces-ceo-succession-and-board-changes 2023-07-02T09:59:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-30-june 2023-06-30T12:51:01+10:00 https://pharmadispatch.com/news/government-formally-introduces-transitional-arrangement 2023-06-30T03:00:01+10:00 https://pharmadispatch.com/news/roche-australia-announces-new-partnership-with-rural-doctors-fou 2023-06-30T03:00:01+10:00 https://pharmadispatch.com/news/new-pbs-listing-for-people-living-with-the-duo-of-diabetes-and-k 2023-06-30T03:00:01+10:00 https://pharmadispatch.com/news/life-sciences-leaders-join-other-business-leaders-in-vinnies-ceo 2023-06-30T03:00:01+10:00 https://pharmadispatch.com/news/new-podcast-urges-stakeholders-to-speak-out-on-access-to-new-tec 2023-06-30T03:00:01+10:00 https://pharmadispatch.com/news/pfizers-dr-emma-andrews-of-the-importance-of-listening-more-and- 2023-06-30T03:00:01+10:00 https://pharmadispatch.com/news/its-broken-promise-and-the-minister-has-chosen-to-rely-on-a-syst 2023-06-29T03:00:01+10:00 https://pharmadispatch.com/news/companies-face-higher-cost-recovery-fees-with-an-increase-of-up- 2023-06-29T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-microba-launches-clinical-development-of-ibd- 2023-06-29T03:00:01+10:00 https://pharmadispatch.com/news/new-pfizer-commissioned-research-highlights-the-benefit-of-addre 2023-06-28T03:00:01+10:00 https://pharmadispatch.com/news/this-is-the-most-consequential-campaign-in-the-history-of-the-pb 2023-06-28T03:00:01+10:00 https://pharmadispatch.com/news/tga-approves-specialised-therapeutics-new-blood-cancer-therapy 2023-06-28T03:00:01+10:00 https://pharmadispatch.com/news/us-based-industry-group-launches-legal-action-against-price-sett 2023-06-27T03:00:01+10:00 https://pharmadispatch.com/news/younger-consumers-want-more-value-and-choices-from-health-insura 2023-06-27T03:00:01+10:00 https://pharmadispatch.com/news/exclusive-pharmacy-guild-launches-campaign-targeting-eight-margi 2023-06-27T03:00:01+10:00 https://pharmadispatch.com/news/ustr-appoints-new-assistant-with-oversight-of-australian-trade-d 2023-06-27T03:00:01+10:00 https://pharmadispatch.com/news/new-leadership-and-a-new-era-starts-for-australias-regulator 2023-06-27T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-73-million-for-19-medtech-and-facility-gra 2023-06-26T15:32:01+10:00 https://pharmadispatch.com/news/mrna-victoria-grant-for-university-bioengineers-to-fast-track-br 2023-06-26T15:07:01+10:00 https://pharmadispatch.com/news/yeast-dust-makes-a-cheap-fast-virus-sensor-for-human-animal-and- 2023-06-26T10:18:01+10:00 https://pharmadispatch.com/news/hbf-starts-returning-110-million-in-covid-19-savings-to-its-memb 2023-06-26T10:08:01+10:00 https://pharmadispatch.com/news/didnt-you-think-to-ask-that-before-you-put-the-measure-in-place 2023-06-26T03:00:01+10:00 https://pharmadispatch.com/news/industry-makes-the-list-of-finalists-for-australian-hr-awards 2023-06-26T03:00:01+10:00 https://pharmadispatch.com/news/frustration-and-rising-anger-as-states-look-to-re-home-odtp-pati 2023-06-26T03:00:01+10:00 https://pharmadispatch.com/news/no-need-for-reviews-or-new-processes-just-direct-them-to-do-it 2023-06-26T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-23-june 2023-06-23T13:34:01+10:00 https://pharmadispatch.com/news/how-can-the-solution-be-the-same-people-having-the-same-discussi 2023-06-23T05:46:01+10:00 https://pharmadispatch.com/news/how-can-the-solution-be-the-same-people-having-the-same-discussi 2023-06-23T03:00:01+10:00 https://pharmadispatch.com/news/ma-says-new-research-adds-to-the-evidence-of-the-need-for-real-c 2023-06-23T03:00:01+10:00 https://pharmadispatch.com/news/csl-to-host-jumar-bioincubator-at-new-global-headquarters 2023-06-23T03:00:01+10:00 https://pharmadispatch.com/news/patient-group-expresses-concern-over-planned-diabetes-tender 2023-06-22T03:00:01+10:00 https://pharmadispatch.com/news/this-was-all-supposed-to-start-from-july-this-year-well-guess-wh 2023-06-22T03:00:01+10:00 https://pharmadispatch.com/news/after-four-years-of-obfuscation-the-government-expects-this-grou 2023-06-22T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-opens-consultation-opens-on-new-national-hepatitis-s 2023-06-21T17:19:01+10:00 https://pharmadispatch.com/news/ama-backs-parliamentary-move-to-restrict-junk-food-advertising 2023-06-21T13:46:01+10:00 https://pharmadispatch.com/news/pha-says-health-funds-best-placed-to-deliver-access-to-dental-ca 2023-06-21T13:27:01+10:00 https://pharmadispatch.com/news/greens-and-crossbencher-join-the-coalition-in-criticising-govern 2023-06-21T04:32:01+10:00 https://pharmadispatch.com/news/global-market-access-head-says-review-an-opportunity-for-austral 2023-06-21T03:00:01+10:00 https://pharmadispatch.com/news/arrotex-targets-growing-biosimilars-with-the-launch-of-new-biolo 2023-06-21T03:00:01+10:00 https://pharmadispatch.com/news/majority-unaware-of-risk-factors-that-could-result-in-heart-fail 2023-06-21T03:00:01+10:00 https://pharmadispatch.com/news/transitional-arrangements-required-after-review-missed-legal-pro 2023-06-20T03:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-the-potential-gains-from-earlier-gains-to- 2023-06-20T03:00:01+10:00 https://pharmadispatch.com/news/prime-minister-says-constructive-dialogue-underway-with-communit 2023-06-19T15:20:01+10:00 https://pharmadispatch.com/news/avita-medical-announces-fda-approval-of-recell-for-skin-repigmen 2023-06-19T12:15:01+10:00 https://pharmadispatch.com/news/first-patient-dosed-in-study-of-tlx250-cdx-exploring-indication- 2023-06-19T12:07:01+10:00 https://pharmadispatch.com/news/wehis-professor-doug-hilton-appointed-chief-executive-of-csiro-1 2023-06-19T12:06:01+10:00 https://pharmadispatch.com/news/wehis-professor-doug-hilton-appointed-chief-executive-of-csiro 2023-06-19T11:58:01+10:00 https://pharmadispatch.com/news/construction-milestone-achieved-for-cancer-centre-and-research-h 2023-06-19T11:37:01+10:00 https://pharmadispatch.com/news/pcpa-launches-digital-platform-to-help-members-meet-new-cpd-rule 2023-06-19T11:37:01+10:00 https://pharmadispatch.com/news/private-health-insurers-say-albanese-government-should-review-mo 2023-06-19T10:57:01+10:00 https://pharmadispatch.com/news/earlier-treatment-with-gileads-car-t-therapy-delivers-on-overall 2023-06-19T03:00:01+10:00 https://pharmadispatch.com/news/novartis-secures-recommendation-for-six-monthly-cholesterol-lowe 2023-06-19T03:00:01+10:00 https://pharmadispatch.com/news/new-research-protocol-to-aid-the-pbacs-assessment-of-pbs-listing 2023-06-19T03:00:01+10:00 https://pharmadispatch.com/news/tga-confirms-fee-adjustments-in-response-to-stakeholder-feedback 2023-06-19T03:00:01+10:00 https://pharmadispatch.com/news/vaxxas-opens-needle-free-vaccine-manufacturing-site-and-global-h 2023-06-19T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-advance-podcast-16-june 2023-06-16T12:47:01+10:00 https://pharmadispatch.com/news/pfizer-says-hta-review-must-deliver-change-beyond-technical-meth 2023-06-16T03:00:01+10:00 https://pharmadispatch.com/news/tga-lodges-instrument-announcing-new-cost-recovery-activity-fees 2023-06-16T03:00:01+10:00 https://pharmadispatch.com/news/federal-agencies-to-face-regular-reviews-under-changes-before-pa 2023-06-16T03:00:01+10:00 https://pharmadispatch.com/news/is-this-the-first-indication-that-a-negotiated-outcome-is-possib 2023-06-15T03:00:01+10:00 https://pharmadispatch.com/news/sector-to-pay-for-the-latest-stalled-reform-with-another-surpris 2023-06-15T03:00:01+10:00 https://pharmadispatch.com/news/senate-launches-a-new-inquiry-into-rare-and-less-common-cancers 2023-06-15T03:00:01+10:00 https://pharmadispatch.com/news/bupa-pulse-check-reveals-that-nutrition-is-a-major-gap-in-oral-h 2023-06-14T17:23:01+10:00 https://pharmadispatch.com/news/currency-shifts-hit-csl-guidance-as-higher-fees-impact-plasma-co 2023-06-14T16:49:01+10:00 https://pharmadispatch.com/news/wesfarmers-api-to-acquire-telehealth-and-prescription-provider-i 2023-06-14T03:00:01+10:00 https://pharmadispatch.com/news/change-is-coming-following-an-appointment-that-indicates-a-great 2023-06-14T03:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-says-yes-to-weight-loss-medicines-but-in-a-wider-fram 2023-06-14T03:00:01+10:00 https://pharmadispatch.com/news/roche-australia-childrens-walk-celebrates-20-years-of-making-a-d 2023-06-13T20:43:01+10:00 https://pharmadispatch.com/news/mark-butler-welcomes-new-health-department-secretary 2023-06-13T11:40:01+10:00 https://pharmadispatch.com/news/new-medicines-australia-group-aims-to-drive-sustainability-acros 2023-06-13T04:00:01+10:00 https://pharmadispatch.com/news/if-the-prime-minister-has-changed-his-mind-he-can-call-me-and-ex 2023-06-13T03:00:01+10:00 https://pharmadispatch.com/news/recognition-for-pbac-chair-leading-oncologist-and-patient-advoca 2023-06-13T03:00:01+10:00 https://pharmadispatch.com/news/private-health-insurers-use-hta-review-submission-to-call-for-co 2023-06-13T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-highlights-the-cost-of-living-challenge-on-health-ins 2023-06-12T18:29:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-most-see-living-with-covid-19-as-the-new-norm 2023-06-09T03:00:01+10:00 https://pharmadispatch.com/news/industry-leaders-join-biointelects-new-executive-strategy-panel 2023-06-09T03:00:01+10:00 https://pharmadispatch.com/news/nz-patients-welcome-biosimilar-but-disappointed-at-failure-to-ex 2023-06-09T03:00:01+10:00 https://pharmadispatch.com/news/bms-welcomes-one-stop-shop-for-clinical-trials-as-an-important-s 2023-06-09T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-9-june 2023-06-08T15:42:01+10:00 https://pharmadispatch.com/news/avita-medical-announces-us-approval-of-recell-for-full-thickness 2023-06-08T13:58:01+10:00 https://pharmadispatch.com/news/new-report-reveals-crippling-impact-of-double-dispensed-quantiti 2023-06-08T03:00:01+10:00 https://pharmadispatch.com/news/new-report-confirms-negative-impact-and-highlights-the-risk-of-u 2023-06-08T03:00:01+10:00 https://pharmadispatch.com/news/england-launches-two-year-pilot-to-fund-access-to-weight-loss-me 2023-06-08T03:00:01+10:00 https://pharmadispatch.com/news/msd-launches-legal-action-against-the-us-government-over-price-n 2023-06-08T03:00:01+10:00 https://pharmadispatch.com/news/tga-approval-for-janssens-car-t-therapy-for-blood-cancer 2023-06-08T03:00:01+10:00 https://pharmadispatch.com/news/paralympians-curtis-shae-and-ben-sign-on-as-bupa-ambassadors 2023-06-07T16:07:01+10:00 https://pharmadispatch.com/news/kinoxis-therapeutics-secures-us-government-grant-to-progress-dru 2023-06-07T15:46:01+10:00 https://pharmadispatch.com/news/neuren-pharmaceuticals-receives-milestone-payment-from-us-partne 2023-06-07T15:37:01+10:00 https://pharmadispatch.com/news/government-delays-the-implementation-of-major-pl-reform 2023-06-07T15:27:01+10:00 https://pharmadispatch.com/news/vaxxas-appoints-former-pfizer-executive-as-chief-medical-officer 2023-06-07T03:00:01+10:00 https://pharmadispatch.com/news/protestors-to-march-on-nzs-beehive-in-call-for-change-on-propose 2023-06-07T03:00:01+10:00 https://pharmadispatch.com/news/lack-of-consultation-causing-confusion-and-concern-with-just-wee 2023-06-07T03:00:01+10:00 https://pharmadispatch.com/news/gilead-launches-new-round-of-funding-for-australian-medical-rese 2023-06-07T03:00:01+10:00 https://pharmadispatch.com/news/sigma-healthcare-wins-chemist-warehouse-pbs-supply-contract 2023-06-06T09:21:01+10:00 https://pharmadispatch.com/news/minister-working-on-transition-arrangements-for-private-odtp-cli 2023-06-06T03:00:01+10:00 https://pharmadispatch.com/news/a-third-revision-for-scheduled-national-diabetes-services-scheme 2023-06-06T03:00:01+10:00 https://pharmadispatch.com/news/immvirx-raising-25-million-to-be-led-by-healthcare-vc-oneventure 2023-06-05T16:37:01+10:00 https://pharmadispatch.com/news/bupa-announces-health-boost-for-the-big-issue-vendors 2023-06-05T11:21:01+10:00 https://pharmadispatch.com/news/hcf-launches-industry-first-pilot-qr-code-claiming-for-extras-se 2023-06-05T10:27:01+10:00 https://pharmadispatch.com/news/chimeric-launches-phase-1-trial-of-chm-1101-in-glioblastoma 2023-06-05T10:17:01+10:00 https://pharmadispatch.com/news/aravax-launches-new-phase-2-trial-of-peanut-allergy-candidate 2023-06-05T10:07:01+10:00 https://pharmadispatch.com/news/emerging-vaccines-are-key-to-combat-the-leadingcause-of-childhoo 2023-06-05T03:00:01+10:00 https://pharmadispatch.com/news/contradiction-causes-confusion-over-the-timing-of-major-diabetes 2023-06-05T03:00:01+10:00 https://pharmadispatch.com/news/health-department-officials-attempt-to-reword-key-election-commi 2023-06-05T03:00:01+10:00 https://pharmadispatch.com/news/list-of-impacted-medicines-not-provided-until-fifth-and-final-me 2023-06-05T03:00:01+10:00 https://pharmadispatch.com/news/viatris-publishes-2022-report-on-its-progress-on-sustainable-acc 2023-06-05T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-2-june 2023-06-02T13:59:01+10:00 https://pharmadispatch.com/news/aat-had-to-decide-between-inaccurate-evidence-or-the-deliberate- 2023-06-02T03:00:01+10:00 https://pharmadispatch.com/news/the-matter-is-closed-but-the-outcome-highlights-the-need-for-tra 2023-06-02T03:00:01+10:00 https://pharmadispatch.com/news/msd-welcomes-a-new-listing-for-keytruda-in-combination-with-eisa 2023-06-02T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-backs-ministers-concerns-over-clunky-hta-dec 2023-06-02T03:00:01+10:00 https://pharmadispatch.com/news/officials-face-questions-on-60-day-dispensing-as-pharmacists-des 2023-06-02T03:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-asking-people-to-dig-deep-to-support-its- 2023-06-01T16:29:01+10:00 https://pharmadispatch.com/news/antengene-welcomes-a-new-option-for-myeloma-patients 2023-06-01T03:00:01+10:00 https://pharmadispatch.com/news/sun-pharmas-cequa-now-reimbursed-for-chronic-severe-dry-eye-dise 2023-06-01T03:00:01+10:00 https://pharmadispatch.com/news/chiesis-medicinal-cannabis-listed-on-the-pbs-for-severe-form-of- 2023-06-01T03:00:01+10:00 https://pharmadispatch.com/news/law-firm-joins-gbma-as-its-latest-associate-member 2023-06-01T03:00:01+10:00 https://pharmadispatch.com/news/fifth-australian-healthcare-index-reveals-further-decline-in-pat 2023-06-01T03:00:01+10:00 https://pharmadispatch.com/news/latest-report-confirms-ongoing-impact-of-pandemic-on-hospitalisa 2023-05-31T11:33:01+10:00 https://pharmadispatch.com/news/new-report-reveals-many-women-feel-unprepared-for-menopause 2023-05-31T11:32:01+10:00 https://pharmadispatch.com/news/new-report-calls-reveals-the-benefits-of-a-greater-focus-on-out- 2023-05-31T11:31:01+10:00 https://pharmadispatch.com/news/the-system-can-innovate-for-patients-when-it-wants-but-history-s 2023-05-31T03:00:01+10:00 https://pharmadispatch.com/news/new-paper-calls-for-a-greater-focus-on-enhancing-patient-input-t 2023-05-31T03:00:01+10:00 https://pharmadispatch.com/news/health-minister-mark-butler-initiates-parliamentary-inquiry-into 2023-05-31T03:00:01+10:00 https://pharmadispatch.com/news/minister-says-the-system-is-clunky-and-its-a-fact-that-people-ar 2023-05-31T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-raises-further-doubts-over-the-governments-plan-for-d 2023-05-31T03:00:01+10:00 https://pharmadispatch.com/news/ndis-growth-still-accelerating-as-it-prepares-for-sustainability 2023-05-30T03:00:01+10:00 https://pharmadispatch.com/news/this-is-about-more-than-dispensed-quantities-its-about-the-futur 2023-05-30T03:00:01+10:00 https://pharmadispatch.com/news/orthocell-taps-former-health-sector-leader-to-chair-its-board 2023-05-29T11:35:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-grants-for-programs-in-mental-ill-health-a 2023-05-29T11:26:01+10:00 https://pharmadispatch.com/news/abbvie-puts-sustainability-on-the-agenda-at-major-dermatology-me 2023-05-29T03:00:01+10:00 https://pharmadispatch.com/news/bi-backed-angels-initiative-passes-1000-registrations-for-acute- 2023-05-29T03:00:01+10:00 https://pharmadispatch.com/news/organon-backs-recommendations-of-senate-report-into-reproductive 2023-05-29T03:00:01+10:00 https://pharmadispatch.com/news/new-petition-calls-on-albanese-government-to-deliver-on-election 2023-05-29T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-podcast-26-may 2023-05-26T07:55:01+10:00 https://pharmadispatch.com/news/what-was-the-point-of-asking-for-pbac-advice-after-dismissing-th 2023-05-26T03:00:01+10:00 https://pharmadispatch.com/news/gilead-joins-in-as-private-cancer-physicians-of-australia-launch 2023-05-26T03:00:01+10:00 https://pharmadispatch.com/news/viatris-leaders-talk-about-a-safety-first-culture-and-making-a-p 2023-05-26T03:00:01+10:00 https://pharmadispatch.com/news/every-element-of-progress-is-important-and-every-step-we-take-is 2023-05-26T03:00:01+10:00 https://pharmadispatch.com/news/cyteph-secures-vital-funding-for-brain-cancer-immunotherapy-phas 2023-05-25T03:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-reports-positive-results-from-trial-of-pxs6302 2023-05-25T03:00:01+10:00 https://pharmadispatch.com/news/wider-listing-for-janssens-prostate-cancer-therapy-welcomed 2023-05-25T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-marks-reimbursement-of-biomarins-achondroplasia-ther 2023-05-25T03:00:01+10:00 https://pharmadispatch.com/news/cartherics-to-present-at-the-2023-bio-international-convention 2023-05-24T09:29:01+10:00 https://pharmadispatch.com/news/the-minister-should-not-have-asked-and-the-committee-should-not- 2023-05-24T03:00:01+10:00 https://pharmadispatch.com/news/updated-approach-to-market-suggests-a-delay-in-planned-cgm-tende 2023-05-24T03:00:01+10:00 https://pharmadispatch.com/news/edited-highlights-from-discussions-at-the-biopharmadispatch-conf 2023-05-23T20:24:01+10:00 https://pharmadispatch.com/news/introduction-of-60-day-quantities-to-delay-other-pbs-listing-pro 2023-05-23T03:00:01+10:00 https://pharmadispatch.com/news/paig-to-host-annual-roundtable-to-discuss-achievements-and-futur 2023-05-23T03:00:01+10:00 https://pharmadispatch.com/news/new-resource-aims-to-improve-health-outcomes-for-australians-liv 2023-05-23T03:00:01+10:00 https://pharmadispatch.com/news/the-full-vox-pop-from-the-2023-biopharmadispatch-conference 2023-05-23T03:00:01+10:00 https://pharmadispatch.com/news/wholesalers-call-for-consultation-to-avoid-a-pandemic-like-surge 2023-05-23T03:00:01+10:00 https://pharmadispatch.com/news/new-mental-health-clinic-helping-ease-burden-on-tasmanians 2023-05-22T14:35:01+10:00 https://pharmadispatch.com/news/victorian-based-digital-health-companies-selected-for-inaugural- 2023-05-22T14:22:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-receives-grant-to-collaborate-with-csiro 2023-05-22T14:15:01+10:00 https://pharmadispatch.com/news/kidney-health-australia-urges-people-to-take-a-two-minute-kidney 2023-05-22T09:00:01+10:00 https://pharmadispatch.com/news/community-shows-support-for-hbf-run-for-a-reason-with-successful 2023-05-22T08:39:01+10:00 https://pharmadispatch.com/news/medibank-backed-east-sydney-private-hospital-unveils-new-operati 2023-05-22T08:13:01+10:00 https://pharmadispatch.com/news/lundbeck-welcomes-great-place-to-work-certification-for-the-sixt 2023-05-22T03:00:01+10:00 https://pharmadispatch.com/news/there-is-nothing-mature-and-orderly-about-the-way-this-has-been- 2023-05-22T03:00:01+10:00 https://pharmadispatch.com/news/csl-seqirus-achieves-major-milestone-in-the-construction-of-new- 2023-05-22T03:00:01+10:00 https://pharmadispatch.com/news/anne-ruston-says-the-governments-own-assessment-has-exposed-its- 2023-05-19T03:00:01+10:00 https://pharmadispatch.com/news/new-zealand-scraps-patient-co-payment-for-funded-prescription-me 2023-05-19T03:00:01+10:00 https://pharmadispatch.com/news/bayer-unveils-new-operating-model-for-australian-pharmaceutical- 2023-05-19T03:00:01+10:00 https://pharmadispatch.com/news/im-really-looking-forward-to-senate-estimates-and-questioning-of 2023-05-19T03:00:01+10:00 https://pharmadispatch.com/news/vertex-welcomes-extended-approval-for-cystic-fibrosis-therapy 2023-05-19T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-video-podcast-19-april 2023-05-18T12:27:01+10:00 https://pharmadispatch.com/news/sigma-says-increase-in-dispensed-quantities-will-have-a-knock-on 2023-05-18T03:00:01+10:00 https://pharmadispatch.com/news/biogen-to-sponsor-powerchair-football-world-cup-in-sydney 2023-05-18T03:00:01+10:00 https://pharmadispatch.com/news/positive-results-for-trial-of-australian-companys-cancer-candida 2023-05-18T03:00:01+10:00 https://pharmadispatch.com/news/my-members-are-angry-and-emotional-and-there-will-need-to-be-a-d 2023-05-18T03:00:01+10:00 https://pharmadispatch.com/news/trent-twomey-says-pre-budget-discussions-based-on-2018-advice-an 2023-05-18T03:00:01+10:00 https://pharmadispatch.com/news/australians-asked-to-leave-a-light-on-to-support-organ-and-tissu 2023-05-17T19:52:01+10:00 https://pharmadispatch.com/news/government-investing-enormous-political-capital-in-a-highly-comp 2023-05-17T03:00:01+10:00 https://pharmadispatch.com/news/bms-australia-receives-accreditation-from-great-places-to-work 2023-05-17T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-welcomes-backflip-on-asthma-medicine-restrictions 2023-05-17T03:00:01+10:00 https://pharmadispatch.com/news/the-sits-and-sounds-of-the-2023-biopharmadispatch-conference 2023-05-17T03:00:01+10:00 https://pharmadispatch.com/news/minister-and-shadow-at-odds-over-plan-to-double-dispensed-quanti 2023-05-16T04:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-medicinal-cannabis-industry-association 2023-05-16T04:00:01+10:00 https://pharmadispatch.com/news/merck-backing-indigenous-communities-in-creating-a-new-approach- 2023-05-16T03:00:01+10:00 https://pharmadispatch.com/news/butler-still-managing-the-lingering-impact-of-the-catch-up-statu 2023-05-15T03:00:01+10:00 https://pharmadispatch.com/news/the-minister-did-not-need-the-committees-advice-to-reverse-these 2023-05-15T03:00:01+10:00 https://pharmadispatch.com/news/companies-facing-a-major-increase-in-pbs-and-nipcost-recovery-fe 2023-05-15T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-shows-australian-specialists-want-faster-access-to-in 2023-05-15T03:00:01+10:00 https://pharmadispatch.com/news/hta-review-confirms-appointment-of-experts-ahead-of-meeting-with 2023-05-12T02:00:01+10:00 https://pharmadispatch.com/news/crossbench-senator-wants-transitional-arrangements-for-60-day-di 2023-05-12T02:00:01+10:00 https://pharmadispatch.com/news/curiosity-in-response-to-mysterious-e-prescribing-budget-measure 2023-05-12T02:00:01+10:00 https://pharmadispatch.com/news/the-2023-24-budget-week-in-review-podcast-11-may 2023-05-12T01:00:01+10:00 https://pharmadispatch.com/news/credit-to-mark-butler-and-now-is-the-time-to-make-sure-this-neve 2023-05-11T02:01:01+10:00 https://pharmadispatch.com/news/post-market-review-identified-cost-and-stigma-as-barriers-to-tre 2023-05-11T02:00:01+10:00 https://pharmadispatch.com/news/credit-to-mark-butler-and-now-is-the-time-to-make-sure-this-neve 2023-05-11T02:00:01+10:00 https://pharmadispatch.com/news/pfizer-reaffirms-support-for-uluru-statement-and-a-voice-to-parl 2023-05-11T02:00:01+10:00 https://pharmadispatch.com/news/pbs-growth-is-now-almost-inevitable-because-of-the-impact-of-new 2023-05-11T02:00:01+10:00 https://pharmadispatch.com/news/far-from-stagnating-the-pbs-has-delivered-record-growth-and-is-o 2023-05-10T02:00:01+10:00 https://pharmadispatch.com/news/new-saving-from-pharmaceuticals-hidden-in-mysterious-budget-meas 2023-05-10T02:00:01+10:00 https://pharmadispatch.com/news/australias-medtech-biotech-and-pharma-sector-to-benefit-from-new 2023-05-10T02:00:01+10:00 https://pharmadispatch.com/news/budget-creates-ndis-expert-advisory-panel-and-looks-to-leverage- 2023-05-10T02:00:01+10:00 https://pharmadispatch.com/news/change-coming-for-odtp-but-some-concern-over-the-lack-of-detail 2023-05-10T02:00:01+10:00 https://pharmadispatch.com/news/australian-company-to-supply-bayer-with-illuccix-for-prostate-ca 2023-05-09T03:58:01+10:00 https://pharmadispatch.com/news/new-report-highlights-the-need-for-change-on-nhra-funded-therapi 2023-05-09T03:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-the-development-and-adoption-of-a-national- 2023-05-09T03:00:01+10:00 https://pharmadispatch.com/news/caution-required-given-the-sectors-experience-with-the-contingen 2023-05-09T03:00:01+10:00 https://pharmadispatch.com/news/only-in-the-rarefied-world-of-a-government-agency-does-removing- 2023-05-08T03:00:01+10:00 https://pharmadispatch.com/news/why-the-industry-should-have-been-consulted-on-increasing-dispen 2023-05-08T03:00:01+10:00 https://pharmadispatch.com/news/singapore-approval-for-specialised-therapeutics-cancer-therapy 2023-05-08T03:00:01+10:00 https://pharmadispatch.com/news/integrity-and-trust-must-be-marbled-into-every-aspect-of-policy- 2023-05-08T03:00:01+10:00 https://pharmadispatch.com/news/minister-wants-the-ndis-to-adopt-a-pbs-decision-making-framework 2023-05-05T03:00:01+10:00 https://pharmadispatch.com/news/experts-meet-to-push-for-progress-on-new-zealands-hepatitis-c-el 2023-05-05T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guilds-trent-twomey-confirmed-for-bpd-annual-conference 2023-05-05T03:00:01+10:00 https://pharmadispatch.com/news/the-pre-budget-week-in-review-podcast-5-may 2023-05-05T02:57:01+10:00 https://pharmadispatch.com/news/minister-encourages-industry-groups-to-come-forward-with-practic 2023-05-04T03:00:01+10:00 https://pharmadispatch.com/news/annual-scientific-meeting-to-focus-on-access-and-affordability 2023-05-04T03:00:01+10:00 https://pharmadispatch.com/news/lillys-investigative-alzheimers-treatment-slowed-disease-progres 2023-05-04T03:00:01+10:00 https://pharmadispatch.com/news/tga-confirms-reduction-in-paracetamol-pack-sizes-from-2025 2023-05-04T03:00:01+10:00 https://pharmadispatch.com/news/new-analysis-reveals-devastating-impact-of-double-dispensed-quan 2023-05-04T03:00:01+10:00 https://pharmadispatch.com/news/naccho-2023-aboriginal-and-torres-strait-islander-pharmacist-sch 2023-05-03T19:19:01+10:00 https://pharmadispatch.com/news/two-significant-people-and-culture-appointments-for-sanofi 2023-05-03T03:00:01+10:00 https://pharmadispatch.com/news/organon-australia-launches-its-first-reconciliation-action-plan 2023-05-03T03:00:01+10:00 https://pharmadispatch.com/news/pbac-provided-advice-because-it-was-requested-during-the-budget- 2023-05-03T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-moves-to-ban-vape-trade-and-plans-changes-to-pharmac 2023-05-03T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-launches-grass-roots-campaign-against-60-day-disp 2023-05-02T03:00:01+10:00 https://pharmadispatch.com/news/hta-review-reference-committee-starts-directing-its-expert 2023-05-02T03:00:01+10:00 https://pharmadispatch.com/news/bms-australia-confirms-support-for-uluru-statement-from-the-hear 2023-05-02T03:00:01+10:00 https://pharmadispatch.com/news/a-real-milestone-for-the-achondroplasia-community-said-dr-kathry 2023-05-02T03:00:01+10:00 https://pharmadispatch.com/news/does-this-indicate-a-new-era-of-the-health-policy-hunger-games-1 2023-05-01T05:57:01+10:00 https://pharmadispatch.com/news/patients-now-waiting-for-the-detail-of-medicare-reform-package 2023-05-01T04:00:01+10:00 https://pharmadispatch.com/news/pbac-to-reconsider-novartis-cholesterol-lowering-biologic-at-int 2023-05-01T04:00:01+10:00 https://pharmadispatch.com/news/novartis-welcomes-the-pbs-listing-of-new-blood-cancer-therapy 2023-05-01T04:00:01+10:00 https://pharmadispatch.com/news/does-this-indicate-a-new-era-of-the-health-policy-hunger-games 2023-05-01T03:00:01+10:00 https://pharmadispatch.com/news/may-listings-include-new-treatment-options-patients-with-ulcerat 2023-05-01T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-28-april 2023-04-28T13:00:01+10:00 https://pharmadispatch.com/news/the-enemy-of-my-enemy-is-friend-is-no-way-to-approach-policy-dev 2023-04-28T00:00:01+10:00 https://pharmadispatch.com/news/mark-butler-set-to-announce-affordability-reforms-of-medicines-f 2023-04-28T00:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-appoints-new-leadership-for-local-animal-he 2023-04-28T00:00:01+10:00 https://pharmadispatch.com/news/nominations-open-for-2023-gsk-award-for-research-excellence 2023-04-28T00:00:01+10:00 https://pharmadispatch.com/news/do-the-officials-responsible-for-this-policy-understand-or-even- 2023-04-27T03:00:01+10:00 https://pharmadispatch.com/news/monash-launches-initiative-to-tackle-access-issues-in-low-and-mi 2023-04-27T03:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-blowout-in-wait-times-for-funded-access-in-nz 2023-04-27T03:00:01+10:00 https://pharmadispatch.com/news/an-fair-political-calculation-to-make-but-its-unlikely-to-be-tha 2023-04-26T03:46:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-community-concern-over-change-to-dispensed-qu 2023-04-26T03:00:01+10:00 https://pharmadispatch.com/news/cannatrek-foundation-to-provide-support-for-veterans-and-first-r 2023-04-25T11:32:01+10:00 https://pharmadispatch.com/news/new-data-shows-that-half-of-australians-did-not-visit-the-dentis 2023-04-25T10:59:01+10:00 https://pharmadispatch.com/news/oncosil-announces-presentation-of-oncosil-clinical-outcomes-data 2023-04-24T18:30:01+10:00 https://pharmadispatch.com/news/twelve-recognised-for-results-in-mas-continuing-education-progra 2023-04-24T17:51:01+10:00 https://pharmadispatch.com/news/modernas-original-covid-19-vaccine-becomes-the-first-to-receive- 2023-04-24T15:51:01+10:00 https://pharmadispatch.com/news/moderna-australia-appoints-regional-lead-for-integrated-evidence 2023-04-24T12:56:01+10:00 https://pharmadispatch.com/news/us-industry-groups-welcome-courts-interim-decision-on-mifepristo 2023-04-24T12:29:01+10:00 https://pharmadispatch.com/news/renewable-electricity-deal-puts-bupa-on-course-to-achieve-2025-c 2023-04-24T12:17:01+10:00 https://pharmadispatch.com/news/parliamentary-committee-calls-for-expanded-access-to-covid-19-an 2023-04-24T10:31:01+10:00 https://pharmadispatch.com/news/emyria-adds-to-its-pipeline-with-new-high-potency-cannabidiol-do 2023-04-24T10:08:01+10:00 https://pharmadispatch.com/news/mark-butler-directs-more-funding-to-long-covid-research-in-respo 2023-04-24T09:29:01+10:00 https://pharmadispatch.com/news/much-anticipated-innovative-therapies-secure-pbac-recommendation 2023-04-24T03:00:01+10:00 https://pharmadispatch.com/news/mixed-outcome-for-diabetes-medicines-following-pbac-review 2023-04-24T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-wins-recognition-as-the-best-place-to-work-in-the-health- 2023-04-24T03:00:01+10:00 https://pharmadispatch.com/news/patient-groups-expresses-deep-disappointment-over-lack-of-progre 2023-04-24T03:00:01+10:00 https://pharmadispatch.com/news/it-would-be-nice-to-assume-the-impact-of-this-change-has-been-pr 2023-04-24T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-21-april 2023-04-21T13:03:01+10:00 https://pharmadispatch.com/news/sanofi-opens-50000-grants-to-boost-community-based-vaccination-e 2023-04-21T03:00:01+10:00 https://pharmadispatch.com/news/health-department-capability-review-in-drafting-stage 2023-04-21T03:00:01+10:00 https://pharmadispatch.com/news/new-data-reveals-significant-disparity-in-access-to-treatment-fo 2023-04-21T03:00:01+10:00 https://pharmadispatch.com/news/albanese-government-triggers-fight-with-pharmacy-ahead-of-budget 2023-04-21T03:00:01+10:00 https://pharmadispatch.com/news/company-launches-expanded-manufacturing-capability-at-melbourne- 2023-04-20T03:00:01+10:00 https://pharmadispatch.com/news/non-disclosure-agreements-do-not-preclude-the-senate-from-seekin 2023-04-20T03:00:01+10:00 https://pharmadispatch.com/news/industry-minister-launches-the-latest-bridge-commercialisation-t 2023-04-20T03:00:01+10:00 https://pharmadispatch.com/news/major-milestone-for-emerging-australian-pharmaceutical-company 2023-04-19T03:00:01+10:00 https://pharmadispatch.com/news/the-secret-pharmacy-clause-that-has-been-online-for-three-years 2023-04-19T03:00:01+10:00 https://pharmadispatch.com/news/telix-reports-first-quarter-of-100-million-in-revenue 2023-04-19T03:00:01+10:00 https://pharmadispatch.com/news/minister-highlights-the-importance-of-lived-experience-in-decisi 2023-04-19T03:00:01+10:00 https://pharmadispatch.com/news/positive-results-in-trial-of-modernas-cancer-vaccine-in-combinat 2023-04-18T03:00:01+10:00 https://pharmadispatch.com/news/hta-review-chair-to-lead-investigation-into-cultural-and-probity 2023-04-18T03:00:01+10:00 https://pharmadispatch.com/news/new-study-shows-the-symptoms-of-long-covid-mirror-those-for-infl 2023-04-17T15:22:01+10:00 https://pharmadispatch.com/news/atmo-biosciences-builds-us-focus-with-board-appointment-and-san- 2023-04-17T14:48:01+10:00 https://pharmadispatch.com/news/immutep-announces-initiation-of-phase-23-trial-of-efti-in-metast 2023-04-17T14:00:01+10:00 https://pharmadispatch.com/news/scholarships-provide-support-for-first-nations-future-health-pro 2023-04-17T13:51:01+10:00 https://pharmadispatch.com/news/proto-axiom-invests-in-university-of-sydney-spin-out-endoaxiom 2023-04-17T12:43:01+10:00 https://pharmadispatch.com/news/telix-says-olaratumab-antibody-licensed-from-lilly-demonstrates- 2023-04-17T12:30:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-announced-new-supply-agreement-for-terbi 2023-04-17T12:18:01+10:00 https://pharmadispatch.com/news/are-these-just-examples-of-poor-behaviour-or-do-they-reflect-a-d 2023-04-17T03:00:01+10:00 https://pharmadispatch.com/news/phrma-joins-action-against-court-ruling-to-ban-fda-approved-medi 2023-04-17T03:00:01+10:00 https://pharmadispatch.com/news/four-weeks-until-the-sixth-annual-biopharmadispatch-conference 2023-04-17T03:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-14-april 2023-04-14T12:17:01+10:00 https://pharmadispatch.com/news/us-industry-association-joins-action-against-court-ruling-to-ove 2023-04-14T03:00:01+10:00 https://pharmadispatch.com/news/choice-of-new-health-department-secretary-is-ultimately-a-decisi 2023-04-14T03:00:01+10:00 https://pharmadispatch.com/news/pharmalex-expands-anz-footprint-through-merger-with-pharmacovigi 2023-04-14T03:00:01+10:00 https://pharmadispatch.com/news/bridgewest-appoints-juno-pharmaceuticals-as-sales-and-marketing- 2023-04-14T03:00:01+10:00 https://pharmadispatch.com/news/health-department-secretary-announces-his-planned-retirement 2023-04-13T09:44:01+10:00 https://pharmadispatch.com/news/key-mechanism-identified-for-reducing-chronic-inflammation-in-ca 2023-04-13T09:16:01+10:00 https://pharmadispatch.com/news/just-another-example-of-the-failed-smash-and-grab-approach-to-po 2023-04-13T03:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-adds-combination-arm-to-pxs5505-myelofibrosis-study 2023-04-13T03:00:01+10:00 https://pharmadispatch.com/news/first-ceo-amongst-new-executive-appointments-for-palin-communica 2023-04-13T03:00:01+10:00 https://pharmadispatch.com/news/psa-calls-for-action-from-new-south-wales-on-funding-nip-vaccine 2023-04-12T14:51:01+10:00 https://pharmadispatch.com/news/first-patient-on-trial-in-colorectal-gastric-and-ovarian-cancer- 2023-04-12T12:29:01+10:00 https://pharmadispatch.com/news/dementia-grants-program-to-provide-new-support-for-18-research-p 2023-04-12T09:08:01+10:00 https://pharmadispatch.com/news/hcf-research-foundation-seeking-a-new-round-of-funding-applicati 2023-04-12T08:54:01+10:00 https://pharmadispatch.com/news/mayne-pharma-completes-divestment-of-us-generics-business 2023-04-12T03:00:01+10:00 https://pharmadispatch.com/news/treasurer-issues-another-pre-budget-warning-about-the-need-for-s 2023-04-12T03:00:01+10:00 https://pharmadispatch.com/news/industry-leaders-unite-in-response-to-us-courts-ruling-that-over 2023-04-12T03:00:01+10:00 https://pharmadispatch.com/news/bayer-to-defend-itself-vigorously-in-response-to-class-action 2023-04-12T03:00:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-secures-regional-rights-to-immuno-oncol 2023-04-12T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-welcomes-the-launch-of-hta-review-consultati 2023-04-12T03:00:01+10:00 https://pharmadispatch.com/news/conditionality-means-transforming-the-pbac-into-a-decision-makin 2023-04-11T03:00:01+10:00 https://pharmadispatch.com/news/building-confidence-in-existing-arrangements-is-the-most-obvious 2023-04-11T03:00:01+10:00 https://pharmadispatch.com/news/building-confidence-in-existing-arrangements-is-the-most-obvious 2023-04-11T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-adds-new-therapies-to-the-life-saving-drugs-program- 2023-04-11T03:00:01+10:00 https://pharmadispatch.com/news/stlukeshealth-survey-reveals-high-levels-of-vaping-concern 2023-04-10T13:26:01+10:00 https://pharmadispatch.com/news/medibanks-amplar-health-delivering-extended-north-coast-health-c 2023-04-10T13:09:01+10:00 https://pharmadispatch.com/news/the-week-in-review-6-april 2023-04-06T12:31:01+10:00 https://pharmadispatch.com/news/australians-rush-to-cgm-but-long-shadow-of-the-tender-still-loom 2023-04-06T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-launches-new-campaign-in-support-of-another-co-pa 2023-04-06T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-widens-access-to-trikafta-ahead-of-may-budget 2023-04-06T03:00:01+10:00 https://pharmadispatch.com/news/launch-of-new-connected-health-innovation-and-commercialisation- 2023-04-05T13:47:01+10:00 https://pharmadispatch.com/news/botanix-secures-investor-commitments-to-progress-its-lead-develo 2023-04-05T13:13:01+10:00 https://pharmadispatch.com/news/ma-leadership-on-ambitions-for-the-hta-review-and-what-the-gover 2023-04-05T12:16:01+10:00 https://pharmadispatch.com/news/patient-voice-aotearoa-calls-action-on-slow-moving-train-wreck-o 2023-04-05T03:00:01+10:00 https://pharmadispatch.com/news/give-patients-the-power-to-direct-decision-making-rather-than-ju 2023-04-05T03:00:01+10:00 https://pharmadispatch.com/news/summit-paper-shows-consensus-on-the-need-to-improve-policy-proce 2023-04-05T03:00:01+10:00 https://pharmadispatch.com/news/tga-priority-review-designation-for-modernas-mrna-rsv-vaccine 2023-04-04T16:49:01+10:00 https://pharmadispatch.com/news/pharmac-launches-consultation-on-the-future-use-of-msds-covid-19 2023-04-04T15:24:01+10:00 https://pharmadispatch.com/news/private-health-insurers-and-leading-doctor-group-welcome-medicar 2023-04-04T15:10:01+10:00 https://pharmadispatch.com/news/optiscan-imaging-established-us-commercial-operation-in-minnesot 2023-04-04T14:44:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-enrols-first-patient-in-trial-of-ath434-mu 2023-04-04T14:29:01+10:00 https://pharmadispatch.com/news/health-department-says-catch-up-reduction-implemented-as-intende 2023-04-04T03:00:01+10:00 https://pharmadispatch.com/news/the-time-from-pbac-minutes-to-pbs-listing-date-was-an-average-of 2023-04-04T03:00:01+10:00 https://pharmadispatch.com/news/albanese-government-restates-commitment-to-listing-pbac-recommen 2023-04-04T03:00:01+10:00 https://pharmadispatch.com/news/medtronic-survey-reveals-a-shift-in-attitudes-to-type-1-diabetes 2023-04-03T10:50:01+10:00 https://pharmadispatch.com/news/firebrick-pharma-completes-recruitment-of-covid-19-nasal-spray-t 2023-04-03T10:37:01+10:00 https://pharmadispatch.com/news/ama-disputes-medicare-compliance-claims-as-review-finds-errors-t 2023-04-03T09:04:01+10:00 https://pharmadispatch.com/news/the-link-between-a-pbs-program-and-a-defunct-chaplaincy-in-schoo 2023-04-03T03:00:01+10:00 https://pharmadispatch.com/news/companies-clinicians-and-patients-welcome-april-listings 2023-04-03T03:00:01+10:00 https://pharmadispatch.com/news/hta-review-reference-committee-pushing-for-greater-transparency 2023-04-02T16:00:01+10:00 https://pharmadispatch.com/news/the-week-in-review-31-march 2023-03-31T14:09:01+11:00 https://pharmadispatch.com/news/the-arduous-journey-to-the-biggest-day-of-pbs-price-cuts-is-almo 2023-03-31T03:00:01+11:00 https://pharmadispatch.com/news/roche-in-new-partnership-to-collect-and-remove-waste-from-sydney 2023-03-31T03:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-a-greater-focus-on-adult-immuniaation-rates 2023-03-31T03:00:01+11:00 https://pharmadispatch.com/news/is-the-albanese-government-backtracking-on-this-election-commitm 2023-03-31T03:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-concerning-levels-of-complacency-over-flu 2023-03-30T03:00:01+11:00 https://pharmadispatch.com/news/industry-groups-welcome-senate-backing-for-national-reconstructi 2023-03-30T03:00:01+11:00 https://pharmadispatch.com/news/could-this-be-the-first-step-in-the-process-of-reimposing-refere 2023-03-30T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-goes-early-with-confirmed-expanded-listing-of-bms-im 2023-03-30T03:00:01+11:00 https://pharmadispatch.com/news/government-further-expands-access-to-pfizers-covid-19-antiviral 2023-03-30T03:00:01+11:00 https://pharmadispatch.com/news/orthocell-appoints-us-based-nerve-surgeons-to-medical-advisory-b 2023-03-29T14:04:01+11:00 https://pharmadispatch.com/news/medibank-announces-the-retirement-of-technology-and-operations-h 2023-03-29T12:20:01+11:00 https://pharmadispatch.com/news/hcf-research-foundation-partners-with-racgp-to-support-gp-resear 2023-03-29T08:58:01+11:00 https://pharmadispatch.com/news/brisbane-based-company-targets-major-global-market 2023-03-29T08:37:01+11:00 https://pharmadispatch.com/news/the-government-program-that-is-adding-a-new-pbs-every-24-months 2023-03-29T03:00:01+11:00 https://pharmadispatch.com/news/senate-launches-inquiry-into-adhd-that-will-consider-access-to-m 2023-03-29T03:00:01+11:00 https://pharmadispatch.com/news/a-new-executive-line-up-for-nurse-led-patient-organisation 2023-03-29T03:00:01+11:00 https://pharmadispatch.com/news/coalition-pressing-the-government-on-major-pbs-issues 2023-03-29T03:00:01+11:00 https://pharmadispatch.com/news/delivery-qum-hits-hiatus-as-transition-to-commission-progresses 2023-03-28T03:00:01+11:00 https://pharmadispatch.com/news/documents-reveal-bureaucratic-attempt-to-scrap-former-government 2023-03-28T03:00:01+11:00 https://pharmadispatch.com/news/new-study-reveals-gaps-in-the-awareness-of-epilepsy-its-impact-a 2023-03-27T16:45:01+11:00 https://pharmadispatch.com/news/health-department-an-agreement-lacks-legitimacy-unless-we-negoti 2023-03-27T13:22:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-and-genesiscare-partner-on-development-o 2023-03-27T11:03:01+11:00 https://pharmadispatch.com/news/hbf-announces-new-110-million-member-pandemic-cashback 2023-03-27T09:32:01+11:00 https://pharmadispatch.com/news/a-price-cut-imposed-on-medicines-funded-through-a-program-that-d 2023-03-27T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-is-moving-to-fix-this-program-but-he-might-also-seek 2023-03-27T03:00:01+11:00 https://pharmadispatch.com/news/tga-wants-import-controls-and-warnings-on-nicotine-vaping-produc 2023-03-27T03:00:01+11:00 https://pharmadispatch.com/news/shadow-health-minister-confirmed-for-2023-bpd-annual-conference 2023-03-26T16:28:01+11:00 https://pharmadispatch.com/news/the-week-in-review-24-march 2023-03-24T11:12:01+11:00 https://pharmadispatch.com/news/medicines-australia-says-no-to-double-digit-tga-fee-increase 2023-03-24T03:00:01+11:00 https://pharmadispatch.com/news/expos-reveals-pharmacs-strategy-of-avoiding-media-included-runni 2023-03-24T03:00:01+11:00 https://pharmadispatch.com/news/communications-is-no-substitute-for-better-decision-making 2023-03-24T03:00:01+11:00 https://pharmadispatch.com/news/gsk-australia-advances-support-for-emerging-industry-talent 2023-03-23T16:18:01+11:00 https://pharmadispatch.com/news/csl-seqirus-seasonal-flu-vaccine-now-available-via-private-provi 2023-03-23T03:00:01+11:00 https://pharmadispatch.com/news/audit-office-still-planning-to-review-pbs-administration 2023-03-23T03:00:01+11:00 https://pharmadispatch.com/news/ma-acknowledges-review-terms-of-reference-that-are-mostly-unchan 2023-03-23T03:00:01+11:00 https://pharmadispatch.com/news/anne-ruston-challenges-minister-over-band-aid-solution-for-diabe 2023-03-23T00:00:01+11:00 https://pharmadispatch.com/news/ama-says-new-study-highlights-the-serious-risks-of-nicotine-vape 2023-03-22T15:18:01+11:00 https://pharmadispatch.com/news/funding-deployed-to-accelerate-global-australian-digital-health- 2023-03-22T13:31:01+11:00 https://pharmadispatch.com/news/industry-groups-unite-and-call-on-senate-to-back-national-recons 2023-03-22T03:00:01+11:00 https://pharmadispatch.com/news/parliament-house-event-to-focus-on-the-need-for-action-on-geneti 2023-03-22T03:00:01+11:00 https://pharmadispatch.com/news/nz-government-proposes-banning-discussion-about-unapproved-medic 2023-03-22T03:00:01+11:00 https://pharmadispatch.com/news/faster-patient-access-must-be-the-north-star-for-hta-review 2023-03-22T03:00:01+11:00 https://pharmadispatch.com/news/final-discretion-outcomes-as-minister-attributes-patient-distres 2023-03-22T03:00:01+11:00 https://pharmadispatch.com/news/bayer-welcomes-new-indication-for-prostate-cancer-therapy 2023-03-22T03:00:01+11:00 https://pharmadispatch.com/news/brandon-biocatalyst-with-andhealth-to-deliver-biomedtech-incubat 2023-03-21T14:15:01+11:00 https://pharmadispatch.com/news/a-career-change-inspired-by-the-emergence-of-targeted-cancer-the 2023-03-21T03:00:01+11:00 https://pharmadispatch.com/news/arthritis-groups-unite-to-call-for-urgent-action-on-its-rising-i 2023-03-21T03:00:01+11:00 https://pharmadispatch.com/news/ombudsmans-state-of-the-health-funds-report-confirms-a-decline-i 2023-03-20T17:04:01+11:00 https://pharmadispatch.com/news/aurora-healthcare-and-medibank-partner-to-boost-access-to-mental 2023-03-20T16:05:01+11:00 https://pharmadispatch.com/news/bupa-puts-first-nations-health-at-the-centre-of-reconciliation-a 2023-03-20T15:55:01+11:00 https://pharmadispatch.com/news/monash-university-in-new-partnership-with-leading-israeli-resear 2023-03-20T15:20:01+11:00 https://pharmadispatch.com/news/australian-company-clinuvel-initiates-second-trial-of-new-anti-s 2023-03-20T14:07:01+11:00 https://pharmadispatch.com/news/organon-partners-with-foundation-to-relaunch-no-limits-4-girls-p 2023-03-20T04:00:01+11:00 https://pharmadispatch.com/news/moderna-officially-launches-australian-mrna-fellowship-program 2023-03-20T03:00:01+11:00 https://pharmadispatch.com/news/one-didnt-ask-and-it-appears-that-the-other-didnt-want-to-do-the 2023-03-20T03:00:01+11:00 https://pharmadispatch.com/news/industry-teams-raise-close-to-400000-as-msd-takes-pharma-cup 2023-03-20T03:00:01+11:00 https://pharmadispatch.com/news/everybody-says-that-about-their-strategy-but-this-is-why-its-dif 2023-03-18T11:56:01+11:00 https://pharmadispatch.com/news/the-week-in-review-17-march 2023-03-17T12:10:01+11:00 https://pharmadispatch.com/news/its-a-finely-made-point-that-raises-more-questions-than-it-answe 2023-03-17T08:55:01+11:00 https://pharmadispatch.com/news/beigene-president-on-why-the-company-chooses-disruption 2023-03-17T05:21:01+11:00 https://pharmadispatch.com/news/proteomics-says-it-will-resubmit-promarkerd-predictive-test-for- 2023-03-17T03:00:01+11:00 https://pharmadispatch.com/news/company-team-fundraising-hits-surgs-with-just-one-day-to-go 2023-03-17T03:00:01+11:00 https://pharmadispatch.com/news/first-of-its-kind-study-now-recruiting-australians-on-insulin-th 2023-03-16T03:00:01+11:00 https://pharmadispatch.com/news/kosi-challenge-fast-approaching-as-fundraising-total-races-past- 2023-03-16T03:00:01+11:00 https://pharmadispatch.com/news/patient-group-wants-a-rethink-on-pain-management-decision 2023-03-16T03:00:01+11:00 https://pharmadispatch.com/news/interim-analysis-shows-accuracy-of-optiscan-imagings-platform 2023-03-15T13:24:01+11:00 https://pharmadispatch.com/news/patrys-says-preclinical-data-supports-synthetic-lethality-mechan 2023-03-15T08:42:01+11:00 https://pharmadispatch.com/news/the-uncomfortable-truth-for-the-industry-of-a-new-budget-reality 2023-03-15T03:00:01+11:00 https://pharmadispatch.com/news/the-great-curiosity-of-this-savings-and-where-its-being-spent 2023-03-15T03:00:01+11:00 https://pharmadispatch.com/news/what-does-this-decision-say-about-the-review-process-and-the-lik 2023-03-15T03:00:01+11:00 https://pharmadispatch.com/news/immutep-announces-the-initiation-of-a-new-breast-cancer-trial 2023-03-14T11:32:01+11:00 https://pharmadispatch.com/news/bupa-says-raising-awareness-a-first-step-to-addressing-the-risk- 2023-03-14T11:13:01+11:00 https://pharmadispatch.com/news/supply-chain-facing-significant-pressures-ahead-of-catch-up-redu 2023-03-14T03:00:01+11:00 https://pharmadispatch.com/news/ssanofi-launches-recruitment-drive-for-its-translational-science 2023-03-14T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-announces-us43bn-acquisition-of-cancer-medicines-company 2023-03-14T03:00:01+11:00 https://pharmadispatch.com/news/the-long-wait-is-finally-over-for-new-zealands-lung-cancer-patie 2023-03-13T11:32:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-funding-for-mitochondrial-donation-pilot-p 2023-03-13T10:30:01+11:00 https://pharmadispatch.com/news/medibanks-amplar-health-extends-to-partnership-aimed-at-addressi 2023-03-13T10:24:01+11:00 https://pharmadispatch.com/news/australian-company-surges-on-fda-approval-of-innovative-therapy 2023-03-13T09:53:01+11:00 https://pharmadispatch.com/news/biden-administration-doubles-down-with-move-to-extend-pricing-po 2023-03-13T03:00:01+11:00 https://pharmadispatch.com/news/msd-still-leading-the-way-with-less-than-a-week-until-the-kosi-c 2023-03-13T03:00:01+11:00 https://pharmadispatch.com/news/government-commits-10m-to-media-buy-for-covid-19-booster-campaig 2023-03-13T03:00:01+11:00 https://pharmadispatch.com/news/the-minister-has-the-power-but-the-costand-precedent-might-be-ba 2023-03-13T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-10-march 2023-03-10T10:08:01+11:00 https://pharmadispatch.com/news/another-opportunity-to-reflect-on-whether-this-industry-is-askin 2023-03-10T03:00:01+11:00 https://pharmadispatch.com/news/an-unprecedented-insight-into-how-the-government-prepares-its-bu 2023-03-10T03:00:01+11:00 https://pharmadispatch.com/news/uk-nice-says-to-funding-novo-nordisks-weight-loss-therapy 2023-03-10T03:00:01+11:00 https://pharmadispatch.com/news/confidential-information-is-considered-to-be-information-that-is 2023-03-10T03:00:01+11:00 https://pharmadispatch.com/news/gbma-announces-appointment-of-two-new-board-members 2023-03-10T03:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-announces-new-recipients-of-positive-action-comm 2023-03-09T05:17:01+11:00 https://pharmadispatch.com/news/clifford-hallam-upgrades-systems-critical-to-pbs-cso-compliance 2023-03-09T03:00:01+11:00 https://pharmadispatch.com/news/more-pressure-on-pharmac-over-the-political-statements-of-its-ch 2023-03-09T03:00:01+11:00 https://pharmadispatch.com/news/government-compromise-to-secure-senate-support-for-tga-changes 2023-03-09T03:00:01+11:00 https://pharmadispatch.com/news/medibank-partners-with-racgp-to-fund-research-into-digital-healt 2023-03-08T10:25:01+11:00 https://pharmadispatch.com/news/we-just-want-to-say-thank-you-its-as-simple-as-that 2023-03-08T05:23:01+11:00 https://pharmadispatch.com/news/government-hunt-for-new-savings-will-target-existing-programs 2023-03-08T03:00:01+11:00 https://pharmadispatch.com/news/parliament-backs-medical-device-reforms-but-process-reveals-lack 2023-03-08T03:00:01+11:00 https://pharmadispatch.com/news/federal-government-extends-appointment-of-pbac-chair-to-2024 2023-03-08T03:00:01+11:00 https://pharmadispatch.com/news/younger-new-zealand-cf-patients-get-the-jump-on-those-in-austral 2023-03-08T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-obviously-were-looking-at-all-of-those-options 2023-03-07T05:33:01+11:00 https://pharmadispatch.com/news/novartis-launches-new-partnership-aimed-at-boosting-cv-care-and- 2023-03-07T03:00:01+11:00 https://pharmadispatch.com/news/australia-not-alone-in-pricing-disputes-as-uk-industry-looks-for 2023-03-07T03:00:01+11:00 https://pharmadispatch.com/news/excess-deaths-climb-to-nearly-20000-for-australia-in-2022 2023-03-06T12:12:01+11:00 https://pharmadispatch.com/news/greenlight-clinical-and-cure-therapeutics-look-to-future-collabo 2023-03-06T11:23:01+11:00 https://pharmadispatch.com/news/new-research-reveals-mental-health-and-chronic-illness-concerns 2023-03-06T10:29:01+11:00 https://pharmadispatch.com/news/starpharma-announces-the-appointment-of-chief-financial-officer 2023-03-06T09:33:01+11:00 https://pharmadispatch.com/news/abbvie-announces-the-appointment-of-a-new-medical-director 2023-03-06T03:00:01+11:00 https://pharmadispatch.com/news/the-race-for-pharma-cup-tightens-with-two-weeks-to-go 2023-03-06T03:00:01+11:00 https://pharmadispatch.com/news/if-this-is-the-outcome-then-the-approach-is-all-wrong-and-needs- 2023-03-06T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-lauds-the-impact-of-general-co-payment-reduction 2023-03-06T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-issues-vague-and-non-committal-response-to-critical-revi 2023-03-06T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-3-march 2023-03-03T10:13:01+11:00 https://pharmadispatch.com/news/sanofi-launches-the-joint-forces-hub-to-support-haemophilia-comm 2023-03-03T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-confirm-leadership-for-cell-a 2023-03-03T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-confirm-leadership-for-cell-a 2023-03-03T03:00:01+11:00 https://pharmadispatch.com/news/eli-lilly-officially-welcomes-employees-to-its-new-sydney-cbd-of 2023-03-03T03:00:01+11:00 https://pharmadispatch.com/news/what-does-this-companys-response-say-about-the-state-of-pbs-poli 2023-03-03T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-confirms-the-exit-of-key-bdmard-in-response-to-catch-up-r 2023-03-03T03:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-announces-the-creation-of-a-new-chronic-disease-bus 2023-03-03T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-confirms-widened-access-for-the-funded-flu-vaccine 2023-03-02T13:06:01+11:00 https://pharmadispatch.com/news/neuren-pharmaceuticals-appoints-experienced-industry-executive-t 2023-03-02T13:00:01+11:00 https://pharmadispatch.com/news/organon-australia-lifts-the-bar-with-significant-extension-to-em 2023-03-02T03:00:01+11:00 https://pharmadispatch.com/news/reports-suggest-pfizer-is-in-talks-to-acquire-us-based-cancer-th 2023-03-02T03:00:01+11:00 https://pharmadispatch.com/news/companies-make-the-list-of-employer-gender-equality-citation-hol 2023-03-02T03:00:01+11:00 https://pharmadispatch.com/news/confirmed-delays-in-response-to-significant-volume-of-other-pbs- 2023-03-02T03:00:01+11:00 https://pharmadispatch.com/news/csl-seqirus-secures-australia-nz-rights-to-cardiovascular-therap 2023-03-02T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-launches-the-joint-forces-hub-to-support-haemophilia-comm 2023-03-02T03:00:01+11:00 https://pharmadispatch.com/news/abbvie-celebrates-recognition-as-leader-in-workplace-gender-equi 2023-03-01T03:01:01+11:00 https://pharmadispatch.com/news/would-it-have-been-better-to-ask-these-questions-two-years-ago-1 2023-03-01T03:01:01+11:00 https://pharmadispatch.com/news/amgen-supported-undergraduates-showcased-at-melbourne-connect-sy 2023-03-01T03:00:01+11:00 https://pharmadispatch.com/news/expanded-reimbursement-for-melanoma-immuno-oncology-combination- 2023-03-01T03:00:01+11:00 https://pharmadispatch.com/news/patients-killing-time-as-wait-continues-for-full-response-to-pha 2023-03-01T03:00:01+11:00 https://pharmadispatch.com/news/abbvie-celebrates-recognition-as-leader-in-workplace-gender-equi 2023-03-01T03:00:01+11:00 https://pharmadispatch.com/news/amgen-supported-undergraduates-showcased-at-melbourne-connect-sy 2023-03-01T03:00:01+11:00 https://pharmadispatch.com/news/government-secures-additional-moderna-doses-and-releases-respons 2023-03-01T03:00:01+11:00 https://pharmadispatch.com/news/merck-partners-with-access-australia-in-fertility-focused-podcas 2023-03-01T03:00:01+11:00 https://pharmadispatch.com/news/new-us-trade-report-challenges-china-over-pharmaceutical-practic 2023-02-28T03:00:01+11:00 https://pharmadispatch.com/news/peter-mac-and-cartherics-in-new-collaboration-to-develop-car-t-t 2023-02-28T03:00:01+11:00 https://pharmadispatch.com/news/csl-reports-positive-results-from-pivotal-late-stage-trial-of-fi 2023-02-28T03:00:01+11:00 https://pharmadispatch.com/news/pharmacs-rare-disorders-advisory-committee-to-consider-several-t 2023-02-28T03:00:01+11:00 https://pharmadispatch.com/news/trajan-raised-full-year-guidance-after-delivering-a-strong-first 2023-02-27T14:24:01+11:00 https://pharmadispatch.com/news/nib-survey-reveals-progress-on-health-habits-at-the-end-of-pande 2023-02-27T11:52:01+11:00 https://pharmadispatch.com/news/dr-rachel-david-calls-for-action-to-keep-retirement-savings-safe 2023-02-27T11:40:01+11:00 https://pharmadispatch.com/news/private-cancer-physicians-partners-with-industry-on-new-patient- 2023-02-27T09:18:01+11:00 https://pharmadispatch.com/news/mtpconnect-appoints-former-victorian-minister-as-its-new-chair 2023-02-27T09:06:01+11:00 https://pharmadispatch.com/news/leukaemia-foundation-calls-for-action-on-too-many-blood-cancer-d 2023-02-27T08:49:01+11:00 https://pharmadispatch.com/news/australians-aged-over-50-urged-not-to-downplay-the-risk-of-shing 2023-02-27T03:00:01+11:00 https://pharmadispatch.com/news/we-are-only-at-the-start-of-this-bad-and-unfair-policy 2023-02-27T03:00:01+11:00 https://pharmadispatch.com/news/latest-discretion-outcomes-provide-more-relief-including-for-the 2023-02-27T03:00:01+11:00 https://pharmadispatch.com/news/industry-teams-are-close-to-breaking-through-a-major-fundraising 2023-02-27T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-17-february-1 2023-02-24T10:56:01+11:00 https://pharmadispatch.com/news/industry-facing-a-decade-of-hefty-increases-in-tga-fees-and-char 2023-02-24T06:12:01+11:00 https://pharmadispatch.com/news/transparency-and-accountability-are-not-optional 2023-02-24T03:00:01+11:00 https://pharmadispatch.com/news/us-based-industry-says-price-controls-already-impacting-rd-decis 2023-02-24T03:00:01+11:00 https://pharmadispatch.com/news/industry-facing-a-decade-of-hefty-increases-in-tga-fees-and-char 2023-02-24T03:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-partners-through-art-to-highlight-the-experience 2023-02-24T03:00:01+11:00 https://pharmadispatch.com/news/australia-key-part-of-the-global-plan-for-emerging-biopharmaceut 2023-02-23T05:13:01+11:00 https://pharmadispatch.com/news/discretion-process-is-not-over-until-theres-a-decision-on-every- 2023-02-23T05:13:01+11:00 https://pharmadispatch.com/news/patients-will-be-a-focus-of-the-sixth-annual-biopharmadispatch-c 2023-02-23T05:13:01+11:00 https://pharmadispatch.com/news/sanofi-celebrates-with-peers-at-macquarie-park-pride-forum 2023-02-23T03:00:01+11:00 https://pharmadispatch.com/news/patient-groups-and-cardiologists-call-for-urgent-reform-of-medic 2023-02-22T14:46:01+11:00 https://pharmadispatch.com/news/hcf-announced-a-third-deferral-of-approved-premium-increase 2023-02-22T14:36:01+11:00 https://pharmadispatch.com/news/australias-most-senior-bureaucrat-says-contact-lifeline-if-it-is 2023-02-22T03:00:01+11:00 https://pharmadispatch.com/news/richard-vines-a-better-designed-spreadsheet-is-not-going-to-help 2023-02-22T03:00:01+11:00 https://pharmadispatch.com/news/new-zealands-pharmac-plans-its-own-tender-for-continuous-glucose 2023-02-21T11:46:01+11:00 https://pharmadispatch.com/news/europe-approves-csls-first-gene-therapy-for-haemophilia-b 2023-02-21T11:42:01+11:00 https://pharmadispatch.com/news/international-recognition-for-emerging-australia-medical-technol 2023-02-21T11:40:01+11:00 https://pharmadispatch.com/news/private-health-insurers-funds-urge-the-government-to-act-and-kee 2023-02-21T11:29:01+11:00 https://pharmadispatch.com/news/everyone-has-a-stake-in-righting-what-is-an-obvious-wrong 2023-02-21T03:00:01+11:00 https://pharmadispatch.com/news/tga-provisionally-approves-modernas-new-bivalent-covid-19-vaccin 2023-02-21T03:00:01+11:00 https://pharmadispatch.com/news/shadow-health-minister-slams-treatment-of-nurse-led-patient-orga 2023-02-21T03:00:01+11:00 https://pharmadispatch.com/news/msd-takes-the-lead-in-the-race-for-the-2023-kosi-challenge-pharm 2023-02-20T14:41:01+11:00 https://pharmadispatch.com/news/ombudsman-says-complaints-still-lower-than-pre-pandemic-levels 2023-02-20T10:51:01+11:00 https://pharmadispatch.com/news/nib-reports-solid-first-half-performance-across-its-businesses 2023-02-20T09:33:01+11:00 https://pharmadispatch.com/news/biocelect-to-partner-french-company-on-japanese-encephalitis-vac 2023-02-20T02:00:01+11:00 https://pharmadispatch.com/news/is-gaslighting-the-reward-for-sacrificing-funding-to-save-a-prog 2023-02-20T02:00:01+11:00 https://pharmadispatch.com/news/new-south-wales-to-trial-expanded-scope-of-practice-for-pharmacy 2023-02-20T02:00:01+11:00 https://pharmadispatch.com/news/savings-for-some-but-call-for-lower-prices-for-more-australian-p 2023-02-20T02:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-17-february 2023-02-17T12:41:01+11:00 https://pharmadispatch.com/news/global-sarcoma-therapy-now-approved-for-new-zealand-patients 2023-02-17T05:00:01+11:00 https://pharmadispatch.com/news/msac-processes-might-be-accelerated-but-only-where-applicants-ca 2023-02-17T03:00:01+11:00 https://pharmadispatch.com/news/new-and-amended-items-scrapped-in-favour-of-additional-funding 2023-02-17T03:00:01+11:00 https://pharmadispatch.com/news/portal-not-ready-for-pl-cost-recovery-so-no-application-for-five 2023-02-17T03:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-opiate-dependence-post-market-review-report-in- 2023-02-17T03:00:01+11:00 https://pharmadispatch.com/news/baa-officials-confirm-over-140-million-scripts-hit-with-higher-c 2023-02-17T03:00:01+11:00 https://pharmadispatch.com/news/arrotex-boosts-sales-capacity-with-the-launch-of-new-national-sa 2023-02-16T03:00:01+11:00 https://pharmadispatch.com/news/growth-of-wesfarmers-health-not-helped-by-new-pbs-price-reductio 2023-02-16T03:00:01+11:00 https://pharmadispatch.com/news/the-final-senate-estimates-hearing-for-outgoing-tga-head 2023-02-16T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-welcomes-early-but-limited-supply-of-ozempic 2023-02-16T03:00:01+11:00 https://pharmadispatch.com/news/unit-growth-for-cochlear-as-markets-return-to-pre-pandemic-level 2023-02-15T13:57:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-australia-supports-efforts-to-defeat-melano 2023-02-15T03:00:01+11:00 https://pharmadispatch.com/news/key-franchise-delivers-for-csl-as-plasma-collections-top-pre-pan 2023-02-15T03:00:01+11:00 https://pharmadispatch.com/news/the-industry-has-no-end-of-rights-in-decision-making-it-just-rar 2023-02-15T03:00:01+11:00 https://pharmadispatch.com/news/push-to-apply-pbs-style-listing-restrictions-to-medical-devices 2023-02-15T03:00:01+11:00 https://pharmadispatch.com/news/no-response-to-evidence-but-medicines-australia-happy-with-discr 2023-02-14T18:35:01+11:00 https://pharmadispatch.com/news/gilead-bms-and-roche-to-host-industry-focused-events-for-worldpr 2023-02-14T15:00:01+11:00 https://pharmadispatch.com/news/kosi-challenge-fundraising-total-close-to-milestone-with-az-lead 2023-02-14T03:00:01+11:00 https://pharmadispatch.com/news/nz-health-minister-says-shore-up-pharmac-funding-or-delistings-w 2023-02-14T03:00:01+11:00 https://pharmadispatch.com/news/time-for-industry-to-nominate-pbac-member-but-no-timeline-for-ms 2023-02-14T03:00:01+11:00 https://pharmadispatch.com/news/genetic-technologies-says-new-publication-highlights-benefits-of 2023-02-13T10:35:01+11:00 https://pharmadispatch.com/news/adapt-ideations-announces-the-appointment-of-new-senior-adviser 2023-02-13T10:21:01+11:00 https://pharmadispatch.com/news/acurabio-partners-with-cytiva-to-alleviate-supply-constraints-fo 2023-02-13T09:53:01+11:00 https://pharmadispatch.com/news/pressure-is-working-but-the-process-is-either-transparent-or-it- 2023-02-13T03:00:01+11:00 https://pharmadispatch.com/news/hta-review-committee-to-meet-and-finalise-terms-of-reference 2023-02-13T03:00:01+11:00 https://pharmadispatch.com/news/call-for-increased-dispensing-quantities-but-have-they-read-the- 2023-02-13T03:00:01+11:00 https://pharmadispatch.com/news/bayer-launches-on-demand-training-partnership-for-pharmacy-staff 2023-02-13T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-10-february 2023-02-10T10:24:01+11:00 https://pharmadispatch.com/news/australia-is-getting-its-own-pharmac-through-legislated-stealth 2023-02-10T03:00:01+11:00 https://pharmadispatch.com/news/senate-committee-asks-the-minister-to-consider-limits-on-new-pow 2023-02-10T03:00:01+11:00 https://pharmadispatch.com/news/bayer-announces-senior-roche-executive-as-its-new-ceo 2023-02-10T03:00:01+11:00 https://pharmadispatch.com/news/merck-launches-new-sustainable-packaging-for-fertility-products 2023-02-10T03:00:01+11:00 https://pharmadispatch.com/news/government-moves-to-quickly-implement-atagi-advice-on-2023-boost 2023-02-09T03:00:01+11:00 https://pharmadispatch.com/news/a-remarkable-grab-for-power-that-needs-to-be-properly-scrutinise 2023-02-08T12:20:01+11:00 https://pharmadispatch.com/news/certa-therapeutics-announces-positive-results-in-phase-2-sclerod 2023-02-08T10:42:01+11:00 https://pharmadispatch.com/news/no-new-spending-proposals-without-cost-offsets-but-does-it-reall 2023-02-08T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-argues-for-a-redesign-to-create-a-fund-of-funds-to-dr 2023-02-08T03:00:01+11:00 https://pharmadispatch.com/news/groups-told-to-start-again-on-push-for-genomic-services 2023-02-08T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-and-gsk-the-early-leaders-in-race-for-the-pharma-cup 2023-02-08T03:00:01+11:00 https://pharmadispatch.com/news/apra-board-member-says-phi-sector-should-feel-cautiously-satisfi 2023-02-07T14:30:01+11:00 https://pharmadispatch.com/news/research-institutes-call-for-budget-action-on-career-paths-and-f 2023-02-07T13:15:01+11:00 https://pharmadispatch.com/news/private-hospitals-welcome-considered-annual-premium-increase 2023-02-07T09:46:01+11:00 https://pharmadispatch.com/news/historic-opportunity-to-correct-an-inequitable-and-unfair-exclus 2023-02-07T03:00:01+11:00 https://pharmadispatch.com/news/minister-quickly-implements-changes-to-hpv-vaccine-access-arrang 2023-02-07T03:00:01+11:00 https://pharmadispatch.com/news/experts-and-health-consumers-urge-the-backing-of-cancer-care-nav 2023-02-07T03:00:01+11:00 https://pharmadispatch.com/news/report-reveals-the-extent-of-government-investment-in-promoting- 2023-02-07T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-approves-29-per-cent-average-increase-for-private-he 2023-02-06T18:28:01+11:00 https://pharmadispatch.com/news/thousands-expected-to-register-for-hbf-run-for-a-reason-after-th 2023-02-06T17:04:01+11:00 https://pharmadispatch.com/news/genetic-technologies-announces-registered-direct-offering 2023-02-06T15:59:01+11:00 https://pharmadispatch.com/news/overwhelming-interest-to-pursue-career-pathways-in-aged-care-and 2023-02-06T14:10:01+11:00 https://pharmadispatch.com/news/emyria-to-expand-mdma-programs-following-tga-psychedelic-decisio 2023-02-06T12:47:01+11:00 https://pharmadispatch.com/news/immutep-reaches-enrolment-target-for-insight-003-trial-in-first- 2023-02-06T12:40:01+11:00 https://pharmadispatch.com/news/stakeholders-welcome-the-tgas-sensible-and-well-considered-inter 2023-02-06T03:00:01+11:00 https://pharmadispatch.com/news/tga-reclassifies-psychedelics-but-heavily-restricts-their-use 2023-02-06T03:00:01+11:00 https://pharmadispatch.com/news/finance-says-thanks-but-no-thanks-on-hta-review-consultation 2023-02-06T03:00:01+11:00 https://pharmadispatch.com/news/us-based-industry-wants-australia-added-to-trade-watch-list-over 2023-02-06T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-3-february 2023-02-03T11:55:01+11:00 https://pharmadispatch.com/news/is-this-the-worst-possible-development-for-the-future-of-genomic 2023-02-03T03:00:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-in-new-partnership-with-heart-of-australia- 2023-02-03T03:00:01+11:00 https://pharmadispatch.com/news/industry-teams-lining-up-for-another-shot-at-the-2022-kosi-chall 2023-02-03T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-the-planned-retirement-of-tga-head-john-sk 2023-02-02T17:05:01+11:00 https://pharmadispatch.com/news/clinuvel-drug-significantly-reduces-critical-uv-skin-damage-in-t 2023-02-02T16:49:01+11:00 https://pharmadispatch.com/news/rare-cancers-says-it-expects-hta-review-process-to-deliver-for-p 2023-02-02T03:00:01+11:00 https://pharmadispatch.com/news/blood-cancer-patients-facing-impossible-choices-amid-soaring-cos 2023-02-02T03:00:01+11:00 https://pharmadispatch.com/news/a-major-coup-for-australian-patients-association-with-new-appoin 2023-02-02T03:00:01+11:00 https://pharmadispatch.com/news/baa-says-make-decision-making-subject-to-administrative-review 2023-02-02T03:00:01+11:00 https://pharmadispatch.com/news/hcf-and-healthscope-avert-higher-costs-with-new-two-year-agreeme 2023-02-01T15:28:01+11:00 https://pharmadispatch.com/news/agilex-biolabs-announces-the-appointment-of-new-ceo 2023-02-01T14:57:01+11:00 https://pharmadispatch.com/news/medibank-kicks-off-australias-first-national-parkrun-road-trip 2023-02-01T14:10:01+11:00 https://pharmadispatch.com/news/ausbiotech-announces-new-appointments-to-its-board 2023-02-01T09:23:01+11:00 https://pharmadispatch.com/news/health-department-refuses-to-respond-to-request-for-documents 2023-02-01T03:00:01+11:00 https://pharmadispatch.com/news/prime-minister-chris-hipkins-reshuffles-ministry-with-a-new-heal 2023-02-01T03:00:01+11:00 https://pharmadispatch.com/news/new-parkinsons-disease-therapy-makes-it-onto-the-pbs 2023-02-01T03:00:01+11:00 https://pharmadispatch.com/news/alteritys-ath434-prevents-loss-of-brain-cells-in-parkinsons-dise 2023-01-31T10:41:01+11:00 https://pharmadispatch.com/news/csl-seqirus-questions-recommended-cut-to-hpv-vaccine-dosing-regi 2023-01-31T03:00:01+11:00 https://pharmadispatch.com/news/confidentiality-is-just-a-term-designed-to-make-secrecy-respecta 2023-01-31T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-says-it-argued-for-greater-transparency-in-r 2023-01-31T03:00:01+11:00 https://pharmadispatch.com/news/cancer-australia-releases-latest-research-funding-report-that-ex 2023-01-31T03:00:01+11:00 https://pharmadispatch.com/news/centenary-institute-announces-its-new-executive-director 2023-01-30T17:01:01+11:00 https://pharmadispatch.com/news/cynata-receives-irb-approval-for-proposed-phase-2-agvhd-clinical 2023-01-30T14:15:01+11:00 https://pharmadispatch.com/news/emyria-confirms-the-first-dosing-for-emd-rx5-phase-3-trial 2023-01-30T12:52:01+11:00 https://pharmadispatch.com/news/mtpconnect-launches-new-6-million-funding-round 2023-01-30T09:53:01+11:00 https://pharmadispatch.com/news/medicines-australia-restates-it-call-for-discount-rate-reduction 2023-01-30T03:00:01+11:00 https://pharmadispatch.com/news/new-covid-19-sub-variants-an-emerging-challenge-for-high-risk-pa 2023-01-30T03:00:01+11:00 https://pharmadispatch.com/news/pbac-recommends-dose-reduction-for-hpv-vaccine-program 2023-01-30T03:00:01+11:00 https://pharmadispatch.com/news/industry-associations-unite-in-joint-call-for-budget-funding-boo 2023-01-30T03:00:01+11:00 https://pharmadispatch.com/news/calvary-medibank-joint-venture-appoints-executive-medical-direct 2023-01-29T12:35:01+11:00 https://pharmadispatch.com/news/the-week-in-review-27-january 2023-01-27T10:30:01+11:00 https://pharmadispatch.com/news/forget-about-experts-and-terms-of-reference-focus-on-a-more-tran 2023-01-27T03:00:01+11:00 https://pharmadispatch.com/news/australia-day-recognition-for-senior-officials-and-pharmacy-lead 2023-01-27T03:00:01+11:00 https://pharmadispatch.com/news/is-this-a-change-of-heart-from-former-health-department-secretar 2023-01-27T03:00:01+11:00 https://pharmadispatch.com/news/new-chair-for-australian-genomics-industry-organisation 2023-01-26T14:38:01+11:00 https://pharmadispatch.com/news/medlab-receives-import-certificate-from-uk-home-office-for-nanab 2023-01-26T12:17:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-launches-ath434-phase-2-clinical-trial-in- 2023-01-26T12:12:01+11:00 https://pharmadispatch.com/news/emvision-says-clinical-trial-progressing-and-asa-milestone-achie 2023-01-26T12:05:01+11:00 https://pharmadispatch.com/news/immuron-and-partners-respond-to-fda-clinical-hold 2023-01-26T11:42:01+11:00 https://pharmadispatch.com/news/fda-approves-ind-for-prader-willi-syndrome-study-of-neurens-nnz- 2023-01-26T11:38:01+11:00 https://pharmadispatch.com/news/pharmaust-progresses-to-elevated-doses-of-mpl-in-motor-neurone-d 2023-01-26T11:36:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-updates-on-cltx-car-t-clinical-trial 2023-01-26T11:35:01+11:00 https://pharmadispatch.com/news/the-event-will-focus-on-reviews-reform-processes-and-now-tenders 2023-01-25T05:10:01+11:00 https://pharmadispatch.com/news/what-part-of-this-review-process-is-commercial-or-decision-makin 2023-01-25T03:00:01+11:00 https://pharmadispatch.com/news/the-word-tender-now-being-used-for-a-major-health-technology 2023-01-25T03:00:01+11:00 https://pharmadispatch.com/news/us-expansion-drives-medadvisors-rapid-growth-in-second-quarter 2023-01-24T03:00:01+11:00 https://pharmadispatch.com/news/what-gives-them-the-right-to-exclude-anyone-from-the-consultatio 2023-01-24T03:00:01+11:00 https://pharmadispatch.com/news/new-zealand-patient-advocate-flees-to-australia-as-medical-refug 2023-01-24T03:00:01+11:00 https://pharmadispatch.com/news/australian-research-answers-mystery-of-why-people-develop-rare-h 2023-01-23T03:00:01+11:00 https://pharmadispatch.com/news/document-release-a-good-start-but-more-transparency-is-required- 2023-01-23T03:00:01+11:00 https://pharmadispatch.com/news/the-tone-of-document-does-not-meet-the-aspirations-of-faster-acc 2023-01-23T03:00:01+11:00 https://pharmadispatch.com/news/stakeholders-challenge-proposed-abolition-on-consultation-proces 2023-01-23T03:00:01+11:00 https://pharmadispatch.com/news/takeda-recognised-a-top-employer-for-the-seventh-consecutive-yea 2023-01-22T10:50:01+11:00 https://pharmadispatch.com/news/modernas-covid-19-vaccine-the-first-to-be-considered-for-full-re 2023-01-21T13:57:01+11:00 https://pharmadispatch.com/news/the-week-in-review-20-january 2023-01-20T10:24:01+11:00 https://pharmadispatch.com/news/pharmac-proposes-funding-for-second-sma-therapy 2023-01-20T03:00:01+11:00 https://pharmadispatch.com/news/positive-change-is-still-possible-but-time-is-quickly-running-ou 2023-01-20T03:00:01+11:00 https://pharmadispatch.com/news/new-zealand-approval-for-specialised-therapeutics-cancer-therapy 2023-01-20T03:00:01+11:00 https://pharmadispatch.com/news/vaxxas-signs-new-deal-with-cepi-to-progress-needle-free-vaccine- 2023-01-20T03:00:01+11:00 https://pharmadispatch.com/news/request-for-tender-seeks-to-restart-australian-prescriber 2023-01-19T03:00:01+11:00 https://pharmadispatch.com/news/modernas-new-respiratory-vaccine-delivers-in-pivotal-phase-3-tri 2023-01-19T03:00:01+11:00 https://pharmadispatch.com/news/new-qum-steward-starts-the-process-of-building-its-capability 2023-01-19T03:00:01+11:00 https://pharmadispatch.com/news/a-tale-of-two-reviews-and-two-very-different-approaches 2023-01-18T03:00:01+11:00 https://pharmadispatch.com/news/health-department-blames-reference-committee-for-consultation-sn 2023-01-18T03:00:01+11:00 https://pharmadispatch.com/news/new-bayer-campaign-seeks-to-aim-awareness-of-emotional-mental-an 2023-01-18T03:00:01+11:00 https://pharmadispatch.com/news/employer-recognition-for-boehringer-ingelheim-with-local-focus-o 2023-01-17T19:02:01+11:00 https://pharmadispatch.com/news/how-can-something-on-a-public-website-be-considered-confidential 2023-01-17T03:00:01+11:00 https://pharmadispatch.com/news/the-good-the-bad-and-the-ugly-of-the-hta-review-terms-of-referen 2023-01-17T03:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-appoints-industry-investment-expert-to-its-board-of-di 2023-01-17T03:00:01+11:00 https://pharmadispatch.com/news/does-this-response-show-that-the-industry-finally-had-enough 2023-01-16T03:00:01+11:00 https://pharmadispatch.com/news/no-easing-into-the-new-year-for-an-industry-pushing-for-change 2023-01-16T03:00:01+11:00 https://pharmadispatch.com/news/a-very-busy-few-months-of-cabinet-consideration-of-pbac-appointm 2023-01-16T03:00:01+11:00 https://pharmadispatch.com/news/are-we-seriously-going-to-do-this-all-over-again 2023-01-12T02:02:01+11:00 https://pharmadispatch.com/news/medicines-australia-slams-selective-and-confidential-consultatio 2023-01-11T20:37:01+11:00 https://pharmadispatch.com/news/the-minister-exercised-their-power-the-pbac-welcomed-it-and-the- 2023-01-09T04:00:01+11:00 https://pharmadispatch.com/news/the-minister-exercised-their-power-the-pbac-welcomed-it-and-the- 2023-01-09T04:00:01+11:00 https://pharmadispatch.com/news/newly-released-cabinet-documents-reveal-change-or-else-directive 2023-01-09T03:00:01+11:00 https://pharmadispatch.com/news/an-incomplete-list-that-reveals-a-policy-that-fails-one-third-of 2022-12-23T10:47:01+11:00 https://pharmadispatch.com/news/finalised-nmp-a-significant-improvement-on-the-first-pre-electio 2022-12-20T10:57:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-year-in-review 2022-12-20T04:00:01+11:00 https://pharmadispatch.com/news/peer-reviewed-paper-reveals-enormous-economic-benefit-of-covid-v 2022-12-19T03:00:01+11:00 https://pharmadispatch.com/news/november-outcomes-confounded-by-next-aprils-catch-up-reductions 2022-12-19T03:00:01+11:00 https://pharmadispatch.com/news/pbac-says-a-price-reduction-of-at-least-15-would-be-appropriate 2022-12-19T03:00:01+11:00 https://pharmadispatch.com/news/is-the-system-capable-is-dispensing-with-the-negotiation-by-subm 2022-12-19T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-16-december 2022-12-16T10:46:01+11:00 https://pharmadispatch.com/news/i-just-think-shes-an-idiot-to-be-perfectly-frank 2022-12-16T03:00:01+11:00 https://pharmadispatch.com/news/it-just-seems-logical-and-reasonable-to-bring-the-two-vaccine-to 2022-12-16T03:00:01+11:00 https://pharmadispatch.com/news/novartis-joins-roche-in-uk-trial-to-extend-access-for-patients-w 2022-12-16T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-to-fund-adrenaline-auto-injectors-25-years-after-the-fir 2022-12-15T13:14:01+11:00 https://pharmadispatch.com/news/insurer-backs-project-researching-why-patients-dont-response-to- 2022-12-15T12:50:01+11:00 https://pharmadispatch.com/news/two-more-industry-leaders-confirmed-for-bpd-annual-conference 2022-12-15T03:00:01+11:00 https://pharmadispatch.com/news/the-path-is-straightforward-as-long-as-it-is-not-considered-a-va 2022-12-15T03:00:01+11:00 https://pharmadispatch.com/news/if-this-process-requires-a-probity-adviser-what-about-the-others 2022-12-15T03:00:01+11:00 https://pharmadispatch.com/news/under-co-payment-prescriptions-top-100-million-for-the-first-tim 2022-12-15T03:00:01+11:00 https://pharmadispatch.com/news/race-oncology-appoints-new-managing-director-and-ceo 2022-12-14T17:31:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-new-funding-arrangement-for-surgical-consu 2022-12-14T17:29:01+11:00 https://pharmadispatch.com/news/pharmaxis-appoints-experienced-industry-executive-to-its-board 2022-12-14T15:34:01+11:00 https://pharmadispatch.com/news/moderna-appoints-director-of-regional-research-centre 2022-12-14T12:27:01+11:00 https://pharmadispatch.com/news/medibank-confirms-complaint-lodged-with-the-information-commissi 2022-12-14T09:17:01+11:00 https://pharmadispatch.com/news/ama-says-new-chronic-disease-data-shows-why-government-needs-to- 2022-12-14T09:03:01+11:00 https://pharmadispatch.com/news/positive-trial-results-for-combination-of-moderna-mrna-vaccine-a 2022-12-14T05:15:01+11:00 https://pharmadispatch.com/news/an-appointment-that-is-just-another-sign-of-a-process-in-serious 2022-12-14T03:00:01+11:00 https://pharmadispatch.com/news/amgen-secures-significant-acquisition-of-horizon-therapeutics 2022-12-14T03:00:01+11:00 https://pharmadispatch.com/news/gsk-boronia-and-the-focus-on-finishing-strong-for-patients 2022-12-14T03:00:01+11:00 https://pharmadispatch.com/news/csl-announces-the-appointment-of-its-new-ceo-and-managing-direct 2022-12-14T03:00:01+11:00 https://pharmadispatch.com/news/the-health-department-appears-to-be-confused-about-the-role-of-i 2022-12-14T03:00:01+11:00 https://pharmadispatch.com/news/positive-preliminary-results-from-trial-involving-az-starpharma- 2022-12-13T14:18:01+11:00 https://pharmadispatch.com/news/major-industry-award-for-australian-scientist-at-the-forefront-o 2022-12-13T03:00:01+11:00 https://pharmadispatch.com/news/the-george-institute-sells-george-clinical-and-reinvests-in-its- 2022-12-13T03:00:01+11:00 https://pharmadispatch.com/news/the-era-of-therapy-based-on-gene-editing-is-now-on-the-horizon 2022-12-13T03:00:01+11:00 https://pharmadispatch.com/news/red-havas-makes-new-appointments-to-its-health-and-social-commun 2022-12-13T03:00:01+11:00 https://pharmadispatch.com/news/lek-elects-new-managing-partner-and-head-of-australia 2022-12-13T03:00:01+11:00 https://pharmadispatch.com/news/vaccination-and-treatment-remain-the-cornerstone-in-updated-covi 2022-12-12T15:11:01+11:00 https://pharmadispatch.com/news/federal-government-decides-against-extending-pandemic-mental-hea 2022-12-12T14:31:01+11:00 https://pharmadispatch.com/news/avita-medical-ubmits-fda-pma-supplement-to-further-expand-indica 2022-12-12T10:12:01+11:00 https://pharmadispatch.com/news/bupa-reveals-it-top-10-most-common-hospital-and-extras-claims-fo 2022-12-12T09:50:01+11:00 https://pharmadispatch.com/news/researchers-infect-a-brain-in-a-dish-in-search-for-zika-antivira 2022-12-12T09:36:01+11:00 https://pharmadispatch.com/news/a-walk-through-time-as-gsk-prepares-to-exit-boronia-production-s 2022-12-12T03:00:01+11:00 https://pharmadispatch.com/news/new-handbook-reveals-a-significant-remaking-of-the-cabinet-proce 2022-12-12T03:00:01+11:00 https://pharmadispatch.com/news/treasury-opens-consultation-process-for-next-years-2023-24-budge 2022-12-12T03:00:01+11:00 https://pharmadispatch.com/news/medibank-says-systems-back-online-after-operation-safeguard 2022-12-11T11:21:01+11:00 https://pharmadispatch.com/news/probity-has-been-the-early-focus-of-health-technology-assessment 2022-12-11T10:35:01+11:00 https://pharmadispatch.com/news/federal-government-extends-dental-program-for-eligible-children 2022-12-11T09:54:01+11:00 https://pharmadispatch.com/news/ethics-approval-for-pharmaceuticals-receives-new-diabetic-foot-u 2022-12-11T08:45:01+11:00 https://pharmadispatch.com/news/the-week-in-review-9-december 2022-12-09T10:37:01+11:00 https://pharmadispatch.com/news/rachel-smalley-this-is-why-i-say-we-need-to-reform-pharmac 2022-12-09T03:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-named-best-place-to-work-and-best-place-to-work-for 2022-12-09T03:00:01+11:00 https://pharmadispatch.com/news/medibank-to-undertake-operation-safeguard-at-the-weekend 2022-12-08T17:47:01+11:00 https://pharmadispatch.com/news/new-collaborations-takes-steps-to-advance-vaccine-manufacturing- 2022-12-08T17:02:01+11:00 https://pharmadispatch.com/news/amgen-announces-new-leadership-for-australia-and-new-zealand 2022-12-08T16:14:01+11:00 https://pharmadispatch.com/news/final-outcomes-add-to-the-evidence-of-the-need-for-a-new-approac 2022-12-08T10:53:01+11:00 https://pharmadispatch.com/news/the-minister-was-never-likely-to-exercise-the-power-but-he-still 2022-12-08T10:41:01+11:00 https://pharmadispatch.com/news/csl-opens-its-new-australian-plasma-fractionation-facility-in-me 2022-12-08T03:00:01+11:00 https://pharmadispatch.com/news/next-year-will-be-even-tougher-unless-the-downward-trajectory-ca 2022-12-08T03:00:01+11:00 https://pharmadispatch.com/news/construction-is-officially-underway-atmodernas-mrna-site 2022-12-08T03:00:01+11:00 https://pharmadispatch.com/news/catholic-health-australia-calls-for-reform-of-premium-approval-p 2022-12-07T17:13:01+11:00 https://pharmadispatch.com/news/ama-says-new-data-reveals-a-worsening-hospital-logjam 2022-12-07T16:55:01+11:00 https://pharmadispatch.com/news/gsks-michelle-strong-on-the-journey-towards-the-end-of-this-chap 2022-12-07T05:14:01+11:00 https://pharmadispatch.com/news/another-bad-day-for-pharmac-with-ombudsman-to-investigate-docume 2022-12-07T03:00:01+11:00 https://pharmadispatch.com/news/gsks-michelle-strong-on-the-journey-towards-the-end-of-this-chap 2022-12-07T03:00:01+11:00 https://pharmadispatch.com/news/today-fm-and-mediaworks-not-relenting-on-criticism-of-pharmac 2022-12-07T03:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-says-horizon-scanning-needs-purpose-and-an-effector-a 2022-12-07T03:00:01+11:00 https://pharmadispatch.com/news/this-process-needs-clear-direction-from-the-government-or-it-wil 2022-12-07T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-hits-a-new-low-with-incompetent-and-childish-response-to 2022-12-06T03:00:01+11:00 https://pharmadispatch.com/news/bms-welcomes-tga-registration-of-first-in-class-tyk2-inhibitor 2022-12-06T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-partners-with-queensland-to-create-the-mrna-translational 2022-12-06T03:00:01+11:00 https://pharmadispatch.com/news/viatris-says-its-stem-workforce-is-critical-to-fulfilling-its-po 2022-12-06T03:00:01+11:00 https://pharmadispatch.com/news/tessara-therapeutics-and-netri-in-new-organ-on-chip-collaboratio 2022-12-05T17:53:01+11:00 https://pharmadispatch.com/news/sanofi-seeking-support-in-its-campaign-to-encourage-the-return-o 2022-12-05T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-welcomes-expanded-reimbursement-for-lung-cancer-therapy 2022-12-05T03:00:01+11:00 https://pharmadispatch.com/news/committee-to-reconsider-astrazenecas-evusheld-at-upcoming-meetin 2022-12-05T03:00:01+11:00 https://pharmadispatch.com/news/new-zealand-patients-celebrate-provisional-agreement-on-cf-thera 2022-12-05T03:00:01+11:00 https://pharmadispatch.com/news/gsk-boronia-site-director-on-valuing-the-past-and-finishing-stro 2022-12-05T03:00:01+11:00 https://pharmadispatch.com/news/collaboration-with-the-university-of-sa-and-successful-capital-r 2022-12-04T15:51:01+11:00 https://pharmadispatch.com/news/rt-health-recognised-in-productreviewcomau-annual-awards 2022-12-04T15:01:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-a-high-level-of-trust-in-member-owned-private 2022-12-04T14:38:01+11:00 https://pharmadispatch.com/news/bupa-announces-its-new-managing-director-of-health-services 2022-12-04T12:23:01+11:00 https://pharmadispatch.com/news/hbf-and-ramsay-health-care-abolish-co-payment-for-robotic-assist 2022-12-04T12:15:01+11:00 https://pharmadispatch.com/news/noxopharm-provides-an-update-on-trial-of-its-oncology-drug-candi 2022-12-04T12:04:01+11:00 https://pharmadispatch.com/news/vaxxas-appoints-doug-cubbin-as-its-new-chief-financial-officer 2022-12-04T11:06:01+11:00 https://pharmadispatch.com/news/the-week-in-review-2-december 2022-12-02T11:09:01+11:00 https://pharmadispatch.com/news/new-report-confirms-the-dramatic-decline-in-nzs-spending-on-medi 2022-12-02T03:00:01+11:00 https://pharmadispatch.com/news/pandemic-preparedness-the-focus-on-latest-pfizer-invites-event 2022-12-02T03:00:01+11:00 https://pharmadispatch.com/news/committee-skips-pbs-by-cancelling-spillover-hearing-of-senate-es 2022-12-02T03:00:01+11:00 https://pharmadispatch.com/news/federal-government-puts-regulatory-changes-before-the-parliament 2022-12-02T03:00:01+11:00 https://pharmadispatch.com/news/federal-agency-launches-investigation-into-medibank 2022-12-01T18:31:01+11:00 https://pharmadispatch.com/news/accc-raises-preliminary-competition-concerns-over-cochlears-acqu 2022-12-01T17:23:01+11:00 https://pharmadispatch.com/news/new-australian-collaboration-to-research-radiopharmaceutical-for 2022-12-01T17:14:01+11:00 https://pharmadispatch.com/news/private-health-insurers-have-handed-back-21-billion-says-accc 2022-12-01T16:55:01+11:00 https://pharmadispatch.com/news/anti-corruption-body-just-months-away-but-what-does-it-mean-for- 2022-12-01T03:00:01+11:00 https://pharmadispatch.com/news/stakeholder-groups-should-intervene-and-make-sure-this-never-hap 2022-12-01T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-officially-launches-consultation-on-nicotine-vaping- 2022-12-01T03:00:01+11:00 https://pharmadispatch.com/news/first-speakers-confirmed-for-2023-biopharmadispatch-annual-confe 2022-12-01T03:00:01+11:00 https://pharmadispatch.com/news/biogen-eisai-collaboration-delivers-hope-for-alzheimers-disease- 2022-12-01T03:00:01+11:00 https://pharmadispatch.com/news/napwha-and-gilead-recognise-four-community-champions-to-mark-wor 2022-12-01T03:00:01+11:00 https://pharmadispatch.com/news/nib-says-survey-shows-why-people-need-to-be-proactive-about-skin 2022-11-30T16:58:01+11:00 https://pharmadispatch.com/news/developer-announces-plans-for-new-medical-research-facility-in-b 2022-11-30T16:55:01+11:00 https://pharmadispatch.com/news/aged-care-providers-urged-to-prepare-for-staffing-crisis-in-dece 2022-11-30T16:53:01+11:00 https://pharmadispatch.com/news/wehi-scientists-recognised-with-csl-florey-medal-for-malaria-res 2022-11-30T03:00:01+11:00 https://pharmadispatch.com/news/will-australia-follow-the-uk-on-missed-diagnosis-and-treatment-d 2022-11-30T03:00:01+11:00 https://pharmadispatch.com/news/viatris-managing-director-appointed-to-chp-board-of-directors 2022-11-30T03:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-greater-investment-in-arthritis-research 2022-11-29T12:44:01+11:00 https://pharmadispatch.com/news/immutep-announces-new-collaboration-for-cancer-treatment-combina 2022-11-29T12:36:01+11:00 https://pharmadispatch.com/news/adherium-wins-us-fda-clearance-for-use-of-its-digital-platform-w 2022-11-29T11:47:01+11:00 https://pharmadispatch.com/news/sonic-healthcare-takes-a-major-strategic-stake-in-microba-life-s 2022-11-29T11:02:01+11:00 https://pharmadispatch.com/news/new-leadership-for-sandoz-australia-and-new-zealand 2022-11-29T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-welcomes-ministerial-interest-in-catch-up-re 2022-11-29T03:00:01+11:00 https://pharmadispatch.com/news/new-all-female-leadership-team-for-the-australian-private-hospit 2022-11-29T03:00:01+11:00 https://pharmadispatch.com/news/johnson-johnson-head-appointed-new-chair-of-medical-device-secto 2022-11-28T18:00:01+11:00 https://pharmadispatch.com/news/queensland-based-microbio-completes-successful-investment-round 2022-11-28T15:16:01+11:00 https://pharmadispatch.com/news/bupa-announces-hisham-el-ansary-to-step-down-in-march 2022-11-28T13:36:01+11:00 https://pharmadispatch.com/news/emyria-accepted-into-us-national-institutes-of-health-research-p 2022-11-28T13:21:01+11:00 https://pharmadispatch.com/news/inventia-secures-nsw-government-support-to-build-a-new-manufactu 2022-11-28T10:21:01+11:00 https://pharmadispatch.com/news/prudential-regulator-intensifies-supervision-of-medibank-in-resp 2022-11-28T10:12:01+11:00 https://pharmadispatch.com/news/cepi-reinvests-in-uqs-second-generation-molecular-clamp-vaccine- 2022-11-28T03:00:01+11:00 https://pharmadispatch.com/news/report-reveals-departmental-confusion-over-former-pms-portfolio- 2022-11-28T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-partners-with-queensland-on-major-new-manufac 2022-11-28T03:00:01+11:00 https://pharmadispatch.com/news/uk-observatory-shows-the-way-on-the-future-of-horizon-scanning-1 2022-11-28T03:00:01+11:00 https://pharmadispatch.com/news/report-reveals-departmental-confusion-over-former-pms-portfolio- 2022-11-28T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-new-pbs-listings-for-1-december-1 2022-11-27T15:32:01+11:00 https://pharmadispatch.com/news/new-study-investigates-the-efficacy-of-apps-for-managing-chronic 2022-11-27T13:19:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-25-november 2022-11-25T10:08:01+11:00 https://pharmadispatch.com/news/anniversary-of-parliamentary-inquiry-report-and-still-no-governm 2022-11-25T03:00:01+11:00 https://pharmadispatch.com/news/committee-recommends-further-changes-to-listing-of-covid-19-anti 2022-11-25T03:00:01+11:00 https://pharmadispatch.com/news/the-absence-of-a-government-response-shows-that-it-is-all-about- 2022-11-25T03:00:01+11:00 https://pharmadispatch.com/news/health-department-called-back-for-spillover-estimates-hearing 2022-11-25T03:00:01+11:00 https://pharmadispatch.com/news/hcf-says-its-long-standing-agreement-with-healthscope-is-likely- 2022-11-24T18:52:01+11:00 https://pharmadispatch.com/news/mtaas-ian-burgess-technicians-play-a-vital-role-in-saving-lives 2022-11-24T18:50:01+11:00 https://pharmadispatch.com/news/i-have-said-repeatedly-in-the-last-11-years-that-while-the-pbac- 2022-11-24T11:34:01+11:00 https://pharmadispatch.com/news/csl-secures-us-approval-for-breakthrough-one-time-haemophilia-ge 2022-11-24T03:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-two-thirds-of-australians-believe-the-worst-o 2022-11-24T03:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-anticipated-new-therapies-at-its-march-meeting 2022-11-24T03:00:01+11:00 https://pharmadispatch.com/news/industry-partners-to-promote-the-importance-of-regular-heart-hea 2022-11-24T03:00:01+11:00 https://pharmadispatch.com/news/australian-venture-capital-fund-joins-partners-in-backing-new-im 2022-11-24T03:00:01+11:00 https://pharmadispatch.com/news/hcf-says-its-long-standing-agreement-with-healthscope-is-likely- 2022-11-23T17:48:01+11:00 https://pharmadispatch.com/news/ninthconsecutive-quarter-of-membership-growth-but-net-profit-dec 2022-11-23T17:33:01+11:00 https://pharmadispatch.com/news/additional-data-released-from-positive-imaging-trial-in-brain-me 2022-11-23T17:25:01+11:00 https://pharmadispatch.com/news/ionopticks-launches-a-new-age-of-proteomics-with-aurora-frontier 2022-11-23T17:06:01+11:00 https://pharmadispatch.com/news/the-problem-in-this-system-is-that-the-payer-will-insist-it-is-r 2022-11-23T03:00:01+11:00 https://pharmadispatch.com/news/the-pharmaceutical-sector-will-be-captured-by-new-privacy-penalt 2022-11-23T03:00:01+11:00 https://pharmadispatch.com/news/new-report-finds-australian-cancer-patients-missing-out-on-vital 2022-11-23T03:00:01+11:00 https://pharmadispatch.com/news/health-department-one-of-the-first-federal-agencies-to-face-capa 2022-11-22T03:00:01+11:00 https://pharmadispatch.com/news/surely-the-time-has-come-to-stop-pretending-bad-outcomes-are-goo 2022-11-22T03:00:01+11:00 https://pharmadispatch.com/news/australian-launch-for-phase-2-trial-of-new-mrna-vaccine 2022-11-21T17:02:01+11:00 https://pharmadispatch.com/news/starpharmas-viraleze-launched-in-hong-kong-and-macau 2022-11-21T11:10:01+11:00 https://pharmadispatch.com/news/medtronic-launches-blueballoonchallenge-to-raise-awareness-and-f 2022-11-21T10:57:01+11:00 https://pharmadispatch.com/news/a-predictable-outcome-that-reveals-deep-scepticism-about-the-val 2022-11-21T03:00:01+11:00 https://pharmadispatch.com/news/ministerial-intervention-in-final-outcomes-as-concern-grows-over 2022-11-21T03:00:01+11:00 https://pharmadispatch.com/news/pbac-advises-against-stand-alone-change-in-base-case-discount-ra 2022-11-21T03:00:01+11:00 https://pharmadispatch.com/news/medibank-updates-on-cybercrime-and-confirm-the-release-of-new-in 2022-11-20T14:46:01+11:00 https://pharmadispatch.com/news/mark-butler-launches-new-campaign-to-combat-australias-national- 2022-11-20T14:32:01+11:00 https://pharmadispatch.com/news/need-for-more-action-to-ensure-australia-meets-hcv-elimination-g 2022-11-19T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-18-november 2022-11-18T12:51:01+11:00 https://pharmadispatch.com/news/novartis-considers-divesting-ophthalmology-and-respiratory-busin 2022-11-18T03:00:01+11:00 https://pharmadispatch.com/news/this-is-what-happens-with-qum-is-really-just-about-saving-money 2022-11-18T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-says-the-push-for-relief-from-price-reductio 2022-11-18T03:00:01+11:00 https://pharmadispatch.com/news/supply-chain-shifts-its-attention-to-managing-catch-up-reduction 2022-11-17T13:37:01+11:00 https://pharmadispatch.com/news/no-official-should-even-demand-deference-from-a-stakeholder 2022-11-17T03:00:01+11:00 https://pharmadispatch.com/news/csl-launches-consumer-campaign-urging-people-to-see-the-differen 2022-11-17T03:00:01+11:00 https://pharmadispatch.com/news/tga-grants-provisional-determination-for-new-pfizer-bivalent-vac 2022-11-17T03:00:01+11:00 https://pharmadispatch.com/news/patients-call-on-all-states-and-territories-to-follow-the-lead-o 2022-11-16T19:14:01+11:00 https://pharmadispatch.com/news/medicinal-cannabis-association-announces-the-appointment-of-five 2022-11-16T15:28:01+11:00 https://pharmadispatch.com/news/new-hope-for-australian-families-carrying-deadly-cancer-gene-var 2022-11-16T15:27:01+11:00 https://pharmadispatch.com/news/cynata-announces-presentation-of-data-demonstrating-consistency- 2022-11-16T15:20:01+11:00 https://pharmadispatch.com/news/government-adds-pfizers-bivalent-covid-19-vaccine-as-booster-dos 2022-11-15T18:54:01+11:00 https://pharmadispatch.com/news/this-is-what-happens-when-a-bad-culture-collides-with-capability 2022-11-15T11:12:01+11:00 https://pharmadispatch.com/news/the-options-will-be-to-accept-delist-or-seek-a-real-political-in 2022-11-15T03:00:01+11:00 https://pharmadispatch.com/news/government-opens-formal-consultation-on-national-newborn-screeni 2022-11-15T03:00:01+11:00 https://pharmadispatch.com/news/global-push-to-raise-awareness-of-biosimilars-as-some-policymake 2022-11-14T16:27:01+11:00 https://pharmadispatch.com/news/male-contraceptive-implanted-at-epworth-freemasons-in-world-firs 2022-11-14T13:52:01+11:00 https://pharmadispatch.com/news/telix-acquires-us-radiochemistry-business-optimal-tracers 2022-11-14T13:06:01+11:00 https://pharmadispatch.com/news/positive-trials-results-for-que-oncologys-non-hormonal-oral-ther 2022-11-14T12:20:01+11:00 https://pharmadispatch.com/news/nib-completes-maple-plan-acquisition-and-launches-its-ndis-brand 2022-11-14T12:10:01+11:00 https://pharmadispatch.com/news/industry-confirms-the-detail-of-the-new-version-of-horizon-scann 2022-11-14T05:00:01+11:00 https://pharmadispatch.com/news/terms-of-reference-the-first-job-for-hta-review-reference-commit 2022-11-14T03:00:01+11:00 https://pharmadispatch.com/news/the-review-reference-committee-needs-to-manage-this-obvious-conf 2022-11-14T03:00:01+11:00 https://pharmadispatch.com/news/new-south-wales-proposes-dramatic-expansion-of-pharmacy-delivere 2022-11-14T03:00:01+11:00 https://pharmadispatch.com/news/new-insulin-management-system-added-to-ndss-and-prostheses-list 2022-11-14T03:00:01+11:00 https://pharmadispatch.com/news/just-because-the-medicine-is-newly-funded-does-not-make-it-new 2022-11-14T03:00:01+11:00 https://pharmadispatch.com/news/government-creates-joint-operation-to-target-cyber-criminal-synd 2022-11-13T15:31:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-more-workers-shifting-towards-healthier-consu 2022-11-13T14:48:01+11:00 https://pharmadispatch.com/news/hcf-life-insurance-products-recognised-with-industry-awards 2022-11-13T14:45:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-11-november 2022-11-11T14:11:01+11:00 https://pharmadispatch.com/news/shadow-health-minister-makes-a-strong-start-at-senate-estimates 2022-11-11T03:00:01+11:00 https://pharmadispatch.com/news/how-can-more-hta-be-the-solution-to-a-problem-with-hta 2022-11-11T03:00:01+11:00 https://pharmadispatch.com/news/promising-results-from-in-utero-treatment-of-baby-with-pompe-dis 2022-11-11T03:00:01+11:00 https://pharmadispatch.com/news/brandon-capital-invests-in-neuroscience-company-nrg-therapeutics 2022-11-11T03:00:01+11:00 https://pharmadispatch.com/news/department-confirms-investigation-of-bad-conduct 2022-11-10T20:58:01+11:00 https://pharmadispatch.com/news/biomebank-announces-world-first-regulatory-approval-for-donor-de 2022-11-10T17:05:01+11:00 https://pharmadispatch.com/news/hackers-start-posting-customer-data-stolen-from-medibank 2022-11-10T03:00:01+11:00 https://pharmadispatch.com/news/ups-opens-sydney-based-healthcare-distribution-facility 2022-11-10T03:00:01+11:00 https://pharmadispatch.com/news/companies-waiting-for-final-outcomes-but-it-may-not-end-next-wee 2022-11-09T12:08:01+11:00 https://pharmadispatch.com/news/bupa-welcomes-fair-work-commissions-interim-decision-on-aged-car 2022-11-09T10:38:01+11:00 https://pharmadispatch.com/news/minister-officially-launches-plan-for-endometriosis-and-pelvic-p 2022-11-09T09:31:01+11:00 https://pharmadispatch.com/news/vaxxas-launches-clinical-trial-of-needle-free-covid-19-vaccine-c 2022-11-09T09:18:01+11:00 https://pharmadispatch.com/news/officials-confirm-pre-budget-submission-to-spending-audit 2022-11-09T05:16:01+11:00 https://pharmadispatch.com/news/tinkering-with-technical-inputs-wont-achieve-the-change-people-w 2022-11-09T03:00:01+11:00 https://pharmadispatch.com/news/impacted-patients-give-their-verdict-on-the-new-pricing-framewor 2022-11-09T03:00:01+11:00 https://pharmadispatch.com/news/epiaxis-therapeutics-in-new-agreement-with-us-research-hospital 2022-11-09T03:00:01+11:00 https://pharmadispatch.com/news/ama-sats-government-confirms-no-evidence-for-medicare-fraud-clai 2022-11-08T16:54:01+11:00 https://pharmadispatch.com/news/uk-approval-for-artryas-salix-coronary-anatomy-product 2022-11-08T09:26:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-updates-on-multiple-system-atrophy-study 2022-11-08T09:23:01+11:00 https://pharmadispatch.com/news/australian-study-provides-evidence-base-for-switching-ms-treatme 2022-11-08T03:00:01+11:00 https://pharmadispatch.com/news/cervical-cancer-foundation-wants-greater-awareness-and-action 2022-11-08T03:00:01+11:00 https://pharmadispatch.com/news/australian-biotech-welcomes-ground-breaking-results-from-researc 2022-11-08T03:00:01+11:00 https://pharmadispatch.com/news/bms-takes-another-step-forward-in-the-pursuit-of-clinical-trial- 2022-11-08T03:00:01+11:00 https://pharmadispatch.com/news/are-states-exercising-a-veto-power-on-national-hta-outcomes 2022-11-08T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-to-widen-access-to-pfizers-pneumococcal-vaccine 2022-11-07T17:17:01+11:00 https://pharmadispatch.com/news/hbf-announces-planned-acquisition-regional-queensland-health-fun 2022-11-07T17:02:01+11:00 https://pharmadispatch.com/news/telix-announces-positive-topline-results-of-late-stage-kidney-ca 2022-11-07T09:55:01+11:00 https://pharmadispatch.com/news/medibank-says-it-will-not-pay-cyberattack-ransom 2022-11-07T09:42:01+11:00 https://pharmadispatch.com/news/department-of-health-says-no-to-the-release-of-information 2022-11-07T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-abbvie-and-novartis-top-new-pharma-reputation-list 2022-11-07T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-launches-independent-review-of-medicare-integrity 2022-11-07T03:00:01+11:00 https://pharmadispatch.com/news/three-more-years-for-medicines-australia-chair 2022-11-07T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-celebrates-major-covid-19-vaccination-milestone 2022-11-06T13:28:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-4-november 2022-11-04T10:59:01+11:00 https://pharmadispatch.com/news/new-chapter-is-the-opportunity-for-a-new-approach-and-a-do-no-ha 2022-11-04T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-mtpconnect-announced-board-changes 2022-11-04T03:00:01+11:00 https://pharmadispatch.com/news/clarity-around-the-principles-with-a-willingness-to-engage-and-s 2022-11-04T03:00:01+11:00 https://pharmadispatch.com/news/2022-list-of-australias-best-workplaces-for-women 2022-11-04T03:00:01+11:00 https://pharmadispatch.com/news/four-new-directors-elected-to-the-medicines-australia-board 2022-11-03T16:34:01+11:00 https://pharmadispatch.com/news/battle-continues-over-the-reform-of-medical-device-pricing 2022-11-03T10:10:01+11:00 https://pharmadispatch.com/news/csl-secures-rights-to-late-stage-mrna-covid-19-vaccine 2022-11-03T03:00:01+11:00 https://pharmadispatch.com/news/major-generics-multinational-looking-to-expand-in-australia 2022-11-03T03:00:01+11:00 https://pharmadispatch.com/news/bms-the-2022-list-of-australias-best-workplaces-for-women 2022-11-03T03:00:01+11:00 https://pharmadispatch.com/news/new-trikafta-approval-as-pbac-considers-expanded-listing 2022-11-03T03:00:01+11:00 https://pharmadispatch.com/news/minister-says-nmp-review-an-important-opportunity-to-set-high-le 2022-11-02T03:00:01+11:00 https://pharmadispatch.com/news/anne-ruston-says-the-need-for-reform-has-been-heard-loud-and-cle 2022-11-02T03:00:01+11:00 https://pharmadispatch.com/news/merck-pulls-medicines-in-response-to-new-pbs-pricing-framework 2022-11-02T03:00:01+11:00 https://pharmadispatch.com/news/these-are-the-opportunities-that-we-see-are-you-interested-in-ha 2022-11-01T15:00:01+11:00 https://pharmadispatch.com/news/medical-device-sector-wants-regulator-to-investigate-health-insu 2022-11-01T10:21:01+11:00 https://pharmadispatch.com/news/private-health-insurers-call-on-others-to-match-level-of-transpa 2022-11-01T10:19:01+11:00 https://pharmadispatch.com/news/australian-digital-health-agency-and-csiro-in-new-collaboration 2022-11-01T10:10:01+11:00 https://pharmadispatch.com/news/orthocells-remplir-added-to-australias-prostheses-list 2022-11-01T10:08:01+11:00 https://pharmadispatch.com/news/world-first-brain-cancer-clinical-trials-launched-in-melbourne 2022-11-01T09:42:01+11:00 https://pharmadispatch.com/news/sanofi-employees-contribute-800-hours-in-we-volunteer-month 2022-11-01T03:00:01+11:00 https://pharmadispatch.com/news/tpg-capital-asia-completes-investment-in-inova-pharmaceuticals 2022-11-01T03:00:01+11:00 https://pharmadispatch.com/news/roche-welcomes-new-lung-cancer-listing-for-immunotherapy 2022-11-01T03:00:01+11:00 https://pharmadispatch.com/news/australia-rises-in-global-rankings-of-early-and-mid-stage-clinic 2022-11-01T03:00:01+11:00 https://pharmadispatch.com/news/will-the-recent-period-of-growth-survive-the-latest-pricing-bomb 2022-10-31T03:00:01+11:00 https://pharmadispatch.com/news/when-did-reform-become-about-avoiding-the-bad-outcomes-it-create 2022-10-31T03:00:01+11:00 https://pharmadispatch.com/news/when-did-reform-become-about-avoiding-the-bad-outcomes-it-create 2022-10-31T02:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-28-october 2022-10-28T13:23:01+11:00 https://pharmadispatch.com/news/power-asymmetry-is-the-biggest-issue-for-advocates-of-hta-reform 2022-10-28T11:19:01+11:00 https://pharmadispatch.com/news/pbs-rebates-rapidly-approaching-a-new-milestone 2022-10-28T11:07:01+11:00 https://pharmadispatch.com/news/power-asymmetry-is-the-biggest-issue-for-advocates-of-hta-reform 2022-10-28T03:00:01+11:00 https://pharmadispatch.com/news/john-young-expects-open-engagement-and-a-focus-on-what-patients- 2022-10-28T03:00:01+11:00 https://pharmadispatch.com/news/program-finalised-for-mondays-bpd-post-budget-summit 2022-10-27T19:25:01+11:00 https://pharmadispatch.com/news/new-zealand-moves-to-widen-access-to-two-critical-vaccines 2022-10-27T03:00:01+11:00 https://pharmadispatch.com/news/senate-requires-legislative-instruments-for-all-section-100-spec 2022-10-27T03:00:01+11:00 https://pharmadispatch.com/news/stakeholder-groups-not-giving-up-but-government-pushing-back-on- 2022-10-27T03:00:01+11:00 https://pharmadispatch.com/news/csl-secures-licence-agreement-for-potential-blood-clot-therapy 2022-10-27T03:00:01+11:00 https://pharmadispatch.com/news/andhealth-and-launchvic-partner-on-new-digital-health-accelerato 2022-10-26T12:46:01+11:00 https://pharmadispatch.com/news/mtpconnect-signs-mou-with-us-based-medical-health-industry-assoc 2022-10-26T12:41:01+11:00 https://pharmadispatch.com/news/mark-butler-about-to-race-past-the-former-governments-nine-year- 2022-10-26T03:00:01+11:00 https://pharmadispatch.com/news/the-decline-in-spending-is-what-the-industry-negotiated-in-its-a 2022-10-26T03:00:01+11:00 https://pharmadispatch.com/news/dumping-the-funding-guarantee-brand-opens-the-door-to-an-honest- 2022-10-26T03:00:01+11:00 https://pharmadispatch.com/news/medical-technology-sector-welcomes-federal-grant-to-local-compan 2022-10-25T11:06:01+11:00 https://pharmadispatch.com/news/cyber-theft-of-identifiable-personal-patient-information-a-wake- 2022-10-25T10:38:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-confirms-new-leadership-for-australia-and-n 2022-10-25T10:00:01+11:00 https://pharmadispatch.com/news/sanofi-backs-bleeding-disorders-awareness-month-with-virtual-eve 2022-10-25T03:00:01+11:00 https://pharmadispatch.com/news/timely-reminder-of-why-this-program-urgently-needs-transparency- 2022-10-25T03:00:01+11:00 https://pharmadispatch.com/news/consumers-health-forum-confirms-interim-leader-as-new-ceo 2022-10-25T03:00:01+11:00 https://pharmadispatch.com/news/key-senator-considering-amendment-to-co-pay-reduction-legislatio 2022-10-25T03:00:01+11:00 https://pharmadispatch.com/news/companies-start-submitting-additional-information-in-support-of- 2022-10-25T03:00:01+11:00 https://pharmadispatch.com/news/bupa-health-insurance-wins-recognition-in-annual-canstar-awards 2022-10-24T16:04:01+11:00 https://pharmadispatch.com/news/nib-sets-pathway-to-net-zero-carbon-emissions-by-2040 2022-10-24T16:02:01+11:00 https://pharmadispatch.com/news/first-satellite-bioanalytical-lab-offers-fastest-option-for-pbmc 2022-10-24T10:45:01+11:00 https://pharmadispatch.com/news/aculeus-therapeutics-reaches-major-milestone-with-launch-of-stud 2022-10-24T09:07:01+11:00 https://pharmadispatch.com/news/university-of-sydney-led-research-consortium-manufactures-living 2022-10-24T08:59:01+11:00 https://pharmadispatch.com/news/new-listings-but-will-it-be-smooth-sailing-in-the-senate-for-co- 2022-10-24T03:00:01+11:00 https://pharmadispatch.com/news/summit-to-focus-on-budget-agreements-system-level-change-and-tax 2022-10-24T03:00:01+11:00 https://pharmadispatch.com/news/further-pricing-reform-put-front-and-centre-of-us-mid-term-elect 2022-10-24T03:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-budget-week-review 2022-10-23T17:10:01+11:00 https://pharmadispatch.com/news/the-week-in-review-21-october 2022-10-21T12:50:01+11:00 https://pharmadispatch.com/news/another-day-and-another-change-that-only-aims-to-further-exclude 2022-10-21T03:00:01+11:00 https://pharmadispatch.com/news/independent-report-delivers-scathing-assessment-of-covid-19-vacc 2022-10-21T03:00:01+11:00 https://pharmadispatch.com/news/gedeon-richter-joins-generic-and-biosimilar-medicines-associatio 2022-10-21T03:00:01+11:00 https://pharmadispatch.com/news/tga-grants-new-provisional-approval-for-moderna-covid-19-vaccine 2022-10-20T13:56:01+11:00 https://pharmadispatch.com/news/australian-company-secures-significant-milestone-payment-with-fd 2022-10-20T12:54:01+11:00 https://pharmadispatch.com/news/pharmaxis-reports-positive-interim-data-from-myelofibrosis-study 2022-10-20T03:00:01+11:00 https://pharmadispatch.com/news/viatris-the-top-ranked-healthcare-company-in-best-workplaces-to- 2022-10-20T03:00:01+11:00 https://pharmadispatch.com/news/msd-australia-helps-shine-a-light-on-the-265-million-australians 2022-10-20T03:00:01+11:00 https://pharmadispatch.com/news/better-access-australia-calls-for-senate-action-on-co-payment-in 2022-10-20T03:00:01+11:00 https://pharmadispatch.com/news/medibank-enters-trading-halt-in-response-to-contact-from-potenti 2022-10-19T17:56:01+11:00 https://pharmadispatch.com/news/hbf-confirms-the-appointment-of-its-new-ceo 2022-10-19T16:13:01+11:00 https://pharmadispatch.com/news/report-says-australia-can-be-a-global-destination-for-digital-he 2022-10-19T15:04:01+11:00 https://pharmadispatch.com/news/new-study-confirms-rhinoswab-as-preferred-method-for-testing-chi 2022-10-19T13:00:01+11:00 https://pharmadispatch.com/news/first-of-its-kind-study-to-explore-cancer-from-a-first-nations-p 2022-10-19T10:11:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-announces-positive-data-from-brain-cance 2022-10-19T09:37:01+11:00 https://pharmadispatch.com/news/auditor-general-yet-to-make-a-decision-on-audit-of-pbs-administr 2022-10-19T03:00:01+11:00 https://pharmadispatch.com/news/we-can-only-hope-this-outcome-is-a-thought-bubble-that-will-be-i 2022-10-19T03:00:01+11:00 https://pharmadispatch.com/news/new-campaign-aims-to-raise-awareness-of-invasive-meningococcal-d 2022-10-19T03:00:01+11:00 https://pharmadispatch.com/news/committee-is-now-recommending-that-companies-engage-in-price-fix 2022-10-18T11:43:01+11:00 https://pharmadispatch.com/news/csl-updates-on-its-strategic-integration-of-vifor-pharma 2022-10-18T03:00:01+11:00 https://pharmadispatch.com/news/pharmacy-expanded-scope-of-practice-pilot-set-to-get-underway 2022-10-18T03:00:01+11:00 https://pharmadispatch.com/news/pharmac-updates-on-the-125-therapies-currently-on-its-option-for 2022-10-18T03:00:01+11:00 https://pharmadispatch.com/news/servier-commissioned-survey-reveals-many-gps-overlooking-their-o 2022-10-18T03:00:01+11:00 https://pharmadispatch.com/news/wholesalers-activate-plans-to-deliver-medicine-to-flood-affected 2022-10-18T03:00:01+11:00 https://pharmadispatch.com/news/csl-awards-two-five-year-fellowships-to-australian-researchers 2022-10-17T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-doubles-commitment-to-solar-with-3000-panels-at-manufactu 2022-10-17T03:00:01+11:00 https://pharmadispatch.com/news/federal-government-announces-detailed-agenda-for-reform-of-the-p 2022-10-17T03:00:01+11:00 https://pharmadispatch.com/news/evusheld-outcome-highlights-the-challenge-of-consistent-and-equi 2022-10-17T03:00:01+11:00 https://pharmadispatch.com/news/september-meeting-delivers-mixed-outcomes-for-covid-19-therapies 2022-10-17T03:00:01+11:00 https://pharmadispatch.com/news/novartis-makes-list-of-australias-most-innovative-health-compani 2022-10-17T03:00:01+11:00 https://pharmadispatch.com/news/nib-announce-capital-raise-and-entry-into-the-ndis-sector 2022-10-16T19:08:01+11:00 https://pharmadispatch.com/news/medibank-continues-to-update-on-recent-cybersecurity-incident 2022-10-16T19:02:01+11:00 https://pharmadispatch.com/news/bupa-launches-its-new-rewards-and-loyalty-program-life-rewards 2022-10-16T18:38:01+11:00 https://pharmadispatch.com/news/new-treatment-guidelines-unveiled-for-first-nations-people-livin 2022-10-16T17:44:01+11:00 https://pharmadispatch.com/news/microbiogen-opens-state-of-the-art-laboratory-facilities-in-sydn 2022-10-16T17:42:01+11:00 https://pharmadispatch.com/news/andhealth-ceo-recognised-with-the-telstra-brilliant-women-in-dig 2022-10-16T17:41:01+11:00 https://pharmadispatch.com/news/the-week-in-review-14-october 2022-10-14T11:53:01+11:00 https://pharmadispatch.com/news/outcomes-just-confirm-the-truly-dreadful-and-damaging-nature-of- 2022-10-14T03:00:01+11:00 https://pharmadispatch.com/news/indicative-outcomes-clearly-driven-by-need-to-deliver-budgeted-s 2022-10-14T03:00:01+11:00 https://pharmadispatch.com/news/is-the-department-assessing-its-own-application-for-discretion 2022-10-14T03:00:01+11:00 https://pharmadispatch.com/news/pharma-inclusion-group-launches-report-on-future-of-workplace-in 2022-10-14T03:00:01+11:00 https://pharmadispatch.com/news/committee-recommends-the-narrowest-of-lung-cancer-screening-prog 2022-10-14T03:00:01+11:00 https://pharmadispatch.com/news/cartherics-opens-new-melbourne-based-lab-to-develop-cancer-immun 2022-10-13T16:06:01+11:00 https://pharmadispatch.com/news/major-change-for-leading-patient-advocate-with-move-to-emerging- 2022-10-13T03:00:01+11:00 https://pharmadispatch.com/news/us-based-bio-looking-for-new-leadership-after-challenging-period 2022-10-13T03:00:01+11:00 https://pharmadispatch.com/news/illumina-and-astrazeneca-team-up-on-ai-based-research-project 2022-10-13T03:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-launches-2022-community-grants-programs 2022-10-13T03:00:01+11:00 https://pharmadispatch.com/news/federal-government-to-set-gender-targets-for-major-nhmrc-researc 2022-10-12T11:21:01+11:00 https://pharmadispatch.com/news/outcomes-start-coming-with-companies-describing-them-as-a-mixed- 2022-10-12T03:00:01+11:00 https://pharmadispatch.com/news/australian-company-taps-well-known-former-government-official-fo 2022-10-12T03:00:01+11:00 https://pharmadispatch.com/news/pfizer-and-gilead-team-up-on-lgbtq-inclusion-for-the-industry 2022-10-12T03:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-lilly-with-promotion-for-benjamin-basil 2022-10-11T15:30:01+11:00 https://pharmadispatch.com/news/these-issues-and-the-process-are-evidence-of-system-under-signif 2022-10-11T10:49:01+11:00 https://pharmadispatch.com/news/major-appointments-and-rebrand-for-australian-medicinal-cannabis 2022-10-11T03:00:01+11:00 https://pharmadispatch.com/news/an-eerie-silence-broken-by-late-notice-of-delay-in-indicative-ou 2022-10-11T03:00:01+11:00 https://pharmadispatch.com/news/pharma-australia-inclusion-group-launches-program-and-welcomes-n 2022-10-10T17:16:01+11:00 https://pharmadispatch.com/news/racgp-backs-call-to-cut-the-red-tape-holding-back-foreign-doctor 2022-10-10T11:52:01+11:00 https://pharmadispatch.com/news/construction-starts-on-new-hospital-driven-by-medibank-joint-ven 2022-10-10T11:50:01+11:00 https://pharmadispatch.com/news/platform-launched-for-aboriginal-and-torres-strait-islander-peop 2022-10-10T11:47:01+11:00 https://pharmadispatch.com/news/biontech-chooses-melbourne-for-asia-pacific-mrna-rd-centre 2022-10-10T03:00:01+11:00 https://pharmadispatch.com/news/csl-seqirus-secures-us-government-agreement-to-develop-vaccine-c 2022-10-10T03:00:01+11:00 https://pharmadispatch.com/news/the-industrys-much-anticipated-day-of-discretion-finally-arrives 2022-10-10T03:00:01+11:00 https://pharmadispatch.com/news/the-industry-dismissed-the-risk-of-double-dipping-last-year 2022-10-10T03:00:01+11:00 https://pharmadispatch.com/news/can-the-industry-learn-that-secrecy-and-avoiding-scrutiny-lead-t 2022-10-10T03:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-7-october 2022-10-07T11:54:01+11:00 https://pharmadispatch.com/news/if-patient-access-will-be-the-victim-then-this-debate-needs-to-b 2022-10-07T03:00:01+11:00 https://pharmadispatch.com/news/submission-to-treasury-review-calls-for-an-end-to-favourable-tax 2022-10-07T03:00:01+11:00 https://pharmadispatch.com/news/is-this-another-assault-on-special-pricing-arrangements 2022-10-07T03:00:01+11:00 https://pharmadispatch.com/news/the-red-flags-are-flying-on-more-cost-recovery-changes 2022-10-06T03:00:01+11:00 https://pharmadispatch.com/news/second-fast-track-designation-for-australian-immunotherapy-compa 2022-10-06T03:00:01+11:00 https://pharmadispatch.com/news/novavax-welcomes-the-recommendations-of-halton-review 2022-10-06T03:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-confirms-it-has-presented-the-evidence-to-mi 2022-10-06T03:00:01+11:00 https://pharmadispatch.com/news/illumina-unveils-novaseq-x-series-to-accelerate-genomic-discover 2022-10-05T14:46:01+11:00 https://pharmadispatch.com/news/perth-hospital-becomes-the-first-in-state-to-use-new-robotic-sur 2022-10-05T12:08:01+11:00 https://pharmadispatch.com/news/atmo-announces-publication-of-positive-gas-capsule-clinical-tria 2022-10-05T11:54:01+11:00 https://pharmadispatch.com/news/ma-deputy-chair-departs-after-promotion-to-senior-role-in-europe 2022-10-05T03:00:01+11:00 https://pharmadispatch.com/news/former-medicines-australia-executive-joins-ministers-office 2022-10-05T03:00:01+11:00 https://pharmadispatch.com/news/two-australian-organisations-to-share-roche-125-year-anniversary 2022-10-05T03:00:01+11:00 https://pharmadispatch.com/news/list-published-of-the-over-2900-pbs-items-designated-for-stock-c 2022-10-04T16:35:01+11:00 https://pharmadispatch.com/news/latest-statistical-update-shows-cancer-survival-rates-continue-t 2022-10-04T13:35:01+11:00 https://pharmadispatch.com/news/australian-biotechnology-incubator-proto-axiom-completes-initial 2022-10-04T12:52:01+11:00 https://pharmadispatch.com/news/nature-publishes-data-on-dunp19-receptors-role-in-cancer-growth 2022-10-04T12:50:01+11:00 https://pharmadispatch.com/news/this-association-needs-to-add-the-set-of-skills-it-does-not-have 2022-10-04T03:00:01+11:00 https://pharmadispatch.com/news/wait-for-indicative-discretion-outcomes-down-to-less-than-a-week 2022-10-04T03:00:01+11:00 https://pharmadispatch.com/news/hbf-run-for-a-reason-is-back-after-three-year-hiatus 2022-10-03T16:06:01+11:00 https://pharmadispatch.com/news/dietitians-australia-calls-for-action-on-aged-care-weight-loss 2022-10-03T16:05:01+11:00 https://pharmadispatch.com/news/private-health-insurers-call-for-reform-of-second-tier-default-b 2022-10-03T16:03:01+11:00 https://pharmadispatch.com/news/tga-provisional-determination-for-modernas-covid-19-bivalent-boo 2022-10-03T13:44:01+11:00 https://pharmadispatch.com/news/australian-company-doses-first-patient-in-mnd-clinical-trial 2022-10-03T13:37:01+11:00 https://pharmadispatch.com/news/bms-welcomes-expanded-pbs-listing-for-key-immunotherapy 2022-10-03T13:08:01+11:00 https://pharmadispatch.com/news/introducing-the-first-week-in-review-episode-of-the-dispatched-p 2022-09-30T12:55:01+10:00 https://pharmadispatch.com/news/tga-provisionally-approves-pfizers-covid-19-vaccine-for-younger- 2022-09-30T04:00:01+10:00 https://pharmadispatch.com/news/new-high-court-justice-a-major-figure-in-pharmas-legal-history 2022-09-30T03:00:01+10:00 https://pharmadispatch.com/news/ipsen-welcomes-first-and-only-pbs-listing-for-ultra-rare-short-s 2022-09-30T03:00:01+10:00 https://pharmadispatch.com/news/new-blood-cancer-listing-means-the-financial-weight-is-lifted 2022-09-30T03:00:01+10:00 https://pharmadispatch.com/news/new-anti-corruption-body-has-real-implications-for-hta-decision- 2022-09-29T11:11:01+10:00 https://pharmadispatch.com/news/more-speakers-confirmed-for-bpd-post-budget-summit 2022-09-29T03:00:01+10:00 https://pharmadispatch.com/news/mps-speak-out-in-support-of-defunded-nps-medicinewise 2022-09-29T03:00:01+10:00 https://pharmadispatch.com/news/agilex-biolabs-expands-capacity-with-the-commissioning-of-new-br 2022-09-28T17:31:01+10:00 https://pharmadispatch.com/news/final-outcome-reveals-lower-than-forecast-spending-on-pharmaceut 2022-09-28T12:05:01+10:00 https://pharmadispatch.com/news/major-new-collaboration-launches-cv-screening-pilot-with-nationa 2022-09-28T11:58:01+10:00 https://pharmadispatch.com/news/pharmac-consulting-on-new-funding-proposals-including-sma-therap 2022-09-28T11:03:01+10:00 https://pharmadispatch.com/news/biogen-and-eisai-announce-major-milestone-for-potential-alzheime 2022-09-28T10:12:01+10:00 https://pharmadispatch.com/news/csl-announces-seven-recipients-of-global-research-acceleration-i 2022-09-28T05:35:01+10:00 https://pharmadispatch.com/news/vertex-australian-joins-global-colleagues-in-day-of-service 2022-09-28T05:13:01+10:00 https://pharmadispatch.com/news/does-mark-butler-want-the-industry-take-some-responsibility 2022-09-28T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-funding-for-long-acting-growth-hormone-treatment 2022-09-27T14:51:01+10:00 https://pharmadispatch.com/news/halton-review-recommends-more-forward-thinking-on-emergencies 2022-09-27T14:11:01+10:00 https://pharmadispatch.com/news/pharmaxis-releases-promising-interim-data-from-skin-scarring-stu 2022-09-27T03:00:01+10:00 https://pharmadispatch.com/news/new-listings-for-october-but-mixed-outcomes-for-patients-on-out- 2022-09-27T03:00:01+10:00 https://pharmadispatch.com/news/australian-expatriate-leading-novartis-global-cardiovascular-fra 2022-09-27T03:00:01+10:00 https://pharmadispatch.com/news/new-leadership-coming-for-bristol-myers-squibb-australia 2022-09-27T03:00:01+10:00 https://pharmadispatch.com/news/botanix-pharmaceuticals-submits-new-drug-application-to-fda 2022-09-26T16:00:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-announces-poster-presentation-from-major-s 2022-09-26T15:59:01+10:00 https://pharmadispatch.com/news/emyria-advances-phase-3-trial-of-cannabinoid-treatment 2022-09-26T15:57:01+10:00 https://pharmadispatch.com/news/grant-go-support-cardiovascular-study-of-cynata-therapeutics-cel 2022-09-26T15:53:01+10:00 https://pharmadispatch.com/news/the-very-real-and-even-likely-scenario-facing-some-companies 2022-09-26T03:00:01+10:00 https://pharmadispatch.com/news/next-aprils-catch-up-reduction-day-will-be-followed-by-annual-mo 2022-09-26T03:00:01+10:00 https://pharmadispatch.com/news/do-the-industrys-agreements-make-the-pivot-to-price-defence-advo 2022-09-26T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-encourages-stakeholder-input-on-revised-poli 2022-09-26T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-australians-want-pharmacists-to-do-more 2022-09-25T09:35:01+10:00 https://pharmadispatch.com/news/provisional-approval-for-pfizer-covid-19-vaccine-as-a-booster-in 2022-09-23T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-launches-consultation-process-on-provisional-bundle-deal 2022-09-23T03:00:01+10:00 https://pharmadispatch.com/news/novavax-leader-hopeful-australia-will-move-ahead-on-boosters 2022-09-22T10:31:01+10:00 https://pharmadispatch.com/news/stockholding-commitment-included-on-the-list-of-industry-concern 2022-09-22T09:11:01+10:00 https://pharmadispatch.com/news/the-industrys-argument-will-succeed-or-fail-based-on-the-legal-i 2022-09-21T03:00:01+10:00 https://pharmadispatch.com/news/industry-says-discussion-forthright-but-department-defends-imple 2022-09-21T03:00:01+10:00 https://pharmadispatch.com/news/csl-seqirus-specialist-recognised-at-women-in-industry-awards 2022-09-21T03:00:01+10:00 https://pharmadispatch.com/news/noxopharm-founder-to-depart-board-as-part-of-natural-evolution 2022-09-20T14:38:01+10:00 https://pharmadispatch.com/news/farewelling-a-legend-and-understanding-the-reality-of-policy 2022-09-20T03:00:01+10:00 https://pharmadispatch.com/news/medibio-appoints-experienced-medical-executive-as-new-ceo 2022-09-19T13:53:01+10:00 https://pharmadispatch.com/news/major-milestone-for-polynovo-for-fda-clearance-of-wound-care-inn 2022-09-19T11:28:01+10:00 https://pharmadispatch.com/news/medibank-commits-to-accelerate-plan-to-achieve-net-zero 2022-09-19T10:07:01+10:00 https://pharmadispatch.com/news/fda-grants-important-designation-to-radiopharm-theranostics-dunp 2022-09-19T09:47:01+10:00 https://pharmadispatch.com/news/federal-government-extends-covid-19-response-measures 2022-09-19T09:27:01+10:00 https://pharmadispatch.com/news/the-choice-is-to-be-more-defensive-or-continue-to-suffer-bad-out 2022-09-19T03:00:01+10:00 https://pharmadispatch.com/news/industry-prepares-to-put-forward-its-evidence-for-agreement-brea 2022-09-19T03:00:01+10:00 https://pharmadispatch.com/news/bayers-ashraf-al-ouf-elevated-to-chair-the-company-across-austra 2022-09-19T03:00:01+10:00 https://pharmadispatch.com/news/department-moving-to-tax-the-medical-device-sector-with-new-levy 2022-09-18T08:51:01+10:00 https://pharmadispatch.com/news/ucb-australia-recognised-in-the-australian-business-awards 2022-09-16T03:00:01+10:00 https://pharmadispatch.com/news/new-zealand-patients-implore-pharmac-to-fund-blood-cancer-therap 2022-09-16T03:00:01+10:00 https://pharmadispatch.com/news/review-identified-major-holes-in-nps-medicinewise-defunding-deci 2022-09-16T03:00:01+10:00 https://pharmadispatch.com/news/did-anyone-actually-read-this-report-before-confirming-the-decis 2022-09-16T03:00:01+10:00 https://pharmadispatch.com/news/former-gsk-executive-to-lead-csls-reputation-management-centre 2022-09-15T03:00:01+10:00 https://pharmadispatch.com/news/he-was-respected-liked-and-just-a-thoroughly-decent-person-who-w 2022-09-15T03:00:01+10:00 https://pharmadispatch.com/news/antengene-follows-first-pbs-listing-with-the-opening-of-new-offi 2022-09-15T03:00:01+10:00 https://pharmadispatch.com/news/black-dog-institute-welcomes-tga-consultation-on-paracetamol 2022-09-15T03:00:01+10:00 https://pharmadispatch.com/news/moderna-continues-to-build-executive-team-with-latest-appointmen 2022-09-15T03:00:01+10:00 https://pharmadispatch.com/news/new-blood-cancer-research-urges-national-reform-for-regions 2022-09-15T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-confirms-the-appointment-of-head-of-corporate-affairs 2022-09-15T03:00:01+10:00 https://pharmadispatch.com/news/bit225-confirms-start-of-new-covid-19-human-study 2022-09-14T13:54:01+10:00 https://pharmadispatch.com/news/epiaxis-therapeutics-announces-collaboration-with-canadian-resea 2022-09-14T13:54:01+10:00 https://pharmadispatch.com/news/immutep-provides-clinical-update-on-efti-and-confirms-board-appo 2022-09-14T13:53:01+10:00 https://pharmadispatch.com/news/noxopharm-reports-promising-results-from-pancreatic-cancer-study 2022-09-14T13:51:01+10:00 https://pharmadispatch.com/news/medibanks-live-better-program-hits-500000-members 2022-09-14T13:05:01+10:00 https://pharmadispatch.com/news/bupa-customers-to-receive-315-million-in-pre-christmas-cashback 2022-09-14T13:04:01+10:00 https://pharmadispatch.com/news/not-too-late-to-gain-a-proper-understanding-of-what-is-really-in 2022-09-14T03:00:01+10:00 https://pharmadispatch.com/news/asia-pacific-takes-the-lead-on-new-gene-and-cell-therapy-trials 2022-09-14T02:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-announces-plan-to-cease-operations-in-response- 2022-09-13T17:01:01+10:00 https://pharmadispatch.com/news/new-research-identifies-link-between-covid-19-and-atrial-fibrill 2022-09-13T16:49:01+10:00 https://pharmadispatch.com/news/ma-chair-labels-implementation-disingenuous-and-a-breach-of-new- 2022-09-13T14:17:01+10:00 https://pharmadispatch.com/news/private-equity-terminates-proposed-acquisition-of-ramsay-health- 2022-09-13T09:51:01+10:00 https://pharmadispatch.com/news/clarity-strengthens-protection-of-sar-bispsma-product-with-china 2022-09-13T08:17:01+10:00 https://pharmadispatch.com/news/botanix-completes-issue-of-first-tranche-of-major-placement 2022-09-13T08:15:01+10:00 https://pharmadispatch.com/news/pharmac-extends-access-criteria-to-covid-19-antiviral-treatments 2022-09-13T03:00:01+10:00 https://pharmadispatch.com/news/document-reveals-valuable-insights-on-impact-of-pricing-reforms 2022-09-13T03:00:01+10:00 https://pharmadispatch.com/news/health-minister-accepts-advice-on-adding-bivalent-vaccine-to-nat 2022-09-13T03:00:01+10:00 https://pharmadispatch.com/news/new-national-president-to-lead-college-of-general-practitioners 2022-09-12T13:32:01+10:00 https://pharmadispatch.com/news/us-fda-grants-orphan-designation-for-radiopharm-theranostics-dun 2022-09-12T11:36:01+10:00 https://pharmadispatch.com/news/antisense-therapeutics-says-dosing-has-commenced-in-combination- 2022-09-12T11:12:01+10:00 https://pharmadispatch.com/news/hbf-reports-significant-member-growth-in-challenging-economic-en 2022-09-12T10:56:01+10:00 https://pharmadispatch.com/news/racgp-welcomes-major-contract-to-deliver-gp-training-in-australi 2022-09-12T10:27:01+10:00 https://pharmadispatch.com/news/starting-in-the-right-place-means-an-honest-assessment-of-the-ri 2022-09-12T03:00:01+10:00 https://pharmadispatch.com/news/secretly-negotiated-collaboration-pre-empts-agreement-outcome 2022-09-12T03:00:01+10:00 https://pharmadispatch.com/news/janssen-appoints-new-managing-director-to-succeed-biljananaumovi 2022-09-12T03:00:01+10:00 https://pharmadispatch.com/news/the-first-set-of-discretion-outcomes-deliver-as-expected 2022-09-09T03:00:01+10:00 https://pharmadispatch.com/news/the-power-is-described-as-ministerial-but-it-will-be-exercised-b 2022-09-09T03:00:01+10:00 https://pharmadispatch.com/news/msd-looking-to-pbs-for-another-new-keytruda-indication 2022-09-09T03:00:01+10:00 https://pharmadispatch.com/news/imugene-doses-first-patient-in-nextherizon-phase-2-clinical-tria 2022-09-08T10:46:01+10:00 https://pharmadispatch.com/news/antisense-therapeutics-announces-revised-clinical-development-pl 2022-09-08T10:44:01+10:00 https://pharmadispatch.com/news/victoria-backs-new-andhealth-created-innovation-and-commercialis 2022-09-08T08:32:01+10:00 https://pharmadispatch.com/news/watch-for-the-impact-of-blue-light-devices-on-eyes-and-sleep-pat 2022-09-08T08:30:01+10:00 https://pharmadispatch.com/news/medibank-in-new-partnership-to-create-orthopaedic-surgical-centr 2022-09-08T08:26:01+10:00 https://pharmadispatch.com/news/merger-combines-doctor-patient-software-management-platforms 2022-09-08T03:00:01+10:00 https://pharmadispatch.com/news/government-introduces-legislation-to-cut-general-pbs-co-payment 2022-09-08T03:00:01+10:00 https://pharmadispatch.com/news/mixed-emotions-for-companies-carrying-the-cost-of-co-pay-reducti 2022-09-08T03:00:01+10:00 https://pharmadispatch.com/news/the-pbs-pricing-framework-has-produced-a-confusing-time-for-bios 2022-09-08T03:00:01+10:00 https://pharmadispatch.com/news/watch-for-the-impact-of-blue-light-devices-on-eyes-and-sleep-pat 2022-09-07T11:21:01+10:00 https://pharmadispatch.com/news/new-molecule-chip-changing-the-face-of-modern-manufacturing 2022-09-07T10:13:01+10:00 https://pharmadispatch.com/news/report-calls-for-more-consideration-of-societal-benefits-in-hta- 2022-09-07T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-delivers-minimal-action-in-interim-response-to-scathing- 2022-09-07T03:00:01+10:00 https://pharmadispatch.com/news/merck-team-gets-behind-jean-hailes-womens-health-week 2022-09-07T03:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-would-it-actually-make-a-difference-to-decision-makin 2022-09-06T15:07:01+10:00 https://pharmadispatch.com/news/immutep-signs-agreement-for-new-phase-2-efti-trial 2022-09-06T11:14:01+10:00 https://pharmadispatch.com/news/recce-pharmaceuticals-announces-appointment-of-executive-chairma 2022-09-06T11:13:01+10:00 https://pharmadispatch.com/news/qimr-berghofer-grants-option-and-license-agreement-for-potential 2022-09-06T11:11:01+10:00 https://pharmadispatch.com/news/esfam-biotech-receives-1-million-for-covid-19-treatment-discover 2022-09-06T11:10:01+10:00 https://pharmadispatch.com/news/occurx-secures-funding-to-progress-potential-inflammation-and-fi 2022-09-06T11:08:01+10:00 https://pharmadispatch.com/news/independence-takes-many-forms-and-it-can-be-over-rated 2022-09-06T03:00:01+10:00 https://pharmadispatch.com/news/prospection-announces-new-data-access-agreement-for-japan 2022-09-05T15:12:01+10:00 https://pharmadispatch.com/news/bupa-backs-the-return-of-sustainable-september-in-melbourne 2022-09-05T14:15:01+10:00 https://pharmadispatch.com/news/hcf-announces-the-return-of-more-pandemic-related-savings 2022-09-05T14:12:01+10:00 https://pharmadispatch.com/news/new-parliamentary-inquiry-to-look-at-the-impact-of-long-covid 2022-09-05T14:11:01+10:00 https://pharmadispatch.com/news/medibank-research-reveals-pandemic-impact-on-workplace-confidenc 2022-09-05T14:09:01+10:00 https://pharmadispatch.com/news/confidentiality-protections-will-constrain-new-hta-international 2022-09-05T12:55:01+10:00 https://pharmadispatch.com/news/chemotherapy-review-calls-for-major-reform-in-interim-report 2022-09-05T11:13:01+10:00 https://pharmadispatch.com/news/reviews-have-been-an-almost-endless-feature-of-australias-use-of 2022-09-05T03:00:01+10:00 https://pharmadispatch.com/news/elevating-the-discussion-is-the-pre-condition-to-achieving-real- 2022-09-05T03:00:01+10:00 https://pharmadispatch.com/news/patient-group-welcomes-new-treatment-but-wants-action-on-newborn 2022-09-05T03:00:01+10:00 https://pharmadispatch.com/news/australia-becomes-one-of-the-first-to-fund-new-sanofi-therapy 2022-09-05T03:00:01+10:00 https://pharmadispatch.com/news/surely-the-best-patient-view-is-one-that-is-fully-informed 2022-09-02T01:00:01+10:00 https://pharmadispatch.com/news/new-national-survey-reveals-more-on-australias-use-of-medicines 2022-09-02T01:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-secures-funding-from-leading-uk-organisation 2022-09-02T00:24:01+10:00 https://pharmadispatch.com/news/clinuvel-reports-sixth-consecutive-annual-profit 2022-09-01T06:32:01+10:00 https://pharmadispatch.com/news/private-hospitals-slam-victorias-move-on-nursing-workforce 2022-09-01T06:23:01+10:00 https://pharmadispatch.com/news/leukaemia-foundation-launches-dedicated-blood-cancer-support-lin 2022-09-01T06:08:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-new-pbs-listings 2022-09-01T06:00:01+10:00 https://pharmadispatch.com/news/gsks-official-return-to-oncology-with-listing-of-ovarian-cancer- 2022-09-01T02:25:01+10:00 https://pharmadispatch.com/news/sanofis-with-vaccines-community-grants-awarded-to-eight-organisa 2022-09-01T01:43:01+10:00 https://pharmadispatch.com/news/antengene-welcomes-the-listing-of-its-first-medicine-on-the-pbs 2022-09-01T01:31:01+10:00 https://pharmadispatch.com/news/major-new-listing-for-people-living-with-chronic-kidney-disease 2022-09-01T00:55:01+10:00 https://pharmadispatch.com/news/rebranded-acurabio-acquired-by-major-investors 2022-08-31T01:39:01+10:00 https://pharmadispatch.com/news/starpharma-wins-recognition-for-development-of-covid-19-antivira 2022-08-31T01:37:01+10:00 https://pharmadispatch.com/news/cynata-therapeutics-appoints-new-non-executive-director 2022-08-31T01:36:01+10:00 https://pharmadispatch.com/news/racgp-welcomes-urgent-care-partnership-between-victoria-and-nsw 2022-08-31T01:25:01+10:00 https://pharmadispatch.com/news/gsk-looking-to-build-with-major-recruitment-drive 2022-08-31T01:00:01+10:00 https://pharmadispatch.com/news/pharmac-acknowledges-stock-issues-in-message-to-suppliers 2022-08-31T01:00:01+10:00 https://pharmadispatch.com/news/recently-listed-insulins-also-on-the-list-for-major-catch-up-cut 2022-08-31T00:30:01+10:00 https://pharmadispatch.com/news/moderna-aims-to-supply-bivalent-covid-19-vaccine-in-september 2022-08-30T23:04:01+10:00 https://pharmadispatch.com/news/emvision-medical-confirms-manufacturing-grant-will-proceed 2022-08-30T22:31:01+10:00 https://pharmadispatch.com/news/optiscan-imaging-submits-510k-application-to-the-us-fda 2022-08-30T22:29:01+10:00 https://pharmadispatch.com/news/university-of-sydney-announces-landmark-investment-to-create-bio 2022-08-30T05:51:01+10:00 https://pharmadispatch.com/news/monash-university-ai-model-could-predict-the-best-epilepsy-medic 2022-08-30T05:45:01+10:00 https://pharmadispatch.com/news/mark-butler-sticks-with-decision-to-defund-nps-medicinewise 2022-08-30T01:00:01+10:00 https://pharmadispatch.com/news/what-does-decision-to-walk-away-from-strategic-asset-mean-for-nm 2022-08-30T01:00:01+10:00 https://pharmadispatch.com/news/pharmacy-administers-almost-one-quarter-of-all-flu-vaccines 2022-08-30T01:00:01+10:00 https://pharmadispatch.com/news/two-australian-organisations-secures-majors-grants-from-gilead 2022-08-29T01:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-a-third-covid-19-treatment-for-listing-on-the-p 2022-08-29T01:00:01+10:00 https://pharmadispatch.com/news/is-mark-butler-moving-to-take-the-politics-out-of-the-pbs 2022-08-29T01:00:01+10:00 https://pharmadispatch.com/news/biomarins-kathryn-evans-uses-new-book-to-call-for-action-on-gend 2022-08-29T01:00:01+10:00 https://pharmadispatch.com/news/novartis-to-spin-off-generics-and-biosimilars-division 2022-08-26T04:00:01+10:00 https://pharmadispatch.com/news/no-part-of-the-sector-will-escape-the-impact-of-these-structural 2022-08-26T01:00:01+10:00 https://pharmadispatch.com/news/more-power-in-the-hands-of-officials-means-the-time-has-come-for 2022-08-26T01:00:01+10:00 https://pharmadispatch.com/news/new-patient-survey-delivers-significant-boost-to-industry-reputa 2022-08-26T01:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-backs-move-to-manage-supply-of-heart-medici 2022-08-25T23:22:01+10:00 https://pharmadispatch.com/news/moderna-secures-the-services-of-former-government-adviser 2022-08-25T01:00:01+10:00 https://pharmadispatch.com/news/viatris-monica-passfield-on-why-csr-is-fundamental-to-the-compan 2022-08-25T00:31:01+10:00 https://pharmadispatch.com/news/new-report-identifies-key-pandemic-trends-for-community-pharmacy 2022-08-24T23:58:01+10:00 https://pharmadispatch.com/news/hospitals-call-for-action-on-workforce-to-resolve-missing-admiss 2022-08-24T23:31:01+10:00 https://pharmadispatch.com/news/quarterly-update-reignites-debate-over-medical-device-pricing 2022-08-24T23:30:01+10:00 https://pharmadispatch.com/news/dimerix-confirms-clarity-20-covid-19-study-concludes-recruitment 2022-08-24T21:10:01+10:00 https://pharmadispatch.com/news/long-covid-19-study-identifies-novel-blood-markers-as-potential- 2022-08-24T21:08:01+10:00 https://pharmadispatch.com/news/choroid-plexus-tissue-shipped-to-sydney-as-ntcell-research-advan 2022-08-24T21:03:01+10:00 https://pharmadispatch.com/news/ramsay-health-care-and-bupa-sign-new-agreement 2022-08-24T20:56:01+10:00 https://pharmadispatch.com/news/nib-reports-strong-topline-growth-across-operations 2022-08-24T20:51:01+10:00 https://pharmadispatch.com/news/medibank-extends-premium-increase-deferral-by-another-month 2022-08-24T20:46:01+10:00 https://pharmadispatch.com/news/gilead-sciences-launches-it-inaugural-reflect-reconciliation-act 2022-08-24T03:00:01+10:00 https://pharmadispatch.com/news/october-increases-in-the-midst-of-a-fierce-price-war 2022-08-24T03:00:01+10:00 https://pharmadispatch.com/news/a-change-that-must-be-the-worst-in-the-history-of-this-program 2022-08-24T01:54:01+10:00 https://pharmadispatch.com/news/a-targeted-consultation-process-for-restarted-nmp-review 2022-08-23T03:00:01+10:00 https://pharmadispatch.com/news/tga-issues-another-provisional-determination-for-a-covid-19-trea 2022-08-23T03:00:01+10:00 https://pharmadispatch.com/news/what-is-the-true-cost-of-these-price-cuts-and-why-is-it-hidden 2022-08-23T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-announces-industry-leading-gender-affirmation-policy 2022-08-23T03:00:01+10:00 https://pharmadispatch.com/news/the-industry-might-be-paying-the-price-for-the-failure-of-its-la 2022-08-23T02:00:01+10:00 https://pharmadispatch.com/news/jazz-taps-well-known-executive-to-lead-australia-and-nz 2022-08-22T03:00:01+10:00 https://pharmadispatch.com/news/review-coming-for-pbs-listed-type-2-diabetes-medicines 2022-08-22T03:00:01+10:00 https://pharmadispatch.com/news/slim-pickings-for-sponsors-in-july-pbac-outcomes 2022-08-22T03:00:01+10:00 https://pharmadispatch.com/news/bayer-now-working-towards-pbs-listing-of-heart-failure-treatment 2022-08-22T02:06:01+10:00 https://pharmadispatch.com/news/pharmac-expands-access-to-treatment-after-two-year-wait 2022-08-22T02:00:01+10:00 https://pharmadispatch.com/news/first-speakers-confirmed-for-bpd-post-budget-summit 2022-08-19T04:00:01+10:00 https://pharmadispatch.com/news/if-its-not-the-intent-it-is-certainly-an-extraordinary-coinciden 2022-08-19T04:00:01+10:00 https://pharmadispatch.com/news/the-appearance-of-a-pricing-policy-targeting-one-group-of-treatm 2022-08-19T03:00:01+10:00 https://pharmadispatch.com/news/telix-revenue-soars-after-us-commercialisation 2022-08-18T14:20:01+10:00 https://pharmadispatch.com/news/companies-make-the-list-of-australias-great-place-to-work 2022-08-18T04:00:01+10:00 https://pharmadispatch.com/news/will-restarted-nmp-review-be-better-than-the-first-attempt 2022-08-18T03:00:01+10:00 https://pharmadispatch.com/news/csl-starts-planning-to-submit-no-antibody-treatment 2022-08-18T03:00:01+10:00 https://pharmadispatch.com/news/new-report-has-laid-bare-the-failures-of-vaccine-rollout 2022-08-18T03:00:01+10:00 https://pharmadispatch.com/news/viatris-opens-new-production-lines-in-queensland 2022-08-18T03:00:01+10:00 https://pharmadispatch.com/news/csl-looking-to-strong-post-pandemic-growth 2022-08-17T09:39:01+10:00 https://pharmadispatch.com/news/process-transparency-is-important-because-it-is-their-greatest-f 2022-08-17T03:00:01+10:00 https://pharmadispatch.com/news/the-formal-process-does-not-mean-decision-makers-cannot-meet 2022-08-17T03:00:01+10:00 https://pharmadispatch.com/news/submission-argues-against-the-release-of-information-that-is-cur 2022-08-16T13:51:01+10:00 https://pharmadispatch.com/news/epiaxis-therapeutics-and-peptilogics-announce-new-collaboration 2022-08-16T11:22:01+10:00 https://pharmadispatch.com/news/avita-medical-announces-topline-results-for-recell-system-trial 2022-08-16T11:20:01+10:00 https://pharmadispatch.com/news/microbio-receives-clearance-to-sell-in-vitro-diagnostic-test-in- 2022-08-16T11:19:01+10:00 https://pharmadispatch.com/news/carina-biotech-capital-raise-backed-by-new-cornerstone-investor 2022-08-16T11:18:01+10:00 https://pharmadispatch.com/news/medibank-and-ahm-extend-age-for-adult-dependants-to-31 2022-08-16T08:59:01+10:00 https://pharmadispatch.com/news/bupa-and-ramsay-resolve-dispute-over-new-hospital-agreement 2022-08-16T08:57:01+10:00 https://pharmadispatch.com/news/viiv-healthcare-backs-research-translating-research-into-plain-s 2022-08-16T05:00:01+10:00 https://pharmadispatch.com/news/no-answers-on-the-destruction-of-official-documents 2022-08-16T03:00:01+10:00 https://pharmadispatch.com/news/major-capital-raise-for-opthea-as-it-prepares-for-commercialisat 2022-08-16T03:00:01+10:00 https://pharmadispatch.com/news/new-zealand-edges-closer-to-funding-cystic-fibrosis-therapy 2022-08-16T03:00:01+10:00 https://pharmadispatch.com/news/monash-university-the-location-for-moderna-manufacturing-facilit 2022-08-16T03:00:01+10:00 https://pharmadispatch.com/news/no-need-to-go-negative-on-review-just-be-realistic-and-prepared 2022-08-15T03:00:01+10:00 https://pharmadispatch.com/news/policy-horizon-scanning-will-add-more-value-than-the-product-ver 2022-08-15T03:00:01+10:00 https://pharmadispatch.com/news/budget-rules-are-confidential-but-the-language-is-revealing 2022-08-15T03:00:01+10:00 https://pharmadispatch.com/news/post-budget-summit-a-critical-time-for-serious-discussions 2022-08-14T15:10:01+10:00 https://pharmadispatch.com/news/the-administration-of-the-process-is-as-important-as-the-process 2022-08-12T03:00:01+10:00 https://pharmadispatch.com/news/csiro-opens-missing-link-lab-to-developing-australian-vaccine-pi 2022-08-12T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-says-follow-other-countries-on-covid-19-antivirals 2022-08-12T03:00:01+10:00 https://pharmadispatch.com/news/csl-announces-plan-to-rename-vifor-and-seqirus 2022-08-12T03:00:01+10:00 https://pharmadispatch.com/news/first-patient-enrolled-in-new-trial-of-novosorb-synpath-treatmen 2022-08-11T13:58:01+10:00 https://pharmadispatch.com/news/partrys-candidate-in-combination-improves-survival-in-brain-canc 2022-08-11T13:56:01+10:00 https://pharmadispatch.com/news/scrapped-covidsafe-app-only-identified-two-positive-cases 2022-08-11T13:53:01+10:00 https://pharmadispatch.com/news/compare-the-market-investor-moves-to-acquire-all-of-iselect 2022-08-11T13:52:01+10:00 https://pharmadispatch.com/news/new-report-promotes-expansion-of-short-stay-hospital-program 2022-08-11T13:49:01+10:00 https://pharmadispatch.com/news/critical-decisions-over-two-months-and-four-sitting-weeks 2022-08-11T03:00:01+10:00 https://pharmadispatch.com/news/uk-push-to-lead-the-world-on-genetic-profiling-of-cancer-patient 2022-08-11T03:00:01+10:00 https://pharmadispatch.com/news/msd-in-new-agreements-with-australian-company-starpharma 2022-08-11T03:00:01+10:00 https://pharmadispatch.com/news/bio-says-fewer-cures-the-only-certain-outcome-of-price-controls 2022-08-11T03:00:01+10:00 https://pharmadispatch.com/news/an-outcome-that-disadvantages-the-respondent-is-not-relevant 2022-08-10T03:00:01+10:00 https://pharmadispatch.com/news/companies-hist-hard-by-the-new-price-cut-flow-on-mechanisms 2022-08-10T03:00:01+10:00 https://pharmadispatch.com/news/victorias-first-mrna-innovation-hub-backed-by-state-government 2022-08-10T03:00:01+10:00 https://pharmadispatch.com/news/paig-announces-pay-it-forward-session-as-part-of-new-look-progra 2022-08-10T03:00:01+10:00 https://pharmadispatch.com/news/tga-registration-for-roche-innovative-eye-therapy 2022-08-10T03:00:01+10:00 https://pharmadispatch.com/news/dimerix-announces-new-patent-family-for-dmx-700 2022-08-09T16:02:01+10:00 https://pharmadispatch.com/news/telix-and-uq-led-consortium-awarded-australian-research-council- 2022-08-09T16:01:01+10:00 https://pharmadispatch.com/news/neuren-commences-enrolment-new-phase-2-trials-of-nnz-2591 2022-08-09T16:00:01+10:00 https://pharmadispatch.com/news/lumos-withdraws-from-participation-in-victorian-manufacturing-pr 2022-08-09T15:58:01+10:00 https://pharmadispatch.com/news/helping-doctors-reduce-out-of-pocket-expenses-for-patients 2022-08-09T15:55:01+10:00 https://pharmadispatch.com/news/hcf-and-ramsay-announce-collaboration-to-develop-new-care-models 2022-08-09T15:54:01+10:00 https://pharmadispatch.com/news/competition-regulator-authorises-honeysuckle-health-to-establish 2022-08-09T15:52:01+10:00 https://pharmadispatch.com/news/industry-says-backing-for-us-pricing-reform-a-tragic-loss-for-pa 2022-08-09T03:00:01+10:00 https://pharmadispatch.com/news/stcounsel-accuses-commonwealth-witnesses-of-evasive-responses-to 2022-08-09T03:00:01+10:00 https://pharmadispatch.com/news/sanofi-starts-installing-solar-panels-at-manufacturing-facility 2022-08-09T03:00:01+10:00 https://pharmadispatch.com/news/what-other-government-records-are-officials-destroying 2022-08-09T03:00:01+10:00 https://pharmadispatch.com/news/blood-cancer-taskforce-launches-optimal-care-pathways 2022-08-09T03:00:01+10:00 https://pharmadispatch.com/news/the-result-of-a-process-that-started-badly-and-only-got-worse 2022-08-08T03:00:01+10:00 https://pharmadispatch.com/news/what-needs-to-change-to-ensure-this-never-happens-again 2022-08-08T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-must-be-very-confused-by-this-situation 2022-08-07T10:33:01+10:00 https://pharmadispatch.com/news/department-switches-excuse-to-block-release-of-a-simple-number 2022-08-05T03:00:01+10:00 https://pharmadispatch.com/news/government-secures-monkeypox-vaccine-from-danish-company 2022-08-05T03:00:01+10:00 https://pharmadispatch.com/news/green-whistle-maker-announces-capital-raise-and-sales-growth 2022-08-04T14:31:01+10:00 https://pharmadispatch.com/news/rapid-review-of-budget-decision-has-been-nothing-if-not-rapid 2022-08-04T13:25:01+10:00 https://pharmadispatch.com/news/osteopore-secures-us-distribution-agreement-for-government-facil 2022-08-04T13:05:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-announces-new-agreements-with-lantheus-a 2022-08-04T13:03:01+10:00 https://pharmadispatch.com/news/medical-developments-international-announces-fully-underwritten- 2022-08-04T13:02:01+10:00 https://pharmadispatch.com/news/nib-offers-its-employees-a-new-range-of-benefits 2022-08-04T13:01:01+10:00 https://pharmadispatch.com/news/bupa-and-ramsay-to-continue-contract-negotiations 2022-08-04T13:00:01+10:00 https://pharmadispatch.com/news/pfizer-raises-offer-for-australian-digital-health-company 2022-08-04T03:00:01+10:00 https://pharmadispatch.com/news/pharmacy-demands-no-place-for-tobacco-in-health-system 2022-08-04T03:00:01+10:00 https://pharmadispatch.com/news/government-confirms-paediatric-access-to-covid-19-vaccine 2022-08-04T03:00:01+10:00 https://pharmadispatch.com/news/want-equal-pay-the-odds-are-better-in-new-zealand 2022-08-03T10:03:01+10:00 https://pharmadispatch.com/news/mark-butler-a-member-of-key-cabinet-sub-committee 2022-08-03T03:00:01+10:00 https://pharmadispatch.com/news/perplexed-by-the-focus-on-cost-of-lung-cancer-screening 2022-08-03T03:00:01+10:00 https://pharmadispatch.com/news/industry-catalyst-launches-next-phase-of-cell-and-gene-collabora 2022-08-03T03:00:01+10:00 https://pharmadispatch.com/news/lumos-diagnostics-announces-plan-to-close-us-facility 2022-08-02T17:30:01+10:00 https://pharmadispatch.com/news/new-study-published-demonstrating-the-utility-of-promarkerd-test 2022-08-02T17:29:01+10:00 https://pharmadispatch.com/news/recruitment-open-for-new-study-of-lung-disease 2022-08-02T17:28:01+10:00 https://pharmadispatch.com/news/immutep-reports-new-data-from-phase-2-tacti-002-trial 2022-08-02T17:26:01+10:00 https://pharmadispatch.com/news/the-challenge-is-to-assess-changes-based-on-the-worst-possible-o 2022-08-02T16:38:01+10:00 https://pharmadispatch.com/news/department-hiding-the-number-of-applications-for-ministerial-dis 2022-08-02T11:00:01+10:00 https://pharmadispatch.com/news/bupa-dental-urges-action-on-oral-health-for-dental-health-week 2022-08-02T08:36:01+10:00 https://pharmadispatch.com/news/election-of-new-national-leadership-for-the-ama 2022-08-02T08:35:01+10:00 https://pharmadispatch.com/news/epworth-the-first-private-hospital-to-offer-pancreatic-cancer-tr 2022-08-02T08:33:01+10:00 https://pharmadispatch.com/news/annual-report-reveals-dramatic-growth-in-private-covid-claims 2022-08-02T08:29:01+10:00 https://pharmadispatch.com/news/tobacco-company-tries-again-with-nicotine-vaping-and-pharmacy 2022-08-02T03:00:01+10:00 https://pharmadispatch.com/news/is-this-relationship-on-nicotine-vaping-really-worth-the-risk 2022-08-02T03:00:01+10:00 https://pharmadispatch.com/news/new-business-unit-director-for-novo-nordisk 2022-08-02T03:00:01+10:00 https://pharmadispatch.com/news/baxter-healthcare-announces-new-general-manager 2022-08-02T03:00:01+10:00 https://pharmadispatch.com/news/beigene-appoints-new-medical-director-for-australia-and-nz 2022-08-01T20:20:01+10:00 https://pharmadispatch.com/news/medicines-australia-confirms-the-appointment-of-new-gr-head 2022-08-01T16:37:01+10:00 https://pharmadispatch.com/news/api-and-sector-leader-to-step-away-following-wesfarmers-integrat 2022-08-01T03:00:01+10:00 https://pharmadispatch.com/news/nurse-led-organisation-seeking-donations-in-response-to-stalled- 2022-08-01T03:00:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-restart-of-nmp-review-in-first-health-secto 2022-08-01T03:00:01+10:00 https://pharmadispatch.com/news/major-day-for-biogen-with-two-significant-pbs-listings 2022-08-01T02:00:01+10:00 https://pharmadispatch.com/news/the-revealing-public-exchange-that-should-have-alarmed-the-indus 2022-07-29T03:00:01+10:00 https://pharmadispatch.com/news/this-fight-on-catch-ups-would-have-been-much-easier-to-win-last- 2022-07-29T03:00:01+10:00 https://pharmadispatch.com/news/legal-arguments-will-fail-because-companies-do-not-want-the-law- 2022-07-29T03:00:01+10:00 https://pharmadispatch.com/news/tga-refutes-claim-it-removed-rapid-antigen-tests-over-omicron-fa 2022-07-28T16:21:01+10:00 https://pharmadispatch.com/news/mark-butler-officially-calls-time-on-bill-to-scrap-confidentiali 2022-07-28T10:36:01+10:00 https://pharmadispatch.com/news/the-current-issue-with-catch-ups-was-raised-last-year-but-dismis 2022-07-28T03:00:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-policy-the-detail-is-what-matters 2022-07-28T03:00:01+10:00 https://pharmadispatch.com/news/tga-launches-legal-action-over-illegal-promotion-of-nicotine-vap 2022-07-28T03:00:01+10:00 https://pharmadispatch.com/news/new-survey-confirms-the-internet-as-a-first-stop-for-health-advi 2022-07-28T03:00:01+10:00 https://pharmadispatch.com/news/published-agenda-reveals-slim-list-for-november-committee-meetin 2022-07-28T03:00:01+10:00 https://pharmadispatch.com/news/this-dispute-is-exactly-why-changes-need-proper-scrutiny 2022-07-27T03:00:01+10:00 https://pharmadispatch.com/news/dispute-over-catch-up-reductions-grows-as-deadline-nears 2022-07-27T03:00:01+10:00 https://pharmadispatch.com/news/perverse-outcomes-does-not-make-the-interpretation-wrong 2022-07-27T03:00:01+10:00 https://pharmadispatch.com/news/transparency-legislation-officially-lapses-but-it-could-return 2022-07-26T03:00:01+10:00 https://pharmadispatch.com/news/former-governments-manufacturing-commitments-under-review 2022-07-26T03:00:01+10:00 https://pharmadispatch.com/news/industry-responds-to-waiver-with-its-own-access-declaration 2022-07-26T03:00:01+10:00 https://pharmadispatch.com/news/new-approval-for-the-biocelect-novavax-covid-19-vaccine 2022-07-26T03:00:01+10:00 https://pharmadispatch.com/news/nib-launches-anaesthetics-network-with-plans-for-national-expans 2022-07-25T10:22:01+10:00 https://pharmadispatch.com/news/annual-survey-confirms-increase-in-private-health-insurance-cove 2022-07-25T10:20:01+10:00 https://pharmadispatch.com/news/physiotherapists-call-for-greater-support-to-address-long-covid 2022-07-25T10:19:01+10:00 https://pharmadispatch.com/news/government-turns-to-wholesalers-to-manage-stockpiling-risk-ahead 2022-07-25T04:00:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-makes-bizarre-claim-over-shortages 2022-07-25T03:00:01+10:00 https://pharmadispatch.com/news/ma-and-gbma-consider-seeking-extension-to-accc-supply-authorisat 2022-07-25T03:00:01+10:00 https://pharmadispatch.com/news/insight-strategys-jody-fassina-on-the-47th-parliament 2022-07-25T03:00:01+10:00 https://pharmadispatch.com/news/one-week-to-apply-for-relief-from-catch-up-price-reductions 2022-07-22T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-preparing-for-new-board-election 2022-07-22T03:00:01+10:00 https://pharmadispatch.com/news/reductions-make-biosimilars-more-expensive-than-the-originator 2022-07-22T03:00:01+10:00 https://pharmadispatch.com/news/telix-surges-on-us-launch-and-sales-of-nuclear-medicine-therapy 2022-07-22T03:00:01+10:00 https://pharmadispatch.com/news/australias-first-national-biotechnology-incubator-announces-roun 2022-07-21T04:00:01+10:00 https://pharmadispatch.com/news/the-reality-of-entering-a-era-of-fiscal-consolidation 2022-07-21T03:00:01+10:00 https://pharmadispatch.com/news/building-real-world-evidence-the-goal-of-new-collaboration 2022-07-21T03:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-and-medicines-australia-weigh-in-on-expedited-reimb 2022-07-19T16:11:01+10:00 https://pharmadispatch.com/news/australian-company-one-step-closer-to-major-product-launch 2022-07-19T11:38:01+10:00 https://pharmadispatch.com/news/tga-tick-for-modernas-paediatric-dose-of-covid-19-vaccine 2022-07-19T11:22:01+10:00 https://pharmadispatch.com/news/this-is-just-the-latest-example-of-selective-decision-making 2022-07-19T03:00:01+10:00 https://pharmadispatch.com/news/industry-gets-behind-annual-foodbank-week-of-care-event 2022-07-18T13:31:01+10:00 https://pharmadispatch.com/news/accc-clears-pfizer-acquisition-of-australian-digital-health-comp 2022-07-18T13:11:01+10:00 https://pharmadispatch.com/news/ausbiotechs-lorraine-chiroiu-a-hollow-victory-and-slap-in-the-fa 2022-07-18T10:18:01+10:00 https://pharmadispatch.com/news/why-bother-the-hta-review-if-the-system-can-already-do-almost-an 2022-07-18T03:00:01+10:00 https://pharmadispatch.com/news/a-deeply-problematic-situation-caused-by-officials-making-it-up- 2022-07-18T03:00:01+10:00 https://pharmadispatch.com/news/government-relents-on-pandemic-response-as-data-reveals-spike-in 2022-07-18T03:00:01+10:00 https://pharmadispatch.com/news/cost-co-pay-reduction-will-be-partially-offset-by-revenue-from-r 2022-07-15T03:00:01+10:00 https://pharmadispatch.com/news/illumina-among-the-first-to-receive-approval-of-science-based-ne 2022-07-14T17:50:01+10:00 https://pharmadispatch.com/news/government-confirms-no-go-on-hta-review-reference-committee 2022-07-14T13:53:01+10:00 https://pharmadispatch.com/news/government-says-challenging-budget-behind-decision-on-tests 2022-07-14T03:00:01+10:00 https://pharmadispatch.com/news/government-preparing-for-consultation-on-chemotherapy-review 2022-07-14T03:00:01+10:00 https://pharmadispatch.com/news/federal-government-provides-financial-support-to-online-cancer-h 2022-07-13T17:29:01+10:00 https://pharmadispatch.com/news/major-regional-promotion-for-the-local-head-of-baxter 2022-07-13T16:37:01+10:00 https://pharmadispatch.com/news/officials-getting-a-practical-but-harsh-lesson-on-supplying-medi 2022-07-13T12:09:01+10:00 https://pharmadispatch.com/news/doctor-groups-call-for-urgent-reinstatement-of-covid-19-teleheal 2022-07-13T10:11:01+10:00 https://pharmadispatch.com/news/bupa-supporting-the-growth-of-kids-helpline-school 2022-07-13T10:10:01+10:00 https://pharmadispatch.com/news/neuroscientific-biopharmaceuticals-seeks-approval-for-phase-1-tr 2022-07-13T09:38:01+10:00 https://pharmadispatch.com/news/study-identifies-kids-with-cancer-at-risk-of-lethal-infections 2022-07-13T09:37:01+10:00 https://pharmadispatch.com/news/telix-pharmaceuticals-announces-major-leadership-appointment 2022-07-13T09:36:01+10:00 https://pharmadispatch.com/news/medibank-partners-to-accelerate-access-to-mental-health-services 2022-07-13T09:35:01+10:00 https://pharmadispatch.com/news/new-review-of-nps-medicinewise-a-re-run-of-previous-process 2022-07-13T03:00:01+10:00 https://pharmadispatch.com/news/no-end-to-reviews-but-the-proposed-audit-is-the-one-that-will-al 2022-07-13T03:00:01+10:00 https://pharmadispatch.com/news/pharmacists-challenge-failure-to-extend-free-rat-program 2022-07-13T03:00:01+10:00 https://pharmadispatch.com/news/roche-marks-125-year-anniversary-with-health-charity-grants-prog 2022-07-12T15:34:01+10:00 https://pharmadispatch.com/news/emerging-australian-company-appoints-industry-research-leader-to 2022-07-12T03:00:01+10:00 https://pharmadispatch.com/news/auditor-general-proposes-first-system-level-audit-of-pbs-since-1 2022-07-12T03:00:01+10:00 https://pharmadispatch.com/news/jazz-pharmaceuticals-welcomes-registration-of-new-aml-treatment 2022-07-12T03:00:01+10:00 https://pharmadispatch.com/news/pbac-recommended-wider-access-before-last-weeks-meeting 2022-07-11T03:00:01+10:00 https://pharmadispatch.com/news/australia-widens-access-to-treatments-but-the-us-authorises-phar 2022-07-11T03:00:01+10:00 https://pharmadispatch.com/news/apparently-we-now-need-management-consultants-to-make-policy-dec 2022-07-11T03:00:01+10:00 https://pharmadispatch.com/news/election-commitment-outsourced-to-nmp-management-consultant 2022-07-10T09:57:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-wider-access-to-fourth-covid-19-vaccine-dos 2022-07-08T04:00:01+10:00 https://pharmadispatch.com/news/the-legal-quirk-of-technology-history-is-a-much-bigger-problem-t 2022-07-08T03:00:01+10:00 https://pharmadispatch.com/news/industry-slams-us-agreement-on-allowing-price-negotiation 2022-07-08T03:00:01+10:00 https://pharmadispatch.com/news/governments-and-companies-discarding-million-of-vaccine-doses 2022-07-08T03:00:01+10:00 https://pharmadispatch.com/news/australian-study-uncovers-a-driving-factor-in-the-development-of 2022-07-07T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-inviting-new-proposals-for-advanced-lung-cancer-again 2022-07-07T03:00:01+10:00 https://pharmadispatch.com/news/tga-grants-provisional-determination-for-pfizers-two-omicron-vac 2022-07-07T03:00:01+10:00 https://pharmadispatch.com/news/new-appointments-for-expanding-red-havas-health 2022-07-06T04:00:01+10:00 https://pharmadispatch.com/news/biomarin-now-looks-to-reimbursement-of-short-stature-therapy 2022-07-06T03:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-in-regular-contact-on-major-priorities 2022-07-05T17:10:01+10:00 https://pharmadispatch.com/news/mark-butler-prescribing-of-pbs-listed-covid-treatments-too-restr 2022-07-05T16:00:01+10:00 https://pharmadispatch.com/news/noxopharm-adds-three-new-us-sites-to-cep-2-sarcoma-study 2022-07-05T11:48:01+10:00 https://pharmadispatch.com/news/dimerix-updates-with-new-and-positive-dmx-700-data 2022-07-05T11:47:01+10:00 https://pharmadispatch.com/news/csiro-supports-cureator-with-funding-for-health-security-stream 2022-07-05T11:46:01+10:00 https://pharmadispatch.com/news/teachers-health-reopens-state-of-the-art-facility-in-sydney 2022-07-05T11:45:01+10:00 https://pharmadispatch.com/news/more-regulation-and-more-bureaucracy-is-not-the-solution 2022-07-05T11:44:01+10:00 https://pharmadispatch.com/news/australian-researchers-identify-new-drug-target-for-inflammatory 2022-07-05T04:00:01+10:00 https://pharmadispatch.com/news/this-is-what-health-technology-assessment-has-become-in-australi 2022-07-05T03:00:01+10:00 https://pharmadispatch.com/news/tga-authorises-government-campaign-promoting-covid-19-treatments 2022-07-04T13:15:01+10:00 https://pharmadispatch.com/news/pre-budget-spending-rules-not-quite-that-strict-after-all 2022-07-04T04:00:01+10:00 https://pharmadispatch.com/news/the-health-system-review-that-is-not-even-being-led-by-health 2022-07-04T03:00:01+10:00 https://pharmadispatch.com/news/few-should-expect-ministerial-discretion-and-few-should-actually 2022-07-04T03:00:01+10:00 https://pharmadispatch.com/news/novartis-considers-spin-out-of-sandoz-off-patent-division 2022-07-04T03:00:01+10:00 https://pharmadispatch.com/news/lung-cancer-screening-would-save-lives-but-too-expensive 2022-07-03T13:36:01+10:00 https://pharmadispatch.com/news/over-1000-medicines-facing-catch-up-reductions-in-april 2022-07-01T05:20:01+10:00 https://pharmadispatch.com/news/the-halton-review-likely-to-be-the-first-of-many-on-pandemic-per 2022-07-01T04:00:01+10:00 https://pharmadispatch.com/news/bayer-secures-new-pbs-listing-with-medicare-funded-diagnostic 2022-07-01T04:00:01+10:00 https://pharmadispatch.com/news/abbvie-delivers-in-its-annual-month-of-possibilities-volunteerin 2022-07-01T04:00:01+10:00 https://pharmadispatch.com/news/beigene-welcomes-expanded-listing-for-targeted-blood-cancer-ther 2022-06-30T18:03:01+10:00 https://pharmadispatch.com/news/out-with-the-old-industry-agreements-and-in-with-the-new 2022-06-30T04:00:01+10:00 https://pharmadispatch.com/news/industry-says-perpetuity-requirement-will-undermine-early-access 2022-06-30T04:00:01+10:00 https://pharmadispatch.com/news/digital-clinical-trial-recruitment-platform-in-new-agreements-wi 2022-06-30T04:00:01+10:00 https://pharmadispatch.com/news/is-the-budget-process-intended-to-undermine-election-commitments 2022-06-29T04:00:01+10:00 https://pharmadispatch.com/news/bi-recruits-sanofi-executive-to-head-new-corporate-affairs-funct 2022-06-29T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-leaders-sleep-rough-in-support-of-vinnies-ceo-sleepout 2022-06-29T04:00:01+10:00 https://pharmadispatch.com/news/mark-butler-says-reform-of-newborn-screening-is-happening 2022-06-28T16:24:01+10:00 https://pharmadispatch.com/news/election-commitment-could-be-lost-to-october-budget-process 2022-06-28T16:18:01+10:00 https://pharmadispatch.com/news/lilly-secures-another-nomination-for-annual-australian-hr-awards 2022-06-28T04:00:01+10:00 https://pharmadispatch.com/news/new-zealand-expands-access-to-free-seasonal-flu-vaccine 2022-06-27T18:04:01+10:00 https://pharmadispatch.com/news/what-does-it-mean-when-the-system-cannot-even-call-patients-by-t 2022-06-27T16:23:01+10:00 https://pharmadispatch.com/news/new-senior-appointments-formedicines-australia-1 2022-06-26T17:17:01+10:00 https://pharmadispatch.com/news/call-for-action-to-address-low-awareness-of-heart-failure-1 2022-06-26T17:17:01+10:00 https://pharmadispatch.com/news/novartis-to-consolidate-production-of-car-t-therapy-in-the-us 2022-06-26T17:17:01+10:00 https://pharmadispatch.com/news/should-time-to-access-be-considered-a-fundamental-human-right-1 2022-06-24T04:31:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-support-for-industry-in-state-budgets-1 2022-06-24T04:31:01+10:00 https://pharmadispatch.com/news/supporting-reform-means-not-mouthing-the-same-excuses-used-to-de 2022-06-23T11:34:01+10:00 https://pharmadispatch.com/news/supporting-reform-means-not-mouthing-the-same-excuses-used-to-de 2022-06-23T04:31:01+10:00 https://pharmadispatch.com/news/seqirus-presents-real-world-data-on-cell-based-flu-vaccines 2022-06-22T16:49:01+10:00 https://pharmadispatch.com/news/ma-says-no-surprise-if-hta-review-timelines-are-impacted 2022-06-22T16:31:01+10:00 https://pharmadispatch.com/news/novavax-global-chief-medical-officer-on-expecting-the-unexpected 2022-06-22T13:01:01+10:00 https://pharmadispatch.com/news/i-think-countries-havent-done-this-lightly-says-mark-butler-on-i 2022-06-22T04:08:01+10:00 https://pharmadispatch.com/news/rca-marks-ten-year-anniversary-and-prepares-to-farewell-co-found 2022-06-22T03:18:01+10:00 https://pharmadispatch.com/news/what-now-for-election-commitments-and-other-new-spending-proposa 2022-06-22T03:00:01+10:00 https://pharmadispatch.com/news/insight-strategys-jody-fassina-on-the-final-senate-composition 2022-06-21T04:00:01+10:00 https://pharmadispatch.com/news/gsk-boss-shares-industry-insights-and-experiences-with-research- 2022-06-21T04:00:01+10:00 https://pharmadispatch.com/news/seriously-can-the-people-arguing-against-this-actually-hear-them 2022-06-20T12:42:01+10:00 https://pharmadispatch.com/news/biogen-awarded-great-place-to-work-certification-for-a-second-st 2022-06-20T11:19:01+10:00 https://pharmadispatch.com/news/annual-cost-recovery-statement-anticipates-higher-fees 2022-06-20T04:00:01+10:00 https://pharmadispatch.com/news/research-based-industry-says-ip-waiver-an-empty-shell-and-fact-f 2022-06-19T13:12:01+10:00 https://pharmadispatch.com/news/kyowa-kirin-welcomes-recommendation-from-pbac-may-intracycle-1 2022-06-19T12:44:01+10:00 https://pharmadispatch.com/news/the-embarrassing-case-against-a-major-labor-election-commitment 2022-06-19T04:00:01+10:00 https://pharmadispatch.com/news/psa-national-board-elects-first-female-national-president 2022-06-17T05:09:01+10:00 https://pharmadispatch.com/news/minister-that-is-what-you-have-been-told-but-it-is-not-what-we-a 2022-06-17T04:49:01+10:00 https://pharmadispatch.com/news/uk-officially-implements-world-first-antibiotic-subscription-mod 2022-06-17T04:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-focus-on-emerging-cancer-diagnostics-and-tr 2022-06-17T04:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-focus-on-emerging-cancer-diagnostics-and-tr 2022-06-16T15:55:01+10:00 https://pharmadispatch.com/news/new-treatments-help-drive-improvements-in-childhood-cancer-survi 2022-06-16T04:27:01+10:00 https://pharmadispatch.com/news/major-acquisition-for-leading-australian-company 2022-06-15T17:13:01+10:00 https://pharmadispatch.com/news/the-challenge-of-dealing-with-the-day-to-day-while-remaining-foc 2022-06-15T16:07:01+10:00 https://pharmadispatch.com/news/progress-for-key-gene-therapies-after-multiple-setbacks 2022-06-15T04:00:01+10:00 https://pharmadispatch.com/news/australian-company-says-clinical-trial-validates-targeting-lsd1- 2022-06-15T04:00:01+10:00 https://pharmadispatch.com/news/tga-approves-adult-booster-dose-of-novavax-covid-19-vaccine 2022-06-15T04:00:01+10:00 https://pharmadispatch.com/news/minister-makes-the-case-for-investment-in-australias-social-prog 2022-06-15T03:00:01+10:00 https://pharmadispatch.com/news/tga-authorises-advertising-of-covid-19-oral-treatments-but-with- 2022-06-14T14:54:01+10:00 https://pharmadispatch.com/news/new-snapshot-reveals-significant-growth-for-australian-biotechno 2022-06-14T04:22:01+10:00 https://pharmadispatch.com/news/ironically-the-wto-is-only-debating-a-waiver-because-of-the-posi 2022-06-14T03:00:01+10:00 https://pharmadispatch.com/news/ma-slams-compromise-agreement-on-covid-ip-waiver 2022-06-14T03:00:01+10:00 https://pharmadispatch.com/news/organons-susanne-fiedler-on-the-opportunity-to-help-build-a-new- 2022-06-14T03:00:01+10:00 https://pharmadispatch.com/news/government-tells-the-industry-to-manage-supply-ahead-of-october- 2022-06-14T03:00:01+10:00 https://pharmadispatch.com/news/major-promotion-for-organon-australia-senior-executive 2022-06-10T01:09:01+10:00 https://pharmadispatch.com/news/patients-push-for-funding-of-new-car-t-blood-cancer-therapy 2022-06-10T00:55:01+10:00 https://pharmadispatch.com/news/medicinal-cannabis-association-looks-to-policy-progress-with-new 2022-06-10T00:39:01+10:00 https://pharmadispatch.com/news/key-highlights-from-the-medicines-australia-conversation-starter 2022-06-10T00:19:01+10:00 https://pharmadispatch.com/news/medicines-australia-issues-conversation-starter-for-hta-review 2022-06-10T00:01:01+10:00 https://pharmadispatch.com/news/biontech-trial-gives-hope-for-pancreatic-cancer-vaccine 2022-06-09T02:46:01+10:00 https://pharmadispatch.com/news/nz-health-minister-unloads-on-australia-over-his-nursing-shortag 2022-06-08T20:51:01+10:00 https://pharmadispatch.com/news/msd-plans-campaign-to-raise-awareness-of-oral-covid-treatments 2022-06-08T20:14:01+10:00 https://pharmadispatch.com/news/the-uk-shows-the-way-forward-on-accelerating-patient-access 2022-06-08T03:16:01+10:00 https://pharmadispatch.com/news/uk-again-leads-the-way-on-early-access-with-new-innovative-medic 2022-06-08T03:00:01+10:00 https://pharmadispatch.com/news/australian-women-at-risk-of-cancer-missing-out-on-genetic-testin 2022-06-08T02:32:01+10:00 https://pharmadispatch.com/news/mark-butler-starts-the-process-of-building-ministerial-office 2022-06-08T02:08:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-priorities-in-first-interview-as-health-min 2022-06-07T04:37:01+10:00 https://pharmadispatch.com/news/bupa-announces-new-virtual-and-in-home-partnership-with-mater-he 2022-06-07T04:35:01+10:00 https://pharmadispatch.com/news/nominations-open-for-gsks-award-for-research-excellence 2022-06-07T03:25:01+10:00 https://pharmadispatch.com/news/emerging-frustrations-but-ma-confident-of-positive-progress 2022-06-06T22:51:01+10:00 https://pharmadispatch.com/news/we-only-know-about-this-one-because-the-company-has-never-given- 2022-06-06T21:21:01+10:00 https://pharmadispatch.com/news/short-hearing-reveals-the-government-plans-a-rigorous-defence 2022-06-06T20:48:01+10:00 https://pharmadispatch.com/news/opposition-sends-health-portfolio-to-the-senate 2022-06-06T04:41:01+10:00 https://pharmadispatch.com/news/organon-celebrates-first-anniversary-with-impact-report 2022-06-04T20:28:01+10:00 https://pharmadispatch.com/news/gilead-announces-recipients-of-2022-research-awards 2022-06-04T20:10:01+10:00 https://pharmadispatch.com/news/mark-butlers-first-full-week-marked-by-legal-hearings-and-critic 2022-06-04T19:43:01+10:00 https://pharmadispatch.com/news/free-flu-vaccine-programs-well-intentioned-but-not-without-chall 2022-06-02T18:59:01+10:00 https://pharmadispatch.com/news/a-knighthood-for-astrazenecas-australian-ceo 2022-06-02T18:14:01+10:00 https://pharmadispatch.com/news/roche-partners-on-the-redevelopment-of-office-rooftop-terrace 2022-06-02T17:25:01+10:00 https://pharmadispatch.com/news/gilead-recognised-for-efforts-inlgbtq-workplace-inclusion 2022-06-02T17:13:01+10:00 https://pharmadispatch.com/news/pfizer-confirms-plan-to-exit-stake-in-consumer-health-business 2022-06-02T03:45:01+10:00 https://pharmadispatch.com/news/sanofi-australia-in-industry-first-partnership-with-the-rum-proj 2022-06-02T02:52:01+10:00 https://pharmadispatch.com/news/merck-shows-its-support-for-multiple-sclerosis-community 2022-06-01T21:32:01+10:00 https://pharmadispatch.com/news/stakeholders-right-to-be-concerned-by-review-response 2022-06-01T20:41:01+10:00 https://pharmadispatch.com/news/medicines-nz-warns-against-cherry-picking-and-meaningless-action 2022-06-01T19:58:01+10:00 https://pharmadispatch.com/news/sandoz-launches-global-initiative-to-promote-biosimilars 2022-05-31T20:18:01+10:00 https://pharmadispatch.com/news/organisations-move-quickly-to-welcome-new-federal-ministry 2022-05-31T19:41:01+10:00 https://pharmadispatch.com/news/experienced-market-access-executive-appointed-to-lead-takeda 2022-05-31T19:15:01+10:00 https://pharmadispatch.com/news/federal-anti-corruption-body-an-opportunity-to-drive-change-in-h 2022-05-31T17:06:01+10:00 https://pharmadispatch.com/news/janssens-biljana-naumovic-promoted-to-senior-global-role 2022-05-31T15:38:01+10:00 https://pharmadispatch.com/news/new-liberal-party-leaders-bring-significant-experience-of-health 2022-05-30T19:02:01+10:00 https://pharmadispatch.com/news/where-exactly-is-the-final-report-of-the-pharmac-review 2022-05-30T18:47:01+10:00 https://pharmadispatch.com/news/medicines-australia-starts-the-search-for-new-head-of-government 2022-05-30T18:12:01+10:00 https://pharmadispatch.com/news/sanofi-developed-scanner-helping-educate-on-haemophilia 2022-05-30T01:00:01+10:00 https://pharmadispatch.com/news/finance-minister-confirms-a-new-era-of-fiscal-discipline-is-here 2022-05-30T01:00:01+10:00 https://pharmadispatch.com/news/the-new-reality-of-fiscal-consolidation-will-hit-discretionary-s 2022-05-30T01:00:01+10:00 https://pharmadispatch.com/news/first-powers-exercised-over-the-pbs-since-labors-election-win 2022-05-30T01:00:01+10:00 https://pharmadispatch.com/news/bms-australia-the-latest-to-earn-great-place-to-work-recognition 2022-05-30T01:00:01+10:00 https://pharmadispatch.com/news/abbvie-appoints-country-head-for-new-zealand 2022-05-26T16:49:01+10:00 https://pharmadispatch.com/news/reviews-should-focus-on-delivering-access-in-100-days 2022-05-26T15:14:01+10:00 https://pharmadispatch.com/news/why-is-disinvestment-now-mentioned-as-much-as-investment 2022-05-26T14:19:01+10:00 https://pharmadispatch.com/news/common-drug-offers-fertility-hope-for-women-with-obesity-1 2022-05-26T14:19:01+10:00 https://pharmadispatch.com/news/an-interesting-time-but-the-return-to-travel-is-happening-rapidl 2022-05-26T03:00:01+10:00 https://pharmadispatch.com/news/an-interesting-time-but-the-return-to-travel-is-happening-rapidl 2022-05-26T02:45:01+10:00 https://pharmadispatch.com/news/second-phase-of-consultation-open-on-discount-rate-review-1 2022-05-26T02:45:01+10:00 https://pharmadispatch.com/news/brandon-capital-backs-new-zealand-immunotherapy-start-up-1 2022-05-26T02:45:01+10:00 https://pharmadispatch.com/news/government-expands-access-to-covid-19-vaccine-booster-1 2022-05-26T02:45:01+10:00 https://pharmadispatch.com/news/anteris-technologies-expands-its-medical-advisory-board 2022-05-25T10:50:01+10:00 https://pharmadispatch.com/news/archer-materials-secures-australian-patent-for-quantum-computing 2022-05-25T10:49:01+10:00 https://pharmadispatch.com/news/new-clinical-trial-to-test-cancer-drug-in-motor-neuron-disease 2022-05-25T10:48:01+10:00 https://pharmadispatch.com/news/australian-dental-association-anticipates-change-in-aged-care 2022-05-25T10:15:01+10:00 https://pharmadispatch.com/news/new-plan-to-build-a-disability-confident-culture-at-medibank 2022-05-25T10:14:01+10:00 https://pharmadispatch.com/news/bupa-giving-customers-greater-transparency-and-choice 2022-05-25T10:13:01+10:00 https://pharmadispatch.com/news/us-based-industry-sets-objectives-for-new-trade-alliance 2022-05-25T04:00:01+10:00 https://pharmadispatch.com/news/patient-voices-a-good-predictor-of-cancer-treatment-outcomes 2022-05-25T04:00:01+10:00 https://pharmadispatch.com/news/horizon-scanning-reflects-the-wider-impetus-for-change 2022-05-25T04:00:01+10:00 https://pharmadispatch.com/news/a-new-minister-means-a-new-approach-and-new-priorities 2022-05-24T08:41:01+10:00 https://pharmadispatch.com/news/mcia-releases-roadmap-to-growth-for-the-australian-medicinal-can 2022-05-24T07:56:01+10:00 https://pharmadispatch.com/news/medibank-extends-covid-support-for-ahm-customers 2022-05-24T07:55:01+10:00 https://pharmadispatch.com/news/google-cloud-partners-with-garvan-to-accelerate-genome-sequencin 2022-05-24T07:53:01+10:00 https://pharmadispatch.com/news/new-government-to-provide-a-major-boost-for-medical-manufacturin 2022-05-24T04:00:01+10:00 https://pharmadispatch.com/news/change-is-underway-in-australiasultimate-company-town 2022-05-24T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-and-merck-join-forces-to-raise-awareness-for-bladder-canc 2022-05-24T04:00:01+10:00 https://pharmadispatch.com/news/new-bone-health-audit-tool-aims-to-enhance-osteoporosis-care 2022-05-24T04:00:01+10:00 https://pharmadispatch.com/news/queensland-to-combat-flu-outbreak-with-free-vaccine-program 2022-05-24T04:00:01+10:00 https://pharmadispatch.com/news/new-report-recommends-inclusive-approach-to-horizon-scanning 2022-05-24T04:00:01+10:00 https://pharmadispatch.com/news/work-to-begin-on-election-commitments-but-with-a-twist 2022-05-23T04:00:01+10:00 https://pharmadispatch.com/news/will-the-new-minister-bring-a-respectful-culture-to-decision-mak 2022-05-23T04:00:01+10:00 https://pharmadispatch.com/news/election-brings-change-and-a-focus-on-new-relationships 2022-05-23T04:00:01+10:00 https://pharmadispatch.com/news/the-mechanics-of-political-change-and-transition-to-a-new-minist 2022-05-22T17:26:01+10:00 https://pharmadispatch.com/news/leading-public-affairs-consultants-share-their-election-predicti 2022-05-20T04:00:01+10:00 https://pharmadispatch.com/news/funding-boost-for-pharmac-but-not-news-on-review 2022-05-20T04:00:01+10:00 https://pharmadispatch.com/news/nsw-residents-report-decline-in-health-due-to-delayed-health-che 2022-05-20T04:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-welcomes-labor-commitment-to-review-quality-use 2022-05-19T13:37:01+10:00 https://pharmadispatch.com/news/medicines-australia-issues-major-party-election-commitments 2022-05-19T11:48:01+10:00 https://pharmadispatch.com/news/discussion-focused-on-structural-change-and-respectful-disagreem 2022-05-19T10:27:01+10:00 https://pharmadispatch.com/news/fda-confirms-a-diagnostic-method-for-medibios-final-depression-v 2022-05-19T10:05:01+10:00 https://pharmadispatch.com/news/anteotechs-updated-covid-19-rat-receives-regulatory-approval-in- 2022-05-19T10:04:01+10:00 https://pharmadispatch.com/news/starpharma-says-spl7013-in-viraleze-virucidal-against-influenza- 2022-05-19T10:00:01+10:00 https://pharmadispatch.com/news/immutep-appoints-leading-oncologists-to-clinical-advisory-board 2022-05-19T09:56:01+10:00 https://pharmadispatch.com/news/gmhba-commits-extra-support-to-members-waiting-for-surgery 2022-05-19T09:35:01+10:00 https://pharmadispatch.com/news/new-strategic-partnership-between-cabrini-and-bupa 2022-05-19T09:34:01+10:00 https://pharmadispatch.com/news/medical-device-sector-welcomes-labor-commitment-to-manufacturing 2022-05-19T09:33:01+10:00 https://pharmadispatch.com/news/msd-australia-recognised-as-a-family-friendly-workplace 2022-05-19T04:00:01+10:00 https://pharmadispatch.com/news/bayer-seeks-local-applications-for-global-grants-program 2022-05-19T04:00:01+10:00 https://pharmadispatch.com/news/connecting-the-medicine-to-the-patient-is-what-matters 2022-05-19T04:00:01+10:00 https://pharmadispatch.com/news/does-anyone-know-if-they-do-can-they-tell-me 2022-05-18T08:15:01+10:00 https://pharmadispatch.com/news/organon-joins-the-list-of-companies-certified-as-a-great-place-t 2022-05-18T03:00:01+10:00 https://pharmadispatch.com/news/priceline-pharmacy-launches-new-styled-flagship-store 2022-05-18T03:00:01+10:00 https://pharmadispatch.com/news/everybody-wants-to-talk-about-faster-access-and-this-is-the-mome 2022-05-18T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-latest-corporate-social-responsibility-report 2022-05-18T03:00:01+10:00 https://pharmadispatch.com/news/the-sights-and-sounds-of-bpd-2022 2022-05-17T20:41:01+10:00 https://pharmadispatch.com/news/ena-respiratory-joins-initiative-to-boost-development-of-nasal-s 2022-05-17T05:13:01+10:00 https://pharmadispatch.com/news/election-implications-and-change-dominate-conference-discussion 2022-05-17T04:00:01+10:00 https://pharmadispatch.com/news/illuminas-susan-tousi-on-the-genomics-potential-to-change-health 2022-05-16T04:00:01+10:00 https://pharmadispatch.com/news/biogen-confirms-new-leadership-for-australia-and-new-zealand-1 2022-05-16T04:00:01+10:00 https://pharmadispatch.com/news/lundbeck-australia-again-recognised-as-a-great-place-to-work 2022-05-15T08:38:01+10:00 https://pharmadispatch.com/news/prime-minister-singles-out-department-of-health-over-vaccine-mis 2022-05-15T08:38:01+10:00 https://pharmadispatch.com/news/gsk-launches-second-year-of-graduate-researcher-program-1 2022-05-15T08:38:01+10:00 https://pharmadispatch.com/news/prime-minister-singles-out-department-of-health-over-vaccine-mis 2022-05-14T11:26:01+10:00 https://pharmadispatch.com/news/industry-backed-plan-to-move-australian-biotechnology-into-the-f 2022-05-13T04:00:01+10:00 https://pharmadispatch.com/news/speakers-line-up-for-the-20222-biopharmadispatch-conference 2022-05-13T04:00:01+10:00 https://pharmadispatch.com/news/gilead-australia-wins-best-employer-australia-recognition 2022-05-12T17:43:01+10:00 https://pharmadispatch.com/news/csl-expects-a-short-delay-in-closing-vifor-acquisition 2022-05-12T13:31:01+10:00 https://pharmadispatch.com/news/genomics-groups-call-for-change-in-pre-election-statements 2022-05-12T04:04:01+10:00 https://pharmadispatch.com/news/is-supply-a-sleeper-issue-with-two-major-changes-coming 2022-05-12T04:00:01+10:00 https://pharmadispatch.com/news/baa-says-start-again-on-hta-review-committee-and-proposes-candid 2022-05-12T04:00:01+10:00 https://pharmadispatch.com/news/rushing-to-start-the-hta-review-is-just-walking-into-a-trap 2022-05-11T04:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-looking-for-a-new-head-of-ethics-and-complia 2022-05-11T04:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-non-committal-on-need-to-delay-hta-review 2022-05-11T04:00:01+10:00 https://pharmadispatch.com/news/clinuvel-progresses-us-based-vitiligo-study 2022-05-10T10:42:01+10:00 https://pharmadispatch.com/news/prescient-expands-ptx-200-aml-cohort-following-additional-comple 2022-05-10T10:40:01+10:00 https://pharmadispatch.com/news/imugene-secures-australian-ethics-approval-for-her-vaxx-trial 2022-05-10T10:39:01+10:00 https://pharmadispatch.com/news/us-fda-ind-approval-for-dimerix-late-stage-study 2022-05-10T10:38:01+10:00 https://pharmadispatch.com/news/tests-a-critical-step-to-treatment-for-vision-loss 2022-05-10T10:37:01+10:00 https://pharmadispatch.com/news/labor-calls-on-coalition-to-match-its-commitment-to-expand-newbo 2022-05-10T04:00:01+10:00 https://pharmadispatch.com/news/we-need-to-know-the-why-before-worrying-about-the-how 2022-05-10T04:00:01+10:00 https://pharmadispatch.com/news/tga-approves-earlier-access-to-gileads-covid-19-antiviral-treatm 2022-05-10T04:00:01+10:00 https://pharmadispatch.com/news/mayne-pharma-wins-federal-government-manufacturing-support 2022-05-10T04:00:01+10:00 https://pharmadispatch.com/news/ma-says-no-to-proposed-chair-of-hta-review-reference-committee 2022-05-09T04:00:01+10:00 https://pharmadispatch.com/news/welcome-outcome-an-opportunity-to-get-real-about-the-realities-o 2022-05-09T04:00:01+10:00 https://pharmadispatch.com/news/national-recognition-for-the-head-of-bms-legal-team 2022-05-08T12:07:01+10:00 https://pharmadispatch.com/news/novartis-confirms-leadership-of-local-integration 2022-05-06T12:06:01+10:00 https://pharmadispatch.com/news/carbon-free-me-backing-bpd-conference-to-manage-and-offset-emiss 2022-05-06T04:00:01+10:00 https://pharmadispatch.com/news/gileads-jaime-mccoy-says-the-priority-must-be-a-proper-strategic 2022-05-06T04:00:01+10:00 https://pharmadispatch.com/news/takedas-brad-edwards-promoted-to-senior-regional-role 2022-05-06T04:00:01+10:00 https://pharmadispatch.com/news/rt-health-helping-families-cover-their-kids-for-longer 2022-05-05T08:38:01+10:00 https://pharmadispatch.com/news/members-health-calls-for-restoration-of-private-health-insurance 2022-05-05T08:36:01+10:00 https://pharmadispatch.com/news/everything-happens-for-a-reason-including-words-and-appointments 2022-05-05T04:00:01+10:00 https://pharmadispatch.com/news/labor-commits-to-review-nps-medicinewise-defunding-decision 2022-05-05T04:00:01+10:00 https://pharmadispatch.com/news/next-minister-confronted-by-unfinished-reviews-processes-and-out 2022-05-05T04:00:01+10:00 https://pharmadispatch.com/news/ramsay-health 2022-05-04T17:29:01+10:00 https://pharmadispatch.com/news/hcf-backs-sport-and-wellness-start-up 2022-05-04T08:07:01+10:00 https://pharmadispatch.com/news/new-ceo-for-australian-unity-private-health-insurance-business 2022-05-04T08:06:01+10:00 https://pharmadispatch.com/news/great-place-to-work-accreditation-for-beigene-australia 2022-05-04T04:00:01+10:00 https://pharmadispatch.com/news/award-winners-recognised-in-pharmaceutical-industry-education 2022-05-04T04:00:01+10:00 https://pharmadispatch.com/news/the-change-coming-for-australians-living-with-diabetes 2022-05-04T04:00:01+10:00 https://pharmadispatch.com/news/dr-falk-and-clinicians-welcomes-reimbursement-of-new-treatment-1 2022-05-04T04:00:01+10:00 https://pharmadispatch.com/news/investment-in-australian-collaboration-targeting-inflammatory-lu 2022-05-03T04:00:01+10:00 https://pharmadispatch.com/news/setting-a-new-benchmark-for-parental-leave-polices 2022-05-03T04:00:01+10:00 https://pharmadispatch.com/news/dr-brendan-shaw-co-payment-cuts-signal-the-end-of-pbs-fiscal-aus 2022-05-02T12:11:01+10:00 https://pharmadispatch.com/news/labor-trumps-coalition-with-plan-to-cut-pbs-co-pay-to-30-1 2022-05-02T04:00:01+10:00 https://pharmadispatch.com/news/long-acting-treatment-for-pbs-but-is-it-affordable-for-patients 2022-05-02T04:00:01+10:00 https://pharmadispatch.com/news/part-of-being-a-custodian-is-saving-decision-makers-from-their-o 2022-05-01T04:00:01+10:00 https://pharmadispatch.com/news/part-of-being-a-custodian-is-saving-decision-makers-from-their-o 2022-05-01T04:00:01+10:00 https://pharmadispatch.com/news/coalition-commits-to-cut-con-concessional-pbs-co-payment 2022-04-30T06:00:01+10:00 https://pharmadispatch.com/news/labor-promises-audit-of-government-spending-and-a-new-budget 2022-04-29T04:00:01+10:00 https://pharmadispatch.com/news/a-point-of-difference-that-is-already-having-implications 2022-04-29T04:00:01+10:00 https://pharmadispatch.com/news/reports-shame-list-identifies-access-gaps-for-new-zealands-cance 2022-04-29T04:00:01+10:00 https://pharmadispatch.com/news/janssen-and-illumina-team-up-on-precision-medicine-development 2022-04-29T04:00:01+10:00 https://pharmadispatch.com/news/cochlear-agrees-to-acquire-oticon-medical 2022-04-28T09:31:01+10:00 https://pharmadispatch.com/news/bupa-warns-agains-vaccination-fatigue-as-flu-season-approaches 2022-04-28T09:30:01+10:00 https://pharmadispatch.com/news/apha-welcomes-focus-on-health-workforce-but-wants-to-see-the-pol 2022-04-28T09:27:01+10:00 https://pharmadispatch.com/news/msd-looks-forward-to-reimbursement-after-recommendations 2022-04-28T04:00:01+10:00 https://pharmadispatch.com/news/csl-and-aspen-medical-names-as-two-of-the-best-places-to-work 2022-04-28T04:00:01+10:00 https://pharmadispatch.com/news/gsk-boosts-parental-leave-across-australia-and-new-zealand-opera 2022-04-28T04:00:01+10:00 https://pharmadispatch.com/news/spike-in-inflation-points-to-dramatic-jump-in-pbs-co-payments 2022-04-28T04:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-announces-the-appointment-of-new-leadership 2022-04-27T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-grants-to-support-community-based-vaccine-education 2022-04-27T04:00:01+10:00 https://pharmadispatch.com/news/will-the-review-fix-the-use-of-pricing-policy-in-pbac-outcomes 2022-04-27T04:00:01+10:00 https://pharmadispatch.com/news/biogens-kylie-bromley-promoted-to-uk-managing-director 2022-04-27T04:00:01+10:00 https://pharmadispatch.com/news/release-of-first-standard-for-use-of-opioids-in-acute-care 2022-04-26T08:05:01+10:00 https://pharmadispatch.com/news/hesta-part-of-consortium-bidding-for-ramsay-health-care 2022-04-26T08:04:01+10:00 https://pharmadispatch.com/news/nib-launches-greenpass-health-membership 2022-04-26T08:03:01+10:00 https://pharmadispatch.com/news/a-custodian-working-towards-giving-an-unambiguous-no 2022-04-26T04:00:01+10:00 https://pharmadispatch.com/news/gilead-welcomes-pbs-listing-of-new-breast-cancer-therapy 2022-04-26T04:00:01+10:00 https://pharmadispatch.com/news/hope-for-more-sufferers-of-migraine-but-more-work-on-weight-los 2022-04-26T04:00:01+10:00 https://pharmadispatch.com/news/viatris-leaders-say-the-focus-is-on-sustainability 2022-04-24T11:48:01+10:00 https://pharmadispatch.com/news/if-this-committee-is-to-have-a-policy-role-the-law-needs-to-chan 2022-04-22T04:00:01+10:00 https://pharmadispatch.com/news/csl-progresses-vifor-acquisition-with-successful-bond-issue 2022-04-22T04:00:01+10:00 https://pharmadispatch.com/news/medicinal-cannabis-setting-new-all-time-highs 2022-04-22T04:00:01+10:00 https://pharmadispatch.com/news/expansion-widely-welcomed-but-implementation-timeline-a-challeng 2022-04-21T14:00:01+10:00 https://pharmadispatch.com/news/call-to-fund-insulin-pump-that-has-been-recommended-and-promised 2022-04-21T13:24:01+10:00 https://pharmadispatch.com/news/bupa-calls-for-reform-to-keep-health-system-out-of-intensive-car 2022-04-21T13:23:01+10:00 https://pharmadispatch.com/news/volpara-health-announces-leadership-and-board-changes 2022-04-21T13:22:01+10:00 https://pharmadispatch.com/news/kazia-therapeutics-says-phase-2-study-of-paxalisib-completed 2022-04-21T13:21:01+10:00 https://pharmadispatch.com/news/medlab-clinical-confirms-northern-hemisphere-distribution 2022-04-21T13:21:01+10:00 https://pharmadispatch.com/news/arovella-therapeutics-announces-manufacturing-agreement-with-q-g 2022-04-21T13:20:01+10:00 https://pharmadispatch.com/news/pbac-is-elevated-in-law-but-also-significantly-constrained 2022-04-21T04:00:01+10:00 https://pharmadispatch.com/news/pre-election-outlook-provides-confusing-picture-on-new-medicines 2022-04-21T04:00:01+10:00 https://pharmadispatch.com/news/pharmacies-part-of-private-equity-takeover-of-ramsay 2022-04-21T02:00:01+10:00 https://pharmadispatch.com/news/uk-adopts-new-evaluation-framework-for-subscription-antibiotics 2022-04-20T04:00:01+10:00 https://pharmadispatch.com/news/the-next-minister-could-fundamentally-alter-these-reviews 2022-04-20T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-backs-research-australias-pre-election-call-for-actio 2022-04-20T04:00:01+10:00 https://pharmadispatch.com/news/zelira-therapeutics-executes-acquisition-of-health-house 2022-04-19T09:13:01+10:00 https://pharmadispatch.com/news/epiaxis-therapeutics-appoints-new-chief-science-officer 2022-04-19T09:12:01+10:00 https://pharmadispatch.com/news/uq-microbiopsy-deal-could-change-the-way-skin-conditions-are-dia 2022-04-19T09:11:01+10:00 https://pharmadispatch.com/news/nib-launches-new-health-insurance-partnership-with-priceline-pha 2022-04-19T09:10:01+10:00 https://pharmadispatch.com/news/this-appointment-will-mean-stakeholders-need-to-block-this-revie 2022-04-19T04:00:01+10:00 https://pharmadispatch.com/news/second-week-of-election-campaign-starts-with-pbs-and-diabetes-co 2022-04-19T04:00:01+10:00 https://pharmadispatch.com/news/agenda-building-for-biopharmadispatch-conference 2022-04-19T04:00:01+10:00 https://pharmadispatch.com/news/a-health-minister-in-the-senate-will-make-a-huge-difference 2022-04-19T04:00:01+10:00 https://pharmadispatch.com/news/vertex-conclusions-based-on-a-flawed-analysis-of-available-data 2022-04-18T09:47:01+10:00 https://pharmadispatch.com/news/prime-minister-confirms-south-australian-senator-for-health-port 2022-04-17T08:41:01+10:00 https://pharmadispatch.com/news/election-buys-more-time-on-controversial-confidentiality-move 2022-04-14T04:00:01+10:00 https://pharmadispatch.com/news/pfizers-anne-harris-on-authentically-working-towards-reconciliat 2022-04-14T04:00:01+10:00 https://pharmadispatch.com/news/naccho-announces-recipients-of-sanofi-supported-scholarships 2022-04-14T04:00:01+10:00 https://pharmadispatch.com/news/announcement-of-hta-review-reference-committee-designed-to-beat- 2022-04-13T04:00:01+10:00 https://pharmadispatch.com/news/the-government-should-consider-withdrawing-from-medicine-provisi 2022-04-13T04:00:01+10:00 https://pharmadispatch.com/news/further-work-halted-as-caretaker-conventions-kick-in 2022-04-13T04:00:01+10:00 https://pharmadispatch.com/news/the-unabashed-rationalist-says-in-many-respects-i-am-different 2022-04-12T13:10:01+10:00 https://pharmadispatch.com/news/youth-mental-health-is-the-silent-pandemic 2022-04-12T10:56:01+10:00 https://pharmadispatch.com/news/the-industry-needs-to-quickly-get-match-fit-for-this-fight 2022-04-12T04:00:01+10:00 https://pharmadispatch.com/news/labor-says-no-to-greg-hunts-hta-review-reference-committee 2022-04-12T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-announces-acquisition-of-australian-digital-health-compan 2022-04-11T11:50:01+10:00 https://pharmadispatch.com/news/department-of-health-the-responsible-person-for-pfizers-covid-tr 2022-04-11T04:00:01+10:00 https://pharmadispatch.com/news/an-appointment-that-is-a-parting-and-very-revealing-gift-to-pati 2022-04-11T04:00:01+10:00 https://pharmadispatch.com/news/stakeholders-must-not-accept-this-generational-threat-to-access 2022-04-11T04:00:01+10:00 https://pharmadispatch.com/news/morrison-to-reveal-health-minister-pick-in-the-next-week-or-so 2022-04-10T14:08:01+10:00 https://pharmadispatch.com/news/it-is-hard-to-imagine-a-worst-appointment-to-lead-hta-review 2022-04-10T10:29:01+10:00 https://pharmadispatch.com/news/government-funded-report-raises-alarm-over-vaping 2022-04-08T04:00:01+10:00 https://pharmadispatch.com/news/newborn-screening-the-how-the-what-and-the-why 2022-04-08T04:00:01+10:00 https://pharmadispatch.com/news/senate-inquiry-delivers-damning-assessment-of-vaccine-plan 2022-04-08T04:00:01+10:00 https://pharmadispatch.com/news/race-receives-human-ethics-approval-for-new-trial 2022-04-07T08:49:01+10:00 https://pharmadispatch.com/news/inoviq-and-university-of-queensland-expand-collaboration 2022-04-07T08:48:01+10:00 https://pharmadispatch.com/news/agilex-biolabs-appoints-a-new-chief-scientific-officer 2022-04-07T08:47:01+10:00 https://pharmadispatch.com/news/the-real-surprise-is-that-this-national-takeover-is-actual-refor 2022-04-07T04:00:01+10:00 https://pharmadispatch.com/news/rush-to-welcome-commitment-to-end-the-lottery-that-is-screening- 2022-04-07T04:00:01+10:00 https://pharmadispatch.com/news/gsk-consumer-healthcare-in-cbd-agreement-with-australian-company 2022-04-07T04:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-announces-support-for-major-new-resilience-projects 2022-04-07T04:00:01+10:00 https://pharmadispatch.com/news/edit-a-thon-returns-to-elevate-online-recognition-of-women-in-st 2022-04-07T04:00:01+10:00 https://pharmadispatch.com/news/minister-your-response-only-confirms-the-need-for-this-reform 2022-04-06T13:19:01+10:00 https://pharmadispatch.com/news/bupa-cautions-against-do-it-yourself-dentistry 2022-04-06T10:28:01+10:00 https://pharmadispatch.com/news/demand-for-flu-vaccinations-expected-to-soar-ahead-of-winter 2022-04-06T10:21:01+10:00 https://pharmadispatch.com/news/labor-announces-dramatic-expansion-of-newborn-screening 2022-04-06T08:16:01+10:00 https://pharmadispatch.com/news/medicines-australia-planning-largest-support-infrastructure-for- 2022-04-06T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-publication-of-rd-tax-incentive-determinatio 2022-04-06T04:00:01+10:00 https://pharmadispatch.com/news/industry-hopeful-ofpre-election-confirmation-of-hta-reference-co 2022-04-06T04:00:01+10:00 https://pharmadispatch.com/news/could-2023-be-the-biggest-delisting-year-in-pbs-history 2022-04-06T04:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-delivers-solid-performance-in-australia 2022-04-06T04:00:01+10:00 https://pharmadispatch.com/news/bio-gene-signs-agreement-on-flavocide-technology 2022-04-05T11:41:01+10:00 https://pharmadispatch.com/news/telix-pharmaceuticals-confirms-us-commercial-launch-of-illuccix 2022-04-05T11:40:01+10:00 https://pharmadispatch.com/news/microba-announces-new-research-partnership-and-senior-appointmen 2022-04-05T11:39:01+10:00 https://pharmadispatch.com/news/medibank-launches-pilot-to-combat-malnutrition-in-seniors 2022-04-05T08:35:01+10:00 https://pharmadispatch.com/news/apha-announces-the-recipients-of-2022-awards-for-excellence 2022-04-05T08:34:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-makes-first-statement-since-budget-defunding 2022-04-05T04:48:01+10:00 https://pharmadispatch.com/news/if-it-can-happen-to-them-it-can-happen-to-anyone 2022-04-05T04:00:01+10:00 https://pharmadispatch.com/news/msds-pbs-listed-covid-19-treatment-delivers-in-late-stage-trial 2022-04-05T04:00:01+10:00 https://pharmadispatch.com/news/brands-will-be-automatically-designated-for-minimum-stockholding 2022-04-05T04:00:01+10:00 https://pharmadispatch.com/news/novartis-announces-a-major-organisational-restructure 2022-04-05T04:00:01+10:00 https://pharmadispatch.com/news/ministers-claim-was-not-really-an-accurate-representation-of-the 2022-04-04T04:00:01+10:00 https://pharmadispatch.com/news/the-company-stood-its-ground-with-final-offer-on-key-therapy 2022-04-04T04:00:01+10:00 https://pharmadispatch.com/news/post-election-pricing-anticipation-of-medicine-sponsors 2022-04-04T04:00:01+10:00 https://pharmadispatch.com/news/australian-healthcare-investor-urges-greater-support-from-peers 2022-04-03T16:47:01+10:00 https://pharmadispatch.com/news/an-outcome-that-was-almost-certainly-ten-years-in-the-making 2022-04-01T04:00:01+11:00 https://pharmadispatch.com/news/patient-group-welcomes-report-of-parliamentary-inquiry 2022-04-01T04:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-gsks-triple-combination-for-severe-asthma 2022-04-01T04:00:01+11:00 https://pharmadispatch.com/news/strong-community-support-for-national-action-on-newborn-screenin 2022-04-01T04:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-viiv-healthcares-long-acting-hiv-treatment 2022-04-01T04:00:01+11:00 https://pharmadispatch.com/news/access-to-treatment-should-be-considered-a-fundamental-human-rig 2022-03-31T04:00:01+11:00 https://pharmadispatch.com/news/budget-disappointment-for-diabetes-patients 2022-03-31T04:00:01+11:00 https://pharmadispatch.com/news/rare-disease-and-new-migraine-biologic-for-july-pbac 2022-03-31T04:00:01+11:00 https://pharmadispatch.com/news/budget-delivers-major-blow-for-nps-medicinewise-with-loss-of-qum 2022-03-31T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-delivers-high-dose-four-strain-flu-vaccine-for-over-60s 2022-03-30T04:00:01+11:00 https://pharmadispatch.com/news/sigma-healthcare-reports-a-year-of-contrasting-halves 2022-03-30T04:00:01+11:00 https://pharmadispatch.com/news/a-declining-forecast-is-a-natural-consequence-of-the-sectors-agr 2022-03-30T04:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-new-listing-but-urges-action-on-newborn-screen 2022-03-30T04:00:01+11:00 https://pharmadispatch.com/news/budget-2022-23-and-the-lowering-of-expectations 2022-03-29T22:28:01+11:00 https://pharmadispatch.com/news/budget-2022-23-the-stakeholder-response 2022-03-29T21:04:01+11:00 https://pharmadispatch.com/news/the-pbs-shows-declining-spend-as-it-now-almost-always-will 2022-03-29T19:00:01+11:00 https://pharmadispatch.com/news/avecho-reports-positive-results-for-phase-2-topical-cbd-osteoart 2022-03-29T17:21:01+11:00 https://pharmadispatch.com/news/medibank-implements-fifth-reconciliation-action-plan 2022-03-29T17:14:01+11:00 https://pharmadispatch.com/news/teachers-health-group-extends-extras-cover 2022-03-29T17:13:01+11:00 https://pharmadispatch.com/news/dimerix-receives-rd-tax-rebate-for-last-financial-year 2022-03-29T17:12:01+11:00 https://pharmadispatch.com/news/hexima-presents-data-on-new-topical-treatment 2022-03-29T17:11:01+11:00 https://pharmadispatch.com/news/microbio-announces-capital-raise-to-support-product-launch 2022-03-29T17:09:01+11:00 https://pharmadispatch.com/news/neuren-receives-fda-approval-for-pitt-hopkins-ind-and-phase-2-tr 2022-03-29T17:09:01+11:00 https://pharmadispatch.com/news/nz-patients-call-on-the-government-to-stop-with-its-hypocrisy 2022-03-29T04:00:01+11:00 https://pharmadispatch.com/news/the-industry-is-not-expecting-any-surprises-in-tonights-budget 2022-03-29T04:00:01+11:00 https://pharmadispatch.com/news/evolving-technologies-challenge-existing-funding-pathways 2022-03-29T04:00:01+11:00 https://pharmadispatch.com/news/did-the-company-accept-the-terms-or-was-it-the-other-way-around 2022-03-29T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-launches-new-self-injecting-device-with-smartphone-app 2022-03-29T04:00:01+11:00 https://pharmadispatch.com/news/price-limits-price-cuts-and-price-policies-the-focus-of-latest-l 2022-03-28T04:00:01+11:00 https://pharmadispatch.com/news/call-for-clear-commitments-on-new-national-medicines-policy-revi 2022-03-28T04:00:01+11:00 https://pharmadispatch.com/news/retiring-minister-delivers-not-so-subtle-swipe-at-bureaucracy 2022-03-28T04:00:01+11:00 https://pharmadispatch.com/news/organisations-setting-our-their-asks-for-2022-23-budget 2022-03-28T04:00:01+11:00 https://pharmadispatch.com/news/former-industry-minister-announces-retirement-from-politics 2022-03-28T04:00:01+11:00 https://pharmadispatch.com/news/it-is-a-great-outcome-but-we-have-a-right-to-know-what-happened 2022-03-27T06:00:01+11:00 https://pharmadispatch.com/news/victoria-the-first-jurisdiction-to-fund-gene-therapy 2022-03-25T07:47:01+11:00 https://pharmadispatch.com/news/one-year-and-over-1000-deaths-since-the-launch-of-odtp-post-mark 2022-03-25T04:00:01+11:00 https://pharmadispatch.com/news/this-obvious-gaslighting-of-stakeholders-needs-to-stop 2022-03-25T04:00:01+11:00 https://pharmadispatch.com/news/ma-and-ausbiotech-join-global-criticism-of-covid-ip-waiver-compr 2022-03-25T04:00:01+11:00 https://pharmadispatch.com/news/beigene-appoints-new-head-of-haematology-for-australia-and-nz 2022-03-25T04:00:01+11:00 https://pharmadispatch.com/news/federal-government-grant-to-expand-viatris-production-in-austral 2022-03-25T04:00:01+11:00 https://pharmadispatch.com/news/organon-employees-making-first-use-of-support-service 2022-03-25T04:00:01+11:00 https://pharmadispatch.com/news/medadvisor-says-digital-prescription-management-to-keep-seniors- 2022-03-24T04:00:01+11:00 https://pharmadispatch.com/news/more-pharmaceutical-companies-refining-their-response-to-russia 2022-03-24T04:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-appoints-leader-of-new-rare-disease-unit 2022-03-24T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-succumbs-to-inevitable-on-national-medicines-policy-re 2022-03-24T04:00:01+11:00 https://pharmadispatch.com/news/political-condescension-the-biggest-reform-in-30-years-and-next- 2022-03-23T04:00:01+11:00 https://pharmadispatch.com/news/new-tga-approved-indication-for-seqirus-hay-fever-nasal-spray 2022-03-23T04:00:01+11:00 https://pharmadispatch.com/news/employment-and-procurement-the-focus-of-pfizers-reconciliation-a 2022-03-23T04:00:01+11:00 https://pharmadispatch.com/news/australian-company-progresses-smartphone-covid-test 2022-03-23T04:00:01+11:00 https://pharmadispatch.com/news/aged-care-and-health-insurance-drive-bupas-asia-pacific-result 2022-03-22T07:50:01+11:00 https://pharmadispatch.com/news/pha-why-should-private-patients-pay-more-than-those-in-the-publi 2022-03-22T07:49:01+11:00 https://pharmadispatch.com/news/agreements-have-fundamentally-changed-the-industrys-experience-o 2022-03-22T04:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-the-extent-of-chronic-health-problems 2022-03-22T04:00:01+11:00 https://pharmadispatch.com/news/terrywhite-chemmart-looking-ahead-to-600-pharmacies 2022-03-22T04:00:01+11:00 https://pharmadispatch.com/news/industry-groups-slam-compromise-covid-19-vaccine-patent-waiver 2022-03-22T04:00:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-welcomes-new-tga-approval-for-zeposia 2022-03-22T04:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-calls-for-budget-focus-on-real-cost-of-living-pre 2022-03-21T04:00:01+11:00 https://pharmadispatch.com/news/new-leadership-forboehringer-ingelheim-australia-and-new-zealand 2022-03-21T04:00:01+11:00 https://pharmadispatch.com/news/clinical-trials-and-new-bureaucracies-will-only-matter-if-they-l 2022-03-21T04:00:01+11:00 https://pharmadispatch.com/news/tenth-annual-kosi-challenge-smashes-fundraising-target 2022-03-21T04:00:01+11:00 https://pharmadispatch.com/news/an-industry-once-again-suffers-the-consequences-of-a-failed-refo 2022-03-18T04:00:01+11:00 https://pharmadispatch.com/news/ma-confident-concerns-over-nmp-review-are-being-heard 2022-03-18T04:00:01+11:00 https://pharmadispatch.com/news/voluntary-administration-for-contract-sales-force-provider 2022-03-18T04:00:01+11:00 https://pharmadispatch.com/news/stakeholders-welcome-support-of-extended-targeted-therapy-cancer 2022-03-18T04:00:01+11:00 https://pharmadispatch.com/news/htanalysts-launches-new-impact-assessment-consulting-service 2022-03-17T04:00:01+11:00 https://pharmadispatch.com/news/alternative-national-medicines-policy-close-to-finalised 2022-03-17T04:00:01+11:00 https://pharmadispatch.com/news/total-surges-past-300000-with-two-days-to-go 2022-03-17T04:00:01+11:00 https://pharmadispatch.com/news/amgen-foundation-commits-50000-to-support-flood-affected-communi 2022-03-17T04:00:01+11:00 https://pharmadispatch.com/news/the-bureaucratic-playbook-is-well-and-truly-in-play-with-nmp-rev 2022-03-16T04:00:01+11:00 https://pharmadispatch.com/news/ipsen-australia-recruits-global-support-for-local-rare-cancer-pa 2022-03-16T04:00:01+11:00 https://pharmadispatch.com/news/companies-recognised-by-federal-governments-gender-equality-agen 2022-03-16T04:00:01+11:00 https://pharmadispatch.com/news/industry-starts-to-harden-its-response-to-russias-invasion-of-uk 2022-03-16T04:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-announces-recipients-of-positive-action-communit 2022-03-15T01:11:01+11:00 https://pharmadispatch.com/news/hunt-and-butler-headline-gbma-budget-week-event 2022-03-15T01:00:01+11:00 https://pharmadispatch.com/news/new-facility-aims-to-enhance-the-delivery-of-cancer-treatment 2022-03-15T01:00:01+11:00 https://pharmadispatch.com/news/seeing-cancer-from-the-other-side-climbing-kosi-in-honour-of-dan 2022-03-15T01:00:01+11:00 https://pharmadispatch.com/news/major-promotion-brings-new-local-leadership-to-sanofi-speciality 2022-03-15T01:00:01+11:00 https://pharmadispatch.com/news/sanofi-deliveringvaccine-to-combat-japanese-encephalitis-outbrea 2022-03-14T04:00:01+11:00 https://pharmadispatch.com/news/fundraising-totals-building-fast-with-just-five-days-to-go 2022-03-14T04:00:01+11:00 https://pharmadispatch.com/news/partnership-wants-change-in-how-universities-and-industry-collab 2022-03-14T04:00:01+11:00 https://pharmadispatch.com/news/global-logistics-companies-might-make-the-russia-decision-for-in 2022-03-14T04:00:01+11:00 https://pharmadispatch.com/news/kosi-challenge-fundraising-total-tops-200000-with-one-week-to-go 2022-03-11T03:04:01+11:00 https://pharmadispatch.com/news/increasing-scrutiny-of-the-industrys-response-to-ukraine 2022-03-11T03:00:01+11:00 https://pharmadispatch.com/news/health-minister-says-pharmac-knows-things-need-to-change 2022-03-11T03:00:01+11:00 https://pharmadispatch.com/news/expanded-approval-for-gsks-shingles-vaccine 2022-03-11T03:00:01+11:00 https://pharmadispatch.com/news/industry-and-patients-looking-ahead-to-caretaker-conventions 2022-03-10T03:00:01+11:00 https://pharmadispatch.com/news/final-tga-approval-for-breakthrough-cancer-combination 2022-03-10T03:00:01+11:00 https://pharmadispatch.com/news/collaboration-welcomes-new-commitment-to-cepi-moonshot 2022-03-10T03:00:01+11:00 https://pharmadispatch.com/news/a-rebrand-for-australias-largest-life-sciences-venture-fund 2022-03-10T03:00:01+11:00 https://pharmadispatch.com/news/sanofi-announces-support-package-for-flood-affected-communities 2022-03-09T04:00:01+11:00 https://pharmadispatch.com/news/government-says-longer-wait-on-price-reduction-impact 2022-03-09T04:00:01+11:00 https://pharmadispatch.com/news/government-warned-rush-will-only-undermine-support-for-national- 2022-03-09T04:00:01+11:00 https://pharmadispatch.com/news/novartis-further-strengthens-gene-therapy-focus-with-new-agreeme 2022-03-09T03:45:01+11:00 https://pharmadispatch.com/news/broad-tga-approval-for-seqirus-cell-based-flu-vaccine 2022-03-08T04:00:01+11:00 https://pharmadispatch.com/news/new-merger-to-form-over-1000-member-pharmacy-alliance 2022-03-08T04:00:01+11:00 https://pharmadispatch.com/news/beigenes-first-australian-employee-marks-international-womens-da 2022-03-08T04:00:01+11:00 https://pharmadispatch.com/news/pharmaceuticals-in-the-list-of-seven-manufacturing-priorities 2022-03-08T04:00:01+11:00 https://pharmadispatch.com/news/the-bigger-question-for-review-is-whether-this-system-has-actual 2022-03-07T04:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-triggered-pandemic-milestone-with-out-of-pocket-cost 2022-03-07T04:00:01+11:00 https://pharmadispatch.com/news/pharma-cup-total-tops-100000-with-two-weeks-to-go 2022-03-07T04:00:01+11:00 https://pharmadispatch.com/news/tender-documents-raise-questions-over-operationof-review-support 2022-03-07T04:00:01+11:00 https://pharmadispatch.com/news/evidence-of-something-profoundly-wrong-with-decision-making 2022-03-03T17:05:01+11:00 https://pharmadispatch.com/news/mixed-views-and-experiences-for-the-overweight-or-obese 2022-03-03T12:23:01+11:00 https://pharmadispatch.com/news/australian-maker-of-green-whistle-jumps-on-fda-decision 2022-03-03T11:49:01+11:00 https://pharmadispatch.com/news/phrma-price-controls-are-not-the-solution-to-this-problem 2022-03-03T11:22:01+11:00 https://pharmadispatch.com/news/we-ended-up-asking-golfers-on-the-seventh-fairway-for-directions 2022-03-03T10:11:01+11:00 https://pharmadispatch.com/news/sigma-upgrades-guidance-on-rapid-antigen-test-sales 2022-03-03T03:00:01+11:00 https://pharmadispatch.com/news/biointelect-boss-on-vaccine-development-and-breaking-down-the-si 2022-03-03T02:00:01+11:00 https://pharmadispatch.com/news/now-the-numbers-are-really-not-adding-up-on-listing-claim 2022-03-03T02:00:01+11:00 https://pharmadispatch.com/news/sandoz-joins-viatris-in-supply-deal-with-symbion-pharmacy-brands 2022-03-02T14:04:01+11:00 https://pharmadispatch.com/news/major-executive-appointments-for-novartis-and-sanofi 2022-03-02T13:23:01+11:00 https://pharmadispatch.com/news/active-agent-in-australian-developed-nasal-spray-highly-active-a 2022-03-02T12:58:01+11:00 https://pharmadispatch.com/news/antisense-therapeutics-confirms-atl1102-poster-presentation 2022-03-02T12:57:01+11:00 https://pharmadispatch.com/news/anteris-technologies-secures-the-backing-of-us-healthcare-invest 2022-03-02T12:56:01+11:00 https://pharmadispatch.com/news/mental-illness-diet-and-physical-activity-targeted-in-new-heart- 2022-03-02T12:50:01+11:00 https://pharmadispatch.com/news/insurers-offer-disaster-relief-for-flood-affected-queensland-and 2022-03-02T12:49:01+11:00 https://pharmadispatch.com/news/quarterly-update-confirms-membership-growth-and-ongoing-impact-o 2022-03-02T12:43:01+11:00 https://pharmadispatch.com/news/another-new-zealand-health-insurer-adds-significant-pharmaceutic 2022-03-02T04:00:01+11:00 https://pharmadispatch.com/news/a-big-week-with-stakeholder-consultation-closing-on-major-review 2022-03-02T04:00:01+11:00 https://pharmadispatch.com/news/labor-announces-it-will-fund-expansion-of-patient-pathways-proga 2022-03-02T04:00:01+11:00 https://pharmadispatch.com/news/new-five-year-supply-agreement-between-viatris-and-symbion 2022-03-02T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-welcomes-listing-of-new-blood-cancer-therapy 2022-03-02T04:00:01+11:00 https://pharmadispatch.com/news/lucy-turnbull-ao-rejoins-the-board-of-immutep 2022-03-01T09:59:01+11:00 https://pharmadispatch.com/news/orthocell-updates-on-us-market-entry-and-growth 2022-03-01T09:59:01+11:00 https://pharmadispatch.com/news/patrys-select-stable-cell-line-for-the-production-of-pat-dx3 2022-03-01T09:57:01+11:00 https://pharmadispatch.com/news/approval-for-neuren-pharmaceuticals-phase-2-trial-in-angelman-sy 2022-03-01T09:56:01+11:00 https://pharmadispatch.com/news/medibank-health-contributes-strong-growth-in-half-year-result 2022-03-01T09:54:01+11:00 https://pharmadispatch.com/news/tavi-now-available-for-more-patients-living-with-severe-aortic-s 2022-03-01T09:53:01+11:00 https://pharmadispatch.com/news/pharma-cup-total-approaching-100000-with-less-than-three-weeks-t 2022-03-01T04:00:01+11:00 https://pharmadispatch.com/news/every-australian-patient-has-a-right-to-understand-the-decision- 2022-03-01T04:00:01+11:00 https://pharmadispatch.com/news/alexion-welcomes-new-listing-and-transition-to-pbs 2022-03-01T04:00:01+11:00 https://pharmadispatch.com/news/beigene-hits-a-major-milestone-with-first-medicine-reimbursed-th 2022-03-01T04:00:01+11:00 https://pharmadispatch.com/news/patient-program-suffering-from-political-and-bureaucratic-inacti 2022-02-28T04:00:01+11:00 https://pharmadispatch.com/news/these-patients-are-still-waiting-for-funded-access-to-treatment 2022-02-28T04:00:01+11:00 https://pharmadispatch.com/news/chris-stemple-elevated-to-medicines-australia-deputy-chair 2022-02-28T04:00:01+11:00 https://pharmadispatch.com/news/report-urges-policy-reform-to-ensure-future-access-to-vaccines 2022-02-28T04:00:01+11:00 https://pharmadispatch.com/news/this-is-the-process-all-patients-should-now-expect 2022-02-28T04:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-for-australians-with-leukaemia 2022-02-28T04:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-astrazenecas-covid-19-treatment 2022-02-27T14:40:01+11:00 https://pharmadispatch.com/news/its-official-health-technology-assessment-is-a-joke 2022-02-27T04:00:01+11:00 https://pharmadispatch.com/news/have-the-industry-and-other-stakeholders-finally-had-enough 2022-02-25T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-gsk-covid-19-vaccine-excels-in-late-stage-trial 2022-02-25T04:00:01+11:00 https://pharmadispatch.com/news/janssen-gets-backing-as-groups-dig-in-on-nmp-review 2022-02-25T04:00:01+11:00 https://pharmadispatch.com/news/new-portal-offers-online-pathway-for-accessing-cancer-treatments 2022-02-25T04:00:01+11:00 https://pharmadispatch.com/news/kazia-therapeutics-to-be-transformed-by-pipeline-progress 2022-02-25T04:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-new-indication-for-leading-eye-therapy 2022-02-25T04:00:01+11:00 https://pharmadispatch.com/news/janssen-says-it-cannot-commit-to-supporting-revised-nmp-in-its-c 2022-02-24T09:50:01+11:00 https://pharmadispatch.com/news/ama-calls-for-pre-election-focus-on-social-determinants-of-child 2022-02-24T08:23:01+11:00 https://pharmadispatch.com/news/new-study-confirms-the-safety-of-key-covid-19-vaccine 2022-02-24T04:00:01+11:00 https://pharmadispatch.com/news/chf-makes-the-case-for-access-as-a-basic-need 2022-02-24T04:00:01+11:00 https://pharmadispatch.com/news/australia-and-nz-beaten-by-poland-on-innovative-cystic-fibrosis- 2022-02-24T01:08:01+11:00 https://pharmadispatch.com/news/government-extends-moderna-vaccine-rollout-to-include-more-child 2022-02-23T12:42:01+11:00 https://pharmadispatch.com/news/record-revenue-and-profit-for-australian-company-clinuvel 2022-02-23T10:53:01+11:00 https://pharmadispatch.com/news/csl-behring-joins-british-pharmaceutical-industry-association 2022-02-23T08:51:01+11:00 https://pharmadispatch.com/news/was-this-vast-and-sprawling-institution-ever-the-intention 2022-02-23T04:00:01+11:00 https://pharmadispatch.com/news/life-saving-medicines-unaffordable-as-pbs-co-pay-heads-to-50-a-s 2022-02-23T04:00:01+11:00 https://pharmadispatch.com/news/ma-holding-firm-on-need-to-push-nmp-review-to-post-election 2022-02-23T04:00:01+11:00 https://pharmadispatch.com/news/arovella-therapeutics-closes-over-subscribed-share-purchase-plan 2022-02-22T17:41:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-announces-plans-for-a-capital-raise 2022-02-22T17:40:01+11:00 https://pharmadispatch.com/news/developed-country-markets-drive-cochlear-growth 2022-02-22T17:39:01+11:00 https://pharmadispatch.com/news/bayer-highlights-new-technology-platforms-in-global-briefing 2022-02-22T17:07:01+11:00 https://pharmadispatch.com/news/federal-funding-for-preventive-health-projects-in-victoria 2022-02-22T09:00:01+11:00 https://pharmadispatch.com/news/calvary-medibank-using-ai-and-remote-monitoring-to-support-covid 2022-02-22T08:59:01+11:00 https://pharmadispatch.com/news/nib-announces-a-strong-first-half-result-1 2022-02-22T08:58:01+11:00 https://pharmadispatch.com/news/an-opportunity-to-reset-what-has-become-difficult-relationship 2022-02-22T04:00:01+11:00 https://pharmadispatch.com/news/minister-resisting-calls-for-halt-to-national-medicines-policy-r 2022-02-22T04:00:01+11:00 https://pharmadispatch.com/news/starpharma-reports-revenue-growth-and-advances-development 2022-02-22T04:00:01+11:00 https://pharmadispatch.com/news/msd-still-leading-the-way-as-companies-add-more-than-15000 2022-02-22T04:00:01+11:00 https://pharmadispatch.com/news/there-is-almost-nothing-objective-about-australias-hta-belief-sy 2022-02-21T04:00:01+11:00 https://pharmadispatch.com/news/amgen-scholars-celebrate-a-summer-of-science-in-melbourne 2022-02-21T04:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-immediate-change-in-discount-rate 2022-02-21T04:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-for-chronic-graft-versus-host-disease 2022-02-21T04:00:01+11:00 https://pharmadispatch.com/news/ma-joins-call-for-more-action-on-global-vaccine-equity 2022-02-21T04:00:01+11:00 https://pharmadispatch.com/news/queensland-researcher-secures-gilead-grant-1 2022-02-21T04:00:01+11:00 https://pharmadispatch.com/news/the-total-reliance-on-educated-guesswork-is-harming-for-patients 2022-02-18T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-backs-naccho-aboriginal-and-torres-strait-islander-pharma 2022-02-17T15:41:01+11:00 https://pharmadispatch.com/news/there-is-no-nuance-or-subtlety-in-the-fact-patients-come-second- 2022-02-17T04:00:01+11:00 https://pharmadispatch.com/news/bizarre-exchanges-at-senate-estimates-hearing 2022-02-17T04:00:01+11:00 https://pharmadispatch.com/news/call-for-pm-to-intervene-on-nmp-as-one-group-starts-redrafting-p 2022-02-17T04:00:01+11:00 https://pharmadispatch.com/news/csl-working-towards-completing-vifor-acquisition 2022-02-16T15:01:01+11:00 https://pharmadispatch.com/news/waiting-hoping-and-anticipating-for-an-announcement-on-gene-ther 2022-02-16T04:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-new-paediatric-indication-for-biologic 2022-02-16T04:00:01+11:00 https://pharmadispatch.com/news/department-of-health-officials-to-front-senate-estimates-today 2022-02-16T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-wins-certification-as-family-friendly-workplace 2022-02-16T04:00:01+11:00 https://pharmadispatch.com/news/a-grab-bag-of-bizarre-theories-amongst-a-smattering-of-sensible- 2022-02-16T04:00:01+11:00 https://pharmadispatch.com/news/exercise-of-discretion-ultimately-a-matter-for-the-next-health-m 2022-02-15T04:00:01+11:00 https://pharmadispatch.com/news/pharmac-consulting-on-widening-access-to-two-off-patent-treatmen 2022-02-15T04:00:01+11:00 https://pharmadispatch.com/news/consumer-group-backflips-on-co-hosting-roundtable-with-the-indus 2022-02-15T04:00:01+11:00 https://pharmadispatch.com/news/gbma-announced-the-appointment-of-new-board-director 2022-02-14T11:52:01+11:00 https://pharmadispatch.com/news/why-stakeholders-are-so-unhappy-with-revised-national-medicines- 2022-02-14T04:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-new-eye-therapy-and-smoking-cessation-review-fi 2022-02-14T04:00:01+11:00 https://pharmadispatch.com/news/move-to-scrap-confidentiality-provisions-set-to-lapse-but-could- 2022-02-14T04:00:01+11:00 https://pharmadispatch.com/news/industry-getting-behind-the-tenth-year-of-fundraising-climb 2022-02-14T04:00:01+11:00 https://pharmadispatch.com/news/enough-is-enough-as-better-access-australia-calls-for-review-to- 2022-02-14T04:00:01+11:00 https://pharmadispatch.com/news/former-ma-chief-executive-claims-victory-in-key-by-election 2022-02-14T04:00:01+11:00 https://pharmadispatch.com/news/the-national-medicines-policy-review-has-accomplished-what-is-a- 2022-02-11T04:00:01+11:00 https://pharmadispatch.com/news/patent-box-legislation-now-before-the-parliament 2022-02-11T04:00:01+11:00 https://pharmadispatch.com/news/biogen-backed-report-highlights-the-coming-impact-of-alzheimers- 2022-02-11T04:00:01+11:00 https://pharmadispatch.com/news/stakeholders-start-to-unite-against-the-failings-of-nmp-review 2022-02-10T09:57:01+11:00 https://pharmadispatch.com/news/independent-mp-calls-for-royal-commission-of-health-sector 2022-02-10T03:00:01+11:00 https://pharmadispatch.com/news/parliamentary-committee-starts-review-of-australia-uk-trade-agre 2022-02-10T03:00:01+11:00 https://pharmadispatch.com/news/mark-butler-becomes-a-father-for-the-third-time 2022-02-10T03:00:01+11:00 https://pharmadispatch.com/news/nmp-panel-host-a-scripted-defensive-and-at-times-confused-stakeh 2022-02-10T03:00:01+11:00 https://pharmadispatch.com/news/gbma-welcomes-accord-healthcare-as-a-new-member 2022-02-10T03:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-astrazeneca-australia-and-new-zealand 2022-02-09T11:11:01+11:00 https://pharmadispatch.com/news/consultation-extended-but-at-the-cost-of-considering-stakeholder 2022-02-09T04:00:01+11:00 https://pharmadispatch.com/news/nz-patients-once-again-relying-on-charity-for-funded-access 2022-02-09T04:00:01+11:00 https://pharmadispatch.com/news/applications-open-for-industry-backed-bridge-programme 2022-02-09T04:00:01+11:00 https://pharmadispatch.com/news/australia-one-of-the-first-developed-countries-to-administer-nov 2022-02-09T04:00:01+11:00 https://pharmadispatch.com/news/csl-campaign-challenging-stereotypes-about-people-working-in-sci 2022-02-08T16:46:01+11:00 https://pharmadispatch.com/news/dimerix-appoints-chief-medical-officer 2022-02-08T10:29:01+11:00 https://pharmadispatch.com/news/medlab-clinical-updates-on-progress-towards-phase-3-trial 2022-02-08T10:28:01+11:00 https://pharmadispatch.com/news/neuroscientific-biopharmaceuticals-reports-outcomes-of-pre-clini 2022-02-08T10:27:01+11:00 https://pharmadispatch.com/news/clarity-pharmaceuticals-announces-us-based-cobra-study-to-procee 2022-02-08T10:26:01+11:00 https://pharmadispatch.com/news/medibank-encourages-australians-to-prioritise-their-health-check 2022-02-08T08:35:01+11:00 https://pharmadispatch.com/news/bupa-extends-foundation-in-new-zealand-through-new-partnerships 2022-02-08T08:34:01+11:00 https://pharmadispatch.com/news/new-paper-reveals-shortcomings-in-pbac-consumer-comment-process 2022-02-08T04:00:01+11:00 https://pharmadispatch.com/news/a-portal-to-an-entirely-new-economic-dimension 2022-02-08T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-joins-bca-in-push-to-be-part-of-a-wider-conversation 2022-02-08T04:00:01+11:00 https://pharmadispatch.com/news/extension-possible-but-is-that-enough-for-stakeholders-wanting-c 2022-02-08T04:00:01+11:00 https://pharmadispatch.com/news/a-piecemeal-review-that-will-only-entrench-piecemeal-approaches 2022-02-07T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-unites-business-units-under-a-single-brand 2022-02-07T04:00:01+11:00 https://pharmadispatch.com/news/janssen-adds-to-communications-and-public-affairs-team 2022-02-07T04:00:01+11:00 https://pharmadispatch.com/news/labor-slams-the-government-over-national-medicines-policy-review 2022-02-07T04:00:01+11:00 https://pharmadispatch.com/news/it-should-be-about-affordability-for-patients-not-the-government 2022-02-06T13:59:01+11:00 https://pharmadispatch.com/news/another-election-at-what-will-be-a-very-important-time-for-the-i 2022-02-04T04:00:01+11:00 https://pharmadispatch.com/news/organon-marks-iwd-with-paid-time-off-to-manage-health-needs 2022-02-04T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-public-affairs-switch-to-az-as-industry-stalwart-steps-ba 2022-02-04T04:00:01+11:00 https://pharmadispatch.com/news/pressure-mounts-to-extend-national-medicines-policy-review 2022-02-04T04:00:01+11:00 https://pharmadispatch.com/news/planet-innovation-and-lumos-diagnostics-collaborate-on-local-rat 2022-02-03T11:06:01+11:00 https://pharmadispatch.com/news/action-plan-to-promote-research-industry-commercialisation 2022-02-03T11:02:01+11:00 https://pharmadispatch.com/news/cytiva-announces-winner-of-australia-nz-biochallenge 2022-02-03T11:00:01+11:00 https://pharmadispatch.com/news/stlukeshealth-to-pay-benefits-for-rapid-antigen-tests 2022-02-03T10:59:01+11:00 https://pharmadispatch.com/news/members-health-welcomes-staged-return-of-elective-surgery-in-nsw 2022-02-03T10:00:01+11:00 https://pharmadispatch.com/news/victorian-research-consortium-to-fight-childhood-cancer 2022-02-03T10:00:01+11:00 https://pharmadispatch.com/news/sector-facing-a-major-change-with-costs-on-track-and-trace 2022-02-03T04:00:01+11:00 https://pharmadispatch.com/news/should-it-be-renamed-the-national-medicines-procurement-policy 2022-02-03T04:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-tells-government-to-try-again-on-revised-nmp 2022-02-03T04:00:01+11:00 https://pharmadispatch.com/news/revised-nmp-adopts-budget-considerations-and-disinvestment 2022-02-02T12:22:01+11:00 https://pharmadispatch.com/news/should-the-sector-contribute-to-a-political-process-that-seems-n 2022-02-02T04:00:01+11:00 https://pharmadispatch.com/news/medicines-nz-challenges-exclusion-of-pharmac-in-health-system-re 2022-02-02T04:00:01+11:00 https://pharmadispatch.com/news/better-access-australia-calls-for-new-pbs-co-payment-structure 2022-02-02T04:00:01+11:00 https://pharmadispatch.com/news/pm-regrets-delayed-military-supervision-of-vaccine-program 2022-02-02T04:00:01+11:00 https://pharmadispatch.com/news/biogen-appoints-new-members-to-its-leadership-team 2022-02-01T04:00:01+11:00 https://pharmadispatch.com/news/new-trial-underway-of-pharmaxis-first-in-class-lox-inhibitor 2022-02-01T04:00:01+11:00 https://pharmadispatch.com/news/guild-calls-for-action-as-medicine-costs-continue-to-rise 2022-02-01T04:00:01+11:00 https://pharmadispatch.com/news/australias-first-reimbursed-thyroid-hrt-not-requiring-refrigerat 2022-02-01T04:00:01+11:00 https://pharmadispatch.com/news/gsk-working-towards-extending-reimbursement-for-respiratory-biol 2022-02-01T04:00:01+11:00 https://pharmadispatch.com/news/three-ma-board-vacancies-become-four-following-a-major-promotion 2022-01-31T04:00:01+11:00 https://pharmadispatch.com/news/over-to-you-minister-it-is-time-to-do-your-job 2022-01-31T04:00:01+11:00 https://pharmadispatch.com/news/more-companies-need-to-start-saying-no-to-bad-outcomes 2022-01-31T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-loses-senior-adviser-to-prime-ministers-office 2022-01-31T04:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-welcomes-expanded-listing-for-blood-cancer-therapy 2022-01-31T04:00:01+11:00 https://pharmadispatch.com/news/three-vacancies-turns-to-four-with-major-promotion-for-deputy-ch 2022-01-29T16:14:01+11:00 https://pharmadispatch.com/news/companies-initiate-studies-of-omicron-specific-vaccines 2022-01-28T04:00:01+11:00 https://pharmadispatch.com/news/organon-boss-to-deliver-keynote-address-to-women-in-life-science 2022-01-28T04:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-faster-access-to-medicines-vaccines-and-treatments 2022-01-28T04:00:01+11:00 https://pharmadispatch.com/news/the-great-resignation-of-five-ways-to-help-women-thrive 2022-01-27T04:00:01+11:00 https://pharmadispatch.com/news/former-senior-pbs-official-recognised-in-australia-day-honours-l 2022-01-27T04:00:01+11:00 https://pharmadispatch.com/news/bpd-conference-2022-just-days-left-for-early-bird-registration 2022-01-27T04:00:01+11:00 https://pharmadispatch.com/news/nice-adopts-standalone-commitment-to-innovation-and-patient-acce 2022-01-27T04:00:01+11:00 https://pharmadispatch.com/news/discussion-on-the-sectors-carbon-footprint-should-least-be-based 2022-01-25T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-joins-the-macquarie-park-innovation-group 2022-01-25T04:00:01+11:00 https://pharmadispatch.com/news/significant-capital-raise-for-emerging-australian-company 2022-01-25T04:00:01+11:00 https://pharmadispatch.com/news/novavax-covid-19-vaccine-to-be-distributed-in-coming-weeks 2022-01-25T04:00:01+11:00 https://pharmadispatch.com/news/release-of-national-medicines-policy-review-submissions-expose-t 2022-01-24T04:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-msd-australia-and-new-zealand 2022-01-24T04:00:01+11:00 https://pharmadispatch.com/news/bayers-ashraf-al-ouf-on-the-need-for-change-a-clear-focus-and-ob 2022-01-24T04:00:01+11:00 https://pharmadispatch.com/news/australians-with-severe-dermatitis-to-benefit-from-pbs-listing 2022-01-24T04:00:01+11:00 https://pharmadispatch.com/news/is-australian-decision-making-really-based-on-health-technology- 2022-01-21T04:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-vertex-australia-and-new-zealand 2022-01-21T04:00:01+11:00 https://pharmadispatch.com/news/industry-makes-the-list-of-australias-top-employers 2022-01-21T04:00:01+11:00 https://pharmadispatch.com/news/major-milestone-as-tga-announces-approval-of-new-covid-19-option 2022-01-21T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-laboratory-studies-suggest-covid-19-treatment-effective-a 2022-01-20T04:00:01+11:00 https://pharmadispatch.com/news/ma-hta-review-could-consider-new-non-pbac-pricing-body 2022-01-20T04:00:01+11:00 https://pharmadispatch.com/news/australia-watching-as-uk-reforms-its-decision-making-framework 2022-01-20T04:00:01+11:00 https://pharmadispatch.com/news/stakeholders-welcome-rebate-extension-for-phone-call-consultatio 2022-01-19T05:56:01+11:00 https://pharmadispatch.com/news/a-legal-review-might-be-more-important-than-the-hta-review 2022-01-19T04:00:01+11:00 https://pharmadispatch.com/news/supply-chain-takes-more-than-half-of-us-brand-medicine-spend 2022-01-19T04:00:01+11:00 https://pharmadispatch.com/news/industry-acceptance-of-the-status-quo-is-a-barrier-to-achieving- 2022-01-18T04:00:01+11:00 https://pharmadispatch.com/news/cabinet-submission-reveals-brutal-assessment-of-nzs-regulatory-e 2022-01-18T04:00:01+11:00 https://pharmadispatch.com/news/five-years-since-greg-hunts-appointment-to-health-portfolio 2022-01-18T04:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-its-strategic-agreement-steering-committee 2022-01-18T04:00:01+11:00 https://pharmadispatch.com/news/gsk-welcomes-tga-approval-of-parp-inhibitor 2022-01-18T04:00:01+11:00 https://pharmadispatch.com/news/cabinet-document-confirms-limits-on-the-reach-of-pbac-advice 2022-01-17T04:00:01+11:00 https://pharmadispatch.com/news/compare-and-contrast-the-actions-of-two-health-ministers-on-pbs- 2022-01-17T04:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-confirms-candidates-to-fill-board-vacancies- 2022-01-17T04:00:01+11:00 https://pharmadispatch.com/news/gsk-rejects-unilever-bid-for-consumer-health-business 2022-01-17T04:00:01+11:00 https://pharmadispatch.com/news/a-milestone-that-i-and-many-others-have-been-waiting-for-and-is- 2022-01-08T20:32:01+11:00 https://pharmadispatch.com/news/bpd-conference-2022-still-time-for-early-bird-registration 2022-01-08T20:15:01+11:00 https://pharmadispatch.com/news/surprise-request-for-tender-before-appointment-of-chair-or-refer 2022-01-08T19:11:01+11:00 https://pharmadispatch.com/news/cynical-hardly-seems-sufficient-to-describe-this-decision 2022-01-04T15:08:01+11:00 https://pharmadispatch.com/news/nicole-cooper-i-am-a-patient-not-a-consumer 2021-12-20T17:56:01+11:00 https://pharmadispatch.com/news/biosimilars-deferrals-and-rescinds-dominate-november-outcomes 2021-12-20T04:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-welcomes-expanded-reimbursement-for-forxiga 2021-12-20T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-20-december-2021 2021-12-20T04:00:01+11:00 https://pharmadispatch.com/news/this-unlawful-situation-is-just-evidence-of-a-lack-of-compassion 2021-12-19T09:49:01+11:00 https://pharmadispatch.com/news/novartis-richard-tew-collaboration-and-intent-but-the-system-nee 2021-12-19T04:00:01+11:00 https://pharmadispatch.com/news/australia-is-one-part-of-modernas-ambitious-global-manufacturing 2021-12-17T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-17-december-2021-2 2021-12-17T04:00:01+11:00 https://pharmadispatch.com/news/pharmac-proposes-bundle-agreement-for-az-therapies 2021-12-16T15:23:01+11:00 https://pharmadispatch.com/news/budget-update-and-looking-ahead-to-the-federal-election-with-ins 2021-12-16T14:52:01+11:00 https://pharmadispatch.com/news/csl-completes-63-billion-placement-to-support-vifor-acquisition 2021-12-16T14:43:01+11:00 https://pharmadispatch.com/news/budget-update-highlights-impact-of-pandemic-on-medicine-use 2021-12-16T12:53:01+11:00 https://pharmadispatch.com/news/paig-jjs-fiona-sheppard-and-pfizers-lee-davelaar 2021-12-16T10:09:01+11:00 https://pharmadispatch.com/news/recce-pharmaceuticals-recruits-first-cohort-in-new-study 2021-12-16T09:13:01+11:00 https://pharmadispatch.com/news/immutep-advances-imp761-manufacturing-with-new-agreement 2021-12-16T09:12:01+11:00 https://pharmadispatch.com/news/carina-biotech-licenses-german-technology-for-car-t 2021-12-16T09:11:01+11:00 https://pharmadispatch.com/news/qimr-berghofer-attracts-support-for-potential-multiple-sclerosis 2021-12-16T09:10:01+11:00 https://pharmadispatch.com/news/one-sector-publicly-calls-out-minister-as-reform-comes-up-agains 2021-12-16T04:00:01+11:00 https://pharmadispatch.com/news/wesfarmers-moves-to-block-woolworths-bid-for-api 2021-12-16T04:00:01+11:00 https://pharmadispatch.com/news/executive-changes-at-mtpconnect 2021-12-16T04:00:01+11:00 https://pharmadispatch.com/news/better-access-australia-welcomes-inquiry-report-podcast 2021-12-16T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-december-2021-1 2021-12-16T04:00:01+11:00 https://pharmadispatch.com/news/a-year-of-significant-giving-for-viatris-and-its-australian-empl 2021-12-15T15:07:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-december-2021 2021-12-15T04:00:01+11:00 https://pharmadispatch.com/news/csl-confirms-164-billion-takeover-of-swiss-company-vifor-pharma 2021-12-15T04:00:01+11:00 https://pharmadispatch.com/news/csl-still-planning-mrna-and-could-go-outside-australia 2021-12-14T17:28:01+11:00 https://pharmadispatch.com/news/amgens-ian-noble-if-it-doesnt-get-measured-it-doesnt-get-done 2021-12-14T16:00:01+11:00 https://pharmadispatch.com/news/biointelect-announces-the-appointment-of-former-ma-board-member 2021-12-14T05:03:01+11:00 https://pharmadispatch.com/news/mercks-josie-downey-talks-leadership-and-the-need-for-outcomes 2021-12-14T04:00:01+11:00 https://pharmadispatch.com/news/budget-update-should-provide-more-detail-on-new-pbs-pricing 2021-12-14T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-14-december-2021 2021-12-14T04:00:01+11:00 https://pharmadispatch.com/news/csl-and-vifor-pharma-confirm-discussions-over-potential-transact 2021-12-14T04:00:01+11:00 https://pharmadispatch.com/news/seqirus-confirms-extended-indication-for-cell-based-flu-vaccine 2021-12-14T04:00:01+11:00 https://pharmadispatch.com/news/federal-government-launches-new-national-preventive-health-strat 2021-12-13T15:16:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-13-december-2021 2021-12-13T04:00:01+11:00 https://pharmadispatch.com/news/accc-extended-pandemic-authorisation-on-medicine-supply 2021-12-13T04:00:01+11:00 https://pharmadispatch.com/news/ma-announces-continuing-education-program-awards 2021-12-12T11:01:01+11:00 https://pharmadispatch.com/news/biljana-naumovic-on-political-will-and-the-need-for-change 2021-12-12T10:44:01+11:00 https://pharmadispatch.com/news/apparently-australias-national-medicines-policy-does-not-need-a- 2021-12-12T04:00:01+11:00 https://pharmadispatch.com/news/nz-regulator-approves-trikafta-as-pbac-considers-the-therapy-tod 2021-12-10T04:22:01+11:00 https://pharmadispatch.com/news/abbvie-announces-winner-of-inaugural-immunology-research-award 2021-12-10T04:04:01+11:00 https://pharmadispatch.com/news/transformational-research-recognised-with-gsk-award-for-research 2021-12-10T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-10-december-2021 2021-12-10T04:00:01+11:00 https://pharmadispatch.com/news/sorry-professor-kidd-but-you-do-not-get-to-say-that 2021-12-10T03:00:01+11:00 https://pharmadispatch.com/news/nz-regulator-approves-trikafta-as-pbac-considers-the-therapy-tod 2021-12-10T03:00:01+11:00 https://pharmadispatch.com/news/resapp-health-establishes-covid-19-scientific-advisory-board 2021-12-09T05:49:01+11:00 https://pharmadispatch.com/news/emyria-announces-positive-initial-mdma-analogue-screening-and-pa 2021-12-09T05:48:01+11:00 https://pharmadispatch.com/news/recce-pharmaceuticals-update-on-clinical-trial-of-burn-wound-inf 2021-12-09T05:47:01+11:00 https://pharmadispatch.com/news/change-in-leadership-for-cochlear-north-america 2021-12-09T05:46:01+11:00 https://pharmadispatch.com/news/telix-in-licences-novel-tumour-microenvironment-pet-tracer 2021-12-09T05:44:01+11:00 https://pharmadispatch.com/news/austcyber-backs-decentralised-solution-for-confidential-health-d 2021-12-09T05:43:01+11:00 https://pharmadispatch.com/news/montefiore-adopts-smart-wfms-automated-workforce-app 2021-12-09T05:42:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-impact-of-pandemic-on-self-care 2021-12-09T05:41:01+11:00 https://pharmadispatch.com/news/pha-says-it-will-be-taking-a-more-active-role-in-providing-data- 2021-12-09T05:40:01+11:00 https://pharmadispatch.com/news/pfizer-and-biontech-provide-an-update-on-the-omicron-variant 2021-12-09T04:54:01+11:00 https://pharmadispatch.com/news/nz-patient-groups-slams-pharmac-and-says-delays-have-cost-lives 2021-12-09T04:00:01+11:00 https://pharmadispatch.com/news/women-in-medicine-make-substantially-less-than-men-of-any-colour 2021-12-09T04:00:01+11:00 https://pharmadispatch.com/news/us-based-industry-rejects-biden-remarks-on-prescription-drug-ref 2021-12-09T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-9-december-2021-2 2021-12-09T04:00:01+11:00 https://pharmadispatch.com/news/emerging-manufacturing-investment-as-ma-calls-for-commitment-on- 2021-12-09T04:00:01+11:00 https://pharmadispatch.com/news/that-makes-20-million-every-week-for-250-weeks-for-new-pbs-listi 2021-12-08T04:00:01+11:00 https://pharmadispatch.com/news/dr-brendan-shaw-australians-now-understand-there-is-a-queue-for- 2021-12-08T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-december-2021 2021-12-08T04:00:01+11:00 https://pharmadispatch.com/news/value-of-australian-company-surges-on-late-stage-trial-result 2021-12-08T04:00:01+11:00 https://pharmadispatch.com/news/closing-the-gap-between-public-pronouncements-and-reality 2021-12-07T04:00:01+11:00 https://pharmadispatch.com/news/gsks-patrick-desbiens-looking-to-support-industry-push-for-chang 2021-12-07T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-7-december-2021 2021-12-07T04:00:01+11:00 https://pharmadispatch.com/news/organons-luke-cornish-on-having-seats-at-the-right-policy-tables 2021-12-07T04:00:01+11:00 https://pharmadispatch.com/news/organon-joins-gbmas-biosimilar-member-tier 2021-12-07T04:00:01+11:00 https://pharmadispatch.com/news/new-zealand-secures-60000-doses-of-pfizers-covid-19-treatment 2021-12-06T15:16:01+11:00 https://pharmadispatch.com/news/australians-should-be-the-first-in-the-world-to-access-new-medic 2021-12-06T04:00:01+11:00 https://pharmadispatch.com/news/patients-need-us-to-overcome-any-shyness-on-making-the-case-for- 2021-12-06T04:00:01+11:00 https://pharmadispatch.com/news/if-the-system-is-so-good-where-is-it-during-the-pandemic 2021-12-06T04:00:01+11:00 https://pharmadispatch.com/news/juvenile-arthritis-foundation-australia-welcomes-new-parliamenta 2021-12-06T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-6-december-2021 2021-12-06T04:00:01+11:00 https://pharmadispatch.com/news/december-intracycle-agenda-confirms-cystic-fibrosis-therapies 2021-12-06T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-3-december-2021 2021-12-03T04:00:01+11:00 https://pharmadispatch.com/news/independent-review-delivers-scathing-assessment-of-new-zealands- 2021-12-03T04:00:01+11:00 https://pharmadispatch.com/news/jj-backs-community-led-covid-19-response-for-nt-communities 2021-12-03T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-marks-international-day-of-people-with-disability 2021-12-03T04:00:01+11:00 https://pharmadispatch.com/news/pharmaceutical-sector-acknowledges-retiring-health-minister 2021-12-03T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-exercises-ministerial-powers-to-extend-art-access 2021-12-03T04:00:01+11:00 https://pharmadispatch.com/news/the-things-you-can-learn-in-15-minutes-the-power-of-parliamentar 2021-12-02T13:16:01+11:00 https://pharmadispatch.com/news/woolworths-makes-a-late-move-for-pharmaceutical-wholesaler 2021-12-02T10:46:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-2-december-2021 2021-12-02T04:00:01+11:00 https://pharmadispatch.com/news/guild-restates-concern-over-out-of-pocket-costs 2021-12-02T04:00:01+11:00 https://pharmadispatch.com/news/final-day-of-parliament-for-2021-for-pbs-changes-set-for-debate 2021-12-02T03:00:01+11:00 https://pharmadispatch.com/news/a-strange-end-to-the-strangest-of-strange-weeks 2021-12-02T03:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-1-december-2021 2021-12-01T03:00:01+11:00 https://pharmadispatch.com/news/industry-backed-study-shows-impact-of-price-controls-on-innovati 2021-12-01T03:00:01+11:00 https://pharmadispatch.com/news/cost-recovery-update-reveals-lower-expenses-and-revenue 2021-12-01T03:00:01+11:00 https://pharmadispatch.com/news/the-senate-is-now-the-final-hurdle-for-pbs-changes 2021-12-01T03:00:01+11:00 https://pharmadispatch.com/news/mas-liz-de-somer-responds-to-the-parliamentary-inquiry-report-an 2021-11-30T15:51:01+11:00 https://pharmadispatch.com/news/atomo-diagnostics-teams-up-with-afao-on-self-test 2021-11-30T12:12:01+11:00 https://pharmadispatch.com/news/leadership-in-healthcare-quality-and-safety-recognised 2021-11-30T12:11:01+11:00 https://pharmadispatch.com/news/bupa-launches-extras-choice-with-new-flextras 2021-11-30T12:09:01+11:00 https://pharmadispatch.com/news/resapp-receives-first-regulatory-approvals-for-cough-counter-sma 2021-11-30T12:07:01+11:00 https://pharmadispatch.com/news/q-sera-announces-agreement-with-terumo-for-rapclot-in-japan 2021-11-30T12:07:01+11:00 https://pharmadispatch.com/news/emyria-appoints-experienced-executive-to-its-board 2021-11-30T12:05:01+11:00 https://pharmadispatch.com/news/victoria-produces-australias-first-mrna-covid-19-vaccine-candida 2021-11-30T12:04:01+11:00 https://pharmadispatch.com/news/new-bard1-exosome-liquid-biopsy-agreement-with-griffith-universi 2021-11-30T12:03:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-30-november-2021 2021-11-30T04:00:01+11:00 https://pharmadispatch.com/news/pbs-bill-hits-ivermectin-roadblock-and-senate-raises-separate-co 2021-11-30T04:00:01+11:00 https://pharmadispatch.com/news/beigenes-adam-roach-looking-to-change-the-conversation 2021-11-29T13:24:01+11:00 https://pharmadispatch.com/news/no-other-patients-are-subject-to-this-type-of-discrimination 2021-11-29T11:01:01+11:00 https://pharmadispatch.com/news/labor-planning-to-back-government-move-on-higher-prescription-co 2021-11-29T04:00:01+11:00 https://pharmadispatch.com/news/extended-listing-for-abbvies-australian-innovation 2021-11-29T04:00:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-progresses-its-reconciliation-action-plan 2021-11-29T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-29-november-2021 2021-11-29T04:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-alarm-over-higher-out-of-pocket-costs 2021-11-29T04:00:01+11:00 https://pharmadispatch.com/news/extending-the-cso-would-be-better-than-increasing-patient-costs 2021-11-29T04:00:01+11:00 https://pharmadispatch.com/news/patient-group-calls-for-more-consultation-on-pbs-price-changes 2021-11-26T04:00:01+11:00 https://pharmadispatch.com/news/new-reports-outlines-the-rights-and-roles-of-australian-cancer-p 2021-11-26T04:00:01+11:00 https://pharmadispatch.com/news/future-proofing-australias-workplaces-and-cities-from-covid-19-r 2021-11-26T04:00:01+11:00 https://pharmadispatch.com/news/stakeholders-respond-to-the-parliamentary-inquiry-report 2021-11-26T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-26-november-2021 2021-11-26T04:00:01+11:00 https://pharmadispatch.com/news/labors-mike-freelander-tables-petition-calling-for-action-on-cf- 2021-11-26T04:00:01+11:00 https://pharmadispatch.com/news/researchers-find-new-target-to-combat-lung-disease 2021-11-25T18:03:01+11:00 https://pharmadispatch.com/news/biotrons-bit225-effective-against-covid-19-in-animal-study 2021-11-25T18:02:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-stress-about-holiday-season-after-a-bad-year 2021-11-25T18:00:01+11:00 https://pharmadispatch.com/news/nib-announces-investment-in-digital-health-start-up 2021-11-25T17:59:01+11:00 https://pharmadispatch.com/news/private-hospitals-working-to-address-elective-surgery-backlog 2021-11-25T17:58:01+11:00 https://pharmadispatch.com/news/dr-rachel-david-apra-report-reveals-risks-to-australias-health-s 2021-11-25T17:57:01+11:00 https://pharmadispatch.com/news/latest-statistical-update-triggers-renewed-debate-over-pl-reform 2021-11-25T17:56:01+11:00 https://pharmadispatch.com/news/the-zimmerman-inquiry-the-good-the-not-so-good-and-what-now 2021-11-25T16:01:01+11:00 https://pharmadispatch.com/news/report-delivers-some-good-amongst-contradictions-more-process-re 2021-11-25T10:00:01+11:00 https://pharmadispatch.com/news/parliamentary-inquiry-on-approval-processes-the-31-recommendatio 2021-11-25T08:30:01+11:00 https://pharmadispatch.com/news/labor-senator-wants-action-on-extending-access-to-prostate-cance 2021-11-25T04:00:01+11:00 https://pharmadispatch.com/news/the-government-does-not-need-new-laws-to-fix-medicine-shortages 2021-11-25T04:00:01+11:00 https://pharmadispatch.com/news/stakeholders-waiting-with-inquiry-report-set-to-be-tabled 2021-11-25T04:00:01+11:00 https://pharmadispatch.com/news/key-biosimilar-and-weight-loss-therapy-headline-march-agenda 2021-11-25T04:00:01+11:00 https://pharmadispatch.com/news/official-reopening-of-biologics-manufacturing-facility-in-adelai 2021-11-25T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-25-november-2021-1 2021-11-24T20:24:01+11:00 https://pharmadispatch.com/news/rare-cancers-richard-vines-time-to-get-real-about-patient-centri 2021-11-24T17:41:01+11:00 https://pharmadispatch.com/news/discretion-on-100-items-is-not-the-same-as-discretion-on-100-dru 2021-11-24T04:00:01+11:00 https://pharmadispatch.com/news/janssen-planning-submission-for-pbs-listing-of-nasal-spray 2021-11-24T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-24-november-2021-2 2021-11-24T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-pasteur-supported-forum-to-tackle-vaccine-hesitancy 2021-11-24T04:00:01+11:00 https://pharmadispatch.com/news/nps-contract-set-to-expire-with-renewal-negotiations-yet-to-comm 2021-11-24T04:00:01+11:00 https://pharmadispatch.com/news/trajan-acquires-german-based-manufacturing-company 2021-11-23T10:29:01+11:00 https://pharmadispatch.com/news/study-investigating-new-treatment-for-pancreatic-cancer-1 2021-11-23T10:29:01+11:00 https://pharmadispatch.com/news/race-oncology-announces-chemotherapy-heart-protection-data 2021-11-23T10:27:01+11:00 https://pharmadispatch.com/news/csls-new-headquarters-will-be-home-to-biotech-incubator 2021-11-23T10:26:01+11:00 https://pharmadispatch.com/news/study-investigating-new-treatment-for-pancreatic-cancer 2021-11-23T08:56:01+11:00 https://pharmadispatch.com/news/hcf-announces-record-member-growth-in-2021 2021-11-23T08:55:01+11:00 https://pharmadispatch.com/news/icon-group-secures-new-investor-to-support-growth 2021-11-23T08:00:01+11:00 https://pharmadispatch.com/news/the-thing-about-ministerial-discretion-is-that-it-is-discretiona 2021-11-23T04:00:01+11:00 https://pharmadispatch.com/news/sanofis-kadmon-confirms-tga-approval-of-new-treatment 2021-11-23T04:00:01+11:00 https://pharmadispatch.com/news/pbs-pricing-framework-means-higher-out-of-pocket-costs-for-milli 2021-11-23T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-23-november-2021 2021-11-23T04:00:01+11:00 https://pharmadispatch.com/news/new-senior-public-affairs-and-finance-appointments-for-beigene 2021-11-23T04:00:01+11:00 https://pharmadispatch.com/news/enabling-legislation-scheduled-for-consideration-on-wednesday 2021-11-22T04:00:01+11:00 https://pharmadispatch.com/news/opposing-scrutiny-is-denyingpatients-and-the-industrys-own-histo 2021-11-22T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-another-listing-for-1-december 2021-11-22T04:00:01+11:00 https://pharmadispatch.com/news/new-analysis-reveals-potential-benefit-of-wider-access-to-cancer 2021-11-22T04:00:01+11:00 https://pharmadispatch.com/news/new-device-approved-for-the-treatment-of-drug-resistant-epilepsy 2021-11-22T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-22-november-2021 2021-11-22T04:00:01+11:00 https://pharmadispatch.com/news/nicole-cooper-we-have-to-do-better 2021-11-20T15:08:01+11:00 https://pharmadispatch.com/news/pharmac-to-switch-patients-to-biosimilar-brand-of-leading-biolog 2021-11-19T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-19-november-2021 2021-11-19T04:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-sanofis-new-therapy-for-pompe-disease 2021-11-19T04:00:01+11:00 https://pharmadispatch.com/news/world-antimicrobial-awareness-week 2021-11-18T10:56:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-announces-the-successful-completion-of-key-tran 2021-11-18T08:55:01+11:00 https://pharmadispatch.com/news/pharmaxis-announces-placement-and-share-purchase-plan 2021-11-18T08:54:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-closes-ipo-with-asx-listing-next-week 2021-11-18T08:53:01+11:00 https://pharmadispatch.com/news/new-report-highlights-lack-of-progress-on-rare-disease-funding-g 2021-11-18T04:00:01+11:00 https://pharmadispatch.com/news/new-report-reveals-extent-of-new-zealands-medicines-access-gap 2021-11-18T04:00:01+11:00 https://pharmadispatch.com/news/new-pbs-pricing-framework-to-protect-the-humans-rights-of-austri 2021-11-18T04:00:01+11:00 https://pharmadispatch.com/news/labor-urges-medical-device-sector-to-get-involved-in-hta-review 2021-11-18T04:00:01+11:00 https://pharmadispatch.com/news/alexions-sara-trafford-jones-says-willingness-is-the-key-to-driv 2021-11-18T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-18-november-2021 2021-11-18T04:00:01+11:00 https://pharmadispatch.com/news/is-the-department-of-health-preparing-to-backflip-on-submissions 2021-11-18T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-17-november-2021 2021-11-17T04:00:01+11:00 https://pharmadispatch.com/news/department-clarifies-application-of-rapid-health-technology-asse 2021-11-17T04:00:01+11:00 https://pharmadispatch.com/news/bayer-employee-challenge-leads-to-35000-charity-donation 2021-11-17T04:00:01+11:00 https://pharmadispatch.com/news/australia-company-announces-new-study-supply-agreement-for-pd-l1 2021-11-17T04:00:01+11:00 https://pharmadispatch.com/news/companies-still-pushing-for-parliamentary-scrutiny-of-price-cut- 2021-11-17T04:00:01+11:00 https://pharmadispatch.com/news/telix-pharmaceuticals-says-first-australian-patient-doses-in-glo 2021-11-16T19:37:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-confirms-presentation-of-abstracts-with-ph 2021-11-16T19:36:01+11:00 https://pharmadispatch.com/news/pharmaust-expands-studies-into-new-zealand 2021-11-16T19:35:01+11:00 https://pharmadispatch.com/news/orthocell-shoulder-tendon-study-database-lock 2021-11-16T19:34:01+11:00 https://pharmadispatch.com/news/us-company-ginkgo-bioworks-plan-to-grow-mrna-in-victoria 2021-11-16T19:32:01+11:00 https://pharmadispatch.com/news/australian-unity-releases-its-first-ever-impact-report 2021-11-16T19:31:01+11:00 https://pharmadispatch.com/news/medibank-announces-rewards-for-customers-doing-at-home-skin-chec 2021-11-16T19:29:01+11:00 https://pharmadispatch.com/news/medical-device-sector-launches-protect-patient-choice-campaign 2021-11-16T19:28:01+11:00 https://pharmadispatch.com/news/the-challenge-is-uncertainty-is-not-new-just-this-version-of-it 2021-11-16T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-november-2021 2021-11-16T04:00:01+11:00 https://pharmadispatch.com/news/novartis-says-pull-back-the-curtains-and-let-patients-in 2021-11-16T04:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-says-review-must-go-beyond-technical-methodo 2021-11-16T04:00:01+11:00 https://pharmadispatch.com/news/arrotex-launches-covid-19-rapid-antigen-testing-service 2021-11-16T04:00:01+11:00 https://pharmadispatch.com/news/hta-review-should-start-with-recognition-it-is-highly-contested- 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/john-alexander-thanks-bennelong-forum-after-announcing-political 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/public-affairs-firm-creates-standalone-health-practice 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/december-listing-means-new-option-for-rare-cancer-patients 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/pbac-to-pilot-patient-group-attendance-at-meetings 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/demand-for-additional-data-holding-up-cystic-fibrosis-therapy 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-releases-new-ten-year-national-diabetes-strategy 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-november-2021 2021-11-15T04:00:01+11:00 https://pharmadispatch.com/news/illumina-opens-new-laboratory-to-support-local-innovation 2021-11-12T10:04:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-12-november-2021 2021-11-12T04:00:01+11:00 https://pharmadispatch.com/news/nps-wants-special-standing-in-revised-national-medicines-policy- 2021-11-11T20:32:01+11:00 https://pharmadispatch.com/news/gilead-calls-for-a-shared-vision-and-modernisation-of-national-m 2021-11-11T20:32:01+11:00 https://pharmadispatch.com/news/no-framework-for-ministerial-discretion-until-december-2022-1 2021-11-11T20:32:01+11:00 https://pharmadispatch.com/news/experienced-researcher-and-us-executive-for-arovella-therapeutic 2021-11-11T08:51:01+11:00 https://pharmadispatch.com/news/immuron-restarts-clinical-development-program 2021-11-11T08:50:01+11:00 https://pharmadispatch.com/news/nirtek-begins-rd-collaboration-with-ttra-funding-support 2021-11-11T08:49:01+11:00 https://pharmadispatch.com/news/bupa-encourages-action-on-dental-and-optical-appointments 2021-11-11T07:57:01+11:00 https://pharmadispatch.com/news/medibank-launches-new-product-that-gives-customers-extras-choice 2021-11-11T07:56:01+11:00 https://pharmadispatch.com/news/members-health-calls-on-victoria-to-follow-nsw-and-end-private-h 2021-11-11T07:55:01+11:00 https://pharmadispatch.com/news/uk-industry-outlines-its-vision-for-the-future-of-regulation 2021-11-11T04:00:01+11:00 https://pharmadispatch.com/news/new-incubator-to-support-translation-of-local-innovation 2021-11-11T04:00:01+11:00 https://pharmadispatch.com/news/two-year-process-with-less-consultation-and-scrutiny-than-one-th 2021-11-11T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-11-november-2021 2021-11-11T04:00:01+11:00 https://pharmadispatch.com/news/a-direct-response-to-the-consequences-of-failing-to-consult 2021-11-11T04:00:01+11:00 https://pharmadispatch.com/news/new-campaign-to-raise-awareness-of-genetic-testing 2021-11-10T04:00:01+11:00 https://pharmadispatch.com/news/price-cut-list-exists-but-the-government-keeping-it-secret 2021-11-10T04:00:01+11:00 https://pharmadispatch.com/news/this-system-is-really-struggling-when-patient-input-is-contingen 2021-11-10T04:00:01+11:00 https://pharmadispatch.com/news/us-fda-clears-pharmaxis-trial-of-pxs5505-in-liver-cancer 2021-11-10T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-10-november-2021 2021-11-10T04:00:01+11:00 https://pharmadispatch.com/news/microbiome-discovery-could-help-save-kids-hearing 2021-11-09T17:27:01+11:00 https://pharmadispatch.com/news/clinuvel-pharmaceuticals-expands-pharmaceutical-portfolio 2021-11-09T17:25:01+11:00 https://pharmadispatch.com/news/uk-preferred-supplier-status-for-australian-ai-company-artrya 2021-11-09T08:12:01+11:00 https://pharmadispatch.com/news/bupa-foundation-announces-funding-for-new-partners 2021-11-09T08:11:01+11:00 https://pharmadispatch.com/news/circuitwise-leader-on-the-passion-of-local-manufacturing 2021-11-09T08:10:01+11:00 https://pharmadispatch.com/news/nib-expands-in-new-zealand-with-acquisition-of-kiwi-insurance 2021-11-09T08:09:01+11:00 https://pharmadispatch.com/news/no-pbac-in-covid-19-decision-making-but-a-form-of-hta-applied 2021-11-09T04:00:01+11:00 https://pharmadispatch.com/news/bio-joins-phrma-in-slamming-us-drug-pricing-compromise 2021-11-09T04:00:01+11:00 https://pharmadispatch.com/news/parliamentary-scrutiny-is-the-best-chance-for-a-good-outcome-on- 2021-11-09T04:00:01+11:00 https://pharmadispatch.com/news/wesfarmers-wins-the-race-for-pharmaceutical-wholesaler 2021-11-09T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-9-november-2021 2021-11-09T04:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-announces-the-appointment-of-new-chair 2021-11-08T09:53:01+11:00 https://pharmadispatch.com/news/pfizer-welcomes-another-potential-game-changer-in-fight-against- 2021-11-08T04:00:01+11:00 https://pharmadispatch.com/news/national-recognition-for-emerging-patient-support-group 2021-11-08T04:00:01+11:00 https://pharmadispatch.com/news/wesfarmers-in-the-box-seat-for-api-after-sigma-withdraws 2021-11-08T04:00:01+11:00 https://pharmadispatch.com/news/parliamentary-scrutiny-is-the-only-opportunity-stakeholders-have 2021-11-08T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-november-2021 2021-11-08T04:00:01+11:00 https://pharmadispatch.com/news/novartis-to-sell-its-one-third-stake-in-roche 2021-11-05T05:42:01+11:00 https://pharmadispatch.com/news/tgas-nz-webinar-misses-on-surge-in-teenage-nicotine-vaping 2021-11-05T04:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-publication-of-nmp-review-stakeholder-submissions 2021-11-05T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-5-november-2021 2021-11-05T04:00:01+11:00 https://pharmadispatch.com/news/approval-for-telix-pharmaceuticals-illuccix-for-prostate-cancer 2021-11-05T04:00:01+11:00 https://pharmadispatch.com/news/save-the-date-biopharmadispatch-conference-2022 2021-11-05T04:00:01+11:00 https://pharmadispatch.com/news/new-research-reveals-increased-use-of-childrens-mental-health-se 2021-11-04T08:13:01+11:00 https://pharmadispatch.com/news/teachers-health-announces-premium-freeze-and-extras-rollover 2021-11-04T08:11:01+11:00 https://pharmadispatch.com/news/nib-foundation-commits-750000-to-lifeline-for-mental-health-supp 2021-11-04T08:10:01+11:00 https://pharmadispatch.com/news/ma-wants-action-on-occasional-inappropriate-outcomes 2021-11-04T04:00:01+11:00 https://pharmadispatch.com/news/pbs-decision-making-is-and-always-has-been-based-on-wide-ministe 2021-11-04T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-4-november-2021 2021-11-04T04:00:01+11:00 https://pharmadispatch.com/news/phrma-slams-compromise-on-prescription-medicine-pricing-reform 2021-11-04T04:00:01+11:00 https://pharmadispatch.com/news/stakeholder-groups-join-the-push-to-make-submissions-public 2021-11-04T04:00:01+11:00 https://pharmadispatch.com/news/an-incredible-and-extreme-case-of-cognitive-dissonance 2021-11-03T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-3-november-2021 2021-11-03T04:00:01+11:00 https://pharmadispatch.com/news/department-of-health-will-not-release-nmp-review-submissions 2021-11-03T04:00:01+11:00 https://pharmadispatch.com/news/advocacy-group-acts-on-failure-to-publish-nmp-review-submissions 2021-11-03T04:00:01+11:00 https://pharmadispatch.com/news/imugene-announces-new-collaboration-with-eureka-therapeutics 2021-11-02T09:46:01+11:00 https://pharmadispatch.com/news/biotron-commences-two-new-clinical-trials-of-bit225-1 2021-11-02T09:45:01+11:00 https://pharmadispatch.com/news/us-fda-clears-bionomics-new-clinical-trial-of-bnc210 2021-11-02T09:45:01+11:00 https://pharmadispatch.com/news/biotron-commences-two-new-clinical-trials-of-bit225 2021-11-02T09:43:01+11:00 https://pharmadispatch.com/news/antisense-therapeutics-advances-development-with-capital-raise 2021-11-02T09:42:01+11:00 https://pharmadispatch.com/news/bupas-new-benefit-pocket-app-offers-health-and-wellbeing-rewards 2021-11-02T09:38:01+11:00 https://pharmadispatch.com/news/nib-says-half-of-sponsorship-now-committed-to-womens-sport 2021-11-02T09:38:01+11:00 https://pharmadispatch.com/news/medical-device-sector-calls-for-immediate-return-of-deferred-cla 2021-11-02T09:36:01+11:00 https://pharmadispatch.com/news/glenys-beauchamp-on-the-importance-of-a-wider-narrative 2021-11-02T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-2-november-2021 2021-11-02T04:00:01+11:00 https://pharmadispatch.com/news/future-of-dispensing-paper-a-pointless-fight-at-the-wrong-time 2021-11-02T04:00:01+11:00 https://pharmadispatch.com/news/organon-australia-and-nz-certified-as-a-family-inclusive-workpla 2021-11-02T04:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-acknowledges-and-thanks-outgoing-chair 2021-11-02T04:00:01+11:00 https://pharmadispatch.com/news/global-biosimilars-industry-calls-for-action-on-expanding-use 2021-11-01T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-a-goal-without-a-plan-is-but-a-wish 2021-11-01T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-additional-november-listings 2021-11-01T04:00:01+11:00 https://pharmadispatch.com/news/new-business-unit-directors-for-bristol-myers-squibb-australia 2021-11-01T04:00:01+11:00 https://pharmadispatch.com/news/pandemic-drives-notable-decrease-in-average-approval-times 2021-11-01T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-1-november-2021 2021-11-01T04:00:01+11:00 https://pharmadispatch.com/news/public-summary-document-reveals-another-addendum-for-cystic-fibr 2021-11-01T04:00:01+11:00 https://pharmadispatch.com/news/rare-disorders-nz-invited-to-present-at-a-united-nations-event 2021-10-29T04:00:01+11:00 https://pharmadispatch.com/news/mark-butler-on-the-hunger-people-have-for-change-in-this-area 2021-10-29T04:00:01+11:00 https://pharmadispatch.com/news/anne-harris-the-pandemic-has-been-a-lesson-on-supply-chain-compl 2021-10-29T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-29-october-2021-1 2021-10-29T04:00:01+11:00 https://pharmadispatch.com/news/quits-sarah-white-these-are-not-healthcare-companies 2021-10-29T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-tables-new-pbs-pricing-framework-in-parliament 2021-10-29T04:00:01+11:00 https://pharmadispatch.com/news/pharmac-says-it-wants-to-fund-vertexs-trikafta-for-cystic-fibros 2021-10-28T04:00:01+11:00 https://pharmadispatch.com/news/officials-confirm-over-15-months-of-dialogue-on-legality-of-arra 2021-10-28T04:00:01+11:00 https://pharmadispatch.com/news/government-cannot-pick-and-choose-the-laws-that-apply-to-its-dec 2021-10-28T04:00:01+11:00 https://pharmadispatch.com/news/ma-sets-path-for-new-directors-and-announces-new-advisory-counci 2021-10-28T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-28-october-2021 2021-10-28T04:00:01+11:00 https://pharmadispatch.com/news/life-sciences-highest-achievers-awarded-with-prestigious-industr 2021-10-27T19:55:01+11:00 https://pharmadispatch.com/news/two-australian-scientists-secure-csl-centenary-fellowships 2021-10-27T19:53:01+11:00 https://pharmadispatch.com/news/bupa-aiming-to-be-a-net-zero-business-by-2040 2021-10-27T08:53:01+11:00 https://pharmadispatch.com/news/medibank-lockdowns-are-ending-but-the-impacts-are-not 2021-10-27T08:52:01+11:00 https://pharmadispatch.com/news/new-medicare-rebates-for-bowel-inflammation-testing 2021-10-27T08:52:01+11:00 https://pharmadispatch.com/news/starpharma-signs-distribution-agreement-for-antiviral-in-vietnam 2021-10-27T08:51:01+11:00 https://pharmadispatch.com/news/noxopharm-announces-patents-and-launch-of-new-trial 2021-10-27T08:50:01+11:00 https://pharmadispatch.com/news/chimeric-achieves-manufacturing-milestone-for-car-t 2021-10-27T08:49:01+11:00 https://pharmadispatch.com/news/this-is-what-two-decades-of-affordability-has-delivered-for-pati 2021-10-27T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-27-october-2021 2021-10-27T04:00:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-updates-on-sustainable-development 2021-10-27T04:00:01+11:00 https://pharmadispatch.com/news/final-foundation-stones-set-for-future-of-australian-regenerativ 2021-10-27T04:00:01+11:00 https://pharmadispatch.com/news/new-pbs-pricing-framework-one-step-closer-to-parliamentary-consi 2021-10-27T04:00:01+11:00 https://pharmadispatch.com/news/call-to-regain-momentum-towards-achieving-hcv-elimination 2021-10-26T04:00:01+11:00 https://pharmadispatch.com/news/gsk-to-launch-its-third-reconciliation-action-plan 2021-10-26T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-26-october-2021 2021-10-26T04:00:01+11:00 https://pharmadispatch.com/news/vertex-welcome-december-consideration-of-trikafta 2021-10-26T04:00:01+11:00 https://pharmadispatch.com/news/shift-responsibility-for-oversight-of-national-medicines-policy 2021-10-26T04:00:01+11:00 https://pharmadispatch.com/news/abbvie-and-australian-and-new-zealand-society-for-immunology-new 2021-10-26T04:00:01+11:00 https://pharmadispatch.com/news/msd-welcomes-new-approval-but-funding-required 2021-10-25T04:00:01+11:00 https://pharmadispatch.com/news/a-system-obsessed-with-avoiding-the-cost-of-treatment 2021-10-25T04:00:01+11:00 https://pharmadispatch.com/news/expanded-listing-for-lillys-breast-cancer-treatment 2021-10-25T04:00:01+11:00 https://pharmadispatch.com/news/national-medicines-policy-needs-to-be-clear-about-prioritising-p 2021-10-25T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-25-october-2021 2021-10-25T04:00:01+11:00 https://pharmadispatch.com/news/there-is-truth-untruth-and-deception 2021-10-22T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-22-october-2021-1 2021-10-22T04:00:01+11:00 https://pharmadispatch.com/news/new-south-wales-wants-to-lead-australia-on-mrna-manufacturing 2021-10-22T04:00:01+11:00 https://pharmadispatch.com/news/industry-comes-together-for-first-meeting-of-reconciliation-netw 2021-10-22T04:00:01+11:00 https://pharmadispatch.com/news/msac-to-consider-national-lung-cancer-screening-program 2021-10-21T04:00:01+11:00 https://pharmadispatch.com/news/savings-measure-contract-required-direct-to-consumer-promotion-o 2021-10-21T03:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-21-october-2021-1 2021-10-21T03:00:01+11:00 https://pharmadispatch.com/news/new-sanofi-pasteur-campaign-focused-on-withvaccines 2021-10-21T03:00:01+11:00 https://pharmadispatch.com/news/pbs-rebates-hit-record-level-in-2020-21 2021-10-21T03:00:01+11:00 https://pharmadispatch.com/news/updated-report-reveals-under-investigation-and-under-treatment-o 2021-10-21T03:00:01+11:00 https://pharmadispatch.com/news/another-mp-adds-voice-n-support-of-change-for-newborn-screening 2021-10-20T15:08:01+11:00 https://pharmadispatch.com/news/exclusive-documents-reveal-the-extent-of-government-astroturfing 2021-10-20T04:00:01+11:00 https://pharmadispatch.com/news/the-pay-gap-for-women-starts-with-a-responsibility-gap 2021-10-20T04:00:01+11:00 https://pharmadispatch.com/news/biomarins-kathryn-evans-talks-gender-leadership-and-the-pay-gap 2021-10-20T04:00:01+11:00 https://pharmadispatch.com/news/csl-in-new-partnership-to-advance-biologic-therapies 2021-10-20T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-20-october-2021 2021-10-20T04:00:01+11:00 https://pharmadispatch.com/news/hcf-to-return-66-million-of-claims-savings-to-customers 2021-10-19T08:05:01+11:00 https://pharmadispatch.com/news/jj-institute-removes-covid-barriers-to-surgical-training 2021-10-19T08:04:01+11:00 https://pharmadispatch.com/news/teachers-health-to-merge-with-nurses-and-midwives-health 2021-10-19T08:03:01+11:00 https://pharmadispatch.com/news/new-leadership-an-opportunity-to-start-again-on-transparency-and 2021-10-19T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-19-october-2021 2021-10-19T04:00:01+11:00 https://pharmadispatch.com/news/mps-call-for-action-to-fix-australias-newborn-screening-program 2021-10-19T04:00:01+11:00 https://pharmadispatch.com/news/novartis-says-considerable-work-required-before-gene-therapy-lis 2021-10-19T04:00:01+11:00 https://pharmadispatch.com/news/because-without-diagnosis-there-is-no-treatment 2021-10-18T04:00:01+11:00 https://pharmadispatch.com/news/pbac-recommends-the-first-gene-therapy-for-pbs-reimbursement 2021-10-18T04:00:01+11:00 https://pharmadispatch.com/news/msds-nicola-richards-we-need-to-clearly-define-and-measure-timel 2021-10-18T04:00:01+11:00 https://pharmadispatch.com/news/federal-government-secures-roche-and-pfizer-covid-19-treatments 2021-10-18T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-18-october-2021 2021-10-18T04:00:01+11:00 https://pharmadispatch.com/news/cell-therapies-appoints-pbac-member-to-its-board 2021-10-18T04:00:01+11:00 https://pharmadispatch.com/news/johnson-johnson-announces-support-for-indigenous-eye-health-prog 2021-10-15T04:04:01+11:00 https://pharmadispatch.com/news/new-position-paper-recommends-a-broader-base-to-fund-health 2021-10-15T04:00:01+11:00 https://pharmadispatch.com/news/recognition-for-bms-head-of-legal-and-compliance 2021-10-15T04:00:01+11:00 https://pharmadispatch.com/news/nicole-cooper-the-business-owner-patient-and-advocate-for-change 2021-10-15T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-october-2021 2021-10-15T04:00:01+11:00 https://pharmadispatch.com/news/prescient-therapeutics-presents-new-omnicar-data 2021-10-14T10:51:01+11:00 https://pharmadispatch.com/news/idt-announces-deal-with-monash-to-produce-mrna-vaccine-for-trial 2021-10-14T10:50:01+11:00 https://pharmadispatch.com/news/pharmaxis-doses-first-patient-in-phase-2-bone-marrow-cancer-tria 2021-10-14T10:49:01+11:00 https://pharmadispatch.com/news/30-million-investment-in-research-to-drive-better-health 2021-10-14T08:25:01+11:00 https://pharmadispatch.com/news/queenslands-largest-private-radiology-provider-uploads-reports-t 2021-10-14T08:19:01+11:00 https://pharmadispatch.com/news/nib-and-ing-become-partners-in-health 2021-10-14T08:18:01+11:00 https://pharmadispatch.com/news/global-vaccine-leader-announces-planned-retirement 2021-10-14T04:00:01+11:00 https://pharmadispatch.com/news/the-most-important-process-for-medicines-policy-in-two-decades 2021-10-14T04:00:01+11:00 https://pharmadispatch.com/news/fda-decides-to-ban-non-tobacco-e-cigarette-flavours 2021-10-14T04:00:01+11:00 https://pharmadispatch.com/news/government-looks-to-innovation-and-new-technologies-in-primary-h 2021-10-14T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-14-october-2021 2021-10-14T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-13-october-2021 2021-10-13T04:00:01+11:00 https://pharmadispatch.com/news/new-zealand-signs-deal-for-msds-covid-19-treatment 2021-10-13T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-launches-new-haemophilia-lived-experience-series 2021-10-13T04:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-gsk-and-another-vacancy-for-medicines-austral 2021-10-13T04:00:01+11:00 https://pharmadispatch.com/news/private-hospitals-call-for-new-pillar-in-national-medicines-poli 2021-10-13T04:00:01+11:00 https://pharmadispatch.com/news/paig-hosts-first-workshop-on-the-age-inclusive-workforce 2021-10-13T04:00:01+11:00 https://pharmadispatch.com/news/resapp-health-submits-premarket-notification-to-the-us-fda 2021-10-12T19:45:01+11:00 https://pharmadispatch.com/news/us-patent-granted-for-neurens-nnz-2591-in-autism 2021-10-12T19:44:01+11:00 https://pharmadispatch.com/news/oncosil-medical-appoints-new-non-executive-director 2021-10-12T19:44:01+11:00 https://pharmadispatch.com/news/gene-therapy-prevents-children-with-eye-disease-from-going-blind 2021-10-12T19:42:01+11:00 https://pharmadispatch.com/news/federal-government-launches-childrens-mental-health-strategy 2021-10-12T19:40:01+11:00 https://pharmadispatch.com/news/gmhba-mandates-covid-19-vaccine-for-all-employees 2021-10-12T19:39:01+11:00 https://pharmadispatch.com/news/bupa-to-return-120-million-in-savings-to-health-insurance-custom 2021-10-12T19:38:01+11:00 https://pharmadispatch.com/news/msac-recommends-funding-for-innovative-heart-valve-procedure 2021-10-12T19:37:01+11:00 https://pharmadispatch.com/news/australia-and-uk-counterparts-on-method-policy-and-process-revie 2021-10-12T04:00:01+11:00 https://pharmadispatch.com/news/announcing-the-possibility-of-extensions-after-the-deadline-has- 2021-10-12T04:00:01+11:00 https://pharmadispatch.com/news/would-it-be-better-to-shift-the-incentive-to-patients 2021-10-12T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-12-october-2021 2021-10-12T04:00:01+11:00 https://pharmadispatch.com/news/api-raises-guidance-as-it-manages-takeover-attempt-and-class-act 2021-10-12T04:00:01+11:00 https://pharmadispatch.com/news/pharmacy-college-scraps-relationship-with-tobacco-company 2021-10-12T04:00:01+11:00 https://pharmadispatch.com/news/beigene-welcomes-australian-approval-for-btk-inhibitor 2021-10-11T04:00:01+11:00 https://pharmadispatch.com/news/the-system-subordinates-the-pharmacists-choice-to-that-of-the-cl 2021-10-11T04:00:01+11:00 https://pharmadispatch.com/news/the-company-deserves-a-lot-better-treatment-than-this 2021-10-11T04:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-distances-itself-from-college-over-tobacco-traini 2021-10-11T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-11-october-2021-1 2021-10-11T04:00:01+11:00 https://pharmadispatch.com/news/lundbeck-and-otsuka-step-up-for-mental-health 2021-10-11T04:00:01+11:00 https://pharmadispatch.com/news/survey-reveals-extent-of-concern-of-medicines-access-in-nz 2021-10-10T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-october-2021 2021-10-08T04:00:01+11:00 https://pharmadispatch.com/news/submission-deadline-means-some-groups-contemplating-not-particip 2021-10-08T04:00:01+11:00 https://pharmadispatch.com/news/ucb-recognised-as-employer-of-choice 2021-10-08T04:00:01+11:00 https://pharmadispatch.com/news/australia-new-zealand-and-an-aligned-response-on-pfizer-approach 2021-10-08T04:00:01+11:00 https://pharmadispatch.com/news/emyria-to-participate-in-foundry-builders-program 2021-10-07T11:35:01+11:00 https://pharmadispatch.com/news/race-oncology-secures-new-us-patent-for-cancer-therapy 2021-10-07T11:34:01+11:00 https://pharmadispatch.com/news/adalta-announces-transfer-of-btb-funding-agreement-to-ad-214-inh 2021-10-07T11:33:01+11:00 https://pharmadispatch.com/news/immuron-will-not-proceed-with-acquisition-of-vaccine-company 2021-10-07T11:32:01+11:00 https://pharmadispatch.com/news/nib-launches-industry-first-247-voicebot-in-australia 2021-10-07T11:31:01+11:00 https://pharmadispatch.com/news/medibank-mandates-covid-19-vaccine-for-retail-and-office-employe 2021-10-07T11:29:01+11:00 https://pharmadispatch.com/news/is-the-australian-government-suffering-from-a-special-kind-of-co 2021-10-07T04:00:01+11:00 https://pharmadispatch.com/news/authorising-one-promotional-campaign-but-not-another 2021-10-07T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-7-october-2021 2021-10-07T04:00:01+11:00 https://pharmadispatch.com/news/vertex-pushing-for-december-consideration-of-resubmissions 2021-10-07T04:00:01+11:00 https://pharmadispatch.com/news/new-survey-highlights-the-need-for-support-for-childhood-cancer 2021-10-06T15:03:01+11:00 https://pharmadispatch.com/news/the-accc-is-holding-up-adoption-of-new-patent-notification-syste 2021-10-06T04:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-cleared-to-progress-to-phase-2-bone-marrow-cancer-tria 2021-10-06T04:00:01+11:00 https://pharmadispatch.com/news/opthea-opens-patient-recruitment-in-europe-for-pivotal-late-stag 2021-10-06T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-6-october-2021-2 2021-10-06T04:00:01+11:00 https://pharmadispatch.com/news/australian-pharmacy-say-a-definite-no-to-tobacco-companies-on-e- 2021-10-05T04:00:01+11:00 https://pharmadispatch.com/news/federal-government-secures-more-doses-of-gsk-covid-19-treatment 2021-10-05T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-to-announce-agreement-for-doses-of-msds-oral-antiviral 2021-10-05T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-5-october-2021 2021-10-05T04:00:01+11:00 https://pharmadispatch.com/news/going-to-have-a-snowballs-chance-in-hell-of-getting-through-ther 2021-10-05T04:00:01+11:00 https://pharmadispatch.com/news/every-stakeholder-should-question-this-apparent-double-standard 2021-10-05T04:00:01+11:00 https://pharmadispatch.com/news/ama-vice-president-calls-for-complete-ban-of-nicotine-e-cigarett 2021-10-01T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-1-october-2021 2021-10-01T04:00:01+10:00 https://pharmadispatch.com/news/accc-extends-pandemic-authorisation-for-ma-and-gbma 2021-10-01T04:00:01+10:00 https://pharmadispatch.com/news/appearance-of-growth-almost-inevitable-given-pricing-framework 2021-10-01T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-officials-regains-rights-to-rsv-treatment 2021-10-01T04:00:01+10:00 https://pharmadispatch.com/news/senate-committee-says-odtp-arrangements-currently-unlawful 2021-10-01T04:00:01+10:00 https://pharmadispatch.com/news/msd-to-acquire-acceleron-in-play-for-late-stage-cv-candidate 2021-10-01T04:00:01+10:00 https://pharmadispatch.com/news/government-announces-funding-for-genomics-and-cv-research 2021-09-30T15:41:01+10:00 https://pharmadispatch.com/news/nib-launches-pilot-program-providing-access-to-health-app 2021-09-30T15:40:01+10:00 https://pharmadispatch.com/news/chimeric-announces-abstract-presentations-to-global-meeting 2021-09-30T15:39:01+10:00 https://pharmadispatch.com/news/antisense-receives-positive-draft-opinion-on-atl1102-development 2021-09-30T15:38:01+10:00 https://pharmadispatch.com/news/new-paper-describes-biology-of-amplias-fak-inhibitor 2021-09-30T15:36:01+10:00 https://pharmadispatch.com/news/final-outcome-reveals-jump-in-topline-pharmaceutical-spend 2021-09-30T10:24:01+10:00 https://pharmadispatch.com/news/landmark-pbs-listings-to-reduce-the-cost-of-medicines-for-austra 2021-09-30T08:14:01+10:00 https://pharmadispatch.com/news/has-the-tga-just-legitimised-nicotine-e-cigarettes-as-a-health-p 2021-09-30T04:00:01+10:00 https://pharmadispatch.com/news/tga-advertising-nicotine-vaping-products-for-smoking-cessation-1 2021-09-30T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-30-september-2021 2021-09-30T04:00:01+10:00 https://pharmadispatch.com/news/csl-partners-with-university-on-advanced-manufacturing-initiativ 2021-09-30T04:00:01+10:00 https://pharmadispatch.com/news/tga-response-to-questions-on-nicotine-e-cigarettes 2021-09-30T04:00:01+10:00 https://pharmadispatch.com/news/leaders-have-a-crucial-but-simple-role-when-it-comes-to-gender-b 2021-09-29T04:00:01+10:00 https://pharmadispatch.com/news/atagi-members-concerned-over-prime-ministers-public-statements 2021-09-29T04:00:01+10:00 https://pharmadispatch.com/news/australian-company-launches-trial-of-new-covid-19-vaccine-platfo 2021-09-29T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-29-september-2021-2 2021-09-29T04:00:01+10:00 https://pharmadispatch.com/news/professor-david-thomas-on-precision-medicine-and-the-need-for-ch 2021-09-29T04:00:01+10:00 https://pharmadispatch.com/news/organon-expands-local-leadership-team 2021-09-29T04:00:01+10:00 https://pharmadispatch.com/news/new-milk-bank-established-in-queensland-for-premature-babies 2021-09-28T15:11:01+10:00 https://pharmadispatch.com/news/ama-push-for-easier-pathways-for-gps-to-work-in-their-local-hosp 2021-09-28T15:10:01+10:00 https://pharmadispatch.com/news/cso-competitor-is-the-latest-suitor-for-api 2021-09-28T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-28-september-2021 2021-09-28T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-push-for-co-pay-change-started-during-7cpa-negotiation 2021-09-28T04:00:01+10:00 https://pharmadispatch.com/news/ma-the-impact-of-failure-to-treat-needs-to-be-monitored 2021-09-28T04:00:01+10:00 https://pharmadispatch.com/news/they-are-all-adverse-medicine-events-that-impact-patients 2021-09-27T04:00:01+10:00 https://pharmadispatch.com/news/the-failure-to-treat-is-a-major-cause-of-adverse-events 2021-09-27T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-27-september-2021 2021-09-27T04:00:01+10:00 https://pharmadispatch.com/news/new-modelling-reveals-pandemic-impact-on-heart-risk 2021-09-27T04:00:01+10:00 https://pharmadispatch.com/news/guild-wants-action-on-medicine-affordability 2021-09-27T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-24-september-2021 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/tga-rushes-out-another-version-of-the-covid-19-advertising-autho 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/lockdown-driven-delay-hardly-cuts-it-for-pharmac-review-1 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/repurposing-treatments-for-covid-19-is-not-so-simple-1 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/amgen-mandates-covid-19-vaccine-for-in-field-staff-1 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-marks-30-years-of-humanitarian-program-1 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-welcomes-expanded-approval-for-forxiga-1 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-joins-industry-finding-to-government-backed-research- 2021-09-24T04:00:01+10:00 https://pharmadispatch.com/news/japanese-patent-for-imugenes-her-vaxx-immunotherapy 2021-09-23T18:53:01+10:00 https://pharmadispatch.com/news/a-new-board-chair-for-rhythm-biosciences 2021-09-23T18:52:01+10:00 https://pharmadispatch.com/news/victoria-funds-creation-of-health-innovation-centre-at-monash 2021-09-23T18:51:01+10:00 https://pharmadispatch.com/news/perth-cardiac-team-first-to-perform-new-procedure-for-severe-hea 2021-09-23T10:44:01+10:00 https://pharmadispatch.com/news/honeysuckle-health-buying-group-given-green-light-by-accc 2021-09-23T10:43:01+10:00 https://pharmadispatch.com/news/bupa-celebrates-customers-turning-to-technology-for-health-care 2021-09-23T10:42:01+10:00 https://pharmadispatch.com/news/comparison-services-delivered-one-quarter-of-sales-in-the-past-y 2021-09-23T10:41:01+10:00 https://pharmadispatch.com/news/making-the-case-for-change-is-not-undermining-anything-it-is-mak 2021-09-23T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-23-september-2021 2021-09-23T04:00:01+10:00 https://pharmadispatch.com/news/organon-looks-to-start-a-conversation-about-unplanned-pregnancy 2021-09-23T04:00:01+10:00 https://pharmadispatch.com/news/legislating-the-agreements-might-need-to-navigate-election-timin 2021-09-23T04:00:01+10:00 https://pharmadispatch.com/news/new-approval-for-specialised-therapeutics-lung-cancer-therapy 2021-09-23T04:00:01+10:00 https://pharmadispatch.com/news/might-it-be-the-right-time-for-another-more-important-review 2021-09-22T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-22-september-2021 2021-09-22T04:00:01+10:00 https://pharmadispatch.com/news/agreement-reveals-review-and-potential-change-on-pbs-cost-recove 2021-09-22T04:00:01+10:00 https://pharmadispatch.com/news/sigma-delivers-growth-but-lowers-forecast-due-to-pandemic 2021-09-22T04:00:01+10:00 https://pharmadispatch.com/news/gilead-mandates-covid-19-vaccine-for-its-australian-team 2021-09-22T04:00:01+10:00 https://pharmadispatch.com/news/australia-png-anti-venom-partnership-extended-for-another-two-ye 2021-09-21T16:15:01+10:00 https://pharmadispatch.com/news/medibank-says-no-gap-endoscopy-now-available-to-sydney-customers 2021-09-21T16:14:01+10:00 https://pharmadispatch.com/news/australian-innovation-focused-on-better-outcomes-in-stroke-1 2021-09-21T16:12:01+10:00 https://pharmadispatch.com/news/pha-submission-reiterates-commitment-to-supporting-transition-1 2021-09-21T16:11:01+10:00 https://pharmadispatch.com/news/researchers-identify-potential-cause-and-treatment-for-obesity-a 2021-09-21T16:10:01+10:00 https://pharmadispatch.com/news/certa-therapeutics-announces-new-clinical-trial-of-investigative 2021-09-21T16:08:01+10:00 https://pharmadispatch.com/news/bionomics-expands-clinical-trial-plan-for-bnc210 2021-09-21T16:06:01+10:00 https://pharmadispatch.com/news/astrazeneca-therapy-shows-significant-promise-in-breast-cancer 2021-09-21T04:00:01+10:00 https://pharmadispatch.com/news/launch-of-specialist-medical-education-website-for-car-t-cell-th 2021-09-21T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-21-september-2021 2021-09-21T04:00:01+10:00 https://pharmadispatch.com/news/new-research-reveals-risk-of-vaping-in-younger-people 2021-09-21T04:00:01+10:00 https://pharmadispatch.com/news/dr-brendan-shaw-ma-agreement-is-the-end-of-the-beginning 2021-09-21T04:00:01+10:00 https://pharmadispatch.com/news/this-law-was-not-delivered-by-moses-on-stone-tablets-and-it-can- 2021-09-20T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-20-september-2021 2021-09-20T04:00:01+10:00 https://pharmadispatch.com/news/the-challenge-of-not-accepting-a-narrow-and-pre-limited-review 2021-09-20T04:00:01+10:00 https://pharmadispatch.com/news/another-new-industry-minister-as-incumbent-resigns 2021-09-20T04:00:01+10:00 https://pharmadispatch.com/news/an-agreement-that-sets-a-strong-agenda-for-reform 2021-09-20T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-17-september-2021-1 2021-09-17T04:00:01+10:00 https://pharmadispatch.com/news/there-is-obviously-a-contemporary-and-common-sense-middle-ground 2021-09-17T04:00:01+10:00 https://pharmadispatch.com/news/ma-unites-with-ausbiotech-to-publicly-oppose-ip-waiver 2021-09-17T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-partners-with-industry-groups-on-vaccines 2021-09-17T04:00:01+10:00 https://pharmadispatch.com/news/australian-sites-and-patients-in-dry-amd-study 2021-09-17T04:00:01+10:00 https://pharmadispatch.com/news/members-health-says-waiting-lists-driving-membership-growth 2021-09-16T10:17:01+10:00 https://pharmadispatch.com/news/hcf-wins-product-rating-award-for-sixth-consecutive-year 2021-09-16T10:15:01+10:00 https://pharmadispatch.com/news/hcf-and-rt-health-to-merge-with-the-goal-of-strong-member-benefi 2021-09-16T10:14:01+10:00 https://pharmadispatch.com/news/emyria-expands-psychiatry-advisory-to-advance-psychedelic-assist 2021-09-16T10:13:01+10:00 https://pharmadispatch.com/news/new-publication-on-radiopharm-theranostics-rad201 2021-09-16T10:10:01+10:00 https://pharmadispatch.com/news/chimeric-appoints-new-experts-to-scientific-advisory-board 2021-09-16T10:09:01+10:00 https://pharmadispatch.com/news/australian-companys-covid-19-tests-approved-in-europe 2021-09-16T10:07:01+10:00 https://pharmadispatch.com/news/time-to-bring-medicine-advertising-laws-into-the-real-world 2021-09-16T04:00:01+10:00 https://pharmadispatch.com/news/study-highlights-the-impact-of-access-issues-on-nz-ms-patients 2021-09-16T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-september-2021 2021-09-16T04:00:01+10:00 https://pharmadispatch.com/news/this-scenario-provide-the-context-of-this-double-standard 2021-09-16T04:00:01+10:00 https://pharmadispatch.com/news/a-new-health-spokesperson-for-the-greens 2021-09-16T04:00:01+10:00 https://pharmadispatch.com/news/what-the-documents-reveal-on-tga-consideration-of-advertising 2021-09-15T04:00:01+10:00 https://pharmadispatch.com/news/documents-reveal-regulators-cover-up-of-unlawful-advertising 2021-09-15T04:00:01+10:00 https://pharmadispatch.com/news/capital-raise-for-prospection-to-support-further-expansion 2021-09-15T04:00:01+10:00 https://pharmadispatch.com/news/maybe-read-the-documents-before-they-are-released 2021-09-15T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-september-2021 2021-09-15T04:00:01+10:00 https://pharmadispatch.com/news/tga-registration-for-new-lung-cancer-therapy 2021-09-14T17:34:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-14-september-2021 2021-09-14T04:00:01+10:00 https://pharmadispatch.com/news/kyowa-kirin-marks-registration-of-xlh-treatment-but-focused-on-p 2021-09-14T04:00:01+10:00 https://pharmadispatch.com/news/accc-extends-npsa-authorisation-to-vaccine-distribution 2021-09-14T04:00:01+10:00 https://pharmadispatch.com/news/new-patient-focused-campaign-to-mark-world-atopic-eczema-day 2021-09-14T04:00:01+10:00 https://pharmadispatch.com/news/experts-map-post-jab-future-in-gsk-sponsored-panel-discussion 2021-09-14T04:00:01+10:00 https://pharmadispatch.com/news/mtaa-backs-call-for-a-national-summit-on-the-future-of-private-h 2021-09-13T14:26:01+10:00 https://pharmadispatch.com/news/international-reference-pricing-not-included-in-list-of-new-us-r 2021-09-13T09:21:01+10:00 https://pharmadispatch.com/news/companies-assess-price-cut-impact-and-look-ahead-to-april-2023 2021-09-13T04:00:01+10:00 https://pharmadispatch.com/news/what-ever-happened-to-the-immediate-and-permanent-removal-of-cos 2021-09-13T04:00:01+10:00 https://pharmadispatch.com/news/psds-reveal-minimal-progress-of-anticipated-therapies 2021-09-13T04:00:01+10:00 https://pharmadispatch.com/news/the-high-cost-to-hospitals-of-a-little-known-condition 2021-09-13T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-13-september-2021-1 2021-09-13T04:00:01+10:00 https://pharmadispatch.com/news/pha-reform-required-to-address-price-differential 2021-09-12T17:18:01+10:00 https://pharmadispatch.com/news/australian-unity-returning-6m-in-covid-19-savings-to-members 2021-09-12T17:17:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-10-september-2021-1 2021-09-10T04:00:01+10:00 https://pharmadispatch.com/news/vaccine-hesitancy-higher-in-rich-countries-than-developing-count 2021-09-10T04:00:01+10:00 https://pharmadispatch.com/news/what-a-pharmaceutical-product-campaign-looks-like-in-disrupted-t 2021-09-10T04:00:01+10:00 https://pharmadispatch.com/news/new-medical-lead-for-sanofi-australia-and-nz 2021-09-10T04:00:01+10:00 https://pharmadispatch.com/news/msd-collaborates-with-australian-institute-on-researcher-exchang 2021-09-10T04:00:01+10:00 https://pharmadispatch.com/news/lundbeck-marks-world-suicide-prevention-day 2021-09-09T17:18:01+10:00 https://pharmadispatch.com/news/adherium-receives-us-clearance-for-next-generation-sensor-with-p 2021-09-09T14:33:01+10:00 https://pharmadispatch.com/news/telix-japanese-prostate-cancer-imaging-study-completes-enrolment 2021-09-09T14:32:01+10:00 https://pharmadispatch.com/news/this-is-the-first-question-you-should-be-asking 2021-09-09T04:00:01+10:00 https://pharmadispatch.com/news/conditional-outcomes-might-be-the-red-flag-of-all-red-flags 2021-09-09T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-9-september-2021 2021-09-09T04:00:01+10:00 https://pharmadispatch.com/news/many-will-have-recognised-this-as-reflecting-everyday-reality 2021-09-09T04:00:01+10:00 https://pharmadispatch.com/news/australian-researchers-leading-in-the-development-of-new-mental- 2021-09-09T04:00:01+10:00 https://pharmadispatch.com/news/lung-foundation-urges-australians-to-act-on-persistent-cough 2021-09-08T04:00:01+10:00 https://pharmadispatch.com/news/industry-leaders-welcome-commitment-to-hta-review 2021-09-08T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-september-2021 2021-09-08T04:00:01+10:00 https://pharmadispatch.com/news/patients-groups-say-proper-patient-involvement-requires-real-cha 2021-09-08T04:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-merck-healthcare-australia-and-nz 2021-09-07T17:30:01+10:00 https://pharmadispatch.com/news/gbma-chair-new-agreement-reflects-the-new-global-supply-chain-re 2021-09-07T12:31:01+10:00 https://pharmadispatch.com/news/ma-chair-this-has-taken-a-village-and-i-think-change-does-take-a 2021-09-07T12:04:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-new-strategic-agreements-for-industry 2021-09-07T06:28:01+10:00 https://pharmadispatch.com/news/the-lesson-of-history-is-that-the-work-starts-now 2021-09-07T06:28:01+10:00 https://pharmadispatch.com/news/ma-delighted-at-the-agreements-really-ambitious-reform-agenda 2021-09-07T06:28:01+10:00 https://pharmadispatch.com/news/gbma-welcomes-new-era-in-securing-medicine-supply 2021-09-07T06:28:01+10:00 https://pharmadispatch.com/news/women-urged-to-consider-their-health-this-womens-health-week 2021-09-07T06:07:01+10:00 https://pharmadispatch.com/news/government-creates-mental-health-pop-up-clinics-across-new-south 2021-09-07T06:06:01+10:00 https://pharmadispatch.com/news/officials-confirm-a-busy-few-months-ahead-on-pl-reform 2021-09-07T06:05:01+10:00 https://pharmadispatch.com/news/dhl-expands-with-new-facilities-in-new-zealand 2021-09-07T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-7-september-2021 2021-09-07T04:00:01+10:00 https://pharmadispatch.com/news/official-admits-embarrassment-over-estimates-confusion 2021-09-06T04:00:01+10:00 https://pharmadispatch.com/news/evidence-of-why-advocacy-is-so-important-to-achieve-change 2021-09-06T04:00:01+10:00 https://pharmadispatch.com/news/pbac-in-lengthy-consideration-of-cystic-fibrosis-therapy 2021-09-06T04:00:01+10:00 https://pharmadispatch.com/news/provisional-approval-for-moderna-and-more-pfizer-doses-arrive 2021-09-06T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-6-september-2021-1 2021-09-06T04:00:01+10:00 https://pharmadispatch.com/news/new-leadership-is-an-opportunity-to-acknowledge-past-failings-an 2021-09-03T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-3-september-2021 2021-09-03T04:00:01+10:00 https://pharmadispatch.com/news/major-milestone-for-australias-covid-19-immunisation-program 2021-09-03T04:00:01+10:00 https://pharmadispatch.com/news/collaborations-produces-benchmark-reports-on-regenerative-medici 2021-09-03T04:00:01+10:00 https://pharmadispatch.com/news/multiple-additions-to-november-pbac-agenda 2021-09-03T04:00:01+10:00 https://pharmadispatch.com/news/orthocell-updates-on-shoulder-tendon-study 2021-09-02T14:05:01+10:00 https://pharmadispatch.com/news/victoria-recognises-andhealth-leader-for-outstanding-contributio 2021-09-02T14:04:01+10:00 https://pharmadispatch.com/news/carina-biotech-closes-financing-to-support-car-t-into-clinic 2021-09-02T14:03:01+10:00 https://pharmadispatch.com/news/neurens-us-partner-launches-new-rett-syndrome-clinical-trial-for 2021-09-02T14:02:01+10:00 https://pharmadispatch.com/news/new-technology-sheds-a-light-on-preventable-eye-conditions 2021-09-02T14:01:01+10:00 https://pharmadispatch.com/news/a-remarkable-collection-of-data-that-reveals-the-impact-of-pande 2021-09-02T02:00:01+10:00 https://pharmadispatch.com/news/a-making-connections-symposium-or-making-some-connections 2021-09-02T02:00:01+10:00 https://pharmadispatch.com/news/tga-files-action-against-company-over-alleged-unlawful-supply-of 2021-09-02T02:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-2-september-2021 2021-09-02T02:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-1-september-2021 2021-09-01T04:00:01+10:00 https://pharmadispatch.com/news/new-report-confirms-hundreds-of-deaths-from-pharmaceutical-opioi 2021-09-01T04:00:01+10:00 https://pharmadispatch.com/news/the-mentality-has-to-change-when-it-comes-to-access 2021-09-01T04:00:01+10:00 https://pharmadispatch.com/news/australias-leukaemia-foundation-unites-in-global-push 2021-09-01T04:00:01+10:00 https://pharmadispatch.com/news/patients-welcome-expanded-listing-for-ucbs-epilepsy-medicine 2021-09-01T04:00:01+10:00 https://pharmadispatch.com/news/nutromics-capital-raise-to-progress-cmm-platform 2021-08-31T13:46:01+10:00 https://pharmadispatch.com/news/immuteps-chinese-partner-to-expand-efti-trial-pipeline 2021-08-31T13:44:01+10:00 https://pharmadispatch.com/news/pharmaxis-wound-and-scar-treatment-clears-phase-one-trial 2021-08-31T13:43:01+10:00 https://pharmadispatch.com/news/new-hub-launched-for-200000-australians-living-with-psoriatic-ar 2021-08-31T13:41:01+10:00 https://pharmadispatch.com/news/private-hospitals-call-on-national-cabinet-to-mandate-vaccinatio 2021-08-31T13:40:01+10:00 https://pharmadispatch.com/news/new-report-reveals-impact-of-us-reform-on-drug-development-1 2021-08-31T05:04:01+10:00 https://pharmadispatch.com/news/paig-more-work-to-be-done-to-achieve-pay-equity-1 2021-08-31T05:04:01+10:00 https://pharmadispatch.com/news/emerging-australian-biotech-appoints-experienced-industry-exec-a 2021-08-31T05:04:01+10:00 https://pharmadispatch.com/news/an-opportunity-to-address-a-disheartening-gap-in-public-discussi 2021-08-31T05:00:01+10:00 https://pharmadispatch.com/news/an-opportunity-to-address-a-disheartening-gap-in-public-discussi 2021-08-31T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-31-august-2021 2021-08-31T04:00:01+10:00 https://pharmadispatch.com/news/emerging-australian-biotech-appoints-experienced-industry-exec-a 2021-08-31T04:00:01+10:00 https://pharmadispatch.com/news/finally-a-no-fault-compensation-for-covid-19-vaccinations 2021-08-30T04:00:01+10:00 https://pharmadispatch.com/news/new-listings-for-schizophrenia-liver-disease-lymphoma-and-anaphy 2021-08-30T04:00:01+10:00 https://pharmadispatch.com/news/incorrect-claim-of-a-first-time-listing 2021-08-30T04:00:01+10:00 https://pharmadispatch.com/news/amr-is-seen-as-an-issue-to-be-fixed-down-the-road 2021-08-30T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-30-august-2021 2021-08-30T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-27-august-2021 2021-08-27T04:00:01+10:00 https://pharmadispatch.com/news/ip-rights-are-critical-ingredient-and-one-of-the-most-ancient-co 2021-08-27T04:00:01+10:00 https://pharmadispatch.com/news/nzs-access-to-vaccines-was-assured-because-pharmac-was-not-invol 2021-08-27T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-proposing-to-switch-patients-to-biosimilar-bdmard 2021-08-27T04:00:01+10:00 https://pharmadispatch.com/news/experts-discuss-the-future-of-cancer-care-across-the-asia-pacifi 2021-08-26T12:57:01+10:00 https://pharmadispatch.com/news/does-this-ban-only-apply-to-pharmaceutical-companies 2021-08-26T04:00:01+10:00 https://pharmadispatch.com/news/the-emerging-spectre-of-international-reference-pricing-for-heal 2021-08-26T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-26-august-2021 2021-08-26T04:00:01+10:00 https://pharmadispatch.com/news/a-remarkable-achievement-in-such-a-short-space-of-time 2021-08-26T04:00:01+10:00 https://pharmadispatch.com/news/andhealth-secures-new-funding-and-announces-tga-partnership 2021-08-25T14:07:01+10:00 https://pharmadispatch.com/news/adalta-and-carina-in-new-collaboration-focused-on-car-t-candidat 2021-08-25T14:05:01+10:00 https://pharmadispatch.com/news/fda-approves-early-stage-trial-for-chimeric-car-t 2021-08-25T14:04:01+10:00 https://pharmadispatch.com/news/nsw-government-joins-the-push-for-mrna-manufacturing 2021-08-25T14:03:01+10:00 https://pharmadispatch.com/news/new-modelling-reveals-what-could-convince-wait-and-see-australia 2021-08-25T04:00:01+10:00 https://pharmadispatch.com/news/tga-scrambling-to-authorise-vaccine-brand-campaigns 2021-08-25T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-25-august-2021-1 2021-08-25T04:00:01+10:00 https://pharmadispatch.com/news/agreements-close-as-the-industry-waits-for-outcome 2021-08-25T04:00:01+10:00 https://pharmadispatch.com/news/it-is-a-complex-situation-but-the-company-should-have-been-consu 2021-08-25T04:00:01+10:00 https://pharmadispatch.com/news/hcf-warns-against-the-risk-of-eyestrain-in-children 2021-08-24T08:38:01+10:00 https://pharmadispatch.com/news/bupa-foundation-extends-pandemic-support-to-assist-kids-helpline 2021-08-24T08:37:01+10:00 https://pharmadispatch.com/news/nib-announces-return-of-15-million-in-covid-19-claims-savings-to 2021-08-24T08:36:01+10:00 https://pharmadispatch.com/news/full-year-result-shows-strong-return-to-growth-for-nib 2021-08-24T08:35:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-24-august-2021 2021-08-24T04:00:01+10:00 https://pharmadispatch.com/news/jj-new-global-ceo-has-expressed-clear-views-on-australia 2021-08-24T04:00:01+10:00 https://pharmadispatch.com/news/inconsistencies-and-contradictions-in-published-outcome 2021-08-24T04:00:01+10:00 https://pharmadispatch.com/news/the-miracle-impact-makes-for-a-horrible-contrast 2021-08-23T14:37:01+10:00 https://pharmadispatch.com/news/australias-first-national-biotech-incubator-established-with-40m 2021-08-23T10:56:01+10:00 https://pharmadispatch.com/news/pbac-recommends-cancer-therapies-and-more-biosimilars 2021-08-23T04:00:01+10:00 https://pharmadispatch.com/news/pbac-rescinds-some-but-extends-most-unimplemented-recommendation 2021-08-23T04:00:01+10:00 https://pharmadispatch.com/news/written-authorities-remain-and-royal-commission-outcome-deferred 2021-08-23T04:00:01+10:00 https://pharmadispatch.com/news/tga-grants-provisional-approval-for-gsk-covid-19-treatment 2021-08-23T04:00:01+10:00 https://pharmadispatch.com/news/a-letter-is-not-intervention-it-is-jut-a-letter 2021-08-23T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-23-august-2021 2021-08-23T04:00:01+10:00 https://pharmadispatch.com/news/gsk-campaign-looking-to-raise-awareness-of-shingles 2021-08-21T04:00:01+10:00 https://pharmadispatch.com/news/outcome-a-recommendation-in-name-only 2021-08-20T16:00:01+10:00 https://pharmadispatch.com/news/the-gap-that-exposes-australias-healthcare-decision-making-1 2021-08-20T05:18:01+10:00 https://pharmadispatch.com/news/the-gap-that-exposes-australias-healthcare-decision-making-2 2021-08-20T05:18:01+10:00 https://pharmadispatch.com/news/the-gap-that-exposes-australias-healthcare-decision-making-1 2021-08-20T05:00:01+10:00 https://pharmadispatch.com/news/companies-share-the-lessons-of-their-reconciliation-journeys-1 2021-08-20T05:00:01+10:00 https://pharmadispatch.com/news/the-only-way-out-is-vaccination-for-every-eligible-person-now-1 2021-08-20T05:00:01+10:00 https://pharmadispatch.com/news/new-report-exposes-government-disdain-for-freedom-of-information 2021-08-20T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-20-august-2021-2 2021-08-20T04:00:01+10:00 https://pharmadispatch.com/news/ebos-tops-revenue-milestone-with-double-digit-growth 2021-08-19T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-19-august-2021-1 2021-08-19T04:00:01+10:00 https://pharmadispatch.com/news/tga-rethink-on-nicotine-vaping-with-a-raft-of-new-restrictions 2021-08-19T04:00:01+10:00 https://pharmadispatch.com/news/this-is-what-qualifies-as-a-new-listing-in-new-zealand 2021-08-18T11:39:01+10:00 https://pharmadispatch.com/news/csl-the-pandemic-has-produced-a-headwind-and-tailwind 2021-08-18T10:13:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-18-august-2021-1 2021-08-18T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-starts-the-search-for-a-new-chair 2021-08-18T04:00:01+10:00 https://pharmadispatch.com/news/just-admitting-failure-might-be-the-biggest-challenge-of-all 2021-08-18T04:00:01+10:00 https://pharmadispatch.com/news/consultation-process-open-for-odtp-post-market-review 2021-08-18T04:00:01+10:00 https://pharmadispatch.com/news/tga-approval-for-speedx-covid-19-diagnostic-test 2021-08-17T14:49:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-secures-funding-to-advance-nuclear-medic 2021-08-17T14:48:01+10:00 https://pharmadispatch.com/news/dimerix-capital-raise-to-progress-late-stage-trial 2021-08-17T14:47:01+10:00 https://pharmadispatch.com/news/women-in-stem-leadership-program-to-go-national 2021-08-17T14:46:01+10:00 https://pharmadispatch.com/news/new-global-agreement-for-australian-inhaler-technology 2021-08-17T14:12:01+10:00 https://pharmadispatch.com/news/incredulity-in-response-to-revelation-on-pharmac-decision-making 2021-08-17T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-17-august-2021 2021-08-17T04:00:01+10:00 https://pharmadispatch.com/news/speed-to-funding-and-patient-uptake-critical-for-competitiveness 2021-08-17T04:00:01+10:00 https://pharmadispatch.com/news/reconciliation-the-focus-for-pharma-australia-inclusion-group 2021-08-17T04:00:01+10:00 https://pharmadispatch.com/news/private-healthcare-australias-annual-hospital-high-claims-2021-r 2021-08-16T13:20:01+10:00 https://pharmadispatch.com/news/new-paper-highlights-the-rapid-rise-in-valvular-heart-disease 2021-08-16T13:18:01+10:00 https://pharmadispatch.com/news/vaccine-rollout-is-still-waiting-the-long-promised-acceleration 2021-08-16T04:00:01+10:00 https://pharmadispatch.com/news/where-was-this-urgency-when-it-was-really-needed 2021-08-16T04:00:01+10:00 https://pharmadispatch.com/news/pandemic-demand-leads-to-shortage-of-leading-biologic 2021-08-16T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-august-2021 2021-08-16T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-13-august-2021 2021-08-13T04:00:01+10:00 https://pharmadispatch.com/news/vaccine-hearing-rescheduled-as-act-goes-into-lockdown 2021-08-13T04:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-change-on-reimbursement-of-regenerative-med 2021-08-13T04:00:01+10:00 https://pharmadispatch.com/news/merck-leverages-social-media-in-support-of-national-science-week 2021-08-13T04:00:01+10:00 https://pharmadispatch.com/news/new-analysis-reveals-the-potential-of-at-home-rehabilitation-1 2021-08-12T10:21:01+10:00 https://pharmadispatch.com/news/emvision-announces-milestone-with-assembly-of-portable-brain-sca 2021-08-12T10:20:01+10:00 https://pharmadispatch.com/news/tevas-benet-irish-and-looking-to-the-future-of-technology 2021-08-12T04:00:01+10:00 https://pharmadispatch.com/news/the-double-doubtful-legality-and-the-delayed-fix-is-costing-live 2021-08-12T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-12-august-2021-1 2021-08-12T04:00:01+10:00 https://pharmadispatch.com/news/collaborations-open-letter-urging-patients-not-to-delay-getting- 2021-08-12T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-11-august-2021-1 2021-08-11T04:00:01+10:00 https://pharmadispatch.com/news/leading-gene-therapy-company-retreats-to-its-us-home 2021-08-11T04:00:01+10:00 https://pharmadispatch.com/news/new-survey-highlights-the-debilitating-impact-of-osteoarthritis 2021-08-11T04:00:01+10:00 https://pharmadispatch.com/news/time-for-action-on-gene-therapy-retreat-to-the-us 2021-08-11T04:00:01+10:00 https://pharmadispatch.com/news/medibank-rewarding-customers-for-getting-the-covid-19-vaccine 2021-08-10T10:00:01+10:00 https://pharmadispatch.com/news/a-focused-effort-needed-in-the-fight-against-neurodegenerative-d 2021-08-10T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-10-august-2021 2021-08-10T04:00:01+10:00 https://pharmadispatch.com/news/tga-approves-moderna-vaccine-but-when-will-it-arrive 2021-08-10T04:00:01+10:00 https://pharmadispatch.com/news/proposed-ip-waiver-only-overlooks-the-real-challenges 2021-08-10T04:00:01+10:00 https://pharmadispatch.com/news/can-the-outcomes-finally-match-the-promises-on-vaccine-rollout 2021-08-09T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-9-august-2021 2021-08-09T04:00:01+10:00 https://pharmadispatch.com/news/besins-geoff-blundell-on-140-years-of-history-with-the-feel-of-a 2021-08-09T03:00:01+10:00 https://pharmadispatch.com/news/system-level-problems-require-system-level-solutions 2021-08-09T03:00:01+10:00 https://pharmadispatch.com/news/money-for-just-12-hours-of-covid-testing-would-save-lives-each-y 2021-08-09T03:00:01+10:00 https://pharmadispatch.com/news/government-announces-plan-to-secure-covid-19-treatment 2021-08-09T03:00:01+10:00 https://pharmadispatch.com/news/department-of-health-ambushes-companies-with-cut-price-tender 2021-08-06T04:00:01+10:00 https://pharmadispatch.com/news/cynical-exercise-unworthy-of-an-australian-public-health-program 2021-08-06T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-6-august-2021-1 2021-08-06T04:00:01+10:00 https://pharmadispatch.com/news/move-to-scrap-confidentiality-protections-could-lapse-and-come-b 2021-08-06T04:00:01+10:00 https://pharmadispatch.com/news/glyscend-therapeutics-commences-clinical-trial-of-potential-diab 2021-08-05T09:02:01+10:00 https://pharmadispatch.com/news/faecal-transplants-to-help-treat-symptoms-of-parkinsons 2021-08-05T09:00:01+10:00 https://pharmadispatch.com/news/lanternpay-and-civica-offer-innovative-pharmacy-solutions-to-nib 2021-08-05T04:00:01+10:00 https://pharmadispatch.com/news/companies-make-australias-best-place-to-work-list 2021-08-05T04:00:01+10:00 https://pharmadispatch.com/news/advocacy-group-slams-federal-agency-over-its-failure-to-expose-c 2021-08-05T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-5-august-2021 2021-08-05T04:00:01+10:00 https://pharmadispatch.com/news/the-long-wait-over-for-gileads-car-t-therapy 2021-08-05T04:00:01+10:00 https://pharmadispatch.com/news/childhood-immunisation-the-example-to-follow-on-newborn-screenin 2021-08-04T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-4-august-2021 2021-08-04T04:00:01+10:00 https://pharmadispatch.com/news/research-backs-high-upfront-spend-on-gene-therapy 2021-08-04T04:00:01+10:00 https://pharmadispatch.com/news/what-does-the-industry-do-if-this-approach-works 2021-08-04T04:00:01+10:00 https://pharmadispatch.com/news/organon-launches-its-first-wellness-month-initiative 2021-08-04T04:00:01+10:00 https://pharmadispatch.com/news/tga-makes-third-change-to-allow-the-promotion-of-vaccine-brands 2021-08-03T04:00:01+10:00 https://pharmadispatch.com/news/human-rights-commissioner-backs-new-zealand-patients-against-pha 2021-08-03T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-3-august-2021 2021-08-03T04:00:01+10:00 https://pharmadispatch.com/news/patient-group-backs-federal-takeover-of-newborn-screening 2021-08-03T04:00:01+10:00 https://pharmadispatch.com/news/seqirus-welcomes-reimbursement-of-new-dry-eye-treatment 2021-08-02T15:32:01+10:00 https://pharmadispatch.com/news/biocurate-and-monash-university-accelerate-research-into-targete 2021-08-02T10:08:01+10:00 https://pharmadispatch.com/news/sanofi-welcomes-the-listing-of-cholesterol-lowering-biologic 2021-08-02T04:00:01+10:00 https://pharmadispatch.com/news/children-gain-funded-access-to-new-oral-treatment-for-spinal-mus 2021-08-02T04:00:01+10:00 https://pharmadispatch.com/news/new-listing-welcomes-but-patients-call-for-action-to-avoid-futur 2021-08-02T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-2-august-2021 2021-08-02T04:00:01+10:00 https://pharmadispatch.com/news/the-government-is-in-no-place-to-give-lectures-on-conflicts-of-i 2021-08-02T04:00:01+10:00 https://pharmadispatch.com/news/abbvies-chris-stemple-on-biosimilars-the-cost-of-delays-and-doin 2021-08-01T04:00:01+10:00 https://pharmadispatch.com/news/ambitious-plan-for-christmas-is-possible-based-on-recent-weeks 2021-07-30T04:00:01+10:00 https://pharmadispatch.com/news/did-wait-and-see-mean-australia-lost-access-to-already-allocated 2021-07-30T04:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-expected-to-officially-launch-national-medicines-polic 2021-07-30T04:00:01+10:00 https://pharmadispatch.com/news/api-says-no-to-wesfarmers-takeover 2021-07-30T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-30-july-2021 2021-07-30T04:00:01+10:00 https://pharmadispatch.com/news/nib-and-medibank-members-can-now-tap-to-claim-by-adding-member-c 2021-07-29T15:24:01+10:00 https://pharmadispatch.com/news/carina-biotech-announces-the-members-of-its-new-medical-advisory 2021-07-29T15:22:01+10:00 https://pharmadispatch.com/news/chimeric-therapeutics-licenses-car-t-therapy-from-the-university 2021-07-29T15:20:01+10:00 https://pharmadispatch.com/news/antisense-therapeutics-announces-transition-to-new-board-chair 2021-07-29T15:19:01+10:00 https://pharmadispatch.com/news/pbac-hopeful-msac-will-approve-pd-l1-test 2021-07-29T05:48:01+10:00 https://pharmadispatch.com/news/new-medicines-resubmissions-and-plenty-of-biosimilars 2021-07-29T04:00:01+10:00 https://pharmadispatch.com/news/transparency-on-pbac-agenda-goes-both-ways 2021-07-29T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-29-july-2021 2021-07-29T04:00:01+10:00 https://pharmadispatch.com/news/government-minister-says-they-chose-to-wait-on-vaccine 2021-07-28T05:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-28-july-2021 2021-07-28T04:00:01+10:00 https://pharmadispatch.com/news/labor-slams-the-governments-vaccine-dysfunction 2021-07-28T04:00:01+10:00 https://pharmadispatch.com/news/ctxone-rebrands-as-oncology-one 2021-07-28T04:00:01+10:00 https://pharmadispatch.com/news/which-was-it-a-deliberate-wait-and-see-or-a-simple-lack-of-urgen 2021-07-28T04:00:01+10:00 https://pharmadispatch.com/news/exclusive-pm-intervened-to-get-action-on-vaccine-procurement 2021-07-27T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-27-july-2021 2021-07-27T04:00:01+10:00 https://pharmadispatch.com/news/you-mean-destroy-the-companies-that-just-saved-humanity 2021-07-27T04:00:01+10:00 https://pharmadispatch.com/news/tga-issues-updated-international-alignment-strategy 2021-07-26T17:40:01+10:00 https://pharmadispatch.com/news/another-new-plan-for-stalled-vaccine-rollout 2021-07-26T04:00:01+10:00 https://pharmadispatch.com/news/another-false-narrative-cannot-hide-one-of-the-worst-ever-policy 2021-07-26T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-26-july-2021 2021-07-26T04:00:01+10:00 https://pharmadispatch.com/news/new-agreement-for-pfizer-vaccine-in-2022-and-2023 2021-07-26T04:00:01+10:00 https://pharmadispatch.com/news/new-atagi-advice-gives-governments-a-change-to-walk-back-their-m 2021-07-24T16:11:01+10:00 https://pharmadispatch.com/news/immutep-announces-completion-of-share-purchase-plan 2021-07-23T08:49:01+10:00 https://pharmadispatch.com/news/bcal-diagnostics-debuts-on-the-australian-securities-exchange 2021-07-23T08:48:01+10:00 https://pharmadispatch.com/news/technovalia-starts-phase-one-trial-of-its-covid-19-vaccine-candi 2021-07-23T08:46:01+10:00 https://pharmadispatch.com/news/bupa-dental-partners-on-trial-to-assess-the-impact-of-head-knock 2021-07-23T08:45:01+10:00 https://pharmadispatch.com/news/medibank-confirms-support-for-customers-living-through-lockdown 2021-07-23T08:43:01+10:00 https://pharmadispatch.com/news/no-need-for-atagi-to-change-its-advice-with-states-already-adjus 2021-07-23T04:00:01+10:00 https://pharmadispatch.com/news/one-year-on-and-that-first-question-has-been-very-clearly-answer 2021-07-23T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-23-july-2021 2021-07-23T04:00:01+10:00 https://pharmadispatch.com/news/australian-company-secures-manufacturing-agreement 2021-07-23T04:00:01+10:00 https://pharmadispatch.com/news/new-reports-says-time-to-prepare-for-cell-and-gene-therapies 2021-07-22T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-22-july-2021 2021-07-22T04:00:01+10:00 https://pharmadispatch.com/news/novartis-richard-tew-on-taking-a-leadership-position-on-change 2021-07-22T04:00:01+10:00 https://pharmadispatch.com/news/prime-minister-puts-the-pressure-on-atagi-over-vaccine 2021-07-22T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-marks-completion-of-alexion-takeover 2021-07-22T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-21-july-2021 2021-07-21T04:00:01+10:00 https://pharmadispatch.com/news/msd-welcomes-new-pbs-listing-for-immunotherapy 2021-07-21T04:00:01+10:00 https://pharmadispatch.com/news/companies-paying-higher-fees-but-not-getting-better-service-leve 2021-07-21T04:00:01+10:00 https://pharmadispatch.com/news/another-shortage-hits-new-zealand-in-the-middle-of-outbreak 2021-07-21T04:00:01+10:00 https://pharmadispatch.com/news/hcf-releases-its-first-modern-slavery-statement 2021-07-20T08:45:01+10:00 https://pharmadispatch.com/news/medibank-expands-no-gap-joint-replacement-pilot-program 2021-07-20T08:42:01+10:00 https://pharmadispatch.com/news/jjs-depuy-synthes-welcomes-approval-of-robotic-technology 2021-07-20T08:41:01+10:00 https://pharmadispatch.com/news/catholic-private-hospitals-call-for-blanket-rule-for-hospital-st 2021-07-20T08:40:01+10:00 https://pharmadispatch.com/news/the-mckell-institute-says-time-to-fully-deploy-pharmacy-in-rollo 2021-07-20T05:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-welcomes-consultation-on-clinical-trial-refo 2021-07-20T05:00:01+10:00 https://pharmadispatch.com/news/supply-constraint-evident-at-day-150-as-malaysia-overtakes-austr 2021-07-20T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-20-july-2021 2021-07-20T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-is-literally-happy-for-people-to-die 2021-07-20T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-can-now-promote-vaccines-beer-and-nicotine 2021-07-20T04:00:01+10:00 https://pharmadispatch.com/news/a-stunning-backflip-that-makes-no-sense-but-for-the-words-of-som 2021-07-19T04:00:01+10:00 https://pharmadispatch.com/news/over-50-pages-that-comes-down-to-the-final-paragraph-on-the-last 2021-07-19T04:00:01+10:00 https://pharmadispatch.com/news/a-fine-line-between-guidance-and-imposed-parameters 2021-07-19T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-19-july-2021 2021-07-19T04:00:01+10:00 https://pharmadispatch.com/news/government-appears-very-confused-over-these-products 2021-07-16T04:00:01+10:00 https://pharmadispatch.com/news/the-lop-sided-world-of-beer-and-e-cigarettes-as-a-public-health- 2021-07-16T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-july-2021 2021-07-16T04:00:01+10:00 https://pharmadispatch.com/news/new-head-of-human-resources-for-bayer-australia-and-new-zealand 2021-07-15T15:25:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-july-2021-1 2021-07-15T04:00:01+10:00 https://pharmadispatch.com/news/the-department-of-healths-73-million-in-uncontested-good-money-a 2021-07-15T04:00:01+10:00 https://pharmadispatch.com/news/suzanne-greenwood-executive-director 2021-07-15T04:00:01+10:00 https://pharmadispatch.com/news/patient-says-pharmac-sends-patients-to-a-cruel-death 2021-07-15T04:00:01+10:00 https://pharmadispatch.com/news/terrywhite-chemmart-announces-senior-leadership-changes 2021-07-14T13:08:01+10:00 https://pharmadispatch.com/news/planet-innovation-opens-new-cleanroom-in-melbourne 2021-07-14T10:34:01+10:00 https://pharmadispatch.com/news/mgc-pharma-recruits-first-patient-in-late-stage-trial 2021-07-14T09:34:01+10:00 https://pharmadispatch.com/news/patrys-full-size-pat-dx3-able-to-cross-the-blood-brain-barrier 2021-07-14T09:33:01+10:00 https://pharmadispatch.com/news/pharmaust-and-wehi-to-investigate-monepantel-in-htlv-1-viral-inf 2021-07-14T09:32:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-14-july-2021-1 2021-07-14T04:00:01+10:00 https://pharmadispatch.com/news/the-offset-debate-is-clearly-not-new-or-going-away 2021-07-14T04:00:01+10:00 https://pharmadispatch.com/news/uniquest-partners-with-csl-to-develop-potential-new-therapy 2021-07-14T04:00:01+10:00 https://pharmadispatch.com/news/biointelect-come-forward-for-support-on-securing-investment 2021-07-14T04:00:01+10:00 https://pharmadispatch.com/news/move-for-api-could-be-a-trigger-for-sector-consolidation 2021-07-14T04:00:01+10:00 https://pharmadispatch.com/news/federal-government-sends-personal-protective-equipment-to-sydney 2021-07-13T09:42:01+10:00 https://pharmadispatch.com/news/new-three-year-agreement-to-cover-national-diabetes-services-sch 2021-07-13T09:41:01+10:00 https://pharmadispatch.com/news/medibank-welcomes-expansion-of-at-home-treatment-to-more-south-a 2021-07-13T09:40:01+10:00 https://pharmadispatch.com/news/biden-administration-opens-new-front-of-medicine-pricing 2021-07-13T04:00:01+10:00 https://pharmadispatch.com/news/lisa-golden-on-biosimilar-uptake-and-the-need-for-a-patient-sign 2021-07-13T04:00:01+10:00 https://pharmadispatch.com/news/major-retailer-makes-a-move-for-medicine-wholesaler 2021-07-13T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-13-july-2021 2021-07-13T04:00:01+10:00 https://pharmadispatch.com/news/just-when-you-thought-the-system-could-not-sink-any-lower 2021-07-13T04:00:01+10:00 https://pharmadispatch.com/news/intervention-put-tga-head-in-a-very-difficult-position 2021-07-12T04:00:01+10:00 https://pharmadispatch.com/news/the-government-intervenes-on-beer-but-ignores-access-delays 2021-07-12T04:00:01+10:00 https://pharmadispatch.com/news/how-about-we-now-allow-beer-for-bdmards 2021-07-12T04:00:01+10:00 https://pharmadispatch.com/news/pharmaceutical-sector-joins-other-in-challenging-critical-infras 2021-07-12T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-12-july-2021 2021-07-12T04:00:01+10:00 https://pharmadispatch.com/news/confidence-requires-fair-and-consistent-decision-making 2021-07-09T04:00:01+10:00 https://pharmadispatch.com/news/there-is-nothing-that-promotes-innovation-or-early-access 2021-07-09T04:00:01+10:00 https://pharmadispatch.com/news/new-medical-leadership-for-novo-nordisk 2021-07-09T04:00:01+10:00 https://pharmadispatch.com/news/government-starting-small-on-manufacturing-support 2021-07-09T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-9-july-2021-1 2021-07-09T04:00:01+10:00 https://pharmadispatch.com/news/sector-to-front-parliamentary-inquiry-into-move-to-dramatically- 2021-07-09T04:00:01+10:00 https://pharmadispatch.com/news/nz-rna-start-up-secures-significant-investment-to-progress-cance 2021-07-08T04:00:01+10:00 https://pharmadispatch.com/news/regulator-has-opened-the-door-to-more-direct-to-consumer-adverti 2021-07-08T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-july-2021 2021-07-08T04:00:01+10:00 https://pharmadispatch.com/news/ma-teams-up-with-naccho-to-establish-joint-committee 2021-07-08T04:00:01+10:00 https://pharmadispatch.com/news/committee-hears-from-the-uk-about-the-differences-with-australia 2021-07-08T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-7-july-2021 2021-07-07T04:00:01+10:00 https://pharmadispatch.com/news/us-australia-medicines-working-group-should-be-re-established 2021-07-07T04:00:01+10:00 https://pharmadispatch.com/news/tga-applying-the-rules-to-argue-they-do-not-apply 2021-07-07T04:00:01+10:00 https://pharmadispatch.com/news/local-biotech-announces-new-collaboration-with-the-florey-instit 2021-07-07T04:00:01+10:00 https://pharmadispatch.com/news/gaping-hole-in-australian-dental-health-is-preventable 2021-07-06T08:16:01+10:00 https://pharmadispatch.com/news/bupa-welcomes-vaccination-push-for-aged-care-workers 2021-07-06T08:15:01+10:00 https://pharmadispatch.com/news/deloitte-wins-contract-to-modernise-national-digital-health-infr 2021-07-06T08:14:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-6-july-2021 2021-07-06T04:00:01+10:00 https://pharmadispatch.com/news/updated-analysis-shows-australias-vaccine-rollout-is-falling-fur 2021-07-06T04:00:01+10:00 https://pharmadispatch.com/news/phrma-tells-us-not-to-follow-australias-lead-on-medicines 2021-07-06T04:00:01+10:00 https://pharmadispatch.com/news/this-is-just-an-unacceptable-double-standard-on-brand-advertisin 2021-07-06T04:00:01+10:00 https://pharmadispatch.com/news/background-and-clarity-on-decision-to-delist-cancer-therapy 2021-07-05T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-expanded-listing-for-xeljanz 2021-07-05T04:00:01+10:00 https://pharmadispatch.com/news/makes-the-case-for-confidentiality 2021-07-05T04:00:01+10:00 https://pharmadispatch.com/news/double-standard-and-selective-application-of-the-law 2021-07-05T04:00:01+10:00 https://pharmadispatch.com/news/local-start-up-and-canadian-partner-on-mrna-manufacturing-projec 2021-07-05T04:00:01+10:00 https://pharmadispatch.com/news/australian-healthcare-associates-reappointed-to-administer-cso 2021-07-05T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-5-july-2021 2021-07-05T04:00:01+10:00 https://pharmadispatch.com/news/government-authorises-the-advertising-of-nicotine-vaping 2021-07-05T04:00:01+10:00 https://pharmadispatch.com/news/the-government-has-achieved-a-very-rare-feat-on-the-vaccine 2021-07-02T04:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-sells-local-rights-to-cystic-fibrosis-therapy 2021-07-02T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-we-are-meeting-our-contractural-commitments 2021-07-02T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-csl-sign-declaration-against-ip-waiver 2021-07-02T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-2-july-2021-2 2021-07-02T04:00:01+10:00 https://pharmadispatch.com/news/the-adherence-opportunity-with-long-acting-treatment 2021-07-02T04:00:01+10:00 https://pharmadispatch.com/news/medibank-announces-105-million-in-premium-relief 2021-07-01T07:48:01+10:00 https://pharmadispatch.com/news/pha-funding-for-new-device-highlights-the-need-for-reform-to-mak 2021-07-01T07:47:01+10:00 https://pharmadispatch.com/news/us-style-managed-care-in-australia-the-eagle-that-never-landed 2021-07-01T07:46:01+10:00 https://pharmadispatch.com/news/fda-grants-approval-for-noxopharms-darrt-2-cancer-study 2021-07-01T07:00:01+10:00 https://pharmadispatch.com/news/experts-welcome-new-listing-to-prevent-premature-births 2021-07-01T04:00:01+10:00 https://pharmadispatch.com/news/janssen-confirms-expanded-listing-to-include-psoriatic-arthritis 2021-07-01T04:00:01+10:00 https://pharmadispatch.com/news/ex-guild-president-the-first-chair-of-new-biosimilar-advisory-bo 2021-07-01T04:00:01+10:00 https://pharmadispatch.com/news/janssen-communications-and-public-affairs 2021-07-01T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-1-july-2021-1 2021-07-01T04:00:01+10:00 https://pharmadispatch.com/news/new-report-looks-to-the-future-of-hospital-pharmacy 2021-07-01T04:00:01+10:00 https://pharmadispatch.com/news/change-on-vaccines-starts-with-a-comprehensive-review-of-nip 2021-07-01T04:00:01+10:00 https://pharmadispatch.com/news/nz-patients-involved-in-breakthrough-crispr-trial 2021-06-30T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-30-june-2021 2021-06-30T04:00:01+10:00 https://pharmadispatch.com/news/gilead-announces-latest-recipients-of-fellowship-grants 2021-06-30T04:00:01+10:00 https://pharmadispatch.com/news/look-to-blood-products-to-see-the-future-for-newborn-screening 2021-06-30T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-lashes-government-over-vaccine-rollout 2021-06-30T04:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-announces-first-positive-results-in-cancer-trial 2021-06-30T04:00:01+10:00 https://pharmadispatch.com/news/biocurate-announces-expansion-of-board-and-investment-committee 2021-06-29T10:41:01+10:00 https://pharmadispatch.com/news/nyradas-updates-on-preclinical-study-of-nyx-pcsk9i-with-statin 2021-06-29T10:40:01+10:00 https://pharmadispatch.com/news/new-collaboration-between-antisense-therapeutics-and-mcri 2021-06-29T10:38:01+10:00 https://pharmadispatch.com/news/capital-raise-for-currus-biologics-to-progress-car-t-development 2021-06-29T10:36:01+10:00 https://pharmadispatch.com/news/members-health-welcomes-support-for-reforms 2021-06-29T10:35:01+10:00 https://pharmadispatch.com/news/private-insurers-say-new-report-highlights-the-need-for-change 2021-06-29T10:34:01+10:00 https://pharmadispatch.com/news/device-sector-says-focus-on-delivering-reform-rather-than-campai 2021-06-29T10:32:01+10:00 https://pharmadispatch.com/news/igr-doesnt-say-much-but-still-a-very-important-document 2021-06-29T04:00:01+10:00 https://pharmadispatch.com/news/csl-updates-on-plans-for-australian-expansion 2021-06-29T04:00:01+10:00 https://pharmadispatch.com/news/new-agreements-are-likely-weeks-more-than-days-away 2021-06-29T04:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-action-on-adult-immunisation 2021-06-29T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-29-june-2021 2021-06-29T04:00:01+10:00 https://pharmadispatch.com/news/intergenerational-report-highlights-new-technologies-but-predict 2021-06-28T10:00:01+10:00 https://pharmadispatch.com/news/the-revised-newborn-screening-program-complex-and-confused 2021-06-28T04:00:01+10:00 https://pharmadispatch.com/news/wehi-and-boehringer-ingelheim-partner-to-develop-innovative-canc 2021-06-28T04:00:01+10:00 https://pharmadispatch.com/news/er-and-biointelect-report-takes-the-system-level-view 2021-06-28T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-28-june-2021 2021-06-28T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-25-june-2021-1 2021-06-25T04:00:01+10:00 https://pharmadispatch.com/news/opal-biosciences-seeking-partners-to-establish-precinct 2021-06-25T04:00:01+10:00 https://pharmadispatch.com/news/liberal-chaired-committee-tells-greg-hunt-to-try-again 2021-06-25T04:00:01+10:00 https://pharmadispatch.com/news/epilepsy-patients-facing-another-forced-switch 2021-06-25T04:00:01+10:00 https://pharmadispatch.com/news/what-are-these-decision-parameters 2021-06-25T04:00:01+10:00 https://pharmadispatch.com/news/chemist-warehouse-opens-second-european-store 2021-06-24T16:11:01+10:00 https://pharmadispatch.com/news/private-insurers-launch-campaign-promoting-reform-of-device-pric 2021-06-24T09:36:01+10:00 https://pharmadispatch.com/news/fundamental-forces-have-not-been-halted-by-pandemic-1 2021-06-24T09:35:01+10:00 https://pharmadispatch.com/news/private-insurers-launch-new-code-of-conduct 2021-06-24T09:34:01+10:00 https://pharmadispatch.com/news/expanded-listings-for-mesothelioma-and-rare-genetic-disorder 2021-06-24T04:00:01+10:00 https://pharmadispatch.com/news/ivf-supporting-australians-to-achieve-parenthood-for-over-40-yea 2021-06-24T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-24-june-2021 2021-06-24T04:00:01+10:00 https://pharmadispatch.com/news/labor-commits-to-agreement-and-hunt-announces-nmp-review 2021-06-24T04:00:01+10:00 https://pharmadispatch.com/news/new-gsk-to-focus-on-vaccines-and-speciality-medicines 2021-06-24T04:00:01+10:00 https://pharmadispatch.com/news/medibank-finalises-new-executive-leadership-team 2021-06-23T10:43:01+10:00 https://pharmadispatch.com/news/fundamental-forces-have-not-been-halted-by-pandemic 2021-06-23T10:42:01+10:00 https://pharmadispatch.com/news/call-for-action-on-equitable-access-to-covid-19-vaccines 2021-06-23T04:00:01+10:00 https://pharmadispatch.com/news/publicly-funded-organisations-dont-get-to-not-answer-questions 2021-06-23T04:00:01+10:00 https://pharmadispatch.com/news/australian-health-insurer-introduces-extensive-medicine-coverage 2021-06-23T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-23-june-2021-1 2021-06-23T04:00:01+10:00 https://pharmadispatch.com/news/international-funders-work-hand-in-hand-to-improve-global-heart- 2021-06-22T15:53:01+10:00 https://pharmadispatch.com/news/repurposing-project-gains-momentum-with-potential-pilot-on-the-h 2021-06-22T04:00:01+10:00 https://pharmadispatch.com/news/new-australian-rd-collaboration-for-pfizers-centers-for-therapeu 2021-06-22T04:00:01+10:00 https://pharmadispatch.com/news/major-capital-raise-for-emerging-australian-biotech 2021-06-22T04:00:01+10:00 https://pharmadispatch.com/news/transparency-fail-over-government-funded-direct-to-consumer-adve 2021-06-22T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-22-june-2021 2021-06-22T04:00:01+10:00 https://pharmadispatch.com/news/orthocell-announces-positive-nerve-regeneration-results-for-celg 2021-06-21T15:28:01+10:00 https://pharmadispatch.com/news/suda-licenses-inkt-cell-therapy-platform-from-imperial-college-l 2021-06-21T13:40:01+10:00 https://pharmadispatch.com/news/starpharma-temporarily-halts-uk-sales-of-nasal-spray-over-promot 2021-06-21T13:13:01+10:00 https://pharmadispatch.com/news/private-insurers-challenge-evidence-given-to-parliamentary-inqui 2021-06-21T10:00:01+10:00 https://pharmadispatch.com/news/people-feel-more-connected-to-colleagues-since-returning-to-offi 2021-06-21T09:23:01+10:00 https://pharmadispatch.com/news/what-an-utterly-hopeless-display-by-this-committee 2021-06-21T04:00:01+10:00 https://pharmadispatch.com/news/is-this-ad-hoc-or-has-the-government-made-a-policy-decision 2021-06-21T04:00:01+10:00 https://pharmadispatch.com/news/there-is-no-ban-on-direct-to-consumer-advertising 2021-06-21T04:00:01+10:00 https://pharmadispatch.com/news/pbac-goes-virtual-again-for-its-july-meeting 2021-06-21T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-21-june-2021 2021-06-21T04:00:01+10:00 https://pharmadispatch.com/news/at-day-121-australias-national-immunisation-program-is-still-sta 2021-06-21T04:00:01+10:00 https://pharmadispatch.com/news/alliance-now-hit-by-an-awkward-pbac-outcomes 2021-06-21T04:00:01+10:00 https://pharmadispatch.com/news/the-so-called-targeted-therapies-alliance-might-have-a-legal-pro 2021-06-18T04:00:01+10:00 https://pharmadispatch.com/news/vertex-pleased-with-this-weeks-stakeholder-meeting 2021-06-18T04:00:01+10:00 https://pharmadispatch.com/news/the-only-surprise-about-vaccine-rollout-is-that-anyone-is-surpri 2021-06-18T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-18-june-2021-1 2021-06-18T04:00:01+10:00 https://pharmadispatch.com/news/first-line-listing-for-ipsens-kidney-cancer-treatment 2021-06-18T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-17-june-2021 2021-06-17T04:00:01+10:00 https://pharmadispatch.com/news/an-indefensible-double-standard-when-it-comes-to-patient-groups 2021-06-17T04:00:01+10:00 https://pharmadispatch.com/news/a-complete-lack-of-transparency-misleading-advice-or-both-1 2021-06-17T04:00:01+10:00 https://pharmadispatch.com/news/industry-waiting-for-final-text-of-uk-australia-fta 2021-06-16T16:50:01+10:00 https://pharmadispatch.com/news/lilly-and-jj-named-finalists-in-australian-hr-awards 2021-06-16T04:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-scoping-on-national-one-stop-shop-for-clinical 2021-06-16T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-june-2021-1 2021-06-16T04:00:01+10:00 https://pharmadispatch.com/news/the-minister-needs-to-do-his-job-on-access-to-medicines 2021-06-15T04:00:01+10:00 https://pharmadispatch.com/news/msd-and-government-in-discussions-over-covid-19-treatment 2021-06-15T04:00:01+10:00 https://pharmadispatch.com/news/paigs-kicks-off-latest-workshop-series-and-recognition-for-gilea 2021-06-15T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-june-2021-1 2021-06-15T04:00:01+10:00 https://pharmadispatch.com/news/public-hearings-a-chance-for-greater-transparency 2021-06-15T04:00:01+10:00 https://pharmadispatch.com/news/nz-clinician-slams-pharmac-over-diabetes-decision 2021-06-15T04:00:01+10:00 https://pharmadispatch.com/news/martin-palin-big-pharmas-key-role-in-our-supply-driven-medical-s 2021-06-11T10:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-11-june-2021-2 2021-06-11T04:00:01+10:00 https://pharmadispatch.com/news/australian-diagnostics-company-going-public 2021-06-11T04:00:01+10:00 https://pharmadispatch.com/news/roche-announces-new-changes-to-progress-transformation 2021-06-11T04:00:01+10:00 https://pharmadispatch.com/news/mercks-leah-goodman-moves-on-but-sticks-with-ma-board 2021-06-11T04:00:01+10:00 https://pharmadispatch.com/news/martin-palin-big-pharmas-key-role-in-our-supply-driven-medical-s 2021-06-11T04:00:01+10:00 https://pharmadispatch.com/news/chemist-warehouse-welcomes-recognition 2021-06-11T04:00:01+10:00 https://pharmadispatch.com/news/national-report-confirms-incidence-of-blood-cancer-continues-to- 2021-06-10T08:24:01+10:00 https://pharmadispatch.com/news/survey-reveals-importance-of-private-insurance-to-mental-health- 2021-06-10T08:22:01+10:00 https://pharmadispatch.com/news/australian-launch-for-worlds-largest-screening-project-for-atria 2021-06-10T08:21:01+10:00 https://pharmadispatch.com/news/enough-is-enough-is-one-response-to-new-screening-process 2021-06-10T04:10:01+10:00 https://pharmadispatch.com/news/what-should-be-in-the-public-domain 2021-06-10T04:00:01+10:00 https://pharmadispatch.com/news/world-bank-says-no-to-ip-waiver-as-wto-debate-resumes 2021-06-10T04:00:01+10:00 https://pharmadispatch.com/news/lilly-welcomes-former-health-minister-to-talk-generational-diver 2021-06-10T04:00:01+10:00 https://pharmadispatch.com/news/true-transparency-requires-more-information-on-inputs-and-influe 2021-06-09T04:00:01+10:00 https://pharmadispatch.com/news/wholesaler-secures-ex-guild-national-president-for-its-board 2021-06-09T04:00:01+10:00 https://pharmadispatch.com/news/biogen-as-a-great-place-to-work 2021-06-09T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-9-june-2021-1 2021-06-09T04:00:01+10:00 https://pharmadispatch.com/news/bayer-advances-cell-and-gene-therapies-for-parkinsons-disease 2021-06-09T04:00:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-advances-program-for-inherited-eye-disease-ther 2021-06-08T16:02:01+10:00 https://pharmadispatch.com/news/first-stroke-patient-treated-with-clinuvels-afamelanotide 2021-06-08T16:00:01+10:00 https://pharmadispatch.com/news/immutep-reports-final-data-from-phase-one-study-of-lag-3-therapy 2021-06-08T15:58:01+10:00 https://pharmadispatch.com/news/jj-recommits-to-reconciliation-with-third-action-plan 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-officially-opens-new-sydney-headquarters 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-june-2021 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/the-industry-remains-confident-on-confidentiality-bill 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/private-market-launch-for-gsks-shingles-vaccine 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/jeppe-theisen-on-transformation-and-the-plan-for-growth 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/consultation-open-on-draft-report-of-smoking-cessation-review 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/us-regulators-back-biogens-alzheimers-breakthrough 2021-06-08T04:00:01+10:00 https://pharmadispatch.com/news/expansion-and-coming-change-to-treatment-delivery 2021-06-07T04:00:01+10:00 https://pharmadispatch.com/news/government-not-backing-down-on-removing-confidentiality-protecti 2021-06-07T04:00:01+10:00 https://pharmadispatch.com/news/further-opens-the-door-to-off-label-use 2021-06-07T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-7-june-2021 2021-06-07T04:00:01+10:00 https://pharmadispatch.com/news/apec-backs-ip-waiver-while-europe-tables-an-alternative 2021-06-07T04:00:01+10:00 https://pharmadispatch.com/news/queensland-enters-the-push-to-grow-australian-manufacturing 2021-06-07T04:00:01+10:00 https://pharmadispatch.com/news/guild-veteran-communications-director-joins-chemist-warehous 2021-06-07T04:00:01+10:00 https://pharmadispatch.com/news/focus-on-mrna-manufacturing-but-options-appear-few 2021-06-04T04:00:01+10:00 https://pharmadispatch.com/news/reality-of-cancer-therapy-pricing 2021-06-04T04:00:01+10:00 https://pharmadispatch.com/news/nicotine-vaping-products-a-challenge-for-pharmacy 2021-06-04T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-4-june-2021-1 2021-06-04T04:00:01+10:00 https://pharmadispatch.com/news/new-data-showing-potential-of-vaxxas-covid-19-vaccine-patch 2021-06-03T17:35:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-updates-on-data-from-cancer-collaboration 2021-06-03T17:34:01+10:00 https://pharmadispatch.com/news/pharmaust-to-proceed-with-early-stage-alsmnd-trial 2021-06-03T17:33:01+10:00 https://pharmadispatch.com/news/first-patient-dosed-in-combination-trial-of-qbiotics-and-msd-the 2021-06-03T17:32:01+10:00 https://pharmadispatch.com/news/the-new-organon-springs-to-life-after-msd-spinout 2021-06-03T14:30:01+10:00 https://pharmadispatch.com/news/pharmac-works-damn-well-unless-youre-sick 2021-06-03T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-3-june-2021 2021-06-03T04:00:01+10:00 https://pharmadispatch.com/news/expansion-to-new-zealand 2021-06-03T04:00:01+10:00 https://pharmadispatch.com/news/new-cancer-indication-for-merck-pfizers-immunotherapy 2021-06-03T04:00:01+10:00 https://pharmadispatch.com/news/more-obfuscation-from-officials-on-opiate-dependence 2021-06-03T04:00:01+10:00 https://pharmadispatch.com/news/merck-secures-win-win-for-ms-community-and-employees 2021-06-03T04:00:01+10:00 https://pharmadispatch.com/news/expanded-approval-for-tagrisso 2021-06-02T10:07:01+10:00 https://pharmadispatch.com/news/no-position-to-issue-lectures-on-transparency 2021-06-02T04:00:01+10:00 https://pharmadispatch.com/news/merck-in-new-collaboration-with-immutep 2021-06-02T04:00:01+10:00 https://pharmadispatch.com/news/nzs-parliament-accepts-petition-calling-for-change 2021-06-02T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-2-june-2021 2021-06-02T04:00:01+10:00 https://pharmadispatch.com/news/curious-exchange-on-covid-19-vaccines-at-senate-estimates 2021-06-02T04:00:01+10:00 https://pharmadispatch.com/news/nib-foundation-offers-grants-to-boost-health 2021-06-01T14:09:01+10:00 https://pharmadispatch.com/news/medibank-announces-changes-to-executive-leadership 2021-06-01T14:07:01+10:00 https://pharmadispatch.com/news/testing-shows-starpharmas-viraleze-highly-active-against-uk-covi 2021-06-01T14:06:01+10:00 https://pharmadispatch.com/news/adherium-submits-to-fda-for-clearance-of-updated-hailie-sensor 2021-06-01T14:05:01+10:00 https://pharmadispatch.com/news/neuren-to-proceed-with-inds-for-three-trials-after-fda-meeting 2021-06-01T14:03:01+10:00 https://pharmadispatch.com/news/cochlear-elevates-director-to-succeed-retiring-chair 2021-06-01T14:02:01+10:00 https://pharmadispatch.com/news/can-the-current-approach-to-vaccine-evaluation-continue 2021-06-01T04:00:01+10:00 https://pharmadispatch.com/news/do-something-about-information-asymmetry 2021-06-01T04:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-pandemic-hit-to-screening-and-diagnosis 2021-06-01T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-1-june-2021-1 2021-06-01T04:00:01+10:00 https://pharmadispatch.com/news/canada-the-guide-on-turning-around-vaccine-program 2021-06-01T04:00:01+10:00 https://pharmadispatch.com/news/csl-invites-applicants-for-2022-centenary-fellowships 2021-06-01T04:00:01+10:00 https://pharmadispatch.com/news/australias-national-immunisation-program-now-stagnating 2021-05-31T04:00:01+10:00 https://pharmadispatch.com/news/not-helping-already-slow-rollout 2021-05-31T04:00:01+10:00 https://pharmadispatch.com/news/senate-estimates-surprise-on-opiate-dependence 2021-05-31T04:00:01+10:00 https://pharmadispatch.com/news/new-gsk-medical-director 2021-05-31T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-31-may-2021 2021-05-31T04:00:01+10:00 https://pharmadispatch.com/news/lotteries-and-and-prizes-to-encourage-vaccination 2021-05-28T04:00:01+10:00 https://pharmadispatch.com/news/patients-dont-care-about-process-they-care-about-their-experienc 2021-05-28T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-28-may-2021 2021-05-28T04:00:01+10:00 https://pharmadispatch.com/news/change-coming-to-department-of-health-leadership 2021-05-28T04:00:01+10:00 https://pharmadispatch.com/news/gsk-finds-a-buyer-for-melbourne-manufacturing-property 2021-05-28T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-builds-it-advocacy-capabilities 2021-05-28T04:00:01+10:00 https://pharmadispatch.com/news/perrigo-welcomes-the-pbs-listing-for-prevention-of-preterm-birth 2021-05-28T04:00:01+10:00 https://pharmadispatch.com/news/australia-clearly-breaching-its-obligations-under-us-trade-agree 2021-05-27T04:00:01+10:00 https://pharmadispatch.com/news/the-model-for-achieving-change 2021-05-27T04:00:01+10:00 https://pharmadispatch.com/news/repurposing-the-latest-example-of-departmental-overreach 2021-05-27T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-27-may-2021-1 2021-05-27T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-the-latest-company-to-launch-reflect-reconciliation-actio 2021-05-27T04:00:01+10:00 https://pharmadispatch.com/news/what-on-earth-is-going-on-in-this-system 2021-05-26T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-26-may-2021 2021-05-26T04:00:01+10:00 https://pharmadispatch.com/news/no-evidence-can-be-the-best-available-evidence 2021-05-26T04:00:01+10:00 https://pharmadispatch.com/news/new-office-in-sydneys-macquarie-park 2021-05-26T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-and-msd-support-beat-bladder-cancer-australia-on-annas-wa 2021-05-26T04:00:01+10:00 https://pharmadispatch.com/news/chimeric-therapeutics-updates-on-car-t-clinical-trial 2021-05-25T15:30:01+10:00 https://pharmadispatch.com/news/adalta-and-ge-healthcare-advance-candidate-to-pre-clinical-devel 2021-05-25T15:29:01+10:00 https://pharmadispatch.com/news/telixs-tlx66-meets-objectives-in-al-amyloidosis-safety-trial 2021-05-25T15:27:01+10:00 https://pharmadispatch.com/news/cancer-council-nsw-funds-new-research-into-advanced-melanoma 2021-05-25T15:03:01+10:00 https://pharmadispatch.com/news/microba-life-sciences-and-illumina-partner-to-accelerate-microbi 2021-05-25T15:02:01+10:00 https://pharmadispatch.com/news/remove-the-ministers-right-to-delegate-some-decision-making 2021-05-25T04:00:01+10:00 https://pharmadispatch.com/news/protections-the-government-has-moved-to-scrap 2021-05-25T04:00:01+10:00 https://pharmadispatch.com/news/new-leaders-to-growing-oncology-business 2021-05-25T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-25-may-2021 2021-05-25T04:00:01+10:00 https://pharmadispatch.com/news/it-was-unintentional-but-a-winner-take-all-tender 2021-05-25T04:00:01+10:00 https://pharmadispatch.com/news/gileads-global-getting-to-zero-grant-program 2021-05-25T04:00:01+10:00 https://pharmadispatch.com/news/spruiks-controversial-and-unproven-theory 2021-05-24T04:00:01+10:00 https://pharmadispatch.com/news/governments-non-use-of-cso-infrastructure 2021-05-24T04:00:01+10:00 https://pharmadispatch.com/news/more-strategic-approach-to-manufacturing 2021-05-24T04:00:01+10:00 https://pharmadispatch.com/news/cancer-therapy-might-point-to-a-wider-issue 2021-05-24T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-24-may-2021 2021-05-24T04:00:01+10:00 https://pharmadispatch.com/news/nz-budget-includes-pharmac-funding-boost 2021-05-21T04:00:01+10:00 https://pharmadispatch.com/news/a-culture-that-embraces-that 2021-05-21T04:00:01+10:00 https://pharmadispatch.com/news/masterclass-on-stewardship-and-achieving-system-level-change 2021-05-21T04:00:01+10:00 https://pharmadispatch.com/news/this-remarkable-inclusion-delivers-for-community-pharmacy 2021-05-21T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-seqirus-call-for 2021-05-21T04:00:01+10:00 https://pharmadispatch.com/news/technology-boosting-already-strong-clinical-trials-sector 2021-05-21T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-21-may-2021 2021-05-21T04:00:01+10:00 https://pharmadispatch.com/news/trust-and-performance-measures-are-missing 2021-05-20T04:00:01+10:00 https://pharmadispatch.com/news/nz-government-rushing-to-fix-legal-barrier-to-vaccine-rollout 2021-05-20T04:00:01+10:00 https://pharmadispatch.com/news/finding-some-common-ground-and-get-on-with-it 2021-05-20T04:00:01+10:00 https://pharmadispatch.com/news/an-opportunity-to-recognise-those-driving-innovation-in-medicine 2021-05-20T04:00:01+10:00 https://pharmadispatch.com/news/vaccine-leaders-reflect-on-a-year-that-started-very-differently 2021-05-20T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-and-cso-wholesalers-welcome-pfizer-return 2021-05-20T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-20-may-2021-1 2021-05-20T04:00:01+10:00 https://pharmadispatch.com/news/pbac-proposal-would-compel-a-minister-to-delist 2021-05-19T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-the-latest-to-front-parliamentary-inquiry 2021-05-19T04:00:01+10:00 https://pharmadispatch.com/news/ministers-job-to-make-difficult-decisions 2021-05-19T04:00:01+10:00 https://pharmadispatch.com/news/gbma-welcomes-a-new-board-member 2021-05-19T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-19-may-2021 2021-05-18T19:07:01+10:00 https://pharmadispatch.com/news/greg-hunts-opening-address-to-biopharmadispatch-2021 2021-05-18T04:00:01+10:00 https://pharmadispatch.com/news/lilly-scores-recognition-for-diversity-and-inclusion 2021-05-18T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-gsk-advance-covid-19-vaccine-to-late-stage-trial 2021-05-18T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-18-may-2021 2021-05-18T04:00:01+10:00 https://pharmadispatch.com/news/dksh-acquires-hahn-healthcare 2021-05-17T04:00:01+10:00 https://pharmadispatch.com/news/vaccine-program-will-quickly-slow 2021-05-17T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-17-may-2021 2021-05-17T04:00:01+10:00 https://pharmadispatch.com/news/pandemic-budget-industry-agreements-fair-prices-and-clinical-tri 2021-05-16T04:00:01+10:00 https://pharmadispatch.com/news/the-details-of-bpd-conference-2021-achieving-carbon-neutrality 2021-05-14T04:00:01+10:00 https://pharmadispatch.com/news/new-bureaucracy-for-supply-chains 2021-05-14T04:00:01+10:00 https://pharmadispatch.com/news/trade-deals-say-no-to-preferential-procurement 2021-05-14T04:00:01+10:00 https://pharmadispatch.com/news/approval-for-telixs-phase-three-prostate-cancer-trial 2021-05-14T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-14-may-2021 2021-05-14T04:00:01+10:00 https://pharmadispatch.com/news/a-natural-consequence-of-price-cut-reality 2021-05-13T04:00:01+10:00 https://pharmadispatch.com/news/achieving-carbon-neutrality 2021-05-13T04:00:01+10:00 https://pharmadispatch.com/news/new-listing-for-immunotherapy-combination 2021-05-13T04:00:01+10:00 https://pharmadispatch.com/news/urges-industry-support-for-new-fellowships 2021-05-13T04:00:01+10:00 https://pharmadispatch.com/news/demonstrate-against-pharmac 2021-05-13T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-13-may-2021 2021-05-13T04:00:01+10:00 https://pharmadispatch.com/news/opposition-to-vaccine-ip-waiver 2021-05-12T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-12-may-2021 2021-05-12T04:00:01+10:00 https://pharmadispatch.com/news/industry-policy-and-the-enduring-impact-of-price-reduction-polic 2021-05-12T04:00:01+10:00 https://pharmadispatch.com/news/budget-2021-22-the-stakeholder-response 2021-05-11T22:56:01+10:00 https://pharmadispatch.com/news/new-research-shows-potential-combinations-for-race-oncology-ther 2021-05-11T17:25:01+10:00 https://pharmadispatch.com/news/avance-clinical-expands-gene-technology-services 2021-05-11T17:22:01+10:00 https://pharmadispatch.com/news/prescient-signs-car-t-agreement-with-peter-mac-cancer-centre 2021-05-11T17:21:01+10:00 https://pharmadispatch.com/news/bionomics-expands-study-of-bnc210-to-include-social-anxiety-diso 2021-05-11T17:20:01+10:00 https://pharmadispatch.com/news/gsk-program-bridging-the-gap-between-academia-and-industry 2021-05-11T17:07:01+10:00 https://pharmadispatch.com/news/challenge-is-not-in-itself-evidence-of-a-problem 2021-05-11T04:00:01+10:00 https://pharmadispatch.com/news/budget-is-not-what-it-used-to-be 2021-05-11T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-11-may-2021 2021-05-11T04:00:01+10:00 https://pharmadispatch.com/news/confidentiality-protections-off-for-budget-week 2021-05-11T04:00:01+10:00 https://pharmadispatch.com/news/less-than-a-week-to-go 2021-05-10T05:00:01+10:00 https://pharmadispatch.com/news/processes-dressed-up-as-outcomes 2021-05-10T04:00:01+10:00 https://pharmadispatch.com/news/question-the-benefit-of-ip-waiver 2021-05-10T04:00:01+10:00 https://pharmadispatch.com/news/pre-budget-womens-health-package 2021-05-10T04:00:01+10:00 https://pharmadispatch.com/news/include-review-recommendations 2021-05-10T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-10-may-2021 2021-05-10T04:00:01+10:00 https://pharmadispatch.com/news/no-new-agreement-in-next-weeks-budget 2021-05-08T04:00:01+10:00 https://pharmadispatch.com/news/tokenism-is-easier-than-action-for-the-us-administration 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/industry-calls-out-governments-on-vaccine-in-response-to-waiver- 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/pbac-meets-ahead-of-next-weeks-2021-222-budget 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-7-may-2021 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/agreement-for-haemophilia-gene-therapy 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/government-extends-biosimilar-education-campaign 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/national-medicines-policy-review-essential 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/uptake-of-adalimumab-biosimilar 2021-05-07T04:00:01+10:00 https://pharmadispatch.com/news/medibank-raises-outlook-for-policyholder-growth 2021-05-06T07:59:01+10:00 https://pharmadispatch.com/news/nib-announces-the-sale-of-whitecoat-to-major-bank 2021-05-06T07:57:01+10:00 https://pharmadispatch.com/news/full-agenda-is-now-available 2021-05-06T04:00:01+10:00 https://pharmadispatch.com/news/use-of-some-medicines-in-aged-care-like-russian-roulette 2021-05-06T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-6-may-2021 2021-05-06T04:00:01+10:00 https://pharmadispatch.com/news/leukaemia-foundation-backs-blood-cancer-research-projects 2021-05-05T08:17:01+10:00 https://pharmadispatch.com/news/new-registration-in-male-prostate-cancer 2021-05-05T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-partnership-looks-to-fill-the-gap-in-screening 2021-05-05T04:00:01+10:00 https://pharmadispatch.com/news/not-just-an-island-nation-when-it-comes-to-geography 2021-05-05T04:00:01+10:00 https://pharmadispatch.com/news/operate-in-the-space-where-science-and-emotion-collide 2021-05-05T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-5-may-2021-1 2021-05-05T04:00:01+10:00 https://pharmadispatch.com/news/groups-call-for-immediate-action-on-aged-care-staffing-standard 2021-05-04T08:12:01+10:00 https://pharmadispatch.com/news/nasty-and-malevolent-new-low 2021-05-04T04:00:01+10:00 https://pharmadispatch.com/news/australian-drug-discovery-to-be-studied-in-the-us 2021-05-04T04:00:01+10:00 https://pharmadispatch.com/news/challenge-might-be-finding-the-facts 2021-05-04T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-4-may-2021 2021-05-04T04:00:01+10:00 https://pharmadispatch.com/news/lundbeck-australia-returns-to-redesigned-office 2021-05-04T04:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-looking-for-new-leadership 2021-05-04T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-30-april-2021 2021-05-03T04:00:01+10:00 https://pharmadispatch.com/news/waive-ip-rights-the-wrong-way-to-go 2021-05-03T04:00:01+10:00 https://pharmadispatch.com/news/gap-in-australians-access-heart-treatment 2021-05-03T03:00:01+10:00 https://pharmadispatch.com/news/will-this-review-be-any-different-to-all-the-others 2021-05-03T03:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-3-may-2021 2021-05-03T03:00:01+10:00 https://pharmadispatch.com/news/government-announces-details-of-new-chemotherapy-review 2021-05-03T03:00:01+10:00 https://pharmadispatch.com/news/patients-missing-out-as-pharmac-reveals-massive-funding-hole 2021-05-03T03:00:01+10:00 https://pharmadispatch.com/news/global-lilly-executive-returning-to-australia-as-regions-chief-m 2021-05-03T03:00:01+10:00 https://pharmadispatch.com/news/australian-childhood-immunisation-rates-continue-to-break-record 2021-05-02T09:35:01+10:00 https://pharmadispatch.com/news/psa-calls-for-action-on-medicines-safety-in-aged-care 2021-04-30T10:35:01+10:00 https://pharmadispatch.com/news/medicinal-cannabis-makes-it-onto-the-pbs 2021-04-30T09:27:01+10:00 https://pharmadispatch.com/news/new-approach-to-polypharmacy-in-seniors 2021-04-30T04:00:01+10:00 https://pharmadispatch.com/news/well-ahead-on-consumer-input 2021-04-30T04:00:01+10:00 https://pharmadispatch.com/news/being-pushed-at-the-worst-possible-time 2021-04-30T04:00:01+10:00 https://pharmadispatch.com/news/committee-asks-minister-to-respond-by-the-end-of-today 2021-04-30T04:00:01+10:00 https://pharmadispatch.com/news/a-very-stark-contrast-between-the-uk-and-australia 2021-04-29T04:00:01+10:00 https://pharmadispatch.com/news/sets-new-standard-for-covid-safe 2021-04-29T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-29-april-2021-1 2021-04-29T04:00:01+10:00 https://pharmadispatch.com/news/csl-funding-to-fast-track-australia-research-programs 2021-04-29T04:00:01+10:00 https://pharmadispatch.com/news/senate-committee-sends-greg-hunt-a-please-explain 2021-04-29T04:00:01+10:00 https://pharmadispatch.com/news/merck-ups-the-ante 2021-04-29T04:00:01+10:00 https://pharmadispatch.com/news/the-reconditioned-age-of-healthcare 2021-04-28T10:16:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-28-april-2021 2021-04-28T04:00:01+10:00 https://pharmadispatch.com/news/msd-sets-2025-as-the-target-for-carbon-neutrality 2021-04-28T04:00:01+10:00 https://pharmadispatch.com/news/the-ai-to-enhance-targeting-of-cancer-therapy 2021-04-28T04:00:01+10:00 https://pharmadispatch.com/news/long-battle-on-confidentiality-change 2021-04-28T04:00:01+10:00 https://pharmadispatch.com/news/heard-industry-concerns 2021-04-28T04:00:01+10:00 https://pharmadispatch.com/news/botanix-says-new-paper-supports-potential-of-its-antimicrobial-p 2021-04-27T10:49:01+10:00 https://pharmadispatch.com/news/nib-provides-business-update-and-full-year-outlook 2021-04-27T09:14:01+10:00 https://pharmadispatch.com/news/new-manufacturing-agreement-for-telix-pharmaceuticals 2021-04-27T09:00:01+10:00 https://pharmadispatch.com/news/great-place-to-work-is-about-more-than-the-benefits 2021-04-27T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-27-april-2021 2021-04-27T04:00:01+10:00 https://pharmadispatch.com/news/sigma-starts-the-search-for-a-new-ceo 2021-04-27T04:00:01+10:00 https://pharmadispatch.com/news/bpd-conference-2021-more-confirmed-speakers 2021-04-27T04:00:01+10:00 https://pharmadispatch.com/news/government-extends-medicare-benefits-for-telehealth-to-end-of-20 2021-04-26T15:41:01+10:00 https://pharmadispatch.com/news/march-2021-pbac-outcomes 2021-04-26T04:00:01+10:00 https://pharmadispatch.com/news/mixed-responses-on-march-outcomes 2021-04-26T04:00:01+10:00 https://pharmadispatch.com/news/proper-word-is-free-not-compassionate 2021-04-26T04:00:01+10:00 https://pharmadispatch.com/news/government-action-the-key-on-trials 2021-04-26T04:00:01+10:00 https://pharmadispatch.com/news/australian-approval-for-new-specialised-therapeutics-therapy 2021-04-26T04:00:01+10:00 https://pharmadispatch.com/news/aily-updates-on-covid-19-vaccine-25-april-2021 2021-04-26T04:00:01+10:00 https://pharmadispatch.com/news/at-home-health-to-include-dialysis 2021-04-26T04:00:01+10:00 https://pharmadispatch.com/news/australian-company-licenses-global-rights-to-potential-first-in- 2021-04-23T04:00:01+10:00 https://pharmadispatch.com/news/api-half-year-result-hit-by-impact-of-pandemic 2021-04-23T04:00:01+10:00 https://pharmadispatch.com/news/meningococcal-disease-appointments 2021-04-23T04:00:01+10:00 https://pharmadispatch.com/news/an-extended-collaboration-between-janssen-and-australian-researc 2021-04-23T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-23-april-2021-1 2021-04-23T04:00:01+10:00 https://pharmadispatch.com/news/case-study-in-how-to-present-the-industrys-perspective 2021-04-23T04:00:01+10:00 https://pharmadispatch.com/news/focus-on-impact-of-confidentiality-change 2021-04-23T04:00:01+10:00 https://pharmadispatch.com/news/stinging-critique-of-australias-decision-making 2021-04-22T14:00:01+10:00 https://pharmadispatch.com/news/chimeric-updates-on-cltx-car-t-cell-clinical-trial 2021-04-22T12:55:01+10:00 https://pharmadispatch.com/news/noxopharm-provides-interim-data-from-noxcovid-veyonda-trial 2021-04-22T12:53:01+10:00 https://pharmadispatch.com/news/federal-government-announces-development-of-a-ten-year-australia 2021-04-22T11:44:01+10:00 https://pharmadispatch.com/news/shifting-the-blame-for-access-delays 2021-04-22T10:16:01+10:00 https://pharmadispatch.com/news/closer-look-of-how-this-area-administers-information 2021-04-22T04:00:01+10:00 https://pharmadispatch.com/news/department-engaged-kpmg-to-audit-nps-over-use-of-grant 2021-04-22T04:00:01+10:00 https://pharmadispatch.com/news/victorian-government 2021-04-22T04:00:01+10:00 https://pharmadispatch.com/news/jj-tops-best-place-to-work-in-afr-list 2021-04-22T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-22-april-2021-1 2021-04-22T04:00:01+10:00 https://pharmadispatch.com/news/emyria-secures-placement-to-advance-development-and-expand-pipel 2021-04-21T11:50:01+10:00 https://pharmadispatch.com/news/at-risk-with-scrapping-of-confidentiality-protections 2021-04-21T04:00:01+10:00 https://pharmadispatch.com/news/australian-consultancy-merges-with-international-leader 2021-04-21T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-taps-company-leader 2021-04-21T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-21-april-2021-1 2021-04-21T04:00:01+10:00 https://pharmadispatch.com/news/race-oncology-appoints-chief-medical-officer 2021-04-20T13:30:01+10:00 https://pharmadispatch.com/news/exopharm-completes-12-million-capital-raise 2021-04-20T13:28:01+10:00 https://pharmadispatch.com/news/approach-worthy-of-a-great-public-health-program 2021-04-20T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-20-april-2021-1 2021-04-20T04:00:01+10:00 https://pharmadispatch.com/news/focus-on-change-and-stewardship 2021-04-20T04:00:01+10:00 https://pharmadispatch.com/news/protection-for-some-with-chronic-conditions 2021-04-20T04:00:01+10:00 https://pharmadispatch.com/news/telix-launches-international-noble-registry-of-spect-based-prost 2021-04-19T12:14:01+10:00 https://pharmadispatch.com/news/bupa-says-new-artificial-intelligence-powered-eye-test-a-healthc 2021-04-19T11:39:01+10:00 https://pharmadispatch.com/news/experienced-health-industry-executive-new-optiscan-chair 2021-04-19T11:30:01+10:00 https://pharmadispatch.com/news/medibank-elevates-chief-customer-officer-to-ceo 2021-04-19T10:34:01+10:00 https://pharmadispatch.com/news/australias-program-accelerates-as-it-approaches-60-day-mark 2021-04-19T04:00:01+10:00 https://pharmadispatch.com/news/overly-optimistic-and-unrealistic-claims 2021-04-19T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-19-april-2021 2021-04-19T04:00:01+10:00 https://pharmadispatch.com/news/scrapping-of-confidentiality-protections 2021-04-18T16:00:01+10:00 https://pharmadispatch.com/news/covax-further-isolates-australia 2021-04-16T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-april-2021 2021-04-16T04:00:01+10:00 https://pharmadispatch.com/news/tga-provisional-determination-a-very-encouraging-day 2021-04-16T04:00:01+10:00 https://pharmadispatch.com/news/new-cost-recovery-statement 2021-04-15T16:56:01+10:00 https://pharmadispatch.com/news/zelira-announces-record-revenue-in-the-march-quarter 2021-04-15T10:45:01+10:00 https://pharmadispatch.com/news/zelira-announces-record-revenue-in-the-march-quarter-1 2021-04-15T10:43:01+10:00 https://pharmadispatch.com/news/racgp-urges-those-eligible-to-come-forward-for-vaccine 2021-04-15T07:57:01+10:00 https://pharmadispatch.com/news/ama-outlines-cant-wait-reforms-to-fix-aged-care 2021-04-15T07:56:01+10:00 https://pharmadispatch.com/news/confidentiality-protections-removed 2021-04-15T04:00:01+10:00 https://pharmadispatch.com/news/this-is-why-the-industry-needs-to-be-worried 2021-04-15T04:00:01+10:00 https://pharmadispatch.com/news/bronchitol-rights-in-russia-and-completes-placement 2021-04-15T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-april-2021-1 2021-04-15T04:00:01+10:00 https://pharmadispatch.com/news/ma-chair-joins-board-of-emerging-local-biotech 2021-04-15T04:00:01+10:00 https://pharmadispatch.com/news/private-insurers-pushing-for-hta-and-pbs-pricing-on-medical-devi 2021-04-14T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-14-april-2021-1 2021-04-14T04:00:01+10:00 https://pharmadispatch.com/news/double-hit-for-new-zealand-cancer-patient 2021-04-14T04:00:01+10:00 https://pharmadispatch.com/news/pushes-back-on-removal-of-confidentiality-protections 2021-04-14T04:00:01+10:00 https://pharmadispatch.com/news/genetic-technologies-appoints-new-chief-financial-officer 2021-04-13T15:26:01+10:00 https://pharmadispatch.com/news/european-approval-for-anteotechs-covid-19-test 2021-04-13T15:24:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-13-april-2021 2021-04-13T04:00:01+10:00 https://pharmadispatch.com/news/no-fault-compensation 2021-04-13T04:00:01+10:00 https://pharmadispatch.com/news/extended-xtandi-registration 2021-04-13T04:00:01+10:00 https://pharmadispatch.com/news/majority-believe-health-is-an-investment 2021-04-12T12:41:01+10:00 https://pharmadispatch.com/news/trial-of-new-australian-covid-19-vaccine 2021-04-12T11:31:01+10:00 https://pharmadispatch.com/news/australian-discovery-could-speed-up-bone-implant-recovery 2021-04-12T09:24:01+10:00 https://pharmadispatch.com/news/bupa-announces-relief-for-flood-affected-customers-in-nsw-and-qu 2021-04-12T08:26:01+10:00 https://pharmadispatch.com/news/astrazeneca-oxford-vaccine-response-looks-like-panic 2021-04-12T04:00:01+10:00 https://pharmadispatch.com/news/largest-listing-day-in-pbs-history 2021-04-12T04:00:01+10:00 https://pharmadispatch.com/news/proposed-law-change-is-a-threat-but-also-an-opportunity 2021-04-12T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-12-april-2021 2021-04-12T04:00:01+10:00 https://pharmadispatch.com/news/trade-agreement-is-completely-false 2021-04-09T04:00:01+10:00 https://pharmadispatch.com/news/more-risk-for-government-this-time-around-in-ma-strategic-agreem 2021-04-09T04:00:01+10:00 https://pharmadispatch.com/news/not-enhance-transparency-of-decision-making 2021-04-09T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-april-2021-2 2021-04-09T04:00:01+10:00 https://pharmadispatch.com/news/scraps-october-timeline-after-accepting-atagi-advice-1 2021-04-09T04:00:01+10:00 https://pharmadispatch.com/news/latest-to-question-move-on-confidentiality-protections 2021-04-09T04:00:01+10:00 https://pharmadispatch.com/news/guilds-trent-twomey-1 2021-04-08T04:00:01+10:00 https://pharmadispatch.com/news/unilaterally-disclose-confidential-prices 2021-04-08T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-april-2021 2021-04-08T04:00:01+10:00 https://pharmadispatch.com/news/industry-and-advocacy-groups-say-change-threatens-access 2021-04-08T04:00:01+10:00 https://pharmadispatch.com/news/gmhba-announces-a-new-member-of-board-of-directors 2021-04-07T10:03:01+10:00 https://pharmadispatch.com/news/nib-marks-one-year-of-providing-covid-19-support 2021-04-07T09:52:01+10:00 https://pharmadispatch.com/news/guilds-trent-twomey 2021-04-07T04:00:01+10:00 https://pharmadispatch.com/news/challenges-government-on-pace-of-vaccine-rollout 2021-04-07T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-7-april-2021 2021-04-07T04:00:01+10:00 https://pharmadispatch.com/news/national-trade-estimate-report 2021-04-07T04:00:01+10:00 https://pharmadispatch.com/news/this-is-the-confidentiality-end-of-days 2021-04-07T04:00:01+10:00 https://pharmadispatch.com/news/exopharm-announces-preclinical-data-from-osteoarthritis-animal-s 2021-04-06T15:40:01+10:00 https://pharmadispatch.com/news/gene-discovery-suggests-new-treatment-approach-for-liver-cancer 2021-04-06T12:09:01+10:00 https://pharmadispatch.com/news/new-data-moves-noxopharm-to-protect-veyonda-in-septic-shock-trea 2021-04-06T09:07:01+10:00 https://pharmadispatch.com/news/early-vaccine-goals-were-predictably-unrealistic 2021-04-06T04:00:01+10:00 https://pharmadispatch.com/news/confidentiality-is-not-a-market-access-discussion 2021-04-06T04:00:01+10:00 https://pharmadispatch.com/news/is-the-rollout-being-adjusted-to-fit-the-governments-language 2021-04-06T04:00:01+10:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-6-april-2021 2021-04-06T04:00:01+10:00 https://pharmadispatch.com/news/comparison-of-device-prices-show-australia-pays-more 2021-04-04T09:40:01+10:00 https://pharmadispatch.com/news/novartis-welcomes-expanded-listing 2021-04-01T04:00:01+11:00 https://pharmadispatch.com/news/the-law-gives-companies-the-power 2021-04-01T04:00:01+11:00 https://pharmadispatch.com/news/world-first-trial-for-australian-company-pharmaxis 2021-04-01T04:00:01+11:00 https://pharmadispatch.com/news/department-publishes-july-pbac-agenda 2021-04-01T04:00:01+11:00 https://pharmadispatch.com/news/roche-has-announced 2021-04-01T04:00:01+11:00 https://pharmadispatch.com/news/abbott 2021-03-31T13:22:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-1-april-2021 2021-03-31T12:25:01+11:00 https://pharmadispatch.com/news/oneview-launches-cloud-based-care-experience-platform 2021-03-31T10:45:01+11:00 https://pharmadispatch.com/news/swinburne-and-medibank-extend-first-of-its-kind-partnership 2021-03-31T10:37:01+11:00 https://pharmadispatch.com/news/2021-22-budget-must-include-device-reform 2021-03-31T10:22:01+11:00 https://pharmadispatch.com/news/httpstelixpharmacom 2021-03-31T10:11:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-31-march-2021 2021-03-31T04:00:01+11:00 https://pharmadispatch.com/news/four-companies-are-lined-up-and-ready 2021-03-31T04:00:01+11:00 https://pharmadispatch.com/news/clock-is-ticking-on-negotiations 2021-03-31T04:00:01+11:00 https://pharmadispatch.com/news/labor-looks-to-medicines-in-new-manufacturing-plan 2021-03-31T04:00:01+11:00 https://pharmadispatch.com/news/starpharmas-covid-19-nasal-spray 2021-03-31T04:00:01+11:00 https://pharmadispatch.com/news/extended-immunotherapy-listing 2021-03-31T04:00:01+11:00 https://pharmadispatch.com/news/inquiry-oblivious-to-the-substance-of-agreement-negotiations 2021-03-30T04:00:01+11:00 https://pharmadispatch.com/news/provide-the-advice 2021-03-30T04:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-new-adrenaline-autoinjectors 2021-03-30T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-30-march-2021 2021-03-30T04:00:01+11:00 https://pharmadispatch.com/news/reform-of-device-pricing-essential 2021-03-29T15:24:01+11:00 https://pharmadispatch.com/news/demoted-to-industry-portfolio 2021-03-29T15:03:01+11:00 https://pharmadispatch.com/news/medibank-announces-support-for-customers-in-flood-affected-areas 2021-03-29T11:47:01+11:00 https://pharmadispatch.com/news/bupa-says-it-is-looking-to-do-more-on-more-environmental-initiat 2021-03-29T11:30:01+11:00 https://pharmadispatch.com/news/emyria-and-cann-group-to-partner-on-medicine-cbd-product-registr 2021-03-29T10:37:01+11:00 https://pharmadispatch.com/news/stemple-says-abbvie-is-ready-for-humira-biosimilars 2021-03-29T04:00:01+11:00 https://pharmadispatch.com/news/biosimilar-adalimumabs-all-set-to-go-against-new-humira-formulat 2021-03-29T04:00:01+11:00 https://pharmadispatch.com/news/australia-company-says-bms-study-validates-its-own-technology 2021-03-29T04:00:01+11:00 https://pharmadispatch.com/news/april-2021-listings 2021-03-29T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-29-march-2021-2 2021-03-29T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-biointelect-roundtable 2021-03-29T04:00:01+11:00 https://pharmadispatch.com/news/ma-delivers-inquiry-a-very-simple-message 2021-03-29T04:00:01+11:00 https://pharmadispatch.com/news/lauren-carey-1 2021-03-26T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-26-march-2021 2021-03-26T04:00:01+11:00 https://pharmadispatch.com/news/new-zealands-pharmac 2021-03-26T04:00:01+11:00 https://pharmadispatch.com/news/vertex-regulatory 2021-03-26T04:00:01+11:00 https://pharmadispatch.com/news/australian-patients-association 2021-03-26T04:00:01+11:00 https://pharmadispatch.com/news/committee-would-like-to-see-from-zimmerman 2021-03-25T04:00:01+11:00 https://pharmadispatch.com/news/on-the-way-to-pbs-reimbursement 2021-03-25T04:00:01+11:00 https://pharmadispatch.com/news/post-market-a-remarkable-coincidence 2021-03-25T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-25-march-2021 2021-03-25T04:00:01+11:00 https://pharmadispatch.com/news/wes-cook 2021-03-25T04:00:01+11:00 https://pharmadispatch.com/news/clinuvel-expands-dna-repair-program 2021-03-24T11:26:01+11:00 https://pharmadispatch.com/news/first-australian-produced-covid-19-vaccine-doses-released 2021-03-24T09:19:01+11:00 https://pharmadispatch.com/news/nib-foundation-appoints-two-new-directors 2021-03-24T09:03:01+11:00 https://pharmadispatch.com/news/mrff-backs-development-of-devices-through-to-early-stage-manufac 2021-03-24T08:56:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-24-march-2021 2021-03-24T04:00:01+11:00 https://pharmadispatch.com/news/companies-acting-to-reduce-and-offset-their-carbon-footprint-4 2021-03-24T04:00:01+11:00 https://pharmadispatch.com/news/department-of-healths-turn-to-front-senate-estimates 2021-03-24T04:00:01+11:00 https://pharmadispatch.com/news/wholesalers-working-to-ensure-supply-in-response-to-floods 2021-03-24T04:00:01+11:00 https://pharmadispatch.com/news/multiple-strategies-including-effective-treatment-options-needed 2021-03-23T12:27:01+11:00 https://pharmadispatch.com/news/respiri-receives-us-fda-clearance-for-wheezo-and-app 2021-03-23T11:57:01+11:00 https://pharmadispatch.com/news/companies-acting-to-reduce-and-offset-their-carbon-footprint-3 2021-03-23T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-23-march-2021 2021-03-23T04:00:01+11:00 https://pharmadispatch.com/news/wales-extends-new-treatment-fund 2021-03-23T04:00:01+11:00 https://pharmadispatch.com/news/all-stakeholders-should-be-aware-of-evidence 2021-03-23T04:00:01+11:00 https://pharmadispatch.com/news/ma-pre-budget-submission 2021-03-23T04:00:01+11:00 https://pharmadispatch.com/news/an-estimated-5-million-australians-claim-sleep-impacted-by-covid 2021-03-22T13:51:01+11:00 https://pharmadispatch.com/news/antisense-therapeutics-appoints-new-non-executive-director 2021-03-22T13:33:01+11:00 https://pharmadispatch.com/news/public-hospital-waits-trigger-risky-buy-now-pay-later-healthcare 2021-03-22T11:24:01+11:00 https://pharmadispatch.com/news/standing-up-against-sexism 2021-03-22T10:45:01+11:00 https://pharmadispatch.com/news/nyrada-raises-11-million-in-new-placement 2021-03-22T09:39:01+11:00 https://pharmadispatch.com/news/undermine-confidence-in-inquiry-outcome 2021-03-22T04:00:01+11:00 https://pharmadispatch.com/news/challenging-path-to-the-pbs 2021-03-22T04:00:01+11:00 https://pharmadispatch.com/news/companies-acting-to-reduce-and-offset-their-carbon-footprint-2 2021-03-22T04:00:01+11:00 https://pharmadispatch.com/news/novartis-oncology-leader-joins-board-of-local-biotech 2021-03-22T04:00:01+11:00 https://pharmadispatch.com/news/trent-twomey-new-pharmacy-guild-national-president 2021-03-22T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-22-march-2021 2021-03-22T04:00:01+11:00 https://pharmadispatch.com/news/new-australian-first-vaccine-in-the-fight-against-influenza 2021-03-22T04:00:01+11:00 https://pharmadispatch.com/news/time-to-get-australias-oral-health-back-on-track 2021-03-21T16:20:01+11:00 https://pharmadispatch.com/news/chiesi-announces-us-launch-of-pharmaxis-bronchitol 2021-03-21T16:11:01+11:00 https://pharmadispatch.com/news/adherium-secures-18-million-commitment-in-share-placement 2021-03-21T16:05:01+11:00 https://pharmadispatch.com/news/tsunami-of-diabetes-in-nz-and-calls-for-better-approach-to-medic 2021-03-19T04:00:01+11:00 https://pharmadispatch.com/news/innovation-and-the-opportunity-for-change 2021-03-19T04:00:01+11:00 https://pharmadispatch.com/news/companies-acting-to-reduce-and-offset-their-carbon-footprint-1 2021-03-19T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-19-march-2021 2021-03-19T04:00:01+11:00 https://pharmadispatch.com/news/new-report-reveals-worsening-health-during-the-pandemic 2021-03-18T12:56:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-appoints-experienced-us-biotech-executive-to-it 2021-03-18T09:31:01+11:00 https://pharmadispatch.com/news/microba-life-sciences-partners-with-unilever-to-target-sleep-thr 2021-03-18T09:30:01+11:00 https://pharmadispatch.com/news/alessa-therapeutics-announces-australia-nz-prostate-cancer-trial 2021-03-18T09:29:01+11:00 https://pharmadispatch.com/news/vaccine-suspension-triggers-bitter-dispute-between-countries 2021-03-18T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-18-march-2021 2021-03-18T04:00:01+11:00 https://pharmadispatch.com/news/government-announces-grants-for-new-mental-health-therapies 2021-03-17T12:19:01+11:00 https://pharmadispatch.com/news/criticism-of-limited-pharmac-review 2021-03-17T10:23:01+11:00 https://pharmadispatch.com/news/companies-acting-to-reduce-and-offset-their-carbon-footprint 2021-03-17T10:08:01+11:00 https://pharmadispatch.com/news/medibank-forms-new-short-stay-no-gap-hospital-joint-venture 2021-03-17T10:02:01+11:00 https://pharmadispatch.com/news/janssens-biljana-naumovic 2021-03-17T04:00:01+11:00 https://pharmadispatch.com/news/carbon-footprint 2021-03-17T04:00:01+11:00 https://pharmadispatch.com/news/new-collaboration-between-australian-company-and-msd 2021-03-17T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-17-march-2021 2021-03-17T04:00:01+11:00 https://pharmadispatch.com/news/new-collaboration-between-immutep-and-msd 2021-03-16T10:38:01+11:00 https://pharmadispatch.com/news/not-the-first-and-not-the-last 2021-03-16T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-16-march-2021 2021-03-16T04:00:01+11:00 https://pharmadispatch.com/news/financed-access-highlights-the-challenges 2021-03-16T04:00:01+11:00 https://pharmadispatch.com/news/late-stage-study-of-eye-therapy 2021-03-15T18:27:01+11:00 https://pharmadispatch.com/news/new-reports-reveals-potential-benefit-of-early-intervention-on-h 2021-03-15T18:02:01+11:00 https://pharmadispatch.com/news/bupa-on-preventing-the-silent-thief-of-sight 2021-03-15T16:21:01+11:00 https://pharmadispatch.com/news/monash-university-researchers-discover-potential-therapeutic-tar 2021-03-15T10:11:01+11:00 https://pharmadispatch.com/news/amgens-ian-noble 2021-03-15T04:00:01+11:00 https://pharmadispatch.com/news/public-hearings 2021-03-15T04:00:01+11:00 https://pharmadispatch.com/news/pecialised-therapeutics-australia-sta-and-latitude-finance 2021-03-15T04:00:01+11:00 https://pharmadispatch.com/news/not-waiting-for-policy-response-to-access-gap 2021-03-15T04:00:01+11:00 https://pharmadispatch.com/news/carlo-montagner-bridging-the-access-gap-for-new-therapies 2021-03-15T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-15-march-2021 2021-03-15T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-12-march-2021 2021-03-12T04:00:01+11:00 https://pharmadispatch.com/news/parliamentary-inquiry-1 2021-03-12T04:00:01+11:00 https://pharmadispatch.com/news/australians-deserve-faster-access-to-new-medicines 2021-03-12T04:00:01+11:00 https://pharmadispatch.com/news/expert-leadership-forum-announced-to-drive-industrys-biotech-blu 2021-03-12T04:00:01+11:00 https://pharmadispatch.com/news/senate-covid-19-vaccines 2021-03-12T04:00:01+11:00 https://pharmadispatch.com/news/wholesalers-start-rollout-of-annual-flu-vaccine-to-pharmacy 2021-03-12T04:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-announces-a-new-plan-for-national-conference 2021-03-12T04:00:01+11:00 https://pharmadispatch.com/news/neuren-completes-drug-substance-manufacturing-for-nnz-2591-trial 2021-03-11T14:04:01+11:00 https://pharmadispatch.com/news/bpd-conference-to-be-certified-carbon-neutral 2021-03-11T05:01:01+11:00 https://pharmadispatch.com/news/five-year-anniversary-of-watershed-pbs-listing 2021-03-11T05:01:01+11:00 https://pharmadispatch.com/news/how-will-such-a-wide-range-of-issues-turn-into-actual-change 2021-03-11T05:01:01+11:00 https://pharmadispatch.com/news/new-mtpconnect-report-highlights-skill-gap 2021-03-11T05:01:01+11:00 https://pharmadispatch.com/news/new-mtpconnect-report-highlights-skill-gap-1 2021-03-11T05:01:01+11:00 https://pharmadispatch.com/news/covid-19-variants-point-to-the-need-for-an-ongoing-vaccine-suppl 2021-03-11T05:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-11-march-2021 2021-03-11T04:00:01+11:00 https://pharmadispatch.com/news/new-nib-foundation-grants 2021-03-10T09:35:01+11:00 https://pharmadispatch.com/news/msd-michael-azrak 2021-03-10T04:00:01+11:00 https://pharmadispatch.com/news/the-government-is-telling-you-how-to-get-an-uncapped-price-premi 2021-03-10T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-10-march-2021-2 2021-03-10T04:00:01+11:00 https://pharmadispatch.com/news/european-protection-for-cartherics-cell-therapy 2021-03-10T04:00:01+11:00 https://pharmadispatch.com/news/azura-ophthalmics-announces-positive-results-in-phase-two-progra 2021-03-09T15:34:01+11:00 https://pharmadispatch.com/news/enhancing-regulatory-and-reimbursement-processes 2021-03-09T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-10-march-2021-1 2021-03-09T04:00:01+11:00 https://pharmadispatch.com/news/paig-iwd-2021 2021-03-09T04:00:01+11:00 https://pharmadispatch.com/news/time-for-intervention-on-this-unlawful-exercise-of-power 2021-03-09T04:00:01+11:00 https://pharmadispatch.com/news/carina-biotech 2021-03-08T12:59:01+11:00 https://pharmadispatch.com/news/bupas-emily-amos-on-the-need-for-bold-reform 2021-03-08T11:35:01+11:00 https://pharmadispatch.com/news/noxopharm-noxcovid-1-clinical-trial 2021-03-08T10:26:01+11:00 https://pharmadispatch.com/news/tests-for-campaign 2021-03-08T04:00:01+11:00 https://pharmadispatch.com/news/vaccine-deaths-1 2021-03-08T04:00:01+11:00 https://pharmadispatch.com/news/should-we-really-be-surprised 2021-03-08T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-8-march-2021 2021-03-08T04:00:01+11:00 https://pharmadispatch.com/news/hbf-dental 2021-03-06T11:37:01+11:00 https://pharmadispatch.com/news/merck-international-womens-day 2021-03-05T11:04:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-5-march-2021 2021-03-05T04:00:01+11:00 https://pharmadispatch.com/news/surprising-covid-19-vaccines 2021-03-05T04:00:01+11:00 https://pharmadispatch.com/news/guild-welcomes-legislation 2021-03-05T04:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-director 2021-03-05T04:00:01+11:00 https://pharmadispatch.com/news/research-reveals-potential-risk-factors-for-nerve-damage-after-c 2021-03-04T11:53:01+11:00 https://pharmadispatch.com/news/research-identifies-cause-and-potential-treatment-for-covid-19-i 2021-03-04T09:13:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-4-march-2021 2021-03-04T04:00:01+11:00 https://pharmadispatch.com/news/world-obesity-day-2021 2021-03-04T04:00:01+11:00 https://pharmadispatch.com/news/pharmac-patient-call-for-action 2021-03-04T04:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-welcomes-support-for-reform-of-odtp 2021-03-04T04:00:01+11:00 https://pharmadispatch.com/news/kazia-therapeutics 2021-03-04T04:00:01+11:00 https://pharmadispatch.com/news/abbvie-mardi-gras-extravaganza 2021-03-04T04:00:01+11:00 https://pharmadispatch.com/news/chermside-day-hospital 2021-03-03T17:12:01+11:00 https://pharmadispatch.com/news/red-havas 2021-03-03T11:58:01+11:00 https://pharmadispatch.com/news/weight-loss-trial-combines-science-with-telehealth 2021-03-03T10:33:01+11:00 https://pharmadispatch.com/news/nib-commits-to-carbon-neutral-by-2022 2021-03-03T10:03:01+11:00 https://pharmadispatch.com/news/bupa-royal-commission-a-once-in-a-generation-opportunity 2021-03-03T09:49:01+11:00 https://pharmadispatch.com/news/hbf-returning-surplus-funds-from-pandemic-to-members 2021-03-03T09:35:01+11:00 https://pharmadispatch.com/news/limit-the-scope-of-pharmac-review 2021-03-03T04:00:01+11:00 https://pharmadispatch.com/news/review-does-not-appear-serious 2021-03-03T04:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-3-march-2021 2021-03-03T04:00:01+11:00 https://pharmadispatch.com/news/senate-inquiry-csl 2021-03-03T04:00:01+11:00 https://pharmadispatch.com/news/australia-the-first-country-to-access-faster-acting-vitamin-d 2021-03-03T04:00:01+11:00 https://pharmadispatch.com/news/gbma-medicine-medical-product-manufacturing-road-map 2021-03-02T11:58:01+11:00 https://pharmadispatch.com/news/cynata-therapeutics 2021-03-02T09:32:01+11:00 https://pharmadispatch.com/news/osprey-expands-us-sales-coverage-with-new-sales-agency-agreement 2021-03-02T09:06:01+11:00 https://pharmadispatch.com/news/two-weeks-to-not-answer 2021-03-02T03:00:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-2-march-2021 2021-03-02T03:00:01+11:00 https://pharmadispatch.com/news/companies-face-coercion-on-risk-shares-and-new-listings 2021-03-02T03:00:01+11:00 https://pharmadispatch.com/news/story-telling-is-now-part-of-the-job-for-medical-directors 2021-03-02T03:00:01+11:00 https://pharmadispatch.com/news/royal-commissions-final-report 2021-03-01T16:40:01+11:00 https://pharmadispatch.com/news/extended-pbs-listing-for-lillys-trulicity 2021-03-01T15:17:01+11:00 https://pharmadispatch.com/news/clinicians-and-patients-welcome-new-option-for-ms-patients 2021-03-01T13:17:01+11:00 https://pharmadispatch.com/news/wavelink-launches-connected-health-business-unit 2021-03-01T13:02:01+11:00 https://pharmadispatch.com/news/new-data-reveals-australians-most-at-risk-of-heart-attack-stroke 2021-03-01T12:50:01+11:00 https://pharmadispatch.com/news/australian-breast-device-registry-helps-with-patient-safety 2021-03-01T12:43:01+11:00 https://pharmadispatch.com/news/botanix-expands-its-management-team 2021-03-01T12:23:01+11:00 https://pharmadispatch.com/news/industry-leader-backs-focus-on-manufacturing-expansion 2021-03-01T09:25:01+11:00 https://pharmadispatch.com/news/daily-updates-on-covid-19-vaccine-manufacturing-supply-and-admin 2021-03-01T04:00:01+11:00 https://pharmadispatch.com/news/patient-groups-sign-up 2021-03-01T04:00:01+11:00 https://pharmadispatch.com/news/arrival-of-anticipated-biosimilars 2021-03-01T04:00:01+11:00 https://pharmadispatch.com/news/listing-the-best-news-ever 2021-03-01T04:00:01+11:00 https://pharmadispatch.com/news/bi-new-propellant-free-inhaler 2021-03-01T04:00:01+11:00 https://pharmadispatch.com/news/funding-for-advances-in-medical-research-technology 2021-02-28T14:25:01+11:00 https://pharmadispatch.com/news/multi-dose-vial 2021-02-26T04:00:01+11:00 https://pharmadispatch.com/news/pharmac-epilepsy 2021-02-26T04:00:01+11:00 https://pharmadispatch.com/news/key-biologic-makes-it-to-the-pbs 2021-02-26T04:00:01+11:00 https://pharmadispatch.com/news/htanalysts-and-greg-otoole 2021-02-25T04:00:01+11:00 https://pharmadispatch.com/news/zimmerman-inquirypublic-hearings 2021-02-25T04:00:01+11:00 https://pharmadispatch.com/news/an-interesting-time 2021-02-25T04:00:01+11:00 https://pharmadispatch.com/news/cochlear-fda-approval 2021-02-24T11:10:01+11:00 https://pharmadispatch.com/news/opthea-confirms-plans-and-protocols 2021-02-24T10:52:01+11:00 https://pharmadispatch.com/news/apra-pandemic-has-had-a-material-effect-on-private-health-insure 2021-02-24T10:42:01+11:00 https://pharmadispatch.com/news/medibank-half-year-result-confirms-return-to-policyholder-growth 2021-02-24T10:02:01+11:00 https://pharmadispatch.com/news/medibank-ceo-craig-drummond-to-retire-from-company 2021-02-24T10:00:01+11:00 https://pharmadispatch.com/news/workplace-gender-equality-agency 2021-02-24T04:00:01+11:00 https://pharmadispatch.com/news/medical-device-reform 2021-02-24T04:00:01+11:00 https://pharmadispatch.com/news/tga-new-medicines 2021-02-24T04:00:01+11:00 https://pharmadispatch.com/news/pyc-therapeutic-appoints-experienced-executive-as-chief-developm 2021-02-23T10:23:01+11:00 https://pharmadispatch.com/news/medibank-backed-report-leads-to-call-for-action-on-loneliness 2021-02-23T09:51:01+11:00 https://pharmadispatch.com/news/pharmaxis-pxs5505 2021-02-23T05:00:01+11:00 https://pharmadispatch.com/news/bpd-conference 2021-02-23T04:00:01+11:00 https://pharmadispatch.com/news/symbion-to-trial-medicine-drone-delivery-in-regional-queensland 2021-02-23T04:00:01+11:00 https://pharmadispatch.com/news/nib-half-year-result-hit-by-malign-impact-of-pandemic 2021-02-22T12:18:01+11:00 https://pharmadispatch.com/news/refusing-to-answer 2021-02-22T04:00:01+11:00 https://pharmadispatch.com/news/australia-launches-program 2021-02-22T04:00:01+11:00 https://pharmadispatch.com/news/disrespect 2021-02-20T06:00:01+11:00 https://pharmadispatch.com/news/csl-reveals-the-extent-of-covid-19-vaccine-program-1 2021-02-19T04:00:01+11:00 https://pharmadispatch.com/news/terrywhite-chemmart 2021-02-19T04:00:01+11:00 https://pharmadispatch.com/news/patients-are-still-waiting 2021-02-19T04:00:01+11:00 https://pharmadispatch.com/news/medlab-and-arrotex 2021-02-19T04:00:01+11:00 https://pharmadispatch.com/news/ohe-research-papers 2021-02-18T04:00:01+11:00 https://pharmadispatch.com/news/uk-life-sciences 2021-02-18T04:00:01+11:00 https://pharmadispatch.com/news/bluebird-bio 2021-02-18T04:00:01+11:00 https://pharmadispatch.com/news/stlukeshealth-paul-lupo-we-need-to-change-the-status-quo 2021-02-17T17:58:01+11:00 https://pharmadispatch.com/news/bupa-dumps-unsustainable-bags-from-store-network 2021-02-17T11:23:01+11:00 https://pharmadispatch.com/news/your-intellectual-property-is-vital-are-you-keeping-it-safe 2021-02-17T11:00:01+11:00 https://pharmadispatch.com/news/czech-republic-authorises-telixs-prostate-cancer-imaging-product 2021-02-17T10:27:01+11:00 https://pharmadispatch.com/news/bionomics 2021-02-17T10:17:01+11:00 https://pharmadispatch.com/news/stewardship 2021-02-17T04:00:01+11:00 https://pharmadispatch.com/news/language-matters 2021-02-17T04:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-criticism 2021-02-17T04:00:01+11:00 https://pharmadispatch.com/news/pbac-review 2021-02-16T04:00:01+11:00 https://pharmadispatch.com/news/psa-odtp 2021-02-16T04:00:01+11:00 https://pharmadispatch.com/news/smoking-cessation 2021-02-16T04:00:01+11:00 https://pharmadispatch.com/news/orthocell-1 2021-02-15T12:19:01+11:00 https://pharmadispatch.com/news/medibanks 2021-02-15T11:42:01+11:00 https://pharmadispatch.com/news/greg-hunt-launches-new-online-tool-to-help-navigate-ivf 2021-02-15T11:22:01+11:00 https://pharmadispatch.com/news/antisense-therapeutics 2021-02-15T10:58:01+11:00 https://pharmadispatch.com/news/neuren-pharmaceuticals 2021-02-15T10:04:01+11:00 https://pharmadispatch.com/news/bupa-announces-premium-release-for-bushfire-victims 2021-02-15T09:39:01+11:00 https://pharmadispatch.com/news/novo-nordisk 2021-02-15T05:00:01+11:00 https://pharmadispatch.com/news/make-the-change 2021-02-15T05:00:01+11:00 https://pharmadispatch.com/news/slow-progress 2021-02-15T05:00:01+11:00 https://pharmadispatch.com/news/avita-medical-reports-significant-jump-in-revenue 2021-02-14T14:28:01+11:00 https://pharmadispatch.com/news/cochlear 2021-02-14T14:11:01+11:00 https://pharmadispatch.com/news/tga-approves-first-australian-commercial-car-t-manufacturing-sit 2021-02-12T09:00:01+11:00 https://pharmadispatch.com/news/chf-joins-growing-call-for-reform-of-opiate-dependence-program 2021-02-12T05:00:01+11:00 https://pharmadispatch.com/news/more-senior-leaders-confirmed-for-2021-biopharmadispatch-confere 2021-02-12T04:00:01+11:00 https://pharmadispatch.com/news/india-aims-to-be-home-to-even-more-medicine-manufacturing 2021-02-12T04:00:01+11:00 https://pharmadispatch.com/news/biointelect-expands-organisation-with-industry-executive-joining 2021-02-12T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-existing-legal-authority-gives-me-the-power-to-deregul 2021-02-11T04:00:01+11:00 https://pharmadispatch.com/news/gsk-launches-this-years-investigator-sponsored-studies-program 2021-02-11T04:00:01+11:00 https://pharmadispatch.com/news/march-looking-more-likely-on-covid-19-immunisation-program 2021-02-11T04:00:01+11:00 https://pharmadispatch.com/news/you-have-these-powers-minister-and-you-used-it-for-this 2021-02-11T04:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-funding-for-cardiovascular-device-clinical-trial-coll 2021-02-10T11:30:01+11:00 https://pharmadispatch.com/news/research-funding-and-advocacy-support-for-genetic-condition 2021-02-10T11:23:01+11:00 https://pharmadispatch.com/news/greg-hunt-launches-first-part-of-multi-year-national-health-surv 2021-02-10T11:21:01+11:00 https://pharmadispatch.com/news/walked-up-the-government-funded-path-to-addiction-and-then-aband 2021-02-10T04:00:01+11:00 https://pharmadispatch.com/news/advocacy-groups-calls-for-immediate-moratorium-on-unlawful-fees 2021-02-10T04:00:01+11:00 https://pharmadispatch.com/news/first-export-to-the-us-triggers-milestone-payment-for-pharmaxis 2021-02-09T11:15:01+11:00 https://pharmadispatch.com/news/biocurate-says-it-eyes-next-phase-of-growth-with-appointment-of- 2021-02-09T10:23:01+11:00 https://pharmadispatch.com/news/we-need-time-to-find-the-document-establishing-the-program 2021-02-09T04:00:01+11:00 https://pharmadispatch.com/news/grossly-unfair-and-it-needs-to-change 2021-02-09T04:00:01+11:00 https://pharmadispatch.com/news/a-new-name-for-osteoporosis-australia-as-it-moves-to-focus-on-bo 2021-02-09T04:00:01+11:00 https://pharmadispatch.com/news/members-health-australians-living-in-a-fools-paradise-about-heal 2021-02-08T13:21:01+11:00 https://pharmadispatch.com/news/government-moves-to-formally-remove-pbs-co-payments-and-safety-n 2021-02-08T04:04:01+11:00 https://pharmadispatch.com/news/response-to-estimates-confusion-was-to-quickly-move-to-make-prog 2021-02-08T04:00:01+11:00 https://pharmadispatch.com/news/how-they-are-proposing-to-formally-remove-patient-rights 2021-02-08T04:00:01+11:00 https://pharmadispatch.com/news/government-moves-to-formally-remove-pbs-co-payments-and-safety-n 2021-02-08T04:00:01+11:00 https://pharmadispatch.com/news/the-parliament-has-been-denied-the-right-to-scrutinise-these-arr 2021-02-05T12:23:01+11:00 https://pharmadispatch.com/news/orthocell 2021-02-05T11:24:01+11:00 https://pharmadispatch.com/news/medibank-acquires-stake-in-primary-care-clinic-operator 2021-02-05T11:16:01+11:00 https://pharmadispatch.com/news/this-program-is-not-just-discriminatory-it-is-unlawful 2021-02-05T04:00:01+11:00 https://pharmadispatch.com/news/bms-in-new-collaboration-for-covid-19-antibody-treatment 2021-02-05T04:00:01+11:00 https://pharmadispatch.com/news/martin-palin-the-best-public-relations-is-going-the-right-thing 2021-02-05T04:00:01+11:00 https://pharmadispatch.com/news/i-am-sorry-greg-hunt-was-given-this-response-to-provide 2021-02-05T04:00:01+11:00 https://pharmadispatch.com/news/major-new-consultancy-acquisition-for-commercial-eyes 2021-02-04T18:02:01+11:00 https://pharmadispatch.com/news/experienced-medtech-executive-sue-macleman-appointed-to-board-of 2021-02-04T17:10:01+11:00 https://pharmadispatch.com/news/pandemic-has-created-a-new-normal-but-cancer-threat-remains-the- 2021-02-04T04:00:01+11:00 https://pharmadispatch.com/news/jane-halton-the-importance-of-a-mature-dialogue-about-stewardshi 2021-02-04T04:00:01+11:00 https://pharmadispatch.com/news/how-does-this-discriminatory-program-even-exist 2021-02-04T04:00:01+11:00 https://pharmadispatch.com/news/australian-developed-covid-nasal-spray-set-to-land-in-europe-in- 2021-02-03T16:07:01+11:00 https://pharmadispatch.com/news/private-insurers-reject-scare-campaign-on-medical-device-reforms 2021-02-03T10:49:01+11:00 https://pharmadispatch.com/news/health-services-urged-to-resume-face-to-face-rehab-for-heart-pat 2021-02-03T10:38:01+11:00 https://pharmadispatch.com/news/bpd-conference-when-how-and-why-did-it-all-start-on-industry-agr 2021-02-03T04:00:01+11:00 https://pharmadispatch.com/news/the-daily-challenge-of-australias-ambitious-covid-19-vaccine-rol 2021-02-03T04:00:01+11:00 https://pharmadispatch.com/news/an-appalling-pbs-discrimination-and-the-back-door-way-to-increas 2021-02-03T04:00:01+11:00 https://pharmadispatch.com/news/ellume-announces-new-agreement-to-scale-up-us-production 2021-02-02T09:58:01+11:00 https://pharmadispatch.com/news/research-australia-calls-for-ambitious-goals-in-pre-budget-submi 2021-02-02T04:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-and-ma-led-the-sector-on-political-donations 2021-02-02T04:00:01+11:00 https://pharmadispatch.com/news/medicines-new-zealand-extremely-concerned-over-eu-export-restric 2021-02-02T04:00:01+11:00 https://pharmadispatch.com/news/keytruda-secures-17th-indication-but-msd-says-change-needed 2021-02-02T04:00:01+11:00 https://pharmadispatch.com/news/emyria-emyria-appoints-navy-veteran-and-consultant-psychiatrist- 2021-02-01T12:56:01+11:00 https://pharmadispatch.com/news/new-collaboration-for-nyrada-focused-on-traumatic-brain-injury 2021-02-01T11:05:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-appoints-industry-veteran-to-board 2021-02-01T10:56:01+11:00 https://pharmadispatch.com/news/leukaemia-foundation-launches-2021-worlds-greatest-shave 2021-02-01T10:48:01+11:00 https://pharmadispatch.com/news/salutary-lesson-from-europes-move-to-shift-blame-for-its-own-vac 2021-02-01T04:00:01+11:00 https://pharmadispatch.com/news/janssens-oral-pah-therapy-makes-it-to-the-pbs 2021-02-01T04:00:01+11:00 https://pharmadispatch.com/news/pbac-says-no-to-more-biosimilar-uptake-drivers-for-bdmards 2021-02-01T04:00:01+11:00 https://pharmadispatch.com/news/gbmas-says-active-ingredient-prescribing-a-game-changer-for-pati 2021-02-01T04:00:01+11:00 https://pharmadispatch.com/news/lets-make-the-physical-examination-of-the-heart-health-check-fit 2021-01-31T16:38:01+11:00 https://pharmadispatch.com/news/psa-focus-budget-one-measures-to-reduce-medicine-related-harm 2021-01-31T16:28:01+11:00 https://pharmadispatch.com/news/leukaemia-foundation-announces-the-appointment-of-new-ceo 2021-01-31T13:16:01+11:00 https://pharmadispatch.com/news/senior-medical-researcher-joins-chimerics-scientific-advisory-bo 2021-01-30T14:08:01+11:00 https://pharmadispatch.com/news/novavax-reports-results-of-late-stage-covid-19-vaccine-trial 2021-01-29T13:07:01+11:00 https://pharmadispatch.com/news/some-governments-trying-to-bend-time-on-covid-19-vaccine 2021-01-29T04:00:01+11:00 https://pharmadispatch.com/news/new-shadows-for-health-trade-and-innovation 2021-01-29T04:00:01+11:00 https://pharmadispatch.com/news/european-restrictions-are-about-more-than-transparency 2021-01-29T04:00:01+11:00 https://pharmadispatch.com/news/australia-is-at-the-front-of-a-queue-of-two-countries 2021-01-28T12:50:01+11:00 https://pharmadispatch.com/news/south-australia-launches-at-home-health-service-in-adelaide 2021-01-28T11:45:01+11:00 https://pharmadispatch.com/news/industry-faces-questions-at-covid-19-senate-inquiry 2021-01-28T11:37:01+11:00 https://pharmadispatch.com/news/orthocell-updates-on-world-first-case-report-for-its-tendon-repa 2021-01-28T10:52:01+11:00 https://pharmadispatch.com/news/new-benchmark-set-to-deliver-optimal-osteoporosis-care-throughou 2021-01-28T06:45:01+11:00 https://pharmadispatch.com/news/attention-turns-to-medical-devices-with-new-hta-on-the-horizon 2021-01-28T04:00:01+11:00 https://pharmadispatch.com/news/chris-bowen-leaving-health-for-climate-change-and-energy 2021-01-28T04:00:01+11:00 https://pharmadispatch.com/news/alexion-acquisition-means-the-end-for-az-ceo-on-csl-board 2021-01-27T16:26:01+11:00 https://pharmadispatch.com/news/industry-executives-join-government-and-other-groups-at-senate-i 2021-01-27T15:59:01+11:00 https://pharmadispatch.com/news/doses-are-going-to-countries-who-were-first-to-back-vaccine-deve 2021-01-27T10:59:01+11:00 https://pharmadispatch.com/news/greg-hunt-launches-the-governments-covid-19-vaccine-information- 2021-01-27T09:12:01+11:00 https://pharmadispatch.com/news/pharmaceutical-companies-recognised-as-top-employers 2021-01-27T04:00:01+11:00 https://pharmadispatch.com/news/recognition-for-department-of-health-associate-secretary 2021-01-27T04:00:01+11:00 https://pharmadispatch.com/news/europe-moves-to-control-and-potentially-block-vaccine-exports 2021-01-27T04:00:01+11:00 https://pharmadispatch.com/news/australian-led-research-finds-global-demand-for-cancer-surgery-s 2021-01-26T15:08:01+11:00 https://pharmadispatch.com/news/bupa-says-the-pandemic-and-school-return-the-right-time-for-eye- 2021-01-26T13:00:01+11:00 https://pharmadispatch.com/news/australian-company-nyrada-reports-new-data-from-trial-or-oral-pc 2021-01-26T12:37:01+11:00 https://pharmadispatch.com/news/tga-grants-pfizer-biontech-vaccine-provisional-approval 2021-01-25T09:17:01+11:00 https://pharmadispatch.com/news/ma-concerned-over-misleading-medicine-shortage-claims 2021-01-25T05:11:01+11:00 https://pharmadispatch.com/news/new-appointment-for-ex-janssen-boss-bruce-goodwin 2021-01-25T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-childhood-immunisation-rate-a-good-sign-for-covid-19-v 2021-01-25T04:00:01+11:00 https://pharmadispatch.com/news/companies-set-to-appear-at-covid-19-senate-inquiry 2021-01-24T14:26:01+11:00 https://pharmadispatch.com/news/suggesting-a-solution-to-a-problem-that-does-not-exist 2021-01-23T14:42:01+11:00 https://pharmadispatch.com/news/the-covid-19-vaccine-manufacturing-and-supply-deals 2021-01-22T04:00:01+11:00 https://pharmadispatch.com/news/bionomics-bms-combination-completes-trial-treatment-phase 2021-01-22T04:00:01+11:00 https://pharmadispatch.com/news/almac-group-survey-reveals-pandemic-impact-on-clinical-trial-act 2021-01-22T04:00:01+11:00 https://pharmadispatch.com/news/industry-slams-last-minute-trump-move-to-cut-medicine-coverage 2021-01-22T04:00:01+11:00 https://pharmadispatch.com/news/queensland-research-institute-in-new-cell-therapy-trial 2021-01-21T04:00:01+11:00 https://pharmadispatch.com/news/this-is-what-being-among-the-first-in-the-world-looks-like 2021-01-21T04:00:01+11:00 https://pharmadispatch.com/news/hundreds-of-exemptions-from-active-ingredient-prescribing 2021-01-21T04:00:01+11:00 https://pharmadispatch.com/news/mixed-news-for-biosimilars-on-april-price-disclosure-reductions 2021-01-21T04:00:01+11:00 https://pharmadispatch.com/news/over-20-ms-projects-funded-under-new-round-of-grants 2021-01-21T04:00:01+11:00 https://pharmadispatch.com/news/cystic-fibrosis-therapy-the-only-one-for-alignment-project-in-ma 2021-01-21T04:00:01+11:00 https://pharmadispatch.com/news/biopharmadispatch-conference-returns-to-may-with-a-focus-on-chal 2021-01-20T04:00:01+11:00 https://pharmadispatch.com/news/investors-back-chimeric-therapeutics-on-asx-debut 2021-01-20T04:00:01+11:00 https://pharmadispatch.com/news/winners-of-the-csanz-bayer-young-investigator-research-grants 2021-01-20T04:00:01+11:00 https://pharmadispatch.com/news/it-looks-like-a-ridiculous-and-illogical-attempt-to-hide-somethi 2021-01-19T04:00:01+11:00 https://pharmadispatch.com/news/the-shocking-double-standard-means-no-more-lectures-on-transpare 2021-01-19T04:00:01+11:00 https://pharmadispatch.com/news/no-generics-or-biosimilars-but-patent-notification-still-coming 2021-01-18T12:37:01+11:00 https://pharmadispatch.com/news/commonwealth-back-to-court-for-clopidogrel-appeal 2021-01-18T04:00:01+11:00 https://pharmadispatch.com/news/bluebird-split-puts-oncology-assets-in-stand-alone-entity 2021-01-18T04:00:01+11:00 https://pharmadispatch.com/news/apparently-its-not-in-the-public-interest-to-know-how-nps-misuse 2021-01-16T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-unveils-first-major-logo-redesign-in-seven-decades 2021-01-15T04:00:01+11:00 https://pharmadispatch.com/news/industry-watching-as-australia-closes-in-on-uk-trade-deal 2021-01-15T04:00:01+11:00 https://pharmadispatch.com/news/noxopharm-says-study-advancing-after-clinical-review 2021-01-15T04:00:01+11:00 https://pharmadispatch.com/news/promising-trial-results-for-lillys-investigative-alzheimers-trea 2021-01-14T04:00:01+11:00 https://pharmadispatch.com/news/world-waiting-for-news-on-jjs-single-shot-vaccine-but-what-about 2021-01-14T04:00:01+11:00 https://pharmadispatch.com/news/emerging-australian-company-looking-to-cross-the-threshold 2021-01-14T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-funding-for-two-new-research-centres 2021-01-13T04:00:01+11:00 https://pharmadispatch.com/news/companies-back-new-cancer-detection-technology 2021-01-13T04:00:01+11:00 https://pharmadispatch.com/news/janssen-confirms-new-leadership-for-australia-and-nz 2021-01-13T04:00:01+11:00 https://pharmadispatch.com/news/msd-global-grant-for-melanoma-patients-australia 2021-01-12T04:00:01+11:00 https://pharmadispatch.com/news/annual-document-release-might-have-lessons-for-today 2021-01-12T04:00:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-partners-with-google-on-quantum-computing 2021-01-12T04:00:01+11:00 https://pharmadispatch.com/news/march-pbac-agenda-but-no-transparency-on-alignment-pilot 2021-01-11T04:00:01+11:00 https://pharmadispatch.com/news/department-dusts-off-old-tga-pbac-alignment-project 2021-01-11T04:00:01+11:00 https://pharmadispatch.com/news/us-courts-blocks-introduction-of-most-favoured-nation-pricing 2021-01-11T04:00:01+11:00 https://pharmadispatch.com/news/abbvies-chris-stemple-australia-facing-increased-scrutiny-on-pri 2021-01-11T04:00:01+11:00 https://pharmadispatch.com/news/minister-confirms-january-listings-for-janssen-and-amgen-therapi 2020-12-28T08:18:01+11:00 https://pharmadispatch.com/news/will-2021-be-the-year-the-industry-breaks-the-cycle 2020-12-22T04:00:01+11:00 https://pharmadispatch.com/news/companies-back-heart-foundation-covid-19-research-grants 2020-12-21T04:00:01+11:00 https://pharmadispatch.com/news/clinicians-and-consumers-welcome-earlier-access-to-lung-cancer-t 2020-12-21T04:00:01+11:00 https://pharmadispatch.com/news/extensions-medicinal-cannabis-a-plan-needed-and-one-company-says 2020-12-21T04:00:01+11:00 https://pharmadispatch.com/news/pbac-calls-for-overall-and-holistic-approach-plan-for-sma-treatm 2020-12-21T04:00:01+11:00 https://pharmadispatch.com/news/cautious-and-uncertain-response-to-pbac-outcomes-on-new-biologic 2020-12-21T04:00:01+11:00 https://pharmadispatch.com/news/new-senior-appointments-for-medicines-australia 2020-12-21T04:00:01+11:00 https://pharmadispatch.com/news/cyberattacks-on-covid-19-vaccines-are-a-very-real-threat-so-what 2020-12-18T04:00:01+11:00 https://pharmadispatch.com/news/ma-ceo-reflects-on-2020-but-looks-to-the-long-term 2020-12-18T04:00:01+11:00 https://pharmadispatch.com/news/international-reference-a-pricing-a-huge-risk-for-australia 2020-12-18T04:00:01+11:00 https://pharmadispatch.com/news/nba-commits-to-ongoing-funding-for-csl-behring-ig-products 2020-12-18T04:00:01+11:00 https://pharmadispatch.com/news/government-top-up-for-mrff-in-response-to-funding-shortfall 2020-12-18T04:00:01+11:00 https://pharmadispatch.com/news/myefo-shows-money-flowing-to-covid-19-vaccines-and-new-listings 2020-12-17T13:56:01+11:00 https://pharmadispatch.com/news/the-pbs-has-an-increasingly-complicated-story-to-tell 2020-12-17T11:31:01+11:00 https://pharmadispatch.com/news/new-government-report-reveals-impact-of-pandemic-on-health-syste 2020-12-17T04:00:01+11:00 https://pharmadispatch.com/news/government-could-extend-pbs-style-hta-and-cost-recovery-to-devic 2020-12-17T04:00:01+11:00 https://pharmadispatch.com/news/advocacy-group-slams-alliance-targeitng-use-of-bdmards 2020-12-17T04:00:01+11:00 https://pharmadispatch.com/news/wholesalers-say-they-are-ready-with-challenges-ahead 2020-12-17T04:00:01+11:00 https://pharmadispatch.com/news/international-recognition-for-merck-anz-transformation-project 2020-12-16T15:57:01+11:00 https://pharmadispatch.com/news/we-would-not-be-on-the-cusp-of-a-vaccine-without-the-industry 2020-12-16T04:00:01+11:00 https://pharmadispatch.com/news/recognition-for-companies-in-list-of-best-employers-for-dads 2020-12-16T04:00:01+11:00 https://pharmadispatch.com/news/early-close-for-over-subscribed-chimeric-ipo 2020-12-16T04:00:01+11:00 https://pharmadispatch.com/news/if-they-cant-do-the-job-get-out-of-the-way 2020-12-15T04:00:01+11:00 https://pharmadispatch.com/news/the-opportunity-with-the-harmonisation-of-standards-for-clinical 2020-12-15T04:00:01+11:00 https://pharmadispatch.com/news/industry-and-patients-launch-legal-challenge-against-most-favour 2020-12-15T04:00:01+11:00 https://pharmadispatch.com/news/martin-palin-the-rules-of-reputation-remain-unchanged 2020-12-14T04:00:01+11:00 https://pharmadispatch.com/news/as-a-panic-buy-audit-finds-the-government-did-an-effective-job 2020-12-14T04:00:01+11:00 https://pharmadispatch.com/news/us-starts-shipping-doses-after-fda-authorisation 2020-12-14T04:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-to-acquire-alexion-in-push-to-expand-portfolio 2020-12-14T04:00:01+11:00 https://pharmadispatch.com/news/csl-and-uq-halt-development-of-covid-19-vaccine 2020-12-11T06:50:01+11:00 https://pharmadispatch.com/news/some-movement-on-pbac-executive-agendas-but-not-over-yet 2020-12-11T04:00:01+11:00 https://pharmadispatch.com/news/new-budget-report-predicts-pbs-to-reach-21-billion-in-2030 2020-12-11T04:00:01+11:00 https://pharmadispatch.com/news/cardiologist-wins-bi-backed-research-grant 2020-12-11T04:00:01+11:00 https://pharmadispatch.com/news/another-positive-study-but-sta-says-no-to-seventh-submission 2020-12-11T04:00:01+11:00 https://pharmadispatch.com/news/novo-nordisks-jeppe-theisen-on-taking-a-wider-view-of-the-system 2020-12-10T04:00:01+11:00 https://pharmadispatch.com/news/us-says-no-sharing-vaccines-until-it-has-everyone-covered 2020-12-10T04:00:01+11:00 https://pharmadispatch.com/news/long-term-study-shows-potential-of-existing-breast-cancer-medici 2020-12-10T04:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-calls-for-more-industry-redi-fellowship-sponsors 2020-12-10T04:00:01+11:00 https://pharmadispatch.com/news/gbma-changes-the-game-with-the-appointment-of-new-chair 2020-12-09T04:00:01+11:00 https://pharmadispatch.com/news/jane-halton-a-return-to-my-domestic-health-policy-roots 2020-12-09T04:00:01+11:00 https://pharmadispatch.com/news/monash-university-announces-new-anti-infectives-research-agreeme 2020-12-09T04:00:01+11:00 https://pharmadispatch.com/news/a-small-number-countries-will-dominate-early-vaccine-distributio 2020-12-08T04:00:01+11:00 https://pharmadispatch.com/news/company-concern-over-lack-of-clarity-on-exemptions 2020-12-08T04:00:01+11:00 https://pharmadispatch.com/news/new-us-pricing-policy-lazy-misguided-and-a-recipe-for-inaction 2020-12-08T04:00:01+11:00 https://pharmadispatch.com/news/some-agreement-inclusions-are-more-important-than-others-apparen 2020-12-08T04:00:01+11:00 https://pharmadispatch.com/news/industry-shock-over-new-agreements-and-rush-to-impose-changes 2020-12-07T04:00:01+11:00 https://pharmadispatch.com/news/nz-government-confirms-pharmac-inquiry 2020-12-07T04:00:01+11:00 https://pharmadispatch.com/news/the-evolution-of-the-deed-is-not-good-news-for-the-industry 2020-12-07T04:00:01+11:00 https://pharmadispatch.com/news/new-dashboard-aims-for-better-understanding-of-social-platform 2020-12-07T04:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-welcomes-new-indication-for-pbs-listed-diabetes-medi 2020-12-07T04:00:01+11:00 https://pharmadispatch.com/news/australian-company-noxopharm-completes-major-share-placement 2020-12-04T04:00:01+11:00 https://pharmadispatch.com/news/metabolic-disease-the-focus-of-gsk-research-award-recipient 2020-12-04T04:00:01+11:00 https://pharmadispatch.com/news/new-zealand-patients-restate-call-for-review-of-pharmac 2020-12-04T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-marks-five-years-of-community-engagement-program 2020-12-04T04:00:01+11:00 https://pharmadispatch.com/news/confusion-over-governments-vaccine-distribution-plan 2020-12-03T17:57:01+11:00 https://pharmadispatch.com/news/uk-vaccine-authorised-rigorous-scientific-assessment-of-every-pi 2020-12-03T08:54:01+11:00 https://pharmadispatch.com/news/tga-head-impressed-with-covid-19-vaccine-efficacy 2020-12-03T04:00:01+11:00 https://pharmadispatch.com/news/minister-puts-vaccine-timing-on-company-and-regulator 2020-12-03T04:00:01+11:00 https://pharmadispatch.com/news/guild-slams-exclusion-from-covid-19-working-groups 2020-12-03T04:00:01+11:00 https://pharmadispatch.com/news/uk-repurposing-sports-stadiums-as-mass-vaccination-centres 2020-12-03T04:00:01+11:00 https://pharmadispatch.com/news/uk-approves-first-covid-19-vaccine 2020-12-02T18:28:01+11:00 https://pharmadispatch.com/news/change-requires-difficult-choices-between-the-past-and-the-futur 2020-12-02T04:00:01+11:00 https://pharmadispatch.com/news/well-it-all-makes-sense-now 2020-12-02T04:00:01+11:00 https://pharmadispatch.com/news/companies-welcomes-new-listing-and-government-action-on-hiv 2020-12-02T04:00:01+11:00 https://pharmadispatch.com/news/clinicians-welcome-expanded-listing-for-ipsens-dysport 2020-12-02T04:00:01+11:00 https://pharmadispatch.com/news/net-pbs-spend-surged-by-over-11-percent-in-2019-20 2020-12-01T12:47:01+11:00 https://pharmadispatch.com/news/australians-will-not-be-among-the-first-in-the-world-to-receive- 2020-12-01T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-pbs-access-to-treatment-for-bacterial-infect 2020-12-01T04:00:01+11:00 https://pharmadispatch.com/news/australian-biotech-acquires-swiss-german-counterpart 2020-12-01T04:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-huge-divide-on-heart-disease 2020-12-01T04:00:01+11:00 https://pharmadispatch.com/news/company-acts-to-delist-in-response-to-international-reference-pr 2020-11-30T04:00:01+11:00 https://pharmadispatch.com/news/could-this-delisting-be-the-canary-in-the-coal-mine 2020-11-30T04:00:01+11:00 https://pharmadispatch.com/news/extended-pbs-listing-for-abbvies-blood-cancer-therapy 2020-11-30T04:00:01+11:00 https://pharmadispatch.com/news/uk-set-to-approve-first-covid-19-vaccine-within-days 2020-11-30T04:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listings-for-lilly-and-bayer-therapies 2020-11-30T04:00:01+11:00 https://pharmadispatch.com/news/process-and-pricing-is-market-access-not-policy-and-speed-is-tra 2020-11-27T04:00:01+11:00 https://pharmadispatch.com/news/industry-frustration-as-negotiations-gets-stuck-on-process-and-p 2020-11-27T04:00:01+11:00 https://pharmadispatch.com/news/stem-cell-news-the-most-unexpected-result-of-my-career 2020-11-27T04:00:01+11:00 https://pharmadispatch.com/news/adult-vaccination-discussed-in-just-one-in-ten-gp-visits 2020-11-26T04:00:01+11:00 https://pharmadispatch.com/news/us-operation-warp-speed-ready-for-covid-19-vaccine-launch 2020-11-26T04:00:01+11:00 https://pharmadispatch.com/news/new-report-recommendations-change-to-address-iron-deficiency 2020-11-26T04:00:01+11:00 https://pharmadispatch.com/news/frustration-after-pharmac-delays-funding-new-diabetes-medicines 2020-11-25T08:13:01+11:00 https://pharmadispatch.com/news/sector-captured-by-proposed-critical-infrastructure-law 2020-11-25T04:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-systems-are-being-more-and-more-tested 2020-11-25T04:00:01+11:00 https://pharmadispatch.com/news/hepatitis-c-treatment-rates-continue-steady-decline 2020-11-25T04:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-elects-two-new-board-members 2020-11-24T16:26:01+11:00 https://pharmadispatch.com/news/so-many-documents-the-request-cannot-be-processed 2020-11-24T04:00:01+11:00 https://pharmadispatch.com/news/monash-to-leverage-mrff-funds-in-amr-fight 2020-11-24T04:00:01+11:00 https://pharmadispatch.com/news/transparency-is-the-proper-response-to-a-scathing-review 2020-11-24T04:00:01+11:00 https://pharmadispatch.com/news/a-third-covid-19-vaccine-hits-efficacy-endpoint 2020-11-23T18:07:01+11:00 https://pharmadispatch.com/news/nps-medicinewise-downplays-scathing-review-in-annual-report 2020-11-23T10:13:01+11:00 https://pharmadispatch.com/news/australias-hta-system-is-indeed-fit-for-purpose 2020-11-23T04:00:01+11:00 https://pharmadispatch.com/news/anna-lavelle-price-cuts-still-a-live-topic-of-conversation 2020-11-23T04:00:01+11:00 https://pharmadispatch.com/news/defeated-trump-moves-on-most-favoured-pricing-regulation 2020-11-23T04:00:01+11:00 https://pharmadispatch.com/news/us-and-uk-just-weeks-from-launching-covid-19-vaccine-programs 2020-11-23T04:00:01+11:00 https://pharmadispatch.com/news/australian-company-mesoblast-in-new-collaboration-with-novartis 2020-11-23T04:00:01+11:00 https://pharmadispatch.com/news/new-backing-for-australian-biotechnology-companies 2020-11-23T04:00:01+11:00 https://pharmadispatch.com/news/lundbeck-and-otsuka-team-up-for-mental-health-wellness-walk 2020-11-23T04:00:01+11:00 https://pharmadispatch.com/news/lillys-ben-basil-on-patient-stories-and-a-different-sense-of-urg 2020-11-20T04:00:01+11:00 https://pharmadispatch.com/news/ma-welcomes-new-study-on-pricing-and-reimbursement-of-antibiotic 2020-11-20T04:00:01+11:00 https://pharmadispatch.com/news/tga-head-on-the-challenges-of-2020-the-vaccine-and-the-future 2020-11-20T04:00:01+11:00 https://pharmadispatch.com/news/immutep-completes-capital-raise-and-expands-collaboration-with-m 2020-11-20T04:00:01+11:00 https://pharmadispatch.com/news/gsk-backs-mtpconnect-industry-researcher-initiative 2020-11-19T04:00:01+11:00 https://pharmadispatch.com/news/novartis-says-pandemic-reshaping-australias-contribution-to-deve 2020-11-19T04:00:01+11:00 https://pharmadispatch.com/news/new-directors-and-life-members-for-arcs-australia 2020-11-19T04:00:01+11:00 https://pharmadispatch.com/news/tga-designates-a-third-covid-19-vaccine-for-provisional-pathway 2020-11-19T04:00:01+11:00 https://pharmadispatch.com/news/language-deficit-a-barrier-to-medicines-access 2020-11-18T04:00:01+11:00 https://pharmadispatch.com/news/sobering-messages-for-industry-some-direct-and-some-subtle 2020-11-18T04:00:01+11:00 https://pharmadispatch.com/news/mylan-country-manager-to-lead-new-viatris 2020-11-18T04:00:01+11:00 https://pharmadispatch.com/news/six-years-of-reviews-ends-with-a-status-quo-result 2020-11-17T04:00:01+11:00 https://pharmadispatch.com/news/moderna-covid-19-vaccine-945-per-cent-effective 2020-11-17T04:00:01+11:00 https://pharmadispatch.com/news/biopharmadispatch-conference-a-day-characterised-by-competing-na 2020-11-17T04:00:01+11:00 https://pharmadispatch.com/news/gbma-backing-first-ever-global-biosimilar-awareness-week 2020-11-16T04:00:01+11:00 https://pharmadispatch.com/news/wider-listing-for-spinraza-but-how-will-they-find-patients 2020-11-16T04:00:01+11:00 https://pharmadispatch.com/news/australiasnational-cabinet-has-endorsed-acovid-19-vaccination-po 2020-11-16T04:00:01+11:00 https://pharmadispatch.com/news/new-report-shows-improvements-on-access-but-more-to-be-done 2020-11-16T04:00:01+11:00 https://pharmadispatch.com/news/csl-in-18bn-manufacturing-and-supply-deal-with-australian-govern 2020-11-16T04:00:01+11:00 https://pharmadispatch.com/news/leader-and-decision-makers-getting-ready-to-gather 2020-11-13T04:00:01+11:00 https://pharmadispatch.com/news/companies-recognised-in-annual-chp-diamond-awards 2020-11-13T04:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-releases-first-of-three-reports-on-skill-gaps 2020-11-13T04:00:01+11:00 https://pharmadispatch.com/news/government-launches-new-review-of-chemotherapy-funding 2020-11-12T04:00:01+11:00 https://pharmadispatch.com/news/tender-documents-for-vaccine-distribution-not-made-public 2020-11-12T04:00:01+11:00 https://pharmadispatch.com/news/government-says-it-agreed-to-indemnify-covid-19-vaccine-makers 2020-11-12T04:00:01+11:00 https://pharmadispatch.com/news/new-report-reveals-growing-confidence-in-biosimilars 2020-11-12T04:00:01+11:00 https://pharmadispatch.com/news/new-research-highlights-the-opportunity-of-an-expedited-listing- 2020-11-11T04:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-independent-oversight-of-post-pbac-price-negotiatio 2020-11-11T04:00:01+11:00 https://pharmadispatch.com/news/more-company-submissions-use-inquiry-to-call-for-change 2020-11-11T04:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-action-on-real-world-evidence 2020-11-11T04:00:01+11:00 https://pharmadispatch.com/news/industry-signs-up-tp-new-precision-medicine-alliance 2020-11-11T04:00:01+11:00 https://pharmadispatch.com/news/easier-to-get-a-hip-replacement-than-a-medicine-for-eczema 2020-11-10T04:00:01+11:00 https://pharmadispatch.com/news/in-the-end-it-is-very-simple-technological-discrimination 2020-11-10T04:00:01+11:00 https://pharmadispatch.com/news/janssen-says-we-cannot-detach-from-international-reality 2020-11-10T04:00:01+11:00 https://pharmadispatch.com/news/it-works-pfizers-covid-19-vaccine-hits-90-efficacy 2020-11-10T04:00:01+11:00 https://pharmadispatch.com/news/use-of-government-funds-the-subject-of-a-current-ongoing-investi 2020-11-09T04:00:01+11:00 https://pharmadispatch.com/news/csl-starts-manufacturing-az-oxford-from-today 2020-11-09T04:00:01+11:00 https://pharmadispatch.com/news/another-blow-for-alzheimers-with-committee-voting-against-potent 2020-11-09T04:00:01+11:00 https://pharmadispatch.com/news/pfizers-anne-harris-on-the-unique-opportunity-for-industry 2020-11-09T04:00:01+11:00 https://pharmadispatch.com/news/what-to-expect-from-the-biden-administration-on-drug-pricing 2020-11-09T04:00:01+11:00 https://pharmadispatch.com/news/australian-company-adds-to-its-oncology-portfolio-with-gist-ther 2020-11-06T08:30:01+11:00 https://pharmadispatch.com/news/health-minister-greg-hunt-to-open-biopharmadispatch-conference 2020-11-06T04:00:01+11:00 https://pharmadispatch.com/news/major-manufacturing-incentive-more-likely-to-hit-in-out-years 2020-11-06T04:00:01+11:00 https://pharmadispatch.com/news/outgoing-janssen-boss-to-be-retained-on-ma-board 2020-11-06T04:00:01+11:00 https://pharmadispatch.com/news/wholesalers-to-compete-for-right-to-distribute-covid-19-vaccines 2020-11-06T04:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-action-on-cv-testing-and-treatment 2020-11-05T04:00:01+11:00 https://pharmadispatch.com/news/gilead-sanofi-bms-and-guild-submissions-to-inquiry 2020-11-05T04:00:01+11:00 https://pharmadispatch.com/news/government-announces-deals-for-two-more-vaccines 2020-11-05T04:00:01+11:00 https://pharmadispatch.com/news/one-medicine-regulated-out-of-the-prioritised-pathway 2020-11-04T04:00:01+11:00 https://pharmadispatch.com/news/is-the-target-better-use-of-bdmards-or-savings 2020-11-04T04:00:01+11:00 https://pharmadispatch.com/news/leah-goodman-supporting-the-race-to-a-covid-19-vaccine 2020-11-04T04:00:01+11:00 https://pharmadispatch.com/news/more-company-submissions-focus-on-genomic-profiling 2020-11-04T04:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-ceo-says-approval-shows-the-importance-of-resilience 2020-11-03T11:26:01+11:00 https://pharmadispatch.com/news/more-of-the-same-or-a-return-to-global-leadership-on-trade 2020-11-03T04:00:01+11:00 https://pharmadispatch.com/news/leah-goodman-on-backing-the-frontline-response-to-the-pandemic 2020-11-03T04:00:01+11:00 https://pharmadispatch.com/news/andrew-little 2020-11-03T04:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-joins-elite-australian-club-with-us-approval 2020-11-03T04:00:01+11:00 https://pharmadispatch.com/news/us-regulator-approves-creation-of-viatris-with-conditions 2020-11-03T04:00:01+11:00 https://pharmadispatch.com/news/is-the-government-managing-stakeholders-or-the-system 2020-11-02T04:00:01+11:00 https://pharmadispatch.com/news/submissions-call-for-action-on-rare-new-technologies-and-even-a- 2020-11-02T04:00:01+11:00 https://pharmadispatch.com/news/more-insight-on-pathways-and-shortcoming-in-newborn-screening 2020-11-02T04:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-divests-commercial-rights-to-pbs-listed-antihyperten 2020-11-02T04:00:01+11:00 https://pharmadispatch.com/news/pbac-to-re-consider-emgality-as-uk-proposes-wide-listing 2020-11-02T04:00:01+11:00 https://pharmadispatch.com/news/pandemic-has-highlights-the-good-and-the-bad-for-australian-life 2020-10-30T04:00:01+11:00 https://pharmadispatch.com/news/biopharmadispatch-2020-conference-the-agenda 2020-10-30T04:00:01+11:00 https://pharmadispatch.com/news/us-bio-ceo-science-is-on-the-presidential-ballot 2020-10-30T04:00:01+11:00 https://pharmadispatch.com/news/oncology-groups-call-for-creation-of-a-single-decision-making-bo 2020-10-30T04:00:01+11:00 https://pharmadispatch.com/news/csl-joins-other-industry-on-worlds-best-employer-list 2020-10-30T04:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-jj-awards-industry-and-excellence-awards 2020-10-30T04:00:01+11:00 https://pharmadispatch.com/news/when-it-comes-to-the-budget-everything-happens-for-a-reason 2020-10-29T04:00:01+11:00 https://pharmadispatch.com/news/industry-backs-new-regenerative-medicine-consoritum 2020-10-29T04:00:01+11:00 https://pharmadispatch.com/news/new-registration-of-msds-keytruda-with-pbac-next 2020-10-29T04:00:01+11:00 https://pharmadispatch.com/news/chris-bowen-guarantee-is-not-worth-the-paper-it-is-not-written-o 2020-10-29T04:00:01+11:00 https://pharmadispatch.com/news/senate-estimates-officials-discuss-covid-19-vaccine-distribution 2020-10-28T04:00:01+11:00 https://pharmadispatch.com/news/government-scrambles-to-address-industry-concerns 2020-10-28T04:00:01+11:00 https://pharmadispatch.com/news/the-savings-are-in-the-budget-but-not-a-budget-measure 2020-10-28T04:00:01+11:00 https://pharmadispatch.com/news/abbvie-inks-new-partnership-with-australias-biocurate 2020-10-28T04:00:01+11:00 https://pharmadispatch.com/news/chris-bowen-pbs-guarantee-a-cruel-sham 2020-10-27T09:25:01+11:00 https://pharmadispatch.com/news/an-opportunity-for-government-to-sharpen-message-on-vaccine 2020-10-27T04:00:01+11:00 https://pharmadispatch.com/news/industry-seeks-urgent-clarity-on-budgeted-price-reductions 2020-10-27T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-says-regulatory-review-before-the-end-of-2021 2020-10-27T04:00:01+11:00 https://pharmadispatch.com/news/csl-mrna-vaccine-not-an-option-under-active-consideration 2020-10-26T10:38:01+11:00 https://pharmadispatch.com/news/companies-unite-to-provide-practical-support-during-pandemic 2020-10-26T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-multiple-sclerosis-listing-for-november 2020-10-26T04:00:01+11:00 https://pharmadispatch.com/news/industry-minister-responds-to-manufacturing-closures 2020-10-26T04:00:01+11:00 https://pharmadispatch.com/news/pharmac-confirms-decision-to-adopt-principal-supply-model 2020-10-26T04:00:01+11:00 https://pharmadispatch.com/news/department-of-health-officials-front-senate-estimates 2020-10-26T04:00:01+11:00 https://pharmadispatch.com/news/industry-anticipates-imminent-release-of-pbs-net-spend 2020-10-23T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-trial-participant-did-not-receive-covid-19-vaccine 2020-10-23T04:00:01+11:00 https://pharmadispatch.com/news/api-navigates-a-year-of-challenges-with-bushfires-and-pandemic 2020-10-23T04:00:01+11:00 https://pharmadispatch.com/news/patients-win-earlier-access-to-astrazenecas-lynparza 2020-10-22T04:00:01+11:00 https://pharmadispatch.com/news/gsk-confirms-decision-to-close-melbourne-manufacturing-site 2020-10-22T04:00:01+11:00 https://pharmadispatch.com/news/how-can-you-turn-around-decades-of-incoherence-on-industry-inves 2020-10-22T04:00:01+11:00 https://pharmadispatch.com/news/atagi-working-group-to-advise-on-covid-19-vaccines 2020-10-22T04:00:01+11:00 https://pharmadispatch.com/news/csl-on-track-to-commence-manufacture-of-az-vaccine-in-november 2020-10-21T04:00:01+11:00 https://pharmadispatch.com/news/services-australia-reports-significant-jump-in-pbs-benefits 2020-10-21T04:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-now-looking-to-wider-pbs-listing 2020-10-21T04:00:01+11:00 https://pharmadispatch.com/news/more-calls-for-change-from-patients-and-companies 2020-10-21T04:00:01+11:00 https://pharmadispatch.com/news/are-negotiations-an-opportunity-to-reset-on-patient-input 2020-10-20T04:00:01+11:00 https://pharmadispatch.com/news/growth-in-immunoglobulin-slows-but-still-key-driver 2020-10-20T04:00:01+11:00 https://pharmadispatch.com/news/a-journey-where-we-take-the-scenic-route-to-get-to-our-destinati 2020-10-20T04:00:01+11:00 https://pharmadispatch.com/news/more-confirmed-speakers-for-biopharmadispatch-conference 2020-10-19T04:00:01+11:00 https://pharmadispatch.com/news/sta-cancer-therapy-progressing-to-late-stage-covid-19-trial 2020-10-19T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-ceo-indicates-efficacy-readout-could-be-just-weeks-away 2020-10-19T04:00:01+11:00 https://pharmadispatch.com/news/pbac-wider-access-to-prep-but-no-loosening-for-originator-bdmard 2020-10-19T04:00:01+11:00 https://pharmadispatch.com/news/migraine-australia-says-community-deflated-and-very-angry 2020-10-19T04:00:01+11:00 https://pharmadispatch.com/news/australian-company-appoints-experienced-industry-exec-as-new-ceo 2020-10-16T04:00:01+11:00 https://pharmadispatch.com/news/csls-annual-general-meeting-goes-virtual 2020-10-16T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-to-close-perth-manufacturing-but-commits-to-melbourne-sit 2020-10-16T04:00:01+11:00 https://pharmadispatch.com/news/cancer-and-infectious-disease-the-lates-focus-of-csl-centenary-f 2020-10-16T04:00:01+11:00 https://pharmadispatch.com/news/uk-regulator-added-to-global-renamed-access-consortium 2020-10-16T04:00:01+11:00 https://pharmadispatch.com/news/chris-bowen-government-has-agreed-to-do-what-it-already-does 2020-10-16T04:00:01+11:00 https://pharmadispatch.com/news/technical-and-legal-hurdles-to-the-adoption-of-genome-sequencing 2020-10-15T04:00:01+11:00 https://pharmadispatch.com/news/ebos-expands-medical-devices-business-with-new-acquisition 2020-10-15T04:00:01+11:00 https://pharmadispatch.com/news/regional-leadership-for-former-janssen-australia-boss 2020-10-15T04:00:01+11:00 https://pharmadispatch.com/news/funding-for-brisbane-based-clinical-trial-manufacturing-facility 2020-10-15T04:00:01+11:00 https://pharmadispatch.com/news/government-claiming-price-cuts-as-new-pbs-listings 2020-10-15T04:00:01+11:00 https://pharmadispatch.com/news/parliament-backs-revised-rd-tax-incentive-changes 2020-10-14T04:00:01+11:00 https://pharmadispatch.com/news/a-system-of-patent-notification-coming-to-australia 2020-10-14T04:00:01+11:00 https://pharmadispatch.com/news/patient-illness-halts-another-covid-19-vaccine-trial 2020-10-14T04:00:01+11:00 https://pharmadispatch.com/news/pbs-new-medicines-funding-guarantee-echoes-of-elections-past 2020-10-13T04:00:01+11:00 https://pharmadispatch.com/news/paig-a-continuous-process-to-move-beyond-unconscious-bias 2020-10-13T04:00:01+11:00 https://pharmadispatch.com/news/new-zealand-secures-advance-supply-of-pfizer-biontech-vaccine 2020-10-13T04:00:01+11:00 https://pharmadispatch.com/news/sta-calls-for-system-overhaul-in-inquiry-submission 2020-10-13T04:00:01+11:00 https://pharmadispatch.com/news/johnson-johnson-joins-new-corporate-mental-health-alliance 2020-10-13T04:00:01+11:00 https://pharmadispatch.com/news/have-cost-offsets-really-been-a-problem-for-the-pbs 2020-10-12T04:00:01+11:00 https://pharmadispatch.com/news/need-for-written-clarity-on-pbs-budget-commitments 2020-10-12T04:00:01+11:00 https://pharmadispatch.com/news/what-spending-if-any-is-being-offset-in-the-2020-21-budget 2020-10-12T04:00:01+11:00 https://pharmadispatch.com/news/us-backs-development-of-az-covid-19-antibodies 2020-10-12T04:00:01+11:00 https://pharmadispatch.com/news/parliament-could-help-ensure-the-guarantee-is-delivered 2020-10-09T04:00:01+11:00 https://pharmadispatch.com/news/pm-adds-finance-to-trade-ministers-portfolio 2020-10-09T04:00:01+11:00 https://pharmadispatch.com/news/government-announces-final-supply-agreement-for-csl-uq-vaccine 2020-10-09T04:00:01+11:00 https://pharmadispatch.com/news/abbvie-recognised-for-innovative-cmi-qr-code 2020-10-09T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-and-the-skilful-making-of-a-political-virtue 2020-10-08T04:00:01+11:00 https://pharmadispatch.com/news/industry-prominent-in-global-diversity-and-inclusion-list 2020-10-08T04:00:01+11:00 https://pharmadispatch.com/news/grattan-institute-wrong-on-the-pbs-again 2020-10-08T04:00:01+11:00 https://pharmadispatch.com/news/recognition-for-sta-in-australian-business-awards 2020-10-08T04:00:01+11:00 https://pharmadispatch.com/news/mas-liz-de-somer-on 2020-10-08T04:00:01+11:00 https://pharmadispatch.com/news/industry-welcomes-funding-but-savings-on-the-way 2020-10-07T04:00:01+11:00 https://pharmadispatch.com/news/novartis-team-up-with-patient-group-for-wellness-day-scheme 2020-10-07T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-going-back-to-the-pbac-on-march-dupixent-outcome 2020-10-07T04:00:01+11:00 https://pharmadispatch.com/news/funding-few-listings-litigation-and-a-move-on-rd-tax 2020-10-07T04:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-partial-backdown-on-rd-tax-cut 2020-10-07T04:00:01+11:00 https://pharmadispatch.com/news/government-makes-28bn-downpayment-on-new-five-year-agreements 2020-10-06T19:30:01+11:00 https://pharmadispatch.com/news/federal-court-delivers-final-order-in-merck-msd-name-case 2020-10-06T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-ceo-disappointed-over-politicisation-of-vaccine 2020-10-06T04:00:01+11:00 https://pharmadispatch.com/news/medicines-nz-releases-election-policies-as-election-day-approach 2020-10-06T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-budget-listing-for-roche-cancer-combination 2020-10-06T04:00:01+11:00 https://pharmadispatch.com/news/at-what-point-do-these-agreements-do-more-harm-than-good 2020-10-06T04:00:01+11:00 https://pharmadispatch.com/news/bms-to-acquire-us-based-cardiovascular-company 2020-10-06T04:00:01+11:00 https://pharmadispatch.com/news/does-the-plan-make-australia-more-competitive-on-manufacturing 2020-10-02T04:00:01+10:00 https://pharmadispatch.com/news/pm-hints-at-budget-announcement-on-rd-tax-incentive 2020-10-02T04:00:01+10:00 https://pharmadispatch.com/news/european-regulator-to-start-review-of-az-oxford-vaccine 2020-10-02T04:00:01+10:00 https://pharmadispatch.com/news/novartis-updates-on-gene-therapy-data-ahead-of-pbac-meeting 2020-10-02T03:34:01+10:00 https://pharmadispatch.com/news/astrazeneca-partners-australian-medtech-company 2020-10-01T04:00:01+10:00 https://pharmadispatch.com/news/industry-groups-stick-to-the-facts-on-industrial-dispute 2020-10-01T04:00:01+10:00 https://pharmadispatch.com/news/i-feel-embarrassed-that-i-accepted-pharmac-decisions-in-the-past 2020-10-01T04:00:01+10:00 https://pharmadispatch.com/news/another-step-forward-for-australian-rare-disease-company 2020-10-01T04:00:01+10:00 https://pharmadispatch.com/news/stakeholders-call-for-quick-action-to-implement-recommendation 2020-09-30T05:00:01+10:00 https://pharmadispatch.com/news/bipartisan-commitment-to-boost-funding-to-pharmac 2020-09-30T04:00:01+10:00 https://pharmadispatch.com/news/an-idea-laid-to-rest-hopefully-once-and-for-all 2020-09-30T04:00:01+10:00 https://pharmadispatch.com/news/researchers-to-test-covid-19-vaccine-in-human-challenge-trial 2020-09-30T04:00:01+10:00 https://pharmadispatch.com/news/pm-to-outline-plan-to-attracted-advanced-manufacturing 2020-09-30T04:00:01+10:00 https://pharmadispatch.com/news/government-goes-deal-to-deal-on-covid-19-vaccine-indemnity 2020-09-29T04:00:01+10:00 https://pharmadispatch.com/news/us-not-the-only-worry-on-international-reference-pricing 2020-09-29T04:00:01+10:00 https://pharmadispatch.com/news/government-to-intervene-in-maritime-industrial-dispute 2020-09-29T04:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-could-retain-outgoing-janssen-boss-on-its-bo 2020-09-29T04:00:01+10:00 https://pharmadispatch.com/news/industry-leader-announces-planned-retirement 2020-09-28T16:00:01+10:00 https://pharmadispatch.com/news/pm-whoever-finds-the-vaccine-must-share-it 2020-09-28T04:00:01+10:00 https://pharmadispatch.com/news/roadmap-to-zero-lives-lost-to-blood-cancer-by-2035 2020-09-28T04:00:01+10:00 https://pharmadispatch.com/news/growth-supports-pbs-sustainability-no-reason-to-be-defensive-abo 2020-09-28T04:00:01+10:00 https://pharmadispatch.com/news/industry-groups-welcome-extension-of-accc-authorisation 2020-09-28T04:00:01+10:00 https://pharmadispatch.com/news/wait-almost-over-for-haemophilia-patients 2020-09-26T07:50:01+10:00 https://pharmadispatch.com/news/budget-outcome-confirms-jump-in-pharmaceutical-spend 2020-09-25T09:52:01+10:00 https://pharmadispatch.com/news/pbac-is-looking-for-a-new-consumer-representative 2020-09-25T04:00:01+10:00 https://pharmadispatch.com/news/at-some-point-we-have-to-trust-somebody 2020-09-25T04:00:01+10:00 https://pharmadispatch.com/news/government-hits-the-industry-with-new-savings-options 2020-09-24T13:58:01+10:00 https://pharmadispatch.com/news/bios-joe-damond-the-us-is-sending-a-signal-about-the-industry-an 2020-09-24T04:00:01+10:00 https://pharmadispatch.com/news/new-white-paper-highlights-need-for-action-on-amr 2020-09-24T04:00:01+10:00 https://pharmadispatch.com/news/flu-vax-an-opportunity-to-enhance-targeted-communication 2020-09-24T04:00:01+10:00 https://pharmadispatch.com/news/new-report-finds-australia-lagging-on-obesity-care 2020-09-24T04:00:01+10:00 https://pharmadispatch.com/news/patient-complaint-triggers-human-rights-intervention-in-pharmac 2020-09-23T04:00:01+10:00 https://pharmadispatch.com/news/high-profile-pbs-listed-medicines-impacted-by-us-executive-order 2020-09-23T04:00:01+10:00 https://pharmadispatch.com/news/kazia-therapeutics-announces-new-collaboration-with-us-cancer-in 2020-09-23T04:00:01+10:00 https://pharmadispatch.com/news/neuren-initiates-manufacture-of-nnz-2591-for-phase-two-trials 2020-09-23T04:00:01+10:00 https://pharmadispatch.com/news/can-you-put-the-agreement-genie-back-in-the-bottle 2020-09-22T04:00:01+10:00 https://pharmadispatch.com/news/venturewise-will-be-operating-until-the-end-of-2020 2020-09-22T04:00:01+10:00 https://pharmadispatch.com/news/how-nps-was-use-government-grant-to-fund-commercial-activity 2020-09-22T04:00:01+10:00 https://pharmadispatch.com/news/department-investigated-nps-over-use-of-government-grant 2020-09-22T04:00:01+10:00 https://pharmadispatch.com/news/ma-less-access-for-australians-the-only-likely-outcome-of-us-pro 2020-09-21T04:00:01+10:00 https://pharmadispatch.com/news/government-pushing-options-to-secure-its-own-certainty 2020-09-21T04:00:01+10:00 https://pharmadispatch.com/news/emerging-cerecin-looking-to-build-its-australian-presence 2020-09-21T04:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-mrff-funding-for-more-covid-19-vaccines 2020-09-21T04:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-sold-access-to-gp-data-through-its-commercial-a 2020-09-18T04:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-the-deadly-impact-of-non-melanoma-skin-can 2020-09-18T04:00:01+10:00 https://pharmadispatch.com/news/pharmaus-minister-confirms-discussion-on-agreement-extensions 2020-09-18T04:00:01+10:00 https://pharmadispatch.com/news/accc-confirms-authorisation-for-wholesalers-for-another-year 2020-09-18T04:00:01+10:00 https://pharmadispatch.com/news/recognition-for-sanofi-employee-well-being-programs 2020-09-18T04:00:01+10:00 https://pharmadispatch.com/news/funding-of-venturewise-contrary-to-the-proper-use-of-commonwealt 2020-09-17T04:00:01+10:00 https://pharmadispatch.com/news/ex-pbac-chair-delivered-scathing-review-of-nps-medicinewise 2020-09-17T04:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-review-what-it-says-on-venturewise 2020-09-17T04:00:01+10:00 https://pharmadispatch.com/news/a-report-that-is-a-page-by-page-deconstruction 2020-09-17T04:00:01+10:00 https://pharmadispatch.com/news/us-executive-order-dumbfounding-and-reckless 2020-09-16T04:00:01+10:00 https://pharmadispatch.com/news/carina-biotech-signs-new-development-deal-with-glytherix 2020-09-16T04:00:01+10:00 https://pharmadispatch.com/news/dimerix-updates-on-latest-kidney-disease-trial-of-dmx-200 2020-09-16T04:00:01+10:00 https://pharmadispatch.com/news/be-under-no-illusion-this-would-be-a-disaster-for-australian-acc 2020-09-16T04:00:01+10:00 https://pharmadispatch.com/news/gilead-acquisition-creates-foundation-for-oncology-franchise 2020-09-15T05:00:01+10:00 https://pharmadispatch.com/news/us-most-favoured-nation-could-hit-access-in-australia-and-nz 2020-09-15T04:00:01+10:00 https://pharmadispatch.com/news/seqirus-announces-grants-to-support-grassroots-vaccination-initi 2020-09-15T04:00:01+10:00 https://pharmadispatch.com/news/starpharma-nasal-spray-virucidal-against-covid-19-virus 2020-09-15T04:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-welcomes-resumption-of-az-oxford-trials 2020-09-14T04:00:01+10:00 https://pharmadispatch.com/news/wholesalers-not-waiting-to-be-asked-on-vaccine-distribution-plan 2020-09-14T03:00:01+10:00 https://pharmadispatch.com/news/the-price-of-paying-twice-or-three-times-for-the-same-certainty 2020-09-14T03:00:01+10:00 https://pharmadispatch.com/news/october-the-target-for-conclusive-efficacy-readout-on-vaccine 2020-09-14T03:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-resumes-dosing-in-covid-19-vaccine-trial 2020-09-13T04:44:01+10:00 https://pharmadispatch.com/news/medicines-australian-announces-transformation 2020-09-11T11:50:01+10:00 https://pharmadispatch.com/news/finance-updates-on-cost-of-covid-19-policy-response 2020-09-11T04:00:01+10:00 https://pharmadispatch.com/news/can-the-supply-chain-manage-two-mass-vaccination-programs-at-onc 2020-09-11T04:00:01+10:00 https://pharmadispatch.com/news/nominations-open-for-ausbiotech-jj-industry-awards 2020-09-11T04:00:01+10:00 https://pharmadispatch.com/news/terrywhite-chemmart-outlines-network-growth-plan 2020-09-11T04:00:01+10:00 https://pharmadispatch.com/news/active-ingredient-prescribing-from-february-next-year 2020-09-11T04:00:01+10:00 https://pharmadispatch.com/news/government-wants-no-risk-on-new-savings-target 2020-09-10T04:00:01+10:00 https://pharmadispatch.com/news/recognition-for-mercks-macquarie-park-office 2020-09-10T04:00:01+10:00 https://pharmadispatch.com/news/tga-plans-to-down-schedule-cannabidiol-to-pharmacist-only 2020-09-10T04:00:01+10:00 https://pharmadispatch.com/news/melbourne-researchers-get-backing-for-potential-ovarian-cancer-t 2020-09-10T04:00:01+10:00 https://pharmadispatch.com/news/az-could-restart-covid-19-vaccine-trial-next-week 2020-09-10T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-pauses-dosing-in-covid-19-trial-after-unexplained-il 2020-09-09T08:35:01+10:00 https://pharmadispatch.com/news/the-timing-of-covid-19-vaccine-hinges-on-delivery-of-one-batch 2020-09-09T04:00:01+10:00 https://pharmadispatch.com/news/cepi-confirms-surge-in-candidates-but-urgently-needs-to-funds 2020-09-09T04:00:01+10:00 https://pharmadispatch.com/news/department-confirms-new-home-for-tga 2020-09-08T12:00:01+10:00 https://pharmadispatch.com/news/distribution-a-significant-challenge-for-new-zealand 2020-09-08T04:00:01+10:00 https://pharmadispatch.com/news/prospections-eric-chung-the-data-goal-is-to-become-predictive 2020-09-08T04:00:01+10:00 https://pharmadispatch.com/news/merck-fellowship-for-brisbane-based-medical-oncologist 2020-09-08T04:00:01+10:00 https://pharmadispatch.com/news/psa-calls-for-action-to-allow-pharmacy-administered-covid-19-vac 2020-09-08T04:00:01+10:00 https://pharmadispatch.com/news/the-middle-of-2021-the-most-likely-for-full-vaccination-program 2020-09-07T12:51:01+10:00 https://pharmadispatch.com/news/it-is-all-political-but-at-least-we-now-have-a-vaccine-to-debate 2020-09-07T04:00:01+10:00 https://pharmadispatch.com/news/msds-michael-azrak-five-years-of-keytruda-and-building-a-better- 2020-09-07T04:00:01+10:00 https://pharmadispatch.com/news/australia-to-offer-incentives-in-race-for-industry-investment 2020-09-07T04:00:01+10:00 https://pharmadispatch.com/news/australia-finally-secures-access-to-a-vaccine 2020-09-06T17:40:01+10:00 https://pharmadispatch.com/news/accelerating-the-process-but-not-skipping-steps 2020-09-04T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-finds-a-buyer-for-adelaide-biologics-facility 2020-09-04T04:00:01+10:00 https://pharmadispatch.com/news/companies-welcome-funding-for-covid-19-projects 2020-09-04T04:00:01+10:00 https://pharmadispatch.com/news/dhl-wants-action-now-on-vaccine-distribution-preparation-and-pla 2020-09-04T04:00:01+10:00 https://pharmadispatch.com/news/first-global-office-for-australia-company-prospection 2020-09-03T04:00:01+10:00 https://pharmadispatch.com/news/us-says-no-to-covax-but-supporting-it-indirectly 2020-09-03T04:00:01+10:00 https://pharmadispatch.com/news/us-goes-for-four-phased-approach-to-mass-vaccination-program 2020-09-03T04:00:01+10:00 https://pharmadispatch.com/news/tga-approval-for-seqirus-cell-based-vaccine 2020-09-03T04:00:01+10:00 https://pharmadispatch.com/news/government-seeking-advice-on-delivery-of-covid-19-vaccine 2020-09-03T04:00:01+10:00 https://pharmadispatch.com/news/not-just-sitting-back-passively-waiting-for-our-phone-to-ring 2020-09-03T04:00:01+10:00 https://pharmadispatch.com/news/labor-moves-to-force-presentation-of-letter-of-intent 2020-09-02T09:29:01+10:00 https://pharmadispatch.com/news/richard-tew-on-permanent-change-and-unbossed-leadership 2020-09-02T04:00:01+10:00 https://pharmadispatch.com/news/australian-company-announces-manufacturing-expansion 2020-09-02T04:00:01+10:00 https://pharmadispatch.com/news/a-system-that-deliberately-financially-discriminates-against-som 2020-09-02T04:00:01+10:00 https://pharmadispatch.com/news/pbs-update-confirms-the-impact-of-innovation 2020-09-02T04:00:01+10:00 https://pharmadispatch.com/news/iqvia-demand-still-suppressed-and-concerns-over-cancer-outcomes 2020-09-01T04:00:01+10:00 https://pharmadispatch.com/news/new-report-triggers-call-for-national-overdose-strategy 2020-09-01T04:00:01+10:00 https://pharmadispatch.com/news/department-of-health-the-first-to-front-inquiry 2020-09-01T04:00:01+10:00 https://pharmadispatch.com/news/industry-expecting-further-consultation-on-review-rescind-remake 2020-09-01T04:00:01+10:00 https://pharmadispatch.com/news/at-least-one-glaring-omission-from-vaccines-advisory-group 2020-08-31T04:00:01+10:00 https://pharmadispatch.com/news/new-listings-for-keytruda-markt-its-fifth-anniversary-on-the-pbs 2020-08-31T04:00:01+10:00 https://pharmadispatch.com/news/many-governments-now-preparing-for-early-access-to-a-vaccine 2020-08-31T04:00:01+10:00 https://pharmadispatch.com/news/the-eleven-weeks-of-inaction-that-cost-australia-in-the-vaccine- 2020-08-30T04:00:01+10:00 https://pharmadispatch.com/news/if-not-now-then-when-would-you-ever-rush-development 2020-08-28T04:00:01+10:00 https://pharmadispatch.com/news/tga-no-emergency-authorisation-but-similar-provisions-available 2020-08-28T04:00:01+10:00 https://pharmadispatch.com/news/gsk-new-asthma-guidelines-mean-no-change-for-most 2020-08-28T04:00:01+10:00 https://pharmadispatch.com/news/bowen-only-a-vaccine-can-destroy-the-covid-19-curve 2020-08-28T04:00:01+10:00 https://pharmadispatch.com/news/new-online-platform-developed-for-advisory-groups 2020-08-28T04:00:01+10:00 https://pharmadispatch.com/news/msac-not-humanly-possible-to-have-faster-process 2020-08-28T04:00:01+10:00 https://pharmadispatch.com/news/chp-australia-self-care-key-to-fighting-pandemic-spread 2020-08-27T04:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-sanofis-pipeline-in-a-product 2020-08-27T04:00:01+10:00 https://pharmadispatch.com/news/paig-shifts-focus-to-reconciliation-actions-plans 2020-08-27T04:00:01+10:00 https://pharmadispatch.com/news/novartis-gene-therapy-tops-november-pbac-agenda 2020-08-26T14:34:01+10:00 https://pharmadispatch.com/news/labor-calls-for-government-action-on-covax 2020-08-26T09:57:01+10:00 https://pharmadispatch.com/news/lillys-ben-basil-on-a-viable-feasible-and-sustainable-outcome 2020-08-26T04:00:01+10:00 https://pharmadispatch.com/news/another-emergency-authorisation-clouds-vaccine-debate 2020-08-26T04:00:01+10:00 https://pharmadispatch.com/news/starpharma-updates-on-development-of-covid-19-treatment 2020-08-26T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-launches-trial-of-covid-19-antibody-combination 2020-08-26T04:00:01+10:00 https://pharmadispatch.com/news/halton-manufacturers-must-contribute-to-covax-facility 2020-08-25T04:00:01+10:00 https://pharmadispatch.com/news/a-tri-party-agreement-with-no-shortage-of-complexity 2020-08-25T04:00:01+10:00 https://pharmadispatch.com/news/us-could-push-for-emergency-authorisation-in-september 2020-08-25T04:00:01+10:00 https://pharmadispatch.com/news/abbvie-working-towards-april-biosimilars 2020-08-25T04:00:01+10:00 https://pharmadispatch.com/news/pbac-delivers-significant-outcomes-at-july-meeting 2020-08-24T04:00:01+10:00 https://pharmadispatch.com/news/bayer-launches-access-program-despite-rejection 2020-08-24T04:00:01+10:00 https://pharmadispatch.com/news/pbac-defers-outcome-on-medicinal-cannabis 2020-08-24T04:00:01+10:00 https://pharmadispatch.com/news/nothing-has-changed-government-faces-a-stark-reality 2020-08-24T04:00:01+10:00 https://pharmadispatch.com/news/inquiry-schedules-first-public-hearing 2020-08-24T04:00:01+10:00 https://pharmadispatch.com/news/an-opportunity-to-reflect-on-wider-approach-to-vaccines 2020-08-21T04:00:01+10:00 https://pharmadispatch.com/news/data-points-to-substantial-increase-in-the-number-of-avoidable-c 2020-08-21T04:00:01+10:00 https://pharmadispatch.com/news/fda-fast-track-for-australian-companys-potential-glioblastoma-tr 2020-08-21T04:00:01+10:00 https://pharmadispatch.com/news/government-appoints-industry-executives-to-covid-19-group 2020-08-21T04:00:01+10:00 https://pharmadispatch.com/news/biogen-teams-up-with-patients-and-advocates-for-challenge 2020-08-21T04:00:01+10:00 https://pharmadispatch.com/news/even-our-letter-of-intent-is-not-as-good-as-in-other-countries 2020-08-20T04:00:01+10:00 https://pharmadispatch.com/news/csl-reports-strong-result-on-the-back-product-growth 2020-08-20T04:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-to-initiate-new-trial-for-potential-myelofibrosis-trea 2020-08-20T04:00:01+10:00 https://pharmadispatch.com/news/inquiry-hearings-could-start-next-week 2020-08-20T04:00:01+10:00 https://pharmadispatch.com/news/csl-our-position-on-az-oxford-has-not-changed 2020-08-19T08:20:01+10:00 https://pharmadispatch.com/news/the-pandemic-poll-date-pharmac-and-principal-supply 2020-08-19T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-vaccine-an-agreement-to-have-an-agreement 2020-08-19T04:00:01+10:00 https://pharmadispatch.com/news/uq-researchers-in-antimicrobial-resistance-breakthrough 2020-08-19T04:00:01+10:00 https://pharmadispatch.com/news/parliamentary-inquiry-to-consider-medicine-approval-processes 2020-08-19T04:00:01+10:00 https://pharmadispatch.com/news/atagi-to-have-high-level-discussion-on-covid-19-vaccines 2020-08-18T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-to-acquire-us-based-principia-biopharma 2020-08-18T04:00:01+10:00 https://pharmadispatch.com/news/iqvia-a-decade-long-decline-to-just-over-1-per-day 2020-08-18T04:00:01+10:00 https://pharmadispatch.com/news/adelaide-to-review-and-draft-revised-msac-guidelines 2020-08-18T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-vaccine-making-it-up-as-they-goagain 2020-08-18T04:00:01+10:00 https://pharmadispatch.com/news/csl-says-not-so-fast-on-az-oxford-switch 2020-08-17T04:00:01+10:00 https://pharmadispatch.com/news/new-board-leadership-for-npsa 2020-08-17T04:00:01+10:00 https://pharmadispatch.com/news/the-governments-is-still-making-it-up-as-they-go 2020-08-17T04:00:01+10:00 https://pharmadispatch.com/news/covax-and-the-risk-of-being-squeezed-by-country-agreements 2020-08-17T04:00:01+10:00 https://pharmadispatch.com/news/i-find-that-remarkable-said-senator-richard-di-natale 2020-08-14T09:26:01+10:00 https://pharmadispatch.com/news/qbiotics-in-new-cancer-collaboration-with-msd 2020-08-14T04:00:01+10:00 https://pharmadispatch.com/news/is-the-pandemic-a-time-for-caution-or-action-on-a-vaccine 2020-08-14T04:00:01+10:00 https://pharmadispatch.com/news/merck-marks-a-critical-national-science-week 2020-08-14T04:00:01+10:00 https://pharmadispatch.com/news/support-for-an-extension-but-not-at-any-price 2020-08-14T04:00:01+10:00 https://pharmadispatch.com/news/dr-brendan-shaw-presidential-order-with-serious-implications-for 2020-08-13T04:00:01+10:00 https://pharmadispatch.com/news/ircumstances-decisions-and-conditions-lead-australia-few-options 2020-08-13T04:00:01+10:00 https://pharmadispatch.com/news/indonesia-jumps-ahead-in-deal-for-late-stage-vaccine 2020-08-13T04:00:01+10:00 https://pharmadispatch.com/news/governments-move-to-limit-product-liability-claims 2020-08-13T04:00:01+10:00 https://pharmadispatch.com/news/coina-government-that-now-needs-to-be-seen-doing-somethingcidenc 2020-08-12T04:00:01+10:00 https://pharmadispatch.com/news/az-csl-licensing-deal-could-be-the-most-likely 2020-08-12T04:00:01+10:00 https://pharmadispatch.com/news/russia-rushes-vaccine-approval-before-testing 2020-08-12T04:00:01+10:00 https://pharmadispatch.com/news/sigma-secures-proceeds-from-sale-of-distribution-centres 2020-08-11T04:00:01+10:00 https://pharmadispatch.com/news/a-national-vaccine-plan-maybe-just-a-few-months-late 2020-08-11T04:00:01+10:00 https://pharmadispatch.com/news/mylan-still-working-its-way-though-insulin-glargine-shortage 2020-08-11T04:00:01+10:00 https://pharmadispatch.com/news/ebos-launches-its-reconciliation-action-plan 2020-08-11T04:00:01+10:00 https://pharmadispatch.com/news/guild-what-sort-of-unethical-tawdry-show-are-they-running 2020-08-10T17:52:01+10:00 https://pharmadispatch.com/news/the-one-certainty-that-really-matters-the-savings-target 2020-08-10T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-another-deal-for-japan-as-australia-waits 2020-08-10T04:00:01+10:00 https://pharmadispatch.com/news/cepi-survey-reveals-potential-vaccine-supply 2020-08-10T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-hits-back-at-unfair-and-ill-informed-attack 2020-08-10T04:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-could-move-to-extend-industry-agreements 2020-08-07T04:00:01+10:00 https://pharmadispatch.com/news/csl-says-it-is-now-exploring-ways-to-manufacture-another-vaccine 2020-08-07T04:00:01+10:00 https://pharmadispatch.com/news/goldman-sachs-us-will-be-first-because-it-has-invested-the-most 2020-08-06T04:00:01+10:00 https://pharmadispatch.com/news/what-is-the-strategy-is-there-a-strategy 2020-08-06T04:00:01+10:00 https://pharmadispatch.com/news/neurohack-brainstorms-solutions-for-young-people-with-sma 2020-08-06T04:00:01+10:00 https://pharmadispatch.com/news/ventolin-with-dose-counter-makes-it-to-the-pbs 2020-08-06T04:00:01+10:00 https://pharmadispatch.com/news/cros-unite-under-arcs-to-call-for-permanent-change 2020-08-06T04:00:01+10:00 https://pharmadispatch.com/news/experienced-market-access-exec-returns-to-amgen 2020-08-06T04:00:01+10:00 https://pharmadispatch.com/news/janssen-signs-new-research-collaboration-with-monash 2020-08-05T04:00:01+10:00 https://pharmadispatch.com/news/uk-government-secures-more-supply-of-az-oxford-vaccine 2020-08-05T04:00:01+10:00 https://pharmadispatch.com/news/federal-court-backs-sandoz-in-latest-lexapro-judgement 2020-08-05T04:00:01+10:00 https://pharmadispatch.com/news/hatchtech-secures-us-approval-of-xeglyze 2020-08-05T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-starts-consulting-on-move-to-scrap-sole-supply 2020-08-05T04:00:01+10:00 https://pharmadispatch.com/news/kodak-goes-from-photos-to-pharmaceuticals 2020-08-04T04:00:01+10:00 https://pharmadispatch.com/news/still-time-to-nominate-for-gsk-research-award 2020-08-04T04:00:01+10:00 https://pharmadispatch.com/news/gilead-invites-applications-for-research-grants-program 2020-08-04T04:00:01+10:00 https://pharmadispatch.com/news/australia-is-not-yet-even-in-the-line-for-a-vaccine 2020-08-04T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-csls-perreault-says-plasma-treatment-could-be-within-re 2020-08-03T04:00:01+10:00 https://pharmadispatch.com/news/pm-hits-vaccine-nationalism-but-has-australialeft-it-late 2020-08-03T04:00:01+10:00 https://pharmadispatch.com/news/roches-rachel-frizberg-achieving-the-potential-of-personalised-h 2020-08-03T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-taskforce-established-to-arrange-vaccine-deals 2020-08-03T04:00:01+10:00 https://pharmadispatch.com/news/new-tumour-agnostic-therapy-makes-pbs-for-lung-cancer 2020-08-03T04:00:01+10:00 https://pharmadispatch.com/news/pandemic-and-lower-safety-net-led-to-surge-free-pbs-prescription 2020-07-31T04:00:01+10:00 https://pharmadispatch.com/news/mark-brooke-grant-could-not-come-at-a-better-time 2020-07-31T04:00:01+10:00 https://pharmadispatch.com/news/jj-the-latest-to-announce-positive-vaccine-trial-results 2020-07-31T04:00:01+10:00 https://pharmadispatch.com/news/atagi-to-discuss-covid-19-vaccine-in-august 2020-07-30T11:56:01+10:00 https://pharmadispatch.com/news/covid-19-pfizer-adopts-a-two-phased-approach-to-vaccine 2020-07-30T11:01:01+10:00 https://pharmadispatch.com/news/the-compulsory-licence-threat-is-just-fake-news 2020-07-30T04:00:01+10:00 https://pharmadispatch.com/news/cso-wholesalers-secure-four-year-contract-extension 2020-07-30T04:00:01+10:00 https://pharmadispatch.com/news/stakeholders-anticipating-policy-review-announcement 2020-07-30T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-early-september-for-the-first-late-stage-trial-results 2020-07-30T04:00:01+10:00 https://pharmadispatch.com/news/ma-appoints-new-members-to-advisory-council 2020-07-29T04:00:01+10:00 https://pharmadispatch.com/news/australia-already-competing-for-second-wave-supply 2020-07-29T04:00:01+10:00 https://pharmadispatch.com/news/otsuka-backing-curious-minds-stem-initiative 2020-07-29T04:00:01+10:00 https://pharmadispatch.com/news/johnson-johnson-to-consolidate-businesses-in-one-location 2020-07-29T04:00:01+10:00 https://pharmadispatch.com/news/us-takes-another-step-to-international-pricing-index 2020-07-28T04:00:01+10:00 https://pharmadispatch.com/news/the-option-is-recombinant-or-downstream-processing 2020-07-28T04:00:01+10:00 https://pharmadispatch.com/news/australian-moving-towards-elimination-but-momentum-has-slowed 2020-07-28T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-us6bn-for-rights-to-new-cancer-treatment 2020-07-28T04:00:01+10:00 https://pharmadispatch.com/news/health-sector-to-pay-tribute-to-late-racgp-president 2020-07-28T04:00:01+10:00 https://pharmadispatch.com/news/manufacturers-will-look-with-jealousy-at-pharmacy-risk-share 2020-07-27T04:00:01+10:00 https://pharmadispatch.com/news/all-that-bluster-from-the-government-amounted-to-not-very-much 2020-07-27T04:00:01+10:00 https://pharmadispatch.com/news/australia-talks-licensing-while-other-countries-just-buy-the-vac 2020-07-27T04:00:01+10:00 https://pharmadispatch.com/news/pfizers-anne-harris-on-her-passions-priorities-and-the-pandemic 2020-07-26T04:00:01+10:00 https://pharmadispatch.com/news/protecting-the-pharmaceutical-industry-from-cyber-attack 2020-07-24T04:00:01+10:00 https://pharmadispatch.com/news/pbac-steps-back-from-transparency-commitment 2020-07-24T04:00:01+10:00 https://pharmadispatch.com/news/new-gilead-legal-counsel-well-known-to-the-industry 2020-07-24T04:00:01+10:00 https://pharmadispatch.com/news/economic-update-raises-some-interesting-questions 2020-07-24T04:00:01+10:00 https://pharmadispatch.com/news/economic-update-confirms-eye-watering-deficits 2020-07-23T11:03:01+10:00 https://pharmadispatch.com/news/biogen-to-trial-spinraza-in-patients-treated-with-gene-therapy 2020-07-23T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-stepping-up-in-support-of-the-smith-family 2020-07-23T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-where-is-australias-vaccine-strategy 2020-07-23T04:00:01+10:00 https://pharmadispatch.com/news/nz-parliamentary-committee-hears-evidence-against-forced-switchi 2020-07-23T04:00:01+10:00 https://pharmadispatch.com/news/merck-in-deal-for-queensland-immunotherapies 2020-07-23T04:00:01+10:00 https://pharmadispatch.com/news/tga-approval-for-sanofi-immunotherapy 2020-07-22T04:00:01+10:00 https://pharmadispatch.com/news/lundbeck-immensely-proud-of-workplace-recognition 2020-07-22T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-imagine-the-response-to-late-stage-data 2020-07-22T04:00:01+10:00 https://pharmadispatch.com/news/abbvies-chris-stemple-on-being-a-best-place-to-work 2020-07-22T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-confirms-another-shortage-in-new-zealand 2020-07-21T04:00:01+10:00 https://pharmadispatch.com/news/companies-told-to-get-legal-advice-before-accepting-changes 2020-07-21T04:00:01+10:00 https://pharmadispatch.com/news/hahn-launches-new-company-to-manage-demand 2020-07-21T04:00:01+10:00 https://pharmadispatch.com/news/new-research-collaboration-for-csl-and-uniquest 2020-07-21T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-a-busy-24-hours-boosts-vaccine-hopes 2020-07-21T04:00:01+10:00 https://pharmadispatch.com/news/does-the-minister-understand-just-how-much-things-have-changed 2020-07-20T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-eu-chases-vaccine-as-sanofi-sticks-with-api-spinout 2020-07-20T04:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-migraine-companies-got-what-they-requested 2020-07-20T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-pharmacists-to-test-for-virus-in-sa 2020-07-20T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-ceo-joining-csl-board 2020-07-17T04:00:01+10:00 https://pharmadispatch.com/news/bms-welcome-approval-of-lung-cancer-combination 2020-07-17T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-sanofi-and-pfizer-backing-new-research-program 2020-07-17T04:00:01+10:00 https://pharmadispatch.com/news/rare-voices-calls-for-action-in-response-to-new-report 2020-07-17T04:00:01+10:00 https://pharmadispatch.com/news/chris-bowen-ministers-knows-he-is-wrong-because-he-has-done-it-h 2020-07-17T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-new-data-and-late-stage-trial-for-moderna-vaccine 2020-07-16T04:00:01+10:00 https://pharmadispatch.com/news/biogen-partners-with-university-of-adelaide-for-neurohack 2020-07-16T04:00:01+10:00 https://pharmadispatch.com/news/gsk-reviewing-the-future-of-boronia-manufacturing-site 2020-07-16T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-scrapping-sole-supply-contracts 2020-07-15T04:00:01+10:00 https://pharmadispatch.com/news/us-orphan-status-for-pharmaxis-cancer-treatment 2020-07-15T04:00:01+10:00 https://pharmadispatch.com/news/industry-leader-urges-caution-on-covid-19-vaccine 2020-07-15T04:00:01+10:00 https://pharmadispatch.com/news/the-three-cs-communication-collaboration-and-commercialisation 2020-07-14T10:21:01+10:00 https://pharmadispatch.com/news/chris-bowen-it-is-greg-hunts-job-to-list-it 2020-07-14T04:00:01+10:00 https://pharmadispatch.com/news/we-can-already-see-the-limitations-of-netflix-for-medicines 2020-07-14T04:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-to-administer-new-research-accelerator 2020-07-14T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-the-politics-of-having-to-wait-for-a-vaccine 2020-07-14T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-ceo-says-covid-19-vaccine-possible-by-october 2020-07-13T04:00:01+10:00 https://pharmadispatch.com/news/merck-extends-agreement-with-australian-company 2020-07-13T04:00:01+10:00 https://pharmadispatch.com/news/the-tga-has-taken-just-two-weeks-to-grant-provisional-approval-t 2020-07-13T04:00:01+10:00 https://pharmadispatch.com/news/msd-looking-for-three-peat-at-australian-hr-awards 2020-07-13T04:00:01+10:00 https://pharmadispatch.com/news/industry-creates-antibiotic-rd-fund-in-response-to-policy-failur 2020-07-13T04:00:01+10:00 https://pharmadispatch.com/news/new-code-of-conduct-means-more-media-opportunities 2020-07-10T04:00:01+10:00 https://pharmadispatch.com/news/the-health-minister-msac-and-the-powers-of-a-medieval-king 2020-07-10T04:00:01+10:00 https://pharmadispatch.com/news/ma-review-timeframe-unnecessarily-short-and-unfair 2020-07-10T04:00:01+10:00 https://pharmadispatch.com/news/the-future-of-parental-leave-the-focus-of-paig-workshops 2020-07-09T04:00:01+10:00 https://pharmadispatch.com/news/australia-leads-region-on-approach-to-cancer-care 2020-07-09T04:00:01+10:00 https://pharmadispatch.com/news/gbma-awareness-activities-reached-over-half-a-million 2020-07-09T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-stands-steadfastly-united-with-industry-on-rd-cut 2020-07-08T04:00:01+10:00 https://pharmadispatch.com/news/ma-backs-msd-concerns-over-zinplava-rejection 2020-07-08T04:00:01+10:00 https://pharmadispatch.com/news/psa-pandemic-highlights-need-for-changed-approach-to-shortages 2020-07-07T15:47:01+10:00 https://pharmadispatch.com/news/process-should-be-fair-for-everyone-including-the-industry 2020-07-07T04:00:01+10:00 https://pharmadispatch.com/news/australian-company-announces-positive-results-from-early-pcsk9-s 2020-07-07T04:00:01+10:00 https://pharmadispatch.com/news/major-supplier-withdraws-from-new-zealand-market 2020-07-07T04:00:01+10:00 https://pharmadispatch.com/news/anao-audits-could-target-mrff-and-blood-products 2020-07-07T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-csl-behring-starts-trial-of-monoclonal-antibody 2020-07-07T04:00:01+10:00 https://pharmadispatch.com/news/the-finance-portfolio-almost-always-calls-the-senate-home 2020-07-06T04:00:01+10:00 https://pharmadispatch.com/news/high-continuation-rate-could-mean-a-cascading-price-cut 2020-07-06T04:00:01+10:00 https://pharmadispatch.com/news/how-many-new-patients-are-even-left-in-the-migraine-subsidy-cap 2020-07-06T04:00:01+10:00 https://pharmadispatch.com/news/msd-disappointed-over-no-right-of-reply 2020-07-06T04:00:01+10:00 https://pharmadispatch.com/news/roche-general-manager-stuart-knight-on-transformation 2020-07-06T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-pfizer-the-latest-to-announce-positive-vaccine-data 2020-07-03T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-positive-news-on-affinity-biosciences-antibodies 2020-07-03T04:00:01+10:00 https://pharmadispatch.com/news/funding-for-new-sanofi-haemophilia-treatments 2020-07-03T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-new-data-reveals-slump-in-new-cancer-treatment 2020-07-02T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-fda-will-not-compromise-standards-on-vaccine-approval 2020-07-02T04:00:01+10:00 https://pharmadispatch.com/news/roche-unveils-new-organisational-system 2020-07-02T04:00:01+10:00 https://pharmadispatch.com/news/mylan-shareholders-approve-merger-with-pfizers-upjohn 2020-07-02T04:00:01+10:00 https://pharmadispatch.com/news/bexsero-for-nip-but-gsk-points-to-atagi-advice 2020-07-02T04:00:01+10:00 https://pharmadispatch.com/news/pricing-need-to-balance-the-full-scope-of-responsibilities-and-r 2020-07-01T04:00:01+10:00 https://pharmadispatch.com/news/majority-of-new-zealanders-would-for-medicines-access 2020-07-01T04:00:01+10:00 https://pharmadispatch.com/news/one-reform-remains-stuck-in-the-too-hard-basket 2020-07-01T04:00:01+10:00 https://pharmadispatch.com/news/gilead-prices-remdesivir-recognising-the-need-to-balance-respons 2020-07-01T04:00:01+10:00 https://pharmadispatch.com/news/government-extends-emergency-dispersing-measures 2020-07-01T04:00:01+10:00 https://pharmadispatch.com/news/punitive-changes-will-force-a-choice-between-rd-and-manufacturin 2020-06-30T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-vaccine-may-not-be-good-enough-for-herd-immunity 2020-06-30T04:00:01+10:00 https://pharmadispatch.com/news/no-new-modelling-or-stakeholder-consultation-on-rd-tax-cut 2020-06-30T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-caught-out-on-pandemic-spending-claim 2020-06-30T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-developers-searching-for-virus-to-trial-vaccines 2020-06-29T05:00:01+10:00 https://pharmadispatch.com/news/could-the-review-process-resolve-disputes-not-just-rescind-outco 2020-06-29T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-tracker-shows-dramatic-slowdown-in-new-compounds 2020-06-29T04:00:01+10:00 https://pharmadispatch.com/news/nz-pharmac-delay-a-terrible-blow-for-dying-patients 2020-06-29T04:00:01+10:00 https://pharmadispatch.com/news/haemophilia-gene-therapies-moving-closer-to-reality 2020-06-26T04:00:01+10:00 https://pharmadispatch.com/news/takeda-invites-australian-researchers-to-apply-for-grants 2020-06-26T04:00:01+10:00 https://pharmadispatch.com/news/uk-launches-netflix-subscription-plan-for-new-antibiotics 2020-06-26T04:00:01+10:00 https://pharmadispatch.com/news/rebate-dispute-could-be-moving-towards-the-courts 2020-06-25T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-launches-its-first-accessibility-inclusion-plan 2020-06-25T04:00:01+10:00 https://pharmadispatch.com/news/the-challenge-is-to-keep-the-momentum-going 2020-06-25T04:00:01+10:00 https://pharmadispatch.com/news/new-paper-highlights-the-need-for-action-on-cv-risk 2020-06-25T04:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-abolished-pbpa-could-have-resolved-dispute 2020-06-24T04:00:01+10:00 https://pharmadispatch.com/news/recognition-for-gilead-in-annual-inclusion-awards 2020-06-24T04:00:01+10:00 https://pharmadispatch.com/news/companies-in-renewed-push-for-reform-of-vial-sharing 2020-06-24T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-early-signs-of-increased-demand-for-steroid 2020-06-23T15:10:01+10:00 https://pharmadispatch.com/news/what-would-it-actually-take-to-speak-out 2020-06-23T04:00:01+10:00 https://pharmadispatch.com/news/past-recommendations-might-be-a-guide-for-greg-hunt 2020-06-23T04:00:01+10:00 https://pharmadispatch.com/news/johnson-johnson-close-to-major-deal-on-covid-19-vaccine 2020-06-23T04:00:01+10:00 https://pharmadispatch.com/news/greens-move-to-ban-political-donations-from-industry-again 2020-06-22T04:00:01+10:00 https://pharmadispatch.com/news/no-real-changes-for-tumour-agnostic-cancer-therapies 2020-06-22T04:00:01+10:00 https://pharmadispatch.com/news/companies-forced-to-fund-most-patients-under-migraine-agreement 2020-06-22T03:00:01+10:00 https://pharmadispatch.com/news/frankenstein-advice-contradicts-the-recommendation 2020-06-22T03:00:01+10:00 https://pharmadispatch.com/news/speaker-lilly-and-patient-group-can-seek-redress 2020-06-19T04:00:01+10:00 https://pharmadispatch.com/news/roche-signs-new-agreement-with-australian-diagnostic-company 2020-06-19T04:00:01+10:00 https://pharmadispatch.com/news/where-have-fees-for-chemotherapy-compounding-gone 2020-06-19T04:00:01+10:00 https://pharmadispatch.com/news/more-questions-about-msac-consideration-of-oncotypedx 2020-06-18T08:04:01+10:00 https://pharmadispatch.com/news/covid-19-new-report-highlights-the-impact-on-life-sciences 2020-06-18T04:00:01+10:00 https://pharmadispatch.com/news/maybe-the-minister-is-asking-the-wrong-question-of-the-wrong-gro 2020-06-18T02:00:01+10:00 https://pharmadispatch.com/news/lilly-advice-means-we-lose-on-every-single-prescription 2020-06-18T02:00:01+10:00 https://pharmadispatch.com/news/janssen-in-new-research-collaboration-with-monash 2020-06-18T02:00:01+10:00 https://pharmadispatch.com/news/chris-bowen-minister-must-retract-deeply-offensive-and-misleadin 2020-06-17T13:33:01+10:00 https://pharmadispatch.com/news/hunt-accuses-company-of-astroturfing-pbac-advice 2020-06-17T11:24:01+10:00 https://pharmadispatch.com/news/for-the-industry-the-aftershock-might-be-worse 2020-06-17T04:00:01+10:00 https://pharmadispatch.com/news/wholesalers-welcome-necessary-changes-in-remuneration 2020-06-17T04:00:01+10:00 https://pharmadispatch.com/news/azs-pascal-soriot-covid-19-vaccine-to-last-for-one-year 2020-06-17T04:00:01+10:00 https://pharmadispatch.com/news/ma-radical-changes-will-only-undermine-supply 2020-06-16T16:00:01+10:00 https://pharmadispatch.com/news/lilly-submits-updated-proposal-for-migraine-biologic 2020-06-16T04:00:01+10:00 https://pharmadispatch.com/news/emerge-health-relaunched-as-chiesi-australia 2020-06-16T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-and-wholesalers-now-for-the-industry 2020-06-16T04:00:01+10:00 https://pharmadispatch.com/news/eczema-patient-group-wins-global-grant-from-sanofi-genzyme 2020-06-16T04:00:01+10:00 https://pharmadispatch.com/news/nz-new-report-reveals-plight-of-medicines-access 2020-06-16T04:00:01+10:00 https://pharmadispatch.com/news/7cpa-changes-for-wholesalers-could-be-the-real-story 2020-06-15T04:00:01+10:00 https://pharmadispatch.com/news/a-reform-contextualised-by-a-contentious-political-debate 2020-06-15T04:00:01+10:00 https://pharmadispatch.com/news/europe-commits-to-az-oxford-covid-19-vaccine 2020-06-15T04:00:01+10:00 https://pharmadispatch.com/news/new-papers-delivers-detailed-assessment-of-pbac-outcomes 2020-06-15T04:00:01+10:00 https://pharmadispatch.com/news/funding-for-projects-to-support-pbac-msac-decision-making 2020-06-15T04:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-new-pharmacy-agreement 2020-06-12T08:13:01+10:00 https://pharmadispatch.com/news/potential-cures-will-disrupt-and-upend-existing-health-systems 2020-06-12T04:00:01+10:00 https://pharmadispatch.com/news/global-award-for-bristol-myers-squibb-and-palin 2020-06-12T04:00:01+10:00 https://pharmadispatch.com/news/the-logical-extension-is-to-apply-review-and-rescind-to-rejectio 2020-06-12T04:00:01+10:00 https://pharmadispatch.com/news/7cpa-done-deal-with-announcement-as-early-as-today 2020-06-12T04:00:01+10:00 https://pharmadispatch.com/news/no-basis-for-the-name-game-on-redactions 2020-06-11T04:00:01+10:00 https://pharmadispatch.com/news/minister-considering-the-matter-of-msac-and-oncotypedx 2020-06-11T04:00:01+10:00 https://pharmadispatch.com/news/opthea-announces-top-line-results-of-opt-302-dme-trial 2020-06-11T04:00:01+10:00 https://pharmadispatch.com/news/biomelbourne-network-women-in-leadership-awards 2020-06-11T04:00:01+10:00 https://pharmadispatch.com/news/whats-the-problem-here-rejected-6-times 2020-06-10T04:00:01+10:00 https://pharmadispatch.com/news/this-is-the-case-we-know-about-are-there-any-others 2020-06-10T04:00:01+10:00 https://pharmadispatch.com/news/company-calls-for-ministerial-intervention-on-msac 2020-06-10T04:00:01+10:00 https://pharmadispatch.com/news/reports-astrazeneca-approached-gilead-about-potential-merger 2020-06-09T04:00:01+10:00 https://pharmadispatch.com/news/queens-birthday-honour-for-pharmacy-leader 2020-06-09T04:00:01+10:00 https://pharmadispatch.com/news/prospections-peter-cronin-the-data-opportunity-of-pandemic-prepa 2020-06-09T04:00:01+10:00 https://pharmadispatch.com/news/australian-companies-up-for-new-pfizer-investment-initiative 2020-06-09T04:00:01+10:00 https://pharmadispatch.com/news/csl-and-cepi-agreement-on-covid-19-vaccine-for-australia 2020-06-05T11:30:01+10:00 https://pharmadispatch.com/news/us-operation-warp-speed-selects-priority-vaccines 2020-06-05T04:00:01+10:00 https://pharmadispatch.com/news/three-years-on-pathways-then-along-comes-this 2020-06-05T04:00:01+10:00 https://pharmadispatch.com/news/federal-government-commits-300m-to-global-vaccine-alliance 2020-06-05T04:00:01+10:00 https://pharmadispatch.com/news/bms-announces-positive-data-for-pbs-listed-biologic 2020-06-05T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-invites-life-on-the-other-side 2020-06-04T09:00:01+10:00 https://pharmadispatch.com/news/maybe-investigate-the-issue-rather-than-just-get-rid-of-it 2020-06-04T04:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-has-immediate-concerns-over-review-and-resci 2020-06-04T04:00:01+10:00 https://pharmadispatch.com/news/project-orbis-review-for-sta-lung-cancer-therapy 2020-06-04T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-investors-call-for-action-to-protect-life-sciences 2020-06-04T04:00:01+10:00 https://pharmadispatch.com/news/chris-bowen-slams-arbitrary-deadline-that-will-only-worsen-acces 2020-06-03T12:52:01+10:00 https://pharmadispatch.com/news/the-rescind-and-inactivate-fix-to-a-political-problem 2020-06-03T04:00:01+10:00 https://pharmadispatch.com/news/pbac-moves-to-review-and-rescind-recommendations 2020-06-03T04:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-66-million-for-coronavirus-related-research 2020-06-03T04:00:01+10:00 https://pharmadispatch.com/news/commonwealth-appeals-clopidogrel-judgement 2020-06-02T13:36:01+10:00 https://pharmadispatch.com/news/csl-opens-applications-for-2021-fellowships 2020-06-02T04:00:01+10:00 https://pharmadispatch.com/news/emgality-inactive-but-lilly-still-working-on-listing 2020-06-02T04:00:01+10:00 https://pharmadispatch.com/news/australian-company-updates-on-trial-with-msds-keytruda 2020-06-02T04:00:01+10:00 https://pharmadispatch.com/news/positive-update-for-biomarin-haemophilia-gene-therapy 2020-06-02T04:00:01+10:00 https://pharmadispatch.com/news/coag-abolished-by-the-national-cabinet-now-what 2020-06-01T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-several-vaccines-likely-of-variable-efficacy 2020-06-01T04:00:01+10:00 https://pharmadispatch.com/news/june-pbs-new-asthma-and-myeloma-listings 2020-06-01T04:00:01+10:00 https://pharmadispatch.com/news/the-industryhas-a-significant-stake-in-what-follows-coag 2020-06-01T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-scrutiny-moves-to-companies-and-their-executives 2020-05-29T05:00:01+10:00 https://pharmadispatch.com/news/prospection-call-for-action-on-linked-datasets 2020-05-29T04:00:01+10:00 https://pharmadispatch.com/news/telehealth-is-good-but-its-not-that-good 2020-05-29T04:00:01+10:00 https://pharmadispatch.com/news/azs-forxiga-secures-key-cv-approval 2020-05-28T04:00:01+10:00 https://pharmadispatch.com/news/moving-one-step-close-to-patent-notification-system 2020-05-28T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-novartis-extends-support-to-partner-patient-groups 2020-05-28T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-msd-enters-vaccine-race-in-dramatic-style 2020-05-28T04:00:01+10:00 https://pharmadispatch.com/news/7cpa-imminent-with-split-outcome-on-sticking-points 2020-05-27T04:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-moves-for-change-in-new-action-plan 2020-05-27T04:00:01+10:00 https://pharmadispatch.com/news/who-halts-key-covid-19-trial-in-response-to-safety-concerns 2020-05-27T04:00:01+10:00 https://pharmadispatch.com/news/official-pbs-statistics-start-to-reveal-impact-of-covid-19 2020-05-27T04:00:01+10:00 https://pharmadispatch.com/news/tylenol-approved-for-australian-patients 2020-05-27T04:00:01+10:00 https://pharmadispatch.com/news/the-law-on-decision-making-is-general-broad-and-vague 2020-05-26T04:00:01+10:00 https://pharmadispatch.com/news/vaccines-based-on-vastly-different-technologies 2020-05-26T04:00:01+10:00 https://pharmadispatch.com/news/decline-in-cases-triggers-debate-over-human-challenge-trials 2020-05-26T04:00:01+10:00 https://pharmadispatch.com/news/new-funding-for-pharmacogenomics-mental-health-research 2020-05-26T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-and-the-challenging-scenario-vaccine-for-government 2020-05-25T04:00:01+10:00 https://pharmadispatch.com/news/update-cost-recovery-statement-as-working-group-meets 2020-05-25T04:00:01+10:00 https://pharmadispatch.com/news/psd-redaction-changes-deferred-again 2020-05-25T04:00:01+10:00 https://pharmadispatch.com/news/no-result-possible-because-of-declining-cases 2020-05-25T04:00:01+10:00 https://pharmadispatch.com/news/lundbeck-announces-new-leadership-for-australia 2020-05-25T04:00:01+10:00 https://pharmadispatch.com/news/complex-new-vaccine-technologies-pose-challenges-for-regulators 2020-05-22T04:00:01+10:00 https://pharmadispatch.com/news/australia-is-hoping-on-one-technology-when-it-comes-to-covid-19- 2020-05-22T04:00:01+10:00 https://pharmadispatch.com/news/medicines-new-zealand-report-on-the-value-of-clinical-trials 2020-05-22T04:00:01+10:00 https://pharmadispatch.com/news/compulsory-licensing-an-unnecessary-but-inevitable-threat 2020-05-21T04:00:01+10:00 https://pharmadispatch.com/news/global-recognition-for-roche-ms-app 2020-05-21T04:00:01+10:00 https://pharmadispatch.com/news/heart-foundation-patients-missing-test-for-statins-during-pandem 2020-05-21T04:00:01+10:00 https://pharmadispatch.com/news/karen-andrews-hoping-for-domestic-production 2020-05-21T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-benefits-well-and-truly-shaded-by-natural-therapies 2020-05-20T04:00:01+10:00 https://pharmadispatch.com/news/a-double-edged-sword-but-it-is-still-better-than-independence 2020-05-20T04:00:01+10:00 https://pharmadispatch.com/news/symbion-marks-175th-year-since-its-creation-in-adelaide 2020-05-20T04:00:01+10:00 https://pharmadispatch.com/news/positive-results-from-early-study-of-moderna-covid-19-vaccine 2020-05-20T04:00:01+10:00 https://pharmadispatch.com/news/the-pbac-at-arms-length-but-it-is-not-independent-in-law-or-in-p 2020-05-19T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-goes-virtual-for-national-volunteer-week 2020-05-19T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-az-commits-to-supply-the-uk 2020-05-19T04:00:01+10:00 https://pharmadispatch.com/news/martin-palin-is-this-the-reputational-moment-for-big-pharma 2020-05-18T04:00:01+10:00 https://pharmadispatch.com/news/sanofis-karen-hood-challenging-the-old-waysof-thinking 2020-05-18T04:00:01+10:00 https://pharmadispatch.com/news/the-search-for-the-vaccine-now-has-a-name 2020-05-18T04:00:01+10:00 https://pharmadispatch.com/news/phrma-delivers-manufacturing-reality-check 2020-05-18T04:00:01+10:00 https://pharmadispatch.com/news/mesoblast-completes-capital-raise-to-support-scale-up-manufactur 2020-05-15T05:00:01+10:00 https://pharmadispatch.com/news/higher-funding-for-7cpa-but-government-not-budging-on-key-differ 2020-05-15T04:00:01+10:00 https://pharmadispatch.com/news/biopharmadispatch-conference-set-for-new-date-in-november 2020-05-15T04:00:01+10:00 https://pharmadispatch.com/news/manufacturing-will-be-the-issue-not-intellectual-property-protec 2020-05-15T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-vaccine-doubts-but-over-400-therapies-in-development 2020-05-14T04:00:01+10:00 https://pharmadispatch.com/news/bms-takes-all-ex-us-rights-to-bluebird-car-t-therapy 2020-05-14T04:00:01+10:00 https://pharmadispatch.com/news/nz-more-for-horse-racing-than-medicines 2020-05-14T04:00:01+10:00 https://pharmadispatch.com/news/johnson-johnson-on-a-three-wave-return-to-the-office 2020-05-14T04:00:01+10:00 https://pharmadispatch.com/news/azs-charles-waterfield-the-new-world-will-be-different-to-the-on 2020-05-13T04:00:01+10:00 https://pharmadispatch.com/news/sanofi-looks-to-reimbursement-for-rare-blood-disorder-therapy 2020-05-13T04:00:01+10:00 https://pharmadispatch.com/news/an-inevitable-request-that-would-have-happened-anyway 2020-05-13T04:00:01+10:00 https://pharmadispatch.com/news/starting-with-denial-moving-to-guilt-and-then-division 2020-05-12T04:00:01+10:00 https://pharmadispatch.com/news/reports-of-scientific-or-technical-experts-are-not-exempt 2020-05-12T04:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-system-still-on-life-support-but-can-be-saved 2020-05-12T04:00:01+10:00 https://pharmadispatch.com/news/australia-remains-the-global-capital-of-melanoma 2020-05-12T04:00:01+10:00 https://pharmadispatch.com/news/industry-unites-to-call-for-action-on-jobkeeper 2020-05-12T04:00:01+10:00 https://pharmadispatch.com/news/abbvie-completes-acquisition-of-allergan 2020-05-11T05:00:01+10:00 https://pharmadispatch.com/news/trapped-in-a-nonsense-discussion-that-misses-the-real-argument 2020-05-11T04:00:01+10:00 https://pharmadispatch.com/news/pvi-tools-advise-against-cut-and-paste-on-consumer-comments 2020-05-11T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-exposed-on-supply-once-again 2020-05-11T04:00:01+10:00 https://pharmadispatch.com/news/gsks-christi-kelsey-feeling-an-incredible-accountability 2020-05-08T05:00:01+10:00 https://pharmadispatch.com/news/pbs-wholesalers-achieve-historic-distribution-milestone 2020-05-08T05:00:01+10:00 https://pharmadispatch.com/news/greens-want-government-funded-vaccine-manufacturing 2020-05-08T04:00:01+10:00 https://pharmadispatch.com/news/pharmacy-welcomes-down-scheduling-of-migraine-medicines 2020-05-08T04:00:01+10:00 https://pharmadispatch.com/news/unprecedented-surge-in-interest-follows-unprecedented-surge-in-d 2020-05-07T04:00:01+10:00 https://pharmadispatch.com/news/bms-extends-home-infusion-for-patients-during-lockdown 2020-05-07T04:00:01+10:00 https://pharmadispatch.com/news/ma-calls-for-action-on-investment-and-manufacturing 2020-05-07T04:00:01+10:00 https://pharmadispatch.com/news/kim-carr-pandemic-reveals-dangerous-weaknesses-in-economy 2020-05-07T04:00:01+10:00 https://pharmadispatch.com/news/michal-juul-srensen-immense-challenges-ahead-on-mental-health 2020-05-06T05:00:01+10:00 https://pharmadispatch.com/news/craig-moore-jump-on-board-and-take-advantage-of-the-momentum 2020-05-06T05:00:01+10:00 https://pharmadispatch.com/news/disappointment-for-biotech-as-ato-rejects-jobkeeper-request 2020-05-06T05:00:01+10:00 https://pharmadispatch.com/news/official-pbs-statistics-yet-to-pick-up-unprecedented-surge 2020-05-06T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-welcomes-csl-production-of-covid-19-immunoglobulin 2020-05-06T04:00:01+10:00 https://pharmadispatch.com/news/sanofis-tim-swan-on-responding-and-adapting 2020-05-05T04:00:01+10:00 https://pharmadispatch.com/news/pfizers-anne-harris-responding-to-the-pandemic-with-an-abundance 2020-05-05T04:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-appoints-us-based-director 2020-05-05T04:00:01+10:00 https://pharmadispatch.com/news/government-pushing-for-australian-manufacture-of-vaccine 2020-05-05T04:00:01+10:00 https://pharmadispatch.com/news/msds-zoe-armstrong-on-the-opportunity-for-permanent-positive-cha 2020-05-04T04:00:01+10:00 https://pharmadispatch.com/news/fda-backs-emergency-use-of-gileads-remdesivir 2020-05-04T04:00:01+10:00 https://pharmadispatch.com/news/pandemic-exposes-the-frailty-of-new-zealands-medicines-supply 2020-05-04T04:00:01+10:00 https://pharmadispatch.com/news/vaccines-may-be-the-immediate-focus-given-the-certain-supply-cha 2020-05-04T04:00:01+10:00 https://pharmadispatch.com/news/merck-healthcares-leah-goodman-on-the-new-normal 2020-05-04T04:00:01+10:00 https://pharmadispatch.com/news/not-one-word-of-this-process-guidance-binds-a-company-so-you-can 2020-05-01T04:00:01+10:00 https://pharmadispatch.com/news/new-az-asthma-presentation-fast-tracked-during-pandemic 2020-05-01T04:00:01+10:00 https://pharmadispatch.com/news/merck-extends-employee-volunteer-program-during-pandemic 2020-05-01T04:00:01+10:00 https://pharmadispatch.com/news/cabinet-backs-amgen-biologic-during-covid-19-pandemic 2020-05-01T04:00:01+10:00 https://pharmadispatch.com/news/az-teams-up-with-oxford-university-on-pandemic-vaccine 2020-05-01T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-uses-pandemic-as-excuse-to-avoid-funding-new-medicine 2020-04-30T04:00:01+10:00 https://pharmadispatch.com/news/still-pursuing-discussant-presentations 2020-04-30T04:00:01+10:00 https://pharmadispatch.com/news/july-pbac-to-consider-medicinal-cannabis-at-july-meeting 2020-04-30T04:00:01+10:00 https://pharmadispatch.com/news/countdown-begins-for-biosimilar-humiras 2020-04-30T04:00:01+10:00 https://pharmadispatch.com/news/us-fda-expected-to-authorise-emergency-use-of-remdesivir 2020-04-30T04:00:01+10:00 https://pharmadispatch.com/news/likely-delay-for-new-pbs-cost-recovery-fees 2020-04-29T05:00:01+10:00 https://pharmadispatch.com/news/case-falls-on-an-unnecessary-undertaking-by-apotex 2020-04-29T04:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-progresses-lox-inhibitor-to-phase-2-cancer-study 2020-04-29T04:00:01+10:00 https://pharmadispatch.com/news/the-dispute-over-rebates-raging-on-as-companies-refuse-to-pay 2020-04-28T05:00:01+10:00 https://pharmadispatch.com/news/ma-no-power-to-publish-information-obtained-in-pbac-submissions 2020-04-28T05:00:01+10:00 https://pharmadispatch.com/news/the-word-irony-is-hardly-sufficient-to-describe-this-situation 2020-04-28T05:00:01+10:00 https://pharmadispatch.com/news/sanofi-flu-vax-for-children-a-positive-step 2020-04-28T05:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-novo-nordisk-new-zealand 2020-04-27T04:00:01+10:00 https://pharmadispatch.com/news/the-irony-of-what-is-a-very-one-sided-discussion 2020-04-27T04:00:01+10:00 https://pharmadispatch.com/news/dupixent-recommendation-headlines-march-outcomes 2020-04-27T04:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-new-covid-19-global-collaboration 2020-04-27T04:00:01+10:00 https://pharmadispatch.com/news/ma-deeply-concerned-over-reports-of-access-issues 2020-04-27T04:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-amgen-australia-1 2020-04-24T10:43:01+10:00 https://pharmadispatch.com/news/api-announces-half-year-result-and-new-chairman-for-sigma 2020-04-24T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-intervenes-on-hospital-stockpiling 2020-04-24T05:00:01+10:00 https://pharmadispatch.com/news/griffith-university-researchers-start-work-on-covid-19-vaccine 2020-04-24T05:00:01+10:00 https://pharmadispatch.com/news/semantic-discussion-on-shortages-missing-the-point 2020-04-24T05:00:01+10:00 https://pharmadispatch.com/news/state-and-territories-the-guilty-party-when-it-comes-to-panic-bu 2020-04-23T04:00:01+10:00 https://pharmadispatch.com/news/new-research-highlights-the-extent-and-impact-of-shortages 2020-04-23T04:00:01+10:00 https://pharmadispatch.com/news/supply-chain-reform-another-potential-victim-of-covid-19 2020-04-23T04:00:01+10:00 https://pharmadispatch.com/news/even-long-time-critics-giving-the-industry-a-qualified-thumbs-up 2020-04-23T04:00:01+10:00 https://pharmadispatch.com/news/something-is-amiss-but-only-time-and-reality-will-tell 2020-04-22T04:00:01+10:00 https://pharmadispatch.com/news/novartis-announces-phase-3-trial-of-hydroxychloroquine 2020-04-22T04:00:01+10:00 https://pharmadispatch.com/news/tga-stock-allocations-a-commercial-matter-for-companies 2020-04-22T04:00:01+10:00 https://pharmadispatch.com/news/ma-dont-forget-about-your-health 2020-04-22T04:00:01+10:00 https://pharmadispatch.com/news/us-targets-australian-ip-laws-in-new-report 2020-04-21T05:00:01+10:00 https://pharmadispatch.com/news/national-level-stock-outs-discussed-in-government-hosted-forum 2020-04-21T05:00:01+10:00 https://pharmadispatch.com/news/medicine-shortages-but-what-shortages 2020-04-21T05:00:01+10:00 https://pharmadispatch.com/news/unavailable-out-of-stock-or-a-shortage-does-the-law-differentiat 2020-04-20T05:00:01+10:00 https://pharmadispatch.com/news/researchers-on-positive-progress-for-potential-covid-19-treatmen 2020-04-20T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-government-secures-three-million-extra-flu-vaccines 2020-04-20T05:00:01+10:00 https://pharmadispatch.com/news/pandemic-stock-outs-not-considered-shortages 2020-04-20T05:00:01+10:00 https://pharmadispatch.com/news/new-industrial-policy-for-australias-biopharmaceutical-and-devic 2020-04-17T05:00:01+10:00 https://pharmadispatch.com/news/starpharma-says-spl7013-shows-significant-activity-covid-19 2020-04-17T05:00:01+10:00 https://pharmadispatch.com/news/covid-19-new-modelling-is-more-like-a-report 2020-04-17T05:00:01+10:00 https://pharmadispatch.com/news/survey-confirms-biotech-are-cutting-costs-and-delaying-trials 2020-04-16T12:35:01+10:00 https://pharmadispatch.com/news/government-on-freight-support-in-the-case-of-emergency 2020-04-16T05:00:01+10:00 https://pharmadispatch.com/news/concern-grows-as-us-data-shows-hit-to-diagnosis-and-treatment 2020-04-16T05:00:01+10:00 https://pharmadispatch.com/news/paig-changes-2020-focus-in-response-to-pandemic 2020-04-16T05:00:01+10:00 https://pharmadispatch.com/news/sta-new-fees-a-major-barrier-to-patient-access 2020-04-16T05:00:01+10:00 https://pharmadispatch.com/news/demand-for-medicines-eases-after-unprecedented-surge 2020-04-15T04:00:01+10:00 https://pharmadispatch.com/news/mas-liz-de-somer-making-sure-the-eco-system-is-not-broken 2020-04-15T04:00:01+10:00 https://pharmadispatch.com/news/covid-19-ausbiotech-seeks-tax-ruling-while-sanofi-gsk-team-up-fo 2020-04-15T04:00:01+10:00 https://pharmadispatch.com/news/rnai-therapeutics-company-secures-2bn-from-blackstone 2020-04-15T04:00:01+10:00 https://pharmadispatch.com/news/modelling-on-the-way-in-and-on-the-way-out 2020-04-14T03:00:01+10:00 https://pharmadispatch.com/news/roche-and-astrazeneca-top-for-innovation-and-invention 2020-04-14T03:00:01+10:00 https://pharmadispatch.com/news/karen-andrews-will-talk-to-industry-about-domestic-manufacturing 2020-04-14T03:00:01+10:00 https://pharmadispatch.com/news/ma-and-gbma-share-the-process-for-working-together 2020-04-14T03:00:01+10:00 https://pharmadispatch.com/news/positive-signs-from-compassionate-use-of-gileads-remdesivir 2020-04-14T03:00:01+10:00 https://pharmadispatch.com/news/covid-19-government-eases-some-access-restrictions 2020-04-09T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-we-must-keep-freight-lines-open 2020-04-09T05:00:01+10:00 https://pharmadispatch.com/news/non-members-can-be-covered-by-accc-authorisation 2020-04-09T05:00:01+10:00 https://pharmadispatch.com/news/medical-leaders-speak-urge-people-to-manage-their-care 2020-04-09T05:00:01+10:00 https://pharmadispatch.com/news/international-freight-on-the-agenda-as-costs-soar 2020-04-08T05:00:01+10:00 https://pharmadispatch.com/news/india-has-lifted-restrictions-on-some-api 2020-04-08T05:00:01+10:00 https://pharmadispatch.com/news/the-value-of-a-long-term-institutionalised-relationship 2020-04-08T05:00:01+10:00 https://pharmadispatch.com/news/people-avoiding-doctor-and-pharmacy-visits 2020-04-08T05:00:01+10:00 https://pharmadispatch.com/news/sector-calls-for-action-as-pandemic-hits-clinical-trials 2020-04-07T05:00:01+10:00 https://pharmadispatch.com/news/covid-19-update-hydroxychloroquine-sinks-in-pre-pandemic-trial 2020-04-07T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-not-everything-will-be-the-same 2020-04-07T05:00:01+10:00 https://pharmadispatch.com/news/pm-to-greg-hunt-the-focus-is-covid-19 2020-04-07T05:00:01+10:00 https://pharmadispatch.com/news/nz-health-minister-ive-been-an-idiot 2020-04-07T05:00:01+10:00 https://pharmadispatch.com/news/intensifying-global-battle-for-medical-supplies 2020-04-06T04:00:01+10:00 https://pharmadispatch.com/news/india-lockdown-causing-concern-over-shipment-delay 2020-04-06T04:00:01+10:00 https://pharmadispatch.com/news/government-invests-220m-in-biosecurity-facility 2020-04-06T04:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-accc-interim-authorisation 2020-04-06T04:00:01+10:00 https://pharmadispatch.com/news/australian-industry-joins-the-covid-19-response 2020-04-06T04:00:01+10:00 https://pharmadispatch.com/news/accc-confirms-limited-authorisation-for-manufacturers-during-cov 2020-04-04T07:00:01+11:00 https://pharmadispatch.com/news/covid-19-hits-medical-research-as-mrff-defers-grants 2020-04-04T07:00:01+11:00 https://pharmadispatch.com/news/opthea-boss-the-new-deputy-chair-of-ausbiotech 2020-04-03T05:00:01+11:00 https://pharmadispatch.com/news/pbac-considering-requests-in-relation-to-covid-19-and-medicines 2020-04-03T05:00:01+11:00 https://pharmadispatch.com/news/company-plans-to-allow-employees-health-workforce-return 2020-04-03T05:00:01+11:00 https://pharmadispatch.com/news/taking-a-huge-risk-when-the-future-looks-so-different 2020-04-02T16:38:01+11:00 https://pharmadispatch.com/news/cynata-therapeutics-updates-on-clinical-trial-program 2020-04-02T14:57:01+11:00 https://pharmadispatch.com/news/chris-bowen-to-greg-hunt-urgent-need-to-strike-7cpa 2020-04-02T08:32:01+11:00 https://pharmadispatch.com/news/covid-19-work-underway-on-vaccine-manufacture-and-allocation 2020-04-02T05:00:01+11:00 https://pharmadispatch.com/news/companies-welcome-april-extensions-to-listed-medicines 2020-04-02T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-secured-supplies-of-potential-covid-19-treatment 2020-04-02T05:00:01+11:00 https://pharmadispatch.com/news/evidence-of-strong-early-demand-for-flu-vaccines 2020-04-02T04:00:01+11:00 https://pharmadispatch.com/news/prepare-for-an-era-of-significant-change-because-the-day-of-reck 2020-04-02T04:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-mercklife-science-anz 2020-04-02T04:00:01+11:00 https://pharmadispatch.com/news/economics-in-the-time-of-the-covid-19-pandemic 2020-04-01T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-new-myeloma-access-headlines-aprils-listings 2020-04-01T04:00:01+11:00 https://pharmadispatch.com/news/covid-19-pharmacy-welcomes-measures-and-medadvisor-to-launch-tel 2020-04-01T04:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-fast-track-refunds-and-scrap-proposed-cuts 2020-04-01T04:00:01+11:00 https://pharmadispatch.com/news/accc-grants-wholesalers-interim-authorisation 2020-03-31T11:01:01+11:00 https://pharmadispatch.com/news/cmo-one-country-blocked-export-of-purchased-health-equipment 2020-03-31T03:00:01+11:00 https://pharmadispatch.com/news/nostradata-demand-for-medicines-almost-doubled-in-just-a-few-wee 2020-03-31T03:00:01+11:00 https://pharmadispatch.com/news/pbs-in-the-middle-of-a-shock-transformation 2020-03-31T03:00:01+11:00 https://pharmadispatch.com/news/merck-expands-volunteering-program-during-covid-19 2020-03-31T03:00:01+11:00 https://pharmadispatch.com/news/jj-identifies-vaccine-candidate-and-commits-to-not-for-profit-su 2020-03-31T03:00:01+11:00 https://pharmadispatch.com/news/data-analytics-more-important-than-ever-as-australia-prepares-fo 2020-03-30T04:00:01+11:00 https://pharmadispatch.com/news/dr-brendan-shaw-change-has-been-constant-but-not-like-this 2020-03-30T04:00:01+11:00 https://pharmadispatch.com/news/covid-19-sector-seeks-partial-relief-from-competition-law 2020-03-30T04:00:01+11:00 https://pharmadispatch.com/news/uncertainty-in-response-to-lockdown-in-india 2020-03-30T04:00:01+11:00 https://pharmadispatch.com/news/shawview-formally-establishes-a-local-presence 2020-03-30T04:00:01+11:00 https://pharmadispatch.com/news/covid-19-new-dispensing-regulation-and-pharmac-finally-responds- 2020-03-27T05:00:01+11:00 https://pharmadispatch.com/news/some-health-workers-could-access-covid-19-vaccine-in-2020 2020-03-27T05:00:01+11:00 https://pharmadispatch.com/news/bill-ferris-ac-the-new-chair-of-the-medical-research-commerciali 2020-03-27T05:00:01+11:00 https://pharmadispatch.com/news/associations-team-up-for-statement-on-clinical-trials 2020-03-27T05:00:01+11:00 https://pharmadispatch.com/news/cmo-to-remain-in-current-role-until-july 2020-03-27T05:00:01+11:00 https://pharmadispatch.com/news/witnessing-a-global-collaboration-rather-than-an-effort-of-indiv 2020-03-26T05:00:01+11:00 https://pharmadispatch.com/news/government-creates-covid-19-coordination-commission 2020-03-26T05:00:01+11:00 https://pharmadispatch.com/news/sensitivity-and-understanding-at-the-most-difficult-of-times 2020-03-26T05:00:01+11:00 https://pharmadispatch.com/news/covid-19-blood-plasma-trial-wholesalers-update-and-accc-authoris 2020-03-26T05:00:01+11:00 https://pharmadispatch.com/news/local-competition-for-supply-moving-to-a-global-challenge 2020-03-25T05:00:01+11:00 https://pharmadispatch.com/news/government-grateful-for-the-proactive-and-collaborative 2020-03-25T05:00:01+11:00 https://pharmadispatch.com/news/new-study-shows-benefit-of-novartis-sma-gene-therapy 2020-03-25T05:00:01+11:00 https://pharmadispatch.com/news/covid-19-accc-pragmatic-on-competition-as-focus-on-treatments-in 2020-03-25T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-australia-the-victim-of-last-minute-diversions 2020-03-24T05:00:01+11:00 https://pharmadispatch.com/news/covid-19-pbac-set-to-go-virtual-for-july-meeting 2020-03-24T05:00:01+11:00 https://pharmadispatch.com/news/companies-cannot-just-switch-off-hcp-engagement 2020-03-24T05:00:01+11:00 https://pharmadispatch.com/news/a-difficult-week-that-could-become-the-norm-with-covid-19 2020-03-23T05:00:01+11:00 https://pharmadispatch.com/news/covid-19-symptomatic-treatments-before-a-vaccine 2020-03-23T05:00:01+11:00 https://pharmadispatch.com/news/this-is-just-the-start-to-a-challenge-that-will-almost-certainly 2020-03-21T10:12:01+11:00 https://pharmadispatch.com/news/covid-19-using-the-power-of-ministerial-language 2020-03-20T05:00:01+11:00 https://pharmadispatch.com/news/the-bim-is-launched-and-underway 2020-03-20T05:00:01+11:00 https://pharmadispatch.com/news/foi-releasing-the-documents 2020-03-20T05:00:01+11:00 https://pharmadispatch.com/news/language-did-not-stop-the-rush-on-toilet-paper-why-will-it-work- 2020-03-20T05:00:01+11:00 https://pharmadispatch.com/news/new-limits-backed-by-moral-suasion-and-existing-law 2020-03-19T13:40:01+11:00 https://pharmadispatch.com/news/the-bim-a-social-platform-for-you-the-biopharmadispatch-audience 2020-03-19T04:00:01+11:00 https://pharmadispatch.com/news/extreme-budget-deterioration-will-have-serious-and-long-lasting- 2020-03-19T04:00:01+11:00 https://pharmadispatch.com/news/government-invokes-emergency-granting-greg-hunt-extraordinary-po 2020-03-19T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-signs-new-collaboration-targeting-covid-19-vaccine 2020-03-19T04:00:01+11:00 https://pharmadispatch.com/news/change-is-coming-and-things-may-never-be-the-same 2020-03-18T05:00:01+11:00 https://pharmadispatch.com/news/therapeutic-substitution-an-option-to-manage-shortages 2020-03-18T05:00:01+11:00 https://pharmadispatch.com/news/biopharmadispatch-2020-conference-update-1 2020-03-18T05:00:01+11:00 https://pharmadispatch.com/news/covid-19-minister-talks-up-vaccine-potential 2020-03-18T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-calls-on-senate-to-reject-rd-tax-changes 2020-03-18T05:00:01+11:00 https://pharmadispatch.com/news/nz-patients-call-for-royal-commission-into-forced-switch 2020-03-17T05:00:01+11:00 https://pharmadispatch.com/news/how-can-information-be-exempt-if-it-is-already-in-the-public-dom 2020-03-17T05:00:01+11:00 https://pharmadispatch.com/news/workarounds-on-supply-chain-reform-proceeding 2020-03-17T05:00:01+11:00 https://pharmadispatch.com/news/work-from-home-rules-as-companies-pull-reps-from-field 2020-03-17T05:00:01+11:00 https://pharmadispatch.com/news/documents-reveal-more-on-pbac-executive 2020-03-16T05:00:01+11:00 https://pharmadispatch.com/news/pbac-work-of-considerable-public-interest 2020-03-16T05:00:01+11:00 https://pharmadispatch.com/news/new-documents-reveal-interesting-attitude-to-industry 2020-03-16T05:00:01+11:00 https://pharmadispatch.com/news/e-cigarettes-out-of-scope-of-new-post-market-review 2020-03-16T05:00:01+11:00 https://pharmadispatch.com/news/covid-19-update-coag-will-just-accept-advice 2020-03-16T05:00:01+11:00 https://pharmadispatch.com/news/ma-looking-to-restock-its-canberra-based-policy-team 2020-03-13T05:00:01+11:00 https://pharmadispatch.com/news/ministerial-intervention-may-be-required-to-manage-spike-in-dema 2020-03-13T05:00:01+11:00 https://pharmadispatch.com/news/governments-combine-with-wehi-to-create-new-drug-discovery-centr 2020-03-13T05:00:01+11:00 https://pharmadispatch.com/news/australian-company-updates-on-emerging-hiv-therapy 2020-03-13T05:00:01+11:00 https://pharmadispatch.com/news/pbac-meeting-cut-to-just-two-days 2020-03-12T05:00:01+11:00 https://pharmadispatch.com/news/what-about-trust-and-transparency-in-government-funding-of-consu 2020-03-12T05:00:01+11:00 https://pharmadispatch.com/news/significant-investment-in-national-medical-stockpile 2020-03-12T05:00:01+11:00 https://pharmadispatch.com/news/investors-unite-to-back-the-george-institutes-research 2020-03-12T05:00:01+11:00 https://pharmadispatch.com/news/7cpa-patient-focussed-over-customer-focussed 2020-03-11T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-will-he-or-wont-he 2020-03-11T05:00:01+11:00 https://pharmadispatch.com/news/no-action-yet-but-evidence-of-some-changed-behaviour 2020-03-11T05:00:01+11:00 https://pharmadispatch.com/news/professor-brendan-murphy-cmo-to-secretary-in-two-weeks 2020-03-11T05:00:01+11:00 https://pharmadispatch.com/news/new-reports-updates-on-us-australia-trade-discussions 2020-03-10T05:00:01+11:00 https://pharmadispatch.com/news/doubts-over-the-will-pricing-commitment 2020-03-10T05:00:01+11:00 https://pharmadispatch.com/news/biogen-secures-gene-switch-technology-from-sangamo 2020-03-10T05:00:01+11:00 https://pharmadispatch.com/news/unclear-role-for-the-industry-minister-in-coronavirus-response 2020-03-10T05:00:01+11:00 https://pharmadispatch.com/news/was-the-advice-rejected-modified-or-just-ratified 2020-03-09T05:00:01+11:00 https://pharmadispatch.com/news/how-would-you-evaluate-a-coronavirus-vaccine 2020-03-09T05:00:01+11:00 https://pharmadispatch.com/news/pbac-rejects-productivity-benefit-as-equity-issue 2020-03-09T05:00:01+11:00 https://pharmadispatch.com/news/former-gsk-executive-to-retire-from-senate 2020-03-09T05:00:01+11:00 https://pharmadispatch.com/news/more-companies-mark-international-womens-day 2020-03-09T05:00:01+11:00 https://pharmadispatch.com/news/international-womens-day 2020-03-06T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-announces-decision-to-fund-pfizer-breast-cancer-therapy 2020-03-06T05:00:01+11:00 https://pharmadispatch.com/news/public-summary-documents-you-are-being-set-up 2020-03-06T05:00:01+11:00 https://pharmadispatch.com/news/recognition-through-ma-continuing-education-program-awards 2020-03-05T16:55:01+11:00 https://pharmadispatch.com/news/ma-appoints-deputy-chair 2020-03-05T08:21:01+11:00 https://pharmadispatch.com/news/no-shortage-of-gp-opportunities-just-a-lot-fewer-reps 2020-03-05T05:00:01+11:00 https://pharmadispatch.com/news/minister-urges-action-to-avoid-referral 2020-03-05T05:00:01+11:00 https://pharmadispatch.com/news/the-hidden-impact-of-exchange-rate-variability 2020-03-05T05:00:01+11:00 https://pharmadispatch.com/news/guild-warns-against-medicine-stockpiling 2020-03-05T05:00:01+11:00 https://pharmadispatch.com/news/npsa-taking-control-of-our-own-destiny 2020-03-04T04:00:01+11:00 https://pharmadispatch.com/news/this-is-the-commitment-to-pbac-decision-making-deliberations-bei 2020-03-04T04:00:01+11:00 https://pharmadispatch.com/news/dear-industry-do-not-accept-any-more-lectures-on-transparency 2020-03-04T04:00:01+11:00 https://pharmadispatch.com/news/trump-get-it-done-we-need-it 2020-03-04T04:00:01+11:00 https://pharmadispatch.com/news/new-ceo-for-hepatitis-australia 2020-03-04T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-announces-new-leadership 2020-03-03T17:26:01+11:00 https://pharmadispatch.com/news/npsa-the-invisible-arm-of-national-medicines-policy 2020-03-03T05:00:01+11:00 https://pharmadispatch.com/news/pbac-wants-price-reduction-from-hcv-companies 2020-03-03T05:00:01+11:00 https://pharmadispatch.com/news/gilead-announces-2020-grant-recipients 2020-03-03T05:00:01+11:00 https://pharmadispatch.com/news/nsw-widens-access-to-pharmacy-flu-vaccine 2020-03-03T05:00:01+11:00 https://pharmadispatch.com/news/australian-company-boosts-search-for-partners-as-investors-cheer 2020-03-03T05:00:01+11:00 https://pharmadispatch.com/news/gilead-to-acquire-us-based-oncology-company 2020-03-03T05:00:01+11:00 https://pharmadispatch.com/news/there-is-no-such-thing-as-scratchings 2020-03-02T05:00:01+11:00 https://pharmadispatch.com/news/gene-therapies-will-cost-nothing-if-a-life-is-not-started 2020-03-02T05:00:01+11:00 https://pharmadispatch.com/news/optimistic-about-the-future-of-antibiotics-otherwise-i-would-not 2020-03-02T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-adds-to-march-listings-with-melanoma-extension 2020-03-02T05:00:01+11:00 https://pharmadispatch.com/news/new-national-agreement-on-gene-and-cell-based-therapies 2020-03-02T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-new-listing-aiming-to-improve-health-outcomes-for-all- 2020-02-28T11:00:01+11:00 https://pharmadispatch.com/news/political-support-for-action-on-eczema 2020-02-28T05:00:01+11:00 https://pharmadispatch.com/news/companies-team-up-in-canberra-for-heart-health 2020-02-28T05:00:01+11:00 https://pharmadispatch.com/news/medadvisor-updates-on-busy-six-months 2020-02-28T05:00:01+11:00 https://pharmadispatch.com/news/richard-di-natale-for-health-until-departure 2020-02-28T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-delivers-another-medicine-shortage 2020-02-28T05:00:01+11:00 https://pharmadispatch.com/news/covid-19-spreads-as-companies-shutdown-travel 2020-02-27T05:00:01+11:00 https://pharmadispatch.com/news/vertex-welcomes-pharmac-funding-for-kalydeco 2020-02-27T05:00:01+11:00 https://pharmadispatch.com/news/biogen-boost-from-recently-acquired-gene-therapies 2020-02-27T05:00:01+11:00 https://pharmadispatch.com/news/babies-are-not-even-screened-for-many-of-these-genetic-diseases 2020-02-27T05:00:01+11:00 https://pharmadispatch.com/news/biopharmadispatch-2020-conference-update 2020-02-26T05:00:01+11:00 https://pharmadispatch.com/news/you-can-do-it-now-or-later-now-will-be-easier 2020-02-26T05:00:01+11:00 https://pharmadispatch.com/news/rca-current-assessment-approaches-too-blunt 2020-02-26T05:00:01+11:00 https://pharmadispatch.com/news/psa-medicine-safety-in-aged-care-a-game-of-russian-roulette 2020-02-26T05:00:01+11:00 https://pharmadispatch.com/news/pbac-member-new-ausbiotech-chair 2020-02-25T10:00:01+11:00 https://pharmadispatch.com/news/george-tambassis-making-our-position-clear-to-government-in-no-u 2020-02-25T05:00:01+11:00 https://pharmadispatch.com/news/chris-bowen-timeline-for-the-review-raises-serious-questions 2020-02-25T05:00:01+11:00 https://pharmadispatch.com/news/an-inner-sanctum-too-quick-to-overlook-potential-failings 2020-02-25T05:00:01+11:00 https://pharmadispatch.com/news/companies-make-wgea-employer-of-choice-list 2020-02-25T05:00:01+11:00 https://pharmadispatch.com/news/expansion-on-the-agenda-for-biointelect 2020-02-25T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-more-time-for-review-if-stakeholders-make-the-case 2020-02-25T05:00:01+11:00 https://pharmadispatch.com/news/sta-dismayed-and-frustrated-over-rejection-of-tumour-profiling-t 2020-02-24T05:00:01+11:00 https://pharmadispatch.com/news/a-tick-and-flick-timeline-for-medicines-policy-review 2020-02-24T05:00:01+11:00 https://pharmadispatch.com/news/proposed-process-and-timeline-will-only-deny-patients 2020-02-24T05:00:01+11:00 https://pharmadispatch.com/news/lloyd-sansom-policy-process-as-important-as-policy-document 2020-02-24T05:00:01+11:00 https://pharmadispatch.com/news/new-co-chairs-and-members-of-pharma-australia-inclusiongroup 2020-02-21T05:00:01+11:00 https://pharmadispatch.com/news/ebos-reports-strong-growth-on-new-business 2020-02-21T05:00:01+11:00 https://pharmadispatch.com/news/tackling-patient-engagement-in-clinical-trials 2020-02-21T05:00:01+11:00 https://pharmadispatch.com/news/what-is-the-value-of-facilitation 2020-02-20T05:00:01+11:00 https://pharmadispatch.com/news/final-ma-board-meeting-for-pfizers-melissa-mcgregor 2020-02-20T05:00:01+11:00 https://pharmadispatch.com/news/sanofi-teams-up-with-us-government-on-coronavirus 2020-02-20T05:00:01+11:00 https://pharmadispatch.com/news/immutep-provides-positive-update-on-immunotherapy-trial 2020-02-19T18:53:01+11:00 https://pharmadispatch.com/news/lung-cancer-the-focus-of-new-listings-in-march 2020-02-19T09:00:01+11:00 https://pharmadispatch.com/news/government-directs-mrrf-funds-to-coronavirus-response 2020-02-19T05:00:01+11:00 https://pharmadispatch.com/news/patients-use-inquiry-to-call-for-action-on-biologics 2020-02-19T05:00:01+11:00 https://pharmadispatch.com/news/experienced-cloud-computer-executive-joins-medadvisor 2020-02-19T05:00:01+11:00 https://pharmadispatch.com/news/chris-bowen-confirmed-to-speak-at-biopharmadispatch-2020 2020-02-19T05:00:01+11:00 https://pharmadispatch.com/news/industry-caught-in-new-compliance-regime 2020-02-18T05:00:01+11:00 https://pharmadispatch.com/news/eu-pushes-australia-on-pharmaceutical-patents 2020-02-18T05:00:01+11:00 https://pharmadispatch.com/news/could-greg-hunt-do-the-unthinkable-on-7cpa 2020-02-18T05:00:01+11:00 https://pharmadispatch.com/news/guild-refers-face-mask-supplier-to-accc 2020-02-18T05:00:01+11:00 https://pharmadispatch.com/news/is-this-committee-using-a-public-statement-to-pressure-the-gover 2020-02-17T05:00:01+11:00 https://pharmadispatch.com/news/maybe-you-could-just-write-and-ask 2020-02-17T05:00:01+11:00 https://pharmadispatch.com/news/researchers-combine-crispr-and-car-t-therapies 2020-02-17T05:00:01+11:00 https://pharmadispatch.com/news/who-is-the-dependent-parasite 2020-02-16T13:35:01+11:00 https://pharmadispatch.com/news/us-based-industry-add-australia-to-trade-watch-list 2020-02-14T05:00:01+11:00 https://pharmadispatch.com/news/msac-prioritises-competition-in-setting-car-t-conditions 2020-02-14T05:00:01+11:00 https://pharmadispatch.com/news/pbac-december-outcomes-asthma-epilepsy-and-opioids 2020-02-14T05:00:01+11:00 https://pharmadispatch.com/news/grattan-institute-delivers-yet-again 2020-02-14T05:00:01+11:00 https://pharmadispatch.com/news/get-ready-for-the-fifth-intergenerational-report 2020-02-13T05:00:01+11:00 https://pharmadispatch.com/news/triaging-submissions-or-decisions 2020-02-13T05:00:01+11:00 https://pharmadispatch.com/news/csl-jumps-again-on-strong-first-half 2020-02-13T05:00:01+11:00 https://pharmadispatch.com/news/sanofi-joins-call-for-exemption-from-cost-offset-policy 2020-02-13T05:00:01+11:00 https://pharmadispatch.com/news/fees-shifting-to-the-post-pbac-pricing-process 2020-02-12T10:04:01+11:00 https://pharmadispatch.com/news/running-a-patient-group-with-the-smell-of-an-oily-rag 2020-02-12T05:00:01+11:00 https://pharmadispatch.com/news/a-system-with-an-underlying-inequity-for-patients 2020-02-12T05:00:01+11:00 https://pharmadispatch.com/news/australian-company-makes-progress-in-small-molecule-pcsk9-inhibi 2020-02-12T05:00:01+11:00 https://pharmadispatch.com/news/starpharma-collects-milestone-payment-from-az 2020-02-12T05:00:01+11:00 https://pharmadispatch.com/news/bayer-launches-reconciliation-action-plan 2020-02-12T05:00:01+11:00 https://pharmadispatch.com/news/upjohn-completes-move-to-cso-distributors 2020-02-11T06:00:01+11:00 https://pharmadispatch.com/news/kirsten-odoherty-access-to-medicines-is-access-to-healthcare 2020-02-11T05:00:01+11:00 https://pharmadispatch.com/news/this-is-what-a-commitment-to-transparency-looks-like 2020-02-11T05:00:01+11:00 https://pharmadispatch.com/news/government-fails-in-bid-to-block-senate-inquiry 2020-02-11T05:00:01+11:00 https://pharmadispatch.com/news/jane-halton-2bn-needed-to-combat-coronavirus 2020-02-10T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-backs-removal-of-cost-offset-in-submission 2020-02-10T05:00:01+11:00 https://pharmadispatch.com/news/industry-uses-inquiry-to-link-access-to-investment 2020-02-10T05:00:01+11:00 https://pharmadispatch.com/news/kirsten-odoherty-on-leadership-and-change 2020-02-10T05:00:01+11:00 https://pharmadispatch.com/news/astrazenecas-manufacturing-and-tree-planting-announcement 2020-02-09T05:00:01+11:00 https://pharmadispatch.com/news/takedas-costa-saroukos-on-integrating-shire 2020-02-07T05:00:01+11:00 https://pharmadispatch.com/news/a-big-day-for-astrazeneca-australia-headlined-by-major-expansion 2020-02-07T05:00:01+11:00 https://pharmadispatch.com/news/new-partnership-to-support-development-of-gene-therapy 2020-02-07T05:00:01+11:00 https://pharmadispatch.com/news/labor-to-move-rd-tax-changes-to-senate-inquiry 2020-02-07T05:00:01+11:00 https://pharmadispatch.com/news/arrotex-boosts-respiratory-portfolio-with-bi-brands 2020-02-07T05:00:01+11:00 https://pharmadispatch.com/news/eczema-support-australia-calls-for-budget-action-on-biologics 2020-02-06T05:00:01+11:00 https://pharmadispatch.com/news/review-report-will-be-released-in-due-course 2020-02-06T05:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-wins-industry-exchange-program-grant 2020-02-06T05:00:01+11:00 https://pharmadispatch.com/news/msd-announces-spin-off-of-legacy-brands-and-biosimilars 2020-02-06T05:00:01+11:00 https://pharmadispatch.com/news/major-speech-a-sign-of-things-to-come 2020-02-05T08:57:01+11:00 https://pharmadispatch.com/news/third-time-not-so-lucky-on-pbac-executive 2020-02-05T05:00:01+11:00 https://pharmadispatch.com/news/any-relationship-between-review-and-venturewise-shutdown 2020-02-05T05:00:01+11:00 https://pharmadispatch.com/news/tga-accepts-clinuvels-scenesse-for-priority-review 2020-02-05T05:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-possible-expanded-role-for-executive 2020-02-04T04:00:01+11:00 https://pharmadispatch.com/news/there-might-be-an-opportunity-for-more-information 2020-02-04T04:00:01+11:00 https://pharmadispatch.com/news/new-website-highlights-challenge-of-judging-process 2020-02-04T04:00:01+11:00 https://pharmadispatch.com/news/chp-calls-for-action-on-health-literacy-with-targets 2020-02-04T04:00:01+11:00 https://pharmadispatch.com/news/end-of-an-era-as-greens-leader-departs-senate 2020-02-04T04:00:01+11:00 https://pharmadispatch.com/news/leukaemia-foundation-launches-new-blood-cancer-report 2020-02-04T04:00:01+11:00 https://pharmadispatch.com/news/ma-remove-offsets-and-find-billions-for-new-listings 2020-02-03T05:00:01+11:00 https://pharmadispatch.com/news/lung-cancer-psd-highlights-roadblocks-to-broad-listing 2020-02-03T05:00:01+11:00 https://pharmadispatch.com/news/kidney-therapy-reappears-on-the-pbs 2020-02-03T05:00:01+11:00 https://pharmadispatch.com/news/az-extends-secondary-school-partnership 2020-02-03T05:00:01+11:00 https://pharmadispatch.com/news/the-cost-of-a-fix-will-only-get-higher-if-they-accept-it-is-a-pr 2020-02-03T05:00:01+11:00 https://pharmadispatch.com/news/300-million-extension-for-continuous-glucose-monitoring 2020-02-03T05:00:01+11:00 https://pharmadispatch.com/news/something-happened-this-week-and-it-might-change-everything 2020-01-31T05:00:01+11:00 https://pharmadispatch.com/news/work-underway-on-nmp-review 2020-01-31T05:00:01+11:00 https://pharmadispatch.com/news/kalydeco-in-nz-six-years-after-australia 2020-01-31T05:00:01+11:00 https://pharmadispatch.com/news/none-of-them-can-be-left-out-of-this-partnership 2020-01-31T05:00:01+11:00 https://pharmadispatch.com/news/roche-welcomes-new-partnership-with-government 2020-01-30T09:30:01+11:00 https://pharmadispatch.com/news/ma-backs-greater-transparency-in-decision-making-process 2020-01-30T04:00:01+11:00 https://pharmadispatch.com/news/consider-the-opportunity-not-just-the-cost 2020-01-30T04:00:01+11:00 https://pharmadispatch.com/news/didier-dargent-the-era-of-disruption-has-arrived 2020-01-30T04:00:01+11:00 https://pharmadispatch.com/news/melissa-mcgregor-leaves-a-lasting-legacy 2020-01-30T04:00:01+11:00 https://pharmadispatch.com/news/roche-teams-up-with-federal-government-on-genome-project 2020-01-30T04:00:01+11:00 https://pharmadispatch.com/news/gilead-announces-first-grants-under-new-hiv-program 2020-01-29T05:00:01+11:00 https://pharmadispatch.com/news/ma-would-be-surprised-by-any-approach-for-savings 2020-01-29T05:00:01+11:00 https://pharmadispatch.com/news/first-meeting-of-nmp-review-stakeholder-group 2020-01-29T05:00:01+11:00 https://pharmadispatch.com/news/msac-advises-government-to-utilise-competition-on-car-t 2020-01-29T05:00:01+11:00 https://pharmadispatch.com/news/when-was-the-last-time-a-health-minister-did-that 2020-01-28T17:40:01+11:00 https://pharmadispatch.com/news/recognition-for-department-of-health-official 2020-01-28T04:00:01+11:00 https://pharmadispatch.com/news/more-confirmed-speakers-for-biopharmadispatch-2020 2020-01-28T04:00:01+11:00 https://pharmadispatch.com/news/research-australia-calls-on-government-to-scrap-rd-tax-cut 2020-01-28T04:00:01+11:00 https://pharmadispatch.com/news/call-for-payers-to-act-to-encourage-antibiotic-rd 2020-01-28T04:00:01+11:00 https://pharmadispatch.com/news/government-confirms-more-cases-of-coronavirus 2020-01-28T04:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-growing-gene-and-cell-therapy-industry 2020-01-24T05:00:01+11:00 https://pharmadispatch.com/news/australian-access-behind-comparable-countries 2020-01-24T05:00:01+11:00 https://pharmadispatch.com/news/csl-behring-welcomes-new-presentations-for-genetic-condition 2020-01-24T05:00:01+11:00 https://pharmadispatch.com/news/couple-call-on-jacinda-ardern-to-act-on-pharmac 2020-01-24T05:00:01+11:00 https://pharmadispatch.com/news/transparency-of-process-is-more-important-than-transparency-of-o 2020-01-23T05:00:01+11:00 https://pharmadispatch.com/news/csl-makes-us-list-of-best-employers-for-diversity 2020-01-23T05:00:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-rinvoq-approval 2020-01-23T05:00:01+11:00 https://pharmadispatch.com/news/apis-richard-vincent-wholesalers-actively-engaged-in-negotiation 2020-01-23T05:00:01+11:00 https://pharmadispatch.com/news/biogen-appoints-senior-executive-as-new-managing-director 2020-01-22T10:46:01+11:00 https://pharmadispatch.com/news/new-leadership-for-the-department-of-health 2020-01-22T09:41:01+11:00 https://pharmadispatch.com/news/ausbiotech-opens-2020-ceo-industry-position-survey 2020-01-22T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-protest-couple-tow-coffin-across-nz 2020-01-22T05:00:01+11:00 https://pharmadispatch.com/news/lundbeck-makes-global-climate-change-a-list 2020-01-22T05:00:01+11:00 https://pharmadispatch.com/news/pbac-executive-it-meets-when-it-meets 2020-01-22T05:00:01+11:00 https://pharmadispatch.com/news/guild-rejects-hospital-call-for-extended-dispensing-powers 2020-01-21T05:00:01+11:00 https://pharmadispatch.com/news/paig-new-structure-executive-committee-and-co-chairs 2020-01-21T05:00:01+11:00 https://pharmadispatch.com/news/former-ma-ceo-transparency-is-a-two-way-street 2020-01-21T05:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-appoints-experienced-industry-and-rd-executive 2020-01-21T05:00:01+11:00 https://pharmadispatch.com/news/one-line-in-a-fact-sheet-that-changed-pbs-decision-making 2020-01-20T05:00:01+11:00 https://pharmadispatch.com/news/how-is-it-considered-or-taken-into-account 2020-01-20T05:00:01+11:00 https://pharmadispatch.com/news/china-backs-stronger-biopharma-ip-in-us-trade-deal 2020-01-20T05:00:01+11:00 https://pharmadispatch.com/news/new-start-up-focussed-on-faster-and-cheaper-drugs 2020-01-20T05:00:01+11:00 https://pharmadispatch.com/news/new-national-president-for-hepatitis-australia 2020-01-17T05:00:01+11:00 https://pharmadispatch.com/news/they-would-have-already-done-it-if-they-could 2020-01-17T05:00:01+11:00 https://pharmadispatch.com/news/new-record-for-csl-as-share-prices-tops-300 2020-01-17T05:00:01+11:00 https://pharmadispatch.com/news/leadership-change-coming-for-novartis 2020-01-16T09:35:01+11:00 https://pharmadispatch.com/news/government-moving-to-simplified-non-legislative-solution 2020-01-16T05:00:01+11:00 https://pharmadispatch.com/news/roche-sarepta-deal-a-positive-sign-for-australian-access 2020-01-16T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-wants-more-diabetes-medicines-at-the-right-price 2020-01-16T05:00:01+11:00 https://pharmadispatch.com/news/former-industry-leader-appointed-to-gsks-global-executive-team 2020-01-16T05:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-adds-support-to-bushfire-relief-efforts 2020-01-15T05:00:01+11:00 https://pharmadispatch.com/news/the-department-of-healths-own-words-say-it-all-on-who-owns-infor 2020-01-15T05:00:01+11:00 https://pharmadispatch.com/news/patients-call-on-pharmac-to-make-good-on-myeloma-treatments 2020-01-15T05:00:01+11:00 https://pharmadispatch.com/news/uk-partners-with-novartis-in-linking-rd-reimbursement-and-manufa 2020-01-15T05:00:01+11:00 https://pharmadispatch.com/news/is-selective-transparency-really-transparency 2020-01-14T05:00:01+11:00 https://pharmadispatch.com/news/us-supply-chain-takes-half-of-medicine-spending 2020-01-14T05:00:01+11:00 https://pharmadispatch.com/news/sponsors-have-more-power-than-they-probably-realise 2020-01-13T07:18:01+11:00 https://pharmadispatch.com/news/gilead-secures-highly-regarded-industry-executive 2020-01-13T05:00:01+11:00 https://pharmadispatch.com/news/sector-focuses-on-ensuring-supply-as-government-extends-emergenc 2020-01-13T05:00:01+11:00 https://pharmadispatch.com/news/dustry-gets-behind-bushfire-affected-communities 2020-01-13T05:00:01+11:00 https://pharmadispatch.com/news/another-biosimilar-humira-for-march-pbac 2020-01-13T05:00:01+11:00 https://pharmadispatch.com/news/a-new-decade-begins 2020-01-13T05:00:01+11:00 https://pharmadispatch.com/news/the-system-is-evidence-based-or-it-is-not 2019-12-23T03:00:01+11:00 https://pharmadispatch.com/news/migraine-patients-still-waiting-and-narrow-tick-for-bexsero 2019-12-23T03:00:01+11:00 https://pharmadispatch.com/news/tga-fines-mundipharma-over-targin-promotion 2019-12-23T03:00:01+11:00 https://pharmadispatch.com/news/industry-gathers-to-pay-tribute-to-deborah-monk 2019-12-19T05:00:01+11:00 https://pharmadispatch.com/news/cochlears-anthony-bishop-the-impact-of-a-humbling-experience 2019-12-19T05:00:01+11:00 https://pharmadispatch.com/news/another-license-deal-with-specialised-therapeutics 2019-12-19T05:00:01+11:00 https://pharmadispatch.com/news/few-biologics-take-price-disclosure-reductions-in-april 2019-12-19T05:00:01+11:00 https://pharmadispatch.com/news/pfizers-melissa-mcgregor-reappointed-ma-deputy-chair 2019-12-18T10:03:01+11:00 https://pharmadispatch.com/news/pharmaxis-updates-on-business-plan-after-bi-halts-study 2019-12-18T09:46:01+11:00 https://pharmadispatch.com/news/just-over-one-week-to-take-advantage-of-early-registration 2019-12-18T05:32:01+11:00 https://pharmadispatch.com/news/pharmac-knew-of-switch-deaths-but-stayed-silent 2019-12-18T05:00:01+11:00 https://pharmadispatch.com/news/antisense-therapeutics-updates-on-dmd-therapy-development 2019-12-18T05:00:01+11:00 https://pharmadispatch.com/news/associations-team-up-for-annual-luncheon 2019-12-18T05:00:01+11:00 https://pharmadispatch.com/news/upjohn-returning-to-wholesalers 2019-12-17T15:30:01+11:00 https://pharmadispatch.com/news/no-overall-growth-but-there-are-growth-drivers 2019-12-17T05:00:01+11:00 https://pharmadispatch.com/news/budget-update-a-sobering-reality-for-sector 2019-12-17T05:00:01+11:00 https://pharmadispatch.com/news/next-initiative-for-value-savings-measure 2019-12-17T05:00:01+11:00 https://pharmadispatch.com/news/servier-lines-up-for-a-third-year-of-decembeard 2019-12-17T05:00:01+11:00 https://pharmadispatch.com/news/budget-update-confirms-how-little-is-spent-on-new-medicines 2019-12-16T10:00:01+11:00 https://pharmadispatch.com/news/upjohns-gareth-richmond-on-creating-the-standalone-entity 2019-12-16T05:00:01+11:00 https://pharmadispatch.com/news/the-pbac-ending-a-topsy-turvy-decade-as-two-programs 2019-12-16T05:00:01+11:00 https://pharmadispatch.com/news/these-new-lists-are-the-targets 2019-12-16T05:00:01+11:00 https://pharmadispatch.com/news/two-countries-and-two-major-outcomes-for-the-industry 2019-12-16T05:00:01+11:00 https://pharmadispatch.com/news/clinical-trials-competition-across-country-and-companies 2019-12-13T05:00:01+11:00 https://pharmadispatch.com/news/high-in-fees-low-on-performance-measures 2019-12-13T05:00:01+11:00 https://pharmadispatch.com/news/deborah-monk-recollections-from-apma-to-medicines-australia 2019-12-13T05:00:01+11:00 https://pharmadispatch.com/news/novartis-launches-innovation-prize-with-a-focus-on-ms 2019-12-13T05:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-abbvie-australia 2019-12-12T12:47:01+11:00 https://pharmadispatch.com/news/key-trade-agreement-scraps-pharma-ip-provision 2019-12-12T05:00:01+11:00 https://pharmadispatch.com/news/still-time-to-take-advantage-of-biopharmadispatch-2020-early-reg 2019-12-12T05:00:01+11:00 https://pharmadispatch.com/news/mrff-program-for-issues-identified-by-pbac 2019-12-12T05:00:01+11:00 https://pharmadispatch.com/news/ma-board-reappoints-dr-anna-lavelle 2019-12-12T05:00:01+11:00 https://pharmadispatch.com/news/msd-announces-us27bn-acquisition-of-arqule 2019-12-11T04:00:01+11:00 https://pharmadispatch.com/news/sanofi-narrows-focus-and-scraps-rd-in-heritage-areas 2019-12-11T04:00:01+11:00 https://pharmadispatch.com/news/model-the-behaviour-you-demand-of-others-1 2019-12-11T04:00:01+11:00 https://pharmadispatch.com/news/invites-to-medicines-policy-review-working-group 2019-12-10T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-cuts-threaten-business-sustainability 2019-12-10T05:00:01+11:00 https://pharmadispatch.com/news/new-report-says-pelosi-plan-would-reduce-us-life-expectancy 2019-12-10T05:00:01+11:00 https://pharmadispatch.com/news/sanofi-acquires-synthorx-ahead-of-strategy-update 2019-12-10T05:00:01+11:00 https://pharmadispatch.com/news/current-approach-to-hta-is-the-barrier-to-personalised-medicine- 2019-12-09T05:00:01+11:00 https://pharmadispatch.com/news/david-thomas-matching-the-new-world-to-an-old-system 2019-12-09T05:00:01+11:00 https://pharmadispatch.com/news/foundathis-is-simply-the-way-it-has-to-betion-medicine 2019-12-09T05:00:01+11:00 https://pharmadispatch.com/news/nz-coroner-opens-inquiry-on-forced-switch 2019-12-09T05:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-mundipharma-anz-with-jane-orr-announcing-reti 2019-12-06T01:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-astonished-after-rd-tax-cut-legislation-tabled-on-fin 2019-12-06T01:00:01+11:00 https://pharmadispatch.com/news/gsk-welcomes-new-approvals-for-asthma-biologic 2019-12-06T01:00:01+11:00 https://pharmadispatch.com/news/nz-to-fund-azs-ovarian-cancer-therapy-finally 2019-12-06T01:00:01+11:00 https://pharmadispatch.com/news/new-patient-alliance-calls-for-independent-review-of-hta 2019-12-05T01:00:01+11:00 https://pharmadispatch.com/news/artificial-intelligence-to-feature-biopharmadispatch-2020 2019-12-05T01:00:01+11:00 https://pharmadispatch.com/news/csl-highlights-pipeline-at-investor-briefing 2019-12-05T01:00:01+11:00 https://pharmadispatch.com/news/outcomes-can-only-be-judged-if-decision-making-is-transparent 2019-12-05T01:00:01+11:00 https://pharmadispatch.com/news/gsk-opens-pulse-program-for-applications 2019-12-05T01:00:01+11:00 https://pharmadispatch.com/news/department-has-just-handed-the-industry-its-argument 2019-12-04T04:00:01+11:00 https://pharmadispatch.com/news/response-reveals-the-reality-of-who-owns-information 2019-12-04T04:00:01+11:00 https://pharmadispatch.com/news/sta-welcomes-singapore-approval-of-breast-cancer-therapy 2019-12-03T15:26:01+11:00 https://pharmadispatch.com/news/national-medicines-policy-review-taking-shape 2019-12-03T12:53:01+11:00 https://pharmadispatch.com/news/dr-frank-stangenberg-haverkamp 2019-12-03T01:00:01+11:00 https://pharmadispatch.com/news/new-business-unit-structure-for-novo-nordisk 2019-12-03T01:00:01+11:00 https://pharmadispatch.com/news/institutions-back-australian-company-with-50m-raise 2019-12-03T01:00:01+11:00 https://pharmadispatch.com/news/noxopharm-updates-on-positive-trial-results 2019-12-03T01:00:01+11:00 https://pharmadispatch.com/news/how-do-you-reverse-a-decade-of-under-funding 2019-12-02T04:00:01+11:00 https://pharmadispatch.com/news/past-and-present-industry-leaders-pay-tribute-to-policy-and-advo 2019-12-02T04:00:01+11:00 https://pharmadispatch.com/news/vertex-happy-with-december-symdeko-listing 2019-12-02T04:00:01+11:00 https://pharmadispatch.com/news/nz-all-i-want-for-christmas-is-to-live 2019-12-02T04:00:01+11:00 https://pharmadispatch.com/news/pbac-calls-for-follow-up-review-of-risperidone-change 2019-12-02T04:00:01+11:00 https://pharmadispatch.com/news/dr-paul-stoffels-the-human-biology-revolution 2019-11-29T04:00:01+11:00 https://pharmadispatch.com/news/consumer-healthcare-products-confirms-new-board 2019-11-29T04:00:01+11:00 https://pharmadispatch.com/news/uk-conservatives-promise-to-expand-cancer-drugs-fund 2019-11-29T04:00:01+11:00 https://pharmadispatch.com/news/companies-investing-to-expand-gene-therapy-manufacturing 2019-11-29T04:00:01+11:00 https://pharmadispatch.com/news/the-search-for-discussant-presentations 2019-11-28T05:00:01+11:00 https://pharmadispatch.com/news/new-study-shows-power-of-ai-in-matching-patients-to-clinical-tri 2019-11-28T05:00:01+11:00 https://pharmadispatch.com/news/new-directors-for-arcs-board 2019-11-28T05:00:01+11:00 https://pharmadispatch.com/news/year-likely-to-end-with-significant-unresolved-issues 2019-11-28T05:00:01+11:00 https://pharmadispatch.com/news/same-product-same-evidence-different-outcome 2019-11-27T05:00:01+11:00 https://pharmadispatch.com/news/the-mystery-of-the-pbac-discussant 2019-11-27T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-to-announce-listing-of-new-hiv-therapy 2019-11-27T05:00:01+11:00 https://pharmadispatch.com/news/ma-analysis-confirms-what-we-have-long-known 2019-11-26T17:22:01+11:00 https://pharmadispatch.com/news/us-pricing-proposal-will-hit-investment-in-high-risk-areas-of-ur 2019-11-26T05:00:01+11:00 https://pharmadispatch.com/news/sanofi-confirms-private-market-launch-for-biologic 2019-11-26T05:00:01+11:00 https://pharmadispatch.com/news/pharmacy-welcomes-government-response-on-aged-care 2019-11-26T05:00:01+11:00 https://pharmadispatch.com/news/australia-towards-the-bottom-of-drug-price-index 2019-11-26T05:00:01+11:00 https://pharmadispatch.com/news/british-labour-would-create-new-drug-company 2019-11-25T05:00:01+11:00 https://pharmadispatch.com/news/more-pressure-on-pharmac-with-call-for-ministerial-inquiry 2019-11-25T05:00:01+11:00 https://pharmadispatch.com/news/vertex-study-demonstrates-potential-power-of-gene-editing 2019-11-25T05:00:01+11:00 https://pharmadispatch.com/news/challenge-the-cult-of-hta-rather-than-extending-it-reach 2019-11-25T05:00:01+11:00 https://pharmadispatch.com/news/novartis-set-for-us9bn-acquisition 2019-11-25T05:00:01+11:00 https://pharmadispatch.com/news/the-zombie-reform-that-is-still-meant-to-happen 2019-11-22T05:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-partners-with-un-on-childhood-obesity 2019-11-22T05:00:01+11:00 https://pharmadispatch.com/news/60-day-dispensing-means-hundreds-of-new-listings 2019-11-22T05:00:01+11:00 https://pharmadispatch.com/news/sustainability-recognition-for-amgen-at-national-awards 2019-11-22T05:00:01+11:00 https://pharmadispatch.com/news/npsa-commitment-to-australias-critical-infrastructure-for-health 2019-11-21T05:00:01+11:00 https://pharmadispatch.com/news/wholesaler-move-to-go-it-alone-is-just-onekey-difference 2019-11-21T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-frustrated-over-refusal-to-treat-with-car-t 2019-11-21T05:00:01+11:00 https://pharmadispatch.com/news/australian-company-noxopharm-updates-on-pipeline 2019-11-21T05:00:01+11:00 https://pharmadispatch.com/news/minister-doubles-down-on-pharmacy-tribunal 2019-11-20T05:00:01+11:00 https://pharmadispatch.com/news/december-extensions-for-two-cancer-medicines 2019-11-20T05:00:01+11:00 https://pharmadispatch.com/news/companies-clinicians-and-patients-welcome-cancer-listings 2019-11-20T05:00:01+11:00 https://pharmadispatch.com/news/bms-celgene-merger-set-to-close 2019-11-20T05:00:01+11:00 https://pharmadispatch.com/news/research-reveals-no-link-between-statins-and-memory-loss 2019-11-19T05:00:01+11:00 https://pharmadispatch.com/news/rather-than-tinkering-the-push-should-be-to-start-again 2019-11-19T05:00:01+11:00 https://pharmadispatch.com/news/more-criticism-of-pharmac-has-actor-passes-away 2019-11-19T05:00:01+11:00 https://pharmadispatch.com/news/another-confirmed-industry-leader-for-biopharmadispatch-2020 2019-11-19T05:00:01+11:00 https://pharmadispatch.com/news/industry-better-than-most-but-more-work-required-on-gender-pay-g 2019-11-19T05:00:01+11:00 https://pharmadispatch.com/news/this-system-is-about-rationing-not-valuing 2019-11-18T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-shifts-following-reports-of-another-death 2019-11-18T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-funding-for-research-into-rare-cancers-and-d 2019-11-18T05:00:01+11:00 https://pharmadispatch.com/news/new-documents-confirm-focus-on-price-and-cost 2019-11-18T05:00:01+11:00 https://pharmadispatch.com/news/experts-gather-in-sydney-for-meeting-on-value 2019-11-18T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-could-up-the-ante-with-speculated-appointment 2019-11-15T05:00:01+11:00 https://pharmadispatch.com/news/malaria-researcher-wins-gsk-award-for-research-excellence 2019-11-15T05:00:01+11:00 https://pharmadispatch.com/news/australian-company-doses-first-patient-in-tumour-agnostic-study 2019-11-15T05:00:01+11:00 https://pharmadispatch.com/news/stakeholders-leave-meeting-none-the-wider-of-negotiation-progres 2019-11-15T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-switch-now-blamed-for-three-deaths 2019-11-14T05:00:01+11:00 https://pharmadispatch.com/news/7cpa-deal-unlikely-in-2019 2019-11-14T05:00:01+11:00 https://pharmadispatch.com/news/new-reports-highlights-system-challenge-for-alzheimers-treatment 2019-11-14T05:00:01+11:00 https://pharmadispatch.com/news/official-opening-of-new-merck-headquarters 2019-11-13T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-releases-update-on-local-regenerative-medicine-sector 2019-11-13T05:00:01+11:00 https://pharmadispatch.com/news/department-confirms-emergency-supply-arrangements-for-bushfire-a 2019-11-13T05:00:01+11:00 https://pharmadispatch.com/news/mark-glover-the-tech-opportunity-for-clinical-trials 2019-11-13T05:00:01+11:00 https://pharmadispatch.com/news/take-a-tour-of-mercks-new-office 2019-11-13T05:00:01+11:00 https://pharmadispatch.com/news/exclusive-key-week-for-7cpa-negotiations 2019-11-12T05:30:01+11:00 https://pharmadispatch.com/news/bowen-maintains-pressure-on-flash-monitors 2019-11-12T05:30:01+11:00 https://pharmadispatch.com/news/an-emerging-alignment-of-historic-significance 2019-11-12T05:30:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-tga-approval-ahead-of-pbac-outcome 2019-11-12T05:30:01+11:00 https://pharmadispatch.com/news/roche-backs-lung-health-advocacy-project 2019-11-12T05:30:01+11:00 https://pharmadispatch.com/news/reducing-submission-churn-by-getting-rid-of-resubmissions 2019-11-11T03:00:01+11:00 https://pharmadispatch.com/news/us-price-reform-stalls-on-key-differences 2019-11-11T03:00:01+11:00 https://pharmadispatch.com/news/bridge-program-announces-2019-pitch-winners 2019-11-11T03:00:01+11:00 https://pharmadispatch.com/news/new-treatment-holds-cv-hope-for-ckd-patients 2019-11-11T03:00:01+11:00 https://pharmadispatch.com/news/not-a-new-scenario-but-how-would-the-industry-respond-today 2019-11-08T03:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-to-bring-forward-formation-of-nmp-review-working-group 2019-11-08T03:00:01+11:00 https://pharmadispatch.com/news/us-house-expected-to-back-pelosi-plan 2019-11-08T03:00:01+11:00 https://pharmadispatch.com/news/martin-palin-on-topicality-integration-and-results 2019-11-07T03:00:01+11:00 https://pharmadispatch.com/news/there-is-no-coming-back-from-that-response 2019-11-07T02:00:01+11:00 https://pharmadispatch.com/news/still-no-disclosed-plans-for-alnylam-in-australia 2019-11-07T02:00:01+11:00 https://pharmadispatch.com/news/ma-responds-on-pbac-conditionality 2019-11-06T03:00:01+11:00 https://pharmadispatch.com/news/no-pharmacy-merger-at-this-time 2019-11-06T03:00:01+11:00 https://pharmadispatch.com/news/this-is-how-the-deferrals-policy-could-have-been-sustained 2019-11-06T03:00:01+11:00 https://pharmadispatch.com/news/how-will-this-be-weaponised-under-greg-hunts-successors 2019-11-06T00:35:01+11:00 https://pharmadispatch.com/news/time-to-consider-limits-on-pbac-decision-making 2019-11-04T22:00:01+11:00 https://pharmadispatch.com/news/the-human-chemistry-can-be-as-important-as-the-actual-chemsitry 2019-11-04T22:00:01+11:00 https://pharmadispatch.com/news/us-has-some-advantages-over-australia-on-health 2019-11-04T22:00:01+11:00 https://pharmadispatch.com/news/it-is-all-about-the-vibe-and-the-dennis-denuto-defence 2019-11-04T05:00:01+11:00 https://pharmadispatch.com/news/quality-use-of-medicines-the-new-national-health-priority 2019-11-04T05:00:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-nps-funding-reduction 2019-11-04T05:00:01+11:00 https://pharmadispatch.com/news/praise-for-departing-hepatitis-australia-ceo 2019-11-04T05:00:01+11:00 https://pharmadispatch.com/news/pathways-new-biosimilar-uptake-drivers-and-migraine 2019-11-04T05:00:01+11:00 https://pharmadispatch.com/news/teva-looking-to-pbs-on-migraine-biologic 2019-11-04T05:00:01+11:00 https://pharmadispatch.com/news/the-government-disregards-pbac-advice-constantly-and-consistentl 2019-11-01T04:00:01+11:00 https://pharmadispatch.com/news/what-was-greg-hunt-even-talking-about 2019-11-01T04:00:01+11:00 https://pharmadispatch.com/news/response-confirms-the-long-held-view-on-conditions 2019-11-01T04:00:01+11:00 https://pharmadispatch.com/news/the-industry-needs-to-test-the-minister-on-this-issue 2019-11-01T04:00:01+11:00 https://pharmadispatch.com/news/new-zealands-medicine-wait-list-grows-again 2019-10-31T05:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-progressing-and-considering-partners 2019-10-31T05:00:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-looking-to-bring-tumour-agnostic-trials-to- 2019-10-31T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-releases-updated-sector-snapshot 2019-10-31T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-confirms-board-change-and-new-deputy-chair 2019-10-31T05:00:01+11:00 https://pharmadispatch.com/news/focus-on-the-right-science-and-the-resources-follow 2019-10-30T05:00:01+11:00 https://pharmadispatch.com/news/emerging-australian-biotech-secures-20m-investment 2019-10-30T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-to-kick-off-2019-national-conference 2019-10-30T05:00:01+11:00 https://pharmadispatch.com/news/positive-lung-cancer-results-for-azs-pd-l1-inhibitor 2019-10-30T05:00:01+11:00 https://pharmadispatch.com/news/new-uq-spin-out-company-to-target-liver-disease 2019-10-30T05:00:01+11:00 https://pharmadispatch.com/news/working-towards-the-conditional-resubmission 2019-10-29T01:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-updates-on-us-bronchitol-progress 2019-10-29T01:00:01+11:00 https://pharmadispatch.com/news/the-risk-of-ministerial-overstatement-on-conditions 2019-10-29T01:00:01+11:00 https://pharmadispatch.com/news/not-bullying-but-there-is-a-history-on-migraine 2019-10-29T01:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-inova-australia-and-new-zealand 2019-10-29T01:00:01+11:00 https://pharmadispatch.com/news/registrations-open-for-biopharmadispatch-2020 2019-10-28T05:00:01+11:00 https://pharmadispatch.com/news/department-issues-official-explanation-of-the-2200 2019-10-28T05:00:01+11:00 https://pharmadispatch.com/news/pbs-and-pbac-metrics-in-annual-report 2019-10-28T05:00:01+11:00 https://pharmadispatch.com/news/death-blamed-on-pharmac-forced-switch 2019-10-28T05:00:01+11:00 https://pharmadispatch.com/news/melbourne-hosts-2019-bridge-symposium 2019-10-28T05:00:01+11:00 https://pharmadispatch.com/news/listing-conditions-make-novartis-migraine-biologic-a-no-go 2019-10-28T05:00:01+11:00 https://pharmadispatch.com/news/minister-confirms-some-november-listings 2019-10-28T05:00:01+11:00 https://pharmadispatch.com/news/it-is-growth-but-it-could-be-a-savings-shortfall 2019-10-26T18:10:01+11:00 https://pharmadispatch.com/news/huge-implications-of-a-convenient-politically-driven-shift 2019-10-25T05:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-progresses-development-of-lox-inhibitor 2019-10-25T05:00:01+11:00 https://pharmadispatch.com/news/bowen-government-loose-with-the-truth-on-pbs 2019-10-25T05:00:01+11:00 https://pharmadispatch.com/news/recognition-for-csls-paul-perreault 2019-10-25T05:00:01+11:00 https://pharmadispatch.com/news/government-considering-recommendations-of-nps-review 2019-10-25T05:00:01+11:00 https://pharmadispatch.com/news/post-market-review-of-smoking-cessation-therapies 2019-10-25T05:00:01+11:00 https://pharmadispatch.com/news/msac-confirms-date-of-car-t-stakeholder-meeting 2019-10-25T05:00:01+11:00 https://pharmadispatch.com/news/five-new-directors-for-medicines-australia-board 2019-10-24T17:00:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-growth-and-over-2bn-in-rebates 2019-10-24T15:00:01+11:00 https://pharmadispatch.com/news/pharmac-no-spinraza-because-of-fixed-budget 2019-10-24T05:00:01+11:00 https://pharmadispatch.com/news/novartis-disappointed-as-msac-cites-uncertainty-and-price-in-car 2019-10-24T05:00:01+11:00 https://pharmadispatch.com/news/bms-reports-positive-data-for-opdivo-in-first-line-lung-cancer 2019-10-24T05:00:01+11:00 https://pharmadispatch.com/news/there-risk-of-a-policy-response-to-a-political-problem 2019-10-24T05:00:01+11:00 https://pharmadispatch.com/news/finally-an-explanation-on-the-2200-new-and-amended-medicines 2019-10-24T05:00:01+11:00 https://pharmadispatch.com/news/department-of-human-services-reports-flat-pbs-spend 2019-10-23T05:00:01+11:00 https://pharmadispatch.com/news/the-pbs-hit-by-policy-pincer-movement 2019-10-23T05:00:01+11:00 https://pharmadispatch.com/news/estimates-today-but-still-waiting-on-annual-report 2019-10-23T05:00:01+11:00 https://pharmadispatch.com/news/biogen-resurrects-alzheimers-therapy 2019-10-23T05:00:01+11:00 https://pharmadispatch.com/news/new-gene-therapy-partnership-between-bluebird-bio-and-novo-nordi 2019-10-22T03:00:01+11:00 https://pharmadispatch.com/news/finance-points-to-improved-pbs-costings-accuracy-in-annual-repor 2019-10-22T03:00:01+11:00 https://pharmadispatch.com/news/extension-for-ma-chair-as-members-prepare-for-agm 2019-10-22T03:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-nine-days-from-agreement-to-listing 2019-10-22T03:00:01+11:00 https://pharmadispatch.com/news/it-was-like-throwing-darts-at-a-dartboard-while-blindfolded 2019-10-21T05:00:01+11:00 https://pharmadispatch.com/news/payments-in-advance-and-a-higher-interest-rate 2019-10-21T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-unlikely-to-lose-sleep-over-that-list 2019-10-21T05:00:01+11:00 https://pharmadispatch.com/news/patients-welcome-much-anticipated-cystic-fibrosis-listings 2019-10-21T05:00:01+11:00 https://pharmadispatch.com/news/inova-sets-four-challenges-for-ipitch 2019-10-21T05:00:01+11:00 https://pharmadispatch.com/news/companies-already-contemplating-the-risk-of-pelosi-plan 2019-10-18T05:00:01+11:00 https://pharmadispatch.com/news/gilead-elimination-in-reach-but-more-work-required 2019-10-18T05:00:01+11:00 https://pharmadispatch.com/news/baby-boom-at-mundipharma-in-response-to-policy-change 2019-10-18T05:00:01+11:00 https://pharmadispatch.com/news/bayer-backs-program-targeting-physical-health-in-rural-australia 2019-10-18T05:00:01+11:00 https://pharmadispatch.com/news/patients-welcome-new-action-plan-for-osteoporosis 2019-10-18T05:00:01+11:00 https://pharmadispatch.com/news/pricing-proposal-will-destroy-the-industry-and-halve-drug-approv 2019-10-17T05:00:01+11:00 https://pharmadispatch.com/news/us-proposal-a-game-over-moment-for-australia 2019-10-17T05:00:01+11:00 https://pharmadispatch.com/news/how-the-federal-government-gets-to-2200-medicines 2019-10-17T05:00:01+11:00 https://pharmadispatch.com/news/threshold-legislations-sparks-renewed-pbs-debate 2019-10-17T05:00:01+11:00 https://pharmadispatch.com/news/department-of-health-ask-the-ministers-office 2019-10-16T05:00:01+11:00 https://pharmadispatch.com/news/government-not-really-telling-the-truth-on-pbs 2019-10-16T05:00:01+11:00 https://pharmadispatch.com/news/psa-confirms-appointment-of-new-ceo 2019-10-16T05:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-shares-his-thoughts-on-review 2019-10-16T05:00:01+11:00 https://pharmadispatch.com/news/hunt-we-have-listed-more-and-cut-listing-times 2019-10-15T11:03:01+11:00 https://pharmadispatch.com/news/what-next-for-tumour-agnostic-therapies 2019-10-15T05:00:01+11:00 https://pharmadispatch.com/news/csl-marks-25-years-since-privatisation 2019-10-15T05:00:01+11:00 https://pharmadispatch.com/news/new-licensing-deal-for-specialised-therapeutics 2019-10-15T05:00:01+11:00 https://pharmadispatch.com/news/bowen-backed-review-knowing-it-would-probably-mean-more-for-pbs 2019-10-15T05:00:01+11:00 https://pharmadispatch.com/news/frank-lichtenberg-70-is-the-new-60-and-80-the-new-70 2019-10-15T05:00:01+11:00 https://pharmadispatch.com/news/are-new-items-the-same-as-new-listings 2019-10-14T11:26:01+11:00 https://pharmadispatch.com/news/sanofis-karen-hood-industry-needs-a-clear-and-specific-plan 2019-10-14T05:00:01+11:00 https://pharmadispatch.com/news/government-backs-new-cell-and-tissue-research-facility 2019-10-14T05:00:01+11:00 https://pharmadispatch.com/news/industry-right-in-the-crosshairs 2019-10-14T05:00:01+11:00 https://pharmadispatch.com/news/industry-prepares-to-gather-in-canberra-for-pharmaus19 2019-10-14T05:00:01+11:00 https://pharmadispatch.com/news/new-cabinet-handbook-brings-forward-budget-process 2019-10-14T05:00:01+11:00 https://pharmadispatch.com/news/lundbeck-and-otsuka-on-the-bridge-for-mental-health 2019-10-14T05:00:01+11:00 https://pharmadispatch.com/news/cancer-and-malaria-the-focus-of-new-csl-centenary-fellowships 2019-10-11T05:00:01+11:00 https://pharmadispatch.com/news/some-of-these-items-are-numbers-just-numbers 2019-10-11T05:00:01+11:00 https://pharmadispatch.com/news/industry-executive-to-lead-emerging-australian-biopharma-adalta 2019-10-11T05:00:01+11:00 https://pharmadispatch.com/news/return-to-new-zealand-unsafe-for-sma-patient 2019-10-11T05:00:01+11:00 https://pharmadispatch.com/news/is-this-number-based-on-something-other-than-actual-items 2019-10-10T05:00:01+11:00 https://pharmadispatch.com/news/leadership-appointment-for-gsk-pfizer-joint-venture 2019-10-10T05:00:01+11:00 https://pharmadispatch.com/news/australian-medicinal-cannabis-company-merges-with-us-based-count 2019-10-10T05:00:01+11:00 https://pharmadispatch.com/news/australian-company-surges-on-fda-approval 2019-10-10T05:00:01+11:00 https://pharmadispatch.com/news/liz-chatwin-our-industry-is-more-than-just-medicines 2019-10-09T05:00:01+11:00 https://pharmadispatch.com/news/the-roi-of-technologically-enhanced-patient-centric-clinical-tri 2019-10-09T05:00:01+11:00 https://pharmadispatch.com/news/no-answer-to-what-seems-a-very-simple-question 2019-10-09T05:00:01+11:00 https://pharmadispatch.com/news/blow-for-the-psa-with-deputy-ceo-departure 2019-10-08T05:00:01+11:00 https://pharmadispatch.com/news/there-is-something-unusual-about-this-negotiation-so-far 2019-10-08T05:00:01+11:00 https://pharmadispatch.com/news/gene-therapy-company-updates-on-cash-runway 2019-10-08T05:00:01+11:00 https://pharmadispatch.com/news/mixed-response-to-latest-pharmac-decision 2019-10-08T05:00:01+11:00 https://pharmadispatch.com/news/broad-listing-rejected-after-companies-stood-firm-on-pd-l1-price 2019-10-07T05:00:01+11:00 https://pharmadispatch.com/news/pbac-and-msd-still-debating-keytruda-pricing 2019-10-07T05:00:01+11:00 https://pharmadispatch.com/news/august-outcomes-confirm-win-for-myeloma-patients 2019-10-07T05:00:01+11:00 https://pharmadispatch.com/news/biogen-impresses-with-new-spinraza-data 2019-10-04T05:00:01+10:00 https://pharmadispatch.com/news/applicants-swamp-new-clinical-trial-grants-program 2019-10-04T05:00:01+10:00 https://pharmadispatch.com/news/fresenius-kabi-joins-gbma 2019-10-04T05:00:01+10:00 https://pharmadispatch.com/news/a-culture-of-patient-access-must-pervade-decision-making 2019-10-04T05:00:01+10:00 https://pharmadispatch.com/news/the-important-part-may-be-the-bit-you-cannot-see 2019-10-03T05:00:01+10:00 https://pharmadispatch.com/news/fdas-project-orbis-head-in-australia 2019-10-03T05:00:01+10:00 https://pharmadispatch.com/news/industry-misses-out-on-stem-cell-advisory-panel 2019-10-03T05:00:01+10:00 https://pharmadispatch.com/news/pbs-savings-fund-other-parts-of-the-health-system 2019-10-03T05:00:01+10:00 https://pharmadispatch.com/news/workshop-considers-how-to-harness-genomics 2019-10-03T05:00:01+10:00 https://pharmadispatch.com/news/new-healthcare-leadership-for-weber-shandwick 2019-10-02T05:00:01+10:00 https://pharmadispatch.com/news/something-the-sector-should-be-watching-closely 2019-10-02T05:00:01+10:00 https://pharmadispatch.com/news/a-big-week-of-biosimilars 2019-10-02T05:00:01+10:00 https://pharmadispatch.com/news/reports-of-seizures-after-pharmac-ignores-advice-and-forces-swit 2019-10-01T05:00:01+10:00 https://pharmadispatch.com/news/msds-michael-azrak-we-cannot-secure-change-alone 2019-10-01T05:00:01+10:00 https://pharmadispatch.com/news/a-change-of-language-that-reflects-the-reality 2019-10-01T05:00:01+10:00 https://pharmadispatch.com/news/ma-member-companies-get-ready-to-vote 2019-10-01T05:00:01+10:00 https://pharmadispatch.com/news/key-lung-cancer-listing-leads-october-announcement 2019-09-30T12:58:01+10:00 https://pharmadispatch.com/news/nominations-set-to-close-for-ma-board 2019-09-30T05:00:01+10:00 https://pharmadispatch.com/news/experienced-industry-executive-joins-gbma-board 2019-09-30T05:00:01+10:00 https://pharmadispatch.com/news/pbac-decides-against-single-nsclc-listing-for-now 2019-09-30T05:00:01+10:00 https://pharmadispatch.com/news/grants-to-support-new-translation-projects 2019-09-30T05:00:01+10:00 https://pharmadispatch.com/news/bms-neil-macgregor-a-review-is-not-about-fixing-yesterdays-probl 2019-09-27T05:00:01+10:00 https://pharmadispatch.com/news/uk-plan-to-wreck-the-countrys-medical-rd-effort 2019-09-27T05:00:01+10:00 https://pharmadispatch.com/news/gsk-launches-local-spectrum-group 2019-09-27T05:00:01+10:00 https://pharmadispatch.com/news/juno-pharmaceuticals-to-market-key-biosimilars 2019-09-27T05:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-vagaries-of-pbs-spend 2019-09-27T05:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-welcomes-new-lynparza-approval 2019-09-26T05:00:01+10:00 https://pharmadispatch.com/news/new-report-confirms-australian-love-for-unsubsidised-medicines 2019-09-26T05:00:01+10:00 https://pharmadispatch.com/news/csl-and-government-backed-fund-back-new-university-spinout 2019-09-26T05:00:01+10:00 https://pharmadispatch.com/news/csl-exits-medicines-australia 2019-09-26T05:00:01+10:00 https://pharmadispatch.com/news/no-doubting-the-wes-cook-legacy 2019-09-26T05:00:01+10:00 https://pharmadispatch.com/news/industry-leader-opts-to-step-down 2019-09-25T15:25:01+10:00 https://pharmadispatch.com/news/growth-demand-will-not-be-for-just-any-growth 2019-09-25T05:00:01+10:00 https://pharmadispatch.com/news/the-new-paig-releases-2020-21-prospectus 2019-09-25T05:00:01+10:00 https://pharmadispatch.com/news/bluebird-bio-updates-on-latest-gene-therapy 2019-09-25T05:00:01+10:00 https://pharmadispatch.com/news/industry-slams-new-us-pricing-proposal 2019-09-25T05:00:01+10:00 https://pharmadispatch.com/news/savings-shortfall-behind-growth-wedge 2019-09-24T05:00:01+10:00 https://pharmadispatch.com/news/former-ma-chair-to-lead-medicinal-cannabis-company 2019-09-24T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-inks-new-agreement-with-theuniversity-of-melbourne 2019-09-24T05:00:01+10:00 https://pharmadispatch.com/news/immutep-secures-milestone-payment-from-gsk 2019-09-24T05:00:01+10:00 https://pharmadispatch.com/news/who-are-these-agreements-really-meant-to-serve 2019-09-23T05:00:01+10:00 https://pharmadispatch.com/news/analysing-the-pbs-may-be-about-to-get-easier 2019-09-23T05:00:01+10:00 https://pharmadispatch.com/news/overcoming-zombies-and-finding-the-new-famous-australians 2019-09-23T05:00:01+10:00 https://pharmadispatch.com/news/the-search-for-the-worlds-best-emerging-science 2019-09-22T05:00:01+10:00 https://pharmadispatch.com/news/james-mcdonnell-industry-on-the-cusp-of-something-quite-extraord 2019-09-20T05:00:01+10:00 https://pharmadispatch.com/news/inova-looking-for-local-innovators 2019-09-20T05:00:01+10:00 https://pharmadispatch.com/news/not-a-great-combination-for-the-sector 2019-09-20T05:00:01+10:00 https://pharmadispatch.com/news/novartis-provides-updated-data-on-gene-therapy 2019-09-20T05:00:01+10:00 https://pharmadispatch.com/news/pharmaceutical-spend-down-slightly-on-bugdet-forecast 2019-09-19T10:43:01+10:00 https://pharmadispatch.com/news/new-study-links-gene-mutation-to-disease 2019-09-19T05:00:01+10:00 https://pharmadispatch.com/news/new-deal-with-australian-cell-therapy-company 2019-09-19T05:00:01+10:00 https://pharmadispatch.com/news/patrick-kilbride-on-restoring-the-global-consensus 2019-09-19T05:00:01+10:00 https://pharmadispatch.com/news/the-industry-preparing-for-no-deal-brexit 2019-09-19T05:00:01+10:00 https://pharmadispatch.com/news/lauren-carey-review-a-great-opportunity-to-shape-future-landscap 2019-09-18T05:00:01+10:00 https://pharmadispatch.com/news/consortium-to-target-utilisation-of-bdmards 2019-09-18T05:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-abbott-working-on-technology-convergence 2019-09-18T05:00:01+10:00 https://pharmadispatch.com/news/innovation-and-ip-the-focus-for-us-delegation 2019-09-18T05:00:01+10:00 https://pharmadispatch.com/news/tga-teams-up-with-fda-and-health-canada-on-oncology-approval 2019-09-18T05:00:01+10:00 https://pharmadispatch.com/news/bms-launches-employee-experience-initiative 2019-09-17T05:00:01+10:00 https://pharmadispatch.com/news/chris-bowen-targeting-government-strength-on-pbs 2019-09-17T05:00:01+10:00 https://pharmadispatch.com/news/lundbeck-acquires-us-biologics-company 2019-09-17T05:00:01+10:00 https://pharmadispatch.com/news/kazia-therapeutics-wins-trans-tasman-innovation-award 2019-09-17T05:00:01+10:00 https://pharmadispatch.com/news/nominations-open-against-a-backdrop-of-change 2019-09-16T05:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-moves-to-broaden-product-focus 2019-09-16T05:00:01+10:00 https://pharmadispatch.com/news/venture-capital-leaders-warns-against-impact-of-government-claim 2019-09-16T05:00:01+10:00 https://pharmadispatch.com/news/industry-watching-for-final-budget-outcome 2019-09-16T05:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-funded-grant-for-stroke-ai-project 2019-09-16T05:00:01+10:00 https://pharmadispatch.com/news/biotech-leaders-in-canberra-to-promote-rd-investment 2019-09-13T03:00:01+10:00 https://pharmadispatch.com/news/industry-hackles-over-compassionate-access-pressure 2019-09-13T03:00:01+10:00 https://pharmadispatch.com/news/mundipharma-could-be-sold-as-part-of-us-opioid-settlement 2019-09-13T03:00:01+10:00 https://pharmadispatch.com/news/icon-acquires-hong-kong-oncology-group 2019-09-13T03:00:01+10:00 https://pharmadispatch.com/news/astrazenecascraps-direct-distribution 2019-09-12T05:00:01+10:00 https://pharmadispatch.com/news/pulling-every-lever-except-the-one-supposed-to-work 2019-09-12T05:00:01+10:00 https://pharmadispatch.com/news/australian-companies-make-innovation-list 2019-09-12T05:00:01+10:00 https://pharmadispatch.com/news/new-sydney-office-for-global-search-specialist 2019-09-12T05:00:01+10:00 https://pharmadispatch.com/news/another-step-towards-novel-combination-therapy-for-multiple-myel 2019-09-11T05:00:01+10:00 https://pharmadispatch.com/news/mesoblast-partners-with-grnenthal-on-cell-therapy 2019-09-11T05:00:01+10:00 https://pharmadispatch.com/news/pharmacy-gathers-for-annual-parliamentary-dinner 2019-09-11T05:00:01+10:00 https://pharmadispatch.com/news/companies-facing-some-surprises-with-new-pathways-and-fees 2019-09-10T17:32:01+10:00 https://pharmadispatch.com/news/alnylam-updates-on-cholesterol-lowering-rna-based-medicine 2019-09-10T05:00:01+10:00 https://pharmadispatch.com/news/az-reports-data-from-immunotherapy-trial 2019-09-10T05:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-chair-calls-for-change 2019-09-10T05:00:01+10:00 https://pharmadispatch.com/news/pharmac-forcing-more-kiwis-overseas-for-treatment 2019-09-09T05:00:01+10:00 https://pharmadispatch.com/news/msd-wins-two-categories-and-shares-another-with-abbvie 2019-09-09T03:00:01+10:00 https://pharmadispatch.com/news/leah-goodman-the-system-is-in-trouble 2019-09-09T03:00:01+10:00 https://pharmadispatch.com/news/dr-emanuele-ostuni-on-building-a-cell-and-gene-organisation 2019-09-09T03:00:01+10:00 https://pharmadispatch.com/news/opthea-updates-on-new-trial-analysis 2019-09-09T03:00:01+10:00 https://pharmadispatch.com/news/roche-gm-stuart-knight-speaks-with-biopharmadispatch 2019-09-06T04:00:01+10:00 https://pharmadispatch.com/news/sigma-focused-on-transformation 2019-09-06T04:00:01+10:00 https://pharmadispatch.com/news/l-and-gene-to-grow-but-not-dominate-yet 2019-09-06T04:00:01+10:00 https://pharmadispatch.com/news/vertex-expands-in-gene-editing-and-stem-cell-therapy 2019-09-06T04:00:01+10:00 https://pharmadispatch.com/news/mundipharma-backing-new-scholarship 2019-09-06T04:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-looking-to-first-line-treatment-for-asthma-therapy 2019-09-05T04:00:01+10:00 https://pharmadispatch.com/news/the-big-one-is-crispr-editing 2019-09-05T04:00:01+10:00 https://pharmadispatch.com/news/the-go-big-or-go-home-challenge 2019-09-05T04:00:01+10:00 https://pharmadispatch.com/news/companies-informed-of-outcome-as-process-moves-towards-foundatio 2019-09-05T04:00:01+10:00 https://pharmadispatch.com/news/coming-next-podcast-with-roches-stuart-knight 2019-09-05T04:00:01+10:00 https://pharmadispatch.com/news/why-are-some-immunotherapies-vaccines-and-others-are-not 2019-09-04T04:00:01+10:00 https://pharmadispatch.com/news/a-touch-of-mission-control-for-novartis-clinical-trials 2019-09-04T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-bends-again-on-cancer-medicines 2019-09-04T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-calls-for-support-on-rd-tax-research 2019-09-04T04:00:01+10:00 https://pharmadispatch.com/news/mixed-response-to-nz-cancer-action-plan 2019-09-03T03:00:01+10:00 https://pharmadispatch.com/news/new-excitement-over-vaccines-that-will-redefine-what-they-mean 2019-09-03T03:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-considering-working-group-for-new-technologies 2019-09-03T03:00:01+10:00 https://pharmadispatch.com/news/ma-foi-act-provides-useful-guidance-on-managing-redactions 2019-09-03T03:00:01+10:00 https://pharmadispatch.com/news/departmental-gift-disclosure-redacts-key-information 2019-09-01T19:00:01+10:00 https://pharmadispatch.com/news/a-laughable-irony-or-serious-and-rank-hypocrisy 2019-09-01T19:00:01+10:00 https://pharmadispatch.com/news/companies-welcome-pbs-update-as-minister-announces-flu-vax-exten 2019-09-01T19:00:01+10:00 https://pharmadispatch.com/news/government-to-create-national-taskforce-on-blood-cancer 2019-09-01T19:00:01+10:00 https://pharmadispatch.com/news/plenty-of-options-if-the-government-moves-to-fill-shortfall 2019-09-01T19:00:01+10:00 https://pharmadispatch.com/news/csl-signs-agreement-with-gene-therapy-company-mustang-bio 2019-08-30T04:00:01+10:00 https://pharmadispatch.com/news/new-report-measures-the-process-not-time-to-access 2019-08-30T04:00:01+10:00 https://pharmadispatch.com/news/ma-launches-centralised-reporting-system 2019-08-30T04:00:01+10:00 https://pharmadispatch.com/news/janssen-extends-collaboration-with-melbourne-based-research-inst 2019-08-30T04:00:01+10:00 https://pharmadispatch.com/news/could-companies-consider-what-was-once-inconceivable 2019-08-29T05:00:01+10:00 https://pharmadispatch.com/news/another-call-for-urgent-action-on-pharmac 2019-08-29T05:00:01+10:00 https://pharmadispatch.com/news/what-hope-for-novel-combination-therapies 2019-08-29T05:00:01+10:00 https://pharmadispatch.com/news/new-and-old-for-novembers-pbac-meeting 2019-08-29T05:00:01+10:00 https://pharmadispatch.com/news/does-money-talk-when-it-comes-to-the-clinical-need-barrier 2019-08-28T05:00:01+10:00 https://pharmadispatch.com/news/global-hta-leader-to-step-down 2019-08-28T05:00:01+10:00 https://pharmadispatch.com/news/industry-recognised-in-2019-great-places-to-work-study 2019-08-28T05:00:01+10:00 https://pharmadispatch.com/news/page-better-than-most-but-work-to-be-done-on-pay-gap 2019-08-28T05:00:01+10:00 https://pharmadispatch.com/news/dispensing-doctors-would-corrupt-the-relationship-with-industry 2019-08-28T05:00:01+10:00 https://pharmadispatch.com/news/is-this-the-worst-idea-ever-proposed-for-the-pbs 2019-08-27T10:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-extent-of-cancer-treatment 2019-08-27T05:00:01+10:00 https://pharmadispatch.com/news/is-it-time-to-accept-the-reality-on-the-pbs 2019-08-27T05:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-considers-board-term-limit 2019-08-27T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2020-save-the-date 2019-08-27T05:00:01+10:00 https://pharmadispatch.com/news/possible-australian-redux-for-celgenes-otezla 2019-08-27T05:00:01+10:00 https://pharmadispatch.com/news/roche-launches-new-employee-value-proposition 2019-08-26T05:00:01+10:00 https://pharmadispatch.com/news/clinical-need-and-financial-opportunity-cost 2019-08-26T05:00:01+10:00 https://pharmadispatch.com/news/john-alexander-joins-students-for-amgen-biotech-experience 2019-08-26T05:00:01+10:00 https://pharmadispatch.com/news/minor-changes-and-pricing-variations-dominate-july-outcomes 2019-08-26T05:00:01+10:00 https://pharmadispatch.com/news/camurus-welcomes-buvidal-listing 2019-08-26T05:00:01+10:00 https://pharmadispatch.com/news/the-post-rebate-era-has-started-with-or-without-supply-chain-ref 2019-08-23T05:00:01+10:00 https://pharmadispatch.com/news/is-there-even-a-plan-for-emerging-therapies-in-australia 2019-08-23T05:00:01+10:00 https://pharmadispatch.com/news/federal-government-still-finalising-car-t-agreement-with-peter-m 2019-08-23T05:00:01+10:00 https://pharmadispatch.com/news/ebos-looking-to-the-next-wave-of-growth 2019-08-23T05:00:01+10:00 https://pharmadispatch.com/news/bayer-makes-another-move-into-cell-therapy 2019-08-22T05:00:01+10:00 https://pharmadispatch.com/news/government-could-come-for-more-given-savings-shortfall 2019-08-22T05:00:01+10:00 https://pharmadispatch.com/news/patients-might-be-hoping-their-medicine-belongs-to-a-large-compa 2019-08-22T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-to-invest-us500m-in-gene-therapy-manufacturing 2019-08-22T05:00:01+10:00 https://pharmadispatch.com/news/fda-rejects-sareptas-second-rna-therapy 2019-08-21T05:00:01+10:00 https://pharmadispatch.com/news/page-co-founders-on-opening-the-door-to-discussions-on-diversity 2019-08-21T05:00:01+10:00 https://pharmadispatch.com/news/biogen-backs-new-learning-resource 2019-08-21T05:00:01+10:00 https://pharmadispatch.com/news/inclinic-sigma-launches-australias-first-telehealth-services-in- 2019-08-21T05:00:01+10:00 https://pharmadispatch.com/news/bayer-agrees-to-sell-animal-health-business 2019-08-21T05:00:01+10:00 https://pharmadispatch.com/news/pm-look-beyond-corporate-interests-on-policy 2019-08-20T05:00:01+10:00 https://pharmadispatch.com/news/is-the-policy-implementation-split-really-that-simple 2019-08-20T05:00:01+10:00 https://pharmadispatch.com/news/sanofi-partners-on-new-insulin-service 2019-08-20T05:00:01+10:00 https://pharmadispatch.com/news/page-co-founders-on-its-creation-achievements-and-personal-refle 2019-08-19T05:00:01+10:00 https://pharmadispatch.com/news/biopharmadispatch-launches-podcasts 2019-08-19T05:00:01+10:00 https://pharmadispatch.com/news/sanofi-hosts-students-for-national-science-week 2019-08-19T05:00:01+10:00 https://pharmadispatch.com/news/industry-secures-extension-after-intervention 2019-08-19T05:00:01+10:00 https://pharmadispatch.com/news/what-happens-when-for-incremental-benefits 2019-08-16T04:00:01+10:00 https://pharmadispatch.com/news/the-word-innovation-has-been-overused-but-this-is-seriously-game 2019-08-16T04:00:01+10:00 https://pharmadispatch.com/news/roche-confirms-new-tecentriq-indication-ahead-of-potential-reimb 2019-08-16T04:00:01+10:00 https://pharmadispatch.com/news/nz-patients-lodge-another-nine-petitions 2019-08-16T04:00:01+10:00 https://pharmadispatch.com/news/new-australian-report-highlights-shift-away-from-one-size-fits-a 2019-08-15T05:00:01+10:00 https://pharmadispatch.com/news/sydney-based-noxoxpharm-looking-to-make-cold-tumours-hot 2019-08-15T05:00:01+10:00 https://pharmadispatch.com/news/bms-launches-new-video-explaining-immuno-oncology 2019-08-15T05:00:01+10:00 https://pharmadispatch.com/news/ma-stalwart-confirms-retirement-after-30-years 2019-08-15T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-decision-making-a-process-an-independent-locked-box 2019-08-14T12:38:01+10:00 https://pharmadispatch.com/news/csl-reports-higher-revenue-and-profit 2019-08-14T08:49:01+10:00 https://pharmadispatch.com/news/history-says-be-alert-but-not-alarmed 2019-08-14T05:00:01+10:00 https://pharmadispatch.com/news/two-gene-therapy-events-per-week 2019-08-14T05:00:01+10:00 https://pharmadispatch.com/news/new-policy-focus-for-pharmacy-guild 2019-08-14T05:00:01+10:00 https://pharmadispatch.com/news/new-collaboration-for-alnylams-rnai-but-still-no-australia 2019-08-14T05:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-access-shortfalls 2019-08-13T05:00:01+10:00 https://pharmadispatch.com/news/how-do-you-make-evidence-based-decisions-when-there-is-no-eviden 2019-08-13T05:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-and-eli-lilly-announced-expanded-research-g 2019-08-13T05:00:01+10:00 https://pharmadispatch.com/news/nationwide-network-of-car-t-treatment-centres 2019-08-12T17:00:01+10:00 https://pharmadispatch.com/news/bayer-backs-two-young-cv-researchers 2019-08-12T05:00:01+10:00 https://pharmadispatch.com/news/allergan-partners-in-gene-therapy 2019-08-12T05:00:01+10:00 https://pharmadispatch.com/news/the-opportunity-of-new-funding-pathways 2019-08-12T05:00:01+10:00 https://pharmadispatch.com/news/research-based-companies-argue-discrimination-on-submission-date 2019-08-12T05:00:01+10:00 https://pharmadispatch.com/news/recommend-this-recommend-all 2019-08-12T05:00:01+10:00 https://pharmadispatch.com/news/new-report-confirms-record-number-of-biomarkers-for-cancer 2019-08-09T05:00:01+10:00 https://pharmadispatch.com/news/recognition-for-gilead-on-lgbti-inclusion 2019-08-09T05:00:01+10:00 https://pharmadispatch.com/news/cancer-survey-highlights-patient-perspective 2019-08-09T05:00:01+10:00 https://pharmadispatch.com/news/abbvie-and-novartis-make-top-ten-innovation-list 2019-08-09T05:00:01+10:00 https://pharmadispatch.com/news/latest-merger-could-reverberate-through-sector 2019-08-08T14:33:01+10:00 https://pharmadispatch.com/news/public-funding-claim-reveals-a-stunning-naivety 2019-08-08T05:00:01+10:00 https://pharmadispatch.com/news/accepting-the-facilitated-pathway-might-be-about-minimising-risk 2019-08-08T05:00:01+10:00 https://pharmadispatch.com/news/victoria-looks-to-grow-biomedical-precinct 2019-08-08T05:00:01+10:00 https://pharmadispatch.com/news/pharmac-bends-on-key-cancer-therapy 2019-08-08T05:00:01+10:00 https://pharmadispatch.com/news/new-global-headquarters-for-csl 2019-08-07T10:00:01+10:00 https://pharmadispatch.com/news/how-we-evaluate-might-be-the-easiest-question-to-answer 2019-08-07T05:00:01+10:00 https://pharmadispatch.com/news/what-happens-when-the-government-is-paying-for-less-failure 2019-08-07T05:00:01+10:00 https://pharmadispatch.com/news/what-is-the-spending-starting-point-for-7cpa 2019-08-07T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-on-the-lookout-for-nsw-manager 2019-08-07T05:00:01+10:00 https://pharmadispatch.com/news/opthea-in-trading-halt-ahead-of-trial-update 2019-08-07T05:00:01+10:00 https://pharmadispatch.com/news/are-some-of-the-unresolved-issues-unresolvable 2019-08-06T05:00:01+10:00 https://pharmadispatch.com/news/npsa-look-elsewhere-when-it-comes-to-pbs-spend 2019-08-06T05:00:01+10:00 https://pharmadispatch.com/news/sta-welcomes-approval-of-new-eye-therapy 2019-08-06T05:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-slow-down-in-uptake-of-hcv-therapies 2019-08-06T05:00:01+10:00 https://pharmadispatch.com/news/ma-members-to-consider-changes-to-board-appointments 2019-08-05T05:00:01+10:00 https://pharmadispatch.com/news/history-shows-virtually-everything-happens-for-a-reason 2019-08-05T05:00:01+10:00 https://pharmadispatch.com/news/canada-supply-chain-concern-over-importation-proposal 2019-08-05T05:00:01+10:00 https://pharmadispatch.com/news/uk-funds-larger-medicine-stockpile-ahead-of-no-deal-brexit 2019-08-05T05:00:01+10:00 https://pharmadispatch.com/news/be-prepared-to-re-argue-principles-like-timely-access 2019-08-02T05:00:01+10:00 https://pharmadispatch.com/news/pbac-rethink-on-hcv-data-collection 2019-08-02T05:00:01+10:00 https://pharmadispatch.com/news/telix-announces-new-collaboration-with-global-biopharma 2019-08-02T05:00:01+10:00 https://pharmadispatch.com/news/companies-welcome-new-listings-headlined-by-new-biosim 2019-08-02T05:00:01+10:00 https://pharmadispatch.com/news/supply-chain-reform-accounting-change-and-serialisation 2019-08-01T05:00:01+10:00 https://pharmadispatch.com/news/cv-mission-to-back-development-of-medicines-and-therapies 2019-08-01T05:00:01+10:00 https://pharmadispatch.com/news/vertex-commenced-discussions-on-symdeko 2019-08-01T05:00:01+10:00 https://pharmadispatch.com/news/nz-patients-consider-new-political-party-to-take-on-pharmac 2019-07-31T05:00:01+10:00 https://pharmadispatch.com/news/gilead-launches-2020-fellowship-research-grants 2019-07-31T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-government-will-be-maintaining-the-existing-criteria 2019-07-31T05:00:01+10:00 https://pharmadispatch.com/news/no-point-adding-consumers-without-wider-reform 2019-07-31T04:00:01+10:00 https://pharmadispatch.com/news/is-a-variation-the-real-price-of-facilitation 2019-07-31T04:00:01+10:00 https://pharmadispatch.com/news/australians-urged-to-register-for-organ-donation 2019-07-31T04:00:01+10:00 https://pharmadispatch.com/news/deal-adds-to-the-evidence-of-an-industry-in-transformation 2019-07-30T05:00:01+10:00 https://pharmadispatch.com/news/australian-company-updates-on-neuroscience-trial 2019-07-30T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-returns-to-pbs-in-parliament 2019-07-30T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-mylan-confirm-off-patent-merger 2019-07-30T05:00:01+10:00 https://pharmadispatch.com/news/another-major-merger-set-to-be-announced 2019-07-29T09:41:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-push-for-sector-mou 2019-07-29T05:00:01+10:00 https://pharmadispatch.com/news/psa-signs-mou-with-hospital-pharmacists 2019-07-29T05:00:01+10:00 https://pharmadispatch.com/news/a-smart-move-or-a-sign-of-changing-times 2019-07-29T05:00:01+10:00 https://pharmadispatch.com/news/new-zealand-opposition-commit-to-cancer-drug-fund 2019-07-29T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-adds-to-august-listings 2019-07-29T05:00:01+10:00 https://pharmadispatch.com/news/is-flexibility-a-sign-of-the-systems-strength-or-does-it-expose- 2019-07-26T05:00:01+10:00 https://pharmadispatch.com/news/a-shrinking-piece-of-the-pie-to-fund-new-medicines 2019-07-26T05:00:01+10:00 https://pharmadispatch.com/news/taking-responsibility-for-comments-posted-on-social-media-assets 2019-07-26T05:00:01+10:00 https://pharmadispatch.com/news/doh-need-to-ensure-effectiveness-of-current-pbs-spend 2019-07-26T05:00:01+10:00 https://pharmadispatch.com/news/currrent-pbs-spend-will-not-be-enough-to-deliver-access 2019-07-26T05:00:01+10:00 https://pharmadispatch.com/news/lillys-benjamin-basil-on-the-dream-opportunity 2019-07-25T05:00:01+10:00 https://pharmadispatch.com/news/share-of-the-pbs-spend-highlights-funding-challenge 2019-07-25T05:00:01+10:00 https://pharmadispatch.com/news/industry-backs-event-to-correct-online-gender-bias 2019-07-25T05:00:01+10:00 https://pharmadispatch.com/news/terrywhite-chemmart-ceo-leads-trek-to-kokoda-for-cancer-funds 2019-07-25T05:00:01+10:00 https://pharmadispatch.com/news/clinicians-welcome-new-multiple-myeloma-combination 2019-07-25T05:00:01+10:00 https://pharmadispatch.com/news/can-we-escape-our-decision-making-safe-haven 2019-07-24T05:00:01+10:00 https://pharmadispatch.com/news/roche-brings-together-patient-leaders-in-canberra 2019-07-24T05:00:01+10:00 https://pharmadispatch.com/news/bayer-hosts-event-to-mark-international-self-care-day 2019-07-24T05:00:01+10:00 https://pharmadispatch.com/news/who-else-will-respond-to-technology-driven-change 2019-07-24T05:00:01+10:00 https://pharmadispatch.com/news/msd-welcomes-another-keytruda-indication 2019-07-23T05:00:01+10:00 https://pharmadispatch.com/news/stakeholders-gather-in-canberra-to-kick-off-7cpa-negotiation 2019-07-23T05:00:01+10:00 https://pharmadispatch.com/news/bms-australia-serving-soup-for-the-soul 2019-07-23T05:00:01+10:00 https://pharmadispatch.com/news/strategic-blueprint-the-future-focus-for-ma-strategy-day 2019-07-23T05:00:01+10:00 https://pharmadispatch.com/news/arrotex-announces-new-executive-team 2019-07-23T05:00:01+10:00 https://pharmadispatch.com/news/japanese-pharma-moves-to-acquire-local-stem-cell-company 2019-07-22T05:00:01+10:00 https://pharmadispatch.com/news/achieving-greater-transparency-with-no-transparency 2019-07-22T05:00:01+10:00 https://pharmadispatch.com/news/the-parental-leave-experience-at-page-workshop 2019-07-22T05:00:01+10:00 https://pharmadispatch.com/news/not-enough-to-secure-streamlined-authority 2019-07-22T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-confirms-wider-access-to-kalydeco 2019-07-22T05:00:01+10:00 https://pharmadispatch.com/news/disappointment-for-australian-innovation 2019-07-19T05:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-acquires-new-oncology-platform 2019-07-19T05:00:01+10:00 https://pharmadispatch.com/news/gene-and-cell-therapy-helps-boost-novartis-second-quarter 2019-07-19T05:00:01+10:00 https://pharmadispatch.com/news/phrma-the-risk-of-international-reference-pricing 2019-07-18T05:00:01+10:00 https://pharmadispatch.com/news/jj-innovation-recognises-undergraduates 2019-07-18T05:00:01+10:00 https://pharmadispatch.com/news/stakeholder-meeting-a-little-different-to-last-time 2019-07-18T05:00:01+10:00 https://pharmadispatch.com/news/takeda-from-car-t-to-off-the-shelf-icart 2019-07-18T05:00:01+10:00 https://pharmadispatch.com/news/gbma-confirms-its-first-biosimilar-member 2019-07-18T05:00:01+10:00 https://pharmadispatch.com/news/bayer-venture-capital-arm-invests-in-off-the-shelf-car-t 2019-07-17T05:00:01+10:00 https://pharmadispatch.com/news/servier-in-new-collaboration-with-melbournes-biocurate 2019-07-17T05:00:01+10:00 https://pharmadispatch.com/news/how-do-we-even-know-what-patients-are-missing-out-on 2019-07-17T05:00:01+10:00 https://pharmadispatch.com/news/ma-simply-cannot-say-no-to-supply-chain-reform 2019-07-17T05:00:01+10:00 https://pharmadispatch.com/news/gilead-ups-stake-in-biotech-and-expands-cell-manufacturing 2019-07-17T05:00:01+10:00 https://pharmadispatch.com/news/imugene-acquires-rights-to-new-oncolytic-virus-technology 2019-07-16T05:00:01+10:00 https://pharmadispatch.com/news/focus-on-the-reality-rather-than-the-language 2019-07-16T05:00:01+10:00 https://pharmadispatch.com/news/patients-hope-new-inquiry-will-target-pharmac 2019-07-16T05:00:01+10:00 https://pharmadispatch.com/news/ma-considering-whether-to-drop-accc-authorisation 2019-07-16T05:00:01+10:00 https://pharmadispatch.com/news/is-this-farewell-to-preserving-prescriber-choice 2019-07-15T05:00:01+10:00 https://pharmadispatch.com/news/supply-chain-payment-reform-triggered-debate-over-an-even-more-c 2019-07-15T05:00:01+10:00 https://pharmadispatch.com/news/the-uniqure-experience-highlights-the-commercial-challenge 2019-07-15T05:00:01+10:00 https://pharmadispatch.com/news/does-hcv-decline-have-implications-for-supply-chain-reform 2019-07-15T05:00:01+10:00 https://pharmadispatch.com/news/uk-first-identified-hta-issues-for-gene-and-cell-therapy-in-2012 2019-07-12T05:00:01+10:00 https://pharmadispatch.com/news/exclusive-reform-will-not-be-implemented-without-sector-agreemen 2019-07-12T05:00:01+10:00 https://pharmadispatch.com/news/no-agreement-and-issue-substantially-addressed-why-bother 2019-07-12T05:00:01+10:00 https://pharmadispatch.com/news/australian-company-prescient-initiates-trial-of-tumour-agnostic- 2019-07-12T05:00:01+10:00 https://pharmadispatch.com/news/reform-faces-a-tough-parliamentary-reality 2019-07-11T05:00:01+10:00 https://pharmadispatch.com/news/different-types-of-gene-therapy-an-easier-funding-pathway-for-so 2019-07-11T05:00:01+10:00 https://pharmadispatch.com/news/impressive-stock-market-debut-for-new-perth-based-biopharma 2019-07-11T05:00:01+10:00 https://pharmadispatch.com/news/dennis-bastas-on-arrotex-the-largest-company-by-volume-in-pbs-hi 2019-07-11T05:00:01+10:00 https://pharmadispatch.com/news/new-chair-for-nps-medicinewise 2019-07-11T05:00:01+10:00 https://pharmadispatch.com/news/what-is-the-role-of-a-prescribing-authority 2019-07-10T05:00:01+10:00 https://pharmadispatch.com/news/next-generation-car-t-could-resolve-key-issue 2019-07-10T05:00:01+10:00 https://pharmadispatch.com/news/stalled-reform-will-happen-one-way-or-another 2019-07-10T05:00:01+10:00 https://pharmadispatch.com/news/a-busy-year-means-review-may-need-to-wait 2019-07-10T05:00:01+10:00 https://pharmadispatch.com/news/reform-on-government-legislation-list-but-not-ready-to-go 2019-07-09T05:00:01+10:00 https://pharmadispatch.com/news/nz-radio-host-prepare-to-die-if-diagnosed-with-cancer 2019-07-09T05:00:01+10:00 https://pharmadispatch.com/news/new-paper-recommends-new-approach-to-vaccines 2019-07-09T05:00:01+10:00 https://pharmadispatch.com/news/gsk-will-try-again-but-not-optimistic-without-change 2019-07-09T05:00:01+10:00 https://pharmadispatch.com/news/dr-john-bashford-strong-research-is-the-basis-for-market-access 2019-07-08T05:00:01+10:00 https://pharmadispatch.com/news/documents-reveal-detail-and-extent-of-keytruda-dispute 2019-07-08T05:00:01+10:00 https://pharmadispatch.com/news/not-really-conflating-two-different-processes 2019-07-08T05:00:01+10:00 https://pharmadispatch.com/news/it-should-go-both-ways-on-clinical-trial-data 2019-07-08T05:00:01+10:00 https://pharmadispatch.com/news/dr-john-bashford-redefining-the-future-for-rare-cancers 2019-07-05T05:00:01+10:00 https://pharmadispatch.com/news/more-scrutiny-of-hospital-pharmacy-is-inevitable 2019-07-05T05:00:01+10:00 https://pharmadispatch.com/news/without-prejudice-meeting-kicks-off-7cpa-consultations 2019-07-05T05:00:01+10:00 https://pharmadispatch.com/news/us-payers-impose-restrictions-on-gene-therapy 2019-07-04T17:45:01+10:00 https://pharmadispatch.com/news/anao-watching-pbs-on-rebate-complexity 2019-07-04T05:00:01+10:00 https://pharmadispatch.com/news/the-stark-example-of-pbs-transformation 2019-07-04T05:00:01+10:00 https://pharmadispatch.com/news/former-sirtex-ceo-pleads-guilty-to-insider-trading 2019-07-04T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-attributes-hiv-decline-to-funding-for-prep 2019-07-04T05:00:01+10:00 https://pharmadispatch.com/news/hospital-pharmacists-unhappy-over-confirmation-of-mark-up-cut 2019-07-04T05:00:01+10:00 https://pharmadispatch.com/news/report-highlights-strengths-and-weaknesses-on-gender-equity 2019-07-04T05:00:01+10:00 https://pharmadispatch.com/news/why-have-the-pbs-and-medicare-taken-diametrically-opposed-paths 2019-07-03T05:00:01+10:00 https://pharmadispatch.com/news/australian-developed-ai-flu-vax-starts-trials-in-the-us 2019-07-03T05:00:01+10:00 https://pharmadispatch.com/news/a-global-walk-for-roche-australia 2019-07-03T05:00:01+10:00 https://pharmadispatch.com/news/theological-dogma-that-is-obsolete-and-not-humane 2019-07-03T05:00:01+10:00 https://pharmadispatch.com/news/biointelect-announces-new-collaboration 2019-07-02T05:00:01+10:00 https://pharmadispatch.com/news/market-preparing-for-arrival-of-arrotex 2019-07-02T05:00:01+10:00 https://pharmadispatch.com/news/the-pbs-and-health-a-tale-of-two-decades 2019-07-02T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-updates-on-dmd-race-with-sarepta-therapeutics 2019-07-02T05:00:01+10:00 https://pharmadispatch.com/news/its-tough-pricing-life-for-patented-medicines 2019-07-01T05:00:01+10:00 https://pharmadispatch.com/news/former-fda-head-joins-pfizer-board 2019-07-01T05:00:01+10:00 https://pharmadispatch.com/news/pbac-public-interest-in-knowing-our-view-on-each-medicine-being- 2019-07-01T05:00:01+10:00 https://pharmadispatch.com/news/up-and-coming-gene-therapies 2019-07-01T05:00:01+10:00 https://pharmadispatch.com/news/a-bit-more-time-for-abbvies-kirsten-odoherty 2019-06-29T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-hosts-local-activation-of-impact2030 2019-06-28T15:55:01+10:00 https://pharmadispatch.com/news/if-you-want-more-groceries-you-need-to-spend-more-money 2019-06-28T05:00:01+10:00 https://pharmadispatch.com/news/bms-adds-to-diversity-and-inclusion-programs 2019-06-28T05:00:01+10:00 https://pharmadispatch.com/news/imc-recognised-for-collaboration-with-csl 2019-06-28T05:00:01+10:00 https://pharmadispatch.com/news/australian-company-progresses-immunotherapy 2019-06-28T05:00:01+10:00 https://pharmadispatch.com/news/patients-could-be-closer-to-securing-combination-therapy 2019-06-28T05:00:01+10:00 https://pharmadispatch.com/news/the-cost-of-immunglobulin-is-on-the-rise 2019-06-27T05:00:01+10:00 https://pharmadispatch.com/news/nz-myeloma-patients-rely-on-hope-and-everything-other-than-pharm 2019-06-27T05:00:01+10:00 https://pharmadispatch.com/news/does-pharmac-serve-patients-or-itself 2019-06-27T05:00:01+10:00 https://pharmadispatch.com/news/nices-dillon-change-required-to-manage-the-coming-revolution-in- 2019-06-27T05:00:01+10:00 https://pharmadispatch.com/news/more-required-to-attract-emerging-therapies 2019-06-26T05:00:01+10:00 https://pharmadispatch.com/news/recognition-for-sanofis-employee-well-being-program 2019-06-26T05:00:01+10:00 https://pharmadispatch.com/news/nz-poor-access-and-poor-outcomes 2019-06-26T05:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-myeloma-gap-for-nz-patients 2019-06-26T05:00:01+10:00 https://pharmadispatch.com/news/abbvie-announces-us63bn-acquisition-of-allergan 2019-06-26T05:00:01+10:00 https://pharmadispatch.com/news/a-possible-comeback-for-mwg 2019-06-25T05:00:01+10:00 https://pharmadispatch.com/news/race-to-commercialise-in-winner-take-all-market 2019-06-25T05:00:01+10:00 https://pharmadispatch.com/news/nz-industry-gathers-for-pivotal-week 2019-06-25T05:00:01+10:00 https://pharmadispatch.com/news/who-remembers-the-first-red-tape-review 2019-06-25T05:00:01+10:00 https://pharmadispatch.com/news/tumour-agnostic-therapies-both-in-approval-process 2019-06-24T17:43:01+10:00 https://pharmadispatch.com/news/biosimilars-start-to-deliver-on-price-disclosure 2019-06-24T05:00:01+10:00 https://pharmadispatch.com/news/no-presence-means-no-internal-advocates 2019-06-24T05:00:01+10:00 https://pharmadispatch.com/news/flexibility-for-all-what-is-workplace-flexibility-really-and-why 2019-06-24T05:00:01+10:00 https://pharmadispatch.com/news/industry-prominent-in-annual-hr-awards 2019-06-24T05:00:01+10:00 https://pharmadispatch.com/news/government-faces-a-very-difficult-choice-on-pbs-future 2019-06-23T13:46:01+10:00 https://pharmadispatch.com/news/guild-announces-new-leadership 2019-06-21T11:58:01+10:00 https://pharmadispatch.com/news/the-challenge-of-attracting-gene-and-cell-therapy-makers 2019-06-21T05:00:01+10:00 https://pharmadispatch.com/news/sill-no-sign-of-payment-reform-progress 2019-06-21T05:00:01+10:00 https://pharmadispatch.com/news/the-government-already-disinvests-in-old-pbs-technologies 2019-06-21T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-will-work-to-ensure-patient-access-to-gene-and-cell-th 2019-06-21T05:00:01+10:00 https://pharmadispatch.com/news/celgene-divests-immunotherapy-ahead-of-merger 2019-06-20T05:00:01+10:00 https://pharmadispatch.com/news/profound-change-required-to-integrate-precision-medicines 2019-06-20T05:00:01+10:00 https://pharmadispatch.com/news/another-country-approves-first-rnai-gene-therapy-still-no-austra 2019-06-20T05:00:01+10:00 https://pharmadispatch.com/news/divesting-in-older-technologies-will-be-required 2019-06-19T18:38:01+10:00 https://pharmadispatch.com/news/australian-advocate-to-chair-of-htai-patient-interest-group 2019-06-19T05:00:01+10:00 https://pharmadispatch.com/news/gsk-getting-back-into-gene-therapy 2019-06-19T05:00:01+10:00 https://pharmadispatch.com/news/formal-consideration-of-rationing-just-a-matter-of-time 2019-06-19T05:00:01+10:00 https://pharmadispatch.com/news/australia-at-risk-of-missing-hcv-elimination-target 2019-06-19T05:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-gilead-australia-and-nz 2019-06-18T05:00:01+10:00 https://pharmadispatch.com/news/emerging-companies-dominate-new-therapies 2019-06-18T05:00:01+10:00 https://pharmadispatch.com/news/patients-welcome-new-pain-national-strategy 2019-06-18T05:00:01+10:00 https://pharmadispatch.com/news/australian-patient-voice-initiative-highlighted-at-international 2019-06-18T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-to-acquire-array-biopharma 2019-06-18T05:00:01+10:00 https://pharmadispatch.com/news/bluebird-bio-confirms-price-of-its-first-gene-therapy 2019-06-17T05:00:01+10:00 https://pharmadispatch.com/news/where-will-the-government-find-the-billions-for-new-listings 2019-06-17T05:00:01+10:00 https://pharmadispatch.com/news/will-it-require-another-factor-f-program 2019-06-17T05:00:01+10:00 https://pharmadispatch.com/news/pbac-pbac-may-intracycle-outcomes-outcomes 2019-06-17T05:00:01+10:00 https://pharmadispatch.com/news/the-cost-of-doing-nothing 2019-06-17T05:00:01+10:00 https://pharmadispatch.com/news/lack-of-investment-drivingback-room-deals 2019-06-14T05:00:01+10:00 https://pharmadispatch.com/news/new-technologies-exposing-flaws-in-hta 2019-06-14T05:00:01+10:00 https://pharmadispatch.com/news/response-on-the-use-of-opportunity-cost 2019-06-14T05:00:01+10:00 https://pharmadispatch.com/news/early-informed-and-high-quality-engagement-essential 2019-06-14T05:00:01+10:00 https://pharmadispatch.com/news/where-was-the-frank-and-complete-discussion 2019-06-13T05:00:01+10:00 https://pharmadispatch.com/news/gene-technology-an-increasing-focus 2019-06-13T05:00:01+10:00 https://pharmadispatch.com/news/evidence-weaponised-through-opportunity-cost 2019-06-13T05:00:01+10:00 https://pharmadispatch.com/news/australia-moved-to-soften-price-transparency-demand 2019-06-12T05:00:01+10:00 https://pharmadispatch.com/news/transparency-debate-puts-australia-in-a-global-context 2019-06-12T05:00:01+10:00 https://pharmadispatch.com/news/when-was-opportunity-cost-adopted-in-pbs-decision-making 2019-06-12T05:00:01+10:00 https://pharmadispatch.com/news/merck-staff-preview-new-sydney-office 2019-06-12T05:00:01+10:00 https://pharmadispatch.com/news/msds-michael-azrak-review-must-be-ambitious-and-transformative 2019-06-11T05:00:01+10:00 https://pharmadispatch.com/news/recognition-in-queens-birthday-honours 2019-06-11T05:00:01+10:00 https://pharmadispatch.com/news/originator-biologic-wins-nz-tender 2019-06-11T05:00:01+10:00 https://pharmadispatch.com/news/there-are-gene-therapies-and-gene-therapies 2019-06-11T05:00:01+10:00 https://pharmadispatch.com/news/what-happens-when-there-are-no-competitors 2019-06-07T05:00:01+10:00 https://pharmadispatch.com/news/australian-company-progresses-immunotherapy-combination 2019-06-07T05:00:01+10:00 https://pharmadispatch.com/news/four-year-term-for-pbacs-industry-nominee 2019-06-07T05:00:01+10:00 https://pharmadispatch.com/news/the-mystery-of-the-1-discount-review 2019-06-06T10:27:01+10:00 https://pharmadispatch.com/news/bms-announces-post-acquisition-leadership 2019-06-06T05:34:01+10:00 https://pharmadispatch.com/news/should-industry-truly-challenge-the-status-quo 2019-06-06T05:00:01+10:00 https://pharmadispatch.com/news/pharmac-we-get-advice-through-other-ways 2019-06-06T05:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-scale-of-us-industry 2019-06-06T05:00:01+10:00 https://pharmadispatch.com/news/bluebird-bio-secures-eu-approval-but-still-no-australia 2019-06-06T05:00:01+10:00 https://pharmadispatch.com/news/should-consumers-input-to-decisions-or-be-able-to-change-them 2019-06-05T05:00:01+10:00 https://pharmadispatch.com/news/new-car-t-data-once-again-highlights-the-evaluation-challenge 2019-06-05T05:00:01+10:00 https://pharmadispatch.com/news/msd-launches-reconciliation-action-plan 2019-06-05T05:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-welcomes-shadow-ministry 2019-06-05T05:00:01+10:00 https://pharmadispatch.com/news/centre-stage-for-immunotherapies-at-asco 2019-06-04T05:00:01+10:00 https://pharmadispatch.com/news/uqs-uniquest-in-cancer-partnership-with-pfizer 2019-06-04T05:00:01+10:00 https://pharmadispatch.com/news/jo-watson-consider-update-of-2009-hta-review 2019-06-04T05:00:01+10:00 https://pharmadispatch.com/news/csl-seeking-applicants-for-125m-fellowships 2019-06-04T05:00:01+10:00 https://pharmadispatch.com/news/az-inks-new-deal-with-starpharma 2019-06-04T05:00:01+10:00 https://pharmadispatch.com/news/agreement-clears-the-way-for-second-biosimilar-rituximab 2019-06-03T15:34:01+10:00 https://pharmadispatch.com/news/merger-of-two-leading-consultancies 2019-06-03T05:00:01+10:00 https://pharmadispatch.com/news/chris-bowen-appointed-shadow-health-minister 2019-06-03T05:00:01+10:00 https://pharmadispatch.com/news/another-meeting-and-still-no-agreement 2019-06-03T05:00:01+10:00 https://pharmadispatch.com/news/new-report-recommends-more-patient-involvement-in-pbs-decisions 2019-06-03T05:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-welcomes-new-diabetes-listing 2019-06-03T05:00:01+10:00 https://pharmadispatch.com/news/high-upfront-cost-but-decades-of-savings 2019-05-31T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-survey-reveals-worst-result-this-decade 2019-05-31T05:00:01+10:00 https://pharmadispatch.com/news/no-respite-for-medicines-in-nz-budget 2019-05-31T05:00:01+10:00 https://pharmadispatch.com/news/investors-cheer-patrys-in-response-to-trial-update 2019-05-31T05:00:01+10:00 https://pharmadispatch.com/news/one-of-the-industrys-longest-serving-leaders-is-retiring 2019-05-30T18:51:01+10:00 https://pharmadispatch.com/news/this-is-where-the-cost-offset-policy-ends 2019-05-30T05:00:01+10:00 https://pharmadispatch.com/news/biomarin-updates-on-haemophilia-gene-therapy 2019-05-30T05:00:01+10:00 https://pharmadispatch.com/news/merck-to-markworld-multiple-sclerosis-day 2019-05-30T05:00:01+10:00 https://pharmadispatch.com/news/bionomics-updates-on-strategic-review 2019-05-30T05:00:01+10:00 https://pharmadispatch.com/news/shorten-wants-health-portfolio 2019-05-29T05:00:01+10:00 https://pharmadispatch.com/news/do-you-value-a-lifetime-benefit-based-on-almost-no-evidence 2019-05-29T04:00:01+10:00 https://pharmadispatch.com/news/someone-finally-explains-how-reform-will-work-or-wont 2019-05-29T04:00:01+10:00 https://pharmadispatch.com/news/pharmac-boss-shrugs-off-criticism 2019-05-29T04:00:01+10:00 https://pharmadispatch.com/news/more-flexibility-on-evaluation-pathways 2019-05-28T05:00:01+10:00 https://pharmadispatch.com/news/another-four-years-for-pbac-deputy-chair 2019-05-28T05:00:01+10:00 https://pharmadispatch.com/news/lung-foundation-issues-urgent-plea-on-vaccine 2019-05-28T05:00:01+10:00 https://pharmadispatch.com/news/ma-have-we-been-responsible-at-the-expense-of-our-viability 2019-05-28T05:00:01+10:00 https://pharmadispatch.com/news/kim-carr-will-not-nominate-for-shadow-ministry 2019-05-27T05:00:01+10:00 https://pharmadispatch.com/news/the-list-and-spend-conflict-makes-new-price-cuts-inevitable 2019-05-27T05:00:01+10:00 https://pharmadispatch.com/news/fda-approves-new-gene-therapy-as-novartis-plans-global-launch 2019-05-27T05:00:01+10:00 https://pharmadispatch.com/news/australia-might-be-lucky-on-zolgensma 2019-05-27T05:00:01+10:00 https://pharmadispatch.com/news/seqirus-signs-agreement-with-gedeon-richter 2019-05-27T05:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-new-ministry-and-hunt-reappointment-1 2019-05-27T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-remains-in-health-as-pm-unveils-new-ministry 2019-05-26T09:03:01+10:00 https://pharmadispatch.com/news/msac-not-the-sole-solution-on-gene-and-cell-therapies 2019-05-24T05:00:01+10:00 https://pharmadispatch.com/news/we-will-not-agree-on-how-to-create-the-demise-of-their-business 2019-05-24T05:00:01+10:00 https://pharmadispatch.com/news/who-will-explain-what-more-money-in-the-pbs-actually-means 2019-05-24T05:00:01+10:00 https://pharmadispatch.com/news/cost-recovery-resourcing-and-cost-offsets 2019-05-23T04:00:01+10:00 https://pharmadispatch.com/news/hcv-listing-no-netflix-deal 2019-05-23T04:00:01+10:00 https://pharmadispatch.com/news/supply-chain-payment-reform-mad 2019-05-23T04:00:01+10:00 https://pharmadispatch.com/news/guild-says-doctors-misguided-and-ill-informed-on-flu-vax 2019-05-22T05:45:01+10:00 https://pharmadispatch.com/news/pbac-chair-review-should-consider-all-new-technologies 2019-05-22T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-calls-for-action-on-rd-tax-changes 2019-05-22T05:00:01+10:00 https://pharmadispatch.com/news/trade-and-the-pbs-a-first-time-challenge 2019-05-22T05:00:01+10:00 https://pharmadispatch.com/news/there-are-reviews-and-there-are-reviews 2019-05-21T05:00:01+10:00 https://pharmadispatch.com/news/new-unit-to-support-consumer-input 2019-05-21T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-marks-international-clinical-trials-day 2019-05-21T05:00:01+10:00 https://pharmadispatch.com/news/mercks-leah-goodman-says-the-long-term-is-now 2019-05-20T05:00:01+10:00 https://pharmadispatch.com/news/celltrion-announces-global-expansion-plan 2019-05-20T05:00:01+10:00 https://pharmadispatch.com/news/who-predicted-this 2019-05-20T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-election-outcome-an-early-focus 2019-05-20T05:00:01+10:00 https://pharmadispatch.com/news/is-it-really-a-national-medicines-policy 2019-05-17T05:00:01+10:00 https://pharmadispatch.com/news/labor-commits-funding-to-boost-hcv-uptake 2019-05-17T05:00:01+10:00 https://pharmadispatch.com/news/csl-appoints-new-operations-leader 2019-05-17T05:00:01+10:00 https://pharmadispatch.com/news/bi-says-no-biosimilars-for-australia 2019-05-17T05:00:01+10:00 https://pharmadispatch.com/news/sta-adopts-unique-pack-tracking-for-medicines 2019-05-17T05:00:01+10:00 https://pharmadispatch.com/news/humira-secures-another-piece-in-humira-patent-puzzle 2019-05-16T05:00:01+10:00 https://pharmadispatch.com/news/address-pressure-points-to-address-technology-gaps 2019-05-16T05:00:01+10:00 https://pharmadispatch.com/news/car-t-funding-raise-serious-questions-over-equity 2019-05-16T05:00:01+10:00 https://pharmadispatch.com/news/nz-isolated-on-biogens-spinraza 2019-05-16T05:00:01+10:00 https://pharmadispatch.com/news/mayne-hit-by-generics-competition 2019-05-15T04:00:01+10:00 https://pharmadispatch.com/news/new-research-reveals-pbac-attitudes-to-sponsor-hearings 2019-05-15T04:00:01+10:00 https://pharmadispatch.com/news/anao-tga-partially-effective-on-cost-recovery 2019-05-15T04:00:01+10:00 https://pharmadispatch.com/news/race-oncology-launches-trial-in-israel 2019-05-15T04:00:01+10:00 https://pharmadispatch.com/news/fda-sticks-with-suffix-and-sets-high-bar-for-interchangeability 2019-05-14T05:00:01+10:00 https://pharmadispatch.com/news/nz-focus-moves-to-epipen-14-years-after-approval 2019-05-14T05:00:01+10:00 https://pharmadispatch.com/news/timely-access-not-so-simple-for-gene-an-cell-therapy 2019-05-14T05:00:01+10:00 https://pharmadispatch.com/news/msac-the-process-for-everything-not-captured-by-pbac 2019-05-13T05:00:01+10:00 https://pharmadispatch.com/news/reflections-on-the-art-of-political-campaigning-and-advocacy 2019-05-13T05:00:01+10:00 https://pharmadispatch.com/news/bluebird-bio-australia-not-in-current-plan 2019-05-13T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-one-week-to-go 2019-05-13T05:00:01+10:00 https://pharmadispatch.com/news/npsa-welcomes-election-commitments 2019-05-13T05:00:01+10:00 https://pharmadispatch.com/news/time-to-be-ambitious-and-drive-the-change-rather-than-be-the-vic 2019-05-12T09:52:01+10:00 https://pharmadispatch.com/news/pharmac-chair-model-under-stress 2019-05-10T05:00:01+10:00 https://pharmadispatch.com/news/labor-to-explore-other-options-on-supply-chain-payment-reform 2019-05-10T05:00:01+10:00 https://pharmadispatch.com/news/bipartisan-commitment-to-review-of-the-national-medicines-policy 2019-05-10T05:00:01+10:00 https://pharmadispatch.com/news/labor-may-seek-to-negotiate-a-strategic-agreement-with-medicines 2019-05-10T05:00:01+10:00 https://pharmadispatch.com/news/groups-unite-in-call-for-political-backing-on-rd 2019-05-10T05:00:01+10:00 https://pharmadispatch.com/news/page-workshop-focuses-on-the-pay-equity-gap 2019-05-10T05:00:01+10:00 https://pharmadispatch.com/news/ma-ceo-time-for-change-is-now 2019-05-09T05:00:01+10:00 https://pharmadispatch.com/news/labor-proposes-rd-tax-collaboration-premium 2019-05-09T05:00:01+10:00 https://pharmadispatch.com/news/bms-hosts-oncology-collaboration-event 2019-05-09T05:00:01+10:00 https://pharmadispatch.com/news/pm-its-not-about-numbers-on-a-chart-or-on-a-ledger-its-about-the 2019-05-09T05:00:01+10:00 https://pharmadispatch.com/news/another-demonstration-against-pharmac 2019-05-08T05:00:01+10:00 https://pharmadispatch.com/news/will-australian-decision-makers-accept-the-risk-and-spend-the-mo 2019-05-08T05:00:01+10:00 https://pharmadispatch.com/news/we-have-a-third-world-system-when-it-comes-to-medicines 2019-05-08T05:00:01+10:00 https://pharmadispatch.com/news/xanadu-trial-disappoints-for-actinogen-medical 2019-05-08T05:00:01+10:00 https://pharmadispatch.com/news/could-restoration-be-the-most-likely-change-under-labor 2019-05-07T05:00:01+10:00 https://pharmadispatch.com/news/bi-backing-new-stroke-research-grant 2019-05-07T05:00:01+10:00 https://pharmadispatch.com/news/new-partnership-targeting-the-most-untreatable-cancers 2019-05-07T05:00:01+10:00 https://pharmadispatch.com/news/reappointed-pbac-chair-to-discuss-the-second-term 2019-05-07T05:00:01+10:00 https://pharmadispatch.com/news/lundbeck-acquires-us-basedabide-therapeutics 2019-05-07T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-local-we-are-series 2019-05-07T05:00:01+10:00 https://pharmadispatch.com/news/new-australian-leadership-for-novo-nordisk 2019-05-06T09:01:01+10:00 https://pharmadispatch.com/news/the-coalitions-record-on-the-pbs-reveals-a-very-complex-picture 2019-05-06T04:00:01+10:00 https://pharmadispatch.com/news/can-numbers-work-both-ways 2019-05-06T04:00:01+10:00 https://pharmadispatch.com/news/the-language-has-changed-but-anything-else 2019-05-04T04:00:01+10:00 https://pharmadispatch.com/news/just-more-of-the-same-on-the-pbs 2019-05-03T05:00:01+10:00 https://pharmadispatch.com/news/promising-results-for-new-car-t-therapy 2019-05-03T05:00:01+10:00 https://pharmadispatch.com/news/gbma-education-closes-the-week-confirming-new-event 2019-05-03T05:00:01+10:00 https://pharmadispatch.com/news/coalition-commits-to-cut-pbs-safety-net 2019-05-02T06:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-overhaul-of-decision-making 2019-05-02T05:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-super-sizes-kosi-challenge 2019-05-02T05:00:01+10:00 https://pharmadispatch.com/news/novartis-secures-gilenya-extension-ahead-of-pbac-consideration 2019-05-02T05:00:01+10:00 https://pharmadispatch.com/news/lung-cancer-review-tops-july-pbac-agenda 2019-05-02T05:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-changing-face-of-drug-development 2019-05-01T05:00:01+10:00 https://pharmadispatch.com/news/roche-says-change-required-for-new-technologies 2019-05-01T05:00:01+10:00 https://pharmadispatch.com/news/companies-ink-deal-in-england-to-find-hcv-patients 2019-05-01T05:00:01+10:00 https://pharmadispatch.com/news/new-australian-life-sciences-investment-fund 2019-05-01T05:00:01+10:00 https://pharmadispatch.com/news/the-days-of-australian-purchasing-power-are-coming-to-an-end 2019-05-01T05:00:01+10:00 https://pharmadispatch.com/news/ma-urges-caution-on-pbac-submission-guidelines 2019-04-30T04:01:01+10:00 https://pharmadispatch.com/news/funding-for-trials-or-proven-treatments 2019-04-30T04:00:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-welcomes-hcv-commitments 2019-04-30T04:00:01+10:00 https://pharmadispatch.com/news/lsdp-funds-the-first-generic-therapy 2019-04-29T15:14:01+10:00 https://pharmadispatch.com/news/pbac-says-yes-to-roche-lung-cancer-combination 2019-04-29T05:00:01+10:00 https://pharmadispatch.com/news/another-call-for-fast-action-to-help-opiate-users 2019-04-29T05:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-significant-changes-for-hcv 2019-04-29T05:00:01+10:00 https://pharmadispatch.com/news/pbac-and-msd-at-odds-over-keytruda 2019-04-29T05:00:01+10:00 https://pharmadispatch.com/news/pbac-says-ok-to-delist-some-hiv-medicines 2019-04-28T15:53:01+10:00 https://pharmadispatch.com/news/gbma-launches-2019-biosimilar-week 2019-04-28T15:03:01+10:00 https://pharmadispatch.com/news/forum-to-consider-a-new-approach-to-cancer-medicines 2019-04-26T05:00:01+10:00 https://pharmadispatch.com/news/expansion-in-the-us-but-still-no-news-on-australia 2019-04-26T05:00:01+10:00 https://pharmadispatch.com/news/election-means-wait-for-nps-review-outcome 2019-04-26T05:00:01+10:00 https://pharmadispatch.com/news/meaningless-assessment-evidence-of-the-need-for-change 2019-04-24T05:00:01+10:00 https://pharmadispatch.com/news/discussions-on-process-improvements-grind-to-a-halt 2019-04-24T05:00:01+10:00 https://pharmadispatch.com/news/overseas-access-funded-as-patients-await-local-approval 2019-04-24T05:00:01+10:00 https://pharmadispatch.com/news/new-details-confirm-pre-election-rush-to-approve-car-t 2019-04-23T05:00:01+10:00 https://pharmadispatch.com/news/msac-strategic-decisions-needed-with-emerging-gene-therapies 2019-04-23T05:00:01+10:00 https://pharmadispatch.com/news/is-that-really-funding-early-access-to-treatment 2019-04-23T05:00:01+10:00 https://pharmadispatch.com/news/researchers-propose-biosimilar-price-regulation-over-uptake 2019-04-23T05:00:01+10:00 https://pharmadispatch.com/news/pefo-confirms-ma-secured-atagi-fee-delay 2019-04-18T05:00:01+10:00 https://pharmadispatch.com/news/right-to-trial-in-blood-cancers-a-limited-version-of-trumps-righ 2019-04-18T05:00:01+10:00 https://pharmadispatch.com/news/ma-starts-communication-on-principles-code 2019-04-18T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-goes-red-for-world-haemophilia-day 2019-04-18T05:00:01+10:00 https://pharmadispatch.com/news/labor-commits-to-early-access-trials 2019-04-17T09:06:01+10:00 https://pharmadispatch.com/news/ausbiotech-laments-the-wearisome-uncertainty-over-fate-of-rd-tax 2019-04-17T05:00:01+10:00 https://pharmadispatch.com/news/jacinda-ardern-work-to-be-done-on-pharmac 2019-04-17T05:00:01+10:00 https://pharmadispatch.com/news/new-study-reveals-positive-news-for-bis-pradaxa 2019-04-17T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-and-jj-partner-to-support-lgbtqi-colleagues 2019-04-17T05:00:01+10:00 https://pharmadispatch.com/news/data-on-out-of-pocket-costs-paints-a-very-mixed-picture 2019-04-16T13:38:01+10:00 https://pharmadispatch.com/news/more-intervention-may-be-needed-on-gene-therapies 2019-04-16T05:00:01+10:00 https://pharmadispatch.com/news/making-the-case-for-us-australia-plus 2019-04-16T05:00:01+10:00 https://pharmadispatch.com/news/seqirus-proud-to-supply-flu-vaccine-to-nip 2019-04-16T05:00:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-need-for-action-as-the-task-just-got-more-di 2019-04-16T05:00:01+10:00 https://pharmadispatch.com/news/funding-and-local-manufacturing-for-novartis-car-t-therapy 2019-04-15T09:35:01+10:00 https://pharmadispatch.com/news/bms-shareholders-back-celgene-acquisition 2019-04-15T05:00:01+10:00 https://pharmadispatch.com/news/another-blow-as-msd-pulls-hcv-promotion 2019-04-15T05:00:01+10:00 https://pharmadispatch.com/news/trade-agreements-could-save-the-pbs 2019-04-15T05:00:01+10:00 https://pharmadispatch.com/news/process-to-allow-choice-of-drug-at-the-discretion-of-the-clinici 2019-04-15T05:00:01+10:00 https://pharmadispatch.com/news/australias-rd-program-works-but-we-cant-rest-on-our-laurels 2019-04-12T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-and-the-federal-election 2019-04-12T05:00:01+10:00 https://pharmadispatch.com/news/it-might-be-caretakers-but-the-announcements-may-not-be-over 2019-04-12T05:00:01+10:00 https://pharmadispatch.com/news/the-new-prana-starts-investor-roadshow 2019-04-12T05:00:01+10:00 https://pharmadispatch.com/news/anao-with-a-special-interest-in-spa-criteria 2019-04-11T05:00:01+10:00 https://pharmadispatch.com/news/patients-slam-government-mps-blocking-pharmac-inquiry 2019-04-11T05:00:01+10:00 https://pharmadispatch.com/news/leading-clinicians-welcomes-new-parkinsons-treatment 2019-04-11T05:00:01+10:00 https://pharmadispatch.com/news/merck-confirms-office-relocation 2019-04-11T05:00:01+10:00 https://pharmadispatch.com/news/ma-secures-major-commitments-from-greg-hunt 2019-04-11T05:00:01+10:00 https://pharmadispatch.com/news/election-imminent-has-final-decisions-emerge 2019-04-11T05:00:01+10:00 https://pharmadispatch.com/news/some-nerves-over-cost-recovery-regulations 2019-04-10T05:00:01+10:00 https://pharmadispatch.com/news/alcon-restarts-life-as-an-independent-company 2019-04-10T05:00:01+10:00 https://pharmadispatch.com/news/recognition-for-ma-chair 2019-04-10T05:00:01+10:00 https://pharmadispatch.com/news/sector-facing-an-uncomfortable-reality 2019-04-10T05:00:01+10:00 https://pharmadispatch.com/news/pharmac-fronts-parliamentary-inquiry 2019-04-09T05:00:01+10:00 https://pharmadispatch.com/news/the-value-in-prescribing-program-targeting-bdmards 2019-04-09T05:00:01+10:00 https://pharmadispatch.com/news/applications-open-for-seqirus-immunisation-grants 2019-04-09T05:00:01+10:00 https://pharmadispatch.com/news/labor-extends-cancer-commitment-to-clinical-trials 2019-04-09T05:00:01+10:00 https://pharmadispatch.com/news/bio-add-australia-to-ip-watch-list 2019-04-09T05:00:01+10:00 https://pharmadispatch.com/news/compounders-call-to-scrap-payment-reform 2019-04-08T05:00:01+10:00 https://pharmadispatch.com/news/ma-calls-for-urgent-political-intervention-on-new-criteria 2019-04-08T05:00:01+10:00 https://pharmadispatch.com/news/the-pbs-is-now-a-political-football-dont-let-it-go-uncontested 2019-04-08T05:00:01+10:00 https://pharmadispatch.com/news/when-did-this-become-a-thing 2019-04-08T05:00:01+10:00 https://pharmadispatch.com/news/budget-cut-to-wholesaler-hospital-remuneration 2019-04-08T05:00:01+10:00 https://pharmadispatch.com/news/18-medicines-recommended-but-not-listed 2019-04-05T09:36:01+11:00 https://pharmadispatch.com/news/department-snubs-industry-concerns-over-spa-criteria 2019-04-05T05:00:01+11:00 https://pharmadispatch.com/news/actinogen-appoints-pharmaxis-chair 2019-04-05T05:00:01+11:00 https://pharmadispatch.com/news/has-the-pbs-ever-been-more-capped 2019-04-05T05:00:01+11:00 https://pharmadispatch.com/news/ma-welcomes-labors-cancer-pledge 2019-04-05T05:00:01+11:00 https://pharmadispatch.com/news/budget-surprise-as-rebate-revenue-goes-to-zero 2019-04-04T05:00:01+11:00 https://pharmadispatch.com/news/planned-reduction-in-post-pbac-timeline-stalls 2019-04-04T05:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-cost-of-pain 2019-04-04T05:00:01+11:00 https://pharmadispatch.com/news/hepatitis-australia-urgent-action-required-as-elimination-goal-s 2019-04-04T05:00:01+11:00 https://pharmadispatch.com/news/ma-says-review-required-to-ensure-patient-access 2019-04-03T05:00:01+11:00 https://pharmadispatch.com/news/pbs-confirmed-as-the-poor-cousin 2019-04-03T05:00:01+11:00 https://pharmadispatch.com/news/budget-reveals-impact-on-individual-products 2019-04-03T05:00:01+11:00 https://pharmadispatch.com/news/budget-2019-20-the-measures 2019-04-03T05:00:01+11:00 https://pharmadispatch.com/news/government-sticks-with-supply-chain-reform 2019-04-02T19:00:01+11:00 https://pharmadispatch.com/news/lundbecks-michal-srensen-on-investing-to-grow 2019-04-02T05:00:01+11:00 https://pharmadispatch.com/news/how-and-when-does-this-therapy-come-to-australia 2019-04-02T05:00:01+11:00 https://pharmadispatch.com/news/ustr-restates-criticism-of-australia-and-nz 2019-04-02T05:00:01+11:00 https://pharmadispatch.com/news/subtle-but-important-change-in-new-listing-claim 2019-04-02T05:00:01+11:00 https://pharmadispatch.com/news/this-proposal-was-just-another-pbs-savings-measure 2019-04-01T05:00:01+11:00 https://pharmadispatch.com/news/what-will-budget-say-about-supply-chain-reform 2019-04-01T05:00:01+11:00 https://pharmadispatch.com/news/richard-vines-how-will-systems-cope 2019-04-01T05:00:01+11:00 https://pharmadispatch.com/news/labor-wait-and-see-on-dispensing-change 2019-04-01T05:00:01+11:00 https://pharmadispatch.com/news/no-dhl-in-new-cso-contracts 2019-04-01T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-boss-refutes-lyrica-criticism 2019-03-31T15:03:01+11:00 https://pharmadispatch.com/news/pharmacy-will-never-accept-what-industry-lives-with 2019-03-29T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-encourages-people-to-join-bio-delegation 2019-03-29T05:00:01+11:00 https://pharmadispatch.com/news/guild-remember-flu-shot 2019-03-29T05:00:01+11:00 https://pharmadispatch.com/news/juno-acquires-injectables-from-az 2019-03-29T05:00:01+11:00 https://pharmadispatch.com/news/should-we-add-tumour-agnostic-to-pan-tumour 2019-03-28T05:00:01+11:00 https://pharmadispatch.com/news/months-of-disagreement-over-banked-savings-measure 2019-03-28T05:00:01+11:00 https://pharmadispatch.com/news/guild-staggered-astonishment-and-anger-over-near-catastrophe 2019-03-27T15:21:01+11:00 https://pharmadispatch.com/news/tumour-agnostic-medicines-will-pose-a-new-reimbursement-challeng 2019-03-27T14:48:01+11:00 https://pharmadispatch.com/news/guild-warns-against-increased-dispensing-quantities 2019-03-27T05:00:01+11:00 https://pharmadispatch.com/news/proud-of-the-performance-but-humbled-by-the-impact 2019-03-27T05:00:01+11:00 https://pharmadispatch.com/news/confusion-of-the-definition-of-funded-access 2019-03-27T05:00:01+11:00 https://pharmadispatch.com/news/roche-extremely-disappointed-over-msac-rejection 2019-03-26T18:35:01+11:00 https://pharmadispatch.com/news/another-term-for-pbac-chair 2019-03-26T05:00:01+11:00 https://pharmadispatch.com/news/is-this-factor-f-or-just-another-announcement 2019-03-26T05:00:01+11:00 https://pharmadispatch.com/news/nominations-open-for-research-awards 2019-03-26T01:25:01+11:00 https://pharmadispatch.com/news/biogen-and-eisai-scrap-development-of-aducanumab 2019-03-25T05:00:01+11:00 https://pharmadispatch.com/news/gsk-locals-join-global-colleagues-in-trek-for-kids 2019-03-25T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-seeks-advice-on-pre-pbac-funding 2019-03-25T05:00:01+11:00 https://pharmadispatch.com/news/article-cites-unnamed-experts-in-pbs-influence-claims 2019-03-25T05:00:01+11:00 https://pharmadispatch.com/news/patients-await-final-piece-in-the-funding-puzzle 2019-03-25T05:00:01+11:00 https://pharmadispatch.com/news/documents-raise-questions-over-decision-timeline 2019-03-24T10:08:01+11:00 https://pharmadispatch.com/news/lung-the-leading-cause-of-cancer-mortality-in-2019 2019-03-22T05:14:01+11:00 https://pharmadispatch.com/news/sigma-sales-of-hcv-therapies-halve 2019-03-22T05:00:01+11:00 https://pharmadispatch.com/news/ex-labor-senator-signs-up-with-former-health-minister 2019-03-22T05:00:01+11:00 https://pharmadispatch.com/news/ma-building-capacity-and-capability-on-living-therapies 2019-03-22T05:00:01+11:00 https://pharmadispatch.com/news/wh-will-drive-discussions-about-cell-and-gene-therapies 2019-03-21T05:00:01+11:00 https://pharmadispatch.com/news/extending-the-promise-of-immunotherapy 2019-03-21T05:00:01+11:00 https://pharmadispatch.com/news/marcus-blackmore-returns-to-lead-company 2019-03-21T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-hits-the-bay-run-for-clean-up-australia-day 2019-03-21T05:00:01+11:00 https://pharmadispatch.com/news/gsk-announces-australian-winners-of-research-challenge 2019-03-21T05:00:01+11:00 https://pharmadispatch.com/news/new-analysis-highlights-focus-on-pbs 2019-03-20T05:00:01+11:00 https://pharmadispatch.com/news/a-focus-on-new-listings-in-the-absence-of-anything-else 2019-03-20T05:00:01+11:00 https://pharmadispatch.com/news/fda-confirms-partial-clinical-hold-on-australian-developed-cance 2019-03-20T05:00:01+11:00 https://pharmadispatch.com/news/2019-bridgetech-program-officially-underway 2019-03-19T21:07:01+11:00 https://pharmadispatch.com/news/grattan-proposes-pbs-savings-for-dental-scheme 2019-03-19T05:00:01+11:00 https://pharmadispatch.com/news/tga-no-impact-on-medicine-supply-with-no-deal-brexit 2019-03-19T05:00:01+11:00 https://pharmadispatch.com/news/sta-welcomes-breast-cancer-approval 2019-03-19T05:00:01+11:00 https://pharmadispatch.com/news/new-listings-for-april-as-caretaker-approaches 2019-03-18T16:56:01+11:00 https://pharmadispatch.com/news/therapeutic-groups-may-not-deliver-like-they-once-did 2019-03-18T15:17:01+11:00 https://pharmadispatch.com/news/who-is-thinking-about-the-future 2019-03-18T05:00:01+11:00 https://pharmadispatch.com/news/labor-attitude-on-spas-probably-more-important-than-greg-hunts 2019-03-18T05:00:01+11:00 https://pharmadispatch.com/news/btf-backs-creation-of-new-perth-based-biotech 2019-03-18T05:00:01+11:00 https://pharmadispatch.com/news/npsa-wholesalers-undervalued-even-with-cso 2019-03-18T05:00:01+11:00 https://pharmadispatch.com/news/sector-to-unite-in-push-for-accounting-change 2019-03-17T12:49:01+11:00 https://pharmadispatch.com/news/bms-does-the-blend-and-spin 2019-03-15T05:00:01+11:00 https://pharmadispatch.com/news/csl-renews-stem-partnership-with-national-youth-science-forum 2019-03-14T13:07:01+11:00 https://pharmadispatch.com/news/new-spa-could-deliver-a-decade-of-cascading-price-cuts 2019-03-14T06:51:01+11:00 https://pharmadispatch.com/news/cost-recovery-regulations-under-review 2019-03-14T05:00:01+11:00 https://pharmadispatch.com/news/government-backs-new-10-year-stem-cell-mission 2019-03-14T05:00:01+11:00 https://pharmadispatch.com/news/new-therapies-face-workarounds-through-existing-pathways 2019-03-14T05:00:01+11:00 https://pharmadispatch.com/news/digital-health-agency-backs-hospital-medication-trial 2019-03-14T05:00:01+11:00 https://pharmadispatch.com/news/api-sigma-has-chosen-a-path-to-downsize 2019-03-14T05:00:01+11:00 https://pharmadispatch.com/news/companies-to-pay-at-least-twice-for-an-spa 2019-03-14T05:00:01+11:00 https://pharmadispatch.com/news/a-lean-decade-for-pbs-even-compared-to-pharmac 2019-03-13T05:00:01+11:00 https://pharmadispatch.com/news/the-choice-for-government-might-be-higher-prices-or-access-delay 2019-03-13T05:00:01+11:00 https://pharmadispatch.com/news/vertex-looking-ahead-on-symdeko 2019-03-13T05:00:01+11:00 https://pharmadispatch.com/news/us-agreement-for-perth-based-zelda-therapeutics 2019-03-12T18:26:01+11:00 https://pharmadispatch.com/news/mundipharmas-jane-orr-wider-availability-the-only-solution 2019-03-12T05:00:01+11:00 https://pharmadispatch.com/news/new-criteria-a-huge-gamble-that-will-test-industrys-patience-wit 2019-03-12T05:00:01+11:00 https://pharmadispatch.com/news/jj-launches-womens-leadership-and-inclusion-network 2019-03-12T05:00:01+11:00 https://pharmadispatch.com/news/research-reveals-potential-for-early-alzheimers-test 2019-03-12T05:00:01+11:00 https://pharmadispatch.com/news/msds-keytruda-secures-11th-approved-indication 2019-03-12T05:00:01+11:00 https://pharmadispatch.com/news/new-criteria-means-virtual-elimination-of-special-pricing-arrang 2019-03-11T05:00:01+11:00 https://pharmadispatch.com/news/red-book-a-bigger-worry-than-mccormack 2019-03-11T05:00:01+11:00 https://pharmadispatch.com/news/ma-decides-to-stick-with-ten 2019-03-11T05:00:01+11:00 https://pharmadispatch.com/news/possible-simplification-of-hcv-prescribing-as-uptake-slumps-furt 2019-03-11T05:00:01+11:00 https://pharmadispatch.com/news/our-current-concept-of-aging-is-wrong 2019-03-11T05:00:01+11:00 https://pharmadispatch.com/news/dont-wait-to-be-heard-tell-your-own-story 2019-03-08T05:00:01+11:00 https://pharmadispatch.com/news/the-gender-gap-on-harassment-and-discrimination-at-work 2019-03-08T05:00:01+11:00 https://pharmadispatch.com/news/where-is-the-money-coming-from-1 2019-03-08T05:00:01+11:00 https://pharmadispatch.com/news/gsk-announces-new-leadership 2019-03-08T05:00:01+11:00 https://pharmadispatch.com/news/gbma-confirms-dates-for-first-biosimilar-awareness-week 2019-03-07T17:20:01+11:00 https://pharmadispatch.com/news/sanofi-disappointment-over-flu-vaccine-decision 2019-03-07T05:00:01+11:00 https://pharmadispatch.com/news/hunt-in-pre-election-pitch-to-pharmacy 2019-03-07T05:00:01+11:00 https://pharmadispatch.com/news/labor-goes-early-in-backing-pharmacy 2019-03-07T05:00:01+11:00 https://pharmadispatch.com/news/recognition-for-ma-continuing-education-program-awards 2019-03-07T05:00:01+11:00 https://pharmadispatch.com/news/is-it-really-that-simple 2019-03-06T05:00:01+11:00 https://pharmadispatch.com/news/uk-launches-national-genome-health-strategy 2019-03-06T05:00:01+11:00 https://pharmadispatch.com/news/different-diseases-different-pathways-different-outcomes 2019-03-05T13:14:01+11:00 https://pharmadispatch.com/news/coroner-calls-for-wide-availability-of-naloxone-nasal-spray 2019-03-05T05:00:01+11:00 https://pharmadispatch.com/news/growth-plan-for-terrywhite-chemmart 2019-03-05T05:00:01+11:00 https://pharmadispatch.com/news/applications-open-for-bi-and-lilly-backed-grants 2019-03-05T05:00:01+11:00 https://pharmadispatch.com/news/msds-michael-azrak-a-pay-equity-ambassador 2019-03-05T05:00:01+11:00 https://pharmadispatch.com/news/new-pbac-appointments-with-more-to-come 2019-03-04T11:52:01+11:00 https://pharmadispatch.com/news/industry-raises-over-200000-as-a-new-name-takes-the-pharmacup 2019-03-04T05:00:01+11:00 https://pharmadispatch.com/news/gilead-announces-interim-general-manager 2019-03-04T05:00:01+11:00 https://pharmadispatch.com/news/ma-to-decide-on-confirmed-board-vacancy 2019-03-04T05:00:01+11:00 https://pharmadispatch.com/news/talks-to-resume-on-friendless-reform 2019-03-04T05:00:01+11:00 https://pharmadispatch.com/news/positive-pathways-and-not-priorities 2019-03-04T05:00:01+11:00 https://pharmadispatch.com/news/companies-race-past-130000-for-rare-cancers-australia 2019-03-01T05:00:01+11:00 https://pharmadispatch.com/news/another-listing-for-immunotherapy-combination 2019-03-01T05:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-gileads-hiv-triple-combination 2019-03-01T05:00:01+11:00 https://pharmadispatch.com/news/lilly-welcomes-new-listing-for-il-17a-inhibitor 2019-02-28T14:39:01+11:00 https://pharmadispatch.com/news/ma-system-disconnect-and-not-yet-fit-for-purpose 2019-02-28T05:00:01+11:00 https://pharmadispatch.com/news/funding-for-take-home-naloxone-program 2019-02-28T05:00:01+11:00 https://pharmadispatch.com/news/more-leadership-change-for-pharmacy 2019-02-28T05:00:01+11:00 https://pharmadispatch.com/news/they-will-impact-the-entire-system 2019-02-27T05:00:01+11:00 https://pharmadispatch.com/news/department-proceeding-with-next-step-in-the-process 2019-02-27T05:00:01+11:00 https://pharmadispatch.com/news/government-sets-industry-objective-for-new-10-year-mission-for-c 2019-02-27T05:00:01+11:00 https://pharmadispatch.com/news/companies-hit-target-with-three-days-to-go 2019-02-27T05:00:01+11:00 https://pharmadispatch.com/news/industry-leaders-front-us-senate-over-pricing 2019-02-27T05:00:01+11:00 https://pharmadispatch.com/news/living-therapies-hundreds-in-development-across-2600-trials 2019-02-26T05:00:01+11:00 https://pharmadispatch.com/news/trial-results-give-hope-on-peanut-allergy 2019-02-26T05:00:01+11:00 https://pharmadispatch.com/news/new-testing-means-patients-no-longer-defined-by-their-symptoms 2019-02-26T05:00:01+11:00 https://pharmadispatch.com/news/hepatitis-australia-raises-concerns-over-new-pbs-fees-and-submis 2019-02-26T05:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-doses-first-patient-in-lox-inhibitor-trial 2019-02-25T05:00:01+11:00 https://pharmadispatch.com/news/janssen-surges-ahead-in-pharmacup2019 2019-02-25T05:00:01+11:00 https://pharmadispatch.com/news/companies-recognised-for-gender-equality 2019-02-25T05:00:01+11:00 https://pharmadispatch.com/news/an-outdated-system 2019-02-25T03:00:01+11:00 https://pharmadispatch.com/news/government-acts-to-accelerate-cancer-listings 2019-02-25T03:00:01+11:00 https://pharmadispatch.com/news/push-for-companies-to-provide-new-trial-data-to-pbs 2019-02-25T03:00:01+11:00 https://pharmadispatch.com/news/david-quilty-retires-from-pharmacyguild 2019-02-22T15:28:01+11:00 https://pharmadispatch.com/news/takeda-confirms-australian-leadership 2019-02-22T05:00:01+11:00 https://pharmadispatch.com/news/fate-of-rd-tax-reform-a-matter-for-election-winner-1 2019-02-22T05:00:01+11:00 https://pharmadispatch.com/news/minister-starts-new-round-of-listing-announcements 2019-02-22T05:00:01+11:00 https://pharmadispatch.com/news/companies-set-to-pass-pharmacup2019-record 2019-02-22T05:00:01+11:00 https://pharmadispatch.com/news/ebos-reports-growth-as-it-prepares-for-chemist-warehouse 2019-02-21T05:00:01+11:00 https://pharmadispatch.com/news/ma-where-are-the-service-standards-and-kpis 2019-02-21T05:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-two-new-board-members 2019-02-21T05:00:01+11:00 https://pharmadispatch.com/news/nine-month-post-pbac-process 2019-02-21T05:00:01+11:00 https://pharmadispatch.com/news/what-next-for-payment-reform 2019-02-20T05:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-greater-focus-on-secondary-cv-events 2019-02-20T05:00:01+11:00 https://pharmadispatch.com/news/fee-crunch-for-smaller-companies-and-patient-populations 2019-02-20T05:00:01+11:00 https://pharmadispatch.com/news/partnership-to-manage-biomedical-translation-bridge-program 2019-02-20T05:00:01+11:00 https://pharmadispatch.com/news/gileads-rob-hetherington-workplaces-have-come-such-a-long-way 2019-02-19T05:00:01+11:00 https://pharmadispatch.com/news/department-of-health-reveals-facts-on-key-listing-stage 2019-02-19T05:00:01+11:00 https://pharmadispatch.com/news/response-reveals-impact-of-higher-price-cut-threshold 2019-02-19T05:00:01+11:00 https://pharmadispatch.com/news/st-asia-announces-new-special-access-program 2019-02-19T05:00:01+11:00 https://pharmadispatch.com/news/bms-davide-piras-the-challenge-in-australia-is-not-dramatically- 2019-02-18T05:00:01+11:00 https://pharmadispatch.com/news/two-weeks-to-go-as-pharmacup2019-races-towards-record 2019-02-18T05:00:01+11:00 https://pharmadispatch.com/news/new-deputy-chair-for-medicines-australia 2019-02-18T05:00:01+11:00 https://pharmadispatch.com/news/this-is-what-a-cost-recovery-customer-should-expect 2019-02-18T05:00:01+11:00 https://pharmadispatch.com/news/no-reporting-or-commitment-efficiencies 2019-02-17T10:04:01+11:00 https://pharmadispatch.com/news/department-to-pay-for-labors-health-reform-commission 2019-02-15T05:00:01+11:00 https://pharmadispatch.com/news/department-confirms-52-pbac-recommendations-still-unfunded 2019-02-15T05:00:01+11:00 https://pharmadispatch.com/news/is-this-an-evidence-based-system 2019-02-15T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-responds-to-criticism-by-announcing-it-will-review-itsel 2019-02-15T05:00:01+11:00 https://pharmadispatch.com/news/offer-a-reduction-and-we-will-be-more-receptive 2019-02-14T05:00:01+11:00 https://pharmadispatch.com/news/strong-result-for-csl 2019-02-14T05:00:01+11:00 https://pharmadispatch.com/news/a-relationship-that-masks-a-difficult-reality 2019-02-14T05:00:01+11:00 https://pharmadispatch.com/news/guild-absorbing-psa-joining-the-7cpa 2019-02-14T05:00:01+11:00 https://pharmadispatch.com/news/new-local-leadership-for-allergan 2019-02-13T05:00:01+11:00 https://pharmadispatch.com/news/the-launch-of-a-new-industry-association 2019-02-13T05:00:01+11:00 https://pharmadispatch.com/news/companies-paying-the-price-of-supply-chain-payment-failure 2019-02-13T05:00:01+11:00 https://pharmadispatch.com/news/sigma-identifies-cost-efficiencies-as-merger-talks-continue 2019-02-12T05:00:01+11:00 https://pharmadispatch.com/news/australia-and-nz-hold-positions-in-global-ip-index 2019-02-12T05:00:01+11:00 https://pharmadispatch.com/news/government-should-delay-and-reconsider-rd-tax-cut 2019-02-12T05:00:01+11:00 https://pharmadispatch.com/news/not-stopping-the-roche-rangers-in-race-for-pharmacup2019 2019-02-12T05:00:01+11:00 https://pharmadispatch.com/news/ma-board-to-decide-on-vacancies 2019-02-11T05:00:01+11:00 https://pharmadispatch.com/news/pd-l1-simplification-is-it-a-therapeutic-group 2019-02-11T05:00:01+11:00 https://pharmadispatch.com/news/sector-proposes-cmi-leaflet-redesign 2019-02-11T05:00:01+11:00 https://pharmadispatch.com/news/phrma-add-australia-to-trade-watch-list 2019-02-11T05:00:01+11:00 https://pharmadispatch.com/news/industry-looking-to-push-comparator-reform 2019-02-08T05:00:01+11:00 https://pharmadispatch.com/news/ma-and-ausbiotech-team-up-for-annual-luncheon 2019-02-08T05:00:01+11:00 https://pharmadispatch.com/news/roche-first-to-hit-10000-in-the-race-for-pharmacup2019 2019-02-08T05:00:01+11:00 https://pharmadispatch.com/news/ex-industry-executive-to-lead-nurses-association 2019-02-08T05:00:01+11:00 https://pharmadispatch.com/news/nz-pm-pbs-comparisons-are-unfair 2019-02-07T05:00:01+11:00 https://pharmadispatch.com/news/ma-advisory-council-meets-for-first-time-in-2019 2019-02-07T05:00:01+11:00 https://pharmadispatch.com/news/new-funding-for-perth-based-phenome-centre 2019-02-07T05:00:01+11:00 https://pharmadispatch.com/news/new-pbs-leadership-takes-shape 2019-02-07T05:00:01+11:00 https://pharmadispatch.com/news/the-boy-who-cried-wolf-on-confidentiality 2019-02-06T05:00:01+11:00 https://pharmadispatch.com/news/department-calls-pdl1-lung-cancer-meeting 2019-02-06T05:00:01+11:00 https://pharmadispatch.com/news/guild-scrap-1-pbs-prescription-discount 2019-02-06T05:00:01+11:00 https://pharmadispatch.com/news/australians-wait-as-uk-extends-funded-access-to-car-t 2019-02-05T05:00:01+11:00 https://pharmadispatch.com/news/the-challenge-of-achieving-balance 2019-02-05T05:00:01+11:00 https://pharmadispatch.com/news/company-concern-over-push-on-published-prices 2019-02-05T05:00:01+11:00 https://pharmadispatch.com/news/history-a-guide-on-how-companies-will-manage-hike 2019-02-05T05:00:01+11:00 https://pharmadispatch.com/news/roche-takes-the-lead-in-pharmacup2019 2019-02-04T05:00:01+11:00 https://pharmadispatch.com/news/new-and-higher-fees-to-fund-changes-to-atagi 2019-02-04T05:00:01+11:00 https://pharmadispatch.com/news/pbs-fee-spike-driven-by-modelling-change 2019-02-04T05:00:01+11:00 https://pharmadispatch.com/news/the-gender-gap-on-flexibility 2019-02-04T05:00:01+11:00 https://pharmadispatch.com/news/dennis-bastas-takes-full-ownership-ahead-of-arrotexmerger 2019-02-01T05:00:01+11:00 https://pharmadispatch.com/news/azs-pascal-soriot-on-pricing-patent-expiries-and-the-opportunity 2019-02-01T05:00:01+11:00 https://pharmadispatch.com/news/us-study-highlights-magnitude-of-rebates 2019-02-01T05:00:01+11:00 https://pharmadispatch.com/news/officials-confirm-relief-on-orphan-designation 2019-02-01T05:00:01+11:00 https://pharmadispatch.com/news/azs-pascal-soriot-my-australia-and-the-new-astrazeneca 2019-01-31T05:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-cost-of-medicine-misuse 2019-01-31T04:00:01+11:00 https://pharmadispatch.com/news/preventable-deaths-decline-but-more-to-be-done 2019-01-31T04:00:01+11:00 https://pharmadispatch.com/news/tga-to-host-cmi-meeting 2019-01-31T04:00:01+11:00 https://pharmadispatch.com/news/challenging-discussions-ma-secures-some-concessions-on-new-fees 2019-01-30T05:00:01+11:00 https://pharmadispatch.com/news/new-fees-deliver-double-hit-for-vaccine-companies 2019-01-30T05:00:01+11:00 https://pharmadispatch.com/news/government-welcomes-more-collaborations 2019-01-30T05:00:01+11:00 https://pharmadispatch.com/news/pharmadispatch-2019-barbara-weisel-on-australia 2019-01-29T05:00:01+11:00 https://pharmadispatch.com/news/need-for-a-quorum-could-force-ma-hand-on-vacancies 2019-01-29T05:00:01+11:00 https://pharmadispatch.com/news/industry-backs-pbac-reappointment 2019-01-29T05:00:01+11:00 https://pharmadispatch.com/news/janssen-still-leading-the-way-on-pharmacup2019 2019-01-29T05:00:01+11:00 https://pharmadispatch.com/news/thriving-or-surviving-and-the-challenge-of-balance 2019-01-29T05:00:01+11:00 https://pharmadispatch.com/news/a-review-that-is-not-a-post-market-review 2019-01-25T05:00:01+11:00 https://pharmadispatch.com/news/this-is-what-constitutes-a-pricing-negotiation-in-2019 2019-01-25T05:00:01+11:00 https://pharmadispatch.com/news/ma-extends-advisory-council-pending-board-election 2019-01-25T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-february-listings-for-psoriasis 2019-01-25T05:00:01+11:00 https://pharmadispatch.com/news/eisais-gary-hendler-dealing-with-brexit-the-cost-of-doing-busine 2019-01-24T05:00:01+11:00 https://pharmadispatch.com/news/in-2019-the-smart-country-that-is-australia-owes-nothing-to-luck 2019-01-24T05:00:01+11:00 https://pharmadispatch.com/news/industry-executive-to-lead-regeneus 2019-01-24T05:00:01+11:00 https://pharmadispatch.com/news/bayer-welcomes-government-funding-to-extend-heart-of-australia 2019-01-23T05:00:01+11:00 https://pharmadispatch.com/news/australia-hosts-meeting-of-global-leadership-team 2019-01-23T05:00:01+11:00 https://pharmadispatch.com/news/rob-hetherington-announces-gilead-departure 2019-01-23T05:00:01+11:00 https://pharmadispatch.com/news/eisais-gary-hendler-on-australia-investment-and-a-pragmatic-appr 2019-01-22T05:00:01+11:00 https://pharmadispatch.com/news/industry-preparing-submissions-on-nps-review 2019-01-22T05:00:01+11:00 https://pharmadispatch.com/news/ma-concern-over-ad-hoc-pbs-reviews 2019-01-22T05:00:01+11:00 https://pharmadispatch.com/news/push-to-end-the-lung-cancer-stigma-as-government-announced-new-l 2019-01-21T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-pushes-sector-on-cmi-access 2019-01-21T05:00:01+11:00 https://pharmadispatch.com/news/no-easy-solution-to-fill-ma-vacancies 2019-01-21T05:00:01+11:00 https://pharmadispatch.com/news/department-delays-further-discussion-on-payment-reform 2019-01-21T05:00:01+11:00 https://pharmadispatch.com/news/who-is-ready-for-rcas-p2p-cycle-challenge 2019-01-21T05:00:01+11:00 https://pharmadispatch.com/news/a-relationship-that-works-for-patients 2019-01-18T05:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-updates-on-loxl2-studies 2019-01-18T05:00:01+11:00 https://pharmadispatch.com/news/clock-ticking-as-caretaker-approaches 2019-01-17T17:34:01+11:00 https://pharmadispatch.com/news/the-genesis-of-the-policy-that-continues-to-shape-pbs-discussion 2019-01-17T05:00:01+11:00 https://pharmadispatch.com/news/takeda-rings-the-bell-in-new-york 2019-01-17T05:00:01+11:00 https://pharmadispatch.com/news/novo-nordisks-michala-fischer-hansen-returning-to-denmark 2019-01-17T05:00:01+11:00 https://pharmadispatch.com/news/chf-end-cost-offset-rule 2019-01-17T05:00:01+11:00 https://pharmadispatch.com/news/fundraising-underway-in-the-race-for-pharmacup2019 2019-01-16T05:00:01+11:00 https://pharmadispatch.com/news/transition-of-6cpa-program-administration-underway 2019-01-16T05:00:01+11:00 https://pharmadispatch.com/news/new-drug-discovery-institute-for-melbourne 2019-01-16T05:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-support-for-industry-back-digital-health-accelerator 2019-01-16T05:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-demise-of-f2 2019-01-15T05:00:01+11:00 https://pharmadispatch.com/news/where-does-the-money-come-from-now 2019-01-15T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-adopts-agile-working 2019-01-15T05:00:01+11:00 https://pharmadispatch.com/news/information-forums-on-pbs-fee-hike 2019-01-15T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-makes-its-cbd-move 2019-01-14T05:00:01+11:00 https://pharmadispatch.com/news/nps-medicinewise-facing-robust-evaluation 2019-01-14T05:00:01+11:00 https://pharmadispatch.com/news/new-report-confirms-exaggerated-spend-on-new-medicines 2019-01-14T05:00:01+11:00 https://pharmadispatch.com/news/where-does-the-government-spend-its-investment-in-the-pbs 2019-01-14T05:00:01+11:00 https://pharmadispatch.com/news/all-eyes-on-dhl-ahead-of-cso-application-cut-off 2019-01-14T05:00:01+11:00 https://pharmadispatch.com/news/the-australian-at-the-centre-of-takedas-deal-for-shire 2019-01-10T09:00:01+11:00 https://pharmadispatch.com/news/bms-to-acquire-celgene 2019-01-04T07:06:01+11:00 https://pharmadispatch.com/news/new-fees-a-pbs-listing-tax 2018-12-20T05:00:01+11:00 https://pharmadispatch.com/news/unresolved-issues-will-make-for-an-even-tougher-2019 2018-12-20T05:00:01+11:00 https://pharmadispatch.com/news/supply-chain-payment-reform-unlikely-in-2019 2018-12-20T05:00:01+11:00 https://pharmadispatch.com/news/gsk-and-pfizer-merge-consumer-health-businesses 2018-12-20T05:00:01+11:00 https://pharmadispatch.com/news/biosimilars-feature-on-march-pbac-agenda 2018-12-20T05:00:01+11:00 https://pharmadispatch.com/news/labor-to-preserve-rd-tax-incentive 2018-12-19T05:01:01+11:00 https://pharmadispatch.com/news/tga-approves-first-car-t-therapy 2018-12-19T05:00:01+11:00 https://pharmadispatch.com/news/a-new-future-for-medical-research-funding 2018-12-18T05:00:01+11:00 https://pharmadispatch.com/news/the-complex-parliamentary-approval-process 2018-12-18T04:01:01+11:00 https://pharmadispatch.com/news/andrew-wilson-it-is-no-longer-just-about-medicines 2018-12-18T04:00:01+11:00 https://pharmadispatch.com/news/pbs-missing-out-on-budget-windfall 2018-12-18T04:00:01+11:00 https://pharmadispatch.com/news/a-new-home-for-medicines-australia 2018-12-18T04:00:01+11:00 https://pharmadispatch.com/news/myefo-government-funds-itself-on-supply-chain-reform 2018-12-17T10:06:01+11:00 https://pharmadispatch.com/news/andrew-wilson-good-things-need-to-be-noted 2018-12-17T05:00:01+11:00 https://pharmadispatch.com/news/the-mystery-deepens-on-pdl1-and-lung-cancer 2018-12-17T05:00:01+11:00 https://pharmadispatch.com/news/outcomes-suggest-another-look-at-biosimilar-policy 2018-12-17T05:00:01+11:00 https://pharmadispatch.com/news/november-pbac-outcomes 2018-12-17T05:00:01+11:00 https://pharmadispatch.com/news/april-2019-price-reductions 2018-12-17T05:00:01+11:00 https://pharmadispatch.com/news/api-moves-on-sigma 2018-12-14T10:10:01+11:00 https://pharmadispatch.com/news/february-push-would-avoid-parliamentary-scrutiny 2018-12-14T05:00:01+11:00 https://pharmadispatch.com/news/new-health-program-highlights-pbs-challenge 2018-12-14T05:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-reports-first-us-sales-of-aridol 2018-12-14T05:00:01+11:00 https://pharmadispatch.com/news/insurers-use-pbs-as-model-for-devices 2018-12-13T05:00:01+11:00 https://pharmadispatch.com/news/bayer-backing-new-kidney-disease-trial 2018-12-13T05:00:01+11:00 https://pharmadispatch.com/news/100000-the-goal-for-pharmacup19 2018-12-13T05:00:01+11:00 https://pharmadispatch.com/news/industry-and-stakeholders-working-through-pan-tumour-response 2018-12-13T05:00:01+11:00 https://pharmadispatch.com/news/new-national-president-for-psa 2018-12-13T05:00:01+11:00 https://pharmadispatch.com/news/digital-partnership-for-gsk-consumer-health 2018-12-13T05:00:01+11:00 https://pharmadispatch.com/news/msd-cautions-on-first-pan-tumour-outcome 2018-12-13T05:00:01+11:00 https://pharmadispatch.com/news/bridge-program-participants-visit-us-based-companies 2018-12-12T05:00:01+11:00 https://pharmadispatch.com/news/tga-approves-new-opdivo-dosing-schedule 2018-12-12T05:00:01+11:00 https://pharmadispatch.com/news/australia-delivers-world-first-for-new-cancer-therapy 2018-12-12T05:00:01+11:00 https://pharmadispatch.com/news/exclusive-pbac-targets-lung-cancer-in-first-pan-tumour-outcome 2018-12-11T18:47:01+11:00 https://pharmadispatch.com/news/hitting-a-nerve-on-workplace-flexibility 2018-12-11T04:00:01+11:00 https://pharmadispatch.com/news/companies-share-their-approach-to-workplace-flexibility 2018-12-11T04:00:01+11:00 https://pharmadispatch.com/news/updated-healthcare-atlas-highlights-medicine-use 2018-12-11T04:00:01+11:00 https://pharmadispatch.com/news/melbourne-company-joins-antimicrobial-challenge 2018-12-11T04:00:01+11:00 https://pharmadispatch.com/news/pfizer-officially-makes-sydney-cbd-its-new-home 2018-12-10T09:55:01+11:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-judge-people-on-output-not-attendance 2018-12-10T04:00:01+11:00 https://pharmadispatch.com/news/the-facts-on-workplace-flexibility 2018-12-10T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-welcomes-collaboration-on-flu-vaccine 2018-12-10T04:00:01+11:00 https://pharmadispatch.com/news/who-understands-and-will-pay-for-the-combined-view 2018-12-10T04:00:01+11:00 https://pharmadispatch.com/news/hurdles-mount-for-supply-chain-payment-reform 2018-12-07T05:00:01+11:00 https://pharmadispatch.com/news/get-ready-for-2019-pharma-2-peak-kosi-challenge 2018-12-07T05:00:01+11:00 https://pharmadispatch.com/news/new-head-of-pbs-pricing-and-policy 2018-12-07T05:00:01+11:00 https://pharmadispatch.com/news/the-combined-view-smorgasboard 2018-12-07T05:00:01+11:00 https://pharmadispatch.com/news/global-hr-accreditation-for-australian-pharma-companies 2018-12-06T05:00:01+11:00 https://pharmadispatch.com/news/psa-welcomes-new-guidelines-but-cautions-on-exclusive-direct 2018-12-06T05:00:01+11:00 https://pharmadispatch.com/news/is-it-part-of-an-overarching-strategic-process 2018-12-06T05:00:01+11:00 https://pharmadispatch.com/news/pharmadispatch-2019-renewed-focus-on-supply-chain 2018-12-06T05:00:01+11:00 https://pharmadispatch.com/news/mtp-welcomes-new-government-funding 2018-12-06T05:00:01+11:00 https://pharmadispatch.com/news/humira-deals-surprised-everyone-including-abbvie 2018-12-05T03:00:01+11:00 https://pharmadispatch.com/news/are-humira-deals-really-pay-for-delay 2018-12-05T03:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-delay-in-senate-report 2018-12-05T03:00:01+11:00 https://pharmadispatch.com/news/the-loss-of-exclusivity-and-assorted-patents 2018-12-05T03:00:01+11:00 https://pharmadispatch.com/news/new-stem-partnership-for-bayer 2018-12-05T03:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-to-scrap-exclusive-direct-distribution-model 2018-12-04T08:33:01+11:00 https://pharmadispatch.com/news/ma-hta-roundtable-an-important-conversation 2018-12-04T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-recognised-for-corporate-volunteering-program 2018-12-04T05:00:01+11:00 https://pharmadispatch.com/news/sector-working-through-new-cso-details 2018-12-04T05:00:01+11:00 https://pharmadispatch.com/news/dhl-announces-new-partnership-with-chemist-warehouse 2018-12-04T05:00:01+11:00 https://pharmadispatch.com/news/change-on-the-way-for-department-of-health 2018-12-04T05:00:01+11:00 https://pharmadispatch.com/news/gilead-announces-2019-fellowship-grants 2018-12-03T05:00:01+11:00 https://pharmadispatch.com/news/new-cso-guidelines-give-dhl-a-choice 2018-12-03T05:00:01+11:00 https://pharmadispatch.com/news/a-smart-move-that-appears-to-resolve-nothing 2018-12-03T05:00:01+11:00 https://pharmadispatch.com/news/what-is-the-cso-and-its-purpose 2018-12-03T05:00:01+11:00 https://pharmadispatch.com/news/labor-to-launch-root-and-branch-review-of-research 2018-12-03T05:00:01+11:00 https://pharmadispatch.com/news/cso-review-no-ban-on-exclusive-direct-distribution 2018-11-30T05:00:01+11:00 https://pharmadispatch.com/news/agenda-confirmed-for-next-weeks-hta-roundtable 2018-11-30T05:00:01+11:00 https://pharmadispatch.com/news/a-landmark-moment-in-pbs-history 2018-11-30T05:00:01+11:00 https://pharmadispatch.com/news/first-recipient-of-the-macquarie-university-pharmaceutical-schol 2018-11-30T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-makes-cancer-medicines-the-focus-for-december 2018-11-30T05:00:01+11:00 https://pharmadispatch.com/news/more-discussion-is-only-leading-to-more-disagreement 2018-11-29T05:00:01+11:00 https://pharmadispatch.com/news/new-director-for-asmi 2018-11-29T05:00:01+11:00 https://pharmadispatch.com/news/other-groups-excluded-from-new-funding-agreements 2018-11-29T05:00:01+11:00 https://pharmadispatch.com/news/federal-court-backs-lundbeck-in-lexapro-case 2018-11-29T05:00:01+11:00 https://pharmadispatch.com/news/ten-pre-election-parliamentary-sitting-days 2018-11-28T08:40:01+11:00 https://pharmadispatch.com/news/a-narrow-path-just-narrowed-further 2018-11-28T05:00:01+11:00 https://pharmadispatch.com/news/australian-company-updates-on-alzheimers-clinical-trial 2018-11-28T05:00:01+11:00 https://pharmadispatch.com/news/pm-drops-hint-on-agreement-extension 2018-11-28T05:00:01+11:00 https://pharmadispatch.com/news/zelda-partners-with-st-vincents-hospital-on-opioid-reduction-stu 2018-11-28T05:00:01+11:00 https://pharmadispatch.com/news/international-comparisons-not-so-easy-1 2018-11-27T05:00:01+11:00 https://pharmadispatch.com/news/biosimilars-competitive-forces-generally-act-more-slowly 2018-11-27T05:00:01+11:00 https://pharmadispatch.com/news/government-pushes-for-work-on-new-therapeutic-group-framework 2018-11-27T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-calls-hta-roundtable 2018-11-27T05:00:01+11:00 https://pharmadispatch.com/news/clock-ticking-on-key-issues-as-election-rapidly-approaches 2018-11-26T05:00:01+11:00 https://pharmadispatch.com/news/in-the-end-will-the-government-just-want-savings 2018-11-26T05:00:01+11:00 https://pharmadispatch.com/news/government-receipts-continue-to-boom 2018-11-26T05:00:01+11:00 https://pharmadispatch.com/news/mixed-result-for-australia-in-new-innovation-report 2018-11-26T05:00:01+11:00 https://pharmadispatch.com/news/government-expands-access-to-continuous-glucose-monitoring-devic 2018-11-26T05:00:01+11:00 https://pharmadispatch.com/news/spa-reform-could-push-pharma-into-financial-services 2018-11-23T05:00:01+11:00 https://pharmadispatch.com/news/pharmac-six-months-to-switch-to-biosimilar 2018-11-23T05:00:01+11:00 https://pharmadispatch.com/news/pharmacy-still-lags-natural-therapies 2018-11-23T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-says-farewell-to-west-ryde 2018-11-23T05:00:01+11:00 https://pharmadispatch.com/news/therapeutic-groups-20-years-of-torment 2018-11-22T05:00:01+11:00 https://pharmadispatch.com/news/no-shortage-of-candidates-for-therapeutic-groups 2018-11-22T05:00:01+11:00 https://pharmadispatch.com/news/queensland-ms-cell-therapy-advances-in-trial 2018-11-22T05:00:01+11:00 https://pharmadispatch.com/news/could-this-be-the-new-norm 2018-11-22T05:00:01+11:00 https://pharmadispatch.com/news/the-consequences-of-rd-tax-change-not-unintended 2018-11-21T05:00:01+11:00 https://pharmadispatch.com/news/are-new-therapeutic-groups-an-option 2018-11-21T05:00:01+11:00 https://pharmadispatch.com/news/more-confirmed-speakers-for-pharmadispatch-2019 2018-11-21T05:00:01+11:00 https://pharmadispatch.com/news/pharmacy-to-evolve-in-response-to-medicine-complexity 2018-11-21T05:00:01+11:00 https://pharmadispatch.com/news/escrow-model-most-likely-for-spa-reform 2018-11-20T05:00:01+11:00 https://pharmadispatch.com/news/what-are-these-unpublished-reviews 2018-11-20T05:00:01+11:00 https://pharmadispatch.com/news/dis-tops-200000-participants 2018-11-20T05:00:01+11:00 https://pharmadispatch.com/news/is-that-consulting-or-informing 2018-11-19T05:00:01+11:00 https://pharmadispatch.com/news/rva-welcomes-funding-for-rare-disease-framework 2018-11-19T05:00:01+11:00 https://pharmadispatch.com/news/allergan-partners-with-glaucoma-australia 2018-11-19T05:00:01+11:00 https://pharmadispatch.com/news/rd-tax-change-driven-by-savings-target 2018-11-19T05:00:01+11:00 https://pharmadispatch.com/news/government-tables-report-response 2018-11-19T05:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-reports-new-positive-results-for-loxl2-program 2018-11-16T05:00:01+11:00 https://pharmadispatch.com/news/government-extends-cso-contracts-and-links-outcome-to-spa-change 2018-11-16T05:00:01+11:00 https://pharmadispatch.com/news/industry-executive-to-lead-anatara 2018-11-16T05:00:01+11:00 https://pharmadispatch.com/news/novartis-confirms-alcon-spinoff-details 2018-11-16T05:00:01+11:00 https://pharmadispatch.com/news/industry-looks-for-protections-on-pathway-reforms 2018-11-15T05:00:01+11:00 https://pharmadispatch.com/news/mpa-meets-for-regular-catch-up 2018-11-15T05:00:01+11:00 https://pharmadispatch.com/news/government-extends-my-health-record-opt-out-period 2018-11-15T05:00:01+11:00 https://pharmadispatch.com/news/sa-recognition-for-novartis 2018-11-15T05:00:01+11:00 https://pharmadispatch.com/news/government-confirms-savings-shortfall 2018-11-14T05:00:01+11:00 https://pharmadispatch.com/news/swisse-wins-china-brand-award 2018-11-14T05:00:01+11:00 https://pharmadispatch.com/news/senate-wants-government-response-on-cancer-report 2018-11-14T05:00:01+11:00 https://pharmadispatch.com/news/us-supply-to-pbs-a-factor-in-trade 2018-11-14T05:00:01+11:00 https://pharmadispatch.com/news/labor-moves-to-force-mhr-opt-out-extension 2018-11-14T05:00:01+11:00 https://pharmadispatch.com/news/compare-and-contrast-the-approach 2018-11-13T05:00:01+11:00 https://pharmadispatch.com/news/major-changes-for-bionomics 2018-11-13T05:00:01+11:00 https://pharmadispatch.com/news/new-study-backs-dpp-4-on-cv-risks 2018-11-13T05:00:01+11:00 https://pharmadispatch.com/news/survey-reveals-patient-practice-gap 2018-11-13T05:00:01+11:00 https://pharmadispatch.com/news/ex-ma-ceo-loses-preselection-battle 2018-11-13T05:00:01+11:00 https://pharmadispatch.com/news/could-this-gift-the-reform-pursued-since-1995 2018-11-12T05:00:01+11:00 https://pharmadispatch.com/news/these-are-the-examples-we-know-about-it 2018-11-12T05:00:01+11:00 https://pharmadispatch.com/news/the-incident-that-captures-the-risk 2018-11-12T05:00:01+11:00 https://pharmadispatch.com/news/patients-gather-for-healthevoices-conference 2018-11-12T05:00:01+11:00 https://pharmadispatch.com/news/is-this-a-system-that-weaponises-the-department-of-finance 2018-11-09T04:00:01+11:00 https://pharmadispatch.com/news/is-it-time-to-start-preparing-again 2018-11-09T04:00:01+11:00 https://pharmadispatch.com/news/melanoma-researchers-win-gsk-award-for-research-excellence 2018-11-09T04:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-otsuka-australia 2018-11-09T04:00:01+11:00 https://pharmadispatch.com/news/amgen-extends-science-program-to-australia 2018-11-09T04:00:01+11:00 https://pharmadispatch.com/news/bms-creates-magical-morning-for-camp-quality-kids 2018-11-09T04:00:01+11:00 https://pharmadispatch.com/news/does-it-make-the-system-better-for-patients 2018-11-08T05:00:01+11:00 https://pharmadispatch.com/news/industry-experts-guide-researchers-and-entrepreneurs 2018-11-08T05:00:01+11:00 https://pharmadispatch.com/news/research-australia-calls-on-senate-to-scrap-rd-tax-changes 2018-11-08T05:00:01+11:00 https://pharmadispatch.com/news/department-calls-industry-pricing-forums 2018-11-08T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-extends-alliance-with-mtpconnect 2018-11-07T05:19:01+11:00 https://pharmadispatch.com/news/another-example-of-prioritisation 2018-11-07T05:00:01+11:00 https://pharmadispatch.com/news/ma-concerned-if-submission-pathways-re-purposed 2018-11-07T05:00:01+11:00 https://pharmadispatch.com/news/nps-review-underway-but-more-to-come 2018-11-07T05:00:01+11:00 https://pharmadispatch.com/news/is-priority-a-good-word-when-it-comes-to-the-pbs 2018-11-06T05:00:01+11:00 https://pharmadispatch.com/news/nps-grows-non-government-revenue 2018-11-06T05:00:01+11:00 https://pharmadispatch.com/news/pbs-not-the-only-program-with-a-payment-lag 2018-11-06T05:00:01+11:00 https://pharmadispatch.com/news/under-co-pay-market-still-growing-strongly 2018-11-06T05:00:01+11:00 https://pharmadispatch.com/news/constant-work-to-evolve-funding-systems 2018-11-05T05:00:01+11:00 https://pharmadispatch.com/news/pharma-facing-period-of-uncertainty-and-change 2018-11-05T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-highlights-success-of-national-conference 2018-11-05T05:00:01+11:00 https://pharmadispatch.com/news/dusc-reports-on-hcv-uptake 2018-11-05T05:00:01+11:00 https://pharmadispatch.com/news/give-pharmaceuticals-bespoke-chapter 2018-11-04T16:37:01+11:00 https://pharmadispatch.com/news/perpetual-announces-new-biomedical-research-awards 2018-11-02T05:00:01+11:00 https://pharmadispatch.com/news/exclusive-ey-report-on-payment-model-skips-vial-sharing 2018-11-02T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-confirms-board-line-up-at-agm 2018-11-02T05:00:01+11:00 https://pharmadispatch.com/news/ma-challenges-escrow-model 2018-11-02T05:00:01+11:00 https://pharmadispatch.com/news/ex-ma-boss-chasing-pre-selection 2018-11-01T05:00:01+11:00 https://pharmadispatch.com/news/a-big-day-for-amicus-therapeutics-in-australia 2018-11-01T05:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-regenerative-medicine-opportunity 2018-11-01T05:00:01+11:00 https://pharmadispatch.com/news/recognition-for-dr-anna-lavelle 2018-11-01T05:00:01+11:00 https://pharmadispatch.com/news/takeda-announces-cockpi-t-australia-2018-research-grants 2018-11-01T05:00:01+11:00 https://pharmadispatch.com/news/pku-patients-hopeful-on-access-to-treatment 2018-10-31T05:00:01+11:00 https://pharmadispatch.com/news/biocurate-signs-first-pharma-agreement-with-novartis 2018-10-31T05:00:01+11:00 https://pharmadispatch.com/news/industry-unsure-on-any-agreement-extension 2018-10-31T05:00:01+11:00 https://pharmadispatch.com/news/lauren-carey-car-t-requires-a-paradigm-shift 2018-10-31T05:00:01+11:00 https://pharmadispatch.com/news/us-move-to-international-reference-pricing 2018-10-30T05:00:01+11:00 https://pharmadispatch.com/news/court-orders-damages-over-venlafaxine-injunction 2018-10-30T05:00:01+11:00 https://pharmadispatch.com/news/further-evidence-of-disagreement-over-new-payment-system 2018-10-30T05:00:01+11:00 https://pharmadispatch.com/news/az-launches-school-based-food-program 2018-10-30T05:00:01+11:00 https://pharmadispatch.com/news/psa-partners-on-6cpa-program-administration 2018-10-29T09:26:01+11:00 https://pharmadispatch.com/news/a-new-face-for-medicines-australia-board 2018-10-29T05:00:01+11:00 https://pharmadispatch.com/news/for-how-long-can-the-new-fund-distribution-of-the-old 2018-10-29T04:00:01+11:00 https://pharmadispatch.com/news/az-backing-schools-based-food-program 2018-10-29T04:00:01+11:00 https://pharmadispatch.com/news/court-delivers-outcome-on-venlafaxine-damages 2018-10-29T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-more-november-listings 2018-10-29T04:00:01+11:00 https://pharmadispatch.com/news/new-documents-reveal-impact-of-humira-biosimilars 2018-10-29T04:00:01+11:00 https://pharmadispatch.com/news/still-not-sharing-cost-recovery-modelling 2018-10-26T05:00:01+11:00 https://pharmadispatch.com/news/industry-seeking-nominations-for-pbac-appointment 2018-10-26T05:00:01+11:00 https://pharmadispatch.com/news/ma-welcomes-governments-mou-with-us-medical-research-leader 2018-10-26T05:00:01+11:00 https://pharmadispatch.com/news/nsw-extends-pharmacy-administered-vaccines 2018-10-26T05:00:01+11:00 https://pharmadispatch.com/news/health-insurers-reveal-high-cost-cancer-claims 2018-10-25T05:00:01+11:00 https://pharmadispatch.com/news/inn-prescribing-in-2019 2018-10-25T05:00:01+11:00 https://pharmadispatch.com/news/one-million-australians-at-risk-of-iron-deficiency 2018-10-25T05:00:01+11:00 https://pharmadispatch.com/news/officials-acknowledge-there-is-not-a-new-listing-every-day 2018-10-25T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-starts-november-listing-announcements 2018-10-24T05:00:01+11:00 https://pharmadispatch.com/news/call-for-action-on-lung-cancer 2018-10-24T02:00:01+11:00 https://pharmadispatch.com/news/advance-rebate-payments-as-new-deeds-impose-reform 2018-10-24T02:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-new-senate-inquiry 2018-10-24T02:00:01+11:00 https://pharmadispatch.com/news/ma-to-consider-new-board-vacancy 2018-10-23T05:00:01+11:00 https://pharmadispatch.com/news/new-study-backs-keytruda-in-bladder-cancer 2018-10-23T05:00:01+11:00 https://pharmadispatch.com/news/msd-progress-on-biosimilar-uptake-but-more-required 2018-10-23T05:00:01+11:00 https://pharmadispatch.com/news/so-who-is-responsible-for-the-pbs 2018-10-23T05:00:01+11:00 https://pharmadispatch.com/news/complicating-the-already-complicated 2018-10-22T05:00:01+11:00 https://pharmadispatch.com/news/companies-start-contemplating-caretaker 2018-10-22T05:00:01+11:00 https://pharmadispatch.com/news/industry-nerves-on-special-pricing-arrangements 2018-10-22T05:00:01+11:00 https://pharmadispatch.com/news/companies-join-walk-to-end-stigma 2018-10-22T05:00:01+11:00 https://pharmadispatch.com/news/guild-backs-government-intervention-on-entitlements 2018-10-19T01:00:01+11:00 https://pharmadispatch.com/news/parliament-backs-tpp-legislation 2018-10-19T01:00:01+11:00 https://pharmadispatch.com/news/merck-gets-behind-national-carers-week 2018-10-19T01:00:01+11:00 https://pharmadispatch.com/news/two-key-industry-appointments 2018-10-19T01:00:01+11:00 https://pharmadispatch.com/news/abbvie-launches-discover-series 2018-10-19T01:00:01+11:00 https://pharmadispatch.com/news/api-highlights-impact-of-direct-distribution-in-results 2018-10-19T01:00:01+11:00 https://pharmadispatch.com/news/companies-repay-1-in-5-pbs-dollars 2018-10-18T02:00:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-new-venclexta-approval 2018-10-18T02:00:01+11:00 https://pharmadispatch.com/news/canadian-government-faces-scrutiny-over-data-protection-extensio 2018-10-18T02:00:01+11:00 https://pharmadispatch.com/news/no-share-split-for-csl 2018-10-18T02:00:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-red-flags-for-pbs 2018-10-17T02:00:01+11:00 https://pharmadispatch.com/news/abbvie-makes-global-top-25-best-place-to-work 2018-10-17T02:00:01+11:00 https://pharmadispatch.com/news/psa-welcomes-queensland-inquiry-recommendations 2018-10-17T02:00:01+11:00 https://pharmadispatch.com/news/three-down-from-lundbeck-in-lexapro-patent-case 2018-10-17T02:00:01+11:00 https://pharmadispatch.com/news/rebates-fall-but-net-spending-up 2018-10-16T11:19:01+11:00 https://pharmadispatch.com/news/new-leadership-for-bristol-myers-squibb 2018-10-16T02:00:01+11:00 https://pharmadispatch.com/news/annual-cost-of-migraine-tops-35-billion 2018-10-16T02:00:01+11:00 https://pharmadispatch.com/news/labor-moves-to-block-trade-related-pbs-changes 2018-10-16T02:00:01+11:00 https://pharmadispatch.com/news/annual-report-reveals-faster-response-times 2018-10-16T02:00:01+11:00 https://pharmadispatch.com/news/lillys-libby-driscoll-not-just-another-headache 2018-10-15T02:00:01+11:00 https://pharmadispatch.com/news/the-burden-of-migraine 2018-10-15T02:00:01+11:00 https://pharmadispatch.com/news/pharmacy-backs-national-consistency-on-vaccination 2018-10-15T02:00:01+11:00 https://pharmadispatch.com/news/abbvie-secures-another-humira-victory 2018-10-15T02:00:01+11:00 https://pharmadispatch.com/news/cancer-services-covered-across-all-phi-categories 2018-10-15T02:00:01+11:00 https://pharmadispatch.com/news/two-down-as-pfizer-settles-pbs-damages-case 2018-10-12T04:00:01+11:00 https://pharmadispatch.com/news/us-bans-drug-gag-orders 2018-10-12T04:00:01+11:00 https://pharmadispatch.com/news/guild-welcomes-faster-business-tax-cuts 2018-10-12T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-moving-on-car-t-access 2018-10-12T04:00:01+11:00 https://pharmadispatch.com/news/csl-announces-fellowship-recipients 2018-10-12T04:00:01+11:00 https://pharmadispatch.com/news/department-of-health-confirms-taa-leadership 2018-10-11T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-launches-2018-21-strategic-plan 2018-10-11T05:00:01+11:00 https://pharmadispatch.com/news/sector-awaits-cso-review-outcome 2018-10-11T05:00:01+11:00 https://pharmadispatch.com/news/abbvie-hosts-cancer-moonshot-seminar 2018-10-11T05:00:01+11:00 https://pharmadispatch.com/news/emerging-sense-of-disillusion-about-agreement 2018-10-10T05:00:01+11:00 https://pharmadispatch.com/news/csl-donates-to-indonesia-earthquake 2018-10-10T05:00:01+11:00 https://pharmadispatch.com/news/at-least-its-better-than-portugal 2018-10-10T05:00:01+11:00 https://pharmadispatch.com/news/psa-welcomes-royal-commission-terms-of-reference 2018-10-10T05:00:01+11:00 https://pharmadispatch.com/news/gsk-extends-parental-leave-benefits 2018-10-09T05:00:01+11:00 https://pharmadispatch.com/news/investors-cheer-new-green-whistle-deal 2018-10-09T05:00:01+11:00 https://pharmadispatch.com/news/new-spinraza-data-points-to-earlier-treatment 2018-10-09T05:00:01+11:00 https://pharmadispatch.com/news/who-remembers-the-vancouver-poster 2018-10-08T05:00:01+11:00 https://pharmadispatch.com/news/gst-highlights-complexity-of-new-payment-system 2018-10-08T04:00:01+11:00 https://pharmadispatch.com/news/no-progress-on-spa-review 2018-10-08T04:00:01+11:00 https://pharmadispatch.com/news/pharmadispatch-2019-post-election-political-implications 2018-10-08T04:00:01+11:00 https://pharmadispatch.com/news/novartis-to-host-world-hospital-congress-symposium 2018-10-08T04:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-funding-for-trial-of-new-stroke-treatment 2018-10-07T05:00:01+11:00 https://pharmadispatch.com/news/new-patient-support-organisation-focused-on-gaucher-disease 2018-10-05T04:00:01+10:00 https://pharmadispatch.com/news/extended-listing-for-janssens-simponi 2018-10-05T04:00:01+10:00 https://pharmadispatch.com/news/new-study-highlights-impact-of-hpv-vaccine 2018-10-05T04:00:01+10:00 https://pharmadispatch.com/news/ma-review-cross-subsidisation-model 2018-10-05T04:00:01+10:00 https://pharmadispatch.com/news/new-chair-starts-for-mtpconnect 2018-10-04T05:00:01+10:00 https://pharmadispatch.com/news/msd-pan-tumour-a-once-in-a-generation-opportunity 2018-10-04T05:00:01+10:00 https://pharmadispatch.com/news/ma-backs-ip-changes-in-response-to-us-trade-push 2018-10-04T05:00:01+10:00 https://pharmadispatch.com/news/gsk-announces-plan-to-ease-payment-ban 2018-10-04T05:00:01+10:00 https://pharmadispatch.com/news/phased-implementation-to-overcome-sector-disagreement 2018-10-03T05:00:01+10:00 https://pharmadispatch.com/news/what-happens-if-the-us-targets-australia 2018-10-03T05:00:01+10:00 https://pharmadispatch.com/news/melbourne-based-biotron-reports-positive-results-from-phase-2-hi 2018-10-03T05:00:01+10:00 https://pharmadispatch.com/news/nobel-prize-for-immunotherapy-scientists 2018-10-03T05:00:01+10:00 https://pharmadispatch.com/news/bms-system-needs-to-do-better 2018-10-03T05:00:01+10:00 https://pharmadispatch.com/news/ministers-confirm-government-sticking-with-cost-offset-rule 2018-10-02T03:00:01+10:00 https://pharmadispatch.com/news/final-guidelines-reveal-minor-changes 2018-10-02T03:00:01+10:00 https://pharmadispatch.com/news/canada-backs-pharma-ip-extension 2018-10-02T03:00:01+10:00 https://pharmadispatch.com/news/new-submission-process-key-to-any-pan-tumour-change 2018-10-02T03:00:01+10:00 https://pharmadispatch.com/news/pfizer-announces-ceo-succession 2018-10-02T03:00:01+10:00 https://pharmadispatch.com/news/one-third-of-consumer-spending-on-other-medicines 2018-10-01T03:00:01+10:00 https://pharmadispatch.com/news/what-would-be-the-reaction 2018-09-28T05:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-more-work-to-be-done-on-processes 2018-09-28T05:00:01+10:00 https://pharmadispatch.com/news/industry-bodies-unite-ahead-of-victorian-election 2018-09-28T05:00:01+10:00 https://pharmadispatch.com/news/allergan-marks-50-years-with-pop-up-gallery 2018-09-28T05:00:01+10:00 https://pharmadispatch.com/news/two-decades-of-reform-based-on-a-false-premise 2018-09-27T05:00:01+10:00 https://pharmadispatch.com/news/new-process-gives-pbac-power-to-prioritise 2018-09-27T05:00:01+10:00 https://pharmadispatch.com/news/registrations-open-for-pharmadispatch-2019 2018-09-27T05:00:01+10:00 https://pharmadispatch.com/news/lilly-backs-recognition-for-diabetes-educator 2018-09-27T05:00:01+10:00 https://pharmadispatch.com/news/the-pbs-as-collateral-damage 2018-09-26T05:00:01+10:00 https://pharmadispatch.com/news/higher-fees-for-new-processes-based-on-submission-categories 2018-09-26T05:00:01+10:00 https://pharmadispatch.com/news/allergan-goes-artistic-to-mark-50-years-in-australia 2018-09-26T05:00:01+10:00 https://pharmadispatch.com/news/new-australian-collaboration-for-merck-and-pfizers-immunotherapy 2018-09-26T05:00:01+10:00 https://pharmadispatch.com/news/mundipharmas-jane-orr-company-open-to-possibilities 2018-09-26T05:00:01+10:00 https://pharmadispatch.com/news/different-presentation-different-result-on-pbs-spend 2018-09-25T12:44:01+10:00 https://pharmadispatch.com/news/review-will-involve-public-consultation 2018-09-25T05:00:01+10:00 https://pharmadispatch.com/news/you-just-read-it-and-laugh-out-loud 2018-09-25T05:00:01+10:00 https://pharmadispatch.com/news/msd-raises-money-for-drought-affected-communities 2018-09-25T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-new-vaccine-funding 2018-09-25T05:00:01+10:00 https://pharmadispatch.com/news/the-commercialisation-of-nps-medicinewise 2018-09-24T05:01:01+10:00 https://pharmadispatch.com/news/uk-industry-slams-court-decision-on-unapproved-use 2018-09-24T05:00:01+10:00 https://pharmadispatch.com/news/the-challenge-for-an-evolving-organisation 2018-09-24T05:00:01+10:00 https://pharmadispatch.com/news/opdivo-secures-approval-for-11th-indication 2018-09-24T05:00:01+10:00 https://pharmadispatch.com/news/gsk-and-mmv-announce-kozenis-approval 2018-09-24T05:00:01+10:00 https://pharmadispatch.com/news/government-to-review-nps-medicinewise 2018-09-21T05:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-2018-value-of-medicines-award 2018-09-21T05:00:01+10:00 https://pharmadispatch.com/news/apotex-arrow-merger-to-close-by-end-of-year 2018-09-21T05:00:01+10:00 https://pharmadispatch.com/news/us-business-leaders-pushing-for-stronger-ip 2018-09-21T05:00:01+10:00 https://pharmadispatch.com/news/a-subtle-shift-might-be-more-likely-than-re-regulation 2018-09-20T05:00:01+10:00 https://pharmadispatch.com/news/mundipharma-welcomes-registration-of-naloxone-nasal-spray 2018-09-20T05:00:01+10:00 https://pharmadispatch.com/news/first-new-malaria-treatment-in-two-decades 2018-09-20T05:00:01+10:00 https://pharmadispatch.com/news/former-industry-leaders-join-china-incubator 2018-09-20T05:00:01+10:00 https://pharmadispatch.com/news/promotion-for-former-lundbeck-australia-boss 2018-09-19T05:00:01+10:00 https://pharmadispatch.com/news/consumers-central-to-any-review-of-national-medicines-policy 2018-09-19T05:00:01+10:00 https://pharmadispatch.com/news/opthea-initiates-first-australian-patients-in-dme-trial 2018-09-19T05:00:01+10:00 https://pharmadispatch.com/news/it-really-is-about-getting-the-basics-right 2018-09-19T05:00:01+10:00 https://pharmadispatch.com/news/catherine-king-promotes-legislated-medicines-fund 2018-09-18T05:00:01+10:00 https://pharmadispatch.com/news/pbs-will-not-pick-up-the-cost-of-bad-investment-decisions 2018-09-18T05:00:01+10:00 https://pharmadispatch.com/news/csl-behring-welcomes-new-approval 2018-09-18T05:00:01+10:00 https://pharmadispatch.com/news/di-natale-thank-you-for-the-work-that-you-do 2018-09-18T05:00:01+10:00 https://pharmadispatch.com/news/andrew-wilson-not-a-numbers-game 2018-09-17T11:37:01+10:00 https://pharmadispatch.com/news/no-parallel-process-for-biosimilars 2018-09-17T05:00:01+10:00 https://pharmadispatch.com/news/us-secures-pricing-policy-changes-from-korea 2018-09-17T05:00:01+10:00 https://pharmadispatch.com/news/ma-sponsored-report-highlights-economic-impact-of-early-retireme 2018-09-17T05:00:01+10:00 https://pharmadispatch.com/news/industry-veteran-to-launch-new-consultancy 2018-09-17T05:00:01+10:00 https://pharmadispatch.com/news/expanded-listings-for-celgene-and-roche-cancer-medicines 2018-09-17T05:00:01+10:00 https://pharmadispatch.com/news/ma-moving-house-after-15-years 2018-09-14T05:00:01+10:00 https://pharmadispatch.com/news/health-still-ranks-1-issue-for-australians 2018-09-14T05:00:01+10:00 https://pharmadispatch.com/news/urbulence-early-impressions-priorities-policy-leadership-and-a-n 2018-09-14T05:00:01+10:00 https://pharmadispatch.com/news/industry-to-gather-for-pharmaus18 2018-09-13T17:49:01+10:00 https://pharmadispatch.com/news/msd-welcomes-hr-recognition 2018-09-13T05:00:01+10:00 https://pharmadispatch.com/news/biomarin-hopeful-as-therapy-navigates-new-lsdp-process 2018-09-13T05:00:01+10:00 https://pharmadispatch.com/news/sydney-based-cellmid-announces-positive-trial-result 2018-09-13T05:00:01+10:00 https://pharmadispatch.com/news/more-speakers-confirmed-for-pharmadispatch-2019 2018-09-13T05:00:01+10:00 https://pharmadispatch.com/news/mandatory-reporting-as-companies-face-demands-for-preferential-t 2018-09-12T05:00:01+10:00 https://pharmadispatch.com/news/unity-on-potential-change-to-orphan-drug-limit 2018-09-12T05:00:01+10:00 https://pharmadispatch.com/news/bi-secures-change-for-pradaxa 2018-09-12T05:00:01+10:00 https://pharmadispatch.com/news/catherine-king-sustainable-funding-a-priority 2018-09-12T05:00:01+10:00 https://pharmadispatch.com/news/still-no-agreement-on-payment-model-as-clock-ticks 2018-09-11T05:00:01+10:00 https://pharmadispatch.com/news/an-issue-that-will-not-simply-go-away 2018-09-11T05:00:01+10:00 https://pharmadispatch.com/news/stakeholders-gather-for-canforum-2018 2018-09-11T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-its-all-about-access-to-medicines 2018-09-11T05:00:01+10:00 https://pharmadispatch.com/news/could-six-become-seven-before-the-end-of-2018 2018-09-10T05:00:01+10:00 https://pharmadispatch.com/news/ma-price-cut-guidelines-will-be-revised 2018-09-10T05:00:01+10:00 https://pharmadispatch.com/news/uk-hits-back-at-industry-over-pricing 2018-09-10T05:00:01+10:00 https://pharmadispatch.com/news/new-collaboration-for-melbournes-monash 2018-09-10T05:00:01+10:00 https://pharmadispatch.com/news/labor-moves-back-to-health 2018-09-10T05:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-companies-elect-new-board-member 2018-09-07T17:30:01+10:00 https://pharmadispatch.com/news/greg-hunt-loses-key-staffer 2018-09-07T04:00:01+10:00 https://pharmadispatch.com/news/sigma-profit-falls-but-sticks-with-guidance 2018-09-07T04:00:01+10:00 https://pharmadispatch.com/news/optheas-opt-302-trial-to-continue-after-positive-review 2018-09-07T04:00:01+10:00 https://pharmadispatch.com/news/starting-the-process-of-re-engagement 2018-09-07T04:00:01+10:00 https://pharmadispatch.com/news/ma-hosts-all-day-policy-meeting 2018-09-06T05:00:01+10:00 https://pharmadispatch.com/news/has-it-ever-been-more-important 2018-09-06T05:00:01+10:00 https://pharmadispatch.com/news/ma-appoints-ex-labor-staffer-to-lead-public-affairs 2018-09-06T05:00:01+10:00 https://pharmadispatch.com/news/industry-backs-labor-on-piwg 2018-09-06T05:00:01+10:00 https://pharmadispatch.com/news/kim-carr-dont-fall-for-the-three-card-trick 2018-09-05T04:05:01+10:00 https://pharmadispatch.com/news/waiting-for-progress-as-implementation-day-approaches 2018-09-05T04:02:01+10:00 https://pharmadispatch.com/news/labor-to-re-establish-key-industry-pbs-dialogue 2018-09-05T04:02:01+10:00 https://pharmadispatch.com/news/polyactiva-recruits-first-patient-in-new-study 2018-09-05T04:01:01+10:00 https://pharmadispatch.com/news/change-required-to-ensure-patient-voice 2018-09-04T04:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-ceo-lorraine-chiroiu-on-early-impressions-and-future- 2018-09-04T04:00:01+10:00 https://pharmadispatch.com/news/psa-still-seeking-feedback-on-discussion-paper 2018-09-04T04:00:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-exchange-students-to-sydney-hq 2018-09-04T04:00:01+10:00 https://pharmadispatch.com/news/a-system-that-has-become-about-winners-and-losers 2018-09-03T05:00:01+10:00 https://pharmadispatch.com/news/trump-agree-or-canada-will-be-out 2018-09-03T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-first-two-international-speakers 2018-09-03T05:00:01+10:00 https://pharmadispatch.com/news/vertex-welcomes-accelerated-orkambi-listing 2018-09-03T05:00:01+10:00 https://pharmadispatch.com/news/the-dire-consequences-of-winners-and-losers 2018-09-03T05:00:01+10:00 https://pharmadispatch.com/news/sta-welcomes-expanded-listing-for-iclusig 2018-09-03T05:00:01+10:00 https://pharmadispatch.com/news/gsk-launches-new-reconciliation-action-plan 2018-08-31T05:00:01+10:00 https://pharmadispatch.com/news/minister-to-announce-members-of-lsdp-expert-panel 2018-08-31T05:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-hcp-payment-reports 2018-08-31T05:00:01+10:00 https://pharmadispatch.com/news/what-does-a-variation-mean 2018-08-30T05:00:01+10:00 https://pharmadispatch.com/news/another-day-another-problem 2018-08-30T05:00:01+10:00 https://pharmadispatch.com/news/viiv-announces-grants-for-hiv-community-programs 2018-08-30T05:00:01+10:00 https://pharmadispatch.com/news/abbvie-wins-recognition 2018-08-30T05:00:01+10:00 https://pharmadispatch.com/news/us-secures-major-data-protection-victory 2018-08-29T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-honoured-and-humbled-to-be-reappointed 2018-08-29T05:00:01+10:00 https://pharmadispatch.com/news/this-is-not-a-legal-issue-it-is-about-a-written-signed-and-state 2018-08-29T05:00:01+10:00 https://pharmadispatch.com/news/patrys-teams-up-with-walter-and-eliza-hall-institute 2018-08-29T05:00:01+10:00 https://pharmadispatch.com/news/companies-gather-for-urgent-meeting-on-price-cut-guidelines 2018-08-28T05:00:01+10:00 https://pharmadispatch.com/news/what-did-the-minister-say 2018-08-28T05:00:01+10:00 https://pharmadispatch.com/news/winners-of-jj-victorian-quickfire-challenge 2018-08-28T05:00:01+10:00 https://pharmadispatch.com/news/ma-ceo-association-will-act-to-address-price-cut-guidelines 2018-08-28T05:00:01+10:00 https://pharmadispatch.com/news/from-will-to-can-and-now-conditional-criteria 2018-08-27T05:00:01+10:00 https://pharmadispatch.com/news/minister-reappointed-but-things-will-be-different 2018-08-27T05:00:01+10:00 https://pharmadispatch.com/news/biogen-welcomes-medsafe-approval-of-spinraza 2018-08-27T05:00:01+10:00 https://pharmadispatch.com/news/global-vision-for-specialised-therapeutics 2018-08-27T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-reappointed-to-health-portfolio 2018-08-26T13:34:01+10:00 https://pharmadispatch.com/news/no-health-ministers-in-new-leadership 2018-08-24T12:00:01+10:00 https://pharmadispatch.com/news/azs-chatwin-time-for-a-new-approach 2018-08-24T05:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-launches-2018-value-of-medicines-award 2018-08-24T05:00:01+10:00 https://pharmadispatch.com/news/neuren-receives-initial-payment-from-acadia 2018-08-24T05:00:01+10:00 https://pharmadispatch.com/news/ebos-reports-earnings-jump-despite-pbs-reforms-and-hcv-decline 2018-08-24T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-resigns-as-leadership-comes-to-a-head 2018-08-23T11:04:01+10:00 https://pharmadispatch.com/news/recommended-but-not-listing-any-time-soon 2018-08-23T05:00:01+10:00 https://pharmadispatch.com/news/insights-from-msds-michael-azrak 2018-08-23T05:00:01+10:00 https://pharmadispatch.com/news/timing-a-challenge-at-november-pbac 2018-08-23T05:00:01+10:00 https://pharmadispatch.com/news/patients-welcome-new-migraine-option 2018-08-23T05:00:01+10:00 https://pharmadispatch.com/news/ma-pre-empt-to-avoid-surprises 2018-08-22T04:00:01+10:00 https://pharmadispatch.com/news/sector-facing-its-now-what-moment 2018-08-22T04:00:01+10:00 https://pharmadispatch.com/news/pfizers-melissa-mcgregor-how-were-working-today-and-tomorrow 2018-08-22T04:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-impact-of-new-ms-treatments 2018-08-22T04:00:01+10:00 https://pharmadispatch.com/news/how-can-this-be-privileged 2018-08-21T04:00:01+10:00 https://pharmadispatch.com/news/documents-are-full-of-irony 2018-08-21T04:00:01+10:00 https://pharmadispatch.com/news/doubts-re-emerge-over-the-ags-investigation 2018-08-21T04:00:01+10:00 https://pharmadispatch.com/news/department-confirms-permanent-appointment 2018-08-21T04:00:01+10:00 https://pharmadispatch.com/news/candidates-start-making-their-case 2018-08-21T04:00:01+10:00 https://pharmadispatch.com/news/seven-candidates-for-ma-board-vacancy 2018-08-20T05:00:01+10:00 https://pharmadispatch.com/news/july-pbac-immunotherapies-biosimilars-and-cystic-fibrosis 2018-08-20T05:00:01+10:00 https://pharmadispatch.com/news/documents-reveal-more-on-confidentiality-controversy 2018-08-20T05:00:01+10:00 https://pharmadispatch.com/news/evidence-of-a-deliberate-work-around 2018-08-20T05:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-any-change-ultimately-a-matter-for-government 2018-08-17T05:05:01+10:00 https://pharmadispatch.com/news/government-unhappy-as-big-day-arrives 2018-08-17T05:00:01+10:00 https://pharmadispatch.com/news/orphan-designation-change-another-barrier 2018-08-17T05:00:01+10:00 https://pharmadispatch.com/news/industry-firmly-split-on-rebate-reform-model 2018-08-17T05:00:01+10:00 https://pharmadispatch.com/news/pfizers-celebrity-doctor-on-humanising-the-industry 2018-08-16T05:00:01+10:00 https://pharmadispatch.com/news/patient-access-at-risk-over-pbac-fee-waiver 2018-08-16T05:00:01+10:00 https://pharmadispatch.com/news/investors-cheer-csl-result-and-outlook 2018-08-16T05:00:01+10:00 https://pharmadispatch.com/news/fda-approval-for-pharmaxis-manufacturing-facility 2018-08-16T05:00:01+10:00 https://pharmadispatch.com/news/transparency-is-the-first-step 2018-08-15T05:00:01+10:00 https://pharmadispatch.com/news/tga-approval-for-allergan-eye-implant 2018-08-15T05:00:01+10:00 https://pharmadispatch.com/news/vertex-working-towards-reimbursement 2018-08-14T16:52:01+10:00 https://pharmadispatch.com/news/survey-reveals-consumers-spending-200m-on-cancer-medicines 2018-08-14T05:00:01+10:00 https://pharmadispatch.com/news/shpa-optimal-health-outcomes-and-economic-objectives 2018-08-14T05:00:01+10:00 https://pharmadispatch.com/news/australians-back-pharmacy-vaccinations 2018-08-14T05:00:01+10:00 https://pharmadispatch.com/news/abbvie-part-of-investment-in-northern-qld-biotech 2018-08-14T05:00:01+10:00 https://pharmadispatch.com/news/merck-biopharma-confirms-new-australian-leader 2018-08-14T05:00:01+10:00 https://pharmadispatch.com/news/exclusive-a-unique-team-and-powerful-combination 2018-08-13T05:05:01+10:00 https://pharmadispatch.com/news/ma-announces-new-chair 2018-08-13T05:04:01+10:00 https://pharmadispatch.com/news/the-monetisation-of-vial-sharing 2018-08-13T05:00:01+10:00 https://pharmadispatch.com/news/department-of-health-responds-on-new-confidentiality-rift 2018-08-13T05:00:01+10:00 https://pharmadispatch.com/news/theres-another-word-for-maximising-drug-cost-efficiencies 2018-08-10T05:00:01+10:00 https://pharmadispatch.com/news/industry-facing-a-new-confidentiality-breach 2018-08-10T05:00:01+10:00 https://pharmadispatch.com/news/biotron-updates-on-proof-of-concept-trial 2018-08-10T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-local-open-chapter 2018-08-09T19:38:01+10:00 https://pharmadispatch.com/news/allcan-launches-cancer-patient-survey 2018-08-09T05:00:01+10:00 https://pharmadispatch.com/news/sector-gathers-for-labors-business-forum 2018-08-09T05:00:01+10:00 https://pharmadispatch.com/news/csanz-announces-bayer-supported-grant-recipients 2018-08-08T17:26:01+10:00 https://pharmadispatch.com/news/bayer-backing-heart-of-australia 2018-08-08T05:00:01+10:00 https://pharmadispatch.com/news/companies-vial-sharing-could-put-patient-safety-at-risk 2018-08-08T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-rankings-confirm-commercialisation-the-issue 2018-08-08T05:00:01+10:00 https://pharmadispatch.com/news/ex-roche-executive-to-lead-qimr-spin-out 2018-08-08T05:00:01+10:00 https://pharmadispatch.com/news/lundbeck-progresses-development-of-its-first-antibody 2018-08-07T17:00:01+10:00 https://pharmadispatch.com/news/confidentiality-at-risk-of-hindering-consultation-and-outcomes 2018-08-07T05:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-completes-successful-capital-raise 2018-08-07T05:00:01+10:00 https://pharmadispatch.com/news/vial-sharing-a-factor-in-debate-over-new-payment-system 2018-08-07T05:00:01+10:00 https://pharmadispatch.com/news/recognition-for-impact-of-medicines-study 2018-08-07T05:00:01+10:00 https://pharmadispatch.com/news/could-reference-pricing-be-an-emerging-battle 2018-08-06T05:01:01+10:00 https://pharmadispatch.com/news/nz-appoints-ex-cabinet-minister-to-chair-pharmac 2018-08-06T05:00:01+10:00 https://pharmadispatch.com/news/driven-by-the-profound-unmet-needs-of-patients 2018-08-06T05:00:01+10:00 https://pharmadispatch.com/news/companies-extend-uk-supply-as-industry-warns-on-brexit 2018-08-06T05:00:01+10:00 https://pharmadispatch.com/news/confidentially-this-is-absolutely-confidential 2018-08-03T05:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-questions-ma-approach-to-national-medicines-policy 2018-08-03T05:00:01+10:00 https://pharmadispatch.com/news/bi-and-lilly-welcome-new-guidelines 2018-08-03T05:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-cost-of-heart-disease 2018-08-03T05:00:01+10:00 https://pharmadispatch.com/news/industry-needs-to-know-what-it-wants 2018-08-02T05:00:01+10:00 https://pharmadispatch.com/news/ma-pushing-addendum-to-national-medicines-policy 2018-08-02T05:00:01+10:00 https://pharmadispatch.com/news/low-cholesterol-should-be-even-lower 2018-08-02T05:00:01+10:00 https://pharmadispatch.com/news/australias-first-guidelines-on-atrial-fibrillation 2018-08-02T05:00:01+10:00 https://pharmadispatch.com/news/ma-exclusive-critical-to-build-a-renewed-momentum 2018-08-02T05:00:01+10:00 https://pharmadispatch.com/news/building-the-dream-or-living-in-la-la-land-pbs-reform-10-years-o 2018-08-01T05:00:01+10:00 https://pharmadispatch.com/news/gbma-announces-biosimilar-national-awareness-week 2018-08-01T05:00:01+10:00 https://pharmadispatch.com/news/page-leadership-pay-gap-and-flexibility 2018-08-01T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-the-latest-to-confirm-magnitude-of-us-rebates 2018-08-01T05:00:01+10:00 https://pharmadispatch.com/news/the-real-impact-of-the-deferral-policy 2018-07-31T05:00:01+10:00 https://pharmadispatch.com/news/australian-company-progresses-eye-therapy 2018-07-31T05:00:01+10:00 https://pharmadispatch.com/news/regeneus-reports-on-cancer-vaccine-trial 2018-07-31T05:00:01+10:00 https://pharmadispatch.com/news/cochlear-completes-final-phase-of-new-brisbane-site 2018-07-31T05:00:01+10:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-goal-is-to-reach-more-people-living-wit 2018-07-30T05:00:01+10:00 https://pharmadispatch.com/news/psa-looks-to-expanded-role-for-pharmacy 2018-07-30T05:00:01+10:00 https://pharmadispatch.com/news/workshop-for-industry-gender-equity-group 2018-07-30T05:00:01+10:00 https://pharmadispatch.com/news/government-moves-to-address-hcv-treatment-decline 2018-07-30T05:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-welcomes-first-listing-in-12-years 2018-07-30T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-open-day-for-automotive-workers 2018-07-27T05:00:01+10:00 https://pharmadispatch.com/news/new-survey-medicine-use-not-quite-right 2018-07-27T05:00:01+10:00 https://pharmadispatch.com/news/bms-welcomes-new-opdivo-listing 2018-07-27T05:00:01+10:00 https://pharmadispatch.com/news/tasmanian-government-backs-pharmacy-for-vaccine-program 2018-07-27T05:00:01+10:00 https://pharmadispatch.com/news/mayne-acquires-another-us-generic 2018-07-26T05:00:01+10:00 https://pharmadispatch.com/news/ma-set-to-fill-board-vacancy 2018-07-26T05:00:01+10:00 https://pharmadispatch.com/news/new-funding-for-ai-and-cancer-projects 2018-07-26T05:00:01+10:00 https://pharmadispatch.com/news/full-year-data-but-rebates-make-it-mostly-meaningless 2018-07-26T05:00:01+10:00 https://pharmadispatch.com/news/novartis-boss-departs-for-japan 2018-07-25T11:59:01+10:00 https://pharmadispatch.com/news/laborwill-include-pbs-in-reform-commission 2018-07-25T05:00:01+10:00 https://pharmadispatch.com/news/compounders-building-support-for-payment-model 2018-07-25T05:00:01+10:00 https://pharmadispatch.com/news/jj-partners-with-childrens-ground 2018-07-25T05:00:01+10:00 https://pharmadispatch.com/news/labor-calls-for-free-vaccine 2018-07-25T05:00:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-hopeful-of-a-response 2018-07-24T05:00:01+10:00 https://pharmadispatch.com/news/new-lease-of-life-for-mas-ceo-working-group 2018-07-24T05:00:01+10:00 https://pharmadispatch.com/news/asmi-marks-international-self-care-day 2018-07-24T05:00:01+10:00 https://pharmadispatch.com/news/fda-acting-to-encourage-biosimilar-market 2018-07-24T05:00:01+10:00 https://pharmadispatch.com/news/does-not-meet-the-criteria-but-then-it-does 2018-07-23T05:05:01+10:00 https://pharmadispatch.com/news/new-leadership-but-not-a-new-challenge 2018-07-23T05:00:01+10:00 https://pharmadispatch.com/news/no-progress-as-compounders-push-alternative-model 2018-07-23T05:00:01+10:00 https://pharmadispatch.com/news/august-schedule-change-for-ivf-therapies 2018-07-23T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-acknowledges-outgoing-ma-chair 2018-07-20T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-wants-action-on-unintended-consequence 2018-07-20T05:00:01+10:00 https://pharmadispatch.com/news/registrations-open-for-rca-canforum-2018 2018-07-20T05:00:01+10:00 https://pharmadispatch.com/news/ma-to-appoint-new-independent-chair 2018-07-19T17:00:01+10:00 https://pharmadispatch.com/news/ma-working-on-long-term-plan 2018-07-19T05:00:01+10:00 https://pharmadispatch.com/news/rca-welcomes-investment-in-genome-sequencing 2018-07-19T05:00:01+10:00 https://pharmadispatch.com/news/bayer-reports-positive-news-on-xarelto 2018-07-19T05:00:01+10:00 https://pharmadispatch.com/news/fast-track-for-melbourne-company 2018-07-19T05:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-launches-new-online-resource 2018-07-18T05:00:01+10:00 https://pharmadispatch.com/news/shipment-of-additional-adult-flu-vaccines-commences 2018-07-18T05:00:01+10:00 https://pharmadispatch.com/news/mundipharma-awards-fifth-annual-clinical-research-fellowship-1 2018-07-18T05:00:01+10:00 https://pharmadispatch.com/news/wa-scientists-develop-world-new-test-for-early-detection-of-mela 2018-07-18T05:00:01+10:00 https://pharmadispatch.com/news/the-sector-should-thank-gilead 2018-07-18T05:00:01+10:00 https://pharmadispatch.com/news/the-1bn-gift-from-gilead 2018-07-17T05:00:01+10:00 https://pharmadispatch.com/news/more-listings-for-august 2018-07-17T05:00:01+10:00 https://pharmadispatch.com/news/pharmacy-backs-my-health-record 2018-07-17T05:00:01+10:00 https://pharmadispatch.com/news/priceline-breaks-fundraising-record 2018-07-17T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-four-of-the-august-listings 2018-07-16T05:05:01+10:00 https://pharmadispatch.com/news/its-confidential-but-not-kind-of-is-it 2018-07-16T05:00:01+10:00 https://pharmadispatch.com/news/ma-in-melbourne-for-strategic-planning 2018-07-16T05:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-new-commercialisation-funding 2018-07-16T05:00:01+10:00 https://pharmadispatch.com/news/dusc-melanoma-adhd-and-eye-disease 2018-07-16T03:00:01+10:00 https://pharmadispatch.com/news/someone-has-the-august-update 2018-07-13T05:00:01+10:00 https://pharmadispatch.com/news/nz-waiting-list-an-international-disgrace 2018-07-13T05:00:01+10:00 https://pharmadispatch.com/news/npsa-the-time-for-action-is-now 2018-07-13T05:00:01+10:00 https://pharmadispatch.com/news/another-move-for-former-ma-chair 2018-07-12T19:51:01+10:00 https://pharmadispatch.com/news/just-remember-to-ask 2018-07-12T05:05:01+10:00 https://pharmadispatch.com/news/pfizer-defers-price-increases-after-trump-intervention 2018-07-12T05:00:01+10:00 https://pharmadispatch.com/news/why-the-move-to-limit-scrutiny 2018-07-12T05:00:01+10:00 https://pharmadispatch.com/news/ignore-doom-and-gloom-merchants 2018-07-12T05:00:01+10:00 https://pharmadispatch.com/news/click-here-for-more-confidentiality-or-less 2018-07-11T05:00:01+10:00 https://pharmadispatch.com/news/is-this-actually-serious-or-just-a-setup 2018-07-11T05:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-regulatory-collaboration 2018-07-11T05:00:01+10:00 https://pharmadispatch.com/news/clinical-trial-gives-new-hope-to-transplant-patients 2018-07-11T05:00:01+10:00 https://pharmadispatch.com/news/benitec-secures-licensing-deal-for-gene-therapy 2018-07-10T05:00:01+10:00 https://pharmadispatch.com/news/janssen-welcomes-approval-through-regulatory-collaboration 2018-07-10T05:00:01+10:00 https://pharmadispatch.com/news/nhmrc-funding-for-prevention-research 2018-07-10T05:00:01+10:00 https://pharmadispatch.com/news/bionomics-reports-on-trial-progress 2018-07-10T05:00:01+10:00 https://pharmadispatch.com/news/cso-wholesalers-want-action-now 2018-07-09T05:00:01+10:00 https://pharmadispatch.com/news/who-is-this-third-party 2018-07-09T05:00:01+10:00 https://pharmadispatch.com/news/affirmative-action-required-for-rare-cancer-patients 2018-07-09T05:00:01+10:00 https://pharmadispatch.com/news/government-goes-again-on-deferrals 2018-07-09T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-survey-reveals-record-sentiment 2018-07-06T05:00:01+10:00 https://pharmadispatch.com/news/private-research-is-not-a-legitimate-purpose 2018-07-06T05:00:01+10:00 https://pharmadispatch.com/news/auscann-completes-334-million-capital-raise 2018-07-06T05:00:01+10:00 https://pharmadispatch.com/news/the-power-of-one-letter 2018-07-06T05:00:01+10:00 https://pharmadispatch.com/news/ma-action-urgently-required-on-confidentiality 2018-07-05T05:10:01+10:00 https://pharmadispatch.com/news/cost-the-concern-for-small-and-mid-size-companies 2018-07-05T05:00:01+10:00 https://pharmadispatch.com/news/consumers-back-pharmacy-on-service-and-regulation 2018-07-05T05:00:01+10:00 https://pharmadispatch.com/news/takeda-launches-australian-innovation-program 2018-07-05T05:00:01+10:00 https://pharmadispatch.com/news/government-exonerates-itself-on-confidentiality-breach 2018-07-04T05:10:01+10:00 https://pharmadispatch.com/news/different-advice-led-to-different-outcomes 2018-07-04T05:05:01+10:00 https://pharmadispatch.com/news/mundipharma-expands-pain-management-portfolio 2018-07-04T05:00:01+10:00 https://pharmadispatch.com/news/decisions-by-economists-or-oncologists 2018-07-04T05:00:01+10:00 https://pharmadispatch.com/news/shingles-vaccine-reminder 2018-07-04T05:00:01+10:00 https://pharmadispatch.com/news/guild-deregulation-an-opportunity-as-much-as-a-risk 2018-07-03T05:00:01+10:00 https://pharmadispatch.com/news/more-change-for-medicine-supply 2018-07-03T05:00:01+10:00 https://pharmadispatch.com/news/how-new-supply-chain-might-operate 2018-07-03T05:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-looking-forward-to-victoza-listing 2018-07-03T05:00:01+10:00 https://pharmadispatch.com/news/march-adds-further-confusion-on-special-pricing-arrangements 2018-07-02T05:00:01+10:00 https://pharmadispatch.com/news/industry-picks-preferred-rebate-reform-model 2018-07-02T05:00:01+10:00 https://pharmadispatch.com/news/novartis-welcomes-kisqali-listing 2018-07-02T05:00:01+10:00 https://pharmadispatch.com/news/novartis-decides-to-spinoff-alcon 2018-07-02T05:00:01+10:00 https://pharmadispatch.com/news/one-company-punished-for-following-process 2018-07-02T05:00:01+10:00 https://pharmadispatch.com/news/the-context-is-what-makes-this-highly-unusual 2018-06-29T05:00:01+10:00 https://pharmadispatch.com/news/super-meeting-talks-alignment 2018-06-29T05:00:01+10:00 https://pharmadispatch.com/news/detailed-report-on-confidentiality-breach-within-days 2018-06-29T05:00:01+10:00 https://pharmadispatch.com/news/msd-a-new-process-with-funding 2018-06-29T05:00:01+10:00 https://pharmadispatch.com/news/two-year-countdown-to-next-reform-round 2018-06-28T05:00:01+10:00 https://pharmadispatch.com/news/40000-could-benefit-from-streamlined-process 2018-06-28T05:00:01+10:00 https://pharmadispatch.com/news/anao-silent-on-documents 2018-06-28T05:00:01+10:00 https://pharmadispatch.com/news/site-found-for-australias-largest-medicinal-cannabis-manufacturi 2018-06-28T05:00:01+10:00 https://pharmadispatch.com/news/anao-requests-documents-on-listing 2018-06-27T09:55:01+10:00 https://pharmadispatch.com/news/data-protection-debate-far-from-over 2018-06-27T05:00:01+10:00 https://pharmadispatch.com/news/not-even-close-to-one-listing-per-day-average 2018-06-27T05:00:01+10:00 https://pharmadispatch.com/news/china-now-the-focus-in-asia 2018-06-27T05:00:01+10:00 https://pharmadispatch.com/news/consultation-on-future-mrff-priorities 2018-06-27T05:00:01+10:00 https://pharmadispatch.com/news/ma-brings-together-groups-for-super 2018-06-26T05:00:01+10:00 https://pharmadispatch.com/news/when-is-marketing-approval 2018-06-26T05:00:01+10:00 https://pharmadispatch.com/news/accc-trying-again-on-pfizer 2018-06-26T05:00:01+10:00 https://pharmadispatch.com/news/indigenous-australians-missing-heart-treatments 2018-06-26T05:00:01+10:00 https://pharmadispatch.com/news/a-disruptive-technology-that-changed-everything 2018-06-25T05:00:01+10:00 https://pharmadispatch.com/news/senate-calls-estimates-spillover-session 2018-06-25T05:00:01+10:00 https://pharmadispatch.com/news/gsk-backs-save-the-children 2018-06-25T05:00:01+10:00 https://pharmadispatch.com/news/sector-working-to-finalise-cso-review-submissions 2018-06-25T05:00:01+10:00 https://pharmadispatch.com/news/new-data-on-mercks-mavenclad 2018-06-22T05:00:01+10:00 https://pharmadispatch.com/news/october-price-disclosure-reductions 2018-06-22T05:00:01+10:00 https://pharmadispatch.com/news/pbs-debate-heats-up 2018-06-22T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-jj-excellence-awards 2018-06-22T05:00:01+10:00 https://pharmadispatch.com/news/hunt-only-negotiated-with-the-department 2018-06-21T05:00:01+10:00 https://pharmadispatch.com/news/debate-over-who-is-responsible-for-what 2018-06-21T05:00:01+10:00 https://pharmadispatch.com/news/stakeholders-gather-for-technical-rebate-reform-discussion 2018-06-21T05:00:01+10:00 https://pharmadispatch.com/news/what-we-do-matters 2018-06-21T05:00:01+10:00 https://pharmadispatch.com/news/at-least-one-company-pre-empted-discretion-process 2018-06-20T05:00:01+10:00 https://pharmadispatch.com/news/data-protection-push-likely-in-australia-eu-fta 2018-06-20T05:00:01+10:00 https://pharmadispatch.com/news/a-week-of-possibilities-becomes-a-month 2018-06-20T05:00:01+10:00 https://pharmadispatch.com/news/busy-day-for-medicines-australia 2018-06-20T05:00:01+10:00 https://pharmadispatch.com/news/one-path-might-be-better-than-the-other 2018-06-19T05:00:01+10:00 https://pharmadispatch.com/news/a-familiar-name-returns-to-lead-msd 2018-06-19T05:00:01+10:00 https://pharmadispatch.com/news/new-studies-back-sandoz-biosimilars 2018-06-19T05:00:01+10:00 https://pharmadispatch.com/news/ma-spas-a-critical-element-to-ensure-access 2018-06-18T16:56:01+10:00 https://pharmadispatch.com/news/july-pbs-schedule-update 2018-06-18T05:00:01+10:00 https://pharmadispatch.com/news/new-appointment-for-gbma 2018-06-18T05:00:01+10:00 https://pharmadispatch.com/news/sirtex-accepts-19bn-takeover 2018-06-18T05:00:01+10:00 https://pharmadispatch.com/news/turnbull-government-still-turning-to-pbs 2018-06-18T05:00:01+10:00 https://pharmadispatch.com/news/hunt-steps-taken-to-put-a-hold-on-any-further-disclosure 2018-06-15T05:00:01+10:00 https://pharmadispatch.com/news/issue-unlikely-to-go-away 2018-06-15T05:00:01+10:00 https://pharmadispatch.com/news/award-for-researchers-for-work-on-abbvies-venclexta 2018-06-15T05:00:01+10:00 https://pharmadispatch.com/news/janssen-scoops-regional-awards 2018-06-15T05:00:01+10:00 https://pharmadispatch.com/news/department-starts-responding-to-company-demands 2018-06-14T05:00:01+10:00 https://pharmadispatch.com/news/what-changed-to-make-it-ok-in-vancouver 2018-06-14T05:00:01+10:00 https://pharmadispatch.com/news/another-lexapro-settlement-for-lundbeck 2018-06-14T05:00:01+10:00 https://pharmadispatch.com/news/little-progress-as-discussions-restart 2018-06-14T05:00:01+10:00 https://pharmadispatch.com/news/nhmrc-not-informed-of-any-significant-variations 2018-06-13T05:00:01+10:00 https://pharmadispatch.com/news/recognition-for-gilead-head-of-rd 2018-06-13T05:00:01+10:00 https://pharmadispatch.com/news/npsa-call-for-urgent-action-to-stamp-out-monopolies 2018-06-13T05:00:01+10:00 https://pharmadispatch.com/news/amgen-welcomes-prolia-in-nz 2018-06-13T05:00:01+10:00 https://pharmadispatch.com/news/ma-confirms-new-ceo 2018-06-12T11:00:01+10:00 https://pharmadispatch.com/news/response-pathetic-as-clock-ticks-on-undertakings 2018-06-12T04:00:01+10:00 https://pharmadispatch.com/news/questions-over-initial-response-and-timeline 2018-06-12T04:00:01+10:00 https://pharmadispatch.com/news/recognition-for-ex-msd-executive 2018-06-12T04:00:01+10:00 https://pharmadispatch.com/news/england-confirms-routine-funding-for-keytruda-in-lung-cancer 2018-06-12T04:00:01+10:00 https://pharmadispatch.com/news/companies-demand-destruction-of-poster 2018-06-08T05:00:01+10:00 https://pharmadispatch.com/news/it-would-not-have-been-a-straightforward-process 2018-06-08T05:00:01+10:00 https://pharmadispatch.com/news/nhmrc-response-on-grant 2018-06-08T05:00:01+10:00 https://pharmadispatch.com/news/merck-and-pfizer-announce-more-bavencio-data 2018-06-08T05:00:01+10:00 https://pharmadispatch.com/news/department-halts-further-publication-of-pricing-poster 2018-06-07T05:05:01+10:00 https://pharmadispatch.com/news/the-confidential-information-has-been-published 2018-06-07T05:00:01+10:00 https://pharmadispatch.com/news/senate-inquiry-ban-pharma-donations 2018-06-07T05:00:01+10:00 https://pharmadispatch.com/news/this-is-why-companies-should-have-been-consulted 2018-06-07T05:00:01+10:00 https://pharmadispatch.com/news/four-cases-with-more-to-come 2018-06-07T04:00:01+10:00 https://pharmadispatch.com/news/this-is-also-highly-unusual 2018-06-06T15:13:01+10:00 https://pharmadispatch.com/news/department-breaches-dozens-of-pbs-contracts 2018-06-06T05:00:01+10:00 https://pharmadispatch.com/news/funding-unlikely-for-breast-cancer-test 2018-06-06T04:00:01+10:00 https://pharmadispatch.com/news/confidential-documents-must-be-returned 2018-06-06T04:00:01+10:00 https://pharmadispatch.com/news/shire-backs-new-australian-company 2018-06-06T04:00:01+10:00 https://pharmadispatch.com/news/overall-survival-win-for-keytruda 2018-06-05T05:00:01+10:00 https://pharmadispatch.com/news/product-failure-laid-the-groundwork-for-success 2018-06-05T05:00:01+10:00 https://pharmadispatch.com/news/older-drugs-the-only-winners-on-discretions 2018-06-05T05:00:01+10:00 https://pharmadispatch.com/news/1landmark-study-shows-chemo-not-needed-for-most-early-breast-can 2018-06-05T05:00:01+10:00 https://pharmadispatch.com/news/politics-is-a-tough-business-but 2018-06-04T05:00:01+10:00 https://pharmadispatch.com/news/dhls-resnick-manufacturers-should-stand-their-ground 2018-06-04T05:00:01+10:00 https://pharmadispatch.com/news/pbac-boost-for-filgrastim-biosimilars 2018-06-04T05:00:01+10:00 https://pharmadispatch.com/news/pharmaceutical-industry-in-the-tax-spotlight 2018-06-03T05:00:01+10:00 https://pharmadispatch.com/news/does-the-review-normally-come-first 2018-06-03T05:00:01+10:00 https://pharmadispatch.com/news/implications-of-anao-review 2018-06-01T05:00:01+10:00 https://pharmadispatch.com/news/another-acquisition-for-australian-first-pharma 2018-06-01T05:00:01+10:00 https://pharmadispatch.com/news/csl-seeking-2019-fellowship-applicants 2018-06-01T05:00:01+10:00 https://pharmadispatch.com/news/sanofi-welcomes-more-flu-vaccine 2018-06-01T05:00:01+10:00 https://pharmadispatch.com/news/bi-statement-on-giotrif 2018-06-01T05:00:01+10:00 https://pharmadispatch.com/news/labor-asks-for-anao-investigation 2018-05-31T10:03:01+10:00 https://pharmadispatch.com/news/criteria-what-criteria 2018-05-31T05:00:01+10:00 https://pharmadispatch.com/news/us-global-asset-manager-increases-stake-in-cynata 2018-05-31T05:00:01+10:00 https://pharmadispatch.com/news/ma-approached-department-on-spas 2018-05-31T05:00:01+10:00 https://pharmadispatch.com/news/ato-highlights-focus-on-industry 2018-05-31T05:00:01+10:00 https://pharmadispatch.com/news/update-from-senate-estimates 2018-05-30T10:48:01+10:00 https://pharmadispatch.com/news/rebate-change-artificially-dropping-pbs-spend 2018-05-30T05:00:01+10:00 https://pharmadispatch.com/news/agreement-done-before-rebate-change-considered 2018-05-30T05:00:01+10:00 https://pharmadispatch.com/news/confirmed-leadership-for-gsk-consumer-health 2018-05-30T05:00:01+10:00 https://pharmadispatch.com/news/more-pbs-damages-cases-likely 2018-05-30T05:00:01+10:00 https://pharmadispatch.com/news/research-the-theme-for-world-ms-day 2018-05-30T05:00:01+10:00 https://pharmadispatch.com/news/timing-a-problem-for-supply-chain-changes 2018-05-29T05:00:01+10:00 https://pharmadispatch.com/news/the-need-for-balance-as-election-approaches 2018-05-29T05:00:01+10:00 https://pharmadispatch.com/news/us-company-goes-to-court-over-bid-for-sirtex 2018-05-29T05:00:01+10:00 https://pharmadispatch.com/news/seqirus-announces-practice-nurse-grants 2018-05-29T05:00:01+10:00 https://pharmadispatch.com/news/and-here-is-the-surprise 2018-05-29T05:00:01+10:00 https://pharmadispatch.com/news/hunt-extra-vaccines-already-on-the-way 2018-05-28T05:00:01+10:00 https://pharmadispatch.com/news/time-to-brace-for-a-surprise 2018-05-28T05:00:01+10:00 https://pharmadispatch.com/news/victory-for-pfizer-over-accc 2018-05-28T05:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-merck-australia-nz 2018-05-28T05:00:01+10:00 https://pharmadispatch.com/news/over-600-attend-biomelbourne-network-connecting-women-lunch 2018-05-28T05:00:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-1-june-listings 2018-05-27T05:00:01+10:00 https://pharmadispatch.com/news/emerging-prota-completes-enrolment-of-new-trial 2018-05-25T05:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-spike-in-hospital-chemo 2018-05-25T05:00:01+10:00 https://pharmadispatch.com/news/australians-want-control-over-health-data-1 2018-05-25T05:00:01+10:00 https://pharmadispatch.com/news/careful-language-as-hcv-elimination-goal-slips 2018-05-24T05:00:01+10:00 https://pharmadispatch.com/news/government-delays-new-cost-recovery-model 2018-05-24T05:00:01+10:00 https://pharmadispatch.com/news/positive-news-for-australian-company-actinogen 2018-05-24T05:00:01+10:00 https://pharmadispatch.com/news/us-company-decides-not-to-match-sirtex-bid 2018-05-24T05:00:01+10:00 https://pharmadispatch.com/news/bms-updates-study-connect-website 2018-05-24T05:00:01+10:00 https://pharmadispatch.com/news/us-congress-backs-right-to-try-law 2018-05-24T05:00:01+10:00 https://pharmadispatch.com/news/asmi-urges-backing-for-legislation 2018-05-23T04:00:01+10:00 https://pharmadispatch.com/news/recognition-for-swisse-for-china-growth 2018-05-23T04:00:01+10:00 https://pharmadispatch.com/news/its-a-long-game-and-we-have-to-build-stakeholder-support-says-ma 2018-05-23T04:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2018-video-recap-5-budget-2018-19 2018-05-23T04:00:01+10:00 https://pharmadispatch.com/news/nominations-open-for-annual-gsk-research-award 2018-05-22T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2018-video-recap-4-predictability-and-certainty 2018-05-22T05:00:01+10:00 https://pharmadispatch.com/news/june-listings-include-key-generics 2018-05-22T05:00:01+10:00 https://pharmadispatch.com/news/call-for-submissions-to-pan-tumour-review 2018-05-22T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2018-video-recap-3-the-national-medicines-policy 2018-05-21T05:00:01+10:00 https://pharmadispatch.com/news/new-savings-are-inevitable 2018-05-21T05:00:01+10:00 https://pharmadispatch.com/news/investors-cheer-csl-upgrade 2018-05-21T05:00:01+10:00 https://pharmadispatch.com/news/comeback-for-another-medicines-working-group 2018-05-21T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-video-recap-2 2018-05-18T05:00:01+10:00 https://pharmadispatch.com/news/compare-and-contrast-the-funding 2018-05-18T05:00:01+10:00 https://pharmadispatch.com/news/savings-are-now-re-prioritisations 2018-05-18T05:00:01+10:00 https://pharmadispatch.com/news/patrys-adds-new-research-collaboration 2018-05-18T05:00:01+10:00 https://pharmadispatch.com/news/busy-week-sets-tone-to-2020 2018-05-17T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-video-recap 2018-05-17T05:00:01+10:00 https://pharmadispatch.com/news/big-day-for-clinical-trials 2018-05-17T05:00:01+10:00 https://pharmadispatch.com/news/minister-meets-industry-on-budget-response 2018-05-17T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-the-jane-halton-masterclass 2018-05-16T05:00:01+10:00 https://pharmadispatch.com/news/industry-is-not-a-cheerleader 2018-05-16T05:00:01+10:00 https://pharmadispatch.com/news/discretion-to-say-no 2018-05-16T05:00:01+10:00 https://pharmadispatch.com/news/the-mystery-of-bp1-statement-6 2018-05-15T14:57:01+10:00 https://pharmadispatch.com/news/labor-setting-its-own-course-on-pbs 2018-05-15T08:42:01+10:00 https://pharmadispatch.com/news/flood-of-requests-for-ministerial-discretion 2018-05-15T05:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-wrap-up 2018-05-15T05:00:01+10:00 https://pharmadispatch.com/news/my-health-record-opt-out-period-confirmed 2018-05-15T05:00:01+10:00 https://pharmadispatch.com/news/minister-calls-meeting-as-budget-response-falls-flat 2018-05-14T05:00:01+10:00 https://pharmadispatch.com/news/sector-gathers-for-pharmadispatch-conference 2018-05-14T05:00:01+10:00 https://pharmadispatch.com/news/department-starts-cso-review 2018-05-14T05:00:01+10:00 https://pharmadispatch.com/news/trump-time-to-end-the-global-freeloading 2018-05-14T05:00:01+10:00 https://pharmadispatch.com/news/ex-adviser-joins-industry 2018-05-11T05:00:01+10:00 https://pharmadispatch.com/news/why-the-second-statement 2018-05-11T05:00:01+10:00 https://pharmadispatch.com/news/a-starvation-diet-over-ten-years 2018-05-10T18:55:01+10:00 https://pharmadispatch.com/news/why-is-the-pbs-being-starved-of-funding 2018-05-10T05:00:01+10:00 https://pharmadispatch.com/news/merger-to-create-generic-giant 2018-05-10T05:00:01+10:00 https://pharmadispatch.com/news/mpa-pbs-needs-further-investment 2018-05-10T05:00:01+10:00 https://pharmadispatch.com/news/failure-to-act-unconscionable 2018-05-10T05:00:01+10:00 https://pharmadispatch.com/news/industry-this-is-your-reward 2018-05-09T05:00:01+10:00 https://pharmadispatch.com/news/budget-2018-19-the-measures 2018-05-09T05:00:01+10:00 https://pharmadispatch.com/news/contingency-reserve-gone 2018-05-09T05:00:01+10:00 https://pharmadispatch.com/news/budget-2018-19-the-response 2018-05-08T22:24:01+10:00 https://pharmadispatch.com/news/consistently-inconsistent-on-pbs-interventions 2018-05-08T05:00:01+10:00 https://pharmadispatch.com/news/missed-opportunity-is-the-risk-for-australia 2018-05-08T05:00:01+10:00 https://pharmadispatch.com/news/seniors-not-prioritising-shingles-vax 2018-05-08T05:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-new-mtpconnect-ceo 2018-05-08T05:00:01+10:00 https://pharmadispatch.com/news/government-acts-quickly-to-list-biogens-spinraza 2018-05-07T05:00:01+10:00 https://pharmadispatch.com/news/the-problem-with-exceptions 2018-05-07T05:00:01+10:00 https://pharmadispatch.com/news/chinese-company-enters-race-for-sirtex 2018-05-07T05:00:01+10:00 https://pharmadispatch.com/news/us-move-to-classify-rebates-as-kickbacks 2018-05-07T05:00:01+10:00 https://pharmadispatch.com/news/bayers-nelson-ambrogio-a-purpose-driven-culture 2018-05-07T05:00:01+10:00 https://pharmadispatch.com/news/health-minister-greg-hunt-has-announced-the-government-will-fund 2018-05-07T05:00:01+10:00 https://pharmadispatch.com/news/labor-alarmed-over-pbac-advice 2018-05-04T10:15:01+10:00 https://pharmadispatch.com/news/the-end-of-an-awkward-marriage 2018-05-04T05:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-commitment-but-remains-very-cautious 2018-05-04T05:00:01+10:00 https://pharmadispatch.com/news/az-welcomes-fasenra-approval 2018-05-04T05:00:01+10:00 https://pharmadispatch.com/news/starpharma-signs-major-deal-with-mundipharma 2018-05-04T05:00:01+10:00 https://pharmadispatch.com/news/it-is-recycling-not-new-spending 2018-05-03T05:00:01+10:00 https://pharmadispatch.com/news/final-speaker-confirmed-for-pharmadispatch-conference 2018-05-03T05:00:01+10:00 https://pharmadispatch.com/news/long-awaited-final-report-expected-today 2018-05-03T05:00:01+10:00 https://pharmadispatch.com/news/major-change-in-department-of-health-leadership 2018-05-03T05:00:01+10:00 https://pharmadispatch.com/news/a-significant-and-precedent-setting-statement 2018-05-02T05:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-announces-new-ceo 2018-05-02T05:00:01+10:00 https://pharmadispatch.com/news/ama-backs-shortage-model-but-wants-more-responsive-pbs 2018-05-02T05:00:01+10:00 https://pharmadispatch.com/news/uwa-and-douglas-partner-on-immunotherapies 2018-05-02T05:00:01+10:00 https://pharmadispatch.com/news/msd-australia-unlikely-to-meet-hcv-target-without-action 2018-05-01T05:00:01+10:00 https://pharmadispatch.com/news/mundipharma-launches-new-treatment-for-common-cold 2018-05-01T05:00:01+10:00 https://pharmadispatch.com/news/new-research-ms-under-the-radar 2018-05-01T05:00:01+10:00 https://pharmadispatch.com/news/medtech-version-of-the-bridge-program 2018-05-01T05:00:01+10:00 https://pharmadispatch.com/news/biosimilars-headline-july-pbac 2018-04-30T05:00:01+10:00 https://pharmadispatch.com/news/there-must-have-been-a-formal-review 2018-04-30T05:00:01+10:00 https://pharmadispatch.com/news/supply-chain-pilot-delayed-until-after-election 2018-04-30T05:00:01+10:00 https://pharmadispatch.com/news/lauren-carey-equitable-outcomes-means-equitable-access 2018-04-30T05:00:01+10:00 https://pharmadispatch.com/news/discretion-price-cut-anniversary 2018-04-27T05:00:01+10:00 https://pharmadispatch.com/news/the-facts-remain-unchallenged 2018-04-27T05:00:01+10:00 https://pharmadispatch.com/news/new-resource-targeting-hbv-stigma 2018-04-27T05:00:01+10:00 https://pharmadispatch.com/news/another-indication-for-opdivo 2018-04-27T05:00:01+10:00 https://pharmadispatch.com/news/march-quarter-drug-prices-remain-low 2018-04-26T05:00:01+10:00 https://pharmadispatch.com/news/not-so-important-after-all 2018-04-26T05:00:01+10:00 https://pharmadispatch.com/news/wider-implications-of-pivotal-legal-advice 2018-04-26T05:00:01+10:00 https://pharmadispatch.com/news/shire-accepts-us64bn-proposal-from-takeda 2018-04-26T05:00:01+10:00 https://pharmadispatch.com/news/new-deal-raises-questions-over-the-need-for-rebate-pilot 2018-04-24T05:00:01+10:00 https://pharmadispatch.com/news/guild-extend-access-to-flu-vaccine 2018-04-24T05:00:01+10:00 https://pharmadispatch.com/news/new-research-on-triple-therapy-in-advance-of-pbs-listing 2018-04-24T05:00:01+10:00 https://pharmadispatch.com/news/patients-to-access-cancer-treatment-at-home 2018-04-24T05:00:01+10:00 https://pharmadispatch.com/news/abbvie-not-yet-on-venclexta-but-future-is-positive 2018-04-23T05:00:01+10:00 https://pharmadispatch.com/news/a-proud-industry-committed-to-doing-the-right-thing 2018-04-23T05:00:01+10:00 https://pharmadispatch.com/news/march-pbac-outcomes-1 2018-04-23T05:00:01+10:00 https://pharmadispatch.com/news/gbma-confirms-biosimilar-education-grant 2018-04-23T05:00:01+10:00 https://pharmadispatch.com/news/mayne-officially-opens-us-facility 2018-04-20T05:00:01+10:00 https://pharmadispatch.com/news/the-question-is-why-now 2018-04-20T05:00:01+10:00 https://pharmadispatch.com/news/new-report-show-rebates-average-44-in-new-zealand 2018-04-20T05:00:01+10:00 https://pharmadispatch.com/news/merck-sells-consumer-health-business 2018-04-20T05:00:01+10:00 https://pharmadispatch.com/news/shire-rejects-third-bid-from-takeda 2018-04-20T05:00:01+10:00 https://pharmadispatch.com/news/pbs-listing-process-descends-into-farce 2018-04-19T05:00:01+10:00 https://pharmadispatch.com/news/a-serious-industry-deserving-of-serious-decisions 2018-04-19T05:00:01+10:00 https://pharmadispatch.com/news/once-contentious-is-now-confusing 2018-04-18T05:00:01+10:00 https://pharmadispatch.com/news/sanofi-sells-european-generics-business 2018-04-18T05:00:01+10:00 https://pharmadispatch.com/news/seqirus-announces-png-antivenom-initiative 2018-04-18T05:00:01+10:00 https://pharmadispatch.com/news/bms-and-janssen-team-up-on-new-anticoagulant 2018-04-18T05:00:01+10:00 https://pharmadispatch.com/news/no-flexibility-on-special-pricing-arrangements-unless 2018-04-17T05:00:01+10:00 https://pharmadispatch.com/news/csl-behring-commits-on-world-haemophilia-day 2018-04-17T05:00:01+10:00 https://pharmadispatch.com/news/digital-health-start-up-looking-to-promote-adherence 2018-04-17T05:00:01+10:00 https://pharmadispatch.com/news/servier-acquires-shire-oncology-business 2018-04-17T05:00:01+10:00 https://pharmadispatch.com/news/uptake-drivers-hit-a-hospital-roadblock 2018-04-16T05:00:01+10:00 https://pharmadispatch.com/news/confusion-and-opportunity-on-special-pricing-arrangements 2018-04-16T05:00:01+10:00 https://pharmadispatch.com/news/are-current-delays-just-deferrals-in-disguise 2018-04-16T05:00:01+10:00 https://pharmadispatch.com/news/merck-employees-celebrate-350th-anniversary 2018-04-16T05:00:01+10:00 https://pharmadispatch.com/news/amgen-joins-digital-health-crc 2018-04-16T05:00:01+10:00 https://pharmadispatch.com/news/minister-announces-new-listings 2018-04-16T05:00:01+10:00 https://pharmadispatch.com/news/new-chair-for-gbma 2018-04-13T05:00:01+10:00 https://pharmadispatch.com/news/more-flexible-application-of-special-pricing-arrangements 2018-04-13T05:00:01+10:00 https://pharmadispatch.com/news/international-recognition-for-australian-patient-initiative 2018-04-13T05:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-new-menb-vaccine 2018-04-13T05:00:01+10:00 https://pharmadispatch.com/news/lundbeck-confirms-settlement-with-alphapharm 2018-04-13T05:00:01+10:00 https://pharmadispatch.com/news/ma-plans-go-ahead-on-consumer-sentiment-index 2018-04-12T05:00:01+10:00 https://pharmadispatch.com/news/value-based-healthcare-inevitable 2018-04-12T05:00:01+10:00 https://pharmadispatch.com/news/the-new-pbs-is-about-contracts-not-hta 2018-04-12T05:00:01+10:00 https://pharmadispatch.com/news/bionomics-progresses-ptsd-trial 2018-04-12T05:00:01+10:00 https://pharmadispatch.com/news/running-for-rare-in-boston 2018-04-11T05:00:01+10:00 https://pharmadispatch.com/news/experts-welcome-expanded-indication-for-serviers-latuda 2018-04-11T05:00:01+10:00 https://pharmadispatch.com/news/belinda-wood-psa-role-an-easy-decision 2018-04-11T05:00:01+10:00 https://pharmadispatch.com/news/btf-fund-manager-invests-in-melbourne-based-company 2018-04-10T16:21:01+10:00 https://pharmadispatch.com/news/industry-calls-for-rd-tax-carve-out 2018-04-10T05:00:01+10:00 https://pharmadispatch.com/news/bridge-program-welcomes-98-new-participants 2018-04-10T05:00:01+10:00 https://pharmadispatch.com/news/novartis-acquires-gene-therapy-company-for-us87bn 2018-04-10T05:00:01+10:00 https://pharmadispatch.com/news/company-anger-over-recall-of-schedule-update 2018-04-10T05:00:01+10:00 https://pharmadispatch.com/news/department-recalls-pbs-update 2018-04-09T05:00:01+10:00 https://pharmadispatch.com/news/hcv-uptake-settling-at-low-levels 2018-04-09T05:00:01+10:00 https://pharmadispatch.com/news/biotron-updates-on-new-hiv-therapy 2018-04-09T05:00:01+10:00 https://pharmadispatch.com/news/industry-reputation-on-the-up-in-latest-patient-survey 2018-04-08T10:33:01+10:00 https://pharmadispatch.com/news/what-happens-if-a-competitor-agrees-to-rebate-change 2018-04-06T05:00:01+10:00 https://pharmadispatch.com/news/bayer-backs-emerging-cv-researchers 2018-04-06T05:00:01+10:00 https://pharmadispatch.com/news/time-key-in-value-project 2018-04-06T05:00:01+10:00 https://pharmadispatch.com/news/industry-caught-in-emerging-trade-war 2018-04-06T05:00:01+10:00 https://pharmadispatch.com/news/more-companies-confirming-magnitude-of-us-rebates 2018-04-05T05:00:01+10:00 https://pharmadispatch.com/news/process-review-looking-at-submission-categories 2018-04-05T05:00:01+10:00 https://pharmadispatch.com/news/ma-advisory-council-to-consider-value-of-medicines-project 2018-04-05T05:00:01+10:00 https://pharmadispatch.com/news/drug-costs-a-concern 2018-04-05T05:00:01+10:00 https://pharmadispatch.com/news/pg-in-talks-over-pfizer-consumer-health-business 2018-04-04T05:46:01+10:00 https://pharmadispatch.com/news/wider-access-for-allergans-ozurdex 2018-04-04T05:00:01+10:00 https://pharmadispatch.com/news/pbac-concerned-if-hcv-decline-continues 2018-04-04T05:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-marks-mt-kosi-success 2018-04-04T05:00:01+10:00 https://pharmadispatch.com/news/clinicians-welcome-tremfya-registration 2018-04-03T18:31:01+10:00 https://pharmadispatch.com/news/industry-still-pushing-for-cost-recovery-delay 2018-04-03T05:00:01+10:00 https://pharmadispatch.com/news/could-accc-help-on-rebate-reform 2018-04-03T05:00:01+10:00 https://pharmadispatch.com/news/takeda-in-potential-bid-for-shire 2018-04-03T05:00:01+10:00 https://pharmadispatch.com/news/martin-palin-humanising-big-companies 2018-04-03T05:00:01+10:00 https://pharmadispatch.com/news/why-is-the-government-ignoring-more-workable-alternatives 2018-03-29T05:00:01+11:00 https://pharmadispatch.com/news/strategy-review-needed-if-treatment-decline-confirmed 2018-03-29T05:00:01+11:00 https://pharmadispatch.com/news/focus-on-patients-member-companies-and-pbs-future 2018-03-29T05:00:01+11:00 https://pharmadispatch.com/news/parliamentary-tribute-to-the-late-donna-staunton 2018-03-29T05:00:01+11:00 https://pharmadispatch.com/news/psa-announces-new-ceo 2018-03-29T05:00:01+11:00 https://pharmadispatch.com/news/concern-grows-as-hcv-initiations-fall-again 2018-03-28T05:00:01+11:00 https://pharmadispatch.com/news/policy-head-appointed-interim-ceo 2018-03-28T05:00:01+11:00 https://pharmadispatch.com/news/tga-strikes-balance-on-shortages 2018-03-28T05:00:01+11:00 https://pharmadispatch.com/news/gsk-buys-novartis-joint-venture-stake 2018-03-28T05:00:01+11:00 https://pharmadispatch.com/news/gilead-secures-another-hcv-approval 2018-03-28T05:00:01+11:00 https://pharmadispatch.com/news/now-is-the-time-to-say-no 2018-03-27T05:00:01+11:00 https://pharmadispatch.com/news/az-backing-local-school-initiative 2018-03-27T05:00:01+11:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-pay-gap-remains-a-major-problem 2018-03-27T05:00:01+11:00 https://pharmadispatch.com/news/guild-more-urgency-required-on-flu-vax 2018-03-27T05:00:01+11:00 https://pharmadispatch.com/news/new-rebate-system-could-rely-on-stickers 2018-03-26T05:00:01+11:00 https://pharmadispatch.com/news/australia-must-make-the-case-for-investment 2018-03-26T05:00:01+11:00 https://pharmadispatch.com/news/april-brings-major-change-for-diabetes-medicines 2018-03-26T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-confirms-new-listings 2018-03-26T05:00:01+11:00 https://pharmadispatch.com/news/gsk-says-withdraws-from-pfizer-consumer-health-sale 2018-03-26T05:00:01+11:00 https://pharmadispatch.com/news/rb-drops-out-of-race-for-pfizer-consumer-health-business 2018-03-23T05:00:01+11:00 https://pharmadispatch.com/news/positive-early-signs-for-new-uptake-drivers 2018-03-23T05:00:01+11:00 https://pharmadispatch.com/news/april-brings-more-good-news-for-mundipharma 2018-03-23T05:00:01+11:00 https://pharmadispatch.com/news/industry-suggests-a-review-of-old-pricing-arrangements 2018-03-22T10:49:01+11:00 https://pharmadispatch.com/news/too-hard-to-assess-clinical-outcomes-from-pbs-medicines 2018-03-22T05:00:01+11:00 https://pharmadispatch.com/news/gbma-on-the-lookout-for-grant-manager 2018-03-22T05:00:01+11:00 https://pharmadispatch.com/news/ma-hoping-for-mid-year-appointment 2018-03-22T05:00:01+11:00 https://pharmadispatch.com/news/dentons-acquires-leading-life-sciences-law-firm 2018-03-22T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-confirms-april-prep-listing 2018-03-21T05:00:01+11:00 https://pharmadispatch.com/news/oral-contraceptive-as-a-discretionary-medicine 2018-03-21T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-rebate-reform-will-happen 2018-03-21T05:00:01+11:00 https://pharmadispatch.com/news/tga-confirms-provisional-approval-criteria 2018-03-21T05:00:01+11:00 https://pharmadispatch.com/news/is-this-stability-and-certainty 2018-03-20T05:00:01+11:00 https://pharmadispatch.com/news/meetings-in-advance-of-sector-discussion 2018-03-20T05:00:01+11:00 https://pharmadispatch.com/news/a-new-immunotherapy-for-april-pbs 2018-03-20T05:00:01+11:00 https://pharmadispatch.com/news/political-battle-over-stem-visas 2018-03-20T05:00:01+11:00 https://pharmadispatch.com/news/patients-families-and-friends-lead-the-way-as-every-record-broke 2018-03-19T05:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-calls-sector-wide-meeting-on-rebate-reform 2018-03-19T05:00:01+11:00 https://pharmadispatch.com/news/latest-dusc-utilisation-review 2018-03-19T05:00:01+11:00 https://pharmadispatch.com/news/immutep-attracts-new-investment 2018-03-19T05:00:01+11:00 https://pharmadispatch.com/news/section-seven-providing-the-best-defence 2018-03-19T05:00:01+11:00 https://pharmadispatch.com/news/new-website-highlights-global-biotech-industry 2018-03-16T05:00:01+11:00 https://pharmadispatch.com/news/rebates-dominate-managing-director-meetings 2018-03-16T05:00:01+11:00 https://pharmadispatch.com/news/company-total-tops-65000-as-mt-kosi-records-tumble 2018-03-16T05:00:01+11:00 https://pharmadispatch.com/news/could-be-rebates-for-new-ebos-cfo 2018-03-16T05:00:01+11:00 https://pharmadispatch.com/news/taking-the-very-simple-and-making-it-complicated 2018-03-15T05:00:01+11:00 https://pharmadispatch.com/news/the-societal-agreement-must-be-retained 2018-03-15T05:00:01+11:00 https://pharmadispatch.com/news/study-confirms-benefit-of-il-17a-inhibitor 2018-03-15T05:00:01+11:00 https://pharmadispatch.com/news/government-working-to-reach-agreement-on-grant 2018-03-15T05:00:01+11:00 https://pharmadispatch.com/news/divide-and-conquer-is-the-strategy 2018-03-14T05:00:01+11:00 https://pharmadispatch.com/news/australia-boosting-bayer-in-the-region 2018-03-14T05:00:01+11:00 https://pharmadispatch.com/news/besins-advises-on-supply-concerns 2018-03-14T05:00:01+11:00 https://pharmadispatch.com/news/us-investors-pursue-immuron 2018-03-14T05:00:01+11:00 https://pharmadispatch.com/news/ma-searching-for-new-ceo 2018-03-13T11:39:01+11:00 https://pharmadispatch.com/news/gp-prescribing-the-gap-as-treatment-numbers-stagnate 2018-03-13T05:00:01+11:00 https://pharmadispatch.com/news/goal-in-sight-as-trekkers-prepare-for-mt-kosi-challenge 2018-03-13T05:00:01+11:00 https://pharmadispatch.com/news/no-secret-over-what-medicines-have-special-pricing-arrangements 2018-03-13T05:00:01+11:00 https://pharmadispatch.com/news/noxopharm-reports-cep-1-study-results 2018-03-13T05:00:01+11:00 https://pharmadispatch.com/news/massive-cost-of-rebate-change 2018-03-12T05:00:01+11:00 https://pharmadispatch.com/news/can-the-sector-really-trust-this-change 2018-03-12T05:00:01+11:00 https://pharmadispatch.com/news/msd-and-eisai-enter-us58bn-cancer-deal 2018-03-12T05:00:01+11:00 https://pharmadispatch.com/news/new-report-confirms-patchy-uptake-of-hcv-therapies 2018-03-12T05:00:01+11:00 https://pharmadispatch.com/news/special-price-agreements-even-more-complex-than-many-think 2018-03-09T05:00:01+11:00 https://pharmadispatch.com/news/australia-not-alone-on-rebates-and-no-growth 2018-03-09T05:00:01+11:00 https://pharmadispatch.com/news/guild-disappointed-with-employer-group 2018-03-09T05:00:01+11:00 https://pharmadispatch.com/news/sydney-based-regeneus-confirms-positive-data 2018-03-09T05:00:01+11:00 https://pharmadispatch.com/news/going-direct-a-symptom-of-reform-impact 2018-03-08T05:00:01+11:00 https://pharmadispatch.com/news/recent-workshop-advances-process-review 2018-03-08T05:00:01+11:00 https://pharmadispatch.com/news/ma-recognises-award-winners 2018-03-08T05:00:01+11:00 https://pharmadispatch.com/news/victorian-aiming-for-more-clinical-trials 2018-03-08T05:00:01+11:00 https://pharmadispatch.com/news/azs-liz-chatwin-time-to-be-more-strategic1 2018-03-07T05:00:01+11:00 https://pharmadispatch.com/news/researcher-highlights-bridge-program-opportunity 2018-03-07T05:00:01+11:00 https://pharmadispatch.com/news/ma-urges-caution-on-any-opioid-change 2018-03-07T05:00:01+11:00 https://pharmadispatch.com/news/wholesalers-facing-another-review 2018-03-07T05:00:01+11:00 https://pharmadispatch.com/news/carlo-montagner-are-entrepreneurs-born-or-made-1 2018-03-06T05:00:01+11:00 https://pharmadispatch.com/news/msd-cooking-up-a-mt-kosi-storm 2018-03-06T05:00:01+11:00 https://pharmadispatch.com/news/is-a-no-growth-pbs-sustainable 2018-03-06T05:00:01+11:00 https://pharmadispatch.com/news/industry-constructive-on-reform-but-not-happy 2018-03-06T05:00:01+11:00 https://pharmadispatch.com/news/little-progress-following-latest-meeting-on-rebate-reform 2018-03-05T04:00:01+11:00 https://pharmadispatch.com/news/ignore-any-claytons-promise-of-new-money 2018-03-05T04:00:01+11:00 https://pharmadispatch.com/news/carlo-montagner-are-entrepreneurs-born-or-made 2018-03-05T04:00:01+11:00 https://pharmadispatch.com/news/uptake-drivers-apply-to-all-biosimilars 2018-03-05T04:00:01+11:00 https://pharmadispatch.com/news/current-therapies-remain-a-problem-for-new-breast-cancer-treatme 2018-03-05T04:00:01+11:00 https://pharmadispatch.com/news/rebates-around-23-billion-in-2017-18 2018-03-02T05:00:01+11:00 https://pharmadispatch.com/news/mayne-boosts-us-product-range 2018-03-02T05:00:01+11:00 https://pharmadispatch.com/news/are-they-really-new-medicines 2018-03-02T05:00:01+11:00 https://pharmadispatch.com/news/department-of-health-creates-new-pbs-taskforce 2018-03-01T05:00:01+11:00 https://pharmadispatch.com/news/az-helped-bennelong-mp-with-close-shave 2018-03-01T05:00:01+11:00 https://pharmadispatch.com/news/us-company-chooses-australia-for-trials 2018-03-01T05:00:01+11:00 https://pharmadispatch.com/news/officials-confirm-pbs-fall-again 2018-03-01T05:00:01+11:00 https://pharmadispatch.com/news/data-demand-a-key-cause-of-dissent 2018-02-28T05:00:01+11:00 https://pharmadispatch.com/news/has-industry-ever-had-this-power 2018-02-28T05:00:01+11:00 https://pharmadispatch.com/news/biogen-backs-new-educational-project 2018-02-28T05:00:01+11:00 https://pharmadispatch.com/news/fda-grants-orphan-designation-to-kazias-gdc-0084 2018-02-28T05:00:01+11:00 https://pharmadispatch.com/news/new-study-backs-catheter-ablation 2018-02-27T06:01:01+11:00 https://pharmadispatch.com/news/government-pushing-on-with-rebate-change-but-implementation-the- 2018-02-27T05:00:01+11:00 https://pharmadispatch.com/news/286bn-in-new-listings-really 2018-02-27T05:00:01+11:00 https://pharmadispatch.com/news/more-teams-join-pharma2peak-cup-competition 2018-02-27T05:00:01+11:00 https://pharmadispatch.com/news/king-review-final-report-complicated 2018-02-27T05:00:01+11:00 https://pharmadispatch.com/news/canberra-is-a-very-small-place 2018-02-26T04:00:01+11:00 https://pharmadispatch.com/news/abbvie-backs-new-parkinsons-campaign 2018-02-26T04:00:01+11:00 https://pharmadispatch.com/news/roundtable-works-on-spinraza-access 2018-02-26T04:00:01+11:00 https://pharmadispatch.com/news/prep-for-pbs-as-early-asapril 2018-02-26T04:00:01+11:00 https://pharmadispatch.com/news/a-good-time-for-senate-estimates 2018-02-26T04:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-ex-senior-official-to-key-role 2018-02-23T05:00:01+11:00 https://pharmadispatch.com/news/positive-results-for-biogens-spinraza-in-later-onset-patients 2018-02-23T05:00:01+11:00 https://pharmadispatch.com/news/amgen-sents-pegfilgrastim-to-juno 2018-02-23T05:00:01+11:00 https://pharmadispatch.com/news/another-deal-for-australian-biotech-company 2018-02-23T05:00:01+11:00 https://pharmadispatch.com/news/jane-orr 2018-02-22T05:00:01+11:00 https://pharmadispatch.com/news/gbma-confirms-new-ceo-on-major-day-for-industry 2018-02-22T05:00:01+11:00 https://pharmadispatch.com/news/further-evidence-of-hcv-drop-in-ebos-result 2018-02-22T05:00:01+11:00 https://pharmadispatch.com/news/this-is-a-reform-negotiation 2018-02-21T05:00:01+11:00 https://pharmadispatch.com/news/department-admits-it-did-not-consult-industry-on-new-model 2018-02-21T05:00:01+11:00 https://pharmadispatch.com/news/industry-recognised-by-gender-quality-agency 2018-02-21T05:00:01+11:00 https://pharmadispatch.com/news/did-the-department-break-its-own-rules 2018-02-21T05:00:01+11:00 https://pharmadispatch.com/news/ex-az-exec-building-local-company 2018-02-21T05:00:01+11:00 https://pharmadispatch.com/news/where-are-the-missing-patients 2018-02-20T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-backs-patient-hackathon 2018-02-20T05:00:01+11:00 https://pharmadispatch.com/news/yervoy-success-highlights-managed-entry-challenge 2018-02-20T05:00:01+11:00 https://pharmadispatch.com/news/mount-kosciuszko-challenge-on-way-to-fundraising-record 2018-02-20T05:00:01+11:00 https://pharmadispatch.com/news/mundipharma-acquires-tolmar-australia 2018-02-19T12:49:01+11:00 https://pharmadispatch.com/news/pbac-hits-pan-tumour-roadblock 2018-02-19T05:00:01+11:00 https://pharmadispatch.com/news/top-employer-status-for-takeda-australia 2018-02-19T05:00:01+11:00 https://pharmadispatch.com/news/hcv-eradication-at-risk-as-uptake-plummets 2018-02-19T05:00:01+11:00 https://pharmadispatch.com/news/vertex-drops-french-trials-but-sticks-with-australia 2018-02-19T05:00:01+11:00 https://pharmadispatch.com/news/government-confirms-stronger-flu-vaccines-for-nip 2018-02-19T05:00:01+11:00 https://pharmadispatch.com/news/msac-back-pdl1-biomarker-test 2018-02-18T11:35:01+11:00 https://pharmadispatch.com/news/constructive-dialogue-required-to-modernise-system 2018-02-16T05:00:01+11:00 https://pharmadispatch.com/news/companies-considering-lsdp-compact 2018-02-16T05:00:01+11:00 https://pharmadispatch.com/news/arthritis-researcher-recognised-with-medicines-new-zealand-award 2018-02-16T05:00:01+11:00 https://pharmadispatch.com/news/industry-facing-pressure-to-accept-rebate-change 2018-02-16T05:00:01+11:00 https://pharmadispatch.com/news/gsk-and-viiv-seek-to-pull-back-the-curtain-on-pbs 2018-02-16T05:00:01+11:00 https://pharmadispatch.com/news/fight-on-cost-recovery-to-save-agreements 2018-02-15T05:00:01+11:00 https://pharmadispatch.com/news/hunt-part-of-the-same-business 2018-02-15T05:00:01+11:00 https://pharmadispatch.com/news/australia-must-walk-the-talk-on-innovation 2018-02-15T05:00:01+11:00 https://pharmadispatch.com/news/terry-white-group-confident-of-stronger-growth 2018-02-15T05:00:01+11:00 https://pharmadispatch.com/news/how-will-companies-respond-to-pbs-price-changes 2018-02-14T05:00:01+11:00 https://pharmadispatch.com/news/sector-welcomes-passage-of-reform-bill 2018-02-14T05:00:01+11:00 https://pharmadispatch.com/news/us-drug-pricing-reform-proposals 2018-02-14T05:00:01+11:00 https://pharmadispatch.com/news/another-busy-pre-budget-period-for-industry 2018-02-13T05:00:01+11:00 https://pharmadispatch.com/news/new-report-says-countries-pay-more-or-no-access-in-the-us 2018-02-13T05:00:01+11:00 https://pharmadispatch.com/news/the-cost-recovery-rules-could-not-be-clearer 2018-02-13T05:00:01+11:00 https://pharmadispatch.com/news/funds-building-for-mt-kosciuszko-challenge 2018-02-13T05:00:01+11:00 https://pharmadispatch.com/news/funding-activity-or-a-revenue-target 2018-02-13T05:00:01+11:00 https://pharmadispatch.com/news/sigma-partners-with-medibank 2018-02-13T05:00:01+11:00 https://pharmadispatch.com/news/exclusive-pba-asked-to-mandate-biosimilars-for-new-patients 2018-02-12T05:00:01+11:00 https://pharmadispatch.com/news/government-guidelines-require-consulting-not-informing 2018-02-12T05:00:01+11:00 https://pharmadispatch.com/news/prep-listing-will-come-down-to-price 2018-02-12T05:00:01+11:00 https://pharmadispatch.com/news/jobs-and-exports-grew-in-2016 2018-02-12T05:00:01+11:00 https://pharmadispatch.com/news/us-price-reform-but-no-direct-negotiation 2018-02-12T05:00:01+11:00 https://pharmadispatch.com/news/msd-calls-out-rivals-for-fight4thepharmacup 2018-02-09T05:00:01+11:00 https://pharmadispatch.com/news/industry-facing-massive-increase-in-fees 2018-02-09T05:00:01+11:00 https://pharmadispatch.com/news/health-debate-heating-up 2018-02-09T05:00:01+11:00 https://pharmadispatch.com/news/should-industry-fund-inefficient-processes 2018-02-09T05:00:01+11:00 https://pharmadispatch.com/news/companies-baulk-at-july-implementation 2018-02-08T05:00:01+11:00 https://pharmadispatch.com/news/allergan-acquires-australian-company 2018-02-08T05:00:01+11:00 https://pharmadispatch.com/news/guild-focus-shifts-to-prescription-codeine 2018-02-08T05:00:01+11:00 https://pharmadispatch.com/news/more-conference-speakers-confirmed 2018-02-08T05:00:01+11:00 https://pharmadispatch.com/news/new-indication-for-lundbecks-abilify-maintena 2018-02-08T05:00:01+11:00 https://pharmadispatch.com/news/labor-all-savings-must-be-reinvested-in-new-medicines 2018-02-08T05:00:01+11:00 https://pharmadispatch.com/news/regional-leadership-for-ex-merck-australia-boss 2018-02-07T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-innovation-report-underwhelming 2018-02-07T05:00:01+11:00 https://pharmadispatch.com/news/toughest-job-in-australian-industry 2018-02-07T05:00:01+11:00 https://pharmadispatch.com/news/companies-await-cost-recovery-changes 2018-02-06T05:00:01+11:00 https://pharmadispatch.com/news/pbs-cost-recovery-is-not-cost-recovery-at-all 2018-02-06T05:00:01+11:00 https://pharmadispatch.com/news/labor-to-back-provisional-approval-bill 2018-02-06T05:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-launches-ceo-survey 2018-02-06T05:00:01+11:00 https://pharmadispatch.com/news/labor-to-back-provisional-approval-bill-1 2018-02-06T05:00:01+11:00 https://pharmadispatch.com/news/rare-cancer-patients-an-ignored-group 2018-02-05T05:00:01+11:00 https://pharmadispatch.com/news/allcan-launches-in-australia 2018-02-05T05:00:01+11:00 https://pharmadispatch.com/news/companies-not-embracing-rebate-change 2018-02-05T05:00:01+11:00 https://pharmadispatch.com/news/sector-right-to-be-nervous-and-cynical 2018-02-05T05:00:01+11:00 https://pharmadispatch.com/news/new-pbs-adviser-for-greg-hunt 2018-02-05T05:00:01+11:00 https://pharmadispatch.com/news/new-medicines-nz-chair-calls-for-change 2018-02-02T05:00:01+11:00 https://pharmadispatch.com/news/celgene-welcomes-updated-revlimid-listing 2018-02-02T05:00:01+11:00 https://pharmadispatch.com/news/launching-pharmadispatch-conference-what-future-the-pbs 2018-02-02T05:00:01+11:00 https://pharmadispatch.com/news/sector-backs-political-process-1 2018-02-02T05:00:01+11:00 https://pharmadispatch.com/news/what-about-pbs-co-payments 2018-02-01T05:00:01+11:00 https://pharmadispatch.com/news/australian-scientist-wins-japanese-prize 2018-02-01T05:00:01+11:00 https://pharmadispatch.com/news/trump-right-to-try 2018-02-01T05:00:01+11:00 https://pharmadispatch.com/news/ma-seeking-clarity-on-rd-tax-incentive 2018-02-01T05:00:01+11:00 https://pharmadispatch.com/news/department-set-to-present-cost-recovery-changes 2018-01-31T05:00:01+11:00 https://pharmadispatch.com/news/not-all-happy-about-lsdp-outcome 2018-01-31T05:00:01+11:00 https://pharmadispatch.com/news/report-recommends-cap-on-rd-tax-incentive-payments 2018-01-31T05:00:01+11:00 https://pharmadispatch.com/news/us-based-company-to-acquire-sirtex 2018-01-31T05:00:01+11:00 https://pharmadispatch.com/news/no-gst-on-scripts-a-concession 2018-01-30T06:00:01+11:00 https://pharmadispatch.com/news/new-report-highlight-incidence-and-impact-of-diabetes 2018-01-30T06:00:01+11:00 https://pharmadispatch.com/news/sun-pharma-seeks-support-for-adrenaline-a-flag 2018-01-30T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-welcomes-new-registration 2018-01-30T06:00:01+11:00 https://pharmadispatch.com/news/complex-hardly-describes-rebate-proposals 2018-01-29T09:42:01+11:00 https://pharmadispatch.com/news/major-change-in-greg-hunts-office 2018-01-29T06:00:01+11:00 https://pharmadispatch.com/news/government-seeking-compact-with-rare-disease-companies 2018-01-29T06:00:01+11:00 https://pharmadispatch.com/news/any-saving-is-small-and-may-not-even-stay-in-the-pbs 2018-01-29T06:00:01+11:00 https://pharmadispatch.com/news/australia-day-recognition-for-pbac-member 2018-01-29T06:00:01+11:00 https://pharmadispatch.com/news/is-industry-already-on-the-hook-for-savings 2018-01-29T06:00:01+11:00 https://pharmadispatch.com/news/the-supply-chain-challenge-for-rebate-change 2018-01-25T06:00:01+11:00 https://pharmadispatch.com/news/new-appointment-for-industry-nominated-pbac-member 2018-01-25T06:00:01+11:00 https://pharmadispatch.com/news/contracts-can-be-a-wonderful-thing 2018-01-25T06:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-welcomes-funding-commitment 2018-01-25T06:00:01+11:00 https://pharmadispatch.com/news/ma-confirms-pre-christmas-rebate-discussions 2018-01-24T06:00:01+11:00 https://pharmadispatch.com/news/the-facts-on-consumer-health-spending 2018-01-24T06:00:01+11:00 https://pharmadispatch.com/news/approval-for-ipsens-kidney-cancer-therapy 2018-01-24T06:00:01+11:00 https://pharmadispatch.com/news/ip-provisions-suspended-but-not-scrapped 2018-01-24T06:00:01+11:00 https://pharmadispatch.com/news/gsk-and-jj-top-antimicrobial-resistance-benchmark 2018-01-24T06:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-whooping-cough-vaccines-in-march 2018-01-23T18:00:01+11:00 https://pharmadispatch.com/news/department-reveals-medicines-not-yet-listed 2018-01-23T06:00:01+11:00 https://pharmadispatch.com/news/mixed-views-on-proposed-rebate-change 2018-01-23T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-acquires-bioverativ-for-us116bn 2018-01-23T06:00:01+11:00 https://pharmadispatch.com/news/bms-welcomes-new-orencia-indication 2018-01-23T06:00:01+11:00 https://pharmadispatch.com/news/exclusive-government-moving-on-rebates 2018-01-22T06:00:01+11:00 https://pharmadispatch.com/news/department-reveals-more-on-deeds 2018-01-22T06:00:01+11:00 https://pharmadispatch.com/news/an-change-with-very-serious-implications 2018-01-22T06:00:01+11:00 https://pharmadispatch.com/news/new-regional-leadership-for-gsk-consumer-health 2018-01-22T06:00:01+11:00 https://pharmadispatch.com/news/tga-sticks-with-same-names-for-biologics 2018-01-19T06:00:01+11:00 https://pharmadispatch.com/news/no-answer-on-contingency-reserve 2018-01-19T06:00:01+11:00 https://pharmadispatch.com/news/turnbull-optimistic-on-pacific-trade-pact 2018-01-19T06:00:01+11:00 https://pharmadispatch.com/news/servier-advancing-local-cancer-discovery 2018-01-19T06:00:01+11:00 https://pharmadispatch.com/news/accuracy-the-issue-when-it-comes-to-rebates 2018-01-18T06:00:01+11:00 https://pharmadispatch.com/news/trial-shows-msds-keytruda-extends-lung-cancer-survival 2018-01-18T06:00:01+11:00 https://pharmadispatch.com/news/orphan-designation-for-benitec-gene-therapy 2018-01-18T06:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-rejects-pharmac-claim 2018-01-18T06:00:01+11:00 https://pharmadispatch.com/news/pharmac-australia-harming-cancer-patients 2018-01-17T18:00:01+11:00 https://pharmadispatch.com/news/pfizers-journey-to-the-sydney-cbd 2018-01-17T06:00:01+11:00 https://pharmadispatch.com/news/even-senate-denied-rebate-forecast 2018-01-17T06:00:01+11:00 https://pharmadispatch.com/news/fda-approves-next-step-for-qimr-berghofer-developed-immunotherap 2018-01-17T06:00:01+11:00 https://pharmadispatch.com/news/finance-met-with-pharmac 2018-01-16T06:00:01+11:00 https://pharmadispatch.com/news/hospitals-take-increasing-share-of-pbs-spend 2018-01-16T06:00:01+11:00 https://pharmadispatch.com/news/ma-executive-moving-to-devices 2018-01-16T06:00:01+11:00 https://pharmadispatch.com/news/msd-welcomes-new-keytruda-approval-1 2018-01-16T06:00:01+11:00 https://pharmadispatch.com/news/time-to-confront-finance-over-ongoing-pbs-attacks 2018-01-15T06:00:01+11:00 https://pharmadispatch.com/news/a-special-place-for-nicotine-patches-in-pbs-history 2018-01-15T06:00:01+11:00 https://pharmadispatch.com/news/cabinet-papers-reveal-origin-of-deferrals-policy 2018-01-15T06:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-secures-another-milestone-payment 2018-01-15T06:00:01+11:00 https://pharmadispatch.com/news/approval-for-another-pd-l1-inhibitor 2018-01-15T06:00:01+11:00 https://pharmadispatch.com/news/neuclone-adds-fifth-biosimilar-candidate-to-portfolio 2018-01-15T06:00:01+11:00 https://pharmadispatch.com/news/vale-donna-staunton 2018-01-08T06:00:01+11:00 https://pharmadispatch.com/news/what-should-be-a-scandal-will-become-a-crisis-without-action 2017-12-21T18:00:01+11:00 https://pharmadispatch.com/news/increased-investment-our-fundamental-concern-in-2018-wes-cook 2017-12-20T06:00:01+11:00 https://pharmadispatch.com/news/medtronic-officially-opens-new-headquarters 2017-12-20T06:00:01+11:00 https://pharmadispatch.com/news/report-shows-need-for-immediate-action-on-real-time-recording 2017-12-20T06:00:01+11:00 https://pharmadispatch.com/news/spare-a-thought-for-officials-in-reshuffle 2017-12-20T06:00:01+11:00 https://pharmadispatch.com/news/australia-best-in-region-for-prostate-cancer-but-there-is-a-catc 2017-12-20T06:00:01+11:00 https://pharmadispatch.com/news/changes-for-health-in-reshuffle 2017-12-19T14:39:01+11:00 https://pharmadispatch.com/news/one-way-or-another-than-money-is-gone-if-it-ever-really-existed 2017-12-19T06:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-investment-and-more-reporting-on-supply-chain 2017-12-19T06:00:01+11:00 https://pharmadispatch.com/news/a-second-interim-report-that-looks-exactly-like-the-first-1 2017-12-19T06:00:01+11:00 https://pharmadispatch.com/news/treat-hcv-now-to-eradicate-quickly-and-save 2017-12-19T06:00:01+11:00 https://pharmadispatch.com/news/old-and-new-challenges-for-greg-hunt-in-2018 2017-12-18T06:00:01+11:00 https://pharmadispatch.com/news/inquiry-delivers-interim-report-kind-of 2017-12-18T06:00:01+11:00 https://pharmadispatch.com/news/outcomes-reveal-tough-time-for-many-major-new-therapies 2017-12-18T06:00:01+11:00 https://pharmadispatch.com/news/sector-happy-with-bennelong-result 2017-12-18T06:00:01+11:00 https://pharmadispatch.com/news/government-expected-to-release-budget-update 2017-12-18T06:00:01+11:00 https://pharmadispatch.com/news/recipients-of-bi-funded-cv-grants-announced 2017-12-15T06:00:01+11:00 https://pharmadispatch.com/news/pfizers-journey-to-the-cbd-begins 2017-12-15T06:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-takes-control-of-promising-loxl2-program 2017-12-15T06:00:01+11:00 https://pharmadispatch.com/news/patients-await-pbac-outcomes 2017-12-15T06:00:01+11:00 https://pharmadispatch.com/news/under-co-payment-market-still-growing 2017-12-15T06:00:01+11:00 https://pharmadispatch.com/news/new-ceo-for-ebos-group 2017-12-14T18:00:01+11:00 https://pharmadispatch.com/news/a-lost-decade-for-the-pbs 2017-12-14T06:00:01+11:00 https://pharmadispatch.com/news/former-ceo-returns-as-csl-chair 2017-12-14T06:00:01+11:00 https://pharmadispatch.com/news/asmi-calls-for-a-switch-agenda 2017-12-14T06:00:01+11:00 https://pharmadispatch.com/news/labor-seeking-feedback-on-health-platform 2017-12-13T06:00:01+11:00 https://pharmadispatch.com/news/australia-must-not-fear-innovation-ferris 2017-12-13T06:00:01+11:00 https://pharmadispatch.com/news/minister-wants-to-negotiate-an-outcome 2017-12-13T06:00:01+11:00 https://pharmadispatch.com/news/just-the-right-time-to-move-on-dr-lynn-weekes 2017-12-12T15:13:01+11:00 https://pharmadispatch.com/news/pbs-the-health-systems-poor-cousin 2017-12-12T06:00:01+11:00 https://pharmadispatch.com/news/bayer-renews-support-for-heart-of-australia 2017-12-12T06:00:01+11:00 https://pharmadispatch.com/news/csl-secures-new-plasma-agreement 2017-12-12T06:00:01+11:00 https://pharmadispatch.com/news/it-is-the-law-not-the-code-says-ma 2017-12-12T06:00:01+11:00 https://pharmadispatch.com/news/labor-to-fund-prep-until-listed-on-the-pbs 2017-12-12T06:00:01+11:00 https://pharmadispatch.com/news/time-to-rethink-code-restrictions-carlo-montagner 2017-12-11T06:00:01+11:00 https://pharmadispatch.com/news/new-cancer-medicines-headline-january-pbs-listings 2017-12-11T06:00:01+11:00 https://pharmadispatch.com/news/ato-cautions-on-tax-transparency-report 2017-12-11T06:00:01+11:00 https://pharmadispatch.com/news/patient-group-leader-leaves-lasting-legacy 2017-12-11T06:00:01+11:00 https://pharmadispatch.com/news/short-timeline-for-senate-inquiry 2017-12-10T16:25:01+11:00 https://pharmadispatch.com/news/pbac-chair-consumer-comments-count 2017-12-08T06:00:01+11:00 https://pharmadispatch.com/news/csl-officially-opens-230m-advanced-manufacturing-facility 2017-12-08T06:00:01+11:00 https://pharmadispatch.com/news/florey-medal-for-gene-therapy-innovator 2017-12-08T06:00:01+11:00 https://pharmadispatch.com/news/leaving-nothing-to-chance-in-bennelong 2017-12-08T06:00:01+11:00 https://pharmadispatch.com/news/ma-distribution-taking-more-of-the-pbs 2017-12-08T06:00:01+11:00 https://pharmadispatch.com/news/merck-welcomes-mavenclad-approval 2017-12-08T06:00:01+11:00 https://pharmadispatch.com/news/australian-companies-down-the-list-on-rd-spend 2017-12-07T06:00:01+11:00 https://pharmadispatch.com/news/gsk-disappointed-over-accc-action 2017-12-07T06:00:01+11:00 https://pharmadispatch.com/news/ma-backs-members-against-misleading-claims 2017-12-07T06:00:01+11:00 https://pharmadispatch.com/news/companies-sticking-with-direct-distribution 2017-12-07T06:00:01+11:00 https://pharmadispatch.com/news/racgp-wants-support-to-fight-antibiotic-resistance 2017-12-06T06:00:01+11:00 https://pharmadispatch.com/news/what-is-inside-the-cso 2017-12-06T06:00:01+11:00 https://pharmadispatch.com/news/new-formulation-reduces-pill-burden 2017-12-06T06:00:01+11:00 https://pharmadispatch.com/news/csl-secures-rights-to-organ-transplant-rejection-therapy 2017-12-06T06:00:01+11:00 https://pharmadispatch.com/news/government-wants-performance-not-regulation-dhls-resnick 2017-12-06T06:00:01+11:00 https://pharmadispatch.com/news/pbs-more-and-more-just-a-safety-net 2017-12-05T06:00:01+11:00 https://pharmadispatch.com/news/australia-still-in-denial-about-innovation 2017-12-05T06:00:01+11:00 https://pharmadispatch.com/news/hcv-therapies-may-not-even-be-in-the-top-10 2017-12-05T06:00:01+11:00 https://pharmadispatch.com/news/expectations-and-cso-standards-are-not-the-same-thing 2017-12-05T06:00:01+11:00 https://pharmadispatch.com/news/hunt-thanks-sector-for-support-on-tga-reforms 2017-12-05T06:00:01+11:00 https://pharmadispatch.com/news/amazon-in-talks-with-us-drugmakers 2017-12-04T06:00:01+11:00 https://pharmadispatch.com/news/australia-facing-risks-of-us-corporate-tax-cut 2017-12-04T06:00:01+11:00 https://pharmadispatch.com/news/its-all-about-rebates 2017-12-04T06:00:01+11:00 https://pharmadispatch.com/news/rca-welcomes-new-listing 2017-12-04T06:00:01+11:00 https://pharmadispatch.com/news/pbs-funding-buckets-would-be-a-disaster 2017-12-01T06:00:01+11:00 https://pharmadispatch.com/news/asmi-says-role-antihistamines-still-have-a-role 2017-12-01T06:00:01+11:00 https://pharmadispatch.com/news/actinogen-capital-raise-to-fund-xanamem-development 2017-12-01T06:00:01+11:00 https://pharmadispatch.com/news/amazon-could-swamp-direct-distribution-as-an-issue 2017-11-30T12:02:01+11:00 https://pharmadispatch.com/news/treatment-free-label-extension-for-novartis-therapy 2017-11-30T06:00:01+11:00 https://pharmadispatch.com/news/uk-moves-ed-drug-over-the-counter 2017-11-30T06:00:01+11:00 https://pharmadispatch.com/news/the-real-challenge-is-getting-behind-the-curtain 2017-11-30T06:00:01+11:00 https://pharmadispatch.com/news/government-must-curate-not-control 2017-11-30T06:00:01+11:00 https://pharmadispatch.com/news/exclusive-biosimilar-a-flagging-saved-companies-from-something-f 2017-11-29T06:00:01+11:00 https://pharmadispatch.com/news/senate-report-wants-tga-pbac-process-change 2017-11-29T06:00:01+11:00 https://pharmadispatch.com/news/government-anticipating-patent-loss-on-key-biologics 2017-11-29T06:00:01+11:00 https://pharmadispatch.com/news/specialists-urge-action-on-treatments-for-liver-cancer 2017-11-29T06:00:01+11:00 https://pharmadispatch.com/news/disruption-is-the-future-of-drug-development 2017-11-28T06:00:01+11:00 https://pharmadispatch.com/news/was-it-just-a-flagging-or-something-more 2017-11-28T06:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-might-be-wondering-what-is-going-on 2017-11-28T06:00:01+11:00 https://pharmadispatch.com/news/potential-delay-disgraceful 2017-11-28T06:00:01+11:00 https://pharmadispatch.com/news/guild-rallies-members-against-companies-going-direct 2017-11-27T06:00:01+11:00 https://pharmadispatch.com/news/an-unworkable-ban-will-not-fix-anything 2017-11-27T06:00:01+11:00 https://pharmadispatch.com/news/get-ready-for-mount-kosciuszko-challenge-2018 2017-11-27T06:00:01+11:00 https://pharmadispatch.com/news/whose-privacy-are-you-protecting 2017-11-27T06:00:01+11:00 https://pharmadispatch.com/news/new-report-identifies-investment-gap-in-nz 2017-11-24T06:00:01+11:00 https://pharmadispatch.com/news/an-investment-gap-in-australia 2017-11-24T06:00:01+11:00 https://pharmadispatch.com/news/health-costs-are-going-up-and-they-are-not-going-away 2017-11-24T06:00:01+11:00 https://pharmadispatch.com/news/what-could-the-minister-actually-do 2017-11-23T12:53:01+11:00 https://pharmadispatch.com/news/get-the-pbs-policy-discussion-out-of-the-budget-process 2017-11-23T06:00:01+11:00 https://pharmadispatch.com/news/trying-to-prevent-leaks-only-makes-them-more-likely-to-happen 2017-11-23T06:00:01+11:00 https://pharmadispatch.com/news/another-company-goes-direct 2017-11-23T06:00:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics 2017-11-23T06:00:01+11:00 https://pharmadispatch.com/news/game-of-chance-secures-ema-for-amsterdam 2017-11-22T06:00:01+11:00 https://pharmadispatch.com/news/sector-must-unite-on-sustainable-funding-for-pbs 2017-11-22T06:00:01+11:00 https://pharmadispatch.com/news/names-changes-for-two-australian-biotechs 2017-11-22T06:00:01+11:00 https://pharmadispatch.com/news/take-off-for-taa-division 2017-11-22T06:00:01+11:00 https://pharmadispatch.com/news/report-urges-single-process-for-co-dependent-technologies 2017-11-21T06:00:01+11:00 https://pharmadispatch.com/news/new-cancer-collaboration-for-walter-and-eliza-hall-institute 2017-11-21T06:00:01+11:00 https://pharmadispatch.com/news/tga-backs-another-priority-review-for-opdivo 2017-11-21T06:00:01+11:00 https://pharmadispatch.com/news/new-doubts-over-timing-of-parliamentary-backing-for-key-reforms 2017-11-21T06:00:01+11:00 https://pharmadispatch.com/news/pbs-leadership-takes-shape 2017-11-20T06:00:01+11:00 https://pharmadispatch.com/news/familiar-face-to-lead-hepatitis-australia-board 2017-11-20T06:00:01+11:00 https://pharmadispatch.com/news/uk-recommends-funding-for-new-breast-cancer-therapies 2017-11-20T06:00:01+11:00 https://pharmadispatch.com/news/biosimilar-awareness-grant-will-proceed 2017-11-20T06:00:01+11:00 https://pharmadispatch.com/news/action-required-on-falling-treatment-rates 2017-11-19T10:51:01+11:00 https://pharmadispatch.com/news/pharmacy-lags-natural-therapies 2017-11-17T06:00:01+11:00 https://pharmadispatch.com/news/departmental-restructure-underway 2017-11-17T06:00:01+11:00 https://pharmadispatch.com/news/sydney-based-biotron-reports-positive-results-from-hbv-studies 2017-11-17T06:00:01+11:00 https://pharmadispatch.com/news/dendright-advances-immunotherapy 2017-11-17T06:00:01+11:00 https://pharmadispatch.com/news/new-venture-for-ex-ma-chief-executive 2017-11-16T06:00:01+11:00 https://pharmadispatch.com/news/companies-welcome-survey-result 2017-11-16T06:00:01+11:00 https://pharmadispatch.com/news/chf-working-on-its-own-financial-sustainability 2017-11-16T06:00:01+11:00 https://pharmadispatch.com/news/us-tax-cut-could-hit-advanced-manufacturing 2017-11-16T06:00:01+11:00 https://pharmadispatch.com/news/biosimilars-remain-centre-stage 2017-11-16T06:00:01+11:00 https://pharmadispatch.com/news/is-that-really-a-minor-or-administrative-change 2017-11-15T06:00:01+11:00 https://pharmadispatch.com/news/new-chief-executive-for-pharmac 2017-11-15T06:00:01+11:00 https://pharmadispatch.com/news/mandatory-reporting-on-mpa-agenda 2017-11-15T06:00:01+11:00 https://pharmadispatch.com/news/ramsay-acquires-queensland-pharmacy-chain 2017-11-15T06:00:01+11:00 https://pharmadispatch.com/news/the-biggest-problem-is-us-guys-we-are-the-problem 2017-11-14T06:00:01+11:00 https://pharmadispatch.com/news/international-comparisons-not-so-easy 2017-11-14T06:00:01+11:00 https://pharmadispatch.com/news/ex-gsk-executive-new-senate-president 2017-11-14T06:00:01+11:00 https://pharmadispatch.com/news/medicines-nz-seeking-new-chair 2017-11-14T06:00:01+11:00 https://pharmadispatch.com/news/australian-developed-testosterone-treatment-coming-off-the-pbs 2017-11-14T06:00:01+11:00 https://pharmadispatch.com/news/uptake-drivers-for-brenzys-in-december 2017-11-13T06:00:01+11:00 https://pharmadispatch.com/news/by-election-for-industrys-strongest-supporter 2017-11-13T06:00:01+11:00 https://pharmadispatch.com/news/perceptions-matter-for-ma 2017-11-13T06:00:01+11:00 https://pharmadispatch.com/news/simply-wrong-or-wilfully-misleading-on-ip 2017-11-13T06:00:01+11:00 https://pharmadispatch.com/news/new-documents-reveal-more-on-key-decisions 2017-11-13T06:00:01+11:00 https://pharmadispatch.com/news/discussions-continue-on-mandatory-reporting 2017-11-10T06:00:01+11:00 https://pharmadispatch.com/news/pbs-schedule-update-delayed 2017-11-10T06:00:01+11:00 https://pharmadispatch.com/news/government-confident-reforms-get-through-before-year-end 2017-11-10T06:00:01+11:00 https://pharmadispatch.com/news/ceo-resigns-from-pharmaceutical-society-of-australia 2017-11-10T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-genzyme-joins-captains-ride-for-rare-disease 2017-11-09T08:57:01+11:00 https://pharmadispatch.com/news/change-needed-or-it-just-gets-worse 2017-11-09T06:00:01+11:00 https://pharmadispatch.com/news/digital-strategy-a-missed-opportunity 2017-11-09T06:00:01+11:00 https://pharmadispatch.com/news/former-health-minister-appointed-to-key-health-post 2017-11-09T06:00:01+11:00 https://pharmadispatch.com/news/another-restructure-coming-for-health 2017-11-09T06:00:01+11:00 https://pharmadispatch.com/news/top-10-not-what-it-used-it-be 2017-11-08T06:00:01+11:00 https://pharmadispatch.com/news/new-name-for-quintilesims 2017-11-08T06:00:01+11:00 https://pharmadispatch.com/news/amgen-veteran-joins-actinogen 2017-11-08T06:00:01+11:00 https://pharmadispatch.com/news/telephony-report-shows-extent-on-pbs-authorities 2017-11-08T06:00:01+11:00 https://pharmadispatch.com/news/slowing-hcv-uptake-a-concern 2017-11-07T06:00:01+11:00 https://pharmadispatch.com/news/venturewise-growing-slowly 2017-11-07T06:00:01+11:00 https://pharmadispatch.com/news/vertex-reports-positive-results-from-another-cf-combination 2017-11-07T06:00:01+11:00 https://pharmadispatch.com/news/government-set-to-table-response-to-senate-cancer-inquiry 2017-11-07T06:00:01+11:00 https://pharmadispatch.com/news/labor-wants-action-on-meningococcal-b 2017-11-07T06:00:01+11:00 https://pharmadispatch.com/news/rebate-response-reveals-the-facts 2017-11-06T06:00:01+11:00 https://pharmadispatch.com/news/rebate-clarity-goes-close-to-revealing-real-hcv-price 2017-11-06T06:00:01+11:00 https://pharmadispatch.com/news/biogen-welcomes-approval-of-australian-first-treatment 2017-11-06T06:00:01+11:00 https://pharmadispatch.com/news/turnbull-and-ardern-back-tpp-11 2017-11-06T06:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-codeine-implementation-a-matter-for-states 2017-11-06T06:00:01+11:00 https://pharmadispatch.com/news/pbac-says-no-to-lifting-bdmard-criteria 2017-11-06T06:00:01+11:00 https://pharmadispatch.com/news/nps-issues-annual-report 2017-11-06T06:00:01+11:00 https://pharmadispatch.com/news/madness-not-to-invest-in-government-relations 2017-11-03T06:00:01+11:00 https://pharmadispatch.com/news/government-too-conservative-on-otc-switch 2017-11-03T06:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-novartis-kisqali 2017-11-03T06:00:01+11:00 https://pharmadispatch.com/news/australians-too-relaxed-about-antibiotic-resistance 2017-11-03T06:00:01+11:00 https://pharmadispatch.com/news/can-both-numbers-be-right 2017-11-02T06:00:01+11:00 https://pharmadispatch.com/news/mixed-news-for-astrazeneca 2017-11-02T06:00:01+11:00 https://pharmadispatch.com/news/government-building-mrff-grants 2017-11-02T06:00:01+11:00 https://pharmadispatch.com/news/medicare-funding-for-cancer-gene-test 2017-11-01T19:00:01+11:00 https://pharmadispatch.com/news/no-end-in-sight-to-slow-uptake 2017-11-01T06:00:01+11:00 https://pharmadispatch.com/news/discretion-could-be-the-most-dangerous-word 2017-11-01T06:00:01+11:00 https://pharmadispatch.com/news/anao-raised-concerns-over-administration-of-deeds 2017-11-01T06:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-jj-innovation-industry-excellence-awards-1 2017-11-01T06:00:01+11:00 https://pharmadispatch.com/news/investors-react-on-direct-distribution 2017-10-31T06:00:01+11:00 https://pharmadispatch.com/news/33-billion-anyone 2017-10-31T06:00:01+11:00 https://pharmadispatch.com/news/cmo-slams-cheap-flux-vax-claims 2017-10-31T06:00:01+11:00 https://pharmadispatch.com/news/lsdp-announcement-imminent 2017-10-31T06:00:01+11:00 https://pharmadispatch.com/news/another-ip-test-for-australia 2017-10-30T06:00:01+11:00 https://pharmadispatch.com/news/extension-study-key-for-orkambi-listing 2017-10-30T06:00:01+11:00 https://pharmadispatch.com/news/pbac-unhappy-on-humira-but-timing-vindicates-abbvie 2017-10-30T06:00:01+11:00 https://pharmadispatch.com/news/pbac-says-no-to-price-cut-conditions 2017-10-30T06:00:01+11:00 https://pharmadispatch.com/news/clinicians-welcome-darzalex-approval 2017-10-30T06:00:01+11:00 https://pharmadispatch.com/news/wholesalers-and-pharmacy-want-action-on-direct-distribution 2017-10-30T06:00:01+11:00 https://pharmadispatch.com/news/snapshot-shows-magnitude-of-life-sciences-sector 2017-10-27T06:00:01+11:00 https://pharmadispatch.com/news/new-projects-funded-by-mtpconnect 2017-10-27T06:00:01+11:00 https://pharmadispatch.com/news/new-branding-for-medicines-australia 2017-10-27T06:00:01+11:00 https://pharmadispatch.com/news/opdivo-delivering-for-bms 2017-10-27T06:00:01+11:00 https://pharmadispatch.com/news/new-medicines-australia-board 2017-10-26T15:30:01+11:00 https://pharmadispatch.com/news/things-get-heated-at-senate-estimates 2017-10-26T11:37:01+11:00 https://pharmadispatch.com/news/encouraged-rather-than-preferred 2017-10-26T06:00:01+11:00 https://pharmadispatch.com/news/australians-blame-lung-cancer-victims 2017-10-26T06:00:01+11:00 https://pharmadispatch.com/news/low-uptake-hits-online-authorities 2017-10-26T06:00:01+11:00 https://pharmadispatch.com/news/new-health-minister-for-nz 2017-10-26T06:00:01+11:00 https://pharmadispatch.com/news/msd-signs-collaboration-with-uniquest 2017-10-26T06:00:01+11:00 https://pharmadispatch.com/news/ma-boards-new-faces 2017-10-26T06:00:01+11:00 https://pharmadispatch.com/news/gender-realignment-for-ma-board 2017-10-25T06:00:01+11:00 https://pharmadispatch.com/news/productivity-commission-delivers-pharmacy-a-gift 2017-10-25T06:00:01+11:00 https://pharmadispatch.com/news/biggest-biotech-ipo-since-csl 2017-10-25T06:00:01+11:00 https://pharmadispatch.com/news/wa-to-protect-pharmacy-integrity 2017-10-25T06:00:01+11:00 https://pharmadispatch.com/news/novartis-pushing-on-alcon 2017-10-25T06:00:01+11:00 https://pharmadispatch.com/news/ebos-takes-strategic-stake-in-medadvisor 2017-10-25T06:00:01+11:00 https://pharmadispatch.com/news/uptake-improves-or-price-cuts-coming 2017-10-24T06:00:01+11:00 https://pharmadispatch.com/news/innovation-the-focus-at-healthy-ageing-conference 2017-10-24T06:00:01+11:00 https://pharmadispatch.com/news/key-figure-retiring-just-as-things-get-interesting 2017-10-24T06:00:01+11:00 https://pharmadispatch.com/news/biointelect-appoints-ex-lilly-market-access-head 2017-10-24T06:00:01+11:00 https://pharmadispatch.com/news/ara-more-clarity-required-on-uptake-drivers 2017-10-23T06:00:01+11:00 https://pharmadispatch.com/news/uptake-driver-will-not-work-for-acute-treatments 2017-10-23T06:00:01+11:00 https://pharmadispatch.com/news/patients-paying-the-price-of-under-treatment 2017-10-23T06:00:01+11:00 https://pharmadispatch.com/news/us-delegation-stands-ground-on-ip 2017-10-23T06:00:01+11:00 https://pharmadispatch.com/news/participants-gather-for-bridge-program-conference 2017-10-23T06:00:01+11:00 https://pharmadispatch.com/news/government-needs-to-back-medicines-on-prevention 2017-10-23T06:00:01+11:00 https://pharmadispatch.com/news/stem-partnership-between-sanofi-and-the-smith-family 2017-10-20T06:00:01+11:00 https://pharmadispatch.com/news/keytruda-holds-survival-gains 2017-10-20T06:00:01+11:00 https://pharmadispatch.com/news/pharmacists-say-doctors-blocking-scheduling-reform 2017-10-20T06:00:01+11:00 https://pharmadispatch.com/news/policy-block-to-reverse-substitution 2017-10-20T06:00:01+11:00 https://pharmadispatch.com/news/new-government-could-mean-change-for-pharmac 2017-10-20T06:00:01+11:00 https://pharmadispatch.com/news/solid-year-for-api-in-the-face-of-tough-conditions 2017-10-20T06:00:01+11:00 https://pharmadispatch.com/news/industry-association-looking-for-new-leader 2017-10-19T18:00:01+11:00 https://pharmadispatch.com/news/an-exception-or-new-paradigm-time-will-tell 2017-10-19T06:00:01+11:00 https://pharmadispatch.com/news/jj-fighting-off-biosimilars-in-the-us 2017-10-19T06:00:01+11:00 https://pharmadispatch.com/news/bill-introduced-but-questions-remain 2017-10-19T06:00:01+11:00 https://pharmadispatch.com/news/ministerial-roundtable-on-bone-health 2017-10-19T06:00:01+11:00 https://pharmadispatch.com/news/who-officially-scraps-proposed-naming-convention 2017-10-18T06:00:01+11:00 https://pharmadispatch.com/news/tributes-for-levinia-crooks-am 2017-10-18T06:00:01+11:00 https://pharmadispatch.com/news/viiv-announces-positive-action-community-grants 2017-10-18T06:00:01+11:00 https://pharmadispatch.com/news/settlement-for-sigma-and-chemist-warehouse 2017-10-18T06:00:01+11:00 https://pharmadispatch.com/news/urgent-action-required-on-the-greatest-epidemic 2017-10-18T06:00:01+11:00 https://pharmadispatch.com/news/from-three-to-two-meetings 2017-10-17T06:00:01+11:00 https://pharmadispatch.com/news/pbs-changes-could-be-in-parliament-this-week 2017-10-17T06:00:01+11:00 https://pharmadispatch.com/news/csl-fellowships-target-cancer-and-cardiovascular-disease 2017-10-17T06:00:01+11:00 https://pharmadispatch.com/news/new-name-for-evolving-novogen 2017-10-17T06:00:01+11:00 https://pharmadispatch.com/news/positive-results-for-bms-immunotherapy-combination-in-lung-cance 2017-10-17T06:00:01+11:00 https://pharmadispatch.com/news/nobody-will-want-to-be-health-minister-in-2022 2017-10-16T06:00:01+11:00 https://pharmadispatch.com/news/us-delegation-in-australia-for-ip-talks 2017-10-16T06:00:01+11:00 https://pharmadispatch.com/news/reforms-required-as-patients-miss-out 2017-10-16T06:00:01+11:00 https://pharmadispatch.com/news/the-end-arrives-for-cetp-inhibitors 2017-10-16T06:00:01+11:00 https://pharmadispatch.com/news/department-delays-biosimilar-implementation-plans 2017-10-16T06:00:01+11:00 https://pharmadispatch.com/news/its-all-about-change-says-abbvies-kirsten-odoherty 2017-10-13T06:00:01+11:00 https://pharmadispatch.com/news/working-life-at-abbvie 2017-10-13T06:00:01+11:00 https://pharmadispatch.com/news/revealed-uptake-driver-implementation-plan 2017-10-13T06:00:01+11:00 https://pharmadispatch.com/news/novartis-to-retain-roche-stake 2017-10-13T06:00:01+11:00 https://pharmadispatch.com/news/new-funding-for-israeli-australian-company 2017-10-13T06:00:01+11:00 https://pharmadispatch.com/news/canteen-trial-funding-as-part-of-new-200m-research-round 2017-10-12T18:00:01+11:00 https://pharmadispatch.com/news/when-not-mandatory-is-actually-mandatory 2017-10-12T06:00:01+11:00 https://pharmadispatch.com/news/reference-brands-rather-than-reference-biologics 2017-10-12T06:00:01+11:00 https://pharmadispatch.com/news/government-funded-flu-vax-the-next-step 2017-10-12T06:00:01+11:00 https://pharmadispatch.com/news/contract-win-for-sigma 2017-10-11T06:00:01+11:00 https://pharmadispatch.com/news/there-are-rules-and-there-are-rules 2017-10-11T06:00:01+11:00 https://pharmadispatch.com/news/transparency-and-efficiency-on-the-agenda 2017-10-11T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-considering-sale-of-consumer-health-business 2017-10-11T06:00:01+11:00 https://pharmadispatch.com/news/one-pager-rules-special-pricing-arrangements 2017-10-10T06:00:01+11:00 https://pharmadispatch.com/news/a-consultation-clause-is-not-a-no-savings-clause 2017-10-10T06:00:01+11:00 https://pharmadispatch.com/news/pm-the-best-part-of-the-job 2017-10-10T06:00:01+11:00 https://pharmadispatch.com/news/amneal-brands-start-coming-off-pbs 2017-10-10T06:00:01+11:00 https://pharmadispatch.com/news/another-460m-for-janssens-imbruvica 2017-10-09T06:00:01+11:00 https://pharmadispatch.com/news/pbac-to-extend-biosimilar-default 2017-10-09T06:00:01+11:00 https://pharmadispatch.com/news/novartis-argues-for-eu-naming-convention 2017-10-09T06:00:01+11:00 https://pharmadispatch.com/news/codeine-debate-goes-on 2017-10-09T06:00:01+11:00 https://pharmadispatch.com/news/upgraded-hpv-vaccine-for-nip 2017-10-09T06:00:01+11:00 https://pharmadispatch.com/news/cda-shuts-down-but-not-without-leaving-a-legacy 2017-10-08T11:37:01+11:00 https://pharmadispatch.com/news/cancer-researcher-wins-gsk-award 2017-10-06T06:00:01+11:00 https://pharmadispatch.com/news/merck-fellowship-in-gastro-intestinal-research 2017-10-06T06:00:01+11:00 https://pharmadispatch.com/news/carers-suffering-without-support 2017-10-06T06:00:01+11:00 https://pharmadispatch.com/news/real-world-study-delivers-for-gsks-breo-ellipta 2017-10-05T11:25:01+11:00 https://pharmadispatch.com/news/dismayed-and-frustrated-over-fifth-rejection 2017-10-05T06:00:01+11:00 https://pharmadispatch.com/news/companies-would-utilise-the-process 2017-10-05T06:00:01+11:00 https://pharmadispatch.com/news/pbac-process-facing-major-overhaul 2017-10-05T06:00:01+11:00 https://pharmadispatch.com/news/az-celebrates-60-years-in-australia 2017-10-05T06:00:01+11:00 https://pharmadispatch.com/news/december-agenda-confirms-the-postponed-six 2017-10-05T06:00:01+11:00 https://pharmadispatch.com/news/exclusive-thousands-could-benefit-from-new-pbs-process 2017-10-04T06:00:01+11:00 https://pharmadispatch.com/news/a-busy-year-for-ausbiotech 2017-10-04T06:00:01+11:00 https://pharmadispatch.com/news/industry-backs-macquarie-scholarship-program 2017-10-04T06:00:01+11:00 https://pharmadispatch.com/news/terrywhite-chemmart-teams-up-with-heart-foundation 2017-10-04T06:00:01+11:00 https://pharmadispatch.com/news/industry-a-big-winner-from-trump-tax-proposal 2017-10-03T06:00:01+11:00 https://pharmadispatch.com/news/new-schizophrenia-therapy-welcomed 2017-10-03T06:00:01+11:00 https://pharmadispatch.com/news/price-cut-probably-beats-a-post-market-review 2017-10-03T06:00:01+11:00 https://pharmadispatch.com/news/everyone-wants-to-rewrite-history 2017-10-03T06:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-to-decide-on-first-uptake-driver 2017-10-03T06:00:01+11:00 https://pharmadispatch.com/news/more-agreements-coming-for-health-sector 2017-09-29T06:00:01+10:00 https://pharmadispatch.com/news/msd-hoping-for-stakeholder-support 2017-09-29T06:00:01+10:00 https://pharmadispatch.com/news/will-clones-qualify-for-uptake-drivers 2017-09-29T06:00:01+10:00 https://pharmadispatch.com/news/new-indication-boost-for-novartis-copd-therapy 2017-09-29T06:00:01+10:00 https://pharmadispatch.com/news/abbvie-teams-up-with-guild-and-secures-global-agreement-on-humir 2017-09-29T06:00:01+10:00 https://pharmadispatch.com/news/amgen-backs-us-naming-system 2017-09-28T06:00:01+10:00 https://pharmadispatch.com/news/its-time-to-tell-our-story 2017-09-28T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-hps 2017-09-28T06:00:01+10:00 https://pharmadispatch.com/news/doubling-down-on-the-ridiculousness 2017-09-28T06:00:01+10:00 https://pharmadispatch.com/news/have-your-say-on-digital-transformation-and-multi-channel-market 2017-09-28T06:00:01+10:00 https://pharmadispatch.com/news/more-from-rebates-than-taxes-on-beer 2017-09-27T06:00:01+10:00 https://pharmadispatch.com/news/sometimes-answers-just-make-no-sense 2017-09-27T06:00:01+10:00 https://pharmadispatch.com/news/cost-recovery-changes-coming 2017-09-27T06:00:01+10:00 https://pharmadispatch.com/news/vaccines-for-parallel-process 2017-09-27T06:00:01+10:00 https://pharmadispatch.com/news/ma-industry-sacrifices-deliver-for-pbs 2017-09-27T06:00:01+10:00 https://pharmadispatch.com/news/spike-in-rebates-offsets-pbs-growth 2017-09-26T11:17:01+10:00 https://pharmadispatch.com/news/us-clearing-path-for-cell-therapies 2017-09-26T06:00:01+10:00 https://pharmadispatch.com/news/groups-call-for-action-on-opioids 2017-09-26T06:00:01+10:00 https://pharmadispatch.com/news/abbvie-steps-up-on-marriage-equality 2017-09-26T06:00:01+10:00 https://pharmadispatch.com/news/more-work-needed-on-contraception 2017-09-26T06:00:01+10:00 https://pharmadispatch.com/news/second-order-issues-distract-from-whats-important 2017-09-25T06:00:01+10:00 https://pharmadispatch.com/news/nz-kingmaker-wants-pharmac-review 2017-09-25T06:00:01+10:00 https://pharmadispatch.com/news/medicines-a-factor-in-massive-decline-in-cv-deaths 2017-09-25T06:00:01+10:00 https://pharmadispatch.com/news/bcna-review-pbs-to-address-financial-burden 2017-09-25T06:00:01+10:00 https://pharmadispatch.com/news/clinical-trials-system-broken 2017-09-25T06:00:01+10:00 https://pharmadispatch.com/news/minister-confirms-interest-in-agreement-with-wholesalers 2017-09-22T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-sues-jj-over-biosimilar-exclusion-contracts 2017-09-22T06:00:01+10:00 https://pharmadispatch.com/news/ferris-australia-falling-behind 2017-09-22T06:00:01+10:00 https://pharmadispatch.com/news/consumers-unhappy-over-codeine 2017-09-22T06:00:01+10:00 https://pharmadispatch.com/news/european-approval-for-new-pd-l1-antibody 2017-09-22T06:00:01+10:00 https://pharmadispatch.com/news/cholesterol-biologics-show-benefit-for-diabetics 2017-09-21T06:00:01+10:00 https://pharmadispatch.com/news/massive-saving-but-not-very-feasible 2017-09-21T06:00:01+10:00 https://pharmadispatch.com/news/why-not-the-who-model 2017-09-21T06:00:01+10:00 https://pharmadispatch.com/news/survey-reveals-extent-of-medicine-use 2017-09-21T06:00:01+10:00 https://pharmadispatch.com/news/a-shortish-history-the-name-game 2017-09-20T06:00:01+10:00 https://pharmadispatch.com/news/msd-backs-european-naming-system 2017-09-20T06:00:01+10:00 https://pharmadispatch.com/news/a-new-industry-and-innovation-minister 2017-09-20T06:00:01+10:00 https://pharmadispatch.com/news/new-mou-for-mtpconnect 2017-09-20T06:00:01+10:00 https://pharmadispatch.com/news/sector-battles-it-our-over-biologic-naming 2017-09-19T06:00:01+10:00 https://pharmadispatch.com/news/first-day-on-the-job-for-new-secretaries 2017-09-19T06:00:01+10:00 https://pharmadispatch.com/news/government-backs-world-first-trial-in-childhood-cancers 2017-09-19T06:00:01+10:00 https://pharmadispatch.com/news/new-zealand-set-to-fund-shingles-vaccine 2017-09-19T06:00:01+10:00 https://pharmadispatch.com/news/someone-must-have-listened 2017-09-18T06:00:01+10:00 https://pharmadispatch.com/news/health-a-focus-as-nz-election-remains-too-close-to-call 2017-09-18T06:00:01+10:00 https://pharmadispatch.com/news/reform-on-top-of-reform 2017-09-18T06:00:01+10:00 https://pharmadispatch.com/news/rescheduling-decisions-on-key-medicines 2017-09-18T06:00:01+10:00 https://pharmadispatch.com/news/ipsens-peter-koetsier-an-opportunity-too-good-to-miss 2017-09-17T06:00:01+10:00 https://pharmadispatch.com/news/ip-australia-consulting-on-government-response-to-pbs-report 2017-09-15T06:00:01+10:00 https://pharmadispatch.com/news/the-work-starts-now-says-takedas-james-jones 2017-09-15T06:00:01+10:00 https://pharmadispatch.com/news/who-sits-in-judgement-of-industry 2017-09-15T06:00:01+10:00 https://pharmadispatch.com/news/fda-approves-first-avastin-biosimilar 2017-09-15T06:00:01+10:00 https://pharmadispatch.com/news/maestro-going-global 2017-09-14T06:00:01+10:00 https://pharmadispatch.com/news/ma-board-candidates-put-their-case 2017-09-14T06:00:01+10:00 https://pharmadispatch.com/news/keytruda-triple-combination-delivers-in-lung 2017-09-14T06:00:01+10:00 https://pharmadispatch.com/news/immunisation-incentive-payment-working 2017-09-14T06:00:01+10:00 https://pharmadispatch.com/news/delay-to-avoid-unintended-consequences-or-misinterpretations 2017-09-13T06:00:01+10:00 https://pharmadispatch.com/news/amgen-launches-education-initiative-in-australia 2017-09-13T06:00:01+10:00 https://pharmadispatch.com/news/salary-survey-reveals-the-latest-on-industry 2017-09-13T06:00:01+10:00 https://pharmadispatch.com/news/tga-annual-performance-report 2017-09-13T06:00:01+10:00 https://pharmadispatch.com/news/step-towards-a-single-agreement 2017-09-12T06:00:01+10:00 https://pharmadispatch.com/news/new-portal-supporting-medicinal-cannabis 2017-09-12T06:00:01+10:00 https://pharmadispatch.com/news/opdivo-shines-in-australian-trial 2017-09-12T06:00:01+10:00 https://pharmadispatch.com/news/voting-underway-in-ma-board-election 2017-09-12T06:00:01+10:00 https://pharmadispatch.com/news/new-indication-for-msds-keytruda 2017-09-12T06:00:01+10:00 https://pharmadispatch.com/news/brian-gladsden-time-to-take-on-our-critics 2017-09-11T06:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-set-to-trigger-another-milestone 2017-09-11T06:00:01+10:00 https://pharmadispatch.com/news/companies-showcase-new-therapies-at-esmo 2017-09-11T06:00:01+10:00 https://pharmadispatch.com/news/mental-health-and-new-brands-headline-october-pbs 2017-09-11T06:00:01+10:00 https://pharmadispatch.com/news/wholesalers-want-strategic-agreement 2017-09-11T06:00:01+10:00 https://pharmadispatch.com/news/sigma-acquires-dose-administration-leader 2017-09-08T06:00:01+10:00 https://pharmadispatch.com/news/higher-pbac-fees-could-win-industry-support 2017-09-08T06:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-new-appointments 2017-09-08T06:00:01+10:00 https://pharmadispatch.com/news/sector-backs-legislation 2017-09-08T06:00:01+10:00 https://pharmadispatch.com/news/the-deepening-mystery-of-savings-fund 2017-09-07T06:00:01+10:00 https://pharmadispatch.com/news/chf-says-no-to-industry 2017-09-07T06:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-progresses-loxl2-inhibitor 2017-09-07T06:00:01+10:00 https://pharmadispatch.com/news/who-was-listening 2017-09-07T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-health 2017-09-06T06:00:01+10:00 https://pharmadispatch.com/news/sometimes-just-getting-together-is-enough 2017-09-06T06:00:01+10:00 https://pharmadispatch.com/news/new-partnership-to-tackle-cancer-and-alzheimers-disease 2017-09-06T06:00:01+10:00 https://pharmadispatch.com/news/new-trial-for-imugenes-her-vaxx-immunotherapy 2017-09-06T06:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-delivers-a-very-direct-message 2017-09-05T12:09:01+10:00 https://pharmadispatch.com/news/new-health-adviser-for-turnbull 2017-09-05T06:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-action-on-hiv 2017-09-05T06:00:01+10:00 https://pharmadispatch.com/news/taking-it-to-the-hill 2017-09-05T06:00:01+10:00 https://pharmadispatch.com/news/new-global-leadership-for-novartis 2017-09-05T06:00:01+10:00 https://pharmadispatch.com/news/juno-joins-gbma 2017-09-05T06:00:01+10:00 https://pharmadispatch.com/news/tpp-countries-scrap-pharma-ip-provisions 2017-09-04T06:00:01+10:00 https://pharmadispatch.com/news/paying-the-price-for-a-ridiculous-charade 2017-09-04T06:00:01+10:00 https://pharmadispatch.com/news/funding-for-pharmacy-codeine-training 2017-09-04T06:00:01+10:00 https://pharmadispatch.com/news/changes-at-sigma 2017-09-04T06:00:01+10:00 https://pharmadispatch.com/news/us-go-ahead-for-adheriums-symbicort-platform 2017-09-04T06:00:01+10:00 https://pharmadispatch.com/news/paradigm-shift-required-for-personalised-medicine 2017-09-01T06:00:01+10:00 https://pharmadispatch.com/news/ramsay-pushing-pharmacy-expansion 2017-09-01T06:00:01+10:00 https://pharmadispatch.com/news/arrow-and-juno-split-amneal-business 2017-09-01T06:00:01+10:00 https://pharmadispatch.com/news/mixed-exposure-for-draft-legislation 2017-09-01T06:00:01+10:00 https://pharmadispatch.com/news/another-confirmed-candidate-for-ma-election 2017-09-01T06:00:01+10:00 https://pharmadispatch.com/news/gsk-opens-shopper-science-lab 2017-08-31T06:00:01+10:00 https://pharmadispatch.com/news/department-appoints-acting-deputy-secretary 2017-08-31T06:00:01+10:00 https://pharmadispatch.com/news/changes-make-for-an-unpredictable-outcome 2017-08-31T06:00:01+10:00 https://pharmadispatch.com/news/first-pbs-treatment-for-disabling-skin-condition 2017-08-31T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-celgene 2017-08-30T06:00:01+10:00 https://pharmadispatch.com/news/more-nominations-for-ma-board 2017-08-30T06:00:01+10:00 https://pharmadispatch.com/news/janssen-welcomes-wider-stelara-listing 2017-08-30T06:00:01+10:00 https://pharmadispatch.com/news/china-hits-blackmores-result 2017-08-30T06:00:01+10:00 https://pharmadispatch.com/news/gilead-hoping-for-another-pharmasset 2017-08-30T06:00:01+10:00 https://pharmadispatch.com/news/australian-patients-lag-on-lung-cancer 2017-08-29T06:04:01+10:00 https://pharmadispatch.com/news/gbma-backs-ip-response 2017-08-29T06:03:01+10:00 https://pharmadispatch.com/news/csl-acquires-gene-therapy-company 2017-08-29T06:02:01+10:00 https://pharmadispatch.com/news/api-withdraws-from-acquisition-process 2017-08-29T06:01:01+10:00 https://pharmadispatch.com/news/pradaxa-tops-warfarin-in-safety-trial 2017-08-29T06:00:01+10:00 https://pharmadispatch.com/news/ip-response-a-virtual-slam-dunk-on-key-issues 2017-08-28T06:05:01+10:00 https://pharmadispatch.com/news/governments-ip-response-the-detail 2017-08-28T06:04:01+10:00 https://pharmadispatch.com/news/reporting-copies-us-arrangement 2017-08-28T06:03:01+10:00 https://pharmadispatch.com/news/pay-for-delay-reporting-extraordinary 2017-08-28T06:02:01+10:00 https://pharmadispatch.com/news/bi-progresses-pharmaxis-therapy 2017-08-28T06:01:01+10:00 https://pharmadispatch.com/news/new-study-boosts-bayers-xarelto 2017-08-28T06:00:01+10:00 https://pharmadispatch.com/news/new-boss-for-az-australia 2017-08-25T06:07:01+10:00 https://pharmadispatch.com/news/ebos-earnings-rise-despite-pbs-reform-impact 2017-08-25T06:00:01+10:00 https://pharmadispatch.com/news/new-research-funding 2017-08-25T06:00:01+10:00 https://pharmadispatch.com/news/novartis-appoints-retail-expert-to-global-digital-role 2017-08-25T06:00:01+10:00 https://pharmadispatch.com/news/study-highlights-long-term-benefits-of-brilinta 2017-08-25T06:00:01+10:00 https://pharmadispatch.com/news/health-adviser-leaves-turnbull-staff 2017-08-24T06:03:01+10:00 https://pharmadispatch.com/news/switch-from-any-bdmard 2017-08-24T06:02:01+10:00 https://pharmadispatch.com/news/complex-agenda-for-november-pbac 2017-08-24T06:01:01+10:00 https://pharmadispatch.com/news/industry-dominates-ato-audits 2017-08-24T06:00:01+10:00 https://pharmadispatch.com/news/new-australian-partnership-for-janssen 2017-08-23T06:00:01+10:00 https://pharmadispatch.com/news/sector-tribute-to-martin-bowles 2017-08-23T06:00:01+10:00 https://pharmadispatch.com/news/mp-roundtable-in-melbourne-today 2017-08-23T06:00:01+10:00 https://pharmadispatch.com/news/one-of-the-least-surprising-announcements 2017-08-23T06:00:01+10:00 https://pharmadispatch.com/news/large-field-for-ma-board-election 2017-08-23T05:00:01+10:00 https://pharmadispatch.com/news/martin-bowles-resigns 2017-08-22T15:53:01+10:00 https://pharmadispatch.com/news/sector-reviewing-draft-legislation 2017-08-22T06:03:01+10:00 https://pharmadispatch.com/news/is-that-really-evidence-based 2017-08-22T06:02:01+10:00 https://pharmadispatch.com/news/pharmaxis-welcomes-pbs-recommendation 2017-08-22T06:01:01+10:00 https://pharmadispatch.com/news/monash-biomedicine-discovery-institute-joins-mrcf 2017-08-22T06:00:01+10:00 https://pharmadispatch.com/news/was-that-such-a-good-idea 2017-08-21T06:06:01+10:00 https://pharmadispatch.com/news/outcomes-reveal-carnage-at-july-pbac 2017-08-21T06:05:01+10:00 https://pharmadispatch.com/news/timing-means-nothing-has-really-changed 2017-08-21T06:04:01+10:00 https://pharmadispatch.com/news/pbac-says-no-to-tighter-prescribing 2017-08-21T06:03:01+10:00 https://pharmadispatch.com/news/labor-wants-action-on-prep 2017-08-21T06:02:01+10:00 https://pharmadispatch.com/news/nz-candidates-agree-on-access-issues 2017-08-21T06:01:01+10:00 https://pharmadispatch.com/news/calls-for-depression-study-participants 2017-08-21T06:00:01+10:00 https://pharmadispatch.com/news/overdiagnosis-of-overdiagnosis 2017-08-18T06:00:01+10:00 https://pharmadispatch.com/news/gbma-will-invite-ma-to-biosimilar-discussions 2017-08-18T06:00:01+10:00 https://pharmadispatch.com/news/an-invitation-to-engage-in-unlawful-conduct 2017-08-18T06:00:01+10:00 https://pharmadispatch.com/news/new-ceo-for-blackmores 2017-08-18T06:00:01+10:00 https://pharmadispatch.com/news/response-to-ip-report-moving-closer 2017-08-17T06:03:01+10:00 https://pharmadispatch.com/news/csl-hurt-by-high-expectations 2017-08-17T06:02:01+10:00 https://pharmadispatch.com/news/jj-ceo-resigns-from-trump-advisory-group 2017-08-17T06:01:01+10:00 https://pharmadispatch.com/news/msd-partnership-boosts-bionomics 2017-08-17T06:00:01+10:00 https://pharmadispatch.com/news/a-big-week-for-industry-and-pbac 2017-08-16T06:03:01+10:00 https://pharmadispatch.com/news/new-publication-launches-tomorrow 2017-08-16T06:02:01+10:00 https://pharmadispatch.com/news/business-leaders-back-msds-frazier 2017-08-16T06:01:01+10:00 https://pharmadispatch.com/news/positive-study-results-for-opthea 2017-08-16T06:00:01+10:00 https://pharmadispatch.com/news/review-carries-on-but-we-face-the-reality 2017-08-15T06:04:01+10:00 https://pharmadispatch.com/news/september-listing-for-new-pfizer-therapy 2017-08-15T06:03:01+10:00 https://pharmadispatch.com/news/msd-boss-quits-trump-advisory-group 2017-08-15T06:02:01+10:00 https://pharmadispatch.com/news/perth-based-biotech-resurrects-cancer-therapy 2017-08-15T06:01:01+10:00 https://pharmadispatch.com/news/guild-what-about-doctor-shopping 2017-08-15T06:00:01+10:00 https://pharmadispatch.com/news/timing-could-be-everything-on-new-price-cuts 2017-08-14T06:04:01+10:00 https://pharmadispatch.com/news/winning-one-part-of-the-drug-development-process 2017-08-14T06:02:01+10:00 https://pharmadispatch.com/news/bi-backs-cv-research-with-grants 2017-08-14T06:01:01+10:00 https://pharmadispatch.com/news/companies-back-same-sex-marriage 2017-08-14T06:00:01+10:00 https://pharmadispatch.com/news/ubs-downgrades-sigma-in-response-to-lower-forecast 2017-08-14T06:00:01+10:00 https://pharmadispatch.com/news/gsks-anne-belcher-patients-benefit-when-the-relationship-works 2017-08-11T06:00:01+10:00 https://pharmadispatch.com/news/government-follows-bayer-with-commitment-to-heart-of-australia 2017-08-11T06:00:01+10:00 https://pharmadispatch.com/news/guild-ama-offensive-and-hypocritical 2017-08-11T06:00:01+10:00 https://pharmadispatch.com/news/tolmar-hosts-fourth-uro-oncology-symposium 2017-08-11T06:00:01+10:00 https://pharmadispatch.com/news/companies-reflect-on-ramsay-distribution 2017-08-10T06:00:01+10:00 https://pharmadispatch.com/news/september-listing-for-gileads-zydelig 2017-08-10T06:00:01+10:00 https://pharmadispatch.com/news/labor-backs-pbac-process-change 2017-08-10T06:00:01+10:00 https://pharmadispatch.com/news/positive-trial-results-for-starpharmas-vivagel-bv 2017-08-10T06:00:01+10:00 https://pharmadispatch.com/news/minister-wants-new-process-for-pan-tumour-medicines 2017-08-09T09:38:01+10:00 https://pharmadispatch.com/news/retirement-for-senior-policy-maker 2017-08-09T06:04:01+10:00 https://pharmadispatch.com/news/guild-draws-battle-lines-over-ramsay 2017-08-09T06:03:01+10:00 https://pharmadispatch.com/news/time-to-act-says-rare-cancers 2017-08-09T06:02:01+10:00 https://pharmadispatch.com/news/mayne-update-falls-short-of-expectations 2017-08-09T06:01:01+10:00 https://pharmadispatch.com/news/sigma-slams-union-over-campaign-targeting-amcal 2017-08-09T06:00:01+10:00 https://pharmadispatch.com/news/strong-support-for-pbac-deputy-chair 2017-08-08T06:00:01+10:00 https://pharmadispatch.com/news/all-eyes-on-second-brand-change-in-draft-legislation 2017-08-08T06:00:01+10:00 https://pharmadispatch.com/news/new-appointment-for-former-health-minister 2017-08-08T06:00:01+10:00 https://pharmadispatch.com/news/could-states-go-their-own-way-on-codeine 2017-08-08T06:00:01+10:00 https://pharmadispatch.com/news/first-deputy-chair-for-pbac 2017-08-07T06:00:01+10:00 https://pharmadispatch.com/news/full-committee-finally-in-place 2017-08-07T06:00:01+10:00 https://pharmadispatch.com/news/implications-of-change-remain-unclear 2017-08-07T06:00:01+10:00 https://pharmadispatch.com/news/a-need-to-be-consistent 2017-08-07T06:00:01+10:00 https://pharmadispatch.com/news/lsdp-review-outcome-still-with-government 2017-08-07T06:00:01+10:00 https://pharmadispatch.com/news/does-this-reserve-actually-exist 2017-08-04T06:03:01+10:00 https://pharmadispatch.com/news/more-work-required-on-biosimilars 2017-08-04T06:02:01+10:00 https://pharmadispatch.com/news/sector-unites-to-slam-review 2017-08-04T06:01:01+10:00 https://pharmadispatch.com/news/global-award-for-pfizer-and-sudler-sydney 2017-08-04T06:00:01+10:00 https://pharmadispatch.com/news/who-has-been-guiding-this-review 2017-08-03T06:00:01+10:00 https://pharmadispatch.com/news/a-very-simple-solution-found-for-submission-cap 2017-08-03T06:00:01+10:00 https://pharmadispatch.com/news/review-recommendations-redundant 2017-08-03T06:00:01+10:00 https://pharmadispatch.com/news/professor-andrew-wilson-pbac-set-for-fundamental-change 2017-08-02T06:03:01+10:00 https://pharmadispatch.com/news/review-needs-to-revisit-report 2017-08-02T06:02:01+10:00 https://pharmadispatch.com/news/big-discounts-for-lyrica-generics 2017-08-02T06:01:01+10:00 https://pharmadispatch.com/news/pfizer-waiting-on-tax-changes-before-any-new-acquisitions 2017-08-02T06:00:01+10:00 https://pharmadispatch.com/news/department-creates-new-division 2017-08-01T06:03:01+10:00 https://pharmadispatch.com/news/agreement-an-opportunity-that-cant-be-lost 2017-08-01T06:02:01+10:00 https://pharmadispatch.com/news/guild-slams-review-interim-report 2017-08-01T06:01:01+10:00 https://pharmadispatch.com/news/medicines-nz-2017-value-of-medicines-award 2017-08-01T06:00:01+10:00 https://pharmadispatch.com/news/pfeiffenberger-great-news-for-patients 2017-07-31T06:05:01+10:00 https://pharmadispatch.com/news/diversity-essential-for-success-says-pfizers-melissa-mcgregor 2017-07-31T06:04:01+10:00 https://pharmadispatch.com/news/tga-unique-identifier-could-undermine-biosimilar-policy 2017-07-31T06:03:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-11bn-for-opdivo 2017-07-31T06:02:01+10:00 https://pharmadispatch.com/news/pharmacy-not-consulted-on-tax-request 2017-07-31T06:01:01+10:00 https://pharmadispatch.com/news/statement-on-ma-ceo 2017-07-31T06:00:01+10:00 https://pharmadispatch.com/news/busy-day-for-astrazeneca 2017-07-28T06:04:01+10:00 https://pharmadispatch.com/news/another-journey-to-the-heart-of-australia 2017-07-28T06:03:01+10:00 https://pharmadispatch.com/news/research-institute-sells-rights-to-cancer-therapy 2017-07-28T06:02:01+10:00 https://pharmadispatch.com/news/dr-pimple-popper-welcomes-new-approval 2017-07-28T06:01:01+10:00 https://pharmadispatch.com/news/more-work-to-be-done 2017-07-28T06:00:01+10:00 https://pharmadispatch.com/news/change-coming-for-ma 2017-07-27T06:05:01+10:00 https://pharmadispatch.com/news/ma-adopts-board-changes 2017-07-27T06:04:01+10:00 https://pharmadispatch.com/news/sigma-and-cw-move-to-resolve-supply-dispute 2017-07-27T06:03:01+10:00 https://pharmadispatch.com/news/psa-backs-ban-on-discounts-to-consumers 2017-07-27T06:02:01+10:00 https://pharmadispatch.com/news/leaders-out-of-step-with-public-opinion-on-reputation 2017-07-27T06:01:01+10:00 https://pharmadispatch.com/news/new-products-lift-amgen 2017-07-27T06:00:01+10:00 https://pharmadispatch.com/news/a-meaningless-measure-in-the-era-of-rebates 2017-07-26T06:03:01+10:00 https://pharmadispatch.com/news/pharmacy-loses-a-friend-in-cabinet 2017-07-26T06:02:01+10:00 https://pharmadispatch.com/news/sector-gives-a-hand-for-ms 2017-07-26T06:01:01+10:00 https://pharmadispatch.com/news/better-than-expected-quarter-for-lilly 2017-07-26T06:00:01+10:00 https://pharmadispatch.com/news/were-adhering-to-deeds-says-department-of-health 2017-07-25T06:03:01+10:00 https://pharmadispatch.com/news/more-changes-on-deeds-and-rebates-likely 2017-07-25T06:02:01+10:00 https://pharmadispatch.com/news/guild-calls-for-codeine-exception 2017-07-25T06:01:01+10:00 https://pharmadispatch.com/news/ndss-change-working-for-consumers 2017-07-25T06:00:01+10:00 https://pharmadispatch.com/news/more-cases-are-probably-coming 2017-07-24T18:04:01+10:00 https://pharmadispatch.com/news/supply-chain-delivered-on-hcv 2017-07-24T06:03:01+10:00 https://pharmadispatch.com/news/americans-want-action-to-protect-innovation 2017-07-24T06:02:01+10:00 https://pharmadispatch.com/news/need-to-keep-pace-with-more-active-consumer 2017-07-24T06:01:01+10:00 https://pharmadispatch.com/news/msd-and-pfizer-back-trump-innovation-plan 2017-07-24T06:00:01+10:00 https://pharmadispatch.com/news/another-senior-official-leaves-pharmaceutical-benefits 2017-07-21T06:03:01+10:00 https://pharmadispatch.com/news/tpp11-discussions-continue 2017-07-21T06:02:01+10:00 https://pharmadispatch.com/news/second-year-of-astellas-c3-prize 2017-07-21T06:01:01+10:00 https://pharmadispatch.com/news/aft-secures-new-deal-for-maxigesic 2017-07-21T06:00:01+10:00 https://pharmadispatch.com/news/new-hcv-therapy-for-pbs-in-august 2017-07-20T06:03:01+10:00 https://pharmadispatch.com/news/first-generics-of-popular-pain-therapy 2017-07-20T06:02:01+10:00 https://pharmadispatch.com/news/quilty-whole-of-sector-challenge-1 2017-07-20T06:01:01+10:00 https://pharmadispatch.com/news/uniquest-seals-long-term-deal-to-tackle-diabetes-and-obesity-1 2017-07-20T06:00:01+10:00 https://pharmadispatch.com/news/government-will-be-rebating-the-rebates-but-not-with-interest 2017-07-19T06:03:01+10:00 https://pharmadispatch.com/news/tga-approves-another-immunotherapy 2017-07-19T06:02:01+10:00 https://pharmadispatch.com/news/novartis-reports-improving-alcon-performance 2017-07-19T06:01:01+10:00 https://pharmadispatch.com/news/jj-raises-full-year-outlook 2017-07-19T06:00:01+10:00 https://pharmadispatch.com/news/growing-concern-over-the-administration-of-deeds 2017-07-18T06:03:01+10:00 https://pharmadispatch.com/news/ustr-acting-on-trade-agreements 2017-07-18T06:02:01+10:00 https://pharmadispatch.com/news/new-trial-of-prostate-cancer-breakthrough 2017-07-18T06:01:01+10:00 https://pharmadispatch.com/news/fda-rejects-new-osteoporosis-biologic 2017-07-18T06:00:01+10:00 https://pharmadispatch.com/news/tension-rising-after-submission-cap 2017-07-17T06:01:01+10:00 https://pharmadispatch.com/news/we-cant-afford-not-to-be-part-of-the-discussion 2017-07-17T06:00:01+10:00 https://pharmadispatch.com/news/soriot-sticking-with-astrazeneca 2017-07-17T06:00:01+10:00 https://pharmadispatch.com/news/affordability-of-medicines-an-issue-for-australian-patients 2017-07-17T06:00:01+10:00 https://pharmadispatch.com/news/idt-announces-departure-of-ceo 2017-07-17T06:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-az-manufacturing-investment 2017-07-14T06:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-pbac-appointment 2017-07-14T06:00:01+10:00 https://pharmadispatch.com/news/victorian-pharma-and-medtech-booming 2017-07-14T06:00:01+10:00 https://pharmadispatch.com/news/the-irony-of-soriots-departure-from-az 2017-07-13T18:06:01+10:00 https://pharmadispatch.com/news/industry-pbac-nomination-finally-revealed 2017-07-13T06:04:01+10:00 https://pharmadispatch.com/news/dusc-outcomes-on-crohns-and-migraine 2017-07-13T06:03:01+10:00 https://pharmadispatch.com/news/study-confirms-efficacy-of-pradaxa-reversal-agent 2017-07-13T06:02:01+10:00 https://pharmadispatch.com/news/major-acquisition-for-australian-poppy-processor 2017-07-13T06:01:01+10:00 https://pharmadispatch.com/news/seventh-indication-for-opdivo 2017-07-13T06:00:01+10:00 https://pharmadispatch.com/news/uk-expansion-for-australian-poppy-processor 2017-07-12T06:01:01+10:00 https://pharmadispatch.com/news/az-to-invest-100m-in-australian-manufacturing 2017-07-12T06:00:01+10:00 https://pharmadispatch.com/news/uk-industry-starts-legal-action-against-new-spending-hurdle 2017-07-12T06:00:01+10:00 https://pharmadispatch.com/news/devil-in-the-detail-on-advertising-change 2017-07-12T06:00:01+10:00 https://pharmadispatch.com/news/how-times-have-changed-1 2017-07-11T06:03:01+10:00 https://pharmadispatch.com/news/gps-ignoring-antibiotic-guidelines 2017-07-11T06:02:01+10:00 https://pharmadispatch.com/news/south-australia-appoints-venture-capital-fund 2017-07-11T06:01:01+10:00 https://pharmadispatch.com/news/government-reviews-medicare-breach 2017-07-11T06:00:01+10:00 https://pharmadispatch.com/news/single-complaints-body-for-advertising-complaints 2017-07-10T06:04:01+10:00 https://pharmadispatch.com/news/sector-cynical-about-rort-claims 2017-07-10T06:03:01+10:00 https://pharmadispatch.com/news/august-meeting-for-industry-nomination 2017-07-10T06:02:01+10:00 https://pharmadispatch.com/news/celgene-acquires-rights-to-pd-1-inhibitor 2017-07-10T06:01:01+10:00 https://pharmadispatch.com/news/australia-and-eu-to-push-trade-deal 2017-07-10T06:00:01+10:00 https://pharmadispatch.com/news/department-of-health-to-watch-for-new-technologies 2017-07-07T06:03:01+10:00 https://pharmadispatch.com/news/sigma-not-giving-up-on-pathology-program 2017-07-07T06:02:01+10:00 https://pharmadispatch.com/news/putting-medicines-costs-in-context 2017-07-07T06:01:01+10:00 https://pharmadispatch.com/news/ministers-try-to-ease-brexit-concerns 2017-07-07T06:00:01+10:00 https://pharmadispatch.com/news/waiting-on-biosimilar-next-steps 2017-07-06T06:03:01+10:00 https://pharmadispatch.com/news/budget-office-forecast-overstates-pbs-spend 2017-07-06T06:02:01+10:00 https://pharmadispatch.com/news/report-should-send-shock-waves-through-health-system 2017-07-06T06:01:01+10:00 https://pharmadispatch.com/news/suda-inks-zolpimist-deal-with-teva 2017-07-06T06:00:01+10:00 https://pharmadispatch.com/news/here-we-go-again 2017-07-05T06:03:01+10:00 https://pharmadispatch.com/news/australian-biotech-appoints-us-political-heir 2017-07-05T06:02:01+10:00 https://pharmadispatch.com/news/its-ludicrous-says-medicines-australia 2017-07-05T06:01:01+10:00 https://pharmadispatch.com/news/more-news-for-sirtex 2017-07-05T06:00:01+10:00 https://pharmadispatch.com/news/industry-still-waiting-on-pbac-appointment 2017-07-04T06:03:01+10:00 https://pharmadispatch.com/news/how-long-will-the-money-last 2017-07-04T06:02:01+10:00 https://pharmadispatch.com/news/ma-welcomes-visa-changes 2017-07-04T06:01:01+10:00 https://pharmadispatch.com/news/abbvie-welcomes-new-humira-listing 2017-07-04T06:00:01+10:00 https://pharmadispatch.com/news/turnbull-government-backflip-on-visa-changes 2017-07-03T06:05:01+10:00 https://pharmadispatch.com/news/new-leadership-for-biogen 2017-07-03T06:04:01+10:00 https://pharmadispatch.com/news/spending-on-hcos-continues-to-fall 2017-07-03T06:03:01+10:00 https://pharmadispatch.com/news/pbac-not-giving-up-on-biomarker-test-for-anti-pd1 2017-07-03T06:02:01+10:00 https://pharmadispatch.com/news/australians-not-protected-on-holdays 2017-07-03T06:01:01+10:00 https://pharmadispatch.com/news/apotex-launches-new-vitamin-range 2017-07-03T06:00:01+10:00 https://pharmadispatch.com/news/d-day-approaching-for-working-visa-changes 2017-06-30T06:03:01+10:00 https://pharmadispatch.com/news/a-week-of-possibilities-at-abbvie 2017-06-30T06:02:01+10:00 https://pharmadispatch.com/news/wholesalers-looking-for-long-term-stability 2017-06-30T06:01:01+10:00 https://pharmadispatch.com/news/sirtex-confirms-guidance-but-announces-restructure 2017-06-30T06:00:01+10:00 https://pharmadispatch.com/news/now-is-the-time-for-an-angry-letter 2017-06-29T06:04:01+10:00 https://pharmadispatch.com/news/concern-over-cost-recovery-changes 2017-06-29T06:04:01+10:00 https://pharmadispatch.com/news/what-do-changes-to-rebate-policy-mean-for-mas-strategic-agreemen 2017-06-29T06:03:01+10:00 https://pharmadispatch.com/news/whats-in-a-deed 2017-06-29T06:02:01+10:00 https://pharmadispatch.com/news/msd-yet-to-decide-on-cetp-inhibitor 2017-06-29T06:01:01+10:00 https://pharmadispatch.com/news/terry-white-partners-for-aged-care-medication-system 2017-06-28T10:02:01+10:00 https://pharmadispatch.com/news/rising-tensions-over-pricing-agreements 2017-06-28T06:03:01+10:00 https://pharmadispatch.com/news/new-leadership-for-servier 2017-06-28T06:02:01+10:00 https://pharmadispatch.com/news/merck-announces-global-research-collaboration 2017-06-28T06:01:01+10:00 https://pharmadispatch.com/news/blackmores-loses-ceo-to-australia-post 2017-06-28T06:00:01+10:00 https://pharmadispatch.com/news/chf-price-changes-not-the-answer 2017-06-27T06:04:01+10:00 https://pharmadispatch.com/news/unified-opposition-signals-report-death-knell 2017-06-27T06:03:01+10:00 https://pharmadispatch.com/news/new-alliance-calls-for-action-on-osteoporosis 2017-06-27T06:02:01+10:00 https://pharmadispatch.com/news/funding-for-project-looking-to-link-datasets 2017-06-27T06:01:01+10:00 https://pharmadispatch.com/news/merck-working-towards-access-for-ms-therapy 2017-06-27T06:00:01+10:00 https://pharmadispatch.com/news/tsunami-of-change-coming 2017-06-26T06:04:01+10:00 https://pharmadispatch.com/news/australia-set-to-be-targeted-in-trump-global-drug-review 2017-06-26T06:03:01+10:00 https://pharmadispatch.com/news/accolade-for-seqirus-manufacturing-leader 2017-06-26T06:02:01+10:00 https://pharmadispatch.com/news/apotex-launches-vaccine-ordering-website 2017-06-26T06:00:01+10:00 https://pharmadispatch.com/news/manufacturers-unite-on-reports-key-recommendations 2017-06-25T06:01:01+10:00 https://pharmadispatch.com/news/mtpconnect-clinical-trials-add-11bn-to-economy 2017-06-23T06:00:01+10:00 https://pharmadispatch.com/news/new-president-for-psa 2017-06-23T06:00:01+10:00 https://pharmadispatch.com/news/how-is-forcing-consumers-to-pay-more-a-good-thing 2017-06-23T06:00:01+10:00 https://pharmadispatch.com/news/stakeholder-response-to-pharmacy-review-report 2017-06-22T17:54:01+10:00 https://pharmadispatch.com/news/breaking-news-pharmacy-review-report 2017-06-22T11:40:01+10:00 https://pharmadispatch.com/news/new-peak-body-for-medical-cannabis-industry 2017-06-22T06:00:01+10:00 https://pharmadispatch.com/news/sector-waits-for-pharmacy-review-report 2017-06-22T06:00:01+10:00 https://pharmadispatch.com/news/european-ruling-threatens-drug-development 2017-06-22T06:00:01+10:00 https://pharmadispatch.com/news/crunch-time-on-working-visa-changes 2017-06-22T05:03:01+10:00 https://pharmadispatch.com/news/aat-delivers-inflectra-pi-decision 2017-06-21T06:03:01+10:00 https://pharmadispatch.com/news/still-waiting-on-two-pbac-appointments 2017-06-21T06:02:01+10:00 https://pharmadispatch.com/news/ian-frazer-to-speak-at-medicines-nz-dinner 2017-06-21T06:01:01+10:00 https://pharmadispatch.com/news/parkinsons-dataset-reveals-variation-across-markets 2017-06-21T06:00:01+10:00 https://pharmadispatch.com/news/inflectra-case-goes-into-day-two 2017-06-20T06:05:01+10:00 https://pharmadispatch.com/news/consultancy-returning-to-its-roots 2017-06-20T06:03:01+10:00 https://pharmadispatch.com/news/az-and-gsk-settle-over-australian-executive 2017-06-20T06:02:01+10:00 https://pharmadispatch.com/news/australia-first-genetic-test-launched-today 2017-06-20T06:01:01+10:00 https://pharmadispatch.com/news/new-campaign-for-return-unwanted-medicines 2017-06-20T06:00:01+10:00 https://pharmadispatch.com/news/company-face-off-does-to-aat 2017-06-19T06:04:01+10:00 https://pharmadispatch.com/news/maybe-biosimilars-can-deliver-on-price-disclosure 2017-06-19T06:04:01+10:00 https://pharmadispatch.com/news/first-price-disclosure-reductions-for-key-medicines 2017-06-19T06:03:01+10:00 https://pharmadispatch.com/news/jj-completes-actelion-acquisition 2017-06-19T06:02:01+10:00 https://pharmadispatch.com/news/sigma-subsidiary-wins-defence-contract 2017-06-19T06:01:01+10:00 https://pharmadispatch.com/news/venture-capital-raised-soars-but-still-a-long-way-to-go 2017-06-19T06:00:01+10:00 https://pharmadispatch.com/news/is-there-a-story-behind-the-shortages 2017-06-16T06:04:01+10:00 https://pharmadispatch.com/news/pricing-a-risk-to-sustainable-supply 2017-06-16T06:03:01+10:00 https://pharmadispatch.com/news/may-listings-for-rare-cancer-and-lung-disease 2017-06-16T06:02:01+10:00 https://pharmadispatch.com/news/clinicians-slam-cochrane-over-hcv-report 2017-06-16T06:01:01+10:00 https://pharmadispatch.com/news/phi-moves-into-pharmaceutical-benefits 2017-06-16T06:00:01+10:00 https://pharmadispatch.com/news/new-therapy-added-but-still-no-news-on-lsdp-future 2017-06-15T06:04:01+10:00 https://pharmadispatch.com/news/miner-grabs-leading-industry-communicator 2017-06-15T06:03:01+10:00 https://pharmadispatch.com/news/pfizer-clarifies-ibrance-access 2017-06-15T06:02:01+10:00 https://pharmadispatch.com/news/surgery-not-the-only-option-for-prostate-cancer 2017-06-15T06:01:01+10:00 https://pharmadispatch.com/news/starpharma-sells-agrochemicals-business 2017-06-15T06:00:01+10:00 https://pharmadispatch.com/news/progress-on-cancer-access-but-more-work-required 2017-06-14T18:04:01+10:00 https://pharmadispatch.com/news/hospital-pharmacists-demand-urgent-improvements 2017-06-14T06:03:01+10:00 https://pharmadispatch.com/news/label-change-for-epipen 2017-06-14T06:02:01+10:00 https://pharmadispatch.com/news/pharmaxis-to-advance-bronchitol-in-the-us 2017-06-14T06:01:01+10:00 https://pharmadispatch.com/news/csl-acquires-strategic-stake-in-chinese-company 2017-06-14T06:00:01+10:00 https://pharmadispatch.com/news/novartis-recruit-australian-industry-leader-for-major-global-rol 2017-06-13T06:00:01+10:00 https://pharmadispatch.com/news/recognition-for-policy-maker-for-hcv 2017-06-13T06:00:01+10:00 https://pharmadispatch.com/news/puppy-love-for-bayer-employees 2017-06-13T06:00:01+10:00 https://pharmadispatch.com/news/never-thought-i-would-see-the-day 2017-06-13T06:00:01+10:00 https://pharmadispatch.com/news/valeant-reduced-debt-with-inova-sale 2017-06-12T10:53:01+10:00 https://pharmadispatch.com/news/investment-relies-on-the-eco-system 2017-06-09T06:04:01+10:00 https://pharmadispatch.com/news/keytruda-delivers-overall-survival-benefit 2017-06-09T06:03:01+10:00 https://pharmadispatch.com/news/new-board-appointment-for-pharmaxis 2017-06-09T06:02:01+10:00 https://pharmadispatch.com/news/report-highlights-importance-of-affordable-medicines 2017-06-09T06:01:01+10:00 https://pharmadispatch.com/news/pfizer-donors-aim-to-become-bloody-legends 2017-06-09T06:00:01+10:00 https://pharmadispatch.com/news/industry-gathers-for-bridge-program-launch 2017-06-08T06:03:01+10:00 https://pharmadispatch.com/news/these-companies-do-give-back-to-the-eco-system 2017-06-08T06:02:01+10:00 https://pharmadispatch.com/news/visa-changes-could-impact-industry-leadership 2017-06-08T06:01:01+10:00 https://pharmadispatch.com/news/quilty-consumers-backing-pharmacy-vaccination 2017-06-08T06:00:01+10:00 https://pharmadispatch.com/news/current-system-inherently-inefficient-for-rare-cancers 2017-06-07T06:03:01+10:00 https://pharmadispatch.com/news/novartis-and-bms-team-up-for-new-trial 2017-06-07T06:02:01+10:00 https://pharmadispatch.com/news/abbvie-tops-pharma-reputation-index 2017-06-07T06:01:01+10:00 https://pharmadispatch.com/news/investment-for-another-uniquest-spinout 2017-06-07T06:00:01+10:00 https://pharmadispatch.com/news/budget-funding-leaves-unfinished-business-for-wholesalers-and-pa 2017-06-06T06:03:01+10:00 https://pharmadispatch.com/news/bruce-goodwin-more-investment-to-come-but-policy-matters 2017-06-06T06:02:01+10:00 https://pharmadispatch.com/news/guild-welcomes-balanced-decision-on-penalty-rates 2017-06-06T06:01:01+10:00 https://pharmadispatch.com/news/worlds-most-decorated-olympian-joins-medibio-board 2017-06-06T06:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-is-the-one-who-should-be-frustrated 2017-06-05T06:04:01+10:00 https://pharmadispatch.com/news/former-pbs-official-joins-az 2017-06-05T06:03:01+10:00 https://pharmadispatch.com/news/sinodinos-cabinet-has-considered-ip-changes 2017-06-05T06:02:01+10:00 https://pharmadispatch.com/news/another-australian-collaboration-for-janssen 2017-06-05T06:01:01+10:00 https://pharmadispatch.com/news/ireland-says-yes-to-orkambi 2017-06-05T06:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-increases-consumer-presence-on-pbac 2017-06-02T06:04:01+10:00 https://pharmadispatch.com/news/canteen-looking-for-industry-partners 2017-06-02T06:03:01+10:00 https://pharmadispatch.com/news/applications-open-for-csl-fellowship-1 2017-06-02T06:02:01+10:00 https://pharmadispatch.com/news/more-bexsero-for-australian-market 2017-06-02T06:01:01+10:00 https://pharmadispatch.com/news/nice-recommends-keytruda-for-cancer-drugs-fund 2017-06-02T06:00:01+10:00 https://pharmadispatch.com/news/bms-adds-another-opdivo-indication 2017-06-01T06:04:01+10:00 https://pharmadispatch.com/news/janssen-signs-new-agreement-with-australian-biotech 2017-06-01T06:03:01+10:00 https://pharmadispatch.com/news/australia-tops-global-pain-index-1 2017-06-01T06:02:01+10:00 https://pharmadispatch.com/news/merck-funding-for-ms-scholarship 2017-06-01T06:01:01+10:00 https://pharmadispatch.com/news/symbion-fires-employee-over-tampering-allegations 2017-06-01T06:00:01+10:00 https://pharmadispatch.com/news/labor-will-not-list-medicines-claims-turnbull 2017-05-31T06:04:01+10:00 https://pharmadispatch.com/news/cancer-patient-makes-governments-health-defence 2017-05-31T06:03:01+10:00 https://pharmadispatch.com/news/cut-out-the-nagging 2017-05-31T06:02:01+10:00 https://pharmadispatch.com/news/major-investor-backs-australian-research 2017-05-31T06:01:01+10:00 https://pharmadispatch.com/news/baxter-partners-with-hospital-on-sustainability-initiative-1 2017-05-31T06:00:01+10:00 https://pharmadispatch.com/news/pbs-at-budget-estimates 2017-05-30T06:04:01+10:00 https://pharmadispatch.com/news/did-pbac-really-stop-making-lsdp-recommendations-in-2012 2017-05-30T06:03:01+10:00 https://pharmadispatch.com/news/dont-worry-we-took-a-screenshot 2017-05-30T06:02:01+10:00 https://pharmadispatch.com/news/entresto-to-combat-rising-heart-failure-burden 2017-05-30T06:01:01+10:00 https://pharmadispatch.com/news/new-job-for-ex-chf-ceo 2017-05-30T06:00:01+10:00 https://pharmadispatch.com/news/new-pbac-members 2017-05-29T06:04:01+10:00 https://pharmadispatch.com/news/changing-mood-on-clinical-trials 2017-05-29T06:03:01+10:00 https://pharmadispatch.com/news/department-clarifies-pbac-role-in-lsdp 2017-05-29T06:02:01+10:00 https://pharmadispatch.com/news/fda-chief-unveils-price-plans 2017-05-29T06:01:01+10:00 https://pharmadispatch.com/news/minister-commends-australian-first 2017-05-29T06:00:01+10:00 https://pharmadispatch.com/news/department-creates-office-of-hta 2017-05-26T06:04:01+10:00 https://pharmadispatch.com/news/massive-underspend-in-biosimilar-awareness-initiative 2017-05-26T06:03:01+10:00 https://pharmadispatch.com/news/visa-changes-a-disaster-for-life-sciences 2017-05-26T06:02:01+10:00 https://pharmadispatch.com/news/complex-story-for-biosimilar-price-cuts 2017-05-26T06:01:01+10:00 https://pharmadispatch.com/news/approval-for-allergans-double-chin-injectable 2017-05-26T06:00:01+10:00 https://pharmadispatch.com/news/an-utterly-pointless-exercise 2017-05-25T06:04:01+10:00 https://pharmadispatch.com/news/parliamentary-hold-up-impacts-tga-review-changes 2017-05-25T06:02:01+10:00 https://pharmadispatch.com/news/ubs-sigma-case-raises-wider-issues 2017-05-25T06:01:01+10:00 https://pharmadispatch.com/news/doing-better-than-we-think-on-clinical-trials 2017-05-25T06:00:01+10:00 https://pharmadispatch.com/news/msd-slams-ezetimibe-review-report 2017-05-24T06:03:01+10:00 https://pharmadispatch.com/news/minister-commends-sector 2017-05-24T06:02:01+10:00 https://pharmadispatch.com/news/ebos-acquires-hospital-pharmacy-service-provider 2017-05-24T06:01:01+10:00 https://pharmadispatch.com/news/new-investment-for-local-biotech 2017-05-24T06:00:01+10:00 https://pharmadispatch.com/news/whos-using-uber 2017-05-23T18:03:01+10:00 https://pharmadispatch.com/news/clinical-trials-alliance-thanks-minister 2017-05-23T06:02:01+10:00 https://pharmadispatch.com/news/mining-magnate-commits-75m-to-cancer-research 2017-05-23T06:01:01+10:00 https://pharmadispatch.com/news/prep-trial-reports-first-hiv-diagnosis 2017-05-23T06:00:01+10:00 https://pharmadispatch.com/news/what-now-for-ezetimibe-review 2017-05-22T06:04:01+10:00 https://pharmadispatch.com/news/the-funding-envelope-as-the-future 2017-05-22T06:03:01+10:00 https://pharmadispatch.com/news/tpp-now-tpp11 2017-05-22T06:02:01+10:00 https://pharmadispatch.com/news/funding-boost-for-clinical-trials 2017-05-22T06:01:01+10:00 https://pharmadispatch.com/news/amgen-welcomes-new-government-investment 2017-05-22T06:00:01+10:00 https://pharmadispatch.com/news/review-is-dead-on-arrival 2017-05-19T06:00:01+10:00 https://pharmadispatch.com/news/affirmative-action-required-to-close-survival-gap 2017-05-19T06:00:01+10:00 https://pharmadispatch.com/news/australia-study-backs-extended-use-of-bms-combination 2017-05-19T06:00:01+10:00 https://pharmadispatch.com/news/patient-treatment-commences-in-cynata-clinical-trial 2017-05-19T06:00:01+10:00 https://pharmadispatch.com/news/there-must-be-an-election-in-the-air 2017-05-18T06:04:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-adds-compound-to-portfolio 2017-05-18T06:03:01+10:00 https://pharmadispatch.com/news/amazon-planning-move-into-pharmacy 2017-05-18T06:02:01+10:00 https://pharmadispatch.com/news/jj-announces-new-actelion-leadership 2017-05-18T06:01:01+10:00 https://pharmadispatch.com/news/new-products-to-drive-jj-growth 2017-05-18T06:00:01+10:00 https://pharmadispatch.com/news/no-vacancy-sign-for-pbac 2017-05-17T06:03:01+10:00 https://pharmadispatch.com/news/az-and-gsk-in-battle-over-australian-executive 2017-05-17T06:02:01+10:00 https://pharmadispatch.com/news/priceline-teams-up-with-stroke-foundation 2017-05-17T06:01:01+10:00 https://pharmadispatch.com/news/australian-company-initiates-trial-of-peanut-allergy-treatment 2017-05-17T06:00:01+10:00 https://pharmadispatch.com/news/research-reveals-vaccination-apathy 2017-05-16T06:04:01+10:00 https://pharmadispatch.com/news/gsk-to-acquire-novartis-consumer-health-stake 2017-05-16T06:03:01+10:00 https://pharmadispatch.com/news/pfizer-hosts-hackathon-to-support-smith-family 2017-05-16T06:02:01+10:00 https://pharmadispatch.com/news/bi-extends-development-of-pharmaxis-compound 2017-05-16T06:01:01+10:00 https://pharmadispatch.com/news/nominations-for-gsk-award-now-open 2017-05-16T06:00:01+10:00 https://pharmadispatch.com/news/its-about-trust-and-mutual-respect 2017-05-15T06:04:01+10:00 https://pharmadispatch.com/news/first-generics-of-gsks-seretide-in-june 2017-05-15T06:03:01+10:00 https://pharmadispatch.com/news/biologics-pbs-share-on-the-rise 2017-05-15T06:02:01+10:00 https://pharmadispatch.com/news/private-launch-for-msd-insomnia-therapy 2017-05-15T06:01:01+10:00 https://pharmadispatch.com/news/az-stakes-immunotherapy-claim 2017-05-15T06:00:01+10:00 https://pharmadispatch.com/news/ex-az-chief-takes-senior-role-at-grnenthal 2017-05-12T18:02:01+10:00 https://pharmadispatch.com/news/ministerial-praise-for-fundamental-bodies 2017-05-12T06:05:01+10:00 https://pharmadispatch.com/news/pbs-front-of-pms-health-agenda 2017-05-12T06:03:01+10:00 https://pharmadispatch.com/news/pharmaceutical-innovation-transforms-hiv-diagnosis 2017-05-12T06:01:01+10:00 https://pharmadispatch.com/news/jj-funds-scholarships-for-indigenous-surgeons 2017-05-12T06:00:01+10:00 https://pharmadispatch.com/news/transformation-and-the-shift-in-sustainability 2017-05-11T06:04:01+10:00 https://pharmadispatch.com/news/comparing-uptake-not-so-simple 2017-05-11T06:03:01+10:00 https://pharmadispatch.com/news/mpa-welcomes-budget-changes 2017-05-11T06:02:01+10:00 https://pharmadispatch.com/news/recognition-for-gsk-manufacturing-innovator 2017-05-11T06:01:01+10:00 https://pharmadispatch.com/news/new-role-for-ex-gsk-boss 2017-05-11T06:00:01+10:00 https://pharmadispatch.com/news/budget-2017-18-the-measures-and-key-points 2017-05-10T06:05:01+10:00 https://pharmadispatch.com/news/novartis-welcomes-entresto-listing 2017-05-10T06:04:01+10:00 https://pharmadispatch.com/news/industry-leaders-welcome-budget 2017-05-10T06:03:01+10:00 https://pharmadispatch.com/news/guild-welcomes-budget-but-psa-says-missed-opportunity 2017-05-10T06:02:01+10:00 https://pharmadispatch.com/news/a-let-off-for-rd-tax-incentive 2017-05-10T06:01:01+10:00 https://pharmadispatch.com/news/research-australia-welcomes-first-mrff-grants 2017-05-10T06:00:01+10:00 https://pharmadispatch.com/news/agreements-reveal-some-surprises 2017-05-09T19:30:01+10:00 https://pharmadispatch.com/news/cook-we-had-unfinished-business 2017-05-09T19:30:01+10:00 https://pharmadispatch.com/news/belinda-wood-we-were-prepared 2017-05-09T19:30:01+10:00 https://pharmadispatch.com/news/wholesalers-welcome-budget-but-looking-to-long-term-solution 2017-05-09T19:00:01+10:00 https://pharmadispatch.com/news/a-day-of-few-surprises-maybe 2017-05-09T06:03:01+10:00 https://pharmadispatch.com/news/pbac-appointments-move-closer 2017-05-09T06:02:01+10:00 https://pharmadispatch.com/news/what-now-for-rd-tax-incentive 2017-05-09T06:01:01+10:00 https://pharmadispatch.com/news/new-pharmac-funding-proposals 2017-05-09T06:00:01+10:00 https://pharmadispatch.com/news/change-to-support-stability-of-supply 2017-05-08T06:04:01+10:00 https://pharmadispatch.com/news/parliament-to-have-final-say-on-reforms 2017-05-08T06:03:01+10:00 https://pharmadispatch.com/news/just-talk-as-industry-gets-on-with-innovating 2017-05-08T06:02:01+10:00 https://pharmadispatch.com/news/funding-welcome-but-time-to-clear-the-waiting-list 2017-05-08T06:01:01+10:00 https://pharmadispatch.com/news/australia-targeted-in-us-trade-review 2017-05-08T06:00:01+10:00 https://pharmadispatch.com/news/brands-far-from-gone-under-software-change 2017-05-05T06:00:01+10:00 https://pharmadispatch.com/news/agreements-done-as-sector-waits-for-budget 2017-05-05T06:00:01+10:00 https://pharmadispatch.com/news/nz-waiting-list-continues-to-grow 2017-05-05T06:00:01+10:00 https://pharmadispatch.com/news/five-plus-five-for-second-brands 2017-05-05T04:11:01+10:00 https://pharmadispatch.com/news/no-therapeutic-groups-but-no-respite-on-reviews 2017-05-04T06:03:01+10:00 https://pharmadispatch.com/news/members-remain-the-focus-for-ma 2017-05-04T06:02:01+10:00 https://pharmadispatch.com/news/department-getting-better-at-engaging-stakeholders 2017-05-04T06:01:01+10:00 https://pharmadispatch.com/news/mtpconnect-funding-call 2017-05-04T06:00:01+10:00 https://pharmadispatch.com/news/budget-win-for-heart-failure-patients 2017-05-03T06:00:01+10:00 https://pharmadispatch.com/news/ceo-for-university-backed-drug-development-joint-venture 2017-05-03T06:00:01+10:00 https://pharmadispatch.com/news/acquisition-for-george-clinical 2017-05-03T06:00:01+10:00 https://pharmadispatch.com/news/diversity-boosts-gsk-result 2017-05-03T06:00:01+10:00 https://pharmadispatch.com/news/fund-will-be-there-but-may-not-be-transparent 2017-05-02T06:04:01+10:00 https://pharmadispatch.com/news/optimism-impacted-by-concerns-over-rd-tax-incentive 2017-05-02T06:03:01+10:00 https://pharmadispatch.com/news/ustr-gives-mixed-message-on-australia 2017-05-02T06:02:01+10:00 https://pharmadispatch.com/news/ministers-act-on-immunisation-change 2017-05-02T06:01:01+10:00 https://pharmadispatch.com/news/high-expectations-hurt-mayne-pharma 2017-05-02T06:00:01+10:00 https://pharmadispatch.com/news/patients-will-suffer-if-we-dont-the-get-revenue-structure-right 2017-05-01T06:04:01+10:00 https://pharmadispatch.com/news/ma-negotiates-solution-on-second-brand 2017-05-01T06:03:01+10:00 https://pharmadispatch.com/news/msds-statement-of-intent-on-biosimilars 2017-05-01T06:02:01+10:00 https://pharmadispatch.com/news/pharmac-to-fund-therapy-that-makes-brain-tumours-fluorescent 2017-05-01T06:01:01+10:00 https://pharmadispatch.com/news/new-research-released-for-kiss-goodbye-to-ms 2017-05-01T06:00:01+10:00 https://pharmadispatch.com/news/uk-industry-calls-for-investment-in-new-medicines 2017-04-28T18:00:01+10:00 https://pharmadispatch.com/news/agreement-started-as-a-dance 2017-04-28T06:03:01+10:00 https://pharmadispatch.com/news/late-changes-but-few-surprises-to-come 2017-04-28T06:02:01+10:00 https://pharmadispatch.com/news/five-trends-to-watch-in-pharma-marketing 2017-04-28T06:01:01+10:00 https://pharmadispatch.com/news/negotiations-finalised-as-ma-seeks-member-support 2017-04-27T06:03:01+10:00 https://pharmadispatch.com/news/some-surprises-for-july-pbac 2017-04-27T06:02:01+10:00 https://pharmadispatch.com/news/move-for-senior-ministerial-adviser 2017-04-27T06:01:01+10:00 https://pharmadispatch.com/news/lsdp-wait-goes-on-and-on 2017-04-27T06:00:01+10:00 https://pharmadispatch.com/news/action-on-comparators-will-take-time-and-trade-offs 2017-04-26T06:04:01+10:00 https://pharmadispatch.com/news/pbs-price-watch-on-diabetes-medicines 2017-04-26T06:03:01+10:00 https://pharmadispatch.com/news/pre-rebate-still-growth-high-but-slowing 2017-04-26T06:02:01+10:00 https://pharmadispatch.com/news/retirement-for-ex-ma-board-member 2017-04-26T06:01:01+10:00 https://pharmadispatch.com/news/disappointing-trial-result-for-sirtex 2017-04-26T06:00:01+10:00 https://pharmadispatch.com/news/the-future-of-managed-entry 2017-04-24T06:04:01+10:00 https://pharmadispatch.com/news/outcomes-reveal-gsk-pricing-victory 2017-04-24T06:03:01+10:00 https://pharmadispatch.com/news/budget-key-for-mrff 2017-04-24T06:02:01+10:00 https://pharmadispatch.com/news/government-to-take-on-anti-vaxxers-in-new-campaign 2017-04-24T06:01:01+10:00 https://pharmadispatch.com/news/steve-waugh-to-mark-apo-wellness-milestone 2017-04-24T06:00:01+10:00 https://pharmadispatch.com/news/pbac-recommends-key-cancer-therapies 2017-04-21T10:30:01+10:00 https://pharmadispatch.com/news/time-and-consultation-will-come 2017-04-21T06:05:01+10:00 https://pharmadispatch.com/news/cancer-medicines-to-headline-pbac-outcomes 2017-04-21T06:04:01+10:00 https://pharmadispatch.com/news/starpharma-striggers-milestone-payment-from-az 2017-04-21T06:03:01+10:00 https://pharmadispatch.com/news/priceline-growth-the-standout-for-api 2017-04-21T06:02:01+10:00 https://pharmadispatch.com/news/pfizer-pads-up-on-support-of-mcgrath-foundation 2017-04-21T06:01:01+10:00 https://pharmadispatch.com/news/supply-chain-award-for-symbion 2017-04-21T06:00:01+10:00 https://pharmadispatch.com/news/pre-budget-almost-done-for-greg-hunt 2017-04-20T06:04:01+10:00 https://pharmadispatch.com/news/sector-concern-over-scrapping-of-457-visas 2017-04-20T06:03:01+10:00 https://pharmadispatch.com/news/ip-australia-delays-legislation 2017-04-20T06:02:01+10:00 https://pharmadispatch.com/news/approval-for-csls-afstyla 2017-04-20T06:01:01+10:00 https://pharmadispatch.com/news/merck-supports-new-cancer-fellowship 2017-04-20T06:00:01+10:00 https://pharmadispatch.com/news/one-step-at-a-time-on-reform-package 2017-04-19T06:03:01+10:00 https://pharmadispatch.com/news/no-australian-impact-for-us-gilenya-decision 2017-04-19T06:02:01+10:00 https://pharmadispatch.com/news/terrywhite-chemmart-reports-record-demand-for-flu-shot 2017-04-19T06:01:01+10:00 https://pharmadispatch.com/news/api-relaunches-larges-health-and-beauty-loyalty-program 2017-04-19T06:00:01+10:00 https://pharmadispatch.com/news/does-international-comparison-reveal-reason-for-new-uptake-drive 2017-04-18T06:04:01+10:00 https://pharmadispatch.com/news/sector-unites-against-rd-tax-change 2017-04-18T06:03:01+10:00 https://pharmadispatch.com/news/australia-failing-to-implement-trade-obligations 2017-04-18T06:02:01+10:00 https://pharmadispatch.com/news/dispute-over-lease-threatens-cancer-research 2017-04-18T06:01:01+10:00 https://pharmadispatch.com/news/queensland-points-to-lower-hiv-notification-rate 2017-04-18T06:00:01+10:00 https://pharmadispatch.com/news/prescribing-game-changer 2017-04-13T06:03:01+10:00 https://pharmadispatch.com/news/progress-possible-on-key-issue 2017-04-13T06:02:01+10:00 https://pharmadispatch.com/news/need-to-understand-impact-of-shortage 2017-04-13T06:01:01+10:00 https://pharmadispatch.com/news/idt-reports-better-than-expected-sales-result 2017-04-13T06:00:01+10:00 https://pharmadispatch.com/news/new-pbs-report-not-quite-timed-to-perfection 2017-04-12T06:02:01+10:00 https://pharmadispatch.com/news/new-leadership-for-prota-therapeutics 2017-04-12T06:01:01+10:00 https://pharmadispatch.com/news/possible-d-day-for-pbs-budget-package 2017-04-12T06:00:01+10:00 https://pharmadispatch.com/news/mesoblast-progresses-phase-3-trial 2017-04-12T06:00:01+10:00 https://pharmadispatch.com/news/where-will-the-money-go 2017-04-11T06:03:01+10:00 https://pharmadispatch.com/news/department-creates-new-hta-consumer-committee 2017-04-11T06:02:01+10:00 https://pharmadispatch.com/news/ma-welcomes-launch-of-commercialisation-program 2017-04-11T06:01:01+10:00 https://pharmadispatch.com/news/new-leadership-for-farmaforce 2017-04-11T06:00:01+10:00 https://pharmadispatch.com/news/package-almost-finalised-as-concern-grows-over-funding-commitmen 2017-04-10T06:04:01+10:00 https://pharmadispatch.com/news/government-set-to-act-on-biosimilar-uptake 2017-04-10T06:03:01+10:00 https://pharmadispatch.com/news/an-agreement-worth-the-price 2017-04-10T06:02:01+10:00 https://pharmadispatch.com/news/psa-calls-for-pharmacy-pay-rise 2017-04-10T06:01:01+10:00 https://pharmadispatch.com/news/asmi-calls-for-new-wave-of-reform 2017-04-10T06:00:01+10:00 https://pharmadispatch.com/news/may-listings-for-leukaemia-lung-disease-and-multiple-sclerosis 2017-04-07T06:03:01+10:00 https://pharmadispatch.com/news/rd-tax-proposal-will-cause-destruction 2017-04-07T06:02:01+10:00 https://pharmadispatch.com/news/extend-tga-gains-to-pbs-listing-process 2017-04-07T06:01:01+10:00 https://pharmadispatch.com/news/eu-trade-deal-opportunity-for-industry 2017-04-07T06:00:01+10:00 https://pharmadispatch.com/news/exclusive-creating-a-medicines-future-fund 2017-04-06T06:00:01+10:00 https://pharmadispatch.com/news/further-evidence-of-extraordinary-transformation 2017-04-06T06:00:01+10:00 https://pharmadispatch.com/news/allergan-welcomes-new-launch 2017-04-06T06:00:01+10:00 https://pharmadispatch.com/news/high-courts-sticks-with-6m-fine 2017-04-06T06:00:01+10:00 https://pharmadispatch.com/news/changes-required-to-promote-sector-growth 2017-04-05T06:03:01+10:00 https://pharmadispatch.com/news/positive-survival-data-for-bms-immunotherapy-combination 2017-04-05T06:02:01+10:00 https://pharmadispatch.com/news/roche-tops-brand-value-list 2017-04-05T06:01:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-relaunches-product-for-cancer-patients 2017-04-05T06:00:01+10:00 https://pharmadispatch.com/news/a-case-of-timing-rather-than-new-saving 2017-04-04T06:04:01+10:00 https://pharmadispatch.com/news/rebates-in-the-us-undermining-patient-access 2017-04-04T06:03:01+10:00 https://pharmadispatch.com/news/ebos-company-buys-australian-rights-to-german-supplement-maker 2017-04-04T06:02:01+10:00 https://pharmadispatch.com/news/jj-confirms-new-name-for-actelion-assets 2017-04-04T06:01:01+10:00 https://pharmadispatch.com/news/story-telling-helps-people-understand-a-leading-cause-of-stroke 2017-04-04T06:00:01+10:00 https://pharmadispatch.com/news/australia-free-riding-and-engaged-in-commercial-blackmail 2017-04-03T06:04:01+10:00 https://pharmadispatch.com/news/extraordinary-attack-reveals-true-feelings 2017-04-03T06:03:01+10:00 https://pharmadispatch.com/news/biosimilars-front-and-centre 2017-04-03T06:02:01+10:00 https://pharmadispatch.com/news/guild-welcomes-senate-support-for-tax-cuts 2017-04-03T06:00:01+10:00 https://pharmadispatch.com/news/rest-easy-on-tgps 2017-03-31T06:03:01+11:00 https://pharmadispatch.com/news/furious-minister-intervenes-on-medsassist 2017-03-31T06:02:01+11:00 https://pharmadispatch.com/news/msd-marks-brenzys-as-bdmards-deliver-savings-windfall 2017-03-31T06:01:01+11:00 https://pharmadispatch.com/news/consultations-underway-on-australias-innovation-plan-to-2030 2017-03-31T06:00:01+11:00 https://pharmadispatch.com/news/here-comes-pbs-reform-lite-budget 2017-03-30T06:03:01+11:00 https://pharmadispatch.com/news/signing-an-agreement-is-just-the-beginning 2017-03-30T06:02:01+11:00 https://pharmadispatch.com/news/msd-welcomes-new-keytruda-approval 2017-03-30T06:01:01+11:00 https://pharmadispatch.com/news/guild-scraps-medsassist 2017-03-30T06:00:01+11:00 https://pharmadispatch.com/news/ma-in-advanced-talks-for-strategic-agreement-with-government 2017-03-29T06:02:01+11:00 https://pharmadispatch.com/news/is-the-horse-about-to-drink 2017-03-29T06:01:01+11:00 https://pharmadispatch.com/news/an-agreement-is-worth-the-price 2017-03-29T06:00:01+11:00 https://pharmadispatch.com/news/exclusive-the-best-and-final-offer 2017-03-28T06:03:01+11:00 https://pharmadispatch.com/news/senate-committee-backs-tga-reforms 2017-03-28T06:02:01+11:00 https://pharmadispatch.com/news/pm-praise-for-pharma-innovation 2017-03-28T06:01:01+11:00 https://pharmadispatch.com/news/industry-looks-to-us-corporate-tax-cut 2017-03-28T06:00:01+11:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-co-creation-and-partnership-the-only-op 2017-03-27T06:06:01+11:00 https://pharmadispatch.com/news/ma-ezetimibe-review-threat-to-pbs-reform-and-pbac-guidelines 2017-03-27T06:05:01+11:00 https://pharmadispatch.com/news/pbs-spike-moderates-as-confusion-reigns-over-rebates 2017-03-27T06:04:01+11:00 https://pharmadispatch.com/news/jj-joins-gsk-in-youtube-ban 2017-03-27T06:03:01+11:00 https://pharmadispatch.com/news/stakeholders-welcome-1-april-lymphoma-listing 2017-03-27T06:02:01+11:00 https://pharmadispatch.com/news/38-million-australian-adults-missing-out-on-free-vaccinations 2017-03-27T06:01:01+11:00 https://pharmadispatch.com/news/top-6-tips-overcoming-barriers-to-social-media-proactivity 2017-03-27T05:59:01+11:00 https://pharmadispatch.com/news/sigma-approaching-50-50-revenue-split 2017-03-24T06:03:01+11:00 https://pharmadispatch.com/news/just-when-the-system-looked-set-to-fail 2017-03-24T06:02:01+11:00 https://pharmadispatch.com/news/pbac-member-to-co-chair-new-mental-health-panel 2017-03-24T06:01:01+11:00 https://pharmadispatch.com/news/trump-were-going-to-try-and-have-the-lowest-prices-anywhere-in-t 2017-03-24T06:00:01+11:00 https://pharmadispatch.com/news/consumers-back-pharmacy-administered-flu-vaccine 2017-03-23T06:04:01+11:00 https://pharmadispatch.com/news/a-single-five-minute-car-trip 2017-03-23T06:03:01+11:00 https://pharmadispatch.com/news/turnbull-government-unveils-national-science-statement 2017-03-23T06:02:01+11:00 https://pharmadispatch.com/news/sinodinos-we-have-to-get-better-at-collaboration 2017-03-23T06:01:01+11:00 https://pharmadispatch.com/news/no-pbs-intervention-for-medicinal-cannabis 2017-03-23T06:00:01+11:00 https://pharmadispatch.com/news/us-frustration-with-australia-not-new 2017-03-22T06:03:01+11:00 https://pharmadispatch.com/news/consumers-fundamental-to-health-system-reform 2017-03-22T06:02:01+11:00 https://pharmadispatch.com/news/china-boost-for-blackmores 2017-03-22T06:01:01+11:00 https://pharmadispatch.com/news/xarelto-tops-aspirin-in-blood-clot-study 2017-03-22T06:00:01+11:00 https://pharmadispatch.com/news/first-meeting-of-ma-advisory-council 2017-03-21T06:03:01+11:00 https://pharmadispatch.com/news/alphapharm-initiates-recall-of-epipen-batches 2017-03-21T06:02:01+11:00 https://pharmadispatch.com/news/real-world-study-backs-sglt-2-inhibitors 2017-03-21T06:01:01+11:00 https://pharmadispatch.com/news/labor-raises-penalty-rates-for-pharmacy-assistants 2017-03-21T06:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-conquer-mt-kosi-challenge 2017-03-20T06:04:01+11:00 https://pharmadispatch.com/news/judge-slams-company-over-specious-evidence 2017-03-20T06:03:01+11:00 https://pharmadispatch.com/news/mixed-response-to-repatha-outcomes-data 2017-03-20T06:02:01+11:00 https://pharmadispatch.com/news/tga-reforms-one-step-closer 2017-03-20T06:01:01+11:00 https://pharmadispatch.com/news/bennelong-forum-hosts-dr-david-gillespie 2017-03-20T06:00:01+11:00 https://pharmadispatch.com/news/gilead-extends-fellowship-reach-with-2017-grants 2017-03-17T06:03:01+11:00 https://pharmadispatch.com/news/team-msd-in-front-with-one-day-to-go 2017-03-17T06:02:01+11:00 https://pharmadispatch.com/news/standstill-on-second-brand-as-ma-pushes-comparators 2017-03-17T06:01:01+11:00 https://pharmadispatch.com/news/trump-proposes-massive-cut-in-medical-research 2017-03-17T06:00:01+11:00 https://pharmadispatch.com/news/this-is-why-australian-industry-should-drive-trade-negotiations 2017-03-16T06:04:01+11:00 https://pharmadispatch.com/news/positive-trial-result-for-azs-lynparza 2017-03-16T06:03:01+11:00 https://pharmadispatch.com/news/narrow-defeat-for-ex-ma-chief 2017-03-16T06:02:01+11:00 https://pharmadispatch.com/news/diabetes-companies-assess-pbac-outcome 2017-03-16T06:01:01+11:00 https://pharmadispatch.com/news/willach-pharmacy-solutions-launches-online-shop 2017-03-16T06:00:01+11:00 https://pharmadispatch.com/news/us-targets-australia-over-drug-pricing 2017-03-15T06:03:01+11:00 https://pharmadispatch.com/news/complacency-driven-by-vaccine-success 2017-03-15T06:02:01+11:00 https://pharmadispatch.com/news/research-australia-congratulates-wa-labor 2017-03-15T06:01:01+11:00 https://pharmadispatch.com/news/another-positive-trial-outcome-for-amgens-repatha 2017-03-15T06:00:01+11:00 https://pharmadispatch.com/news/what-primary-health-reform-means-for-the-sector 2017-03-14T06:04:01+11:00 https://pharmadispatch.com/news/patients-turn-to-online-peers-for-advice-and-support 2017-03-14T06:03:01+11:00 https://pharmadispatch.com/news/race-for-mount-kosciuszko-enters-the-final-week 2017-03-14T06:02:01+11:00 https://pharmadispatch.com/news/trump-announces-fda-appointment 2017-03-14T06:01:01+11:00 https://pharmadispatch.com/news/key-leadership-changes-for-novogen 2017-03-14T06:00:01+11:00 https://pharmadispatch.com/news/tillack-propose-an-alternative-rather-than-just-criticise-and-co 2017-03-13T06:04:01+11:00 https://pharmadispatch.com/news/no-herceptin-for-bexsero 2017-03-13T06:03:01+11:00 https://pharmadispatch.com/news/major-party-unity-ticket-on-pharmacy 2017-03-13T06:02:01+11:00 https://pharmadispatch.com/news/government-proposes-no-jab-no-pay-no-play-policy 2017-03-13T06:01:01+11:00 https://pharmadispatch.com/news/mayne-pharma-adds-another-drug-to-us-portfolio 2017-03-10T06:00:01+11:00 https://pharmadispatch.com/news/mysterious-april-price-cuts-but-massive-savings 2017-03-10T06:00:01+11:00 https://pharmadispatch.com/news/pbs-reformer-departs-public-service-today 2017-03-10T06:00:01+11:00 https://pharmadispatch.com/news/merck-adds-colour-to-mount-kosciuszko-challenge 2017-03-10T06:00:01+11:00 https://pharmadispatch.com/news/seqirus-vaccine-now-available-through-the-private-market 2017-03-10T06:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-wins-friends-at-app 2017-03-10T06:00:01+11:00 https://pharmadispatch.com/news/alternative-facts-on-biosimilars 2017-03-10T06:00:01+11:00 https://pharmadispatch.com/news/apotex-acquires-vaccine-distribution-business 2017-03-09T22:14:01+11:00 https://pharmadispatch.com/news/pbac-numbers-just-meet-legal-requirement 2017-03-09T06:03:01+11:00 https://pharmadispatch.com/news/hooper-current-distribution-model-unsustainable 2017-03-09T06:02:01+11:00 https://pharmadispatch.com/news/priceline-celebrates-300th-store 2017-03-09T06:01:01+11:00 https://pharmadispatch.com/news/pfizer-chips-in-to-clean-up-local-community 2017-03-09T06:00:01+11:00 https://pharmadispatch.com/news/new-cancer-listings-for-april 2017-03-08T06:03:01+11:00 https://pharmadispatch.com/news/rebates-ignored-as-cormann-blames-pbs-for-spike-in-government-sp 2017-03-08T06:02:01+11:00 https://pharmadispatch.com/news/new-tga-approval-for-msds-keytruda 2017-03-08T06:01:01+11:00 https://pharmadispatch.com/news/merck-moving-to-extend-cladribine-for-multiple-sclerosis 2017-03-08T06:00:01+11:00 https://pharmadispatch.com/news/timing-is-everything-when-it-comes-to-reform 2017-03-07T06:00:01+11:00 https://pharmadispatch.com/news/first-biosimilar-etanercept-confirmed-for-april 2017-03-07T06:00:01+11:00 https://pharmadispatch.com/news/sector-clashes-with-grattan-institute-over-report 2017-03-07T06:00:01+11:00 https://pharmadispatch.com/news/broad-skill-set-and-experience-for-ma-advisory-council 2017-03-07T06:00:01+11:00 https://pharmadispatch.com/news/ma-joins-hanson-vaccination-backlash 2017-03-06T12:40:01+11:00 https://pharmadispatch.com/news/sector-slams-misleading-grattan-institute-report 2017-03-06T06:00:01+11:00 https://pharmadispatch.com/news/new-grattan-report-only-proves-its-failure 2017-03-06T06:00:01+11:00 https://pharmadispatch.com/news/price-linkages-set-to-be-tested-again 2017-03-06T06:00:01+11:00 https://pharmadispatch.com/news/government-announces-nip-flu-vaccines 2017-03-06T06:00:01+11:00 https://pharmadispatch.com/news/peace-deal-for-pharmacy-guild-and-diabetes-australia 2017-03-06T06:00:01+11:00 https://pharmadispatch.com/news/teams-competing-for-the-pharma-2-peak-kosi-challenge 2017-03-03T06:03:01+11:00 https://pharmadispatch.com/news/chf-initially-backed-pbs-deferrals 2017-03-03T06:02:01+11:00 https://pharmadispatch.com/news/labor-to-host-health-roundtable 2017-03-03T06:01:01+11:00 https://pharmadispatch.com/news/on-the-front-foot-with-pfizer-proactive-supply 2017-03-03T06:00:01+11:00 https://pharmadispatch.com/news/lsdp-the-focus-at-senate-estimates 2017-03-02T06:04:01+11:00 https://pharmadispatch.com/news/carol-bennett-responds-to-questions 2017-03-02T06:03:01+11:00 https://pharmadispatch.com/news/promotion-for-allergans-glen-curran 2017-03-02T06:02:01+11:00 https://pharmadispatch.com/news/accc-welcomes-ma-reports 2017-03-02T06:01:01+11:00 https://pharmadispatch.com/news/another-anti-pd-l1-cancer-therapy-emerging 2017-03-02T06:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-industry-critic-to-advisory-council 2017-03-01T06:03:01+11:00 https://pharmadispatch.com/news/a-brave-appointment 2017-03-01T06:02:01+11:00 https://pharmadispatch.com/news/ma-publishes-latest-transparency-reports 2017-03-01T06:01:01+11:00 https://pharmadispatch.com/news/parliamentary-interest-in-keytruda-for-mesothelioma 2017-03-01T06:00:01+11:00 https://pharmadispatch.com/news/is-it-speculation-or-semantics 2017-02-28T06:03:01+11:00 https://pharmadispatch.com/news/peter-mac-joins-bms-global-immuno-oncology-network 2017-02-28T06:02:01+11:00 https://pharmadispatch.com/news/tga-approval-for-csl-behring-lung-therapy 2017-02-28T06:01:01+11:00 https://pharmadispatch.com/news/guild-ups-pressure-on-greg-hunt 2017-02-28T06:00:01+11:00 https://pharmadispatch.com/news/ma-says-no-to-central-reporting-system 2017-02-27T06:04:01+11:00 https://pharmadispatch.com/news/pbs-spikes-by-28-per-cent-but-its-just-not-real 2017-02-27T06:03:01+11:00 https://pharmadispatch.com/news/no-risk-deal-greatest-ever-negotiated 2017-02-27T06:02:01+11:00 https://pharmadispatch.com/news/acquisition-turbocharge-for-mayne-pharma 2017-02-27T06:01:01+11:00 https://pharmadispatch.com/news/competition-working-in-hcv-market 2017-02-27T06:00:01+11:00 https://pharmadispatch.com/news/securing-certainty-to-avoid-the-worst-reforms 2017-02-24T06:02:01+11:00 https://pharmadispatch.com/news/guild-welcomes-fair-work-commission-ruling 2017-02-24T06:01:01+11:00 https://pharmadispatch.com/news/industry-leaders-back-us-tax-change 2017-02-24T06:00:01+11:00 https://pharmadispatch.com/news/pharmaceuticals-dominate-bayer-result 2017-02-24T06:00:01+11:00 https://pharmadispatch.com/news/industry-pbac-nomination-progresses 2017-02-23T06:04:01+11:00 https://pharmadispatch.com/news/minister-will-review-unpopular-policy 2017-02-23T06:03:01+11:00 https://pharmadispatch.com/news/new-medicines-australia-board-meets 2017-02-23T06:02:01+11:00 https://pharmadispatch.com/news/hep-c-revenue-boost-for-ebos 2017-02-23T06:01:01+11:00 https://pharmadispatch.com/news/dramatic-sales-shift-for-blackmores 2017-02-23T06:00:01+11:00 https://pharmadispatch.com/news/pbac-uncertainty-as-meeting-approaches 2017-02-22T06:05:01+11:00 https://pharmadispatch.com/news/janssen-backs-nzs-first-social-bond 2017-02-22T06:03:01+11:00 https://pharmadispatch.com/news/wa-labor-commits-to-medical-research-future-fund 2017-02-22T06:02:01+11:00 https://pharmadispatch.com/news/different-application-for-pharmac 2017-02-22T06:01:01+11:00 https://pharmadispatch.com/news/melbourne-based-company-secure-first-cannabis-licence 2017-02-22T06:00:01+11:00 https://pharmadispatch.com/news/more-frustration-over-co-dependent-technologies 2017-02-21T06:03:01+11:00 https://pharmadispatch.com/news/focus-remains-on-supply-shortages 2017-02-21T06:02:01+11:00 https://pharmadispatch.com/news/more-australians-living-with-insulin-treated-diabetes 2017-02-21T06:01:01+11:00 https://pharmadispatch.com/news/merger-boost-for-terrywhite-chemmart-group 2017-02-21T06:00:01+11:00 https://pharmadispatch.com/news/milton-catelin-leading-what-is-now-a-very-different-organisation 2017-02-20T06:04:01+11:00 https://pharmadispatch.com/news/az-boosted-by-positive-breast-cancer-trial 2017-02-20T06:03:01+11:00 https://pharmadispatch.com/news/industry-disagreement-over-uk-rebate-demand 2017-02-20T06:02:01+11:00 https://pharmadispatch.com/news/savings-measures-remain-in-the-budget 2017-02-20T06:01:01+11:00 https://pharmadispatch.com/news/australia-and-nz-sign-innovation-treaty 2017-02-20T06:00:01+11:00 https://pharmadispatch.com/news/doctors-want-the-ultimate-decision-on-biologic-choice 2017-02-17T06:03:01+11:00 https://pharmadispatch.com/news/ex-ma-ceo-nominates-for-nsw-state-seat 2017-02-17T06:02:01+11:00 https://pharmadispatch.com/news/experts-argue-the-benefits-of-a-new-lsdp 2017-02-17T06:01:01+11:00 https://pharmadispatch.com/news/policy-options-ready-to-go 2017-02-17T06:00:01+11:00 https://pharmadispatch.com/news/real-or-just-rhetoric 2017-02-16T06:04:01+11:00 https://pharmadispatch.com/news/csl-delivers-exceptionally-strong-performance 2017-02-16T06:03:01+11:00 https://pharmadispatch.com/news/no-new-pbs-listings-in-march 2017-02-16T06:02:01+11:00 https://pharmadispatch.com/news/another-setback-in-search-for-new-alzheimers-therapy 2017-02-16T06:01:01+11:00 https://pharmadispatch.com/news/parliamentary-support-for-fight-against-prostate-cancer 2017-02-16T06:00:01+11:00 https://pharmadispatch.com/news/not-the-only-options-considered 2017-02-15T06:03:01+11:00 https://pharmadispatch.com/news/pc-risks-australian-rd-and-patient-access 2017-02-15T06:02:01+11:00 https://pharmadispatch.com/news/teva-result-boosted-by-actavis-acquisition 2017-02-15T06:01:01+11:00 https://pharmadispatch.com/news/chf-wants-evidence-based-claims-for-complementary-medicines 2017-02-15T06:00:01+11:00 https://pharmadispatch.com/news/trade-agreement-provides-us-a-clear-path-into-pbs-policy 2017-02-14T06:03:01+11:00 https://pharmadispatch.com/news/government-turns-to-pbs-on-health-again 2017-02-14T06:02:01+11:00 https://pharmadispatch.com/news/pharmacy-cautious-on-complementary-medicines 2017-02-14T06:01:01+11:00 https://pharmadispatch.com/news/experts-want-focus-on-teenage-immunisation 2017-02-14T06:00:01+11:00 https://pharmadispatch.com/news/has-the-abc-forgotten-what-it-did-on-statins 2017-02-13T06:05:01+11:00 https://pharmadispatch.com/news/could-there-be-a-better-way-to-guarantee-supply 2017-02-13T06:04:01+11:00 https://pharmadispatch.com/news/industry-concern-over-manufacturing-decline 2017-02-13T06:03:01+11:00 https://pharmadispatch.com/news/csl-therapy-shows-potential-in-diabetic-kidney-disease 2017-02-13T06:02:01+11:00 https://pharmadispatch.com/news/reckitt-benckiser-acquires-ex-bms-nutrition-company 2017-02-13T06:01:01+11:00 https://pharmadispatch.com/news/allergan-sets-high-expectations-for-2017 2017-02-13T06:00:01+11:00 https://pharmadispatch.com/news/why-taking-the-pressure-out-of-sales-helps-you-sell 2017-02-10T06:04:01+11:00 https://pharmadispatch.com/news/pfizer-to-close-adelaide-biologic-facility 2017-02-10T06:03:01+11:00 https://pharmadispatch.com/news/abc-gets-it-wrong-on-donations 2017-02-10T06:02:01+11:00 https://pharmadispatch.com/news/pm-trims-cabinets-budget-committee 2017-02-10T06:01:01+11:00 https://pharmadispatch.com/news/department-gets-the-shts 2017-02-10T06:00:01+11:00 https://pharmadispatch.com/news/gbma-sticks-with-uptake-drivers 2017-02-09T06:05:01+11:00 https://pharmadispatch.com/news/specialty-medicines-boost-for-sanofi 2017-02-09T06:04:01+11:00 https://pharmadispatch.com/news/vaccines-and-consumer-health-deliver-for-gsk 2017-02-09T06:03:01+11:00 https://pharmadispatch.com/news/australia-undermining-proud-tradition-of-ip-led-innovation 2017-02-09T06:02:01+11:00 https://pharmadispatch.com/news/psa-releases-new-code-of-ethics 2017-02-09T06:01:01+11:00 https://pharmadispatch.com/news/consensus-statement-of-device-registries 2017-02-09T06:00:01+11:00 https://pharmadispatch.com/news/hunt-have-another-go 2017-02-08T06:04:01+11:00 https://pharmadispatch.com/news/the-billion-dollar-pbs-hole 2017-02-08T06:03:01+11:00 https://pharmadispatch.com/news/bionomics-receives-first-milestone-payment 2017-02-08T06:02:01+11:00 https://pharmadispatch.com/news/ip-change-permanently-adopted 2017-02-08T06:01:01+11:00 https://pharmadispatch.com/news/australia-must-do-better-on-innovation 2017-02-08T06:00:01+11:00 https://pharmadispatch.com/news/the-numbers-dont-lie-or-do-they 2017-02-07T06:03:01+11:00 https://pharmadispatch.com/news/vertex-commits-to-early-access 2017-02-07T06:02:01+11:00 https://pharmadispatch.com/news/tga-corrects-paper-on-herbal-regulation 2017-02-07T06:01:01+11:00 https://pharmadispatch.com/news/new-specialty-medicines-program-for-pharmacy 2017-02-07T06:00:01+11:00 https://pharmadispatch.com/news/a-necessary-but-risky-discussion 2017-02-06T06:05:01+11:00 https://pharmadispatch.com/news/canberra-protest-to-go-ahead 2017-02-06T06:04:01+11:00 https://pharmadispatch.com/news/ma-welcomes-labors-budget-discussion-paper 2017-02-06T06:03:01+11:00 https://pharmadispatch.com/news/amgen-jumps-on-repatha-outcomes-trial 2017-02-06T06:02:01+11:00 https://pharmadispatch.com/news/pfizer-considers-acquisitions-and-divestments 2017-02-06T06:01:01+11:00 https://pharmadispatch.com/news/more-grants-for-medical-research 2017-02-06T06:00:01+11:00 https://pharmadispatch.com/news/az-and-msd-fourth-quarter-results 2017-02-03T18:00:01+11:00 https://pharmadispatch.com/news/new-measures-to-address-a-flagging-failure 2017-02-03T06:03:01+11:00 https://pharmadispatch.com/news/pharmac-defends-rationing-cancer-medicines 2017-02-03T06:02:01+11:00 https://pharmadispatch.com/news/rescheduling-disappointment-for-bayer 2017-02-03T06:01:01+11:00 https://pharmadispatch.com/news/st-adopts-new-sales-model 2017-02-02T06:02:01+11:00 https://pharmadispatch.com/news/trump-targets-drug-pricing-with-trade-policy 2017-02-02T06:01:01+11:00 https://pharmadispatch.com/news/sector-backs-political-process 2017-02-02T06:00:01+11:00 https://pharmadispatch.com/news/lilly-welcomes-taltz-listing 2017-02-02T06:00:01+11:00 https://pharmadispatch.com/news/ma-to-activate-on-possible-prescribing-change 2017-02-01T06:03:01+11:00 https://pharmadispatch.com/news/no-erc-for-greg-hunt 2017-02-01T06:02:01+11:00 https://pharmadispatch.com/news/new-cancer-listings-headline-pbs 2017-02-01T06:01:01+11:00 https://pharmadispatch.com/news/pfizer-fourth-quarter-result 2017-02-01T06:00:01+11:00 https://pharmadispatch.com/news/wider-risk-of-ezetimibe-review 2017-01-31T06:03:01+11:00 https://pharmadispatch.com/news/msd-report-missed-full-benefits 2017-01-31T06:02:01+11:00 https://pharmadispatch.com/news/greg-hunts-office-taking-shape 2017-01-31T06:01:01+11:00 https://pharmadispatch.com/news/commonwealth-responds-on-meningococcal 2017-01-31T06:00:01+11:00 https://pharmadispatch.com/news/exclusive-are-we-looking-at-pbs-reform-lite 2017-01-30T06:05:01+11:00 https://pharmadispatch.com/news/cynical-response-to-latest-review 2017-01-30T06:04:01+11:00 https://pharmadispatch.com/news/political-move-for-former-ma-ceo 2017-01-30T06:03:01+11:00 https://pharmadispatch.com/news/december-pbac-outcomes 2017-01-30T06:02:01+11:00 https://pharmadispatch.com/news/abbvie-and-bms-hit-by-high-expectations 2017-01-30T06:01:01+11:00 https://pharmadispatch.com/news/haemophilia-boosts-biogen-as-spin-off-looms 2017-01-30T06:00:01+11:00 https://pharmadispatch.com/news/australia-day-recognition-for-long-serving-ma-board-member 2017-01-27T06:04:01+11:00 https://pharmadispatch.com/news/award-for-unsung-but-well-known-public-servant 2017-01-27T06:03:01+11:00 https://pharmadispatch.com/news/novartis-working-through-glivec-patent-expiry 2017-01-27T06:02:01+11:00 https://pharmadispatch.com/news/jj-acquires-actelion-for-us30bn 2017-01-27T06:01:01+11:00 https://pharmadispatch.com/news/medical-researcher-named-australian-of-the-year 2017-01-27T06:00:01+11:00 https://pharmadispatch.com/news/turnbull-sticks-by-trade-enhancing-agreement 2017-01-25T06:04:01+11:00 https://pharmadispatch.com/news/australia-asking-for-trouble-on-ip 2017-01-25T06:03:01+11:00 https://pharmadispatch.com/news/mou-for-ma-and-mtpconnect 2017-01-25T06:02:01+11:00 https://pharmadispatch.com/news/jj-said-to-push-on-despite-actelion-study-setback 2017-01-25T06:01:01+11:00 https://pharmadispatch.com/news/jj-considering-strategic-options-for-diabetes-businesses 2017-01-25T06:00:01+11:00 https://pharmadispatch.com/news/at-least-get-the-facts-right 2017-01-24T06:04:01+11:00 https://pharmadispatch.com/news/mpa-welcomes-new-ministers 2017-01-24T06:03:01+11:00 https://pharmadispatch.com/news/increase-uptake-to-promote-access 2017-01-24T06:02:01+11:00 https://pharmadispatch.com/news/trump-officially-withdraws-us-from-tpp 2017-01-24T06:01:01+11:00 https://pharmadispatch.com/news/gilead-working-towards-epclusa-listing 2017-01-24T06:00:01+11:00 https://pharmadispatch.com/news/cabinet-documents-reveal-government-considered-tenders 2017-01-23T06:03:01+11:00 https://pharmadispatch.com/news/history-makes-it-hard-to-bet-against-pharmacy 2017-01-23T06:02:01+11:00 https://pharmadispatch.com/news/offset-requirement-not-new 2017-01-23T06:01:01+11:00 https://pharmadispatch.com/news/cabinet-debated-csl-sale 2017-01-23T06:00:01+11:00 https://pharmadispatch.com/news/australian-to-lead-gsk-pharma-globally 2017-01-20T06:05:01+11:00 https://pharmadispatch.com/news/uk-introduces-drug-ration-threshold 2017-01-20T06:04:01+11:00 https://pharmadispatch.com/news/major-boost-for-bi-diabetes-therapy 2017-01-20T06:03:01+11:00 https://pharmadispatch.com/news/csl-upgrade-on-strong-sales 2017-01-20T06:02:01+11:00 https://pharmadispatch.com/news/juno-to-launch-new-speciality-antibiotic 2017-01-20T06:01:01+11:00 https://pharmadispatch.com/news/servier-trio-top-leader-board 2017-01-20T06:00:01+11:00 https://pharmadispatch.com/news/new-minister-same-challenge 2017-01-19T06:04:01+11:00 https://pharmadispatch.com/news/sector-reminds-new-minister-of-unresolved-issues 2017-01-19T06:03:01+11:00 https://pharmadispatch.com/news/key-comments-from-greg-hunt-on-day-one 2017-01-19T06:02:01+11:00 https://pharmadispatch.com/news/whos-ready-for-this-years-mount-kosciuszko-challenge 2017-01-19T06:01:01+11:00 https://pharmadispatch.com/news/bayer-ceo-meets-with-trump-on-monsanto 2017-01-19T06:00:01+11:00 https://pharmadispatch.com/news/pm-appoints-greg-hunt-to-health 2017-01-18T10:14:01+11:00 https://pharmadispatch.com/news/no-real-answer-for-government-senator 2017-01-18T06:03:01+11:00 https://pharmadispatch.com/news/new-region-head-for-gsk-pharmaceuticals 2017-01-18T06:02:01+11:00 https://pharmadispatch.com/news/another-listing-for-bayers-adempas 2017-01-18T06:01:01+11:00 https://pharmadispatch.com/news/tpp-ratification-could-complicate-pharma-ip 2017-01-18T06:00:01+11:00 https://pharmadispatch.com/news/sussan-ley-adds-to-her-legacy-with-february-cancer-listings 2017-01-17T06:04:01+11:00 https://pharmadispatch.com/news/budget-office-confirms-one-off-spike-in-pbs-spend 2017-01-17T06:03:01+11:00 https://pharmadispatch.com/news/chewing-gum-passes-the-test 2017-01-17T06:02:01+11:00 https://pharmadispatch.com/news/pbac-looking-for-diabetes-specialist 2017-01-17T06:01:01+11:00 https://pharmadispatch.com/news/company-reappointed-to-administer-cso 2017-01-17T06:00:01+11:00 https://pharmadispatch.com/news/pbs-headlines-ley-legacy 2017-01-16T06:07:01+11:00 https://pharmadispatch.com/news/a-new-minister-makes-change-inevitable 2017-01-16T06:06:01+11:00 https://pharmadispatch.com/news/no-1-february-listing-for-biosimilar-etanercept 2017-01-16T06:05:01+11:00 https://pharmadispatch.com/news/trump-companies-getting-away-with-murder 2017-01-16T06:04:01+11:00 https://pharmadispatch.com/news/guild-in-pursuit-over-deloitte 2017-01-16T06:03:01+11:00 https://pharmadispatch.com/news/jj-moves-closer-to-actelion-acquisition 2017-01-16T06:02:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-tga-approval-of-new-leukaemia-therapy 2017-01-16T06:01:01+11:00 https://pharmadispatch.com/news/mtpconnect-launches-final-sector-plan 2017-01-16T06:00:01+11:00 https://pharmadispatch.com/news/uncertainty-as-minister-faces-investigation 2017-01-09T14:22:01+11:00 https://pharmadispatch.com/news/managed-entry-on-march-agenda 2016-12-23T06:03:01+11:00 https://pharmadispatch.com/news/diabetes-companies-receieve-price-cut-dusc-report 2016-12-22T06:04:01+11:00 https://pharmadispatch.com/news/jj-back-in-the-hunt-for-actelion 2016-12-22T06:02:01+11:00 https://pharmadispatch.com/news/co-pay-delay-for-another-year 2016-12-22T06:01:01+11:00 https://pharmadispatch.com/news/servier-trio-smash-fundraising-target 2016-12-22T06:00:01+11:00 https://pharmadispatch.com/news/productivity-commission-proposes-a-free-ride-for-australia 2016-12-21T06:04:01+11:00 https://pharmadispatch.com/news/we-bring-innovation-and-government-should-recognise-it 2016-12-21T06:03:01+11:00 https://pharmadispatch.com/news/codeine-up-schedule-a-silly-decision 2016-12-21T06:02:01+11:00 https://pharmadispatch.com/news/takeda-welcomes-adcetris-recommendation 2016-12-21T06:01:01+11:00 https://pharmadispatch.com/news/ausbiotech-scrap-rd-tax-cap 2016-12-21T06:00:01+11:00 https://pharmadispatch.com/news/no-pbs-surprise-in-myefo 2016-12-20T06:03:01+11:00 https://pharmadispatch.com/news/exclusive-minister-hits-back-on-unsustainable-orkambi-price 2016-12-20T06:03:01+11:00 https://pharmadispatch.com/news/guild-declares-no-confidence-in-pharmacy-review 2016-12-20T06:02:01+11:00 https://pharmadispatch.com/news/lower-spending-on-rd-tax-incentive 2016-12-20T06:00:01+11:00 https://pharmadispatch.com/news/two-new-board-members-for-ma 2016-12-19T08:45:01+11:00 https://pharmadispatch.com/news/cancer-outcomes-dominate-november-pbac 2016-12-19T06:00:01+11:00 https://pharmadispatch.com/news/official-pbs-stats-confirm-impact-of-hcv-therapies 2016-12-19T06:00:01+11:00 https://pharmadispatch.com/news/gbma-welcomes-a-flag-but-more-required 2016-12-19T06:00:01+11:00 https://pharmadispatch.com/news/minister-announces-new-listings-ahead-of-myefo 2016-12-19T06:00:01+11:00 https://pharmadispatch.com/news/nerves-for-mayne-investors 2016-12-18T06:00:01+11:00 https://pharmadispatch.com/news/former-ausbiotech-ceo-appointed-to-ma-board 2016-12-16T08:45:01+11:00 https://pharmadispatch.com/news/a-not-so-merry-christmas-for-bdmard-companies 2016-12-16T06:04:01+11:00 https://pharmadispatch.com/news/first-time-reductions-lead-april-cuts 2016-12-16T06:03:01+11:00 https://pharmadispatch.com/news/life-science-sector-rallies-against-rd-tax-cut 2016-12-16T06:02:01+11:00 https://pharmadispatch.com/news/new-information-confirms-what-we-already-knew-about-pbs 2016-12-16T06:01:01+11:00 https://pharmadispatch.com/news/decem-beard-enters-week-3-at-servier 2016-12-15T17:28:01+11:00 https://pharmadispatch.com/news/big-fall-in-pbs-spend-for-2016-17 2016-12-15T06:03:01+11:00 https://pharmadispatch.com/news/tga-still-considering-naming-convention 2016-12-15T06:02:01+11:00 https://pharmadispatch.com/news/sanofi-leads-race-for-actelion-as-jj-drops-out 2016-12-15T06:01:01+11:00 https://pharmadispatch.com/news/shareholders-back-monsanto-deal-with-bayer 2016-12-15T06:00:01+11:00 https://pharmadispatch.com/news/strange-pbs-request-from-racgp 2016-12-14T06:04:01+11:00 https://pharmadispatch.com/news/csl-invests-in-btf-fund 2016-12-14T06:03:01+11:00 https://pharmadispatch.com/news/concessional-patients-dominate-pbs-script-numbers 2016-12-14T06:02:01+11:00 https://pharmadispatch.com/news/leadership-changes-for-alexion 2016-12-14T06:01:01+11:00 https://pharmadispatch.com/news/new-ceo-for-mtaa 2016-12-14T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-leadership-helps-santa 2016-12-13T06:03:01+11:00 https://pharmadispatch.com/news/new-bayer-therapy-for-the-pbs 2016-12-13T06:02:01+11:00 https://pharmadispatch.com/news/seqirus-partners-with-toll 2016-12-13T06:01:01+11:00 https://pharmadispatch.com/news/budget-challenge-tests-the-limits-of-political-influence 2016-12-13T06:00:01+11:00 https://pharmadispatch.com/news/viiv-announces-180000-in-grants 2016-12-13T06:00:01+11:00 https://pharmadispatch.com/news/biosimilar-options-under-consideration 2016-12-12T06:04:01+11:00 https://pharmadispatch.com/news/ato-publishes-tax-list-as-sector-faces-renewed-scrutiny 2016-12-12T06:03:01+11:00 https://pharmadispatch.com/news/no-agreement-on-dispensing-fee 2016-12-12T06:02:01+11:00 https://pharmadispatch.com/news/trump-fda-choice-says-scrap-efficacy 2016-12-12T06:01:01+11:00 https://pharmadispatch.com/news/a-remarkable-year-for-what-was-once-an-afterthought 2016-12-12T06:00:01+11:00 https://pharmadispatch.com/news/collaborative-cancer-research-funding-passes-110m 2016-12-12T06:00:01+11:00 https://pharmadispatch.com/news/baxter-recgnised-on-gender 2016-12-09T06:00:01+11:00 https://pharmadispatch.com/news/medadvisor-inks-deal-with-pfizer 2016-12-09T05:54:01+11:00 https://pharmadispatch.com/news/biosimilar-initiative-goes-live 2016-12-09T05:45:01+11:00 https://pharmadispatch.com/news/decem-beard-growing-at-servier 2016-12-08T10:40:01+11:00 https://pharmadispatch.com/news/a-somewhat-misleading-headline 2016-12-08T06:04:01+11:00 https://pharmadispatch.com/news/gsk-invests-to-support-female-entrepreneurs 2016-12-08T06:03:01+11:00 https://pharmadispatch.com/news/more-coming-on-biosimilars 2016-12-08T06:02:01+11:00 https://pharmadispatch.com/news/government-highlights-innovation-policy-but 2016-12-08T06:01:01+11:00 https://pharmadispatch.com/news/trajan-hosts-innovation-minister 2016-12-08T06:00:01+11:00 https://pharmadispatch.com/news/ex-australian-gsk-boss-to-lead-viiv 2016-12-07T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-considering-actelion-bid 2016-12-07T06:00:01+11:00 https://pharmadispatch.com/news/pbs-for-msds-zepatier 2016-12-07T06:00:01+11:00 https://pharmadispatch.com/news/nz-health-minister-joins-pm-race 2016-12-07T06:00:01+11:00 https://pharmadispatch.com/news/bruce-goodwin-sitting-on-the-sidelines-not-an-option 2016-12-06T06:00:01+11:00 https://pharmadispatch.com/news/novartis-unlikely-to-bid-for-actelion 2016-12-06T06:00:01+11:00 https://pharmadispatch.com/news/minister-announces-funding-for-largest-australian-clinical-trial 2016-12-06T06:00:01+11:00 https://pharmadispatch.com/news/nps-drug-cost-list-missed-rebates 2016-12-05T16:04:01+11:00 https://pharmadispatch.com/news/antibiotics-and-chemo-top-generic-price-increase 2016-12-05T06:03:01+11:00 https://pharmadispatch.com/news/dr-mona-marabani-australia-not-the-uk 2016-12-05T06:02:01+11:00 https://pharmadispatch.com/news/investors-expect-jj-deal-on-actelion 2016-12-05T06:01:01+11:00 https://pharmadispatch.com/news/change-not-for-the-better 2016-12-05T06:00:01+11:00 https://pharmadispatch.com/news/chf-makes-do-with-less 2016-12-05T06:00:01+11:00 https://pharmadispatch.com/news/dr-paul-cornes-lead-or-be-led-on-biosimilars 2016-12-02T06:03:01+11:00 https://pharmadispatch.com/news/csl-progresses-three-new-therapies 2016-12-02T06:02:01+11:00 https://pharmadispatch.com/news/guild-issues-reminder-on-workplace-laws 2016-12-02T06:01:01+11:00 https://pharmadispatch.com/news/wider-access-to-eye-therapy 2016-12-02T06:00:01+11:00 https://pharmadispatch.com/news/five-nominations-for-two-ma-vacancies 2016-12-01T06:04:01+11:00 https://pharmadispatch.com/news/servier-supporting-bowel-cancer-australia-for-decembeard 2016-12-01T06:03:01+11:00 https://pharmadispatch.com/news/new-option-for-australians-with-thyroid-cancer 2016-12-01T06:02:01+11:00 https://pharmadispatch.com/news/children-gain-access-to-asthma-biologic 2016-12-01T06:01:01+11:00 https://pharmadispatch.com/news/jj-raises-actelion-offer 2016-12-01T06:00:01+11:00 https://pharmadispatch.com/news/gsks-anne-belcher-progress-towards-a-broader-partnership-with-go 2016-11-30T06:03:01+11:00 https://pharmadispatch.com/news/new-cancer-senate-inquiry 2016-11-30T06:01:01+11:00 https://pharmadispatch.com/news/mundipharma-submits-australian-therapy-for-european-approval 2016-11-30T06:00:01+11:00 https://pharmadispatch.com/news/if-you-do-not-fail-it-means-you-do-not-innovate 2016-11-30T06:00:01+11:00 https://pharmadispatch.com/news/uk-expert-biosimilars-fundamental-to-solving-healthcare-affordab 2016-11-29T06:02:01+11:00 https://pharmadispatch.com/news/beards-can-save-lives 2016-11-29T06:01:01+11:00 https://pharmadispatch.com/news/growing-the-company-rather-than-protecting-it 2016-11-29T06:00:01+11:00 https://pharmadispatch.com/news/new-licensing-deal-for-starpharma 2016-11-29T06:00:01+11:00 https://pharmadispatch.com/news/the-new-astrazeneca-emerges-in-cambridge 2016-11-28T06:04:01+11:00 https://pharmadispatch.com/news/jj-confirms-takeover-discussions-with-actelion 2016-11-28T06:03:01+11:00 https://pharmadispatch.com/news/key-ma-staffer-joins-gsk 2016-11-28T06:02:01+11:00 https://pharmadispatch.com/news/labor-moves-to-elevate-health 2016-11-28T06:01:01+11:00 https://pharmadispatch.com/news/api-recognises-industry-at-annual-awards 2016-11-28T06:00:01+11:00 https://pharmadispatch.com/news/alzheimers-disappointment-with-failure-of-lillys-bace-inhibitor 2016-11-25T06:02:01+11:00 https://pharmadispatch.com/news/sanofi-pasteur-announces-2016-vaxigrants-recipients 2016-11-25T06:01:01+11:00 https://pharmadispatch.com/news/sigma-inks-partnership-with-fred-it 2016-11-25T06:00:01+11:00 https://pharmadispatch.com/news/failures-a-sign-of-industrys-greatness 2016-11-25T06:00:01+11:00 https://pharmadispatch.com/news/turnbull-and-shorten-back-current-pharmacy-model 2016-11-24T06:04:01+11:00 https://pharmadispatch.com/news/cookie-monster-says-no-to-sugar 2016-11-24T06:03:01+11:00 https://pharmadispatch.com/news/bennelong-mp-pays-tribute-to-former-staffer 2016-11-24T06:02:01+11:00 https://pharmadispatch.com/news/gsk-backs-new-study-in-young-smokers 2016-11-24T06:01:01+11:00 https://pharmadispatch.com/news/industry-dominates-auspar-use 2016-11-24T06:00:01+11:00 https://pharmadispatch.com/news/tambassis-seminal-issue-that-goes-to-trust 2016-11-23T06:04:01+11:00 https://pharmadispatch.com/news/rising-risk-of-cardiovascular-complacency 2016-11-23T06:03:01+11:00 https://pharmadispatch.com/news/trump-to-scrap-tpp-on-day-one 2016-11-23T06:02:01+11:00 https://pharmadispatch.com/news/ausbiotech-building-evidence-against-rd-tax-change 2016-11-23T06:01:01+11:00 https://pharmadispatch.com/news/review-a-chance-to-avoid-the-tipping-point 2016-11-23T06:00:01+11:00 https://pharmadispatch.com/news/pharmacy-points-to-success-of-codeine-monitoring 2016-11-23T06:00:01+11:00 https://pharmadispatch.com/news/sending-a-very-bad-signal 2016-11-22T06:00:01+11:00 https://pharmadispatch.com/news/innovation-minister-hosts-sector 2016-11-22T06:00:01+11:00 https://pharmadispatch.com/news/pbs-the-template-for-senate-inquiry-into-prostheses-pricing 2016-11-22T06:00:01+11:00 https://pharmadispatch.com/news/novartis-acquires-blood-disease-company 2016-11-22T06:00:01+11:00 https://pharmadispatch.com/news/cancer-is-different-says-canadian-expert 2016-11-21T06:05:01+11:00 https://pharmadispatch.com/news/new-cancer-and-asthma-listing-for-1-december 2016-11-21T06:04:01+11:00 https://pharmadispatch.com/news/bms-welcomes-5th-approval-for-opdivo 2016-11-21T06:03:01+11:00 https://pharmadispatch.com/news/no-bexsero-funding-without-new-submission 2016-11-21T06:02:01+11:00 https://pharmadispatch.com/news/nz-could-make-minor-concessions-for-us-tpp-support 2016-11-21T06:01:01+11:00 https://pharmadispatch.com/news/speeches-to-rare-cancers-australia-forum 2016-11-21T06:00:01+11:00 https://pharmadispatch.com/news/government-resisting-push-for-dispensing-fee-increase 2016-11-18T06:05:01+11:00 https://pharmadispatch.com/news/nervous-times-for-diabetes-companies 2016-11-18T06:04:01+11:00 https://pharmadispatch.com/news/roche-navigates-comparator-issue-with-new-actemra-listing 2016-11-18T06:03:01+11:00 https://pharmadispatch.com/news/martin-bowles-talks-up-health-reform-agenda 2016-11-18T06:02:01+11:00 https://pharmadispatch.com/news/sa-health-minister-calls-for-bexsero-funding 2016-11-18T06:01:01+11:00 https://pharmadispatch.com/news/expansion-for-emerging-australian-poppy-processor 2016-11-18T06:00:01+11:00 https://pharmadispatch.com/news/positive-news-for-sussan-ley 2016-11-17T06:04:01+11:00 https://pharmadispatch.com/news/is-anyone-listening 2016-11-17T06:03:01+11:00 https://pharmadispatch.com/news/study-backs-pradaxa-reversal-agent 2016-11-17T06:02:01+11:00 https://pharmadispatch.com/news/gsk-award-recognises-research-focussed-on-chronic-conditions 2016-11-17T06:01:01+11:00 https://pharmadispatch.com/news/medical-research-community-recognises-achievement 2016-11-17T06:00:01+11:00 https://pharmadispatch.com/news/halton-random-acts-of-violence-are-going-to-happen-sometimes 2016-11-16T06:05:01+11:00 https://pharmadispatch.com/news/industry-leaders-pay-tribute-to-halton 2016-11-16T06:04:01+11:00 https://pharmadispatch.com/news/pbs-for-amgens-cholesterol-lowering-biologic 2016-11-16T06:03:01+11:00 https://pharmadispatch.com/news/rmit-recognised-at-global-quickfire-challenge 2016-11-16T06:02:01+11:00 https://pharmadispatch.com/news/stakeholders-gather-for-pharmacy-forum 2016-11-16T06:01:01+11:00 https://pharmadispatch.com/news/pharmaxis-signs-collaboration-with-woolcock-institute 2016-11-16T06:00:01+11:00 https://pharmadispatch.com/news/viiv-partners-with-napwha-on-patient-app 2016-11-15T18:01:01+11:00 https://pharmadispatch.com/news/youre-not-different-and-youre-not-special 2016-11-15T06:05:01+11:00 https://pharmadispatch.com/news/hcv-therapies-break-2bn-mark 2016-11-15T06:04:01+11:00 https://pharmadispatch.com/news/novartis-looking-at-amneal 2016-11-15T06:03:01+11:00 https://pharmadispatch.com/news/gsk-tops-access-to-medicine-index 2016-11-15T06:02:01+11:00 https://pharmadispatch.com/news/prime-minister-opens-monash-biomedicine-discovery-institute-1 2016-11-15T06:00:01+11:00 https://pharmadispatch.com/news/tpp-demise-means-different-things-in-australia-and-nz 2016-11-14T06:00:01+11:00 https://pharmadispatch.com/news/turnbull-weve-got-to-own-up-to-the-vulnerability-in-health 2016-11-14T06:00:01+11:00 https://pharmadispatch.com/news/minister-launches-first-pharmacy-trial 2016-11-14T06:00:01+11:00 https://pharmadispatch.com/news/zostavax-shortage-hits 2016-11-14T06:00:01+11:00 https://pharmadispatch.com/news/halton-the-human-element-of-reform 2016-11-14T06:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-board-nominations 2016-11-11T06:05:01+11:00 https://pharmadispatch.com/news/investors-decide-trump-victory-better-than-the-alternative 2016-11-11T06:04:01+11:00 https://pharmadispatch.com/news/pfizer-could-sell-consumer-health-business 2016-11-11T06:03:01+11:00 https://pharmadispatch.com/news/gsk-consumer-the-big-winner-at-sigma-supplier-awards 2016-11-11T06:02:01+11:00 https://pharmadispatch.com/news/ministers-announce-new-antimicrobial-resistance-strategy 2016-11-11T06:01:01+11:00 https://pharmadispatch.com/news/new-advice-on-pharmacy-integration-with-gp 2016-11-11T06:00:01+11:00 https://pharmadispatch.com/news/generics-dump-price-discounts 2016-11-10T06:04:01+11:00 https://pharmadispatch.com/news/trump-victory-means-change-for-pharma 2016-11-10T06:03:01+11:00 https://pharmadispatch.com/news/dusc-september-outcome-statement 2016-11-10T06:02:01+11:00 https://pharmadispatch.com/news/research-australia-welcomes-mrff-strategy 2016-11-10T06:01:01+11:00 https://pharmadispatch.com/news/tga-consults-on-advertising-regulation 2016-11-10T06:00:01+11:00 https://pharmadispatch.com/news/sussan-ley-labor-plan-against-australian-law 2016-11-09T06:00:01+11:00 https://pharmadispatch.com/news/pharmacy-pay-dispute 2016-11-09T06:00:01+11:00 https://pharmadispatch.com/news/political-intervention-on-this-really 2016-11-09T06:00:01+11:00 https://pharmadispatch.com/news/turnbull-government-maintains-pbs-focus 2016-11-09T06:00:01+11:00 https://pharmadispatch.com/news/labor-calls-for-political-intervention 2016-11-08T06:04:01+11:00 https://pharmadispatch.com/news/nps-claims-75m-in-pbs-savings 2016-11-08T06:02:01+11:00 https://pharmadispatch.com/news/mtpconnect-wants-action-on-clinical-trials 2016-11-08T06:01:01+11:00 https://pharmadispatch.com/news/no-pbs-changes-as-a-result-of-tpp 2016-11-08T06:00:01+11:00 https://pharmadispatch.com/news/stay-up-to-date 2016-11-07T15:52:01+11:00 https://pharmadispatch.com/news/the-fiscal-challenge-and-making-reform-work 2016-11-07T06:04:01+11:00 https://pharmadispatch.com/news/government-announces-global-innovation-strategy 2016-11-07T06:03:01+11:00 https://pharmadispatch.com/news/maybe-caught-in-ongoing-us-investigation 2016-11-07T06:02:01+11:00 https://pharmadispatch.com/news/bionomics-msd-symposium-in-adelaide 2016-11-07T06:01:01+11:00 https://pharmadispatch.com/news/leaks-reveal-politics-of-drug-pricing 2016-11-07T06:00:01+11:00 https://pharmadispatch.com/news/gsk-announces-sydney-plant-closure 2016-11-04T06:00:01+11:00 https://pharmadispatch.com/news/abc-announces-changes-to-catalyst 2016-11-04T06:00:01+11:00 https://pharmadispatch.com/news/bayer-extends-support-for-heart-of-australia 2016-11-04T06:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-clarity-on-data-protection 2016-11-04T06:00:01+11:00 https://pharmadispatch.com/news/australia-falling-behind-on-pharma-innovation 2016-11-03T06:04:01+11:00 https://pharmadispatch.com/news/prescribing-shift-impacts-hospital-drug-spend 2016-11-03T06:03:01+11:00 https://pharmadispatch.com/news/industry-watching-for-any-change-on-comparators 2016-11-03T06:02:01+11:00 https://pharmadispatch.com/news/the-work-is-already-done 2016-11-03T06:01:01+11:00 https://pharmadispatch.com/news/priceline-launches-new-marketing-creative 2016-11-03T06:00:01+11:00 https://pharmadispatch.com/news/business-group-opposes-ip-extension-for-biologics 2016-11-02T06:00:01+11:00 https://pharmadispatch.com/news/simple-error-causes-problems-for-gsk 2016-11-02T06:00:01+11:00 https://pharmadispatch.com/news/blood-authority-annual-report 2016-11-02T06:00:01+11:00 https://pharmadispatch.com/news/minister-to-launch-national-shingles-vaccination-program 2016-11-02T06:00:01+11:00 https://pharmadispatch.com/news/tillack-increases-show-gmwg-has-a-heartbeat 2016-11-01T06:04:01+11:00 https://pharmadispatch.com/news/price-increases-may-not-be-one-off 2016-11-01T06:03:01+11:00 https://pharmadispatch.com/news/extension-for-pharmacy-review 2016-11-01T06:02:01+11:00 https://pharmadispatch.com/news/consultation-underway-on-tga-reforms 2016-11-01T06:01:01+11:00 https://pharmadispatch.com/news/jj-partners-with-day-of-stem 2016-11-01T06:00:01+11:00 https://pharmadispatch.com/news/treatment-naive-only-would-not-work-says-pbac 2016-10-31T06:00:01+11:00 https://pharmadispatch.com/news/pbac-doing-exactly-what-it-said 2016-10-31T06:00:01+11:00 https://pharmadispatch.com/news/specialists-drive-use-of-noacs 2016-10-31T06:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-major-new-listings 2016-10-31T06:00:01+11:00 https://pharmadispatch.com/news/six-monthly-eye-implant-for-pbs 2016-10-31T06:00:01+11:00 https://pharmadispatch.com/news/come-to-me-with-your-ideas 2016-10-28T06:05:01+11:00 https://pharmadispatch.com/news/between-a-rock-and-a-hard-place 2016-10-28T06:04:01+11:00 https://pharmadispatch.com/news/minister-could-reinvigorate-the-reinvigorated-amwg 2016-10-28T06:03:01+11:00 https://pharmadispatch.com/news/pfizer-commits-20-million-to-australian-clinical-trials 2016-10-28T06:02:01+11:00 https://pharmadispatch.com/news/university-of-melbourne-joins-pfizer-research-network 2016-10-28T06:01:01+11:00 https://pharmadispatch.com/news/tough-quarter-for-blackmores 2016-10-28T06:00:01+11:00 https://pharmadispatch.com/news/careful-what-you-wish-for-on-rebates 2016-10-27T06:04:01+11:00 https://pharmadispatch.com/news/pharmaceutical-prices-fall-in-september-quarter 2016-10-27T06:03:01+11:00 https://pharmadispatch.com/news/swisse-partners-with-csiro 2016-10-27T06:02:01+11:00 https://pharmadispatch.com/news/chief-scientist-defends-rd-tax-cap 2016-10-27T06:01:01+11:00 https://pharmadispatch.com/news/new-brand-for-terry-white-and-chemmart 2016-10-27T06:00:01+11:00 https://pharmadispatch.com/news/the-language-will-give-it-away 2016-10-26T06:00:01+11:00 https://pharmadispatch.com/news/new-us-approval-for-keytruda 2016-10-26T06:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-jj-innovation-industry-excellence-awards 2016-10-26T06:00:01+11:00 https://pharmadispatch.com/news/when-growth-is-no-growth 2016-10-26T06:00:01+11:00 https://pharmadispatch.com/news/chf-backs-wider-role-for-pharmacy 2016-10-26T06:00:01+11:00 https://pharmadispatch.com/news/minister-acts-on-industry-forum 2016-10-25T06:06:01+11:00 https://pharmadispatch.com/news/no-shortage-of-dance-partners-for-industry 2016-10-25T06:05:01+11:00 https://pharmadispatch.com/news/new-report-highlights-biotech-potential 2016-10-25T06:04:01+11:00 https://pharmadispatch.com/news/industry-front-and-centre-of-growth-centre-grants 2016-10-25T06:03:01+11:00 https://pharmadispatch.com/news/gsk-teams-up-with-victoria-on-manufacturing 2016-10-25T06:02:01+11:00 https://pharmadispatch.com/news/guild-wary-of-ramsay-pharmacy-move 2016-10-25T06:01:01+11:00 https://pharmadispatch.com/news/next-round-of-pharmacy-trials 2016-10-25T06:00:01+11:00 https://pharmadispatch.com/news/price-negotiator-to-join-ex-pbac-chair-in-geneva 2016-10-24T06:04:01+11:00 https://pharmadispatch.com/news/anticipated-study-backs-inflximab-switch 2016-10-24T06:03:01+11:00 https://pharmadispatch.com/news/cancer-australia-marks-pink-ribbon-day-with-new-breast-cancer-st 2016-10-24T06:02:01+11:00 https://pharmadispatch.com/news/terry-white-group-shareholders-approve-chemmart-merger 2016-10-24T06:01:01+11:00 https://pharmadispatch.com/news/spittle-a-difference-between-listening-and-hearing 2016-10-24T06:00:01+11:00 https://pharmadispatch.com/news/biotech-sector-gathers-in-melbourne 2016-10-24T06:00:01+11:00 https://pharmadispatch.com/news/minister-had-to-fight-on-lsdp 2016-10-21T06:00:01+11:00 https://pharmadispatch.com/news/retail-underpins-api-profit-growth 2016-10-21T06:00:01+11:00 https://pharmadispatch.com/news/busy-year-for-pbac 2016-10-21T06:00:01+11:00 https://pharmadispatch.com/news/prostheses-cuts-very-different-to-the-pbs 2016-10-21T06:00:01+11:00 https://pharmadispatch.com/news/government-sticks-with-savings 2016-10-20T06:04:01+11:00 https://pharmadispatch.com/news/ma-debates-board-changes 2016-10-20T06:03:01+11:00 https://pharmadispatch.com/news/further-confirmation-of-pbs-jump 2016-10-20T06:02:01+11:00 https://pharmadispatch.com/news/new-80-million-molecular-and-life-sciences-research-centre 2016-10-20T06:01:01+11:00 https://pharmadispatch.com/news/acquisition-and-capital-raise-for-medadvisor 2016-10-20T06:00:01+11:00 https://pharmadispatch.com/news/a-rare-moment-in-time 2016-10-19T06:06:01+11:00 https://pharmadispatch.com/news/pbac-chair-steps-in-on-pbs-changes 2016-10-19T06:05:01+11:00 https://pharmadispatch.com/news/highlights-from-day-one-of-the-canberra-forum 2016-10-19T06:04:01+11:00 https://pharmadispatch.com/news/health-minister-sussan-leys-speech-to-rare-cancers-australia-for 2016-10-19T06:03:01+11:00 https://pharmadispatch.com/news/coalition-sticking-with-the-politics-of-pbs 2016-10-19T06:02:01+11:00 https://pharmadispatch.com/news/janssen-marks-prezcobix-listing 2016-10-19T06:01:01+11:00 https://pharmadispatch.com/news/first-pharmacy-trial-getting-underway 2016-10-19T06:00:01+11:00 https://pharmadispatch.com/news/rebates-top-15-billion 2016-10-18T06:03:01+11:00 https://pharmadispatch.com/news/can-prices-fall-any-further 2016-10-18T06:02:01+11:00 https://pharmadispatch.com/news/new-research-centre-in-queensland 2016-10-18T06:01:01+11:00 https://pharmadispatch.com/news/pfizer-marks-national-carers-week 2016-10-18T06:00:01+11:00 https://pharmadispatch.com/news/pbs-process-could-change-in-response-to-tga-review 2016-10-17T06:06:01+11:00 https://pharmadispatch.com/news/stakeholders-meet-for-rare-cancers 2016-10-17T06:05:01+11:00 https://pharmadispatch.com/news/tga-proposes-changes-to-orphan-drug-program 2016-10-17T06:04:01+11:00 https://pharmadispatch.com/news/cholesterol-lowering-drug-headlines-price-disclosure-additions 2016-10-17T06:03:01+11:00 https://pharmadispatch.com/news/merck-delivers-update-strategic-plan 2016-10-17T06:01:01+11:00 https://pharmadispatch.com/news/global-access-to-radiation-therapy-could-save-four-million-lives 2016-10-17T06:00:01+11:00 https://pharmadispatch.com/news/another-round-of-senate-estimates 2016-10-17T06:00:01+11:00 https://pharmadispatch.com/news/pm-turns-to-pbs-again 2016-10-14T06:00:01+11:00 https://pharmadispatch.com/news/senate-backs-new-national-cancer-register 2016-10-14T06:00:01+11:00 https://pharmadispatch.com/news/recognition-for-australian-prostate-cancer-innovation 2016-10-14T06:00:01+11:00 https://pharmadispatch.com/news/funding-confirmed-for-shingles-vaccine 2016-10-14T06:00:01+11:00 https://pharmadispatch.com/news/value-means-different-things-to-different-people 2016-10-13T06:00:01+11:00 https://pharmadispatch.com/news/savings-getting-harder-to-find 2016-10-13T06:00:01+11:00 https://pharmadispatch.com/news/first-speech-for-pharmacist-mp 2016-10-13T06:00:01+11:00 https://pharmadispatch.com/news/guidelines-confirm-positive-outcome-on-comparators 2016-10-13T06:00:01+11:00 https://pharmadispatch.com/news/new-therapy-for-specialised-therapeutics-1 2016-10-13T06:00:01+11:00 https://pharmadispatch.com/news/predatory-pricing-and-1-december-increases 2016-10-12T06:00:01+11:00 https://pharmadispatch.com/news/tga-updates-advisory-statement-for-nsaids 2016-10-12T06:00:01+11:00 https://pharmadispatch.com/news/get-out-from-behind-the-shadows 2016-10-12T06:00:01+11:00 https://pharmadispatch.com/news/pm-uses-pbs-in-health-attack 2016-10-12T06:00:01+11:00 https://pharmadispatch.com/news/government-considering-new-innovation-fund 2016-10-12T06:00:01+11:00 https://pharmadispatch.com/news/cancer-therapies-grabbing-headlines 2016-10-11T06:00:01+11:00 https://pharmadispatch.com/news/gsk-in-the-clear-on-panadol-osteo 2016-10-11T06:00:01+11:00 https://pharmadispatch.com/news/brian-gladsden-industrys-call-to-action 2016-10-11T06:00:01+11:00 https://pharmadispatch.com/news/ex-sanofi-boss-new-head-of-consumer-brand-company 2016-10-10T21:37:01+11:00 https://pharmadispatch.com/news/pfizer-sticking-with-originators 2016-10-10T18:20:01+11:00 https://pharmadispatch.com/news/a-major-shift-for-pbs-eye-therapies 2016-10-10T06:00:01+11:00 https://pharmadispatch.com/news/1-november-pbs-listings-and-lowest-cost-comparator 2016-10-10T06:00:01+11:00 https://pharmadispatch.com/news/richard-vines-the-moral-discussion-is-over 2016-10-10T06:00:01+11:00 https://pharmadispatch.com/news/no-room-for-complacency-on-mental-health 2016-10-10T06:00:01+11:00 https://pharmadispatch.com/news/jj-acquires-rights-to-azs-rhinocort 2016-10-10T06:00:01+11:00 https://pharmadispatch.com/news/psa-rebukes-hospital-pharmacists 2016-10-10T06:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-api 2016-10-07T06:00:01+11:00 https://pharmadispatch.com/news/australians-prioritise-health-and-medical-research 2016-10-07T06:00:01+11:00 https://pharmadispatch.com/news/consumers-making-their-own-choices 2016-10-07T06:00:01+11:00 https://pharmadispatch.com/news/labor-moves-to-block-telstra-health 2016-10-07T06:00:01+11:00 https://pharmadispatch.com/news/pbac-vacancies-as-industry-goes-again 2016-10-06T06:01:01+11:00 https://pharmadispatch.com/news/deregulation-or-regulation 2016-10-06T06:00:01+11:00 https://pharmadispatch.com/news/an-opportunity-to-celebrate-australian-researchers 2016-10-06T06:00:01+11:00 https://pharmadispatch.com/news/discovery-could-accelerate-drug-development 2016-10-06T06:00:01+11:00 https://pharmadispatch.com/news/bill-ferris-we-have-to-get-better-at-collaboration 2016-10-06T06:00:01+11:00 https://pharmadispatch.com/news/new-appointments-in-pharmaceutical-evaluation 2016-10-05T06:00:01+11:00 https://pharmadispatch.com/news/sussan-ley-takes-tga 2016-10-05T06:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-amgen-australia 2016-10-05T06:00:01+11:00 https://pharmadispatch.com/news/wider-pbs-access-for-novartis-interleukin-17a-inhibitor 2016-10-05T06:00:01+11:00 https://pharmadispatch.com/news/funding-boost-for-australian-healthcare-startups 2016-10-05T06:00:01+11:00 https://pharmadispatch.com/news/ministerial-praise-for-astrazeneca 2016-10-04T06:00:01+11:00 https://pharmadispatch.com/news/minister-wants-to-hear-from-industry 2016-10-04T06:00:01+11:00 https://pharmadispatch.com/news/issues-in-illusory-growth 2016-10-04T06:00:01+11:00 https://pharmadispatch.com/news/pbac-recommends-novartis-heart-failure-therapy 2016-10-04T06:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-csl-behrings-long-acting-haemophilia-treatment 2016-10-04T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-completes-hospira-integration 2016-10-04T06:00:01+11:00 https://pharmadispatch.com/news/az-licences-biologic-to-allergan 2016-10-04T06:00:01+11:00 https://pharmadispatch.com/news/budget-outcome-confirms-pbs-spike 2016-09-30T13:24:01+10:00 https://pharmadispatch.com/news/cso-is-essential-and-not-lazy-policy 2016-09-30T06:00:01+10:00 https://pharmadispatch.com/news/cutting-to-the-quick 2016-09-30T06:00:01+10:00 https://pharmadispatch.com/news/trouble-over-data-overblown 2016-09-30T06:00:01+10:00 https://pharmadispatch.com/news/department-invites-applicants-to-access-cso-and-ndss 2016-09-30T06:00:01+10:00 https://pharmadispatch.com/news/bayer-welcomes-advertising-sanction-2 2016-09-30T06:00:01+10:00 https://pharmadispatch.com/news/when-power-fails-wholesalers-surge-2 2016-09-30T00:20:01+10:00 https://pharmadispatch.com/news/review-calls-for-reform-of-rd-tax-incentive 2016-09-29T06:00:01+10:00 https://pharmadispatch.com/news/business-welcomes-rd-tax-report-but-cautions-on-change 2016-09-29T06:00:01+10:00 https://pharmadispatch.com/news/recognition-for-psa-pharmacist 2016-09-29T06:00:01+10:00 https://pharmadispatch.com/news/mylan-and-lupin-consider-bids-for-bayer-dermatology 2016-09-29T06:00:01+10:00 https://pharmadispatch.com/news/dont-try-aggressive-approaches-with-me 2016-09-29T06:00:01+10:00 https://pharmadispatch.com/news/tga-approval-times-dropped-in-2015-16 2016-09-28T23:05:01+10:00 https://pharmadispatch.com/news/dont-ignore-backdown-on-backpacker-tax 2016-09-28T06:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-secures-another-bronchitol-approval 2016-09-28T06:00:01+10:00 https://pharmadispatch.com/news/pricing-only-has-to-be-reasonably-viable 2016-09-28T06:00:01+10:00 https://pharmadispatch.com/news/first-line-study-outcome-for-amgens-multiple-myeloma-therapy 2016-09-28T06:00:01+10:00 https://pharmadispatch.com/news/patents-are-not-the-issue-when-it-comes-to-access 2016-09-27T18:00:01+10:00 https://pharmadispatch.com/news/pfizer-decides-against-split 2016-09-27T06:00:01+10:00 https://pharmadispatch.com/news/policy-addressing-regulation-bottlenecks 2016-09-27T06:00:01+10:00 https://pharmadispatch.com/news/un-gets-it-wrong-on-access-barriers 2016-09-27T06:00:01+10:00 https://pharmadispatch.com/news/of-course-its-about-influencing-prescribing-thats-the-point 2016-09-26T06:04:01+10:00 https://pharmadispatch.com/news/independent-reviews-downgraded-1 2016-09-26T06:03:01+10:00 https://pharmadispatch.com/news/fda-approves-amgens-humira-biosimilar 2016-09-26T06:00:01+10:00 https://pharmadispatch.com/news/warning-signs-pbs-not-stopping 2016-09-26T06:00:01+10:00 https://pharmadispatch.com/news/online-too-to-calculate-pbs-savings 2016-09-26T06:00:01+10:00 https://pharmadispatch.com/news/the-mystery-that-is-finance 2016-09-23T06:01:01+10:00 https://pharmadispatch.com/news/valeant-moves-to-sell-inova 2016-09-23T06:00:01+10:00 https://pharmadispatch.com/news/uwa-drug-offers-new-hope-to-young-muscular-dystrophy-sufferers 2016-09-23T06:00:01+10:00 https://pharmadispatch.com/news/king-calls-for-submissions 2016-09-23T06:00:01+10:00 https://pharmadispatch.com/news/bayer-could-drop-monsanto-name 2016-09-22T06:30:01+10:00 https://pharmadispatch.com/news/acquisition-boosts-terry-white-result 2016-09-22T06:00:01+10:00 https://pharmadispatch.com/news/all-may-not-be-as-it-seems-but-who-will-know 2016-09-22T06:00:01+10:00 https://pharmadispatch.com/news/more-work-needed-on-antimicrobial-resistance 2016-09-22T06:00:01+10:00 https://pharmadispatch.com/news/from-country-victoria-to-leading-pfizer-australia 2016-09-21T06:00:01+10:00 https://pharmadispatch.com/news/industry-biosimilar-group-set-to-continue 2016-09-21T06:00:01+10:00 https://pharmadispatch.com/news/gsk-confirms-witty-successor 2016-09-21T06:00:01+10:00 https://pharmadispatch.com/news/bayer-promotes-improved-outlook 2016-09-21T06:00:01+10:00 https://pharmadispatch.com/news/greens-go-hard-against-tpp 2016-09-21T06:00:01+10:00 https://pharmadispatch.com/news/former-victorian-premier-to-lead-cancer-drugs-access-push 2016-09-20T06:05:01+10:00 https://pharmadispatch.com/news/mtaa-chief-executive-resigns 2016-09-20T06:03:01+10:00 https://pharmadispatch.com/news/expanded-tga-approval-for-kalydeco 2016-09-20T06:00:01+10:00 https://pharmadispatch.com/news/gsk-backed-open-source-malaria-study 2016-09-20T06:00:01+10:00 https://pharmadispatch.com/news/amgen-and-ucb-announce-positive-results-of-osteoporosis-study-1 2016-09-20T06:00:01+10:00 https://pharmadispatch.com/news/halton-leaves-a-remarkable-pbs-legacy 2016-09-19T06:05:01+10:00 https://pharmadispatch.com/news/familiar-face-for-finance 2016-09-19T06:04:01+10:00 https://pharmadispatch.com/news/ley-human-consequences-always-outweigh-the-financial-consequence 2016-09-19T06:03:01+10:00 https://pharmadispatch.com/news/senate-passes-rd-tax-cut 2016-09-19T06:00:01+10:00 https://pharmadispatch.com/news/patients-before-profits 2016-09-19T06:00:01+10:00 https://pharmadispatch.com/news/jj-adds-to-medical-optics-business 2016-09-19T06:00:01+10:00 https://pharmadispatch.com/news/hacking-their-way-to-healthcare-solutions 2016-09-19T06:00:01+10:00 https://pharmadispatch.com/news/jane-halton-resigns-from-finance 2016-09-16T10:48:01+10:00 https://pharmadispatch.com/news/government-congratulated-for-tga-review-response 2016-09-16T06:00:01+10:00 https://pharmadispatch.com/news/regulation-reform-welcome-but-get-reimbursement-right 2016-09-16T06:00:01+10:00 https://pharmadispatch.com/news/industry-you-deserve-much-better-than-this 2016-09-16T06:00:01+10:00 https://pharmadispatch.com/news/the-senate-has-its-response 2016-09-16T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-gsk-australia 2016-09-15T14:59:01+10:00 https://pharmadispatch.com/news/pbs-a-risk-to-budget-repair 2016-09-15T06:00:01+10:00 https://pharmadispatch.com/news/australia-worst-in-world-for-financial-stress-in-lymphoma-fight 2016-09-15T06:00:01+10:00 https://pharmadispatch.com/news/promotion-for-labor-senator 2016-09-15T06:00:01+10:00 https://pharmadispatch.com/news/minister-ley-reforms-mean-faster-access 2016-09-15T06:00:01+10:00 https://pharmadispatch.com/news/tga-review-government-responses-to-the-key-recommendations 2016-09-15T06:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-government-response-to-tga-review 2016-09-15T06:00:01+10:00 https://pharmadispatch.com/news/labor-backs-rd-tax-cut-bill 2016-09-14T06:00:01+10:00 https://pharmadispatch.com/news/does-tppa-actually-mean-any-change 2016-09-14T06:00:01+10:00 https://pharmadispatch.com/news/australians-consider-themselves-healthy-but 2016-09-14T06:00:01+10:00 https://pharmadispatch.com/news/pbs-brake-on-government-health-spending 2016-09-14T06:00:01+10:00 https://pharmadispatch.com/news/minister-slams-labor-over-cancer-registry 2016-09-14T06:00:01+10:00 https://pharmadispatch.com/news/bayer-raises-offer-for-monsanto 2016-09-14T06:00:01+10:00 https://pharmadispatch.com/news/new-pbac-member-appointed-to-run-mental-health-commission 2016-09-13T06:00:01+10:00 https://pharmadispatch.com/news/official-extends-time-at-tga 2016-09-13T06:00:01+10:00 https://pharmadispatch.com/news/accc-secures-undertaking-on-genetic-test 2016-09-13T06:00:01+10:00 https://pharmadispatch.com/news/movements-in-anti-hypertensive-market 2016-09-13T06:00:01+10:00 https://pharmadispatch.com/news/ley-system-will-cannibalise-itself-without-reform 2016-09-13T06:00:01+10:00 https://pharmadispatch.com/news/australian-secures-award-grant-from-merck 2016-09-13T06:00:01+10:00 https://pharmadispatch.com/news/i-learnt-how-to-spell-pharmacoeconomics 2016-09-12T06:00:01+10:00 https://pharmadispatch.com/news/try-again-on-pbac-nomination 2016-09-12T06:00:01+10:00 https://pharmadispatch.com/news/statins-better-than-thought 2016-09-12T06:00:01+10:00 https://pharmadispatch.com/news/consumers-benefit-from-pharmacy-regulation 2016-09-12T06:00:01+10:00 https://pharmadispatch.com/news/ma-moves-organisation-to-long-term-focus 2016-09-12T06:00:01+10:00 https://pharmadispatch.com/news/australians-with-psoriasis-feel-discrimination-and-bullying 2016-09-11T11:01:01+10:00 https://pharmadispatch.com/news/wes-cook-reappointed-ma-chair 2016-09-09T06:00:01+10:00 https://pharmadispatch.com/news/second-brand-dispute-may-never-be-resolved 2016-09-09T06:00:01+10:00 https://pharmadispatch.com/news/hep-c-and-retail-boosts-sigma-result 2016-09-09T06:00:01+10:00 https://pharmadispatch.com/news/pbac-veteran-to-lead-government-prostheses-group 2016-09-09T06:00:01+10:00 https://pharmadispatch.com/news/guild-staffer-joins-ministers-office 2016-09-08T06:00:01+10:00 https://pharmadispatch.com/news/mining-health-data-the-future-not-mining 2016-09-08T06:00:01+10:00 https://pharmadispatch.com/news/first-generic-glivec-for-1-october 2016-09-08T06:00:01+10:00 https://pharmadispatch.com/news/landmark-listing-that-framed-access-debate 2016-09-08T06:00:01+10:00 https://pharmadispatch.com/news/dorothy-not-going-it-alone-in-pfizers-latest-social-media-campai 2016-09-07T06:00:01+10:00 https://pharmadispatch.com/news/pharmacy-backs-mbs-opportunity 2016-09-07T06:00:01+10:00 https://pharmadispatch.com/news/bayer-ups-offer-for-monsanto 2016-09-07T06:00:01+10:00 https://pharmadispatch.com/news/mark-crotty-the-new-ceo-of-juno 2016-09-07T06:00:01+10:00 https://pharmadispatch.com/news/australians-back-mrff-investment 2016-09-06T06:00:01+10:00 https://pharmadispatch.com/news/pbs-changes-have-led-to-under-treatment 2016-09-06T06:00:01+10:00 https://pharmadispatch.com/news/gsk-updates-on-positive-copd-study 2016-09-06T06:00:01+10:00 https://pharmadispatch.com/news/msd-readies-for-zepatier-launch 2016-09-06T06:00:01+10:00 https://pharmadispatch.com/news/forum-report-calls-for-more-action 2016-09-05T06:00:01+10:00 https://pharmadispatch.com/news/official-announcement-imminent 2016-09-05T06:00:01+10:00 https://pharmadispatch.com/news/minster-takes-charge-of-tga 2016-09-05T06:00:01+10:00 https://pharmadispatch.com/news/australia-could-miss-out-on-biosimilar-opportunity 2016-09-05T06:00:01+10:00 https://pharmadispatch.com/news/minister-marks-2bn-price-cuts 2016-09-05T06:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-criticises-lack-of-consultation-on-rd-cut 2016-09-04T10:56:01+10:00 https://pharmadispatch.com/news/new-leadership-takes-charge-of-ausbiotech 2016-09-02T06:00:01+10:00 https://pharmadispatch.com/news/rd-tax-cut-pushed-back-a-year 2016-09-02T06:00:01+10:00 https://pharmadispatch.com/news/guidelines-progressing-toward-sign-off 2016-09-02T06:00:01+10:00 https://pharmadispatch.com/news/chf-wants-more-on-transparency 2016-09-02T06:00:01+10:00 https://pharmadispatch.com/news/new-global-leadership-for-novo-nordisk 2016-09-02T06:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-ongoing-price-hit-to-pharmacy 2016-09-01T06:00:01+10:00 https://pharmadispatch.com/news/only-demonstrates-the-need-to-question-the-process 2016-09-01T06:00:01+10:00 https://pharmadispatch.com/news/coalition-moves-on-rd-tax-cut 2016-09-01T06:00:01+10:00 https://pharmadispatch.com/news/reports-largely-as-expected 2016-09-01T05:00:01+10:00 https://pharmadispatch.com/news/tga-warns-on-overseas-weight-loss-drugs 2016-08-31T06:00:01+10:00 https://pharmadispatch.com/news/guild-backs-call-for-action-on-real-time-monitoring 2016-08-31T06:00:01+10:00 https://pharmadispatch.com/news/who-really-owns-the-ramsay-pharmacies 2016-08-31T06:00:01+10:00 https://pharmadispatch.com/news/biosimilars-coming-together-for-innovative-health-policy 2016-08-31T06:00:01+10:00 https://pharmadispatch.com/news/historic-day-for-industry 2016-08-31T06:00:01+10:00 https://pharmadispatch.com/news/government-acts-on-national-cancer-registry 2016-08-31T06:00:01+10:00 https://pharmadispatch.com/news/abbvie-makesbest-employer-list 2016-08-30T16:49:01+10:00 https://pharmadispatch.com/news/brilliant-innovation-policy-but-mixed-messages-a-risk 2016-08-30T06:00:01+10:00 https://pharmadispatch.com/news/linfox-moves-into-supply-chain 2016-08-30T06:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-appoints-leadership-group 2016-08-30T06:00:01+10:00 https://pharmadispatch.com/news/office-move-for-csl-behring 2016-08-30T06:00:01+10:00 https://pharmadispatch.com/news/international-award-for-health-destination-program 2016-08-30T06:00:01+10:00 https://pharmadispatch.com/news/more-money-for-mrff 2016-08-29T06:00:01+10:00 https://pharmadispatch.com/news/review-questionnaire-raising-questions 2016-08-29T06:00:01+10:00 https://pharmadispatch.com/news/record-growth-for-the-new-mayne 2016-08-29T06:00:01+10:00 https://pharmadispatch.com/news/the-needle-matters-for-diabetics 2016-08-29T06:00:01+10:00 https://pharmadispatch.com/news/test-for-new-comparator-wording 2016-08-29T06:00:01+10:00 https://pharmadispatch.com/news/industry-in-trouble-over-pricing-again 2016-08-28T14:31:01+10:00 https://pharmadispatch.com/news/hcv-boosts-ebos-result 2016-08-26T06:00:01+10:00 https://pharmadispatch.com/news/upward-trend-continues 2016-08-26T06:00:01+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-november-pbac-agenda 2016-08-26T06:00:01+10:00 https://pharmadispatch.com/news/milton-catelin-the-standout-candidate 2016-08-26T06:00:01+10:00 https://pharmadispatch.com/news/di-natale-keeps-health-in-reshuffle 2016-08-26T06:00:01+10:00 https://pharmadispatch.com/news/viiv-grants-for-hiv-care 2016-08-25T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-but-the-challenge-remains-the-same 2016-08-25T06:00:01+10:00 https://pharmadispatch.com/news/gsk-tops-change-the-world-list 2016-08-25T06:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-another-biosimilar-infliximab 2016-08-25T06:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-health-care-homes-but-not-at-the-expense-of-pharm 2016-08-25T06:00:01+10:00 https://pharmadispatch.com/news/busy-november-meeting-for-pbac 2016-08-25T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-adds-az-antibiotics-business 2016-08-25T05:00:01+10:00 https://pharmadispatch.com/news/new-ceo-for-medicines-australia 2016-08-24T07:29:01+10:00 https://pharmadispatch.com/news/lichtenberg-a-positive-but-slow-impact-from-new-cancer-drugs 2016-08-24T06:00:01+10:00 https://pharmadispatch.com/news/first-study-shows-impact-of-new-medicines-in-nz 2016-08-24T06:00:01+10:00 https://pharmadispatch.com/news/bayer-and-monsanto-edging-towards-deal 2016-08-24T06:00:01+10:00 https://pharmadispatch.com/news/time-for-hay-fever-help-1 2016-08-24T06:00:01+10:00 https://pharmadispatch.com/news/industry-critic-questions-abc-deal-with-swisse-1 2016-08-24T06:00:01+10:00 https://pharmadispatch.com/news/press-gallery-and-political-veteran-joins-ley-staff 2016-08-23T06:00:01+10:00 https://pharmadispatch.com/news/age-matters-when-it-comes-to-medicine-use 2016-08-23T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-wins-battle-for-medivation 2016-08-23T06:00:01+10:00 https://pharmadispatch.com/news/educational-changes-going-well-in-australia-says-gsk-leader 2016-08-22T15:24:01+10:00 https://pharmadispatch.com/news/greens-want-wonder-drug-work-around-after-pbac-rejection 2016-08-22T06:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-time-to-take-charge 2016-08-22T06:00:01+10:00 https://pharmadispatch.com/news/pbac-has-another-go-at-managed-entry 2016-08-22T06:00:01+10:00 https://pharmadispatch.com/news/july-pbac-outcomes 2016-08-22T06:00:01+10:00 https://pharmadispatch.com/news/time-to-move-this-debate-on 2016-08-21T10:28:01+10:00 https://pharmadispatch.com/news/bayer-not-giving-up-on-monsanto 2016-08-19T18:00:01+10:00 https://pharmadispatch.com/news/innovative-abbvie-recognised-for-the-fifth-year-in-a-row 2016-08-19T06:00:01+10:00 https://pharmadispatch.com/news/nz-patients-suffering-and-dying 2016-08-19T06:00:01+10:00 https://pharmadispatch.com/news/outcry-in-uk-over-nice-decision-on-cancer-therapies 2016-08-19T06:00:01+10:00 https://pharmadispatch.com/news/csl-expecting-strong-growth-ahead 2016-08-18T06:00:01+10:00 https://pharmadispatch.com/news/no-pbs-in-savings-bill 2016-08-18T06:00:01+10:00 https://pharmadispatch.com/news/novartis-set-to-award-major-prizes-in-melbourne 2016-08-18T06:00:01+10:00 https://pharmadispatch.com/news/asmi-welcomes-labelling-order 2016-08-18T06:00:01+10:00 https://pharmadispatch.com/news/msd-joins-race-for-medivation 2016-08-18T06:00:01+10:00 https://pharmadispatch.com/news/ma-updates-members-on-comparator-wording 2016-08-17T06:01:01+10:00 https://pharmadispatch.com/news/ministers-office-takes-shape 2016-08-17T06:00:01+10:00 https://pharmadispatch.com/news/looking-for-review-outcomes 2016-08-17T06:00:01+10:00 https://pharmadispatch.com/news/chf-data-release-a-treasure-trove 2016-08-17T06:00:01+10:00 https://pharmadispatch.com/news/the-battle-has-only-just-begun 2016-08-16T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-recruits-another-senior-staffer 2016-08-16T06:00:01+10:00 https://pharmadispatch.com/news/biogen-backs-student-biotech-showcase 2016-08-16T06:00:01+10:00 https://pharmadispatch.com/news/potential-resolution-on-comparators 2016-08-16T06:00:01+10:00 https://pharmadispatch.com/news/compound-derived-from-australian-rainforest-progresses-in-human 2016-08-16T06:00:01+10:00 https://pharmadispatch.com/news/make-or-break-meeting-on-comparators 2016-08-15T06:00:01+10:00 https://pharmadispatch.com/news/we-need-more-diversity-in-our-leadership-says-abbvies-kirsten-od 2016-08-15T06:00:01+10:00 https://pharmadispatch.com/news/minister-gets-in-front-on-new-listings 2016-08-15T06:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-questions-tpp-response 2016-08-15T06:00:01+10:00 https://pharmadispatch.com/news/easier-ways-to-delay-listings-than-deferrals 2016-08-15T06:00:01+10:00 https://pharmadispatch.com/news/immigration-wants-further-discussions-on-clinical-trials-tax 2016-08-12T06:00:01+10:00 https://pharmadispatch.com/news/blackmores-to-launch-online-medicine-interaction-tool 2016-08-12T06:00:01+10:00 https://pharmadispatch.com/news/drive-change-rather-than-respond-to-it 2016-08-12T06:00:01+10:00 https://pharmadispatch.com/news/choosing-wisely-targets-medicine-use-by-older-australians 2016-08-12T06:00:01+10:00 https://pharmadispatch.com/news/cmi-push-impractical-and-dangerous 2016-08-11T06:00:01+10:00 https://pharmadispatch.com/news/reform-in-need-of-a-long-term-vision 2016-08-11T06:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-consumer-support-for-pharmacy 2016-08-11T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-pharmacy-trials-must-be-rolled-out-quickly 2016-08-11T06:00:01+10:00 https://pharmadispatch.com/news/four-year-transition-for-label-changes 2016-08-11T06:00:01+10:00 https://pharmadispatch.com/news/dusc-confirms-review-targets 2016-08-11T06:00:01+10:00 https://pharmadispatch.com/news/is-regulator-shifting-on-product-information 2016-08-10T06:00:01+10:00 https://pharmadispatch.com/news/patients-not-effectively-managing-diabetes 2016-08-10T06:00:01+10:00 https://pharmadispatch.com/news/comparator-change-a-tipping-point-for-access 2016-08-10T06:00:01+10:00 https://pharmadispatch.com/news/another-program-to-support-collaborations 2016-08-10T06:00:01+10:00 https://pharmadispatch.com/news/biogen-unveils-new-name-for-haemophilia-spin-off 2016-08-10T06:00:01+10:00 https://pharmadispatch.com/news/new-partnership-for-capital-k 2016-08-09T06:00:01+10:00 https://pharmadispatch.com/news/recognition-for-pharmacy-chain 2016-08-09T06:00:01+10:00 https://pharmadispatch.com/news/jj-backs-health-innovation-competition 2016-08-09T06:00:01+10:00 https://pharmadispatch.com/news/companies-question-private-meeting 2016-08-09T06:00:01+10:00 https://pharmadispatch.com/news/pharmac-funds-pradaxa-antidote 2016-08-09T06:00:01+10:00 https://pharmadispatch.com/news/guidelines-done-by-november-but-industry-not-giving-up 2016-08-08T06:00:01+10:00 https://pharmadispatch.com/news/industry-concern-over-tga-committee-changes 2016-08-08T06:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-supports-cv-research-innovation 2016-08-08T06:00:01+10:00 https://pharmadispatch.com/news/evidence-backs-ezetimibe-price-increase 2016-08-08T06:00:01+10:00 https://pharmadispatch.com/news/disappointment-as-key-immunotherapy-misses-study-endpoint 2016-08-08T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-appointed-to-erc 2016-08-05T06:00:01+10:00 https://pharmadispatch.com/news/merger-creates-pharmacy-giant 2016-08-05T06:00:01+10:00 https://pharmadispatch.com/news/ma-loses-another-member 2016-08-05T06:00:01+10:00 https://pharmadispatch.com/news/still-sorting-ministerial-responsibilities 2016-08-05T06:00:01+10:00 https://pharmadispatch.com/news/pbac-facing-a-year-of-change 2016-08-04T06:00:01+10:00 https://pharmadispatch.com/news/gender-a-consideration-for-pbac 2016-08-04T06:00:01+10:00 https://pharmadispatch.com/news/minister-announces-details-of-btf 2016-08-04T06:00:01+10:00 https://pharmadispatch.com/news/fundamental-misunderstanding-on-clinical-trials 2016-08-04T06:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-awards-open-for-applications 2016-08-03T06:00:01+10:00 https://pharmadispatch.com/news/pharmac-confirms-keytruda-funding 2016-08-03T06:00:01+10:00 https://pharmadispatch.com/news/legacy-hospira-and-new-products-boost-pfizer 2016-08-03T06:00:01+10:00 https://pharmadispatch.com/news/biogen-attracts-interest 2016-08-03T06:00:01+10:00 https://pharmadispatch.com/news/industry-looks-to-rally-on-comparators 2016-08-03T06:00:01+10:00 https://pharmadispatch.com/news/tariff-hit-for-clinical-trials 2016-08-02T06:00:01+10:00 https://pharmadispatch.com/news/comparators-still-troubling-industry 2016-08-02T06:00:01+10:00 https://pharmadispatch.com/news/it-actually-shows-the-complete-opposite-of-that 2016-08-02T06:00:01+10:00 https://pharmadispatch.com/news/no-jab-no-pay-working 2016-08-02T06:00:01+10:00 https://pharmadispatch.com/news/new-cuts-for-combination-items 2016-08-02T06:00:01+10:00 https://pharmadispatch.com/news/richard-vines-equity-should-be-a-reason-to-fund-access-not-an-ex 2016-08-01T06:00:01+10:00 https://pharmadispatch.com/news/minor-breaches-cost-bms-10000 2016-08-01T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-report-changed-approach 2016-08-01T06:00:01+10:00 https://pharmadispatch.com/news/launches-boost-msd 2016-08-01T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-ready-to-progress-medivation-takeover 2016-08-01T06:00:01+10:00 https://pharmadispatch.com/news/consultation-process-underway-today 2016-08-01T06:00:01+10:00 https://pharmadispatch.com/news/more-change-in-sussan-leys-office 2016-07-29T06:01:01+10:00 https://pharmadispatch.com/news/az-inks-new-deal-with-australian-biotech 2016-07-29T06:00:01+10:00 https://pharmadispatch.com/news/csl-welcomes-qiv-approval 2016-07-29T06:00:01+10:00 https://pharmadispatch.com/news/amgen-raises-outlook-on-sales-growth 2016-07-29T06:00:01+10:00 https://pharmadispatch.com/news/gsk-partners-with-nps-commercial-arm 2016-07-29T06:00:01+10:00 https://pharmadispatch.com/news/minister-celebrates-early-hcv-success 2016-07-29T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-cautiously-welcome-review-discussion-paper 2016-07-28T06:00:01+10:00 https://pharmadispatch.com/news/at-least-one-question-already-answered 2016-07-28T06:00:01+10:00 https://pharmadispatch.com/news/tambassis-review-forgot-one-question 2016-07-28T06:00:01+10:00 https://pharmadispatch.com/news/australia-leading-the-world 2016-07-28T06:00:01+10:00 https://pharmadispatch.com/news/gsk-posts-strong-results-and-invests-in-uk 2016-07-28T06:00:01+10:00 https://pharmadispatch.com/news/the-pbs-as-a-safety-net-1 2016-07-27T06:00:01+10:00 https://pharmadispatch.com/news/garvan-to-launch-first-clinical-whole-genome-sequencing-service 2016-07-27T06:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-biosimilar-etanercept 2016-07-27T06:00:01+10:00 https://pharmadispatch.com/news/pharmacy-discussion-paper-contentious-and-provocative 2016-07-27T06:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-policy-stability-essential 2016-07-26T06:00:01+10:00 https://pharmadispatch.com/news/official-pbs-data-catching-up 2016-07-26T06:00:01+10:00 https://pharmadispatch.com/news/full-year-data-reveals-spike-but-is-it-real 2016-07-26T06:00:01+10:00 https://pharmadispatch.com/news/hunt-the-changing-face-of-australian-innovation 2016-07-26T06:00:01+10:00 https://pharmadispatch.com/news/new-chief-of-staff-for-sussan-ley 2016-07-25T06:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-labor-ministry 2016-07-25T06:00:01+10:00 https://pharmadispatch.com/news/tightly-held-process-coming-to-an-end 2016-07-25T06:00:01+10:00 https://pharmadispatch.com/news/tga-approves-first-biosimilar-etanercept 2016-07-25T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-on-the-attack 2016-07-25T06:00:01+10:00 https://pharmadispatch.com/news/who-thought-that-would-be-a-good-idea 2016-07-22T06:20:01+10:00 https://pharmadispatch.com/news/back-to-work-for-sussan-ley 2016-07-22T06:00:01+10:00 https://pharmadispatch.com/news/hcv-sales-close-in-on-11bn 2016-07-22T06:00:01+10:00 https://pharmadispatch.com/news/roche-still-resisting-infliximab-comparator 2016-07-22T06:00:01+10:00 https://pharmadispatch.com/news/strong-first-half-result-for-roche 2016-07-22T06:00:01+10:00 https://pharmadispatch.com/news/august-pbs-for-biosimilar-ivf-therapy 2016-07-21T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-kicks-off-anniversary-celebrations 2016-07-21T06:00:01+10:00 https://pharmadispatch.com/news/jj-raises-full-year-forecast 2016-07-21T06:00:01+10:00 https://pharmadispatch.com/news/new-guidelines-will-impact-innovation 2016-07-21T06:00:01+10:00 https://pharmadispatch.com/news/price-disclosure-change-not-all-that-it-seems 2016-07-21T06:00:01+10:00 https://pharmadispatch.com/news/post-election-departures-from-sussan-leys-office 2016-07-20T06:01:01+10:00 https://pharmadispatch.com/news/changes-for-labor-frontbench 2016-07-20T06:00:01+10:00 https://pharmadispatch.com/news/wholesalers-looking-forward-to-review-discussion-paper 2016-07-20T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-merck-australia 2016-07-20T06:00:01+10:00 https://pharmadispatch.com/news/under-co-pay-data-confirms-transformation 2016-07-19T06:00:01+10:00 https://pharmadispatch.com/news/get-ready-for-1-october 2016-07-19T06:00:01+10:00 https://pharmadispatch.com/news/not-much-has-changed 2016-07-19T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-new-ministry 2016-07-19T06:00:01+10:00 https://pharmadispatch.com/news/sigma-adds-new-senior-strategy-role-to-executive 2016-07-19T05:38:01+10:00 https://pharmadispatch.com/news/sussan-ley-retains-health 2016-07-18T07:00:01+10:00 https://pharmadispatch.com/news/we-need-to-have-the-confidence-to-engage 2016-07-18T06:00:01+10:00 https://pharmadispatch.com/news/osteoporosis-therapy-delisted-from-1-august 2016-07-18T06:00:01+10:00 https://pharmadispatch.com/news/australia-wants-to-steal-us-patents 2016-07-18T06:00:01+10:00 https://pharmadispatch.com/news/is-the-managed-entry-scheme-dead 2016-07-18T06:00:01+10:00 https://pharmadispatch.com/news/ma-pays-tribute-to-outgoing-ausbiotech-ceo 2016-07-18T06:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-ceo-hands-over-leadership 2016-07-15T06:49:01+10:00 https://pharmadispatch.com/news/monday-is-d-day-for-pharmaceutical-sector 2016-07-15T06:00:01+10:00 https://pharmadispatch.com/news/court-victory-for-former-health-minister 2016-07-15T06:00:01+10:00 https://pharmadispatch.com/news/silence-on-health-but-not-hoverboards 2016-07-15T06:00:01+10:00 https://pharmadispatch.com/news/psa-starts-review-of-key-documents 2016-07-15T06:00:01+10:00 https://pharmadispatch.com/news/the-hidden-impact-of-osteoporosis 2016-07-15T06:00:01+10:00 https://pharmadispatch.com/news/no-briefings-to-ministers-officials-told 2016-07-14T06:00:01+10:00 https://pharmadispatch.com/news/more-information-means-improved-adherence 2016-07-14T06:00:01+10:00 https://pharmadispatch.com/news/department-announces-new-cmo 2016-07-14T06:00:01+10:00 https://pharmadispatch.com/news/arcs-extends-reach-with-new-global-partnership 2016-07-14T06:00:01+10:00 https://pharmadispatch.com/news/new-senior-appointment-for-pharmacy-services-company 2016-07-13T18:00:01+10:00 https://pharmadispatch.com/news/coalition-will-need-to-find-a-new-reform-pathway 2016-07-13T06:00:01+10:00 https://pharmadispatch.com/news/finance-silent-on-pbs-review 2016-07-13T06:00:01+10:00 https://pharmadispatch.com/news/tolmar-backs-pioneering-prostate-cancer-research 2016-07-13T06:00:01+10:00 https://pharmadispatch.com/news/az-considering-bid-for-medivation 2016-07-13T06:00:01+10:00 https://pharmadispatch.com/news/pharmacy-service-the-future-for-pharmacy 2016-07-12T06:00:01+10:00 https://pharmadispatch.com/news/genetic-test-could-reduce-need-for-chemo 2016-07-12T06:00:01+10:00 https://pharmadispatch.com/news/five-products-drive-growth-spike-in-retail-pharmacy 2016-07-12T06:00:01+10:00 https://pharmadispatch.com/news/global-control-of-drug-pricing-an-undergraduate-concept 2016-07-11T12:55:01+10:00 https://pharmadispatch.com/news/dusc-documents-released 2016-07-11T06:00:01+10:00 https://pharmadispatch.com/news/gsk-and-az-join-brexit-taskforce 2016-07-11T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-not-interested-in-being-scapegoated 2016-07-11T06:00:01+10:00 https://pharmadispatch.com/news/true-impact-of-diabetes-epidemic-vastly-underestimated 2016-07-11T06:00:01+10:00 https://pharmadispatch.com/news/back-to-work-as-turnbull-claims-victory 2016-07-11T06:00:01+10:00 https://pharmadispatch.com/news/aids-no-longer-a-public-health-issue-say-experts 2016-07-10T06:00:01+10:00 https://pharmadispatch.com/news/gsk-vaccinates-australian-olympic-team 2016-07-08T06:00:01+10:00 https://pharmadispatch.com/news/ryan-dont-touch-medicare 2016-07-08T06:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-lodges-pbac-submission 2016-07-08T06:00:01+10:00 https://pharmadispatch.com/news/pharmac-adopts-new-decision-criteria 2016-07-08T06:00:01+10:00 https://pharmadispatch.com/news/scott-morrison-may-have-missed-the-memo 2016-07-07T06:00:01+10:00 https://pharmadispatch.com/news/health-system-far-from-a-money-pit 2016-07-07T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-medivation-start-takeover-talks 2016-07-07T06:00:01+10:00 https://pharmadispatch.com/news/election-result-moves-closer 2016-07-07T06:00:01+10:00 https://pharmadispatch.com/news/health-a-real-issue-for-us-admits-turnbull 2016-07-06T06:00:01+10:00 https://pharmadispatch.com/news/turnbulls-admission-the-first-step-of-many-in-health 2016-07-06T06:00:01+10:00 https://pharmadispatch.com/news/no-issue-with-new-ndss-arrangements 2016-07-06T06:00:01+10:00 https://pharmadispatch.com/news/abc-suspends-catalyst-reporter 2016-07-06T06:00:01+10:00 https://pharmadispatch.com/news/money-has-to-come-from-somewhere 2016-07-05T06:00:01+10:00 https://pharmadispatch.com/news/contemplating-a-labor-government 2016-07-05T06:00:01+10:00 https://pharmadispatch.com/news/priceline-gets-behind-female-athletes 2016-07-05T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-donation-to-east-timor 2016-07-04T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-untenable-in-health 2016-07-04T06:00:01+10:00 https://pharmadispatch.com/news/election-good-for-some-not-so-for-others 2016-07-04T06:00:01+10:00 https://pharmadispatch.com/news/the-rise-of-xenophon-could-mark-the-end-of-king 2016-07-04T06:00:01+10:00 https://pharmadispatch.com/news/pbac-summary-documents-reveal-more 2016-07-04T06:00:01+10:00 https://pharmadispatch.com/news/new-analysis-backs-psa-program 2016-07-04T06:00:01+10:00 https://pharmadispatch.com/news/labors-careful-wording-on-health 2016-07-01T06:00:01+10:00 https://pharmadispatch.com/news/next-week-for-price-cuts 2016-07-01T06:00:01+10:00 https://pharmadispatch.com/news/self-care-and-online-the-future-for-consumer-health 2016-07-01T06:00:01+10:00 https://pharmadispatch.com/news/msd-welcomes-tcs-prescribing-change 2016-07-01T06:00:01+10:00 https://pharmadispatch.com/news/mayne-shares-jump-after-us-deal 2016-07-01T06:00:01+10:00 https://pharmadispatch.com/news/could-listings-be-delayed-until-october 2016-06-30T06:00:01+10:00 https://pharmadispatch.com/news/few-surprises-in-election-responses-to-ma 2016-06-30T06:00:01+10:00 https://pharmadispatch.com/news/tga-extends-pilot-changes-to-pre-submission-process 2016-06-30T06:00:01+10:00 https://pharmadispatch.com/news/a-dramatic-but-illusory-growth-spurt 2016-06-30T06:00:01+10:00 https://pharmadispatch.com/news/mayne-acquires-us-generic-portfolio 2016-06-29T06:00:01+10:00 https://pharmadispatch.com/news/hcv-sales-top-one-billion 2016-06-29T06:00:01+10:00 https://pharmadispatch.com/news/shorten-scrapping-co-pay-hike-a-values-decision 2016-06-29T06:00:01+10:00 https://pharmadispatch.com/news/pharmac-set-to-fund-keytruda 2016-06-29T06:00:01+10:00 https://pharmadispatch.com/news/research-australia-calls-for-award-nominations 2016-06-28T14:34:01+10:00 https://pharmadispatch.com/news/global-expert-says-biosimilars-promote-wider-use-of-cancer-thera 2016-06-28T06:00:01+10:00 https://pharmadispatch.com/news/does-anything-really-change-after-saturday 2016-06-28T06:00:01+10:00 https://pharmadispatch.com/news/looking-for-political-commitment-on-mrff 2016-06-28T06:00:01+10:00 https://pharmadispatch.com/news/chf-some-way-to-go-on-health-policy 2016-06-28T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-bi-agree-asset-swap 2016-06-28T06:00:01+10:00 https://pharmadispatch.com/news/industry-coming-to-terms-with-brexit 2016-06-27T18:00:01+10:00 https://pharmadispatch.com/news/pbs-still-growing-but-is-all-as-it-seems 2016-06-27T06:00:01+10:00 https://pharmadispatch.com/news/ma-updates-on-organisational-change-and-leadership 2016-06-27T06:00:01+10:00 https://pharmadispatch.com/news/health-announcements-as-election-enters-final-week 2016-06-27T06:00:01+10:00 https://pharmadispatch.com/news/pharmac-set-to-fund-pradaxa-antidote 2016-06-27T06:00:01+10:00 https://pharmadispatch.com/news/battle-for-medivation-heating-up 2016-06-27T06:00:01+10:00 https://pharmadispatch.com/news/new-study-backs-early-use-of-novartis-heart-failure-therapy 2016-06-24T06:00:01+10:00 https://pharmadispatch.com/news/joe-demarte-re-elected-psa-national-president 2016-06-24T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-meet-for-biosimilars-forum 2016-06-24T06:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-missing-the-point-on-ip 2016-06-23T15:11:01+10:00 https://pharmadispatch.com/news/australian-officials-already-talking-down-ip-report 2016-06-23T06:00:01+10:00 https://pharmadispatch.com/news/wider-indication-but-frustration-for-biogen 2016-06-23T06:00:01+10:00 https://pharmadispatch.com/news/the-changes-keep-coming 2016-06-23T06:00:01+10:00 https://pharmadispatch.com/news/grattan-asks-for-donations 2016-06-23T06:00:01+10:00 https://pharmadispatch.com/news/government-advice-confirmed-trade-reality 2016-06-22T06:00:01+10:00 https://pharmadispatch.com/news/sector-goes-head-to-head-at-ip-hearing 2016-06-22T06:00:01+10:00 https://pharmadispatch.com/news/some-are-hard-to-please-on-pbs-pricing 2016-06-22T06:00:01+10:00 https://pharmadispatch.com/news/key-role-for-pharmacists-in-managing-antibiotic-use 2016-06-22T06:00:01+10:00 https://pharmadispatch.com/news/ndss-changes-an-opportunity-for-pharmacy 2016-06-22T06:00:01+10:00 https://pharmadispatch.com/news/biosimilar-forum-set-for-later-this-week 2016-06-21T06:00:01+10:00 https://pharmadispatch.com/news/labor-we-wont-smash-an-industry-were-trying-to-build 2016-06-21T06:00:01+10:00 https://pharmadispatch.com/news/first-pharmacist-administered-vaccine-in-victoria 2016-06-21T06:00:01+10:00 https://pharmadispatch.com/news/caretaker-could-delay-notification-of-1-october-price-cuts 2016-06-21T06:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-starts-ip-hearings 2016-06-21T06:00:01+10:00 https://pharmadispatch.com/news/different-approach-required-for-new-cancer-therapies 2016-06-20T06:00:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-ip-the-productivity-commission-might-give-the-u 2016-06-20T06:00:01+10:00 https://pharmadispatch.com/news/still-waiting-for-lsdp-report 2016-06-20T06:00:01+10:00 https://pharmadispatch.com/news/recognition-for-janssen-mental-health-campaign 2016-06-20T06:00:01+10:00 https://pharmadispatch.com/news/coalition-scraps-payment-outsourcing-plan 2016-06-20T06:00:01+10:00 https://pharmadispatch.com/news/roundtable-on-pharmaceutical-patents 2016-06-17T06:00:01+10:00 https://pharmadispatch.com/news/gbma-biosimilar-policy-discussion-has-evolved 2016-06-17T06:00:01+10:00 https://pharmadispatch.com/news/victorian-government-backs-new-manufacturing-facility 2016-06-17T06:00:01+10:00 https://pharmadispatch.com/news/a-pointless-exercise-that-only-harms-australia 2016-06-17T06:00:01+10:00 https://pharmadispatch.com/news/shire-local-leadership-confirmed 2016-06-16T06:00:01+10:00 https://pharmadispatch.com/news/pharmacy-clean-sweep-with-labor-backing 2016-06-16T06:00:01+10:00 https://pharmadispatch.com/news/labor-outguns-coalition-on-diabetes-commitment 2016-06-16T06:00:01+10:00 https://pharmadispatch.com/news/labor-to-increase-penalties-for-misleading-claims 2016-06-16T06:00:01+10:00 https://pharmadispatch.com/news/positive-renal-data-for-pbs-listed-jardiance 2016-06-16T06:00:01+10:00 https://pharmadispatch.com/news/winners-of-jj-innovation-quickfire-challenge 2016-06-16T06:00:01+10:00 https://pharmadispatch.com/news/grattan-does-it-again 2016-06-15T18:23:01+10:00 https://pharmadispatch.com/news/next-step-for-sanofi-in-medivation-takeover 2016-06-15T06:00:01+10:00 https://pharmadispatch.com/news/standoff-between-bayer-and-monsanto 2016-06-15T06:00:01+10:00 https://pharmadispatch.com/news/vertex-proposes-early-access-arrangement 2016-06-15T06:00:01+10:00 https://pharmadispatch.com/news/blow-for-leading-australian-biotech 2016-06-15T06:00:01+10:00 https://pharmadispatch.com/news/trial-shows-cv-benefit-of-novo-nordisks-victoza 2016-06-15T06:00:01+10:00 https://pharmadispatch.com/news/labor-scraps-opposition-to-rd-tax-cut 2016-06-14T06:00:01+10:00 https://pharmadispatch.com/news/queens-birthday-honours-for-key-pharma-figures 2016-06-14T06:00:01+10:00 https://pharmadispatch.com/news/recognition-for-csl-manufacturing-facility 2016-06-14T06:00:01+10:00 https://pharmadispatch.com/news/symbion-keeps-delivering-through-tasmanian-floods 2016-06-14T06:00:01+10:00 https://pharmadispatch.com/news/blackmores-makes-it-into-top-100 2016-06-14T06:00:01+10:00 https://pharmadispatch.com/news/new-data-on-biosimilars 2016-06-14T06:00:01+10:00 https://pharmadispatch.com/news/the-reference-that-gave-away-the-second-idc 2016-06-10T06:00:01+10:00 https://pharmadispatch.com/news/why-is-this-so-important 2016-06-10T06:00:01+10:00 https://pharmadispatch.com/news/nz-funds-opdivo-from-1-july 2016-06-10T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-pasteur-calls-for-bright-ideas 2016-06-10T06:00:01+10:00 https://pharmadispatch.com/news/been-here-before-says-ausbiotech-on-ip-report 2016-06-10T06:00:01+10:00 https://pharmadispatch.com/news/health-idc-on-pbs-but-was-it-the-only-one 2016-06-09T06:00:01+10:00 https://pharmadispatch.com/news/guild-secures-more-support-for-pharmacy 2016-06-09T06:00:01+10:00 https://pharmadispatch.com/news/maybe-pharma-secures-us-approval 2016-06-09T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-wants-medivation-board-gone-by-1-august 2016-06-09T06:00:01+10:00 https://pharmadispatch.com/news/july-pbs-schedule-reflects-caretaker-impact 2016-06-08T06:00:01+10:00 https://pharmadispatch.com/news/ma-productivity-commission-does-not-understand-pharma-ip 2016-06-08T06:00:01+10:00 https://pharmadispatch.com/news/aamri-says-funding-for-the-full-spectrum-essential 2016-06-08T06:00:01+10:00 https://pharmadispatch.com/news/us-judge-overturns-hep-c-patent-case 2016-06-08T06:00:01+10:00 https://pharmadispatch.com/news/chf-releases-election-platform 2016-06-07T06:00:01+10:00 https://pharmadispatch.com/news/positive-trial-results-for-pfizers-ibrance 2016-06-07T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-pfizer-australia 2016-06-07T06:00:01+10:00 https://pharmadispatch.com/news/strong-backing-for-pharmacy-from-pm 2016-06-07T06:00:01+10:00 https://pharmadispatch.com/news/seqirus-donates-flu-vax-to-fiji 2016-06-07T06:00:01+10:00 https://pharmadispatch.com/news/mrff-should-fund-research-into-complementary-meds-says-asmi 2016-06-07T06:00:01+10:00 https://pharmadispatch.com/news/the-sectors-only-friends-as-things-get-tougher 2016-06-06T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-sill-interested-in-mega-mergers 2016-06-06T06:00:01+10:00 https://pharmadispatch.com/news/specialists-key-to-biosimilar-uptake 2016-06-06T06:00:01+10:00 https://pharmadispatch.com/news/tga-moves-to-increase-transparency 2016-06-06T06:00:01+10:00 https://pharmadispatch.com/news/shire-completes-baxalta-acquisition 2016-06-06T06:00:01+10:00 https://pharmadispatch.com/news/time-to-get-serious-about-patient-input 2016-06-03T06:00:01+10:00 https://pharmadispatch.com/news/80m-collaboration-launched-to-discover-new-medicines 2016-06-03T06:00:01+10:00 https://pharmadispatch.com/news/another-three-months-for-lee-hill-at-ma 2016-06-03T06:00:01+10:00 https://pharmadispatch.com/news/coalition-raises-spectre-of-deferrals-in-xolair-listing 2016-06-03T06:00:01+10:00 https://pharmadispatch.com/news/gbma-marks-first-year-of-strategic-agreement 2016-06-03T06:00:01+10:00 https://pharmadispatch.com/news/clinicians-welcome-prescribing-change 2016-06-02T06:00:01+10:00 https://pharmadispatch.com/news/pbs-for-janssens-stelara 2016-06-02T06:00:01+10:00 https://pharmadispatch.com/news/applications-open-for-csl-fellowship 2016-06-02T06:00:01+10:00 https://pharmadispatch.com/news/new-budget-analysis-confirms-pbs-spend-challenge 2016-06-02T06:00:01+10:00 https://pharmadispatch.com/news/abstracts-now-open-for-gptec2016 2016-06-02T06:00:01+10:00 https://pharmadispatch.com/news/arrow-pharmas-leon-moore-talks-transition 2016-06-01T06:00:01+10:00 https://pharmadispatch.com/news/abbott-launches-new-glucose-monitoring-system 2016-06-01T06:00:01+10:00 https://pharmadispatch.com/news/coalition-targets-childhood-cancers 2016-06-01T06:00:01+10:00 https://pharmadispatch.com/news/priceline-launches-next-generation-store 2016-06-01T06:00:01+10:00 https://pharmadispatch.com/news/baxter-inks-chemo-compounding-deal-with-ramsay 2016-06-01T06:00:01+10:00 https://pharmadispatch.com/news/biotech-leaders-optimistic-but-concerned-for-future-of-rd-tax-in 2016-06-01T06:00:01+10:00 https://pharmadispatch.com/news/shire-baxalta-merger-expected-to-close-this-week 2016-05-31T06:00:01+10:00 https://pharmadispatch.com/news/ma-continues-search-for-new-ceo 2016-05-31T06:00:01+10:00 https://pharmadispatch.com/news/another-biosimilar-gets-the-nod-in-eu 2016-05-31T06:00:01+10:00 https://pharmadispatch.com/news/teva-pharma-pursuing-innovation-in-australia 2016-05-30T06:00:01+10:00 https://pharmadispatch.com/news/caretaker-starts-to-impact-listings 2016-05-30T06:00:01+10:00 https://pharmadispatch.com/news/still-concerns-about-the-bigger-picture 2016-05-30T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-wanting-a-devils-bargain-on-medivation 2016-05-30T06:00:01+10:00 https://pharmadispatch.com/news/pbs-spending-shifting-to-hospital 2016-05-30T06:00:01+10:00 https://pharmadispatch.com/news/new-senior-appointments-for-research-australia 2016-05-30T06:00:01+10:00 https://pharmadispatch.com/news/15-billion-in-lost-revenue-if-current-skills-gap-left-to-widen 2016-05-27T06:06:01+10:00 https://pharmadispatch.com/news/pbs-spikes-on-hcv-and-cancer-spending 2016-05-27T06:00:01+10:00 https://pharmadispatch.com/news/another-us-approval-for-csl 2016-05-27T06:00:01+10:00 https://pharmadispatch.com/news/ex-sigma-execs-avoid-custodial-sentence 2016-05-27T06:00:01+10:00 https://pharmadispatch.com/news/australians-rate-industry-according-to-new-analysis 2016-05-27T06:00:01+10:00 https://pharmadispatch.com/news/tga-releases-performance-snapshot 2016-05-27T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-pushing-on-with-medivation-bid 2016-05-26T06:00:01+10:00 https://pharmadispatch.com/news/medicare-catching-up-on-hcv-therapies 2016-05-26T06:00:01+10:00 https://pharmadispatch.com/news/get-in-front-of-this-issue-before-its-too-late 2016-05-26T06:00:01+10:00 https://pharmadispatch.com/news/real-time-reporting-must-be-a-high-priority-says-psa 2016-05-26T06:00:01+10:00 https://pharmadispatch.com/news/labor-keeping-health-front-and-centre 2016-05-26T06:00:01+10:00 https://pharmadispatch.com/news/a-match-made-in-heaven 2016-05-25T06:00:01+10:00 https://pharmadispatch.com/news/biosimilar-stakeholder-forum-moves-one-step-closer 2016-05-25T06:00:01+10:00 https://pharmadispatch.com/news/early-results-from-on-q-recruitment-salary-and-job-satisfaction- 2016-05-25T06:00:01+10:00 https://pharmadispatch.com/news/generics-and-restriction-changes-for-1-june 2016-05-25T06:00:01+10:00 https://pharmadispatch.com/news/us-approval-for-seqirus-qiv 2016-05-25T06:00:01+10:00 https://pharmadispatch.com/news/monsanto-spurns-bayer-but-open-to-more-talks 2016-05-25T06:00:01+10:00 https://pharmadispatch.com/news/central-agencies-control-health-spendingsurprise-surprise 2016-05-24T06:00:01+10:00 https://pharmadispatch.com/news/labor-coalition-health-policy-in-tatters 2016-05-24T06:00:01+10:00 https://pharmadispatch.com/news/bayer-confirms-us62bn-bid-for-monsanto 2016-05-24T06:00:01+10:00 https://pharmadispatch.com/news/more-needs-to-be-done-says-rare-cancers 2016-05-24T06:00:01+10:00 https://pharmadispatch.com/news/accc-confirms-nurofen-appeal 2016-05-24T06:00:01+10:00 https://pharmadispatch.com/news/locally-developed-option 2016-05-24T06:00:01+10:00 https://pharmadispatch.com/news/greens-will-ignore-pbac-on-prep 2016-05-23T06:00:01+10:00 https://pharmadispatch.com/news/greens-back-support-for-collaborations-and-commercialisation 2016-05-23T06:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-coalitions-commitment-on-clinical-trials 2016-05-23T06:00:01+10:00 https://pharmadispatch.com/news/pbs-dominates-election-sunday 2016-05-23T06:00:01+10:00 https://pharmadispatch.com/news/a-strange-day-topped-by-greens-pbac-stance 2016-05-23T06:00:01+10:00 https://pharmadispatch.com/news/gsk-recalls-three-batches-of-childrens-panadol 2016-05-20T18:00:01+10:00 https://pharmadispatch.com/news/election-result-could-be-messy 2016-05-20T06:00:01+10:00 https://pharmadispatch.com/news/bayer-makes-move-for-monsanto 2016-05-20T06:00:01+10:00 https://pharmadispatch.com/news/coalition-commits-to-clinical-trials 2016-05-20T06:00:01+10:00 https://pharmadispatch.com/news/industry-should-pay-for-antibiotic-incentive 2016-05-20T06:00:01+10:00 https://pharmadispatch.com/news/complementary-medicines-sector-slams-abc 2016-05-19T06:00:01+10:00 https://pharmadispatch.com/news/bayer-symbions-supplier-of-the-year 2016-05-19T06:00:01+10:00 https://pharmadispatch.com/news/novartis-halts-trial-after-positive-results 2016-05-19T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-responds-to-listing-request 2016-05-19T06:00:01+10:00 https://pharmadispatch.com/news/labor-moves-on-health 2016-05-19T05:00:01+10:00 https://pharmadispatch.com/news/just-1-in-8-drugs-make-it-to-market 2016-05-18T06:00:01+10:00 https://pharmadispatch.com/news/prima-biomed-find-immunotherapy-partner 2016-05-18T06:00:01+10:00 https://pharmadispatch.com/news/structural-change-as-novartis-elevates-oncology 2016-05-18T06:00:01+10:00 https://pharmadispatch.com/news/the-long-battle-for-f1-gets-underway 2016-05-18T06:00:01+10:00 https://pharmadispatch.com/news/research-reveals-low-awareness 2016-05-17T06:00:01+10:00 https://pharmadispatch.com/news/novartis-copd-therapy-shows-superiority-in-trial 2016-05-17T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-negotiation-not-confrontation 2016-05-17T06:00:01+10:00 https://pharmadispatch.com/news/report-claims-codeine-misuse-still-a-problem 2016-05-17T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-acquires-anacor-for-us52bn 2016-05-17T06:00:01+10:00 https://pharmadispatch.com/news/australian-alliance-supporting-pacific-during-el-nio 2016-05-16T06:00:01+10:00 https://pharmadispatch.com/news/telstra-health-to-develop-and-operate-national-cancer-screening- 2016-05-16T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-moves-against-medivation-board 2016-05-16T06:00:01+10:00 https://pharmadispatch.com/news/coalition-shuts-down-pathology-problem 2016-05-16T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-says-no-to-us-executing-states 2016-05-16T06:00:01+10:00 https://pharmadispatch.com/news/a-questionable-victory 2016-05-16T06:00:01+10:00 https://pharmadispatch.com/news/wider-access-to-continuous-glucose-monitoring 2016-05-16T06:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-better-contraception-support 2016-05-14T15:34:01+10:00 https://pharmadispatch.com/news/hep-c-sales-hit-half-a-billion-in-just-nine-weeks 2016-05-13T06:00:01+10:00 https://pharmadispatch.com/news/bi-welcomes-approval-of-first-noac-reversal-agent 2016-05-13T06:00:01+10:00 https://pharmadispatch.com/news/european-approval-for-csls-idelvion 2016-05-13T06:00:01+10:00 https://pharmadispatch.com/news/bayer-backing-for-new-stroke-resource 2016-05-13T06:00:01+10:00 https://pharmadispatch.com/news/the-focus-shifts-to-f1-as-pbs-spending-gives-the-appearance-of-a 2016-05-13T06:00:01+10:00 https://pharmadispatch.com/news/the-world-has-changed 2016-05-12T06:00:01+10:00 https://pharmadispatch.com/news/the-7-drivers-of-corporate-reputation 2016-05-12T06:00:01+10:00 https://pharmadispatch.com/news/senior-australians-underestimating-risks 2016-05-12T06:00:01+10:00 https://pharmadispatch.com/news/promotion-for-ex-pbac-chair 2016-05-12T06:00:01+10:00 https://pharmadispatch.com/news/do-the-caretaker-conventions-really-apply 2016-05-11T13:12:01+10:00 https://pharmadispatch.com/news/distorted-picture-of-pbs-spend 2016-05-11T06:00:01+10:00 https://pharmadispatch.com/news/leaders-take-different-paths-on-health 2016-05-11T06:00:01+10:00 https://pharmadispatch.com/news/improvements-in-cv-health-drive-reduction-in-overall-burden-of-d 2016-05-11T06:00:01+10:00 https://pharmadispatch.com/news/health-funds-still-favour-natural-therapies-over-medicines 2016-05-11T06:00:01+10:00 https://pharmadispatch.com/news/final-approval-for-pharmacy-delivered-vaccinations-in-victoria 2016-05-11T06:00:01+10:00 https://pharmadispatch.com/news/racgp-endorses-clinical-prostate-test-guidelines 2016-05-11T06:00:01+10:00 https://pharmadispatch.com/news/uncertainty-for-1-july-listings 2016-05-10T06:00:01+10:00 https://pharmadispatch.com/news/no-direction-not-to-publish 2016-05-10T06:00:01+10:00 https://pharmadispatch.com/news/eary-political-backing-for-pharmacy 2016-05-10T06:00:01+10:00 https://pharmadispatch.com/news/tga-review-to-deliver-red-tape-savings 2016-05-10T06:00:01+10:00 https://pharmadispatch.com/news/medivation-succumbs-to-pressure 2016-05-10T06:00:01+10:00 https://pharmadispatch.com/news/one-minute-for-pbs-at-estimates 2016-05-09T06:00:01+10:00 https://pharmadispatch.com/news/questions-over-lack-of-transparency 2016-05-09T06:00:01+10:00 https://pharmadispatch.com/news/experts-unite-over-revised-pbac-guidelines 2016-05-09T06:00:01+10:00 https://pharmadispatch.com/news/greens-want-truvada-listed-for-prep 2016-05-09T06:00:01+10:00 https://pharmadispatch.com/news/incredible-transformation-in-drug-development 2016-05-09T06:00:01+10:00 https://pharmadispatch.com/news/health-and-pbs-likely-features-of-a-long-campaign 2016-05-09T06:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-looking-for-leaders 2016-05-09T06:00:01+10:00 https://pharmadispatch.com/news/pm-calls-election-as-sector-faces-long-caretaker-period 2016-05-08T10:48:01+10:00 https://pharmadispatch.com/news/sanofi-talks-tough-on-medivation 2016-05-06T06:24:01+10:00 https://pharmadispatch.com/news/taking-the-right-option 2016-05-06T06:00:01+10:00 https://pharmadispatch.com/news/spending-shift-from-f2-to-f1 2016-05-06T06:00:01+10:00 https://pharmadispatch.com/news/gbma-welcomes-budget-certainty 2016-05-06T06:00:01+10:00 https://pharmadispatch.com/news/keytruda-delivers-for-msd-in-first-quarter 2016-05-06T06:00:01+10:00 https://pharmadispatch.com/news/time-to-hand-over-your-phone 2016-05-05T06:00:01+10:00 https://pharmadispatch.com/news/why-the-forecast-is-important 2016-05-05T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-considers-its-own-move-for-medivation 2016-05-05T06:00:01+10:00 https://pharmadispatch.com/news/extra-money-for-pharmac 2016-05-05T06:00:01+10:00 https://pharmadispatch.com/news/sector-calls-for-certainty-and-predictability 2016-05-05T06:00:01+10:00 https://pharmadispatch.com/news/official-report-confirms-fall-in-pbs-spend 2016-05-05T06:00:01+10:00 https://pharmadispatch.com/news/jj-medical-boost-for-indigenous-doctors 2016-05-05T06:00:01+10:00 https://pharmadispatch.com/news/something-quite-odd 2016-05-04T18:00:01+10:00 https://pharmadispatch.com/news/abbvie-offers-pharmacy-hcv-relief 2016-05-04T06:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-no-surprises-budget 2016-05-04T06:00:01+10:00 https://pharmadispatch.com/news/new-products-and-hospira-boost-pfizer 2016-05-04T06:00:01+10:00 https://pharmadispatch.com/news/no-new-savings-but-price-disclosure-savings-forecast-to-hit-20-b 2016-05-03T19:30:01+10:00 https://pharmadispatch.com/news/budget-2016-17-the-measures 2016-05-03T19:30:01+10:00 https://pharmadispatch.com/news/breaking-political-rules-in-health 2016-05-03T06:00:01+10:00 https://pharmadispatch.com/news/patients-devastated-by-orkambi-rejection 2016-05-03T06:00:01+10:00 https://pharmadispatch.com/news/the-field-is-starting-to-explode 2016-05-03T06:00:01+10:00 https://pharmadispatch.com/news/viiv-and-change-headline-gsks-2015-result 2016-05-03T06:00:01+10:00 https://pharmadispatch.com/news/comparator-concern-for-mental-health-groups 2016-05-03T06:00:01+10:00 https://pharmadispatch.com/news/the-first-listing-of-many-for-bms-opdivo 2016-05-02T14:29:01+10:00 https://pharmadispatch.com/news/on-q-recruitment-salary-and-job-satisfaction-survey-in-its-tenth 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/company-results-amgen-abbvie-bms-az-gilead-celgene-and-ipsen 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/another-impractical-report-on-ip 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/sector-responds-to-productivity-commission-ip-report 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/special-mention-in-us-trade-report 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/major-deals-for-abbvie-and-abbott-as-sanofi-pushes-on-medivation 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/accc-could-appeal-nurofen-fine 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/gsk-partnership-leads-to-major-breakthrough-for-newborns-in-deve 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/code-of-conduct-determinations 2016-05-02T06:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-calls-for-pharma-ip-changes 2016-04-29T09:21:01+10:00 https://pharmadispatch.com/news/australian-researchers-identify-vitamin-d-ms-link 2016-04-29T06:00:01+10:00 https://pharmadispatch.com/news/seeing-red-for-ms 2016-04-29T06:00:01+10:00 https://pharmadispatch.com/news/substitution-gets-real-with-msds-etanercept 2016-04-29T06:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-significant-new-listings-in-july 2016-04-29T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-makes-takeover-bid-for-medivation 2016-04-29T06:00:01+10:00 https://pharmadispatch.com/news/new-ebook-offers-guidance-on-managing-reputation 2016-04-29T06:00:01+10:00 https://pharmadispatch.com/news/blackmores-profit-still-soaring 2016-04-29T06:00:01+10:00 https://pharmadispatch.com/news/comparator-pricing-undermining-formulary-split 2016-04-28T06:00:01+10:00 https://pharmadispatch.com/news/infliximab-price-starting-to-bite-bdmards 2016-04-28T06:00:01+10:00 https://pharmadispatch.com/news/lowest-first-quarter-cpi-drug-price-rise-in-two-decades 2016-04-28T06:00:01+10:00 https://pharmadispatch.com/news/senior-australians-missing-immunisations 2016-04-28T06:00:01+10:00 https://pharmadispatch.com/news/ma-marks-world-ip-day 2016-04-28T06:00:01+10:00 https://pharmadispatch.com/news/bayer-reports-strong-profit-growth 2016-04-28T06:00:01+10:00 https://pharmadispatch.com/news/an-important-week-for-ma-against-a-confusing-backdrop 2016-04-27T06:00:01+10:00 https://pharmadispatch.com/news/new-strategic-plan-for-medicines-nz 2016-04-27T06:00:01+10:00 https://pharmadispatch.com/news/novartis-considering-sale-of-roche-stake 2016-04-27T06:00:01+10:00 https://pharmadispatch.com/news/tolmar-anzup-uro-oncology-clinical-research-fellowship-2016 2016-04-27T06:00:01+10:00 https://pharmadispatch.com/news/new-products-boost-lilly 2016-04-27T06:00:01+10:00 https://pharmadispatch.com/news/pbac-says-no-to-ivf-biosimilar 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/government-wins-as-staggering-hcv-uptake-continues-to-soar 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/pbac-sticks-by-panadol-osteo-decision 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/vertex-will-try-again-on-orkambi 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/csl-marks-official-centenary 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/senate-bluster-not-backed-by-any-recommendations 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-march-pbac-outcomes 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/outcome-raises-concern-of-future-of-managed-entry 2016-04-26T06:00:01+10:00 https://pharmadispatch.com/news/two-more-post-market-reviews-2 2016-04-22T15:26:01+10:00 https://pharmadispatch.com/news/csl-sticks-with-ma 2016-04-22T06:00:01+10:00 https://pharmadispatch.com/news/us-calls-australia-and-nz-on-trade-games 2016-04-22T06:00:01+10:00 https://pharmadispatch.com/news/priceline-retail-transforming-api 2016-04-22T06:00:01+10:00 https://pharmadispatch.com/news/progress-for-industry-working-groups 2016-04-22T06:00:01+10:00 https://pharmadispatch.com/news/novartis-investing-in-new-products 2016-04-22T06:00:01+10:00 https://pharmadispatch.com/news/ma-vigorously-opposes-comparator-change 2016-04-21T06:00:01+10:00 https://pharmadispatch.com/news/patients-are-technical-experts 2016-04-21T06:00:01+10:00 https://pharmadispatch.com/news/guild-wants-new-hcv-model 2016-04-21T06:00:01+10:00 https://pharmadispatch.com/news/estimates-in-phoney-election-campaign 2016-04-21T06:00:01+10:00 https://pharmadispatch.com/news/bi-highlights-rd-investment 2016-04-21T06:00:01+10:00 https://pharmadispatch.com/news/government-does-well-by-shifting-risk 2016-04-20T06:00:01+10:00 https://pharmadispatch.com/news/the-pbs-debate-could-be-about-to-change 2016-04-20T06:00:01+10:00 https://pharmadispatch.com/news/bayer-team-back-winning-hackathon-idea 2016-04-20T06:00:01+10:00 https://pharmadispatch.com/news/prep-approval-moving-closer 2016-04-20T06:00:01+10:00 https://pharmadispatch.com/news/company-results-roche 2016-04-20T06:00:01+10:00 https://pharmadispatch.com/news/hcv-sales-soar-in-march 2016-04-19T06:00:01+10:00 https://pharmadispatch.com/news/andrew-wilson-pbac-is-constantly-evolving 2016-04-19T06:00:01+10:00 https://pharmadispatch.com/news/jannsen-welcomes-ribomustin-listing 2016-04-19T06:00:01+10:00 https://pharmadispatch.com/news/low-ranking-for-australia-in-new-innovation-report 2016-04-19T06:00:01+10:00 https://pharmadispatch.com/news/az-considers-bid-for-medivation 2016-04-19T06:00:01+10:00 https://pharmadispatch.com/news/sector-faces-the-reality-of-early-election 2016-04-19T06:00:01+10:00 https://pharmadispatch.com/news/csl-announces-rd-support-program 2016-04-18T06:00:01+10:00 https://pharmadispatch.com/news/abbvie-welcomes-1-may-hcv-listing 2016-04-18T06:00:01+10:00 https://pharmadispatch.com/news/spittle-the-right-thing-to-do 2016-04-18T06:00:01+10:00 https://pharmadispatch.com/news/andrew-wilson-an-exciting-time-to-be-pbac-chair 2016-04-18T06:00:01+10:00 https://pharmadispatch.com/news/valeant-looks-to-divest-assets 2016-04-18T06:00:01+10:00 https://pharmadispatch.com/news/the-search-for-a-ceo-takes-the-next-step 2016-04-15T06:00:01+10:00 https://pharmadispatch.com/news/lee-hill-this-is-a-very-exciting-opportunity 2016-04-15T06:00:01+10:00 https://pharmadispatch.com/news/department-moves-to-delist-popular-blood-pressure-combination 2016-04-15T06:00:01+10:00 https://pharmadispatch.com/news/implement-tppa-requirements-medicines-nz-tells-government 2016-04-15T06:00:01+10:00 https://pharmadispatch.com/news/consider-the-principle-not-the-product 2016-04-15T06:00:01+10:00 https://pharmadispatch.com/news/gsk-to-pursue-wider-listing-for-volibris 2016-04-14T06:00:01+10:00 https://pharmadispatch.com/news/measuring-the-true-cost-of-the-pbs 2016-04-14T06:00:01+10:00 https://pharmadispatch.com/news/gbma-the-mechanism-is-failing 2016-04-14T06:00:01+10:00 https://pharmadispatch.com/news/200-facing-new-price-disclosure-rules 2016-04-14T06:00:01+10:00 https://pharmadispatch.com/news/apotex-pulls-products-as-reforms-hit 2016-04-13T11:42:01+10:00 https://pharmadispatch.com/news/ma-progressing-ceo-hunt 2016-04-13T06:00:01+10:00 https://pharmadispatch.com/news/devil-in-the-budget-detail 2016-04-13T06:00:01+10:00 https://pharmadispatch.com/news/viiv-announced-positive-action-community-grants 2016-04-13T06:00:01+10:00 https://pharmadispatch.com/news/treasury-confirms-mrff-hole 2016-04-13T06:00:01+10:00 https://pharmadispatch.com/news/accc-seeks-6m-fine-over-nurofen 2016-04-13T06:00:01+10:00 https://pharmadispatch.com/news/first-meeting-of-biosimilar-awareness-reference-group 2016-04-12T06:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-commitment-of-health-ministers 2016-04-12T06:00:01+10:00 https://pharmadispatch.com/news/health-ministers-recognition 2016-04-12T06:00:01+10:00 https://pharmadispatch.com/news/blackmores-hit-as-china-changes-take-effect 2016-04-12T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-ceo-slams-us-tax-changes 2016-04-11T06:00:01+10:00 https://pharmadispatch.com/news/not-enough-being-done-to-stimulate-medical-innovation 2016-04-11T06:00:01+10:00 https://pharmadispatch.com/news/progress-for-alzheimers-therapies 2016-04-11T06:00:01+10:00 https://pharmadispatch.com/news/department-companies-have-raised-delisting-concerns 2016-04-11T06:00:01+10:00 https://pharmadispatch.com/news/new-resource-for-parkinsons-disease 2016-04-11T06:00:01+10:00 https://pharmadispatch.com/news/values-arent-just-words-on-the-wall 2016-04-11T06:00:01+10:00 https://pharmadispatch.com/news/did-it-really-deserve-that-response 2016-04-08T06:00:01+10:00 https://pharmadispatch.com/news/scrapped-merger-sparks-tax-debate 2016-04-08T06:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-government-wrong-on-incentive 2016-04-08T06:00:01+10:00 https://pharmadispatch.com/news/are-generics-really-new-medicines 2016-04-08T06:00:01+10:00 https://pharmadispatch.com/news/gbma-biosimilar-benefits-no-longer-theoretical 2016-04-08T06:00:01+10:00 https://pharmadispatch.com/news/industry-nominated-pbac-member 2016-04-07T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-teams-up-with-experts-on-flu-resource 2016-04-07T06:00:01+10:00 https://pharmadispatch.com/news/the-gift-that-keeps-on-giving-1 2016-04-07T06:00:01+10:00 https://pharmadispatch.com/news/department-confirms-co-payment-discount-uptake 2016-04-07T06:00:01+10:00 https://pharmadispatch.com/news/speculation-pfizer-could-pursue-another-takeover 2016-04-07T06:00:01+10:00 https://pharmadispatch.com/news/health-struggling-as-budget-nears 2016-04-06T06:00:01+10:00 https://pharmadispatch.com/news/pbac-exempted-just-six-combinations-from-1-april-price-cuts-so-f 2016-04-06T06:00:01+10:00 https://pharmadispatch.com/news/new-cholesterol-lowering-biologics-headline-cardiology-meeting 2016-04-06T06:00:01+10:00 https://pharmadispatch.com/news/new-tax-rules-threaten-pfizer-allergan-deal 2016-04-06T06:00:01+10:00 https://pharmadispatch.com/news/positive-study-result-for-bayers-xarelto 2016-04-06T06:00:01+10:00 https://pharmadispatch.com/news/new-treatment-to-help-gps-face-up-to-rosacea 2016-04-06T06:00:01+10:00 https://pharmadispatch.com/news/biointelect-acquired-by-biotech-capital 2016-04-05T06:00:01+10:00 https://pharmadispatch.com/news/carlo-montagner-innovation-will-suffer 2016-04-05T06:00:01+10:00 https://pharmadispatch.com/news/unprecedented-commercial-challenge 2016-04-05T06:00:01+10:00 https://pharmadispatch.com/news/baxter-increases-use-of-clean-power 2016-04-05T06:00:01+10:00 https://pharmadispatch.com/news/professor-ian-frazer-to-chair-mrff-advisory-group 2016-04-05T06:00:01+10:00 https://pharmadispatch.com/news/acknowledge-medicines-sector 2016-04-05T06:00:01+10:00 https://pharmadispatch.com/news/gsk-to-drop-patents-in-poorest-countries 2016-04-04T06:00:01+10:00 https://pharmadispatch.com/news/budget-important-not-just-because-of-the-measures 2016-04-04T06:00:01+10:00 https://pharmadispatch.com/news/spend-what-is-budgeted-says-sigmas-mark-hooper 2016-04-04T06:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-coag-focus-on-avoidance 2016-04-04T06:00:01+10:00 https://pharmadispatch.com/news/price-cuts-flow-through-to-private-market 2016-04-04T06:00:01+10:00 https://pharmadispatch.com/news/soriot-if-sweden-does-it-why-cant-australia 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/leading-a-company-in-transition-1 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/companies-will-cut-rd-spending 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/pat-clear-award-goes-to-long-serving-msd-exec 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/include-pharmacy-in-health-care-home 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/industry-critic-questions-guidelines-development 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/bms-hiv-combination-pbs-listed-from-today 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/more-positive-news-for-specialised-therapeutics 2016-04-01T06:00:01+11:00 https://pharmadispatch.com/news/why-ceda-is-wrong 2016-03-31T06:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-gileads-taf-based-regimen-for-hiv 2016-03-31T06:00:01+11:00 https://pharmadispatch.com/news/confused-ceda-proposal-would-eliminate-spending-on-generics 2016-03-31T06:00:01+11:00 https://pharmadispatch.com/news/vertex-secures-wider-tga-approval-for-kalydeco 2016-03-31T06:00:01+11:00 https://pharmadispatch.com/news/nz-highest-melanoma-rates-and-worst-access-1 2016-03-31T06:00:01+11:00 https://pharmadispatch.com/news/government-set-to-announce-chronic-health-reform 2016-03-31T06:00:01+11:00 https://pharmadispatch.com/news/biosimilar-a-flags-by-inference 2016-03-30T06:00:01+11:00 https://pharmadispatch.com/news/pcfa-opens-funding-round 2016-03-30T06:00:01+11:00 https://pharmadispatch.com/news/private-equity-acquires-medical-director 2016-03-30T06:00:01+11:00 https://pharmadispatch.com/news/a-rather-glaring-omission-1 2016-03-30T06:00:01+11:00 https://pharmadispatch.com/news/demand-for-hcv-therapies-incredibly-high 2016-03-29T06:00:01+11:00 https://pharmadispatch.com/news/gileads-harvoni-dominates-early-weeks 2016-03-29T06:00:01+11:00 https://pharmadispatch.com/news/diverse-range-of-views-on-community-pharmacy 2016-03-29T06:00:01+11:00 https://pharmadispatch.com/news/msd-wins-hcv-patent-case 2016-03-29T06:00:01+11:00 https://pharmadispatch.com/news/tga-considers-report-on-codeine-combinations 2016-03-29T06:00:01+11:00 https://pharmadispatch.com/news/the-one-constant-is-change 2016-03-24T06:00:01+11:00 https://pharmadispatch.com/news/sigma-looks-to-hospital-pharmacy 2016-03-24T06:00:01+11:00 https://pharmadispatch.com/news/gsk-consumer-health-celebrates-first-year 2016-03-24T06:00:01+11:00 https://pharmadispatch.com/news/sta-donation-to-international-medical-training 2016-03-24T06:00:01+11:00 https://pharmadispatch.com/news/roche-pbs-reform-means-change 2016-03-23T06:00:01+11:00 https://pharmadispatch.com/news/consideration-of-delivery-charges-a-reality 2016-03-23T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-names-smith-family-their-charity-of-choice-for-2016 2016-03-23T06:00:01+11:00 https://pharmadispatch.com/news/playing-games-on-patent-term-extensions 2016-03-23T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-help-me-to-quit 2016-03-22T06:00:01+11:00 https://pharmadispatch.com/news/discounts-remain-an-institutionalised-feature-of-pbs-pricing 2016-03-22T06:00:01+11:00 https://pharmadispatch.com/news/leading-us-lipid-expert-backs-ezetimibe 2016-03-22T06:00:01+11:00 https://pharmadispatch.com/news/early-budget-and-election-means-change 2016-03-22T06:00:01+11:00 https://pharmadispatch.com/news/should-the-sector-unite-to-deal-with-challenging-times 2016-03-21T06:00:01+11:00 https://pharmadispatch.com/news/minister-announced-pharmacy-trials-without-recommendation 2016-03-21T06:00:01+11:00 https://pharmadispatch.com/news/gbma-very-pleased-with-agreement-and-gmwg 2016-03-21T06:00:01+11:00 https://pharmadispatch.com/news/the-complexity-of-rebates 2016-03-21T06:00:01+11:00 https://pharmadispatch.com/news/paul-spittle-a-time-of-change-and-humility 2016-03-21T06:00:01+11:00 https://pharmadispatch.com/news/the-drug-development-odd-couple 2016-03-21T06:00:01+11:00 https://pharmadispatch.com/news/a-complete-list 2016-03-18T06:00:01+11:00 https://pharmadispatch.com/news/sector-gives-gives-less-than-positive-assessment 2016-03-18T06:00:01+11:00 https://pharmadispatch.com/news/minister-never-expected-all-pharmacies-to-offer-discount 2016-03-18T06:00:01+11:00 https://pharmadispatch.com/news/fourth-approval-for-opdivo 2016-03-18T06:00:01+11:00 https://pharmadispatch.com/news/biosimilars-take-centre-stage-at-app 2016-03-17T16:12:01+11:00 https://pharmadispatch.com/news/new-zealanders-waiting-too-long 2016-03-17T06:00:01+11:00 https://pharmadispatch.com/news/us-patent-win-for-amgen 2016-03-17T06:00:01+11:00 https://pharmadispatch.com/news/ma-leaders-commend-associations-new-approach 2016-03-16T16:50:01+11:00 https://pharmadispatch.com/news/government-must-act-on-research-and-access 2016-03-16T06:00:01+11:00 https://pharmadispatch.com/news/az-welcomes-lynparnza-registration 2016-03-16T06:00:01+11:00 https://pharmadispatch.com/news/online-sector-dominates-innovation-and-science-australia-board 2016-03-16T06:00:01+11:00 https://pharmadispatch.com/news/choosing-wisely-issues-latest-recommendations 2016-03-16T06:00:01+11:00 https://pharmadispatch.com/news/could-hardly-have-been-more-different 2016-03-16T06:00:01+11:00 https://pharmadispatch.com/news/health-minister-sussan-leys-speech-to-ma-dinner 2016-03-16T06:00:01+11:00 https://pharmadispatch.com/news/industry-questions-new-pbac-guidelines 2016-03-16T06:00:01+11:00 https://pharmadispatch.com/news/april-pbs-schedule-update 2016-03-15T06:00:01+11:00 https://pharmadispatch.com/news/at-least-one-empty-chair 2016-03-15T06:00:01+11:00 https://pharmadispatch.com/news/gbma-adds-another-member 2016-03-15T06:00:01+11:00 https://pharmadispatch.com/news/how-low-can-they-go 2016-03-15T06:00:01+11:00 https://pharmadispatch.com/news/immuno-oncology-changing-the-way-companies-operate 2016-03-14T06:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-completely-overwhelmed 2016-03-14T06:00:01+11:00 https://pharmadispatch.com/news/industry-contribution-astonishing 2016-03-14T06:00:01+11:00 https://pharmadispatch.com/news/the-pbs-as-a-safety-net 2016-03-14T06:00:01+11:00 https://pharmadispatch.com/news/all-ears-on-sussan-ley 2016-03-14T06:00:01+11:00 https://pharmadispatch.com/news/gallagher-infliximab-a-flag-the-right-decision 2016-03-11T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-investment-and-jobs-for-south-australia 2016-03-11T06:00:01+11:00 https://pharmadispatch.com/news/ferris-australia-dead-last-on-collaboration 2016-03-11T06:00:01+11:00 https://pharmadispatch.com/news/patient-groups-back-industry 2016-03-11T06:00:01+11:00 https://pharmadispatch.com/news/cook-start-reform-discussions-with-the-outcome-in-mind 2016-03-10T10:00:01+11:00 https://pharmadispatch.com/news/potential-double-dissolution-means-more-uncertainty 2016-03-10T06:00:01+11:00 https://pharmadispatch.com/news/parallel-process-for-orkambi 2016-03-10T06:00:01+11:00 https://pharmadispatch.com/news/emerging-supply-chain-pressures 2016-03-10T06:00:01+11:00 https://pharmadispatch.com/news/pyne-abbvie-backed-therapy-evidence-of-success 2016-03-10T06:00:01+11:00 https://pharmadispatch.com/news/industry-groups-back-rd-tax-incentive 2016-03-09T06:00:01+11:00 https://pharmadispatch.com/news/baxalta-focussed-on-innovation 2016-03-09T06:00:01+11:00 https://pharmadispatch.com/news/pharmac-and-the-facts 2016-03-09T06:00:01+11:00 https://pharmadispatch.com/news/shocked-at-the-change-says-cf-patient 2016-03-09T06:00:01+11:00 https://pharmadispatch.com/news/new-addition-for-maestro 2016-03-08T06:00:01+11:00 https://pharmadispatch.com/news/the-time-is-now-for-social 2016-03-08T06:00:01+11:00 https://pharmadispatch.com/news/health-and-medical-rd-in-top-tier 2016-03-08T06:00:01+11:00 https://pharmadispatch.com/news/gsk-responds-to-tropical-cyclone-winston-in-fiji 2016-03-08T06:00:01+11:00 https://pharmadispatch.com/news/department-drops-five-page-limit 2016-03-08T06:00:01+11:00 https://pharmadispatch.com/news/csl-announces-new-translation-hub-for-melbourne 2016-03-08T06:00:01+11:00 https://pharmadispatch.com/news/five-page-limit-ridiculous 2016-03-07T06:00:01+11:00 https://pharmadispatch.com/news/new-dusc-reports-published 2016-03-07T06:00:01+11:00 https://pharmadispatch.com/news/a-matter-of-interpretation-on-insulin-glargine 2016-03-07T06:00:01+11:00 https://pharmadispatch.com/news/pbac-set-for-significant-meeting 2016-03-07T06:00:01+11:00 https://pharmadispatch.com/news/standing-room-only-for-pbs-reform-briefing 2016-03-07T06:00:01+11:00 https://pharmadispatch.com/news/large-numbers-expected-at-briefing 2016-03-04T06:00:01+11:00 https://pharmadispatch.com/news/greens-shoots-expose-the-reality 2016-03-04T06:00:01+11:00 https://pharmadispatch.com/news/95m-for-over-treatment-study 2016-03-04T06:00:01+11:00 https://pharmadispatch.com/news/australia-takes-centre-stage-at-conference 2016-03-04T06:00:01+11:00 https://pharmadispatch.com/news/medicine-maze-confusing-for-cancer-patients 2016-03-03T06:00:01+11:00 https://pharmadispatch.com/news/we-must-be-positive-and-pragmatic 2016-03-03T06:00:01+11:00 https://pharmadispatch.com/news/pharmac-faces-growing-criticism 2016-03-03T06:00:01+11:00 https://pharmadispatch.com/news/rebates-hit-by-data-problems 2016-03-03T06:00:01+11:00 https://pharmadispatch.com/news/pbs-rebates-set-to-hit-1-billion 2016-03-02T06:00:01+11:00 https://pharmadispatch.com/news/companies-activate-on-new-pbac-guidelines 2016-03-02T06:00:01+11:00 https://pharmadispatch.com/news/senateshj-appoints-new-healthcare-boss 2016-03-02T06:00:01+11:00 https://pharmadispatch.com/news/pcfa-and-anzup-announce-joint-prostate-cancer-fight 2016-03-02T06:00:01+11:00 https://pharmadispatch.com/news/lundbeck-announces-new-australian-leadership 2016-03-02T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-chips-in-to-clean-up-local-environment 2016-03-02T06:00:01+11:00 https://pharmadispatch.com/news/industry-marks-biggest-ever-pbs-listing 2016-03-01T06:00:01+11:00 https://pharmadispatch.com/news/experts-want-action-on-treatment-rates 2016-03-01T06:00:01+11:00 https://pharmadispatch.com/news/a-watershed-moment-says-sussan-ley 2016-03-01T06:00:01+11:00 https://pharmadispatch.com/news/gallagher-a-tangible-example-of-what-industry-can-do 2016-03-01T06:00:01+11:00 https://pharmadispatch.com/news/tolmar-partners-with-nz-diagnostics-company 2016-03-01T06:00:01+11:00 https://pharmadispatch.com/news/eu-recommends-approval-for-csls-idelvion 2016-03-01T06:00:01+11:00 https://pharmadispatch.com/news/industry-gets-behind-pollie-pedal 2016-02-29T06:00:01+11:00 https://pharmadispatch.com/news/mp-backs-patient-push-for-access 2016-02-29T06:00:01+11:00 https://pharmadispatch.com/news/australia-must-protect-its-record-on-access-to-hiv-medicines 2016-02-29T06:00:01+11:00 https://pharmadispatch.com/news/laws-might-need-to-change 2016-02-29T06:00:01+11:00 https://pharmadispatch.com/news/bayer-reports-record-sales-and-calls-on-eu-to-back-innovation 2016-02-29T06:00:01+11:00 https://pharmadispatch.com/news/room-with-a-patient-view 2016-02-26T06:00:01+11:00 https://pharmadispatch.com/news/minister-set-to-announce-prostheses-reforms 2016-02-26T06:00:01+11:00 https://pharmadispatch.com/news/staff-the-big-winners-from-blackmores-result 2016-02-26T06:00:01+11:00 https://pharmadispatch.com/news/australia-tops-global-pain-index 2016-02-26T06:00:01+11:00 https://pharmadispatch.com/news/australian-groups-win-vertex-cf-grants 2016-02-26T06:00:01+11:00 https://pharmadispatch.com/news/jj-ranked-most-innovative 2016-02-26T06:00:01+11:00 https://pharmadispatch.com/news/companies-welcome-flu-vax-forum 2016-02-25T06:00:01+11:00 https://pharmadispatch.com/news/investor-boost-for-ebos-after-result 2016-02-25T06:00:01+11:00 https://pharmadispatch.com/news/greens-senator-backs-clinical-trials 2016-02-25T06:00:01+11:00 https://pharmadispatch.com/news/new-campaign-aims-to-raise-awareness-of-home-gp-visits 2016-02-25T06:00:01+11:00 https://pharmadispatch.com/news/medical-channel-acquires-medical-media 2016-02-24T05:00:01+11:00 https://pharmadispatch.com/news/ongoing-debate-over-tpp 2016-02-24T05:00:01+11:00 https://pharmadispatch.com/news/give-pharmacy-a-greater-role-guild-tells-inquiry 2016-02-24T05:00:01+11:00 https://pharmadispatch.com/news/new-osteoporosis-therapy-shines-in-study 2016-02-24T05:00:01+11:00 https://pharmadispatch.com/news/bms-confirms-new-gm 2016-02-24T05:00:01+11:00 https://pharmadispatch.com/news/australians-back-pbs-and-oppose-cuts 2016-02-23T06:00:01+11:00 https://pharmadispatch.com/news/consumers-rejecting-pbs-discount 2016-02-23T06:00:01+11:00 https://pharmadispatch.com/news/industry-exec-to-lead-growth-centre 2016-02-23T06:00:01+11:00 https://pharmadispatch.com/news/gsk-brings-researchers-in-house 2016-02-23T06:00:01+11:00 https://pharmadispatch.com/news/more-leadership-change-for-industry 2016-02-23T06:00:01+11:00 https://pharmadispatch.com/news/tga-approves-entresto-as-novartis-signals-pricing-innovation 2016-02-22T18:00:01+11:00 https://pharmadispatch.com/news/sussan-ley-leading-trade-delegation-as-department-strikes 2016-02-22T06:00:01+11:00 https://pharmadispatch.com/news/an-embarrassing-joke-for-sussan-ley-if-it-werent-so-serious 2016-02-22T06:00:01+11:00 https://pharmadispatch.com/news/industry-concern-over-comparators 2016-02-22T06:00:01+11:00 https://pharmadispatch.com/news/the-extreme-parallel-process 2016-02-22T06:00:01+11:00 https://pharmadispatch.com/news/guild-rejects-co-pay-discount-criticism 2016-02-22T06:00:01+11:00 https://pharmadispatch.com/news/department-directs-the-playbook-against-device-sector 2016-02-19T06:00:01+11:00 https://pharmadispatch.com/news/new-guidelines-set-for-public-consultation 2016-02-19T06:00:01+11:00 https://pharmadispatch.com/news/australias-new-trade-minister 2016-02-19T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-still-searching-for-australian-innovation 2016-02-18T06:00:01+11:00 https://pharmadispatch.com/news/sigma-renews-relationship-with-chemist-warehouse 2016-02-18T06:00:01+11:00 https://pharmadispatch.com/news/delistings-and-higher-patient-costs-inevitable 2016-02-18T06:00:01+11:00 https://pharmadispatch.com/news/breakthrough-designation-for-az-pd-l1 2016-02-18T06:00:01+11:00 https://pharmadispatch.com/news/a-strong-start-for-csl-in-its-centenary-year 2016-02-17T06:00:01+11:00 https://pharmadispatch.com/news/stakeholder-meetings-long-and-detailed 2016-02-17T06:00:01+11:00 https://pharmadispatch.com/news/nostradata-lacklustre-start-with-more-pain-to-come 2016-02-17T06:00:01+11:00 https://pharmadispatch.com/news/health-set-savings-target 2016-02-17T06:00:01+11:00 https://pharmadispatch.com/news/goes-to-work-on-biosimilars 2016-02-16T06:00:01+11:00 https://pharmadispatch.com/news/survival-up-as-cancer-cases-triple 2016-02-16T06:00:01+11:00 https://pharmadispatch.com/news/former-industry-minister-announces-resignation 2016-02-16T06:00:01+11:00 https://pharmadispatch.com/news/companies-get-behind-rare-cancers-climb 2016-02-16T06:00:01+11:00 https://pharmadispatch.com/news/stick-with-australian-products-says-asmi 2016-02-16T06:00:01+11:00 https://pharmadispatch.com/news/australian-talent-making-a-difference 2016-02-15T06:00:01+11:00 https://pharmadispatch.com/news/ex-gsk-executive-promoted-to-ministry 2016-02-15T06:00:01+11:00 https://pharmadispatch.com/news/ma-rejected-5-compromise-solution 2016-02-15T06:00:01+11:00 https://pharmadispatch.com/news/ex-pfixer-rd-head-joins-la-trobe 2016-02-15T06:00:01+11:00 https://pharmadispatch.com/news/pharmacists-training-to-administer-flu-vax 2016-02-15T06:00:01+11:00 https://pharmadispatch.com/news/shire-focussed-on-integrating-new-assets 2016-02-15T06:00:01+11:00 https://pharmadispatch.com/news/anniversary-of-the-meeting-that-changed-everything 2016-02-12T06:00:01+11:00 https://pharmadispatch.com/news/bi-confirms-new-diabetes-listing 2016-02-12T06:00:01+11:00 https://pharmadispatch.com/news/collaboration-on-hcv-therapies-critical 2016-02-12T06:00:01+11:00 https://pharmadispatch.com/news/labor-cautious-on-tpp 2016-02-12T06:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-baxter 2016-02-11T06:00:01+11:00 https://pharmadispatch.com/news/department-shifts-argument-on-pandaol-osteo 2016-02-11T06:00:01+11:00 https://pharmadispatch.com/news/pbs-schedule-confirms-march-hep-c-listing 2016-02-11T06:00:01+11:00 https://pharmadispatch.com/news/pharmacy-facing-a-challenging-year 2016-02-11T06:00:01+11:00 https://pharmadispatch.com/news/andrew-robb-to-retire-at-election 2016-02-11T06:00:01+11:00 https://pharmadispatch.com/news/payment-system-needs-to-be-modernised-says-minister 2016-02-10T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-allergan-post-merger-global-leadership 2016-02-10T06:00:01+11:00 https://pharmadispatch.com/news/asmi-calls-for-reform-of-ip 2016-02-10T06:00:01+11:00 https://pharmadispatch.com/news/medicinal-cannabis-legislation-introduced-today 2016-02-10T06:00:01+11:00 https://pharmadispatch.com/news/wes-cook-board-seeking-feedback-on-review 2016-02-09T06:06:01+11:00 https://pharmadispatch.com/news/uk-recommends-amgens-repatha 2016-02-09T06:00:01+11:00 https://pharmadispatch.com/news/ma-ceo-truly-excited-about-role 2016-02-09T06:00:01+11:00 https://pharmadispatch.com/news/promotion-for-mercks-andre-musto 2016-02-09T06:00:01+11:00 https://pharmadispatch.com/news/ma-and-psa-budget-submissions 2016-02-09T06:00:01+11:00 https://pharmadispatch.com/news/a-procurement-policy-developing 2016-02-08T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-finalises-new-organisation 2016-02-08T06:00:01+11:00 https://pharmadispatch.com/news/officials-face-senate-questions 2016-02-08T06:00:01+11:00 https://pharmadispatch.com/news/a-year-of-transition-for-az 2016-02-08T06:00:01+11:00 https://pharmadispatch.com/news/department-gets-familiar-with-its-market-power 2016-02-08T06:00:01+11:00 https://pharmadispatch.com/news/overwhelming-response-backs-ma-review 2016-02-05T06:00:01+11:00 https://pharmadispatch.com/news/tga-approves-first-asthma-biologic 2016-02-05T06:00:01+11:00 https://pharmadispatch.com/news/new-senior-appointment-for-commercial-eyes 2016-02-05T06:00:01+11:00 https://pharmadispatch.com/news/msd-looks-to-new-therapies 2016-02-05T06:00:01+11:00 https://pharmadispatch.com/news/doubts-remains-as-ministers-sign-tpp 2016-02-05T06:00:01+11:00 https://pharmadispatch.com/news/minister-links-jakavi-listing-to-innovation-agenda 2016-02-05T06:00:01+11:00 https://pharmadispatch.com/news/is-the-board-really-the-problem 2016-02-04T06:00:01+11:00 https://pharmadispatch.com/news/no-justification-for-new-savings-says-medicines-partnership 2016-02-04T06:00:01+11:00 https://pharmadispatch.com/news/new-therapy-for-specialised-therapeutics 2016-02-04T06:00:01+11:00 https://pharmadispatch.com/news/make-changes-but-keep-codeine-in-pharmacy-says-asmi 2016-02-04T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-boosted-by-hospira-oncology-and-vaccines 2016-02-04T06:00:01+11:00 https://pharmadispatch.com/news/pbs-not-protected-from-further-savings 2016-02-03T06:00:01+11:00 https://pharmadispatch.com/news/more-change-inside-the-department-of-health 2016-02-03T06:00:01+11:00 https://pharmadispatch.com/news/batch-of-pbs-listed-diuretic-recalled 2016-02-03T06:00:01+11:00 https://pharmadispatch.com/news/pbs-spending-per-person-plummets 2016-02-03T06:00:01+11:00 https://pharmadispatch.com/news/department-confirms-limits-of-5-cut 2016-02-02T06:00:01+11:00 https://pharmadispatch.com/news/treasury-quantifies-gst-on-medicines 2016-02-02T06:00:01+11:00 https://pharmadispatch.com/news/sector-support-for-political-process 2016-02-02T06:00:01+11:00 https://pharmadispatch.com/news/listing-welcome-but-process-still-a-problem 2016-02-02T06:00:01+11:00 https://pharmadispatch.com/news/humira-continues-to-drive-abbvie-growth 2016-02-02T06:00:01+11:00 https://pharmadispatch.com/news/think-about-the-value-of-others-first 2016-02-01T06:00:01+11:00 https://pharmadispatch.com/news/treasury-secretary-joins-offset-chorus 2016-02-01T06:00:01+11:00 https://pharmadispatch.com/news/gbma-scraps-spending-reports 2016-02-01T06:00:01+11:00 https://pharmadispatch.com/news/chf-says-scrap-co-pay-hike-1 2016-02-01T06:00:01+11:00 https://pharmadispatch.com/news/some-good-news-for-ma-on-biosimilars 2016-02-01T06:00:01+11:00 https://pharmadispatch.com/news/results-amgen-and-lilly 2016-02-01T06:00:01+11:00 https://pharmadispatch.com/news/api-retail-grows-as-dispensary-declines 2016-01-29T06:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-confirms-diabetes-therapy-now-approved-for-weight-l 2016-01-29T06:00:01+11:00 https://pharmadispatch.com/news/msd-licenses-australian-cancer-discovery 2016-01-29T06:00:01+11:00 https://pharmadispatch.com/news/board-changes-for-asmi 2016-01-29T06:00:01+11:00 https://pharmadispatch.com/news/first-board-meeting-for-new-ceo 2016-01-29T06:00:01+11:00 https://pharmadispatch.com/news/financial-results-bms-and-biogen 2016-01-29T06:00:01+11:00 https://pharmadispatch.com/news/cpi-reports-pharmaceutical-price-drop 2016-01-28T06:00:01+11:00 https://pharmadispatch.com/news/whats-in-a-name 2016-01-28T06:00:01+11:00 https://pharmadispatch.com/news/uk-says-no-to-infliximab-substitution 2016-01-28T06:00:01+11:00 https://pharmadispatch.com/news/sigma-to-offer-hearing-checks 2016-01-28T06:00:01+11:00 https://pharmadispatch.com/news/gmwg-communiques-give-little-away 2016-01-28T06:00:01+11:00 https://pharmadispatch.com/news/currency-and-alcon-hit-to-novartis-growth 2016-01-28T06:00:01+11:00 https://pharmadispatch.com/news/msds-fiedler-proud-of-cultural-transformation 2016-01-27T06:00:01+11:00 https://pharmadispatch.com/news/official-recognised-for-modernising-pbs 2016-01-27T06:00:01+11:00 https://pharmadispatch.com/news/fda-sets-biosimilar-review-date 2016-01-27T06:00:01+11:00 https://pharmadispatch.com/news/jj-reports-higher-profit-despite-currency-impact 2016-01-27T06:00:01+11:00 https://pharmadispatch.com/news/nz-could-be-a-canary-in-the-coal-mine-for-australia 2016-01-25T06:00:01+11:00 https://pharmadispatch.com/news/companies-want-action-on-antibiotics 2016-01-25T06:00:01+11:00 https://pharmadispatch.com/news/competition-driving-down-private-prices 2016-01-25T06:00:01+11:00 https://pharmadispatch.com/news/gavi-commits-to-msd-ebola-vaccine 2016-01-25T06:00:01+11:00 https://pharmadispatch.com/news/massive-panadol-osteo-switch-in-2016 2016-01-22T06:07:01+11:00 https://pharmadispatch.com/news/one-new-medicine-for-new-zealand-patients-in-2015 2016-01-22T06:00:01+11:00 https://pharmadispatch.com/news/perception-and-reality-when-it-comes-to-vaccination 2016-01-22T06:00:01+11:00 https://pharmadispatch.com/news/ma-board-gets-underway-in-2016 2016-01-22T06:00:01+11:00 https://pharmadispatch.com/news/changes-not-limited-to-industry 2016-01-21T06:00:01+11:00 https://pharmadispatch.com/news/consumers-facing-panadol-osteo-price-rise 2016-01-21T06:00:01+11:00 https://pharmadispatch.com/news/cancer-medicines-making-headlines-again 2016-01-21T06:00:01+11:00 https://pharmadispatch.com/news/lundbeck-still-in-pursuit-of-damages 2016-01-21T06:00:01+11:00 https://pharmadispatch.com/news/the-smart-move-is-very-clear 2016-01-20T06:00:01+11:00 https://pharmadispatch.com/news/financial-loss-as-funding-cut-hits-consumer-body 2016-01-20T06:00:01+11:00 https://pharmadispatch.com/news/farmaforce-appoints-first-pharmacy-team 2016-01-20T06:00:01+11:00 https://pharmadispatch.com/news/michael-wonder-pbac-and-pbs-in-2015 2016-01-20T06:00:01+11:00 https://pharmadispatch.com/news/promotion-for-ex-novartis-australia-boss 2016-01-20T06:00:01+11:00 https://pharmadispatch.com/news/patients-want-panadol-osteo-review 2016-01-19T06:00:01+11:00 https://pharmadispatch.com/news/michael-wonder-looks-at-cancer-approvals 2016-01-19T06:00:01+11:00 https://pharmadispatch.com/news/another-biosimilar-fast-approaching 2016-01-19T06:00:01+11:00 https://pharmadispatch.com/news/generics-dominate-february-pbs-schedule-update 2016-01-19T06:00:01+11:00 https://pharmadispatch.com/news/lundbecks-di-carlo-promoted-to-us 2016-01-18T10:27:01+11:00 https://pharmadispatch.com/news/michael-wonder-looks-back-at-2015-tga-approvals 2016-01-18T06:00:01+11:00 https://pharmadispatch.com/news/who-is-really-misleading-consumers-on-panadol-osteo 2016-01-18T06:00:01+11:00 https://pharmadispatch.com/news/combinations-obliterated-by-price-cuts 2016-01-18T06:00:01+11:00 https://pharmadispatch.com/news/french-study-shut-down-after-serious-adverse-events 2016-01-18T06:00:01+11:00 https://pharmadispatch.com/news/questions-emerge-over-price-cuts 2016-01-18T06:00:01+11:00 https://pharmadispatch.com/news/gsk-new-approach-drives-organisational-change 2016-01-15T06:00:01+11:00 https://pharmadispatch.com/news/who-is-the-ma-interim-ceo 2016-01-15T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-structures-for-potential-split 2016-01-15T06:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-interim-ceo 2016-01-14T09:09:01+11:00 https://pharmadispatch.com/news/savings-outstrip-cost-of-new-listings 2016-01-14T06:00:01+11:00 https://pharmadispatch.com/news/psa-leadership-program 2016-01-14T06:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-bms-immunotherapy 2016-01-14T06:00:01+11:00 https://pharmadispatch.com/news/priceline-partners-with-kyrgios 2016-01-14T06:00:01+11:00 https://pharmadispatch.com/news/patient-anger-palpable-says-guild 2016-01-14T06:00:01+11:00 https://pharmadispatch.com/news/still-no-word-on-pbac-member 2016-01-13T06:00:01+11:00 https://pharmadispatch.com/news/gilead-funds-nine-research-projects 2016-01-13T06:00:01+11:00 https://pharmadispatch.com/news/msd-acquires-uk-based-cancer-company 2016-01-13T06:00:01+11:00 https://pharmadispatch.com/news/greens-want-faster-action-on-prep 2016-01-13T06:00:01+11:00 https://pharmadispatch.com/news/response-raises-more-questions 2016-01-12T06:00:01+11:00 https://pharmadispatch.com/news/looking-ahead-and-beyond-2016 2016-01-12T06:00:01+11:00 https://pharmadispatch.com/news/jakavi-listing-date-confirmed 2016-01-12T06:00:01+11:00 https://pharmadispatch.com/news/shire-and-baxalta-agree-merger 2016-01-12T06:00:01+11:00 https://pharmadispatch.com/news/new-cabinet-documents-reveal-how-little-things-have-changed 2016-01-11T06:00:01+11:00 https://pharmadispatch.com/news/government-knew-about-higher-panadol-costs 2016-01-11T06:00:01+11:00 https://pharmadispatch.com/news/wholesalers-target-review-with-new-leadership 2016-01-11T06:00:01+11:00 https://pharmadispatch.com/news/pbac-wants-parallel-process-change 2016-01-11T06:00:01+11:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-march-pbac 2016-01-11T06:00:01+11:00 https://pharmadispatch.com/news/shire-set-to-announce-baxalta-takeover 2016-01-11T06:00:01+11:00 https://pharmadispatch.com/news/looking-ahead-to-2016 2016-01-04T00:21:01+11:00 https://pharmadispatch.com/news/csl-still-considering-ma-future 2015-12-23T06:00:01+11:00 https://pharmadispatch.com/news/undertainty-over-2016-private-flu-vax-market 2015-12-23T06:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-sanofi 2015-12-23T06:00:01+11:00 https://pharmadispatch.com/news/uk-industry-restructures-rebates 2015-12-23T06:00:01+11:00 https://pharmadispatch.com/news/departing-soelberg-cautiously-optimistic 2015-12-22T06:00:01+11:00 https://pharmadispatch.com/news/more-support-hcv-listings 2015-12-22T06:00:01+11:00 https://pharmadispatch.com/news/no-progress-on-national-rare-disease-plan 2015-12-22T06:00:01+11:00 https://pharmadispatch.com/news/ma-begins-the-search 2015-12-22T06:00:01+11:00 https://pharmadispatch.com/news/time-to-start-listening 2015-12-21T06:00:01+11:00 https://pharmadispatch.com/news/maestro-breaks-down-november-pbac-outcomes 2015-12-21T06:00:01+11:00 https://pharmadispatch.com/news/hcv-listings-simply-terrific 2015-12-21T06:00:01+11:00 https://pharmadispatch.com/news/ato-information-dump-corporate-assassination 2015-12-21T06:00:01+11:00 https://pharmadispatch.com/news/cook-time-to-look-ahead 2015-12-21T06:00:01+11:00 https://pharmadispatch.com/news/over-1-billion-for-hep-c-medicines 2015-12-20T05:31:01+11:00 https://pharmadispatch.com/news/pbac-extends-access-to-soliris 2015-12-18T15:22:01+11:00 https://pharmadispatch.com/news/lilly-says-no-on-insulin-glargine 2015-12-18T12:52:01+11:00 https://pharmadispatch.com/news/tim-james-departs-ma 2015-12-18T11:29:01+11:00 https://pharmadispatch.com/news/rd-returns-challenged-by-high-costs 2015-12-18T06:00:01+11:00 https://pharmadispatch.com/news/wood-we-have-a-lot-in-common 2015-12-18T06:00:01+11:00 https://pharmadispatch.com/news/astellas-to-seek-wider-listing-for-xtandi 2015-12-18T06:00:01+11:00 https://pharmadispatch.com/news/new-tga-biosimilar-guideline 2015-12-18T06:00:01+11:00 https://pharmadispatch.com/news/ato-reveals-company-tax-list 2015-12-18T06:00:01+11:00 https://pharmadispatch.com/news/more-positive-new-for-pharmaxis 2015-12-17T06:00:01+11:00 https://pharmadispatch.com/news/ministers-only-looking-at-one-side-of-the-equation 2015-12-17T06:00:01+11:00 https://pharmadispatch.com/news/1-april-price-disclosure-cuts-just-the-beginning 2015-12-17T05:53:01+11:00 https://pharmadispatch.com/news/wood-we-understood-the-consequences-of-not-having-an-agreement 2015-12-16T15:35:01+11:00 https://pharmadispatch.com/news/gsk-vaccine-manufacturing-boost 2015-12-16T10:29:01+11:00 https://pharmadispatch.com/news/myefo-passes-with-no-mention-of-hep-c 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/pbs-cuts-not-even-news-anymore 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/rd-tax-claims-soar 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/pbs-cut-feeds-into-health-spending 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/another-tender-in-health 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/more-detail-on-translation-fund 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/government-scraps-blood-merger 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-and-bi-in-20-billion-asset-swap 2015-12-16T06:00:01+11:00 https://pharmadispatch.com/news/pbs-down-again 2015-12-15T12:54:01+11:00 https://pharmadispatch.com/news/amgen-moves-into-primary-care 2015-12-15T08:00:01+11:00 https://pharmadispatch.com/news/gbma-adds-new-board-members 2015-12-15T06:00:01+11:00 https://pharmadispatch.com/news/pbs-money-goes-elsewhere 2015-12-15T06:00:01+11:00 https://pharmadispatch.com/news/court-backs-accc-on-nurofen 2015-12-15T06:00:01+11:00 https://pharmadispatch.com/news/biosimilars-savings-soar-by-end-of-decade 2015-12-15T06:00:01+11:00 https://pharmadispatch.com/news/still-waiting-for-lsdp-review-report 2015-12-15T06:00:01+11:00 https://pharmadispatch.com/news/guild-cautions-on-co-pay-discounts 2015-12-15T06:00:01+11:00 https://pharmadispatch.com/news/department-publishes-additional-pbac-outcomes 2015-12-14T06:00:01+11:00 https://pharmadispatch.com/news/sector-prepares-for-budget-update 2015-12-14T06:00:01+11:00 https://pharmadispatch.com/news/industry-executive-to-lead-private-health-funds 2015-12-14T06:00:01+11:00 https://pharmadispatch.com/news/az-set-for-another-acquisition 2015-12-14T06:00:01+11:00 https://pharmadispatch.com/news/were-heading-in-the-right-direction-says-hourigan 2015-12-14T06:00:01+11:00 https://pharmadispatch.com/news/another-leader-heads-overseas 2015-12-14T06:00:01+11:00 https://pharmadispatch.com/news/another-leadership-change-for-industry 2015-12-11T10:39:01+11:00 https://pharmadispatch.com/news/job-swap-for-janssens-hourigan 2015-12-11T06:00:01+11:00 https://pharmadispatch.com/news/csl-ships-first-exports-from-new-manufacturing-facility 2015-12-11T06:00:01+11:00 https://pharmadispatch.com/news/msd-congratulates-nobel-prize-winner 2015-12-11T06:00:01+11:00 https://pharmadispatch.com/news/new-fund-will-grow-the-sector 2015-12-11T06:00:01+11:00 https://pharmadispatch.com/news/otc-delistings-dominate-january-pbs-update 2015-12-11T06:00:01+11:00 https://pharmadispatch.com/news/bait-and-switch-on-sustainability 2015-12-11T06:00:01+11:00 https://pharmadispatch.com/news/minister-says-a-lot-in-10-minutes 2015-12-10T06:00:01+11:00 https://pharmadispatch.com/news/minister-support-for-innovation-separate-to-pbs 2015-12-10T06:00:01+11:00 https://pharmadispatch.com/news/another-year-passes-for-co-pay-hike 2015-12-10T06:00:01+11:00 https://pharmadispatch.com/news/what-did-we-learn-yesterday 2015-12-10T06:00:01+11:00 https://pharmadispatch.com/news/a-busy-day-in-bennelong 2015-12-09T06:00:01+11:00 https://pharmadispatch.com/news/novartis-to-open-iconic-headquarters 2015-12-09T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-pleased-with-inflectra-progress 2015-12-09T06:00:01+11:00 https://pharmadispatch.com/news/department-reassures-patients-over-soliris-access 2015-12-09T06:00:01+11:00 https://pharmadispatch.com/news/court-backs-government-right-to-compensation 2015-12-08T06:00:01+11:00 https://pharmadispatch.com/news/minister-treasury-and-finance-dont-write-me-a-cheque-for-new-lis 2015-12-08T06:00:01+11:00 https://pharmadispatch.com/news/minister-officially-opens-abbvie-hq 2015-12-08T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-integrates-hospira 2015-12-08T06:00:01+11:00 https://pharmadispatch.com/news/commercialisation-the-first-step-for-mrff 2015-12-08T06:00:01+11:00 https://pharmadispatch.com/news/psa-announces-redevelopment-of-national-headquarters 2015-12-08T06:00:01+11:00 https://pharmadispatch.com/news/australia-must-do-more-on-innovation 2015-12-07T06:00:01+11:00 https://pharmadispatch.com/news/australia-under-prescribing-anticoagulants 2015-12-07T06:00:01+11:00 https://pharmadispatch.com/news/silence-on-biosimilars 2015-12-07T06:00:01+11:00 https://pharmadispatch.com/news/biosimilars-industry-forum-to-meet-department 2015-12-07T06:00:01+11:00 https://pharmadispatch.com/news/expanded-drug-funding-role-for-phi 2015-12-07T06:00:01+11:00 https://pharmadispatch.com/news/labor-announces-new-innovation-measures 2015-12-07T06:00:01+11:00 https://pharmadispatch.com/news/industry-finds-itself-in-a-familiar-position 2015-12-04T06:31:01+11:00 https://pharmadispatch.com/news/new-report-backs-impact-of-rd-tax-incentive 2015-12-04T06:00:01+11:00 https://pharmadispatch.com/news/higher-treatment-rates-drive-increase-in-hospitalisations 2015-12-04T06:00:01+11:00 https://pharmadispatch.com/news/tga-updates-champix-pi 2015-12-04T06:00:01+11:00 https://pharmadispatch.com/news/senate-backs-corporate-tax-changes 2015-12-04T06:00:01+11:00 https://pharmadispatch.com/news/senate-inquiry-recommends-new-innovation-agency 2015-12-04T06:00:01+11:00 https://pharmadispatch.com/news/change-a-constant-in-department-of-health 2015-12-03T06:00:01+11:00 https://pharmadispatch.com/news/gilead-confirms-truvada-tga-submission 2015-12-03T06:00:01+11:00 https://pharmadispatch.com/news/incarda-therapeutics-announces-australian-operation 2015-12-03T06:00:01+11:00 https://pharmadispatch.com/news/australia-set-to-follow-europe-on-biosimilar-enbrel 2015-12-03T06:00:01+11:00 https://pharmadispatch.com/news/the-infliximab-fact-sheet-and-the-facts 2015-12-02T06:00:01+11:00 https://pharmadispatch.com/news/biosimilar-focus-turns-to-prescribing-and-uptake 2015-12-02T06:00:01+11:00 https://pharmadispatch.com/news/strong-first-day-for-medadvisor 2015-12-02T06:00:01+11:00 https://pharmadispatch.com/news/minister-blames-a-company-over-access-again 2015-12-02T06:00:01+11:00 https://pharmadispatch.com/news/innovation-prime-minister-yes-please 2015-12-01T06:00:01+11:00 https://pharmadispatch.com/news/companies-back-hepatitis-australia 2015-12-01T06:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-extend-data-exclusivity-period 2015-12-01T06:00:01+11:00 https://pharmadispatch.com/news/another-2bn-for-mrff 2015-12-01T06:00:01+11:00 https://pharmadispatch.com/news/department-distributes-biosimilar-fact-sheet 2015-12-01T06:00:01+11:00 https://pharmadispatch.com/news/amgen-submits-biosimilar-humira-in-the-us 2015-11-30T06:00:01+11:00 https://pharmadispatch.com/news/december-almost-here-but-the-year-far-from-over 2015-11-30T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-moves-closer-to-sale-of-animal-health-unit 2015-11-30T06:00:01+11:00 https://pharmadispatch.com/news/msd-launches-website-resource-for-hcps 2015-11-30T06:00:01+11:00 https://pharmadispatch.com/news/shire-prepares-another-bid-for-baxalta 2015-11-30T06:00:01+11:00 https://pharmadispatch.com/news/new-second-line-treatment-for-metastatic-renal-cell-carcinoma 2015-11-27T06:00:01+11:00 https://pharmadispatch.com/news/victoria-expands-the-role-of-community-pharmacy 2015-11-27T06:00:01+11:00 https://pharmadispatch.com/news/pbs-drug-use-varies-across-australia1 2015-11-27T06:00:01+11:00 https://pharmadispatch.com/news/stakeholder-support-for-mental-health-reforms 2015-11-27T06:00:01+11:00 https://pharmadispatch.com/news/department-releases-new-stakeholder-engagement-framework 2015-11-27T06:00:01+11:00 https://pharmadispatch.com/news/innovation-about-more-than-apps 2015-11-26T06:00:01+11:00 https://pharmadispatch.com/news/novartis-australia-brings-patients-closer-to-clinical-trial-desi 2015-11-26T06:00:01+11:00 https://pharmadispatch.com/news/review-sets-pharmacy-battlelines 2015-11-26T06:00:01+11:00 https://pharmadispatch.com/news/lucy-turnbull-sticks-with-prima-biomed 2015-11-26T06:00:01+11:00 https://pharmadispatch.com/news/us-unhappy-but-pfizer-allergan-a-big-tax-win-for-ireland 2015-11-26T06:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-the-latest-to-announce-job-cuts 2015-11-25T06:00:01+11:00 https://pharmadispatch.com/news/accc-fines-epharmacy-group 2015-11-25T06:00:01+11:00 https://pharmadispatch.com/news/for-benefit-medicines-launches-with-breast-cancer-therapies 2015-11-25T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-allergan-merger-could-face-new-regulatory-hurdles 2015-11-25T06:00:01+11:00 https://pharmadispatch.com/news/economic-benefit-of-vitamin-b3-supplementation 2015-11-25T06:00:01+11:00 https://pharmadispatch.com/news/pharmacy-review-panel-a-mixed-bag 2015-11-25T06:00:01+11:00 https://pharmadispatch.com/news/lichtenberg-a-rather-striking-result-in-australia 2015-11-24T06:00:01+11:00 https://pharmadispatch.com/news/get-this-right-and-many-problems-might-go-away 2015-11-24T06:00:01+11:00 https://pharmadispatch.com/news/new-study-shows-dire-need-for-access 2015-11-24T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-and-allergan-announce-merger 2015-11-24T06:00:01+11:00 https://pharmadispatch.com/news/rey-highlights-of-the-lichtenberg-study 2015-11-24T06:00:01+11:00 https://pharmadispatch.com/news/csl-subsidiary-launches-first-product-under-new-name-2 2015-11-24T06:00:01+11:00 https://pharmadispatch.com/news/merger-going-ahead-despite-us-tax-change 2015-11-23T06:00:01+11:00 https://pharmadispatch.com/news/panel-sticks-with-current-s3-restrictions 2015-11-23T06:00:01+11:00 https://pharmadispatch.com/news/give-tga-right-to-refuse-listing 2015-11-23T06:00:01+11:00 https://pharmadispatch.com/news/government-should-create-incentives-for-innovation 2015-11-23T06:00:01+11:00 https://pharmadispatch.com/news/journey-to-the-heart-of-australia 2015-11-23T06:00:01+11:00 https://pharmadispatch.com/news/reviews-missed-the-boat-on-advertising 2015-11-23T04:45:01+11:00 https://pharmadispatch.com/news/policyhack-outcomes-back-ip-and-rd-tax-change 2015-11-20T06:00:01+11:00 https://pharmadispatch.com/news/melbourne-researchers-win-gsk-award-for-research-excellence 2015-11-20T06:00:01+11:00 https://pharmadispatch.com/news/tga-buys-time-on-codeine-scheduling-change 2015-11-20T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-and-allergan-in-final-stages-of-merger-talks 2015-11-20T06:00:01+11:00 https://pharmadispatch.com/news/ims-and-nostradata-announce-joint-venture 2015-11-19T06:00:01+11:00 https://pharmadispatch.com/news/research-australia-awards-2 2015-11-19T06:00:01+11:00 https://pharmadispatch.com/news/a-factsheet-for-biosimilar-implementation-plan 2015-11-19T06:00:01+11:00 https://pharmadispatch.com/news/pbac-challenged-on-infliximab-assumptions 2015-11-18T06:00:01+11:00 https://pharmadispatch.com/news/tga-approves-new-antibiotic-1 2015-11-18T06:00:01+11:00 https://pharmadispatch.com/news/new-chair-of-innovation-australia-1 2015-11-18T06:00:01+11:00 https://pharmadispatch.com/news/self-care-the-sustainable-option 2015-11-18T06:00:01+11:00 https://pharmadispatch.com/news/export-the-pbs-to-china 2015-11-18T06:00:01+11:00 https://pharmadispatch.com/news/we-all-only-get-a-certain-number-of-neurons 2015-11-17T06:00:01+11:00 https://pharmadispatch.com/news/history-is-the-guide-on-biosimilar-policy 2015-11-17T06:00:01+11:00 https://pharmadispatch.com/news/another-acquisition-for-ebos 2015-11-17T06:00:01+11:00 https://pharmadispatch.com/news/are-australians-slowly-getting-it-on-antibiotics 2015-11-17T06:00:01+11:00 https://pharmadispatch.com/news/dusc-notes-higher-than-expected-use-of-pain-therapy 2015-11-16T06:00:01+11:00 https://pharmadispatch.com/news/further-restrictions-on-benzodiazepine 2015-11-16T06:00:01+11:00 https://pharmadispatch.com/news/ma-single-committee-for-co-dependent-technologies 2015-11-16T06:00:01+11:00 https://pharmadispatch.com/news/from-science-to-market 2015-11-16T06:00:01+11:00 https://pharmadispatch.com/news/supporting-the-heart-of-australia 2015-11-16T06:00:01+11:00 https://pharmadispatch.com/news/nostradata-growth-keeps-falling 2015-11-16T06:00:01+11:00 https://pharmadispatch.com/news/new-copd-options-and-the-first-generics-for-osteoporosis-therapy 2015-11-13T06:00:01+11:00 https://pharmadispatch.com/news/timely-access-included-in-2016-20-national-diabetes-strategy 2015-11-13T06:00:01+11:00 https://pharmadispatch.com/news/codeine-change-could-add-127-billion-to-mbs 2015-11-13T06:00:01+11:00 https://pharmadispatch.com/news/tax-avoidance-measures-facing-senate-delay 2015-11-13T06:00:01+11:00 https://pharmadispatch.com/news/implementation-plan-for-inflectra 2015-11-13T06:00:01+11:00 https://pharmadispatch.com/news/inefficiency-and-uncertainty-in-current-processes 2015-11-13T06:00:01+11:00 https://pharmadispatch.com/news/s3-advertising-changes-the-right-choice-for-consumers 2015-11-12T18:00:01+11:00 https://pharmadispatch.com/news/otc-companies-should-forget-tv 2015-11-12T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-accepts-biosimilar-a-flag 2015-11-12T06:00:01+11:00 https://pharmadispatch.com/news/new-dermal-patch-for-the-treatment-of-non-melanoma-skin-cancer 2015-11-12T06:00:01+11:00 https://pharmadispatch.com/news/asmi-appoints-new-board 2015-11-12T06:00:01+11:00 https://pharmadispatch.com/news/asmi-celebrates-at-diamond-awards-annual-dinner 2015-11-12T06:00:01+11:00 https://pharmadispatch.com/news/new-biosimilars-keep-coming 2015-11-11T06:00:01+11:00 https://pharmadispatch.com/news/self-care-the-focus-of-todays-asmi-conference 2015-11-11T06:00:01+11:00 https://pharmadispatch.com/news/make-no-mistake-its-8-years-on-data-exclusivity-says-ustr 2015-11-11T06:00:01+11:00 https://pharmadispatch.com/news/gbma-locks-up-on-biosimilar-policy 2015-11-11T05:24:01+11:00 https://pharmadispatch.com/news/gbma-triumph-highlights-risk-for-ma 2015-11-10T06:00:01+11:00 https://pharmadispatch.com/news/government-set-to-reject-review-recommendation 2015-11-10T06:00:01+11:00 https://pharmadispatch.com/news/low-nhmrc-success-rate-a-concern 2015-11-10T06:00:01+11:00 https://pharmadispatch.com/news/australia-wins-from-pharma-tariff-abolition 2015-11-10T06:00:01+11:00 https://pharmadispatch.com/news/senate-report-backs-multinational-tax-changes 2015-11-10T06:00:01+11:00 https://pharmadispatch.com/news/company-results-astrazeneca-and-celgene 2015-11-09T18:00:01+11:00 https://pharmadispatch.com/news/single-supplier-for-2016-flu-vax 2015-11-09T06:00:01+11:00 https://pharmadispatch.com/news/global-role-for-genzymes-andre-turenne 2015-11-09T06:00:01+11:00 https://pharmadispatch.com/news/new-sanofi-strategy-could-mean-sales-and-acquisitions 2015-11-09T06:00:01+11:00 https://pharmadispatch.com/news/australia-greedy-on-tppa 2015-11-09T06:00:01+11:00 https://pharmadispatch.com/news/call-for-correction-on-codeine 2015-11-09T06:00:01+11:00 https://pharmadispatch.com/news/minister-announces-upgrade-for-flu-vax 2015-11-06T06:31:01+11:00 https://pharmadispatch.com/news/msds-fiedler-calls-ceo-roundtable-on-gender-equality 2015-11-06T06:00:01+11:00 https://pharmadispatch.com/news/msd-and-baxter-recognised-gender-equality 2015-11-06T06:00:01+11:00 https://pharmadispatch.com/news/job-losses-adding-up 2015-11-06T06:00:01+11:00 https://pharmadispatch.com/news/ma-backs-mandatory-patient-medication-records-3 2015-11-06T06:00:01+11:00 https://pharmadispatch.com/news/the-problem-of-osteoporosis-in-men 2015-11-06T06:00:01+11:00 https://pharmadispatch.com/news/tppa-text-released 2015-11-06T06:00:01+11:00 https://pharmadispatch.com/news/an-opportunity-mapped-out-over-coffee 2015-11-05T06:00:01+11:00 https://pharmadispatch.com/news/ebos-acquisition-a-strategic-move-across-pharmaceutical-value-ch 2015-11-05T06:00:01+11:00 https://pharmadispatch.com/news/another-biosimilar-set-for-december-listing-1 2015-11-05T06:00:01+11:00 https://pharmadispatch.com/news/reports-pfizer-approached-gsk-about-merger 2015-11-05T06:00:01+11:00 https://pharmadispatch.com/news/submissions-make-wide-ranging-recommendations 2015-11-05T06:00:01+11:00 https://pharmadispatch.com/news/pbac-remit-includes-innovation-and-industry-sustainability 2015-11-04T06:34:01+11:00 https://pharmadispatch.com/news/pharmac-gives-itself-top-marks 2015-11-04T06:13:01+11:00 https://pharmadispatch.com/news/immune-therapies-reshaping-standard-of-care 2015-11-04T06:00:01+11:00 https://pharmadispatch.com/news/common-ground-on-hcv-listings-but-differences-remain 2015-11-04T06:00:01+11:00 https://pharmadispatch.com/news/29-medicines-set-to-be-removed-from-pbs 2015-11-03T18:50:01+11:00 https://pharmadispatch.com/news/anger-over-targeting-of-official 2015-11-03T06:00:01+11:00 https://pharmadispatch.com/news/servier-boosting-portfolio 2015-11-03T06:00:01+11:00 https://pharmadispatch.com/news/tolmar-backs-urology-meetings 2015-11-03T06:00:01+11:00 https://pharmadispatch.com/news/increase-and-widen-gst-to-health 2015-11-03T06:00:01+11:00 https://pharmadispatch.com/news/that-list-includes-over-600-generics 2015-11-03T06:00:01+11:00 https://pharmadispatch.com/news/hospira-did-not-request-infliximab-a-flag 2015-11-03T06:00:01+11:00 https://pharmadispatch.com/news/company-targets-official 2015-11-02T06:00:01+11:00 https://pharmadispatch.com/news/new-pbs-adviser-for-sussan-ley-1 2015-11-02T06:00:01+11:00 https://pharmadispatch.com/news/company-results-baxalta-bayer-novo-nordisk 2015-11-02T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-and-allergan-aiming-for-deal-within-weeks 2015-11-02T06:00:01+11:00 https://pharmadispatch.com/news/ex-guild-president-calls-for-coordinated-approach-to-phi-review 2015-11-02T06:00:01+11:00 https://pharmadispatch.com/news/a-united-approach-to-address-the-biggest-challenge 2015-10-30T06:00:01+11:00 https://pharmadispatch.com/news/blackmores-soars-on-china-growth 2015-10-30T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-and-allergan-discuss-merger 2015-10-30T06:00:01+11:00 https://pharmadispatch.com/news/amgen-raises-outlook-and-anticipates-launches 2015-10-30T06:00:01+11:00 https://pharmadispatch.com/news/genzyme-the-highlight-for-sanofi 2015-10-30T06:00:01+11:00 https://pharmadispatch.com/news/8strong-growth-for-gsk-vaccines-and-hiv-therapies0 2015-10-29T06:12:01+11:00 https://pharmadispatch.com/news/guild-welcomes-my-health-record-trials 2015-10-29T06:02:01+11:00 https://pharmadispatch.com/news/people-discerning-about-dr-google 2015-10-29T05:52:01+11:00 https://pharmadispatch.com/news/pbs-the-model-for-wider-health-system-reform 2015-10-29T05:24:01+11:00 https://pharmadispatch.com/news/gbma-welcomes-guilds-biosimilar-statement 2015-10-29T05:11:01+11:00 https://pharmadispatch.com/news/guild-backs-government-on-biosimilars 2015-10-28T18:00:01+11:00 https://pharmadispatch.com/news/new-ceo-for-shpa 2015-10-28T18:00:01+11:00 https://pharmadispatch.com/news/forum-to-consider-new-options-for-cancer 2015-10-28T06:00:01+11:00 https://pharmadispatch.com/news/cube-extends-management-team-with-new-hire 2015-10-28T06:00:01+11:00 https://pharmadispatch.com/news/company-results-novartis-pfizer-bms-and-merck 2015-10-28T06:00:01+11:00 https://pharmadispatch.com/news/gilead-funded-researchers-showcase-results 2015-10-27T06:00:01+11:00 https://pharmadispatch.com/news/ma-still-pushing-as-key-date-approaches 2015-10-27T06:00:01+11:00 https://pharmadispatch.com/news/industry-seeks-to-align-pbac-nominations 2015-10-27T06:00:01+11:00 https://pharmadispatch.com/news/guild-time-for-action-on-services 2015-10-27T06:00:01+11:00 https://pharmadispatch.com/news/servier-invests-in-australian-researchers 2015-10-26T06:00:01+11:00 https://pharmadispatch.com/news/lilly-raises-outlook 2015-10-26T06:00:01+11:00 https://pharmadispatch.com/news/roche-progressing-new-therapies 2015-10-26T06:00:01+11:00 https://pharmadispatch.com/news/cook-we-need-constructive-respectful-and-productive-relationship 2015-10-26T06:00:01+11:00 https://pharmadispatch.com/news/perrigo-building-mylan-defence 2015-10-26T06:00:01+11:00 https://pharmadispatch.com/news/new-study-backs-b3-derivative-in-new-skin-cancers 2015-10-23T06:00:01+11:00 https://pharmadispatch.com/news/government-rethink-on-rd-tax-cut 2015-10-23T06:00:01+11:00 https://pharmadispatch.com/news/api-retail-push-delivering-results 2015-10-23T06:00:01+11:00 https://pharmadispatch.com/news/guild-proposes-real-time-monitoring-for-codeine 2015-10-23T06:00:01+11:00 https://pharmadispatch.com/news/farmaforce-set-for-asx-debut 2015-10-23T06:00:01+11:00 https://pharmadispatch.com/news/biogen-growth-but-restucture-means-job-cuts 2015-10-23T06:00:01+11:00 https://pharmadispatch.com/news/not-off-the-tableunless-an-offset-is-found 2015-10-22T06:00:01+11:00 https://pharmadispatch.com/news/no-price-agreement-on-hep-c-therapies 2015-10-22T06:00:01+11:00 https://pharmadispatch.com/news/this-could-be-an-opportunity 2015-10-22T06:00:01+11:00 https://pharmadispatch.com/news/opsumit-growth-boosts-actelion 2015-10-22T06:00:01+11:00 https://pharmadispatch.com/news/its-not-new-money 2015-10-21T06:00:01+11:00 https://pharmadispatch.com/news/cochlear-urges-government-to-scrap-rd-tax-cap 2015-10-21T06:00:01+11:00 https://pharmadispatch.com/news/more-complaints-but-fines-drop 2015-10-21T06:00:01+11:00 https://pharmadispatch.com/news/bis-wes-cook-steps-into-ma-chair 2015-10-21T06:00:01+11:00 https://pharmadispatch.com/news/valeant-shifts-business-towards-higher-rd-spend 2015-10-21T06:00:01+11:00 https://pharmadispatch.com/news/tga-considers-pradaxa-antidote-as-fda-approves 2015-10-20T06:00:01+11:00 https://pharmadispatch.com/news/pm-backs-budget-co-pay-increase-kind-of 2015-10-20T06:00:01+11:00 https://pharmadispatch.com/news/is-the-latest-review-a-risk-for-new-cholesterol-biologics 2015-10-20T06:00:01+11:00 https://pharmadispatch.com/news/petition-backs-ms-listing 2015-10-20T06:00:01+11:00 https://pharmadispatch.com/news/a-morning-dose-of-health-news-sets-you-up-for-the-day 2015-10-19T06:00:01+11:00 https://pharmadispatch.com/news/volatlie-market-hits-janssen-jobs 2015-10-19T06:00:01+11:00 https://pharmadispatch.com/news/decision-looms-on-acting-chair 2015-10-19T06:00:01+11:00 https://pharmadispatch.com/news/new-faces-front-estimates 2015-10-19T06:00:01+11:00 https://pharmadispatch.com/news/medadvisor-ipo-heavily-oversubscribed 2015-10-19T06:00:01+11:00 https://pharmadispatch.com/news/two-more-post-market-reviews 2015-10-18T16:28:01+11:00 https://pharmadispatch.com/news/csl-announces-1-billion-share-buyback 2015-10-16T06:00:01+11:00 https://pharmadispatch.com/news/ma-board-sticks-with-existing-members 2015-10-16T06:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-seeks-member-input-on-pbac 2015-10-16T06:00:01+11:00 https://pharmadispatch.com/news/merck-launches-global-rebrand 2015-10-16T06:00:01+11:00 https://pharmadispatch.com/news/codeine-change-would-cost-257-million 2015-10-16T06:00:01+11:00 https://pharmadispatch.com/news/the-word-sustainability 2015-10-15T18:00:01+11:00 https://pharmadispatch.com/news/risk-share-revenue-soars 2015-10-15T06:00:01+11:00 https://pharmadispatch.com/news/savings-hit-2-billion-as-pbs-falls 2015-10-15T06:00:01+11:00 https://pharmadispatch.com/news/new-ma-board-taking-shape 2015-10-15T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-partners-with-mcgrath-foundation 2015-10-14T17:38:01+11:00 https://pharmadispatch.com/news/december-listing-for-inflectra 2015-10-14T06:00:01+11:00 https://pharmadispatch.com/news/new-studies-boost-amgens-prolia 2015-10-14T06:00:01+11:00 https://pharmadispatch.com/news/msd-progressing-keytruda-in-lung-cancer 2015-10-14T06:00:01+11:00 https://pharmadispatch.com/news/guild-backs-walk4braincancer 2015-10-14T06:00:01+11:00 https://pharmadispatch.com/news/labor-has-7-in-health-and-sport-portfolio80 2015-10-14T06:00:01+11:00 https://pharmadispatch.com/news/currency-hits-jj-result 2015-10-14T06:00:01+11:00 https://pharmadispatch.com/news/new-cancer-therapy-headlines-november-listings 2015-10-13T06:00:01+11:00 https://pharmadispatch.com/news/acting-ma-chair-likely 2015-10-13T06:00:01+11:00 https://pharmadispatch.com/news/new-app-to-help-australian-cancer-patients 2015-10-13T06:00:01+11:00 https://pharmadispatch.com/news/australians-skipping-gp-advice-for-hay-fever 2015-10-13T06:00:01+11:00 https://pharmadispatch.com/news/biosimilars-framework 2015-10-13T06:00:01+11:00 https://pharmadispatch.com/news/ma-chair-steps-down 2015-10-12T09:43:01+11:00 https://pharmadispatch.com/news/prioritising-patients-will-be-essential 2015-10-12T06:00:01+11:00 https://pharmadispatch.com/news/empowering-patients-with-arthritis 2015-10-12T06:00:01+11:00 https://pharmadispatch.com/news/october-price-cuts-to-hit-market-value 2015-10-12T06:00:01+11:00 https://pharmadispatch.com/news/tpp-stance-driven-by-political-considerations 2015-10-12T06:00:01+11:00 https://pharmadispatch.com/news/whats-a-comparable-outcome 2015-10-12T00:00:01+11:00 https://pharmadispatch.com/news/tpp-requires-market-protection-period-for-biologics 2015-10-10T06:22:01+11:00 https://pharmadispatch.com/news/msd-extends-collaboration-with-australian-biotech 2015-10-09T06:00:01+11:00 https://pharmadispatch.com/news/final-day-of-ma-election 2015-10-09T06:00:01+11:00 https://pharmadispatch.com/news/innovation-hackathon 2015-10-09T06:00:01+11:00 https://pharmadispatch.com/news/an-apology-might-be-the-place-to-start 2015-10-09T06:00:01+11:00 https://pharmadispatch.com/news/high-court-overturns-gene-patents 2015-10-08T06:00:01+11:00 https://pharmadispatch.com/news/biosimilar-implementation-plan-coming 2015-10-08T06:00:01+11:00 https://pharmadispatch.com/news/wonder-compares-australia-and-europe-on-cancer-medicines 2015-10-08T06:00:01+11:00 https://pharmadispatch.com/news/sigmas-hooper-new-npsa-chair 2015-10-08T06:00:01+11:00 https://pharmadispatch.com/news/time-for-urgent-action 2015-10-08T06:00:01+11:00 https://pharmadispatch.com/news/grants-to-support-research-into-macular-disease 2015-10-08T06:00:01+11:00 https://pharmadispatch.com/news/tppa-is-all-about-perspective 2015-10-07T06:00:01+11:00 https://pharmadispatch.com/news/industry-groups-consider-pbac-candidates 2015-10-07T06:00:01+11:00 https://pharmadispatch.com/news/more-biosimilars-coming 2015-10-07T06:00:01+11:00 https://pharmadispatch.com/news/award-nomination-for-ex-pbs-head 2015-10-07T06:00:01+11:00 https://pharmadispatch.com/news/nobel-prize-for-retired-merck-scientist 2015-10-07T06:00:01+11:00 https://pharmadispatch.com/news/mixed-views-on-tpp-outcome 2015-10-07T06:00:01+11:00 https://pharmadispatch.com/news/gladsden-time-for-a-fresh-start-and-clear-thinking 2015-10-06T06:00:01+11:00 https://pharmadispatch.com/news/countries-agree-historic-tpp 2015-10-06T06:00:01+11:00 https://pharmadispatch.com/news/opposition-builds-to-codeine-schedule-change 2015-10-06T06:00:01+11:00 https://pharmadispatch.com/news/structural-reform-coming 2015-10-06T06:00:01+11:00 https://pharmadispatch.com/news/australia-second-tier-biotech-country 2015-10-06T06:00:01+11:00 https://pharmadispatch.com/news/tpp-talks-extended-by-a-day 2015-10-02T06:00:01+10:00 https://pharmadispatch.com/news/rescheduling-codeine-not-the-answer 2015-10-02T06:00:01+10:00 https://pharmadispatch.com/news/pm-pushes-innovation 2015-10-02T06:00:01+10:00 https://pharmadispatch.com/news/mixed-results-on-impact-of-drugs-costs 2015-10-02T06:00:01+10:00 https://pharmadispatch.com/news/changes-inside-department-of-health 2015-10-01T15:58:01+10:00 https://pharmadispatch.com/news/gbma-alarm-over-potential-compromise 2015-10-01T06:00:01+10:00 https://pharmadispatch.com/news/nash-retains-tga 2015-10-01T06:00:01+10:00 https://pharmadispatch.com/news/groups-unite-to-call-for-action-on-hep-c 2015-10-01T06:00:01+10:00 https://pharmadispatch.com/news/abbott-a-loyal-and-true-friend-of-pharmacy-2 2015-10-01T06:00:01+10:00 https://pharmadispatch.com/news/new-code-era-starts-today 2015-10-01T06:00:01+10:00 https://pharmadispatch.com/news/mcdonald-we-need-a-wider-focus 2015-09-30T06:00:01+10:00 https://pharmadispatch.com/news/new-therapies-mean-new-treatment-models 2015-09-30T06:00:01+10:00 https://pharmadispatch.com/news/question-low-value-treatments 2015-09-30T06:00:01+10:00 https://pharmadispatch.com/news/compromise-under-discussion 2015-09-30T06:00:01+10:00 https://pharmadispatch.com/news/nsw-govt-scraps-co-pays-for-s100-medicines 2015-09-29T06:00:01+10:00 https://pharmadispatch.com/news/pushing-timelines-in-guidelines-review 2015-09-29T06:00:01+10:00 https://pharmadispatch.com/news/positive-trial-results-for-afinitor 2015-09-29T06:00:01+10:00 https://pharmadispatch.com/news/second-opinions-could-help-address-waste 2015-09-29T06:00:01+10:00 https://pharmadispatch.com/news/new-tga-biosimilar-guideline-close 2015-09-29T06:00:01+10:00 https://pharmadispatch.com/news/trade-talks-nearing-the-end 2015-09-28T06:00:01+10:00 https://pharmadispatch.com/news/political-debate-misses-complexity-part-2 2015-09-28T06:00:01+10:00 https://pharmadispatch.com/news/medicare-review-could-impact-pbs 2015-09-28T06:00:01+10:00 https://pharmadispatch.com/news/policy-stability-essential-says-pharmaxis-ceo 2015-09-28T06:00:01+10:00 https://pharmadispatch.com/news/global-recognition-of-ground-breaking-changes 2015-09-28T06:00:01+10:00 https://pharmadispatch.com/news/bms-confirms-tga-registration-for-new-hiv-combo 2015-09-25T06:00:01+10:00 https://pharmadispatch.com/news/political-debate-misses-complexity 2015-09-25T06:00:01+10:00 https://pharmadispatch.com/news/no-rest-for-crotty 2015-09-25T06:00:01+10:00 https://pharmadispatch.com/news/labor-mocks-innovation-claims 2015-09-25T06:00:01+10:00 https://pharmadispatch.com/news/another-report-confirms-falling-pbs-spend 2015-09-25T06:00:01+10:00 https://pharmadispatch.com/news/hourigan-encouraged-by-turnbull 2015-09-24T06:00:01+10:00 https://pharmadispatch.com/news/infliximab-pi-shows-tga-change 2015-09-24T06:00:01+10:00 https://pharmadispatch.com/news/industry-peddling-propaganda-says-minister 2015-09-24T06:00:01+10:00 https://pharmadispatch.com/news/report-did-not-warrant-that-response 2015-09-24T06:00:01+10:00 https://pharmadispatch.com/news/positive-results-for-avastin-biosimilar 2015-09-24T06:00:01+10:00 https://pharmadispatch.com/news/system-starting-to-show-wear-and-tear 2015-09-23T06:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-announces-positive-phase-1-results-for-bi-partnership- 2015-09-23T06:00:01+10:00 https://pharmadispatch.com/news/cannings-relationship-needs-a-circuit-breaker-1 2015-09-23T06:00:01+10:00 https://pharmadispatch.com/news/another-patent-win-for-lundbeck 2015-09-23T06:00:01+10:00 https://pharmadispatch.com/news/link-acquired-by-uk-based-clinigen-1 2015-09-23T06:00:01+10:00 https://pharmadispatch.com/news/where-will-the-money-come-from 2015-09-22T06:00:01+10:00 https://pharmadispatch.com/news/the-added-significance-of-ken-wyatts-appointment 2015-09-22T06:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-turnbulls-health-team 2015-09-22T06:00:01+10:00 https://pharmadispatch.com/news/bi-confirms-new-inhaler-technology-for-pbs 2015-09-22T06:00:01+10:00 https://pharmadispatch.com/news/industry-pbac-nominations-move-closer 2015-09-22T06:00:01+10:00 https://pharmadispatch.com/news/pharmaceutical-spending-fell-in-2014-15 2015-09-21T09:49:01+10:00 https://pharmadispatch.com/news/dont-underestimate-this-outcome 2015-09-21T06:00:01+10:00 https://pharmadispatch.com/news/more-stakeholder-responses-to-cancer-report 2015-09-21T06:00:01+10:00 https://pharmadispatch.com/news/make-or-break-talks-for-tpp 2015-09-21T06:00:01+10:00 https://pharmadispatch.com/news/who-is-ken-wyatt 2015-09-21T06:00:01+10:00 https://pharmadispatch.com/news/turnbull-we-need-to-focus-on-translation 2015-09-21T06:00:01+10:00 https://pharmadispatch.com/news/malcolm-turnbull-announces-new-ministry 2015-09-20T15:41:01+10:00 https://pharmadispatch.com/news/dismay-over-rule-of-rescue 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/consumer-survey-backs-pharmacy 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/senate-cancer-report-the-recommendations 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/the-commitees-view-key-excerpts-of-the-report 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/psa-wants-consensus-on-biosimilars 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-senate-cancer-report 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/report-signals-the-real-start 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/jardiance-shows-reduction-in-cv-deaths 2015-09-18T06:00:01+10:00 https://pharmadispatch.com/news/pharma-impacted-corporate-tax-changes 2015-09-17T06:00:01+10:00 https://pharmadispatch.com/news/minister-wants-to-stay 2015-09-17T06:00:01+10:00 https://pharmadispatch.com/news/dont-forget-process-ma-tells-guideline-review 2015-09-17T06:00:01+10:00 https://pharmadispatch.com/news/mylan-opens-hostile-bid-for-perrigo 2015-09-17T06:00:01+10:00 https://pharmadispatch.com/news/b-flags-a-historial-concept 2015-09-17T06:00:01+10:00 https://pharmadispatch.com/news/senate-recommends-comprehensive-review-of-pbac-1 2015-09-17T06:00:01+10:00 https://pharmadispatch.com/news/are-things-back-to-normal 2015-09-16T06:00:01+10:00 https://pharmadispatch.com/news/robb-wants-to-stay-in-trade 2015-09-16T06:00:01+10:00 https://pharmadispatch.com/news/mundipharma-signs-distribution-agreement-with-melbourne-based-co 2015-09-16T06:00:01+10:00 https://pharmadispatch.com/news/minister-responds-to-sensipar-petition 2015-09-16T06:00:01+10:00 https://pharmadispatch.com/news/strangely-aligned-to-its-purpose 2015-09-16T06:00:01+10:00 https://pharmadispatch.com/news/department-scraps-a-flag-concept 2015-09-15T06:00:01+10:00 https://pharmadispatch.com/news/gsk-goes-to-court 2015-09-15T06:00:01+10:00 https://pharmadispatch.com/news/generational-change-coming 2015-09-15T06:00:01+10:00 https://pharmadispatch.com/news/a-busy-start-to-the-week 2015-09-15T06:00:01+10:00 https://pharmadispatch.com/news/work-a-thing-you-do-not-a-place-you-need-to-be 2015-09-14T06:00:01+10:00 https://pharmadispatch.com/news/october-pbs-changes 2015-09-14T06:00:01+10:00 https://pharmadispatch.com/news/patients-progressing-to-severe-disease-as-they-wait-for-access 2015-09-14T06:00:01+10:00 https://pharmadispatch.com/news/cancer-report-tomorrow 2015-09-14T06:00:01+10:00 https://pharmadispatch.com/news/prescribing-relaxed-under-red-tape-review 2015-09-14T06:00:01+10:00 https://pharmadispatch.com/news/leading-drug-development-provider-looking-at-australian-expansio 2015-09-11T10:05:01+10:00 https://pharmadispatch.com/news/pfizer-sticks-with-research-based-associations 2015-09-11T06:00:01+10:00 https://pharmadispatch.com/news/like-comparing-a-car-to-an-a380-jet 2015-09-11T06:00:01+10:00 https://pharmadispatch.com/news/better-than-expected-result-for-sigma-on-non-pbs-revenue 2015-09-11T06:00:01+10:00 https://pharmadispatch.com/news/australian-children-with-crohns-disease-given-access-to-at-home- 2015-09-11T06:00:01+10:00 https://pharmadispatch.com/news/tillack-fair-pricing-and-uptake-drivers-the-key 2015-09-11T06:00:01+10:00 https://pharmadispatch.com/news/ma-looking-forward-but-delivers-brutal-assessment-of-its-negotia 2015-09-10T06:00:01+10:00 https://pharmadispatch.com/news/market-returns-to-growth 2015-09-10T06:00:01+10:00 https://pharmadispatch.com/news/msd-announces-itself-with-biosimilar-enbrel 2015-09-10T06:00:01+10:00 https://pharmadispatch.com/news/5-billion-hole-in-pbs-budget 2015-09-09T06:00:01+10:00 https://pharmadispatch.com/news/another-delay 2015-09-09T06:00:01+10:00 https://pharmadispatch.com/news/negotiating-prices-a-major-factor-in-access-delays 2015-09-09T06:00:01+10:00 https://pharmadispatch.com/news/mylan-goes-to-perrigo-shareholders 2015-09-09T06:00:01+10:00 https://pharmadispatch.com/news/az-inks-deal-with-australian-biotech 2015-09-08T06:00:01+10:00 https://pharmadispatch.com/news/new-study-confirms-poor-adherence 2015-09-08T06:00:01+10:00 https://pharmadispatch.com/news/csl-standing-firm-on-pay-offer 2015-09-08T06:00:01+10:00 https://pharmadispatch.com/news/cancer-groups-want-action-from-inquiry 2015-09-08T06:00:01+10:00 https://pharmadispatch.com/news/apotex-partners-with-medadvisor 2015-09-08T06:00:01+10:00 https://pharmadispatch.com/news/wider-implications-of-pfizer-acquisition 2015-09-07T06:00:01+10:00 https://pharmadispatch.com/news/biosimilar-policy-set-to-be-tested 2015-09-07T06:00:01+10:00 https://pharmadispatch.com/news/patients-we-need-access 2015-09-07T06:00:01+10:00 https://pharmadispatch.com/news/international-workshop-set-to-discuss-access 2015-09-07T06:00:01+10:00 https://pharmadispatch.com/news/review-targets-opiods-and-antibiotics 2015-09-07T06:00:01+10:00 https://pharmadispatch.com/news/australia-putting-tpp-at-risk 2015-09-04T06:00:01+10:00 https://pharmadispatch.com/news/companies-respond-to-senate-tax-questions-1 2015-09-04T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-completes-hospira-acquisition 2015-09-04T06:00:01+10:00 https://pharmadispatch.com/news/novartis-launches-first-biosimilar-in-the-us 2015-09-04T06:00:01+10:00 https://pharmadispatch.com/news/positive-results-for-new-osteoporosis-therapy 2015-09-03T06:00:01+10:00 https://pharmadispatch.com/news/novartis-and-amgen-enter-neuroscience-collaboration 2015-09-03T06:00:01+10:00 https://pharmadispatch.com/news/amwg-set-to-resume 2015-09-03T06:00:01+10:00 https://pharmadispatch.com/news/tga-advisory-group-said-no-to-biosimilar-a-flag 2015-09-03T06:00:01+10:00 https://pharmadispatch.com/news/sun-pharma-completes-acquisition-of-gsk-opiates-business 2015-09-02T06:00:01+10:00 https://pharmadispatch.com/news/once-daily-vyvanse-pbs-listed 2015-09-02T06:00:01+10:00 https://pharmadispatch.com/news/more-recognition-for-abbvie 2015-09-02T06:00:01+10:00 https://pharmadispatch.com/news/chnages-for-ibuprofen 2015-09-02T06:00:01+10:00 https://pharmadispatch.com/news/new-pbs-option-for-psoriasis-patients 2015-09-01T06:00:01+10:00 https://pharmadispatch.com/news/australia-in-front-on-keytruda 2015-09-01T06:00:01+10:00 https://pharmadispatch.com/news/16-nominate-for-ma-board 2015-09-01T06:00:01+10:00 https://pharmadispatch.com/news/bms-collaborates-with-brisbane-based-research-institute 2015-09-01T06:00:01+10:00 https://pharmadispatch.com/news/msd-says-thank-you 2015-09-01T06:00:01+10:00 https://pharmadispatch.com/news/chf-backs-biosimilar-a-flagging 2015-09-01T06:00:01+10:00 https://pharmadispatch.com/news/time-for-change-say-industry-leaders 2015-08-31T06:00:01+10:00 https://pharmadispatch.com/news/jj-backs-new-innovation-prize 2015-08-28T06:00:01+10:00 https://pharmadispatch.com/news/tens-of-thousands-delaying-treatment 2015-08-28T06:00:01+10:00 https://pharmadispatch.com/news/bayers-nelson-ambrogio 2015-08-28T06:00:01+10:00 https://pharmadispatch.com/news/deal-to-close-next-week 2015-08-28T06:00:01+10:00 https://pharmadispatch.com/news/new-fda-biosimilar-naming-convention 2015-08-28T06:00:01+10:00 https://pharmadispatch.com/news/innovate-to-grow 2015-08-27T06:00:01+10:00 https://pharmadispatch.com/news/bennelong-forum-hosts-deputy-pm 2015-08-27T06:00:01+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-the-november-pbac-agenda-2 2015-08-27T06:00:01+10:00 https://pharmadispatch.com/news/selected-highlights-from-november-pbac 2015-08-27T06:00:01+10:00 https://pharmadispatch.com/news/potential-upside-for-ebos 2015-08-27T06:00:01+10:00 https://pharmadispatch.com/news/ma-board-election 2015-08-26T06:00:01+10:00 https://pharmadispatch.com/news/blackmores-reports-record-result 2015-08-26T06:00:01+10:00 https://pharmadispatch.com/news/submission-deadline-extended 2015-08-26T06:00:01+10:00 https://pharmadispatch.com/news/mp-adult-vaccination-rate-too-low 2015-08-26T06:00:01+10:00 https://pharmadispatch.com/news/strong-growth-for-ebos 2015-08-26T06:00:01+10:00 https://pharmadispatch.com/news/patients-delaying-treatment 2015-08-25T06:00:01+10:00 https://pharmadispatch.com/news/patients-not-happy 2015-08-25T06:00:01+10:00 https://pharmadispatch.com/news/avoiding-weight-loss-discussions 2015-08-25T06:00:01+10:00 https://pharmadispatch.com/news/murby-work-against-pbac-recommendation 2015-08-25T06:00:01+10:00 https://pharmadispatch.com/news/us-approved-pfizer-acquistion 2015-08-25T06:00:01+10:00 https://pharmadispatch.com/news/new-guide-on-industry-hco-collaborations-1 2015-08-25T06:00:01+10:00 https://pharmadispatch.com/news/pricing-disputes-inevitable 2015-08-24T06:00:01+10:00 https://pharmadispatch.com/news/groups-line-up-against-a-flag 2015-08-24T06:00:01+10:00 https://pharmadispatch.com/news/a-flag-not-so-simple 2015-08-24T06:00:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-time-for-action-on-new-therapies 2015-08-24T06:00:01+10:00 https://pharmadispatch.com/news/july-pbac-outcome-highlights 2015-08-24T06:00:01+10:00 https://pharmadispatch.com/news/maestro-breaks-down-july-pbac 2015-08-24T06:00:01+10:00 https://pharmadispatch.com/news/pbac-a-flags-infliximab 2015-08-21T16:00:01+10:00 https://pharmadispatch.com/news/charity-award-for-ms-research-australia 2015-08-21T06:00:01+10:00 https://pharmadispatch.com/news/focus-on-pbac-infliximab-outcome 2015-08-21T06:00:01+10:00 https://pharmadispatch.com/news/patient-access-hep-c-therapy-from-india 2015-08-21T06:00:01+10:00 https://pharmadispatch.com/news/tga-approves-biosim-inflximab-with-all-indications 2015-08-20T10:01:01+10:00 https://pharmadispatch.com/news/ma-loses-a-member 2015-08-20T06:00:01+10:00 https://pharmadispatch.com/news/billion-dollar-crunch 2015-08-20T06:00:01+10:00 https://pharmadispatch.com/news/f1-cut-applied-to-molecules 2015-08-20T06:00:01+10:00 https://pharmadispatch.com/news/disconnect-on-corporate-tax 2015-08-20T06:00:01+10:00 https://pharmadispatch.com/news/another-ip-review 2015-08-20T06:00:01+10:00 https://pharmadispatch.com/news/will-pharmacists-have-to-pay-delivery-charges 2015-08-19T06:00:01+10:00 https://pharmadispatch.com/news/petition-wants-action-on-drug-access 2015-08-19T06:00:01+10:00 https://pharmadispatch.com/news/first-tax-report-passes-on-pharma 2015-08-19T06:00:01+10:00 https://pharmadispatch.com/news/political-leaders-speak-in-support-of-innovation 2015-08-19T06:00:01+10:00 https://pharmadispatch.com/news/2016-annus-horribilis-for-pharmaceutical-sector 2015-08-18T06:00:01+10:00 https://pharmadispatch.com/news/shire-could-up-bid-for-baxalta 2015-08-18T06:00:01+10:00 https://pharmadispatch.com/news/department-consults-on-pbac-guidelines 2015-08-18T06:00:01+10:00 https://pharmadispatch.com/news/real-story-is-behind-the-medicare-numbers 2015-08-18T06:00:01+10:00 https://pharmadispatch.com/news/innovation-at-abbvie 2015-08-18T06:00:01+10:00 https://pharmadispatch.com/news/long-list-of-september-changes 2015-08-17T06:00:01+10:00 https://pharmadispatch.com/news/janssen-confirms-hep-c-removal 2015-08-17T06:00:01+10:00 https://pharmadispatch.com/news/pharma-companies-recognised-in-hr-awards 2015-08-17T06:00:01+10:00 https://pharmadispatch.com/news/tax-inquiry-set-to-deliver-first-report 2015-08-17T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-stacking-up-approvals 2015-08-17T06:00:01+10:00 https://pharmadispatch.com/news/tga-approves-first-biosimilar-infliximab 2015-08-14T06:00:01+10:00 https://pharmadispatch.com/news/psa15-the-most-successful-to-date 2015-08-14T06:00:01+10:00 https://pharmadispatch.com/news/industry-appointment-far-from-certain 2015-08-14T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-accc-approval 2015-08-14T06:00:01+10:00 https://pharmadispatch.com/news/priceline-pharmacy-backing-womens-sport 2015-08-14T06:00:01+10:00 https://pharmadispatch.com/news/immunoglobulin-sales-boost-csl 2015-08-13T06:00:01+10:00 https://pharmadispatch.com/news/robb-doubts-industry-trust 2015-08-13T06:00:01+10:00 https://pharmadispatch.com/news/parliament-backs-20bn-mrff 2015-08-13T06:00:01+10:00 https://pharmadispatch.com/news/still-no-pbs-for-brintellix 2015-08-13T06:00:01+10:00 https://pharmadispatch.com/news/accc-backs-pfizers-hospira-acquistion 2015-08-12T19:35:01+10:00 https://pharmadispatch.com/news/us-decision-highlights-challenge-for-pcsk9-companies 2015-08-12T06:00:01+10:00 https://pharmadispatch.com/news/stay-strong-gbma-tells-andrew-robb 2015-08-12T06:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-action-required-on-chronic-disease 2015-08-12T06:00:01+10:00 https://pharmadispatch.com/news/victoria-wants-industry 2015-08-12T06:00:01+10:00 https://pharmadispatch.com/news/visualising-the-acid-pocket 2015-08-12T06:00:01+10:00 https://pharmadispatch.com/news/gps-demand-change-on-obesity 2015-08-12T06:00:01+10:00 https://pharmadispatch.com/news/good-buy-comes-at-a-price-for-sigma 2015-08-11T06:00:01+10:00 https://pharmadispatch.com/news/mixed-story-on-manufacturing 2015-08-11T06:00:01+10:00 https://pharmadispatch.com/news/cancer-screening-pioneer-appointed-first-emeritus-scientist-by-c 2015-08-11T06:00:01+10:00 https://pharmadispatch.com/news/the-launch-of-jobsdispatch 2015-08-11T06:00:01+10:00 https://pharmadispatch.com/news/az-announced-another-cancer-collaboration-1 2015-08-11T06:00:01+10:00 https://pharmadispatch.com/news/inquiry-backs-mrff 2015-08-10T14:30:01+10:00 https://pharmadispatch.com/news/when-the-marines-landed-in-australia 2015-08-10T06:01:01+10:00 https://pharmadispatch.com/news/andre-musto-collaboration-is-key 2015-08-10T06:00:01+10:00 https://pharmadispatch.com/news/market-recovers-in-july 2015-08-10T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-sells-north-ryde-site 2015-08-10T06:00:01+10:00 https://pharmadispatch.com/news/capped-pbs-the-biggest-strategic-threat 2015-08-10T06:00:01+10:00 https://pharmadispatch.com/news/company-results-allergan-mylan-and-merck-serono 2015-08-10T06:00:01+10:00 https://pharmadispatch.com/news/stop-dropping-the-ball-on-prostate-health 2015-08-07T06:00:01+10:00 https://pharmadispatch.com/news/new-look-maestro 2015-08-07T06:00:01+10:00 https://pharmadispatch.com/news/pharma-exports-plummet 2015-08-07T06:00:01+10:00 https://pharmadispatch.com/news/new-job-for-ex-gmia-ceo 2015-08-07T06:00:01+10:00 https://pharmadispatch.com/news/new-look-maestro-1 2015-08-07T06:00:01+10:00 https://pharmadispatch.com/news/bi-reports-slight-growth 2015-08-06T06:19:01+10:00 https://pharmadispatch.com/news/shire-makes-us30bn-for-baxalta 2015-08-06T06:01:01+10:00 https://pharmadispatch.com/news/another-deal-for-pharmaxis 2015-08-06T06:00:01+10:00 https://pharmadispatch.com/news/what-is-a-biologic 2015-08-06T06:00:01+10:00 https://pharmadispatch.com/news/quilty-peoples-lives-are-depending-upon-it 2015-08-06T06:00:01+10:00 https://pharmadispatch.com/news/guild-backs-better-approach-to-chronic-conditions 2015-08-05T06:12:01+10:00 https://pharmadispatch.com/news/department-rejects-anao-pharmacy-claims 2015-08-05T06:00:01+10:00 https://pharmadispatch.com/news/novartis-oncologys-christoph-lorez 2015-08-05T06:00:01+10:00 https://pharmadispatch.com/news/department-drops-venezuela 2015-08-05T06:00:01+10:00 https://pharmadispatch.com/news/still-waiting-for-senate-cancer-drugs-report 2015-08-05T06:00:01+10:00 https://pharmadispatch.com/news/eu-approves-pfizers-acquisition-of-hospira 2015-08-05T05:47:01+10:00 https://pharmadispatch.com/news/in-contrast-nz-stands-firm-on-pharmac-changes 2015-08-04T06:00:01+10:00 https://pharmadispatch.com/news/robb-shifts-blame-to-us 2015-08-04T06:00:01+10:00 https://pharmadispatch.com/news/csl-australia-needs-to-get-everything-right-on-investment 2015-08-04T06:00:01+10:00 https://pharmadispatch.com/news/trade 2015-08-04T06:00:01+10:00 https://pharmadispatch.com/news/australian-must-share-tpp-blame 2015-08-03T06:00:01+10:00 https://pharmadispatch.com/news/chf-survey-backs-wider-role-for-pharmacy 2015-08-03T06:00:01+10:00 https://pharmadispatch.com/news/soliris-boosts-alexion 2015-08-03T06:00:01+10:00 https://pharmadispatch.com/news/sandoz-boss-to-lead-gbma 2015-08-03T06:00:01+10:00 https://pharmadispatch.com/news/regulated-into-irrelevance 2015-08-03T03:00:01+10:00 https://pharmadispatch.com/news/amgen-raises-guidance 2015-07-31T06:12:01+10:00 https://pharmadispatch.com/news/patients-welcome-new-myeloma-therapy 2015-07-31T06:00:01+10:00 https://pharmadispatch.com/news/janssen-registers-new-infliximab 2015-07-31T06:00:01+10:00 https://pharmadispatch.com/news/viiv-the-highlight-for-gsk 2015-07-31T06:00:01+10:00 https://pharmadispatch.com/news/genzyme-and-lower-costs-boost-sanofi 2015-07-31T06:00:01+10:00 https://pharmadispatch.com/news/az-result-better-than-expected 2015-07-31T06:00:01+10:00 https://pharmadispatch.com/news/australia-not-moving-on-tpp 2015-07-30T06:00:01+10:00 https://pharmadispatch.com/news/name-change-for-gmia 2015-07-30T06:00:01+10:00 https://pharmadispatch.com/news/msd-more-needs-to-be-done-on-hep-c 2015-07-30T06:00:01+10:00 https://pharmadispatch.com/news/lessons 2015-07-30T06:00:01+10:00 https://pharmadispatch.com/news/company-results-gilead-1 2015-07-30T06:00:01+10:00 https://pharmadispatch.com/news/csl-competitive-advanced-manufacturing-within-reach-for-australi 2015-07-29T18:00:01+10:00 https://pharmadispatch.com/news/a-bear-with-a-sore-head-2000-to-2001 2015-07-29T06:00:01+10:00 https://pharmadispatch.com/news/new-leadership-coming-for-bms-australia 2015-07-29T06:00:01+10:00 https://pharmadispatch.com/news/teva-drops-pursuit-of-mylan 2015-07-29T06:00:01+10:00 https://pharmadispatch.com/news/company-results-pfizer-and-merck-co 2015-07-29T06:00:01+10:00 https://pharmadispatch.com/news/hepatitis-groups-want-action 2015-07-28T06:00:01+10:00 https://pharmadispatch.com/news/apa-a-very-special-day 2015-07-28T06:00:01+10:00 https://pharmadispatch.com/news/the-slow-motion-train-wreck-1999-to-2000 2015-07-28T06:00:01+10:00 https://pharmadispatch.com/news/teva-acquires-allergan-global-generics-business-for-us405bn 2015-07-28T06:00:01+10:00 https://pharmadispatch.com/news/company-results-abbvie-biogen-and-valeant 2015-07-28T06:00:01+10:00 https://pharmadispatch.com/news/time-to-mend-political-fences 2015-07-27T06:00:01+10:00 https://pharmadispatch.com/news/mark-crotty 2015-07-27T06:00:01+10:00 https://pharmadispatch.com/news/calm-before-the-storm-1996-to-1998 2015-07-27T06:00:01+10:00 https://pharmadispatch.com/news/fresenius-kabi-sells-oncology-compounding-business 2015-07-27T06:00:01+10:00 https://pharmadispatch.com/news/pbac-patients-must-understand-managed-entry-risks 2015-07-27T06:00:01+10:00 https://pharmadispatch.com/news/company-results-celgene-and-shire 2015-07-27T06:00:01+10:00 https://pharmadispatch.com/news/ma-launches-new-facts-book 2015-07-27T06:00:01+10:00 https://pharmadispatch.com/news/minister-confirms-wider-lucentis-listing 2015-07-24T06:03:01+10:00 https://pharmadispatch.com/news/new-pbs-adviser-for-sussan-ley 2015-07-24T06:00:01+10:00 https://pharmadispatch.com/news/bms-and-pfizer-welcome-expanded-eliquis-listing 2015-07-24T06:00:01+10:00 https://pharmadispatch.com/news/lilly-posts-better-than-expected-result 2015-07-24T05:50:01+10:00 https://pharmadispatch.com/news/opdivo-boosts-bms 2015-07-24T05:37:01+10:00 https://pharmadispatch.com/news/dahmen-steps-down-as-mpa-chair 2015-07-24T04:32:01+10:00 https://pharmadispatch.com/news/crotty-leaves-a-stronger-more-focussed-organisation 2015-07-23T14:20:01+10:00 https://pharmadispatch.com/news/australian-generic-prices-match-uk 2015-07-23T06:00:01+10:00 https://pharmadispatch.com/news/self-care-the-focus-of-asmi-conference-1 2015-07-23T06:00:01+10:00 https://pharmadispatch.com/news/guilds-new-corporate-plan 2015-07-23T06:00:01+10:00 https://pharmadispatch.com/news/first-meeting-of-biosimilars-companies 2015-07-23T06:00:01+10:00 https://pharmadispatch.com/news/new-therapies-offer-hope-in-alzheimers-disease 2015-07-23T06:00:01+10:00 https://pharmadispatch.com/news/sandoz-the-highlight-for-novartis 2015-07-22T07:00:01+10:00 https://pharmadispatch.com/news/groups-joins-choosing-wisely-australia 2015-07-22T06:28:01+10:00 https://pharmadispatch.com/news/three-industry-bodies-to-nominate-pbac-member 2015-07-22T06:00:01+10:00 https://pharmadispatch.com/news/chf-look-beyond-tax-for-health-funding 2015-07-22T06:00:01+10:00 https://pharmadispatch.com/news/price-disclosure-change-hits-life-cycle-extensions 2015-07-21T06:00:01+10:00 https://pharmadispatch.com/news/biosimilars-forum-moving-closer 2015-07-21T06:00:01+10:00 https://pharmadispatch.com/news/bms-halts-another-opdivo-trial 2015-07-21T05:21:01+10:00 https://pharmadispatch.com/news/xenophon-ma-tax-submission-a-veiled-threat 2015-07-20T06:00:01+10:00 https://pharmadispatch.com/news/prescribing-restrictions-could-be-too-tough-says-dusc 2015-07-20T06:00:01+10:00 https://pharmadispatch.com/news/australian-health-spending-low-but-outcomes-good 2015-07-20T06:00:01+10:00 https://pharmadispatch.com/news/could-therapeutic-groups-be-on-the-way-back 2015-07-20T06:00:01+10:00 https://pharmadispatch.com/news/pbs-listing-for-roches-gazyva 2015-07-20T06:00:01+10:00 https://pharmadispatch.com/news/grattan-at-it-again 2015-07-17T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-confirms-new-contract-for-prevenar-13 2015-07-17T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-announces-new-global-structure 2015-07-17T06:00:01+10:00 https://pharmadispatch.com/news/ma-hits-back-on-tax 2015-07-17T06:00:01+10:00 https://pharmadispatch.com/news/evidence-backs-medication-reviews 2015-07-16T06:00:01+10:00 https://pharmadispatch.com/news/1-august-pbs-update 2015-07-16T06:00:01+10:00 https://pharmadispatch.com/news/new-country-manager-for-novartis 2015-07-16T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-working-to-secure-approval-for-hospira-acquisition 2015-07-16T06:00:01+10:00 https://pharmadispatch.com/news/celgene-acquires-receptos-for-us72bn 2015-07-16T05:21:01+10:00 https://pharmadispatch.com/news/department-finalising-pbac-member-nominating-bodies 2015-07-15T06:00:01+10:00 https://pharmadispatch.com/news/retail-script-market-still-falling 2015-07-15T06:00:01+10:00 https://pharmadispatch.com/news/asmi-calls-for-nominations 2015-07-15T06:00:01+10:00 https://pharmadispatch.com/news/tolmar-anzup-clinical-research-fellowship-goes-to-brisbane-oncol 2015-07-15T06:00:01+10:00 https://pharmadispatch.com/news/jj-beats-estimates-despite-currency 2015-07-15T06:00:01+10:00 https://pharmadispatch.com/news/tga-approves-abbvie-hep-c-therapy 2015-07-14T06:06:01+10:00 https://pharmadispatch.com/news/new-market-access-head-for-amgen 2015-07-14T06:00:01+10:00 https://pharmadispatch.com/news/ma-mrff-needs-industry-backing 2015-07-14T06:00:01+10:00 https://pharmadispatch.com/news/psa-follow-britains-lead-on-gp-pharmacist-collaboration 2015-07-14T06:00:01+10:00 https://pharmadispatch.com/news/how-times-have-changed 2015-07-14T06:00:01+10:00 https://pharmadispatch.com/news/push-for-australian-biosimilars-forum 2015-07-13T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-working-towards-pbs-for-toujeo 2015-07-13T06:00:01+10:00 https://pharmadispatch.com/news/amgens-prolia-leading-the-way 2015-07-13T06:00:01+10:00 https://pharmadispatch.com/news/clinicians-should-have-final-say-on-biosimilars 2015-07-13T06:00:01+10:00 https://pharmadispatch.com/news/next-stop-hawaii-for-tpp 2015-07-13T06:00:01+10:00 https://pharmadispatch.com/news/ma-stop-free-trade-hysteria 2015-07-10T06:00:01+10:00 https://pharmadispatch.com/news/novartis-welcomes-heart-failure-blockbuster 2015-07-10T06:00:01+10:00 https://pharmadispatch.com/news/ma-not-backing-down-on-corporate-tax 2015-07-10T06:00:01+10:00 https://pharmadispatch.com/news/amneal-signs-up-with-gmia 2015-07-10T06:00:01+10:00 https://pharmadispatch.com/news/guild-report-breaks-the-urban-myth 2015-07-10T06:00:01+10:00 https://pharmadispatch.com/news/quilty-new-revenue-streams-essential 2015-07-09T06:00:01+10:00 https://pharmadispatch.com/news/ma-welcomed-university-research-review 2015-07-09T06:00:01+10:00 https://pharmadispatch.com/news/new-pharmacy-board-chair-welcomed 2015-07-09T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-need-clarity 2015-07-09T06:00:01+10:00 https://pharmadispatch.com/news/labor-urges-ip-trade-review 2015-07-08T06:00:01+10:00 https://pharmadispatch.com/news/acrux-and-lilly-allege-axiron-patent-infringement 2015-07-08T06:00:01+10:00 https://pharmadispatch.com/news/time-to-take-control 2015-07-08T06:00:01+10:00 https://pharmadispatch.com/news/wilson-evidence-the-key-factor 2015-07-08T06:00:01+10:00 https://pharmadispatch.com/news/teva-set-to-formalise-mylan-takeover-bid 2015-07-07T06:26:01+10:00 https://pharmadispatch.com/news/a-shop-front-for-pricing-negotiations 2015-07-07T06:00:01+10:00 https://pharmadispatch.com/news/ma-kicks-off-code-education-campaign 2015-07-07T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-gather-for-biosimilar-consultation 2015-07-07T06:00:01+10:00 https://pharmadispatch.com/news/loss-for-australian-medical-research 2015-07-07T06:00:01+10:00 https://pharmadispatch.com/news/company-did-not-request-biosimilar-a-flag 2015-07-06T06:00:01+10:00 https://pharmadispatch.com/news/pbac-documents-reveal-accelerated-consideration-of-msds-keytruda 2015-07-06T06:00:01+10:00 https://pharmadispatch.com/news/hard-spending-cap-on-new-hep-c-therapies 2015-07-06T06:00:01+10:00 https://pharmadispatch.com/news/procurement-dressed-up-as-science 2015-07-06T06:00:01+10:00 https://pharmadispatch.com/news/uni-of-adelaide-wins-guidelines-review 2015-07-06T06:00:01+10:00 https://pharmadispatch.com/news/where-did-it-go-wrong 2015-07-03T06:00:01+10:00 https://pharmadispatch.com/news/az-inks-rd-agreement-with-university-of-adelaide 2015-07-03T06:00:01+10:00 https://pharmadispatch.com/news/ex-sigma-execs-plead-guilty 2015-07-03T06:00:01+10:00 https://pharmadispatch.com/news/novartis-facing-us33bn-claim 2015-07-03T06:00:01+10:00 https://pharmadispatch.com/news/it-was-about-theatre-not-facts 2015-07-02T06:00:01+10:00 https://pharmadispatch.com/news/ato-the-issue-is-whether-companies-are-distributors 2015-07-02T06:00:01+10:00 https://pharmadispatch.com/news/psa-welcomes-support-for-pharmacists-in-general-practices 2015-07-02T06:00:01+10:00 https://pharmadispatch.com/news/opening-statement-from-pfizers-david-gallagher 2015-07-02T06:00:01+10:00 https://pharmadispatch.com/news/tax-inquiry-goes-largely-as-expected 2015-07-01T08:51:01+10:00 https://pharmadispatch.com/news/astrazeneca-tops-hcp-consultant-spend 2015-07-01T06:00:01+10:00 https://pharmadispatch.com/news/bayer-tops-hco-grants-list 2015-07-01T06:00:01+10:00 https://pharmadispatch.com/news/clinicians-welcome-new-lucentis-listing 2015-07-01T06:00:01+10:00 https://pharmadispatch.com/news/pbs-listing-for-new-breast-cancer-therapies 2015-07-01T06:00:01+10:00 https://pharmadispatch.com/news/concern-over-decline-in-screening-for-breast-cancer 2015-07-01T06:00:01+10:00 https://pharmadispatch.com/news/biogen-backed-ms-campaign 2015-07-01T06:00:01+10:00 https://pharmadispatch.com/news/pbs-adviser-move-to-department 2015-07-01T06:00:01+10:00 https://pharmadispatch.com/news/industry-readies-for-tax-inquiry 2015-06-30T06:02:01+10:00 https://pharmadispatch.com/news/add-a-flagging-to-listing-conditions 2015-06-30T06:00:01+10:00 https://pharmadispatch.com/news/novartis-acquires-australian-biotech-spinifex 2015-06-30T06:00:01+10:00 https://pharmadispatch.com/news/tga-approval-for-bms-hep-c-therapy 2015-06-30T06:00:01+10:00 https://pharmadispatch.com/news/biosimilars-it-just-got-more-confusing 2015-06-29T06:00:01+10:00 https://pharmadispatch.com/news/changes-for-some-hsd-medicines 2015-06-29T06:00:01+10:00 https://pharmadispatch.com/news/companies-consider-f1-options 2015-06-29T06:00:01+10:00 https://pharmadispatch.com/news/two-months-doesnt-sound-a-long-time 2015-06-29T06:00:01+10:00 https://pharmadispatch.com/news/prime-minister-announces-listing-of-keytruda 2015-06-28T08:07:01+10:00 https://pharmadispatch.com/news/concern-over-the-fate-of-protos 2015-06-26T11:52:01+10:00 https://pharmadispatch.com/news/stakeholder-responses-to-tga-review-report 2015-06-26T06:04:01+10:00 https://pharmadispatch.com/news/new-price-change-dates-confirmed 2015-06-26T05:53:01+10:00 https://pharmadispatch.com/news/first-meeting-of-health-industry-forum 2015-06-26T05:36:01+10:00 https://pharmadispatch.com/news/us-senate-backs-trade-fast-track 2015-06-26T05:18:01+10:00 https://pharmadispatch.com/news/patients-warehoused-waiting-for-new-hcv-therapies 2015-06-26T05:02:01+10:00 https://pharmadispatch.com/news/ma-keen-to-work-with-government-on-access 2015-06-25T12:26:01+10:00 https://pharmadispatch.com/news/just-another-distraction 2015-06-25T12:00:01+10:00 https://pharmadispatch.com/news/uk-says-use-cheapest-infliximab 2015-06-25T06:00:01+10:00 https://pharmadispatch.com/news/another-step-forward-for-tpp 2015-06-25T06:00:01+10:00 https://pharmadispatch.com/news/quilty-6cpa-meets-our-key-objectives 2015-06-25T06:00:01+10:00 https://pharmadispatch.com/news/trust-us-on-biosimilars-not-good-enough-says-ex-chf-chair 2015-06-25T06:00:01+10:00 https://pharmadispatch.com/news/tga-review-recommends-major-changes 2015-06-25T06:00:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-xalkori-listing 2015-06-24T06:07:01+10:00 https://pharmadispatch.com/news/bi-confirms-tga-submission-for-pradaxa-antidote 2015-06-24T06:00:01+10:00 https://pharmadispatch.com/news/msd-grant-for-indigenous-health 2015-06-24T06:00:01+10:00 https://pharmadispatch.com/news/time-to-look-ahead 2015-06-24T06:00:01+10:00 https://pharmadispatch.com/news/minister-rejects-ma-criticism 2015-06-24T06:00:01+10:00 https://pharmadispatch.com/news/new-tga-guidelines-keep-it-simple 2015-06-24T06:00:01+10:00 https://pharmadispatch.com/news/government-walks-away-from-ma-agreement 2015-06-23T12:11:01+10:00 https://pharmadispatch.com/news/a-boost-for-self-care 2015-06-23T06:00:01+10:00 https://pharmadispatch.com/news/pbac-sets-date-for-biosimilar-forum 2015-06-23T06:00:01+10:00 https://pharmadispatch.com/news/ma-urges-caution-on-corporate-tax-reform 2015-06-23T06:00:01+10:00 https://pharmadispatch.com/news/gmia-where-is-the-patient-safety-issue 2015-06-23T06:00:01+10:00 https://pharmadispatch.com/news/ma-grattan-institute-misses-the-point-again 2015-06-23T06:00:01+10:00 https://pharmadispatch.com/news/another-extension-to-cancer-inquiry-reporting-date 2015-06-22T18:00:01+10:00 https://pharmadispatch.com/news/common-sense-should-prevail 2015-06-22T06:00:01+10:00 https://pharmadispatch.com/news/pharma-companies-to-front-tax-inquiry 2015-06-22T06:00:01+10:00 https://pharmadispatch.com/news/senate-inquiry-into-mrff 2015-06-22T06:00:01+10:00 https://pharmadispatch.com/news/changes-at-the-guild 2015-06-22T06:00:01+10:00 https://pharmadispatch.com/news/mixed-messages-on-pbs 2015-06-22T06:00:01+10:00 https://pharmadispatch.com/news/biosimilar-debate-still-going 2015-06-22T06:00:01+10:00 https://pharmadispatch.com/news/agreement-deadline-extended 2015-06-19T06:30:01+10:00 https://pharmadispatch.com/news/australians-travelling-for-clinical-trials 2015-06-19T06:00:01+10:00 https://pharmadispatch.com/news/pharmacy-urges-senate-support-for-pbs-bill 2015-06-19T06:00:01+10:00 https://pharmadispatch.com/news/1-october-price-cuts 2015-06-19T06:00:01+10:00 https://pharmadispatch.com/news/pbac-clarifies-position-on-biosimilars 2015-06-18T19:30:01+10:00 https://pharmadispatch.com/news/pbac-safety-of-biosimilar-medicines 2015-06-18T19:30:01+10:00 https://pharmadispatch.com/news/biosimilars-dominate-senate-discussion 2015-06-18T11:54:01+10:00 https://pharmadispatch.com/news/csl-acquires-rights-to-intravenous-flu-drug 2015-06-18T06:52:01+10:00 https://pharmadispatch.com/news/rheumatologist-voice-switching-concerns 2015-06-18T06:00:01+10:00 https://pharmadispatch.com/news/non-government-sectors-get-one-hour 2015-06-18T06:00:01+10:00 https://pharmadispatch.com/news/another-listing-for-az-diabetes-drug 2015-06-18T06:00:01+10:00 https://pharmadispatch.com/news/frazier-australia-could-be-a-dominant-power-in-medicines 2015-06-18T06:00:01+10:00 https://pharmadispatch.com/news/joe-demarte-elected-psa-national-president 2015-06-18T06:00:01+10:00 https://pharmadispatch.com/news/government-promotes-benefits-of-new-fta 2015-06-18T06:00:01+10:00 https://pharmadispatch.com/news/merck-ceo-cautions-australia-on-access-and-pricing 2015-06-17T15:29:01+10:00 https://pharmadispatch.com/news/abbott-labs-backs-mylan 2015-06-17T06:30:01+10:00 https://pharmadispatch.com/news/new-cancer-listings-but-tougher-prescribing-for-fertility-drugs 2015-06-17T06:00:01+10:00 https://pharmadispatch.com/news/pbs-bill-senate-agrees-to-a-close-look 2015-06-17T06:00:01+10:00 https://pharmadispatch.com/news/innovation-required-in-prostate-cancer-treatment 2015-06-17T06:00:01+10:00 https://pharmadispatch.com/news/ma-dont-scrap-orphan-drug-fee-waiver 2015-06-17T06:00:01+10:00 https://pharmadispatch.com/news/government-announces-new-chemo-funding-package 2015-06-16T06:26:01+10:00 https://pharmadispatch.com/news/staff-changes-for-sussan-ley 2015-06-16T06:00:01+10:00 https://pharmadispatch.com/news/confronting-hep-c-stigma-in-pursuit-of-a-cure 2015-06-16T06:00:01+10:00 https://pharmadispatch.com/news/a-new-home-for-pharma-and-biotech-recruitment 2015-06-16T06:00:01+10:00 https://pharmadispatch.com/news/csl-lower-tax-to-attract-investment 2015-06-16T06:00:01+10:00 https://pharmadispatch.com/news/labor-backs-a-closer-look-at-pbs-changes 2015-06-16T06:00:01+10:00 https://pharmadispatch.com/news/nps-go-back-to-your-doctor 2015-06-16T06:00:01+10:00 https://pharmadispatch.com/news/anti-industry-mp-at-it-again 2015-06-16T06:00:01+10:00 https://pharmadispatch.com/news/the-pbs-debate 2015-06-16T05:37:01+10:00 https://pharmadispatch.com/news/biosimilars-the-interchangeability-debate 2015-06-15T06:00:01+10:00 https://pharmadispatch.com/news/minister-told-to-wait-for-the-evidence 2015-06-15T06:00:01+10:00 https://pharmadispatch.com/news/pbs-bill-scheduled-for-debate-today 2015-06-15T06:00:01+10:00 https://pharmadispatch.com/news/gsk-backed-campaign-to-raise-awareness-of-prostate-risks 2015-06-15T06:00:01+10:00 https://pharmadispatch.com/news/fda-advised-to-approve-cholesterol-lowering-biologics 2015-06-15T06:00:01+10:00 https://pharmadispatch.com/news/mylan-novartis-or-pfizer-preferred-buyers 2015-06-12T06:09:01+10:00 https://pharmadispatch.com/news/gmia-substitution-only-part-of-the-story 2015-06-12T06:00:01+10:00 https://pharmadispatch.com/news/no-pbs-at-new-health-industry-forum 2015-06-12T06:00:01+10:00 https://pharmadispatch.com/news/bayer-sells-diabetes-care-business 2015-06-11T17:08:01+10:00 https://pharmadispatch.com/news/transparency-for-some-but-not-all 2015-06-11T06:06:01+10:00 https://pharmadispatch.com/news/bms-recognised-as-a-best-employer 2015-06-11T06:00:01+10:00 https://pharmadispatch.com/news/guild-pbs-bill-faces-extremely-tight-timetable 2015-06-11T06:00:01+10:00 https://pharmadispatch.com/news/ex-chf-chair-says-no-to-biosimilar-substitution 2015-06-11T06:00:01+10:00 https://pharmadispatch.com/news/scrap-innovation-patent-system 2015-06-11T06:00:01+10:00 https://pharmadispatch.com/news/entering-the-policy-super-cycle 2015-06-10T17:02:01+10:00 https://pharmadispatch.com/news/study-backs-januvia-safety 2015-06-10T06:00:01+10:00 https://pharmadispatch.com/news/the-winners-in-2015-so-far-1 2015-06-10T06:00:01+10:00 https://pharmadispatch.com/news/ma-use-higher-gst-to-attract-investment 2015-06-10T06:00:01+10:00 https://pharmadispatch.com/news/pharmacists-urged-to-support-bowel-cancer-awareness-month 2015-06-10T06:00:01+10:00 https://pharmadispatch.com/news/tolmar-announces-details-of-uro-oncology-symposium 2015-06-10T06:00:01+10:00 https://pharmadispatch.com/news/wholesalers-happy-but-looking-to-review 2015-06-09T06:00:01+10:00 https://pharmadispatch.com/news/more-recognition-for-jane-halton 2015-06-09T06:00:01+10:00 https://pharmadispatch.com/news/teva-prepares-to-make-proposal 2015-06-09T06:00:01+10:00 https://pharmadispatch.com/news/pbs-changes-set-to-face-senate-scrutiny 2015-06-09T06:00:01+10:00 https://pharmadispatch.com/news/nejm-published-vytorin-study 2015-06-05T06:01:01+10:00 https://pharmadispatch.com/news/a-change-of-emphasis-on-biosimilars 2015-06-05T06:00:01+10:00 https://pharmadispatch.com/news/department-of-health-respond-on-biosimilars 2015-06-05T06:00:01+10:00 https://pharmadispatch.com/news/tga-backs-noacs-on-blood-monitoring 2015-06-05T06:00:01+10:00 https://pharmadispatch.com/news/its-all-in-a-name 2015-06-05T06:00:01+10:00 https://pharmadispatch.com/news/tgas-new-annual-charge-exemption-scheme 2015-06-04T06:27:01+10:00 https://pharmadispatch.com/news/department-wrong-on-quebec 2015-06-04T06:00:01+10:00 https://pharmadispatch.com/news/just-eight-days-left 2015-06-04T06:00:01+10:00 https://pharmadispatch.com/news/i-learnt-a-new-word-monopsony-says-tax-commissioner 2015-06-03T13:27:01+10:00 https://pharmadispatch.com/news/its-a-complex-issue 2015-06-03T06:00:01+10:00 https://pharmadispatch.com/news/stop-playing-games-mylan-tells-teva 2015-06-03T06:00:01+10:00 https://pharmadispatch.com/news/ato-pbs-hits-company-profits 2015-06-03T06:00:01+10:00 https://pharmadispatch.com/news/nps-backs-antibiotics-strategy 2015-06-03T06:00:01+10:00 https://pharmadispatch.com/news/government-pushes-pbs-legislation 2015-06-02T20:27:01+10:00 https://pharmadispatch.com/news/pharmacy-and-biosimilars-dominate-senate-discussion 2015-06-02T08:47:01+10:00 https://pharmadispatch.com/news/national-strategy-to-address-antibiotic-overuse 2015-06-02T06:58:01+10:00 https://pharmadispatch.com/news/we-will-do-better-bowles-tells-senate 2015-06-02T06:00:01+10:00 https://pharmadispatch.com/news/positive-results-for-bayers-stivarga-in-gastro-intestinal-cancer 2015-06-02T06:00:01+10:00 https://pharmadispatch.com/news/boost-for-bms-immunotherapy-combination 2015-06-02T06:00:01+10:00 https://pharmadispatch.com/news/confusion-over-pbs-co-pays 2015-06-02T06:00:01+10:00 https://pharmadispatch.com/news/the-decade-of-no-growth 2015-06-01T10:48:01+10:00 https://pharmadispatch.com/news/a-list-full-of-generics 2015-06-01T06:00:01+10:00 https://pharmadispatch.com/news/teva-building-stake-in-mylan 2015-06-01T06:00:01+10:00 https://pharmadispatch.com/news/bms-and-msd-report-on-immunotherapies 2015-06-01T06:00:01+10:00 https://pharmadispatch.com/news/merck-serono-welcomes-expanded-listing-for-erbitux 2015-06-01T06:00:01+10:00 https://pharmadispatch.com/news/pbac-cautious-on-triple-combinations 2015-06-01T06:00:01+10:00 https://pharmadispatch.com/news/minister-announces-another-new-listing 2015-05-31T07:55:01+10:00 https://pharmadispatch.com/news/claims-industry-misled-on-biosimilars 2015-05-29T06:00:01+10:00 https://pharmadispatch.com/news/tremendous-sense-of-disappointment-over-pbac-comments 2015-05-29T06:00:01+10:00 https://pharmadispatch.com/news/novartis-wins-symbion-engage-award 2015-05-29T06:00:01+10:00 https://pharmadispatch.com/news/australia-not-the-only-country-dealing-with-biosimilars 2015-05-29T06:00:01+10:00 https://pharmadispatch.com/news/representing-the-most-important-group-of-all 2015-05-28T14:15:01+10:00 https://pharmadispatch.com/news/pbac-sets-delisting-principles 2015-05-28T06:03:01+10:00 https://pharmadispatch.com/news/time-will-tell-on-biosimilars 2015-05-28T06:00:01+10:00 https://pharmadispatch.com/news/biogen-greets-oceans-of-hope-yacht-ahead-of-world-ms-day 2015-05-28T06:00:01+10:00 https://pharmadispatch.com/news/government-acts-to-establish-mrff 2015-05-28T06:00:01+10:00 https://pharmadispatch.com/news/wholesalers-welcome-6cpa 2015-05-27T17:35:01+10:00 https://pharmadispatch.com/news/the-package 2015-05-27T11:34:01+10:00 https://pharmadispatch.com/news/minister-confirms-industry-rep-for-pbac 2015-05-27T09:59:01+10:00 https://pharmadispatch.com/news/gmia-and-guild-agreements 2015-05-27T07:58:01+10:00 https://pharmadispatch.com/news/biosimilar-changes-could-surprise 2015-05-27T06:09:01+10:00 https://pharmadispatch.com/news/coming-down-to-the-final-hours 2015-05-27T06:00:01+10:00 https://pharmadispatch.com/news/federal-court-backs-rb-in-gsk-patent-dispute 2015-05-27T06:00:01+10:00 https://pharmadispatch.com/news/labor-pathetic-cruel-and-heartless 2015-05-27T06:00:01+10:00 https://pharmadispatch.com/news/coalition-backs-pbs-changes 2015-05-26T14:47:01+10:00 https://pharmadispatch.com/news/volume-down-cost-up-1 2015-05-26T06:00:01+10:00 https://pharmadispatch.com/news/gmia-refocussed-and-regenerated 2015-05-26T06:00:01+10:00 https://pharmadispatch.com/news/di-natale-sticks-with-health 2015-05-26T06:00:01+10:00 https://pharmadispatch.com/news/pbs-savings-package-imminent 2015-05-25T16:25:01+10:00 https://pharmadispatch.com/news/wilson-the-popular-choice 2015-05-25T06:00:01+10:00 https://pharmadispatch.com/news/ma-hits-pause-pbs-campaign 2015-05-25T06:00:01+10:00 https://pharmadispatch.com/news/sanofi-seeks-funding-for-gp-diabetes-training 2015-05-25T06:00:01+10:00 https://pharmadispatch.com/news/well-known-names-reappear-with-strides-acquisition 2015-05-25T06:00:01+10:00 https://pharmadispatch.com/news/janssens-imbruvica-set-for-pbac 2015-05-25T06:00:01+10:00 https://pharmadispatch.com/news/tpp-boosted-by-us-senate-vote 2015-05-22T06:13:01+10:00 https://pharmadispatch.com/news/relationship-tested-like-never-before 2015-05-22T06:00:01+10:00 https://pharmadispatch.com/news/minister-starts-clearing-the-decks-on-pbs 2015-05-22T06:00:01+10:00 https://pharmadispatch.com/news/another-1bn-added-to-pbs-savings-target 2015-05-22T05:41:01+10:00 https://pharmadispatch.com/news/minister-defends-pbs-as-ma-launches-public-campaign 2015-05-21T09:51:01+10:00 https://pharmadispatch.com/news/ministers-launch-new-clinical-trials-website 2015-05-21T06:00:01+10:00 https://pharmadispatch.com/news/shpa-announces-ceo-departure 2015-05-21T06:00:01+10:00 https://pharmadispatch.com/news/tpp-trigger-moves-closer 2015-05-21T05:54:01+10:00 https://pharmadispatch.com/news/ama-criticising-its-own-process 2015-05-20T05:25:01+10:00 https://pharmadispatch.com/news/leo-pulls-product-from-pbs 2015-05-19T16:06:01+10:00 https://pharmadispatch.com/news/ma-not-going-quietly-on-agreement 2015-05-19T15:23:01+10:00 https://pharmadispatch.com/news/pharmaxis-soars-on-bi-deal 2015-05-19T06:00:01+10:00 https://pharmadispatch.com/news/any-access-delay-puts-patients-at-risk 2015-05-19T06:00:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-6cpa-progress 2015-05-19T06:00:01+10:00 https://pharmadispatch.com/news/nominations-open-for-research-australia-awards 2015-05-19T06:00:01+10:00 https://pharmadispatch.com/news/gmia-quiet-on-agreement 2015-05-19T06:00:01+10:00 https://pharmadispatch.com/news/patients-need-consistent-advice-on-corticosteroids 2015-05-19T06:00:01+10:00 https://pharmadispatch.com/news/ma-recruits-ex-abbott-staffer 2015-05-19T06:00:01+10:00 https://pharmadispatch.com/news/very-different-outlooks 2015-05-18T06:00:01+10:00 https://pharmadispatch.com/news/pbs-share-of-health-starts-to-rise 2015-05-18T06:00:01+10:00 https://pharmadispatch.com/news/previously-delisted-drug-reappears 2015-05-18T06:00:01+10:00 https://pharmadispatch.com/news/securing-a-pbs-listing-in-the-current-political-environment 2015-05-18T06:00:01+10:00 https://pharmadispatch.com/news/ma-wants-balance-and-equity 2015-05-18T06:00:01+10:00 https://pharmadispatch.com/news/guild-confirms-agreement 2015-05-18T05:43:01+10:00 https://pharmadispatch.com/news/guild-secures-agreement-but-ma-misses-out 2015-05-16T10:40:01+10:00 https://pharmadispatch.com/news/stop-wasting-the-ministers-time-industry-told 2015-05-15T06:00:01+10:00 https://pharmadispatch.com/news/labor-wants-higher-rd-spending 2015-05-15T06:00:01+10:00 https://pharmadispatch.com/news/last-day-of-edition-17 2015-05-15T06:00:01+10:00 https://pharmadispatch.com/news/transformation-impacts-gsk-2014-result 2015-05-15T06:00:01+10:00 https://pharmadispatch.com/news/pharmacy-edges-closer-to-agreement 2015-05-14T06:00:01+10:00 https://pharmadispatch.com/news/new-agreement-for-nps-medicinewise 2015-05-14T06:00:01+10:00 https://pharmadispatch.com/news/budget-silence-not-a-rejection-of-hepatitis-c-therapy-funding 2015-05-14T06:00:01+10:00 https://pharmadispatch.com/news/bowles-announces-major-changes 2015-05-14T05:32:01+10:00 https://pharmadispatch.com/news/get-ready-for-the-pasp 2015-05-13T06:00:01+10:00 https://pharmadispatch.com/news/research-sector-welcomes-mrff-commitment 2015-05-13T05:48:01+10:00 https://pharmadispatch.com/news/many-australians-in-the-dark-on-schizophrenia 2015-05-13T05:30:01+10:00 https://pharmadispatch.com/news/sector-responds-to-the-budget 2015-05-13T05:12:01+10:00 https://pharmadispatch.com/news/pbs-forecast-revised-up-again 2015-05-13T04:22:01+10:00 https://pharmadispatch.com/news/the-announced-measures 2015-05-12T19:37:01+10:00 https://pharmadispatch.com/news/government-ready-to-go-on-savings-but-wants-agreement 2015-05-12T19:35:01+10:00 https://pharmadispatch.com/news/dont-blame-us-department-tells-industry 2015-05-12T06:00:01+10:00 https://pharmadispatch.com/news/guild-mocks-189-billion-claim 2015-05-12T06:00:01+10:00 https://pharmadispatch.com/news/enough-is-enough-on-organ-donation 2015-05-12T06:00:01+10:00 https://pharmadispatch.com/news/no-need-for-pharmacy-in-supermarkets 2015-05-12T06:00:01+10:00 https://pharmadispatch.com/news/govt-announces-budget-cancer-package 2015-05-12T06:00:01+10:00 https://pharmadispatch.com/news/tga-approves-harvoni-1 2015-05-12T05:37:01+10:00 https://pharmadispatch.com/news/changes-coming-to-the-department 2015-05-11T06:00:01+10:00 https://pharmadispatch.com/news/what-to-look-for-in-the-budget 2015-05-11T06:00:01+10:00 https://pharmadispatch.com/news/pharma-enters-post-mou-era 2015-05-11T06:00:01+10:00 https://pharmadispatch.com/news/different-paths-to-reimbursement 2015-05-11T06:00:01+10:00 https://pharmadispatch.com/news/new-listings-welcome-but 2015-05-09T11:03:01+10:00 https://pharmadispatch.com/news/minister-announces-13-billion-for-new-pbs-listings-and-a-vaccine 2015-05-09T05:45:01+10:00 https://pharmadispatch.com/news/no-april-fools-jokes-for-industry-in-2016 2015-05-08T06:00:01+10:00 https://pharmadispatch.com/news/james-budget-reaction-unprecedented 2015-05-08T06:00:01+10:00 https://pharmadispatch.com/news/gsk-going-its-own-way 2015-05-08T05:14:01+10:00 https://pharmadispatch.com/news/biosimilars-breaking-down-traditional-divides 2015-05-07T06:00:01+10:00 https://pharmadispatch.com/news/cabinet-set-to-endorse-budget 2015-05-07T06:00:01+10:00 https://pharmadispatch.com/news/39-nces-registered-in-2014 2015-05-07T06:00:01+10:00 https://pharmadispatch.com/news/ma-budget-appeal-to-prime-minister 2015-05-07T06:00:01+10:00 https://pharmadispatch.com/news/how-did-it-get-to-this 2015-05-07T05:04:01+10:00 https://pharmadispatch.com/news/di-natale-new-greens-leader 2015-05-06T12:51:01+10:00 https://pharmadispatch.com/news/tpp-almost-done 2015-05-06T06:07:01+10:00 https://pharmadispatch.com/news/thanks-but-no-thanks 2015-05-06T06:00:01+10:00 https://pharmadispatch.com/news/teva-still-pursuing-mylan 2015-05-06T05:44:01+10:00 https://pharmadispatch.com/news/tga-likely-to-back-substitution 2015-05-06T05:00:01+10:00 https://pharmadispatch.com/news/amneal-completes-acquisition-of-actavis-generics-business 2015-05-05T06:01:01+10:00 https://pharmadispatch.com/news/40-million-diabetes-saving 2015-05-05T06:00:01+10:00 https://pharmadispatch.com/news/a-savings-measure-dressed-up-as-something-else 2015-05-05T06:00:01+10:00 https://pharmadispatch.com/news/guild-slams-mean-and-tricky-budget-proposal 2015-05-04T17:34:01+10:00 https://pharmadispatch.com/news/disbelief-over-biosimilar-substitution 2015-05-04T12:33:01+10:00 https://pharmadispatch.com/news/the-ten-pbs-budget-measures 2015-05-04T06:00:01+10:00 https://pharmadispatch.com/news/industry-targeted-in-budget-process 2015-05-04T06:00:01+10:00 https://pharmadispatch.com/news/codeine-upscheduling-bad-medicine-bad-policy-bad-economics 2015-05-04T06:00:01+10:00 https://pharmadispatch.com/news/roche-tops-biologics-leader-board 2015-05-04T06:00:01+10:00 https://pharmadispatch.com/news/company-results-gilead 2015-05-04T06:00:01+10:00 https://pharmadispatch.com/news/wider-changes-to-pbs-safety-net 2015-05-04T06:00:01+10:00 https://pharmadispatch.com/news/from-white-to-red 2015-05-01T18:25:01+10:00 https://pharmadispatch.com/news/sanofi-reports-higher-than-expected-profit 2015-05-01T06:06:01+10:00 https://pharmadispatch.com/news/chf-change-of-heart 2015-05-01T06:00:01+10:00 https://pharmadispatch.com/news/gsk-transparency-on-2014-payments 2015-05-01T06:00:01+10:00 https://pharmadispatch.com/news/industry-reaching-breaking-point 2015-05-01T06:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-remicade-biosimilar 2015-04-30T06:00:01+10:00 https://pharmadispatch.com/news/we-dont-need-your-agreement 2015-04-30T06:00:01+10:00 https://pharmadispatch.com/news/another-busy-agenda 2015-04-30T06:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-and-uniquest-announce-new-collaboration 2015-04-30T05:48:01+10:00 https://pharmadispatch.com/news/perrigio-rejects-third-mylan-bid 2015-04-30T04:39:01+10:00 https://pharmadispatch.com/news/dont-walk-away 2015-04-29T06:00:01+10:00 https://pharmadispatch.com/news/psa-warns-on-budget-cuts 2015-04-29T06:00:01+10:00 https://pharmadispatch.com/news/pharmacy-sales-boost-blackmores 2015-04-29T06:00:01+10:00 https://pharmadispatch.com/news/choosing-wisely-launches-with-strong-focus-on-medicines 2015-04-29T06:00:01+10:00 https://pharmadispatch.com/news/results-pfizer-merck-and-bms 2015-04-29T06:00:01+10:00 https://pharmadispatch.com/news/gmia-welcome-biosimilar-a-flagging 2015-04-28T16:10:01+10:00 https://pharmadispatch.com/news/australians-back-pharmacy-ethics-and-honesty 2015-04-28T15:43:01+10:00 https://pharmadispatch.com/news/chf-backs-common-sense-on-delistings 2015-04-28T14:57:01+10:00 https://pharmadispatch.com/news/mylan-says-no-to-teva 2015-04-28T06:22:01+10:00 https://pharmadispatch.com/news/australia-set-to-lead-the-world-on-biosimilars 2015-04-28T06:00:01+10:00 https://pharmadispatch.com/news/pbs-savings-set-to-deliver-4-billion 2015-04-28T06:00:01+10:00 https://pharmadispatch.com/news/the-2bn-cost-of-diabetic-macular-oedema 2015-04-28T06:00:01+10:00 https://pharmadispatch.com/news/new-ebook-on-partnering-with-patients 2015-04-28T06:00:01+10:00 https://pharmadispatch.com/news/pbac-guidelines-review-must-consider-wider-benefits 2015-04-27T12:14:01+10:00 https://pharmadispatch.com/news/from-awareness-to-activation-partnering-with-patients-for-medica 2015-04-27T11:41:01+10:00 https://pharmadispatch.com/news/ley-pbs-talks-going-well 2015-04-27T09:52:01+10:00 https://pharmadispatch.com/news/listing-within-reach-says-msds-sellars 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/pbac-says-yes-to-biosimilar-substitution 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/recommendation-a-watershed-moment-1 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/now-for-implementation 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/az-and-celgene-partner-on-immunotherapies 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/mandatory-price-cut-or-price-disclosure-change 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/maestro-take-on-pbac-outcomes 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/mylan-lifts-perrigio-bid 2015-04-27T06:00:01+10:00 https://pharmadispatch.com/news/ley-to-announce-pbac-guidelines-review 2015-04-25T07:11:01+10:00 https://pharmadispatch.com/news/novartis-smaller-but-more-profitable 2015-04-24T18:04:01+10:00 https://pharmadispatch.com/news/march-pbac-outcomes 2015-04-24T13:10:01+10:00 https://pharmadispatch.com/news/cost-reductions-and-higher-prices-boost-lilly 2015-04-24T06:17:01+10:00 https://pharmadispatch.com/news/king-reinvest-savings-in-health 2015-04-24T06:10:01+10:00 https://pharmadispatch.com/news/budget-deadline-day 2015-04-24T06:00:01+10:00 https://pharmadispatch.com/news/gordon-naylor-to-lead-csls-global-flu-vaccine-business 2015-04-23T08:57:01+10:00 https://pharmadispatch.com/news/across-the-board-price-cut 2015-04-23T06:00:01+10:00 https://pharmadispatch.com/news/roche-cancer-portfolio-drives-growth 2015-04-23T06:00:01+10:00 https://pharmadispatch.com/news/perrigio-says-no-to-mylan 2015-04-23T06:00:01+10:00 https://pharmadispatch.com/news/bi-expecting-moderate-growth 2015-04-23T06:00:01+10:00 https://pharmadispatch.com/news/lowest-cpi-drug-price-rise-in-two-decades 2015-04-22T12:52:01+10:00 https://pharmadispatch.com/news/new-leadership-for-astrazeneca 2015-04-22T09:00:01+10:00 https://pharmadispatch.com/news/amgen-tops-first-quarter-forecast 2015-04-22T06:06:01+10:00 https://pharmadispatch.com/news/budget-d-day-approaching 2015-04-22T06:00:01+10:00 https://pharmadispatch.com/news/companies-are-using-parallel-process-for-cancer-medicines 2015-04-22T06:00:01+10:00 https://pharmadispatch.com/news/teva-us40bn-move-for-mylan 2015-04-22T06:00:01+10:00 https://pharmadispatch.com/news/bdmards-price-cut-confirmed 2015-04-21T06:00:01+10:00 https://pharmadispatch.com/news/australia-uses-hta-to-delay-access69 2015-04-21T06:00:01+10:00 https://pharmadispatch.com/news/pbac-misses-at-senate-inquiry 2015-04-20T18:37:01+10:00 https://pharmadispatch.com/news/department-trialling-new-parallel-process-for-breakthrough-thera 2015-04-20T16:12:01+10:00 https://pharmadispatch.com/news/rare-cancers-patients-have-suffered-from-systematic-neglect 2015-04-20T12:31:01+10:00 https://pharmadispatch.com/news/industry-takes-on-pbs-process 2015-04-20T08:33:01+10:00 https://pharmadispatch.com/news/mylan-confirms-teva-interest 2015-04-20T06:27:01+10:00 https://pharmadispatch.com/news/budget-proposals-target-f1-medicines 2015-04-20T06:00:01+10:00 https://pharmadispatch.com/news/biologics-facing-price-cut 2015-04-20T06:00:01+10:00 https://pharmadispatch.com/news/three-weeks-that-will-shape-the-next-five-years 2015-04-20T06:00:01+10:00 https://pharmadispatch.com/news/tga-delivers-world-first-for-keytruda 2015-04-20T06:00:01+10:00 https://pharmadispatch.com/news/carrot-and-stick-on-immunisation 2015-04-20T06:00:01+10:00 https://pharmadispatch.com/news/pharmac-says-no-to-transparency 2015-04-17T06:47:01+10:00 https://pharmadispatch.com/news/haemophilia-patients-waiting-and-waiting 2015-04-17T06:00:01+10:00 https://pharmadispatch.com/news/mental-health-review-recommends-a-move-away-from-pbs 2015-04-17T06:00:01+10:00 https://pharmadispatch.com/news/whats-under-consideration 2015-04-16T06:00:01+10:00 https://pharmadispatch.com/news/lundbeck-goes-private 2015-04-16T06:00:01+10:00 https://pharmadispatch.com/news/patients-dominate-senate-hearing 2015-04-16T06:00:01+10:00 https://pharmadispatch.com/news/cancer-debate-set-for-hearing 2015-04-16T05:59:01+10:00 https://pharmadispatch.com/news/pharma-sets-sets-the-standard 2015-04-15T15:55:01+10:00 https://pharmadispatch.com/news/government-targets-pbs-in-budget 2015-04-15T06:00:01+10:00 https://pharmadispatch.com/news/minister-invites-input-on-diabetes-strategy 2015-04-15T06:00:01+10:00 https://pharmadispatch.com/news/chf-backs-review-but-urges-caution 2015-04-15T06:00:01+10:00 https://pharmadispatch.com/news/strong-currency-hits-jj 2015-04-15T06:00:01+10:00 https://pharmadispatch.com/news/half-of-all-pbac-submissions-had-at-least-on-significant-problem 2015-04-14T06:00:01+10:00 https://pharmadispatch.com/news/get-funding-pathways-right 2015-04-14T06:00:01+10:00 https://pharmadispatch.com/news/promotion-for-ex-novartis-australia-head 2015-04-14T06:00:01+10:00 https://pharmadispatch.com/news/boost-for-mesoblast 2015-04-13T18:42:01+10:00 https://pharmadispatch.com/news/adrian-bootes 2015-04-13T06:00:01+10:00 https://pharmadispatch.com/news/yervoy-registration-catches-up-with-pbs-listing 2015-04-13T06:00:01+10:00 https://pharmadispatch.com/news/ley-set-budget-savings-target 2015-04-13T06:00:01+10:00 https://pharmadispatch.com/news/the-trap-has-been-set 2015-04-13T06:00:01+10:00 https://pharmadispatch.com/news/lsdp-could-cease 2015-04-13T06:00:01+10:00 https://pharmadispatch.com/news/chf-consumers-must-be-at-the-centre-of-new-primary-health-networ 2015-04-12T12:33:01+10:00 https://pharmadispatch.com/news/companies-sign-on-with-psa 2015-04-12T06:00:01+10:00 https://pharmadispatch.com/news/minister-receives-first-tga-review-report 2015-04-10T06:00:01+10:00 https://pharmadispatch.com/news/psa-issues-call-to-action 2015-04-10T06:00:01+10:00 https://pharmadispatch.com/news/more-industry-ma 2015-04-10T06:00:01+10:00 https://pharmadispatch.com/news/quilty-slams-intellectually-lazy-review 2015-04-09T18:00:01+10:00 https://pharmadispatch.com/news/otsuka-takes-back-abilify-1 2015-04-09T17:40:01+10:00 https://pharmadispatch.com/news/a-completely-different-world 2015-04-09T06:00:01+10:00 https://pharmadispatch.com/news/the-winners-in-2015-so-far 2015-04-09T06:00:01+10:00 https://pharmadispatch.com/news/carr-indecision-and-chaos-on-industry-policy 2015-04-09T06:00:01+10:00 https://pharmadispatch.com/news/no-competition 2015-04-08T06:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-announces-positive-trial-results 2015-04-08T06:00:01+10:00 https://pharmadispatch.com/news/more-chemotherapy-delistings 2015-04-08T06:00:01+10:00 https://pharmadispatch.com/news/first-changes-from-prescribing-review 2015-04-07T06:00:01+10:00 https://pharmadispatch.com/news/labor-welcomes-piwg-backflip 2015-04-07T06:00:01+10:00 https://pharmadispatch.com/news/pbs-changes-and-new-listings-for-1-may 2015-04-07T06:00:01+10:00 https://pharmadispatch.com/news/key-labor-senator-steps-down 2015-04-07T06:00:01+10:00 https://pharmadispatch.com/news/ma-no-excel-for-transparency-reports 2015-04-02T06:15:01+11:00 https://pharmadispatch.com/news/government-distances-itself-from-harper 2015-04-02T06:00:01+11:00 https://pharmadispatch.com/news/medicine-exports-slump-to-ten-year-low 2015-04-02T06:00:01+11:00 https://pharmadispatch.com/news/minister-confrims-new-listings 2015-04-02T06:00:01+11:00 https://pharmadispatch.com/news/napwha-welcomes-viivs-triumeq 2015-04-02T06:00:01+11:00 https://pharmadispatch.com/news/could-piwg-get-another-chance 2015-04-01T14:28:01+11:00 https://pharmadispatch.com/news/guild-rejects-review-recommendations 2015-04-01T06:00:01+11:00 https://pharmadispatch.com/news/price-cuts-hit-pharmacy 2015-04-01T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-pasteur-announces-arrival-of-new-flu-vaccine 2015-04-01T06:00:01+11:00 https://pharmadispatch.com/news/first-day-on-the-job-for-bayers-new-leadership 2015-04-01T06:00:01+11:00 https://pharmadispatch.com/news/competition-report-urges-caution-on-ip 2015-04-01T06:00:01+11:00 https://pharmadispatch.com/news/amneal-acquires-actavis-generics-business 2015-03-31T10:06:01+11:00 https://pharmadispatch.com/news/savings-cuts-1-in-5-from-the-pbs 2015-03-31T06:00:01+11:00 https://pharmadispatch.com/news/three-companies-fight-off-complaint 2015-03-31T06:00:01+11:00 https://pharmadispatch.com/news/teva-makes-acquisition 2015-03-31T06:00:01+11:00 https://pharmadispatch.com/news/corporate-tax-undermining-investment 2015-03-30T15:57:01+11:00 https://pharmadispatch.com/news/10-billion-in-the-bank 2015-03-30T06:00:01+11:00 https://pharmadispatch.com/news/the-future-is-social 2015-03-30T06:00:01+11:00 https://pharmadispatch.com/news/its-as-if-the-savings-dont-even-exist 2015-03-30T06:00:01+11:00 https://pharmadispatch.com/news/privacy-commissioner-backs-accc 2015-03-30T06:00:01+11:00 https://pharmadispatch.com/news/dont-stop-advocating-di-natale-tells-summit 2015-03-30T06:00:01+11:00 https://pharmadispatch.com/news/choosing-wisely-australia-advisory-group-chair 2015-03-27T18:00:01+11:00 https://pharmadispatch.com/news/code-authorisation-imminent 2015-03-27T06:11:01+11:00 https://pharmadispatch.com/news/government-shields-pbs-in-tpp 2015-03-27T06:00:01+11:00 https://pharmadispatch.com/news/di-natale-moves-again-on-pharmacy 2015-03-27T06:00:01+11:00 https://pharmadispatch.com/news/msd-halts-keytruda-trial 2015-03-26T06:00:01+11:00 https://pharmadispatch.com/news/only-very-small-survival-gains 2015-03-26T06:00:01+11:00 https://pharmadispatch.com/news/gsk-and-novartis-unite-on-leukaemia-listing 2015-03-26T06:00:01+11:00 https://pharmadispatch.com/news/quilty-de-link-prices-and-pharmacy-pay 2015-03-26T06:00:01+11:00 https://pharmadispatch.com/news/sun-completes-ranbaxy-acquisition 2015-03-26T06:00:01+11:00 https://pharmadispatch.com/news/new-actavis-to-exit-australian-generics-market 2015-03-25T09:49:01+11:00 https://pharmadispatch.com/news/new-co-chair-for-parliamentary-friends-group 2015-03-25T06:00:01+11:00 https://pharmadispatch.com/news/uncertainty-over-nsw-co-pay-move 2015-03-25T06:00:01+11:00 https://pharmadispatch.com/news/sandoz-pulls-chemo-drugs 2015-03-25T06:00:01+11:00 https://pharmadispatch.com/news/new-skin-cancer-report-shuns-access 2015-03-25T05:28:01+11:00 https://pharmadispatch.com/news/does-pbac-have-any-place-in-political-debate 2015-03-24T18:00:01+11:00 https://pharmadispatch.com/news/tolmar-welcomes-new-prostate-cancer-guidelines 2015-03-24T06:00:01+11:00 https://pharmadispatch.com/news/pbac-blames-companies-for-delays 2015-03-24T06:00:01+11:00 https://pharmadispatch.com/news/clinicians-welcome-genzymes-lemtrada 2015-03-24T06:00:01+11:00 https://pharmadispatch.com/news/di-natale-to-open-rare-disease-summit 2015-03-24T06:00:01+11:00 https://pharmadispatch.com/news/new-brand-and-biosimilars-for-biogen 2015-03-24T06:00:01+11:00 https://pharmadispatch.com/news/maestro-takes-a-closer-look-at-compare 2015-03-23T06:00:01+11:00 https://pharmadispatch.com/news/compare-report-sparks-debate-in-nz 2015-03-23T06:00:01+11:00 https://pharmadispatch.com/news/nsw-to-scrap-co-pays 2015-03-23T06:00:01+11:00 https://pharmadispatch.com/news/abbvie-confirms-viekira-pak-for-july-pbac 2015-03-23T06:00:01+11:00 https://pharmadispatch.com/news/dusc-concern-over-crohns-disease 2015-03-23T06:00:01+11:00 https://pharmadispatch.com/news/australians-want-access 2015-03-23T06:00:01+11:00 https://pharmadispatch.com/news/sigma-focussed-on-growing-non-pbs-revenues 2015-03-20T06:00:01+11:00 https://pharmadispatch.com/news/chf-backs-faster-access 2015-03-20T06:00:01+11:00 https://pharmadispatch.com/news/no-backward-step-from-ley 2015-03-20T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-wider-access-to-prevanar 2015-03-20T06:00:01+11:00 https://pharmadispatch.com/news/pharmacists-kicked-in-the-guts 2015-03-19T06:00:01+11:00 https://pharmadispatch.com/news/new-ceo-of-consumers-health-forum 2015-03-19T06:00:01+11:00 https://pharmadispatch.com/news/accc-to-appeal-pfizer-decision 2015-03-19T06:00:01+11:00 https://pharmadispatch.com/news/ma-chair-everything-is-negotiable-but 2015-03-19T06:00:01+11:00 https://pharmadispatch.com/news/sussan-ley-pbac-approved-25-billion-in-new-listings 2015-03-19T06:00:01+11:00 https://pharmadispatch.com/news/two-very-different-conversations 2015-03-19T06:00:01+11:00 https://pharmadispatch.com/news/government-blames-companies-for-access-delays 2015-03-18T15:11:01+11:00 https://pharmadispatch.com/news/pbs-growth-certain-to-accelerate 2015-03-18T06:00:01+11:00 https://pharmadispatch.com/news/exclusive-minister-to-announce-new-post-market-review-process 2015-03-18T06:00:01+11:00 https://pharmadispatch.com/news/zalcberg-set-to-highlight-his-own-experience 2015-03-18T06:00:01+11:00 https://pharmadispatch.com/news/australians-missing-out 2015-03-18T06:00:01+11:00 https://pharmadispatch.com/news/actavis-launches-new-osteoporosis-resource 2015-03-18T06:00:01+11:00 https://pharmadispatch.com/news/department-hits-back-on-cancer 2015-03-18T06:00:01+11:00 https://pharmadispatch.com/news/sanofis-pcsk9-hits-endpoint 2015-03-17T06:13:01+11:00 https://pharmadispatch.com/news/savings-locked-away 2015-03-17T06:00:01+11:00 https://pharmadispatch.com/news/psa-pharmacists-misrepresented-on-homeopathy 2015-03-17T06:00:01+11:00 https://pharmadispatch.com/news/groups-unite-to-reject-tpp-scare-campaign 2015-03-17T06:00:01+11:00 https://pharmadispatch.com/news/gmia-want-substitution-review 2015-03-17T06:00:01+11:00 https://pharmadispatch.com/news/az-scraps-price-agreement 2015-03-16T06:00:01+11:00 https://pharmadispatch.com/news/pbs-changes-and-new-listings-for-1-april 2015-03-16T06:00:01+11:00 https://pharmadispatch.com/news/guild-hits-back 2015-03-16T06:00:01+11:00 https://pharmadispatch.com/news/acc-highlights 2015-03-16T06:00:01+11:00 https://pharmadispatch.com/news/biosimilars-in-the-spotlight 2015-03-15T19:22:01+11:00 https://pharmadispatch.com/news/minister-welcomes-consumers-to-pbac 2015-03-15T17:53:01+11:00 https://pharmadispatch.com/news/figher-harder-xenophon-tells-pharmacy 2015-03-14T15:52:01+11:00 https://pharmadispatch.com/news/sussan-ley-give-me-options-on-pbs 2015-03-13T06:00:01+11:00 https://pharmadispatch.com/news/what-about-a-united-front 2015-03-13T05:40:01+11:00 https://pharmadispatch.com/news/boost-for-pharmaxis 2015-03-12T11:04:01+11:00 https://pharmadispatch.com/news/rca-appoints-ex-pfizer-exec 2015-03-12T06:00:01+11:00 https://pharmadispatch.com/news/critics-using-audit-to-for-anti-guild-agenda 2015-03-12T06:00:01+11:00 https://pharmadispatch.com/news/nhmrc-it-doesnt-work-1 2015-03-12T06:00:01+11:00 https://pharmadispatch.com/news/recall-over-packaging-issues 2015-03-12T06:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-education-awards 2015-03-12T06:00:01+11:00 https://pharmadispatch.com/news/msds-keytruda-wins-accelerated-approval-in-the-uk 2015-03-12T06:00:01+11:00 https://pharmadispatch.com/news/price-disclosure-threatens-access 2015-03-12T05:49:01+11:00 https://pharmadispatch.com/news/you-cant-have-the-prices-without-the-consequences 2015-03-11T06:00:01+11:00 https://pharmadispatch.com/news/asmi-supplements-for-calcium-deficiency 2015-03-11T06:00:01+11:00 https://pharmadispatch.com/news/news-prices-another-blow-to-benchmarkers 2015-03-11T06:00:01+11:00 https://pharmadispatch.com/news/tga-hits-kpis-in-latest-report 2015-03-11T06:00:01+11:00 https://pharmadispatch.com/news/gilead-sovaldi-meets-listing-criteria 2015-03-11T06:00:01+11:00 https://pharmadispatch.com/news/underlying-growth-for-aspen-australia 2015-03-10T18:00:01+11:00 https://pharmadispatch.com/news/hcv-a-rare-disease-in-ten-years 2015-03-10T06:00:01+11:00 https://pharmadispatch.com/news/cabinet-queue-set-to-grow 2015-03-10T06:00:01+11:00 https://pharmadispatch.com/news/political-tit-for-tat-over-cpa-audit 2015-03-09T06:00:01+11:00 https://pharmadispatch.com/news/new-biosimilar-study 2015-03-09T06:00:01+11:00 https://pharmadispatch.com/news/new-venture-for-ex-ma-board-member 2015-03-09T06:00:01+11:00 https://pharmadispatch.com/news/pbac-shift-on-cancer-medicines 2015-03-09T06:00:01+11:00 https://pharmadispatch.com/news/prostate-cancer 2015-03-09T06:00:01+11:00 https://pharmadispatch.com/news/limitations-on-who-can-be-pbac-chair 2015-03-09T06:00:01+11:00 https://pharmadispatch.com/news/what-a-day-1 2015-03-06T06:51:01+11:00 https://pharmadispatch.com/news/accc-targets-nurofen-packaging 2015-03-06T06:00:01+11:00 https://pharmadispatch.com/news/sector-welcomes-igr 2015-03-06T06:00:01+11:00 https://pharmadispatch.com/news/anao-wants-cpa-changes 2015-03-06T06:00:01+11:00 https://pharmadispatch.com/news/abbvie-pays-us21-billion-for-pharmacyclics 2015-03-06T06:00:01+11:00 https://pharmadispatch.com/news/what-a-day 2015-03-06T06:00:01+11:00 https://pharmadispatch.com/news/record-fda-approval-for-bms-cancer-therapy 2015-03-06T06:00:01+11:00 https://pharmadispatch.com/news/igr-buys-into-slowing-growth 2015-03-05T09:52:01+11:00 https://pharmadispatch.com/news/novartis-tiered-co-pays-for-high-cost-medicines 2015-03-05T06:27:01+11:00 https://pharmadispatch.com/news/janssen-secures-infliximab-in-nz 2015-03-05T06:05:01+11:00 https://pharmadispatch.com/news/xenophon-backs-pharmacy 2015-03-05T06:00:01+11:00 https://pharmadispatch.com/news/why-the-igr-is-so-important 2015-03-05T06:00:01+11:00 https://pharmadispatch.com/news/bi-to-submit-pradaxa-antidote 2015-03-05T06:00:01+11:00 https://pharmadispatch.com/news/new-ibd-resource-for-patients 2015-03-05T06:00:01+11:00 https://pharmadispatch.com/news/greens-want-australian-nice 2015-03-05T06:00:01+11:00 https://pharmadispatch.com/news/rex-complexity-with-multiple-layers 2015-03-04T06:00:01+11:00 https://pharmadispatch.com/news/faster-cabinet-approvals 2015-03-04T06:00:01+11:00 https://pharmadispatch.com/news/govt-softens-on-pbs-co-pay 2015-03-04T06:00:01+11:00 https://pharmadispatch.com/news/gsk-divests-opiates-business 2015-03-04T06:00:01+11:00 https://pharmadispatch.com/news/they-cant-really-believe-this 2015-03-04T06:00:01+11:00 https://pharmadispatch.com/news/audit-on-the-way 2015-03-03T06:00:01+11:00 https://pharmadispatch.com/news/robb-anti-trade-groups-peddling-pbs-nonsense 2015-03-03T06:00:01+11:00 https://pharmadispatch.com/news/attention-turning-to-pbs-co-pays 2015-03-03T06:00:01+11:00 https://pharmadispatch.com/news/ato-targets-pharma 2015-03-03T06:00:01+11:00 https://pharmadispatch.com/news/bayer-responds-to-patients 2015-03-03T06:00:01+11:00 https://pharmadispatch.com/news/janssen-highlights-its-own-experience 2015-03-03T06:00:01+11:00 https://pharmadispatch.com/news/piwg-euthanased 2015-03-02T06:00:01+11:00 https://pharmadispatch.com/news/nz-patients-not-enough-funding 2015-03-02T06:00:01+11:00 https://pharmadispatch.com/news/time-to-modernise-pbs 2015-03-02T06:00:01+11:00 https://pharmadispatch.com/news/clinician-welcomes-new-schizophrenia-option 2015-03-02T06:00:01+11:00 https://pharmadispatch.com/news/brindell-a-lot-has-changed 2015-03-02T06:00:01+11:00 https://pharmadispatch.com/news/companies-were-circling-the-prey-1 2015-02-27T06:57:01+11:00 https://pharmadispatch.com/news/companies-were-circling-the-prey 2015-02-27T06:00:01+11:00 https://pharmadispatch.com/news/making-an-already-difficult-situation-worse 2015-02-27T06:00:01+11:00 https://pharmadispatch.com/news/ma-action-needed-now 2015-02-26T17:24:01+11:00 https://pharmadispatch.com/news/its-all-semantics-on-conditions 2015-02-26T05:00:01+11:00 https://pharmadispatch.com/news/what-does-that-even-mean 2015-02-26T05:00:01+11:00 https://pharmadispatch.com/news/healthcare-drives-ebos 2015-02-26T04:41:01+11:00 https://pharmadispatch.com/news/industry-exec-appointed-nps-chair 2015-02-26T02:59:01+11:00 https://pharmadispatch.com/news/conditional-recommendations-not-allowed 2015-02-25T17:18:01+11:00 https://pharmadispatch.com/news/federal-court-backs-pfizer-against-accc 2015-02-25T13:03:01+11:00 https://pharmadispatch.com/news/teva-set-for-launch 2015-02-25T06:00:01+11:00 https://pharmadispatch.com/news/guild-calls-for-change 2015-02-25T06:00:01+11:00 https://pharmadispatch.com/news/zalcberg-government-must-recognise-the-problem 2015-02-25T06:00:01+11:00 https://pharmadispatch.com/news/orphan-designation-for-links-paser 2015-02-25T06:00:01+11:00 https://pharmadispatch.com/news/australia-falling-behind 2015-02-25T05:00:01+11:00 https://pharmadispatch.com/news/the-trade-agreement-fallacy 2015-02-24T06:00:01+11:00 https://pharmadispatch.com/news/department-takes-another-look 2015-02-24T06:00:01+11:00 https://pharmadispatch.com/news/patients-go-personal 2015-02-24T06:00:01+11:00 https://pharmadispatch.com/news/not-much-time-for-pbs 2015-02-24T06:00:01+11:00 https://pharmadispatch.com/news/asmi-welcomes-review 2015-02-24T06:00:01+11:00 https://pharmadispatch.com/news/is-generic-substitution-high-enough 2015-02-23T06:00:01+11:00 https://pharmadispatch.com/news/budget-key-for-nps 2015-02-23T06:00:01+11:00 https://pharmadispatch.com/news/biogen-welcomes-ms-listing 2015-02-23T06:00:01+11:00 https://pharmadispatch.com/news/ama-opposes-discount-flu-vax 2015-02-23T06:00:01+11:00 https://pharmadispatch.com/news/valeant-still-chasing-acquisitions 2015-02-23T06:00:01+11:00 https://pharmadispatch.com/news/surprise-change 2015-02-20T06:00:01+11:00 https://pharmadispatch.com/news/guild-look-to-pharmacy-on-adherence 2015-02-20T06:00:01+11:00 https://pharmadispatch.com/news/no-submission-from-cancer-australia 2015-02-20T06:00:01+11:00 https://pharmadispatch.com/news/focus-on-misuse 2015-02-20T06:00:01+11:00 https://pharmadispatch.com/news/non-adherence-a-major-issue-says-nps 2015-02-19T18:00:01+11:00 https://pharmadispatch.com/news/another-company-walks-over-pricing 2015-02-19T06:00:01+11:00 https://pharmadispatch.com/news/a-new-reality 2015-02-19T06:00:01+11:00 https://pharmadispatch.com/news/gmia-action-required-on-biosimilars 2015-02-19T06:00:01+11:00 https://pharmadispatch.com/news/chf-targets-pricing-and-pharmacy 2015-02-19T06:00:01+11:00 https://pharmadispatch.com/news/europe-leads-the-way-in-approving-first-mab-biosimilar 2015-02-18T06:00:01+11:00 https://pharmadispatch.com/news/slow-progress-on-pricing-of-new-presentations 2015-02-18T06:00:01+11:00 https://pharmadispatch.com/news/it-was-all-over-by-the-end-of-2013 2015-02-18T06:00:01+11:00 https://pharmadispatch.com/news/canspeak-we-cant-afford-to-wait 2015-02-18T06:00:01+11:00 https://pharmadispatch.com/news/pbs-growth-higher-than-expected 2015-02-17T06:00:01+11:00 https://pharmadispatch.com/news/a-new-era-begins 2015-02-17T06:00:01+11:00 https://pharmadispatch.com/news/claims-highly-political-and-fanciful 2015-02-17T06:00:01+11:00 https://pharmadispatch.com/news/bayer-seeks-expanded-listing-for-eylea 2015-02-17T06:00:01+11:00 https://pharmadispatch.com/news/changes-at-the-top-making-things-difficult 2015-02-16T06:00:01+11:00 https://pharmadispatch.com/news/inside-story-from-pbs-meeting 2015-02-16T06:00:01+11:00 https://pharmadispatch.com/news/everyone-waiting-on-pbac 2015-02-16T06:00:01+11:00 https://pharmadispatch.com/news/halton-warns-on-health-costs 2015-02-16T06:00:01+11:00 https://pharmadispatch.com/news/nz-takes-it-to-another-level 2015-02-16T06:00:01+11:00 https://pharmadispatch.com/news/minister-hosts-pbs-meeting 2015-02-13T06:36:01+11:00 https://pharmadispatch.com/news/new-listings 2015-02-13T06:00:01+11:00 https://pharmadispatch.com/news/guild-rejects-supermarket-attack-1 2015-02-13T06:00:01+11:00 https://pharmadispatch.com/news/critics-back-accc-backdown 2015-02-13T06:00:01+11:00 https://pharmadispatch.com/news/australian-study-in-stroke-breakthrough 2015-02-13T06:00:01+11:00 https://pharmadispatch.com/news/quilty-negotiation-is-urgent-and-time-critical 2015-02-12T18:00:01+11:00 https://pharmadispatch.com/news/role-for-pharmacy-in-boosting-bowel-cancer-screening 2015-02-12T06:00:01+11:00 https://pharmadispatch.com/news/budget-submissions-psa-and-asmi 2015-02-12T06:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-government-actions-not-matching-rhetoric 2015-02-12T06:00:01+11:00 https://pharmadispatch.com/news/csl-reports-strong-growth-but-moderates-forecast 2015-02-12T06:00:01+11:00 https://pharmadispatch.com/news/patient-story-cant-be-dismissed 2015-02-12T06:00:01+11:00 https://pharmadispatch.com/news/australia-finally-implements-trips 2015-02-11T18:00:01+11:00 https://pharmadispatch.com/news/pharma-the-losers-from-rd-tax-changes 2015-02-11T06:01:01+11:00 https://pharmadispatch.com/news/new-market-access-head-for-pfizer 2015-02-11T06:00:01+11:00 https://pharmadispatch.com/news/cancer-inquiry-extended 2015-02-11T06:00:01+11:00 https://pharmadispatch.com/news/time-for-a-review 2015-02-10T06:02:01+11:00 https://pharmadispatch.com/news/opportunity-in-instability 2015-02-10T06:00:01+11:00 https://pharmadispatch.com/news/who-next-for-pfizer 2015-02-10T06:00:01+11:00 https://pharmadispatch.com/news/no-backdown-on-pbs-co-pays 2015-02-10T06:00:01+11:00 https://pharmadispatch.com/news/tim-james 2015-02-10T06:00:01+11:00 https://pharmadispatch.com/news/accc-backdown-on-code 2015-02-09T09:00:01+11:00 https://pharmadispatch.com/news/ley-acts-on-myozyme 2015-02-09T06:00:01+11:00 https://pharmadispatch.com/news/federal-court-backs-bayer-on-eylea 2015-02-09T06:00:01+11:00 https://pharmadispatch.com/news/mp-you-reap-what-you-sow 2015-02-09T06:00:01+11:00 https://pharmadispatch.com/news/janssen-delisting-diabetes-drug 2015-02-09T06:00:01+11:00 https://pharmadispatch.com/news/ley-to-oppose-spill-motion-non-committal-on-leadership 2015-02-09T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-to-buy-hospira 2015-02-06T06:35:01+11:00 https://pharmadispatch.com/news/change-at-the-top-for-bayer 2015-02-06T06:24:01+11:00 https://pharmadispatch.com/news/results-merck-co-gsk-and-astrazeneca 2015-02-06T06:19:01+11:00 https://pharmadispatch.com/news/tga-approves-new-hiv-triple-therapy 2015-02-06T06:02:01+11:00 https://pharmadispatch.com/news/a-legacy-worth-debating 2015-02-06T06:00:01+11:00 https://pharmadispatch.com/news/sue-hill-resigns-as-pbac-chair 2015-02-05T12:47:01+11:00 https://pharmadispatch.com/news/political-drama-comes-at-the-worst-time 2015-02-05T06:00:01+11:00 https://pharmadispatch.com/news/amgen-gets-busy-on-biosimilars 2015-02-05T06:00:01+11:00 https://pharmadispatch.com/news/gilead-supercharged 2015-02-05T06:00:01+11:00 https://pharmadispatch.com/news/pbs-falling-behind-says-ma-chief 2015-02-05T06:00:01+11:00 https://pharmadispatch.com/news/ma-cautions-on-igr 2015-02-05T06:00:01+11:00 https://pharmadispatch.com/news/are-hopes-for-a-second-mou-fading-1 2015-02-04T06:22:01+11:00 https://pharmadispatch.com/news/australias-greatest-cancer-challenge 2015-02-04T06:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-new-xolair-approval 2015-02-04T06:00:01+11:00 https://pharmadispatch.com/news/sector-helps-fund-political-process 2015-02-03T06:00:01+11:00 https://pharmadispatch.com/news/chemmart-launches-ovarian-cancer-campaign 2015-02-03T06:00:01+11:00 https://pharmadispatch.com/news/early-staff-changes-for-sussan-ley 2015-02-03T06:00:01+11:00 https://pharmadispatch.com/news/australian-prescriber-backs-common-sense-on-conflicts 2015-02-03T06:00:01+11:00 https://pharmadispatch.com/news/abbvie-with-high-hopes-for-hep-c-therapy 2015-02-03T06:00:01+11:00 https://pharmadispatch.com/news/well-walk-says-ma 2015-02-02T06:00:01+11:00 https://pharmadispatch.com/news/hsd-growing-fast-but-pbs-still-falling 2015-02-02T06:00:01+11:00 https://pharmadispatch.com/news/what-an-absolute-nonsense 2015-02-02T06:00:01+11:00 https://pharmadispatch.com/news/consumers-win-as-pfizer-fights-on-price 2015-02-02T06:00:01+11:00 https://pharmadispatch.com/news/more-support-for-pharmacy-vaccination 2015-02-02T06:00:01+11:00 https://pharmadispatch.com/news/results-lilly-biogen-novo-nordisk-celgene-abbott 2015-02-01T19:56:01+11:00 https://pharmadispatch.com/news/currency-impacts-roche 2015-01-30T06:04:01+11:00 https://pharmadispatch.com/news/gates-warns-against-vaccine-price-cut 2015-01-30T06:00:01+11:00 https://pharmadispatch.com/news/ranbaxy-highlights-strong-growth-of-australia-business 2015-01-30T06:00:01+11:00 https://pharmadispatch.com/news/api-not-expecting-more-reform 2015-01-30T06:00:01+11:00 https://pharmadispatch.com/news/international-comparisons-not-always-what-they-seem 2015-01-29T06:00:01+11:00 https://pharmadispatch.com/news/actavis-transformation-underway 2015-01-29T06:00:01+11:00 https://pharmadispatch.com/news/amgen-comfortably-beats-expectations 2015-01-29T06:00:01+11:00 https://pharmadispatch.com/news/bms-looks-to-new-products 2015-01-29T06:00:01+11:00 https://pharmadispatch.com/news/otsuka-launches-australian-operation 2015-01-28T06:00:01+11:00 https://pharmadispatch.com/news/private-equity-backing-for-mdbriefcase 2015-01-28T06:00:01+11:00 https://pharmadispatch.com/news/medtronic-completes-covidien-acquisition 2015-01-28T06:00:01+11:00 https://pharmadispatch.com/news/transformational-year-for-novartis 2015-01-28T06:00:01+11:00 https://pharmadispatch.com/news/mid-range-per-capita 2015-01-28T06:00:01+11:00 https://pharmadispatch.com/news/us-dollar-hits-pfizer-sales 2015-01-28T06:00:01+11:00 https://pharmadispatch.com/news/can-we-finally-end-this-phoney-debate 2015-01-27T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-move-on-teva 2015-01-27T06:00:01+11:00 https://pharmadispatch.com/news/pbs-data-hard-to-read-but 2015-01-27T06:00:01+11:00 https://pharmadispatch.com/news/recognition-for-clinicians-and-medical-researchers 2015-01-27T06:00:01+11:00 https://pharmadispatch.com/news/pbac-recommends-roches-kadcyla 2015-01-27T06:00:01+11:00 https://pharmadispatch.com/news/queensland-lnp-backs-pharmacy 2015-01-27T06:00:01+11:00 https://pharmadispatch.com/news/consumers-back-pharmacy-in-primary-care 2015-01-27T06:00:01+11:00 https://pharmadispatch.com/news/intervention-required 2015-01-23T06:00:01+11:00 https://pharmadispatch.com/news/hepatitis-australia-collective-anguish-over-access-wait 2015-01-23T06:00:01+11:00 https://pharmadispatch.com/news/acoss-pbs-budget-claims-in-tatters 2015-01-23T06:00:01+11:00 https://pharmadispatch.com/news/cdf-chair-regrets-undermining-nice 2015-01-23T06:00:01+11:00 https://pharmadispatch.com/news/no-time-to-wait-on-new-therapies-groups-tell-inquiry 2015-01-22T06:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-genzyme-australia 2015-01-22T06:00:01+11:00 https://pharmadispatch.com/news/psa-updates-guidelines-as-states-move-on-vaccination 2015-01-22T06:00:01+11:00 https://pharmadispatch.com/news/jj-raises-2015-outlook 2015-01-22T06:00:01+11:00 https://pharmadispatch.com/news/is-the-pbac-taking-on-too-much 2015-01-22T06:00:01+11:00 https://pharmadispatch.com/news/tga-scraps-naming-convention 2015-01-22T06:00:01+11:00 https://pharmadispatch.com/news/perth-boy-first-to-receive-new-insulin-device 2015-01-22T06:00:01+11:00 https://pharmadispatch.com/news/europe-to-share-generic-drug-assessments-with-tga 2015-01-21T06:20:01+11:00 https://pharmadispatch.com/news/its-all-about-certainty 2015-01-21T06:00:01+11:00 https://pharmadispatch.com/news/self-care-boosting-blackmores 2015-01-21T06:00:01+11:00 https://pharmadispatch.com/news/industry-unites-on-labelling-change-timeline 2015-01-21T06:00:01+11:00 https://pharmadispatch.com/news/guild-wants-in-on-medicare-consultation 2015-01-20T06:00:01+11:00 https://pharmadispatch.com/news/chf-dont-forget-consumers 2015-01-20T06:00:01+11:00 https://pharmadispatch.com/news/uk-cancer-outcomes-still-lagging-comparable-countries 2015-01-20T06:00:01+11:00 https://pharmadispatch.com/news/gilead-to-appeal-patent-rejection 2015-01-20T06:00:01+11:00 https://pharmadispatch.com/news/confusion-over-biosimilars 2015-01-19T06:00:01+11:00 https://pharmadispatch.com/news/acoss-makes-bizarre-pbs-claim-in-budget-submission 2015-01-19T06:00:01+11:00 https://pharmadispatch.com/news/pointless-debate-on-advertising-ignores-reality 2015-01-19T06:00:01+11:00 https://pharmadispatch.com/news/health-no-longer-part-of-the-inner-sanctum 2015-01-19T06:00:01+11:00 https://pharmadispatch.com/news/companies-front-hep-c-inquiry 2015-01-19T06:00:01+11:00 https://pharmadispatch.com/news/cancer-treatment-at-a-special-point-in-history 2015-01-16T06:00:01+11:00 https://pharmadispatch.com/news/chf-calls-for-national-summit 2015-01-16T06:00:01+11:00 https://pharmadispatch.com/news/sometimes-equity-needs-to-trump-cost 2015-01-16T06:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-calls-for-global-approach-to-drug-pricing 2015-01-15T06:00:01+11:00 https://pharmadispatch.com/news/pfizer-developing-pcsk9-pill-and-vaccine 2015-01-15T06:00:01+11:00 https://pharmadispatch.com/news/embarrassment-for-the-fda 2015-01-15T06:00:01+11:00 https://pharmadispatch.com/news/jj-wants-major-reforms 2015-01-15T06:00:01+11:00 https://pharmadispatch.com/news/pbs-schedule-changes 2015-01-14T06:00:01+11:00 https://pharmadispatch.com/news/uk-defunds-some-cancer-drugs 2015-01-14T06:00:01+11:00 https://pharmadispatch.com/news/bms-immunotherapy-shines-in-another-trial 2015-01-14T06:00:01+11:00 https://pharmadispatch.com/news/shire-resets-after-abbvie 2015-01-14T06:00:01+11:00 https://pharmadispatch.com/news/another-state-backs-pharmacy-vaccination 2015-01-14T06:00:01+11:00 https://pharmadispatch.com/news/cabinet-considered-impact-of-tpp-ip-provisions 2015-01-13T06:00:01+11:00 https://pharmadispatch.com/news/pbs-doesnt-even-rate-a-mention-in-new-budget-report 2015-01-13T06:00:01+11:00 https://pharmadispatch.com/news/chf-ceo-exits 2015-01-13T06:00:01+11:00 https://pharmadispatch.com/news/more-submissions-to-tga-review 2015-01-13T06:00:01+11:00 https://pharmadispatch.com/news/no-shortage-of-pbs-expertise-for-new-minister 2015-01-12T06:00:01+11:00 https://pharmadispatch.com/news/new-listings-dominate-march-agenda 2015-01-12T06:00:01+11:00 https://pharmadispatch.com/news/cabinet-documents-reveal-not-much-has-changed 2015-01-12T06:00:01+11:00 https://pharmadispatch.com/news/chf-urges-caution-on-regulation 2015-01-12T06:00:01+11:00 https://pharmadispatch.com/news/co-pay-approaching-40 2015-01-12T06:00:01+11:00 https://pharmadispatch.com/news/repay-us-with-interest 2014-12-22T06:00:01+11:00 https://pharmadispatch.com/news/pbac-scrap-herceptin-program 2014-12-22T06:00:01+11:00 https://pharmadispatch.com/news/recommendation-rate-reveals-little 2014-12-22T06:00:01+11:00 https://pharmadispatch.com/news/who-is-sussan-ley 2014-12-21T17:35:01+11:00 https://pharmadispatch.com/news/new-minister-for-health 2014-12-21T15:15:01+11:00 https://pharmadispatch.com/news/looking-ahead-to-2015 2014-12-20T08:19:01+11:00 https://pharmadispatch.com/news/quicker-access-a-priority 2014-12-19T06:00:01+11:00 https://pharmadispatch.com/news/consumer-prices-will-fall-further 2014-12-19T06:00:01+11:00 https://pharmadispatch.com/news/new-report-confirms-importance-of-access 2014-12-19T06:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-will-respond-to-misleading-comments 2014-12-18T06:00:01+11:00 https://pharmadispatch.com/news/industry-backs-piwg-replacement 2014-12-18T06:00:01+11:00 https://pharmadispatch.com/news/more-backing-for-pharmacist-vaccination 2014-12-18T06:00:01+11:00 https://pharmadispatch.com/news/the-savings-are-still-there-theyre-just-budgeted 2014-12-18T06:00:01+11:00 https://pharmadispatch.com/news/department-sticks-to-1bn-line-on-sovaldi 2014-12-17T06:00:01+11:00 https://pharmadispatch.com/news/pbs-shifts-to-higher-cost-medicines 2014-12-17T06:00:01+11:00 https://pharmadispatch.com/news/department-defends-government-on-cancer-medicines 2014-12-17T06:00:01+11:00 https://pharmadispatch.com/news/confirmation-of-new-gmia-ceo 2014-12-17T06:00:01+11:00 https://pharmadispatch.com/news/the-gift-that-keeps-on-giving 2014-12-17T06:00:01+11:00 https://pharmadispatch.com/news/are-the-days-of-big-downward-revisions-over 2014-12-16T06:00:01+11:00 https://pharmadispatch.com/news/sponsored-medical-graduate-thanks-industry 2014-12-16T06:00:01+11:00 https://pharmadispatch.com/news/piwg-abolition-an-absolute-nonsense 2014-12-16T06:00:01+11:00 https://pharmadispatch.com/news/government-drops-the-p-word-again 2014-12-15T06:00:01+11:00 https://pharmadispatch.com/news/pharmaceuticals-is-ours-to-manage 2014-12-15T06:00:01+11:00 https://pharmadispatch.com/news/a-sign-of-things-to-come 2014-12-15T06:00:01+11:00 https://pharmadispatch.com/news/patent-cliff-getting-lower 2014-12-15T06:00:01+11:00 https://pharmadispatch.com/news/piwg-loss-a-strategic-blow 2014-12-15T06:00:01+11:00 https://pharmadispatch.com/news/mas-old-transparency-reports 2014-12-15T06:00:01+11:00 https://pharmadispatch.com/news/old-criteria-for-new-diabetes-drug-for-now 2014-12-12T06:00:01+11:00 https://pharmadispatch.com/news/takedas-adcetris-boosts-overall-survival 2014-12-12T06:00:01+11:00 https://pharmadispatch.com/news/chf-something-not-right-on-prescribing 2014-12-12T06:00:01+11:00 https://pharmadispatch.com/news/actavis-takes-back-actonel 2014-12-12T06:00:01+11:00 https://pharmadispatch.com/news/pbs-co-pay-delay-looks-like-a-year 2014-12-11T06:00:01+11:00 https://pharmadispatch.com/news/weve-been-saying-the-same-thing-for-years 2014-12-11T06:00:01+11:00 https://pharmadispatch.com/news/layton-leaving-chemmart 2014-12-11T06:00:01+11:00 https://pharmadispatch.com/news/clinicians-welcome-another-hep-c-option 2014-12-11T06:00:01+11:00 https://pharmadispatch.com/news/mercks-cubist-deal-hit-by-patent-loss 2014-12-11T06:00:01+11:00 https://pharmadispatch.com/news/government-sticks-on-pbs-co-pay 2014-12-10T06:00:01+11:00 https://pharmadispatch.com/news/-56 2014-12-10T06:00:01+11:00 https://pharmadispatch.com/news/cancer-drugs-fund 2014-12-10T06:00:01+11:00 https://pharmadispatch.com/news/-57 2014-12-10T06:00:01+11:00 https://pharmadispatch.com/news/merck-acquires-cubist 2014-12-09T06:21:01+11:00 https://pharmadispatch.com/news/-53 2014-12-09T06:00:01+11:00 https://pharmadispatch.com/news/-54 2014-12-09T06:00:01+11:00 https://pharmadispatch.com/news/patent-cases 2014-12-09T06:00:01+11:00 https://pharmadispatch.com/news/-55 2014-12-09T06:00:01+11:00 https://pharmadispatch.com/news/-50 2014-12-08T06:00:01+11:00 https://pharmadispatch.com/news/-51 2014-12-08T06:00:01+11:00 https://pharmadispatch.com/news/us-based-merck-set-for-another-acquisition 2014-12-08T06:00:01+11:00 https://pharmadispatch.com/news/-52 2014-12-08T06:00:01+11:00 https://pharmadispatch.com/news/dutton-well-be-back-on-co-payments 2014-12-08T06:00:01+11:00 https://pharmadispatch.com/news/-46 2014-12-05T06:00:01+11:00 https://pharmadispatch.com/news/-48 2014-12-05T06:00:01+11:00 https://pharmadispatch.com/news/accc-extends-the-life-of-edition-17 2014-12-05T06:00:01+11:00 https://pharmadispatch.com/news/time-critical-for-cancer-patients 2014-12-05T06:00:01+11:00 https://pharmadispatch.com/news/consultation-on-draft-guidelines-for-pca-test 2014-12-05T06:00:01+11:00 https://pharmadispatch.com/news/-49 2014-12-04T06:03:01+11:00 https://pharmadispatch.com/news/why-just-cancer 2014-12-04T06:00:01+11:00 https://pharmadispatch.com/news/sanofi-teams-up-with-sigma-and-diabetes-australia 2014-12-04T06:00:01+11:00 https://pharmadispatch.com/news/queensland-embraces-new-defibrillation-technology 2014-12-04T06:00:01+11:00 https://pharmadispatch.com/news/ma-cautiously-welcomes-senate-inquiry 2014-12-04T06:00:01+11:00 https://pharmadispatch.com/news/-47 2014-12-04T06:00:01+11:00 https://pharmadispatch.com/news/-42 2014-12-03T06:00:01+11:00 https://pharmadispatch.com/news/-43 2014-12-03T06:00:01+11:00 https://pharmadispatch.com/news/-44 2014-12-03T06:00:01+11:00 https://pharmadispatch.com/news/-45 2014-12-03T06:00:01+11:00 https://pharmadispatch.com/news/senate-inquiry-on-cancer-medicines 2014-12-03T06:00:01+11:00 https://pharmadispatch.com/news/subtle-change-on-pbs-sustainability 2014-12-02T06:00:01+11:00 https://pharmadispatch.com/news/diabetes 2014-12-02T06:00:01+11:00 https://pharmadispatch.com/news/-41 2014-12-02T06:00:01+11:00 https://pharmadispatch.com/news/watch-for-the-language 2014-12-02T06:00:01+11:00 https://pharmadispatch.com/news/-37 2014-12-01T06:00:01+11:00 https://pharmadispatch.com/news/-38 2014-12-01T06:00:01+11:00 https://pharmadispatch.com/news/-39 2014-12-01T06:00:01+11:00 https://pharmadispatch.com/news/-40 2014-12-01T06:00:01+11:00 https://pharmadispatch.com/news/code 2014-12-01T06:00:01+11:00 https://pharmadispatch.com/news/pharmacy-backs-victorian 2014-11-28T06:16:01+11:00 https://pharmadispatch.com/news/-36 2014-11-28T06:00:01+11:00 https://pharmadispatch.com/news/code-of-conduct-conference-day 2014-11-28T06:00:01+11:00 https://pharmadispatch.com/news/australian-patients-waiting-too-long-for-life-saving-therapies 2014-11-28T06:00:01+11:00 https://pharmadispatch.com/news/new-consumer-rep-for-msac 2014-11-27T06:00:01+11:00 https://pharmadispatch.com/news/-33 2014-11-27T06:00:01+11:00 https://pharmadispatch.com/news/-34 2014-11-27T06:00:01+11:00 https://pharmadispatch.com/news/-35 2014-11-27T06:00:01+11:00 https://pharmadispatch.com/news/trips 2014-11-26T06:00:01+11:00 https://pharmadispatch.com/news/-31 2014-11-26T06:00:01+11:00 https://pharmadispatch.com/news/-32 2014-11-26T06:00:01+11:00 https://pharmadispatch.com/news/pharmac 2014-11-25T06:00:01+11:00 https://pharmadispatch.com/news/declining-pbs-flattens-health-spending 2014-11-25T06:00:01+11:00 https://pharmadispatch.com/news/award-for-psa-director 2014-11-25T06:00:01+11:00 https://pharmadispatch.com/news/-29 2014-11-25T06:00:01+11:00 https://pharmadispatch.com/news/-30 2014-11-25T06:00:01+11:00 https://pharmadispatch.com/news/battle-far-from-over 2014-11-24T06:00:01+11:00 https://pharmadispatch.com/news/ldp-senator-swipe-at-minister 2014-11-24T06:00:01+11:00 https://pharmadispatch.com/news/-26 2014-11-24T06:00:01+11:00 https://pharmadispatch.com/news/-27 2014-11-24T06:00:01+11:00 https://pharmadispatch.com/news/-28 2014-11-24T06:00:01+11:00 https://pharmadispatch.com/news/mtaa-calls-for-reform 2014-11-21T06:00:01+11:00 https://pharmadispatch.com/news/bayers-sargent-re-elected-asmi-president 2014-11-21T06:00:01+11:00 https://pharmadispatch.com/news/-23 2014-11-21T06:00:01+11:00 https://pharmadispatch.com/news/-24 2014-11-21T06:00:01+11:00 https://pharmadispatch.com/news/-25 2014-11-21T06:00:01+11:00 https://pharmadispatch.com/news/ma-accepts-accc-condition 2014-11-21T06:00:01+11:00 https://pharmadispatch.com/news/ministers-finally-kill-off-anztpa 2014-11-21T06:00:01+11:00 https://pharmadispatch.com/news/drug-development-costs-top-us26-billion 2014-11-20T06:00:01+11:00 https://pharmadispatch.com/news/rb-takes-out-asmi-award 2014-11-20T06:00:01+11:00 https://pharmadispatch.com/news/pbac-membership 2014-11-20T06:00:01+11:00 https://pharmadispatch.com/news/-22 2014-11-20T06:00:01+11:00 https://pharmadispatch.com/news/nps-wants-urgent-action-on-antibiotics 2014-11-19T06:00:01+11:00 https://pharmadispatch.com/news/high-prices-driving-highest-otc-spend 2014-11-19T06:00:01+11:00 https://pharmadispatch.com/news/ma-welcomes-china-fta 2014-11-19T06:00:01+11:00 https://pharmadispatch.com/news/-19 2014-11-19T06:00:01+11:00 https://pharmadispatch.com/news/-20 2014-11-19T06:00:01+11:00 https://pharmadispatch.com/news/-21 2014-11-19T06:00:01+11:00 https://pharmadispatch.com/news/whose-advocacy-agenda 2014-11-18T06:00:01+11:00 https://pharmadispatch.com/news/chemo-could-be-obsolete-for-advanced-melanoma 2014-11-18T06:00:01+11:00 https://pharmadispatch.com/news/self-care-the-focus-of-asmi-conference 2014-11-18T06:00:01+11:00 https://pharmadispatch.com/news/high-court-backs-bayer-on-yaz-patent 2014-11-18T06:00:01+11:00 https://pharmadispatch.com/news/-18 2014-11-18T06:00:01+11:00 https://pharmadispatch.com/news/pharma-tariff-win-in-china-fta 2014-11-18T06:00:01+11:00 https://pharmadispatch.com/news/-17 2014-11-16T19:57:01+11:00 https://pharmadispatch.com/news/-16 2014-11-16T17:53:01+11:00 https://pharmadispatch.com/news/-15 2014-11-16T16:07:01+11:00 https://pharmadispatch.com/news/-14 2014-11-14T11:36:01+11:00 https://pharmadispatch.com/news/cameron-and-abbott-back-new-gsk-manufacturing-investment 2014-11-14T11:21:01+11:00 https://pharmadispatch.com/news/asmi-tga-review 2014-11-14T08:58:01+11:00 https://pharmadispatch.com/news/doha-legal-advice-pbac-not-able-to-impose-conditions-on-recommen 2014-11-14T06:00:01+11:00 https://pharmadispatch.com/news/-11 2014-11-14T06:00:01+11:00 https://pharmadispatch.com/news/-13 2014-11-14T06:00:01+11:00 https://pharmadispatch.com/news/tga-review-more-narrow 2014-11-13T18:00:01+11:00 https://pharmadispatch.com/news/co-pays-to-hit 2014-11-13T15:48:01+11:00 https://pharmadispatch.com/news/-10 2014-11-13T06:00:01+11:00 https://pharmadispatch.com/news/-12 2014-11-13T06:00:01+11:00 https://pharmadispatch.com/news/biogen-welcomes-new-ms-approval 2014-11-13T06:00:01+11:00 https://pharmadispatch.com/news/ma-lsdp-review 2014-11-13T06:00:01+11:00 https://pharmadispatch.com/news/diabetics-feeling-bullied 2014-11-13T06:00:01+11:00 https://pharmadispatch.com/news/actavis-in-talks-to-acquire-allergan-for-over-us60-billion 2014-11-13T05:11:01+11:00 https://pharmadispatch.com/news/psa-urges-caution-on-medical-cannabis 2014-11-12T06:26:01+11:00 https://pharmadispatch.com/news/frances-moves-further-on-avastin-in-macular-degeneration 2014-11-12T02:00:01+11:00 https://pharmadispatch.com/news/pneumonia-still-a-problem-in-australia 2014-11-12T02:00:01+11:00 https://pharmadispatch.com/news/-9 2014-11-12T02:00:01+11:00 https://pharmadispatch.com/news/-8 2014-11-11T06:08:01+11:00 https://pharmadispatch.com/news/women-feeling-the-stress 2014-11-10T20:27:01+11:00 https://pharmadispatch.com/news/pfizer-urges-caution-on-co-payment-changes 2014-11-10T19:11:01+11:00 https://pharmadispatch.com/news/-7 2014-11-10T11:14:01+11:00 https://pharmadispatch.com/news/allergan-battle-continues 2014-11-09T15:46:01+11:00 https://pharmadispatch.com/news/-6 2014-11-09T13:37:01+11:00 https://pharmadispatch.com/news/doh-modelling 2014-11-09T11:05:01+11:00 https://pharmadispatch.com/news/look-to-history-on-tpp 2014-11-09T08:46:01+11:00 https://pharmadispatch.com/news/improving-intellectual-property-underscores-innovation-and-healt 2014-11-09T08:43:01+11:00 https://pharmadispatch.com/news/-5 2014-11-08T08:41:01+11:00 https://pharmadispatch.com/news/-4 2014-11-07T11:39:01+11:00 https://pharmadispatch.com/news/renewed-hope-for-tpp 2014-11-07T11:15:01+11:00 https://pharmadispatch.com/news/eisai-welcomes-fycompa-listing 2014-11-07T11:10:01+11:00 https://pharmadispatch.com/news/who-loses-the-plot 2014-11-07T11:08:01+11:00 https://pharmadispatch.com/news/az-reports-higher-revenue 2014-11-07T11:06:01+11:00 https://pharmadispatch.com/news/another-lexapro-win-for-lundbeck 2014-11-07T11:00:01+11:00 https://pharmadispatch.com/news/gsk-award-recognises-queensland-researcher 2014-11-07T10:54:01+11:00 https://pharmadispatch.com/news/generics-facing-lexapro-damages-claim 2014-11-07T10:49:01+11:00 https://pharmadispatch.com/news/pharmacy-welcomes-backing-of-major-parties 2014-11-07T10:47:01+11:00 https://pharmadispatch.com/news/research-australia-awards-1 2014-11-07T10:45:01+11:00 https://pharmadispatch.com/news/actavis-confirms-acquisition-interest 2014-11-07T10:44:01+11:00 https://pharmadispatch.com/news/cpa-audit-delayed 2014-11-05T10:10:01+11:00 https://pharmadispatch.com/news/low-value-becomes-no-value 2014-11-05T10:08:01+11:00 https://pharmadispatch.com/news/pharmaxis-enrols-first-patient-in-pivotal-bronchitol-trial 2014-11-05T10:04:01+11:00 https://pharmadispatch.com/news/allergan-confirms-potential-white-knight 2014-11-05T10:03:01+11:00 https://pharmadispatch.com/news/pic-disbanded-after-gmia-withdraws 2014-11-05T10:02:01+11:00 https://pharmadispatch.com/news/psa-health-destination-pilot-boosted-profits 2014-11-05T10:00:01+11:00 https://pharmadispatch.com/news/new-study-highlights-shingles-stroke-risk 2014-11-05T09:59:01+11:00 https://pharmadispatch.com/news/us-govt-study-backs-pradaxa 2014-11-05T09:56:01+11:00 https://pharmadispatch.com/news/a-pbs-in-transformation 2014-11-03T07:33:01+11:00 https://pharmadispatch.com/news/code-defeat-for-high-profile-doctor 2014-11-03T07:32:01+11:00 https://pharmadispatch.com/news/industry-questions-pbac-on-vaccines 2014-11-03T07:31:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-copd-listing 2014-11-03T07:24:01+11:00 https://pharmadispatch.com/news/pfizer-monash-partnership-underway 2014-11-03T07:21:01+11:00 https://pharmadispatch.com/news/psa-new-model-is-the-future-for-pharmacy 2014-11-03T07:20:01+11:00 https://pharmadispatch.com/news/risk-share-revenue-tops-1billion 2014-10-31T06:12:01+11:00 https://pharmadispatch.com/news/ma-slams-vagueness-of-diabetes-review-draft-report 2014-10-31T06:10:01+11:00 https://pharmadispatch.com/news/nap-campaign-disputes-ama-attack 2014-10-31T06:10:01+11:00 https://pharmadispatch.com/news/ausbiotech-appoints-new-chairman 2014-10-31T06:08:01+11:00 https://pharmadispatch.com/news/another-pbs-indication-for-botox 2014-10-31T06:07:01+11:00 https://pharmadispatch.com/news/new-national-asthma-strategy 2014-10-31T06:06:01+11:00 https://pharmadispatch.com/news/government-backs-global-vaccine-initiative 2014-10-31T06:00:01+11:00 https://pharmadispatch.com/news/pbs-reform-delivers-one-year-savings-of-13-billion 2014-10-29T07:27:01+11:00 https://pharmadispatch.com/news/merck-co-aims-to-be-global-leader 2014-10-29T07:25:01+11:00 https://pharmadispatch.com/news/-3 2014-10-29T07:25:01+11:00 https://pharmadispatch.com/news/pm-urges-medical-researchers-to-get-behind-mrff 2014-10-29T07:24:01+11:00 https://pharmadispatch.com/news/australia-key-for-new-jj-innovation-centre 2014-10-29T07:24:01+11:00 https://pharmadispatch.com/news/clinical-genomics-secures-access-to-chinese-market 2014-10-29T07:23:01+11:00 https://pharmadispatch.com/news/results-merck-co-sanofi-novartis-amgen-and-pfizer 2014-10-29T07:22:01+11:00 https://pharmadispatch.com/news/pbs-criteria-changes-secure-listing-but-vertex-will-pay 2014-10-27T09:00:01+11:00 https://pharmadispatch.com/news/industry-leaders-back-reps 2014-10-27T08:59:01+11:00 https://pharmadispatch.com/news/industry-welcomes-tga-review 2014-10-27T08:58:01+11:00 https://pharmadispatch.com/news/consumer-group-gets-it-wrong-very-wrong 2014-10-27T08:58:01+11:00 https://pharmadispatch.com/news/results-bms-lilly-and-celgene 2014-10-27T08:56:01+11:00 https://pharmadispatch.com/news/patients-thank-minister-for-kalydeco 2014-10-27T08:55:01+11:00 https://pharmadispatch.com/news/tim-james-the-door-is-open 2014-10-25T11:19:01+11:00 https://pharmadispatch.com/news/sansom-and-delaat-to-lead-tga-review 2014-10-25T10:32:01+11:00 https://pharmadispatch.com/news/api-revenue-takes-pbs-reform-hit 2014-10-25T10:30:01+11:00 https://pharmadispatch.com/news/pbs-flat-as-a-pancake 2014-10-25T10:30:01+11:00 https://pharmadispatch.com/news/chemmart-goes-ahead-with-skin-cancer-screening-service 2014-10-25T10:29:01+11:00 https://pharmadispatch.com/news/ama-no-clear-rationale-for-pbs-authorities 2014-10-25T10:29:01+11:00 https://pharmadispatch.com/news/commercial-eyes-founder-wins-pat-clear-award 2014-10-25T10:28:01+11:00 https://pharmadispatch.com/news/gsk-considers-viiv-ipo 2014-10-25T10:28:01+11:00 https://pharmadispatch.com/news/important-debates-obscured-by-absurdities 2014-10-25T10:27:01+11:00 https://pharmadispatch.com/news/pbs-flatlines-as-officials-reveal-real-growth-number 2014-10-25T10:27:01+11:00 https://pharmadispatch.com/news/we-need-to-be-more-responsive 2014-10-25T10:26:01+11:00 https://pharmadispatch.com/news/labor-mp-backs-kalydeco-listing 2014-10-25T10:26:01+11:00 https://pharmadispatch.com/news/new-data-confirms-slow-but-increasing-uptake-of-noacs 2014-10-25T10:25:01+11:00 https://pharmadispatch.com/news/ama-dismisses-nap-evidence 2014-10-25T10:24:01+11:00 https://pharmadispatch.com/news/new-humira-indication-in-time-for-pbac 2014-10-25T10:23:01+11:00 https://pharmadispatch.com/news/ausbiotech-leader-elected-to-atse 2014-10-25T10:21:01+11:00 https://pharmadispatch.com/news/allergan-hits-back-at-valeant 2014-10-25T10:21:01+11:00 https://pharmadispatch.com/news/abbvie-and-shire-agree-on-merger-termination 2014-10-25T10:20:01+11:00 https://pharmadispatch.com/news/companies-bidding-for-omega 2014-10-25T10:18:01+11:00 https://pharmadispatch.com/news/hospitality-the-wildcard 2014-10-20T06:57:01+11:00 https://pharmadispatch.com/news/accc-signals-need-for-regulatory-reform 2014-10-20T06:56:01+11:00 https://pharmadispatch.com/news/accc-draft-determination-the-detail 2014-10-20T06:56:01+11:00 https://pharmadispatch.com/news/guardian-tops-pharmacy-satisfaction-survey 2014-10-20T06:55:01+11:00 https://pharmadispatch.com/news/kalydeco-mums-speak-out 2014-10-20T06:54:01+11:00 https://pharmadispatch.com/news/amgen-heads-to-court-on-cholesterol-biologics 2014-10-20T06:53:01+11:00 https://pharmadispatch.com/news/consumer-group-accuses-industry-of-well-everything 2014-10-20T06:53:01+11:00 https://pharmadispatch.com/news/asmi-nz-leads-the-way-on-rescheduling 2014-10-20T06:51:01+11:00 https://pharmadispatch.com/news/separate-agreements-in-name-only 2014-10-01T07:47:01+10:00 https://pharmadispatch.com/news/dramatic-day-for-the-pbs 2014-10-01T07:47:01+10:00 https://pharmadispatch.com/news/department-misses-the-point-on-ma-code 2014-10-01T07:46:01+10:00 https://pharmadispatch.com/news/major-parties-back-trips-changes 2014-10-01T07:45:01+10:00 https://pharmadispatch.com/news/hri-announces-new-stent-research 2014-09-30T08:17:01+10:00 https://pharmadispatch.com/news/more-positive-phase-3-data-for-bms-melanoma-therapy 2014-09-30T08:16:01+10:00 https://pharmadispatch.com/news/meng-c-vaccine-recalled 2014-09-30T08:15:01+10:00 https://pharmadispatch.com/news/pharmacist-union-wants-in-on-negotiations 2014-09-30T07:58:01+10:00 https://pharmadispatch.com/news/-2 2014-09-30T07:45:01+10:00 https://pharmadispatch.com/news/-1 2014-09-30T07:37:01+10:00 https://pharmadispatch.com/news/new-article-for-paul 2014-09-18T15:41:01+10:00 https://pharmadispatch.com/news/regrets-over-pbpa 2014-08-27T07:43:55+10:00 https://pharmadispatch.com/news/set-responses-only 2014-08-27T07:43:33+10:00 https://pharmadispatch.com/news/still-no-clarity-on-msac 2014-08-27T07:43:23+10:00 https://pharmadispatch.com/news/new-hope-for-cancer-sufferers 2014-08-27T07:39:01+10:00 https://pharmadispatch.com/news/continuing-shift-away-from-the-pbs 2014-08-26T07:52:48+10:00 https://pharmadispatch.com/news/new-resource-for-patients-at-risk-of-stroke 2014-08-26T07:52:22+10:00 https://pharmadispatch.com/news/follow-up-analysis-from-maestro 2014-08-26T07:52:11+10:00 https://pharmadispatch.com/news/debate-ignores-private-market-but-consumers-dont 2014-08-26T07:52:01+10:00 https://pharmadispatch.com/news/now-its-getting-embarrassing 2014-08-26T07:52:00+10:00 https://pharmadispatch.com/news/its-all-about-price 2014-08-25T07:56:32+10:00 https://pharmadispatch.com/news/step-therapy-by-stealth 2014-08-25T07:56:12+10:00 https://pharmadispatch.com/news/positives-but-with-price-cuts 2014-08-25T07:56:02+10:00 https://pharmadispatch.com/news/new-md-for-biogen-idec-australia-nz 2014-08-25T07:56:01+10:00 https://pharmadispatch.com/news/pbac-buying-time-on-sovaldi 2014-08-25T07:55:53+10:00 https://pharmadispatch.com/news/pbs-flatlines-over-the-next-decade 2014-08-22T13:23:45+10:00 https://pharmadispatch.com/news/changes-at-gmia 2014-08-22T07:49:02+10:00 https://pharmadispatch.com/news/all-eyes-on-hep-c 2014-08-22T07:48:27+10:00 https://pharmadispatch.com/news/bms-and-celgene-partner-in-new-cancer-trial 2014-08-22T07:48:09+10:00 https://pharmadispatch.com/news/derision-for-ama-proposal 2014-08-22T07:47:27+10:00 https://pharmadispatch.com/news/doh-non-pbs-drugs-driving-higher-consumer-costs 2014-08-21T07:53:28+10:00 https://pharmadispatch.com/news/a-highly-selective-analysis 2014-08-21T07:53:15+10:00 https://pharmadispatch.com/news/pharmac-funds-new-cancer-medicines-finally 2014-08-21T07:53:01+10:00 https://pharmadispatch.com/news/innovation-centre-for-sanofi 2014-08-21T07:52:47+10:00 https://pharmadispatch.com/news/only-a-165-million-correction 2014-08-20T07:59:36+10:00 https://pharmadispatch.com/news/doh-no-single-sector-should-carry-reform-burden 2014-08-20T07:59:26+10:00 https://pharmadispatch.com/news/guild-launches-national-media-campaign 2014-08-20T07:59:18+10:00 https://pharmadispatch.com/news/foundation-set-for-new-novartis-building 2014-08-20T07:59:05+10:00 https://pharmadispatch.com/news/grattan-analysis-unravels-with-time 2014-08-19T08:08:33+10:00 https://pharmadispatch.com/news/research-donations-at-risk 2014-08-19T08:07:22+10:00 https://pharmadispatch.com/news/high-generic-use-claims-nz-but-is-it-really-higher-than-australi 2014-08-19T08:07:11+10:00 https://pharmadispatch.com/news/pharma-leaders-on-pollie-pedal 2014-08-19T08:06:58+10:00 https://pharmadispatch.com/news/every-day-of-delay-people-die 2014-08-18T07:59:12+10:00 https://pharmadispatch.com/news/is-this-really-the-best-system-in-the-world 2014-08-18T07:59:03+10:00 https://pharmadispatch.com/news/problems-mount-for-us-disclosure-model 2014-08-18T07:58:54+10:00 https://pharmadispatch.com/news/chf-wants-ama-proposal 2014-08-18T07:58:47+10:00 https://pharmadispatch.com/news/uks-nice-says-yes-to-sovaldi 2014-08-18T07:58:35+10:00 https://pharmadispatch.com/news/medtronic-boss-in-line-for-leadership-award 2014-08-18T07:58:24+10:00 https://pharmadispatch.com/news/no-modelling-on-pbs-safety-net-change 2014-08-15T07:59:27+10:00 https://pharmadispatch.com/news/ma-appoints-new-board-member 2014-08-15T07:59:13+10:00 https://pharmadispatch.com/news/qrxpharma-halts-development-of-pain-drug 2014-08-15T07:57:40+10:00 https://pharmadispatch.com/news/labor-seizes-heart-foundation-report 2014-08-15T07:56:59+10:00 https://pharmadispatch.com/news/new-report-highlights-copd-challenge 2014-08-14T07:52:16+10:00 https://pharmadispatch.com/news/tga-approval-times-accelerating-for-new-drugs 2014-08-14T07:51:01+10:00 https://pharmadispatch.com/news/funding-of-clinical-trials-reforms-underway 2014-08-14T07:50:43+10:00 https://pharmadispatch.com/news/nz-shuns-transparency 2014-08-14T07:50:25+10:00 https://pharmadispatch.com/news/healthy-profit-for-csl 2014-08-14T07:49:59+10:00 https://pharmadispatch.com/news/could-ma-walk-away-from-authorisation-process 2014-08-13T08:09:36+10:00 https://pharmadispatch.com/news/commission-of-audit-not-going-away 2014-08-13T08:08:15+10:00 https://pharmadispatch.com/news/court-dismisses-az-crestor-appeal 2014-08-13T08:07:44+10:00 https://pharmadispatch.com/news/govt-analysing-co-pay-options 2014-08-13T08:07:34+10:00 https://pharmadispatch.com/news/gsk-wants-local-innovators 2014-08-13T08:07:17+10:00 https://pharmadispatch.com/news/why-the-fuss-about-medicare-co-pay 2014-08-12T07:55:20+10:00 https://pharmadispatch.com/news/kalydeco-can-the-stalemate-be-broken 2014-08-12T07:55:11+10:00 https://pharmadispatch.com/news/dont-rely-on-ama-chf-tells-government 2014-08-12T07:54:58+10:00 https://pharmadispatch.com/news/sanofi-acquires-rights-to-new-inhaled-insulin 2014-08-12T07:54:44+10:00 https://pharmadispatch.com/news/payment-shake-up-for-pbs-and-medicare 2014-08-11T07:59:09+10:00 https://pharmadispatch.com/news/another-new-brand-in-the-generics-market 2014-08-11T07:59:03+10:00 https://pharmadispatch.com/news/support-for-ma-code 2014-08-11T07:58:56+10:00 https://pharmadispatch.com/news/generic-listings-continue-to-dominate 2014-08-11T07:58:48+10:00 https://pharmadispatch.com/news/australia-hits-mylan-result 2014-08-11T07:58:33+10:00 https://pharmadispatch.com/news/psa-seeking-input-on-services 2014-08-11T07:58:16+10:00 https://pharmadispatch.com/news/no-listing-but-an-expanded-indication 2014-08-11T07:58:08+10:00 https://pharmadispatch.com/news/pfizer-pbs-constrains-innovation 2014-08-08T08:02:57+10:00 https://pharmadispatch.com/news/new-option-in-ovarian-cancer 2014-08-08T08:02:39+10:00 https://pharmadispatch.com/news/patents-not-papers-says-macfarlane 2014-08-08T08:02:26+10:00 https://pharmadispatch.com/news/allergan-standing-its-ground 2014-08-08T08:02:12+10:00 https://pharmadispatch.com/news/a-willingness-to-change-on-cancer-medicines 2014-08-07T07:54:53+10:00 https://pharmadispatch.com/news/igr-was-wrong-on-pbs-very-wrong-but-right-on-medicare 2014-08-07T07:54:44+10:00 https://pharmadispatch.com/news/dont-stop-taking-pradaxa 2014-08-07T07:54:32+10:00 https://pharmadispatch.com/news/global-role-for-nhmrc-head 2014-08-07T07:54:18+10:00 https://pharmadispatch.com/news/department-of-health-rejects-international-comparisons 2014-08-06T07:54:32+10:00 https://pharmadispatch.com/news/does-disclosure-really-require-consent 2014-08-06T07:54:16+10:00 https://pharmadispatch.com/news/industry-sounds-alarm-over-slump-in-exports 2014-08-06T07:54:04+10:00 https://pharmadispatch.com/news/novartis-welcomes-new-copd-therapy-with-private-launch 2014-08-06T07:53:44+10:00 https://pharmadispatch.com/news/igr-a-bad-omen 2014-08-05T07:59:01+10:00 https://pharmadispatch.com/news/bi-rejects-criticism-over-pradaxa 2014-08-05T07:58:47+10:00 https://pharmadispatch.com/news/treat-code-fines-like-proceeds-of-crime-says-chf 2014-08-05T07:58:35+10:00 https://pharmadispatch.com/news/govt-interested-in-co-pay-proposal 2014-08-05T07:58:19+10:00 https://pharmadispatch.com/news/pharmaxis-sues-novaquest 2014-08-05T07:58:07+10:00 https://pharmadispatch.com/news/change-important-says-department-of-health 2014-08-04T07:56:58+10:00 https://pharmadispatch.com/news/dusc-analysis-highlights-the-impact-of-innovation 2014-08-04T07:56:46+10:00 https://pharmadispatch.com/news/new-global-proposal-for-biosimilar-names 2014-08-04T07:56:30+10:00 https://pharmadispatch.com/news/patience-the-key-for-teva 2014-08-04T07:56:14+10:00 https://pharmadispatch.com/news/copd-market-set-for-change 2014-08-04T07:55:05+10:00 https://pharmadispatch.com/news/allergan-sues-valeant 2014-08-04T07:54:51+10:00 https://pharmadispatch.com/news/exclusive-global-generics-leader-coming-to-australia 2014-08-01T07:55:40+10:00 https://pharmadispatch.com/news/teva-very-serious 2014-08-01T07:55:21+10:00 https://pharmadispatch.com/news/outcomes-key-for-new-cholesterol-lowering-biologics 2014-08-01T07:54:55+10:00 https://pharmadispatch.com/news/company-results-astrazeneca-and-bayer 2014-08-01T07:54:21+10:00 https://pharmadispatch.com/news/ranbaxy-celebrates-launch-of-generic-nexium 2014-08-01T07:53:51+10:00 https://pharmadispatch.com/news/new-help-for-kids-impacted-by-stroke 2014-08-01T07:53:13+10:00 https://pharmadispatch.com/news/accc-spammed-on-code-authorisation 2014-07-31T07:55:45+10:00 https://pharmadispatch.com/news/improved-result-for-ranbaxy-australia 2014-07-31T07:55:27+10:00 https://pharmadispatch.com/news/location-rule-comments-lame 2014-07-31T07:55:17+10:00 https://pharmadispatch.com/news/perfect-timing-for-az-respiratory-acquisition 2014-07-31T07:55:03+10:00 https://pharmadispatch.com/news/pfizer-to-acquire-baxter-vaccines 2014-07-31T07:53:45+10:00 https://pharmadispatch.com/news/department-dismisses-industry-biosimilar-proposal 2014-07-30T08:03:58+10:00 https://pharmadispatch.com/news/another-flawed-analysis-from-grattan 2014-07-30T08:03:46+10:00 https://pharmadispatch.com/news/two-thirds-of-pbac-recommendations-not-listed 2014-07-30T08:03:34+10:00 https://pharmadispatch.com/news/no-need-for-pidg 2014-07-30T08:03:24+10:00 https://pharmadispatch.com/news/company-results-pfizer-merck-co-amgen 2014-07-30T08:03:06+10:00 https://pharmadispatch.com/news/nexium-price-battle-begins 2014-07-29T07:54:51+10:00 https://pharmadispatch.com/news/once-in-a-generation-structural-shift 2014-07-29T07:54:34+10:00 https://pharmadispatch.com/news/the-shifting-sands-of-the-pbs 2014-07-29T07:54:19+10:00 https://pharmadispatch.com/news/additions-to-hospira-leadership-team 2014-07-29T07:54:00+10:00 https://pharmadispatch.com/news/humira-still-delivering-for-abbvie 2014-07-29T07:53:47+10:00 https://pharmadispatch.com/news/spike-in-pbs-spend-not-what-it-seems 2014-07-28T07:42:35+10:00 https://pharmadispatch.com/news/new-data-confirms-pbs-transformation 2014-07-28T07:42:27+10:00 https://pharmadispatch.com/news/nonsense-rules-in-tpp-debate 2014-07-28T07:42:17+10:00 https://pharmadispatch.com/news/social-media-debate-not-done-yet 2014-07-28T07:42:05+10:00 https://pharmadispatch.com/news/australia-facing-liver-disease-crisis 2014-07-28T07:41:55+10:00 https://pharmadispatch.com/news/health-fund-backs-new-bowel-cancer-test 2014-07-28T07:41:47+10:00 https://pharmadispatch.com/news/device-technologies-upsizes 2014-07-28T07:41:39+10:00 https://pharmadispatch.com/news/prices-keep-falling 2014-07-25T07:44:09+10:00 https://pharmadispatch.com/news/industry-critic-argues-for-regulation 2014-07-25T07:44:00+10:00 https://pharmadispatch.com/news/bi-on-the-offensive-through-social-media 2014-07-25T07:43:38+10:00 https://pharmadispatch.com/news/company-results-biogen-gsk-and-roche 2014-07-25T07:39:06+10:00 https://pharmadispatch.com/news/the-cabinet-clock-already-ticking 2014-07-24T08:07:08+10:00 https://pharmadispatch.com/news/uncertainty-surrounds-msac 2014-07-24T08:06:25+10:00 https://pharmadispatch.com/news/new-challenges-on-hiv 2014-07-24T08:05:51+10:00 https://pharmadispatch.com/news/submissions-already-making-their-way-to-accc 2014-07-24T08:00:26+10:00 https://pharmadispatch.com/news/are-people-arguing-over-something-thats-not-going-to-happen 2014-07-23T07:55:22+10:00 https://pharmadispatch.com/news/pharmacy-gp-tie-up-on-primary-care 2014-07-23T07:55:11+10:00 https://pharmadispatch.com/news/bms-recognised-in-sustainability-awards 2014-07-23T07:54:59+10:00 https://pharmadispatch.com/news/asmi-hits-back-at-criticism-of-complementary-medicines 2014-07-23T07:54:44+10:00 https://pharmadispatch.com/news/pbs-listing-for-ranbaxys-nexium-generic 2014-07-22T08:01:14+10:00 https://pharmadispatch.com/news/merck-serono-taps-az-exec-for-md-role 2014-07-22T08:00:08+10:00 https://pharmadispatch.com/news/diabetes-patients-facing-mental-health-challenge 2014-07-22T07:58:58+10:00 https://pharmadispatch.com/news/jj-teams-up-with-macquarie-university 2014-07-22T07:58:31+10:00 https://pharmadispatch.com/news/new-pharmacy-pain-management-resource 2014-07-22T07:58:10+10:00 https://pharmadispatch.com/news/popular-allergy-treatment-goes-otc 2014-07-22T07:57:59+10:00 https://pharmadispatch.com/news/social-media-is-changing-everything-for-the-pbs-and-theres-no-go 2014-07-21T07:49:05+10:00 https://pharmadispatch.com/news/parallel-process-starting-to-work 2014-07-21T07:49:01+10:00 https://pharmadispatch.com/news/xenophon-where-is-the-report-you-promised 2014-07-21T07:48:41+10:00 https://pharmadispatch.com/news/abbvie-shire-creates-new-top-10-global-power 2014-07-21T07:48:22+10:00 https://pharmadispatch.com/news/mixed-results-for-australia-in-global-innovation-index 2014-07-21T07:48:12+10:00 https://pharmadispatch.com/news/political-leaders-unite-on-mh17 2014-07-21T07:47:54+10:00 https://pharmadispatch.com/news/181-new-listings-is-mostly-generics 2014-07-18T07:50:44+10:00 https://pharmadispatch.com/news/cystic-fibrosis-mums-hit-back 2014-07-18T07:50:21+10:00 https://pharmadispatch.com/news/enduring-industry-partnership-for-png 2014-07-18T07:50:12+10:00 https://pharmadispatch.com/news/dutton-launches-new-asthma-medication-resource 2014-07-18T07:49:53+10:00 https://pharmadispatch.com/news/emerging-markets-and-growth-products-boost-novartis 2014-07-18T07:49:41+10:00 https://pharmadispatch.com/news/gsks-geoff-mcdonald-on-transparency-and-another-mou 2014-07-17T07:56:21+10:00 https://pharmadispatch.com/news/more-delistings-inevitable 2014-07-17T07:56:12+10:00 https://pharmadispatch.com/news/delay-in-generic-oxycontin 2014-07-17T07:55:50+10:00 https://pharmadispatch.com/news/jj-profit-jumps-on-growing-hepatitis-portfolio 2014-07-17T07:54:31+10:00 https://pharmadispatch.com/news/co-pay-makes-it-through-hor-now-for-the-senate 2014-07-17T07:54:19+10:00 https://pharmadispatch.com/news/labor-fund-life-saving-drugs-as-quickly-as-possible 2014-07-16T07:56:45+10:00 https://pharmadispatch.com/news/cross-party-support-for-soliris 2014-07-16T07:56:38+10:00 https://pharmadispatch.com/news/labor-mp-attacks-industry-again 2014-07-16T07:56:28+10:00 https://pharmadispatch.com/news/what-next-for-oxycontin 2014-07-16T07:56:21+10:00 https://pharmadispatch.com/news/ip-not-even-discussed-at-canada-meeting 2014-07-16T07:56:08+10:00 https://pharmadispatch.com/news/link-announces-new-approval 2014-07-16T07:56:00+10:00 https://pharmadispatch.com/news/parliamentary-researchers-question-need-for-co-pay-increase 2014-07-15T07:54:50+10:00 https://pharmadispatch.com/news/cf-patients-back-on-facebook 2014-07-15T07:54:34+10:00 https://pharmadispatch.com/news/another-pbac-departure 2014-07-15T07:54:22+10:00 https://pharmadispatch.com/news/shire-willing-to-back-abbvie-takeover 2014-07-15T07:54:10+10:00 https://pharmadispatch.com/news/asmi-confirms-annual-conference 2014-07-15T07:53:52+10:00 https://pharmadispatch.com/news/dutton-comments-offensive-and-utterly-untrue 2014-07-14T07:53:59+10:00 https://pharmadispatch.com/news/another-pbs-windfall-for-government 2014-07-14T07:53:51+10:00 https://pharmadispatch.com/news/coalition-seats-dominate-stroke-rankings 2014-07-14T07:53:43+10:00 https://pharmadispatch.com/news/two-year-senate-inquiry-on-health 2014-07-14T07:52:51+10:00 https://pharmadispatch.com/news/abbvie-in-takeover-talks-with-shire 2014-07-14T07:52:38+10:00 https://pharmadispatch.com/news/another-example-of-why-australia-must-avoid-pharmac 2014-07-11T08:12:56+10:00 https://pharmadispatch.com/news/new-funding-for-diabetes-research 2014-07-11T07:59:21+10:00 https://pharmadispatch.com/news/new-study-ends-safety-concerns-over-drospirenone 2014-07-11T07:59:04+10:00 https://pharmadispatch.com/news/vigilance-required-on-pandemic-preparedness 2014-07-11T07:58:48+10:00 https://pharmadispatch.com/news/momentum-building-towards-another-mou 2014-07-10T07:43:56+10:00 https://pharmadispatch.com/news/queensland-extends-pharmacy-vaccination-trial 2014-07-10T07:34:28+10:00 https://pharmadispatch.com/news/qrxpharma-chairman-and-directors-resign 2014-07-10T07:34:18+10:00 https://pharmadispatch.com/news/gsk-welcomes-addition-to-respiratory-range 2014-07-10T07:34:07+10:00 https://pharmadispatch.com/news/could-australia-follow-europe-on-eye-drugs 2014-07-09T06:56:01+10:00 https://pharmadispatch.com/news/abbvie-raises-bid-for-shire 2014-07-09T06:55:34+10:00 https://pharmadispatch.com/news/financing-setback-for-pharmaxis-puts-global-bronchitol-deal-at-r 2014-07-09T06:55:13+10:00 https://pharmadispatch.com/news/guild-welcomes-changes-to-hiv-testing-and-treatment-access 2014-07-09T06:54:39+10:00 https://pharmadispatch.com/news/allergan-rejects-valeant-board-nominees 2014-07-09T06:35:13+10:00 https://pharmadispatch.com/news/sanofi-and-janssen-team-up-on-diabetes 2014-07-08T07:59:37+10:00 https://pharmadispatch.com/news/dutton-makes-pointed-reference-to-sovaldi 2014-07-08T07:59:30+10:00 https://pharmadispatch.com/news/co-pay-increases-to-hit-older-australians-finds-study 2014-07-08T07:59:23+10:00 https://pharmadispatch.com/news/no-significant-growth-for-pharmacy 2014-07-08T07:59:14+10:00 https://pharmadispatch.com/news/new-study-highlights-long-term-efficacy-of-shires-vyvanse 2014-07-08T07:59:03+10:00 https://pharmadispatch.com/news/agreement-on-abraxane-now-for-cabinet 2014-07-07T07:31:46+10:00 https://pharmadispatch.com/news/stalemate-on-kalydeco 2014-07-07T07:29:46+10:00 https://pharmadispatch.com/news/were-different-says-chfs-stankevicius 2014-07-07T07:22:10+10:00 https://pharmadispatch.com/news/review-questions-value-of-insulin-pumps 2014-07-07T07:19:45+10:00 https://pharmadispatch.com/news/pharmaxis-enters-trading-halt 2014-07-07T07:17:37+10:00 https://pharmadispatch.com/news/cda-calls-for-change-at-senate-inquiry 2014-07-04T07:54:21+10:00 https://pharmadispatch.com/news/exclusive-company-blames-price-disclosure-for-delistings 2014-07-04T07:54:10+10:00 https://pharmadispatch.com/news/more-insight-into-pbac-decisions 2014-07-04T07:53:29+10:00 https://pharmadispatch.com/news/were-falling-behind-says-ma 2014-07-04T07:53:19+10:00 https://pharmadispatch.com/news/chf-goes-again 2014-07-04T07:53:09+10:00 https://pharmadispatch.com/news/another-term-for-kardachi-at-psa 2014-07-04T07:51:27+10:00 https://pharmadispatch.com/news/dpp-4-market-takes-a-hit-but-msd-still-dominates 2014-07-03T07:50:07+10:00 https://pharmadispatch.com/news/sector-question-amwg-objectives 2014-07-03T07:49:18+10:00 https://pharmadispatch.com/news/ipn-acquires-pretium 2014-07-03T07:48:56+10:00 https://pharmadispatch.com/news/undermining-the-myths-of-health-spending 2014-07-03T07:48:41+10:00 https://pharmadispatch.com/news/biogen-adds-to-haemophilia-portfolio 2014-07-03T07:48:23+10:00 https://pharmadispatch.com/news/the-authorisation-process-begins 2014-07-03T07:48:06+10:00 https://pharmadispatch.com/news/robb-meets-industry-in-switzerland 2014-07-02T07:42:46+10:00 https://pharmadispatch.com/news/hco-funding-favours-the-new 2014-07-02T07:39:01+10:00 https://pharmadispatch.com/news/remember-code-of-ethics-says-psa 2014-07-02T07:38:30+10:00 https://pharmadispatch.com/news/cancer-cases-rising-fast 2014-07-02T07:38:12+10:00 https://pharmadispatch.com/news/sandoz-pleased-to-be-back 2014-07-02T07:37:49+10:00 https://pharmadispatch.com/news/recognition-of-a-remarkable-contribution 2014-07-01T07:59:22+10:00 https://pharmadispatch.com/news/novartis-tops-hco-funding-table 2014-07-01T07:59:05+10:00 https://pharmadispatch.com/news/sandoz-joins-gmia 2014-07-01T07:58:17+10:00 https://pharmadispatch.com/news/pfizer-tops-consultant-spend 2014-07-01T07:58:08+10:00 https://pharmadispatch.com/news/pharmacy-makes-the-case-at-victorian-inquiry 2014-07-01T07:47:51+10:00 https://pharmadispatch.com/news/pharmaxis-bronchitol-nominated-for-prix-galien-award 2014-07-01T07:47:38+10:00 https://pharmadispatch.com/news/company-names-doctor-in-education-event-report 2014-06-30T08:01:27+10:00 https://pharmadispatch.com/news/fewer-than-1-in-10-pbs-scripts-to-general-patients 2014-06-30T08:01:10+10:00 https://pharmadispatch.com/news/mou-expires-with-commission-of-audit-lurking 2014-06-30T08:00:53+10:00 https://pharmadispatch.com/news/audit-office-slams-commercialisation-australia-over-500000-grant 2014-06-30T08:00:43+10:00 https://pharmadispatch.com/news/new-resource-for-hep-b-patients 2014-06-30T08:00:29+10:00 https://pharmadispatch.com/news/takeover-talk-continues 2014-06-30T08:00:17+10:00 https://pharmadispatch.com/news/were-waiting-for-a-response-from-government-says-alexion 2014-06-27T08:01:01+10:00 https://pharmadispatch.com/news/what-happened-to-the-presumption-of-innocence 2014-06-27T08:00:27+10:00 https://pharmadispatch.com/news/medicare-data-hardly-worth-the-trouble 2014-06-27T07:59:05+10:00 https://pharmadispatch.com/news/pharmaceutical-sector-pays-tribute-to-halton 2014-06-27T07:58:46+10:00 https://pharmadispatch.com/news/asmi-disappointment-over-reform-delay 2014-06-27T07:58:35+10:00 https://pharmadispatch.com/news/medadvisor-tie-up-with-bupa 2014-06-27T07:58:11+10:00 https://pharmadispatch.com/news/halton-heads-to-finance 2014-06-26T17:00:58+10:00 https://pharmadispatch.com/news/government-senator-wants-action-from-alexion 2014-06-26T07:57:01+10:00 https://pharmadispatch.com/news/quilty-the-reality-of-spd-about-to-hit-pharmacy 2014-06-26T07:55:51+10:00 https://pharmadispatch.com/news/gp-use-of-medicines-falling 2014-06-26T07:55:34+10:00 https://pharmadispatch.com/news/bms-melanoma-drug-demonstrates-superior-overall-survival-trial-h 2014-06-26T07:55:17+10:00 https://pharmadispatch.com/news/savings-race-towards-20-billion 2014-06-25T07:42:12+10:00 https://pharmadispatch.com/news/australia-performing-poorly-on-access 2014-06-25T07:41:52+10:00 https://pharmadispatch.com/news/bayer-publishes-grants-to-hcos 2014-06-25T07:41:41+10:00 https://pharmadispatch.com/news/ma-get-on-with-clinical-trials-reform 2014-06-25T07:41:33+10:00 https://pharmadispatch.com/news/new-bionomics-collaboration-with-merck 2014-06-25T07:41:26+10:00 https://pharmadispatch.com/news/shire-deploys-az-defence 2014-06-25T07:41:13+10:00 https://pharmadispatch.com/news/allergan-rebuffs-valeant-again 2014-06-25T07:40:59+10:00 https://pharmadispatch.com/news/deakin-uni-moves-into-medical-education 2014-06-24T07:58:06+10:00 https://pharmadispatch.com/news/pbac-fires-early-shot-at-gileads-sovaldi 2014-06-24T07:56:43+10:00 https://pharmadispatch.com/news/az-looking-to-boost-pfizer-defence 2014-06-24T07:56:31+10:00 https://pharmadispatch.com/news/new-program-encourages-pharmacy-to-focus-on-s3 2014-06-24T07:56:09+10:00 https://pharmadispatch.com/news/lundbeck-reports-positive-results-for-brintellix 2014-06-24T07:55:51+10:00 https://pharmadispatch.com/news/tga-monitoring-serviers-ivabradine-after-study-setback 2014-06-24T07:55:37+10:00 https://pharmadispatch.com/news/industry-welcomes-first-meeting-of-new-access-group 2014-06-23T08:03:07+10:00 https://pharmadispatch.com/news/generics-facing-damages-over-failed-patent-appeal 2014-06-23T08:02:58+10:00 https://pharmadispatch.com/news/new-ma-120-meal-cap-for-exceptional-circumstances-only 2014-06-23T08:02:37+10:00 https://pharmadispatch.com/news/shire-rejects-abbvie-takeover 2014-06-23T08:02:23+10:00 https://pharmadispatch.com/news/the-focus-is-retail-for-apis-priceline-network 2014-06-23T08:02:14+10:00 https://pharmadispatch.com/news/another-billion-dollar-windfall-but-some-drugs-escape-price-cuts 2014-06-20T07:56:51+10:00 https://pharmadispatch.com/news/the-pbs-is-not-what-it-used-to-be 2014-06-20T07:56:31+10:00 https://pharmadispatch.com/news/will-allergan-move-on-shire 2014-06-20T07:56:06+10:00 https://pharmadispatch.com/news/pharma-sleeps-out-for-homeless 2014-06-20T07:55:20+10:00 https://pharmadispatch.com/news/no-pharma-ip-concessions-in-tpp-says-robb 2014-06-19T07:57:53+10:00 https://pharmadispatch.com/news/coalition-mp-slams-focus-on-medical-research 2014-06-19T07:57:18+10:00 https://pharmadispatch.com/news/one-step-closer-to-higher-pbs-co-pays 2014-06-19T07:56:26+10:00 https://pharmadispatch.com/news/pharmaxis-promotes-success-at-key-european-cf-meeting 2014-06-19T07:56:10+10:00 https://pharmadispatch.com/news/bayer-appoints-new-head-of-nz-pharma-business 2014-06-19T07:55:42+10:00 https://pharmadispatch.com/news/ma-members-endorse-change 2014-06-18T07:58:05+10:00 https://pharmadispatch.com/news/red-faces-for-valeant-adviser 2014-06-18T07:57:39+10:00 https://pharmadispatch.com/news/australian-health-system-scores-well-in-international-survey 2014-06-18T07:57:21+10:00 https://pharmadispatch.com/news/guild-launches-its-own-otc-range 2014-06-18T07:56:59+10:00 https://pharmadispatch.com/news/drs-should-repay-payments-if-they-withhold-consent-demands-chf 2014-06-17T07:56:30+10:00 https://pharmadispatch.com/news/model-the-behaviour-you-demand-of-others 2014-06-17T07:56:19+10:00 https://pharmadispatch.com/news/robb-slams-anti-trade-groups 2014-06-17T07:56:06+10:00 https://pharmadispatch.com/news/takeovers-not-limited-to-pharma 2014-06-17T07:55:54+10:00 https://pharmadispatch.com/news/pharmacy-could-help-boost-falling-immunisation-rates 2014-06-17T07:55:39+10:00 https://pharmadispatch.com/news/industry-readies-for-more-reform 2014-06-16T07:55:59+10:00 https://pharmadispatch.com/news/consumers-reject-new-ma-code 2014-06-16T07:55:39+10:00 https://pharmadispatch.com/news/ma-chief-goes-global 2014-06-16T07:55:20+10:00 https://pharmadispatch.com/news/allergan-adopts-poison-pill-defence 2014-06-16T07:55:06+10:00 https://pharmadispatch.com/news/tpp-hits-another-hurdle 2014-06-16T07:54:53+10:00 https://pharmadispatch.com/news/department-proposed-pbs-reform-options-to-commission-of-audit 2014-06-13T08:03:46+10:00 https://pharmadispatch.com/news/fewer-people-not-filling-scripts-due-to-cost 2014-06-13T07:58:49+10:00 https://pharmadispatch.com/news/parliamentary-budget-office-identifies-pbs-savings 2014-06-13T07:58:33+10:00 https://pharmadispatch.com/news/victoria-considers-a-wider-role-for-pharmacy 2014-06-13T07:58:19+10:00 https://pharmadispatch.com/news/companies-adopting-wait-and-see-approach-to-abbott-government-sa 2014-06-13T07:58:08+10:00 https://pharmadispatch.com/news/transparency-model-revealed 2014-06-12T08:03:09+10:00 https://pharmadispatch.com/news/mckeon-backs-concept-of-research-future-fund 2014-06-12T07:57:44+10:00 https://pharmadispatch.com/news/pfizer-cfo-az-bid-failed-because-of-price 2014-06-12T07:57:35+10:00 https://pharmadispatch.com/news/psa-heading-to-paris-and-berlin 2014-06-12T07:57:23+10:00 https://pharmadispatch.com/news/new-ma-code-rules-out-parallel-track 2014-06-11T07:57:23+10:00 https://pharmadispatch.com/news/gmia-we-expect-to-be-involved 2014-06-11T07:54:52+10:00 https://pharmadispatch.com/news/allergan-rejects-latest-valeant-takeover-bid 2014-06-11T07:54:39+10:00 https://pharmadispatch.com/news/merck-spends-us3-85-billion-to-acquire-hep-c-candidate 2014-06-11T07:54:24+10:00 https://pharmadispatch.com/news/tga-drip-feed-on-quality-issues 2014-06-10T07:38:30+10:00 https://pharmadispatch.com/news/transparency-helps-it-doesnt-hinder 2014-06-10T07:38:16+10:00 https://pharmadispatch.com/news/industry-wants-new-mou 2014-06-10T07:37:57+10:00 https://pharmadispatch.com/news/industry-awaits-price-cuts 2014-06-10T07:37:33+10:00 https://pharmadispatch.com/news/government-snubs-health-sector-for-trade-and-investment-council 2014-06-10T07:36:47+10:00 https://pharmadispatch.com/news/tpp-in-2015-says-robb 2014-06-06T07:52:39+10:00 https://pharmadispatch.com/news/ma-companies-set-to-approve-new-code 2014-06-06T07:52:26+10:00 https://pharmadispatch.com/news/new-nps-multiple-medicines-website 2014-06-06T07:52:10+10:00 https://pharmadispatch.com/news/genzyme-still-hopeful-on-myozyme 2014-06-05T08:01:14+10:00 https://pharmadispatch.com/news/guild-backs-common-sense-on-penalty-rates 2014-06-05T07:59:30+10:00 https://pharmadispatch.com/news/industry-leaders-looking-to-divest-older-drugs 2014-06-05T07:59:06+10:00 https://pharmadispatch.com/news/asmi-backs-researchers-in-fight-over-supplements 2014-06-05T07:58:53+10:00 https://pharmadispatch.com/news/crotty-simple-changes-could-drive-investment 2014-06-04T07:50:37+10:00 https://pharmadispatch.com/news/nhmrc-ceo-cost-not-an-issue-on-clinical-trials 2014-06-04T07:50:23+10:00 https://pharmadispatch.com/news/continuing-challenges-for-gsk-but-pharma-manufacturing-delivers 2014-06-04T07:50:05+10:00 https://pharmadispatch.com/news/fight-for-allergan-turns-nasty 2014-06-04T07:49:46+10:00 https://pharmadispatch.com/news/asco-highlights-bms-and-astrazeneca 2014-06-04T07:49:31+10:00 https://pharmadispatch.com/news/the-incredible-shrinking-general-category 2014-06-03T07:52:11+10:00 https://pharmadispatch.com/news/medical-research-fund-set-to-fund-clinical-trials 2014-06-03T07:51:45+10:00 https://pharmadispatch.com/news/tga-defends-actions-on-ranbaxy-toansa 2014-06-03T07:51:28+10:00 https://pharmadispatch.com/news/asco-highlights 2014-06-03T07:51:13+10:00 https://pharmadispatch.com/news/faster-transfusion-time-for-patients 2014-06-03T07:51:00+10:00 https://pharmadispatch.com/news/co-pays-and-listings-the-focus-of-senate-estimates 2014-06-02T16:08:59+10:00 https://pharmadispatch.com/news/renewed-speculation-on-halton 2014-06-02T08:02:03+10:00 https://pharmadispatch.com/news/ranbaxy-suspends-imports-from-toansa 2014-06-02T08:00:15+10:00 https://pharmadispatch.com/news/will-you-miss-it-when-its-gone 2014-06-02T07:59:52+10:00 https://pharmadispatch.com/news/apotex-the-new-no-1 2014-06-02T07:59:40+10:00 https://pharmadispatch.com/news/new-reports-focus-on-antipsychotic-use 2014-06-02T07:59:16+10:00 https://pharmadispatch.com/news/targeted-therapies-shine-at-asco 2014-06-02T07:59:05+10:00 https://pharmadispatch.com/news/the-myth-of-rising-consumer-health-costs 2014-05-30T07:54:37+10:00 https://pharmadispatch.com/news/govt-set-to-publish-full-pbac-minutes 2014-05-30T07:54:24+10:00 https://pharmadispatch.com/news/best-employer-accreditation-for-bms 2014-05-30T07:53:53+10:00 https://pharmadispatch.com/news/diet-essential-for-preventing-macular-degeneration 2014-05-30T07:53:43+10:00 https://pharmadispatch.com/news/dont-trust-wikipedia-on-health 2014-05-30T07:53:27+10:00 https://pharmadispatch.com/news/commission-of-audit-is-not-dead-yet 2014-05-29T08:01:40+10:00 https://pharmadispatch.com/news/we-will-respond-in-kind-says-dutton 2014-05-29T08:01:22+10:00 https://pharmadispatch.com/news/valeant-makes-another-move-on-allergan 2014-05-29T08:01:07+10:00 https://pharmadispatch.com/news/industry-executive-appointed-to-ansto-board 2014-05-29T08:00:49+10:00 https://pharmadispatch.com/news/vaccine-doco-wins-health-journalism-award 2014-05-29T08:00:32+10:00 https://pharmadispatch.com/news/govt-points-to-pbs-in-medicare-debate 2014-05-28T07:57:59+10:00 https://pharmadispatch.com/news/40-years-of-funding 2014-05-28T07:57:16+10:00 https://pharmadispatch.com/news/guild-disappointed-at-dutton-response 2014-05-28T07:56:38+10:00 https://pharmadispatch.com/news/new-website-lists-14-current-shortages 2014-05-28T07:54:19+10:00 https://pharmadispatch.com/news/consumers-win-as-viagra-goes-generic 2014-05-27T07:53:26+10:00 https://pharmadispatch.com/news/sector-praise-for-departing-ma-chief 2014-05-27T07:53:08+10:00 https://pharmadispatch.com/news/guild-welcomes-counterfeit-drugs-seizure 2014-05-27T07:53:00+10:00 https://pharmadispatch.com/news/australian-developed-bowel-cancer-test-set-for-launch 2014-05-27T07:52:40+10:00 https://pharmadispatch.com/news/pfizer-concedes-for-now 2014-05-27T07:52:18+10:00 https://pharmadispatch.com/news/ma-looking-for-new-chief-executive 2014-05-26T11:50:54+10:00 https://pharmadispatch.com/news/the-changing-pbs 2014-05-26T07:59:34+10:00 https://pharmadispatch.com/news/we-need-to-talk-about-the-pbs 2014-05-26T07:57:50+10:00 https://pharmadispatch.com/news/diagnosed-with-the-wrong-cancer-say-patients 2014-05-26T07:57:22+10:00 https://pharmadispatch.com/news/cancer-drugs-the-first-focus-of-latest-review 2014-05-26T07:57:09+10:00 https://pharmadispatch.com/news/not-out-by-too-much-just-3-billion 2014-05-26T07:56:42+10:00 https://pharmadispatch.com/news/gsk-announces-closure-of-melbourne-rd-facility 2014-05-23T12:29:41+10:00 https://pharmadispatch.com/news/crotty-hits-back-on-industry-growth-proposal 2014-05-23T07:56:00+10:00 https://pharmadispatch.com/news/robb-wants-freer-trade 2014-05-23T07:51:32+10:00 https://pharmadispatch.com/news/us-insurers-hit-out-against-drug-pricing 2014-05-23T07:51:21+10:00 https://pharmadispatch.com/news/ma-and-ausbiotech-team-up-for-industry-growth-proposal 2014-05-22T07:44:11+10:00 https://pharmadispatch.com/news/first-meeting-of-new-clinical-trials-reform-group 2014-05-22T07:43:51+10:00 https://pharmadispatch.com/news/no-apotex-branding-in-nps-app 2014-05-22T07:43:21+10:00 https://pharmadispatch.com/news/liberal-senator-criticises-rd-future-fund 2014-05-22T07:43:06+10:00 https://pharmadispatch.com/news/new-front-opens-in-pbs-diabetes-battle 2014-05-21T08:06:12+10:00 https://pharmadispatch.com/news/dutton-defends-health-budget 2014-05-21T08:05:55+10:00 https://pharmadispatch.com/news/analysts-not-calling-time-on-pfizer-pursuit-of-az 2014-05-21T08:05:15+10:00 https://pharmadispatch.com/news/tga-set-to-launch-medicines-shortage-initiative 2014-05-21T08:05:05+10:00 https://pharmadispatch.com/news/1-2-billion-in-new-listings-but-3-3-billion-in-price-cuts 2014-05-20T07:56:08+10:00 https://pharmadispatch.com/news/what-a-stupid-question 2014-05-20T07:55:59+10:00 https://pharmadispatch.com/news/some-unhappy-az-shareholders 2014-05-20T07:55:46+10:00 https://pharmadispatch.com/news/courts-backs-pfizer-on-lyrica-injunction 2014-05-20T07:55:36+10:00 https://pharmadispatch.com/news/asap-listing-for-breakthrough-drugs-says-lung-foundation 2014-05-20T07:55:28+10:00 https://pharmadispatch.com/news/new-study-to-test-oct-in-diagnosis-of-basal-cell-carcinoma 2014-05-20T07:55:19+10:00 https://pharmadispatch.com/news/pfizer-makes-final-offer-for-az 2014-05-19T10:39:27+10:00 https://pharmadispatch.com/news/budget-confirms-pbs-transformation-but-its-not-over 2014-05-19T07:56:14+10:00 https://pharmadispatch.com/news/pbs-revenue-is-the-wildcard-for-growth 2014-05-19T07:55:55+10:00 https://pharmadispatch.com/news/the-long-journey-to-commercialisation 2014-05-19T07:55:46+10:00 https://pharmadispatch.com/news/tpp-countries-make-progress-on-pharma-ip 2014-05-19T07:55:33+10:00 https://pharmadispatch.com/news/uk-wants-more-from-pfizer 2014-05-19T07:55:18+10:00 https://pharmadispatch.com/news/time-for-action-on-clinical-trials 2014-05-19T07:55:08+10:00 https://pharmadispatch.com/news/dutton-defended-pbs-in-budget-discussions 2014-05-16T08:03:43+10:00 https://pharmadispatch.com/news/partner-on-20bn-fund-dutton-tells-industry 2014-05-16T08:03:34+10:00 https://pharmadispatch.com/news/nz-takes-a-different-path-on-health 2014-05-16T08:03:27+10:00 https://pharmadispatch.com/news/gsk-advances-victorian-poppy-trials 2014-05-16T08:03:18+10:00 https://pharmadispatch.com/news/another-multi-billion-dollar-saving-just-months-away 2014-05-15T07:59:52+10:00 https://pharmadispatch.com/news/researchers-look-beyond-the-politics-on-20bn-fund 2014-05-15T07:59:40+10:00 https://pharmadispatch.com/news/budget-disappointment-for-cancer-drugs 2014-05-15T07:58:44+10:00 https://pharmadispatch.com/news/valeant-bid-for-allergan-gets-nasty 2014-05-15T07:58:28+10:00 https://pharmadispatch.com/news/pbs-still-in-decline-as-govt-confirms-9-9bn-in-price-disclosure- 2014-05-14T08:02:56+10:00 https://pharmadispatch.com/news/mixed-budget-response-from-pharma-sector 2014-05-14T07:59:12+10:00 https://pharmadispatch.com/news/co-pay-increase-will-boost-private-market 2014-05-14T07:58:44+10:00 https://pharmadispatch.com/news/patients-slugged-to-fund-rd 2014-05-14T07:58:37+10:00 https://pharmadispatch.com/news/government-creates-20-billion-medical-research-fund 2014-05-14T07:58:30+10:00 https://pharmadispatch.com/news/still-contemplating-commission-of-audit 2014-05-14T07:58:19+10:00 https://pharmadispatch.com/news/budget-slugs-patients-to-fund-medical-research-endowment-fund 2014-05-13T20:33:24+10:00 https://pharmadispatch.com/news/what-now-for-asthma-therapies 2014-05-13T07:46:30+10:00 https://pharmadispatch.com/news/abc-backdown-on-statin-claims 2014-05-13T07:46:21+10:00 https://pharmadispatch.com/news/nz-patients-pharmac-at-what-price 2014-05-13T07:45:56+10:00 https://pharmadispatch.com/news/what-about-a-fixed-funding-envelope 2014-05-13T07:45:43+10:00 https://pharmadispatch.com/news/positive-results-for-amgen-and-azs-brodalumab 2014-05-13T07:45:27+10:00 https://pharmadispatch.com/news/industry-trepidation-over-first-post-mou-budget 2014-05-12T08:17:11+10:00 https://pharmadispatch.com/news/pfizers-gallagher-urges-government-to-consult 2014-05-12T08:17:02+10:00 https://pharmadispatch.com/news/patients-front-pbac-member-over-kalydeco 2014-05-12T08:16:55+10:00 https://pharmadispatch.com/news/gsk-payments-disclosure 2014-05-12T08:16:46+10:00 https://pharmadispatch.com/news/opposition-builds-to-takeover-of-az 2014-05-12T08:16:38+10:00 https://pharmadispatch.com/news/study-setback-for-servier-heart-failure-drug 2014-05-12T08:16:31+10:00 https://pharmadispatch.com/news/allergan-still-searching-for-a-white-knight 2014-05-12T08:16:24+10:00 https://pharmadispatch.com/news/research-australia-awards 2014-05-12T08:16:14+10:00 https://pharmadispatch.com/news/industry-reaches-agreement-on-biosimilars 2014-05-09T08:08:43+10:00 https://pharmadispatch.com/news/new-ma-code-almost-done 2014-05-09T08:07:45+10:00 https://pharmadispatch.com/news/sanofi-launches-diabetes-app 2014-05-09T08:06:18+10:00 https://pharmadispatch.com/news/guild-works-on-clearing-backlog 2014-05-09T08:06:10+10:00 https://pharmadispatch.com/news/whats-a-broken-promise 2014-05-08T08:11:44+10:00 https://pharmadispatch.com/news/if-it-aint-broke-well-you-know-how-it-goes 2014-05-08T08:11:33+10:00 https://pharmadispatch.com/news/100-million-lost-in-a-year-from-price-disclosure-says-sigma 2014-05-08T08:05:29+10:00 https://pharmadispatch.com/news/new-boss-for-psa 2014-05-08T08:05:19+10:00 https://pharmadispatch.com/news/merck-not-interested-in-mega-mergers 2014-05-08T08:05:10+10:00 https://pharmadispatch.com/news/sanofi-welcomes-listing-of-new-cancer-drug 2014-05-08T08:04:54+10:00 https://pharmadispatch.com/news/haemophilia-community-welcome-approval-of-alprolix 2014-05-08T08:04:45+10:00 https://pharmadispatch.com/news/labor-hosts-health-roundtable-on-commission-of-audit 2014-05-07T07:59:55+10:00 https://pharmadispatch.com/news/new-zealand-cautions-australia-against-pharmac 2014-05-07T07:59:35+10:00 https://pharmadispatch.com/news/industry-tells-govt-to-steer-clear-of-report 2014-05-07T07:59:17+10:00 https://pharmadispatch.com/news/commercial-eyes-working-on-convergence 2014-05-07T07:58:46+10:00 https://pharmadispatch.com/news/new-drug-for-pulmonary-hypertension 2014-05-07T07:58:35+10:00 https://pharmadispatch.com/news/labor-mp-calls-on-dutton-to-reject-kalydeco-conditions 2014-05-06T07:56:28+10:00 https://pharmadispatch.com/news/pfizer-bid-could-go-hostile 2014-05-06T07:56:20+10:00 https://pharmadispatch.com/news/medicines-partnership-condemns-commission-of-audit 2014-05-06T07:56:05+10:00 https://pharmadispatch.com/news/pharma-backs-ms-campaign 2014-05-06T07:56:01+10:00 https://pharmadispatch.com/news/stakeholders-back-combination-products-in-asthma 2014-05-06T07:55:54+10:00 https://pharmadispatch.com/news/more-asthmacopd-therapies-on-the-way 2014-05-06T07:55:40+10:00 https://pharmadispatch.com/news/commission-of-audit-unravels-at-senate-hearing 2014-05-05T07:57:04+10:00 https://pharmadispatch.com/news/proposed-pbs-entity-could-breach-us-australia-fta 2014-05-05T07:56:53+10:00 https://pharmadispatch.com/news/dutton-talks-up-industry-investment-ironically 2014-05-05T07:56:07+10:00 https://pharmadispatch.com/news/industry-needs-to-change-says-novogen-ceo 2014-05-05T07:55:52+10:00 https://pharmadispatch.com/news/az-snubs-latest-pfizer-bid 2014-05-05T07:55:43+10:00 https://pharmadispatch.com/news/wrong-prices-in-report-says-gmia 2014-05-05T07:55:22+10:00 https://pharmadispatch.com/news/department-met-head-of-uk-cancer-drugs-fund 2014-05-05T07:55:04+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-the-july-pbac-agenda 2014-05-02T08:03:34+10:00 https://pharmadispatch.com/news/commission-of-audit-friendless 2014-05-02T08:03:13+10:00 https://pharmadispatch.com/news/an-undergraduate-and-unimplementable-report 2014-05-02T08:02:25+10:00 https://pharmadispatch.com/news/more-change-speculated 2014-05-02T08:02:04+10:00 https://pharmadispatch.com/news/commission-of-audit-delivers-pbs-doomsday 2014-05-01T15:00:59+10:00 https://pharmadispatch.com/news/pbs-extracts-from-the-national-commission-of-audit-towards-respo 2014-05-01T15:00:48+10:00 https://pharmadispatch.com/news/recommended-wider-health-system-reforms 2014-05-01T15:00:38+10:00 https://pharmadispatch.com/news/consolidate-rd-funding-programs 2014-05-01T15:00:27+10:00 https://pharmadispatch.com/news/simplistic-report-reflects-poor-understanding-of-pbs 2014-05-01T15:00:19+10:00 https://pharmadispatch.com/news/nothing-to-do-with-us 2014-05-01T08:01:20+10:00 https://pharmadispatch.com/news/industry-mostly-satisfied-with-spd-regulations 2014-05-01T08:01:12+10:00 https://pharmadispatch.com/news/api-reports-68mil-negative-impact-from-price-disclosure 2014-05-01T08:01:01+10:00 https://pharmadispatch.com/news/cf-patients-meet-dutton-on-kalydeco 2014-05-01T08:00:50+10:00 https://pharmadispatch.com/news/no-everyone-likes-a-price-comparison 2014-05-01T08:00:39+10:00 https://pharmadispatch.com/news/psa-announces-new-committees 2014-05-01T08:00:29+10:00 https://pharmadispatch.com/news/michael-wonder-takes-a-look-at-the-march-pbac-outcomes 2014-04-30T07:59:25+10:00 https://pharmadispatch.com/news/department-winds-back-chf-funding 2014-04-30T07:59:18+10:00 https://pharmadispatch.com/news/pharmacy-cutting-back-on-services 2014-04-30T07:59:01+10:00 https://pharmadispatch.com/news/allergan-seeking-a-white-knight 2014-04-30T07:58:52+10:00 https://pharmadispatch.com/news/company-results-bayer-abbvie-sanofi-merck-co-and-bms 2014-04-30T07:58:36+10:00 https://pharmadispatch.com/news/pfizer-moving-on-astrazeneca 2014-04-29T07:56:44+10:00 https://pharmadispatch.com/news/confusion-over-pbac-outcomes 2014-04-29T07:56:29+10:00 https://pharmadispatch.com/news/little-satisfaction-for-cancer-drug-advocates 2014-04-29T07:56:16+10:00 https://pharmadispatch.com/news/patients-demand-dutton-intervene-on-kalydeco 2014-04-29T07:55:58+10:00 https://pharmadispatch.com/news/managed-entry-listing-for-alexions-soliris 2014-04-29T07:55:42+10:00 https://pharmadispatch.com/news/anyone-can-get-a-headline-arguing-for-price-cuts 2014-04-29T07:55:26+10:00 https://pharmadispatch.com/news/gp-co-payment-will-hit-pbs 2014-04-28T08:01:02+10:00 https://pharmadispatch.com/news/rearguard-budget-action-from-pharma-sector 2014-04-28T08:00:54+10:00 https://pharmadispatch.com/news/commission-of-audit-pbs-forecast-is-probably-already-wrong 2014-04-28T08:00:40+10:00 https://pharmadispatch.com/news/the-dangers-of-monthly-medicare-data 2014-04-28T08:00:33+10:00 https://pharmadispatch.com/news/dutton-announces-new-listings-2 2014-04-28T08:00:25+10:00 https://pharmadispatch.com/news/dont-attack-dutton-urges-patient-group 2014-04-28T08:00:18+10:00 https://pharmadispatch.com/news/company-results-az-biogen-novartis-lilly-celgene-boehringer-inge 2014-04-28T08:00:09+10:00 https://pharmadispatch.com/news/pbs-doesnt-escape-commission-of-audit 2014-04-24T07:47:19+10:00 https://pharmadispatch.com/news/cancer-the-focus-of-senate-questions 2014-04-24T07:47:07+10:00 https://pharmadispatch.com/news/publication-of-march-pbac-outcomes-delayed 2014-04-24T07:47:00+10:00 https://pharmadispatch.com/news/cpi-further-evidence-of-price-disclosure-impact-says-shaw 2014-04-24T07:46:54+10:00 https://pharmadispatch.com/news/qrxpharma-slumps-on-fda-rejection-of-moxduo 2014-04-24T07:46:45+10:00 https://pharmadispatch.com/news/company-results-amgen-gilead 2014-04-24T07:46:20+10:00 https://pharmadispatch.com/news/are-budget-rumours-premature-facts 2014-04-23T07:56:24+10:00 https://pharmadispatch.com/news/industry-concern-over-spd-regulations 2014-04-23T07:56:06+10:00 https://pharmadispatch.com/news/wholesalers-could-have-most-to-lose-from-pfizer-takeover-of-az 2014-04-23T07:55:54+10:00 https://pharmadispatch.com/news/over-four-million-aussies-vitamin-d-deficient 2014-04-23T07:55:44+10:00 https://pharmadispatch.com/news/catherine-king-on-kalydeco-listing 2014-04-23T07:55:34+10:00 https://pharmadispatch.com/news/novartis-and-gsk-exchange-assets 2014-04-22T17:16:27+10:00 https://pharmadispatch.com/news/private-market-pricing-to-advantage 2014-04-22T08:20:27+10:00 https://pharmadispatch.com/news/pfizer-moves-on-az 2014-04-22T08:16:34+10:00 https://pharmadispatch.com/news/valeant-teams-up-with-private-equity-to-pursue-allergan 2014-04-22T08:12:59+10:00 https://pharmadispatch.com/news/quiet-last-hurrah-for-eapd 2014-04-22T07:58:58+10:00 https://pharmadispatch.com/news/impairment-clouds-api-earnings 2014-04-22T07:51:22+10:00 https://pharmadispatch.com/news/company-results-actelion 2014-04-22T07:49:19+10:00 https://pharmadispatch.com/news/api-confirms-131-million-impairment 2014-04-17T10:55:41+10:00 https://pharmadispatch.com/news/exclusive-dutton-reinvigorates-access-group 2014-04-17T07:55:55+10:00 https://pharmadispatch.com/news/conflict-of-interest-claims-dismissed 2014-04-17T07:51:31+10:00 https://pharmadispatch.com/news/api-extends-trading-halt 2014-04-17T07:51:12+10:00 https://pharmadispatch.com/news/is-the-code-of-conduct-worth-it 2014-04-16T07:57:47+10:00 https://pharmadispatch.com/news/disconnect-over-isds 2014-04-16T07:57:30+10:00 https://pharmadispatch.com/news/company-results-roche-and-jj 2014-04-16T07:57:14+10:00 https://pharmadispatch.com/news/delegates-to-vote-at-cpexpo14 2014-04-16T07:55:43+10:00 https://pharmadispatch.com/news/action-needed-now-says-ma 2014-04-15T08:10:42+10:00 https://pharmadispatch.com/news/most-aussies-back-pharmacy-despite-criticism 2014-04-15T08:08:56+10:00 https://pharmadispatch.com/news/another-day-another-attack 2014-04-15T08:07:05+10:00 https://pharmadispatch.com/news/asset-write-down-for-api 2014-04-15T08:06:13+10:00 https://pharmadispatch.com/news/nps-urges-families-act-on-antipsychotics-in-elderly 2014-04-15T07:58:29+10:00 https://pharmadispatch.com/news/csiro-budget-cuts-a-travesty-says-labor 2014-04-15T07:54:48+10:00 https://pharmadispatch.com/news/ministers-agree-to-higher-organ-donation-target 2014-04-15T07:53:35+10:00 https://pharmadispatch.com/news/everyone-must-contribute-to-savings-says-hockey 2014-04-14T07:52:45+10:00 https://pharmadispatch.com/news/is-this-finally-progress-on-clinical-trials-reform 2014-04-14T07:52:31+10:00 https://pharmadispatch.com/news/volume-down-cost-up 2014-04-14T07:52:16+10:00 https://pharmadispatch.com/news/future-growth-will-look-very-different 2014-04-14T07:51:17+10:00 https://pharmadispatch.com/news/tpp-meeting-set-for-may 2014-04-14T07:50:34+10:00 https://pharmadispatch.com/news/where-is-the-money-coming-from 2014-04-11T07:42:10+10:00 https://pharmadispatch.com/news/quality-of-life-added-to-lsdp-review 2014-04-11T07:41:57+10:00 https://pharmadispatch.com/news/just-when-you-thought-pharmac-couldnt-get-any-worse 2014-04-11T07:41:35+10:00 https://pharmadispatch.com/news/training-boost-for-pharmacy-interns 2014-04-11T07:41:17+10:00 https://pharmadispatch.com/news/asmi-backs-new-nhmrc-resource 2014-04-11T07:40:52+10:00 https://pharmadispatch.com/news/us-still-unhappy-with-australia 2014-04-10T07:45:30+10:00 https://pharmadispatch.com/news/patients-welcome-lsdp-review-industry-not-so-sure 2014-04-10T07:45:17+10:00 https://pharmadispatch.com/news/thumbs-down-for-homeopathy 2014-04-10T07:45:12+10:00 https://pharmadispatch.com/news/greens-want-action-on-rx-overdoses 2014-04-10T07:44:53+10:00 https://pharmadispatch.com/news/exclusive-lsdp-review-gets-go-ahead 2014-04-09T08:03:47+10:00 https://pharmadispatch.com/news/industry-will-have-to-wait-for-details-of-jaepa 2014-04-09T08:01:19+10:00 https://pharmadispatch.com/news/not-all-gloom-and-doom-on-manufacturing 2014-04-09T08:01:08+10:00 https://pharmadispatch.com/news/pharmaxis-partners-with-researchers-on-new-respiratory-device 2014-04-09T08:00:55+10:00 https://pharmadispatch.com/news/lundbeck-seeks-pbs-listing-for-new-antidepressant 2014-04-09T08:00:43+10:00 https://pharmadispatch.com/news/companies-set-to-fight-us9-billion-actos-verdict 2014-04-09T08:00:28+10:00 https://pharmadispatch.com/news/rare-voices-welcomes-tga-collaboration-with-eu 2014-04-08T07:58:28+10:00 https://pharmadispatch.com/news/australia-strikes-trade-deal-with-japan 2014-04-08T07:58:20+10:00 https://pharmadispatch.com/news/only-3-in-10-compliance-reviews-found-no-breach-says-tga 2014-04-08T07:58:13+10:00 https://pharmadispatch.com/news/sun-pharma-acquires-troubled-ranbaxy 2014-04-08T07:58:06+10:00 https://pharmadispatch.com/news/asthma-action-kit-for-pharmacy 2014-04-08T07:57:59+10:00 https://pharmadispatch.com/news/sustainability-on-the-agenda-for-nms-2014 2014-04-08T07:57:49+10:00 https://pharmadispatch.com/news/sustainability-weve-heard-it-all-before 2014-04-07T08:01:26+10:00 https://pharmadispatch.com/news/is-pharma-having-a-conversation-with-itself 2014-04-07T07:58:05+10:00 https://pharmadispatch.com/news/for-amgens-prolia-the-timing-was-perfect 2014-04-07T07:57:52+10:00 https://pharmadispatch.com/news/will-australia-follow-the-eu-on-clinical-trials-reform 2014-04-07T07:57:42+10:00 https://pharmadispatch.com/news/robb-talks-up-benefits-of-free-trade 2014-04-07T07:57:34+10:00 https://pharmadispatch.com/news/treasury-secretary-targets-health-spending 2014-04-04T06:54:45+11:00 https://pharmadispatch.com/news/black-box-warning-for-serviers-protos 2014-04-04T06:54:28+11:00 https://pharmadispatch.com/news/mckeon-will-inform-future-policy-says-government 2014-04-04T06:54:14+11:00 https://pharmadispatch.com/news/new-papers-highlight-benefits-of-vitamin-d 2014-04-04T06:53:55+11:00 https://pharmadispatch.com/news/bayer-deploys-xarelto-reps-in-support-of-national-stroke-foundat 2014-04-03T07:04:28+11:00 https://pharmadispatch.com/news/more-reform-risks-sustainability-says-gmia 2014-04-03T07:01:59+11:00 https://pharmadispatch.com/news/whats-that-about-job-losses 2014-04-03T07:01:41+11:00 https://pharmadispatch.com/news/action-needed-on-diabetic-kidney-disease 2014-04-03T07:01:21+11:00 https://pharmadispatch.com/news/no-going-back-on-generic-pricing 2014-04-02T07:00:39+11:00 https://pharmadispatch.com/news/20-billion-enough-says-ma 2014-04-02T07:00:25+11:00 https://pharmadispatch.com/news/pharmacy-rolls-out-genetic-test 2014-04-02T07:00:05+11:00 https://pharmadispatch.com/news/new-cv-data-for-takedas-nesina 2014-04-02T06:59:46+11:00 https://pharmadispatch.com/news/thats-not-a-cut 2014-04-01T06:59:19+11:00 https://pharmadispatch.com/news/new-cholesterol-busting-biologics-shine-at-acc 2014-04-01T06:59:07+11:00 https://pharmadispatch.com/news/clinicians-welcome-new-remicade-listing 2014-04-01T06:58:58+11:00 https://pharmadispatch.com/news/commission-of-audit-boards-and-agencies 2014-04-01T06:58:48+11:00 https://pharmadispatch.com/news/pbs-slump-continues 2014-03-31T06:58:35+11:00 https://pharmadispatch.com/news/tga-confirms-surprise-inspection-of-ranbaxy-facility 2014-03-31T06:58:25+11:00 https://pharmadispatch.com/news/di-natale-not-happy-as-transparency-model-hits-legal-hurdles 2014-03-31T06:57:58+11:00 https://pharmadispatch.com/news/cut-clinical-trial-red-tape-urges-ma 2014-03-31T06:57:52+11:00 https://pharmadispatch.com/news/policy-needs-to-keep-up-consumer-says-asmi 2014-03-31T06:57:39+11:00 https://pharmadispatch.com/news/game-playing-adds-to-delays 2014-03-28T06:57:21+11:00 https://pharmadispatch.com/news/clinicians-and-patients-want-action 2014-03-28T06:57:09+11:00 https://pharmadispatch.com/news/patients-must-make-the-case-for-change 2014-03-28T06:57:00+11:00 https://pharmadispatch.com/news/sigma-reports-90m-impact-from-price-disclosure 2014-03-28T06:56:48+11:00 https://pharmadispatch.com/news/ama-misunderstood-study-fundings-says-asmi 2014-03-28T06:56:35+11:00 https://pharmadispatch.com/news/msd-and-pfizer-ink-world-first-dpp-4-diabetes-partnership 2014-03-27T12:24:42+11:00 https://pharmadispatch.com/news/houston-we-have-a-problem 2014-03-27T06:20:22+11:00 https://pharmadispatch.com/news/pbac-chair-is-it-the-time-taken-for-a-decision-or-the-decision-i 2014-03-27T06:20:15+11:00 https://pharmadispatch.com/news/rum-drug-collections-top-540-tonnes 2014-03-27T06:20:07+11:00 https://pharmadispatch.com/news/gps-must-take-control-of-bowel-cancer-screening 2014-03-27T06:19:58+11:00 https://pharmadispatch.com/news/call-for-action-on-cancer-drug-delays 2014-03-26T06:57:42+11:00 https://pharmadispatch.com/news/new-senate-inquiry-on-health-costs 2014-03-26T06:57:35+11:00 https://pharmadispatch.com/news/dusc-targets-new-drugs 2014-03-26T06:57:23+11:00 https://pharmadispatch.com/news/switch-to-otc-for-more-savings-says-asmi 2014-03-26T06:57:15+11:00 https://pharmadispatch.com/news/could-pbac-follow-uk-decision-on-vaccine 2014-03-25T06:55:33+11:00 https://pharmadispatch.com/news/clinicians-and-patients-cheer-viivs-tivicay 2014-03-25T06:55:28+11:00 https://pharmadispatch.com/news/new-formulation-to-cut-opioid-abuse 2014-03-25T06:55:20+11:00 https://pharmadispatch.com/news/pharmacy-condemns-ad 2014-03-25T06:55:14+11:00 https://pharmadispatch.com/news/aussies-flock-to-non-pbs-medicines 2014-03-24T06:51:20+11:00 https://pharmadispatch.com/news/response-almost-as-quiet-as-reports-release 2014-03-24T06:51:13+11:00 https://pharmadispatch.com/news/the-wrong-people-oversaw-patent-review 2014-03-24T06:51:05+11:00 https://pharmadispatch.com/news/looking-for-another-new-pbac-member 2014-03-24T06:50:57+11:00 https://pharmadispatch.com/news/what-to-make-of-duttons-speech 2014-03-24T06:50:44+11:00 https://pharmadispatch.com/news/parliament-finally-moves-on-trips-protocol 2014-03-24T06:50:36+11:00 https://pharmadispatch.com/news/final-report-of-the-patent-review-quietly-appears 2014-03-21T07:02:19+11:00 https://pharmadispatch.com/news/three-key-findings-of-the-pharmaceutical-patents-review 2014-03-21T07:02:10+11:00 https://pharmadispatch.com/news/everyone-taking-credit-for-price-disclosure 2014-03-21T07:02:03+11:00 https://pharmadispatch.com/news/slow-progress-on-clinical-trials-reform 2014-03-21T07:01:53+11:00 https://pharmadispatch.com/news/investment-linked-to-pbs-says-shine 2014-03-20T07:10:14+11:00 https://pharmadispatch.com/news/ma-chair-industry-role-in-process-yet-to-be-resolved 2014-03-20T07:09:53+11:00 https://pharmadispatch.com/news/chemmart-doubles-flu-vaccine-service 2014-03-20T07:09:41+11:00 https://pharmadispatch.com/news/asmi-defends-benefits-of-glucosamine 2014-03-20T07:07:49+11:00 https://pharmadispatch.com/news/ma-chair-savings-agenda-is-done 2014-03-19T06:43:26+11:00 https://pharmadispatch.com/news/mixed-results-on-lyrica-injunction 2014-03-19T06:43:21+11:00 https://pharmadispatch.com/news/major-parties-close-door-on-lobbyist-reform 2014-03-19T06:43:12+11:00 https://pharmadispatch.com/news/who-says-price-disclosure-doesnt-deliver 2014-03-18T05:46:32+11:00 https://pharmadispatch.com/news/aussies-back-means-testing-and-cuts 2014-03-18T05:46:27+11:00 https://pharmadispatch.com/news/getting-the-forecast-right-is-almost-impossible 2014-03-18T05:46:22+11:00 https://pharmadispatch.com/news/new-therapies-key-to-improving-treatment 2014-03-18T05:46:12+11:00 https://pharmadispatch.com/news/2-4-billion-in-new-savings-but-is-it-a-last-hurrah 2014-03-17T06:53:26+11:00 https://pharmadispatch.com/news/a-tale-of-two-reports 2014-03-17T06:53:23+11:00 https://pharmadispatch.com/news/health-solutions-the-only-way-to-go-as-price-disclosure-hits-pha 2014-03-17T06:53:13+11:00 https://pharmadispatch.com/news/focus-on-front-of-shop-urges-asmi 2014-03-17T06:53:08+11:00 https://pharmadispatch.com/news/tolmar-launches-in-home-service 2014-03-17T06:53:02+11:00 https://pharmadispatch.com/news/risk-a-natural-part-of-business-says-dutton 2014-03-14T06:48:27+11:00 https://pharmadispatch.com/news/sector-unites-against-further-reform 2014-03-14T06:48:15+11:00 https://pharmadispatch.com/news/industry-department-silent-on-pbpa 2014-03-14T06:48:08+11:00 https://pharmadispatch.com/news/psa-looking-for-new-ceo 2014-03-14T06:48:02+11:00 https://pharmadispatch.com/news/urgent-change-required-says-crotty 2014-03-13T06:52:58+11:00 https://pharmadispatch.com/news/patients-want-intervention-on-kalydeco 2014-03-13T06:52:53+11:00 https://pharmadispatch.com/news/assurances-for-gmia-on-price-increases 2014-03-13T06:52:48+11:00 https://pharmadispatch.com/news/your-calculations-are-wrong-says-dept-and-heres-why 2014-03-13T06:52:41+11:00 https://pharmadispatch.com/news/last-pbpa-meeting-held-by-email 2014-03-12T07:02:58+11:00 https://pharmadispatch.com/news/sigma-backs-medadvisor-compliance-program 2014-03-12T07:02:52+11:00 https://pharmadispatch.com/news/malaysias-ihh-mulls-bid-for-healthscope 2014-03-12T07:02:46+11:00 https://pharmadispatch.com/news/ogilvy-recruit-ex-afr-journo 2014-03-12T07:02:39+11:00 https://pharmadispatch.com/news/is-pbac-using-conditional-recommendations-to-target-particular-d 2014-03-11T06:57:37+11:00 https://pharmadispatch.com/news/fewer-health-care-cards-would-mean-fewer-scripts 2014-03-11T06:57:29+11:00 https://pharmadispatch.com/news/market-prepares-for-viagra-generics 2014-03-11T06:57:20+11:00 https://pharmadispatch.com/news/industry-shock-over-scrapping-of-pbpa 2014-03-10T06:59:21+11:00 https://pharmadispatch.com/news/industry-will-miss-pbpa-but-so-will-the-government-eventually 2014-03-10T06:59:17+11:00 https://pharmadispatch.com/news/pbac-not-imposing-conditions-seriously 2014-03-10T06:59:06+11:00 https://pharmadispatch.com/news/tga-approves-bayers-stivarga-for-bowel-cancer 2014-03-10T06:59:01+11:00 https://pharmadispatch.com/news/twittersphere-hit-on-new-lipid-lowering-biologics 2014-03-10T06:58:55+11:00 https://pharmadispatch.com/news/dutton-set-to-scrap-pbpa-but-industry-rep-for-pbac 2014-03-07T13:19:06+11:00 https://pharmadispatch.com/news/another-billion-dollar-windfall-on-the-way 2014-03-07T07:04:45+11:00 https://pharmadispatch.com/news/asmi-reassurance-over-vitamin-e 2014-03-07T07:04:37+11:00 https://pharmadispatch.com/news/biotron-shares-soar-on-trial-result 2014-03-07T07:04:25+11:00 https://pharmadispatch.com/news/senate-green-light-for-price-disclosure-changes 2014-03-06T06:55:09+11:00 https://pharmadispatch.com/news/we-need-to-be-sensible-on-mou 2014-03-06T06:55:04+11:00 https://pharmadispatch.com/news/greens-want-clarity-on-lsdp-review 2014-03-06T06:54:59+11:00 https://pharmadispatch.com/news/guild-attacks-chemist-warehouse 2014-03-06T06:54:55+11:00 https://pharmadispatch.com/news/private-market-launch-for-novartis-menb-vaccine 2014-03-06T06:54:51+11:00 https://pharmadispatch.com/news/minister-opens-the-door-to-new-mou 2014-03-05T06:51:22+11:00 https://pharmadispatch.com/news/mou-2-a-wedge-for-pharmacy 2014-03-05T06:51:17+11:00 https://pharmadispatch.com/news/harvey-cancels-retirement 2014-03-05T06:51:13+11:00 https://pharmadispatch.com/news/bi-partisan-support-for-rare-disease-patient-registry 2014-03-05T06:51:09+11:00 https://pharmadispatch.com/news/new-xarelto-study-versus-aspirin 2014-03-05T06:51:04+11:00 https://pharmadispatch.com/news/labor-beefs-up-health-team 2014-03-05T06:50:59+11:00 https://pharmadispatch.com/news/1-october-a-pricing-bloodbath 2014-03-04T06:48:36+11:00 https://pharmadispatch.com/news/di-natale-demands-transparency-briefing 2014-03-04T06:48:30+11:00 https://pharmadispatch.com/news/swisse-hits-back-over-la-trobe-partnership 2014-03-04T06:48:19+11:00 https://pharmadispatch.com/news/gps-unite-against-pharmacy-push-into-primary-care 2014-03-04T06:48:15+11:00 https://pharmadispatch.com/news/tga-reviews-emergency-contraceptive 2014-03-04T06:48:10+11:00 https://pharmadispatch.com/news/gary-phillips-on-transforming-pharmaxis 2014-03-04T06:48:01+11:00 https://pharmadispatch.com/news/could-there-be-another-mou-after-all 2014-03-03T06:55:36+11:00 https://pharmadispatch.com/news/over-150million-in-savings-from-dpp-4s 2014-03-03T06:55:27+11:00 https://pharmadispatch.com/news/budget-will-be-a-political-challenge-not-just-a-policy-challenge 2014-03-03T06:55:17+11:00 https://pharmadispatch.com/news/mpa-morning-tea-swamped-by-other-events 2014-03-03T06:55:11+11:00 https://pharmadispatch.com/news/pressure-builds-on-dutton-over-life-saving-drugs 2014-03-03T06:55:04+11:00 https://pharmadispatch.com/news/higher-patient-co-pays 2014-03-03T06:54:57+11:00 https://pharmadispatch.com/news/clinicians-and-patients-welcome-new-registrations-and-pbs-listin 2014-03-03T06:54:52+11:00 https://pharmadispatch.com/news/no-savings-from-us-says-guild 2014-03-03T06:54:44+11:00 https://pharmadispatch.com/news/new-all-in-one-processor-for-cochlear-implants 2014-03-03T06:54:40+11:00 https://pharmadispatch.com/news/billions-in-pbs-savings-still-to-come 2014-02-28T07:15:49+11:00 https://pharmadispatch.com/news/disclosure-model-opt-out-for-doctors 2014-02-28T07:15:43+11:00 https://pharmadispatch.com/news/new-leadership-team-for-hospira 2014-02-28T07:15:37+11:00 https://pharmadispatch.com/news/pfizer-direct-sticks-with-dhl 2014-02-28T07:15:27+11:00 https://pharmadispatch.com/news/nexium-goes-otc 2014-02-28T07:15:18+11:00 https://pharmadispatch.com/news/msd-accepts-gliptin-price-cut 2014-02-27T07:01:22+11:00 https://pharmadispatch.com/news/decision-on-lsdp-review-imminent 2014-02-27T07:01:09+11:00 https://pharmadispatch.com/news/tga-backs-ranbaxy-on-quality-for-now 2014-02-27T07:01:00+11:00 https://pharmadispatch.com/news/asmi-urges-caution-on-new-study 2014-02-27T07:00:53+11:00 https://pharmadispatch.com/news/abbott-joins-health-savings-push 2014-02-26T06:58:14+11:00 https://pharmadispatch.com/news/two-more-chips-fall-in-diabetes-pricing-battle 2014-02-26T06:57:34+11:00 https://pharmadispatch.com/news/health-funds-bypass-pharmacy 2014-02-26T06:57:17+11:00 https://pharmadispatch.com/news/no-deal-signed-in-singapore 2014-02-26T06:57:06+11:00 https://pharmadispatch.com/news/pbac-recommendations-not-conditional-says-department 2014-02-25T06:33:11+11:00 https://pharmadispatch.com/news/dispute-over-price-disclosure-distortion 2014-02-25T06:32:58+11:00 https://pharmadispatch.com/news/slow-progress-on-tppa 2014-02-25T06:32:39+11:00 https://pharmadispatch.com/news/medicare-the-main-cost-driver-in-health 2014-02-24T09:49:45+11:00 https://pharmadispatch.com/news/health-system-gets-sustainability-treatment 2014-02-24T09:49:37+11:00 https://pharmadispatch.com/news/industry-concern-over-unregistered-comparators 2014-02-24T09:49:22+11:00 https://pharmadispatch.com/news/reprieve-for-serviers-protos 2014-02-24T09:49:14+11:00 https://pharmadispatch.com/news/patients-keep-pushing-on-kalydeco 2014-02-24T09:49:06+11:00 https://pharmadispatch.com/news/the-facts-on-pbs-concessional-category 2014-02-21T08:36:39+11:00 https://pharmadispatch.com/news/pharmacy-facing-year-of-reviews 2014-02-21T08:36:31+11:00 https://pharmadispatch.com/news/minister-nixes-patent-review 2014-02-21T08:36:20+11:00 https://pharmadispatch.com/news/time-for-change-says-dutton 2014-02-20T10:08:53+11:00 https://pharmadispatch.com/news/minister-standing-ground-on-gliptins 2014-02-20T10:08:40+11:00 https://pharmadispatch.com/news/the-obesity-word-unhelpful-when-it-comes-to-weight-loss 2014-02-20T10:08:27+11:00 https://pharmadispatch.com/news/adherence-an-issue-with-adhd 2014-02-20T10:08:17+11:00 https://pharmadispatch.com/news/calls-for-reform-go-unchallenged 2014-02-19T09:52:10+11:00 https://pharmadispatch.com/news/experts-rebut-tppa-claims 2014-02-19T09:52:00+11:00 https://pharmadispatch.com/news/simple-message-winning-the-day 2014-02-19T09:51:50+11:00 https://pharmadispatch.com/news/actavis-to-acquire-forest 2014-02-19T09:51:06+11:00 https://pharmadispatch.com/news/back-generic-sector-says-gmia 2014-02-18T10:06:36+11:00 https://pharmadispatch.com/news/make-report-public-says-patent-review-panel 2014-02-18T10:06:30+11:00 https://pharmadispatch.com/news/pharma-boost-from-korea-fta 2014-02-18T10:06:22+11:00 https://pharmadispatch.com/news/pbs-price-cut-advocates-take-centre-stage 2014-02-18T10:06:01+11:00 https://pharmadispatch.com/news/savings-hit-9bn-with-another-4bn-pbs-wipeout 2014-02-17T09:26:44+11:00 https://pharmadispatch.com/news/pbs-forecast-meaningless-in-era-of-big-price-cuts 2014-02-17T09:26:33+11:00 https://pharmadispatch.com/news/medicare-still-growing-as-pbs-slumps 2014-02-17T09:26:24+11:00 https://pharmadispatch.com/news/private-market-keeps-growing 2014-02-17T09:26:17+11:00 https://pharmadispatch.com/news/accc-case-a-game-changer 2014-02-14T09:57:20+11:00 https://pharmadispatch.com/news/pfizers-atorva-deal-was-not-the-only-one 2014-02-14T09:57:14+11:00 https://pharmadispatch.com/news/industry-dismisses-mactiernan-claims 2014-02-14T09:57:08+11:00 https://pharmadispatch.com/news/guild-facing-backlash-over-program-caps 2014-02-14T09:56:48+11:00 https://pharmadispatch.com/news/labor-mp-launches-parliamentary-attack-on-industry 2014-02-13T09:48:59+11:00 https://pharmadispatch.com/news/government-defeats-labor-amendments-on-tga-bill-for-now 2014-02-13T09:48:53+11:00 https://pharmadispatch.com/news/tga-a-rabbit-warren-says-industry 2014-02-13T09:48:39+11:00 https://pharmadispatch.com/news/guild-takes-control-of-hmrs-and-a-new-incentive-payment-for-phar 2014-02-13T09:48:30+11:00 https://pharmadispatch.com/news/a-healthy-and-competitive-commercial-environment-claims-pharmac 2014-02-13T09:48:22+11:00 https://pharmadispatch.com/news/solid-6-months-for-csl 2014-02-13T09:48:18+11:00 https://pharmadispatch.com/news/seniors-demand-equality-on-immunisation 2014-02-12T09:57:27+11:00 https://pharmadispatch.com/news/pharmacists-flock-to-medadvisor 2014-02-12T09:57:18+11:00 https://pharmadispatch.com/news/nps-generates-savings-but-not-like-price-cuts 2014-02-12T09:57:11+11:00 https://pharmadispatch.com/news/tpp-claims-nonsense-says-robb 2014-02-12T09:57:05+11:00 https://pharmadispatch.com/news/pharmacy-doesnt-like-price-disclosure-but-that-wasnt-always-the- 2014-02-11T09:59:41+11:00 https://pharmadispatch.com/news/patients-send-a-big-message-on-kalydeco 2014-02-11T09:59:31+11:00 https://pharmadispatch.com/news/someone-else-jumps-on-the-pricing-bandwagon 2014-02-11T09:59:13+11:00 https://pharmadispatch.com/news/new-review-finds-wider-health-benefits-from-supplement-use 2014-02-11T09:59:06+11:00 https://pharmadispatch.com/news/another-gliptin-letter-as-halton-rejects-ma-reference-pricing-ch 2014-02-10T10:05:38+11:00 https://pharmadispatch.com/news/do-lower-standards-of-evidence-apply-to-price-cuts 2014-02-10T10:05:26+11:00 https://pharmadispatch.com/news/minister-yet-to-decide-fate-of-lsdp-review 2014-02-10T10:05:20+11:00 https://pharmadispatch.com/news/strong-uptake-of-abortion-pill 2014-02-10T10:05:14+11:00 https://pharmadispatch.com/news/who-is-finance-trying-to-fool 2014-02-10T10:05:09+11:00 https://pharmadispatch.com/news/rule-out-co-pay-increase-demands-labor 2014-02-10T10:04:59+11:00 https://pharmadispatch.com/news/results-astrazeneca-gsk-sanofi 2014-02-10T10:04:55+11:00 https://pharmadispatch.com/news/does-the-access-to-medicines-working-group-have-a-future 2014-02-07T09:32:12+11:00 https://pharmadispatch.com/news/listen-to-the-facts-on-vaccinations-urges-nps-medicinewise 2014-02-07T09:32:04+11:00 https://pharmadispatch.com/news/dont-take-the-new-zealand-path-warns-ma 2014-02-07T09:31:54+11:00 https://pharmadispatch.com/news/gmia-dismisses-grattan-testimony-to-senate-inquiry 2014-02-06T10:31:17+11:00 https://pharmadispatch.com/news/halt-all-post-market-reviews-says-ma 2014-02-06T10:31:06+11:00 https://pharmadispatch.com/news/apps-the-future-of-medicine-management 2014-02-06T10:11:28+11:00 https://pharmadispatch.com/news/company-results-merck-msd-and-covance 2014-02-06T10:08:51+11:00 https://pharmadispatch.com/news/tga-reviews-popular-osteoporosis-drug 2014-02-06T09:40:34+11:00 https://pharmadispatch.com/news/ma-stares-down-critics-on-transparency 2014-02-05T10:41:27+11:00 https://pharmadispatch.com/news/head-office-woes-for-novartis 2014-02-05T10:40:28+11:00 https://pharmadispatch.com/news/la-trobe-surprised-by-harvey-resignation 2014-02-05T10:39:26+11:00 https://pharmadispatch.com/news/asmi-backs-vitamin-e-use 2014-02-05T10:24:31+11:00 https://pharmadispatch.com/news/pfizer-breast-cancer-drug-hits-endpoint-in-trial 2014-02-05T10:22:19+11:00 https://pharmadispatch.com/news/900mil-slump-in-pbsrpbs-benefits-but-its-not-the-real-story 2014-02-04T10:06:58+11:00 https://pharmadispatch.com/news/ma-further-pricing-reform-will-break-pbs 2014-02-04T10:06:33+11:00 https://pharmadispatch.com/news/pharma-sector-gives-half-a-million-to-political-parties 2014-02-04T10:06:01+11:00 https://pharmadispatch.com/news/local-clinicians-welcome-registration-of-new-ms-treatment 2014-02-04T10:05:36+11:00 https://pharmadispatch.com/news/more-funding-for-pharmacy-says-psa 2014-02-04T10:05:14+11:00 https://pharmadispatch.com/news/what-game-is-the-ama-playing 2014-02-03T10:04:02+11:00 https://pharmadispatch.com/news/dpp4s-become-a-political-challenge 2014-02-03T10:03:49+11:00 https://pharmadispatch.com/news/biogen-welcomes-constructive-pbac-on-ms-drug 2014-02-03T10:03:36+11:00 https://pharmadispatch.com/news/save-pbs-to-save-medicare-says-labor 2014-02-03T10:03:24+11:00 https://pharmadispatch.com/news/company-results-lilly-and-celgene 2014-02-03T10:02:56+11:00 https://pharmadispatch.com/news/what-pharma-patents-review 2014-01-31T10:04:01+11:00 https://pharmadispatch.com/news/pbs-stable-as-other-areas-grow 2014-01-31T10:03:50+11:00 https://pharmadispatch.com/news/australia-ranks-5th-in-global-ip-index 2014-01-31T10:03:39+11:00 https://pharmadispatch.com/news/company-results-novartis-and-biogen 2014-01-31T10:03:26+11:00 https://pharmadispatch.com/news/investor-pulls-pin-on-the-global-mail 2014-01-31T10:03:16+11:00 https://pharmadispatch.com/news/new-leadership-for-chf 2014-01-30T10:07:56+11:00 https://pharmadispatch.com/news/another-government-report-highlights-falling-pbs 2014-01-30T10:07:52+11:00 https://pharmadispatch.com/news/uks-nice-says-no-to-societal-benefit-test 2014-01-30T10:07:41+11:00 https://pharmadispatch.com/news/results-pfizer-and-amgen 2014-01-30T10:07:20+11:00 https://pharmadispatch.com/news/tpp-progress-slows 2014-01-30T10:06:52+11:00 https://pharmadispatch.com/news/therapeutic-group-for-dpp-4s 2014-01-29T09:11:51+11:00 https://pharmadispatch.com/news/tga-watching-ranbaxy-again 2014-01-29T09:08:50+11:00 https://pharmadispatch.com/news/tga-approves-viivs-new-hiv-therapy 2014-01-29T09:06:56+11:00 https://pharmadispatch.com/news/disappointment-for-pfizer-lung-cancer-drug 2014-01-29T09:04:50+11:00 https://pharmadispatch.com/news/oncology-boosts-bms 2014-01-29T09:01:27+11:00 https://pharmadispatch.com/news/when-it-comes-to-pricing-controversy-department-and-ma-agree-on- 2014-01-28T10:09:41+11:00 https://pharmadispatch.com/news/industry-questions-pbac-power-on-conditional-recommendations 2014-01-28T10:09:04+11:00 https://pharmadispatch.com/news/use-medibank-money-for-cancer-drugs-says-walker 2014-01-28T10:08:29+11:00 https://pharmadispatch.com/news/senate-questions-go-quiet-on-pbs 2014-01-28T10:08:10+11:00 https://pharmadispatch.com/news/order-of-australia-for-research-australia-chair 2014-01-28T10:07:37+11:00 https://pharmadispatch.com/news/chf-gets-it-wrong-again 2014-01-24T10:00:18+11:00 https://pharmadispatch.com/news/glitpin-price-cut-part-of-a-bastardised-process 2014-01-24T10:00:00+11:00 https://pharmadispatch.com/news/chf-discredits-itself-at-taxpayer-expense 2014-01-24T09:59:47+11:00 https://pharmadispatch.com/news/reinvest-price-disclosure-savings-in-transforming-pharmacy-says- 2014-01-24T09:59:30+11:00 https://pharmadispatch.com/news/sanofi-enters-alliance-with-university-of-melbourne 2014-01-23T10:25:16+11:00 https://pharmadispatch.com/news/englands-cancer-drug-fund-under-pressure 2014-01-23T10:24:28+11:00 https://pharmadispatch.com/news/jj-profit-soars-37-per-cent 2014-01-23T10:23:33+11:00 https://pharmadispatch.com/news/petition-urges-funding-for-soliris 2014-01-22T10:08:01+11:00 https://pharmadispatch.com/news/commission-of-audit-gets-an-extension 2014-01-22T10:07:46+11:00 https://pharmadispatch.com/news/new-study-shows-low-vitamin-d-a-risk-for-ms-patients 2014-01-22T10:07:17+11:00 https://pharmadispatch.com/news/msd-stands-its-ground-on-januvia-pricing 2014-01-21T10:13:17+11:00 https://pharmadispatch.com/news/in-the-end-it-comes-down-to-the-minister 2014-01-21T10:13:03+11:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-the-march-pbac-agenda 2014-01-20T09:59:27+11:00 https://pharmadispatch.com/news/international-comparisons-over-simplify-and-certain-to-mislead 2014-01-20T09:59:11+11:00 https://pharmadispatch.com/news/abbvies-odoherty-pbs-sustainable-for-government-but-not-industry 2014-01-20T09:59:01+11:00 https://pharmadispatch.com/news/pbs-claims-would-be-funny-if-they-werent-so-serious 2014-01-20T09:58:57+11:00 https://pharmadispatch.com/news/industry-engaged-in-a-satanic-plot 2014-01-20T09:58:39+11:00 https://pharmadispatch.com/news/vaccines-in-rooms-full-of-toilet-paper-claims-ama 2014-01-17T09:57:45+11:00 https://pharmadispatch.com/news/new-guidelines-more-user-friendly-but-more-change-to-come 2014-01-17T09:57:33+11:00 https://pharmadispatch.com/news/di-natale-defends-commission-of-audit-inquiry 2014-01-17T09:57:23+11:00 https://pharmadispatch.com/news/robb-highlights-amgen-and-csl-in-speech-promoting-tpp 2014-01-16T10:07:03+11:00 https://pharmadispatch.com/news/all-options-on-the-table-commission-tells-senate 2014-01-16T10:06:41+11:00 https://pharmadispatch.com/news/newman-rejects-ama-call-to-stop-pharmacy-flu-vax-trial 2014-01-16T10:05:48+11:00 https://pharmadispatch.com/news/az-upgrades-forecast-on-pipeline-and-diabetes-deal 2014-01-16T10:05:21+11:00 https://pharmadispatch.com/news/patients-want-compassion-on-meningococcal-vaccine 2014-01-15T10:01:34+11:00 https://pharmadispatch.com/news/ex-pfizer-exec-takes-the-helm-at-shire-australia 2014-01-15T10:00:29+11:00 https://pharmadispatch.com/news/commission-of-audit-front-senate-committee-today 2014-01-15T09:59:40+11:00 https://pharmadispatch.com/news/pbac-not-directed-to-deliver-more-positive-recommendations 2014-01-14T09:59:46+11:00 https://pharmadispatch.com/news/benefits-of-vitamin-d-for-bone-health-indisputable-says-asmi 2014-01-14T09:59:24+11:00 https://pharmadispatch.com/news/pharmacy-groups-unite-for-flu-vaccine-pilot-in-qld 2014-01-14T09:59:01+11:00 https://pharmadispatch.com/news/end-game-nears-in-gliptin-pricing-controversy 2014-01-13T10:08:52+11:00 https://pharmadispatch.com/news/time-the-enemy-for-grattan 2014-01-13T10:08:30+11:00 https://pharmadispatch.com/news/mixed-views-on-new-pbac-approach 2014-01-13T10:08:06+11:00 https://pharmadispatch.com/news/another-busy-pbac-meeting 2014-01-13T10:07:33+11:00 https://pharmadispatch.com/news/time-for-sector-to-unite-and-get-on-the-front-foot 2014-01-13T10:07:02+11:00 https://pharmadispatch.com/news/a-final-dispatch-for-2013-outcomes-indicate-a-new-approach-by-th 2014-01-01T00:36:54+11:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-the-november-pbac-outcomes 2013-12-23T00:37:31+11:00 https://pharmadispatch.com/news/1-april-cuts-add-another-1-5-billion-to-savings 2013-12-20T09:42:44+11:00 https://pharmadispatch.com/news/2013-was-tough-but-2014-will-be-tougher 2013-12-20T09:42:21+11:00 https://pharmadispatch.com/news/pbac-approves-wider-access-to-hiv-drugs 2013-12-20T09:42:10+11:00 https://pharmadispatch.com/news/az-buys-bms-out-of-diabetes-partnership 2013-12-20T09:41:48+11:00 https://pharmadispatch.com/news/kalydeco-listing-sooner-rather-than-later 2013-12-19T10:19:43+11:00 https://pharmadispatch.com/news/race-for-new-cholesterol-drugs-heats-up 2013-12-19T10:19:30+11:00 https://pharmadispatch.com/news/gsk-changes-may-catch-amgen 2013-12-19T10:19:13+11:00 https://pharmadispatch.com/news/roche-welcomes-new-tarceva-listing-from-1-january 2013-12-19T10:19:04+11:00 https://pharmadispatch.com/news/gsk-cuts-doctor-payments 2013-12-18T09:08:00+11:00 https://pharmadispatch.com/news/myefo-confirms-pbs-driving-down-health-costs 2013-12-18T09:07:23+11:00 https://pharmadispatch.com/news/hockey-leaves-the-door-ajar-on-pbs 2013-12-18T09:06:51+11:00 https://pharmadispatch.com/news/dutton-announces-more-new-listings-2 2013-12-18T09:06:23+11:00 https://pharmadispatch.com/news/another-2-7-billion-gone-from-the-pbs 2013-12-17T16:15:31+11:00 https://pharmadispatch.com/news/deadline-passes-for-dpp-4-price-cut 2013-12-17T09:02:47+11:00 https://pharmadispatch.com/news/121-drugs-face-1-april-price-disclosure-cuts 2013-12-17T09:02:29+11:00 https://pharmadispatch.com/news/what-to-expect-from-myefo 2013-12-17T09:02:11+11:00 https://pharmadispatch.com/news/cancer-medicines-less-than-0-5-of-total-health-spending 2013-12-17T09:01:57+11:00 https://pharmadispatch.com/news/did-they-read-the-same-report 2013-12-17T09:01:45+11:00 https://pharmadispatch.com/news/dept-making-it-up-as-they-go-on-diabetes-says-industry 2013-12-16T09:47:26+11:00 https://pharmadispatch.com/news/are-we-really-going-to-do-this-again 2013-12-16T09:47:17+11:00 https://pharmadispatch.com/news/govt-scraps-quarterly-credits-for-rd-tax-inventive 2013-12-16T09:47:09+11:00 https://pharmadispatch.com/news/big-shift-in-top-ten-still-to-come 2013-12-16T09:47:00+11:00 https://pharmadispatch.com/news/patients-and-doctors-differ-on-e-health-records 2013-12-16T09:46:48+11:00 https://pharmadispatch.com/news/pbs-drives-health-spending-down 2013-12-13T01:54:23+11:00 https://pharmadispatch.com/news/abbvie-oral-hep-c-regimen-cures-96-in-late-stage-trial 2013-12-13T01:54:06+11:00 https://pharmadispatch.com/news/tpp-held-up-by-us-australia-disputes 2013-12-13T01:53:34+11:00 https://pharmadispatch.com/news/pbs-winds-back-the-clock 2013-12-12T01:43:28+11:00 https://pharmadispatch.com/news/growth-will-return-probably-sooner-rather-than-later 2013-12-12T01:43:17+11:00 https://pharmadispatch.com/news/tpp-misses-2013-deadline 2013-12-12T01:43:04+11:00 https://pharmadispatch.com/news/pharmaxis-welcomes-another-bronchitol-approval 2013-12-12T01:42:55+11:00 https://pharmadispatch.com/news/62m-under-co-pay-scripts-as-pbs-plummets 2013-12-11T02:15:22+11:00 https://pharmadispatch.com/news/chf-hits-the-jackpot-on-chemo-review 2013-12-11T02:12:47+11:00 https://pharmadispatch.com/news/crestor-surprises-with-market-share 2013-12-11T02:08:44+11:00 https://pharmadispatch.com/news/mylan-completes-agila-acquisition 2013-12-11T02:07:30+11:00 https://pharmadispatch.com/news/more-tppa-leaks-reveal-tense-discussions-on-ip-and-medicines 2013-12-10T02:08:25+11:00 https://pharmadispatch.com/news/international-comparisons-suddenly-the-fashion-on-pbs 2013-12-10T02:07:57+11:00 https://pharmadispatch.com/news/get-real-on-cancer-drug-debate 2013-12-10T02:07:25+11:00 https://pharmadispatch.com/news/australia-complacent-on-cv-disease 2013-12-10T02:04:10+11:00 https://pharmadispatch.com/news/extend-ip-for-biologics-us-business-tells-australia 2013-12-09T01:55:56+11:00 https://pharmadispatch.com/news/pbs-facing-the-squeeze-in-2014 2013-12-09T01:55:36+11:00 https://pharmadispatch.com/news/spend-savings-on-pbs-labor-tells-govt 2013-12-09T01:55:24+11:00 https://pharmadispatch.com/news/pbac-wants-action-on-antipsychotics 2013-12-09T01:55:11+11:00 https://pharmadispatch.com/news/one-step-closer-for-pharmacy-on-vaccination 2013-12-09T01:54:58+11:00 https://pharmadispatch.com/news/40-price-cut-or-youll-be-delisted-dpp-4-companies-told 2013-12-06T02:10:05+11:00 https://pharmadispatch.com/news/csl-licenses-cancer-drug-to-janssen 2013-12-06T02:09:39+11:00 https://pharmadispatch.com/news/familiar-names-dominate-new-committees 2013-12-06T02:09:12+11:00 https://pharmadispatch.com/news/high-court-finds-methods-of-medical-treatment-are-patentable 2013-12-05T00:04:23+11:00 https://pharmadispatch.com/news/light-at-the-end-of-the-tunnel-for-kalydeco 2013-12-05T00:03:02+11:00 https://pharmadispatch.com/news/the-2-billion-cost-of-blindness-and-eye-disease 2013-12-05T00:02:25+11:00 https://pharmadispatch.com/news/telstra-makes-another-move-into-health 2013-12-05T00:01:07+11:00 https://pharmadispatch.com/news/dutton-announces-more-new-listings 2013-12-03T23:16:54+11:00 https://pharmadispatch.com/news/bi-and-lilly-unite-with-idf-on-new-diabetes-survey 2013-12-03T23:15:08+11:00 https://pharmadispatch.com/news/norgine-welcomes-new-listing 2013-12-03T23:14:58+11:00 https://pharmadispatch.com/news/government-commits-another-200-million-to-global-fund 2013-12-03T23:14:46+11:00 https://pharmadispatch.com/news/report-triggers-new-round-of-debate 2013-12-02T23:06:33+11:00 https://pharmadispatch.com/news/dusc-targets-cancer-therapies 2013-12-02T23:06:24+11:00 https://pharmadispatch.com/news/moylan-to-co-chair-development-of-new-diabetes-strategy 2013-12-02T23:06:08+11:00 https://pharmadispatch.com/news/new-option-for-melanoma-patients 2013-12-02T23:05:56+11:00 https://pharmadispatch.com/news/11784 2013-12-01T22:50:05+11:00 https://pharmadispatch.com/news/grattan-institute-confused-again 2013-12-01T22:46:35+11:00 https://pharmadispatch.com/news/focus-on-the-facts-ma-tells-commission-of-audit 2013-12-01T22:46:21+11:00 https://pharmadispatch.com/news/82-million-for-chemo-drugs 2013-12-01T22:46:07+11:00 https://pharmadispatch.com/news/we-need-a-national-plan-says-rare-voices 2013-12-01T22:45:56+11:00 https://pharmadispatch.com/news/australia-moves-up-the-obesity-ladder 2013-12-01T22:45:44+11:00 https://pharmadispatch.com/news/historic-days-looms-for-pbs 2013-11-28T22:49:34+11:00 https://pharmadispatch.com/news/ms-patients-waiting-for-sunday 2013-11-28T22:48:49+11:00 https://pharmadispatch.com/news/guild-gets-specific-on-health-services 2013-11-28T22:48:39+11:00 https://pharmadispatch.com/news/more-gp-training-required-on-depression 2013-11-28T22:48:24+11:00 https://pharmadispatch.com/news/new-resource-for-lung-cancer-diagnosis 2013-11-28T22:48:12+11:00 https://pharmadispatch.com/news/pbs-in-the-frame-a-softening-up-process-begins 2013-11-27T22:57:45+11:00 https://pharmadispatch.com/news/warfarin-slumps-as-patients-flock-to-noacs 2013-11-27T22:57:37+11:00 https://pharmadispatch.com/news/information-session-on-price-disclosure-changes 2013-11-27T22:57:27+11:00 https://pharmadispatch.com/news/more-change-in-the-generic-sector 2013-11-27T22:57:09+11:00 https://pharmadispatch.com/news/prescribers-and-patients-embrace-noacs 2013-11-26T22:32:05+11:00 https://pharmadispatch.com/news/chf-needs-to-be-clear-and-consistent 2013-11-26T22:31:47+11:00 https://pharmadispatch.com/news/ip-sparks-tpp-debate 2013-11-26T22:31:22+11:00 https://pharmadispatch.com/news/sort-biosimilars-gmia-tells-commission-of-audit 2013-11-26T22:31:10+11:00 https://pharmadispatch.com/news/new-symbicort-puffer-set-for-pbs 2013-11-26T22:30:52+11:00 https://pharmadispatch.com/news/grattan-at-it-again-this-time-gst-on-pbs-co-pays 2013-11-25T22:47:48+11:00 https://pharmadispatch.com/news/when-it-comes-to-cancer-patients-and-consumers-are-not-the-same- 2013-11-25T22:47:28+11:00 https://pharmadispatch.com/news/grattan-institute-seems-very-confused-on-pbs 2013-11-25T22:47:11+11:00 https://pharmadispatch.com/news/aussies-love-their-medicine-but-worry-about-access-delays 2013-11-24T23:14:18+11:00 https://pharmadispatch.com/news/dutton-sets-a-new-tone-but-sector-cant-break-the-focus-on-cost 2013-11-24T23:14:05+11:00 https://pharmadispatch.com/news/patients-facing-a-terrible-situation-without-changes-says-ma-cha 2013-11-24T23:13:43+11:00 https://pharmadispatch.com/news/patients-use-the-internet-but-dont-trust-it 2013-11-24T23:13:34+11:00 https://pharmadispatch.com/news/shaw-slams-productivity-commission 2013-11-24T23:13:22+11:00 https://pharmadispatch.com/news/australian-patients-worry-about-access-delays 2013-11-21T21:49:50+11:00 https://pharmadispatch.com/news/dutton-regrets-price-disclosure-changes 2013-11-21T21:49:40+11:00 https://pharmadispatch.com/news/statins-scripts-carry-on-falling 2013-11-21T21:49:36+11:00 https://pharmadispatch.com/news/amgen-reports-positive-data-from-new-cholesterol-busting-biologi 2013-11-21T21:49:24+11:00 https://pharmadispatch.com/news/global-generics-company-exits-australia 2013-11-20T22:42:18+11:00 https://pharmadispatch.com/news/a-quiet-estimates-for-the-pbs 2013-11-20T22:42:02+11:00 https://pharmadispatch.com/news/commission-of-audit-brings-in-health-department 2013-11-20T22:41:52+11:00 https://pharmadispatch.com/news/guild-sharpens-its-tone-on-price-disclosure 2013-11-20T22:41:37+11:00 https://pharmadispatch.com/news/deliver-on-pro-business-rhetoric-ausbiotech-tells-government 2013-11-19T22:54:17+11:00 https://pharmadispatch.com/news/guild-victory-on-chemo-funding-fix 2013-11-19T22:53:53+11:00 https://pharmadispatch.com/news/msd-drug-boosts-melanoma-survival 2013-11-19T22:53:22+11:00 https://pharmadispatch.com/news/genzymes-aubagio-set-for-1-december 2013-11-19T22:52:54+11:00 https://pharmadispatch.com/news/new-data-backs-pradaxa 2013-11-19T22:52:18+11:00 https://pharmadispatch.com/news/ma-meets-dutton 2013-11-19T06:56:00+11:00 https://pharmadispatch.com/news/pbac-locks-in-sglt2-companies 2013-11-19T06:55:47+11:00 https://pharmadispatch.com/news/lundbeck-victorious-in-lexapro-case-while-bayer-scores-tactical- 2013-11-19T06:55:37+11:00 https://pharmadispatch.com/news/nps-and-ama-unite-on-antibiotics 2013-11-19T06:55:28+11:00 https://pharmadispatch.com/news/bard-wins-prestigious-medical-device-award 2013-11-19T06:55:20+11:00 https://pharmadispatch.com/news/pbac-insider-speaks-out 2013-11-18T06:36:43+11:00 https://pharmadispatch.com/news/review-an-opportunity-for-all-including-the-pbac 2013-11-18T06:36:33+11:00 https://pharmadispatch.com/news/dutton-welcomes-ex-mp-as-head-of-diabetes-australia 2013-11-18T06:36:22+11:00 https://pharmadispatch.com/news/australian-link-to-industry-attack-on-uks-nice 2013-11-18T06:36:09+11:00 https://pharmadispatch.com/news/an-austrian-company-growing-in-cochlears-backyard 2013-11-18T06:35:56+11:00 https://pharmadispatch.com/news/lilly-invests-in-insulin-manufacturing-as-global-epidemic-grows 2013-11-18T06:35:47+11:00 https://pharmadispatch.com/news/statin-scripts-fall 2013-11-15T07:13:12+11:00 https://pharmadispatch.com/news/fairfax-youre-confused-and-youre-confusing-the-rest-of-us 2013-11-15T07:12:57+11:00 https://pharmadispatch.com/news/hepatitis-fuelling-growth-in-liver-disease 2013-11-15T07:12:40+11:00 https://pharmadispatch.com/news/gsk-award-adult-immunisation-grants 2013-11-15T07:12:18+11:00 https://pharmadispatch.com/news/dutton-promises-to-fix-chemotherapy-problems 2013-11-14T04:50:10+11:00 https://pharmadispatch.com/news/its-all-about-price-and-regulation-says-who-but-what-about-patie 2013-11-14T04:49:36+11:00 https://pharmadispatch.com/news/msds-australia-set-to-launch-its-own-innovation 2013-11-14T04:48:26+11:00 https://pharmadispatch.com/news/leaders-recognised-in-research-australia-awards 2013-11-14T04:48:07+11:00 https://pharmadispatch.com/news/health-department-silent-on-chf-grants 2013-11-13T06:47:29+11:00 https://pharmadispatch.com/news/novartis-sells-diagnostic-unit 2013-11-13T06:47:17+11:00 https://pharmadispatch.com/news/experts-call-for-a-new-national-action-framework-on-dementia 2013-11-13T06:47:06+11:00 https://pharmadispatch.com/news/new-insulin-device-adds-colour 2013-11-13T06:46:53+11:00 https://pharmadispatch.com/news/four-months-to-cabinet 2013-11-12T06:44:56+11:00 https://pharmadispatch.com/news/media-watch-slams-catalyst-over-statins 2013-11-12T06:44:47+11:00 https://pharmadispatch.com/news/department-publishes-patent-watch-list 2013-11-12T06:44:33+11:00 https://pharmadispatch.com/news/nps-reports-a-big-jump-in-pbs-savings-and-adds-mbs 2013-11-12T06:44:18+11:00 https://pharmadispatch.com/news/pbs-cuts-near-10-billion 2013-11-11T07:11:56+11:00 https://pharmadispatch.com/news/time-to-make-sure-were-getting-it-right 2013-11-11T07:11:42+11:00 https://pharmadispatch.com/news/uncertainty-over-the-fate-of-life-saving-drugs-review 2013-11-11T07:11:28+11:00 https://pharmadispatch.com/news/industry-engages-commission-of-audit 2013-11-11T07:11:16+11:00 https://pharmadispatch.com/news/new-health-channel-just-highlights-the-need-for-change 2013-11-11T07:11:05+11:00 https://pharmadispatch.com/news/new-survey-reveals-australian-patients-back-industry-rd 2013-11-08T07:01:30+11:00 https://pharmadispatch.com/news/diabetes-cancer-cholesterol-ms-and-osteoporosis-drugs-confirmed- 2013-11-08T06:59:51+11:00 https://pharmadispatch.com/news/estimates-herald-changing-of-the-guard 2013-11-08T06:59:29+11:00 https://pharmadispatch.com/news/letters-start-arriving-confirming-1-december-listings 2013-11-07T07:04:59+11:00 https://pharmadispatch.com/news/government-scraps-education-tax-cap 2013-11-07T07:04:37+11:00 https://pharmadispatch.com/news/new-technique-promises-safer-detection-for-cf-patients 2013-11-07T07:04:18+11:00 https://pharmadispatch.com/news/non-pbs-grey-market-the-fastest-growing 2013-11-06T06:50:44+11:00 https://pharmadispatch.com/news/chf-dodges-transparency-again-2 2013-11-06T06:50:30+11:00 https://pharmadispatch.com/news/time-for-the-facts-on-heart-disease 2013-11-06T06:50:14+11:00 https://pharmadispatch.com/news/another-billion-dollar-fine-against-a-pharma-company 2013-11-06T06:49:33+11:00 https://pharmadispatch.com/news/risk-share-revenue-soars-to-350m 2013-11-05T06:59:06+11:00 https://pharmadispatch.com/news/pbs-looks-very-different-today 2013-11-05T06:58:50+11:00 https://pharmadispatch.com/news/leading-clinician-expects-strong-uptake-of-tecfidera 2013-11-05T06:58:39+11:00 https://pharmadispatch.com/news/independent-review-slams-pbac-over-vimovo 2013-11-04T06:43:04+11:00 https://pharmadispatch.com/news/busy-start-for-new-ma-chair 2013-11-04T06:43:01+11:00 https://pharmadispatch.com/news/review-provides-further-evidence-of-process-issues 2013-11-04T06:42:58+11:00 https://pharmadispatch.com/news/pbs-sustainable-says-dutton 2013-11-04T06:42:51+11:00 https://pharmadispatch.com/news/uncertainty-continues-for-diabetes-companies 2013-11-04T06:42:41+11:00 https://pharmadispatch.com/news/new-job-for-carol-bennett 2013-11-04T06:42:29+11:00 https://pharmadispatch.com/news/nps-backs-statin-use-against-abc 2013-11-01T07:02:41+11:00 https://pharmadispatch.com/news/ama-calls-for-change-in-gmia-code 2013-11-01T07:02:28+11:00 https://pharmadispatch.com/news/time-for-a-reality-check 2013-11-01T07:02:00+11:00 https://pharmadispatch.com/news/easier-bronchitol-prescribing-from-today 2013-11-01T07:01:31+11:00 https://pharmadispatch.com/news/results-az-sanofi-and-bayer 2013-11-01T07:01:21+11:00 https://pharmadispatch.com/news/companies-reassess-listing-timelines 2013-10-31T06:43:21+11:00 https://pharmadispatch.com/news/far-from-a-small-change 2013-10-31T06:43:06+11:00 https://pharmadispatch.com/news/results-biogen-soars-on-tecfidera-and-pfizer-beats-expectations- 2013-10-31T06:42:46+11:00 https://pharmadispatch.com/news/dutton-confirms-new-20-million-cabinet-threshold 2013-10-30T11:40:26+11:00 https://pharmadispatch.com/news/pfizers-masum-hossain-on-the-pbs-and-cancer-drugs-trying-to-fix- 2013-10-30T07:00:50+11:00 https://pharmadispatch.com/news/leading-clinician-slams-the-abc-over-statins 2013-10-30T07:00:34+11:00 https://pharmadispatch.com/news/abbvie-raising-awareness-of-psoriasis 2013-10-30T07:00:14+11:00 https://pharmadispatch.com/news/results-humira-boosts-abbvie-as-merck-loses-ground-in-diabetes 2013-10-30T07:00:03+11:00 https://pharmadispatch.com/news/a-stable-environment-says-dutton 2013-10-29T06:39:35+11:00 https://pharmadispatch.com/news/pbs-falls-but-average-script-cost-continues-to-rise 2013-10-29T06:39:21+11:00 https://pharmadispatch.com/news/new-meningococcal-vaccine-fronts-pbac 2013-10-29T06:39:11+11:00 https://pharmadispatch.com/news/pbac-set-to-consider-kalydeco-again-in-march 2013-10-29T06:39:02+11:00 https://pharmadispatch.com/news/dutton-announces-new-listings 2013-10-28T07:06:32+11:00 https://pharmadispatch.com/news/a-strong-start-for-dutton-on-pbs-but-does-he-realise 2013-10-28T07:05:17+11:00 https://pharmadispatch.com/news/evidence-of-pbs-change-emerged-a-long-time-ago 2013-10-28T07:03:41+11:00 https://pharmadispatch.com/news/bayers-eylea-storms-to-market-lead 2013-10-28T07:03:14+11:00 https://pharmadispatch.com/news/company-results-lilly-gsk-and-celgene 2013-10-28T07:02:08+11:00 https://pharmadispatch.com/news/dutton-secures-key-cabinet-post 2013-10-25T07:12:20+11:00 https://pharmadispatch.com/news/another-rough-day-for-the-pharma-sector 2013-10-25T07:12:04+11:00 https://pharmadispatch.com/news/amgens-pantzer-wins-industry-award 2013-10-25T07:11:54+11:00 https://pharmadispatch.com/news/statecraft-secures-services-of-tga-official 2013-10-25T07:11:46+11:00 https://pharmadispatch.com/news/political-debate-turns-to-pbs-already 2013-10-24T07:06:22+11:00 https://pharmadispatch.com/news/in-politics-memories-fade-fast 2013-10-24T07:05:50+11:00 https://pharmadispatch.com/news/amgen-goes-from-strength-to-strength 2013-10-24T07:05:39+11:00 https://pharmadispatch.com/news/obesity-is-a-chronic-disease-say-experts 2013-10-24T07:05:29+11:00 https://pharmadispatch.com/news/pfizer-disappointed-after-missing-ma-board 2013-10-23T07:02:42+11:00 https://pharmadispatch.com/news/calibrate-approach-to-ministers-new-reality 2013-10-23T07:02:30+11:00 https://pharmadispatch.com/news/commission-of-audit-to-examine-everything-says-hockey 2013-10-23T07:02:01+11:00 https://pharmadispatch.com/news/stakeholders-united-in-support-of-dpp-4s-at-diabetes-review-foru 2013-10-22T06:53:44+11:00 https://pharmadispatch.com/news/big-change-for-pharma-sector-with-new-leadership-and-new-ministe 2013-10-22T06:53:28+11:00 https://pharmadispatch.com/news/its-official-tambassis-the-new-guild-president 2013-10-22T06:53:09+11:00 https://pharmadispatch.com/news/labor-sticks-to-its-what-it-know-best-with-health-and-industry-p 2013-10-21T06:36:55+11:00 https://pharmadispatch.com/news/labor-making-its-own-transition 2013-10-21T06:36:46+11:00 https://pharmadispatch.com/news/formation-of-anztpa-more-complex-than-you-think-says-tga 2013-10-21T06:36:32+11:00 https://pharmadispatch.com/news/ma-backs-tga-on-transparency 2013-10-21T06:36:19+11:00 https://pharmadispatch.com/news/roche-reports-strong-growth-for-first-nine-months-of-2013 2013-10-21T06:36:09+11:00 https://pharmadispatch.com/news/pfizer-calls-on-government-to-establish-cancer-drug-fund 2013-10-18T05:23:08+11:00 https://pharmadispatch.com/news/cancer-fund-makes-sense-if-it-helps-patients 2013-10-18T05:22:29+11:00 https://pharmadispatch.com/news/pharmaxis-cuts-costs-as-bronchitol-sales-accelerate 2013-10-18T05:22:20+11:00 https://pharmadispatch.com/news/pbac-approves-sutent-for-pancreatic-cancer-at-special-meeting 2013-10-18T05:21:53+11:00 https://pharmadispatch.com/news/genzyme-hits-the-bike-path-for-ms 2013-10-18T05:21:44+11:00 https://pharmadispatch.com/news/cv-drugs-on-the-slide-as-patent-expiries-bite 2013-10-17T07:11:27+11:00 https://pharmadispatch.com/news/race-for-new-cholesterol-market-heating-up 2013-10-17T07:11:14+11:00 https://pharmadispatch.com/news/bms-az-diabetes-partnership-celebrates-new-dpp-4-combo 2013-10-17T07:11:03+11:00 https://pharmadispatch.com/news/a-fresh-start-for-chf 2013-10-16T06:59:55+11:00 https://pharmadispatch.com/news/changes-in-scotland-show-the-way-for-australia 2013-10-16T06:59:36+11:00 https://pharmadispatch.com/news/experts-welcome-new-breast-cancer-drugs 2013-10-16T06:59:31+11:00 https://pharmadispatch.com/news/no-excuse-for-the-use-of-warfarin-in-australia-says-global-exper 2013-10-15T06:58:02+11:00 https://pharmadispatch.com/news/survey-finds-most-australians-are-unaware-of-atrial-fibrillation 2013-10-15T06:57:53+11:00 https://pharmadispatch.com/news/ama-backs-company-submissions-on-transparency 2013-10-15T06:57:43+11:00 https://pharmadispatch.com/news/plibersek-appointed-deputy-opposition-leader 2013-10-15T06:57:35+11:00 https://pharmadispatch.com/news/terry-white-pushes-for-pharmacy-access-to-medicare-rebates 2013-10-15T06:57:23+11:00 https://pharmadispatch.com/news/nps-medicine-use-is-a-balance 2013-10-15T06:57:02+11:00 https://pharmadispatch.com/news/top-10-heads-south 2013-10-14T07:04:04+11:00 https://pharmadispatch.com/news/is-it-really-the-time-for-a-grand-policy-vision 2013-10-14T07:03:56+11:00 https://pharmadispatch.com/news/new-budget-rules-and-the-pbs 2013-10-14T07:03:38+11:00 https://pharmadispatch.com/news/shaw-same-tired-arguments-from-the-same-people 2013-10-14T07:03:28+11:00 https://pharmadispatch.com/news/energised-medical-profession-could-be-industrys-best-asset-on-tr 2013-10-14T07:03:20+11:00 https://pharmadispatch.com/news/pressure-builds-over-1-december-listings-as-treasury-counts-the- 2013-10-11T07:18:31+11:00 https://pharmadispatch.com/news/focus-on-health-not-price-competition-says-quilty 2013-10-11T07:17:56+11:00 https://pharmadispatch.com/news/martin-palin-when-diseases-are-no-laughing-matter 2013-10-11T07:17:45+11:00 https://pharmadispatch.com/news/tga-decides-against-appealing-aat-decision 2013-10-11T07:17:34+11:00 https://pharmadispatch.com/news/takedas-james-jones-welcomes-a-more-assertive-industry 2013-10-10T07:12:28+11:00 https://pharmadispatch.com/news/industry-arguments-against-transparency-lame-says-di-natale 2013-10-10T07:12:18+11:00 https://pharmadispatch.com/news/pharmac-fans-myopic-says-ma 2013-10-10T07:12:08+11:00 https://pharmadispatch.com/news/tpp-leaders-still-working-on-year-end-target 2013-10-10T07:11:59+11:00 https://pharmadispatch.com/news/groups-unite-for-world-sight-day 2013-10-10T07:11:50+11:00 https://pharmadispatch.com/news/a-change-in-government-from-the-departments-perspective 2013-10-09T07:20:38+11:00 https://pharmadispatch.com/news/shaw-hits-back-at-critics-over-pbs-savings 2013-10-09T07:20:29+11:00 https://pharmadispatch.com/news/head-to-head-trial-boosts-erbitux-in-advance-of-pbac 2013-10-09T07:20:17+11:00 https://pharmadispatch.com/news/the-drugs-behind-the-falling-pbs 2013-10-08T07:18:28+11:00 https://pharmadispatch.com/news/twg-model-dead-in-the-water 2013-10-08T07:15:37+11:00 https://pharmadispatch.com/news/chf-transparency-submission-a-sign-of-what-could-be-coming 2013-10-08T07:15:21+11:00 https://pharmadispatch.com/news/tga-oks-ranbaxy-products-from-mohali-for-now 2013-10-08T07:15:14+11:00 https://pharmadispatch.com/news/mixed-news-on-trade-agreement 2013-10-08T07:15:04+11:00 https://pharmadispatch.com/news/csl-settles-lawsuit-avoid-further-costs-and-distractions 2013-10-08T07:14:54+11:00 https://pharmadispatch.com/news/overdiagnosis-anyone 2013-10-04T07:14:15+10:00 https://pharmadispatch.com/news/the-rebranding-of-disease-mongering-as-overdiagnosis 2013-10-04T07:14:01+10:00 https://pharmadispatch.com/news/derision-of-disease-awareness-misplaced 2013-10-04T07:13:47+10:00 https://pharmadispatch.com/news/strategic-acquisition-for-clinical-genomics 2013-10-04T07:13:38+10:00 https://pharmadispatch.com/news/jason-smith-of-novartis-emerging-lack-of-flexibility-in-a-system 2013-10-03T07:05:59+10:00 https://pharmadispatch.com/news/merck-co-sharpens-rd-focus-announces-job-cuts 2013-10-03T07:05:46+10:00 https://pharmadispatch.com/news/the-next-step-for-celgene 2013-10-03T07:05:35+10:00 https://pharmadispatch.com/news/pbs-share-of-federal-health-spending-plummets 2013-10-02T06:55:47+10:00 https://pharmadispatch.com/news/dept-confirms-reappointment-of-pbac-member 2013-10-02T06:55:39+10:00 https://pharmadispatch.com/news/guild-sells-share-of-it-group-to-telstra 2013-10-02T06:55:31+10:00 https://pharmadispatch.com/news/ma-stay-away-from-ethics-in-patent-grants 2013-10-02T06:55:13+10:00 https://pharmadispatch.com/news/when-it-comes-to-the-pbs-savings-are-in-the-billions 2013-10-01T06:53:41+10:00 https://pharmadispatch.com/news/finally-they-agree-on-something 2013-10-01T06:53:34+10:00 https://pharmadispatch.com/news/amgen-and-gsk-hopeful-of-1-december-listing-for-prolia-in-men 2013-10-01T06:53:27+10:00 https://pharmadispatch.com/news/novartis-and-bayer-dispute-rolls-into-2014 2013-10-01T06:53:18+10:00 https://pharmadispatch.com/news/more-pbs-cuts-coming 2013-09-30T06:52:06+10:00 https://pharmadispatch.com/news/industry-ponders-implications-as-hiv-groups-combine-for-pbac-sub 2013-09-30T06:51:11+10:00 https://pharmadispatch.com/news/does-anyone-really-know-whats-happening-with-the-pbs 2013-09-30T06:50:45+10:00 https://pharmadispatch.com/news/uncertainty-remains-over-1-december-listings-and-cabinet-thresho 2013-09-30T06:50:31+10:00 https://pharmadispatch.com/news/barnes-heading-for-singapore 2013-09-30T06:50:17+10:00 https://pharmadispatch.com/news/budget-outcome-reveals-pbs-in-free-fall 2013-09-27T12:41:49+10:00 https://pharmadispatch.com/news/a-new-senate-a-new-ballgame 2013-09-27T06:57:02+10:00 https://pharmadispatch.com/news/new-gmia-code-introduces-the-complying-member 2013-09-27T06:56:23+10:00 https://pharmadispatch.com/news/ma-another-closure-to-hit-exports 2013-09-27T06:56:11+10:00 https://pharmadispatch.com/news/biogen-employees-help-out-on-volunteer-day 2013-09-27T06:55:43+10:00 https://pharmadispatch.com/news/novartis-takes-top-primary-care-award 2013-09-26T05:36:13+10:00 https://pharmadispatch.com/news/pfizer-announced-closure-of-sydney-manufacturing 2013-09-26T05:35:06+10:00 https://pharmadispatch.com/news/pbs-continues-decade-long-decline 2013-09-26T04:55:32+10:00 https://pharmadispatch.com/news/az-facing-fresh-generic-attack-on-nexium 2013-09-26T04:38:46+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-the-november-pbac-agenda 2013-09-26T04:36:01+10:00 https://pharmadispatch.com/news/quilty-the-future-is-what-you-make-of-it 2013-09-26T04:35:10+10:00 https://pharmadispatch.com/news/ausbiotech-calls-for-tax-break-for-aussie-innovations 2013-09-25T07:01:58+10:00 https://pharmadispatch.com/news/ip-drags-tpp-negotiations 2013-09-25T07:00:58+10:00 https://pharmadispatch.com/news/qbiotics-taps-investors-to-fund-cancer-drug-development 2013-09-25T07:00:40+10:00 https://pharmadispatch.com/news/tga-safety-advisory-on-noacs 2013-09-25T06:59:12+10:00 https://pharmadispatch.com/news/merck-seronos-shaju-backer-be-prepared-to-put-our-case 2013-09-24T06:41:35+10:00 https://pharmadispatch.com/news/ma-companies-unite-against-transparency-model 2013-09-24T06:40:11+10:00 https://pharmadispatch.com/news/pbs-forecasts-way-off 2013-09-24T06:39:39+10:00 https://pharmadispatch.com/news/chf-campaign-promoting-a-cheap-and-nasty-regime 2013-09-24T06:35:03+10:00 https://pharmadispatch.com/news/chf-missing-the-point-on-pbs 2013-09-24T06:30:13+10:00 https://pharmadispatch.com/news/is-the-mou-already-dead 2013-09-23T06:01:27+10:00 https://pharmadispatch.com/news/fate-of-the-mou-does-it-really-matter 2013-09-23T06:01:20+10:00 https://pharmadispatch.com/news/another-pbs-cut 2013-09-23T06:01:13+10:00 https://pharmadispatch.com/news/1-december-listings-an-early-test-for-dutton 2013-09-23T06:01:04+10:00 https://pharmadispatch.com/news/private-market-growing-and-growing 2013-09-23T06:00:53+10:00 https://pharmadispatch.com/news/value-in-early-engagement-with-regulators-and-payors 2013-09-20T07:24:56+10:00 https://pharmadispatch.com/news/pharmaxis-trims-board 2013-09-20T07:24:22+10:00 https://pharmadispatch.com/news/prima-slumps-after-ovarian-cancer-drug-disappoints-in-trial 2013-09-20T07:24:08+10:00 https://pharmadispatch.com/news/doha-becomes-doh-with-sport 2013-09-19T06:24:55+10:00 https://pharmadispatch.com/news/company-cfos-join-opposition-to-transparency-model 2013-09-19T06:24:42+10:00 https://pharmadispatch.com/news/merck-serono-launches-patient-access-program-for-erbitux 2013-09-19T06:24:33+10:00 https://pharmadispatch.com/news/ban-samples-maybe-ask-the-government-first 2013-09-19T06:24:22+10:00 https://pharmadispatch.com/news/pfizer-transparency-model-unworkable-and-commercially-unviable 2013-09-18T06:56:19+10:00 https://pharmadispatch.com/news/tga-acts-after-fda-bans-more-ranbaxy-imports-again 2013-09-18T06:56:10+10:00 https://pharmadispatch.com/news/tga-approves-new-skin-cancer-drug-but-no-pbs 2013-09-18T06:55:59+10:00 https://pharmadispatch.com/news/sclavos-joins-terry-white-board 2013-09-18T06:55:50+10:00 https://pharmadispatch.com/news/chf-slams-aat-over-painkillers 2013-09-18T06:55:41+10:00 https://pharmadispatch.com/news/pfizer-may-be-the-first-of-many 2013-09-18T06:55:29+10:00 https://pharmadispatch.com/news/a-new-ministry-but-what-now 2013-09-17T07:21:29+10:00 https://pharmadispatch.com/news/pharma-and-health-groups-welcome-new-ministry 2013-09-17T07:21:12+10:00 https://pharmadispatch.com/news/businessman-joins-calls-for-overhaul-of-cancer-drug-red-tape 2013-09-17T07:20:58+10:00 https://pharmadispatch.com/news/dutton-in-health-and-sport-as-macfarlane-returns-to-industry 2013-09-16T15:12:45+10:00 https://pharmadispatch.com/news/us-disappointed-at-australian-ip-stance 2013-09-16T07:20:06+10:00 https://pharmadispatch.com/news/wes-cook-lessons-from-the-pradaxa-journey 2013-09-16T07:19:42+10:00 https://pharmadispatch.com/news/how-about-a-1500-fine-for-every-unique-visitor 2013-09-16T07:19:34+10:00 https://pharmadispatch.com/news/new-prescribing-conditions-for-controversial-painkillers 2013-09-16T07:19:26+10:00 https://pharmadispatch.com/news/mixed-views-on-mirabella-no-show 2013-09-16T07:19:16+10:00 https://pharmadispatch.com/news/the-new-government-means-change-for-everyone 2013-09-16T07:19:08+10:00 https://pharmadispatch.com/news/diabetes-forum-constructive-but-what-does-it-change 2013-09-13T07:14:11+10:00 https://pharmadispatch.com/news/sigma-profit-crunched-by-pbs-reforms 2013-09-13T07:14:03+10:00 https://pharmadispatch.com/news/az-and-merck-msd-enter-cancer-drug-pact 2013-09-13T07:13:56+10:00 https://pharmadispatch.com/news/guild-softens-language 2013-09-12T07:08:06+10:00 https://pharmadispatch.com/news/pfizer-successful-drug-development-requires-early-failure 2013-09-12T07:07:59+10:00 https://pharmadispatch.com/news/change-coming-for-pharmacy-and-they-know-it 2013-09-12T07:07:51+10:00 https://pharmadispatch.com/news/boehringer-ingelheims-wes-cook-time-for-a-fresh-start-on-pbs 2013-09-11T06:57:58+10:00 https://pharmadispatch.com/news/15-nominations-for-ma-board 2013-09-11T06:57:50+10:00 https://pharmadispatch.com/news/department-backs-down-on-diabetes-review-forum 2013-09-11T06:57:41+10:00 https://pharmadispatch.com/news/getting-control-of-the-health-agenda-and-the-rules-of-engagement 2013-09-10T07:04:52+10:00 https://pharmadispatch.com/news/industry-confronts-growing-list-of-issues-on-transparency 2013-09-10T07:04:42+10:00 https://pharmadispatch.com/news/abbott-rethink-on-industry-portfolio 2013-09-10T07:04:30+10:00 https://pharmadispatch.com/news/gsk-sells-popular-consumer-brands 2013-09-10T07:03:11+10:00 https://pharmadispatch.com/news/the-transition-to-government-from-someone-who-knows 2013-09-09T06:39:33+10:00 https://pharmadispatch.com/news/most-survive-at-least-to-fight-on-for-another-day 2013-09-09T06:39:25+10:00 https://pharmadispatch.com/news/how-a-coalition-government-is-different-to-labor 2013-09-09T06:39:13+10:00 https://pharmadispatch.com/news/early-months-critical-for-pharma-sector 2013-09-09T06:39:05+10:00 https://pharmadispatch.com/news/mou-in-chaos-says-liberal-party 2013-09-06T08:04:28+10:00 https://pharmadispatch.com/news/staffers-comments-nothing-to-do-with-us-says-tga 2013-09-06T07:04:53+10:00 https://pharmadispatch.com/news/a-conflict-is-a-conflict 2013-09-06T07:04:39+10:00 https://pharmadispatch.com/news/labor-gives-guild-nothing 2013-09-06T07:04:19+10:00 https://pharmadispatch.com/news/coalition-rebuffs-pharmacy-on-compensation-and-other-things 2013-09-05T07:25:48+10:00 https://pharmadispatch.com/news/signs-not-good-for-the-guild 2013-09-05T07:25:25+10:00 https://pharmadispatch.com/news/labors-health-policies-cost-zero 2013-09-05T07:24:55+10:00 https://pharmadispatch.com/news/close-the-policy-gaps-says-ama 2013-09-05T07:24:34+10:00 https://pharmadispatch.com/news/diabetes-review-could-take-two-years 2013-09-04T07:05:59+10:00 https://pharmadispatch.com/news/coalition-could-face-an-early-test-on-pbs 2013-09-04T07:05:49+10:00 https://pharmadispatch.com/news/pharmacy-leadership-heads-overseas 2013-09-04T07:05:40+10:00 https://pharmadispatch.com/news/a-political-concession-with-real-risk 2013-09-04T07:05:29+10:00 https://pharmadispatch.com/news/weight-loss-empire-feels-the-pinch 2013-09-04T07:05:19+10:00 https://pharmadispatch.com/news/who-really-represents-diabetes-patients 2013-09-03T07:07:29+10:00 https://pharmadispatch.com/news/herbalism-and-homeopathy-over-prescription-medicines 2013-09-03T07:07:18+10:00 https://pharmadispatch.com/news/new-study-reveals-issues-with-warfarin 2013-09-03T07:07:07+10:00 https://pharmadispatch.com/news/urgent-pbs-supply-without-prescription-for-some-patients 2013-09-03T07:07:01+10:00 https://pharmadispatch.com/news/unease-over-transparency-as-ma-launches-code-review 2013-09-02T07:08:41+10:00 https://pharmadispatch.com/news/pbac-looking-for-another-new-member 2013-09-02T07:07:46+10:00 https://pharmadispatch.com/news/pharmacy-in-for-a-long-battle-as-industry-likely-to-lock-in-furt 2013-09-02T07:07:36+10:00 https://pharmadispatch.com/news/for-pradaxa-the-wait-is-finally-over 2013-09-02T07:07:29+10:00 https://pharmadispatch.com/news/its-not-all-warfare-between-the-guild-and-government 2013-09-02T07:07:20+10:00 https://pharmadispatch.com/news/artg-gsks-tafinlar-and-a-new-statin 2013-09-02T07:07:12+10:00 https://pharmadispatch.com/news/pbs-how-much-out-and-how-much-in 2013-08-30T07:04:02+10:00 https://pharmadispatch.com/news/european-austerity-hits-pharmaxis 2013-08-30T07:03:49+10:00 https://pharmadispatch.com/news/chf-backs-greens-swipes-the-guild-again 2013-08-30T07:03:31+10:00 https://pharmadispatch.com/news/pbac-chair-to-industry-time-to-rethink-your-business-model 2013-08-29T07:26:49+10:00 https://pharmadispatch.com/news/greens-join-coalition-on-pbs-and-target-post-market-reviews 2013-08-29T07:26:42+10:00 https://pharmadispatch.com/news/diabetes-groups-conclude-review-and-improve-access 2013-08-29T07:26:35+10:00 https://pharmadispatch.com/news/biogen-to-launch-tecfidera-pfp 2013-08-29T07:26:29+10:00 https://pharmadispatch.com/news/for-young-aussie-men-ignorance-is-bliss-when-it-comes-to-prostat 2013-08-29T07:26:22+10:00 https://pharmadispatch.com/news/coalition-banks-835-million-from-price-disclosure-changes 2013-08-28T11:44:01+10:00 https://pharmadispatch.com/news/someone-should-have-shouted-pradaxa 2013-08-28T07:34:18+10:00 https://pharmadispatch.com/news/bayer-retains-rights-to-onyx-portfolio 2013-08-28T07:34:13+10:00 https://pharmadispatch.com/news/shire-announce-availability-of-new-adhd-drug 2013-08-28T07:34:08+10:00 https://pharmadispatch.com/news/soriot-makes-another-acquisition-for-az 2013-08-28T07:34:02+10:00 https://pharmadispatch.com/news/plibersek-and-dutton-clash-over-pbs 2013-08-27T14:49:28+10:00 https://pharmadispatch.com/news/diabetes-review-will-fail-if-its-just-about-price-says-ma 2013-08-27T07:14:52+10:00 https://pharmadispatch.com/news/chf-reaches-out-to-pharmacists-but-not-the-guild 2013-08-27T07:14:44+10:00 https://pharmadispatch.com/news/pbac-issues-reaching-a-critical-mass 2013-08-27T07:14:31+10:00 https://pharmadispatch.com/news/welcome-the-debate-on-the-pricing-of-cancer-drugs 2013-08-27T07:14:26+10:00 https://pharmadispatch.com/news/amgen-seals-deal-for-onyx 2013-08-27T07:14:20+10:00 https://pharmadispatch.com/news/new-high-profile-board-members-for-return-unwanted-medicines-pro 2013-08-27T07:14:11+10:00 https://pharmadispatch.com/news/new-research-highlights-benefits-of-surgery-for-type-2-diabetes 2013-08-27T07:14:04+10:00 https://pharmadispatch.com/news/review-finds-significant-process-issues-within-pbac-says-fladric 2013-08-26T06:50:31+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-outcomes-from-julys-pbac-meeting 2013-08-26T06:50:26+10:00 https://pharmadispatch.com/news/pbacs-rejection-of-independent-review-outcomes-only-shows-the-ne 2013-08-26T06:50:21+10:00 https://pharmadispatch.com/news/industry-be-careful-what-you-wish-for 2013-08-26T06:50:16+10:00 https://pharmadispatch.com/news/vertex-disappointed-at-pbacs-rejection-of-kalydeco-for-life-savi 2013-08-26T06:50:10+10:00 https://pharmadispatch.com/news/pbac-pre-empts-diabetes-review-outcome-again 2013-08-26T06:50:05+10:00 https://pharmadispatch.com/news/ama-joins-opposition-to-guild 2013-08-26T06:49:59+10:00 https://pharmadispatch.com/news/consumers-flocking-to-chemist-warehouse 2013-08-26T06:49:52+10:00 https://pharmadispatch.com/news/d-day-with-publication-of-july-pbac-outcomes 2013-08-23T07:17:45+10:00 https://pharmadispatch.com/news/bruce-annabel-pharmacy-needs-to-transition 2013-08-23T07:17:34+10:00 https://pharmadispatch.com/news/hepatitis-australia-calls-on-coalition-to-back-labor-on-support 2013-08-23T07:14:55+10:00 https://pharmadispatch.com/news/a-good-political-move-at-no-cost 2013-08-23T07:13:00+10:00 https://pharmadispatch.com/news/coalition-promises-faster-listings-by-doubling-cabinet-threshold 2013-08-22T13:13:48+10:00 https://pharmadispatch.com/news/claim-and-counter-claim-on-health 2013-08-22T07:08:59+10:00 https://pharmadispatch.com/news/health-remains-the-top-voter-concern 2013-08-22T06:52:19+10:00 https://pharmadispatch.com/news/chf-guild-fight-a-personal-battle-but-far-from-a-genuine-debate 2013-08-22T06:52:04+10:00 https://pharmadispatch.com/news/1-december-price-disclosure-cuts-revealed-over-1-billion-in-savi 2013-08-21T07:16:49+10:00 https://pharmadispatch.com/news/cystic-fibrosis-patients-turn-to-social-media-for-kalydeco 2013-08-21T07:16:39+10:00 https://pharmadispatch.com/news/rudd-to-use-pbs-spend-as-leverage-to-encourage-industry-investme 2013-08-21T07:16:30+10:00 https://pharmadispatch.com/news/high-stakes-game-will-end-badly-for-someone 2013-08-21T07:16:21+10:00 https://pharmadispatch.com/news/guild-disgraceful-campaign-designed-to-mislead 2013-08-20T07:13:23+10:00 https://pharmadispatch.com/news/ms-therapies-off-the-hook 2013-08-20T07:13:15+10:00 https://pharmadispatch.com/news/dusc-raises-concerns-over-antipsychotics-again 2013-08-20T07:13:05+10:00 https://pharmadispatch.com/news/dusc-to-publish-utilisation-analyses 2013-08-19T07:08:13+10:00 https://pharmadispatch.com/news/fixed-dose-combinations-targeted 2013-08-19T07:08:00+10:00 https://pharmadispatch.com/news/more-doha-job-cuts-as-efficiency-dividend-hits 2013-08-19T07:07:52+10:00 https://pharmadispatch.com/news/cost-of-cancer-medicines-is-not-the-real-issue 2013-08-19T07:07:45+10:00 https://pharmadispatch.com/news/patent-review-panel-should-have-been-smarter 2013-08-19T07:07:35+10:00 https://pharmadispatch.com/news/no-backing-down-for-the-guild-as-minister-defends-changes 2013-08-19T07:07:28+10:00 https://pharmadispatch.com/news/another-company-dragged-into-china-corruption-scandal 2013-08-19T07:07:19+10:00 https://pharmadispatch.com/news/amgen-hits-hurdle-in-onyx-takeover 2013-08-19T07:07:11+10:00 https://pharmadispatch.com/news/pharma-patents-review-going-nowhere 2013-08-16T07:20:26+10:00 https://pharmadispatch.com/news/first-atorvastatin-cut-likely-to-be-over-50 2013-08-16T07:20:19+10:00 https://pharmadispatch.com/news/pharmaxis-pushes-on-with-new-strategy 2013-08-16T07:20:13+10:00 https://pharmadispatch.com/news/cystic-fibrosis-patients-set-for-a-long-wait-after-pbac-defers-k 2013-08-15T07:51:26+10:00 https://pharmadispatch.com/news/mixed-views-on-life-saving-drugs-conference-call 2013-08-15T07:31:23+10:00 https://pharmadispatch.com/news/pbac-chair-teams-up-with-industry-critics 2013-08-15T07:31:12+10:00 https://pharmadispatch.com/news/csl-talks-down-australia-despite-strong-profit-growth 2013-08-15T07:31:00+10:00 https://pharmadispatch.com/news/pressure-grows-over-life-saving-drugs-review 2013-08-14T07:04:28+10:00 https://pharmadispatch.com/news/chf-lashes-out-of-pockets-costs-and-pharmacy 2013-08-14T07:03:59+10:00 https://pharmadispatch.com/news/pefo-gives-nothing-new-on-pbs 2013-08-14T07:03:39+10:00 https://pharmadispatch.com/news/gsk-immunisation-grants-deadline-extended 2013-08-14T07:03:29+10:00 https://pharmadispatch.com/news/terms-of-reference-reveal-all-current-life-saving-drugs-will-be- 2013-08-13T07:19:45+10:00 https://pharmadispatch.com/news/treasury-the-big-winner-as-risk-share-revenue-grows 2013-08-13T07:19:33+10:00 https://pharmadispatch.com/news/hepatitis-australia-welcomes-federal-funding 2013-08-13T07:19:23+10:00 https://pharmadispatch.com/news/review-forum-becomes-a-conference-call 2013-08-12T07:30:25+10:00 https://pharmadispatch.com/news/patients-demand-political-intervention-on-life-saving-drugs 2013-08-12T07:30:17+10:00 https://pharmadispatch.com/news/doha-under-pressure-as-election-looms 2013-08-12T07:30:09+10:00 https://pharmadispatch.com/news/guild-getting-closer-to-compensation-as-it-ramps-up-pre-election 2013-08-12T07:30:02+10:00 https://pharmadispatch.com/news/meeting-the-challenge-of-dr-google 2013-08-12T07:29:52+10:00 https://pharmadispatch.com/news/stakeholders-short-changed-at-diabetes-review-forum 2013-08-09T07:00:01+10:00 https://pharmadispatch.com/news/guild-bets-everything-in-pursuit-of-pre-election-political-commi 2013-08-09T06:59:42+10:00 https://pharmadispatch.com/news/guild-leads-the-way 2013-08-09T06:59:34+10:00 https://pharmadispatch.com/news/price-disclosure-change-full-of-surprises 2013-08-08T07:14:16+10:00 https://pharmadispatch.com/news/global-experts-challenge-nhmrc-on-psa-testing 2013-08-08T07:13:34+10:00 https://pharmadispatch.com/news/amgen-ups-bid-for-onyx 2013-08-08T07:13:25+10:00 https://pharmadispatch.com/news/merck-serono-delivers-strong-earnings-growth-on-cost-cutting-pro 2013-08-08T07:13:16+10:00 https://pharmadispatch.com/news/stakeholders-dont-agree-on-very-much 2013-08-07T07:03:58+10:00 https://pharmadispatch.com/news/what-about-a-united-front-and-shared-policy-platform 2013-08-07T07:03:47+10:00 https://pharmadispatch.com/news/sigma-downgraded-but-management-gets-benefit-of-the-doubt 2013-08-07T07:03:44+10:00 https://pharmadispatch.com/news/long-term-use-of-ccbs-may-increase-breast-cancer-risk 2013-08-07T07:03:43+10:00 https://pharmadispatch.com/news/medicine-exports-fall-as-industry-warns-on-impact-of-unpredictab 2013-08-07T07:03:38+10:00 https://pharmadispatch.com/news/guild-claims-32k-hit-to-pharmacy-from-price-disclosure-change 2013-08-06T07:15:46+10:00 https://pharmadispatch.com/news/greens-back-gmia-proposals 2013-08-06T07:12:20+10:00 https://pharmadispatch.com/news/new-survey-reveals-aussies-ignorant-of-their-own-health 2013-08-06T07:08:21+10:00 https://pharmadispatch.com/news/mja-study-backs-nps-cv-programs 2013-08-06T07:08:14+10:00 https://pharmadispatch.com/news/sector-unites-against-price-disclosure-change 2013-08-05T07:29:52+10:00 https://pharmadispatch.com/news/doha-announces-another-post-market-review 2013-08-05T07:29:48+10:00 https://pharmadispatch.com/news/government-defers-self-education-tax-cap 2013-08-05T07:29:47+10:00 https://pharmadispatch.com/news/statement-raises-more-questions-than-it-answers-on-pbs 2013-08-05T07:29:44+10:00 https://pharmadispatch.com/news/pharma-facing-pivotal-election 2013-08-05T07:29:38+10:00 https://pharmadispatch.com/news/pharma-joins-the-ranks-of-the-sideswiped-industries 2013-08-05T07:29:32+10:00 https://pharmadispatch.com/news/government-hits-industry-for-835-million-in-new-price-disclosure 2013-08-02T14:08:03+10:00 https://pharmadispatch.com/news/another-2-billion-in-pbs-cuts-to-fund-budget-hole 2013-08-02T13:09:32+10:00 https://pharmadispatch.com/news/guild-wants-a-share-of-tobacco-excise-increase 2013-08-02T07:09:34+10:00 https://pharmadispatch.com/news/new-report-highlights-benefits-of-pharma-employee-assistance-pro 2013-08-02T07:09:28+10:00 https://pharmadispatch.com/news/more-experts-join-chorus-on-antibiotics 2013-08-02T07:08:21+10:00 https://pharmadispatch.com/news/company-results-az-sanofi-bayer 2013-08-02T07:08:04+10:00 https://pharmadispatch.com/news/industry-gears-up-for-fight-over-biosimilars 2013-08-01T07:20:58+10:00 https://pharmadispatch.com/news/novartis-on-the-attack-through-code-of-conduct 2013-08-01T07:20:53+10:00 https://pharmadispatch.com/news/government-dead-bats-cancer-report 2013-08-01T07:20:47+10:00 https://pharmadispatch.com/news/pharmacy-tax-cap-to-hit-patient-safety 2013-08-01T07:20:42+10:00 https://pharmadispatch.com/news/government-defends-record-on-cancer-medicines 2013-07-31T12:48:29+10:00 https://pharmadispatch.com/news/aussies-lose-out-on-cancer-medicines 2013-07-31T07:28:03+10:00 https://pharmadispatch.com/news/gmia-chair-ups-the-ante-in-pre-election-push-for-more-generics 2013-07-31T07:26:18+10:00 https://pharmadispatch.com/news/a-world-class-system-or-is-it 2013-07-31T07:19:32+10:00 https://pharmadispatch.com/news/industry-not-spared-in-cancer-report 2013-07-31T07:17:01+10:00 https://pharmadispatch.com/news/report-highlights-nightmare-process-for-co-dependent-technologie 2013-07-31T07:15:27+10:00 https://pharmadispatch.com/news/company-results-pfizer-amgen-merck-co 2013-07-31T07:13:03+10:00 https://pharmadispatch.com/news/is-the-pbs-facing-another-big-cut 2013-07-30T07:33:47+10:00 https://pharmadispatch.com/news/new-pfizer-structure-could-be-prelude-to-breakup 2013-07-30T07:28:07+10:00 https://pharmadispatch.com/news/retaining-savings-in-the-pbs-would-benefit-everyone 2013-07-30T07:24:39+10:00 https://pharmadispatch.com/news/company-results-biogen-soars-on-tecfidera-sales 2013-07-30T07:22:02+10:00 https://pharmadispatch.com/news/dramatic-decline-in-general-pbs-scripts 2013-07-29T06:06:26+10:00 https://pharmadispatch.com/news/generic-tops-pbs-benefits-but-biologics-on-the-rise 2013-07-29T05:35:53+10:00 https://pharmadispatch.com/news/pharmaceuticals-industry-council-introduces-new-chair 2013-07-29T05:30:46+10:00 https://pharmadispatch.com/news/industry-hoping-for-us-style-fast-track-approval-process 2013-07-29T05:28:18+10:00 https://pharmadispatch.com/news/complacent-heart-attack-survivors-a-real-problem-says-baker-idi 2013-07-29T05:24:29+10:00 https://pharmadispatch.com/news/company-results-gilead-abbvie 2013-07-29T05:07:57+10:00 https://pharmadispatch.com/news/artg-shires-vyvanse-another-nexium 2013-07-29T05:04:51+10:00 https://pharmadispatch.com/news/new-data-confirms-halt-in-pbs-growth 2013-07-26T07:15:28+10:00 https://pharmadispatch.com/news/eylea-approaching-50-market-share-as-pbac-targets-lucentis 2013-07-26T07:14:01+10:00 https://pharmadispatch.com/news/company-results-roche-and-bms 2013-07-26T07:08:43+10:00 https://pharmadispatch.com/news/canberra-winner-of-the-real-thing-campaign 2013-07-26T07:05:18+10:00 https://pharmadispatch.com/news/ma-gmia-agree-on-at-least-one-thing 2013-07-25T07:15:05+10:00 https://pharmadispatch.com/news/2nd-qtr-results-lilly-gsk 2013-07-25T07:14:33+10:00 https://pharmadispatch.com/news/positive-results-for-genentech-leukaemia-drug 2013-07-25T07:14:06+10:00 https://pharmadispatch.com/news/us-and-european-associations-endorse-trial-transparency-principl 2013-07-25T07:13:32+10:00 https://pharmadispatch.com/news/chf-backed-fewer-pbs-concession-cards 2013-07-24T07:08:49+10:00 https://pharmadispatch.com/news/bizarre-proposal-not-good-for-consumers 2013-07-24T07:05:05+10:00 https://pharmadispatch.com/news/tga-bans-natural-sex-pill-found-to-contain-viagra-like-substance 2013-07-24T07:03:48+10:00 https://pharmadispatch.com/news/az-drawn-into-china-scandal 2013-07-24T06:49:36+10:00 https://pharmadispatch.com/news/consumer-champion-joins-nps-board 2013-07-24T06:45:12+10:00 https://pharmadispatch.com/news/doha-proposed-stepped-therapy-in-pbs-talks 2013-07-23T06:59:10+10:00 https://pharmadispatch.com/news/pbac-targeting-lucentis-with-off-label-avastin-use 2013-07-23T06:52:19+10:00 https://pharmadispatch.com/news/we-appear-to-have-broken-the-law-admits-gsk 2013-07-23T06:41:51+10:00 https://pharmadispatch.com/news/department-funds-chf-on-chemo-review 2013-07-23T06:40:22+10:00 https://pharmadispatch.com/news/pradaxa-not-the-first-unlikely-to-be-the-last 2013-07-22T06:48:51+10:00 https://pharmadispatch.com/news/industry-waiting-for-answers 2013-07-22T06:45:59+10:00 https://pharmadispatch.com/news/china-bribery-investigation-widens-to-other-companies 2013-07-22T06:43:55+10:00 https://pharmadispatch.com/news/pfizer-withdraws-from-race-for-onyx 2013-07-22T06:40:51+10:00 https://pharmadispatch.com/news/actelion-raises-guidance-after-successful-cost-cutting-program 2013-07-22T06:39:47+10:00 https://pharmadispatch.com/news/tpp-by-year-end-doable-says-us 2013-07-22T06:38:03+10:00 https://pharmadispatch.com/news/bms-confirms-yervoy-for-1-august 2013-07-19T06:52:55+10:00 https://pharmadispatch.com/news/pbac-simplifies-bronchitol-prescribing 2013-07-19T06:49:54+10:00 https://pharmadispatch.com/news/amgens-xgeva-excels-in-bone-tumour-trial 2013-07-19T06:47:58+10:00 https://pharmadispatch.com/news/lundbeck-progressing-alzheimers-therapy 2013-07-19T06:45:50+10:00 https://pharmadispatch.com/news/the-long-wait-over-for-pradaxa 2013-07-18T07:11:42+10:00 https://pharmadispatch.com/news/election-creates-uncertainty-for-new-listings 2013-07-18T07:11:34+10:00 https://pharmadispatch.com/news/update-post-pbac-listing-times-under-the-mou-including-pradaxa 2013-07-18T07:11:29+10:00 https://pharmadispatch.com/news/lucentis-falls-but-novartis-raises-outlook-on-lower-than-expecte 2013-07-18T06:57:05+10:00 https://pharmadispatch.com/news/gsk-responds-to-500-million-bribery-allegations 2013-07-17T07:19:02+10:00 https://pharmadispatch.com/news/tpp-talks-underway-as-reminder-of-another-trade-agreement-resurf 2013-07-17T07:16:45+10:00 https://pharmadispatch.com/news/education-tax-cap-bad-for-health-says-guild 2013-07-17T07:13:24+10:00 https://pharmadispatch.com/news/potential-roche-bid-for-alexion 2013-07-17T07:10:21+10:00 https://pharmadispatch.com/news/jj-result-beats-forecast-on-higher-than-expected-drug-sales 2013-07-17T07:07:39+10:00 https://pharmadispatch.com/news/workload-pushes-pbac-process 2013-07-16T04:53:43+10:00 https://pharmadispatch.com/news/patients-pledge-to-make-diabetes-election-issue 2013-07-16T04:53:13+10:00 https://pharmadispatch.com/news/merck-msd-and-lilly-advance-alzheimers-drugs 2013-07-16T04:51:13+10:00 https://pharmadispatch.com/news/gsks-geoff-mcdonald-transparency-goes-both-ways 2013-07-15T06:59:31+10:00 https://pharmadispatch.com/news/companies-hit-the-pain-threshold 2013-07-15T06:55:17+10:00 https://pharmadispatch.com/news/gsk-joins-public-attack-on-reviews 2013-07-15T06:52:33+10:00 https://pharmadispatch.com/news/new-reports-shows-why-pbs-has-its-upside 2013-07-15T06:50:49+10:00 https://pharmadispatch.com/news/artg-biogens-tecfidera 2013-07-15T06:44:10+10:00 https://pharmadispatch.com/news/amgen-and-servier-announce-product-collaboration 2013-07-14T12:00:00+10:00 https://pharmadispatch.com/news/zytiga-joins-xarelto-for-1-august-bms-confident-on-yervoy 2013-07-12T07:18:25+10:00 https://pharmadispatch.com/news/psa-promotes-online-outreach-to-patients 2013-07-12T07:00:12+10:00 https://pharmadispatch.com/news/gsk-facing-bribery-claims-in-china 2013-07-12T06:58:15+10:00 https://pharmadispatch.com/news/mundipharma-wins-oxycontin-patent-case 2013-07-11T07:12:55+10:00 https://pharmadispatch.com/news/chief-scientist-sounds-alarm-on-antibiotics 2013-07-11T06:59:04+10:00 https://pharmadispatch.com/news/when-it-comes-to-antibiotics-chief-scientist-gets-it 2013-07-11T06:57:24+10:00 https://pharmadispatch.com/news/patent-settlements-deliver-significant-savings 2013-07-11T06:51:02+10:00 https://pharmadispatch.com/news/roche-scraps-development-of-diabetes-drug 2013-07-11T06:47:29+10:00 https://pharmadispatch.com/news/tga-approves-kalydeco-on-eve-of-pbac-consideration 2013-07-10T07:42:49+10:00 https://pharmadispatch.com/news/pharmacs-fentanyl-price-a-90-discount-to-pbs 2013-07-10T07:27:03+10:00 https://pharmadispatch.com/news/bms-nivolumab-set-to-dominate-global-nsclc-market 2013-07-10T07:15:44+10:00 https://pharmadispatch.com/news/patients-call-for-action-on-bowel-cancer-screening-program 2013-07-10T07:12:59+10:00 https://pharmadispatch.com/news/bayers-xarelto-gets-headstart-on-competition 2013-07-09T07:09:14+10:00 https://pharmadispatch.com/news/new-bms-resource-helps-families-explain-melanoma 2013-07-09T06:58:43+10:00 https://pharmadispatch.com/news/afinitor-returns-to-pbac-but-suffers-blow-in-uk 2013-07-09T06:55:25+10:00 https://pharmadispatch.com/news/novartis-secukinumab-achieves-superiority-in-head-to-head-trial- 2013-07-09T06:52:37+10:00 https://pharmadispatch.com/news/pivotal-pbac-meeting-as-industry-asks-the-question 2013-07-08T07:19:28+10:00 https://pharmadispatch.com/news/is-the-us-government-watching-as-pbac-considers-review 2013-07-08T07:19:12+10:00 https://pharmadispatch.com/news/bruce-annabel-a-new-pharmacy-model-to-emerge 2013-07-08T07:16:17+10:00 https://pharmadispatch.com/news/psa-calls-for-action-on-chronic-disease 2013-07-08T06:55:33+10:00 https://pharmadispatch.com/news/artg-update-novartis-jakavi-gsks-trobalt 2013-07-08T06:54:29+10:00 https://pharmadispatch.com/news/kalydeco-another-test-for-pbac 2013-07-08T06:53:31+10:00 https://pharmadispatch.com/news/guild-government-declares-war-on-pharmacy 2013-07-05T07:03:31+10:00 https://pharmadispatch.com/news/is-there-political-upside-in-taking-on-pharmacy 2013-07-05T06:57:30+10:00 https://pharmadispatch.com/news/new-vaccines-cut-needle-burden 2013-07-05T06:55:24+10:00 https://pharmadispatch.com/news/stem-cell-transplants-deliver-hope-for-hiv-cure 2013-07-05T06:55:17+10:00 https://pharmadispatch.com/news/gmia-releases-4-point-election-action-plan 2013-07-04T07:16:38+10:00 https://pharmadispatch.com/news/governments-target-pharmaceutical-spend-as-austerity-bites 2013-07-04T07:15:08+10:00 https://pharmadispatch.com/news/us-setback-for-mercks-insomnia-drug 2013-07-04T07:13:34+10:00 https://pharmadispatch.com/news/more-australians-choosing-cheaper-private-market-over-pbs 2013-07-03T07:18:58+10:00 https://pharmadispatch.com/news/companies-join-amgen-in-race-for-onyx 2013-07-03T06:58:32+10:00 https://pharmadispatch.com/news/nps-medicinewise-pleads-for-an-end-to-overuse-of-antibiotics 2013-07-03T06:49:47+10:00 https://pharmadispatch.com/news/breaking-rudd-confirms-plibersek-in-health 2013-07-02T07:25:23+10:00 https://pharmadispatch.com/news/chf-price-disclosure-savings-modest 2013-07-02T07:19:48+10:00 https://pharmadispatch.com/news/gmia-doubles-up-on-leadership 2013-07-02T07:14:48+10:00 https://pharmadispatch.com/news/study-backs-eliquis-safety-over-warfarin 2013-07-02T07:12:49+10:00 https://pharmadispatch.com/news/private-market-launch-for-menarinis-priligy 2013-07-02T07:00:38+10:00 https://pharmadispatch.com/news/1-billion-in-new-listings 2013-07-01T07:10:44+10:00 https://pharmadispatch.com/news/august-listing-for-one-anticoagulant-but-its-not-pradaxa 2013-07-01T07:10:35+10:00 https://pharmadispatch.com/news/time-to-come-clean-on-pradaxa-and-the-process 2013-07-01T07:10:21+10:00 https://pharmadispatch.com/news/govt-sticks-to-mou-with-latest-listing-announcement 2013-07-01T07:04:37+10:00 https://pharmadispatch.com/news/two-the-popular-number-when-it-comes-to-ad-boards 2013-07-01T06:59:46+10:00 https://pharmadispatch.com/news/chf-welcomes-consultation-on-chemo-review 2013-07-01T06:58:11+10:00 https://pharmadispatch.com/news/onyx-rejects-amgens-us10-billion-takeover 2013-07-01T06:56:42+10:00 https://pharmadispatch.com/news/new-oncology-platform-for-merck-serono 2013-07-01T06:50:29+10:00 https://pharmadispatch.com/news/industry-spent-less-than-1-million-on-ad-boards 2013-06-28T10:26:33+10:00 https://pharmadispatch.com/news/plibersek-likely-to-remain-in-health 2013-06-28T07:13:33+10:00 https://pharmadispatch.com/news/amgen-makes-top-50-of-brws-best-place-to-work-list 2013-06-28T06:59:11+10:00 https://pharmadispatch.com/news/roche-and-astrazeneca-enter-rd-alliance 2013-06-28T06:54:39+10:00 https://pharmadispatch.com/news/no-announcement-but-pbac-has-two-new-members 2013-06-27T07:03:20+10:00 https://pharmadispatch.com/news/what-now-for-health 2013-06-27T07:01:11+10:00 https://pharmadispatch.com/news/political-call-to-action-on-zelboraf 2013-06-27T06:52:07+10:00 https://pharmadispatch.com/news/industry-unhappy-over-change-to-pbs-schedule 2013-06-27T06:50:07+10:00 https://pharmadispatch.com/news/more-govt-funds-for-dementia 2013-06-27T06:48:33+10:00 https://pharmadispatch.com/news/govt-faces-more-pressure-over-listings 2013-06-26T06:55:50+10:00 https://pharmadispatch.com/news/industry-welcomes-bipartisan-political-commitment-on-clinical-tr 2013-06-26T06:49:59+10:00 https://pharmadispatch.com/news/groups-claim-confusion-over-pbs-schedule 2013-06-26T06:41:48+10:00 https://pharmadispatch.com/news/worst-of-the-patent-cliff-over-as-biologics-start-to-dominate 2013-06-26T06:38:33+10:00 https://pharmadispatch.com/news/reminder-for-parents-on-meningitis-and-vaccines 2013-06-26T06:32:12+10:00 https://pharmadispatch.com/news/international-expert-slams-unreasonable-drug-rejection 2013-06-25T06:49:15+10:00 https://pharmadispatch.com/news/gmia-reminds-industry-of-cross-previous-policy-positions-on-pate 2013-06-25T06:45:52+10:00 https://pharmadispatch.com/news/gmia-and-interesting-reminders 2013-06-25T06:44:31+10:00 https://pharmadispatch.com/news/gsk-commits-another-80k-to-promote-adult-immunisation 2013-06-25T06:42:52+10:00 https://pharmadispatch.com/news/final-call-for-nominations-for-research-australia-awards 2013-06-25T06:41:05+10:00 https://pharmadispatch.com/news/martin-cross-the-new-ma-chair 2013-06-24T10:28:21+10:00 https://pharmadispatch.com/news/martin-cross-redux-a-smart-choice-for-ma 2013-06-24T10:28:16+10:00 https://pharmadispatch.com/news/david-gallagher-industry-has-a-responsibility-to-advocate-for-ne 2013-06-24T07:19:53+10:00 https://pharmadispatch.com/news/media-backs-patients-on-access-delays 2013-06-24T07:14:36+10:00 https://pharmadispatch.com/news/barnes-end-of-the-beginning-as-fight-looms-over-disclosure-thres 2013-06-24T07:12:15+10:00 https://pharmadispatch.com/news/chf-confuse-themselves-on-disclosure-model-and-everyone-else 2013-06-24T07:10:13+10:00 https://pharmadispatch.com/news/playing-a-political-game-on-transparency 2013-06-24T07:08:32+10:00 https://pharmadispatch.com/news/nuts-and-bolts-of-the-transparency-model 2013-06-24T07:05:28+10:00 https://pharmadispatch.com/news/trials-update-73rd-american-diabetes-association-scientific-sess 2013-06-24T07:04:24+10:00 https://pharmadispatch.com/news/transparency-model-goes-public 2013-06-21T10:32:09+10:00 https://pharmadispatch.com/news/labor-mp-speaks-out-on-pbac 2013-06-21T06:57:15+10:00 https://pharmadispatch.com/news/finally-some-common-sense 2013-06-21T06:54:57+10:00 https://pharmadispatch.com/news/mps-farewell-parliament-with-parting-shots-on-pbs 2013-06-21T06:50:44+10:00 https://pharmadispatch.com/news/more-evidence-hpv-vaccine-benefits 2013-06-21T06:49:15+10:00 https://pharmadispatch.com/news/when-it-comes-to-diabetes-reviews-arent-the-only-problem 2013-06-20T06:54:34+10:00 https://pharmadispatch.com/news/onglyza-disappoints-in-cv-trial 2013-06-20T06:51:48+10:00 https://pharmadispatch.com/news/pharmaxis-analysis-shows-cost-savings-from-bronchitol-use 2013-06-20T06:50:38+10:00 https://pharmadispatch.com/news/az-turnaround-starts-with-new-global-hq 2013-06-20T06:48:18+10:00 https://pharmadispatch.com/news/another-ian-frazer-vaccine-in-development 2013-06-20T06:45:14+10:00 https://pharmadispatch.com/news/industry-meets-it-friends-in-canberra 2013-06-19T06:19:49+10:00 https://pharmadispatch.com/news/gmia-stop-originators-creaming-profits 2013-06-19T06:16:24+10:00 https://pharmadispatch.com/news/ma-backs-coalition-rd-commitments 2013-06-19T06:13:24+10:00 https://pharmadispatch.com/news/show-of-unity-by-pharmacy-groups 2013-06-19T06:10:21+10:00 https://pharmadispatch.com/news/senate-committee-rejects-di-natale-bill 2013-06-18T07:12:41+10:00 https://pharmadispatch.com/news/industry-lambasts-asthma-review 2013-06-18T07:12:28+10:00 https://pharmadispatch.com/news/further-confirmation-of-pradaxa-safety 2013-06-18T06:29:03+10:00 https://pharmadispatch.com/news/industry-gives-review-meeting-a-pass-mark-barely 2013-06-17T05:56:21+10:00 https://pharmadispatch.com/news/ma-to-publish-transparency-model-with-options 2013-06-17T05:54:06+10:00 https://pharmadispatch.com/news/michael-wonder-international-comparison-of-recent-reimbursement- 2013-06-17T05:51:25+10:00 https://pharmadispatch.com/news/dr-lynn-weekes-of-nps-medicinewise-a-more-comfortable-relationsh 2013-06-17T05:49:30+10:00 https://pharmadispatch.com/news/inflation-rise-for-pbac-fees-unlikely-to-fill-budget-hole 2013-06-17T05:46:50+10:00 https://pharmadispatch.com/news/psa-unity-essential-for-pharmacy-profession 2013-06-17T05:45:15+10:00 https://pharmadispatch.com/news/trials-bms-and-abbvies-elotuzumab-amgens-trebananib-novartis-jak 2013-06-17T05:43:33+10:00 https://pharmadispatch.com/news/four-years-to-align-industry-codes 2013-06-14T06:54:34+10:00 https://pharmadispatch.com/news/psa-delivers-pointed-welcome-to-new-guild-leader 2013-06-14T06:53:15+10:00 https://pharmadispatch.com/news/eular-update-amgen-and-azs-brodalumab-roches-actemra 2013-06-14T06:50:24+10:00 https://pharmadispatch.com/news/next-step-in-guild-succession-plan 2013-06-13T07:11:08+10:00 https://pharmadispatch.com/news/calls-for-yet-another-review-of-ip-law 2013-06-13T07:06:12+10:00 https://pharmadispatch.com/news/qbiotics-capital-raise-to-fund-development-of-blushwood-cancer-c 2013-06-13T07:02:45+10:00 https://pharmadispatch.com/news/order-of-australia-for-nps-ceo 2013-06-13T06:50:19+10:00 https://pharmadispatch.com/news/eular-update-bms-orencia 2013-06-13T06:46:53+10:00 https://pharmadispatch.com/news/what-next-for-martin-cross 2013-06-12T06:58:29+10:00 https://pharmadispatch.com/news/industry-sceptical-over-review-meeting 2013-06-12T06:48:18+10:00 https://pharmadispatch.com/news/govt-announces-3-million-in-grants-for-dementia-research 2013-06-12T06:39:22+10:00 https://pharmadispatch.com/news/govt-moves-on-second-brands 2013-06-11T07:03:11+10:00 https://pharmadispatch.com/news/it-is-just-a-process 2013-06-11T07:01:50+10:00 https://pharmadispatch.com/news/countdown-to-cabinet 2013-06-11T06:57:06+10:00 https://pharmadispatch.com/news/bmj-pursues-diabetes-drugs 2013-06-11T06:56:41+10:00 https://pharmadispatch.com/news/tactical-win-for-bms-in-abilify-patent-case 2013-06-11T06:51:45+10:00 https://pharmadispatch.com/news/trials-bayers-eylea 2013-06-11T06:49:40+10:00 https://pharmadispatch.com/news/az-makes-another-acquisition 2013-06-11T06:48:04+10:00 https://pharmadispatch.com/news/reviews-a-radical-change-from-existing-process-senator 2013-06-07T07:09:46+10:00 https://pharmadispatch.com/news/di-natale-picks-apart-post-market-reviews 2013-06-07T07:03:05+10:00 https://pharmadispatch.com/news/we-will-not-be-cowed-on-patent-costs-halton 2013-06-07T06:54:48+10:00 https://pharmadispatch.com/news/mp-industry-has-lost-trust-in-government 2013-06-07T06:52:43+10:00 https://pharmadispatch.com/news/halton-new-chair-of-world-health-assembly 2013-06-07T06:50:44+10:00 https://pharmadispatch.com/news/senator-links-evergreening-to-access-issues 2013-06-06T07:05:09+10:00 https://pharmadispatch.com/news/two-pharma-companies-win-best-employer-accreditation 2013-06-06T07:04:52+10:00 https://pharmadispatch.com/news/almost-1000-drugs-in-development-for-cancer 2013-06-06T07:03:24+10:00 https://pharmadispatch.com/news/cutbacks-a-risk-but-did-they-have-a-choice 2013-06-06T06:53:21+10:00 https://pharmadispatch.com/news/jobs-go-at-ma-as-cost-cuts-drive-new-strategic-focus 2013-06-05T14:08:52+10:00 https://pharmadispatch.com/news/government-will-not-back-di-natale-code-bill 2013-06-05T07:00:17+10:00 https://pharmadispatch.com/news/where-is-the-final-report-of-the-patent-review 2013-06-05T06:58:20+10:00 https://pharmadispatch.com/news/efficacy-of-tnf-inhibitors-a-barrier-for-new-therapies 2013-06-05T06:56:34+10:00 https://pharmadispatch.com/news/ehealth-gaining-momentum-as-more-australians-sign-up-for-pcehr 2013-06-05T06:55:36+10:00 https://pharmadispatch.com/news/asco-update-3-boehringer-ingelheims-nintedanib 2013-06-05T06:52:37+10:00 https://pharmadispatch.com/news/twg-sets-practical-threshold-for-payment-reporting 2013-06-04T07:02:04+10:00 https://pharmadispatch.com/news/psa-seeking-a-wider-role-as-bronger-speaks-out 2013-06-04T06:58:35+10:00 https://pharmadispatch.com/news/csiro-denies-misleading-novartis 2013-06-04T06:56:43+10:00 https://pharmadispatch.com/news/nps-cautions-over-use-of-statins-in-elderly 2013-06-04T06:54:59+10:00 https://pharmadispatch.com/news/eu-fines-nine-companies-over-pay-for-delay 2013-06-04T06:53:28+10:00 https://pharmadispatch.com/news/asco-update-2-novartis-afinitor-bayers-nexavar 2013-06-04T06:49:45+10:00 https://pharmadispatch.com/news/doha-correspondence-highlights-review-process-issues 2013-06-02T22:59:57+10:00 https://pharmadispatch.com/news/consumers-win-as-generic-crestor-hits-the-market 2013-06-02T22:53:54+10:00 https://pharmadispatch.com/news/ian-noble-trust-is-essential-for-reform 2013-06-02T22:50:12+10:00 https://pharmadispatch.com/news/the-private-market-an-alternative-pbs-only-cheaper 2013-06-02T22:41:25+10:00 https://pharmadispatch.com/news/updated-analysis-nz-falls-further-behind-on-access 2013-06-02T22:38:53+10:00 https://pharmadispatch.com/news/high-dose-safety-concerns-over-nsaids 2013-06-02T22:36:18+10:00 https://pharmadispatch.com/news/asco-update-bms-nivolumab-merck-kgaa-erbitux-amgens-t-vec-pfizer 2013-06-02T22:32:19+10:00 https://pharmadispatch.com/news/ma-chief-goes-homeless-for-a-cause 2013-06-02T22:19:49+10:00 https://pharmadispatch.com/news/all-eyes-on-biogens-tecfidera 2013-05-31T07:07:35+10:00 https://pharmadispatch.com/news/cf-patients-take-it-up-to-pm-on-drug-funding 2013-05-31T06:43:45+10:00 https://pharmadispatch.com/news/michael-wonder-of-maestro-database-breaks-down-the-july-pbac-age 2013-05-31T06:39:54+10:00 https://pharmadispatch.com/news/nominations-open-for-shire-brave-awards 2013-05-31T06:36:49+10:00 https://pharmadispatch.com/news/michael-wonder-of-maestro-database-breaks-down-the-july-pbac-age 2013-05-30T07:04:35+10:00 https://pharmadispatch.com/news/major-parties-should-not-prioritise-their-own-funding-over-patie 2013-05-30T07:02:32+10:00 https://pharmadispatch.com/news/patients-anticipate-funding-for-vertex-cf-drug 2013-05-30T07:01:52+10:00 https://pharmadispatch.com/news/pbac-agenda-reveals-independent-review-just-the-third-since-2005 2013-05-29T16:17:44+10:00 https://pharmadispatch.com/news/anao-audit-blow-to-pharmacy 2013-05-29T06:52:19+10:00 https://pharmadispatch.com/news/nps-medicinewise-open-to-paid-work-with-industry 2013-05-29T06:48:01+10:00 https://pharmadispatch.com/news/renewed-political-debate-over-pbs-policy 2013-05-29T06:45:34+10:00 https://pharmadispatch.com/news/pharmaxis-sets-new-path-but-cuts-30-of-staff 2013-05-29T06:42:19+10:00 https://pharmadispatch.com/news/az-acquires-crestor-combo-candidate 2013-05-29T06:38:58+10:00 https://pharmadispatch.com/news/a-pattern-develops-on-reviews 2013-05-28T07:01:24+10:00 https://pharmadispatch.com/news/industry-and-govt-come-to-blows-over-pbs-reports 2013-05-28T06:59:26+10:00 https://pharmadispatch.com/news/transparency-model-agreed 2013-05-28T06:47:52+10:00 https://pharmadispatch.com/news/industry-dismay-over-pbac-diabetes-decision 2013-05-27T07:36:35+10:00 https://pharmadispatch.com/news/industry-deserves-better-than-this 2013-05-27T07:23:11+10:00 https://pharmadispatch.com/news/decision-on-transparency-model-today 2013-05-27T07:20:36+10:00 https://pharmadispatch.com/news/maestro-google-for-market-access 2013-05-27T07:16:07+10:00 https://pharmadispatch.com/news/ma-says-time-to-review-pbs-as-minister-acknowledges-slowing-grow 2013-05-27T07:12:43+10:00 https://pharmadispatch.com/news/medimark-the-future-of-industry-sponsored-medical-education 2013-05-27T06:35:26+10:00 https://pharmadispatch.com/news/tpp-more-time-required-on-ip-and-market-access 2013-05-27T06:25:11+10:00 https://pharmadispatch.com/news/doha-no-link-between-pbac-deferral-and-diabetes-review 2013-05-24T04:27:49+10:00 https://pharmadispatch.com/news/nps-medicinewise-moves-into-medical-tests 2013-05-24T04:00:53+10:00 https://pharmadispatch.com/news/ubs-global-life-sciences-conference-mylan-merck-kgaa 2013-05-24T03:53:44+10:00 https://pharmadispatch.com/news/tga-approves-lillys-cialis-for-urinary-tract-symptoms 2013-05-24T03:46:47+10:00 https://pharmadispatch.com/news/pharmac-gets-the-jump-on-australia-on-consumer-consultation 2013-05-23T07:01:48+10:00 https://pharmadispatch.com/news/ubs-global-life-sciences-conference-amgen-merck-bms-regeneron 2013-05-23T06:49:39+10:00 https://pharmadispatch.com/news/sanofi-and-regeneron-announce-positive-results-for-dupilumab-in- 2013-05-23T06:45:18+10:00 https://pharmadispatch.com/news/research-australia-opens-nominations-for-annual-awards 2013-05-23T06:40:54+10:00 https://pharmadispatch.com/news/gsk-to-cut-120-australian-jobs-with-closure-of-packaging-busines 2013-05-22T12:47:52+10:00 https://pharmadispatch.com/news/guild-2010-reforms-300k-hit-to-pharmacies 2013-05-22T07:06:28+10:00 https://pharmadispatch.com/news/diabetes-review-call-for-submissions-goes-public 2013-05-22T07:04:51+10:00 https://pharmadispatch.com/news/tpp-unlikely-this-year 2013-05-22T07:03:11+10:00 https://pharmadispatch.com/news/pfizer-discontinues-development-of-cancer-drug 2013-05-22T06:54:44+10:00 https://pharmadispatch.com/news/actavis-acquires-warner-chilcott-in-us5-billion-deal 2013-05-21T20:41:54+10:00 https://pharmadispatch.com/news/mercks-insomnia-drug-effective-but-safer-at-lower-dose 2013-05-21T18:24:08+10:00 https://pharmadispatch.com/news/bayers-riociguat-shows-benefits-in-pulmonary-arterial-hypertensi 2013-05-21T17:38:09+10:00 https://pharmadispatch.com/news/industry-and-government-slug-it-out-over-forecasts 2013-05-21T06:49:04+10:00 https://pharmadispatch.com/news/did-anyone-in-govt-actually-read-the-ma-report 2013-05-21T06:48:21+10:00 https://pharmadispatch.com/news/another-20-million-in-az-manufacturing-but-operating-environment 2013-05-21T06:46:09+10:00 https://pharmadispatch.com/news/novartis-afinitor-extends-time-without-disease-progression-in-wo 2013-05-21T06:44:00+10:00 https://pharmadispatch.com/news/government-hits-back-over-ma-report 2013-05-20T11:18:03+10:00 https://pharmadispatch.com/news/ma-debate-over-financial-sustainability-over 2013-05-20T11:03:37+10:00 https://pharmadispatch.com/news/report-cracks-pbs-sustainability-as-savings-flood-govt-coffers 2013-05-20T06:57:39+10:00 https://pharmadispatch.com/news/jody-fassina-statecraft-shifting-the-goalposts-on-pbs-sustainabi 2013-05-20T06:55:25+10:00 https://pharmadispatch.com/news/susanne-fiedler-managing-director-msd-australia-and-nz 2013-05-20T06:53:42+10:00 https://pharmadispatch.com/news/department-defends-post-market-review-process 2013-05-20T06:47:29+10:00 https://pharmadispatch.com/news/department-companies-game-the-system-on-second-brands 2013-05-20T06:45:16+10:00 https://pharmadispatch.com/news/new-trial-shows-bmd-benefit-of-forteo-prolia-in-combo 2013-05-20T06:43:08+10:00 https://pharmadispatch.com/news/asco-and-oncology-trials-bms-melanoma-combo-roches-obinutuzumab- 2013-05-20T06:41:31+10:00 https://pharmadispatch.com/news/artg-allergans-lumigan-and-bms-kombiglyze 2013-05-20T06:38:50+10:00 https://pharmadispatch.com/news/5-3bn-budget-hit-to-pbs-general-and-concessional-categories 2013-05-17T07:04:03+10:00 https://pharmadispatch.com/news/budget-cut-should-end-discussion-on-further-savings 2013-05-17T06:58:04+10:00 https://pharmadispatch.com/news/pharmaxis-heads-to-the-us-for-critical-fda-meeting 2013-05-17T06:49:47+10:00 https://pharmadispatch.com/news/medicines-nz-slams-pharmac-budget 2013-05-17T06:47:36+10:00 https://pharmadispatch.com/news/pbs-undergoing-massive-structural-change 2013-05-16T06:56:30+10:00 https://pharmadispatch.com/news/new-listings-not-keeping-pace-with-savings-as-forecast-heads-sou 2013-05-16T06:53:51+10:00 https://pharmadispatch.com/news/paying-for-zytiga-a-matter-of-life-and-death 2013-05-16T06:50:47+10:00 https://pharmadispatch.com/news/doha-claims-faster-post-pbac-process-under-mou-but-avoids-detail 2013-05-16T06:48:19+10:00 https://pharmadispatch.com/news/govt-cuts-pbs-spend-by-2-8-billion-price-disclosure-to-deliver-3 2013-05-15T07:02:03+10:00 https://pharmadispatch.com/news/another-cut-in-pbs-spending-is-it-opportunity-lost 2013-05-15T06:52:21+10:00 https://pharmadispatch.com/news/doha-funded-for-legal-action 2013-05-15T06:48:03+10:00 https://pharmadispatch.com/news/budget-confirms-innovation-initiatives 2013-05-15T06:46:47+10:00 https://pharmadispatch.com/news/australian-pharmacists-and-bayer-in-world-first 2013-05-15T06:44:43+10:00 https://pharmadispatch.com/news/slow-start-for-global-biosimilar-market-but-growth-will-come 2013-05-15T06:42:23+10:00 https://pharmadispatch.com/news/gsk-pharma-drags-on-australian-result 2013-05-14T15:57:47+10:00 https://pharmadispatch.com/news/the-pbs-budget-numbers-to-look-for-and-where-to-find-them 2013-05-14T07:09:55+10:00 https://pharmadispatch.com/news/dusc-analysis-targets-novartis-gilenya 2013-05-14T07:08:22+10:00 https://pharmadispatch.com/news/guild-opens-a-new-front-in-fight-over-chemo-drugs 2013-05-14T06:53:00+10:00 https://pharmadispatch.com/news/a-twist-for-amgens-vectibix 2013-05-14T06:49:46+10:00 https://pharmadispatch.com/news/tga-calls-for-submissions-on-picmi 2013-05-14T06:45:22+10:00 https://pharmadispatch.com/news/artg-update-erivedge-for-basal-cell-carcinoma 2013-05-14T06:42:25+10:00 https://pharmadispatch.com/news/a-mother-to-the-pm-you-can-open-doors-i-cant 2013-05-13T07:10:07+10:00 https://pharmadispatch.com/news/senate-report-delivers-just-one-recommendation-on-chemo-drugs 2013-05-13T06:49:10+10:00 https://pharmadispatch.com/news/msd-building-an-office-where-people-can-also-have-fun 2013-05-13T06:43:54+10:00 https://pharmadispatch.com/news/tga-updating-protos-pi-following-european-review 2013-05-13T06:42:08+10:00 https://pharmadispatch.com/news/merck-and-gsk-drop-prices-for-hpv-vaccine-in-developing-countrie 2013-05-13T06:37:46+10:00 https://pharmadispatch.com/news/artg-update-roches-perjeta 2013-05-13T06:33:31+10:00 https://pharmadispatch.com/news/what-is-going-on-with-the-guild 2013-05-13T06:22:43+10:00 https://pharmadispatch.com/news/a-downward-revision-is-a-cut 2013-05-11T12:21:47+10:00 https://pharmadispatch.com/news/federal-court-backs-az-in-nexium-patent-case 2013-05-10T16:20:20+10:00 https://pharmadispatch.com/news/savings-are-all-upside-for-government 2013-05-10T05:24:00+10:00 https://pharmadispatch.com/news/chf-and-ma-back-moves-to-enhance-pbac-accountability 2013-05-10T05:17:12+10:00 https://pharmadispatch.com/news/ranbaxy-profit-plummets-90 2013-05-10T05:09:37+10:00 https://pharmadispatch.com/news/australian-office-for-vertex 2013-05-09T18:37:19+10:00 https://pharmadispatch.com/news/pbs-budget-heading-south 2013-05-09T06:46:22+10:00 https://pharmadispatch.com/news/another-cancer-announcement-but-patients-still-waiting-on-medici 2013-05-09T06:41:27+10:00 https://pharmadispatch.com/news/diabetes-roundtable-as-pbac-calls-for-submissions 2013-05-09T06:38:13+10:00 https://pharmadispatch.com/news/sigma-signals-acquisitions-to-offset-impact-of-pbs-cuts 2013-05-09T06:00:10+10:00 https://pharmadispatch.com/news/ma-australians-deserve-better-than-cost-containment 2013-05-08T11:45:26+10:00 https://pharmadispatch.com/news/busting-the-myths-of-pbs-sustainability 2013-05-08T07:13:02+10:00 https://pharmadispatch.com/news/lessons-for-australia-as-scotland-looks-to-community-opinion-on- 2013-05-08T06:52:43+10:00 https://pharmadispatch.com/news/an-important-brake-on-pbac-power 2013-05-08T06:48:42+10:00 https://pharmadispatch.com/news/bayer-hit-back-at-today-tonight 2013-05-07T12:12:23+10:00 https://pharmadispatch.com/news/another-member-departs-pbac-in-disarray 2013-05-07T07:15:14+10:00 https://pharmadispatch.com/news/zelboraf-decision-appalling-and-a-turning-point 2013-05-07T07:01:59+10:00 https://pharmadispatch.com/news/education-program-leads-to-better-pain-management 2013-05-07T06:48:21+10:00 https://pharmadispatch.com/news/pbac-self-destructs-could-history-repeat 2013-05-06T06:04:19+10:00 https://pharmadispatch.com/news/budget-savings-would-not-breach-the-mou 2013-05-06T05:40:59+10:00 https://pharmadispatch.com/news/august-price-cuts-deliver-govt-another-200-million 2013-05-06T05:38:51+10:00 https://pharmadispatch.com/news/beattie-abandon-patent-review 2013-05-06T05:35:09+10:00 https://pharmadispatch.com/news/plibersek-buys-time-on-chemotherapy-drugs 2013-05-06T05:32:52+10:00 https://pharmadispatch.com/news/conscientious-objections-to-immunisation-soar 2013-05-06T05:01:01+10:00 https://pharmadispatch.com/news/artg-update-eliquis-in-atrial-fibrillation 2013-05-06T04:44:44+10:00 https://pharmadispatch.com/news/first-qtr-results-sanofi-shire-gilead-regeneron 2013-05-06T04:30:59+10:00 https://pharmadispatch.com/news/dusc-signals-diabetes-price-cut 2013-05-03T06:49:54+10:00 https://pharmadispatch.com/news/concern-over-antipsychotic-use-in-elderly 2013-05-03T04:21:03+10:00 https://pharmadispatch.com/news/gmia-welcomes-patent-review-but-calls-for-more-specifics 2013-05-03T04:19:10+10:00 https://pharmadispatch.com/news/guild-raises-risk-of-pbs-budget-cuts 2013-05-02T13:47:46+10:00 https://pharmadispatch.com/news/merck-cuts-2013-forecast 2013-05-02T11:19:51+10:00 https://pharmadispatch.com/news/australians-back-zytiga-listing-without-delay 2013-05-02T06:55:04+10:00 https://pharmadispatch.com/news/medicines-nz-report-a-stark-reminder-of-pharmac-realities 2013-05-02T06:50:24+10:00 https://pharmadispatch.com/news/us-industry-rebukes-patent-review-for-disregarding-australias-in 2013-05-02T06:47:26+10:00 https://pharmadispatch.com/news/patent-debate-too-simplistic 2013-05-02T06:43:13+10:00 https://pharmadispatch.com/news/high-demand-forces-biocsl-to-restart-production-of-flu-vaccine 2013-05-01T13:15:03+10:00 https://pharmadispatch.com/news/post-market-reviews-not-unique-to-australia 2013-05-01T11:34:00+10:00 https://pharmadispatch.com/news/facts-get-lost-in-chf-campaign 2013-05-01T04:42:50+10:00 https://pharmadispatch.com/news/ma-patent-review-biased-full-of-factual-errors 2013-05-01T04:34:29+10:00 https://pharmadispatch.com/news/pfizer-trims-forecast-and-looks-to-pipeline-as-patent-expiries-c 2013-05-01T04:00:47+10:00 https://pharmadispatch.com/news/humira-drives-abbvie-growth 2013-04-30T16:31:05+10:00 https://pharmadispatch.com/news/pfizer-and-merck-to-collaborate-on-diabetes 2013-04-30T09:57:24+10:00 https://pharmadispatch.com/news/ma-holding-govt-to-mou-despite-budget-woes 2013-04-30T07:28:51+10:00 https://pharmadispatch.com/news/legislation-not-going-away 2013-04-30T07:28:14+10:00 https://pharmadispatch.com/news/mgsm-targets-pharma-leaders 2013-04-30T06:52:10+10:00 https://pharmadispatch.com/news/senator-scott-ryan-bias-goes-both-ways 2013-04-29T09:46:59+10:00 https://pharmadispatch.com/news/michael-wonder-gives-his-perspective-on-march-pbac-outcomes 2013-04-29T06:50:57+10:00 https://pharmadispatch.com/news/jody-fassina-of-statecraft-dont-forget-the-senate 2013-04-29T06:50:07+10:00 https://pharmadispatch.com/news/dr-mark-tennyson-executive-medical-director-amgen-australia 2013-04-29T06:50:01+10:00 https://pharmadispatch.com/news/families-bewildered-by-myozyme-rejection 2013-04-29T06:50:00+10:00 https://pharmadispatch.com/news/two-code-of-conduct-wins-for-az 2013-04-29T06:49:39+10:00 https://pharmadispatch.com/news/bayers-eylea-approaching-40-market-share 2013-04-29T06:45:32+10:00 https://pharmadispatch.com/news/beattie-urges-industry-not-to-over-react-to-patent-review 2013-04-29T06:44:38+10:00 https://pharmadispatch.com/news/cancer-specialists-unite-on-drug-pricing 2013-04-29T06:42:30+10:00 https://pharmadispatch.com/news/latest-attack-on-industry-all-about-the-timing 2013-04-29T06:38:47+10:00 https://pharmadispatch.com/news/pbac-approves-ru486 2013-04-26T16:04:43+10:00 https://pharmadispatch.com/news/pbs-reforms-impacting-cpi 2013-04-26T07:03:18+10:00 https://pharmadispatch.com/news/another-blow-for-pharmaxis-as-bronchitol-misses-trial-endpoint 2013-04-26T07:00:51+10:00 https://pharmadispatch.com/news/mixed-results-as-companies-battle-patent-cliff-gsk-bi-nvs-lilly- 2013-04-26T06:59:21+10:00 https://pharmadispatch.com/news/govt-uses-40-price-cut-to-end-six-month-rule-for-alzheimers-medi 2013-04-24T07:11:23+10:00 https://pharmadispatch.com/news/api-outlook-dominated-by-industry-headwinds 2013-04-24T07:08:24+10:00 https://pharmadispatch.com/news/amgen-profit-grows-as-prolia-sales-surge 2013-04-24T07:05:32+10:00 https://pharmadispatch.com/news/is-anymore-evidence-required-to-confirm-that-reviews-are-all-abo 2013-04-24T07:00:29+10:00 https://pharmadispatch.com/news/qa-health-debate-confirms-the-challenge-for-industry 2013-04-23T07:04:45+10:00 https://pharmadispatch.com/news/losses-mount-for-ranbaxy-australia-with-another-8-million-in-201 2013-04-23T06:57:45+10:00 https://pharmadispatch.com/news/australian-patents-shifting-from-europe-to-asia 2013-04-23T06:55:32+10:00 https://pharmadispatch.com/news/reissued-ims-letter-refutes-attacks-on-data-collection-program 2013-04-23T06:50:46+10:00 https://pharmadispatch.com/news/beattie-plays-down-patent-review 2013-04-22T06:48:41+10:00 https://pharmadispatch.com/news/harvey-backs-ma-transparency-model-to-senate-inquiry 2013-04-22T06:48:18+10:00 https://pharmadispatch.com/news/zippy-is-this-the-future-of-pharmacy 2013-04-22T06:42:43+10:00 https://pharmadispatch.com/news/australia-welcomes-japan-to-tpp-negotiations 2013-04-22T06:40:36+10:00 https://pharmadispatch.com/news/rare-diseases-growing-a-voice 2013-04-22T06:39:04+10:00 https://pharmadispatch.com/news/ims-clarifies-confusion-over-dr-letter 2013-04-22T06:37:45+10:00 https://pharmadispatch.com/news/rd-productivity-since-2003 2013-04-22T06:35:16+10:00 https://pharmadispatch.com/news/artg-update-3 2013-04-22T06:34:26+10:00 https://pharmadispatch.com/news/new-price-disclosure-regulations-take-effect 2013-04-19T06:55:27+10:00 https://pharmadispatch.com/news/api-grows-pharmacy-footprint-as-pbs-reforms-deliver-96-million-d 2013-04-19T06:53:39+10:00 https://pharmadispatch.com/news/jj-delivers-strong-first-quarter-on-the-back-of-prescription-dru 2013-04-19T06:47:02+10:00 https://pharmadispatch.com/news/governments-welcome-progress-towards-joint-regulatory-agency 2013-04-19T06:39:43+10:00 https://pharmadispatch.com/news/ceda-report-littered-with-factual-errors 2013-04-18T07:20:52+10:00 https://pharmadispatch.com/news/is-the-clock-ticking-down-on-a-new-round-of-reform 2013-04-18T07:20:48+10:00 https://pharmadispatch.com/news/1-in-5-hmrs-done-outside-the-home 2013-04-18T07:20:44+10:00 https://pharmadispatch.com/news/calls-for-pbs-reform-get-louder-as-ceda-joins-debate 2013-04-17T07:06:08+10:00 https://pharmadispatch.com/news/dusc-targets-ms-therapies 2013-04-17T07:03:25+10:00 https://pharmadispatch.com/news/panel-recommends-breast-cancer-medicines-for-healthy-women 2013-04-17T06:49:19+10:00 https://pharmadispatch.com/news/pharmacist-union-farewells-guild-president 2013-04-17T06:45:52+10:00 https://pharmadispatch.com/news/chf-calls-for-reform-of-pharmacy-agreement 2013-04-17T06:44:38+10:00 https://pharmadispatch.com/news/sclavos-to-steps-down-to-avoid-political-distractions 2013-04-16T06:06:04+10:00 https://pharmadispatch.com/news/new-guild-president-facing-a-perfect-storm-of-challenges 2013-04-16T06:04:48+10:00 https://pharmadispatch.com/news/gmia-govt-to-bank-3-billion-in-savings-from-recent-patent-cases 2013-04-16T05:59:24+10:00 https://pharmadispatch.com/news/amwg-meeting-re-energises-relationship 2013-04-15T06:32:39+10:00 https://pharmadispatch.com/news/cmi-flop-not-educational-or-patient-focussed 2013-04-15T06:28:49+10:00 https://pharmadispatch.com/news/cmi-research-is-more-evidence-of-the-urgent-need-for-change 2013-04-15T06:24:12+10:00 https://pharmadispatch.com/news/department-faces-questions-on-reviews-lyrica-and-the-life-saving 2013-04-15T06:20:40+10:00 https://pharmadispatch.com/news/duckett-backs-cut-to-drug-patents 2013-04-15T06:16:05+10:00 https://pharmadispatch.com/news/patent-review-unrealistic-on-directing-rd 2013-04-15T06:12:37+10:00 https://pharmadispatch.com/news/artg-update-sanofis-glp-1-agonist 2013-04-15T06:07:30+10:00 https://pharmadispatch.com/news/ausbiotech-backs-mckeon-and-hits-out-at-pharma-patent-review 2013-04-12T07:23:33+10:00 https://pharmadispatch.com/news/children-at-risk-call-for-sanctions-against-anti-vaccination-gro 2013-04-12T07:16:41+10:00 https://pharmadispatch.com/news/budget-games-on-medical-research 2013-04-12T07:07:26+10:00 https://pharmadispatch.com/news/only-the-good-parts-of-the-mou-expire-next-year 2013-04-11T07:06:20+10:00 https://pharmadispatch.com/news/govt-rejects-1-million-loss-claim-on-chemo-drugs 2013-04-11T06:59:36+10:00 https://pharmadispatch.com/news/new-clinical-trial-for-bronchitol-as-pharmaxis-acts-to-reduce-co 2013-04-11T06:58:00+10:00 https://pharmadispatch.com/news/chf-slams-aat-decision-on-painkillers 2013-04-11T06:49:13+10:00 https://pharmadispatch.com/news/ma-and-gmia-clash-again 2013-04-10T07:08:48+10:00 https://pharmadispatch.com/news/boost-for-bms-az-diabetes-partnership-as-exenatide-transition-co 2013-04-10T07:06:28+10:00 https://pharmadispatch.com/news/qld-to-raise-patent-review-with-federal-govt 2013-04-10T06:59:31+10:00 https://pharmadispatch.com/news/reduced-co-pay-take-for-govt-leads-to-pbac-rejection 2013-04-09T07:04:21+10:00 https://pharmadispatch.com/news/gmia-chairman-patent-reform-an-opportunity-for-savings-in-upcomi 2013-04-09T06:56:03+10:00 https://pharmadispatch.com/news/industry-calls-for-urgent-action-on-clinical-trials 2013-04-09T06:53:15+10:00 https://pharmadispatch.com/news/critics-ramp-up-industry-attacks-with-plan-for-govt-takeover-of- 2013-04-08T07:09:04+10:00 https://pharmadispatch.com/news/big-week-for-ma-with-amwg-meeting-and-board-retreat 2013-04-08T07:04:16+10:00 https://pharmadispatch.com/news/confused-about-the-govts-position-on-ip-you-wouldnt-be-alone 2013-04-08T07:01:12+10:00 https://pharmadispatch.com/news/mckeon-review-go-beyond-ctag-recommendations-to-keep-australia-c 2013-04-08T06:58:52+10:00 https://pharmadispatch.com/news/patent-report-delivered-with-little-involvement-by-doha 2013-04-08T06:56:43+10:00 https://pharmadispatch.com/news/artg-update-2 2013-04-08T06:54:26+10:00 https://pharmadispatch.com/news/new-website-and-app-to-promote-comparison-of-reimbursement-syste 2013-04-05T07:02:21+11:00 https://pharmadispatch.com/news/gruen-we-would-have-gone-even-further 2013-04-05T07:00:21+11:00 https://pharmadispatch.com/news/patent-victory-for-bayer 2013-04-05T06:51:28+11:00 https://pharmadispatch.com/news/patent-report-triggers-ferocious-debate-as-gruen-defends-recomme 2013-04-04T07:44:37+11:00 https://pharmadispatch.com/news/a-tough-year-for-pharma-as-rd-and-manufacturing-hang-on 2013-04-04T07:41:19+11:00 https://pharmadispatch.com/news/lifestyle-factors-fuelling-the-fire-of-liver-disease 2013-04-04T07:38:37+11:00 https://pharmadispatch.com/news/govt-urged-to-stop-fiddling-on-anticoagulants 2013-04-03T06:31:44+11:00 https://pharmadispatch.com/news/govt-patent-report-delivers-a-stunning-blow-to-innovators 2013-04-03T06:27:16+11:00 https://pharmadispatch.com/news/patent-report-a-victory-for-generic-sector-but-where-to-from-her 2013-04-03T06:24:26+11:00 https://pharmadispatch.com/news/tga-medicines-safety-update 2013-04-03T04:32:16+11:00 https://pharmadispatch.com/news/finally-pbac-resolution-for-anticoagulants 2013-04-02T07:12:13+11:00 https://pharmadispatch.com/news/anticoagulants-a-political-opportunity-for-minister 2013-04-02T07:12:07+11:00 https://pharmadispatch.com/news/another-day-another-pbac-departure 2013-04-02T07:01:47+11:00 https://pharmadispatch.com/news/transparency-group-make-progress-on-payment-disclosure-model 2013-04-02T06:56:35+11:00 https://pharmadispatch.com/news/gsk-spending-announcement-a-sign-of-things-to-come 2013-04-02T06:54:19+11:00 https://pharmadispatch.com/news/more-good-news-for-biogens-oral-ms-therapy 2013-04-02T06:51:10+11:00 https://pharmadispatch.com/news/submissions-to-chemo-drug-inquiry-call-for-more-funding 2013-03-28T07:16:57+11:00 https://pharmadispatch.com/news/the-real-thing-to-raise-hep-c-awareness 2013-03-28T07:04:01+11:00 https://pharmadispatch.com/news/ma-goes-digital-with-code-ipad-app 2013-03-28T06:58:56+11:00 https://pharmadispatch.com/news/confusion-over-pbac-decision-on-ru486 2013-03-27T07:19:43+11:00 https://pharmadispatch.com/news/di-natale-cautions-industry-on-code-bill 2013-03-27T06:58:15+11:00 https://pharmadispatch.com/news/neumann-excited-about-the-challenge-in-health-as-industry-welcom 2013-03-26T06:53:23+11:00 https://pharmadispatch.com/news/bayers-eylea-secures-30-market-share-in-just-third-month 2013-03-26T06:51:12+11:00 https://pharmadispatch.com/news/experts-say-debate-on-adhd-medication-particularly-unhelpful 2013-03-26T06:47:46+11:00 https://pharmadispatch.com/news/march-to-put-melanoma-on-national-agenda 2013-03-26T06:45:28+11:00 https://pharmadispatch.com/news/prime-minister-promotes-co-chair-of-parliamentary-friends-of-med 2013-03-25T12:52:05+11:00 https://pharmadispatch.com/news/originators-come-out-on-top-in-pbac-substitution-battle-2 2013-03-25T07:15:18+11:00 https://pharmadispatch.com/news/evidence-of-who-really-speaks-for-patients 2013-03-25T07:13:10+11:00 https://pharmadispatch.com/news/nz-warns-against-adoption-of-grattan-institute-proposals 2013-03-25T07:10:21+11:00 https://pharmadispatch.com/news/nz-patients-pharmac-lacks-a-sense-of-equity-and-fairness 2013-03-25T07:06:14+11:00 https://pharmadispatch.com/news/big-news-week-for-ms-therapies 2013-03-25T06:54:04+11:00 https://pharmadispatch.com/news/guild-calls-on-govt-to-scrap-monthly-pbs-claims-processing-data 2013-03-24T12:14:37+11:00 https://pharmadispatch.com/news/senate-inquiry-spells-t-r-o-u-b-l-e-for-industry 2013-03-22T07:33:06+11:00 https://pharmadispatch.com/news/another-2300-jobs-to-go-at-az-as-soriot-announces-new-global-str 2013-03-22T07:24:06+11:00 https://pharmadispatch.com/news/prima-taps-german-research-funds-to-support-cvac-development 2013-03-22T07:22:37+11:00 https://pharmadispatch.com/news/breaking-news-di-natale-secures-senate-inquiry-for-code-legislat 2013-03-21T11:48:06+11:00 https://pharmadispatch.com/news/minister-too-much-certainty-is-not-a-good-thing 2013-03-20T23:06:21+11:00 https://pharmadispatch.com/news/ma-chair-sets-a-new-tone-on-industry-priorities 2013-03-20T23:04:16+11:00 https://pharmadispatch.com/news/industry-looking-for-a-post-mou-agenda 2013-03-20T23:02:46+11:00 https://pharmadispatch.com/news/john-young-end-the-policy-diversions 2013-03-20T23:00:20+11:00 https://pharmadispatch.com/news/a-system-under-pressure-as-another-pbac-member-departs 2013-03-20T07:37:42+11:00 https://pharmadispatch.com/news/az-focuses-global-rd-effort-as-more-jobs-go 2013-03-20T07:29:49+11:00 https://pharmadispatch.com/news/blow-for-pharmaxis-as-fda-rejects-bronchitol 2013-03-20T07:26:35+11:00 https://pharmadispatch.com/news/first-head-to-head-trial-for-ra-biologics-delivers-for-roche 2013-03-20T07:06:54+11:00 https://pharmadispatch.com/news/patient-groups-back-portal-for-patient-support-programs 2013-03-20T07:02:09+11:00 https://pharmadispatch.com/news/mp-pbac-is-politicised-damaged-and-compromised 2013-03-19T07:39:12+11:00 https://pharmadispatch.com/news/pricing-debate-reveals-divide-as-govt-sides-with-industry 2013-03-19T07:37:59+11:00 https://pharmadispatch.com/news/mp-speaks-with-authority-on-pbs-issues 2013-03-19T07:35:09+11:00 https://pharmadispatch.com/news/stroke-foundation-calls-for-action-as-burden-of-disease-hits-50- 2013-03-19T07:00:03+11:00 https://pharmadispatch.com/news/industry-unites-to-reject-grattan-institute-proposal 2013-03-18T06:35:44+11:00 https://pharmadispatch.com/news/grattan-institute-over-simplifies-and-cherry-picks-pharmac 2013-03-18T06:34:02+11:00 https://pharmadispatch.com/news/greens-raise-the-possibility-of-not-proceeding-with-code-legisla 2013-03-18T06:31:39+11:00 https://pharmadispatch.com/news/govt-avoids-wholesale-changes-to-pbac-while-opposition-slams-lac 2013-03-18T06:30:31+11:00 https://pharmadispatch.com/news/gsk-1-billion-price-tag-for-new-drugs-a-myth 2013-03-18T06:29:04+11:00 https://pharmadispatch.com/news/deaths-from-heart-disease-continue-to-fall 2013-03-18T06:26:21+11:00 https://pharmadispatch.com/news/progress-on-tpp-as-japan-joins-negotiations-but-ip-remains-an-is 2013-03-18T06:24:38+11:00 https://pharmadispatch.com/news/researchers-urge-caution-on-hiv-functional-cure-study 2013-03-18T06:22:53+11:00 https://pharmadispatch.com/news/guild-under-attack-again 2013-03-17T12:14:39+11:00 https://pharmadispatch.com/news/the-lack-of-transparency-in-pbac-appointments-is-a-problem 2013-03-15T07:06:58+11:00 https://pharmadispatch.com/news/sigma-takes-85-million-hit-from-pbs-reforms 2013-03-15T07:01:51+11:00 https://pharmadispatch.com/news/cipla-opens-regional-office-in-melbourne 2013-03-15T06:59:51+11:00 https://pharmadispatch.com/news/new-pbac-appointments-shrouded-in-a-lack-of-transparency 2013-03-14T13:35:06+11:00 https://pharmadispatch.com/news/nps-chair-a-wider-role-and-more-sources-of-income 2013-03-14T07:02:33+11:00 https://pharmadispatch.com/news/internet-pharmacy-is-good-for-consumers-and-should-not-be-demoni 2013-03-14T06:53:14+11:00 https://pharmadispatch.com/news/ma-warning-on-internet-pharmacy 2013-03-14T06:51:09+11:00 https://pharmadispatch.com/news/transparency-group-meets-to-considers-draft-model-today 2013-03-13T07:19:36+11:00 https://pharmadispatch.com/news/gonorrhea-infects-nps-policy-priorities 2013-03-13T07:18:03+11:00 https://pharmadispatch.com/news/novartis-alumni-takes-the-reins-at-pharmaxis-business-model-unde 2013-03-13T07:06:26+11:00 https://pharmadispatch.com/news/diabetes-review-submissions-more-funding-for-insulin-pumps 2013-03-13T07:03:57+11:00 https://pharmadispatch.com/news/nps-goes-where-it-should-not 2013-03-12T06:52:53+11:00 https://pharmadispatch.com/news/govt-tells-cancer-patients-to-ask-for-freebies 2013-03-12T06:41:37+11:00 https://pharmadispatch.com/news/industry-survey-confirms-clinical-trial-delays 2013-03-12T06:37:48+11:00 https://pharmadispatch.com/news/change-pharmacy-agreement-negotiations-says-psa 2013-03-12T06:35:15+11:00 https://pharmadispatch.com/news/the-policy-disconnect-on-diabetes-medicines 2013-03-11T07:15:51+11:00 https://pharmadispatch.com/news/anticoagulants-on-the-agenda-as-election-approaches 2013-03-11T07:13:55+11:00 https://pharmadispatch.com/news/pbac-sanofi-and-az-battle-generics 2013-03-11T07:09:53+11:00 https://pharmadispatch.com/news/new-pbs-savings-a-real-risk-says-guild 2013-03-11T07:07:40+11:00 https://pharmadispatch.com/news/guild-vindicated-with-changes-to-home-medicines-review 2013-03-11T07:05:21+11:00 https://pharmadispatch.com/news/aussie-apathy-on-health-overweight-and-relaxed-about-it 2013-03-11T07:03:04+11:00 https://pharmadispatch.com/news/more-aussies-on-vitamins-than-prescription-medicines 2013-03-11T07:01:49+11:00 https://pharmadispatch.com/news/artg-update-alphapharm-lines-up-for-crestor-market 2013-03-11T06:57:42+11:00 https://pharmadispatch.com/news/a-new-front-opens-in-ma-gmia-battle 2013-03-08T07:20:23+11:00 https://pharmadispatch.com/news/doha-would-be-enjoying-the-fight 2013-03-08T07:18:43+11:00 https://pharmadispatch.com/news/rare-event-triggers-product-notification-for-gsk-flu-vaccine 2013-03-08T06:50:45+11:00 https://pharmadispatch.com/news/australians-happy-with-their-own-health-and-their-gp 2013-03-08T06:49:35+11:00 https://pharmadispatch.com/news/govt-has-no-case-for-compensation-on-crestor-but-what-about-refo 2013-03-07T07:08:48+11:00 https://pharmadispatch.com/news/gmia-pursue-compensation-and-reform-patent-laws 2013-03-07T06:49:43+11:00 https://pharmadispatch.com/news/pharmacy-the-big-winner-and-they-know-it 2013-03-07T06:47:01+11:00 https://pharmadispatch.com/news/new-course-in-health-pr 2013-03-07T06:38:51+11:00 https://pharmadispatch.com/news/judge-slams-attack-on-expert-witness 2013-03-06T07:11:35+11:00 https://pharmadispatch.com/news/tough-times-for-az-as-crestor-generics-ready-for-launch 2013-03-06T07:09:21+11:00 https://pharmadispatch.com/news/mesoblasts-boosts-cash-to-support-development 2013-03-06T07:06:13+11:00 https://pharmadispatch.com/news/consumers-win-as-private-prescriptions-easily-beat-pbs-on-price 2013-03-05T07:08:06+11:00 https://pharmadispatch.com/news/gsk-rejects-committees-push-for-charitable-foundation 2013-03-05T06:57:54+11:00 https://pharmadispatch.com/news/prana-jumps-as-new-data-boosts-pbt2-alzheimers-treatment 2013-03-05T06:55:42+11:00 https://pharmadispatch.com/news/companies-go-political-over-post-market-reviews 2013-03-04T07:15:08+11:00 https://pharmadispatch.com/news/why-no-coalition-commitment-on-the-mou-is-a-problem 2013-03-04T07:00:07+11:00 https://pharmadispatch.com/news/bayers-eylea-makes-a-strong-start 2013-03-04T06:58:33+11:00 https://pharmadispatch.com/news/qld-health-blueprint-talks-up-clinical-trials 2013-03-04T06:57:22+11:00 https://pharmadispatch.com/news/di-natale-legislation-a-pressure-point 2013-03-04T06:57:03+11:00 https://pharmadispatch.com/news/profit-fall-hits-blackmores 2013-03-04T06:56:06+11:00 https://pharmadispatch.com/news/nps-miss-on-side-effects 2013-03-04T06:55:11+11:00 https://pharmadispatch.com/news/martin-cross-what-happens-when-the-music-stops 2013-03-01T05:55:53+11:00 https://pharmadispatch.com/news/report-highlights-impact-of-pain-on-relationships 2013-03-01T05:52:35+11:00 https://pharmadispatch.com/news/coalition-hits-out-on-mou-but-does-not-commit 2013-02-28T06:11:51+11:00 https://pharmadispatch.com/news/lilly-partnership-delivers-for-acrux 2013-02-28T06:10:02+11:00 https://pharmadispatch.com/news/chf-meets-gmia-but-remains-non-committal-on-substitution-proposa 2013-02-27T07:18:47+11:00 https://pharmadispatch.com/news/ranbaxy-result-hit-by-recall 2013-02-27T07:16:59+11:00 https://pharmadispatch.com/news/ausbiotech-cautious-on-anztpa-implementation-paper 2013-02-27T07:15:56+11:00 https://pharmadispatch.com/news/debate-heats-up-but-what-now 2013-02-26T07:05:34+11:00 https://pharmadispatch.com/news/pipeline-setback-for-merck-serono 2013-02-26T07:03:09+11:00 https://pharmadispatch.com/news/remove-interim-from-the-job-title 2013-02-26T06:43:37+11:00 https://pharmadispatch.com/news/ma-invokes-mou-as-review-and-generics-deliver-56-price-cut-to-pf 2013-02-25T06:54:35+11:00 https://pharmadispatch.com/news/post-market-reviews-make-a-mockery-of-the-mou 2013-02-25T06:53:03+11:00 https://pharmadispatch.com/news/generic-industry-comes-out-swinging 2013-02-25T06:50:30+11:00 https://pharmadispatch.com/news/tga-expects-delays-in-key-reforms 2013-02-25T06:48:08+11:00 https://pharmadispatch.com/news/lyrica-hits-endpoint-in-epilepsy-trial 2013-02-25T06:47:02+11:00 https://pharmadispatch.com/news/guild-to-survey-membership-on-issues-for-next-agreement 2013-02-25T06:45:47+11:00 https://pharmadispatch.com/news/artg-update 2013-02-25T06:43:20+11:00 https://pharmadispatch.com/news/opportunities-for-industry-as-political-debate-turns-to-health 2013-02-22T07:43:52+11:00 https://pharmadispatch.com/news/ausbiotech-back-pc-findings-on-compulsory-licensing 2013-02-22T07:16:33+11:00 https://pharmadispatch.com/news/medicines-australia-parliamentary-dinner-chair-mark-fladrich 2013-02-21T13:21:04+11:00 https://pharmadispatch.com/news/fladrich-appointment-could-prove-a-masterstroke 2013-02-21T07:43:29+11:00 https://pharmadispatch.com/news/criticism-of-price-increases-off-the-mark 2013-02-21T07:06:57+11:00 https://pharmadispatch.com/news/consumers-want-more-participation-in-research 2013-02-21T07:05:19+11:00 https://pharmadispatch.com/news/new-chair-for-ma 2013-02-20T07:29:20+11:00 https://pharmadispatch.com/news/no-listing-date-and-then-a-listing-date 2013-02-20T07:28:44+11:00 https://pharmadispatch.com/news/update-post-pbac-listing-times-under-the-mou 2013-02-20T07:26:12+11:00 https://pharmadispatch.com/news/cabinet-approves-hep-c-medicines-2 2013-02-20T07:24:56+11:00 https://pharmadispatch.com/news/chfs-own-goal-on-transparency 2013-02-19T07:07:47+11:00 https://pharmadispatch.com/news/health-funds-favour-homeopathy-and-herbalism-over-prescriptions 2013-02-19T07:04:39+11:00 https://pharmadispatch.com/news/chf-dodges-transparency-again 2013-02-19T07:03:33+11:00 https://pharmadispatch.com/news/innovation-statements-makes-clear-that-govt-purchasing-impacts-i 2013-02-18T07:42:42+11:00 https://pharmadispatch.com/news/gmia-fights-to-set-the-agenda 2013-02-18T07:39:47+11:00 https://pharmadispatch.com/news/just-a-type-of-rat-poison-says-mp 2013-02-18T07:37:41+11:00 https://pharmadispatch.com/news/barnes-transparency-principles-finalised 2013-02-18T07:36:29+11:00 https://pharmadispatch.com/news/patent-system-in-systemic-failure-according-to-generics-industry 2013-02-18T07:26:38+11:00 https://pharmadispatch.com/news/industry-hits-back-at-pbac-chair 2013-02-18T07:21:36+11:00 https://pharmadispatch.com/news/ma-hits-back-at-department-over-evergreening-claims 2013-02-15T07:39:54+11:00 https://pharmadispatch.com/news/senator-richard-di-natale-an-honest-broker 2013-02-15T07:25:51+11:00 https://pharmadispatch.com/news/ma-and-gmia-come-to-blows 2013-02-15T07:12:44+11:00 https://pharmadispatch.com/news/seven-policy-options-of-the-gmia 2013-02-14T08:32:31+11:00 https://pharmadispatch.com/news/gmia-remove-originators-from-the-pbs-and-save-200-million 2013-02-14T06:46:53+11:00 https://pharmadispatch.com/news/patients-could-be-waiting-for-new-presentations 2013-02-14T06:44:16+11:00 https://pharmadispatch.com/news/senator-this-is-a-cheap-shot 2013-02-14T06:32:22+11:00 https://pharmadispatch.com/news/immunisation-strategy-3-years-late-and-delayed-again 2013-02-14T06:25:46+11:00 https://pharmadispatch.com/news/record-result-for-csl 2013-02-14T06:23:39+11:00 https://pharmadispatch.com/news/another-day-another-review 2013-02-13T07:03:55+11:00 https://pharmadispatch.com/news/in-conversation-with-andrew-carter-managing-director-commercial- 2013-02-13T07:00:01+11:00 https://pharmadispatch.com/news/amgen-and-ucb-focus-on-post-menopausal-osteoporosis 2013-02-13T06:30:43+11:00 https://pharmadispatch.com/news/gmia-options-paper-looking-beyond-the-election 2013-02-12T07:29:38+11:00 https://pharmadispatch.com/news/gmia-scrap-price-disclosure-and-introduce-barriers-to-originator 2013-02-12T07:25:00+11:00 https://pharmadispatch.com/news/cabinet-d-day-for-hep-c-medicines 2013-02-12T07:13:23+11:00 https://pharmadispatch.com/news/no-moratorium-but-hmrs-to-be-reviewed 2013-02-12T07:08:33+11:00 https://pharmadispatch.com/news/new-leader-for-pfizer-australia 2013-02-11T15:58:23+11:00 https://pharmadispatch.com/news/countdown-closing-in-on-cabinet-consideration 2013-02-11T07:06:01+11:00 https://pharmadispatch.com/news/tga-reaffirms-benefits-of-pradaxa 2013-02-11T07:00:59+11:00 https://pharmadispatch.com/news/battle-over-patent-term-extension-gets-public-hearing 2013-02-11T06:59:43+11:00 https://pharmadispatch.com/news/late-stage-pipeline-and-emerging-markets-the-key-for-gsk 2013-02-11T06:57:39+11:00 https://pharmadispatch.com/news/growth-platforms-deliver-for-sanofi 2013-02-11T06:54:40+11:00 https://pharmadispatch.com/news/have-emerging-markets-emerged 2013-02-10T15:35:51+11:00 https://pharmadispatch.com/news/govt-budgets-another-640-million-saving-on-chemo-drugs 2013-02-08T07:06:51+11:00 https://pharmadispatch.com/news/six-months-to-cabinet-but-not-to-listing 2013-02-08T07:01:31+11:00 https://pharmadispatch.com/news/govt-no-evidence-that-discounting-is-higher-in-first-month 2013-02-08T06:59:47+11:00 https://pharmadispatch.com/news/industry-frustration-over-gaming-of-mou 2013-02-07T06:59:40+11:00 https://pharmadispatch.com/news/more-industry-critics-join-ma-transparency-group 2013-02-07T06:50:29+11:00 https://pharmadispatch.com/news/record-export-performance-despite-difficult-business-environment 2013-02-07T06:40:46+11:00 https://pharmadispatch.com/news/govt-wants-massive-price-cut-for-medicines-to-treat-alzheimers-d 2013-02-06T07:31:53+11:00 https://pharmadispatch.com/news/estimated-2011-12-pbs-spend-was-wrong-by-358-million 2013-02-05T12:13:32+11:00 https://pharmadispatch.com/news/ausbiotech-joins-ma-fight-against-govt-on-new-presentations 2013-02-05T07:01:03+11:00 https://pharmadispatch.com/news/organisations-lining-up-against-the-guild-on-hmrs-and-everything 2013-02-05T06:57:22+11:00 https://pharmadispatch.com/news/patient-groups-urge-listing-without-delay 2013-02-05T06:54:17+11:00 https://pharmadispatch.com/news/expert-calls-for-review-of-pbs-co-payment-structure 2013-02-05T06:49:52+11:00 https://pharmadispatch.com/news/ma-calls-for-ministerial-intervention-as-australian-patients-mis 2013-02-04T07:20:10+11:00 https://pharmadispatch.com/news/agreement-its-a-problem-but-solution-could-be-hard-to-find 2013-02-04T07:18:42+11:00 https://pharmadispatch.com/news/countdown-20-days-to-meet-mou-cabinet-commitment 2013-02-04T07:00:42+11:00 https://pharmadispatch.com/news/nps-dismisses-guild-call-on-home-medicine-reviews 2013-02-04T06:57:03+11:00 https://pharmadispatch.com/news/more-change-on-the-way-at-az 2013-02-04T06:55:36+11:00 https://pharmadispatch.com/news/merck-delays-osteoporosis-drug 2013-02-04T06:53:12+11:00 https://pharmadispatch.com/news/ma-budget-submission-social-compact-under-pressure 2013-02-01T09:31:17+11:00 https://pharmadispatch.com/news/publication-of-pbac-agenda-sparks-potential-patent-dispute 2013-02-01T07:16:34+11:00 https://pharmadispatch.com/news/fda-committee-sends-pharmaxis-back-to-the-drawing-board 2013-02-01T07:05:02+11:00 https://pharmadispatch.com/news/medicines-australia-welcome-coalition-commitment-on-pbs 2013-01-31T15:33:31+11:00 https://pharmadispatch.com/news/doctors-and-pharmacists-fight-it-out-over-online-poll 2013-01-31T12:46:16+11:00 https://pharmadispatch.com/news/doha-response-on-listing-delays-masks-bigger-story 2013-01-31T07:37:43+11:00 https://pharmadispatch.com/news/substitution-battle-heads-to-pbac 2013-01-31T07:36:01+11:00 https://pharmadispatch.com/news/election-announcement-with-implications-for-the-pharmaceutical-s 2013-01-30T14:40:15+11:00 https://pharmadispatch.com/news/cabinet-and-share-of-voice 2013-01-30T07:56:47+11:00 https://pharmadispatch.com/news/pfizer-weathering-patent-losses-and-building-pipeline 2013-01-30T07:49:32+11:00 https://pharmadispatch.com/news/lilly-beats-expectations-on-the-back-of-new-products-and-cost-co 2013-01-30T07:47:21+11:00 https://pharmadispatch.com/news/api-usual-distribution-operations-despite-flood 2013-01-30T07:45:53+11:00 https://pharmadispatch.com/news/politics-and-personal-relationships-key-to-cabinet-process 2013-01-29T07:46:18+11:00 https://pharmadispatch.com/news/anticoagulant-review-a-bargain-for-government 2013-01-29T07:29:02+11:00 https://pharmadispatch.com/news/complementary-medicines-strike-out-in-compliance-audits 2013-01-29T07:24:34+11:00 https://pharmadispatch.com/news/a-busy-time-of-transition-for-bms 2013-01-29T07:21:41+11:00 https://pharmadispatch.com/news/i-have-discretion-on-price-disclosure-process-minister-tells-cou 2013-01-25T07:27:05+11:00 https://pharmadispatch.com/news/what-do-the-supermarkets-think-about-pharmacy-growing-their-reta 2013-01-25T07:23:45+11:00 https://pharmadispatch.com/news/health-and-beauty-the-key-to-future-growth-for-api 2013-01-25T07:21:13+11:00 https://pharmadispatch.com/news/new-general-manager-for-lilly-australia-nz 2013-01-24T08:14:04+11:00 https://pharmadispatch.com/news/fourth-quarter-reports-jj-novartis-amgen 2013-01-24T08:12:47+11:00 https://pharmadispatch.com/news/australian-isolation-on-anticoagulants-as-uk-nice-backs-eliquis 2013-01-24T07:21:34+11:00 https://pharmadispatch.com/news/consumer-pharmaceutical-prices-fall-again-but-it-is-not-what-it- 2013-01-24T07:18:32+11:00 https://pharmadispatch.com/news/round-2-apesma-and-the-pharmacy-guild 2013-01-23T08:22:30+11:00 https://pharmadispatch.com/news/hand-written-code-complaint-frustrates-all-involved 2013-01-23T08:21:10+11:00 https://pharmadispatch.com/news/tga-publishes-evidence-in-response-to-criticism-of-labelling-and 2013-01-23T07:46:39+11:00 https://pharmadispatch.com/news/aspirin-link-to-macular-degeneration 2013-01-23T07:41:35+11:00 https://pharmadispatch.com/news/over-9-million-in-government-funding-for-the-chf 2013-01-22T07:50:45+11:00 https://pharmadispatch.com/news/ama-scrap-pbs-authority-system 2013-01-22T07:37:45+11:00 https://pharmadispatch.com/news/guild-rejects-claims-of-a-culture-of-underpayments 2013-01-22T07:32:53+11:00 https://pharmadispatch.com/news/draconian-laws-the-next-move-against-industry-sales 2013-01-21T07:31:42+11:00 https://pharmadispatch.com/news/risks-and-opportunity-in-an-election-year 2013-01-21T07:27:24+11:00 https://pharmadispatch.com/news/pharmaleaders-kirsten-odoherty-managing-director-abbvie-australi 2013-01-21T07:19:13+11:00 https://pharmadispatch.com/news/the-focus-is-innovation-at-abbvie-australia 2013-01-21T07:16:57+11:00 https://pharmadispatch.com/news/nps-backs-champix-safety 2013-01-21T07:14:30+11:00 https://pharmadispatch.com/news/amgen-targets-asia-pacific-with-singapore-investment 2013-01-21T07:13:19+11:00 https://pharmadispatch.com/news/support-grows-for-pbs-listing-of-hep-c-medicines 2013-01-18T08:18:41+11:00 https://pharmadispatch.com/news/nps-encourages-pharmacists-to-educate-consumers-about-generics 2013-01-18T08:14:14+11:00 https://pharmadispatch.com/news/tga-wants-better-communication 2013-01-18T08:11:21+11:00 https://pharmadispatch.com/news/new-az-global-structure-not-expected-to-impact-locally 2013-01-17T07:46:46+11:00 https://pharmadispatch.com/news/progress-for-novartis-men-b-vaccine 2013-01-17T07:44:51+11:00 https://pharmadispatch.com/news/vaccination-turf-war-heats-up 2013-01-16T08:18:42+11:00 https://pharmadispatch.com/news/another-tga-safety-advisory-for-dodgy-products 2013-01-16T08:15:48+11:00 https://pharmadispatch.com/news/pfizer-considers-global-fast-track-for-new-breast-cancer-drug 2013-01-16T08:03:34+11:00 https://pharmadispatch.com/news/what-can-we-expect-in-2013 2013-01-14T09:57:37+11:00 https://pharmadispatch.com/news/time-to-look-beyond-the-next-two-years 2012-12-21T07:16:15+11:00 https://pharmadispatch.com/news/accc-rebuffs-industry-critics-in-code-authorisation 2012-12-20T14:19:17+11:00 https://pharmadispatch.com/news/doha-confirms-its-participation-in-tpp-discussions 2012-12-20T06:56:12+11:00 https://pharmadispatch.com/news/amgen-to-pay-us762-million-in-settlement-and-fines 2012-12-20T06:53:51+11:00 https://pharmadispatch.com/news/pfizer-to-reduce-us-sales-force 2012-12-20T06:41:23+11:00 https://pharmadispatch.com/news/review-was-all-about-price 2012-12-19T04:34:48+11:00 https://pharmadispatch.com/news/bi-deserves-better-than-what-it-got-yesterday 2012-12-19T04:32:32+11:00 https://pharmadispatch.com/news/ma-pradaxa-decision-a-bureaucratic-merry-go-round-and-debacle 2012-12-18T14:25:04+11:00 https://pharmadispatch.com/news/another-patient-delay-as-pradaxa-heads-back-to-the-pbac 2012-12-18T13:59:06+11:00 https://pharmadispatch.com/news/has-regulation-fallen-behind-the-online-revolution 2012-12-18T05:36:13+11:00 https://pharmadispatch.com/news/australians-using-google-for-health-information 2012-12-18T05:32:53+11:00 https://pharmadispatch.com/news/time-to-expose-double-standards 2012-12-17T08:08:01+11:00 https://pharmadispatch.com/news/gmia-remains-vigilant-of-new-budget-cuts 2012-12-17T07:43:38+11:00 https://pharmadispatch.com/news/nps-goes-into-data-collection 2012-12-17T07:39:03+11:00 https://pharmadispatch.com/news/new-service-takes-gp-consultation-online 2012-12-17T07:33:51+11:00 https://pharmadispatch.com/news/pradaxa-announcement-imminent 2012-12-14T07:31:45+11:00 https://pharmadispatch.com/news/annual-mapbac-meeting-constructive-and-useful 2012-12-14T07:30:17+11:00 https://pharmadispatch.com/news/new-ama-guidance-on-industry-relationships-but-nothing-on-transp 2012-12-14T07:29:04+11:00 https://pharmadispatch.com/news/is-the-solution-two-markets-administered-separately 2012-12-13T07:31:09+11:00 https://pharmadispatch.com/news/progress-on-trade-pact-as-us-works-on-pharmac 2012-12-13T07:23:41+11:00 https://pharmadispatch.com/news/ama-loses-its-secretary-general 2012-12-13T07:21:34+11:00 https://pharmadispatch.com/news/private-market-competing-with-and-beating-the-pbs 2012-12-12T08:16:48+11:00 https://pharmadispatch.com/news/diagnosis-early-detection-and-treatments-improving-cancer-outcom 2012-12-12T08:08:44+11:00 https://pharmadispatch.com/news/implications-of-a-growing-private-market 2012-12-11T07:45:57+11:00 https://pharmadispatch.com/news/pradaxa-achieved-better-patient-outcomes-after-a-major-bleeding- 2012-12-11T07:34:52+11:00 https://pharmadispatch.com/news/competition-for-anti-coagulation-market-heats-up-but-all-eyes-re 2012-12-10T08:08:34+11:00 https://pharmadispatch.com/news/trade-pact-an-opportunity-for-industry-to-expose-critics 2012-12-10T08:08:15+11:00 https://pharmadispatch.com/news/is-the-chf-conflicted-in-budget-discussions 2012-12-10T08:07:56+11:00 https://pharmadispatch.com/news/csl-invests-in-local-manufacturing 2012-12-10T08:07:32+11:00 https://pharmadispatch.com/news/73-medicines-and-vaccines-in-development-to-treat-hiv 2012-12-10T08:07:11+11:00 https://pharmadispatch.com/news/new-report-confirms-that-medicines-cut-health-costs 2012-12-10T08:06:47+11:00 https://pharmadispatch.com/news/analysts-disagree-on-novartis 2012-12-10T08:06:27+11:00 https://pharmadispatch.com/news/cost-of-developing-a-new-medicine-continues-to-rise 2012-12-09T10:55:02+11:00 https://pharmadispatch.com/news/pharmacy-joins-opposition-to-new-pbs-budget-cuts 2012-12-07T07:12:53+11:00 https://pharmadispatch.com/news/cost-of-developing-new-medicines-continues-to-rise 2012-12-07T07:11:43+11:00 https://pharmadispatch.com/news/az-reports-survival-analysis-from-faslodex-study 2012-12-07T07:09:45+11:00 https://pharmadispatch.com/news/ma-chair-restates-industry-opposition-to-new-savings 2012-12-06T08:02:18+11:00 https://pharmadispatch.com/news/ma-chair-outlines-a-vision-for-australian-industry 2012-12-06T08:00:23+11:00 https://pharmadispatch.com/news/chf-budget-submission-acknowledges-discussions-but-silent-on-the 2012-12-06T07:53:47+11:00 https://pharmadispatch.com/news/a-united-front-from-industry-but-what-is-the-chf-doing 2012-12-05T07:31:17+11:00 https://pharmadispatch.com/news/price-of-medicines-not-keeping-pace-with-inflation 2012-12-05T07:29:46+11:00 https://pharmadispatch.com/news/merck-speculates-on-new-alzheimers-treatment 2012-12-05T07:28:32+11:00 https://pharmadispatch.com/news/gmia-calls-on-govt-not-to-impose-new-pbs-cuts 2012-12-04T06:56:00+11:00 https://pharmadispatch.com/news/tga-updates-gilenya-pi 2012-12-04T06:54:26+11:00 https://pharmadispatch.com/news/ma-says-chemo-drug-issue-shows-why-now-is-not-the-time-for-more- 2012-12-03T07:53:06+11:00 https://pharmadispatch.com/news/more-industry-critics-join-transparency-group 2012-12-03T07:51:18+11:00 https://pharmadispatch.com/news/consumers-should-hope-for-the-inclusion-of-pharmaceuticals-in-tr 2012-12-03T07:39:35+11:00 https://pharmadispatch.com/news/dr-dominic-barnes-leading-the-industry-through-a-minefield-to-gr 2012-12-03T07:30:00+11:00 https://pharmadispatch.com/news/ranbaxy-halts-production-of-atorvastatin 2012-12-03T07:29:24+11:00 https://pharmadispatch.com/news/novartis-highlights-strength-of-oncology-pipeline 2012-12-03T07:26:14+11:00 https://pharmadispatch.com/news/progress-for-msd-insomnia-drug 2012-12-03T07:24:40+11:00 https://pharmadispatch.com/news/chemo-drug-pricing-reveals-much-wider-issue 2012-11-30T07:40:32+11:00 https://pharmadispatch.com/news/nz-defends-pharmac-in-trade-negotiations-kind-of 2012-11-30T06:40:47+11:00 https://pharmadispatch.com/news/gsk-tops-access-to-medicines-index-for-third-straight-time 2012-11-29T06:45:05+11:00 https://pharmadispatch.com/news/25-price-cut-for-atorvastatin-but-private-prescription-still-che 2012-11-29T06:42:02+11:00 https://pharmadispatch.com/news/listing-times-for-high-cost-medicines-has-improved-under-the-mou 2012-11-28T07:48:00+11:00 https://pharmadispatch.com/news/csl-upgrades-profit-forecast 2012-11-28T07:22:10+11:00 https://pharmadispatch.com/news/novartis-declares-a-crisis-in-uk-pharmaceutical-rd 2012-11-28T07:11:13+11:00 https://pharmadispatch.com/news/canadian-study-highlights-warfarin-safety-risk 2012-11-28T07:09:00+11:00 https://pharmadispatch.com/news/more-industry-jobs-lost-with-gsk-restructure 2012-11-27T11:43:40+11:00 https://pharmadispatch.com/news/campaign-in-support-of-hep-c-medicines-as-cabinet-queue-grows 2012-11-27T07:08:46+11:00 https://pharmadispatch.com/news/ranbaxy-australia-not-impacted-by-us-recall 2012-11-27T07:01:22+11:00 https://pharmadispatch.com/news/welcome-to-pharmadispatch 2012-11-25T16:26:19+11:00 https://pharmadispatch.com/news/more-job-losses-but-wheres-the-outcry 2012-11-25T06:45:35+11:00 https://pharmadispatch.com/news/govt-talks-tough-industry-maintains-opposition-to-new-measures 2012-11-25T06:42:01+11:00 https://pharmadispatch.com/news/companies-face-extended-time-to-list-post-cabinet-approval 2012-11-25T06:40:03+11:00 https://pharmadispatch.com/news/high-stakes-in-chemo-pricing-debate 2012-11-25T06:33:35+11:00 https://pharmadispatch.com/news/pharma-industry-doing-well-when-it-come-to-access-initiatives 2012-11-20T07:27:10+11:00 https://pharmadispatch.com/news/general-co-payment-volumes-yet-to-recover-from-increase-part-2 2012-11-19T17:12:34+11:00 https://pharmadispatch.com/news/industry-confronts-pbs-groundhog-day 2012-11-19T16:22:20+11:00 https://pharmadispatch.com/news/lyrica-delay-shows-that-the-mou-will-be-gamed 2012-11-19T16:07:32+11:00 https://pharmadispatch.com/news/cabinet-approves-pfizers-lyrica 2012-11-19T16:06:01+11:00 https://pharmadispatch.com/news/government-expected-budget-discussions-in-return-for-extending-d 2012-11-19T01:24:27+11:00 https://pharmadispatch.com/news/pharmacy-the-big-winner-in-health-survey 2012-11-17T16:49:40+11:00 https://pharmadispatch.com/news/industry-confronts-pbs-groundhog-day-2 2012-11-16T12:27:02+11:00 https://pharmadispatch.com/news/ma-calls-for-incentives-to-promote-investment-in-antibiotic-rese 2012-11-15T17:18:41+11:00 https://pharmadispatch.com/news/general-pbs-patients-hit-as-co-payment-heads-towards-40 2012-11-15T04:03:22+11:00 https://pharmadispatch.com/news/cancer-medicines-are-expensive-so-what 2012-11-14T12:26:21+11:00 https://pharmadispatch.com/news/pharma-not-recognised-as-innovative-despite-rd-spend 2012-11-13T16:40:54+11:00 https://pharmadispatch.com/news/pharma-not-considered-innovative-despite-massive-rd-spend 2012-11-13T05:12:01+11:00 https://pharmadispatch.com/news/industry-support-for-call-to-remove-critic-from-transparency-wor 2012-11-12T16:39:48+11:00 https://pharmadispatch.com/news/latest-study-shows-no-increased-risk-of-cv-events-with-champix 2012-11-12T16:39:02+11:00 https://pharmadispatch.com/news/industry-critic-goes-too-far 2012-11-12T12:25:40+11:00 https://pharmadispatch.com/news/uk-industry-takes-on-nhs-failure-to-invest-in-medicines 2012-11-11T16:38:08+11:00 https://pharmadispatch.com/news/australias-communists-are-the-latest-fringe-group-to-criticise-t 2012-11-11T16:37:10+11:00 https://pharmadispatch.com/news/industry-critics-mobilise-in-advance-of-accc-conference 2012-11-11T16:35:08+11:00 https://pharmadispatch.com/news/general-pbs-patients-hit-as-co-payment-heads-towards-40-2 2012-11-10T17:03:41+11:00 https://pharmadispatch.com/news/gsk-to-continue-vaccine-development-despite-setback 2012-11-10T16:34:24+11:00 https://pharmadispatch.com/news/merck-co-progresses-hep-c-therapies 2012-11-10T16:33:38+11:00 https://pharmadispatch.com/news/a-bonanza-for-government-that-could-be-coming-to-an-end-part-3 2012-11-10T16:30:40+11:00 https://pharmadispatch.com/news/generic-lipitor-delivers-ranbaxy-a-short-term-boost 2012-11-10T16:27:07+11:00 https://pharmadispatch.com/news/industry-enters-the-budget-danger-zone 2012-11-10T12:24:55+11:00 https://pharmadispatch.com/news/novartis-promotes-a-pipeline-full-of-potential-blockbusters 2012-11-08T16:26:14+11:00 https://pharmadispatch.com/news/cash-boost-for-biota-from-rd-tax-incentive 2012-11-07T16:25:31+11:00 https://pharmadispatch.com/news/ausbiotech-declares-conference-a-success 2012-11-07T16:24:42+11:00 https://pharmadispatch.com/news/staff-costs-drive-12-million-jump-in-tga-fees 2012-11-07T16:21:44+11:00 https://pharmadispatch.com/news/new-cholesterol-treatments-share-the-stage-at-aha 2012-11-06T16:20:50+11:00 https://pharmadispatch.com/news/710 2012-11-06T16:18:09+11:00 https://pharmadispatch.com/news/a-bonanza-for-government-that-could-be-coming-to-an-end 2012-11-04T15:55:11+11:00 https://pharmadispatch.com/news/department-of-innovation-slams-tga-review 2012-11-04T15:54:34+11:00 https://pharmadispatch.com/news/second-mou-may-not-suit-government 2012-11-04T12:24:10+11:00 https://pharmadispatch.com/news/ausbiotech-signals-closer-relationship-with-ma-with-board-electi 2012-11-03T15:53:43+11:00 https://pharmadispatch.com/news/its-not-all-about-funding-according-to-us-expert 2012-11-03T15:53:02+11:00 https://pharmadispatch.com/news/review-of-alzheimers-medicines-calls-for-tougher-continuation-ru 2012-11-03T15:51:44+11:00 https://pharmadispatch.com/news/pfizer-revenue-falls-on-lipitor-patent-loss 2012-11-01T16:54:25+11:00 https://pharmadispatch.com/news/pfizer-revenue-falls-on-lipitor-patent-loss-2 2012-11-01T15:50:56+11:00 https://pharmadispatch.com/news/busy-day-for-maybe-pharma 2012-11-01T15:50:01+11:00 https://pharmadispatch.com/news/e-health-initiatives-giving-consumers-the-power 2012-10-31T15:48:36+11:00 https://pharmadispatch.com/news/nps-medicinewise-responds-to-questions 2012-10-31T15:46:58+11:00 https://pharmadispatch.com/news/psa-signs-mou-with-japanese-counterpart 2012-10-31T15:46:14+11:00 https://pharmadispatch.com/news/consumer-group-calls-for-incentives 2012-10-30T15:44:53+11:00 https://pharmadispatch.com/news/strong-results-as-bayer-boosts-its-consumer-division 2012-10-30T15:44:05+11:00 https://pharmadispatch.com/news/pfizer-reschedules-results-announcement 2012-10-30T15:43:08+11:00 https://pharmadispatch.com/news/unworkable-sunshine-act-must-be-avoided 2012-10-30T12:23:20+11:00 https://pharmadispatch.com/news/budget-pressure-adds-up-to-clever-accounting-for-nps-medicinewis 2012-10-29T15:39:27+11:00 https://pharmadispatch.com/news/guild-mourns-former-leader 2012-10-28T15:38:53+11:00 https://pharmadispatch.com/news/merger-delivers-for-biota-staff 2012-10-28T15:37:47+11:00 https://pharmadispatch.com/news/boost-for-pharmaxis-as-uk-nice-approves-bronchitol 2012-10-28T15:36:55+11:00 https://pharmadispatch.com/news/impact-of-patent-losses-dominate-announcements 2012-10-27T15:36:06+11:00 https://pharmadispatch.com/news/nps-to-announce-record-pbs-savings 2012-10-27T15:35:21+11:00 https://pharmadispatch.com/news/disclosure-of-doctor-payments-coming-as-accc-targets-patient-pro 2012-10-27T15:34:25+11:00 https://pharmadispatch.com/news/ma-guessed-right-with-transparency-working-group 2012-10-27T12:22:31+11:00 https://pharmadispatch.com/news/as-one-china-boom-ends-another-begins 2012-10-26T15:33:35+11:00 https://pharmadispatch.com/news/pradaxa-review-a-stalling-tactic 2012-10-26T15:32:53+11:00 https://pharmadispatch.com/news/payments-to-individual-doctors-on-the-agenda-as-accc-issues-draf 2012-10-26T15:32:01+11:00 https://pharmadispatch.com/news/another-12-months-before-under-co-pay-data-made-public 2012-10-25T15:31:22+11:00 https://pharmadispatch.com/news/astrazeneca-and-sanofi-hit-global-patent-clff 2012-10-25T10:04:20+11:00 https://pharmadispatch.com/news/api-grows-retail-and-cuts-discounts-to-manage-pbs-reforms 2012-10-24T15:30:25+11:00 https://pharmadispatch.com/news/job-cuts-hit-industry-giant-as-patent-expiry-bites 2012-10-24T15:29:29+11:00 https://pharmadispatch.com/news/lilly-looks-to-its-pipeline-as-zyprexa-generics-hit-sales 2012-10-24T09:58:59+11:00 https://pharmadispatch.com/news/hello-world-2 2012-10-24T02:54:09+11:00 https://pharmadispatch.com/news/pat-clear-awards-for-pfizers-mendel-grobler 2012-10-23T15:28:45+11:00 https://pharmadispatch.com/news/minister-announces-listings-and-price-increases 2012-10-23T15:27:49+11:00 https://pharmadispatch.com/news/a-major-victory-for-bayers-eylea 2012-10-23T15:26:56+11:00 https://pharmadispatch.com/news/industry-gets-caught-as-bad-forecasts-and-under-spending-frame-p 2012-10-23T15:20:54+11:00 https://pharmadispatch.com/news/cabinet-to-get-tougher-as-the-queue-gets-longer 2012-10-23T15:18:37+11:00 https://pharmadispatch.com/news/generics-hit-as-bms-looks-to-the-future 2012-10-23T10:01:08+11:00 https://pharmadispatch.com/news/strong-results-for-gilead-as-it-progresses-hep-c-therapy 2012-10-23T09:57:45+11:00 https://pharmadispatch.com/news/amgen-posts-another-strong-result-on-the-back-of-us-sales 2012-10-23T09:56:35+11:00 https://pharmadispatch.com/news/biota-merger-gets-go-ahead 2012-10-23T09:55:40+11:00 https://pharmadispatch.com/news/melbourne-based-avexa-in-partnership-discussions-for-its-lead-co 2012-10-22T09:55:21+11:00 https://pharmadispatch.com/news/sirtex-aiming-to-become-global-leader 2012-10-22T09:54:12+11:00 https://pharmadispatch.com/news/govt-takes-500-million-from-research 2012-10-21T15:16:50+11:00 https://pharmadispatch.com/news/govt-cuts-forecast-health-spending-by-1-66-billion 2012-10-21T14:43:21+11:00 https://pharmadispatch.com/news/az-disappointed-as-govt-banks-almost-1-billion-from-high-potency 2012-10-21T14:41:49+11:00 https://pharmadispatch.com/news/govt-mid-year-review-should-give-clearer-picture-on-pbs-spend 2012-10-21T14:40:16+11:00 https://pharmadispatch.com/news/focus-on-patient-need-the-best-way-forward-for-start-ups 2012-10-21T14:39:32+11:00 https://pharmadispatch.com/news/nhmrc-grants-announced-but-other-programs-remain-in-doubt 2012-10-21T14:38:30+11:00 https://pharmadispatch.com/news/liveris-calls-on-govt-to-encourage-biotech-and-advanced-manufact 2012-10-21T14:37:42+11:00 https://pharmadispatch.com/news/increased-risk-of-cv-events-with-diclofenac 2012-10-21T14:36:55+11:00 https://pharmadispatch.com/news/short-term-risks-for-industry-as-pressure-builds-on-health 2012-10-21T12:21:30+11:00 https://pharmadispatch.com/news/political-support-essential-to-ensure-the-future-of-australian-p 2012-10-21T12:20:24+11:00 https://pharmadispatch.com/news/another-china-patent-win-for-benitecs-hepatitis-drug 2012-10-21T09:53:11+11:00 https://pharmadispatch.com/news/positive-signs-for-viralytcs-melanoma-drug 2012-10-21T09:52:25+11:00 https://pharmadispatch.com/news/govt-should-focus-on-commercialisation-initiatives 2012-10-18T14:36:09+11:00 https://pharmadispatch.com/news/a-second-chance-for-anna 2012-10-18T14:35:27+11:00 https://pharmadispatch.com/news/melanoma-patients-still-waiting-on-pbac-and-hoping 2012-10-17T14:34:35+11:00 https://pharmadispatch.com/news/setback-for-biota-merger 2012-10-17T14:33:51+11:00 https://pharmadispatch.com/news/novartis-gilenya-achieved-fastest-ever-cabinet-approval 2012-10-17T14:33:06+11:00 https://pharmadispatch.com/news/pradaxa-decision-closer 2012-10-17T14:32:29+11:00 https://pharmadispatch.com/news/govt-only-on-track-to-achieve-mou-savings 2012-10-17T14:31:47+11:00 https://pharmadispatch.com/news/health-officials-confirm-savings-required-to-offset-new-listings 2012-10-17T14:30:59+11:00 https://pharmadispatch.com/news/nps-will-need-to-compete-for-its-200-million 2012-10-17T14:30:15+11:00 https://pharmadispatch.com/news/partnerships-the-way-to-go-post-gfc-according-to-industry-leader 2012-10-17T14:29:19+11:00 https://pharmadispatch.com/news/five-australian-biotechs-in-the-spotlight-at-investor-conference 2012-10-16T14:28:33+11:00 https://pharmadispatch.com/news/research-grants-facing-the-axe-in-mid-year-review 2012-10-16T14:27:42+11:00 https://pharmadispatch.com/news/patents-critical-for-investors-in-biotechnology 2012-10-16T14:27:00+11:00 https://pharmadispatch.com/news/health-officials-face-senate-scrutiny-wednesday 2012-10-16T14:26:17+11:00 https://pharmadispatch.com/news/chemist-warehouse-breached-advertising-rule-with-free-lipitor 2012-10-15T14:10:44+11:00 https://pharmadispatch.com/news/govt-the-big-winner-as-drug-falls-below-co-pay 2012-10-15T14:05:31+11:00 https://pharmadispatch.com/news/ausbiotech-cautions-govt-on-patent-reviews 2012-10-15T14:04:50+11:00 https://pharmadispatch.com/news/new-class-action-against-jj 2012-10-15T14:04:11+11:00 https://pharmadispatch.com/news/pharmaceutical-patent-term-at-risk-as-government-reviews-5-year- 2012-10-14T14:03:16+11:00 https://pharmadispatch.com/news/minister-to-find-savings-in-health-as-ma-agrees-to-meet 2012-10-14T14:02:22+11:00 https://pharmadispatch.com/news/merck-and-amgen-to-square-off-in-battle-for-osteoporosis-market 2012-10-14T14:01:11+11:00 https://pharmadispatch.com/news/govt-sending-the-wrong-signal-on-pharmaceutical-patents 2012-10-14T12:19:14+11:00 https://pharmadispatch.com/news/no-real-choice-for-ma-as-savings-push-gathers-steam 2012-10-14T12:18:23+11:00 https://pharmadispatch.com/news/prime-biomeds-ovarian-cancer-treatment-finds-success-in-trials 2012-10-14T10:19:20+11:00 https://pharmadispatch.com/news/nusep-to-spinout-fast-growing-prime-biologics-business 2012-10-14T09:51:39+11:00 https://pharmadispatch.com/news/biogens-bg-12-emerging-as-leading-challenger-for-oral-ms-market 2012-10-13T14:00:08+11:00 https://pharmadispatch.com/news/byetta-boosts-local-diabetes-alliance 2012-10-11T13:59:20+11:00 https://pharmadispatch.com/news/18-months-and-all-we-have-is-a-website-seriosuly 2012-10-11T12:17:29+11:00 https://pharmadispatch.com/news/tga-announce-recall-of-another-vaccine-batch 2012-10-10T13:58:35+11:00 https://pharmadispatch.com/news/tga-confirm-decision-to-put-new-ibuprofen-combo-on-supermarket-s 2012-10-10T13:57:40+11:00 https://pharmadispatch.com/news/az-takes-global-rights-for-ardelyx-renal-drug 2012-10-10T13:56:56+11:00 https://pharmadispatch.com/news/pharmaceuticals-as-a-share-of-the-federal-health-budget-the-lowe 2012-10-10T12:15:48+11:00 https://pharmadispatch.com/news/no-comment-from-pharmaxis-on-takeover-speculation 2012-10-10T10:20:42+11:00 https://pharmadispatch.com/news/qrxpharma-licenses-leading-product-to-canadian-partner 2012-10-10T09:50:28+11:00 https://pharmadispatch.com/news/pharmaxis-moves-ahead-as-bronchitol-makes-progress-in-europe 2012-10-10T09:48:45+11:00 https://pharmadispatch.com/news/new-pic-chair-highlights-industry-challenges 2012-10-09T13:55:57+11:00 https://pharmadispatch.com/news/pharmaceuticals-share-of-health-health-budget-hits-lowest-level- 2012-10-09T13:54:27+11:00 https://pharmadispatch.com/news/lilly-set-on-becoming-a-global-diabetes-powerhouse 2012-10-09T09:47:46+11:00 https://pharmadispatch.com/news/lilly-shares-jump-on-alzheimers-hope 2012-10-08T13:53:42+11:00 https://pharmadispatch.com/news/merck-backs-australian-vaccine-technology 2012-10-08T13:52:59+11:00 https://pharmadispatch.com/news/industry-conferences-an-opportunity-for-pharma-and-biotech 2012-10-08T13:52:12+11:00 https://pharmadispatch.com/news/patients-win-as-cheap-generic-lipitor-floods-the-market 2012-10-08T13:48:52+11:00 https://pharmadispatch.com/news/novartis-well-placed-to-manage-impact-of-patent-losses 2012-10-07T13:47:42+11:00 https://pharmadispatch.com/news/tga-seizes-counterfeit-medicines 2012-10-07T13:47:00+11:00 https://pharmadispatch.com/news/new-pbs-savings-on-their-way-if-history-the-guide 2012-10-06T13:45:51+10:00 https://pharmadispatch.com/news/health-department-recalls-anatomy-poster-over-errors 2012-10-06T13:40:02+10:00 https://pharmadispatch.com/news/32-pbs-savings-measures-announced-since-2002-03-7-of-the-last-11 2012-10-06T12:38:13+10:00 https://pharmadispatch.com/news/a-second-mou-is-the-industrys-best-chance-to-influence-reform 2012-10-06T12:16:25+10:00 https://pharmadispatch.com/news/tga-announce-recall-of-batches-of-typhoid-vaccines 2012-10-04T13:38:33+10:00 https://pharmadispatch.com/news/pbac-announce-drug-utilisation-and-listing-review-for-type-2-dia 2012-10-04T13:37:29+10:00 https://pharmadispatch.com/news/mayne-pharma-targets-us-generics-market-with-acquisition-of-metr 2012-10-04T09:47:02+10:00 https://pharmadispatch.com/news/industry-welcomes-mckeon-review-of-health-and-medical-research 2012-10-03T13:36:31+10:00 https://pharmadispatch.com/news/experimental-merck-co-diabetes-drug-proves-effective-in-latest-t 2012-10-03T13:35:34+10:00 https://pharmadispatch.com/news/gardasil-given-the-green-light-from-us-safety-study 2012-10-03T13:34:53+10:00 https://pharmadispatch.com/news/medical-students-join-call-for-end-to-political-stalemate-on-int 2012-10-03T13:33:57+10:00 https://pharmadispatch.com/news/amgen-on-the-rise-as-share-price-hits-all-time-high 2012-10-03T09:40:39+10:00 https://pharmadispatch.com/news/az-pulled-tga-submission-for-latest-nexium-combo 2012-10-02T13:33:04+10:00 https://pharmadispatch.com/news/health-funds-continue-to-shun-prescription-medicines 2012-10-02T13:27:39+10:00 https://pharmadispatch.com/news/its-now-a-grand-conspiracy-according-to-industry-critics 2012-10-02T12:15:24+10:00 https://pharmadispatch.com/news/change-underway-at-az-as-new-ceo-suspends-share-buyback-what-wil 2012-10-02T09:37:45+10:00 https://pharmadispatch.com/news/industry-leaders-call-for-stronger-ip-protection-in-trade-agreem 2012-10-01T13:26:17+10:00 https://pharmadispatch.com/news/ausbiotech-urges-caution-on-compulsory-licences 2012-10-01T13:25:24+10:00 https://pharmadispatch.com/news/terry-white-pushes-retail-to-offset-pbs-cuts 2012-10-01T09:36:46+10:00 https://pharmadispatch.com/news/new-savings-measures-for-pbs-on-the-cards-as-government-extends- 2012-09-30T13:21:05+10:00 https://pharmadispatch.com/news/3-billion-lost-from-pbs-forecasts-in-just-14-months 2012-09-30T13:20:54+10:00 https://pharmadispatch.com/news/the-forecast-for-pbs-spending-has-fallen-dramatically-saving-the 2012-09-30T12:53:11+10:00 https://pharmadispatch.com/news/hard-to-justify-a-new-round-of-pbs-savings 2012-09-30T12:14:34+10:00 https://pharmadispatch.com/news/pbs-hot-issues-revealed-in-ministerial-briefings 2012-09-27T13:18:56+10:00 https://pharmadispatch.com/news/trade-agreement-can-improve-nzs-pharmac 2012-09-27T13:18:11+10:00 https://pharmadispatch.com/news/dementia-on-the-rise-as-population-continues-to-age 2012-09-27T13:17:26+10:00 https://pharmadispatch.com/news/it-executives-back-e-health-despite-slow-consumer-uptake 2012-09-27T13:16:38+10:00 https://pharmadispatch.com/news/states-yet-to-accept-federal-governments-funding-100-extra-train 2012-09-27T13:15:26+10:00 https://pharmadispatch.com/news/big-bad-pharma-to-blame-again 2012-09-27T12:13:37+10:00 https://pharmadispatch.com/news/governments-fight-over-who-needs-to-fund-extra-training-places 2012-09-26T13:14:40+10:00 https://pharmadispatch.com/news/better-outlook-for-global-and-local-pharma 2012-09-26T13:14:01+10:00 https://pharmadispatch.com/news/pharmaxis-breaking-new-ground-for-australian-pharma 2012-09-26T09:36:03+10:00 https://pharmadispatch.com/news/government-report-confirms-pbs-slowdown-but-concessional-patient 2012-09-25T13:12:46+10:00 https://pharmadispatch.com/news/another-tough-year-ahead-for-wholesalers 2012-09-25T13:12:02+10:00 https://pharmadispatch.com/news/companies-face-higher-fees-for-pbs-listing 2012-09-25T13:11:20+10:00 https://pharmadispatch.com/news/transparency-call-as-industry-targets-pharmac 2012-09-25T13:10:22+10:00 https://pharmadispatch.com/news/anger-grows-over-health-fund-plans-for-dr-review-website 2012-09-25T13:09:35+10:00 https://pharmadispatch.com/news/ama-calls-for-action-from-health-ministers 2012-09-25T13:08:47+10:00 https://pharmadispatch.com/news/pre-payment-to-avoid-the-means-test-leads-to-blowout-in-cost-of- 2012-09-23T13:08:34+10:00 https://pharmadispatch.com/news/pbs-spending-slows-as-the-patent-cliff-and-price-disclosure-hit 2012-09-17T13:06:28+10:00 https://pharmadispatch.com/news/is-the-pharmaceutical-industry-tired-of-being-lectured-by-its-cr 2012-09-17T12:12:32+10:00 https://pharmadispatch.com/news/boost-for-biota-with-revised-merger-proposal-set-to-get-go-ahead 2012-09-17T09:35:16+10:00 https://pharmadispatch.com/jobs/pharmacy-seeks-accountant 2014-09-24T07:52:01+10:00 https://pharmadispatch.com/jobs/pfizer-seeking-project-management-executive 2014-09-24T07:04:01+10:00 https://pharmadispatch.com/events/victorian-government-slashes-funding-to-cancer-treatment-allianc 2024-05-10T03:00:01+10:00 https://pharmadispatch.com/events/beigene-president-on-why-the-company-chooses-disruption 2023-03-17T03:00:01+11:00